PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wu, P; Wee, P; Jiang, J; Chen, XM; Wang, ZX				Wu, Peng; Wee, Ping; Jiang, Jennifer; Chen, Xinmei; Wang, Zhixiang			Differential Regulation of Transcription Factors by Location-Specific EGF Receptor Signaling via a Spatio-Temporal Interplay of ERK Activation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; BETA(2)-ADRENERGIC RECEPTOR; INTRACELLULAR TRAFFICKING; TYROSINE PHOSPHORYLATION; MEDIATED ENDOCYTOSIS; CELL-CYCLE; ENDOSOMES; INTERNALIZATION; STIMULATION	It is well established that EGFR signals from both the plasma membrane (PM) and endosome (EN). However, very little is known about whether and how the EGFR signals at the PM and EN to differentially regulate various signaling pathways and the physiological outcomes. In this communication, we established a system that allowed the specific activations of EGFR at different cell locations: PM and EN. PM activation of EGFR is achieved by activation of endocytosis-deficient mutant EGFR1010LL/AA stably expressed in CHO cells (CHO-LL/AA cell). EN activation of EGFR is achieved by activating the wild type EGFR stably expressed in CHO cells (CHO-EGFR cell) after its internalization into EN with a previously reported protocol. We showed that both EGFR activations at PM and EN activated ERK to a similar level, but differentially stimulated transcriptional factors c-jun and c-fos. We further showed that EGFR activations at PM and EN resulted in differential spatio-temporal dynamics of phosphorylated ERK which caused the differential activation of two downstream substrates ELK1 and RSK. Finally we showed that EGFR signaling from PM and EN led to different physiological outcomes. CHO-LL/AA cells that only generate PM EGFR signals have a larger cell size and slower proliferation rate than CHO-EGFR cells. We conclude that location-specific EGFR activation differentially regulates cell functions through a spatio-temporal interplay of ERK activation.	[Wu, Peng] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada; Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta	Wu, P (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.	zhixiang.wang@ualberta.ca			Canadian Institutes of Health Research - CIHR [RES0006924, CIHR ICI 111387]	Canadian Institutes of Health Research - CIHR(Canadian Institutes of Health Research (CIHR))	This work is funded by an operating grant (Project: RES0006924, Title: CIHR ICI 111387 Wang) from the Canadian Institutes of Health Research - CIHR (Weblink: http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Ahsan A, 2009, CANCER RES, V69, P5108, DOI 10.1158/0008-5472.CAN-09-0466; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clague MJ, 2001, J CELL SCI, V114, P3075; COHEN S, 1985, J BIOL CHEM, V260, P2351; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Haugh JM, 1999, J BIOL CHEM, V274, P34350, DOI 10.1074/jbc.274.48.34350; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Johannessen LE, 2000, EXP CELL RES, V260, P136, DOI 10.1006/excr.2000.5004; KAY DG, 1986, J BIOL CHEM, V261, P8473; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu L, 2011, TRAFFIC, V12, P201, DOI 10.1111/j.1600-0854.2010.01141.x; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McCaffrey G, 2009, TRAFFIC, V10, P938, DOI 10.1111/j.1600-0854.2009.00909.x; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Okamoto I, 2010, FEBS J, V277, P309, DOI 10.1111/j.1742-4658.2009.07449.x; Pawson T, 1997, NATURE, V385, P582, DOI 10.1038/385582b0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STOKOE D, 1994, SCIENCE, V266, P1792, DOI 10.1126/science.266.5192.1792-a; Tengholm A, 2009, VITAM HORM, V80, P287, DOI 10.1016/S0083-6729(08)00611-0; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wang Y., 2002, SCI STKE, V161, pl17; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Winckler B, 2011, TRAFFIC, V12, P1099, DOI 10.1111/j.1600-0854.2011.01213.x; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	70	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41354	10.1371/journal.pone.0041354	http://dx.doi.org/10.1371/journal.pone.0041354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984397	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500003
J	Song, MJ; Brady-Kalnay, SM; McBride, SH; Phillips-Mason, P; Dean, D; Tate, MLK				Song, Min Jae; Brady-Kalnay, Susann M.; McBride, Sara H.; Phillips-Mason, Polly; Dean, David; Tate, Melissa L. Knothe			Mapping the Mechanome of Live Stem Cells Using a Novel Method to Measure Local Strain Fields In Situ at the Fluid-Cell Interface	PLOS ONE			English	Article							MARROW STROMAL CELLS; LAMINAR SHEAR-STRESS; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; HYDROSTATIC-PRESSURE; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CHONDROGENIC PHENOTYPE; MECHANICAL MODULATION; LINEAGE COMMITMENT	During mesenchymal condensation, the initial step of skeletogenesis, transduction of minute mechanical forces to the nucleus is associated with up or down-regulation of genes, ultimately resulting in formation of the skeletal template and appropriate cell lineage commitment. The summation of these biophysical cues affects the cell's shape and fate. Here, we predict and measure surface strain, in live stem cells, in response to controlled delivery of stresses, providing a platform to direct short-term structure - function relationships and long-term fate decisions. We measure local strains on stem cell surfaces using fluorescent microbeads coated with Concanavalin A. During delivery of controlled mechanical stresses, 4-Dimensional (x,y,z,t) displacements of the bound beads are measured as surface strains using confocal microscopy and image reconstruction. Similarly, micro-particle image velocimetry (mu-piv) is used to track flow fields with fluorescent microspheres. The measured flow velocity gradient is used to calculate stress imparted by fluid drag at the surface of the cell. We compare strain measured on cell surfaces with those predicted computationally using parametric estimates of the cell's elastic and shear modulus. Finally, cross-correlating stress - strain data to measures of gene transcription marking lineage commitment enables us to create stress - strain - fate maps, for live stem cells in situ. The studies show significant correlations between live stem cell stress - strain relationships and lineage commitment. The method presented here provides a novel means to probe the live stem cell's mechanome, enabling mechanistic studies of the role of mechanics in lineage commitment as it unfolds.	[Song, Min Jae; McBride, Sara H.; Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Brady-Kalnay, Susann M.; Phillips-Mason, Polly] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Dean, David] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Song, MJ (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	knothetate@case.edu	Knothe Tate, Melissa L./O-2086-2015; Dean, David/F-9605-2017	Knothe Tate, Melissa L./0000-0002-3552-2525; Dean, David/0000-0002-1217-3764	National Institutes of Health grant (NIDCR) [R01-DE013740]; National Science Foundation grant [CMMI-0826435]; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013740] Funding Source: NIH RePORTER	National Institutes of Health grant (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Foundation grant(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by a National Institutes of Health grant (NIDCR, R01-DE013740), a National Science Foundation grant (CMMI-0826435, Nano Bio Mechanics Program), and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI [10.1089/ten.tea.2010.0014, 10.1089/ten.TEA.2010.0014]; Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Anderson EJ, 2005, ANN BIOMED ENG, V33, P52, DOI 10.1007/s10439-005-8962-y; Anderson EJ, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-46; Anderson EJ, 2007, TISSUE ENG, V13, P2525, DOI 10.1089/ten.2006.0443; Anderson EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-27; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Arnsdorf EJ, 2010, J BIOMECH, V43, P2881, DOI 10.1016/j.jbiomech.2010.07.033; Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Billotte W G, 2001, Biomed Sci Instrum, V37, P1; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Campbell JJ, 2006, BIORHEOLOGY, V43, P455; Chowdhury F, 2008, BIOPHYS J, V95, P5719, DOI 10.1529/biophysj.108.139832; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elder SH, 2005, BIOMECH MODEL MECHAN, V3, P141, DOI 10.1007/s10237-004-0058-3; Ensley AE, 2012, TISSUE ENG PT A, V18, P127, DOI [10.1089/ten.tea.2010.0290, 10.1089/ten.TEA.2010.0290]; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gardiner M. B., 2005, HHMI B, V18, P32; Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kasirer-Friede A, 2010, BLOOD, V115, P2274, DOI 10.1182/blood-2009-08-238238; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Kraemer BF, 2011, PLATELETS, V22, P415, DOI 10.3109/09537104.2011.556277; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kuhn LT, 2010, TISSUE ENG PART C-ME, V16, P1357, DOI [10.1089/ten.tec.2009.0701, 10.1089/ten.TEC.2009.0701]; Malek AM, 1996, J CELL SCI, V109, P713; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; McBride SH, 2011, ANN BIOMED ENG, V39, P1570, DOI 10.1007/s10439-010-0242-9; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; Nikmanesh M, 2012, BIOTECHNOL BIOENG, V109, P583, DOI 10.1002/bit.23302; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Rouleau L, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001891; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Smith RL, 2000, BIORHEOLOGY, V37, P95; Song MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012796; Stolberg S, 2009, BIOTECHNOL PROGR, V25, P10, DOI 10.1002/btpr.124; Takahashi I, 1998, J CELL SCI, V111, P2067; Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Tate MLK, 2010, J ORTHOP RES, V28, P1657, DOI 10.1002/jor.21190; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Vinardell T, 2012, EUR CELLS MATER, V23, P121, DOI 10.22203/eCM.v023a09; Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5; Wang H, 2006, BIOCHEM BIOPH RES CO, V346, P860, DOI 10.1016/j.bbrc.2006.05.196; Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008; Ye C, 2008, CLIN BIOMECH, V23, pS118, DOI 10.1016/j.clinbiomech.2007.08.018; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Zeng Y, 2011, CELL MOL BIOL, V57, P1550, DOI 10.1170/179; Zhang P, 2011, STEM CELLS DEV, V20, P977, DOI 10.1089/scd.2010.0152; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zimmermann Joshua A., 2011, Molecular & Cellular Biomechanics, V8, P297; Zimmermann Joshua A., 2011, Molecular & Cellular Biomechanics, V8, P275	62	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43601	10.1371/journal.pone.0043601	http://dx.doi.org/10.1371/journal.pone.0043601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970134	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400006
J	Gadziola, MA; Grimsley, JMS; Faure, PA; Wenstrup, JJ				Gadziola, Marie A.; Grimsley, Jasmine M. S.; Faure, Paul A.; Wenstrup, Jeffrey J.			Social Vocalizations of Big Brown Bats Vary with Behavioral Context	PLOS ONE			English	Article							EPTESICUS-FUSCUS; ALARM CALLS; ACOUSTIC FEATURES; MYOTIS-LUCIFUGUS; ECHOLOCATION; RESPONSES; SOUNDS; SPECIFICITY; EXPRESSION; IDENTITY	Bats are among the most gregarious and vocal mammals, with some species demonstrating a diverse repertoire of syllables under a variety of behavioral contexts. Despite extensive characterization of big brown bat (Eptesicus fuscus) biosonar signals, there have been no detailed studies of adult social vocalizations. We recorded and analyzed social vocalizations and associated behaviors of captive big brown bats under four behavioral contexts: low aggression, medium aggression, high aggression, and appeasement. Even limited to these contexts, big brown bats possess a rich repertoire of social vocalizations, with 18 distinct syllable types automatically classified using a spectrogram cross-correlation procedure. For each behavioral context, we describe vocalizations in terms of syllable acoustics, temporal emission patterns, and typical syllable sequences. Emotion-related acoustic cues are evident within the call structure by context-specific syllable types or variations in the temporal emission pattern. We designed a paradigm that could evoke aggressive vocalizations while monitoring heart rate as an objective measure of internal physiological state. Changes in the magnitude and duration of elevated heart rate scaled to the level of evoked aggression, confirming the behavioral state classifications assessed by vocalizations and behavioral displays. These results reveal a complex acoustic communication system among big brown bats in which acoustic cues and call structure signal the emotional state of a caller.	[Gadziola, Marie A.; Grimsley, Jasmine M. S.; Wenstrup, Jeffrey J.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Gadziola, Marie A.; Wenstrup, Jeffrey J.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Faure, Paul A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; McMaster University	Gadziola, MA (corresponding author), NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA.	jjw@neomed.edu		Grimsley, Jasmine/0000-0002-7993-9699; WENSTRUP, JEFFREY/0000-0002-3566-2480	National Institute on Deafness and Other Communication Disorders [R01 DC00937-20]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000937] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders grant R01 DC00937-20 and supplements 18S1 and 19S1 to J.J.W., and by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to P. A. F. The McMaster Bat Lab was supported by infrastructure grants from the Canada Foundation for Innovation and the Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVOLA A, 1974, Annales Zoologici Fennici, V11, P1; BARCLAY RMR, 1979, J MAMMAL, V60, P632, DOI 10.2307/1380109; BARCLAY RMR, 1979, BEHAV ECOL SOCIOBIOL, V6, P137, DOI 10.1007/BF00292560; Bastian A, 2008, J ACOUST SOC AM, V124, P598, DOI 10.1121/1.2924123; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bohn KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006746; Boughman JW, 1997, BEHAV ECOL SOCIOBIOL, V40, P61, DOI 10.1007/s002650050316; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; CLARK CW, 1987, ETHOLOGY, V76, P101; Clement Matthew J., 2006, P57; Davidson SM, 2004, ANIM BEHAV, V67, P883, DOI 10.1016/j.anbehav.2003.06.016; DAVIS WH, 1968, J MAMMAL, V49, P44, DOI 10.2307/1377726; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Faure PA, 2003, J NEUROSCI, V23, P3052; Fenton B, 1985, COMMUNICATION CHIROP; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Gadziola MA, 2012, J NEUROPHYSIOL, V107, P1047, DOI 10.1152/jn.00422.2011; GOULD E, 1975, DEV PSYCHOBIOL, V8, P333, DOI 10.1002/dev.420080407; GOULD E, 1975, J MAMMAL, V56, P15, DOI 10.2307/1379603; GOULD E, 1971, Communications in Behavioral Biology Part A Original Articles, V5, P263; Gould E., 1983, Special Publication American Society of Mammalogists, P265; GOULD E, 1973, J MAMMAL, V54, P998, DOI 10.2307/1379103; Hendrickx AG, 1995, NONHUMAN PRIMATES BI, P335; Janssen S, 2009, J COMP PHYSIOL A, V195, P663, DOI 10.1007/s00359-009-0441-8; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Kazial KA, 2004, ANIM BEHAV, V67, P855, DOI 10.1016/j.anbehav.2003.04.016; Knornschild M, 2006, NATURWISSENSCHAFTEN, V93, P451, DOI 10.1007/s00114-006-0127-9; Knornschild M, 2010, BIOL LETTERS, V6, P156, DOI 10.1098/rsbl.2009.0685; Kurta A., 1990, MAMM SPECIES, V356, P1, DOI DOI 10.2307/3504258; LEGER DW, 1978, BEHAV ECOL SOCIOBIOL, V3, P177, DOI 10.1007/BF00294989; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; MASTERS WM, 1991, J ACOUST SOC AM, V89, P1402, DOI 10.1121/1.400660; Mateo JM, 2010, BIOL LETTERS, V6, P623, DOI 10.1098/rsbl.2010.0118; Mellinger D. K., 2004, Canadian Acoustics, V32, P55; Mellinger DK, 2011, J ACOUST SOC AM, V129, P4055, DOI 10.1121/1.3531926; Mellinger DK, 2000, J ACOUST SOC AM, V107, P3518, DOI 10.1121/1.429434; Monroy JA, 2011, J COMP PHYSIOL A, V197, P459, DOI 10.1007/s00359-010-0614-5; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MOSS CF, 1988, ANIMAL SONAR PROCESS, P115; Neuweiler G., 2000, BIOL BATS; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Pongracz P, 2006, APPL ANIMAL BEHAV SC, P1; Pozzi L, 2010, AM J PRIMATOL, V72, P337, DOI 10.1002/ajp.20786; Ren Y, 2009, ALGORITHMS, V2, P1410, DOI 10.3390/a2041410; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Russ JM, 2005, ANIM BEHAV, V70, P397, DOI 10.1016/j.anbehav.2004.11.006; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schneider JN, 2011, J ACOUST SOC AM, V130, P2275, DOI 10.1121/1.3628331; Simmons JA, 1998, P NATL ACAD SCI USA, V95, P12647, DOI 10.1073/pnas.95.21.12647; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; WAIPING V, 1988, J MAMMAL, V69, P641, DOI 10.2307/1381364; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	67	58	61	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44550	10.1371/journal.pone.0044550	http://dx.doi.org/10.1371/journal.pone.0044550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970247	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000028
J	Hughes, AR; Rooker, K; Murdock, M; Kimbro, DL				Hughes, A. Randall; Rooker, Kelly; Murdock, Meagan; Kimbro, David L.			Predator Cue and Prey Density Interactively Influence Indirect Effects on Basal Resources in Intertidal Oyster Reefs	PLOS ONE			English	Article							TEMPORAL VARIATION; TROPHIC CASCADES; RISK ALLOCATION; HABITAT; COMPLEXITY; RESPONSES; COMMUNITY; BEHAVIOR; AVOIDANCE; STRENGTH	Predators can influence prey abundance and traits by direct consumption, as well as by non-consumptive effects of visual, olfactory, or tactile cues. The strength of these non-consumptive effects (NCEs) can be influenced by a variety of factors, including predator foraging mode, temporal variation in predator cues, and the density of competing prey. Testing the relative importance of these factors for determining NCEs is critical to our understanding of predator-prey interactions in a variety of settings. We addressed this knowledge gap by conducting two mesocosm experiments in a tri-trophic intertidal oyster reef food web. More specifically, we tested how a predatory fish (hardhead catfish, Ariopsis felis) directly influenced their prey (mud crabs, Panopeus spp.) and indirectly affected basal resources (juvenile oysters, Crassostrea virginica), as well as whether these direct and indirect effects changed across a density gradient of competing prey. Per capita crab foraging rates were inversely influenced by crab density, but they were not affected by water-borne predator cues. As a result, direct consumptive effects on prey foraging rates were stronger than non-consumptive effects. In contrast, predator cue and crab density interactively influenced indirect predator effects on oyster mortality in two experiments, with trait-mediated and density-mediated effects of similar magnitude operating to enhance oyster abundance. Consistent differences between a variable predator cue environment and other predator cue treatments (no cue and constant cue) suggests that an understanding of the natural risk environment experienced by prey is critical to testing and interpreting trait-mediated indirect interactions. Further, the prey response to the risk environment may be highly dependent on prey density, particularly in prey populations with strong intra-specific interactions.	[Hughes, A. Randall; Rooker, Kelly; Murdock, Meagan; Kimbro, David L.] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA; [Rooker, Kelly] Bridgewater Coll, Dept Biol, Bridgewater, VA USA	State University System of Florida; Florida State University	Hughes, AR (corresponding author), Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA.	rhughes@bio.fsu.edu			National Science Foundation (NSF) [OCE-0961633]; companion Research Experience for Undergraduates (REU) supplement; Division Of Ocean Sciences [1338372] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); companion Research Experience for Undergraduates (REU) supplement; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	his work was supported by National Science Foundation (NSF) grant OCE-0961633 and a companion Research Experience for Undergraduates (REU) supplement to D.L.K. and A.R.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; BAHR LM, 1976, ECOLOGY, V57, P121, DOI 10.2307/1936403; Bednekoff PA, 2004, P ROY SOC B-BIOL SCI, V271, P1491, DOI 10.1098/rspb.2004.2739; Belovsky GE, 2011, ECOL LETT, V14, P335, DOI 10.1111/j.1461-0248.2011.01591.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 1998, MODEL SELECTION INFE; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Ferrari MCO, 2010, BEHAV ECOL, V21, P532, DOI 10.1093/beheco/arq023; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Freeman AS, 2006, SCIENCE, V313, P831, DOI 10.1126/science.1125485; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Grason EW, 2012, OECOLOGIA, V169, P105, DOI 10.1007/s00442-011-2188-5; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Kimbro DL, 2012, ECOLOGY, V93, P334, DOI 10.1890/11-0596.1; Large SI, 2011, MAR ECOL PROG SER, V422, P41, DOI 10.3354/meps08930; Laurila A, 2004, OIKOS, V107, P90, DOI 10.1111/j.0030-1299.2004.13126.x; Lehnert RL, 2002, ESTUARIES, V25, P1015, DOI 10.1007/BF02691348; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Luckenbach MW, 2005, J COASTAL RES, P64; Okuyama T, 2007, ECOL LETT, V10, P264, DOI 10.1111/j.1461-0248.2007.01019.x; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Reynolds PL, 2011, J ECOL, V99, P1272, DOI 10.1111/j.1365-2745.2011.01837.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Sanford E, 2003, SCIENCE, V300, P1135, DOI 10.1126/science.1083437; Sanford E, 2009, ECOLOGY, V90, P3108, DOI 10.1890/08-2055.1; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2004, ECOL LETT, V7, P403, DOI 10.1111/j.1461-0248.2004.00592.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Tinker MT, 2009, EVOL ECOL RES, V11, P841; Trussell GC, 2008, ECOLOGY, V89, P2798, DOI 10.1890/08-0250.1; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Trussell GC, 2011, ECOLOGY, V92, P1799, DOI 10.1890/10-2222.1; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	46	13	13	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44839	10.1371/journal.pone.0044839	http://dx.doi.org/10.1371/journal.pone.0044839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970316	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000052
J	Tare, P; China, A; Nagaraja, V				Tare, Priyanka; China, Arnab; Nagaraja, Valakunja			Distinct and Contrasting Transcription Initiation Patterns at Mycobacterium tuberculosis Promoters	PLOS ONE			English	Article							RIBOSOMAL-RNA SYNTHESIS; ESCHERICHIA-COLI K-12; GENE-REGULATION; POLYMERASE; DNA; PATHWAY; COMPLEX; OPERON; RESISTANCE; MECHANISM	Although sequencing of Mycobacterium tuberculosis genome lead to better understanding of transcription units and gene functions, interactions occurring during transcription initiation between RNA polymerase and promoters is yet to be elucidated. Different stages of transcription initiation include promoter specific binding of RNAP, isomerization, abortive initiation and promoter clearance. We have now analyzed these events with four promoters of M. tuberculosis viz. P-gyrB1, P-gyrR, P-rrnPCL1 and P-metU. The promoters differed from each other in their rates of open complex formation, decay, promoter clearance and abortive transcription. The equilibrium binding and kinetic studies of various steps revealed distinct rate limiting events for each of the promoter, which also differed markedly in their characteristics from the respective promoters of Mycobacterium smegmatis. Surprisingly, the transcription at gyr promoter was enhanced in the presence of initiating nucleotides and decreased in the presence of alarmone, pppGpp, a pattern typically seen with rRNA promoters studied so far. The gyr promoter of M. smegmatis, on the other hand, was not subjected to pppGpp mediated regulation. The marked differences in the transcription initiation pathway seen with rrn and gyr promoters of M. smegmatis and M. tuberculosis suggest that such species specific differences in the regulation of expression of the crucial housekeeping genes could be one of the key determinants contributing to the differences in growth rate and lifestyle of the two organisms. Moreover, the distinct rate limiting steps during transcription initiation of each one of the promoters studied point at variations in their intracellular regulation.	[Tare, Priyanka; China, Arnab; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Tare, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in		China, Arnab/0000-0003-2832-2338	University Grant Commission; Council of Scientific and Industrial Research, Government of India; Centre of Excellence in tuberculosis research from Department of Biotechnology, Government of India	University Grant Commission(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Centre of Excellence in tuberculosis research from Department of Biotechnology, Government of India	PT and AC are recipients of Senior Research Fellowships from University Grant Commission and Council of Scientific and Industrial Research, Government of India, respectively. VN is a J.C. Bose Fellow of Department of Science and Technology, Government of India and is recipient of Centre of Excellence in tuberculosis research grant from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Chakraborty A, 2006, J BIOL CHEM, V281, P8511, DOI 10.1074/jbc.M512906200; China A, 2010, MICROBIOL-SGM, V156, P1942, DOI 10.1099/mic.0.038620-0; China A, 2010, PROTEIN EXPRES PURIF, V69, P235, DOI 10.1016/j.pep.2009.09.022; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gomez M, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P111; GonzalezyMerchand JA, 1997, J BACTERIOL, V179, P6949, DOI 10.1128/jb.179.22.6949-6958.1997; Helmann JD, 2009, METHODS, V47, P1, DOI 10.1016/j.ymeth.2008.12.001; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Johnson R, 2006, CURR ISSUES MOL BIOL, V8, P97; KENRI T, 1994, GENE, V138, P261, DOI 10.1016/0378-1119(94)90821-4; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; MENZEL R, 1987, J BACTERIOL, V169, P1272, DOI 10.1128/jb.169.3.1272-1278.1987; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Mukherjee R, 2008, BIOCHEM BIOPH RES CO, V369, P899, DOI 10.1016/j.bbrc.2008.02.118; NAGASE T, 1988, GENE, V67, P49; OHLSEN KL, 1992, J BIOL CHEM, V267, P19813; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Smith I, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P219; Stadthagen-Gomez G, 2008, FEMS MICROBIOL LETT, V280, P102, DOI 10.1111/j.1574-6968.2007.01050.x; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; Unniraman S, 1999, GENES CELLS, V4, P697, DOI 10.1046/j.1365-2443.1999.00296.x; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; Unniraman S, 2001, J BIOL CHEM, V276, P41850, DOI 10.1074/jbc.M106252200; Vasanthakrishna M, 1997, MICROBIOL-SGM, V143, P3591, DOI 10.1099/00221287-143-11-3591; Verma A, 1999, J BACTERIOL, V181, P4326, DOI 10.1128/JB.181.14.4326-4333.1999	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43900	10.1371/journal.pone.0043900	http://dx.doi.org/10.1371/journal.pone.0043900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970148	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308462000008
J	Dai, B; David, V; Martin, A; Huang, JS; Li, H; Jiao, Y; Gu, WK; Quarles, LD				Dai, Bing; David, Valentin; Martin, Aline; Huang, Jinsong; Li, Hua; Jiao, Yan; Gu, Weikuan; Quarles, L. Darryl			A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model	PLOS ONE			English	Article							GROWTH-FACTOR 23; CHRONIC-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; LEFT-VENTRICULAR HYPERTROPHY; X-LINKED HYPOPHOSPHATEMIA; DISTAL CONVOLUTED TUBULE; FACTOR-KAPPA-B; KLOTHO GENE; VITAMIN-D; HEMODIALYSIS-PATIENTS	Elevations of circulating Fibroblast growth factor 23 (FGF23) are associated with adverse cardiovascular outcomes and progression of renal failure in chronic kidney disease (CKD). Efforts to identify gene products whose transcription is directly regulated by FGF23 stimulation of fibroblast growth factor receptors (FGFR)/alpha-Klotho complexes in the kidney is confounded by both systemic alterations in calcium, phosphorus and vitamin D metabolism and intrinsic alterations caused by the underlying renal pathology in CKD. To identify FGF23 responsive genes in the kidney that might explain the association between FGF23 and adverse outcomes in CKD, we performed comparative genome wide analysis of gene expression profiles in the kidney of the Collagen 4 alpha 3 null mice (Col4a3(-/-)) model of progressive kidney disease with kidney expression profiles of Hypophosphatemic (Hyp) and FGF23 transgenic mouse models of elevated FGF23. The different complement of potentially confounding factors in these models allowed us to identify genes that are directly targeted by FGF23. This analysis found that alpha-Klotho, an anti-aging hormone and FGF23 co-receptor, was decreased by FGF23. We also identified additional FGF23-responsive transcripts and activation of networks associated with renal damage and chronic inflammation, including lipocalin 2 (Lcn2), transforming growth factor beta (TGF-beta) and tumor necrosis factor-alpha (TNF-alpha) signaling pathways. Finally, we found that FGF23 suppresses angiotensin-converting enzyme 2 (ACE2) expression in the kidney, thereby providing a pathway for FGF23 regulation of the renin-angiotensin system. These gene products provide a possible mechanistic links between elevated FGF23 and pathways responsible for renal failure progression and cardiovascular diseases.	[Dai, Bing; David, Valentin; Martin, Aline; Huang, Jinsong; Li, Hua; Jiao, Yan; Gu, Weikuan; Quarles, L. Darryl] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	Dai, B (corresponding author), Shanghai Changzheng Hosp, Div Nephrol, Shanghai, Peoples R China.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896	National Institutes of Health from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [RO1-AR45955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR045955, R01AR045955] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding provided by National Institutes of Health Grant RO1-AR45955 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Belge H, 2010, M S-MED SCI, V26, P566, DOI 10.1051/medsci/2010266-7566; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chan MR, 2009, AM J KIDNEY DIS, V53, P321, DOI 10.1053/j.ajkd.2008.06.027; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Datta R, 2010, P NATL ACAD SCI USA, V107, P6448, DOI 10.1073/pnas.1001905107; David V, 2011, AM J PHYSIOL-RENAL, V300, pF783, DOI 10.1152/ajprenal.00304.2010; David V, 2009, ENDOCRINOLOGY, V150, P4012, DOI 10.1210/en.2009-0216; de Borst MH, 2011, J AM SOC NEPHROL, V22, P1603, DOI 10.1681/ASN.2010121251; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Freue GVC, 2010, MOL CELL PROTEOMICS, V9, P1954, DOI 10.1074/mcp.M110.000554; GESEK FA, 1995, AM J PHYSIOL-RENAL, V268, pF89, DOI 10.1152/ajprenal.1995.268.1.F89; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Haussler MR, 2010, J STEROID BIOCHEM, V121, P88, DOI 10.1016/j.jsbmb.2010.03.019; Haussler U, 2005, AM J PHYSIOL-RENAL, V289, pF808, DOI 10.1152/ajprenal.00434.2003; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Imanishi Y, 2004, KIDNEY INT, V65, P1943, DOI 10.1111/j.1523-1755.2004.00604.x; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2010, KIDNEY INT, V78, P947, DOI 10.1038/ki.2010.281; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Koleganova N, 2009, NEPHROL DIAL TRANSPL, V24, P2488, DOI 10.1093/ndt/gfp137; Komaba H, 2010, KIDNEY INT, V77, P292, DOI 10.1038/ki.2009.466; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Kuro-O M, 2011, KIDNEY INT, V79, pS20, DOI 10.1038/ki.2011.26; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Marsell R, 2008, NEPHROL DIAL TRANSPL, V23, P827, DOI 10.1093/ndt/gfm672; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Meldrum KK, 2002, J UROLOGY, V168, P248, DOI 10.1016/S0022-5347(05)64902-6; Meyer MH, 2004, PHYSIOL GENOMICS, V18, P4, DOI 10.1152/physiolgenomics.00210.2003; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Nehgme R, 1997, J CLIN ENDOCR METAB, V82, P2450, DOI 10.1210/jc.82.8.2450; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; PEREIRA BJG, 1994, KIDNEY INT, V45, P890, DOI 10.1038/ki.1994.117; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Santer R, 2002, HUM GENET, V110, P21, DOI 10.1007/s00439-001-0638-6; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; Stubbs Jason R, 2009, Nephrol News Issues, V23, P33; Stubbs JR, 2009, NEPHROL NEWS ISSUES, V23, P36; Stubbs JR, 2011, J BONE MINER RES; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Tu Z, 2001, J IMMUNOL, V166, P6839, DOI 10.4049/jimmunol.166.11.6839; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Voegele AF, 2002, BIOCHEMISTRY-US, V41, P14532, DOI 10.1021/bi026513v; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Wetmore JB, 2009, NAT CLIN PRACT NEPHR, V5, P24, DOI 10.1038/ncpneph0977; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yang J, 2002, DEV BIOL, V246, P296, DOI 10.1006/dbio.2002.0646; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoder Bradley K., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010362; Yuan BZ, 2004, ENDOCRINOLOGY, V145, P3804, DOI 10.1210/en.2004-0192	85	136	143	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44161	10.1371/journal.pone.0044161	http://dx.doi.org/10.1371/journal.pone.0044161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970174	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400041
J	Richardson, AJ; Burton, JR; Sewell, RP; Spreckelsen, TF; Montgomery, P				Richardson, Alexandra J.; Burton, Jennifer R.; Sewell, Richard P.; Spreckelsen, Thees F.; Montgomery, Paul			Docosahexaenoic Acid for Reading, Cognition and Behavior in Children Aged 7-9 Years: A Randomized, Controlled Trial (The DOLAB Study)	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FATTY-ACIDS; DOUBLE-BLIND; SUPPLEMENTATION; ADHD; HYPERACTIVITY; METAANALYSIS	Background: Omega-3 fatty acids are dietary essentials, and the current low intakes in most modern developed countries are believed to contribute to a wide variety of physical and mental health problems. Evidence from clinical trials indicates that dietary supplementation with long-chain omega-3 may improve child behavior and learning, although most previous trials have involved children with neurodevelopmental disorders such as attention-deficit/hyperactivity disorder (ADHD) or developmental coordination disorder (DCD). Here we investigated whether such benefits might extend to the general child population. Objectives: To determine the effects of dietary supplementation with the long-chain omega-3 docosahexaenoic acid (DHA) on the reading, working memory, and behavior of healthy schoolchildren. Design: Parallel group, fixed-dose, randomized, double-blind, placebo-controlled trial (RCT). Setting: Mainstream primary schools in Oxfordshire, UK (n = 74). Participants: Healthy children aged 7-9 years initially underperforming in reading (<= 33rd centile). 1376 invited, 362 met study criteria. Intervention: 600 mg/day DHA (from algal oil), or taste/color matched corn/soybean oil placebo. Main Outcome Measures: Age-standardized measures of reading, working memory, and parent-and teacher-rated behavior. Results: ITT analyses showed no effect of DHA on reading in the full sample, but significant effects in the pre-planned subgroup of 224 children whose initial reading performance was <= 20th centile (the target population in our original study design). Parent-rated behavior problems (ADHD-type symptoms) were significantly reduced by active treatment, but little or no effects were seen for either teacher-rated behaviour or working memory. Conclusions: DHA supplementation appears to offer a safe and effective way to improve reading and behavior in healthy but underperforming children from mainstream schools. Replication studies are clearly warranted, as such children are known to be at risk of low educational and occupational outcomes in later life.	[Richardson, Alexandra J.; Burton, Jennifer R.; Sewell, Richard P.; Spreckelsen, Thees F.; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England	University of Oxford	Richardson, AJ (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	alex.richardson@spi.ox.ac.uk	Spreckelsen, Thees/L-9281-2019	Spreckelsen, Thees/0000-0002-5043-2077; Richardson, Alex/0000-0001-5650-4409	Martek Biosciences Inc.; Waterloo Foundation	Martek Biosciences Inc.; Waterloo Foundation	The study was funded by Martek Biosciences Inc. (http://www.lifesdha.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Waterloo Foundation for its support for Dr Richardson's work in this area.	BARKLEY RA, 1990, PEDIATRICS, V86, P184; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Collishaw S, 2012, J ABNORM CHILD PSYCH, V40, P119, DOI 10.1007/s10802-011-9543-1; Conners C.K., 1989, CONNERS RATING SCALE; Crowe FL, 2008, BRIT J NUTR, V99, P168, DOI 10.1017/S000711450779387X; Elliott B, 1997, BRIT ABILITY SCALES; Ells L.J., 2006, SYSTEMATIC REV EFFEC; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Heckman JJ, 2007, REV AGR ECON, V29, P446, DOI 10.1111/j.1467-9353.2007.00359.x; Hibbeln JR, 2009, PROSTAG LEUKOTR ESS, V81, P179, DOI 10.1016/j.plefa.2009.06.005; Hobbs G, 2010, BRIT EDUC RES J, V36, P673, DOI 10.1080/01411920903083111; Kirby A, 2010, RES DEV DISABIL, V31, P718, DOI 10.1016/j.ridd.2010.01.014; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Milte CM, 2012, NUTRITION, V28, P670, DOI 10.1016/j.nut.2011.12.009; Nevo E, 2011, J EXP CHILD PSYCHOL, V109, P73, DOI 10.1016/j.jecp.2010.09.010; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Richardson AJ, 2002, PROG NEURO-PSYCHOPH, V26, P233, DOI 10.1016/S0278-5846(01)00254-8; Richardson AJ, 2006, INT REV PSYCHIATR, V18, P155, DOI 10.1080/09540260600583031; Richardson AJ, 2012, EVID-BASED MENT HEAL, V15, P46, DOI 10.1136/ebmental-2011-100523; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; Schab DW, 2004, J DEV BEHAV PEDIATR, V25, P423, DOI 10.1097/00004703-200412000-00007; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Sinn N, 2007, J DEV BEHAV PEDIATR, V28, P82, DOI 10.1097/01.DBP.0000267558.88457.a5; Sun X, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1553; Verkerk AO, 2009, INT J CARDIOL, V132, P138, DOI 10.1016/j.ijcard.2007.07.145	28	106	108	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43909	10.1371/journal.pone.0043909	http://dx.doi.org/10.1371/journal.pone.0043909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970149	gold, Green Accepted, Green Published			2022-12-27	WOS:000308458400023
J	Zhang, T; Zhu, QL; Zhang, XL; Ding, YF; Steinhoff, M; Black, S; Zhao, GM				Zhang, Tao; Zhu, Qiuli; Zhang, Xuelan; Ding, Yunfang; Steinhoff, Mark; Black, Steven; Zhao, Genming			The Clinical Characteristics and Direct Medical Cost of Influenza in Hospitalized Children: A Five-Year Retrospective Study in Suzhou, China	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; PANDEMIC INFLUENZA; HONG-KONG; VACCINES RECOMMENDATIONS; ADVISORY-COMMITTEE; SEASONAL INFLUENZA; INFECTION-RATES; VIRUS-INFECTION; YOUNG-CHILDREN; A H1N1	Background: There have been few studies on children hospitalized with influenza published from mainland China. We performed a retrospective review of medical charts to describe the epidemiology, clinical features and direct medical cost of laboratory-proven influenza hospitalized children in Suzhou, China. Methods: Retrospective study on children with documented influenza infection hospitalized at Suzhou Children Hospital during 2005-2009 was conducted using a structured chart review instrument. Results: A total of 480 children were positive by immuno-fluorescent assay for influenza during 2005-2009. The hospitalizations for influenza occurred in 8-12 months of the year, most commonly in the winter with a second late summer peak (August-September). Influenza A accounted for 86.3%, and of these 286 (59.6%) were male, and 87.2% were <5 years of age. The median length of hospital stay was 7 days. Fever was the most common symptom, occurring in 398 (82.9%) children. There were 394 (82.1%) children with pneumonia and 70.2% of these hospitalized children had radiographic evidence of a pulmonary infiltrate. One hundred and twelve children (23.3%) required oxygen treatments and 13 (2.7%) were transferred to the ICU. Multivariable logistic regression showed that compared with the <= 6 months children, those aged >60 months old had shorter hospital stay (OR = 0.45); children with oxygen treatment tended to have longer hospital stays than those without oxygen treatment (OR = 2.14). The mean cost of each influenza-related hospitalization was US$ 624 (US$ 1323 for children referred to ICU and US$ 617 for those cared for on the wards). High risk children had higher total cost than low-risk patients. Conclusion: Compared to other countries, in Suzhou, children hospitalized with influenza have longer hospital stay and higher percentage of pneumonia. The direct medical cost is high relative to family income. Effective strategies of influenza immunization of young children in China may be beneficial in addressing this disease burden.	[Zhang, Tao; Zhu, Qiuli; Zhao, Genming] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Dept Epidemiol,Minist Educ, Shanghai 200433, Peoples R China; [Zhang, Xuelan; Ding, Yunfang] Suzhou Univ, Suzhou Childrens Hosp, Suzhou 215006, Peoples R China; [Steinhoff, Mark; Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA	Fudan University; Soochow University - China; Cincinnati Children's Hospital Medical Center	Zhang, T (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Dept Epidemiol,Minist Educ, Shanghai 200433, Peoples R China.	gmzhao@shmu.edu.cn			SINO-US; US CDC Influenza Branch; Shanghai Leading Academic Discipline Project [B118, 08-GWZX0201]	SINO-US; US CDC Influenza Branch; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was partly funded by SINO-US collaborative Program on Emerging and Re-emerging Infectious Diseases, a grant from the US CDC Influenza Branch and Shanghai Leading Academic Discipline Project Number: B118 and Project Number: 08-GWZX0201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Bender JM, 2010, PEDIATR INFECT DIS J, V29, P6, DOI 10.1097/INF.0b013e3181b4b950; Burton C, 2008, Can Commun Dis Rep, V34, P17; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chiu SS, 2012, VACCINE, V30, P1895, DOI 10.1016/j.vaccine.2011.12.027; Dawood FS, 2010, J PEDIATR-US, V157, P808, DOI 10.1016/j.jpeds.2010.05.012; Fang LQ, 2012, AM J EPIDEMIOL, V175, P890, DOI 10.1093/aje/kwr411; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fitzner KA, 2001, HEALTH POLICY, V56, P215, DOI 10.1016/S0168-8510(00)00140-8; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Hsieh YH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-106; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Ji W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-82; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Kwong KL, 2009, J PAEDIATR CHILD H, V45, P660, DOI 10.1111/j.1440-1754.2009.01591.x; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Small PA, 2010, JAMA-J AM MED ASSOC, V303, P2355, DOI 10.1001/jama.2010.779; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Streng A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-233; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tang LF, 2008, INDIAN PEDIATR, V45, P971; Ya XR, 2011, J HLTH LAB TECH, V121, p[178, 182]	36	13	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44391	10.1371/journal.pone.0044391	http://dx.doi.org/10.1371/journal.pone.0044391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957069	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800062
J	Distefano, G; Caruso, M; La Malfa, S; Gentile, A; Wu, SB				Distefano, Gaetano; Caruso, Marco; La Malfa, Stefano; Gentile, Alessandra; Wu, Shu-Biao			High Resolution Melting Analysis Is a More Sensitive and Effective Alternative to Gel-Based Platforms in Analysis of SSR - An Example in Citrus	PLOS ONE			English	Article							GENETIC DIVERSITY; CURVE-ANALYSIS; MARKERS; IDENTIFICATION; ORIGIN; TRANSFERABILITY; POLYMORPHISM; PHYLOGENY; SEQUENCES; HOMOPLASY	High resolution melting curve analysis (HRM) has been used as an efficient, accurate and cost-effective tool to detect single nucleotide polymorphisms (SNPs) or insertions or deletions (INDELs). However, its efficiency, accuracy and applicability to discriminate microsatellite polymorphism have not been extensively assessed. The traditional protocols used for SSR genotyping include PCR amplification of the DNA fragment and the separation of the fragments on electrophoresis-based platform. However, post-PCR handling processes are laborious and costly. Furthermore, SNPs present in the sequences flanking repeat motif cannot be detected by polyacrylamide-gel-electrophoresis based methods. In the present study, we compared the discriminating power of HRM with the traditional electrophoresis-based methods and provided a panel of primers for HRM genotyping in Citrus. The results showed that sixteen SSR markers produced distinct polymorphic melting curves among the Citrus spp investigated through HRM analysis. Among those, 10 showed more genotypes by HRM analysis than capillary electrophoresis owing to the presence of SNPs in the amplicons. For the SSR markers without SNPs present in the flanking region, HRM also gave distinct melting curves which detected same genotypes as were shown in capillary electrophoresis (CE) analysis. Moreover, HRM analysis allowed the discrimination of most of the 15 citrus genotypes and the resulting genetic distance analysis clustered them into three main branches. In conclusion, it has been approved that HRM is not only an efficient and cost-effective alternative of electrophoresis-based method for SSR markers, but also a method to uncover more polymorphisms contributed by SNPs present in SSRs. It was therefore suggested that the panel of SSR markers could be used in a variety of applications in the citrus biodiversity and breeding programs using HRM analysis. Furthermore, we speculate that the HRM analysis can be employed to analyse SSR markers in a wide range of applications in all other species.	[Distefano, Gaetano; Caruso, Marco; La Malfa, Stefano; Gentile, Alessandra] Univ Catania, Dipartimento Sci Prod Agr & Alimentari, Catania, Italy; [Distefano, Gaetano; Wu, Shu-Biao] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of Catania; University of New England	Distefano, G (corresponding author), Univ Catania, Dipartimento Sci Prod Agr & Alimentari, Catania, Italy.	gentilea@unict.it; shubiao.wu@une.edu.au	Caruso, Marco/F-8207-2011; Wu, Shu-Biao/R-5951-2019; Caruso, Marco/AAA-7279-2021	Caruso, Marco/0000-0001-9068-4490; Wu, Shu-Biao/0000-0002-1790-6015; Caruso, Marco/0000-0001-9068-4490; Gentile, Alessandra/0000-0002-4135-5620; Distefano, Gaetano/0000-0002-6080-6466; La Malfa, Stefano/0000-0001-5869-0348	Assessorato Risorse Agricole e Alimentari, Regione Siciliana	Assessorato Risorse Agricole e Alimentari, Regione Siciliana	This work was supported by Assessorato Risorse Agricole e Alimentari, Regione Siciliana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Arthofer W, 2011, MOL GENET GENOMICS, V286, P225, DOI 10.1007/s00438-011-0641-0; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barkley NA, 2009, PLANT SYST EVOL, V282, P71, DOI 10.1007/s00606-009-0208-2; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Bhargava A, 2010, MOL BIOTECHNOL, V44, P250, DOI 10.1007/s12033-009-9230-4; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Chen YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-96; DENG ZN, 1995, J HORTIC SCI, V70, P117, DOI 10.1080/14620316.1995.11515281; Doyle J. J., 1987, PHYTOCHEM B, P11; Fang DQ, 1997, THEOR APPL GENET, V95, P408, DOI 10.1007/s001220050577; FAOSTAT, 2012, FAOST STAT DAT; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Ganopoulos I, 2011, FOOD CONTROL, V22, P532, DOI 10.1016/j.foodcont.2010.09.040; Herrero R, 1996, THEOR APPL GENET, V92, P599, DOI 10.1007/BF00224564; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Khan IA, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P1, DOI 10.1079/9780851990194.0000; Lehmensiek A, 2008, THEOR APPL GENET, V117, P721, DOI 10.1007/s00122-008-0813-4; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LURO F, 1995, HORTSCIENCE, V30, P1063, DOI 10.21273/HORTSCI.30.5.1063; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Mackay JF, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-8; Mader E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-69; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Muleo R, 2009, GENOME, V52, P252, DOI 10.1139/G09-002; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Novelli VM, 2006, GENET MOL BIOL, V29, P90, DOI 10.1590/S1415-47572006000100018; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Sambrook J., 2001, MOL CLONING LAB MANU; Scora R. W., 1988, Citriculture. Sixth international citrus congress, Middle-East, Tel Aviv, Israel, 6-11 March 1988. Volume 1., P277; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; van Oppen MJH, 2000, MOL BIOL EVOL, V17, P489, DOI 10.1093/oxfordjournals.molbev.a026329; White HE, 2007, CLIN CHEM, V53, P1960, DOI 10.1373/clinchem.2007.093351; Wu SB, 2010, MOL BREEDING, V25, P351, DOI 10.1007/s11032-009-9324-5; Wu SB, 2009, MOL GENET GENOMICS, V282, P273, DOI 10.1007/s00438-009-0464-4; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8	44	54	55	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44202	10.1371/journal.pone.0044202	http://dx.doi.org/10.1371/journal.pone.0044202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957003	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500055
J	Yang, J; Naumann, MC; Tsai, YT; Tosi, J; Erol, D; Lin, CS; Davis, RJ; Tsang, SH				Yang, Jin; Naumann, Matthew C.; Tsai, Yi-Ting; Tosi, Joaquin; Erol, Deniz; Lin, Chyuan-Sheng; Davis, Richard J.; Tsang, Stephen H.			Vigabatrin-Induced Retinal Toxicity Is Partially Mediated by Signaling in Rod and Cone Photoreceptors	PLOS ONE			English	Article							GABA-TRANSAMINASE INHIBITOR; CGMP PHOSPHODIESTERASE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; LIGHT; DEFICIENCY; TRANSDUCIN; EPILEPSY; CHILDREN; MUTATION	Vigabatrin (VGB) is a commonly prescribed antiepileptic drug designed to inhibit GABA-transaminase, effectively halting seizures. Unfortunately, VGB treatment is also associated with the highest frequencies of peripheral visual field constriction of any of the antiepileptic drugs and the mechanisms that lead to these visual field defects are uncertain. Recent studies have demonstrated light exposure exacerbates vigabatrin-induced retinal toxicity. We further assessed this relationship by examining the effects of vigabatrin treatment on the retinal structures of mice with genetically altered photoreception. In keeping with previous studies, we detected increased toxicity in mice exposed to continuous light. To study whether cone or rod photoreceptor function was involved in the pathway to toxicity, we tested mice with mutations in the cone-specific Gnat2 or rod-specific Pde6g genes, and found the mutations significantly reduced VGB toxicity. Our results confirm light is a significant enhancer of vigabatrin toxicity and that a portion of this is mediated, directly or indirectly, by phototransduction signaling in rod and cone photoreceptors.	[Yang, Jin; Naumann, Matthew C.; Tsai, Yi-Ting; Tosi, Joaquin; Erol, Deniz; Lin, Chyuan-Sheng; Davis, Richard J.; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Yang, Jin] Tianjin Med Univ Eye Ctr, Tianjin, Peoples R China; [Lin, Chyuan-Sheng] Columbia Univ, Herbert Irving Canc Res Ctr, New York, NY 10027 USA	Columbia University; Tianjin Medical University; Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA.	sht2@columbia.edu			National Institutes of Health [5P30CA013696, R01EY018213, P30EY019007]; Department of Defense [DOD-TS080017-W81XWH-09-1-0575]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY018213, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health grants 5P30CA013696, R01EY018213, P30EY019007, the Department of Defense grant DOD-TS080017-W81XWH-09-1-0575, and the Foundation Fighting Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Buncic JR, 2004, OPHTHALMOLOGY, V111, P1935, DOI 10.1016/j.ophtha.2004.03.036; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; DJAMGOZ MBA, 1995, TRENDS NEUROSCI, V18, P118, DOI 10.1016/0166-2236(95)93886-3; Duboc A, 2004, ANN NEUROL, V55, P695, DOI 10.1002/ana.20081; Durbin S, 2009, INVEST OPHTH VIS SCI, V50, P4011, DOI 10.1167/iovs.08-3237; GIBSON JP, 1990, TOXICOL PATHOL, V18, P225, DOI 10.1177/019262339001800201; Izumi Y, 2004, EPILEPSIA, V45, P1043, DOI 10.1111/j.0013-9580.2004.01004.x; Jammoul F, 2009, ANN NEUROL, V65, P98, DOI 10.1002/ana.21526; Kinirons P, 2006, EPILEPSY RES, V70, P229, DOI 10.1016/j.eplepsyres.2006.05.009; Kjellstrom U, 2009, GRAEF ARCH CLIN EXP, V247, P1057, DOI 10.1007/s00417-009-1093-7; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; LIVINGSTON JH, 1989, BRIT J CLIN PHARMACO, V27, pS109, DOI 10.1111/j.1365-2125.1989.tb03470.x; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Moskowitz A, 2012, DOC OPHTHALMOL, V124, P197, DOI 10.1007/s10633-012-9320-7; Sills GJ, 2003, EPILEPSIA, V44, P886, DOI 10.1046/j.1528-1157.2003.04203.x; Sills GJ, 2001, NEUROLOGY, V57, P196, DOI 10.1212/WNL.57.2.196; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Tsang SH, 2008, AM J OPHTHALMOL, V146, P780, DOI 10.1016/j.ajo.2008.06.017; van der Torren Kors, 2002, Documenta Ophthalmologica, V104, P181, DOI 10.1023/A:1014615517996; Wang QP, 2008, EUR J NEUROSCI, V27, P2177, DOI 10.1111/j.1460-9568.2008.06175.x; Waterhouse EJ, 2009, NEUROPSYCH DIS TREAT, V5, P505; Yee JM, 1998, EPILEPSY RES, V29, P195; Zhang Y, 2009, CHINA J CLIN NEUROSC, V5, P457	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43889	10.1371/journal.pone.0043889	http://dx.doi.org/10.1371/journal.pone.0043889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22970106	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500027
J	Kaur, J; Hoang, DT; Sun, XL; Possamai, L; JafariAsbagh, M; Patil, S; Menczer, F				Kaur, Jasleen; Diep Thi Hoang; Sun, Xiaoling; Possamai, Lino; JafariAsbagh, Mohsen; Patil, Snehal; Menczer, Filippo			Scholarometer: A Social Framework for Analyzing Impact across Disciplines	PLOS ONE			English	Article								The use of quantitative metrics to gauge the impact of scholarly publications, authors, and disciplines is predicated on the availability of reliable usage and annotation data. Citation and download counts are widely available from digital libraries. However, current annotation systems rely on proprietary labels, refer to journals but not articles or authors, and are manually curated. To address these limitations, we propose a social framework based on crowdsourced annotations of scholars, designed to keep up with the rapidly evolving disciplinary and interdisciplinary landscape. We describe a system called Scholarometer, which provides a service to scholars by computing citation-based impact measures. This creates an incentive for users to provide disciplinary annotations of authors, which in turn can be used to compute disciplinary metrics. We first present the system architecture and several heuristics to deal with noisy bibliographic and annotation data. We report on data sharing and interactive visualization services enabled by Scholarometer. Usage statistics, illustrating the data collected and shared through the framework, suggest that the proposed crowdsourcing approach can be successful. Secondly, we illustrate how the disciplinary bibliometric indicators elicited by Scholarometer allow us to implement for the first time a universal impact measure proposed in the literature. Our evaluation suggests that this metric provides an effective means for comparing scholarly impact across disciplinary boundaries.	[Kaur, Jasleen; Diep Thi Hoang; Sun, Xiaoling; Possamai, Lino; JafariAsbagh, Mohsen; Patil, Snehal; Menczer, Filippo] Indiana Univ, Sch Informat & Comp, Ctr Complex Networks & Syst Res, Bloomington, IN 47405 USA; [Diep Thi Hoang] Vietnam Natl Univ, Univ Engn & Technol, Hanoi, Vietnam; [Sun, Xiaoling] Dalian Univ Technol, Dept Comp Sci & Technol, Dalian, Peoples R China; [Possamai, Lino] Univ Padua, Dept Pure & Appl Math, Padua, Italy	Indiana University System; Indiana University Bloomington; Vietnam National University Hanoi; Dalian University of Technology; University of Padua	Kaur, J (corresponding author), Indiana Univ, Sch Informat & Comp, Ctr Complex Networks & Syst Res, Bloomington, IN 47405 USA.	jakaur@indiana.edu		Hoang, Diep Thi/0000-0001-9200-2668; Kaur, Jasleen/0000-0002-1243-1452; Menczer, Filippo/0000-0003-4384-2876	Hongfei Lin at Dalian University of Technology; China Scholarship Council; Massimo Marchiori at University of Padua; University of Bologna; Lilly Endowment; National Science Foundation [IIS-0811994]	Hongfei Lin at Dalian University of Technology; China Scholarship Council(China Scholarship Council); Massimo Marchiori at University of Padua; University of Bologna; Lilly Endowment; National Science Foundation(National Science Foundation (NSF))	The authors acknowledge support from Hongfei Lin at Dalian University of Technology, the China Scholarship Council, Massimo Marchiori at University of Padua, the University of Bologna, the Lilly Endowment, and National Science Foundation (award IIS-0811994) for funding the computing infrastructure that hosts the Scholarometer service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; Benz D, 2010, VLDB J, V19, P849, DOI 10.1007/s00778-010-0208-4; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Golder SA, 2006, J INF SCI, V32, P198, DOI 10.1177/0165551506062337; Harzing A. W., 2007, PUBLISH PERISH; Heymann P., 2008, P INT C WEB SEARCH W, P195, DOI DOI 10.1145/1341531.1341558; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hoang D. T, 2010, PROC WEB SCI C EXTEN; Hotho A, 2006, LECT NOTES INFORM IN; Labbu C., 2010, ISSI NEWSLETTER, V6, P48; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Mika P, 2007, J WEB SEMANT, V5, P5, DOI 10.1016/j.websem.2006.11.002; Pudovkin A, 2009, P 5 INT C WEB INF SC; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Schreiber M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/040201; Schubert A, 2007, SCIENTOMETRICS, V70, P201, DOI 10.1007/s11192-007-0112-x; Sun X, 2012, AMBIGUOUS AUTHOR QUE; Sun X, 2011, P 3 IEEE C SOC COMP; von Ahn L, 2006, COMPUTER, V39, P92, DOI 10.1109/MC.2006.196; Weng L, 2011, P 16 IEEE INT C COMP, DOI [10.1109/CGAMES.2011.6000337, DOI 10.1109/CGAMES.2011.6000337]; Weng L, 2011, P 6 INT C FDN DIG GA	24	22	22	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43235	10.1371/journal.pone.0043235	http://dx.doi.org/10.1371/journal.pone.0043235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984414	gold, Green Published, Green Submitted			2022-12-27	WOS:000308738500007
J	Taylor, PJ; Stoffberg, S; Monadjem, A; Schoeman, MC; Bayliss, J; Cotterill, FPD				Taylor, Peter J.; Stoffberg, Samantha; Monadjem, Ara; Schoeman, Martinus Corrie; Bayliss, Julian; Cotterill, Fenton P. D.			Four New Bat Species (Rhinolophus hildebrandtii Complex) Reflect Plio-Pleistocene Divergence of Dwarfs and Giants across an Afromontane Archipelago	PLOS ONE			English	Article							ECHOLOCATION CALL FREQUENCY; EASTERN ARC MOUNTAINS; HORSESHOE BAT; GEOMETRIC MORPHOMETRICS; INSECTIVOROUS BATS; ACTIVITY PATTERNS; PREY SELECTION; ISLAND RULE; HABITAT USE; EVOLUTION	Gigantism and dwarfism evolve in vertebrates restricted to islands. We describe four new species in the Rhinolophus hildebrandtii species-complex of horseshoe bats, whose evolution has entailed adaptive shifts in body size. We postulate that vicissitudes of palaeoenvironments resulted in gigantism and dwarfism in habitat islands fragmented across eastern and southern Africa. Mitochondrial and nuclear DNA sequences recovered two clades of R. hildebrandtii senso lato which are paraphyletic with respect to a third lineage (R. eloquens). Lineages differ by 7.7 to 9.0% in cytochrome b sequences. Clade 1 includes R. hildebrandtii sensu stricto from the east African highlands and three additional vicariants that speciated across an Afromontane archipelago through the Plio-Pleistocene, extending from the Kenyan Highlands through the Eastern Arc, northern Mozambique and the Zambezi Escarpment to the eastern Great Escarpment of South Africa. Clade 2 comprises one species confined to lowland savanna habitats (Mozambique and Zimbabwe). A third clade comprises R. eloquens from East Africa. Speciation within Clade 1 is associated with fixed differences in echolocation call frequency, and cranial shape and size in populations isolated since the late Pliocene (ca 3.74 Mya). Relative to the intermediate-sized savanna population (Clade 2), these island-populations within Clade 1 are characterised by either gigantism (South African eastern Great Escarpment and Mts Mabu and Inago in Mozambique) or dwarfism (Lutope-Ngolangola Gorge, Zimbabwe and Soutpansberg Mountains, South Africa). Sympatry between divergent clades (Clade 1 and Clade 2) at Lutope-Ngolangola Gorge (NW Zimbabwe) is attributed to recent range expansions. We propose an "Allometric Speciation Hypothesis", which attributes the evolution of this species complex of bats to divergence in constant frequency (CF) sonar calls. The origin of species-specific peak frequencies (overall range = 32 to 46 kHz) represents the allometric effect of adaptive divergence in skull size, represented in the evolution of gigantism and dwarfism in habitat islands.	[Taylor, Peter J.] Univ Venda, Dept Ecol & Resource Management, Thohoyandou, South Africa; [Taylor, Peter J.] Durban Nat Sci Museum, Durban, South Africa; [Stoffberg, Samantha] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa; [Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini; [Taylor, Peter J.; Schoeman, Martinus Corrie] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Bayliss, Julian] Mulanje Mt Conservat Trust, Mulanje, Malawi; [Bayliss, Julian] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Cotterill, Fenton P. D.] Univ Stellenbosch, Dept Bot & Zool, Africa Earth Observ Network, ZA-7600 Stellenbosch, South Africa	University of Venda; Stellenbosch University; University of Kwazulu Natal; University of Cambridge; National Research Foundation - South Africa; Stellenbosch University	Taylor, PJ (corresponding author), Univ Venda, Dept Ecol & Resource Management, Thohoyandou, South Africa.	peter.taylor@univen.ac.za	Monadjem, Ara/K-7279-2014; Schoeman, Corrie/G-2616-2010; Taylor, Peter John/N-3172-2019; Taylor, Peter/E-8655-2011	Monadjem, Ara/0000-0003-1906-4023; Taylor, Peter/0000-0001-9048-7366; Bayliss, Julian/0000-0002-1480-294X; Cotterill, Fenton/0000-0003-4561-018X	Darwin Initiative [15/036]; Mulanje Mountain Conservation Trust; African Butterfly Research Institute; Instituto de Investigacao Agraria de Mocambique; National Research Foundation of South Africa; Claude Leon Foundation; All Out Africa	Darwin Initiative; Mulanje Mountain Conservation Trust; African Butterfly Research Institute; Instituto de Investigacao Agraria de Mocambique; National Research Foundation of South Africa(National Research Foundation - South Africa); Claude Leon Foundation; All Out Africa	This research was supported by logistic and financial support from the Darwin Initiative (Darwin Initiative Award 15/036: Monitoring and Managing Biodiversity Loss in South-East Africa's Montane Ecosystems), the Mulanje Mountain Conservation Trust, the African Butterfly Research Institute and the Instituto de Investigacao Agraria de Mocambique to JB. PJT and SS received grants from the National Research Foundation of South Africa. SS was further supported by a Claude Leon Foundation Postdoctoral Fellowships. FPDC thanks the Bay Foundations for support over the period core data were collected. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lientjie Cohen provided invaluable support with collection of samples from Mpumalanga Province. Michael Curran and Mirjam Kopp collected one of the specimens from Mt Mabu and kindly provided acoustic data of two individuals from Mt Mabu - both were working under the the British government funded Darwin Initiative project 'Monitoring and Managing Biodiversity Loss on South-East Africa's Montane Ecosystems' (Award 15/036). This collaborative project, led by the Royal Botanic Gardens, Kew, also included BirdLife International, the Instituto de Investigacao Agraria de Mocambique, the Mulanje Mountain Conservation Trust, Malawi, and the Forest Research Institute of Malawi. April Reside and Julien Cornut assisted with the capture of Mozambican specimens. Leigh Richards (Durban Natural Science Museum) and Teresa Kearney (Ditsong National Natural Science Museum) provided invaluable assistance with loans of specimens and queries about specimens. Alick Ndlovu, Kith Mkwananzi and John Minshull enthustiastically helped with successful collecting in Zimbabwe. MCS and SS are very grateful to Pieter Malan, Gerhard Groenewald and the Toyota Enviro Outreach for logistical support. AM received financial and logistic support from All Out Africa. We are grateful to Dr J. M. Bishop for the use of unpublished cytochrome b primers. Support from Africa Earth Observatory Network (AEON) enabled geobiological inputs into the present paper. This is AEON Publication No. 105.	Abebe T, 2010, TERRA NOVA, V22, P470, DOI 10.1111/j.1365-3121.2010.00968.x; Addinsoft, 2007, XLSTAT VERS 2007 5; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Bates P. J. J., 1997, BATS INDIAN SUBCONTI; Bauer FU, 2010, INT J EARTH SCI, V99, P1575, DOI 10.1007/s00531-010-0549-7; Bayliss J, 2010, BIODIVERSITY CONSERV; Blackburn DC, 2009, MOL ECOL, V18, P1904, DOI 10.1111/j.1365-294X.2009.04156.x; Branch WR, 2010, AFR J HERPETOL, V59, P157, DOI 10.1080/21564574.2010.516275; Branch WR, 2009, ZOOTAXA, P41, DOI 10.11646/zootaxa.2113.1.2; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Chen SF, 2009, P ROY SOC B-BIOL SCI, V276, P3901, DOI 10.1098/rspb.2009.1185; Congdon C., 2010, METAMORPHOSIS, V21, P45; CORTI M, 1993, TRENDS ECOL EVOL, V8, P302, DOI 10.1016/0169-5347(93)90261-M; Cotterill F.P.D., 2003, P59; Cotterill FPD, 2011, S AFR J GEOL, V114, P489, DOI 10.2113/gssajg.114.3-4.489; Cotterill FPD, 2002, J ZOOL, V256, P165, DOI 10.1017/S0952836902000201; Cracraft J, 1989, WHAT PHILOS BIOL IS, P33; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Csorba G, 2003, HORSESHOE BATS WORLD; Daniels S, 2011, ZOOLOGICAL J LINNEAN, V164, P498; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Droxler AW, 2003, GEOPHYS MONOGRAPH; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eastman JM, 2011, SYST BIOL, V60, P503, DOI 10.1093/sysbio/syr020; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenton M. B., 1985, TRANSV MUS B, V21, P5; FENTON MB, 1981, J MAMMAL, V62, P233, DOI 10.2307/1380701; FENTON MB, 1977, BIOTROPICA, V9, P73, DOI 10.2307/2387662; FENTON MB, 1980, BIOTROPICA, V12, P81, DOI 10.2307/2387723; FENTON MB, 1979, J COMP PHYSIOL, V132, P77, DOI 10.1007/BF00617734; Fenton MB, 1975, LIFE SCI CONTRIBUTIO, P104; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; Francis Charles M., 1998, P169; Galley C, 2007, P ROY SOC B-BIOL SCI, V274, P535, DOI 10.1098/rspb.2006.0046; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Goodman Steven M., 2010, Zootaxa, V2551, P1; GRANTHAM TA, 1995, ANNU REV ECOL SYST, V26, P301; Groves C, 2011, UNGULATE TAXONOMY; Groves C.P., 2001, PRIMATE TAXONOMY; Guillen Servent Antonio, 2003, pxii; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARTLEY DJ, 1988, J ACOUST SOC AM, V84, P1201, DOI 10.1121/1.396621; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; HILL J. E., 1987, B BRIT MUS NAT HIST, V72, P225; Houston R. D., 2004, ECHOLOCATION BATS DO, P339, DOI DOI 10.1016/0370-1573(95)00083-6; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunn CA, 2001, SYST BIOL, V50, P391, DOI 10.1080/713849647; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jacobs DS, 1996, FUNCT ECOL, V10, P622, DOI 10.2307/2390172; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; JONES G, 1993, P ROY SOC B-BIOL SCI, V251, P119, DOI 10.1098/rspb.1993.0017; Jones G., 1992, P87, DOI 10.1109/TFTSA.1992.274228; Jones G, 1999, J EXP BIOL, V202, P3359; Jones G, 1996, SYM ZOOL S, P111; Jones G., 2004, ECHOLOCATION BATS DO, P345; Juste J, 2007, ACTA CHIROPTEROL, V9, P27, DOI 10.3161/1733-5329(2007)9[27:TOLBBM]2.0.CO;2; Kearney TC, 2002, ACTA CHIROPTEROL, V4, P55, DOI 10.3161/001.004.0107; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; Kjer KM, 2007, MOL PHYLOGENET EVOL, V43, P999, DOI 10.1016/j.ympev.2007.02.028; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; LIDICKER WZ, 1968, J MAMMAL, V49, P609, DOI 10.2307/1378724; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Marcus LF, 1996, NATO ADV SCI I A-LIF, V284, P1; McNab BK, 2001, J COMP PHYSIOL B, V171, P201, DOI 10.1007/s003600000163; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2006, J BIOGEOGR, V33, P1571, DOI 10.1111/j.1365-2699.2006.01523.x; Monadjem A, 2007, S AFR J WILDL RES, V37, P9, DOI 10.3957/0379-4369-37.1.9; Monadjem A, 2010, ACTA CHIROPTEROL, V12, P371, DOI 10.3161/150811010X537963; Mucina Ladislav, 2006, V19, P2; National Research Council, 2010, UND CLIM INFL HUM EV; Nicolas V, 2006, MOL PHYLOGENET EVOL, V38, P779, DOI 10.1016/j.ympev.2005.11.024; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; PALMEIRIM JM, 1991, MAMMALIA, V55, P381, DOI 10.1515/mamm.1991.55.3.381; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Partridge TC., 2010, CENOZOIC MAMMALS AFR, P3, DOI DOI 10.1525/CALIFORNIA/9780520257214.003.0001; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prendini Lorenzo, 2001, P113; Quigley MC, 2010, GEOL SOC SPEC PUBL, V346, P243, DOI 10.1144/SP346.13; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Robinson MF, 1996, J ZOOL, V239, P389, DOI 10.1111/j.1469-7998.1996.tb05459.x; Rohlf F.J., 2009, TPSDIG VERSION 214; Rohlf F. James, 2002, VVolume 64, P175; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ, 2008, TPSRELW VERSION 1 48; Rohling EJ, 2010, EARTH PLANET SC LETT, V291, P97, DOI 10.1016/j.epsl.2009.12.054; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Schmidt NM, 1993, CONSERV ECOL, V7, P6; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smithers RHN, 1983, MAMMALS SO AFRICAN S; Speigel C, 2010, GEOLOGY, V35, P427, DOI [10.1130/G23108A, DOI 10.1130/G23108A]; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P34; Stanley WT, 2010, BIOL J LINN SOC, V100, P669, DOI 10.1111/j.1095-8312.2010.01448.x; Stanley WT, 2005, J ZOOL, V266, P341, DOI 10.1017/S0952836905007016; STOFFBERG S, 2007, THESIS U CAPE TOWN C; Stoffberg S, 2010, MOL PHYLOGENET EVOL, V54, P1, DOI 10.1016/j.ympev.2009.09.021; SUTHERS RA, 1988, J COMP PHYSIOL A, V162, P799, DOI 10.1007/BF00610969; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Taylor P. J., 2009, AFRICAN ZOOLOGY, V277, P317; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Taylor Peter J., 2005, Durban Museum Novitates, V30, P24; Taylor Peter J., 2011, Zootaxa, V3024, P1; Taylor PJ, 2009, BIOL J LINN SOC, V96, P913, DOI 10.1111/j.1095-8312.2008.01153.x; Teeling EC, 2003, MOL PHYLOGENET EVOL, V28, P308, DOI 10.1016/S1055-7903(03)00117-9; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; Voelker G, 2010, GLOBAL ECOL BIOGEOGR, V19, P111, DOI 10.1111/j.1466-8238.2009.00500.x; WHITE F, 1981, AFR J ECOL, V19, P33, DOI 10.1111/j.1365-2028.1981.tb00651.x; White F, 1983, NATURAL RESOURCES RE, P161; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	127	66	66	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41744	10.1371/journal.pone.0041744	http://dx.doi.org/10.1371/journal.pone.0041744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984399	Green Published, gold			2022-12-27	WOS:000308738500005
J	Kim, YW; Bae, SM; Lim, H; Kim, YJ; Ahn, WS				Kim, Yong-Wan; Bae, Su Mi; Lim, Hyunsun; Kim, Yoon Ji; Ahn, Woong Shick			Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers	PLOS ONE			English	Article							BIOLOGICAL VARIATION; ANALYTICAL IMPRECISION; PROTEOMIC BIOMARKERS; APOLIPOPROTEIN A1; TUMOR-MARKERS; CA-125 LEVELS; CA 125; CA125; PROTEIN; TRANSTHYRETIN	CA125 as a biomarker of ovarian cancer is ineffective for the general population. The aim of this study was to evaluate multiplexed bead-based immunoassay of multiple ovarian cancer-associated biomarkers such as transthyretin and apolipoprotein A1, together with CA125, to improve the identification and evaluation of prognosis of ovarian cancer. We measured the serum levels of CA125, transthyretin, and apolipoprotein A1 from the serum of 61 healthy individuals, 84 patients with benign ovarian disease, and 118 patients with ovarian cancer using a multiplex liquid assay system, Luminex 100. The results were then analyzed according to healthy and/or benign versus ovarian cancer subjects. When CA125 was combined with the other biomarkers, the overall sensitivity and specificity were significantly improved in the ROC curve, which showed 95% and 97% sensitivity and specificity, respectively. At 95% specificity for all stages the sensitivity increased to 95.5% compared to 67% for CA125 alone. For stage I+II, the sensitivity increased from 30% for CA125 alone to 93.9%. For stage III+IV, the corresponding values were 96.5% and 91.6%, respectively. Also, the three biomarkers were sufficient for maximum separation between noncancer (healthy plus benign group) and stage I+II or all stages (I-IV) of disease. The new combination of transthyretin, and apolipoprotein A1 with CA125 improved both the sensitivity and the specificity of ovarian cancer diagnosis compared with those of individual biomarkers. These findings suggest the benefit of the combination of these markers for the diagnosis of ovarian cancer.	[Kim, Yong-Wan; Bae, Su Mi; Kim, Yoon Ji] Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Seoul, South Korea; [Lim, Hyunsun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Biomed Res Ctr, Seoul, South Korea; [Ahn, Woong Shick] Catholic Univ Korea, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Catholic University of Korea; Yonsei University; Yonsei University Health System; Catholic University of Korea	Kim, YW (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Seoul, South Korea.	ahnlab1@catholic.ac.kr			National Research Foundation of Korea (NRF), Seoul, Republic of Korea [5-2011-A0154-00119]	National Research Foundation of Korea (NRF), Seoul, Republic of Korea	The study was supported by the National Research Foundation of Korea (NRF), Seoul, Republic of Korea (Grant # 5-2011-A0154-00119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; Aslam N, 2000, BRIT J OBSTET GYNAEC, V107, P689, DOI 10.1111/j.1471-0528.2000.tb13314.x; Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bast RC, 2004, T AM CLIN CLIMAT ASS, V115, P247; Bast Robert C Jr, 2004, Trans Am Clin Climatol Assoc, V115, P233; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Donach M, 2010, TUMOR BIOL, V31, P209, DOI 10.1007/s13277-010-0032-x; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Greene MH, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-2232; GRUNDY SM, 1990, ARCH INTERN MED, V150, P1579; Grzegorzewska Alicja E, 2004, Adv Perit Dial, V20, P185; Gupta D, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-13; HELZLSOUER KJ, 1993, JAMA-J AM MED ASSOC, V269, P1123, DOI 10.1001/jama.269.9.1123; Hensley ML, 2010, J CLIN ONCOL, V28, P2128, DOI 10.1200/JCO.2009.26.6346; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; JACOBS I, 1989, HUM REPROD, V4, P1; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Kim KA, 2004, AM J ROENTGENOL, V182, P1259, DOI 10.2214/ajr.182.5.1821259; Kim YW, 2012, ONCOL REP, V28, P585, DOI 10.3892/or.2012.1829; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Liede A, 2002, J CLIN ONCOL, V20, P1570, DOI 10.1200/JCO.20.6.1570; Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87; Liu MY, 2005, CLIN CHEM, V51, P1102, DOI 10.1373/clinchem.2004.047084; Lopez LA, 1996, AGE AGEING, V25, P45, DOI 10.1093/ageing/25.1.45; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Maggino T, 2000, EUR J GYNAECOL ONCOL, V21, P64; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Menon U, 2000, CURR OPIN OBSTET GYN, V12, P39, DOI 10.1097/00001703-200002000-00007; Moore LE, 2006, CANCER EPIDEM BIOMAR, V15, P1641, DOI 10.1158/1055-9965.EPI-05-0980; Moore LE, 2012, CANCER-AM CANCER SOC, V118, P91, DOI 10.1002/cncr.26241; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Morice P, 2003, ANN ONCOL, V14, P74, DOI 10.1093/annonc/mdg003; Murakoshi Y, 2011, CANCER SCI, V102, P630, DOI 10.1111/j.1349-7006.2010.01818.x; Nicholas BL, 2010, AM J RESP CRIT CARE, V181, P1049, DOI 10.1164/rccm.200906-0857OC; Nosov V, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.042; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; Predanic M, 2000, FERTIL STERIL, V73, P522, DOI 10.1016/S0015-0282(99)00554-3; Rein BJD, 2011, J ONCOL, V2011, DOI 10.1155/2011/475983; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Sasaroli D, 2009, BIOMARK MED, V3, P275, DOI 10.2217/BMM.09.21; Schweigert Florian J, 2004, Proteome Sci, V2, P5, DOI 10.1186/1477-5956-2-5; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Tcherkassova J, 2011, TUMOR BIOL, V32, P831, DOI 10.1007/s13277-011-0186-1; Trape J, 2005, CLIN CHEM, V51, P219; Tuxen MK, 2001, CLIN CHEM LAB MED, V39, P531, DOI 10.1515/CCLM.2001.089; Tuxen MK, 1999, GYNECOL ONCOL, V74, P12, DOI 10.1006/gyno.1999.5414; West-Norager M, 2007, J CHROMATOGR B, V847, P30, DOI 10.1016/j.jchromb.2006.09.048; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zhang B, 2010, ANN CLIN LAB SCI, V40, P218; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	59	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44960	10.1371/journal.pone.0044960	http://dx.doi.org/10.1371/journal.pone.0044960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970327	Green Submitted, gold, Green Published			2022-12-27	WOS:000308748400037
J	Nielsen, MV; Sarpong, N; Krumkamp, R; Dekker, D; Loag, W; Amemasor, S; Agyekum, A; Marks, F; Huenger, F; Krefis, AC; Hagen, RM; Adu-Sarkodie, Y; May, J; Schwarz, NG				Nielsen, Maja Verena; Sarpong, Nimako; Krumkamp, Ralf; Dekker, Denise; Loag, Wibke; Amemasor, Solomon; Agyekum, Alex; Marks, Florian; Huenger, Frank; Krefis, Anne Caroline; Hagen, Ralf Matthias; Adu-Sarkodie, Yaw; May, Juergen; Schwarz, Norbert Georg			Incidence and Characteristics of Bacteremia among Children in Rural Ghana	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; ANTIMICROBIAL RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; BACTERIAL-MENINGITIS; INVASIVE BACTERIAL; SEVERE MALARIA; HEALTH-CARE; DISEASE; AFRICA	The objective of the study was to describe systemic bacterial infections occurring in acutely ill and hospitalized children in a rural region in Ghana, regarding frequency, incidence, antimicrobial susceptibility patterns and associations with anthropometrical data. Blood cultures were performed in all children below the age of five years, who were admitted to Agogo Presbyterian Hospital (APH), Asante Region, Ghana, between September 2007 and July 2009. Medical history and anthropometrical data were assessed using a standardized questionnaire at admission. Incidences were calculated after considering the coverage population adjusted for village-dependent health-seeking behavior. Among 1,196 hospitalized children, 19.9% (n = 238) were blood culture positive. The four most frequent isolated pathogens were nontyphoidal salmonellae (NTS) (53.3%; n = 129), Staphylococcus aureus (13.2%; n = 32), Streptococcus pneumoniae (9.1%; n = 22) and Salmonella ser. Typhi (7.0%; n = 17). Yearly cumulative incidence of bacteremia was 46.6 cases/1,000 (CI 40.9-52.2). Yearly cumulative incidences per 1,000 of the four most frequent isolates were 25.2 (CI 21.1-29.4) for NTS, 6.3 (CI 4.1-8.4) for S. aureus, 4.3 (CI 2.5-6.1) for S. pneumoniae and 3.3 (CI 1.8-4.9) for Salmonella ser. Typhi. Wasting was positively associated with bacteremia and systemic NTS bloodstream infection. Children older than three months had more often NTS bacteremia than younger children. Ninety-eight percent of NTS and 100% of Salmonella ser. Typhi isolates were susceptible to ciprofloxacin, whereas both tested 100% susceptible to ceftriaxone. Seventy-seven percent of NTS and 65% of Salmonella ser. Typhi isolates were multi-drug resistant (MDR). Systemic bacterial infections in nearly 20% of hospitalized children underline the need for microbiological diagnostics, to guide targeted antimicrobial treatment and prevention of bacteremia. If microbiological diagnostics are lacking, calculated antimicrobial treatment of severely ill children in malaria-endemic areas should be considered.	[Nielsen, Maja Verena; Krumkamp, Ralf; Dekker, Denise; Loag, Wibke; Krefis, Anne Caroline; Hagen, Ralf Matthias; May, Juergen; Schwarz, Norbert Georg] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Sarpong, Nimako; Dekker, Denise; Amemasor, Solomon; Agyekum, Alex; Huenger, Frank] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Marks, Florian] Int Vaccine Inst, Seoul, South Korea; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Huenger, Frank] Inst Transfus Med, Lab Med & Med Microbiol, Dortmund, Germany	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; International Vaccine Institute; Kwame Nkrumah University Science & Technology	Nielsen, MV (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	maja.v.nielsen@googlemail.com	Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837; Marks, Florian/0000-0002-6043-7170; May, Jurgen/0000-0001-7831-8420	UBS Optimus Foundation	UBS Optimus Foundation	This work was supported by the UBS Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; CIA, 2012, CIA FACTB 2012; COMMEY JOO, 1994, E AFR MED J, V71, P113; Cook J, 2008, VACCINE, V26, P6305, DOI 10.1016/j.vaccine.2008.09.040; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Enwere G, 1998, ANN TROP PAEDIATR, V18, P275, DOI 10.1080/02724936.1998.11747959; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Ghana. Cities & Urban Localities, 2011, GHANA CITIES URBAN L; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Holliman RE, 2007, T ROY SOC TROP MED H, V101, P405, DOI 10.1016/j.trstmh.2006.08.014; Ilic K, 2012, EUR J PEDIATR, V171, P767, DOI 10.1007/s00431-011-1592-5; Ladhani S, 2004, ARCH DIS CHILD, V89, P568, DOI 10.1136/adc.2003.026781; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Meremikwu MM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-110; Mills-Robertson F, 2003, J APPL MICROBIOL, V94, P289, DOI 10.1046/j.1365-2672.2003.01833.x; MOTARJEMI Y, 1993, B WORLD HEALTH ORGAN, V71, P79; Motarjemi Y, 1994, World Health Forum, V15, P69; Nadjm B, 2010, BMJ-BRIT MED J, V340, pc1350; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Renner LA, 2007, PEDIATR INFECT DIS J, V26, P356, DOI 10.1097/01.inf.0000258693.19247.8e; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schwarz NG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-319; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; *UNICEF, 2004, STAT WORLDS CHILDR; Vinnemeier CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036678; WHO, 2011, AG PRESB HOSP GHAN; Wilkens Julia, 1997, Clin Microbiol Infect, V3, P616, DOI 10.1111/j.1469-0691.1997.tb00467.x	38	68	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44063	10.1371/journal.pone.0044063	http://dx.doi.org/10.1371/journal.pone.0044063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970162	Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400009
J	Lins, RMMA; Souza, NA; Brazil, RP; Maingon, RDC; Peixoto, AA				Lins, Rachel M. M. A.; Souza, Nataly A.; Brazil, Reginaldo P.; Maingon, Rhayza D. C.; Peixoto, Alexandre A.			Fixed Differences in the paralytic Gene Define Two Lineages within the Lutzomyia longipalpis Complex Producing Different Types of Courtship Songs	PLOS ONE			English	Article							MALE SEX-PHEROMONES; BRAZILIAN POPULATIONS; SPECIES COMPLEX; PERIOD GENE; VISCERAL LEISHMANIASIS; FEMALE PREFERENCE; CRUZI MANGABEIRA; DIPTERA; PSYCHODIDAE; DIVERGENCE	The sand fly Lutzomyia longipalpis (Diptera: Psychodidae: Phlebotominae), the most important vector of American visceral leishmaniasis, is widely distributed in Latin America. There is currently a consensus that it represents a species complex, however, the number and distribution of the different siblings is still uncertain. Previous analyses have indicated that Brazilian populations of this vector can be divided into two main groups according to the type of courtship song (Burst vs. Pulse) males produce during copulation. Nevertheless, no diagnostic differences have been observed between these two groups with most molecular markers used to date. We analyzed the molecular divergence in a fragment of the paralytic (para) gene, a locus involved in the control of courtship songs in Drosophila, among a number of Lu. longipalpis populations from Brazil producing Burst and Pulse-type songs. Our results revealed a very high level of divergence and fixed differences between populations producing the two types of songs. We also compared Lu. longipalpis with a very closely related species, Lutzomyia cruzi, which produces Burst-type songs. The results indicated a higher number of fixed differences between Lu. cruzi and the Pulse-type populations of Lu. longipalpis than with those producing Burst-type songs. The data confirmed our previous assumptions that the presence of different sibling species of the Lu. longipalpis complex in Brazil can be divided into two main groups, one representing a single species and a second more heterogeneous group that probably represents a number of incipient species. We hypothesize that para might be one of the genes directly involved in the control of the courtship song differences between these two groups or that it is linked to other loci associated with reproductive isolation of the Brazilian species.	[Lins, Rachel M. M. A.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Souza, Nataly A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Leishmanioses, BR-21045900 Rio De Janeiro, Brazil; [Brazil, Reginaldo P.] Fiocruz MS, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Maingon, Rhayza D. C.] Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Ctr Appl Entomol & Parasitol, Keele, Staffs, England; [Peixoto, Alexandre A.] INCT EM, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Keele University	Lins, RMMA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil.	apeixoto@ioc.fiocruz.br	Brazil, Reginaldo Peçanha/AAF-6777-2019		Howard Hughes Medical Institute; CNPq; Capes; FAPERJ; FIOCRUZ	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This work was supported by grants from the Howard Hughes Medical Institute, CNPq, Capes, FAPERJ and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Arrivillaga JC, 2001, J MED ENTOMOL, V38, P783, DOI 10.1603/0022-2585-38.6.783; Bauzer LGSR, 2002, INSECT MOL BIOL, V11, P315, DOI 10.1046/j.1365-2583.2002.00340.x; Bauzer LGSR, 2002, MOL BIOL EVOL, V19, P1624, DOI 10.1093/oxfordjournals.molbev.a004224; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Brazil RP, 2002, MEM I OSWALDO CRUZ, V97, P435, DOI 10.1590/S0074-02762002000300030; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; de Souza NA, 2002, T ROY SOC TROP MED H, V96, P102, DOI 10.1016/S0035-9203(02)90258-0; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; FU YX, 1993, GENETICS, V133, P693; Gleason JM, 2005, BEHAV GENET, V35, P265, DOI 10.1007/s10519-005-3219-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton JGC, 1999, CHEM COMMUN, P355, DOI 10.1039/a900242a; Hamilton JGC, 2005, MED VET ENTOMOL, V19, P480, DOI 10.1111/j.1365-2915.2005.00594.x; Hamilton JGC, 2004, J MED ENTOMOL, V41, P1021, DOI 10.1603/0022-2585-41.6.1021; Hamilton JGC, 1999, CHEM COMMUN, P2335, DOI 10.1039/a907910f; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Joseph Sambrook DR, 2001, MOL CLONING LAB MANU; Jowett T, 1998, DROSOPHILA PRACTICAL, P347; Klappert K, 2007, EVOLUTION, V61, P1481, DOI 10.1111/j.1558-5646.2007.00125.x; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LANZARO GC, 1993, AM J TROP MED HYG, V48, P839, DOI 10.4269/ajtmh.1993.48.839; LANZARO GC, 1995, PARASITOL TODAY, V11, P151, DOI 10.1016/0169-4758(95)80137-5; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lins RMMA, 2008, MEM I OSWALDO CRUZ, V103, P736, DOI 10.1590/S0074-02762008000700019; Maingon RDC, 2003, MOL ECOL, V12, P1879, DOI 10.1046/j.1365-294X.2003.01871.x; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; Peixoto AA, 2002, ADV GENET, V47, P117, DOI 10.1016/S0065-2660(02)47004-6; Peixoto AA, 1998, GENETICS, V148, P827; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pinto IS, 2010, J MED ENTOMOL, V47, P16, DOI 10.1603/033.047.0102; Ritchie MG, 1998, ANIM BEHAV, V56, P713, DOI 10.1006/anbe.1998.0799; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Saarikettu M, 2005, BEHAV GENET, V35, P257, DOI 10.1007/s10519-005-3218-z; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Souza NA, 2008, MEM I OSWALDO CRUZ, V103, P216, DOI 10.1590/S0074-02762008000200017; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Ward RD, 1988, BIOSYSTEMATICS HAEMA, P258; Warren B, 2009, CURR BIOL, V19, P485, DOI 10.1016/j.cub.2009.01.059; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; Wen SY, 2011, ZOOL SCI, V28, P469, DOI 10.2108/zsj.28.469; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Yin HZ, 1999, MED VET ENTOMOL, V13, P72, DOI 10.1046/j.1365-2915.1999.00139.x	59	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44323	10.1371/journal.pone.0044323	http://dx.doi.org/10.1371/journal.pone.0044323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970200	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000018
J	Bettenbuhl, M; Rusconi, M; Engbert, R; Holschneider, M				Bettenbuehl, Mario; Rusconi, Marco; Engbert, Ralf; Holschneider, Matthias			Bayesian Selection of Markov Models for Symbol Sequences: Application to Microsaccadic Eye Movements	PLOS ONE			English	Article							SACCADIC INTRUSIONS; GENERATION	Complex biological dynamics often generate sequences of discrete events which can be described as a Markov process. The order of the underlying Markovian stochastic process is fundamental for characterizing statistical dependencies within sequences. As an example for this class of biological systems, we investigate the Markov order of sequences of microsaccadic eye movements from human observers. We calculate the integrated likelihood of a given sequence for various orders of the Markov process and use this in a Bayesian framework for statistical inference on the Markov order. Our analysis shows that data from most participants are best explained by a first-order Markov process. This is compatible with recent findings of a statistical coupling of subsequent microsaccade orientations. Our method might prove to be useful for a broad class of biological systems.	[Bettenbuehl, Mario; Rusconi, Marco; Holschneider, Matthias] Univ Potsdam, Inst Math, Focus Area Dynam Complex Syst, Potsdam, Germany; [Bettenbuehl, Mario; Engbert, Ralf] Univ Potsdam, Dept Psychol, DFG Res Unit Computat Modeling Behav Cognit & Neu, Potsdam, Germany	University of Potsdam; University of Potsdam	Bettenbuhl, M (corresponding author), Univ Potsdam, Inst Math, Focus Area Dynam Complex Syst, Potsdam, Germany.	mario.bettenbuehl@uni-potsdam.de	Engbert, Ralf/AAC-4860-2020	Engbert, Ralf/0000-0002-2909-5811; Holschneider, Matthias/0000-0003-3987-105X	Deutsche Forschungsgemeinschaft (Research Unit 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics) [EN 471/3-2]	Deutsche Forschungsgemeinschaft (Research Unit 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics)(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft (Research Unit 868 Computational Modeling of Behavioral, Cognitive, and Neural Dynamics, grant EN 471/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; Abadi RV, 2000, VISION RES, V40, P2813, DOI 10.1016/S0042-6989(00)00146-2; Badii R., 1999, COMPLEXITY HIERARCHI; Bettenbuhl M, 2010, J EYE MOVEMENT RES, V3; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Jeffreys H., 1998, THEORY PROBABILITY; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Leigh R, 1999, NEUROLOGY EYE MOVEME, V55; Liversedge S., 2011, OXFORD HDB EYE MOVEM; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Mergenthaler K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.138104; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Perron O, 1907, MATH ANN, V64, P248, DOI 10.1007/BF01449896; Poletti M, 2010, J NEUROSCI, V30, P11143, DOI 10.1523/JNEUROSCI.1925-10.2010; Rieke F., 1997, SPIKES EXPLORING NEU; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; ROSENBLATT M, 1962, J SOC IND APPL MATH, V10, P537, DOI 10.1137/0110041; Salman MS, 2009, J CHILD NEUROL, V24, P161, DOI 10.1177/0883073808322326; Taylor H. M., 1984, INTRO STOCHASTIC MOD; TROOST BT, 1977, ANN NEUROL, V2, P397, DOI 10.1002/ana.410020509; van Kampen N. G., 1981, STOCHASTIC PROCESSES; VASUDEVAN R, 1972, KYBERNETIK, V11, P24, DOI 10.1007/BF00267762; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43388	10.1371/journal.pone.0043388	http://dx.doi.org/10.1371/journal.pone.0043388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970124	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400009
J	Cook, M; Mani, P; Wentzell, JS; Kretzschmar, D				Cook, Mandy; Mani, Priya; Wentzell, Jill S.; Kretzschmar, Doris			Increased RhoA Prenylation in the loechrig (loe) Mutant Leads to Progressive Neurodegeneration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAS-LIKE GTPASES; DROSOPHILA-MELANOGASTER; NEURITE OUTGROWTH; CELL; ISOPRENOIDS; ENERGY; INHIBITION; EXPRESSION; REDUCTASE	The Drosophila mutant loechrig (loe) shows age-dependent degeneration of the nervous system and is caused by the loss of a neuronal isoform of the AMP-activated protein kinase (AMPK) c-subunit (also known as SNF4Ac). The trimeric AMPK complex is activated by low energy levels and metabolic insults and regulates multiple important signal pathways that control cell metabolism. A well-known downstream target of AMPK is hydroxyl-methylglutaryl-CoA reductase (HMGR), a key enzyme in isoprenoid synthesis, and we have previously shown that HMGR genetically interacts with loe and affects the severity of the degenerative phenotype. Prenylation of proteins like small G-proteins is an important posttranslational modification providing lipid moieties that allow the association of these proteins with membranes, thereby facilitating their subsequent activation. Rho proteins have been extensively studied in neuronal outgrowth, however, much less is known about their function in neuronal maintenance. Here we show that the loe mutation interferes with isoprenoid synthesis, leading to increased prenylation of the small GTPase Rho1, the fly orthologue of vertebrate RhoA. We also demonstrate that increased prenylation and Rho1 activity causes neurodegeneration and aggravates the behavioral and degenerative phenotypes of loe. Because we cannot detect defects in the development of the central nervous system in loe, this suggests that loe only interferes with the function of the RhoA pathway in maintaining neuronal integrity during adulthood. In addition, our results show that alterations in isoprenoids can result in progressive neurodegeneration, supporting findings in vertebrates that prenylation may play a role in neurodegenerative diseases like Alzheimer's Disease.	[Cook, Mandy; Mani, Priya; Wentzell, Jill S.; Kretzschmar, Doris] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University	Cook, M (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	kretzsch@ohsu.edu		kretzschmar, doris/0000-0002-0519-2377	National Institutes of Health [P30NS061800]; Alzheimer Forschung Initiative e.V.; Medical Research Foundation of Oregon; Oregon Tax Check-off program (on Aging & Alzheimer's Disease Center - Oregon Partnership); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Forschung Initiative e.V.; Medical Research Foundation of Oregon; Oregon Tax Check-off program (on Aging & Alzheimer's Disease Center - Oregon Partnership); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant P30NS061800, Alzheimer Forschung Initiative e. V. (www.alzheimer-forschung.de), Medical Research Foundation of Oregon (www. ohsu.edu/xd/about/foundation/./medical-research-foundation), and the Oregon Tax Check-off program (on Aging & Alzheimer's Disease Center - Oregon Partnership for ...www.ohsu.edu/xd/research/centers./tax-checkoff-giving.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Cole SL, 2006, NEUROBIOL DIS, V22, P209, DOI 10.1016/j.nbd.2005.11.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; KRETZSCHMAR D, 1992, EMBO J, V11, P2531, DOI 10.1002/j.1460-2075.1992.tb05318.x; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Novelli G, 2012, J INHERIT METAB DIS; ORGAD S, 1987, EUR J BIOCHEM, V164, P31, DOI 10.1111/j.1432-1033.1987.tb10988.x; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; Spindler SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039581; Spradling AC, 1999, GENETICS, V153, P135; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Swanson TL, 2005, DEV BIOL, V288, P160, DOI 10.1016/j.ydbio.2005.09.029; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Tschape JA, 2003, J NEURAL TRANSM-SUPP, P51; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44440	10.1371/journal.pone.0044440	http://dx.doi.org/10.1371/journal.pone.0044440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970217	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400070
J	Lose, F; Srinivasan, S; O'Mara, T; Marquart, L; Chambers, S; Gardiner, RA; Aitken, JF; Spurdle, AB; Batra, J; Clements, JA				Lose, Felicity; Srinivasan, Srilakshmi; O'Mara, Tracy; Marquart, Louise; Chambers, Suzanne; Gardiner, Robert A.; Aitken, Joanne F.; Spurdle, Amanda B.; Batra, Jyotsna; Clements, Judith A.		Australian Prostate Canc BioResour	Genetic Association of the KLK4 Locus with Risk of Prostate Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; SERINE-PROTEASE; HUMAN GENOME; KALLIKREIN-4; EXPRESSION; TISSUES; ANTIGEN; POLYMORPHISMS; PROMOTER; HEALTHY	The Kallikrein-related peptidase, KLK4, has been shown to be significantly overexpressed in prostate tumours in numerous studies and is suggested to be a potential biomarker for prostate cancer. KLK4 may also play a role in prostate cancer progression through its involvement in epithelial-mesenchymal transition, a more aggressive phenotype, and metastases to bone. It is well known that genetic variation has the potential to affect gene expression and/or various protein characteristics and hence we sought to investigate the possible role of single nucleotide polymorphisms (SNPs) in the KLK4 gene in prostate cancer. Assessment of 61 SNPs in the KLK4 locus (+/- 610 kb) in approximately 1300 prostate cancer cases and 1300 male controls for associations with prostate cancer risk and/or prostate tumour aggressiveness Gleason score <7 versus >= 7) revealed 7 SNPs to be associated with a decreased risk of prostate cancer at the P-trend<0.05 significance level. Three of these SNPs, rs268923, rs56112930 and the HapMap tagSNP rs7248321, are located several kb upstream of KLK4; rs1654551 encodes a non-synonymous serine to alanine substitution at position 22 of the long isoform of the KLK4 protein, and the remaining 3 risk-associated SNPs, rs1701927, rs1090649 and rs806019, are located downstream of KLK4 and are in high linkage disequilibrium with each other (r(2)>= 0.98). Our findings provide suggestive evidence of a role for genetic variation in the KLK4 locus in prostate cancer predisposition.	[Lose, Felicity; O'Mara, Tracy; Spurdle, Amanda B.; Batra, Jyotsna] Queensland Inst Med Res, Genet & Populat Hlth Div, Mol Canc Epidemiol Grp, Brisbane, Qld 4006, Australia; [Srinivasan, Srilakshmi; O'Mara, Tracy; Clements, Judith A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia; [Marquart, Louise] Queensland Inst Med Res, Stat Unit, Brisbane, Qld 4006, Australia; [Chambers, Suzanne; Aitken, Joanne F.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Chambers, Suzanne; Aitken, Joanne F.] Canc Council Queensland, Viertel Ctr Canc Res, Brisbane, Qld, Australia; [Chambers, Suzanne; Gardiner, Robert A.] Univ Queensland, Royal Brisbane Hosp, Clin Res Ctr, Brisbane, Qld, Australia; [Lose, Felicity; Spurdle, Amanda B.; Australian Prostate Canc BioResour] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Griffith University; Menzies Health Institute Queensland; Cancer Council Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Queensland University of Technology (QUT)	Lose, F (corresponding author), Queensland Inst Med Res, Genet & Populat Hlth Div, Mol Canc Epidemiol Grp, 300 Herston Rd, Brisbane, Qld 4006, Australia.	jyotsna.batra@qut.edu.au	O'Mara, Tracy/M-7508-2016; Batra, Jyotsna/B-4130-2011; Marquart-Wilson, Louise/CAI-1964-2022; Spurdle, Amanda B/A-4978-2011; Srilakshmi, Srinivasan/AAR-5334-2021; Samaratunga, Hemamali M L/D-1559-2013; Chambers, Suzanne K/H-5957-2012	O'Mara, Tracy/0000-0002-5436-3232; Spurdle, Amanda B/0000-0003-1337-7897; Samaratunga, Hemamali M L/0000-0001-5796-1791; Chambers, Suzanne K/0000-0003-2369-6111; Marquart, Louise/0000-0003-4607-9060; Clements, Judith/0000-0001-6026-1964; Lose, Felicity/0000-0001-8337-3547; batra, Jyotsna/0000-0003-4646-6247; Aitken, Joanne Frances/0000-0001-6859-2186	National Health and Medical Research Council (Early Career Fellowship); National Health and Medical Research Council (Career Development Award); National Health and Medical Research Council (Senior Research Fellowship); National Health and Medical Research Council (Principal Research Fellowship); National Health and Medical Research Council [390130, 614296]; Prostate Cancer Foundation of Australia [PG7]; Research infrastructure grant; Cancer Council Queensland, Prostate Cancer Research Program; Queensland Government Smart State award; Australian Postgraduate Award; Institute of Health and Biomedical Innovation	National Health and Medical Research Council (Early Career Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Career Development Award)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Senior Research Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Principal Research Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia; Research infrastructure grant; Cancer Council Queensland, Prostate Cancer Research Program(Cancer Council Queensland); Queensland Government Smart State award; Australian Postgraduate Award(Australian Government); Institute of Health and Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by the National Health and Medical Research Council (Early Career Fellowship [to JB], Career Development Award [to SC], Senior Research Fellowship [to ABS], Principal Research Fellowship [to JAC], Project Grant [390130] and Enabling Grant [614296 to Australian Prostate Cancer BioResource]; the Prostate Cancer Foundation of Australia (Project Grant [PG7] and Research infrastructure grant [to Australian Prostate Cancer BioResource]); The Cancer Council Queensland, Prostate Cancer Research Program [to SC]; Queensland Government Smart State award [to TO]; Australian Postgraduate Award [to SS and TO]; and the Institute of Health and Biomedical Innovation [to JB, SS and TO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2002, TFSEARCH SEARCHING T; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Avgeris M, 2011, PROSTATE, V71, P1780, DOI 10.1002/pros.21395; Baade PD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-452; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Day CH, 2002, ONCOGENE, V21, P7114, DOI 10.1038/sj.onc.1205786; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Eeles R, 2008, NAT GENET, V40, P1035, DOI 10.1038/ng0908-1035; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goard CA, 2007, MOL ONCOL, V1, P303, DOI 10.1016/j.molonc.2007.09.001; Gonzalez MI, 2001, J BIOL CHEM, V276, P6420, DOI 10.1074/jbc.M008689200; Grabe N., 2000, ALIBABA2 1; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaushal A, 2008, PROSTATE, V68, P381, DOI 10.1002/pros.20685; Klein RJ, 2010, CANCER PREV RES, V3, P611, DOI 10.1158/1940-6207.CAPR-09-0206; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Lai J, 2007, CARCINOGENESIS, V28, P1032, DOI 10.1093/carcin/bgl236; Lai J, 2009, MOL CANCER RES, V7, P129, DOI 10.1158/1541-7786.MCR-08-0218; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lose F., 2011, UROL ONCOL; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; Mavridis K, 2010, FUTURE ONCOL, V6, P269, DOI 10.2217/FON.09.149; Mikolajczyk SD, 2001, CANCER RES, V61, P6958; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; Obiezu CV, 2005, CLIN CHEM, V51, P1432, DOI 10.1373/clinchem.2005.049692; Obiezu CV, 2002, CLIN CHEM, V48, P1232; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Seiz L, 2010, BIOL CHEM, V391, P391, DOI 10.1515/BC.2010.033; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wilkinson R, 2012, CANCER IMMUNOL IMMUN, V61, P169, DOI 10.1007/s00262-011-1095-2; Xi ZJ, 2004, CANCER RES, V64, P2365, DOI 10.1158/0008-5472.CAN-03-2025; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yousef GM, 1999, CANCER RES, V59, P4252; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44520	10.1371/journal.pone.0044520	http://dx.doi.org/10.1371/journal.pone.0044520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970239	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400083
J	Mangalat, N; Liu, YY; Fatheree, NY; Ferris, MJ; Van Arsdall, MR; Chen, ZX; Rahbar, MH; Gleason, WA; Norori, J; Tran, DQ; Rhoads, JM				Mangalat, Nisha; Liu, Yuying; Fatheree, Nicole Y.; Ferris, Michael J.; Van Arsdall, Melissa R.; Chen, Zhongxue; Rahbar, Mohammad H.; Gleason, Wallace A.; Norori, Johana; Tran, Dat Q.; Rhoads, J. Marc			Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NECROTIZING ENTEROCOLITIS; DOUBLE-BLIND; CYTOKINES; PROBIOTICS; CELLS; SENSITIVITY; ATCC-55730; VALIDATION; DIARRHEA	Background: There are few carefully-designed studies investigating the safety of individual probiotics approved under Investigational New Drug policies. Objectives: The primary aim of this prospective, double-blind placebo-controlled trial was to investigate if daily treatment of adults with Lactobacillus reuteri DSM 17938 (LR) for 2 months is safe and well-tolerated. Our secondary aim was to determine if LR treatment has immune effects as determined by regulatory T cell percentages, expression of toll-like receptors (TLR)-2 and -4 on circulating peripheral blood mononuclear cells (PMBCs), cytokine expression by stimulated PBMC, and intestinal inflammation as measured by fecal calprotectin. Methods: Forty healthy adults were randomized to a daily dose of 5 x 10(8) CFUs of LR (n = 30) or placebo (n = 10) for 2 months. Participants completed a daily diary card and had 7 clinic visits during treatment and observation. Results: There were no severe adverse events (SAEs) and no significant differences in adverse events (AEs). There were no differences in PBMC subclasses, TLRs, or cytokine expression after treatment. The probiotic-treated group had a significantly higher fecal calprotectin level than the placebo group after 2 months of treatment: 50 mu g/g (IQR 24-127 mu g/g) vs. 17 mu g/g (IQR 11-26 mu g/g), p = 0.03, although values remained in the normal clinical range (0-162.9 mu g/g). LR vials retained >10(8) CFUs viable organisms/ml. Conclusions: LR is safe and well tolerated in adults, without significant changes in immunologic markers. There was a small but significant increase in fecal calprotectin, perhaps indicating some element of immune recognition at the intestinal level.	[Mangalat, Nisha; Liu, Yuying; Fatheree, Nicole Y.; Van Arsdall, Melissa R.; Gleason, Wallace A.; Tran, Dat Q.; Rhoads, J. Marc] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Ferris, Michael J.; Norori, Johana] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Ferris, Michael J.; Norori, Johana] Res Inst Children, New Orleans, LA USA; [Chen, Zhongxue; Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Biostat Epidemiol Res Design Core, Houston, TX USA; [Rahbar, Mohammad H.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Mangalat, N (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA.	J.Marc.Rhoads@uth.tmc.edu	Chen, Zhongxue/K-1372-2013; Liu, Yuying/ABB-8417-2021	Chen, Zhongxue/0000-0003-2537-7843; Liu, Yuying/0000-0003-3848-9254	National Institutes of Health, National Center for Complementary and Alternative Medicine [NIH/NCCAM U01AT003519]; University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences (NIH CTSA) [UL1 RR024148]; Biogaia, Inc.; National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM) [5U01AT003519]; University of Texas Health Science Center at Houston, CCTR [UL1]; Public Health Service [DK56338]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT003519] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences (NIH CTSA); Biogaia, Inc.; National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); University of Texas Health Science Center at Houston, CCTR; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM U01AT003519) to JMR and the University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences (NIH CTSA grant UL1 RR024148). Biogaia Inc. provided the study product and placebo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JMR was a sponsored speaker (Biogaia, Inc.) at the 2011 annual meeting of the Latin American Society of Pediatric Gastorenterology. Biogaia Inc. provided the study product and placebo. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.; The authors would like to acknowledge the significant effort by NIH Program Official Linda Duffy, PhD, MPH, for contributions in structuring the U01 study design, inclusion of validation approaches and biosafety parameters, and implementation of the protocols under phased regulatory approved IND; the clinical and pharmacy staff at the University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences (CCTR) for meticulous work in the study; and the US Food and Drug Administration, Center for Biologics and Evaluation Research (FDA/CBER). Biogaia Inc. provided the study product and placebo but played no role in design, data interpretation, or analysis. Funding support was from the National Institutes of Health, National Center for Complementary and Alternative Medicine (NIH/NCCAM) (5U01AT003519) and the University of Texas Health Science Center at Houston, CCTR (UL1). Helpful review and recommendations were provided through the Texas Digestive Disease Center which is funded b Public Health Service grant DK56338. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary and Alternative Medicine (NCCAM), the CCTR at Houston, or the National Institutes of Health. JMR was a sponsored speaker (Biogaia, Inc.) at the 2011 annual meeting of the Latin American Society of Pediatric Gastroenterology.	Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002; Cimperman L, 2011, J CLIN GASTROENTEROL, V45, P785, DOI 10.1097/MCG.0b013e3182166a42; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Hacini-Rachinel F, 2009, J IMMUNOL, V183, P5477, DOI 10.4049/jimmunol.0804267; Hempel S, 2011, AHRQ PUBLICATION, V11-EHC045-EF; Janetzki S, 2010, CANCER IMMUNOL IMMUN, V59, P609, DOI 10.1007/s00262-009-0788-2; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Judd TA, 2011, J GASTROEN HEPATOL, V26, P1493, DOI 10.1111/j.1440-1746.2011.06846.x; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Kunz AN, 2004, J PEDIATR GASTR NUTR, V38, P457, DOI 10.1097/00005176-200404000-00017; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lee JH, 2009, INT J COLORECTAL DIS, V24, P231, DOI 10.1007/s00384-008-0618-6; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu MY, 2005, CLIN CHEM, V51, P1102, DOI 10.1373/clinchem.2004.047084; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Luong ML, 2010, TRANSPL INFECT DIS, V12, P561, DOI 10.1111/j.1399-3062.2010.00580.x; Mackay Andrew D., 1999, Clin Microbiol Infect, V5, P290, DOI 10.1111/j.1469-0691.1999.tb00144.x; Maeda S, 2012, VET IMMUNOL IMMUNOP, V148, P226, DOI 10.1016/j.vetimm.2012.04.021; Mire-Sluis AR, 1998, J IMMUNOL METHODS, V216, P103; Mondel M, 2009, MUCOSAL IMMUNOL, V2, P166, DOI 10.1038/mi.2008.77; Nechansky A, 2008, BIOMARK INSIGHTS, V3, P227; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Richens JL, 2010, J BIOMOL SCREEN, V15, P562, DOI 10.1177/1087057110362099; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Saavedra J, 2000, AM J GASTROENTEROL, V95, pS16, DOI 10.1016/S0002-9270(99)00811-4; Sanders ME, 2008, CLIN INFECT DIS, V46, pS58, DOI 10.1086/523341; Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222; Thorpe R, 2011, BIOLOGICALS, V39, P262, DOI 10.1016/j.biologicals.2011.06.005; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Vinderola G, 2005, CLIN DIAGN LAB IMMUN, V12, P1075, DOI 10.1128/CDLI.12.9.1075-1084.2005	40	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43910	10.1371/journal.pone.0043910	http://dx.doi.org/10.1371/journal.pone.0043910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970150	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400024
J	Paini, DR; Yemshanov, D				Paini, Dean R.; Yemshanov, Denys			Modelling the Arrival of Invasive Organisms via the International Marine Shipping Network: A Khapra Beetle Study	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; SPREAD; SENSITIVITY; DISPERSAL; INTRODUCTIONS; TRANSPORT; THREAT; ERA; MAP	Species can sometimes spread significant distances beyond their natural dispersal ability by anthropogenic means. International shipping routes and the transport of shipping containers, in particular are a commonly recognised pathway for the introduction of invasive species. Species can gain access to a shipping container and remain inside, hidden and undetected for long periods. Currently, government biosecurity agencies charged with intercepting and removing these invasive species when they arrive to a county's border only assess the most immediate point of loading in evaluating a shipping container's risk profile. However, an invasive species could have infested a container previous to this point and travelled undetected before arriving at the border. To assess arrival risk for an invasive species requires analysing the international shipping network in order to identify the most likely source countries and the domestic ports of entry where the species is likely to arrive. We analysed an international shipping network and generated pathway simulations using a first-order Markov chain model to identify possible source ports and countries for the arrival of Khapra beetle (Trogoderma granarium) to Australia. We found Kaohsiung (Taiwan) and Busan (Republic of Korea) to be the most likely sources for Khapra beetle arrival, while the port of Melbourne was the most likely point of entry to Australia. Sensitivity analysis revealed significant stability in the rankings of foreign and Australian ports. This methodology provides a reliable modelling tool to identify and rank possible sources for an invasive species that could arrive at some time in the future. Such model outputs can be used by biosecurity agencies concerned with inspecting incoming shipping containers and wishing to optimise their inspection protocols.	[Paini, Dean R.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, Australia; [Paini, Dean R.] CSIRO, Ecosyst Sci, Acton, Australia; [Yemshanov, Denys] Great Lakes Forestry Ctr, Canada Canadian Forest Serv, Sault Ste Marie, ON, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Paini, DR (corresponding author), Cooperat Res Ctr Natl Plant Biosecur, Bruce, Australia.	Dean.Paini@csiro.au	Paini, Dean R/C-2341-2009		Cooperative Research Corporation for National Plant Biosecurity [CRC 10161]; Australian Government's Cooperative Research Centres Program	Cooperative Research Corporation for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Cooperative Research Corporation for National Plant Biosecurity (http://www.crcplantbiosecurity.com.au/), CRC 10161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DRP acknowledges the support of the Australian Government's Cooperative Research Centres Program. We extend our thanks to Peter Caley and Tom Harwood for comments on earlier versions of the manuscript; Marty Siltanen and Kirsty Wilson for technical diligence with preparing the data and help with running the pathway model simulations. Thanks also go to the Australian Federal Department of Agriculture, Fisheries and Forestry for providing the shipping network data.	Allen EA, 2002, CAN J PLANT PATHOL, V24, P103, DOI 10.1080/07060660309506983; Andrews CI, 2004, RISK ANAL, V24, P1323, DOI 10.1111/j.0272-4332.2004.00529.x; BELL CH, 1994, J STORED PROD RES, V30, P99, DOI 10.1016/0022-474X(94)90189-9; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Bossenbroek JM, 2001, ECOL APPL, V11, P1778, DOI 10.2307/3061095; BRASIER CM, 1973, NATURE, V242, P607, DOI 10.1038/242607a0; Buchan LAJ, 1999, ECOL APPL, V9, P254, DOI 10.2307/2641184; CABI CPC, 2011, CAB INT CROP PROT CO; Cook DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026084; Cook DC, 2011, AUST J AGR RESOUR EC, V55, P599, DOI 10.1111/j.1467-8489.2011.00558.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Global Invasive Species Database, 2012, GLOBAL INVASIVE SPEC; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hayes KR, 2003, MAR POLLUT BULL, V46, P91, DOI 10.1016/S0025-326X(02)00321-1; HendersonSellers B, 1996, ECOL MODEL, V86, P291, DOI 10.1016/0304-3800(95)00066-6; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Hurlock ET, 1961, PEST TECHNOL, V3, P144; IMO, 2011, INT SHIPP FACTS FIG; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Kammer F, 2005, LECT NOTES COMPUT SC, V3418, P143; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Kiritani Keizi, 2003, P44; Koch FH, 2011, BIOL INVASIONS, V13, P969, DOI 10.1007/s10530-010-9883-8; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Li HB, 2006, SCALING AND UNCERTAINTY ANALYSIS IN ECOLOGY: METHODS AND APPLICATIONS, P45; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; Plant Health Australia, 2005, IND BIOS PLAN GRAINS; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; Ridsell-Smith J, 2008, IMPACT EXOTIC PEST I; Swartzman G. L., 1987, ECOLOGICAL SIMULATIO; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1489, DOI 10.1098/rspb.2007.0148; Walker W.E., 2003, INTEGRATED ASSESSMEN, DOI [10.1076/iaij.4.1.5.16466, 10.1076/iaij, DOI 10.1076/IAIJ, DOI 10.1076/IAIJ.4.1.5.16466]; Wasserman S, 1994, SOCIAL NETWORK ANAL; Webster J, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P1; Yemshanov D, 2012, BIOL INVASIONS, V14, P797, DOI 10.1007/s10530-011-0117-5; Yemshanov D, 2012, DIVERS DISTRIB, V18, P33, DOI 10.1111/j.1472-4642.2011.00848.x	43	29	29	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44589	10.1371/journal.pone.0044589	http://dx.doi.org/10.1371/journal.pone.0044589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970258	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400092
J	Saggurti, N; Mahapatra, B; Sabarwal, S; Ghosh, S; Johri, A				Saggurti, Niranjan; Mahapatra, Bidhubhusan; Sabarwal, Shrutika; Ghosh, Subash; Johri, Aradhana			Male Out-Migration: A Factor for the Spread of HIV Infection among Married Men and Women in Rural India	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; SOUTH-AFRICA; MIGRANT WORKERS; RISK-FACTORS; POPULATION; MOBILITY	Introduction: Thus far, the reasons for increasing HIV prevalence in northern and eastern Indian states are unknown. We investigated the role of male out-migration in the spread of human immunodeficiency virus (HIV) infection through a case-control study in rural India. Methods: Currently married men and women were recruited from HIV testing and treatment centers across seven selected districts with high rates of male out-migration in eastern and northern India in 2010 using a case-control study design. Case subjects (men: 595, women: 609) were people who tested HIV seropositive and control subjects (men: 611, women: 600) were those tested HIV seronegative. For each gender, we obtained adjusted odds ratios (AORs) and population attributable risks (PARs) for migration, and behavioral factors. Results: For men, the prevalence of HIV was significantly higher among those with a migration history (AOR, 4.4); for women, the prevalence of HIV was higher among those with migrant husbands (AOR, 2.3). For both genders, the returned male migration (men: AOR, 3.7; women: AOR, 2.8) was significantly associated with higher prevalence of HIV infection. The PAR associated with male migration was higher for men (54.5%-68.6%) than for women (32.7%-56.9%) across the study areas. Discussion: Male out-migration is the most important risk factor influencing the spread of HIV infection in rural areas with high out-migration rates, thereby emphasizing the need for interventions, particularly, for returned migrants and spouses of those migrants.	[Saggurti, Niranjan; Mahapatra, Bidhubhusan; Sabarwal, Shrutika] Populat Council, HIV & AIDS Program, New Delhi, India; [Ghosh, Subash; Johri, Aradhana] Govt India, Minist Hlth & Family Welf, Dept AIDS Control, Natl AIDS Control Org, New Delhi, India		Saggurti, N (corresponding author), Populat Council, HIV & AIDS Program, New Delhi, India.	bbmahapatra@popcouncil.org	Mahapatra, Bidhubhusan/M-1411-2019; Mahapatra, Bidhubhusan/A-8830-2013	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Saggurti, Niranjan/0000-0002-5267-8425	United Nations Development Programme (UNDP)	United Nations Development Programme (UNDP)	United Nations Development Programme (UNDP) provided a grant to Population Council to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; Chirwa WC, 1997, INT MIGR REV, V31, P628, DOI 10.2307/2547289; Decosas J, 1997, AIDS, V11, pS77; Duckett M, 2000, Dev Bull, P18; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; [International Institute for Population Sciences (IIPS) ORC Macro], 2007, NAT FAM HLTH SURV 3; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Lurie M, 1997, S AFR MED J, V87, P908; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010; Mrinalika Dhapola, 2007, Economic and Political Weekly, V42, P40; Mundandi C, 2006, TROP MED INT HEALTH, V11, P705, DOI 10.1111/j.1365-3156.2006.01614.x; [National AIDS Control Organisation (NACO) Department of AIDS Control MoHFW], 2007, HIV FACT SHEETS BAS; [National Institute for Medical Statistics (NIMS) National AIDS Control Organisation (NACO)], 2010, TECHN REP IND HIV ES; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Parrado EA, 2004, PERSPECT SEX REPRO H, V36, P150, DOI 10.1111/j.1931-2393.2004.tb00016.x; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Population Council, 2008, PATT MIGR MOB HIV RI; Poudel KC, 2004, TROP DOCT, V34, P30, DOI 10.1177/004947550403400115; QUINN TC, 1994, P NATL ACAD SCI USA, V91, P2407, DOI 10.1073/pnas.91.7.2407; Registrar General of India (RGI), 2001, CENS IND MIGR PART; Registrar General of India (RGI), 2011, CENS IND PROV POP TO; Saggurti N, 2011, AIDS BEHAV; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S6; Saggurti N, 2009, AIDS BEHAV, V13, P921, DOI 10.1007/s10461-009-9564-8; Sogarwal Ruchi, 2009, J Indian Med Assoc, V107, P276; Soskolne V, 2002, SOC SCI MED, V55, P1297, DOI 10.1016/S0277-9536(01)00282-9; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; Yang XS, 2004, INT MIGR REV, V38, P212, DOI 10.1111/j.1747-7379.2004.tb00194.x; Zuma K, 2003, INT J STD AIDS, V14, P814, DOI 10.1258/095646203322556147	33	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43222	10.1371/journal.pone.0043222	http://dx.doi.org/10.1371/journal.pone.0043222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970120	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400007
J	Zhao, RY; Mifsud, NA; Xiao, K; Chan, KF; Oveissi, S; Jackson, HM; Dimopoulos, N; Guillaume, P; Knights, AJ; Lowen, T; Robson, NC; Russell, SE; Scotet, E; Davis, ID; Maraskovsky, E; Cebon, J; Luescher, IF; Chen, WS				Zhao, Rona Y.; Mifsud, Nicole A.; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M.; Dimopoulos, Nektaria; Guillaume, Philippe; Knights, Ashley J.; Lowen, Tamara; Robson, Neil C.; Russell, Sarah E.; Scotet, Emmanuel; Davis, Ian D.; Maraskovsky, Eugene; Cebon, Jonathan; Luescher, Immanuel F.; Chen, Weisan			A Novel HLA-B18 Restricted CD8+T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen	PLOS ONE			English	Article							CD8(+) T-CELLS; NEWLY SYNTHESIZED PROTEINS; HUMAN-MALIGNANT-MELANOMA; IMMUNODOMINANCE HIERARCHY; ISCOMATRIX ADJUVANT; STANDARD PROTEASOME; NY-ESO-1 PROTEIN; SURFACE ANTIGENS; UP-REGULATION; IN-VIVO	NY-ESO-1 has been a major target of many immunotherapy trials because it is expressed by various cancers and is highly immunogenic. In this study, we have identified a novel HLA-B*1801-restricted CD8(+) T cell epitope, NY-ESO-1(88-96) (LEFYLAMPF) and compared its direct- and cross-presentation to that of the reported NY-ESO-1(157-165) epitope restricted to HLA-A*0201. Although both epitopes were readily cross-presented by DCs exposed to various forms of full-length NY-ESO-1 antigen, remarkably NY-ESO-1(88-96) is much more efficiently cross-presented from the soluble form, than NY-ESO-1(157-165). On the other hand, NY-ESO-1(157-165) is efficiently presented by NY-ESO-1-expressing tumor cells and its presentation was not enhanced by IFN-gamma treatment, which induced immunoproteasome as demonstrated by Western blots and functionally a decreased presentation of Melan A(26-35); whereas NY-ESO-1(88-96) was very inefficiently presented by the same tumor cell lines, except for one that expressed high level of immunoproteasome. It was only presented when the tumor cells were first IFN-gamma treated, followed by infection with recombinant vaccinia virus encoding NY-ESO-1, which dramatically increased NY-ESO-1 expression. These data indicate that the presentation of NY-ESO-1(88-96) is immunoproteasome dependent. Furthermore, a survey was conducted on multiple samples collected from HLA-B18(+) melanoma patients. Surprisingly, all the detectable responses to NY-ESO-1(88-96) from patients, including those who received NY-ESO-1 ISCOMATRIX (TM) vaccine were induced spontaneously. Taken together, these results imply that some epitopes can be inefficiently presented by tumor cells although the corresponding CD8(+) T cell responses are efficiently primed in vivo by DCs cross-presenting these epitopes. The potential implications for cancer vaccine strategies are further discussed.	[Zhao, Rona Y.; Mifsud, Nicole A.; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M.; Dimopoulos, Nektaria; Knights, Ashley J.; Lowen, Tamara; Robson, Neil C.; Russell, Sarah E.; Davis, Ian D.; Cebon, Jonathan; Chen, Weisan] Austin Hlth, Melbourne Austin Branch, Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Guillaume, Philippe; Luescher, Immanuel F.] Ludwig Inst Canc Res, Lausanne Branch, Lausanne, Switzerland; [Scotet, Emmanuel] Inst Biol, Nantes, France; [Maraskovsky, Eugene] CSL Ltd, Parkville, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; CSL	Zhao, RY (corresponding author), Austin Hlth, Melbourne Austin Branch, Ludwig Inst Canc Res, Heidelberg, Vic, Australia.	weisan.chen@latrobe.edu.au	Oveissi, Sara/W-9426-2019; SCOTET, Emmanuel/L-2576-2015; SCOTET, Emmanuel/AAC-9971-2019; Cebon, Jonathan S/H-1643-2013; Chen, Weisan/E-7828-2012; Davis, Ian D/A-1430-2012	Oveissi, Sara/0000-0002-7353-5108; SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Chen, Weisan/0000-0002-5221-9771; Davis, Ian D/0000-0002-9066-8244; Cebon, Jonathan/0000-0002-3898-950X; Mifsud, Nicole/0000-0001-8647-2102	NHMRC [433608, 542508, 603104]; Cancer Council Victoria grant [381409]; Victorian Cancer Agency Clinician Researcher Fellowship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Cancer Agency Clinician Researcher Fellowship	This project was partly supported by the NHMRC project grants 433608 and 542508, and the Cancer Council Victoria grant 381409 to WC. WC is an NHMRC Senior Research Fellow (603104). IDD is supported in part by a Victorian Cancer Agency Clinician Researcher Fellowship and is an Honorary Practitioner Fellow of the Australian National Health and Medical Research Council (NHMRC). JC is an NHMRC Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ahmad M, 2004, CANCER IMMUNOL IMMUN, V53, P844, DOI 10.1007/s00262-004-0540-x; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chapatte L, 2006, CANCER RES, V66, P5461, DOI 10.1158/0008-5472.CAN-05-4310; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Chen W, 2004, J IMMUNOL, V173, P5021, DOI 10.4049/jimmunol.173.8.5021; Chen WS, 2006, ADV CANCER RES, V95, P203, DOI 10.1016/S0065-230X(06)95006-4; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Dannull J, 2007, BLOOD, V110, P4341, DOI 10.1182/blood-2007-04-083188; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7; Dimopoulos N, 2009, J IMMUNOL METHODS, V340, P90, DOI 10.1016/j.jim.2008.09.023; DIPPOLD WG, 1980, P NATL ACAD SCI-BIOL, V77, P6114, DOI 10.1073/pnas.77.10.6114; Donohue KB, 2006, IMMUNOLOGY, V119, P63, DOI 10.1111/j.1365-2567.2006.02406.x; Dutoit V, 2002, J CLIN INVEST, V110, P1813, DOI 10.1172/JCI200216428; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; GACZYNSKA M, 1993, ENZYME PROTEIN, V47, P354, DOI 10.1159/000468693; Jackson H, 2006, J IMMUNOL, V176, P5908, DOI 10.4049/jimmunol.176.10.5908; Jackson HM, 2004, J IMMUNOL METHODS, V291, P51, DOI 10.1016/j.jim.2004.04.017; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kammertoens T, 2005, TRENDS MOL MED, V11, P225, DOI 10.1016/j.molmed.2005.03.002; Macagno A, 2001, EUR J IMMUNOL, V31, P3271, DOI 10.1002/1521-4141(200111)31:11<3271::AID-IMMU3271>3.0.CO;2-2; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Murphy R, 2005, PREP BIOCHEM BIOTECH, V35, P119, DOI 10.1081/PB-200054732; Nicholaou T, 2009, CLIN CANCER RES, V15, P2166, DOI 10.1158/1078-0432.CCR-08-2484; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Odunsi K, 2003, CANCER RES, V63, P6076; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Robson NC, 2010, BLOOD, V116, P218, DOI 10.1182/blood-2009-10-249458; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Schreiber H, 2002, SEMIN CANCER BIOL, V12, P25, DOI 10.1006/scbi.2001.0401; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schultz ES, 2002, J EXP MED, V195, P391, DOI 10.1084/jem.20011974; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44707	10.1371/journal.pone.0044707	http://dx.doi.org/10.1371/journal.pone.0044707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970293	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000308458400108
J	Philip, N; Vaikkinen, HJ; Tetley, L; Waters, AP				Philip, Nisha; Vaikkinen, Heli J.; Tetley, Laurence; Waters, Andrew P.			A Unique Kelch Domain Phosphatase in Plasmodium Regulates Ookinete Morphology, Motility and Invasion	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASE; MALARIA PARASITE; LIFE-CYCLE; MOSQUITO TRANSMISSION; SER/THR PHOSPHATASES; SEXUAL DEVELOPMENT; PROTEOMIC ANALYSES; GAMETE FORMATION; REPEAT DOMAINS; KINASE	Signalling through post-translational modification (PTM) of proteins is a process central to cell homeostasis, development and responses to external stimuli. The best characterised PTM is protein phosphorylation which is reversibly catalysed at specific residues through the action of protein kinases (addition) and phosphatases (removal). Here, we report characterisation of an orphan protein phosphatase that possesses a domain architecture previously only described in Plantae. Through gene disruption and the production of active site mutants, the enzymatically active Protein Phosphatase containing Kelch-Like domains (PPKL, PBANKA_132950) is shown to play an essential role in the development of an infectious ookinete. PPKL is produced in schizonts and female gametocytes, is maternally inherited where its absence leads to the development of a malformed, immotile, non-infectious ookinete with an extended apical protrusion. The distribution of PPKL includes focussed localization at the ookinete apical tip implying a link between its activity and the correct deployment of the apical complex and microtubule cytoskeleton. Unlike wild type parasites, ppkl(-) ookinetes do not have a pronounced apical distribution of their micronemes yet secretion of microneme cargo is unaffected in the mutant implying that release of microneme cargo is either highly efficient at the malformed apical prominence or secretion may also occur from other points of the parasite, possibly the pellicular pores.	[Philip, Nisha; Vaikkinen, Heli J.; Tetley, Laurence; Waters, Andrew P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow	Philip, N (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Sir Graeme Davies Bldg, Glasgow, Lanark, Scotland.	Nisha.philip@glasgow.ac.uk; Andy.Waters@glasgow.ac.uk		Philip, Nisha/0000-0001-9901-1997	European Molecular Biology Organization Long-Term Fellowship (EMBO LTF); Wellcome Trust [083811/Z/07/Z]; EU FP7 Network of Excellence EviMalar [242095]	European Molecular Biology Organization Long-Term Fellowship (EMBO LTF)(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); EU FP7 Network of Excellence EviMalar	The work was funded by a European Molecular Biology Organization Long-Term Fellowship (EMBO LTF) to NP, Wellcome Trust to APW (083811/Z/07/Z) and EU FP7 Network of Excellence EviMalar to APW (242095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Agarwal S, 2011, J CELL BIOCHEM, V112, P1295, DOI 10.1002/jcb.23034; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Ben Rached F, 2012, BIOL CELL, V104, P34, DOI 10.1111/boc.201100081; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Budhwar R, 2011, CELL CYCLE, V10, P767, DOI 10.4161/cc.10.5.14828; Bushell ESC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000539; CANNING EU, 1973, PARASITOLOGY, V67, P29, DOI 10.1017/S0031182000046266; Dixit A, 2010, J BIOL CHEM, V285, P38315, DOI 10.1074/jbc.M110.119255; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007; Hirai M, 2006, J BIOCHEM, V140, P747, DOI 10.1093/jb/mvj205; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kim TW, 2011, MOL CELL, V43, P561, DOI 10.1016/j.molcel.2011.05.037; Kostich M, 2002, GENOME BIOL, V3; Kutuzov MA, 2002, CELL SIGNAL, V14, P745, DOI 10.1016/S0898-6568(02)00018-9; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Li JL, 1998, MOL BIOCHEM PARASIT, V95, P287, DOI 10.1016/S0166-6851(98)00106-6; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Melnikova I, 2004, NAT REV DRUG DISCOV, V3, P993, DOI 10.1038/nrd1600; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Philip N, 2007, P NATL ACAD SCI USA, V104, P7845, DOI 10.1073/pnas.0611601104; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Reininger L, 2009, J BIOL CHEM, V284, P20858, DOI 10.1074/jbc.M109.017988; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Tremp AZ, 2011, J BIOL CHEM, V286, P5383, DOI 10.1074/jbc.M110.187195; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yokoyama D, 1998, BIOCHEM BIOPH RES CO, V247, P18, DOI 10.1006/bbrc.1998.8730; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	51	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44617	10.1371/journal.pone.0044617	http://dx.doi.org/10.1371/journal.pone.0044617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957089	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308463800082
J	Rossi, C; Shrier, I; Marshall, L; Cnossen, S; Schwartzman, K; Klein, MB; Schwarzer, G; Greenaway, C				Rossi, Carmine; Shrier, Ian; Marshall, Lee; Cnossen, Sonya; Schwartzman, Kevin; Klein, Marina B.; Schwarzer, Guido; Greenaway, Chris			Seroprevalence of Chronic Hepatitis B Virus Infection and Prior Immunity in Immigrants and Refugees: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMPREHENSIVE IMMUNIZATION STRATEGY; GLOBAL EPIDEMIOLOGY; COST-EFFECTIVENESS; ELIMINATE TRANSMISSION; ADVISORY-COMMITTEE; UNITED-STATES; RECOMMENDATIONS; MIGRANTS	Background: International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies. Methods and Findings: Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV. Conclusions: The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries.	[Rossi, Carmine; Shrier, Ian; Marshall, Lee; Cnossen, Sonya; Greenaway, Chris] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Rossi, Carmine; Shrier, Ian; Schwartzman, Kevin; Klein, Marina B.; Greenaway, Chris] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Schwartzman, Kevin] McGill Univ, Resp Epidemiol & Clin Res Unit, Montreal Chest Inst, Montreal, PQ, Canada; [Klein, Marina B.] McGill Univ, Div Infect Dis, Ctr Hlth, Montreal, PQ, Canada; [Schwarzer, Guido] Univ Freiburg, Inst Med Biometry & Med Informat, D-79106 Freiburg, Germany; [Greenaway, Chris] McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; University of Freiburg; McGill University	Rossi, C (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	carmine.rossi@mail.mcgill.ca	Shrier, Ian/AAI-6502-2020; Schwarzer, Guido/A-8168-2009	Shrier, Ian/0000-0001-9914-3498; Schwarzer, Guido/0000-0001-6214-9087; Klein, Marina/0000-0002-3063-8430	Fonds de la Recherche en Sante du Quebec (FRSQ) through the Bourse de Maitrise; Chercheur Boursier Clinicien programs	Fonds de la Recherche en Sante du Quebec (FRSQ) through the Bourse de Maitrise; Chercheur Boursier Clinicien programs	CR, MK and CG receive salary support from the Fonds de la Recherche en Sante du Quebec (FRSQ; www.frsq.gouv.qc.ca/en/index.shtml) through the Bourse de Maitrise (CR) and the Chercheur Boursier Clinicien programs (MK, CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Australian Society for Infectious Diseases, 2009, DIAGN MAN PREV INF R; BOUCHARDY C, 1995, CANCER CAUSE CONTROL, V6, P539, DOI 10.1007/BF00054163; Centers for Disease Control and Prevention, 2011, HEP 2 2012 YELL BOOK; Cohen C, 2011, J VIRAL HEPATITIS, V18, P377, DOI 10.1111/j.1365-2893.2010.01401.x; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; DesMeules Marie, 2005, J Immigr Health, V7, P221, DOI 10.1007/s10903-005-5118-y; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; European Centre for Disease Control and Prevention, 2010, HEP B C EU NEIGHB PR; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Gayer M, 2007, EMERG INFECT DIS, V13, P1625, DOI 10.3201/eid1311.061093; Greenaway C, 2011, CMAJ, V183, pE847; GRULICH AE, 1995, BRIT J CANCER, V71, P400, DOI 10.1038/bjc.1995.82; Haworth E A, 1999, Ethn Health, V4, P93; Health Protection Agency, 2011, MIGR HLTH GUID; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Institute of Medicine, 2010, HEP LIV CANC NAT STR; International Organization for Migration, 2010, FACTS FIG; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LEVINE OS, 1994, EPIDEMIOL REV, V16, P418, DOI 10.1093/oxfordjournals.epirev.a036161; MacKellar DA, 2001, AM J PUBLIC HEALTH, V91, P965, DOI 10.2105/AJPH.91.6.965; Maechler M., 2011, LME4 LINEAR MIXED EF; McDermott S, 2011, J IMMIGR MINOR HEALT, V13, P15, DOI 10.1007/s10903-010-9347-3; McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456; McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006; Merrill RM, 2011, INT J INFECT DIS, V15, pE78, DOI 10.1016/j.ijid.2010.09.005; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Rein DB, 2010, J VIRAL HEPATITIS, V17, P28, DOI 10.1111/j.1365-2893.2009.01165.x; Rein DB, 2011, PUBLIC HEALTH REP, V126, P560, DOI 10.1177/003335491112600412; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Schwarzer G., 2007, R NEWS, V7, P40; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Ward JW, 2011, LANCET, V378, P552, DOI 10.1016/S0140-6736(11)60839-8; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wong R, 2008, AM J MED, V121, P525, DOI 10.1016/j.amjmed.2008.03.005; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; World Bank, 2011, WE CLASS COUNTR; World Health Organization, 2008, HEP B	42	102	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44611	10.1371/journal.pone.0044611	http://dx.doi.org/10.1371/journal.pone.0044611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957088	Green Published, gold			2022-12-27	WOS:000308463800081
J	Shetty, PK; Thamake, SI; Biswas, S; Johansson, SL; Vishwanatha, JK				Shetty, Praveenkumar K.; Thamake, Sanjay I.; Biswas, Swati; Johansson, Sonny L.; Vishwanatha, Jamboor K.			Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DEPENDENT PLASMINOGEN ACTIVATION; PROSTATE-CANCER; CELL-LINES; T-PA; PROTEIN EXPRESSION; II OVEREXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; TARGETING SRC	Alternative survival pathways are commonly seen to be upregulated upon inhibition of receptor tyrosine kinases (RTK), including Her-2. It is established that treatment with Herceptin leads to selective overexpression and activation of epidermal growth factor receptor (EGFR) and Src which further contributes to oncogenesis in Herceptin resistant and triple negative breast cancer (TNBC) patients. Here, we show a co-regulated upregulation in the expression of Annexin A2 (AnxA2), a known substrate of Src and one of the regulators of EGFR receptor endocytosis, in Herceptin resistant and Her-2 negative breast cancer. Immunohistochemical expression analysis revealed a reciprocal regulation between Her-2 and AnxA2 in breast cancer clinical samples as well as in cell lines as confirmed by protein and RNA analysis. The siRNA and Herceptin mediated downregulation/inhibition of Her-2 in Her-2 amplified cells induced AnxA2 expression and membrane translocation. In this study we report a possible involvement of AnxA2 in maintaining constitutively activated EGFR downstream signaling intermediates and hence in cell proliferation, migration and viability. This effect was consistent in Herceptin resistant JIMT-1 cells as well as in Her-2 negative breast cancer. The siRNA mediated AnxA2 downregulation leads to increased apoptosis, decreased cell viability and migration. Our studies further indicate the role of AnxA2 in EGFR-Src membrane bound signaling complex and ligand induced activation of downstream signaling pathways. Targeting this AnxA2 dependent positive regulation of EGFR signaling cascade may be of therapeutic value in Her-2 negative breast cancer.	[Shetty, Praveenkumar K.; Vishwanatha, Jamboor K.] SDM Coll Med Sci & Hosp, Dept Biochem, Dharwad, Karnataka, India; [Thamake, Sanjay I.; Vishwanatha, Jamboor K.] Univ N Texas, Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX USA; [Johansson, Sonny L.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Biswas, Swati] Univ Texas Dallas, Dept Math Sci, Dallas, TX 75230 USA	University of North Texas System; University of North Texas Health Science Center; University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Dallas	Shetty, PK (corresponding author), SDM Coll Med Sci & Hosp, Dept Biochem, Dharwad, Karnataka, India.	jamboor.vishwanatha@unthsc.edu		Vishwanatha, Jamboor/0000-0002-0266-6020	National Institutes of Health [MD001633, MD006882]; Cancer Research Foundation of North Texas; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Foundation of North Texas; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants from the National Institutes of Health (MD001633 and MD006882) and Cancer Research Foundation of North Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Banerjee Abhijit G, 2003, Mol Cancer, V2, P34, DOI 10.1186/1476-4598-2-34; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boyer J, 2004, ANTICANCER RES, V24, P417; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Choudhury A, 2004, INT J CANCER, V108, P71, DOI 10.1002/ijc.11497; Chuthapisith S, 2007, INT J ONCOL, V30, P1545; Chuthapisith S, 2009, EUR J CANCER, V45, P1274, DOI 10.1016/j.ejca.2008.12.026; CIOCCA DR, 1993, J NATL CANCER I, V85, P570, DOI 10.1093/jnci/85.7.570; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diaz VM, 2004, GUT, V53, P993, DOI 10.1136/gut.2003.026831; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Emoto K, 2001, ANTICANCER RES, V21, P1339; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Kauraniemi P, 2004, ONCOGENE, V23, P1010, DOI 10.1038/sj.onc.1207200; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Ohno Y, 2009, BRIT J CANCER, V101, P287, DOI 10.1038/sj.bjc.6605128; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Ribeiro-Silva A, 2006, AM J CLIN PATHOL, V125, P512, DOI 10.1309/D744C4NM15J3B00D; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shimizu M, 2011, CANCER RES, V71, P277, DOI 10.1158/0008-5472.CAN-10-2523; Snoj N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2209; Takano S, 2008, ANN SURG ONCOL, V15, P3157, DOI 10.1245/s10434-008-0061-5; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Toyama T, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-309; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Valapala M, 2011, J CELL SCI, V124, P1453, DOI 10.1242/jcs.079236; Viale G, 2008, BREAST CANC RES TREA; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; Yao HX, 2009, LUNG CANCER, V65, P41, DOI 10.1016/j.lungcan.2008.10.024; Yoo JC, 2007, BIOCHEM BIOPH RES CO, V356, P906, DOI 10.1016/j.bbrc.2007.03.061; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang Y, 2010, J CLIN ONCOL, V9, pP660; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200	58	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44299	10.1371/journal.pone.0044299	http://dx.doi.org/10.1371/journal.pone.0044299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957061	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800054
J	Xie, GQ; Xu, J; Ye, CY; Chen, DP; Xu, CG; Yang, L; Ma, YY; Hu, XH; Li, L; Sun, LJ; Zhao, XZ; Mao, ZG; Mei, CL				Xie, Guoqiang; Xu, Jing; Ye, Chaoyang; Chen, Dongping; Xu, Chenggang; Yang, Li; Ma, Yiyi; Hu, Xiaohong; Li, Lin; Sun, Lijun; Zhao, Xuezhi; Mao, Zhiguo; Mei, Changlin			Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; UNTREATED PATIENTS; NATURAL-HISTORY; METHYLPREDNISOLONE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; PROGNOSIS	Background: Idiopathic membranous nephropathy (IMN) is the most common pathological type for nephrotic syndrome in adults in western countries and China. The benefits and harms of immunosuppressive treatment in IMN remain controversial. Objectives: To assess the efficacy and safety of different immunosuppressive agents in the treatment of nephrotic syndrome caused by IMN. Methods: PubMed, EMBASE, Cochrane Library and wanfang, weipu, qinghuatongfang, were searched for relevant studies published before December 2011. Reference lists of nephrology textbooks, review articles were checked. A meta-analysis of randomized controlled trials (RCTs) meeting the criteria was performed using Review Manager. Main Results: 17 studies were included, involving 696 patients. Calcineurin inhibitors had a better effect when compared to alkylating agents, on complete remission (RR 1.61, 95% CI 1.13, to 2.30 P = 0.008), partial or complete remission (effective) (CR/PR, RR 1.29, 95% CI 1.09 to 1.52 P = 0.003), and fewer side effects. Among calcineurin inhibitors, tacrolimus (TAC) was shown statistical significance in inducing more remissions. When compared to cyclophosphamide (CTX), leflunomide (LET) showed no beneficial effect, mycophenolate mofetil (MMF) showed significant beneficial on effectiveness (CR/PR, RR: 1.41, 95% CI 1.16 to 1.72 P = 0.0006) but not significant on complete remission (CR, RR: 1.38, 95% CI 0.89 to 2.13 P = 0.15). Conclusions: This analysis based on Chinese adults and short duration RCTs suggested calcineurin inhibitors, especially TAC, were more effective in proteinuria reduction in IMN with acceptable side effects. Long duration RCTs were needed to confirm the long-term effects of those agents in nephrotic IMN.	[Xie, Guoqiang; Xu, Jing; Ye, Chaoyang; Chen, Dongping; Xu, Chenggang; Yang, Li; Ma, Yiyi; Hu, Xiaohong; Li, Lin; Sun, Lijun; Zhao, Xuezhi; Mao, Zhiguo; Mei, Changlin] Second Mil Med Univ, Changzheng Hosp, Div Nephrol, Kidney Inst CPLA, Shanghai, Peoples R China	Naval Medical University	Xie, GQ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Div Nephrol, Kidney Inst CPLA, Shanghai, Peoples R China.	maozhiguo93@gmail.com; chlmei1954@126.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, yiyi/0000-0002-0772-957X	Shanghai Higher Education Outstanding Young Teacher Scientific Research Special Fund, Shanghai Municipal Education Commission; Outstanding Young Scholars project, Second Military Medical University; Medical Educational Reforming and Research Grant of Changzheng Hospital; National Nature Science Fund of China [81000281]	Shanghai Higher Education Outstanding Young Teacher Scientific Research Special Fund, Shanghai Municipal Education Commission; Outstanding Young Scholars project, Second Military Medical University; Medical Educational Reforming and Research Grant of Changzheng Hospital; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Higher Education Outstanding Young Teacher Scientific Research Special Fund, Shanghai Municipal Education Commission; Outstanding Young Scholars project, Second Military Medical University; Medical Educational Reforming and Research Grant of Changzheng Hospital. This work was funded in part by the National Nature Science Fund of China (81000281). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WW, 2009, OCCUPATION HLTH, V25, P2009; Bai GZ, 2011, J GUIYANG COLL TRADI, V33, P52; Chan TM, 2007, NEPHROLOGY, V12, P576, DOI 10.1111/j.1440-1797.2007.00822.x; Chen M, 2010, AM J MED SCI, V339, P233, DOI 10.1097/MAJ.0b013e3181ca3a7d; Chen WZ, 2009, J PRACTICAL MED, V25, P1674; DONADIO JV, 1988, KIDNEY INT, V33, P708, DOI 10.1038/ki.1988.56; HONKANEN E, 1992, NEPHROL DIAL TRANSPL, V7, P35; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Li G, 2011, CHINESE J INTEGRATED, V12, P872; Li GF, 2011, CHINESE J INTEGRATED, V12, P522; Li MX, 2004, J CLIN NEPHROLOGY, V4, P160; Liu J. P., 2009, THESIS; PONTICELLI C, 1989, NEW ENGL J MED, V320, P8, DOI 10.1056/NEJM198901053200102; PONTICELLI C, 1995, KIDNEY INT, V48, P1600, DOI 10.1038/ki.1995.453; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; Praga M, 2007, KIDNEY INT, V71, P924, DOI 10.1038/sj.ki.5002215; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; Ren Y, 2011, J MODERN CHINESE DOC, V49, P73; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203; Schieppati A, 2004, COCHRANE DB SYST REV; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Wu Q., 2011, CHINA PHARM, V14, P115; Xu J, 2010, NEPHROLOGY, V15, P43; Zhang W, 2011, CHINESE J INTEGRATED, V12, P59; Zhou W., 2009, SICHUAN MED J, V30, P1889; Zhou W., 2009, J CLIN INTERNAL MED, V26, P479; Zhu KY, 2009, CHINA PRACTICAL MED, V4, P99; 孙广东, 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P469	29	15	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44330	10.1371/journal.pone.0044330	http://dx.doi.org/10.1371/journal.pone.0044330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957065	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800058
J	Bridier, A; Sanchez-Vizuete, MD; Le Coq, D; Aymerich, S; Meylheuc, T; Maillard, JY; Thomas, V; Dubois-Brissonnet, F; Briandet, R				Bridier, Arnaud; Sanchez-Vizuete, Maria del Pilar; Le Coq, Dominique; Aymerich, Stephane; Meylheuc, Thierry; Maillard, Jean-Yves; Thomas, Vincent; Dubois-Brissonnet, Florence; Briandet, Romain			Biofilms of a Bacillus subtilis Hospital Isolate Protect Staphylococcus aureus from Biocide Action	PLOS ONE			English	Article							BACTERIAL BIOFILMS; LISTERIA-MONOCYTOGENES; SPECIES BIOFILMS; RESISTANCE; CONTAMINATION; INFECTION; OUTBREAK; AGENTS; PENETRATION; GLYCOCALYX	The development of a biofilm constitutes a survival strategy by providing bacteria a protective environment safe from stresses such as microbicide action and can thus lead to important health-care problems. In this study, biofilm resistance of a Bacillus subtilis strain (called hereafter NDmedical) recently isolated from endoscope washer-disinfectors to peracetic acid was investigated and its ability to protect the pathogen Staphylococcus aureus in mixed biofilms was evaluated. Biocide action within Bacillus subtilis biofilms was visualised in real time using a non-invasive 4D confocal imaging method. The resistance of single species and mixed biofilms to peracetic acid was quantified using standard plate counting methods and their architecture was explored using confocal imaging and electronic microscopy. The results showed that the NDmedical strain demonstrates the ability to make very large amount of biofilm together with hyper-resistance to the concentration of PAA used in many formulations (3500 ppm). Evidences strongly suggest that the enhanced resistance of the NDmedical strain was related to the specific three-dimensional structure of the biofilm and the large amount of the extracellular matrix produced which can hinder the penetration of peracetic acid. When grown in mixed biofilm with Staphylococcus aureus, the NDmedical strain demonstrated the ability to protect the pathogen from PAA action, thus enabling its persistence in the environment. This work points out the ability of bacteria to adapt to an extremely hostile environment, and the necessity of considering multi-organism ecosystems instead of single species model to decipher the mechanisms of biofilm resistance to antimicrobials agents.	[Bridier, Arnaud; Sanchez-Vizuete, Maria del Pilar; Le Coq, Dominique; Aymerich, Stephane; Meylheuc, Thierry; Dubois-Brissonnet, Florence; Briandet, Romain] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Bridier, Arnaud; Sanchez-Vizuete, Maria del Pilar; Le Coq, Dominique; Aymerich, Stephane; Meylheuc, Thierry; Dubois-Brissonnet, Florence; Briandet, Romain] AgroParisTech, UMR MICALIS, Jouy En Josas, France; [Le Coq, Dominique] CNRS, Jouy En Josas, France; [Maillard, Jean-Yves] Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales; [Thomas, Vincent] STERIS, Fontenay Aux Roses, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Cardiff University	Bridier, A (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	romain.briandet@jouy.inra.fr	Maillard, Jean-Yves/N-4113-2014; Thomas, Vincent/A-8941-2012; Thomas, Vincent/AAB-8982-2019; Thomas, Vincent/AAB-6394-2022; Briandet, Romain/AAD-2102-2020; bridier, arnaud/D-7183-2013	Maillard, Jean-Yves/0000-0002-8617-9288; Thomas, Vincent/0000-0003-4034-9525; Thomas, Vincent/0000-0003-4034-9525; Briandet, Romain/0000-0002-8123-3492; bridier, arnaud/0000-0003-4812-3301; Le Coq, Dominique/0000-0001-5756-2280; Dubois-Brissonnet, Florence/0000-0003-2998-7518; Bridier, Arnaud/0000-0002-7221-8944	Medicen, Ile-de-France, competitiveness cluster; National Institute for Agronomic Research; Essonne department	Medicen, Ile-de-France, competitiveness cluster; National Institute for Agronomic Research; Essonne department	This project was funded by the Medicen, Ile-de-France, competitiveness cluster and the National Institute for Agronomic Research. Financial support of the confopcal microscope was provided by the the Essonne department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899; Bridier A, 2011, ANTIMICROB AGENTS CH, V55, P2648, DOI 10.1128/AAC.01760-10; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Bridier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016177; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Cooper IR, 2010, J HOSP INFECT, V74, P152, DOI 10.1016/j.jhin.2009.07.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEBEER D, 1994, APPL ENVIRON MICROB, V60, P4339, DOI 10.1128/AEM.60.12.4339-4344.1994; Deva AK, 1998, J HOSP INFECT, V39, P149, DOI 10.1016/S0195-6701(98)90329-2; DiazGranados CA, 2009, INFECT CONT HOSP EP, V30, P550, DOI 10.1086/597235; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Fassel TA, 1999, METHOD ENZYMOL, V310, P194; Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gardam M A, 2000, Can J Infect Dis, V11, P202; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Grobe KJ, 2002, J IND MICROBIOL BIOT, V29, P10, DOI 10.1038/sj.jim.7000256; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Jang A, 2006, APPL MICROBIOL BIOT, V72, P368, DOI 10.1007/s00253-005-0274-5; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; Kressel AB, 2001, INFECT CONT HOSP EP, V22, P414, DOI 10.1086/501926; Lee RM, 1998, GASTROINTEST ENDOSC, V47, P377, DOI 10.1016/S0016-5107(98)70222-6; Leriche V, 2003, ENVIRON MICROBIOL, V5, P64, DOI 10.1046/j.1462-2920.2003.00394.x; Machado Alexandre P., 2006, Arq. Gastroenterol., V43, P255, DOI 10.1590/S0004-28032006000400002; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Martin DJH, 2008, J HOSP INFECT, V69, P377, DOI 10.1016/j.jhin.2008.04.010; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; Perl TM, 1998, ANN PHARMACOTHER, V32, pS7, DOI 10.1177/106002809803200104; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romling U, 2004, CELLULOSE, V11, P413, DOI 10.1023/B:CELL.0000046411.74345.8f; Rutala WA, 2004, J HOSP INFECT, V56, pS27, DOI 10.1016/j.jhin.2003.12.035; Shemesh M, 2010, J BACTERIOL, V192, P6352, DOI 10.1128/JB.01025-10; Simoes LC, 2010, APPL ENVIRON MICROB, V76, P6673, DOI 10.1128/AEM.00872-10; Simoes M, 2009, WATER RES, V43, P229, DOI 10.1016/j.watres.2008.10.010; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; 1997, 1040 NF EN AFNOR	48	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44506	10.1371/journal.pone.0044506	http://dx.doi.org/10.1371/journal.pone.0044506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973457	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308577600064
J	Sharma, S; Sun, XT; Rafikov, R; Kumar, S; Hou, YL; Oishi, PE; Datar, SA; Raff, G; Fineman, JR; Black, SM				Sharma, Shruti; Sun, Xutong; Rafikov, Ruslan; Kumar, Sanjiv; Hou, Yali; Oishi, Peter E.; Datar, Sanjeev A.; Raff, Gary; Fineman, Jeffrey R.; Black, Stephen M.			PPAR-gamma Regulates Carnitine Homeostasis and Mitochondrial Function in a Lamb Model of Increased Pulmonary Blood Flow	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; NITRIC-OXIDE SYNTHASE; ARTERIAL ENDOTHELIAL-CELLS; GTP CYCLOHYDROLASE I; GENE-EXPRESSION; SHEAR-STRESS; VASCULAR-DISEASE; LIPID-METABOLISM; LAMINAR-FLOW; FETAL LAMBS	Objective: Carnitine homeostasis is disrupted in lambs with endothelial dysfunction secondary to increased pulmonary blood flow (Shunt). Our recent studies have also indicated that the disruption in carnitine homeostasis correlates with a decrease in PPAR-gamma expression in Shunt lambs. Thus, this study was carried out to determine if there is a causal link between loss of PPAR-gamma signaling and carnitine dysfunction, and whether the PPAR-gamma agonist, rosiglitazone preserves carnitine homeostasis in Shunt lambs. Methods and Results: siRNA-mediated PPAR-gamma knockdown significantly reduced carnitine palmitoyltransferases 1 and 2 (CPT1 and 2) and carnitine acetyltransferase (CrAT) protein levels. This decrease in carnitine regulatory proteins resulted in a disruption in carnitine homeostasis and induced mitochondrial dysfunction, as determined by a reduction in cellular ATP levels. In turn, the decrease in cellular ATP attenuated NO signaling through a reduction in eNOS/Hsp90 interactions and enhanced eNOS uncoupling. In vivo, rosiglitazone treatment preserved carnitine homeostasis and attenuated the development of mitochondrial dysfunction in Shunt lambs maintaining ATP levels. This in turn preserved eNOS/Hsp90 interactions and NO signaling. Conclusion: Our study indicates that PPAR-gamma signaling plays an important role in maintaining mitochondrial function through the regulation of carnitine homeostasis both in vitro and in vivo. Further, it identifies a new mechanism by which PPAR-gamma regulates NO signaling through Hsp90. Thus, PPAR-gamma agonists may have therapeutic potential in preventing the endothelial dysfunction in children with increased pulmonary blood flow.	[Sharma, Shruti; Sun, Xutong; Rafikov, Ruslan; Kumar, Sanjiv; Hou, Yali; Black, Stephen M.] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA; [Oishi, Peter E.; Datar, Sanjeev A.; Fineman, Jeffrey R.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Fineman, Jeffrey R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Raff, Gary] Univ Calif Davis, Dept Surg, Davis, CA 95616 USA	University System of Georgia; Augusta University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Sharma, S (corresponding author), Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA USA.	sblack@georgiahealth.edu	Rafikov, Ruslan/AAG-9352-2019	Sharma, Shruti/0000-0001-8200-108X; Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL60190, HL67841, HL72123, HL70061, R21HD057406]; Fondation Leducq; AHA Scientist Development Grant [11SDG7460024]; National Institutes of Health Training Grant [5T32-HL-06699]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060190, R01HL067841, R01HL072123, R01HL061284, R01HL070061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); AHA Scientist Development Grant(American Heart Association); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HL60190 (SMB), HL67841 (SMB), HL72123 (SMB), HL70061 (SMB), R21HD057406 (SMB), and HL61284 (JRF) all from the National Institutes of Health, and by a grant from the Fondation Leducq (SMB and JRF), an AHA Scientist Development Grant 11SDG7460024 (SS) and by National Institutes of Health Training Grant, 5T32-HL-06699 (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameshima S, 2003, CIRC RES, V92, P1162, DOI 10.1161/01.RES.0000073585.50092.14; Bao YX, 2008, MOL CELL BIOCHEM, V317, P189, DOI 10.1007/s11010-008-9848-8; Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; D'Argenio G, 2010, J BIOL CHEM, V285, P27078, DOI 10.1074/jbc.M110.109678; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Dhaunsi GS, 2010, EUR J PHARMACOL, V638, P108, DOI 10.1016/j.ejphar.2010.04.030; Ewing JF, 1998, FREE RADICAL BIO MED, V25, P621, DOI 10.1016/S0891-5849(98)00083-5; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Gupta D, 2010, DIABETES OBES METAB, V12, P1036, DOI 10.1111/j.1463-1326.2010.01299.x; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hart CM, 2008, J INVEST MED, V56, P515, DOI 10.2310/JIM.0b013e318165e89d; Hart CM, 2008, J INVEST MED, V56, P518, DOI 10.2310/JIM.0b013e318165e921; Hashimoto R, 2010, J ATHEROSCLER THROMB, V17, P785, DOI 10.5551/jat.4556; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Ikejima H, 2008, J HYPERTENS, V26, P964, DOI 10.1097/HJH.0b013e3282f52c36; Kelly LK, 2004, AM J PHYSIOL-LUNG C, V286, pL984, DOI 10.1152/ajplung.00224.2003; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim EK, 2010, RESPIROLOGY, V15, P659, DOI 10.1111/j.1440-1843.2010.01756.x; Kim S, 2005, J NUTR, V135, P33, DOI 10.1093/jn/135.1.33; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Konduri GG, 2000, BIOL NEONATE, V78, P220, DOI 10.1159/000014274; Konduri GG, 2002, AM J PHYSIOL-HEART C, V283, pH1600, DOI 10.1152/ajpheart.00245.2002; Lakshminrusimha S, 2007, AM J PHYSIOL-HEART C, V293, pH1491, DOI 10.1152/ajpheart.00185.2007; Lapsys NM, 2000, J CLIN ENDOCR METAB, V85, P4293, DOI 10.1210/jc.85.11.4293; Liu JK, 2002, P NATL ACAD SCI USA, V99, P1876, DOI 10.1073/pnas.261709098; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; MARBACH EP, 1967, CLIN CHEM, V13, P314; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Mata-Greenwood E, 2003, AM J PHYSIOL-LUNG C, V285, pL209, DOI 10.1152/ajplung.00171.2002; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Nisbet RE, 2007, PPAR RES, V2007, DOI 10.1155/2007/18797; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Poleni PE, 2007, OSTEOARTHR CARTILAGE, V15, P493, DOI 10.1016/j.joca.2006.10.009; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; REDDY VM, 1995, CIRCULATION, V92, P606, DOI 10.1161/01.CIR.92.3.606; Richir MC, 2009, PHARMACOL RES, V60, P519, DOI 10.1016/j.phrs.2009.06.007; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2007, AM J PHYSIOL-LUNG C, V293, pL960, DOI 10.1152/ajplung.00449.2006; Sharma S, 2012, FREE RADICAL BIO MED, V53, P216, DOI 10.1016/j.freeradbiomed.2012.03.016; Shen W, 2011, BR J PHARM; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sun XT, 2011, AM J RESP CELL MOL, V45, P163, DOI 10.1165/rcmb.2009-0467OC; Sutliff Roy L, 2010, Ther Adv Respir Dis, V4, P143, DOI 10.1177/1753465809369619; Tian J, 2009, PHYSIOL GENOMICS, V40, P48, DOI 10.1152/physiolgenomics.00094.2009; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; Viccica G, 2010, J Endocrinol Invest, V33, P9; Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002; Wedgwood S, 2001, AM J PHYSIOL-LUNG C, V281, pL490, DOI 10.1152/ajplung.2001.281.2.L490; Wiseman DA, 2007, AM J PHYSIOL-LUNG C, V292, pL165, DOI 10.1152/ajplung.00459.2005; Yuen CY, 2011, CARDIOVASC RES	61	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e41555	10.1371/journal.pone.0041555	http://dx.doi.org/10.1371/journal.pone.0041555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962578	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600005
J	Jentsch, U; Lunga, P; Lacey, C; Weber, J; Cairns, J; Pinheiro, G; Joseph, S; Stevens, W; McCormack, S				Jentsch, Ute; Lunga, Precious; Lacey, Charles; Weber, Jonathan; Cairns, Janet; Pinheiro, Gisela; Joseph, Sarah; Stevens, Wendy; McCormack, Sheena			The Implementation and Appraisal of a Novel Confirmatory HIV-1 Testing Algorithm in the Microbicides Development Programme 301 Trial (MDP301)	PLOS ONE			English	Article							P24 ANTIGEN; REAL-TIME; INFECTION; ANTIBODY; DIAGNOSIS; PCR; RNA; SPECIFICITY; SUITABILITY; PERFORMANCE	We describe the application of a novel HIV confirmatory testing algorithm to determine the primary efficacy endpoint in a large Phase III microbicide trial. 9385 women were enrolled between 2005 and 2009. Of these women, 537 (6%) had at least one positive HIV rapid test after enrolment. This triggered the use of the algorithm which made use of archived serum and Buffy Coat samples. The overall sample set was.95% complete. 419 (78%) of the rapid test positive samples were confirmed as primary endpoints using a combination of assays for the detection of HIV-specific antibodies (EIA's and Western Blot), and for components of the virus itself (PCR for the detection of nucleic acids and EIA for p24 antigen). 63 (12%) cases were confirmed as being HIV-positive at screening or enrolment and 55 (10%) were confirmed as HIV negative. The testing algorithm confirmed the endpoint at the same visit as that of the first positive rapid test in 90% of cases and at the time of the preceding visit in 10% of cases. Of the 63 cases which were subsequently confirmed to be HIV-1 positive at or before enrolment, 54 specimens contained no detectable HIV antibodies at screening or enrolment. However, 43 were positive using an EIA which detects both HIV antigen and antibody and also had a positive p24 antigen or HIV PCR test, which was highly suggestive of acute infection. There were 6 unusual cases which had undetectable HIV-1 DNA or RNA. In 4 of the 6 cases the presence of HIV-1-specific antibodies was confirmed by Western Blot. One of these cases with an indeterminate Western Blot was a previous vaccine trial participant. The algorithm served the objectives of the study well and can be recommended for use in determining HIV as an endpoint in clinical trials.	[Jentsch, Ute; Pinheiro, Gisela; Stevens, Wendy] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa; [Lunga, Precious; Cairns, Janet; Joseph, Sarah; McCormack, Sheena] MRC Clin Trials Unit, London, England; [Lacey, Charles] Univ York, York YO10 5DD, N Yorkshire, England; [Weber, Jonathan] Imperial Coll Sch Med, London, England	University of Witwatersrand; Medical Research Council Clinical Trials Unit; University of York - UK; Imperial College London	Jentsch, U (corresponding author), Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa.	ujentsch@cls.co.za			British Government Department for International Development (DIFD); UK Medical Research Council;  [G0100137]; MRC [G0100137] Funding Source: UKRI; Medical Research Council [G0100137] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	British Government Department for International Development (DIFD); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Microbicides Development Programme 301, a partnership of African, UK and Spanish academic government/institutions and commercial organisations was funded by the British Government Department for International Development (DIFD) and the UK Medical Research Council. This trial is registered at http://isrctn.org, number ISRCTN 64716212 (grant number G0100137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim Q, 2010, SCI EXPRESS, P1; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; BEHETS F, 1991, J CLIN MICROBIOL, V29, P2280, DOI 10.1128/JCM.29.10.2280-2284.1991; Bogh M, 2001, J CLIN VIROL, V20, P149, DOI 10.1016/S1386-6532(00)00147-5; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; BREDBERGRADEN U, 1988, AIDS, V2, P281, DOI 10.1097/00002030-198808000-00007; Bruzzone B, 2008, TROP MED INT HEALTH, V13, P900, DOI 10.1111/j.1365-3156.2008.02090.x; Busch MP, 1997, AM J MED, V102, P117; CDC, 2010, FDA APPR RAP HIV ANT; Claassen M, 2006, J CLIN VIROL, V37, P68, DOI 10.1016/j.jcv.2006.06.008; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Everett DB, 2007, TROP MED INT HEALTH, V12, P1323, DOI 10.1111/j.1365-3156.2007.01933.x; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; Everett DB, 2009, J CLIN MICROBIOL, V47, P1058, DOI 10.1128/JCM.01998-08; Food and Drug Administration, 2010, APPR LETT ARCHITECT; Gray RH, 2007, BRIT MED J, V335, P1; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; HENRARD DR, 1994, TRANSFUSION, V34, P376, DOI 10.1046/j.1537-2995.1994.34594249046.x; Jackson JB, 1997, J CLIN MICROBIOL, V35, P1118, DOI 10.1128/JCM.35.5.1118-1121.1997; Jenny-Avital ER, 2001, CLIN INFECT DIS, V32, P1227, DOI 10.1086/319752; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Ly TD, 2001, EUR J CLIN MICROBIOL, V20, P104, DOI 10.1007/s100960000430; Ly TD, 2004, J VIROL METHODS, V122, P185, DOI 10.1016/j.jviromet.2004.08.018; Madhivanan P, 2007, BMJ-BRIT MED J, V335, P165, DOI 10.1136/bmj.39275.457188.AE; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Morandi PA, 1998, J CLIN MICROBIOL, V36, P1534, DOI 10.1128/JCM.36.6.1534-1538.1998; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; Salinas A, 2007, CLIN INFECT DIS, V45, P139, DOI 10.1086/518709; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Silbermann B, 2008, AIDS RES HUM RETROV, V24, P1445, DOI 10.1089/aid.2008.0107; Skidmore S, 2009, INT J STD AIDS, V20, P205, DOI 10.1258/ijsa.2008.008263; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Terzi R, 2007, AIDS, V21, P262, DOI 10.1097/QAD.0b013e328011922c; WHO UNAIDS, 2002, 12 WHO UNAIDS; World Health Organization, 2004, RAP HIV TESTS GUID U; World Health Organization (WHO) UNAIDS/WHO, 1997, WKLY EPIDEMIOL REC, V12, P81; Zaman MM, 2002, CLIN INFECT DIS, V34, P417	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42322	10.1371/journal.pone.0042322	http://dx.doi.org/10.1371/journal.pone.0042322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984401	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700004
J	Lesimple, C; Fureix, C; De Margerie, E; Seneque, E; Menguy, H; Hausberger, M				Lesimple, Clemence; Fureix, Carole; De Margerie, Emmanuel; Seneque, Emilie; Menguy, Herve; Hausberger, Martine			Towards a Postural Indicator of Back Pain in Horses (Equus caballus)	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; ELECTROMYOGRAPHIC RECORDINGS; SURFACE ELECTROMYOGRAPHY; DIFFERENT POSITIONS; BEHAVIOR; MANIPULATION; DISORDERS; TREADMILL; WORK; DYSFUNCTION	Postures have long been used and proved useful to describe animals' behaviours and emotional states, but remains difficult to assess objectively in field conditions. A recent study performed on horses using geometric morphometrics revealed important postural differences between 2 horse populations differing in management conditions (leisure horses living in social groups used for occasional "relaxed" riding/riding school horses living in individual boxes used in daily riding lessons with more constraining techniques). It was suggested that these postural differences may reflect chronic effects of riding techniques on the horses' kinematics and muscular development. In the present study, we tried to evaluate the interest of postural measures to assess welfare in horses. This study was separated into 2 parts. First, 18 horses coming from these 2 types of populations (leisure/riding school horses) were submitted to 2 back evaluations by 1) manual examination (experienced practitioner) and 2) sEMG measures along the spine. We then measured neck roundness on 16 of these 18 horses. The results highlighted high correlations between manual and sEMG examinations over the spine. sEMG measures at the different locations were strongly correlated all over the spine. Moreover, neck postures and muscular activities were strongly correlated, horses with concave necks having higher sEMG measures both at precise locations (i.e. cervical sites) but also when comparing neck postures to the whole spine muscular activity highlighting the functioning of horses' back as a whole. Lastly, strong differences appeared between the populations, leisure horses being evaluated as having sounder spines, exhibiting lower sEMG measures and rounder neck than the riding school horses. sEMG measures and neck "roundness" seemed therefore to be reliable indicators of back disorders, easy to evaluate in field conditions. This highlights the accuracy of using postural elements to evaluate the animals' general state and has important implications for animals' welfare evaluations.	[Lesimple, Clemence; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Biol Stn,UMR 6552, Paimpont, France; [Fureix, Carole; De Margerie, Emmanuel; Seneque, Emilie; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, UMR 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Lesimple, C (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Biol Stn,UMR 6552, Paimpont, France.	clemence.lesimple@univ-rennes1.fr		/0000-0003-0664-1151; de Margerie, Emmanuel/0000-0002-5380-3355	Caisse Centrale de la Mutualite Sociale Agricole; French Research Ministry	Caisse Centrale de la Mutualite Sociale Agricole; French Research Ministry(Ministry of Research, France)	This study was supported by the Caisse Centrale de la Mutualite Sociale Agricole and the French Research Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroz C, 2000, J OCCUP ENVIRON MED, V42, P660, DOI 10.1097/00043764-200006000-00018; ARENA JG, 1989, PAIN, V37, P57, DOI 10.1016/0304-3959(89)90153-X; ARENA JG, 1991, PAIN, V45, P23, DOI 10.1016/0304-3959(91)90160-Y; Aublet H, 1975, MANUEL HIPPOLOGIE, P4; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Biau S, 2004, PFERDEHEILKUNDE, V20, P135, DOI 10.21836/PEM20040204; Bugajska J, 2011, MED PR, V62, P153; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Cauvin E, 1997, IN PRACTICE, V19, P522; Chiung-Yu C, 2007, J MANIP PHYSIOL THER, V31, P224; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Cooper JJ, 2005, APPL ANIM BEHAV SCI, V90, P351, DOI 10.1016/j.applanim.2004.08.005; CRAM JR, 1988, BIOFEEDBACK SELF-REG, V13, P123, DOI 10.1007/BF01001496; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Denoix JM, 1989, APPROCHE KINESITHERA, V18, p[23, 79]; Donaldson S, 2003, APPL PSYCHOPHYS BIOF, V28, P121, DOI 10.1023/A:1023858524879; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fuller PO, 2011, ZOOLOGY, V114, P104, DOI 10.1016/j.zool.2010.11.003; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Geisser ME, 2005, J PAIN, V6, P711, DOI 10.1016/j.jpain.2005.06.008; Giacomini PG, 2004, EUR J PAIN, V8, P579, DOI 10.1016/j.ejpain.2004.02.004; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Hamaoui A, 2011, GAIT POSTURE, V34, P457, DOI 10.1016/j.gaitpost.2011.06.017; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Haussler KK, 1996, J EQUINE VET SCI, V16, P279, DOI 10.1016/S0737-0806(96)80220-6; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Huzzey JM, 2005, J DAIRY SCI, V88, P2454, DOI 10.3168/jds.S0022-0302(05)72923-4; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; Kierko A, 2011, ANN AGR ENV MED; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; KOWNACKI M, 1978, GENET POL, V19, P61; Krawczel PD, 2008, J DAIRY SCI, V91, P1903, DOI 10.3168/jds.2007-0520; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lepicard EM, 2003, PSYCHIAT RES, V118, P273, DOI 10.1016/S0165-1781(03)00069-6; Lepicard EM, 2000, BEHAV BRAIN RES, V117, P185, DOI 10.1016/S0166-4328(00)00304-1; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Luttmann A, 2010, INT J IND ERGONOM, V40, P549, DOI 10.1016/j.ergon.2010.04.006; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; Martin BB, 1999, VET CLIN N AM-EQUINE, V15, P61; Mortk PJ, 2008, CLIN BIOMECH, V24, P169; Murphy S, 2004, APPL ERGON, V35, P113, DOI 10.1016/j.apergo.2004.01.001; Odberg F O, 1999, Equine Vet J Suppl, P26; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Reeves NP, 2005, J ELECTROMYOGR KINES, V15, P53, DOI 10.1016/j.jelekin.2004.07.001; Ridgway K, 1999, VET CLIN N AM-EQUINE, V15, P263; Rosario JLP, 2010, INT J PSYCHOPHYSIOL, V77, P276, DOI 10.1016/j.ijpsycho.2010.06.126; SAINSBURY P, 1954, J NEUROL NEUROSUR PS, V17, P216, DOI 10.1136/jnnp.17.3.216; Schaubroeck J, 2000, J ORGAN BEHAV, V21, P163, DOI 10.1002/(SICI)1099-1379(200003)21:2<163::AID-JOB37>3.0.CO;2-L; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; WOLF SL, 1982, BEHAV THER, V13, P395, DOI 10.1016/S0005-7894(82)80003-8; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; Xin H, 1999, J ANIM SCI, V77, P1; Zsoldos RR, 2010, EQUINE VET J, V42, P455, DOI 10.1111/j.2042-3306.2010.00263.x	67	34	35	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44604	10.1371/journal.pone.0044604	http://dx.doi.org/10.1371/journal.pone.0044604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970261	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000035
J	Chaves-Campos, J; Coghill, LM; de Leon, FJG; Johnson, SG				Chaves-Campos, Johel; Coghill, Lyndon M.; Garcia de Leon, Francisco J.; Johnson, Steven G.			The Effect of Aquatic Plant Abundance on Shell Crushing Resistance in a Freshwater Snail	PLOS ONE			English	Article							PHOSPHORUS ENRICHMENT; PHENOTYPIC PLASTICITY; MULTIMODEL INFERENCE; BEHAVIORAL ECOLOGY; INDUCED DEFENSES; MODEL SELECTION; GRAZING SNAILS; PREDATOR; MORPHOLOGY; CALCIFICATION	Most of the shell material in snails is composed of calcium carbonate but the organic shell matrix determines the properties of calcium carbonate crystals. It has been shown that the deposition of calcium carbonate is affected by the ingestion of organic compounds. We hypothesize that organic compounds not synthesized by the snails are important for shell strength and must be obtained from the diet. We tested this idea indirectly by evaluating whether the abundance of the organic matter that snails eat is related to the strength of their shells. We measured shell crushing resistance in the snail Mexipyrgus churinceanus and the abundance of the most common aquatic macrophyte, the water lily Nymphaea ampla, in ten bodies of water in the valley of Cuatro Cienegas, Mexico. We used stable isotopes to test the assumption that these snails feed on water lily organic matter. We also measured other factors that can affect crushing resistance, such as the density of crushing predators, snail density, water pH, and the concentration of calcium and phosphorus in the water. The isotope analysis suggested that snails assimilate water lily organic matter that is metabolized by sediment bacteria. The variable that best explained the variation in crushing resistance found among sites was the local abundance of water lilies. We propose that the local amount of water lily organic matter provides organic compounds important in shell biomineralization, thus determining crushing resistance. Hence, we propose that a third trophic level could be important in the coevolution of snail defensive traits and predatory structures.	[Chaves-Campos, Johel; Coghill, Lyndon M.; Johnson, Steven G.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Garcia de Leon, Francisco J.] Ctr Invest Biol Noroeste, Lab Genet Conservac, La Paz, Baja California, Mexico	University of Louisiana System; University of New Orleans; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Chaves-Campos, J (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	sgjohnso@uno.edu	León, Francisco García-De/AAH-9391-2019; Chaves-Campos, Johel/AAF-9147-2020	León, Francisco García-De/0000-0003-2323-2560; Chaves-Campos, Johel/0000-0001-8026-7626	University of New Orleans; CIBNOR	University of New Orleans; CIBNOR	The University of New Orleans provided support to SGJ, JC-C and LMC. The CIBNOR provided support to FJGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; Avery R, 2006, MAR ECOL PROG SER, V323, P159, DOI 10.3354/meps323159; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; Bourdeau PE, 2011, FUNCT ECOL, V25, P177, DOI 10.1111/j.1365-2435.2010.01762.x; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cairns A, 2009, ENVIRON REV, V17, P67, DOI 10.1139/A09-005; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chaves-Campos J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022472; Chivers DP, 2008, EVOL ECOL, V22, P561, DOI 10.1007/s10682-007-9182-8; Dalziel B, 2005, J EXP MAR BIOL ECOL, V317, P25, DOI 10.1016/j.jembe.2004.11.015; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Dinger E, 2001, AQUATIC INVERTEBRATE; Doi H, 2006, INT REV HYDROBIOL, V91, P501, DOI 10.1002/iroh.200610898; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Elser JJ, 2005, FRESHWATER BIOL, V50, P1826, DOI 10.1111/j.1365-2427.2005.01453.x; Evans S.B., 2005, USING CHEM DATA DEFI; Glass NH, 2009, AQUAT ECOL, V43, P1085, DOI 10.1007/s10452-008-9226-3; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Hershler R, 2002, SMITHSON CONTRIB EAR, P255; Hershler R, 1984, Journal of the Arizona-Nevada Academy of Science, V19, P61; Hood G.M., 2009, POPTOOLS VERSION 3 1; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Hoverman JT, 2005, OECOLOGIA, V144, P481, DOI 10.1007/s00442-005-0082-8; Hulsey CD, 2006, J FISH BIOL, V68, P1399, DOI 10.1111/j.0022-1112.2006.01021.x; Hulsey CD, 2005, EVOL ECOL RES, V7, P303; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Kurata K, 2001, MAR ECOL PROG SER, V223, P167, DOI 10.3354/meps223167; Kwong KL, 2010, BIOL INVASIONS, V12, P1153, DOI 10.1007/s10530-009-9537-x; Lysne SJ, 2007, J FRESHWATER ECOL, V22, P647, DOI 10.1080/02705060.2007.9664825; MADSEN H, 1992, HYDROBIOLOGIA, V228, P203, DOI 10.1007/BF00006587; Manly BFJ, 1997, RANDOMIZATION BOOTST; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; McGoldrick DJ, 2008, CAN J FISH AQUAT SCI, V65, P1983, DOI 10.1139/F08-109; MONTGOMERY D. C., 2001, INTRO LINEAR REGRESS; MOSS B, 1972, J ECOL, V60, P917, DOI 10.2307/2258575; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; PALMER AR, 1983, MAR BIOL, V75, P287, DOI 10.1007/BF00406014; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRINGLE CM, 1993, LIMNOL OCEANOGR, V38, P753, DOI 10.4319/lo.1993.38.4.0753; R Core Team, 2018, R LANG ENV STAT COMP; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Rohlf FJ, 2009, TPS DIG 2 14; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; Saporito RA, 2007, P NATL ACAD SCI USA, V104, P8885, DOI 10.1073/pnas.0702851104; SEELEY RH, 1986, P NATL ACAD SCI USA, V83, P6897, DOI 10.1073/pnas.83.18.6897; Stephens MJ, 2002, PHARYNGEAL MORPHOLOG; Stott LD, 2002, EARTH PLANET SC LETT, V195, P249, DOI 10.1016/S0012-821X(01)00585-4; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Vermeij GJ, 1987, NATURAL HIST SHELLS; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang WB, 2004, J SHELLFISH RES, V23, P1065	69	7	8	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44374	10.1371/journal.pone.0044374	http://dx.doi.org/10.1371/journal.pone.0044374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970206	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400063
J	Hoekstra, LA; Moroz, LL; Heyland, A				Hoekstra, Luke A.; Moroz, Leonid L.; Heyland, Andreas			Novel Insights into the Echinoderm Nervous System from Histaminergic and FMRFaminergic-Like Cells in the Sea Cucumber Leptosynapta clarki	PLOS ONE			English	Article							GIANT-NEURON SYSTEM; HOLOTHURIA-GLABERRIMA ECHINODERMATA; URCHIN HOLOPNEUSTES-PURPURASCENS; NITRIC-OXIDE PATHWAY; HEPTAPEPTIDE GFSKLYFAMIDE; CONNECTIVE-TISSUE; NEUROPEPTIDES; OPHIUROIDS; SETTLEMENT; BEHAVIOR	Understanding of the echinoderm nervous system is limited due to its distinct organization in comparison to other animal phyla and by the difficulty in accessing it. The transparent and accessible, apodid sea cucumber Leptosynapta clarki provides novel opportunities for detailed characterization of echinoderm neural systems. The present study used immunohistochemistry against FMRFamide and histamine to describe the neural organization in juvenile and adult sea cucumbers. Histaminergic-and FMRFaminergic-like immunoreactivity is reported in several distinct cell types throughout the body of L. clarki. FMRFamide-like immunoreactive cell bodies were found in the buccal tentacles, esophageal region and in proximity to the radial nerve cords. Sensory-like cells in the tentacles send processes toward the circumoral nerve ring, while unipolar and bipolar cells close to the radial nerve cords display extensive processes in close association with muscle and other cells of the body wall. Histamine-like immunoreactivity was identified in neuronal somatas located in the buccal tentacles, circumoral nerve ring and in papillae distributed across the body. The tentacular cells send processes into the nerve ring, while the processes of cells in the body wall papillae extend to the surface epithelium and radial nerve cords. Pharmacological application of histamine produced a strong coordinated, peristaltic response of the body wall suggesting the role of histamine in the feeding behavior. Our immunohistochemical data provide evidence for extensive connections between the hyponeural and ectoneural nervous system in the sea cucumber, challenging previously held views on a clear functional separation of the sub-components of the nervous system. Furthermore, our data indicate a potential function of histamine in coordinated, peristaltic movements; consistent with feeding patterns in this species. This study on L. clarki illustrates how using a broader range of neurotransmitter systems can provide better insight into the anatomy, function and evolution of echinoderm nervous sytems.	[Hoekstra, Luke A.; Moroz, Leonid L.; Heyland, Andreas] Univ Washington, Friday Harbor Labs, Seattle, WA 98195 USA; [Hoekstra, Luke A.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, Gainesville, FL USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Heyland, Andreas] Univ Guelph, Guelph, ON N1G 2W1, Canada	University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Guelph	Hoekstra, LA (corresponding author), Univ Washington, Friday Harbor Labs, Seattle, WA 98195 USA.	aheyland@uoguelph.ca		Moroz, Leonid/0000-0002-1333-3176; Heyland, Andreas/0000-0002-7592-4473	Washington Research Foundation; NSERC [400230]; McKnight Brain Research Foundation; UF Opportunity Funds; United States National Institutes of Health [(NIH) 5R01GM097502, NIH 5R21RR025699, NIH 5R21DA030118];  [NSF IOS-1146575];  [NSF CNS-0821622]; Direct For Biological Sciences [1146575] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030118] Funding Source: NIH RePORTER	Washington Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); McKnight Brain Research Foundation; UF Opportunity Funds; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge funding from the Washington Research Foundation to LAH, the NSERC Discovery Grant (400230) and McKnight Brain Research Foundation Funds to AH, as well as UF Opportunity Funds, NSF IOS-1146575, NSF CNS-0821622, United States National Institutes of Health (NIH) 5R01GM097502, NIH 5R21RR025699 and NIH 5R21DA030118 to LLM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTIERI S M D L, 1986, Boletim de Fisiologia Animal (Sao Paulo), V10, P21; Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Burke RD, 2011, EVOL DEV, V13, P110, DOI 10.1111/j.1525-142X.2010.00460.x; COBB JLS, 1982, CELL TISSUE RES, V226, P675; COBB JLS, 1981, CELL TISSUE RES, V219, P197; COBB JLS, 1985, BIOL BULL, V168, P432, DOI 10.2307/1541523; COBB JLS, 1987, INVERTEBRATE NERVOUS, P483; Diaz-Balzac CA, 2007, BIOL BULL-US, V213, P28, DOI 10.2307/25066616; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P33, DOI 10.1007/s00435-009-0098-4; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; DIAZMIRANDA L, 1992, BIOL BULL, V182, P241, DOI 10.2307/1542117; Elphick MR, 2001, J EXP BIOL, V204, P875; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; Emanuel MB, 1999, CLIN EXP ALLERGY, V29, P1; Garcia-Arraras JE, 2001, J EXP BIOL, V204, P865; GARCIAARRARAS JE, 1991, NEUROSCI LETT, V132, P199, DOI 10.1016/0304-3940(91)90301-9; Heinzeller Thomas, 2001, P41; Hill RB, 1993, COMP PHYSL ECHINODER; Hyman LH, 1955, INVERTEBRATES ECHINO; Inoue M, 1999, P ROY SOC B-BIOL SCI, V266, P993, DOI 10.1098/rspb.1999.0735; Jacobs EH, 2000, TRENDS PHARMACOL SCI, V21, P293, DOI 10.1016/S0165-6147(00)01504-2; KOBZAR' G T, 1984, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V20, P419; LAI ZC, 1988, GENE DEV, V2, P173, DOI 10.1101/gad.2.2.173; Lambert P, 1997, SEA CUCUMBERS BRIT C; Leguia M, 2004, MOL BIOL CELL, V15, p431A; Leguia M, 2006, MOL REPROD DEV, V73, P1550, DOI 10.1002/mrd.20586; LORENZ W, 1973, GEN PHARMACOL, V4, P229; Mashanov VS, 2007, EVOL DEV, V9, P244, DOI 10.1111/j.1525-142X.2007.00157.x; Mashanov VS, 2010, GLIA, V58, P1581, DOI 10.1002/glia.21031; Mashanov VS, 2006, ZOOMORPHOLOGY, V125, P27, DOI 10.1007/s00435-005-0010-9; Mashanov VS, 2004, ACTA ZOOL-STOCKHOLM, V85, P29, DOI 10.1111/j.0001-7272.2004.00155.x; McCoole MD, 2011, J EXP BIOL, V214, P1773, DOI 10.1242/jeb.054486; MENDES E G, 1970, Comparative and General Pharmacology, V1, P11, DOI 10.1016/0010-4035(70)90003-0; METTRICK DF, 1965, COMP BIOCHEM PHYSIOL, V16, P547, DOI 10.1016/0010-406X(65)90318-X; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; Muneoka Y., 1995, Zoological Science (Tokyo), V12, P105; Muneoka Y, 2000, ACTA BIOL HUNG, V51, P111; PETERS BH, 1985, CELL TISSUE RES, V239, P219, DOI 10.1007/BF00214922; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; PROTAS LL, 1980, GEN PHARMACOL, V11, P113, DOI 10.1016/0306-3623(80)90019-1; Rasband W., 2006, IMAGEJ; REITE OB, 1972, PHYSIOL REV, V52, P778, DOI 10.1152/physrev.1972.52.3.778; SEWELL MA, 1994, MAR ECOL PROG SER, V114, P149, DOI 10.3354/meps114149; Smith SL, 1992, INVESTIGATION HISTAM, P89; STUBBS TR, 1981, CELL TISSUE RES, V220, P373; Sutherby J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-14; Swanson RL, 2007, J EXP BIOL, V210, P3228, DOI 10.1242/jeb.004192; Swanson RL, 2006, MAR ECOL PROG SER, V314, P1, DOI 10.3354/meps314001; Swanson RL, 2012, MAR BIOL, V159, P915, DOI 10.1007/s00227-011-1869-2; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Takahashi K, 1966, MUSCLE PHYSL, P513; VANDENSPIEGEL D, 1995, TISSUE CELL, V27, P457, DOI 10.1016/S0040-8166(95)80066-2; VON EULER U. S., 1952, ACTA PHYSIOL LATINOAMER, V2, P101; von Uexkull J, 1900, Z BIOL-MUNICH, V39, P73; Walker RJ, 2009, INVERTEBR NEUROSCI, V9, P111, DOI 10.1007/s10158-010-0097-7; WEISS KR, 1986, J NEUROSCI, V6, P2403; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Wyman LC, 1930, J EXP ZOOL, V57, P441, DOI 10.1002/jez.1400570304	64	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44220	10.1371/journal.pone.0044220	http://dx.doi.org/10.1371/journal.pone.0044220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970182	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400048
J	Miyasike-daSilva, V; McIlroy, WE				Miyasike-daSilva, Veronica; McIlroy, William E.			Does It Really Matter Where You Look When Walking on Stairs? Insights from a Dual-Task Study	PLOS ONE			English	Article							OBSTACLE AVOIDANCE; VISION; ADULTS; YOUNG; FALLS; GAIT; AGE	Although the visual system is known to provide relevant information to guide stair locomotion, there is less understanding of the specific contributions of foveal and peripheral visual field information. The present study investigated the specific role of foveal vision during stair locomotion and ground-stairs transitions by using a dual-task paradigm to influence the ability to rely on foveal vision. Fifteen healthy adults (26.9 +/- 3.3 years; 8 females) ascended a 7-step staircase under four conditions: no secondary tasks (CONTROL); gaze fixation on a fixed target located at the end of the pathway (TARGET); visual reaction time task (VRT); and auditory reaction time task (ART). Gaze fixations towards stair features were significantly reduced in TARGET and VRT compared to CONTROL and ART. Despite the reduced fixations, participants were able to successfully ascend stairs and rarely used the handrail. Step time was increased during VRT compared to CONTROL in most stair steps. Navigating on the transition steps did not require more gaze fixations than the middle steps. However, reaction time tended to increase during locomotion on transitions suggesting additional executive demands during this phase. These findings suggest that foveal vision may not be an essential source of visual information regarding stair features to guide stair walking, despite the unique control challenges at transition phases as highlighted by phase-specific challenges in dual-tasking. Instead, the tendency to look at the steps in usual conditions likely provides a stable reference frame for extraction of visual information regarding step features from the entire visual field.	[Miyasike-daSilva, Veronica; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [McIlroy, William E.] Toronto Rehabil Inst, Mobil Team, Toronto, ON, Canada; [McIlroy, William E.] Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON, Canada	University of Waterloo; University of Toronto; University Health Network Toronto; Toronto Rehabilitation Institute	Miyasike-daSilva, V (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	wmcilroy@uwaterloo.ca		McIlroy, William/0000-0003-2319-1746	Natural Sciences and Engineering Research Council of Canada (NSERC); CAPES Foundation, Ministry of Education of Brazil	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the awards from the Natural Sciences and Engineering Research Council of Canada (NSERC) and CAPES Foundation, Ministry of Education of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archea J., 1979, GUIDELINES STAIR SAF; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Brabyn J, 2001, OPTOMETRY VISION SCI, V78, P264, DOI 10.1097/00006324-200105000-00008; Den Otter AR, 2011, GAIT POSTURE, V34, P169, DOI 10.1016/j.gaitpost.2011.04.004; Graci V, 2010, OPTOMETRY VISION SCI, V87, P21, DOI 10.1097/OPX.0b013e3181c1d547; King EC, 2010, EXP BRAIN RES, V207, P105, DOI 10.1007/s00221-010-2434-9; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Miyasike-DaSilva V, 2011, EXP BRAIN RES, V209, P73, DOI 10.1007/s00221-010-2520-z; Ojha HA, 2009, PHYS THER, V89, P1080, DOI 10.2522/ptj.20080187; Patla AE, 1998, ECOL PSYCHOL, V10, P287, DOI 10.1207/s15326969eco103&4_7; SHELDON JH, 1960, BRIT MED J, V2, P1685, DOI 10.1136/bmj.2.5214.1685; SIMONEAU GG, 1991, J GERONTOL, V46, pM188, DOI 10.1093/geronj/46.6.M188; Siu KC, 2008, EXP BRAIN RES, V184, P115, DOI 10.1007/s00221-007-1087-9; Templer J.A., 1992, STAIRCASE STUDIES HA; WILD D, 1981, RHEUMATOL REHABIL, V20, P153, DOI 10.1093/rheumatology/20.3.153; Zietz D, 2009, J MOTOR BEHAV, V41, P357, DOI 10.3200/JMBR.41.4.357-366	16	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44722	10.1371/journal.pone.0044722	http://dx.doi.org/10.1371/journal.pone.0044722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970297	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400112
J	Nakasujja, N; Allebeck, P; Agren, H; Musisi, S; Katabira, E				Nakasujja, Noeline; Allebeck, Peter; Agren, Hans; Musisi, Seggane; Katabira, Elly			Cognitive Dysfunction among HIV Positive and HIV Negative Patients with Psychosis in Uganda	PLOS ONE			English	Article							KYNURENIC ACID; SECONDARY MANIA; RISK-FACTORS; IMPAIRMENT; DEMENTIA; INFECTION; DISORDERS; DEPRESSION; VALIDITY; SCALE	Background: Cognitive impairment is an established phenomenon in HIV infected individuals and patients that have psychosis. However there is need to establish the severity of the impairment if patients are co morbid with both conditions. Aim: To compare cognitive function among HIV positive individuals and HIV negative individuals with psychosis. Methods: We recruited patients with psychosis at two national referral hospitals. A standardized demographics questionnaire and psychiatric, physical, and laboratory assessments were conducted. Types of psychosis were diagnosed using the Mini International Neuropsychiatric Inventory-PLUS while cognitive functioning was determined using the Mini mental state examination (MMSE) and a neuropsychological test battery. Follow-up assessments on cognitive function and severity of psychiatric illness were performed at 3 and 6 months. Pairwise comparison and multivariable logistic regression analysis were used to determine the differences between the HIV positive and HIV negative individuals. Results: There were 156 HIV positive and 322 HIV negative participants. The mean age was 33 years for the HIV positive group and 29 years for the HIV negative group (p<0.001). The HIV positive individuals were almost three times (OR = 2.62 CI 95% 1.69-4.06) more likely to be cognitively impaired on the MMSE as well as the following cognitive tests:- WHO-UCLA Auditory Verbal Learning Test (OR 1.79, 95% CI 1.09-2.92), Verbal Fluency (OR 3.42, 95% CI 2.24-5.24), Color Trails 1 (OR 2.03, 95% CI 1.29-3.02) and Color Trails 2 (OR 3.50 95% 2.00-6.10) all p = 0.01. There was improvement in cognitive function at follow up; however the impairment remained higher for the HIV positive group (p<0.001). Conclusion: Cognitive impairment in psychosis was worsened by HIV infection. Care plans to minimize the effect of this impairment should be structured for the management of individuals with HIV and psychosis.	[Nakasujja, Noeline; Musisi, Seggane] Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda; [Nakasujja, Noeline; Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Agren, Hans] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Katabira, Elly] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	Makerere University; Karolinska Institutet; University of Gothenburg; Makerere University	Nakasujja, N (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda.	drnoeline@yahoo.com	Nakasujja, Noeline/GSI-4189-2022		Makerere University-Swedish International Development Cooperation Agency/Department for Research Cooperation cooperation grant	Makerere University-Swedish International Development Cooperation Agency/Department for Research Cooperation cooperation grant	Source of funding: Makerere University-Swedish International Development Cooperation Agency/Department for Research Cooperation cooperation grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atlas A, 2007, BRAIN BEHAV IMMUN, V21, P86, DOI 10.1016/j.bbi.2006.02.005; Baran H, 2000, J NEURAL TRANSM, V107, P1127, DOI 10.1007/s007020070026; Bora E, 2010, SCHIZOPHRENIA BULL, V36, P36, DOI 10.1093/schbul/sbp094; De Ronchi D, 2000, INT J PSYCHIAT MED, V30, P173, DOI 10.2190/PLGX-N48F-RBHJ-UF8K; Dolder CR, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200401001-00006; Dube B, 2005, J PSYCHIATR NEUROSCI, V30, P237; ELMALLAKH RS, 1992, J CLIN PSYCHIAT, V53, P293; Fitzgerald D, 2004, AUST NZ J PSYCHIAT, V38, P501, DOI 10.1111/j.1440-1614.2004.01403.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDBERG TE, 1995, CURR OPIN PSYCHIATR, V8, P34, DOI 10.1097/00001504-199501000-00009; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hill SK, 2009, SCHIZOPHR RES, V113, P167, DOI 10.1016/j.schres.2009.04.020; Hori H, 2006, SCHIZOPHR RES, V86, P138, DOI 10.1016/j.schres.2006.05.004; Horwah E, 2002, J INT ASS PHYS AIDS, V1, pS4; IACONO WG, 1992, AM J PSYCHIAT, V149, P1070; Kapiriri L, 2009, J AIDS HIV RES, V1, P034; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maling S, 2011, AIDS CARE, V23, P171, DOI 10.1080/09540121.2010.498939; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Nakimuli-Mpungu E, 2006, AM J PSYCHIAT, V163, P1349, DOI 10.1176/appi.ajp.163.8.1349; Nakimuli-Mpungu E, 2008, PSYCHOSOMATICS, V49, P530, DOI 10.1176/appi.psy.49.6.530; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; Nilsson LK, 2005, SCHIZOPHR RES, V80, P315, DOI 10.1016/j.schres.2005.07.013; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Robertson KR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-8; Sacktor N, 2006, NEUROLOGY, V67, P311, DOI 10.1212/01.wnl.0000225183.74521.72; Sacktor NC, 2005, AIDS, V19, P1367; Sacktor NC, 2000, J NEUROVIROL, V6, P84, DOI 10.3109/13550280009006385; SCHMAND B, 1994, PSYCHOL MED, V24, P869, DOI 10.1017/S0033291700028968; SEWELL DD, 1994, AM J PSYCHIAT, V151, P237; Shapshak P, 2011, AIDS, V25, P123, DOI 10.1097/QAD.0b013e328340fd42; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Starace F, 2002, ACTA PSYCHIAT SCAND, V106, P20, DOI 10.1034/j.1600-0447.2002.02289.x; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	37	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44415	10.1371/journal.pone.0044415	http://dx.doi.org/10.1371/journal.pone.0044415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970214	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400068
J	Sahni, J; Song, YM; Scharenberg, AM				Sahni, Jaya; Song, Yumei; Scharenberg, Andrew M.			The B. subtilis MgtE Magnesium Transporter Can Functionally Compensate TRPM7-Deficiency in Vertebrate B-Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; HUMAN SOLUTE CARRIER; CORA MG2+ CHANNEL; SALMONELLA-ENTERICA; PLASMA-MEMBRANE; SLC41A1; TRPM7; VIRULENCE; PROTEIN; AGGREGATION	Recent studies have shown that the vertebrate magnesium transporters Solute carrier family 41, members 1 and 2 (SLC41A1, SLC41A2) and Magnesium transporter subtype 1 (MagT1) can endow vertebrate B-cells lacking the ion-channel kinase Transient receptor potential cation channel, subfamily M, member 7 (TRPM7) with a capacity to grow and proliferate. SLC41A1 and SLC41A2 display distant homology to the prokaryotic family of Mg2+ transporters, MgtE, first characterized in Bacillus subtilis. These sequence similarities prompted us to investigate whether MgtE could potentially compensate for the lack of TRPM7 in the vertebrate TRPM7-deficient DT40 B-cell model system. Here, we report that overexpression of MgtE is able to rescue the growth of TRPM7-KO DT40 B-cells. However, contrary to a previous report that describes regulation of MgtE channel gating by Mg2+ in a bacterial spheroplast model system, whole cell patch clamp analysis revealed no detectable current development in TRPM7-deficient cells expressing MgtE. In addition, we observed that MgtE expression is strongly downregulated at high magnesium concentrations, similar to what has been described for its vertebrate homolog, SLC41A1. We also show that the N-terminal cytoplasmic domain of MgtE is required for normal MgtE channel function, functionally confirming the predicted importance of this domain in regulation of MgtE-mediated Mg2+ entry. Overall, our findings show that consistent with its proposed function, Mg2+ uptake mediated by MgtE is able to restore cell growth and proliferation of TRPM7-deficient cells and supports the concept of functional homology between MgtE and its vertebrate homologs.	[Sahni, Jaya; Song, Yumei; Scharenberg, Andrew M.] Seattle Childrens Res Inst, Seattle, WA USA; [Scharenberg, Andrew M.] Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Sahni, J (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.	slc41a2@gmail.com; andrewms@u.washington.edu			National Institutes of Health [P01GM078195, GM64316]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064316, P01GM078195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P01GM078195 and GM64316 to AMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2010, INFECT IMMUN, V78, P1239, DOI 10.1128/IAI.00865-09; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Caldwell RA, 2011, AM J PHYSIOL-LUNG C, V301, pL346, DOI 10.1152/ajplung.00044.2011; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Mandt T, 2011, BIOCHEM J, V439, P129, DOI 10.1042/BJ20110807; McLane MW, 2007, SYNAPSE, V61, P875, DOI 10.1002/syn.20438; Merino S, 2001, FEMS MICROBIOL LETT, V198, P189, DOI 10.1111/j.1574-6968.2001.tb10641.x; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6517, DOI 10.1128/JB.00772-08; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6509, DOI 10.1128/JB.00144-08; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Sahni J, 2010, CELL CYCLE, V9, P3565, DOI 10.4161/cc.9.17.12798; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Sponder G, 2010, MAGNESIUM RES, V23, P105, DOI 10.1684/mrh.2010.0206; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; TOWNSEND DE, 1995, J BACTERIOL, V177, P5350, DOI 10.1128/jb.177.18.5350-5354.1995; Vilas GL, 2011, BIOCHEMISTRY-US, V50, P2157, DOI 10.1021/bi101887z; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Wolf Federica I, 2011, Magnes Res, V24, pS86, DOI 10.1684/mrh.2011.0288; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407	38	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44452	10.1371/journal.pone.0044452	http://dx.doi.org/10.1371/journal.pone.0044452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970223	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400074
J	Eschenbacher, WH; Song, MS; Chen, Y; Bhandari, P; Zhao, P; Jowdy, CC; Engelhard, JT; Dorn, GW				Eschenbacher, William H.; Song, Moshi; Chen, Yun; Bhandari, Poonam; Zhao, Peter; Jowdy, Casey C.; Engelhard, John T.; Dorn, Gerald W., II			Two Rare Human Mitofusin 2 Mutations Alter Mitochondrial Dynamics and Induce Retinal and Cardiac Pathology in Drosophila	PLOS ONE			English	Article							NEUROPATHY TYPE 2A; MUSCLE DYSFUNCTION; MEMBRANE FUSION; IN-VIVO; MFN2; DISEASE; HEART; NEURODEGENERATION; MORPHOLOGY; COMPLEXES	Mitochondrial fusion is essential to organelle homeostasis and organ health. Inexplicably, loss of function mutations of mitofusin 2 (Mfn2) specifically affect neurological tissue, causing Charcot Marie Tooth syndrome (CMT) and atypical optic atrophy. As CMT-linked Mfn2 mutations are predominantly within the GTPase domain, we postulated that Mfn2 mutations in other functional domains might affect non-neurological tissues. Here, we defined in vitro and in vivo consequences of rare human mutations in the poorly characterized Mfn2 HR1 domain. Human exome sequencing data identified 4 rare non-synonymous Mfn2 HR1 domain mutations, two bioinformatically predicted as damaging. Recombinant expression of these (Mfn2 M393I and R400Q) in Mfn2-null murine embryonic fibroblasts (MEFs) revealed incomplete rescue of characteristic mitochondrial fragmentation, compared to wild-type human Mfn2 (hMfn2); Mfn2 400Q uniquely induced mitochondrial fragmentation in normal MEFs. To compare Mfn2 mutation effects in neurological and non-neurological tissues in vivo, hMfn2 and the two mutants were expressed in Drosophila eyes or heart tubes made deficient in endogenous fly mitofusin (dMfn) through organ-specific RNAi expression. The two mutants induced similar Drosophila eye phenotypes: small eyes and an inability to rescue the eye pathology induced by suppression of dMfn. In contrast, Mfn2 400Q induced more severe cardiomyocyte mitochondrial fragmentation and cardiac phenotypes than Mfn2 393I, including heart tube dilation, depressed fractional shortening, and progressively impaired negative geotaxis. These data reveal a central functional role for Mfn2 HR1 domains, describe organ-specific effects of two Mfn2 HR1 mutations, and strongly support prospective studies of Mfn2 400Q in heritable human heart disease of unknown genetic etiology.	[Eschenbacher, William H.; Song, Moshi; Chen, Yun; Bhandari, Poonam; Zhao, Peter; Jowdy, Casey C.; Engelhard, John T.; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL)	Eschenbacher, WH (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu			National Institutes of Health (NIH) [R21 HL1072726, R01HL598888]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) R21 HL1072726 and R01HL598888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Caldeira J., 2011, GUT; Casasnovas C, 2010, J MED GENET, V47, P249, DOI 10.1136/jmg.2009.072488; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Choma MA, 2006, CIRCULATION, V114, pE35, DOI 10.1161/CIRCULATIONAHA.105.593541; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Engelfried K, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-53; FERNANDEZ JAS, 1994, ANN MED INTERNE, V11, P455; Goldstein JA, 2011, HUM MOL GENET, V20, P894, DOI 10.1093/hmg/ddq528; Griffin EE, 2006, BBA-MOL CELL RES, V1763, P482, DOI 10.1016/j.bbamcr.2006.02.003; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Guillet V, 2010, NEUROGENETICS, V11, P127, DOI 10.1007/s10048-009-0207-z; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; McCorquodale DS, 2011, J NEUROL, V258, P1234, DOI 10.1007/s00415-011-5910-7; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; Sandu C, 2010, J CELL BIOL, V190, P1039, DOI 10.1083/jcb.201004086; Santel A, 2001, J CELL SCI, V114, P867; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; Yoshida H, 1991, Kokyu To Junkan, V39, P295; Yun J, 2008, J NEUROSCI, V28, P14500, DOI 10.1523/JNEUROSCI.5141-08.2008; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	42	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44296	10.1371/journal.pone.0044296	http://dx.doi.org/10.1371/journal.pone.0044296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957060	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800053
J	Ge, LS; Cornforth, AN; Hoa, NT; Delgado, C; Chiou, SK; Zhou, YH; Jadus, MR				Ge, Lisheng; Cornforth, Andrew N.; Hoa, Neil T.; Delgado, Christina; Chiou, Shiun Kwei; Zhou, Yi Hong; Jadus, Martin R.			Differential Glioma-Associated Tumor Antigen Expression Profiles of Human Glioma Cells Grown in Hypoxia	PLOS ONE			English	Article							POTENTIAL TARGETS; GLIOBLASTOMA; VACCINATION; IDENTIFICATION; IMMUNOTHERAPY; ANGIOGENESIS; SURVIVAL; VACCINES; COMPLEX; PROTEIN	Human U251 and D54 glioma cells were tested for expression of 25 glioma-associated tumor antigen precursor proteins (TAPP) under hypoxic (1% O-2) or normoxic (21% O-2) conditions. Hypoxic glioma cell lines increased their mRNA expression for nine TAPP (Aim2, Art-4, EphA2, EZH2, Fosl1, PTH-rP, Sox 11, Whsc2 and YKL-40), as assessed by quantitative reverse transcriptase real-time/polymerase chain reaction (qRT-PCR). Increased differences with three hypoxic-induced TAPP: EZH2, Whsc2 and YKL-40 were shown at the protein levels by fluorescent antibody staining and quantitative electrophoretic analysis. Two TAPP (MRP3 and Trp1) were down-regulated by hypoxia in glioma cell lines. Growing the glioma cells under hypoxia for 13 days, followed by returning them back to normoxic conditions for 7 days, and restored the original normoxic TAPP profile. Thus, hypoxia was an environmental factor that stimulated the transient expression of these antigens. Intracranial xenografts grown in nude mice derived from U251 cells that had been cultured under neurosphere stem cell conditions showed increased expression of Whsc2 or YKL-40, demonstrating that these in vitro properties of glioma also occur in vivo. Whsc2-specific cytotoxic T lymphocytes killed the hypoxic U251 glioma cells better than normoxic glioma cells. The antigens expressed by hypoxic tumor cells may be a better source of starting tumor material for loading dendritic cells for novel immunotherapy of glioma using tumor-associated antigens.	[Ge, Lisheng; Hoa, Neil T.; Delgado, Christina; Jadus, Martin R.] Vet Affairs Med Ctr, Diagnost & Mol Hlth Care Grp, Long Beach, CA USA; [Cornforth, Andrew N.] Calif Stem Cell Inc, Irvine, CA USA; [Hoa, Neil T.; Delgado, Christina; Chiou, Shiun Kwei; Jadus, Martin R.] Vet Affairs Med Ctr, Res Serv Healthcare Grp, Long Beach, CA USA; [Zhou, Yi Hong; Jadus, Martin R.] Univ Calif Irvine, Chao Comprehens Canc Ctr, Neurooncol Program, Orange, CA 92668 USA; [Zhou, Yi Hong] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA USA; [Zhou, Yi Hong] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Ge, LS (corresponding author), Vet Affairs Med Ctr, Diagnost & Mol Hlth Care Grp, Long Beach, CA USA.	martin.jadus@va.gov	Ge, Li/T-3955-2018	Ge, Li/0000-0002-1824-8034	Veterans Affairs Medical Cente; University of California, Irvine, School of Medicine and Committee on Research Award	Veterans Affairs Medical Cente; University of California, Irvine, School of Medicine and Committee on Research Award(University of California System)	This work was supported by grants supplied by the Veterans Affairs Medical Center (MRJ) and University of California, Irvine, School of Medicine and Committee on Research Award (YHZ). The funders had no role in study design, data collection and anlaysis, decision to publish or preparation of the manuscript.	Bar EE, 2011, BRAIN PATHOL, V21, P119, DOI 10.1111/j.1750-3639.2010.00460.x; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Dutoit V, 2012, BRAIN, V135, P1042, DOI 10.1093/brain/aws042; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; FINCH CA, 1972, NEW ENGL J MED, V286, P407, DOI 10.1056/NEJM197202242860806; Ge LS, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/296453; Grauer OM, 2009, BRAIN PATHOL, V19, P674, DOI 10.1111/j.1750-3639.2009.00315.x; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Haque A, 2011, PROG MOL BIOL TRANSL, V98, P187, DOI 10.1016/B978-0-12-385506-0.00005-3; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Heimberger AB, 2011, NEURO-ONCOLOGY, V13, P3, DOI 10.1093/neuonc/noq169; Hickey MJ, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-100; Hoa N, 2010, J IMMUNOL, V185, P4793, DOI 10.4049/jimmunol.1001526; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ito M, 2001, CANCER RES, V61, P2038; Izumoto S, 2012, ADV EXP MED BIOL, V746, P166, DOI 10.1007/978-1-4614-3146-6_13; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Jarboe JS, 2007, CANCER RES, V67, P7983, DOI 10.1158/0008-5472.CAN-07-1493; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kim W, 2010, NEUROSURG CLIN N AM, V21, P139, DOI 10.1016/j.nec.2009.09.005; Kruse CA, 2001, BRAIN TUMOR IMMUNOTHERAPY, P149; Kruse CA, 1997, CANCER IMMUNOL IMMUN, V45, P77, DOI 10.1007/s002620050405; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li J, 2008, NEURO-ONCOLOGY, V10, P45, DOI 10.1215/15228517-2007-036; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Niu YM, 2009, CANCER SCI, V100, P2167, DOI 10.1111/j.1349-7006.2009.01298.x; Nutt CL, 2005, CLIN CANCER RES, V11, P2258, DOI 10.1158/1078-0432.CCR-04-1601; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Parney IF, 2012, ADV EXP MED BIOL, V746, P42, DOI 10.1007/978-1-4614-3146-6_4; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Sathornsumetee S, 2008, J CLIN ONCOL, V26, P271, DOI 10.1200/JCO.2007.13.3652; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Toda M, 2012, ADV EXP MED BIOL, V746, P77, DOI 10.1007/978-1-4614-3146-6_6; Yajima N, 2005, CLIN CANCER RES, V11, P5900, DOI 10.1158/1078-0432.CCR-05-0559; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamanaka R, 2012, ADV EXP MED BIOL, V746, P187, DOI 10.1007/978-1-4614-3146-6_15; Yu JS, 2001, CANCER RES, V61, P842; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhang JG, 2008, J NEURO-ONCOL, V88, P65, DOI 10.1007/s11060-008-9534-4; Zhang JG, 2007, CLIN CANCER RES, V13, P566, DOI 10.1158/1078-0432.CCR-06-1576	55	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42661	10.1371/journal.pone.0042661	http://dx.doi.org/10.1371/journal.pone.0042661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957023	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800015
J	Ridnour, LA; Barasch, KM; Windhausen, AN; Dorsey, TH; Lizardo, MM; Yfantis, HG; Lee, DH; Switzer, CH; Cheng, RYS; Heinecke, JL; Brueggemann, E; Hines, HB; Khanna, C; Glynn, SA; Ambs, S; Wink, DA				Ridnour, Lisa A.; Barasch, Kimberly M.; Windhausen, Alisha N.; Dorsey, Tiffany H.; Lizardo, Michael M.; Yfantis, Harris G.; Lee, Dong H.; Switzer, Christopher H.; Cheng, Robert Y. S.; Heinecke, Julie L.; Brueggemann, Ernst; Hines, Harry B.; Khanna, Chand; Glynn, Sharon A.; Ambs, Stefan; Wink, David A.			Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation	PLOS ONE			English	Article							TISSUE INHIBITOR; TUMOR PROGRESSION; S-NITROSATION; EXPRESSION; CELLS; METALLOPROTEINASE-1; PREDICTS; INDUCTION; APOPTOSIS; SURVIVAL	Prediction of therapeutic response and cancer patient survival can be improved by the identification of molecular markers including tumor Akt status. A direct correlation between NOS2 expression and elevated Akt phosphorylation status has been observed in breast tumors. Tissue inhibitor matrix metalloproteinase-1 (TIMP-1) has been proposed to exert oncogenic properties through CD63 cell surface receptor pathway initiation of pro-survival PI3k/Akt signaling. We employed immunohistochemistry to examine the influence of TIMP-1 on the functional relationship between NOS2 and phosphorylated Akt in breast tumors and found that NOS2-associated Akt phosphorylation was significantly increased in tumors expressing high TIMP-1, indicating that TIMP-1 may further enhance NO-induced Akt pathway activation. Moreover, TIMP-1 silencing by antisense technology blocked NO-induced PI3k/Akt/BAD phosphorylation in cultured MDA-MB-231 human breast cancer cells. TIMP-1 protein nitration and TIMP-1/CD63 co-immunoprecipitation was observed at NO concentrations that induced PI3k/Akt/BAD pro-survival signaling. In the survival analysis, elevated tumor TIMP-1 predicted poor patient survival. This association appears to be mainly restricted to tumors with high NOS2 protein. In contrast, TIMP-1 did not predict poor survival in patient tumors with low NOS2 expression. In summary, our findings suggest that tumors with high TIMP-1 and NOS2 behave more aggressively by mechanisms that favor Akt pathway activation.	[Ridnour, Lisa A.; Barasch, Kimberly M.; Windhausen, Alisha N.; Switzer, Christopher H.; Cheng, Robert Y. S.; Heinecke, Julie L.; Glynn, Sharon A.; Wink, David A.] NCI, Radiat Biol Branch, Bethesda, MD 20892 USA; [Dorsey, Tiffany H.; Glynn, Sharon A.; Ambs, Stefan] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA; [Lizardo, Michael M.; Khanna, Chand] NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Yfantis, Harris G.; Lee, Dong H.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; [Brueggemann, Ernst; Hines, Harry B.] USAMRIID, Ft Detrick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; United States Army Medical Research Institute of Infectious Diseases	Ridnour, LA (corresponding author), NCI, Radiat Biol Branch, Bethesda, MD 20892 USA.	ridnourl@mail.nih.gov; wink@mail.nih.gov	Switzer, Christopher/D-9203-2013; Glynn, Sharon A/D-7136-2013; Cheng, Robert/E-9799-2013	Glynn, Sharon A/0000-0003-1459-2580; Cheng, Robert/0000-0003-0287-6439; Azad, Mahan/0000-0002-8633-3513; Heinecke, Julie/0000-0001-5447-1914; Ambs, Stefan/0000-0001-7651-9309; Wink, David/0000-0002-5652-7480; Ridnour, Lisa A./0000-0001-9446-8349	United States National Institutes of Health, National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010887, ZIABC010898] Funding Source: NIH RePORTER	United States National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Intramural Research Program of the United States National Institutes of Health, National Cancer Institute, and Center for Cancer Research supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ambs S, 2011, CELL CYCLE, V10, P619, DOI 10.4161/cc.10.4.14864; American Cancer Society, 2010, AM CANC SOC FACTS FI; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Brennan PA, 2008, HEAD NECK-J SCI SPEC, V30, P208, DOI 10.1002/hed.20675; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Clemons NJ, 2010, CARCINOGENESIS, V31, P1669, DOI 10.1093/carcin/bgq130; Connelly ST, 2005, ORAL ONCOL, V41, P261, DOI 10.1016/j.oraloncology.2004.09.007; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Davidsen ML, 2006, BRIT J CANCER, V95, P1114, DOI 10.1038/sj.bjc.6603378; Death AK, 2002, J AM COLL CARDIOL, V39, P1943, DOI 10.1016/S0735-1097(02)01907-1; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; Duarte S, 2012, HEPATOLOGY IN PRESS; Ekmekcioglu S, 2000, CLIN CANCER RES, V6, P4768; Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Hsu YC, 2007, J DERMATOL SCI, V45, P37, DOI 10.1016/j.jdermsci.2006.10.002; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kim JE, 2004, J BIOL CHEM, V279, P9758, DOI 10.1074/jbc.M312722200; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lackner MR, 2010, EXPERT REV MOL DIAGN, V10, P75, DOI [10.1586/erm.09.78, 10.1586/ERM.09.78]; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Lambert E, 2009, INT J BIOCHEM CELL B, V41, P1102, DOI 10.1016/j.biocel.2008.10.017; Li GY, 1999, CANCER RES, V59, P6267; Li SF, 2008, ADV CANCER RES, V101, P45, DOI 10.1016/S0065-230X(08)00403-X; Lipton A, 2008, J CLIN ONCOL, V26, P2653, DOI 10.1200/JCO.2007.15.4336; Lipton A, 2007, CANCER, V109, P1933, DOI 10.1002/cncr.22637; Liu XW, 2005, CANCER RES, V65, P898; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Nakagawa SA, 2010, J BONE JOINT SURG AM, V92A, P1738, DOI 10.2106/JBJS.H.00717; Patruno A, 2012, J CELL PHYSIOL, V227, P2767, DOI 10.1002/jcp.23024; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raspollini MR, 2004, GYNECOL ONCOL, V92, P806, DOI 10.1016/j.ygyno.2003.12.023; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Ridnour LA, 2008, NITRIC OXIDE-BIOL CH, V19, P73, DOI 10.1016/j.niox.2008.04.006; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Schrohl AS, 2006, CLIN CANCER RES, V12, P7054, DOI 10.1158/1078-0432.CCR-06-0950; Simon DI, 1996, P NATL ACAD SCI USA, V93, P4736, DOI 10.1073/pnas.93.10.4736; Sohn JJ, 2012, PLOS ONE IN PRESS; Sorensen NM, 2007, CLIN CANCER RES, V13, P4117, DOI 10.1158/1078-0432.CCR-07-0186; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sumbayev VV, 2008, IMMUNOL LETT, V115, P126, DOI 10.1016/j.imlet.2007.10.013; Switzer CH, 2009, ONCOGENE, V28, P3837, DOI 10.1038/onc.2009.244; Switzer CH, 2012, CANCER RES, V72, P2394, DOI 10.1158/0008-5472.CAN-11-3115; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003; Wurtz SO, 2008, ACTA ONCOL, V47, P580, DOI 10.1080/02841860802022976; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	57	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44081	10.1371/journal.pone.0044081	http://dx.doi.org/10.1371/journal.pone.0044081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957045	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800037
J	Castine, SA; Erler, DV; Trott, LA; Paul, NA; de Nys, R; Eyre, BD				Castine, Sarah A.; Erler, Dirk V.; Trott, Lindsay A.; Paul, Nicholas A.; de Nys, Rocky; Eyre, Bradley D.			Denitrification and Anammox in Tropical Aquaculture Settlement Ponds: An Isotope Tracer Approach for Evaluating N-2 Production	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; DISSIMILATORY NITRATE REDUCTION; MANGANESE REDUCTION; NITROGEN DYNAMICS; SEDIMENTS; NITRITE; NITRIFICATION; INHIBITION; ESTUARY	Settlement ponds are used to treat aquaculture discharge water by removing nutrients through physical (settling) and biological (microbial transformation) processes. Nutrient removal through settling has been quantified, however, the occurrence of, and potential for microbial nitrogen (N) removal is largely unknown in these systems. Therefore, isotope tracer techniques were used to measure potential rates of denitrification and anaerobic ammonium oxidation (anammox) in the sediment of settlement ponds in tropical aquaculture systems. Dinitrogen gas (N-2) was produced in all ponds, although potential rates were low (0-7.07 nmol N cm(-3) h(-1)) relative to other aquatic systems. Denitrification was the main driver of N-2 production, with anammox only detected in two of the four ponds. No correlations were detected between the measured sediment variables (total organic carbon, total nitrogen, iron, manganese, sulphur and phosphorous) and denitrification or anammox. Furthermore, denitrification was not carbon limited as the addition of particulate organic matter (paired t-Test; P = 0.350, n = 3) or methanol (paired t-Test; P = 0.744, n = 3) did not stimulate production of N-2. A simple mass balance model showed that only 2.5% of added fixed N was removed in the studied settlement ponds through the denitrification and anammox processes. It is recommended that settlement ponds be used in conjunction with additional technologies (i.e. constructed wetlands or biological reactors) to enhance N-2 production and N removal from aquaculture wastewater.	[Castine, Sarah A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Australian Inst Marine Sci,AIMS JCU, Townsville, Qld 4811, Australia; [Erler, Dirk V.; Eyre, Bradley D.] So Cross Univ, Sch Environm Sci & Management, Ctr Coastal Biogeochem, Lismore, NSW 2480, Australia; [Trott, Lindsay A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine Trop Biol, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; James Cook University; Southern Cross University; Australian Institute of Marine Science; James Cook University	Castine, SA (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Sch Marine & Trop Biol, Australian Inst Marine Sci,AIMS JCU, Townsville, Qld 4811, Australia.	sarah.castine@my.jcu.edu.au	Erler, Dirk/I-7209-2012; Paul, Nicholas/B-6496-2009; Eyre, Bradley/C-2527-2013; de Nys, Rocky/D-6741-2012	Eyre, Bradley/0000-0001-5502-0680; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535; Erler, Dirk/0000-0003-1242-7311	AIMS@JCU	AIMS@JCU	This research was funded by an AIMS@JCU research scholarship awarded to Sarah Castine at the beginning of her PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2010, APPL MICROBIOL BIOT, V85, P773, DOI 10.1007/s00253-009-2265-4; Alongi DM, 2000, MAR ECOL PROG SER, V194, P87, DOI 10.3354/meps194087; Amano T, 2011, MICROBES ENVIRON, V26, P1, DOI 10.1264/jsme2.ME10150; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Archer HE, 2003, WATER SCI TECHNOL, V48, P9, DOI 10.2166/wst.2003.0076; Avnimelech Y, 1999, AQUACULTURE, V176, P227, DOI 10.1016/S0044-8486(99)00085-X; Bartoli M, 2005, MAR POLLUT BULL, V50, P1386, DOI 10.1016/j.marpolbul.2005.06.011; Bolan NS, 2009, BIORESOURCE TECHNOL, V100, P5490, DOI 10.1016/j.biortech.2009.03.004; Brunet RC, 1996, FEMS MICROBIOL ECOL, V21, P131, DOI 10.1111/j.1574-6941.1996.tb00340.x; Bulow SE, 2010, DEEP-SEA RES PT I, V57, P384, DOI 10.1016/j.dsr.2009.10.014; Burford MA, 2004, AQUACULTURE, V229, P129, DOI 10.1016/S0044-8486(03)00358-2; Burford MA, 2001, MAR ECOL PROG SER, V224, P187, DOI 10.3354/meps224187; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; Christensen PB, 2000, AQUAT MICROB ECOL, V21, P73, DOI 10.3354/ame021073; Clarke K., 2005, PRIMER 6 COMPUTER PR; Craggs RJ, 2004, NEW ZEAL J AGR RES, V47, P449, DOI 10.1080/00288233.2004.9513613; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2002, APPL ENVIRON MICROB, V68, P3802, DOI 10.1128/AEM.68.8.3802-3808.2002; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; Dong LF, 2000, MAR ECOL PROG SER, V203, P109, DOI 10.3354/meps203109; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Engstrom P, 2005, GEOCHIM COSMOCHIM AC, V69, P2057, DOI 10.1016/j.gca.2004.09.032; Erler D, 2007, AQUACULT INT, V15, P55, DOI 10.1007/s10499-006-9068-8; Erler DV, 2008, ENVIRON SCI TECHNOL, V42, P9144, DOI 10.1021/es801175t; Galloway JN, 2008, SCIENCE, V320; Giblin AE, 2010, ESTUAR COAST, V33, P1054, DOI 10.1007/s12237-010-9280-7; Guven D, 2005, APPL ENVIRON MICROB, V71, P1066, DOI 10.1128/AEM.71.2.1066-1071.2005; Hietanen S, 2008, HYDROBIOLOGIA, V596, P67, DOI 10.1007/s10750-007-9058-5; Hulth S, 1999, GEOCHIM COSMOCHIM AC, V63, P49, DOI 10.1016/S0016-7037(98)00285-3; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Jackson CJ, 2003, AQUACULTURE, V226, P23, DOI 10.1016/S0044-8486(03)00464-2; Jensen MM, 2007, APPL ENVIRON MICROB, V73, P3151, DOI 10.1128/AEM.01898-06; Jetten MSM, 2001, CURR OPIN BIOTECH, V12, P283, DOI 10.1016/S0958-1669(00)00211-1; Jorgensen BB, 2010, ISME J, V4, P1083, DOI 10.1038/ismej.2010.106; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; KING D, 1984, J GEN MICROBIOL, V130, P2935; Koop-Jakobsen K, 2009, ESTUAR COAST, V32, P238, DOI 10.1007/s12237-008-9131-y; Li M, 2011, MICROBES ENVIRON, V26, P15, DOI 10.1264/jsme2.ME10131; LORING DH, 1992, EARTH-SCI REV, V32, P235, DOI 10.1016/0012-8252(92)90001-A; Madrid VM, 2006, FEMS MICROBIOL ECOL, V57, P169, DOI 10.1111/j.1574-6941.2006.00123.x; Meyer-Reil LA, 2000, MAR POLLUT BULL, V41, P255, DOI 10.1016/S0025-326X(00)00114-4; Minjeaud L, 2009, AQUAT SCI, V71, P425, DOI 10.1007/s00027-009-0100-8; Nicholls JC, 2009, AQUAT MICROB ECOL, V55, P105, DOI 10.3354/ame01285; Porrello S, 2003, AQUACULTURE, V219, P485, DOI 10.1016/S0044-8486(02)00637-3; Risgaard-Petersen N, 2005, AQUAT MICROB ECOL, V40, P67, DOI 10.3354/ame040067; Roy D, 2010, J IND MICROBIOL BIOT, V37, P1105, DOI 10.1007/s10295-010-0869-4; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tanner CC, 2003, WATER SCI TECHNOL, V48, P331, DOI 10.2166/wst.2003.0138; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thomas Y, 2010, MAR POLLUT BULL, V61, P387, DOI 10.1016/j.marpolbul.2010.07.005; Trimmer M, 2005, APPL ENVIRON MICROB, V71, P1923, DOI 10.1128/AEM.71.4.1923-1930.2005; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P577, DOI 10.4319/lo.2009.54.2.0577; Yin SX, 2002, SOIL BIOL BIOCHEM, V34, P1131, DOI 10.1016/S0038-0717(02)00049-4	56	22	24	1	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e42810	10.1371/journal.pone.0042810	http://dx.doi.org/10.1371/journal.pone.0042810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962581	Green Published, gold, Green Accepted			2022-12-27	WOS:000308577600008
J	Chung, W; Abel, SM; Chakraborty, AK				Chung, Woo; Abel, Steven M.; Chakraborty, Arup K.			Protein Clusters on the T Cell Surface May Suppress Spurious Early Signaling Events	PLOS ONE			English	Article							RECEPTOR MICROCLUSTERS; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; ACTIVATION; LAT; MICRODOMAINS; ZAP-70; PHOSPHORYLATION; TRANSDUCTION; ORGANIZATION	T cells play an important role in the adaptive immune system, quickly activating effector functions in response to small numbers of antigenic peptides but rarely activating in response to constant interaction with most endogenous peptides. Emerging experimental evidence suggests that key membrane-bound signaling proteins such as the T cell receptor and the adaptor protein Lat are spatially organized into small clusters on the T cell membrane. We use spatially resolved, stochastic computer simulations to study how the inhomogeneous distribution of molecules affects the portion of the T cell signaling network in which the kinase ZAP-70, originating in T cell receptor clusters, phosphorylates Lat. To gain insight into the effects of protein clustering, we compare the signaling response from membranes with clustered proteins to the signaling response from membranes with homogeneously distributed proteins. Given a fixed amount of ZAP-70 (a proxy for degree of TCR stimulation) that must diffuse into contact with Lat molecules, the spatially homogeneous system responds faster and results in higher levels of phosphorylated Lat. Analysis of the spatial distribution of proteins demonstrates that, in the homogeneous system, nearest ZAP-70 and Lat proteins are closer on average and fewer Lat molecules share the same closest ZAP-70 molecule, leading to the faster response time. The results presented here suggest that spatial clustering of proteins on the T cell membrane may suppress the propagation of signal from ZAP-70 to Lat, thus providing a regulatory mechanism by which T cells suppress transient, spurious signals induced by stimulation of T cell receptors by endogenous peptides. Because this suppression of spurious signals may occur at a cost to sensitivity, we discuss recent experimental results suggesting other potential mechanisms by which ZAP-70 and Lat may interact to initiate T cell activation.	[Chung, Woo; Abel, Steven M.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Harvard, Charlestown, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Chung, W (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu		Abel, Steven/0000-0003-0491-8647	NIH Director's Pioneer award; NIH grant [1P01AI091580-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	NIH Director's Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an NIH Director's Pioneer award and NIH grant 1P01AI091580-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Artyomov MN, 2010, P NATL ACAD SCI USA, V107, P16916, DOI 10.1073/pnas.1010568107; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Costa MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006316; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dushek O, 2008, BIOPHYS J, V94, P3447, DOI 10.1529/biophysj.107.116897; Dushek O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000578; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Kindt T.J., 2007, KUBY IMMUNOLOGY; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lis M, 2009, BIOINFORMATICS, V25, P2289, DOI 10.1093/bioinformatics/btp387; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Mugler A, 2012, BIOPHYS J, V102, P1069, DOI 10.1016/j.bpj.2012.02.005; Peirce M, 2000, J BIOL CHEM, V275, P34976, DOI 10.1074/jbc.M005819200; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Torigoe C, 2007, J IMMUNOL, V178, P3530, DOI 10.4049/jimmunol.178.6.3530; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44444	10.1371/journal.pone.0044444	http://dx.doi.org/10.1371/journal.pone.0044444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973450	Green Published, gold			2022-12-27	WOS:000308577600054
J	Jones, GN; Moschidou, D; Puga-Iglesias, TI; Kuleszewicz, K; Vanleene, M; Shefelbine, SJ; Bou-Gharios, G; Fisk, NM; David, AL; De Coppi, P; Guillot, PV				Jones, Gemma N.; Moschidou, Dafni; Puga-Iglesias, Tamara-Isabel; Kuleszewicz, Katarzyna; Vanleene, Maximilien; Shefelbine, Sandra J.; Bou-Gharios, George; Fisk, Nicholas M.; David, Anna L.; De Coppi, Paolo; Guillot, Pascale V.			Ontological Differences in First Compared to Third Trimester Human Fetal Placental Chorionic Stem Cells	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; MESENCHYMAL STROMAL CELLS; PROGENITOR CELLS; AMNIOTIC-FLUID; CORD BLOOD; PLX-PAD; C-KIT; BONE; MOUSE; EXPRESSION	Human mesenchymal stromal/stem cells (MSC) isolated from fetal tissues hold promise for use in tissue engineering applications and cell-based therapies, but their collection is restricted ethically and technically. In contrast, the placenta is a potential source of readily-obtainable stem cells throughout pregnancy. In fetal tissues, early gestational stem cells are known to have advantageous characteristics over neonatal and adult stem cells. Accordingly, we investigated whether early fetal placental chorionic stem cells (e-CSC) were physiologically superior to their late gestation fetal chorionic counterparts (l-CSC). We showed that e-CSC shared a common phenotype with l-CSC, differentiating down the osteogenic, adipogenic and neurogenic pathways, and containing a subset of cells endogenously expressing NANOG, SOX2, c-MYC, and KLF4, as well as an array of genes expressed in pluripotent stem cells and primordial germ cells, including CD24, NANOG, SSEA4, SSEA3, TRA-1-60, TRA-1-81, STELLA, FRAGILIS, NANOS3, DAZL and SSEA1. However, we showed that e-CSC have characteristics of an earlier state of stemness compared to l-CSC, such as smaller size, faster kinetics, uniquely expressing OCT4A variant 1 and showing higher levels of expression of NANOG, SOX2, c-MYC and KLF4 than l-CSC. Furthermore e-CSC, but not l-CSC, formed embryoid bodies containing cells from the three germ layer lineages. Finally, we showed that e-CSC demonstrate higher tissue repair in vivo; when transplanted in the osteogenesis imperfecta mice, e-CSC, but not l-CSC increased bone quality and plasticity; and when applied to a skin wound, e-CSC, but not l-CSC, accelerated healing compared to controls. Our results provide insight into the ontogeny of the stemness phenotype during fetal development and suggest that the more primitive characteristics of early compared to late gestation fetal chorionic stem cells may be translationally advantageous.	[Jones, Gemma N.; Moschidou, Dafni; Puga-Iglesias, Tamara-Isabel; Kuleszewicz, Katarzyna; Guillot, Pascale V.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Vanleene, Maximilien; Shefelbine, Sandra J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Bou-Gharios, George] Univ Oxford, Kennedy Inst Rheumatol, London, England; [Fisk, Nicholas M.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [David, Anna L.] UCL, Prenatal Cell & Gene Therapy Grp, Inst Womens Hlth, London, England; [De Coppi, Paolo] UCL Inst Child Hlth, Surg Unit, London, England	Imperial College London; Imperial College London; University of Oxford; University of Queensland; University of London; University College London; University of London; University College London	Jones, GN (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England.	Pascale.Guillot@imperial.ac.uk	Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975; De Coppi, Paolo/0000-0002-1659-0207; Kuleszewicz, Kasia/0000-0003-1381-6589; David, Anna/0000-0002-0199-6140; Guillot, Pascale V/0000-0002-3796-1572	Genesis Research Trust; Henry Smith Charity; Action Medical Research; Medical Research Council; Kidney Research United Kingdom; Biotechnology and Biological Science Research Council; Great Ormond Street Hospital Children's Charity; National Institute for Health Research (NIHR); Department of Health's NIHR Biomedical Research Centers funding scheme; Action Medical Research [1749] Funding Source: researchfish	Genesis Research Trust; Henry Smith Charity; Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research United Kingdom(Kidney Research UK (KRUK)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Ormond Street Hospital Children's Charity; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health's NIHR Biomedical Research Centers funding scheme; Action Medical Research	This research was funded by Genesis Research Trust, Henry Smith Charity and Action Medical Research. GNJ was supported by the Medical Research Council. DM was supported by Kidney Research United Kingdom. KK was supported by Biotechnology and Biological Science Research Council. PDC was supported by Great Ormond Street Hospital Children's Charity. ALD is supported by the National Institute for Health Research (NIHR) through a Senior Lectureship and the Department of Health's NIHR Biomedical Research Centers funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2010, J R SOC INTERFACE, V7, pS689, DOI 10.1098/rsif.2010.0347.focus; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Arnaud P, 2010, REPRODUCTION, V140, P411, DOI 10.1530/REP-10-0173; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Bacenkova D, 2011, CYTOTHERAPY, V13, P1047, DOI 10.3109/14653249.2011.592522; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chan J, 2008, HUM REPROD, V23, P2427, DOI 10.1093/humrep/den302; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Ciuca DR, 2011, ROM J MORPHOL EMBRYO, V52, P803; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Miguel MP, 2002, P NATL ACAD SCI USA, V99, P10458, DOI 10.1073/pnas.122249399; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donovan PJ, 1998, INT J DEV BIOL, V42, P1043; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Fariha MMN, 2011, CYTOTHERAPY, V13, P582, DOI 10.3109/14653249.2010.549121; Guillot P, 2008, J PATHOL, V214, P627, DOI 10.1002/path.2325; Guillot PV, 2008, BLOOD, V111, P1717, DOI 10.1182/blood-2007-08-105809; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hoyer PE, 2005, MOL CELL ENDOCRINOL, V234, P1, DOI 10.1016/j.mce.2004.09.012; Hua JL, 2009, TISSUE CELL, V41, P448, DOI 10.1016/j.tice.2009.05.004; Hua JL, 2009, REPROD BIOMED ONLINE, V19, P99, DOI 10.1016/S1472-6483(10)60052-1; Huygen S, 2002, BLOOD, V100, P2744, DOI 10.1182/blood.V100.8.2744; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Jones GN, 2012, STEM CELL TRANSL MED, V1, P70, DOI 10.5966/sctm.2011-0007; Kim MJ, 2011, CELL TISSUE RES, V346, P53, DOI 10.1007/s00441-011-1249-8; Kucia M, 2007, DEV DYNAM, V236, P3309, DOI 10.1002/dvdy.21180; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, ACTA NEUROBIOL EXP, V66, P331; Kyo S, 1997, BIOCHEM BIOPH RES CO, V241, P498, DOI 10.1006/bbrc.1997.7767; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li X, 2011, STEM CELLS, V29, P263, DOI 10.1002/stem.572; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Mohr S, 2010, REPROD SCI, V17, P1006, DOI 10.1177/1933719110377471; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamoto K, 2007, EXP CELL RES, V313, P2550, DOI 10.1016/j.yexcr.2007.04.028; Park JH, 2004, MOL CELLS, V17, P309; Park S, 2011, PLACENTA, V32, P269, DOI 10.1016/j.placenta.2010.12.027; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Poloni A, 2012, CELL PROLIFERAT, V45, P66, DOI 10.1111/j.1365-2184.2011.00799.x; Poloni A, 2008, CYTOTHERAPY, V10, P690, DOI 10.1080/14653240802419310; Portmann-Lanz CB, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.893; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Prather WR, 2009, CYTOTHERAPY, V11, P427, DOI 10.1080/14653240902849762; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Ramot Y, 2009, TOXICOL PATHOL, V37, P606, DOI 10.1177/0192623309338383; Ratajczak MZ, 2011, METHOD CELL BIOL, V103, P31, DOI 10.1016/B978-0-12-385493-3.00003-6; Ryan JM, 2011, STEM CELL REV; Saiti D, 2007, BIOMARK INSIGHTS, V2, P241; Schmidt D, 2006, CIRCULATION, V114, pI125, DOI 10.1161/CIRCULATIONAHA.105.001040; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Shin DM, 2010, LEUKEMIA, V24, P1450, DOI 10.1038/leu.2010.121; Shin KS, 2010, CELL PROLIFERAT, V43, P435, DOI 10.1111/j.1365-2184.2010.00693.x; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Spitalieri P, 2009, CLONING STEM CELLS, V11, P535, DOI 10.1089/clo.2009.0046; Sung HJ, 2010, J KOREAN MED SCI, V25, P1418, DOI 10.3346/jkms.2010.25.10.1418; Susman S, 2010, ROM J MORPHOL EMBRYO, V51, P733; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Vanleene M, 2011, BLOOD, V117, P1053, DOI 10.1182/blood-2010-05-287565; Weber B, 2011, PLACENTA, V32, pS316, DOI 10.1016/j.placenta.2011.04.001; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zhang ZY, 2012, BIOMATERIALS	86	48	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43395	10.1371/journal.pone.0043395	http://dx.doi.org/10.1371/journal.pone.0043395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962584	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600011
J	Li, L; Stefan, MI; Le Novere, N				Li, Lu; Stefan, Melanie I.; Le Novere, Nicolas			Calcium Input Frequency, Duration and Amplitude Differentially Modulate the Relative Activation of Calcineurin and CaMKII	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; BIDIRECTIONAL SYNAPTIC PLASTICITY; NMDA RECEPTORS; CALMODULIN-BINDING; NEURONAL PHOSPHOPROTEIN; CA-2+ CALMODULIN; RAT-BRAIN; AREA CA1; DARPP-32	NMDA receptor dependent long-term potentiation (LTP) and long-term depression (LTD) are two prominent forms of synaptic plasticity, both of which are triggered by post-synaptic calcium elevation. To understand how calcium selectively stimulates two opposing processes, we developed a detailed computational model and performed simulations with different calcium input frequencies, amplitudes, and durations. We show that with a total amount of calcium ions kept constant, high frequencies of calcium pulses stimulate calmodulin more efficiently. Calcium input activates both calcineurin and Ca2+/calmodulin-dependent protein kinase II (CaMKII) at all frequencies, but increased frequencies shift the relative activation from calcineurin to CaMKII. Irrespective of amplitude and duration of the inputs, the total amount of calcium ions injected adjusts the sensitivity of the system to calcium input frequencies. At a given frequency, the quantity of CaMKII activated is proportional to the total amount of calcium. Thus, an input of a small amount of calcium at high frequencies can induce the same activation of CaMKII as a larger amount, at lower frequencies. Finally, the extent of activation of CaMKII signals with high calcium frequency is further controlled by other factors, including the availability of calmodulin, and by the potency of phosphatase inhibitors.	[Li, Lu; Stefan, Melanie I.; Le Novere, Nicolas] EMBL European Bioinformat Inst, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Li, L (corresponding author), EMBL European Bioinformat Inst, Hinxton, England.	lenov@ebi.ac.uk		Li, Lu/0000-0002-6199-522X; Stefan, Melanie/0000-0002-6086-7357				AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bhalla US, 2002, J COMPUT NEUROSCI, V13, P49, DOI 10.1023/A:1019644427655; Black DJ, 2007, BIOCHEMISTRY-US, V46, P13415, DOI 10.1021/bi700774s; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Byrne MJ, 2009, J COMPUT NEUROSCI, V27, P621, DOI 10.1007/s10827-009-0173-3; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coomber C, 1998, COMPUT CHEM, V22, P251, DOI 10.1016/S0097-8485(97)00002-8; CROUCH TH, 1980, BIOCHEMISTRY-US, V19, P3692, DOI 10.1021/bi00557a009; d'Alcantara P, 2003, EUR J NEUROSCI, V17, P2521, DOI 10.1046/j.1460-9568.2003.02693.x; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DESDOUITS F, 1995, BIOCHEM BIOPH RES CO, V206, P652, DOI 10.1006/bbrc.1995.1092; Dormand J.R., 1980, J COMPUT APPL MATH, V6, P19, DOI [10.1016/0771-050X(80)90013-3, DOI 10.1016/0771-050X(80)90013-3]; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dupont G, 2003, CELL CALCIUM, V34, P485, DOI 10.1016/S0143-4160(03)00152-0; Franks KM, 2001, NEUROCOMPUTING, V38, P9, DOI 10.1016/S0925-2312(01)00415-5; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Graupner M, 2007, PLOS COMPUT BIOL, V3, P2299, DOI 10.1371/journal.pcbi.0030221; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayer A, 2005, PLOS COMPUT BIOL, V1, P137, DOI 10.1371/journal.pcbi.0010020; HEMMINGS HC, 1990, J BIOL CHEM, V265, P20369; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Huang KP, 2000, BIOCHEMISTRY-US, V39, P7291, DOI 10.1021/bi000336l; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KING MM, 1984, J BIOL CHEM, V259, P8080; KLEE CB, 1991, NEUROCHEM RES, V16, P1059, DOI 10.1007/BF00965851; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; Lucic V, 2008, EUR BIOPHYS J BIOPHY, V38, P83, DOI 10.1007/s00249-008-0362-4; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MICHELSON S, 1994, J THEOR BIOL, V171, P281, DOI 10.1006/jtbi.1994.1231; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Petersen JD, 2003, J NEUROSCI, V23, P11270; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; REGEHR WG, 1992, J NEUROSCI, V12, P4202; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Stefan MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029406; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Takahashi K, 2004, BIOINFORMATICS, V20, P538, DOI 10.1093/bioinformatics/btg442; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Urakubo H, 2008, J NEUROSCI, V28, P3310, DOI 10.1523/JNEUROSCI.0303-08.2008; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1; Zhabotinsky AM, 2006, J NEUROSCI, V26, P7337, DOI 10.1523/JNEUROSCI.0729-06.2006	104	65	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43810	10.1371/journal.pone.0043810	http://dx.doi.org/10.1371/journal.pone.0043810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962589	gold, Green Published, Green Accepted			2022-12-27	WOS:000308577600017
J	Lichtenegger, FS; Mueller, K; Otte, B; Beck, B; Hiddemann, W; Schendel, DJ; Subklewe, M				Lichtenegger, Felix S.; Mueller, Katharina; Otte, Bettina; Beck, Barbara; Hiddemann, Wolfgang; Schendel, Dolores J.; Subklewe, Marion			CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; CANCER-IMMUNOTHERAPY; COSTIMULATORY MOLECULE; IN-VIVO; MATURATION; VACCINATION; EXPRESSION; IMMUNITY; GENERATION; INDUCTION	Background: Dendritic cells (DCs) determine the activation and polarization of T cells via expression of costimulatory molecules and secretion of cytokines. The function of DCs derived from monocytes ex vivo strongly depends on the composition of the maturation cocktail used. Methodology/Principal Findings: We analyzed the effect of costimulatory molecule expression and cytokine secretion by DCs on T and natural killer (NK) cell activation by conducting a head-to-head comparison of a Toll-like receptor (TLR) agonist-based cocktail with the standard combination of proinflammatory cytokines or IL-10 alone. We could show that TLR-induced DCs are characterized by a predominance of costimulatory over coinhibitory molecules and by high secretion of IL-12p70, but not IL-10. Functionally, these signals translated into an increase in IFN-gamma secreting Th1 cells and a decrease in regulatory T cells. T cell activation and polarization were dependent on IL-12p70 and CD86, but remarkably not on CD80 signaling. By means of IL-12p70 secretion, only TLR-induced DCs activated NK cells. Conclusions/Significance: TLR-matured DCs are highly suitable for application in immunotherapeutic strategies that rely on strong type 1 polarization and NK cell activation. Their effects particularly depend on high CD86 expression and IL-12p70 secretion.	[Lichtenegger, Felix S.; Mueller, Katharina; Otte, Bettina; Beck, Barbara; Hiddemann, Wolfgang; Subklewe, Marion] Klinikum Univ Munchen, Dept Internal Med 3, Munich, Germany; [Schendel, Dolores J.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lichtenegger, FS (corresponding author), Klinikum Univ Munchen, Dept Internal Med 3, Munich, Germany.	Felix.Lichtenegger@med.uni-muenchen.de	Subklewe, Marion/N-5873-2014; Lichtenegger, Felix S/H-3222-2019	Subklewe, Marion/0000-0001-9154-9469; 	BayImmuNet, the Bavarian Immunotherapy Network	BayImmuNet, the Bavarian Immunotherapy Network	This work was supported by funds from BayImmuNet, the Bavarian Immunotherapy Network (http://www.bayimmunet.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Beck B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-151; Boudreau JE, 2011, MOL THER, V19, P841, DOI 10.1038/mt.2011.57; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Correll A, 2010, EXP DERMATOL, V19, pE213, DOI 10.1111/j.1600-0625.2009.01055.x; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; De Becker G, 1998, EUR J IMMUNOL, V28, P3161, DOI 10.1002/(SICI)1521-4141(199810)28:10<3161::AID-IMMU3161>3.3.CO;2-H; Dohnal AM, 2007, CYTOTHERAPY, V9, P755, DOI 10.1080/14653240701589221; Eksioglu EA, 2010, FRONT BIOSCI-LANDMRK, V15, P321, DOI 10.2741/3623; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Fujii S, 2009, ARCH IMMUNOL THER EX, V57, P189, DOI 10.1007/s00005-009-0025-x; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 2005, MOL IMMUNOL, V42, P535, DOI 10.1016/j.molimm.2004.07.038; Kalinski P, 1999, J IMMUNOL, V162, P3231; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LARSEN CP, 1992, J EXP MED, V176, P1215, DOI 10.1084/jem.176.4.1215; LARSEN CP, 1994, J IMMUNOL, V152, P5208; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Osada T, 2006, CANCER IMMUNOL IMMUN, V55, P1122, DOI 10.1007/s00262-005-0089-3; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Schuler G, 2011, CANCER J, V17, P337, DOI 10.1097/PPO.0b013e3182350077; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seliger B, 2008, TRENDS MOL MED, V14, P550, DOI 10.1016/j.molmed.2008.09.010; Skalova K, 2010, VACCINE, V28, P5153, DOI 10.1016/j.vaccine.2010.05.042; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; Steinbrink K, 1997, J IMMUNOL, V159, P4772; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tuyaerts S, 2007, CANCER IMMUNOL IMMUN, V56, P1513, DOI 10.1007/s00262-007-0334-z; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; Um SJ, 2010, LUNG CANCER, V70, P188, DOI 10.1016/j.lungcan.2010.02.006; Van Tendeloo VF, 2010, P NATL ACAD SCI USA, V107, P13824, DOI 10.1073/pnas.1008051107; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Zobywalski A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-18	51	48	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44266	10.1371/journal.pone.0044266	http://dx.doi.org/10.1371/journal.pone.0044266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962607	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600035
J	Wang, X; Li, Y; He, Y; Liang, HS; Liu, EZ				Wang, Xu; Li, Ying; He, Yan; Liang, Hong-Sheng; Liu, En-Zhong			A Novel Animal Model of Partial Optic Nerve Transection Established Using an Optic Nerve Quantitative Amputator	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SECONDARY DEGENERATION; AXONAL REGENERATION; IN-VIVO; SURVIVAL; DEATH; INJURY; APOPTOSIS; TRANSPLANTATION; MINOCYCLINE	Background: Research into retinal ganglion cell (RGC) degeneration and neuroprotection after optic nerve injury has received considerable attention and the establishment of simple and effective animal models is of critical importance for future progress. Methodology/Principal Findings: In the present study, the optic nerves of Wistar rats were semi-transected selectively with a novel optic nerve quantitative amputator. The variation in RGC density was observed with retro-labeled fluorogold at different time points after nerve injury. The densities of surviving RGCs in the experimental eyes at different time points were 1113.69 +/- 188.83 RGC/mm(2) (the survival rate was 63.81% compared with the contralateral eye of the same animal) 1 week post surgery; 748.22 +/- 134.75/mm(2) (46.16% survival rate) 2 weeks post surgery; 505.03 +/- 118.67/mm(2) (30.52% survival rate) 4 weeks post surgery; 436.86 +/- 76.36/mm(2) (24.01% survival rate) 8 weeks post surgery; and 378.20 +/- 66.74/mm(2) (20.30% survival rate) 12 weeks post surgery. Simultaneously, we also measured the axonal distribution of optic nerve fibers; the latency and amplitude of pattern visual evoke potentials (P-VEP); and the variation in pupil diameter response to pupillary light reflex. All of these observations and profiles were consistent with post injury variation characteristics of the optic nerve. These results indicate that we effectively simulated the pathological process of primary and secondary injury after optic nerve injury. Conclusions/Significance: The present quantitative transection optic nerve injury model has increased reproducibility, effectiveness and uniformity. This model is an ideal animal model to provide a foundation for researching new treatments for nerve repair after optic nerve and/or central nerve injury.	[Wang, Xu; Liang, Hong-Sheng; Liu, En-Zhong] Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 1, Harbin, Peoples R China; [Wang, Xu] 211 Hosp PLA, Dept Neurosurg, Harbin, Peoples R China; [Li, Ying] Harbin Med Univ, Dept Food Hyg & Nutr, Coll Publ Hlth, Harbin, Peoples R China; [He, Yan] Harbin Med Univ, Dept Pathol, Basic Med Coll, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, X (corresponding author), Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 1, Harbin, Peoples R China.	liying_helen@163.com; enzhongliu@gmail.com			National Natural Science Fund of China [81172649]; Program for New Century Excellent Talents in University [NCET-10-0148]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the National Natural Science Fund of China (No. 81172649) and Program for New Century Excellent Talents in University (NCET-10-0148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABANE A, 1995, J NEUROSURG, V82, P284, DOI 10.3171/jns.1995.82.2.0284; Baptiste DC, 2005, NEUROSCIENCE, V134, P575, DOI 10.1016/j.neuroscience.2005.04.011; Bergamin O, 2003, OPHTHALMOLOGY, V110, P106, DOI 10.1016/S0161-6420(02)01445-8; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bruno V, 1993, Funct Neurol, V8, P279; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; Dibas A, 2010, MOL VIS, V16, P330; Diem R, 2001, J NEUROSCI, V21, P2058, DOI 10.1523/JNEUROSCI.21-06-02058.2001; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; Fileta JB, 2008, J NEUROSCI METH, V170, P1, DOI 10.1016/j.jneumeth.2007.12.008; HALLIDAY AM, 1972, LANCET, V1, P982; Huang TL, 2011, EXP EYE RES, V92, P112, DOI 10.1016/j.exer.2010.12.008; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Klocker N, 2001, J NEUROSCI METH, V110, P147, DOI 10.1016/S0165-0270(01)00435-6; Koeberle PD, 2010, CELL DEATH DIFFER, V17, P134, DOI 10.1038/cdd.2009.113; Levkovitch-Verbin H, 2006, ARCH OPHTHALMOL-CHIC, V124, P520, DOI 10.1001/archopht.124.4.520; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Liu Y, 2010, MOL VIS, V16, P2903; Loewenfeld IE, 1999, PUPIL ANATOMY PHYSL, V1, P2278; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; MAIER J, 1987, VISION RES, V27, P165, DOI 10.1016/0042-6989(87)90179-9; MURAKAMI M, 1989, J NEUROSURG, V71, P254, DOI 10.3171/jns.1989.71.2.0254; Osborne NN, 2004, EYE, V18, P1075, DOI 10.1038/sj.eye.6701588; PAIGEN K, 1995, NAT MED, V1, P215, DOI 10.1038/nm0395-215; Paxinos G., 1986, RAT BRAIN STEREOTAXI, P54; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; SIEVERS J, 1989, J COMP NEUROL, V281, P467, DOI 10.1002/cne.902810310; So KF, 1998, VISION RES, V38, P1525, DOI 10.1016/S0042-6989(97)00226-5; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; THANOS S, 1993, J NEUROSCI, V13, P455; Tsai RK, 2010, EXP EYE RES, V90, P537, DOI 10.1016/j.exer.2010.01.004; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Wang RB, 2010, J NEUROTRAUM, V27, P763, DOI 10.1089/neu.2009.1005; Watanabe M, 1997, CLIN NEUROSCI, V4, P233; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; Zhao TT, 2011, GRAEF ARCH CLIN EXP, V249, P1021, DOI 10.1007/s00417-011-1635-7	46	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44360	10.1371/journal.pone.0044360	http://dx.doi.org/10.1371/journal.pone.0044360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973439	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600041
J	Bruno, E; Nimaga, K; Foba, I; Vignoles, P; Genton, P; Doumbo, O; Gerard, D; Preux, PM; Farnarier, G				Bruno, Elisa; Nimaga, Karamoko; Foba, Ibrahima; Vignoles, Philippe; Genton, Pierre; Doumbo, Ogobara; Gerard, Daniel; Preux, Pierre-Marie; Farnarier, Guy			Results of an Action-Research on Epilepsy in Rural Mali	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; TREATMENT GAP; COMMUNITY; MANAGEMENT; PROGRAM; CARE; EXAMPLE; ACCESS; TRIAL	Purpose: To evaluate the RARE (Reseau Action-Recherche sur l'Epilepsie) program, a model of managing and treating people with epilepsy (PWE) at a primary health-care level in rural areas of Mali, we assessed treatment efficacy and compliance of patients who underwent the first year follow-up. Methods: A network of rural general practitioners (GPs) settled in six rural districts of the regions of Koulikoro, Segou and Sikasso, was involved in the diagnosis, evaluation and monitoring of all the identified PWE and in the distribution of phenobarbital (PB). All the participants were included in a prospective database and followed-up by GPs at 4 months intervals during the first year. Seizure frequency, treatment doses and appearance of adverse events (AEs) were systematically recorded. Efficacy was evaluated in terms of reduction of seizures frequency while noncompliance in terms of time to study withdrawal for any cause. Key findings: 596 patients treated with PB were included in the analysis. Of these, 74.0% completed the first year follow-up. At the final visit, 59.6% were seizure-free: 31.0% for 12 months, 10.2% for 8 months and 18.4% for 4 months. Adults and patients with convulsive seizures were the most drug-resistant (p<0.002). Few AEs were recorded. The multivariate analysis showed that being a woman, presenting convulsive seizures, having more than 5 seizures/month and had never be treated were predictors of withdrawal (p <= 0.05) at 12 months. Significance: This study showed a good response and compliance to the treatment and allowed the identification of some factors associated with failure of management in a setting very near to clinical practice. Awareness campaigns are needed to assure a broader accessibility to treatment and to improve the compliance and continuity with treatment programs.	[Bruno, Elisa; Vignoles, Philippe; Preux, Pierre-Marie] Univ Limoges, Sch Med, Inst Trop Neurol, CHU,INSERM,Trop Neuroepidemiol U1094, Limoges, France; [Bruno, Elisa] Univ Catania, Sect Neurosci, Dept Gian Filippo Ingrassia, Catania, Italy; [Nimaga, Karamoko; Foba, Ibrahima] Assoc Med Campagne, Reseau Act Rech Epilepsie RARE Network, Bamako, Mali; [Foba, Ibrahima; Doumbo, Ogobara] Fac Med, Dept Epidemiol Parasit Dis, Bamako, Mali; [Genton, Pierre; Doumbo, Ogobara; Farnarier, Guy] Sante S Nongovt Org, Bamako, Mali; [Genton, Pierre; Gerard, Daniel; Farnarier, Guy] Sanofi Aventis, Access Drugs Dept, Paris, France; [Genton, Pierre; Farnarier, Guy] Aix Marseille Univ, Dept Clin Neurophysiol, CHRU, Hop Nord, Marseille, France; [Genton, Pierre; Farnarier, Guy] Aix Marseille Univ, Fac Med, Marseille, France; [Genton, Pierre; Doumbo, Ogobara; Farnarier, Guy] Sante S Nongovt Org, Marseille, France	CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Limoges; University of Catania; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Bruno, E (corresponding author), Univ Limoges, Sch Med, Inst Trop Neurol, CHU,INSERM,Trop Neuroepidemiol U1094, Limoges, France.	pierre-marie.preux@unilim.fr	Preux, Pierre-Marie/N-3538-2019; Bruno, Elisa/P-4317-2018; PREUX, Pierre-Marie/B-8393-2014	Preux, Pierre-Marie/0000-0002-2171-2977; Bruno, Elisa/0000-0001-8166-1190; PREUX, Pierre-Marie/0000-0002-2171-2977	Sanofi-Aventis within the project "RARE: Reseau Action-Recherche sur l'Epilepsie"	Sanofi-Aventis within the project "RARE: Reseau Action-Recherche sur l'Epilepsie"	This work was supported by Sanofi-Aventis within the project "RARE: Reseau Action-Recherche sur l'Epilepsie" coordinated by the NGO Sante-Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMOLEKUN B, 1995, TROP GEOGR MED, V47, P115; [Anonymous], 1993, EPILEPSIA, V34, P592; Arborio S, 1999, MED TROPICALE, V59, P170; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Barennes H, 2011, ARCH DIS CHILD, V96, P309, DOI 10.1136/adc.2009.181255; Birbeck GL, 2010, EPILEPSY CURR, V10, P105, DOI 10.1111/j.1535-7511.2010.01372.x; Calisir N, 2006, EPILEPSIA, V47, P1691, DOI 10.1111/j.1528-1167.2006.00635.x; Coulibaly S., 2007, EDUC HEALTH, V20, P1; Das K, 2007, SEIZURE-EUR J EPILEP, V16, P601, DOI 10.1016/j.seizure.2007.04.008; Desplats D, 2004, Med Trop (Mars), V64, P539; Diop AG, 2001, EPILEPSIA, V42, P439, DOI 10.1046/j.1528-1157.2001.38800.x; ELECHI CA, 1991, TROP GEOGR MED, V43, P242; Farnarier G, 2005, EPILEPSIA, V46, P73; Farnarier G, 2000, Med Trop (Mars), V60, P151; Farnarier G., 1999, EPILEPSIES, V11, P222; Farnarier G, 1998, EPILEPSIES, V10, P105; Farnarier G, 2010, EPILEPSIES, V22, P151; FEKSI AT, 1991, EPILEPSY RES, V8, P252, DOI 10.1016/0920-1211(91)90072-N; Genton P, 2005, EPILEPSIA, V46, P88; Genton P., 2003, EPILEPSIES, V15, P201; Grunitzky, 2001, EPILEPSIES, V13, P185; Humbert AJ, 2001, EPILEPSIES, V13, P3338; Jaffre Y, 2001, EPILEPSIES, V13, P29; JILEK W G, 1970, African Journal of Medical Sciences, V1, P305; JILEKAALL L, 1992, EPILEPSIA, V33, P645, DOI 10.1111/j.1528-1157.1992.tb02341.x; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Mani KS, 2001, LANCET, V357, P1316, DOI 10.1016/S0140-6736(00)04516-5; Mani KS, 1998, NEUROL INDIA, V46, P1; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Murthy JMK, 2003, EPILEPSIA, V44, P38, DOI 10.1046/j.1528-1157.44.s.1.3.x; Nimaga K, 2000, B WORLD HEALTH ORGAN, V80, P1; Organization WH, 1990, IN SUPP PEOPL EP; Pal DK, 1998, LANCET, V351, P19, DOI 10.1016/S0140-6736(97)06250-8; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Preux PM, 2000, EPILEPSIA, V41, P432, DOI 10.1111/j.1528-1157.2000.tb00185.x; Radhakrishnan K, 2010, ANN INDIAN ACAD NEUR, V13, P236, DOI 10.4103/0972-2327.74184; SHORVON SD, 1988, EPILEPSIA, V29, pS36, DOI 10.1111/j.1528-1157.1988.tb05790.x; Unwin N, 1999, PUBLIC HEALTH, V113, P141, DOI 10.1016/S0033-3506(99)00139-0; Van Dormael M, HUMAN RESOURCES HLTH, P6, DOI [10.1186/1478-4491-1186-1125, DOI 10.1186/1478-4491-1186-1125]; Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4; WATTS AE, 1989, BRIT MED J, V298, P805, DOI 10.1136/bmj.298.6676.805; WFN, 2004, ATL COUNTR RES NEUR; WHO, 2000, EP MAN PRIM HLTH LEV; WHO, 1994, EP WHO AFR REG BRIDG; WHO, 2006, TRAV ENS SANT	45	13	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44469	10.1371/journal.pone.0044469	http://dx.doi.org/10.1371/journal.pone.0044469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22970109	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300093
J	Rachel, RA; Nagashima, K; O'Sullivan, TN; Frost, LS; Stefano, FP; Marigo, V; Boesze-Battaglia, K				Rachel, Rivka A.; Nagashima, Kunio; O'Sullivan, T. Norene; Frost, Laura S.; Stefano, Frank P.; Marigo, Valeria; Boesze-Battaglia, Kathleen			Melanoregulin, Product of the dsu Locus, Links the BLOC-Pathway and Oa1 in Organelle Biogenesis	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; OCULAR ALBINISM TYPE-1; PROTEIN-COUPLED RECEPTOR; COAT-COLOR PHENOTYPE; DILUTE SUPPRESSOR; GENE-PRODUCT; MELANOSOME TRANSPORT; MYOSIN-VA; MOUSE; HOMOLOG	Humans with Hermansky-Pudlak Syndrome (HPS) or ocular albinism (OA1) display abnormal aspects of organelle biogenesis. The multigenic disorder HPS displays broad defects in biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and lysosomes. A phenotype of ocular pigmentation in OA1 is a smaller number of macromelanosomes, in contrast to HPS, where in many cases the melanosomes are smaller than normal. In these studies we define the role of the Mreg(dsu) gene, which suppresses the coat color dilution of Myo5a, melanophilin, and Rab27a mutant mice in maintaining melanosome size and distribution. We show that the product of the Mreg(dsu) locus, melanoregulin (MREG), interacts both with members of the HPS BLOC-2 complex and with Oa1 in regulating melanosome size. Loss of MREG function facilitates increase in the size of micromelanosomes in the choroid of the HPS BLOC-2 mutants ruby, ruby2, and cocoa, while a transgenic mouse overexpressing melanoregulin corrects the size of retinal pigment epithelium (RPE) macromelanosomes in Oa1(ko/ko) mice. Collectively, these results suggest that MREG levels regulate pigment incorporation into melanosomes. Immunohistochemical analysis localizes melanoregulin not to melanosomes, but to small vesicles in the cytoplasm of the RPE, consistent with a role for this protein in regulating membrane interactions during melanosome biogenesis. These results provide the first link between the BLOC pathway and Oa1 in melanosome biogenesis, thus supporting the hypothesis that intracellular G-protein coupled receptors may be involved in the biogenesis of other organelles. Furthermore these studies provide the foundation for therapeutic approaches to correct the pigment defects in the RPE of HPS and OA1.	[Rachel, Rivka A.] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA; [Nagashima, Kunio] SAIC Frederick, Frederick Natl Lab Canc Res, Frederick, MD USA; [O'Sullivan, T. Norene] NCI, Frederick, MD 21701 USA; [Frost, Laura S.; Stefano, Frank P.; Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Philadelphia, PA 19104 USA; [Stefano, Frank P.] Univ Penn, Sch Dent Med, Live Cell Imaging Core, Philadelphia, PA 19104 USA; [Marigo, Valeria] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; University of Pennsylvania; Universita di Modena e Reggio Emilia	Rachel, RA (corresponding author), NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA.	battagli@dental.upenn.edu	Marigo, Valeria/B-7947-2015	Marigo, Valeria/0000-0002-4428-2084	Vision of Children; National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Eye Institute [EY-10420, EY018705]; National Cancer Institute [HHSN26120080001E]; Vision of Children Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010420, R29EY010420, R21EY018705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022465] Funding Source: NIH RePORTER	Vision of Children; National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vision of Children Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the following individuals for expert technical assistance, with animals: Deborah Swing, Erika Truffer, Stephanie Springer, Holly Morris and Rob Koogle; with genotyping: Deborah Householder and Anna Trivett; with electron microscopy: Michelle Gignac; Alvina Bragin for expert technical assistance. We thank the Vision of Children for facilitating this collaboration and for funding productive meetings, and Drs. Nancy Jenkins and Neal Copeland for supporting the majority of the work in their laboratory at the National Cancer Institute.; This project was funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, extramural grants from the National Eye Institute, EY-10420 and EY018705 (KBB), federal funds from the National Cancer Institute under contract HHSN26120080001E (KN), and by the Vision of Children Foundation (VM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; BALKEMA GW, 1990, VISUAL NEUROSCI, V4, P595, DOI 10.1017/S0952523800005794; Bassi MT, 1996, GENOME RES, V6, P880, DOI 10.1101/gr.6.9.880; Cortese K, 2005, INVEST OPHTH VIS SCI, V46, P4358, DOI 10.1167/iovs.05-0834; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Gautam R, 2004, J BIOL CHEM, V279, P12935, DOI 10.1074/jbc.M311311200; Giordano F, 2009, HUM MOL GENET, V18, P4530, DOI 10.1093/hmg/ddp415; Gunay-Aygun M, 2004, SEMIN THROMB HEMOST, V30, P537, DOI 10.1055/s-2004-835674; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Gwynn B, 2000, BLOOD, V96, P4227; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Helip-Wooley A, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-33; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; LAVAIL JH, 1978, J COMP NEUROL, V182, P399, DOI 10.1002/cne.901820304; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; MOORE KJ, 1988, GENETICS, V119, P933; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; Nguyen T, 2004, J INVEST DERMATOL, V122, P452, DOI 10.1046/j.0022-202X.2004.22117.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Rachel RA, 2002, J NEUROSCI, V22, P4249, DOI 10.1523/JNEUROSCI.22-11-04249.2002; Samaraweera P, 2001, EXP EYE RES, V72, P319, DOI 10.1006/exer.2000.0962; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; SCHNUR RE, 1994, AM J HUM GENET, V55, P484; Shen B, 2001, PIGM CELL RES, V14, P243, DOI 10.1034/j.1600-0749.2001.140403.x; Shen B, 2001, TRAFFIC, V2, P202, DOI 10.1034/j.1600-0854.2001.020306.x; Staleva L, 2006, EXP EYE RES, V82, P311, DOI 10.1016/j.exer.2005.07.003; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SWEET HO, 1983, J HERED, V74, P305, DOI 10.1093/oxfordjournals.jhered.a109794; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Tobin Gregory J., 1996, Methods (Orlando), V10, P208, DOI 10.1006/meth.1996.0096; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Young A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024376; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42446	10.1371/journal.pone.0042446	http://dx.doi.org/10.1371/journal.pone.0042446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984402	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700005
J	Sample, SJ; Racette, MA; Hao, ZL; Thomas, CF; Behan, M; Muir, P				Sample, Susannah J.; Racette, Molly A.; Hao, Zhengling; Thomas, Cathy F.; Behan, Mary; Muir, Peter			Functional Adaptation in Female Rats: The Role of Estrogen Signaling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR-ALPHA; SENSORY NEURONS; ADAPTIVE RESPONSE; BONE-FORMATION; MICE LACKING; GROWTH; EXPRESSION; GPR30; BETA	Background: Sex steroids have direct effects on the skeleton. Estrogen acts on the skeleton via the classical genomic estrogen receptors alpha and beta (ER alpha and ER beta), a membrane ER, and the non-genomic G-protein coupled estrogen receptor (GPER). GPER is distributed throughout the nervous system, but little is known about its effects on bone. In male rats, adaptation to loading is neuronally regulated, but this has not been studied in females. Methodology/Principal Findings: We used the rat ulna end-loading model to induce an adaptive modeling response in ovariectomized (OVX) female Sprague-Dawley rats. Rats were treated with a placebo, estrogen (17 beta-estradiol), or G-1, a GPER-specific agonist. Fourteen days after OVX, rats underwent unilateral cyclic loading of the right ulna; half of the rats in each group had brachial plexus anesthesia (BPA) of the loaded limb before loading. Ten days after loading, serum estrogen concentrations, dorsal root ganglion (DRG) gene expression of ER alpha, ER beta, GPER, CGRP alpha, TRPV1, TRPV4 and TRPA1, and load-induced skeletal responses were quantified. We hypothesized that estrogen and G-1 treatment would influence skeletal responses to cyclic loading through a neuronal mechanism. We found that estrogen suppresses periosteal bone formation in female rats. This physiological effect is not GPER-mediated. We also found that absolute mechanosensitivity in female rats was decreased, when compared with male rats. Blocking of adaptive bone formation by BPA in Placebo OVX females was reduced. Conclusions: Estrogen acts to decrease periosteal bone formation in female rats in vivo. This effect is not GPER-mediated. Gender differences in absolute bone mechanosensitivity exist in young Sprague-Dawley rats with reduced mechanosensitivity in females, although underlying bone formation rate associated with growth likely influences this observation. In contrast to female and male rats, central neuronal signals had a diminished effect on adaptive bone formation in estrogen-deficient female rats.	[Sample, Susannah J.; Racette, Molly A.; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Thomas, Cathy F.; Behan, Mary] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sample, SJ (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005	Clinical and Translational Science Award (CTSA) program; National Center for Research Resources (NCRR) [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916, UL1RR025011] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010423] Funding Source: NIH RePORTER	Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project described was supported by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Burt-Pichat B, 2005, ENDOCRINOLOGY, V146, P503, DOI 10.1210/en.2004-0884; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chagin AS, 2007, J CLIN ENDOCR METAB, V92, P4873, DOI 10.1210/jc.2007-0814; Cohen J., ANAL BEHAV SCI, V1988, P531; Dun SL, 2009, J NEUROSCI RES, V87, P1610, DOI 10.1002/jnr.21980; Fitts JM, 2011, J PHARMACOL EXP THER, V338, P246, DOI 10.1124/jpet.110.173955; Ford J, 2011, J BONE MINER RES, V26, P298, DOI 10.1002/jbmr.209; Heino TJ, 2008, J ENDOCRINOL, V197, pR1, DOI 10.1677/JOE-07-0629; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hou YX, 2010, ARCH ORAL BIOL, V55, P309, DOI 10.1016/j.archoralbio.2010.02.002; Hsieh YF, 1999, BONE, V25, P379, DOI 10.1016/S8756-3282(99)00181-7; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; Jarvinen TLN, 2003, BONE, V32, P642, DOI 10.1016/S8756-3282(03)00100-5; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; Kotha SP, 2004, J BIOMECH, V37, P541, DOI 10.1016/j.jbiomech.2003.08.009; Kuhn J, 2008, EUR J NEUROSCI, V27, P1700, DOI 10.1111/j.1460-9568.2008.06131.x; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Martin CD, 2007, NEUROSCI LETT, V427, P148, DOI 10.1016/j.neulet.2007.08.055; Mosley JR, 2002, BONE, V30, P314, DOI 10.1016/S8756-3282(01)00626-3; Ohlsson C, 2012, P NATL ACAD SCI USA, V109, P983, DOI 10.1073/pnas.1111436109; Papka RE, 2002, NEUROSCI LETT, V319, P71, DOI 10.1016/S0304-3940(01)02562-9; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Reed WR, 2009, J NEUROPHYSIOL, V102, P1062, DOI 10.1152/jn.00165.2009; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Roepke TA, 2010, ENDOCRINOLOGY, V151, P4926, DOI 10.1210/en.2010-0573; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Saxon LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE484, DOI 10.1152/ajpendo.00189.2007; Saxon LK, 2006, BONE, V39, P1261, DOI 10.1016/j.bone.2006.06.030; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; SOHRABJI F, 1994, J NEUROSCI, V14, P459; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Windahl SH, 2009, AM J PHYSIOL-ENDOC M, V296, pE490, DOI 10.1152/ajpendo.90691.2008; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009	48	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43215	10.1371/journal.pone.0043215	http://dx.doi.org/10.1371/journal.pone.0043215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984413	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700015
J	Araujo, THA; Souza-Brito, LI; Libin, P; Deforche, K; Edwards, D; de Albuquerque, AE; Vandamme, AM; Galvao-Castro, B; Alcantara, LC				Almeida Araujo, Thessika Hialla; Souza-Brito, Leandro Inacio; Libin, Pieter; Deforche, Koen; Edwards, Dustin; de Albuquerque-Junior, Antonio Eduardo; Vandamme, Anne-Mieke; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos			A Public HTLV-1 Molecular Epidemiology Database for Sequence Management and Data Mining	PLOS ONE			English	Article							VIRUS TYPE-I; T-CELL LEUKEMIA; BLOOD-DONORS; INFECTION	Background: It is estimated that 15 to 20 million people are infected with the human T-cell lymphotropic virus type 1 (HTLV-1). At present, there are more than 2,000 unique HTLV-1 isolate sequences published. A central database to aggregate sequence information from a range of epidemiological aspects including HTLV-1 infections, pathogenesis, origins, and evolutionary dynamics would be useful to scientists and physicians worldwide. Described here, we have developed a database that collects and annotates sequence data and can be accessed through a user- friendly search interface. The HTLV-1 Molecular Epidemiology Database website is available at http://htlv1db.bahia.fiocruz.br/. Methodology/Principal Findings: All data was obtained from publications available at GenBank or through contact with the authors. The database was developed using Apache Webserver 2.1.6 and SGBD MySQL. The webpage interfaces were developed in HTML and sever-side scripting written in PHP. The HTLV-1 Molecular Epidemiology Database is hosted on the Goncalo Moniz/FIOCRUZ Research Center server. There are currently 2,457 registered sequences with 2,024 (82.37%) of those sequences representing unique isolates. Of these sequences, 803 (39.67%) contain information about clinical status (TSP/HAM, 17.19%; ATL, 7.41%; asymptomatic, 12.89%; other diseases, 2.17%; and no information, 60.32%). Further, 7.26% of sequences contain information on patient gender while 5.23% of sequences provide the age of the patient. Conclusions/Significance: The HTLV-1 Molecular Epidemiology Database retrieves and stores annotated HTLV-1 proviral sequences from clinical, epidemiological, and geographical studies. The collected sequences and related information are now accessible on a publically available and user- friendly website. This open-access database will support clinical research and vaccine development related to viral genotype.	[Almeida Araujo, Thessika Hialla; de Albuquerque-Junior, Antonio Eduardo; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Fundacao Oswaldo Cruz, Goncalo Moniz Res Center, Salvador, BA, Brazil; [Souza-Brito, Leandro Inacio; Galvao-Castro, Bernardo; Junior Alcantara, Luiz Carlos] Bahia Fdn Sci Dev, Bahia Sch Med & Publ Hlth, Salvador, BA, Brazil; [Libin, Pieter; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Edwards, Dustin] NCI, Anim Models & Retroviral Vaccines Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Libin, Pieter; Deforche, Koen] MyBioData, Rotselaar, Belgium; [Vandamme, Anne-Mieke] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal	Fundacao Oswaldo Cruz; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Araujo, THA (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Center, Salvador, BA, Brazil.	lalcan@bahia.fiocruz.br	Alcantara, Luiz Carlos Júnior/AAK-9468-2021; Vandamme, Anne-Mieke/I-4127-2012	Vandamme, Anne-Mieke/0000-0002-6594-2766; Alcantara, Luiz/0000-0002-6769-9931; Edwards, Dustin/0000-0001-6409-8041	Brazilian Ministry of Health [TC120/2010]	Brazilian Ministry of Health	This work was supported by funds from Brazilian Ministry of Health (TC120/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; deThe G, 1996, J ACQ IMMUN DEF SYND, V13, pS191, DOI 10.1097/00042560-199600001-00029; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; Gessain A, 1996, J ACQ IMMUN DEF SYND, V13, pS228, DOI 10.1097/00042560-199600001-00034; GESSAIN A, 1985, LANCET, V2, P407; Goncalves DU, 2003, AM J TROP MED HYG, V68, P562, DOI 10.4269/ajtmh.2003.68.562; HANCHARD B, 1990, HUMAN RETROVIROLOGY : HTLV, P173; La Grenade L, 1998, ARCH DERMATOL, V134, P439, DOI 10.1001/archderm.134.4.439; McCallum RM, 1997, MED CLIN N AM, V81, P261, DOI 10.1016/S0025-7125(05)70514-9; MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943; MUELLER N, 1991, CANCER CAUSE CONTROL, V2, P37, DOI 10.1007/BF00052359; Mueller N, 1996, J ACQ IMMUN DEF SYND, V13, pS2, DOI 10.1097/00042560-199600001-00002; Nishioka K, 1996, J ACQUIRED DEFICIENC, V13, P57; OSAME M, 1986, LANCET, V1, P1031; Poiesz J, 1980, P NATL ACAD SCI USA, V77, P7415; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; YAMAGUCHI K, 1994, LANCET, V343, P213, DOI 10.1016/S0140-6736(94)90994-6; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	18	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e42123	10.1371/journal.pone.0042123	http://dx.doi.org/10.1371/journal.pone.0042123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970114	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400002
J	Gao, XH; Wu, Y; Zhang, Y; Zhang, NX; Tang, J; Qiu, J; Lin, XF; Du, YK				Gao, Xiaohui; Wu, Yu; Zhang, Yu; Zhang, Naixing; Tang, Jie; Qiu, Jun; Lin, Xiaofang; Du, Yukai			Effectiveness of School-based Education on HIV/AIDS Knowledge, Attitude, and Behavior among Secondary School Students in Wuhan, China	PLOS ONE			English	Article							PEER EDUCATION; UNIVERSITY-STUDENTS; AIDS KNOWLEDGE; RURAL STUDENTS; HIV PREVENTION; CONDOM USE; PROGRAM; STATE	Background: Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) are among the most complex health problems in the world. Young people are at high risk of HIV and AIDS infections and are, therefore, in need of targeted prevention. School-based HIV/AIDS health education may be an effective way to prevent the spread of AIDS among adolescents. Methods: The study was a school-based intervention conducted in three middle schools and two high schools in Wuhan, China, which included 702 boys and 766 girls, with ages from 11 to 18 years old. The intervention was a one-class education program about HIV/AIDS for participants. HIV/AIDS knowledge, attitude, and high-risk behaviors were investigated using an anonymous self-administered questionnaire before and after the education intervention. Chi-square test was used to compare differences before and after the intervention. Non-conditional logistic regression analysis was used to identify the factors that affect HIV/AIDS knowledge. Results: Misconceptions about basic medical knowledge and non-transmission modes of HIV/AIDS among all the students prevail. Approximately 10% to 40% of students had negative attitudes about HIV/AIDS before the intervention. After the intervention, all of the students had significant improvements in knowledge and attitude about HIV/AIDS (P,. 05), indicating that educational intervention increased the students' knowledge significantly and changed their attitudes positively. Logistic regression analyses indicated that before the intervention the students' level of knowledge about HIV/AIDS was significantly associated with grade, economic status of the family, and attitudes toward participation in HIV/AIDS health information campaigns. Conclusions: HIV/AIDS education programs were welcomed by secondary students and positively influenced HIV/AIDS-related knowledge and attitudes. A systematic and long-term intervention among secondary school students must be conducted for the prevention of HIV.	[Gao, Xiaohui; Wu, Yu; Zhang, Yu; Tang, Jie; Qiu, Jun; Lin, Xiaofang; Du, Yukai] Huazhong Univ Sci & Technol, Dept Child & Maternal Hlth Care, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Zhang, Naixing] Huazhong Univ Sci & Technol, Dept Social Med & Hlth Management, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Tang, Jie] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangzhou Medical University	Gao, XH (corresponding author), Huazhong Univ Sci & Technol, Dept Child & Maternal Hlth Care, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	duyukai100@163.com	Jie, Tang/AAS-7192-2021	Tang, Jie/0000-0002-0568-8444	Joint School on Education, Sociology, Technology and Medicine Research Paper Award in China, Medical Planning Project [YX10001]; Yuanxuan College Foundation in Hong Kong	Joint School on Education, Sociology, Technology and Medicine Research Paper Award in China, Medical Planning Project; Yuanxuan College Foundation in Hong Kong	This research was supported by Joint School on Education, Sociology, Technology and Medicine Research Paper Award in China, Medical Planning Project No. YX10001 (URL: http://www.compe.cn/). We thank the support of Yuanxuan College Foundation in Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpabio II, 2009, J ADOLESCENT HEALTH, V44, P118, DOI 10.1016/j.jadohealth.2008.05.005; Albrektsson Madelene, 2009, Open AIDS J, V3, P55, DOI 10.2174/1874613600903010055; [Anonymous], WUHAN STAT YB 2011; Babikian T, 2004, AIDS BEHAV, V8, P47, DOI 10.1023/B:AIBE.0000017525.92015.5d; Berten H, 2009, J ADOLESCENCE, V32, P1303, DOI 10.1016/j.adolescence.2008.12.004; Blake SM, 2005, PREV MED, V40, P239, DOI 10.1016/j.ypmed.2004.05.028; Borgia P, 2005, J ADOLESCENT HEALTH, V36, P508, DOI 10.1016/j.jadohealth.2004.03.005; Caron F, 2004, HEALTH EDUC RES, V19, P185, DOI 10.1093/her/cyg017; Cartagena RG, 2006, J ADOLESCENT HEALTH, V39, P925; Cheng Y, 2008, J ADOLESCENT HEALTH, V42, P184, DOI 10.1016/j.jadohealth.2007.07.016; Citak GG, 2009, PROCD SOC BEHV, V1, P2086, DOI 10.1016/j.sbspro.2009.01.367; Ergene T, 2005, AIDS EDUC PREV, V17, P268, DOI 10.1521/aeap.17.4.268.66533; Francis DA, 2009, INT J EDUC DEV, P314; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Halpern CT, 2008, SOC SCI MED, V67, P628, DOI 10.1016/j.socscimed.2008.05.001; Kyrychenko P, 2006, J ADOLESCENT HEALTH, V39, P900, DOI 10.1016/j.jadohealth.2006.06.006; Liao W, 2010, BIOMED ENVIRON SCI, V23, P409, DOI 10.1016/S0895-3988(10)60083-9; Lowe J, 2008, J SCH NURS, V24, P229, DOI 10.1177/1059840508319866; MOH, 2010, CHIN 2010 UNGASS COU; Nwokocha Ada R C, 2002, J Pediatr Adolesc Gynecol, V15, P93, DOI 10.1016/S1083-3188(01)00150-4; Oni AA, 2005, J ASSOC NURSE AIDS C, V16, P40, DOI 10.1016/j.jana.2005.01.003; Oshi DC, 2005, J BIOSOC SCI, V37, P175, DOI 10.1017/S0021932004006820; SCAWC, 2007, JOINT ASS HIV AIDS P; Tapia-Aguirre V, 2004, ARCH MED RES, V35, P334, DOI 10.1016/j.arcmed.2004.05.002; UN, 2011, UN UN ACC ZER NEW HI; UNAIDS, 2010, REP GLOB AIDS EP; Ungan M, 2003, PATIENT EDUC COUNS, V51, P163, DOI 10.1016/S0738-3991(02)00190-8; UNGASS, 2009, GUID CONSTR COR IND; Van Rossem R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-30; Wu Q, 2010, INT J STD AIDS, V21, P87, DOI 10.1258/ijsa.2009.008508; Zimet GD, 1998, HDB SEXUALITY RELATE, P365	31	32	37	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44881	10.1371/journal.pone.0044881	http://dx.doi.org/10.1371/journal.pone.0044881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970322	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000054
J	Kwong, A; Ng, EKO; Wong, CLP; Law, FBF; Au, T; Wong, HN; Kurian, AW; West, DW; Ford, JM; Ma, ESK				Kwong, Ava; Ng, Enders Kai On; Wong, Chris Lei Po; Law, Fian Bic Fai; Au, Tommy; Wong, Hong Nei; Kurian, Allison W.; West, Dee W.; Ford, James M.; Ma, Edmond Siu Kwan			Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis	PLOS ONE			English	Article							GERMLINE MUTATIONS; HEREDITARY BREAST; HIGH PROPORTION; OVARIAN-CANCER; PREVALENCE; FAMILIES; WOMEN; GUIDELINES; AGE	Background: Ethnic variations in breast cancer epidemiology and genetics have necessitated investigation of the spectra of BRCA1 and BRCA2 mutations in different populations. Knowledge of BRCA mutations in Chinese populations is still largely unknown. We conducted a multi-center study to characterize the spectra of BRCA mutations in Chinese breast and ovarian cancer patients from Southern China. Methodology/Principal Findings: A total of 651 clinically high-risk breast and/or ovarian cancer patients were recruited from the Hong Kong Hereditary Breast Cancer Family Registry from 2007 to 2011. Comprehensive BRCA1 and BRCA2 mutation screening was performed using bi-directional sequencing of all coding exons of BRCA1 and BRCA2. Sequencing results were confirmed by in-house developed full high resolution DNA melting (HRM) analysis. Among the 451 probands analyzed, 69 (15.3%) deleterious BRCA mutations were identified, comprising 29 in BRCA1 and 40 in BRCA2. The four recurrent BRCA1 mutations (c.470_471delCT, c.3342_3345delAGAA, c.5406+1_5406+3delGTA and c.981_982delAT) accounted for 34.5% (10/29) of all BRCA1 mutations in this cohort. The four recurrent BRCA2 mutations (c.2808_2811delACAA, c.3109C>T, c.7436_7805del370 and c.9097_9098insA) accounted for 40% (16/40) of all BRCA2 mutations. Haplotype analysis was performed to confirm 1 BRCA1 and 3 BRCA2 mutations are putative founder mutations. Rapid HRM mutation screening for a panel of the founder mutations were developed and validated. Conclusion: In this study, our findings suggest that BRCA mutations account for a substantial proportion of hereditary breast/ovarian cancer in Southern Chinese population. Knowing the spectrum and frequency of the founder mutations in this population will assist in the development of a cost-effective rapid screening assay, which in turn facilitates genetic counseling and testing for the purpose of cancer risk assessment.	[Kwong, Ava; Ng, Enders Kai On; Wong, Hong Nei] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Ng, Enders Kai On; Wong, Chris Lei Po; Law, Fian Bic Fai; Au, Tommy; Ma, Edmond Siu Kwan] Hong Kong Sanat & Hosp, Dept Mol Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Ng, Enders Kai On; Wong, Chris Lei Po; Law, Fian Bic Fai; Au, Tommy; Ma, Edmond Siu Kwan] Hong Kong Sanat & Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Wong, Chris Lei Po; Law, Fian Bic Fai; Ma, Edmond Siu Kwan] Hong Kong Hereditary Breast Canc Family Registry, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava; Kurian, Allison W.; West, Dee W.; Ford, James M.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Kwong, Ava; Kurian, Allison W.; West, Dee W.; Ford, James M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of Hong Kong; Stanford University; Stanford University	Kwong, A (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	akwong@asiabreastregistry.com	Ma, Shiu Kwan Edmond/AAZ-7637-2021; Kwong, Ava/D-8005-2013; Ng, Enders/T-3881-2019; wong, chris/GSN-0962-2022; Ng, Enders K.O./F-2787-2010; Kurian, Allison/A-4560-2019	Ma, Shiu Kwan Edmond/0000-0002-1259-2205; Kwong, Ava/0000-0002-6968-9489; Ng, Enders/0000-0002-6955-0030; Ng, Enders K.O./0000-0002-6955-0030; Ford, James/0000-0002-2513-7025; Ng, Enders Kai-on/0000-0002-5293-3529; Kurian, Allison/0000-0002-6175-9470	National Institutes of Health [1R03CA130065]; NATIONAL CANCER INSTITUTE [R03CA130065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (1R03CA130065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2008, BREAST CANC RES TREA; Choi DH, 2004, J CLIN ONCOL, V22, P1638, DOI 10.1200/JCO.2004.04.179; Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fukutomi, 1997, Breast Cancer, V4, P256, DOI 10.1007/BF02966517; Han SA, 2011, CLIN ONCOL-UK, V23, P434, DOI 10.1016/j.clon.2010.11.007; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; HK Census, 2006, HK CENSUS STAT TABLE; Ho GH, 2000, CANCER-AM CANCER SOC, V89, P811, DOI 10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R; Hu Zhen, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9156; Ikeda N, 2001, INT J CANCER, V91, P83, DOI 10.1002/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5; Inoue R, 1997, INT J CANCER, V74, P199, DOI 10.1002/(SICI)1097-0215(19970422)74:2<199::AID-IJC11>3.0.CO;2-9; Katagiri T, 1998, J HUM GENET, V43, P42, DOI 10.1007/s100380050035; Khoo Ui-Soon, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9015; Kurian AW, 2008, J CLIN ONCOL; Kwong A, 2010, BREAST CANC RES TREA; Kwong Ava, 2009, Hugo J, V3, P63, DOI 10.1007/s11568-010-9136-z; Kwong A, 2009, BREAST CANCER RES TR, V117, P683, DOI 10.1007/s10549-009-0385-2; Lee Ann S G, 2003, Hum Mutat, V22, P178, DOI 10.1002/humu.9162; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Li WF, 2007, BREAST CANC RES TREA; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Matsuda MLD, 2002, INT J CANCER, V98, P596, DOI 10.1002/ijc.10194; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Sekine M, 2001, CLIN CANCER RES, V7, P3144; Sng JH, 2000, BRIT J CANCER, V82, P538; Song CG, 2006, J CANCER RES CLIN, V132, P617, DOI 10.1007/s00432-006-0105-9; Tang NLS, 2001, CLIN CHIM ACTA, V313, P179, DOI 10.1016/S0009-8981(01)00671-4; Tang NLS, 1999, J NATL CANCER I, V91, P882, DOI 10.1093/jnci/91.10.882; The Hong Kong Cancer Registry, 2005, FAST STATS FEM BREAS; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Zhi XC, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9083; Zhou Yuan-zheng, 2004, Zhonghua Yi Xue Za Zhi, V84, P294	38	79	86	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43994	10.1371/journal.pone.0043994	http://dx.doi.org/10.1371/journal.pone.0043994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970155	Green Published, gold			2022-12-27	WOS:000308462000010
J	Lei, L; Li, ZY; Zhong, GM				Lei, Lei; Li, Zhongyu; Zhong, Guangming			Rottlerin-Mediated Inhibition of Chlamydia trachomatis Growth and Uptake of Sphingolipids Is Independent of p38-Regulated/Activated Protein Kinase (PRAK)	PLOS ONE			English	Article							F-ACTIN REARRANGEMENT; INFECTED CELLS; PATHWAY; ACQUISITION; ACTIVATION; APOPTOSIS; MK5	We previously found that rottlerin, a plant-derived small molecule compound, profoundly inhibited Chlamydia trachomatis growth and blocked sphingolipid trafficking from host cell Golgi into chlamydial inclusions. Since the p38-regulated/activated protein kinase (PRAK) is a known target of rottlerin and is activated in Chlamydia trachomatis-infected cells, we investigated the potential role of this kinase in rottlerin-mediated anti-chlamydial activity. However, we found that a PRAK-specific inhibitor failed to inhibit chlamydial growth, suggesting that the kinase activity of PRAK may not be required for chlamydial intracellular replication. This conclusion was supported by the observation that chlamydial organisms replicated equally well in mouse embryonic fibroblast cells with or without PRAK. Moreover, neither the PRAK inhibitor nor PRAK deficiency altered host sphingolipid trafficking into chlamydial inclusions. Finally, rottlerin maintained its anti-chlamydial activity in PRAK-deficient cells. Together, these observations have demonstrated that PRAK is not required for either the rottlerin-mediated anti-chlamydial activity or rottlerin inhibition of sphingolipid trafficking, suggesting that rottlerin may achieve its inhibitory role by targeting other host factors.	[Lei, Lei; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Li, Zhongyu] Univ S China, Hengyang, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of South China	Lei, L (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	zhongg@uthscsa.edu	Lei, Lei/I-3002-2013		National Institutes of Health [R01AI64537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01AI64537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BK, 2006, J INVEST DERMATOL, V126, P1348, DOI 10.1038/sj.jid.5700244; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BRUNHAM RC, 1988, J INFECT DIS, V158, P510, DOI 10.1093/infdis/158.3.510; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Elwell CA, PLOS PATHOG, V7; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Kostenko Sergiy, 2011, World J Biol Chem, V2, P73, DOI 10.4331/wjbc.v2.i5.73; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Lei L, MICROB PATHOG, V51, P101; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Maioli E, 2012, SCI WORLD J, DOI 10.1100/2012/350826; Miller KE, 2006, AM FAM PHYSICIAN, V73, P1411; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ni H, 1998, BIOCHEM BIOPH RES CO, V243, P492, DOI 10.1006/bbrc.1998.8135; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2005, INFECT IMMUN, V73, P4414, DOI 10.1128/IAI.73.7.4414-4419.2005; Shivshankar P, 2008, APPL ENVIRON MICROB, V74, P1243, DOI 10.1128/AEM.02151-07; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tillman DM, 2003, CANCER RES, V63, P5118	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44733	10.1371/journal.pone.0044733	http://dx.doi.org/10.1371/journal.pone.0044733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970301	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000048
J	Masuda, N; Nakamura, M				Masuda, Naoki; Nakamura, Mitsuhiro			Coevolution of Trustful Buyers and Cooperative Sellers in the Trust Game	PLOS ONE			English	Article							INDIRECT RECIPROCITY; SOCIAL NORMS; MAINTAIN COOPERATION; REPUTATION; EVOLUTION; DYNAMICS; MARKET	Many online marketplaces enjoy great success. Buyers and sellers in successful markets carry out cooperative transactions even if they do not know each other in advance and a moral hazard exists. An indispensable component that enables cooperation in such social dilemma situations is the reputation system. Under the reputation system, a buyer can avoid transacting with a seller with a bad reputation. A transaction in online marketplaces is better modeled by the trust game than other social dilemma games, including the donation game and the prisoner's dilemma. In addition, most individuals participate mostly as buyers or sellers; each individual does not play the two roles with equal probability. Although the reputation mechanism is known to be able to remove the moral hazard in games with asymmetric roles, competition between different strategies and population dynamics of such a game are not sufficiently understood. On the other hand, existing models of reputation-based cooperation, also known as indirect reciprocity, are based on the symmetric donation game. We analyze the trust game with two fixed roles, where trustees (i.e., sellers) but not investors (i.e., buyers) possess reputation scores. We study the equilibria and the replicator dynamics of the game. We show that the reputation mechanism enables cooperation between unacquainted buyers and sellers under fairly generous conditions, even when such a cooperative equilibrium coexists with an asocial equilibrium in which buyers do not buy and sellers cheat. In addition, we show that not many buyers may care about the seller's reputation under cooperative equilibrium. Buyers' trusting behavior and sellers' reputation-driven cooperative behavior coevolve to alleviate the social dilemma.	[Masuda, Naoki; Nakamura, Mitsuhiro] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo, Japan; [Masuda, Naoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Masuda, N (corresponding author), Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo, Japan.	masuda@mist.i.u-tokyo.ac.jp		Nakamura, Mitsuhiro/0000-0003-4191-6915; Masuda, Naoki/0000-0003-1567-801X	MEXT, Japan [20760258]; Japan Society for the Promotion of Science (JSPS), Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by Grants-in-Aid for Scientific Research (No. 20760258) from MEXT, Japan, and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; [Anonymous], 1995, EVOLUTIONARY GAME TH; Basu S, 2009, P NATL ACAD SCI USA, V106, P1009, DOI 10.1073/pnas.0811967106; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bolton GE, 2004, MANAGE SCI, V50, P1587, DOI 10.1287/mnsc.1030.0199; Bracht J, 2009, J PUBLIC ECON, V93, P1036, DOI 10.1016/j.jpubeco.2009.06.004; Brandt H, 2006, J THEOR BIOL, V239, P183, DOI 10.1016/j.jtbi.2005.08.045; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Bravo G, 2008, RATION SOC, V20, P85, DOI 10.1177/1043463107085441; Brown J, 2006, CALIF MANAGE REV, V49, P61, DOI 10.2307/41166371; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; Dasgupta P., 1988, TRUST MAKING BREAKIN, P49; Dellarocas C, 2003, MANAGE SCI, V49, P1407, DOI 10.1287/mnsc.49.10.1407.17308; Diekmann A, 2005, 3 ESSA C, P1; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; GREIF A, 1993, AM ECON REV, V83, P525; Greif A, 2006, POLIT ECON I DECIS, P1, DOI 10.1017/CBO9780511791307; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Johnstone RA, 2007, P ROY SOC B-BIOL SCI, V274, P3175, DOI 10.1098/rspb.2007.1322; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Keser C, 2003, IBM SYST J, V42, P498, DOI 10.1147/sj.423.0498; KLEIN B, 1981, J POLIT ECON, V89, P615, DOI 10.1086/260996; Kreps DM, 1990, PERSPECTIVES POSITIV, P90, DOI [DOI 10.1017/CBO9780511571657.006, 10.1017/CBO9780511571657.006]; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Malaga R. A., 2001, Electronic Commerce Research, V1, P403, DOI 10.1023/A:1011557319152; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P4404, DOI 10.1073/pnas.97.8.4404; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P605, DOI 10.1098/rspb.2008.1182; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2007, J THEOR BIOL, V244, P518, DOI 10.1016/j.jtbi.2006.08.018; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; Resnick P, 2002, ADV APP M-E, V11, P127; Resnick P, 2006, EXP ECON, V9, P79, DOI 10.1007/s10683-006-4309-2; SAMUELSON L, 1992, J ECON THEORY, V57, P363, DOI 10.1016/0022-0531(92)90041-F; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K., 2010, CALCULUS SELFISHNESS; Uchida S, 2010, J THEOR BIOL, V263, P13, DOI 10.1016/j.jtbi.2009.11.013	47	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44169	10.1371/journal.pone.0044169	http://dx.doi.org/10.1371/journal.pone.0044169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970176	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000013
J	Singh, PK; Rai, RK; Singh, L				Singh, Prashant Kumar; Rai, Rajesh Kumar; Singh, Lucky			Examining the Effect of Household Wealth and Migration Status on Safe Delivery Care in Urban India, 1992-2006	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; SUB-SAHARAN AFRICA; NUTRITIONAL-STATUS; DEVELOPING-COUNTRIES; INTERNAL MIGRATION; COEFFICIENT ALPHA; INFANT-MORTALITY; CHILD-MORTALITY; ANTENATAL CARE; DIFFERENTIALS	Background: Although the urban health issue has been of long-standing interest to public health researchers, majority of the studies have looked upon the urban poor and migrants as distinct subgroups. Another concern is, whether being poor and at the same time migrant leads to a double disadvantage in the utilization of maternal health services? This study aims to examine the trends and factors that affect safe delivery care utilization among the migrants and the poor in urban India. Methodology/Principal Findings: Using data from the National Family Health Survey, 1992-93 and 2005-06, this study grouped the household wealth and migration status into four distinct categories poor-migrant, poor-non migrant, non poor-migrant, non poor-non migrant. Both chi-square test and binary logistic regression were performed to examine the influence of household wealth and migration status on safe delivery care utilization among women who had experienced a birth in the four years preceding the survey. Results suggest a decline in safe delivery care among poor-migrant women during 1992-2006. The present study identifies two distinct groups in terms of safe delivery care utilization in urban India one for poor-migrant and one for non poor-non migrants. While poor-migrant women were most vulnerable, non poor-non migrant women were the highest users of safe delivery care. Conclusion: This study reiterates the inequality that underlies the utilization of maternal healthcare services not only by the urban poor but also by poor-migrant women, who deserve special attention. The ongoing programmatic efforts under the National Urban Health Mission should start focusing on the poorest of the poor groups such as poor-migrant women. Importantly, there should be continuous evaluation to examine the progress among target groups within urban areas.	[Singh, Prashant Kumar; Singh, Lucky] Int Inst Populat Sci, Bombay, Maharashtra, India; [Rai, Rajesh Kumar] Tata Inst Social Sci, Bombay, Maharashtra, India	International Institute for Population Sciences; Tata Institute of Social Sciences	Singh, PK (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	prashant_iips@yahoo.co.in		Singh, Prashant Kumar/0000-0003-1742-5534; Singh, Lucky/0000-0003-2590-6135; Rai, Rajesh Kumar/0000-0002-5249-9937	Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India	Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India	No specific funding was received for this study. PKS & LS is supported by the Government of India/National Eligibility Test (UGC/NET) Doctoral Fellowship Award from the Ministry of Health and Family Welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S., 2007, DEMOGR INDIA, V36, P121; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Akin A, 1996, CONTRACEPTION ABORTI; Alagarajan M, 2003, POPUL RES POLICY REV, V22, P557, DOI 10.1023/B:POPU.0000020963.63244.8c; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; [Anonymous], 2011, WORLD HLTH STAT; [Anonymous], STAT MODELS CAUSAL A; Arokiasamy P, 2004, POPULATION, V59, P949, DOI 10.2307/3654939; Bell J, 2003, DHS ANAL STUDIES, V7; Bhagat R. B., 2010, Asia-Pacific Population Journal, V25, P27; Bhagat R.B., 2009, ASIAN POPUL STUD, V5, P5, DOI [10.1080/17441730902790024, DOI 10.1080/17441730902790024]; Bhat P. N. M., 2005, Economic and Political Weekly, V40, P385; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bloom SS, 1994, HLTH POLICY PLANNING, V14, P38; BROCKERHOFF M, 1995, SOC SCI MED, V40, P1371, DOI 10.1016/0277-9536(94)00268-X; Celik Y, 2000, SOC SCI MED, V50, P1797, DOI 10.1016/S0277-9536(99)00418-9; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386; CSDH, 2008, CLOSING GAP GENERATI; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Desai S, 2011, REPROD HEALTH MATTER, V19, P42, DOI 10.1016/S0968-8080(11)37553-2; Desai S, 2008, DEMOGRAPHY, V45, P245; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Firestone R, 2011, SOC SCI MED, V72, P1420, DOI 10.1016/j.socscimed.2011.03.003; Fotso JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-218; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Garrett JL, 1999, WORLD DEV, V27, P1955, DOI 10.1016/S0305-750X(99)00091-1; Ghosh D, 2006, PROF GEOGR, V58, P278, DOI 10.1111/j.1467-9272.2006.00568.x; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; Gupta M, 2008, J URBAN HEALTH, V85, P291, DOI 10.1007/s11524-007-9250-y; Gwatkin DR, 2000, SOICOECONOMIC DIFFER; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Hayward MD, 1999, DEMOGRAPHY, V36, P77, DOI 10.2307/2648135; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; Hussein J, 2010, BJOG-INT J OBSTET GY, V117, P304, DOI 10.1111/j.1471-0528.2009.02457.x; International Institute for Population Sciences, 1995, NATL FAM HLTH SURV M; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF, V1; Islam MM, 2008, J BIOSOC SCI, V40, P83, DOI 10.1017/S0021932007002271; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835; Kumar C, 2013, J COMMUN HEALTH, V38, P120, DOI 10.1007/s10900-012-9590-8; Laishram Ladusingh, 2007, Asian Population Studies, V3, P79, DOI 10.1080/17441730701270897; Lalou R., 1997, POPULATION, V147-1689, P147; Lindstrom DP, 2006, SOC SCI MED, V63, P706, DOI 10.1016/j.socscimed.2006.02.007; Lu Y, 2008, SOC SCI MED, V67, P1331, DOI 10.1016/j.socscimed.2008.06.017; Lu Y, 2010, SOC SCI MED, V70, P412, DOI 10.1016/j.socscimed.2009.10.028; Madise NJ, 2003, SOC BIOL, V50, P148; MADISE NJ, 1995, J BIOSOC SCI, V27, P95, DOI 10.1017/S0021932000007033; Magadi MA, 2003, POP STUD-J DEMOG, V57, P347, DOI 10.1080/0032472032000137853; Menon Purnima, 2000, Food and Nutrition Bulletin, V21, P282; Ministry of Health and Family Welfare, 2000, NATL POP POL 2000; Ministry of Health and Family Welfare, 2002, NAT HLTH POL 2002; Ministry of Health and Family Welfare, 2006, NAT RUR HLTH MISS 20; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Mohanty SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026857; Mohanty Sanjay K., 2009, Genus, V65, P113; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Montgomery MR, 2009, POPULATION B, V64; More NS, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-21; National Sample Survey Organization, 2001, HOUS CONS EXP IND 19; National Urban Health Mission, 2008, URB HLTH MI IN PRESS; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Newbold KB, 2003, SOC SCI MED, V57, P1981, DOI 10.1016/S0277-9536(03)00064-9; Odimegwu Clifford, 2005, Afr J Reprod Health, V9, P59; OECD, 2011, SPEC FOC IN EM EC EE; Palloni A, 2001, ANN NY ACAD SCI, V954, P140; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; Pathak PK, 2010, ASIAN POPUL STUD, V6, P173, DOI 10.1080/17441730.2010.494444; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Planning Commission, 2006, POV EST 2004 05; Planning Commission, 2002, 10 5 YEAR PLAN 2002; Prakash A, 1994, Indian Pediatr, V31, P978; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; Rao KV, 1998, 10 INT I POP SCI HO; Reddy KS, 2012, NATL MED J INDIA, V25, P65; Registrar General of India, 2001, SLUM POP IND 1; Registrar General of India, 2001, PRIM CENS ABSTR TOT; Registrar General of India, 2012, CENS 2011 POP TOT DA; Retherford RD, 1997, NATL FAMILY HLTH SUR; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rutstein SO, 2004, DHS COMP REP; Salam A, 2006, J OBSTET GYN INDIA, V56, P123; Sastry N, 1997, SOC SCI MED, V44, P989, DOI 10.1016/S0277-9536(96)00224-9; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; StataCorp, 2007, STAT STAT SOFTW REL; Stephenson R, 2003, J BIOSOC SCI, V35, P15, DOI 10.1017/S0021932003000154; Sternberg P, 2004, HEALTH PROMOT INT, V19, P389, DOI 10.1093/heapro/dah312; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Tran TK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-120; UN, 2008, WORLD URB PROSP 2007; Urban Health Resource Centre (UHRC), 2006, STAT URB HLTH RAJ; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; Vearey J, 2010, HEALTH PLACE, V16, P694, DOI 10.1016/j.healthplace.2010.02.007; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization(WHO), 2006, PROV EFF ANT CAR INT; Zhan SK, 2002, HEALTH POLICY PLANN, V17, P47, DOI 10.1093/heapol/17.suppl_1.47; Zhao Qi, 2009, BMC Womens Health, V9, P5, DOI 10.1186/1472-6874-9-5	107	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44901	10.1371/journal.pone.0044901	http://dx.doi.org/10.1371/journal.pone.0044901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970324	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000055
J	Kronforst, KD; Mancuso, CJ; Pettengill, M; Ninkovic, J; Coombs, MRP; Stevens, C; Otto, M; Mallard, C; Wang, XY; Goldmann, D; Levy, O				Kronforst, Kenny D.; Mancuso, Christy J.; Pettengill, Matthew; Ninkovic, Jana; Coombs, Melanie R. Power; Stevens, Chad; Otto, Michael; Mallard, Carina; Wang, Xiaoyang; Goldmann, Donald; Levy, Ofer			A Neonatal Model of Intravenous Staphylococcus epidermidis Infection in Mice < 24 h Old Enables Characterization of Early Innate Immune Responses	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; HUMAN NEWBORN; MOUSE MODEL; IN-VITRO; SUSCEPTIBILITY; SEPSIS; AUREUS; PENTOXIFYLLINE; EXPRESSION; VIRULENCE	Staphylococcus epidermidis (SE) causes late onset sepsis and significant morbidity in catheterized preterm newborns. Animal models of SE infection are useful in characterizing disease mechanisms and are an important approach to developing improved diagnostics and therapeutics. Current murine models of neonatal bacterial infection employ intraperitoneal or subcutaneous routes at several days of age, and may, therefore, not accurately reflect distinct features of innate immune responses to bacteremia. In this study we developed, validated, and characterized a murine model of intravenous (IV) infection in neonatal mice <24 hours (h) old to describe the early innate immune response to SE. C57BL/6 mice <24 h old were injected IV with 10(6), 10(7), 10(8) colony-forming units (CFU) of SE 1457, a clinical isolate from a central catheter infection. A prospective injection scoring system was developed and validated, with only high quality injections analyzed. Newborn mice were euthanized between 2 and 48 h post-injection and spleen, liver, and blood collected to assess bacterial viability, gene expression, and cytokine production. High quality IV injections demonstrated inoculum-dependent infection of spleen, liver and blood. Within 2 h of injection, SE induced selective transcription of TLR2 and MyD88 in the liver, and increased systemic production of plasma IL-6 and TNF-alpha. Despite clearance of bacteremia and solid organ infection within 48 h, inoculum-dependent impairment in weight gain was noted. We conclude that a model of IV SE infection in neonatal mice <24 h old is feasible, demonstrating inoculum-dependent infection of solid organs and a pattern of bacteremia, rapid and selective innate immune activation, and impairment of weight gain typical of infected human neonates. This novel model can now be used to characterize immune ontogeny, evaluate infection biomarkers, and assess preventative and therapeutic modalities.	[Kronforst, Kenny D.; Mancuso, Christy J.; Pettengill, Matthew; Ninkovic, Jana; Stevens, Chad; Goldmann, Donald; Levy, Ofer] Boston Childrens Hosp, Boston, MA USA; [Pettengill, Matthew; Ninkovic, Jana; Goldmann, Donald; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Coombs, Melanie R. Power] Dalhousie Univ, Halifax, NS, Canada; [Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Mallard, Carina; Wang, Xiaoyang] Univ Gothenburg, Gothenburg, Sweden	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Dalhousie University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Gothenburg	Kronforst, KD (corresponding author), Boston Childrens Hosp, Boston, MA USA.	ofer.levy@childrens.harvard.edu	Coombs, Melanie/GQH-9000-2022	Otto, Michael/0000-0002-2222-4115; Coombs, Melanie/0000-0002-2036-8414; Wang, Xiaoyang/0000-0001-9717-8160; Levy, Ofer/0000-0002-5859-1945; Mallard, Carina/0000-0001-8953-919X; Pettengill, Matthew/0000-0002-4579-0187	National Institute of Allergy and Infectious Diseases, National Institutes of Health [RO1 AI067353-01A1, 3R01AI067353-05S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support provided by National Institute of Allergy and Infectious Diseases, National Institutes of Health RO1 AI067353-01A1 and Administrative Supplement 3R01AI067353-05S1 (to OL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Belderbos ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033419; Burl S, 2011, PLOS ONE, V13; Chau V, 2012, PEDIATR RES, V71, P274, DOI 10.1038/pr.2011.40; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Fleiss B, 2010, PLOS ONE, V6; GALLIMORE B, 1991, J INFECT DIS, V164, P1220, DOI 10.1093/infdis/164.6.1220; GUNN BA, 1989, J CLIN MICROBIOL, V27, P507, DOI 10.1128/JCM.27.3.507-511.1989; Hartel C, 2008, ARCH DIS CHILD-FETAL, V93, pF140, DOI 10.1136/adc.2007.124685; Healy CM, 2004, PEDIATRICS, V114, P953, DOI 10.1542/peds.2004-0043; Hoff J, 2000, LAB ANIMAL, V29, P47; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; JAX Mice and services, 2009, MIC PUP APP AG; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Kienstra KA, 2007, J AM ASSOC LAB ANIM, V46, P50; KINSMAN OS, 1980, J MED MICROBIOL, V13, P281, DOI 10.1099/00222615-13-2-281; Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; KRAUSE PJ, 1987, AM J PATHOL, V129, P217; Le Rouzic V, 2011, INFLAMMATION, V34, P576, DOI 10.1007/s10753-010-9265-5; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Mack D, 2002, ANTIMICROB AGENTS CH, V46, P178, DOI 10.1128/AAC.46.1.178-183.2002; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MADERAZO EG, 1990, ANTIMICROB AGENTS CH, V34, P1100, DOI 10.1128/AAC.34.6.1100; Major AS, 1996, J VIROL, V70, P5968, DOI 10.1128/JVI.70.9.5968-5974.1996; Mallard C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/102153; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; MCKAY SE, 1979, J MED MICROBIOL, V12, P99, DOI 10.1099/00222615-12-1-99; Mohamed MA, 2007, CYTOKINE, V39, P171, DOI 10.1016/j.cyto.2007.07.004; Mrozek J D, 2000, J Perinatol, V20, P96, DOI 10.1038/sj.jp.7200319; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Placencia FX, 2009, PEDIATR RES, V65, P420, DOI 10.1203/PDR.0b013e3181994a53; Radbruch A, 2009, EUR J IMMUNOL, V39, P1991, DOI 10.1002/eji.200939772; RODEWALD AK, 1992, J INFECT DIS, V166, P635, DOI 10.1093/infdis/166.3.635; Santos-Sierra S, 2006, J ENDOTOXIN RES, V12, P307, DOI 10.1179/096805106X118762; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Schultz C, 2004, CLIN EXP IMMUNOL, V135, P130, DOI 10.1111/j.1365-2249.2004.02313.x; Schultz C, 2002, PEDIATR RES, V51, P317, DOI 10.1203/00006450-200203000-00009; Srinivasan L, 2012, CURR OPIN PEDIATR, V24, P165, DOI 10.1097/MOP.0b013e3283504df3; Strunk T, 2012, PEDIATR RES, V72, P10, DOI 10.1038/pr.2012.48; Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Sweeney TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025249; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang XY, 2012, ADV NEUROIMMUNE BIOL, V3, P41, DOI 10.3233/NIB-2012-012034; Widerstrom M, 2012, EUR J CLIN MICROBIOL, V31, P7, DOI 10.1007/s10096-011-1270-6; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001; Zhang JP, 2010, PEDIATR RES, V68, P479, DOI 10.1203/PDR.0b013e3181f90810; Zhou SH, 2007, J IMMUNOL, V178, P5173, DOI 10.4049/jimmunol.178.8.5173	56	32	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43897	10.1371/journal.pone.0043897	http://dx.doi.org/10.1371/journal.pone.0043897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970147	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400022
J	Morissette, L; Christensen, V; Pauly, D				Morissette, Lyne; Christensen, Villy; Pauly, Daniel			Marine Mammal Impacts in Exploited Ecosystems: Would Large Scale Culling Benefit Fisheries?	PLOS ONE			English	Article							NORTH-ATLANTIC; CLIMATE-CHANGE; ST-LAWRENCE; BENGUELA ECOSYSTEM; SOUTHERN BENGUELA; GLOBAL FISHERIES; DIET COMPOSITION; MINKE WHALES; TROPHIC ROLE; FUR-SEAL	Competition between marine mammals and fisheries for marine resources-whether real or perceived-has become a major issue for several countries and in international fora. We examined trophic interactions between marine mammals and fisheries based on a resource overlap index, using seven Ecopath models including marine mammal groups. On a global scale, most food consumed by marine mammals consisted of prey types that were not the main target of fisheries. For each ecosystem, the primary production required (PPR) to sustain marine mammals was less than half the PPR to sustain fisheries catches. We also developed an index representing the mean trophic level of marine mammal's consumption (TLQ) and compared it with the mean trophic level of fisheries' catches (TLC). Our results showed that overall TLQ was lower than TLC (2.88 versus 3.42). As fisheries increasingly exploit lower-trophic level species, the competition with marine mammals may become more important. We used mixed trophic impact analysis to evaluate indirect trophic effects of marine mammals, and in some cases found beneficial effects on some prey. Finally, we assessed the change in the trophic structure of an ecosystem after a simulated extirpation of marine mammal populations. We found that this lead to alterations in the structure of the ecosystems, and that there was no clear and direct relationship between marine mammals' predation and the potential catch by fisheries. Indeed, total biomass, with no marine mammals in the ecosystem, generally remained surprisingly similar, or even decreased for some species.	[Morissette, Lyne] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Morissette, Lyne; Christensen, Villy; Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of Quebec; University of British Columbia	Morissette, L (corresponding author), Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada.	lyne.morissette@globetrotter.net	Pauly, Daniel Marc/AAY-2316-2021; Christensen, Villy/C-3945-2009	Christensen, Villy/0000-0003-0688-2633; Pauly, Daniel/0000-0003-3756-4793	Lenfest Ocean Program	Lenfest Ocean Program	This research was carried out as a contribution to a doctoral thesis at the Fisheries Centre of the University of British Columbia, with financial support from the Lenfest Ocean Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN KR, 1971, J FISH RES BOARD CAN, V28, P1573, DOI 10.1139/f71-236; Angel MV, 1995, IEE C POLL LAND SEA, V165, p9/1; [Anonymous], 1995, MAR FISH REV; [Anonymous], 2000, MAR FISH REV; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bowen W. Donald, 1999, P423; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Christensen LB., 2006, MARINE MAMMAL POPULA, Vvol. 14; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Christensen V., 2008, ECOPATH ECOSIM VERSI; Christensen V, 2002, P INCO DC C PLAC FIS, P39; Christensen V, 2011, ECOSYSTEM APPROACHES TO FISHERIES: A GLOBAL PERSPECTIVE, P189; Clark R.B., 2001, MARINE POLLUTION, V5th; Dans SL, 2003, ECOL APPL, V13, P754, DOI 10.1890/1051-0761(2003)013[0754:ICODIT]2.0.CO;2; DeMaster DP, 2001, J MAMMAL, V82, P641, DOI 10.1644/1545-1542(2001)082<0641:PACTIO>2.0.CO;2; Dillingham PW, 2006, CAN J FISH AQUAT SCI, V63, P107, DOI 10.1139/F05-208; Dwyer E, 1999, SAINT JOHN TIME 0614; Essington TE, 2007, CAN J FISH AQUAT SCI, V64, P628, DOI 10.1139/F07-042; Estes JA, 2005, MAR MAMMAL SCI, V21, P169, DOI 10.1111/j.1748-7692.2005.tb01218.x; FAO/FISHCODE, 2001, REP BIOEC MOD WORKSH; Fisheries Resource Conservation Council, 2002, FRCC2002R2 MIN FISH; Froese R., 2012, FISHBASE VERSION 08; Gales N., 2003, MARINE MAMMALS FISHE; Gerber LR, 2009, SCIENCE, V323, P880, DOI 10.1126/science.1169981; Grellier K, 2006, CAN J FISH AQUAT SCI, V63, P1982, DOI 10.1139/F06-092; Gulland J.A., 1983, Marine Ecology (London), V5, P839; HAMMOND PS, 1994, J APPL ECOL, V31, P340, DOI 10.2307/2404548; HARDWOOD J, 2001, J MAMMAL, V82, P630; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARWOOD J, 1988, MAR MAMMAL SCI, V4, P13, DOI 10.1111/j.1748-7692.1988.tb00179.x; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaneko H, 2006, MAR MAMMAL SCI, V22, P261, DOI 10.1111/j.1748-7692.2006.00030.x; Kaschner K., 2005, STATE ANIMALS 3, P95; KASCHNER K, 2001, FISHERIES CTR RES RE, V9, P35; Kenney Robert D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P155; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Laake JL, 2002, FISH B-NOAA, V100, P434; Lawson JW, 1995, SEALS WHALES FISH MA, P261; Lawson JW, 2008, NAFO S ROL MAR MAMM; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lindstrom U, 2002, ICES J MAR SCI, V59, P58, DOI 10.1006/jmsc.2001.1135; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; Loreng H, 2004, ACIA INT SCI S CLIM; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lydersen C, 2006, ECOGRAPHY, V14, P219; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; Mackinson S, 2003, MAR MAMMAL SCI, V19, P661, DOI 10.1111/j.1748-7692.2003.tb01123.x; MARTELL S, 2002, FISHERIES CTR RES RE, V10, P16; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Morissete L, 2006, MAR MAMMAL SCI, V22, P74, DOI 10.1111/j.1748-7692.2006.00007.x; Morissette L, 2005, NATO SCI S SS IV EAR, V50, P127; Morissette L., 2003, CAN TECH REP FISH AQ, V2497, P94; Morissette L, 2009, FISHERIES CTR RES RE, V17, P3; MORISSETTE L, 2001, THESIS U QUEBEC RIMO; Morissette L, 2010, FISH FISH, V11, P388, DOI 10.1111/j.1467-2979.2010.00366.x; Morissette L, 2010, MAR ECOL PROG SER, V404, P289, DOI 10.3354/meps08443; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Research Council, 2003, DECL STELL SEA LION; NORTHRIDGE S, 1991, 251 FAO S1; Olson R.J., 2003, B I ATCC, V22, P133; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; PARSONS TR, 1992, MAR POLLUT BULL, V25, P51, DOI 10.1016/0025-326X(92)90185-9; PATTERSON K, 1992, REV FISH BIOL FISHER, V2, P321, DOI 10.1007/BF00043521; Pauly D, 2005, PHILOS T ROY SOC B, V360, P415, DOI 10.1098/rstb.2004.1597; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 1995, ICES COUNC M; PERRIN WF, 2005, CMS TECHNICAL SERIES, V9; Pitcher TJ, 2005, FISHERIES CTR RES RE, V13, P3; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; Plaganyi EE., 2007, FAO FISHERIES TECHNI; Plaganzi E., 2002, ENCY MARINE MAMMALS, P268; Preikshot D., 1998, FISHERIES CTR RES RE, V6, P72; Punt AE, 1995, S AFR J MARINE SCI, V16, P255; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Sanae C, 2006, GLOBAL CHANGE BIOL, V12, P907; Savenkoff C, 2007, ECOL MODEL, V204, P115, DOI 10.1016/j.ecolmodel.2006.12.029; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shannon LJ, 2004, AFR J MAR SCI, V26, P179, DOI 10.2989/18142320409504056; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Sindermann C. J., 1996, OCEAN POLLUTION EFFE; Smith TD, 1995, DEV MAR BIO, V4, P527; SPARRE P, 1991, ICES MAR SC, V193, P12; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Tjelmeland S, 2005, ICES J MAR SCI, V62, P285, DOI 10.1016/j.icesjms.2004.12.011; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; Trzcinski MK, 2006, ECOL APPL, V16, P2276, DOI 10.1890/1051-0761(2006)016[2276:CDOAAC]2.0.CO;2; ULANOWICZ R E, 1990, Coenoses, V5, P7; Vasconcellos V, 1997, ECOL MODEL, V100, P125; Wallace SS, 1998, FISHERIES CTR RES RE, V6, P58; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Whipple SJ, 2000, FISH FISH, V1, P22, DOI 10.1046/j.1467-2979.2000.00007.x; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x; 2001, INCREASING COMPETITI; [No title captured]	111	53	56	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43966	10.1371/journal.pone.0043966	http://dx.doi.org/10.1371/journal.pone.0043966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970153	Green Published, gold			2022-12-27	WOS:000308458400027
J	Nazarian, A; Sichtig, H; Riva, A				Nazarian, Alireza; Sichtig, Heike; Riva, Alberto			A Knowledge-Based Method for Association Studies on Complex Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-GENE INTERACTIONS; COMMON HUMAN-DISEASES; RHEUMATOID-ARTHRITIS; MISSING HERITABILITY; NEURAL-NETWORKS; CROHNS-DISEASE; RISK LOCUS; SUSCEPTIBILITY; POPULATION	Complex disorders are a class of diseases whose phenotypic variance is caused by the interplay of multiple genetic and environmental factors. Analyzing the complexity underlying the genetic architecture of such traits may help develop more efficient diagnostic tests and therapeutic protocols. Despite the continuous advances in revealing the genetic basis of many of complex diseases using genome-wide association studies (GWAS), a major proportion of their genetic variance has remained unexplained, in part because GWAS are unable to reliably detect small individual risk contributions and to capture the underlying genetic heterogeneity. In this paper we describe a hypothesis-based method to analyze the association between multiple genetic factors and a complex phenotype. Starting from sets of markers selected based on preexisting biomedical knowledge, our method generates multi-marker models relevant to the biological process underlying a complex trait for which genotype data is available. We tested the applicability of our method using the WTCCC case-control dataset. Analyzing a number of biological pathways, the method was able to identify several immune system related multi-SNP models significantly associated with Rheumatoid Arthritis (RA) and Crohn's disease (CD). RA-associated multi-SNP models were also replicated in an independent case-control dataset. The method we present provides a framework for capturing joint contributions of genetic factors to complex traits. In contrast to hypothesis-free approaches, its results can be given a direct biological interpretation. The replicated multi-SNP models generated by our analysis may serve as a predictor to estimate the risk of RA development in individuals of Caucasian ancestry.	[Nazarian, Alireza] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, UF Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Nazarian, A (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	ariva@ufl.edu		Riva, Alberto/0000-0001-9150-8333	National Institutes of Health (NIH) [R01 HL87681-01]; Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians; University of Florida Genetics Institute; University of Florida; Wellcome Trust [076113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians; University of Florida Genetics Institute(University of Florida); University of Florida(University of Florida); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL87681-01, "Genome-Wide Association Studies in Sickle Cell Anemia and in Centenarians", and by funds from the University of Florida Genetics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the University of Florida Open-Access Publishing fund.; The authors would like to thank Dr. Paola Sebastiani for useful discussions, and Dr. Peter Gregersen for providing us with the NARAC dataset. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113.	Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bolstad WM., 2007, INTRO BAYESIAN STAT; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Cooles FAH, 2011, CURR OPIN RHEUMATOL, V23, P233, DOI 10.1097/BOR.0b013e32834518a3; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Vries R, 2011, CURR OPIN RHEUMATOL, V23, P227, DOI 10.1097/BOR.0b013e3283457524; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eshelman L., 1991, FDN GENETIC ALGORITH, P265, DOI DOI 10.1016/B978-0-08-050684-5.50020-3; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Friedman S, 2011, HARRISONS PRINCIPLES, V1; Friedman S, 2011, HARRISONS PRINCIPLES, V2; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; HAAS JP, 1995, TISSUE ANTIGENS, V45, P317, DOI 10.1111/j.1399-0039.1995.tb02460.x; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Martienssen R, 1999, TRENDS GENET, V15, P435, DOI 10.1016/S0168-9525(99)01833-8; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Moore Jason H, 2002, Pac Symp Biocomput, P53; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Nuzzo A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-278; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Ritchie MD, 2007, APPL SOFT COMPUT, V7, P471, DOI 10.1016/j.asoc.2006.01.013; Riva A, 2010, J BIOMED INFORM, V43, P419, DOI 10.1016/j.jbi.2009.11.005; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sherriff A, 2001, ADV GENET, V42, P287, DOI 10.1016/S0065-2660(01)42029-3; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Van Belle G., 2004, BIOSTATISTICS METHOD; Wang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011384; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Ziegler A, 2008, BIOMETRICAL J, V50, P8, DOI 10.1002/bimj.200710398; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	51	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44162	10.1371/journal.pone.0044162	http://dx.doi.org/10.1371/journal.pone.0044162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970175	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400042
J	Castillo, P; Ibanez, F; Guajardo, A; Llanos, MN; Ronco, AM				Castillo, Paula; Ibanez, Freddy; Guajardo, Angelica; Llanos, Miguel N.; Ronco, Ana M.			Impact of Cadmium Exposure during Pregnancy on Hepatic Glucocorticoid Receptor Methylation and Expression in Rat Fetus	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; DNA METHYLATION; EPIGENETIC MECHANISMS; DEVELOPMENTAL PLASTICITY; PLACENTAL CADMIUM; GENE-EXPRESSION; BIRTH-WEIGHT; FETAL-GROWTH; RESTRICTION; DISRUPTION	Adverse fetal environment due to maternal undernutrition or exposure to environmental chemicals alters glucocorticoid (GC) metabolism increasing the risk of metabolic disorders in adulthood. In this study, we investigated the effects of maternal exposure to cadmium (Cd, 50 ppm) during pregnancy in the methylation of fetal hepatic glucocorticoid receptor promoter (GR) and the correlation with its expression and that of the DNA methyltransferases (DNMT1a and 3a). We also studied the expression of liver phosphoenolpyruvate carboxykinase (PEPCK) and acyl-CoA oxidase (AOX), two enzymes involved in the metabolism of carbohydrates and lipids respectively. The methylation of the rat GR gene exon 1(10) (GR1(10)) in nucleotides -2536 to -2361 was analyzed by pyrosequencing. Quantitative real time PCR was used to assess hepatic GR, PEPCK and AOX mRNA, and their protein levels using Western blotting analysis. Differential methylation was noted across groups at all CpG sites in the GR exon 110 in a sex-dependent manner. In males, CpG were more methylated than the controls (185 +/- 21%, p<0.001) but only CpG sites 1,6,7 and 9 showed a significantly different extent of methylation. In addition, a lower expression of GR (mRNA and protein) was found. On the contrary, in females, CpG were less methylated than the controls (62 +/- 11%, p<0.05) and overexpressed, affecting PEPCK and AOX expression, which did not change in males. The GR methylation profile correlates with DNMT3a expression which may explain epigenetic sex-dependent changes on GR1(10) promoter induced by Cd treatment. In conclusion, Cd exposure during pregnancy affects fetal liver DNMT3a resulting in sex-dependent changes in methylation and expression of GR1(10). Although these effects do not seem to be directly involved in the low birth weight and height, they may have relevant implications for long-term health.	[Castillo, Paula; Ibanez, Freddy; Guajardo, Angelica; Llanos, Miguel N.; Ronco, Ana M.] Univ Chile, Inst Nutr & Food Technol INTA, Lab Nutr & Metab Regulat, Santiago, Chile	Universidad de Chile	Castillo, P (corresponding author), Univ Chile, Inst Nutr & Food Technol INTA, Lab Nutr & Metab Regulat, Santiago, Chile.	amronco@inta.uchile.cl	Ronco, Ana M/F-9393-2015; Llanos, Miguel/M-9595-2017		Fondo Nacional de Ciencia y Tecnologia de Chile (Fondecyt) [1100168]	Fondo Nacional de Ciencia y Tecnologia de Chile (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Ciencia y Tecnologia de Chile (Fondecyt) grant #1100168 to AMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Baserga M, 2010, AM J PHYSIOL-REG I, V299, pR334, DOI 10.1152/ajpregu.00122.2010; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Berglund M, 2011, ENVIRON RES, V111, P1271, DOI 10.1016/j.envres.2011.09.002; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Clifton VL, 2004, PLACENTA, V25, pS45, DOI 10.1016/j.placenta.2004.01.004; David Allis C., 2007, EPIGENETICS-US; Doi T, 2011, TOXICOL SCI, V120, P475, DOI 10.1093/toxsci/kfr022; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Henson MC, 2004, EXP BIOL MED, V229, P383, DOI 10.1177/153537020422900506; HIDALGO J, 1987, TOXICOLOGY, V45, P113, DOI 10.1016/0300-483X(87)90119-3; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Jiang X, 2012, FASEB J, V26; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kasten-Jolly J, 2010, TOXICOL APPL PHARM, V247, P105, DOI 10.1016/j.taap.2010.06.003; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P284, DOI 10.1289/ehp.1103711; KUHNERT BR, 1988, OBSTET GYNECOL, V71, P67; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lathers CM, 2002, J CLIN PHARMACOL, V42, P7, DOI 10.1177/0091270002042001001; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Odermatt A, 2006, J STEROID BIOCHEM, V102, P222, DOI 10.1016/j.jsbmb.2006.09.010; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Piasek M, 2001, REPROD TOXICOL, V15, P673, DOI 10.1016/S0890-6238(01)00174-5; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Ronco AM, 2009, TOXICOL LETT, V188, P186, DOI 10.1016/j.toxlet.2009.04.008; Ronco AM, 2005, BIOMETALS, V18, P233, DOI 10.1007/s10534-005-0583-2; Ronco AM, 2010, TOXICOL IN VITRO, V24, P1532, DOI 10.1016/j.tiv.2010.07.003; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; SHE QB, 1994, BIOCHEM BIOPH RES CO, V205, P1748, DOI 10.1006/bbrc.1994.2871; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Takiguchi M, 2003, EXP CELL RES, V286, P355, DOI 10.1016/S0014-4827(03)00062-4; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Whorwood CB, 2001, ENDOCRINOLOGY, V142, P2854, DOI 10.1210/en.142.7.2854; Yang KP, 2006, AM J PHYSIOL-ENDOC M, V290, pE135, DOI 10.1152/ajpendo.00356.2005; Zepeda R, 2011, TOXICOL APPL PHARM, V251, P137; Zepeda R, 2012, CARDIOVASC TOXICOL, V12, P64, DOI 10.1007/s12012-011-9139-6	63	33	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44139	10.1371/journal.pone.0044139	http://dx.doi.org/10.1371/journal.pone.0044139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957049	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800041
J	de Giuseppe, PO; Martins, NH; Meza, AN; dos Santos, CR; Pereira, HD; Murakami, MT				de Giuseppe, Priscila O.; Martins, Nadia H.; Meza, Andreia N.; dos Santos, Camila R.; Pereira, Humberto D'Muniz; Murakami, Mario T.			Insights into Phosphate Cooperativity and Influence of Substrate Modifications on Binding and Catalysis of Hexameric Purine Nucleoside Phosphorylases	PLOS ONE			English	Article							TRANSITION-STATE ANALOGS; RAY-DIFFRACTION DATA; ESCHERICHIA-COLI; TRICHOMONAS-VAGINALIS; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; STRUCTURAL BASIS; GENE-THERAPY; IN-VITRO	The hexameric purine nucleoside phosphorylase from Bacillus subtilis (BsPNP233) displays great potential to produce nucleoside analogues in industry and can be exploited in the development of new anti-tumor gene therapies. In order to provide structural basis for enzyme and substrates rational optimization, aiming at those applications, the present work shows a thorough and detailed structural description of the binding mode of substrates and nucleoside analogues to the active site of the hexameric BsPNP233. Here we report the crystal structure of BsPNP233 in the apo form and in complex with 11 ligands, including clinically relevant compounds. The crystal structure of six ligands (adenine, 2'deoxyguanosine, aciclovir, ganciclovir, 8-bromoguanosine, 6-chloroguanosine) in complex with a hexameric PNP are presented for the first time. Our data showed that free bases adopt alternative conformations in the BsPNP233 active site and indicated that binding of the co-substrate (2'deoxy) ribose 1-phosphate might contribute for stabilizing the bases in a favorable orientation for catalysis. The BsPNP233-adenosine complex revealed that a hydrogen bond between the 5' hydroxyl group of adenosine and Arg(43*) side chain contributes for the ribosyl radical to adopt an unusual C3'-endo conformation. The structures with 6-chloroguanosine and 8-bromoguanosine pointed out that the Cl-6 and Br-8 substrate modifications seem to be detrimental for catalysis and can be explored in the design of inhibitors for hexameric PNPs from pathogens. Our data also corroborated the competitive inhibition mechanism of hexameric PNPs by tubercidin and suggested that the acyclic nucleoside ganciclovir is a better inhibitor for hexameric PNPs than aciclovir. Furthermore, comparative structural analyses indicated that the replacement of Ser(90) by a threonine in the B. cereus hexameric adenosine phosphorylase (Thr(91)) is responsible for the lack of negative cooperativity of phosphate binding in this enzyme.	[de Giuseppe, Priscila O.; Martins, Nadia H.; Meza, Andreia N.; dos Santos, Camila R.; Murakami, Mario T.] Ctr Nacl Pesquisa Energia & Mat, LNBio, Sao Paulo, Brazil; [Pereira, Humberto D'Muniz] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Cristalog, Sao Paulo, Brazil	Universidade de Sao Paulo	de Giuseppe, PO (corresponding author), Ctr Nacl Pesquisa Energia & Mat, LNBio, Sao Paulo, Brazil.	mario.murakami@lnbio.org.br	Oliveira de Giuseppe, Priscila/GLR-1319-2022; Pereira, Humberto M/J-7824-2016; Murakami, Mario T/F-5640-2016; Santos, Camila/F-7095-2013; Murakami, Mario T/C-2087-2012	Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Pereira, Humberto M/0000-0002-8652-6729; Murakami, Mario T/0000-0002-0405-8010; Santos, Camila/0000-0003-0652-4211; 	FAPESP [2007/00194-9, 2010/51890-8]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the following research funding agencies: FAPESP [www.fapesp.br/] (grants numbers 2007/00194-9, 2010/51890-8) and CNPq [www.cnpq.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS G, 1964, P NATL ACAD SCI USA, V52, P493, DOI 10.1073/pnas.52.2.493; Afshar S, 2009, PROTEIN SCI, V18, P1107, DOI 10.1002/pro.91; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basso LA, 2001, BIOCHEMISTRY-US, V40, P8196, DOI 10.1021/bi010584x; Bennett EM, 2003, CHEM BIOL, V10, P1173, DOI 10.1016/j.chembiol.2003.11.008; Bennett EM, 2003, J BIOL CHEM, V278, P47110, DOI 10.1074/jbc.M304622200; Bzowska A, 1998, ACTA BIOCHIM POL, V45, P755, DOI 10.18388/abp.1998_4269; BZOWSKA A, 1988, J BIOL CHEM, V263, P9212; Caceres RA, 2012, BIOCHIMIE, V94, P155, DOI 10.1016/j.biochi.2011.10.003; Canduri F, 2005, ACTA CRYSTALLOGR D, V61, P856, DOI 10.1107/S0907444905005421; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Castilho MS, 2010, BIOORGAN MED CHEM, V18, P1421, DOI 10.1016/j.bmc.2010.01.022; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dessanti P, 2012, ACTA CRYSTALLOGR D, V68, P239, DOI 10.1107/S090744491200073X; dos Santos DM, 2003, BIOCHEM BIOPH RES CO, V308, P553, DOI 10.1016/S0006-291X(03)01433-5; ELKOUNI MH, 1987, BIOCHEM PHARMACOL, V36, P3815, DOI 10.1016/0006-2952(87)90443-6; ELKOUNI MH, 1983, P NATL ACAD SCI-BIOL, V80, P6667; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erion MD, 1997, BIOCHEMISTRY-US, V36, P11725, DOI 10.1021/bi961969w; Evans Gary B, 2007, Nucleic Acids Symp Ser (Oxf), P63; FAULDS D, 1990, DRUGS, V39, P597, DOI 10.2165/00003495-199039040-00008; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grenha R, 2005, ACTA CRYSTALLOGR F, V61, P459, DOI 10.1107/S174430910501095X; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; HWANG BK, 1994, CAN J BOT, V72, P480, DOI 10.1139/b94-064; JENSEN KF, 1978, BIOCHIM BIOPHYS ACTA, V525, P346, DOI 10.1016/0005-2744(78)90229-2; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Koellner G, 2002, J MOL BIOL, V315, P351, DOI 10.1006/jmbi.2001.5211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krohne TU, 2001, HEPATOLOGY, V34, P511, DOI 10.1053/jhep.2001.26749; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Long MC, 2007, J ANTIMICROB CHEMOTH, V59, P118, DOI 10.1093/jac/dkl448; Madrid DC, 2008, J BIOL CHEM, V283, P35899, DOI 10.1074/jbc.M807218200; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; Martiniello-Wilks R, 2004, J GENE MED, V6, P43, DOI 10.1002/jgm.474; Martins NH, 2011, ACTA CRYSTALLOGR F, V67, P618, DOI 10.1107/S1744309111010414; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikleusevic G, 2011, BIOCHIMIE, V93, P1610, DOI 10.1016/j.biochi.2011.05.030; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Munagala N, 2002, BIOCHEMISTRY-US, V41, P10382, DOI 10.1021/bi026025n; Munagala NR, 2003, MOL BIOCHEM PARASIT, V127, P143, DOI 10.1016/S0166-6851(02)00330-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWEN SP, 1964, CANCER CHEMOTH REP, P19; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Parker WB, 2005, NUCLEOS NUCLEOT NUCL, V24, P387, DOI 10.1081/NCN-200059807; Parker WB, 2003, CANCER GENE THER, V10, P23, DOI 10.1038/sj.cgt.7700520; Patel RN., 2006, BIOCATALYSIS PHARM B; Pereira HD, 2005, J MOL BIOL, V353, P584, DOI 10.1016/j.jmb.2005.08.045; PERLMAN ME, 1994, BIOCHEMISTRY-US, V33, P7547, DOI 10.1021/bi00190a007; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; Postigo MP, 2010, J CHEM INF MODEL, V50, P1693, DOI 10.1021/ci100128k; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Ray AS, 2004, ANTIMICROB AGENTS CH, V48, P1089, DOI 10.1128/AAC.48.4.1089-1095.2004; Rinaldo-Matthis A, 2007, BIOCHEMISTRY-US, V46, P659, DOI 10.1021/bi061515r; Rocchietti S, 2004, BIOMACROMOLECULES, V5, P2195, DOI 10.1021/bm049765f; Sgarrella F, 2007, BBA-GEN SUBJECTS, V1770, P1498, DOI 10.1016/j.bbagen.2007.07.004; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; SORSCHER EJ, 1994, GENE THER, V1, P233; Tahirov TH, 2004, J MOL BIOL, V337, P1149, DOI 10.1016/j.jmb.2004.02.016; Tai CK, 2010, CANCER GENE THER, V17, P614, DOI 10.1038/cgt.2010.17; THIERS BH, 1990, DERMATOL CLIN, V8, P583, DOI 10.1016/S0733-8635(18)30490-X; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Torii T, 2006, NUCLEOS NUCLEOT NUCL, V25, P655, DOI 10.1080/15257770600686394; Ubiali D, 2004, ADV SYNTH CATAL, V346, P1361, DOI 10.1002/adsc.200404019; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Calenbergh S, 2012, CURR TOP MED CHEM, V12, P694, DOI 10.2174/156802612799984580; Wright JM, 2010, PARASITOL RES, V107, P847, DOI 10.1007/s00436-010-1938-3; Xie XX, 2011, BIOTECHNOL LETT, V33, P1107, DOI 10.1007/s10529-011-0535-6; Zang Y, 2005, J BIOL CHEM, V280, P22318, DOI 10.1074/jbc.M501843200; Zhang Y, 2005, CURR TOP MED CHEM, V5, P1259, DOI 10.2174/156802605774463105	79	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44282	10.1371/journal.pone.0044282	http://dx.doi.org/10.1371/journal.pone.0044282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957058	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800051
J	Fuchs, M; Scholz, M; Sendelbeck, A; Atorf, J; Schlegel, C; Enz, R; Brandstatter, JH				Fuchs, Michaela; Scholz, Michael; Sendelbeck, Anna; Atorf, Jenny; Schlegel, Christine; Enz, Ralf; Brandstaetter, Johann Helmut			Rod Photoreceptor Ribbon Synapses in DBA/2J Mice Show Progressive Age-Related Structural Changes	PLOS ONE			English	Article							RETINAL GENE-EXPRESSION; IRIS ATROPHY; OPTIC-NERVE; GLAUCOMA; COMPLEMENT; MODEL; COMPONENT; BASSOON; RIBEYE; C1Q	The DBA/2J mouse is a commonly used animal model in glaucoma research. The eyes of DBA/2J mice show severe age-related changes that finally lead to the degeneration of retinal ganglion cells and the optic nerve. Recent electroretinogram studies identified functional deficits, which suggest that also photoreceptor cells are involved in the pathological processes occurring in the DBA/2J mouse retina. In a comparative study, we examined anatomical and molecular changes in the retinae of DBA/2J and C57BL/6 control mice with light and electron microscopy and with PCR analyses. In the retina of the DBA/2J mouse, we found a thinning of the outer plexiform layer, the first synaptic layer in the transfer of visual signals, and age-dependent and progressive degenerative structural changes at rod photoreceptor ribbon synapses. The structural ribbon changes represent a photoreceptor synaptic phenotype that has not yet been described in this animal model of secondary angle-closure glaucoma. Furthermore, genes of the classical complement cascade were upregulated in the photoreceptor cells of aging DBA/2J mice, suggesting a putative link between ribbon synapse degradation and the innate immune system.	[Fuchs, Michaela; Sendelbeck, Anna; Schlegel, Christine; Brandstaetter, Johann Helmut] FAU Erlangen Nuremberg, Dept Biol, Erlangen, Germany; [Scholz, Michael] FAU Erlangen Nuremberg, Inst Anat Lehrstuhl 2, Erlangen, Germany; [Atorf, Jenny] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Enz, Ralf] Univ Hosp Erlangen, Inst Biochem, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fuchs, M (corresponding author), FAU Erlangen Nuremberg, Dept Biol, Erlangen, Germany.	Ralf.Enz@biochem.uni-erlangen.de; jbrandst@biologie.uni-erlangen.de		Scholz, Michael/0000-0001-8440-6785; Fuchs, Michaela/0000-0001-7778-6708; Atorf, Jenny/0000-0003-0935-1897	Deutsche Forschungsgemeinschaft [SFB 539]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (SFB 539, A7) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birke MT, 2010, INVEST OPHTH VIS SCI, V51, P5759, DOI 10.1167/iovs.10-5558; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; Dyka FM, 2005, J NEUROCHEM, V94, P120, DOI 10.1111/j.1471-4159.2005.03177.x; Dyka FM, 2004, J NEUROCHEM, V90, P190, DOI 10.1111/j.1471-4159.2004.02474.x; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heiduschka P, 2010, EXP EYE RES, V91, P779, DOI 10.1016/j.exer.2010.09.001; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang W, 2011, EXP EYE RES, V93, P700, DOI 10.1016/j.exer.2011.09.001; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; John Simon W M, 2005, Invest Ophthalmol Vis Sci, V46, P2649; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Moon JI, 2005, CELL TISSUE RES, V320, P51, DOI 10.1007/s00441-004-1062-8; Panagis L, 2011, INVEST OPHTH VIS SCI, V52, P7807, DOI 10.1167/iovs.10-7063; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Regus-Leidig H, 2010, MOL VIS, V16, P2690; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Reim K, 2009, J CELL SCI, V122, P1352, DOI 10.1242/jcs.045401; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Scholz M, 2008, INVEST OPHTH VIS SCI, V49, P613, DOI 10.1167/iovs.07-0745; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036	36	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44645	10.1371/journal.pone.0044645	http://dx.doi.org/10.1371/journal.pone.0044645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957094	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800087
J	Jie, KE; van der Putten, K; Wesseling, S; Joles, JA; Bergevoet, MW; Pepers-de Kort, F; Doevendans, PA; Yasui, Y; Liu, Q; Verhaar, MC; Gaillard, CA; Braam, B				Jie, Kim E.; van der Putten, Karien; Wesseling, Sebastiaan; Joles, Jaap A.; Bergevoet, Marloes W.; Pepers-de Kort, Floor; Doevendans, Pieter A.; Yasui, Yutaka; Liu, Qi; Verhaar, Marianne C.; Gaillard, Carlo A.; Braam, Branko			Short-Term Erythropoietin Treatment Does Not Substantially Modulate Monocyte Transcriptomes of Patients with Combined Heart and Renal Failure	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY-DISEASE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; CARDIORENAL SYNDROME; RECEPTOR DENSITY; EPOETIN-ALPHA; RISK-FACTORS; ANEMIA; ATHEROSCLEROSIS	Background: Combined heart and renal failure is associated with high cardiovascular morbidity and mortality. Anti-oxidant and anti-inflammatory, non-hematopoietic effects of erythropoietin (EPO) treatment have been proposed. Monocytes may act as biosensors of the systemic environment. We hypothesized that monocyte transcriptomes of patients with cardiorenal syndrome (CRS) reflect the pathophysiology of the CRS and respond to short-term EPO treatment at a recommended dose for treatment of renal anemia. Methods: Patients with CRS and anemia (n = 18) included in the EPOCARES trial were matched to healthy controls (n = 12). Patients were randomized to receive 50 IU/kg/week EPO or not. RNA from CD14(+)-monocytes was subjected to genome wide expression analysis (Illumina) at baseline and 18 days (3 EPO injections) after enrolment. Transcriptomes from patients were compared to healthy controls and effect of EPO treatment was evaluated within patients. Results: In CRS patients, expression of 471 genes, including inflammation and oxidative stress related genes was different from healthy controls. Cluster analysis did not separate patients from healthy controls. The 6 patients with the highest hsCRP levels had more differentially expressed genes than the 6 patients with the lowest hsCRP levels. Analysis of the variation in log(2) ratios of all individual 18 patients indicated that 4 of the 18 patients were different from the controls, whereas the other 14 were quite similar. After short-term EPO treatment, every patient clustered to his or her own baseline transcriptome. Two week EPO administration only marginally affected expression profiles on average, however, individual gene responses were variable. Conclusions: In stable, treated CRS patients with mild anemia, monocyte transcriptomes were modestly altered, and indicated imprints of inflammation and oxidative stress. EPO treatment with a fixed dose has hematopoietic effects, had no appreciable beneficial actions on monocyte transcription profiles, however, could also not be associated with undesirable transcriptional responses.	[Jie, Kim E.; Wesseling, Sebastiaan; Joles, Jaap A.; Bergevoet, Marloes W.; Verhaar, Marianne C.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [van der Putten, Karien] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands; [van der Putten, Karien; Gaillard, Carlo A.] Meander Med Ctr Amersfoort, Dept Internal Med, Amersfoort, Netherlands; [Pepers-de Kort, Floor] Serv XS BV, Leiden, Netherlands; [Doevendans, Pieter A.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Yasui, Yutaka; Liu, Qi] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Gaillard, Carlo A.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [Braam, Branko] Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB, Canada; [Braam, Branko] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center; University of Alberta; Vrije Universiteit Amsterdam; University of Alberta; University of Alberta	Jie, KE (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands.	branko.braam@ualberta.ca	Gaillard, Carlo/AAC-6729-2022; Yasui, Yutaka/E-2564-2015; Joles, Jaap/AAX-3249-2020; Verhaar, Marianne/AAM-6788-2020	Gaillard, Carlo/0000-0002-8964-0236; Yasui, Yutaka/0000-0002-7717-8638; Verhaar, Marianne/0000-0002-3276-6428; Wesseling, Sebas/0000-0002-8162-1030	Dutch Heart Foundation; University Medical Center Utrecht; Roche Pharmaceuticals; New Investigator Grant from the Heart and Stroke Foundation of Canada	Dutch Heart Foundation(Netherlands Heart Foundation); University Medical Center Utrecht; Roche Pharmaceuticals(Roche Holding); New Investigator Grant from the Heart and Stroke Foundation of Canada	External funding for this study was obtained from the Dutch Heart Foundation, by the University Medical Center Utrecht (MD/PhD fellowship to KEJ) and from Roche Pharmaceuticals. BB was supported by a New Investigator Grant from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Ardigo D, 2007, CLIN CHEM LAB MED, V45, P1109, DOI 10.1515/CCLM.2007.261; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bluyssen HAR, 2010, AM J PHYSIOL-CELL PH, V299, pC354, DOI 10.1152/ajpcell.00513.2009; Bongartz LG, 2005, EUR HEART J, V26, P11, DOI 10.1093/eurheartj/ehi020; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Brodde O E, 1986, Contrib Nephrol, V50, P28; Chang YK, 2009, J UROLOGY, V181, P1434, DOI 10.1016/j.juro.2008.10.105; Chon H, 2006, HYPERTENSION, V47, P803, DOI 10.1161/01.HYP.0000210554.61293.90; Chon H, 2004, HYPERTENSION, V43, P947, DOI 10.1161/01.HYP.0000123071.35142.72; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Coulon S, 2011, NAT MED, V17, P1456, DOI 10.1038/nm.2462; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FRASER J, 1981, J CLIN INVEST, V67, P1777, DOI 10.1172/JCI110217; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Jackson G, 2000, BRIT MED J, V320, P167, DOI 10.1136/bmj.320.7228.167; Jie KE, 2006, AM J PHYSIOL-RENAL, V291, pF932, DOI 10.1152/ajprenal.00200.2006; Jie KE, 2011, HEART, V97, P60, DOI 10.1136/hrt.2010.194654; Koomans HA, 2004, J AM SOC NEPHROL, V15, P524, DOI 10.1097/01.ASN.0000113320.57127.B9; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lind L, 2003, ATHEROSCLEROSIS, V169, P203, DOI 10.1016/S0021-9150(03)00012-1; Lisowska KA, 2010, ARTIF ORGANS, V34, P654, DOI 10.1111/j.1525-1594.2009.00948.x; Malaponte G, 2002, NEPHROL DIAL TRANSPL, V17, P1964, DOI 10.1093/ndt/17.11.1964; Maouche S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-302; Meier P, 2009, HEART, V95, P900, DOI 10.1136/hrt.2008.145383; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rastmanesh MM, 2008, EUR J PHARMACOL, V593, P99, DOI 10.1016/j.ejphar.2008.07.013; Rastmanesh MM, 2009, EUR J PHARMACOL, V602, P163, DOI 10.1016/j.ejphar.2008.11.014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Schirmer SH, 2009, J MOL CELL CARDIOL, V46, P177, DOI 10.1016/j.yjmcc.2008.10.029; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sprague AH, 2009, BIOCH PHARM; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; van der Putten K, J NEPHROL, V23, P363; van der Putten K, 2010, EUR J HEART FAIL, V12, P943, DOI 10.1093/eurjhf/hfq099; Wibaut-Berlaimont V, 2005, J THROMB HAEMOST, V3, P677, DOI 10.1111/j.1538-7836.2005.01211.x	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41339	10.1371/journal.pone.0041339	http://dx.doi.org/10.1371/journal.pone.0041339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957013	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800005
J	Li, H; Yu, XM; Wang, JX; Hong, ZH; Tang, NLS				Li, Hui; Yu, Xiao-Min; Wang, Jia-Xin; Hong, Ze-Hui; Tang, Nelson Leung-Sang			The VNTR Polymorphism of the DC-SIGNR Gene and Susceptibility to HIV-1 Infection: A Meta-Analysis	PLOS ONE			English	Article							REGION POLYMORPHISMS; VARIANTS; PATHOGENESIS; POPULATION; SDF-1	Background: Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin related (DC-SIGNR) can bind to the human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein and is thus important for the host-pathogen interaction in HIV-1 infection. Studies of the association between the variable number tandem repeat (VNTR) polymorphism of the DC-SIGNR gene and HIV-1 susceptibility have produced controversial results. Methods and Findings: We conducted a meta-analysis of the data contained in the literature to clarify these findings. In total, 10 studies consisting of 2683 HIV-1 patients and 3263 controls (2130 healthy controls and 1133 HIV-1 exposed but seronegative (HESN) controls) were included. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were assessed in the main analyses. Further stratified analyses by ethnicity and sample size were performed. By dividing the controls into two groups, healthy controls and HIV-1 exposed but seronegative (HESN) controls, we explored different genetic models to detect any association between the VNTR polymorphism and predisposition to HIV-1 infection. The results showed that the 5-repeat allele carriers (OR = 0.84, 95% CI = 0.73-0.96) and the 5/5 homozygous (OR = 0.68, 95% CI = 0.50-0.93) had significantly reduced risk when using the HIV-1 exposed but seronegative (HESN) as controls. The stratified analyses by ethnicity and sample size confirmed these findings. However, a low to moderate degree of heterogeneity was also found across studies. Conclusions: Our findings demonstrate that the VNTR polymorphism of the DC-SIGNR gene is associated with a moderate effect on host susceptibility to HIV-1 infection. Similar to the 32-bp deletion in the chemokine receptor-5 gene (CCR5 Delta 32), the DC-SIGNR VNTR 5-repeat allele might have a role in resistance to HIV infection, particularly in Asian populations.	[Li, Hui; Hong, Ze-Hui] Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China; [Yu, Xiao-Min] Southeast Univ, Sch Med, Dept Biochem, Nanjing, Jiangsu, Peoples R China; [Li, Hui; Yu, Xiao-Min; Hong, Ze-Hui] Southeast Univ, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Wang, Jia-Xin] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Wang, Jia-Xin] Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Fac Med, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-Sang] CUHK, Shenzhen Res Inst, Shenzhen, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Yunnan University; Yunnan University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, H (corresponding author), Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China.	hongzehui@seu.edu.cn	Tang, Nelson L/P-5018-2017	Tang, Nelson L/0000-0002-3607-5819	National Natural Science Foundation of China [31000955, 30900812, 90919007]; Science & Technology of Southeast University [KJ2010439, KJ2010437]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology of Southeast University	This work was supported by grants from the National Natural Science Foundation of China (31000955, 30900812 and 90919007) and the fund from Science & Technology of Southeast University (KJ2010439 and KJ2010437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro LB, 2006, J INFECT DIS, V194, P1184, DOI 10.1086/507845; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Chaudhary O, 2008, J CLIN VIROL, V43, P196, DOI 10.1016/j.jcv.2008.06.005; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gramberg T, 2006, VIROLOGY, V347, P354, DOI 10.1016/j.virol.2005.11.033; Guo Y, 2006, J BIOL CHEM, V281, P16794, DOI 10.1074/jbc.M602430200; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kasten S, 2000, Eur J Med Res, V5, P323; Lichterfeld M, 2003, CLIN IMMUNOL, V107, P55, DOI 10.1016/S1521-6616(02)00050-5; Liu HL, 2006, J INFECT DIS, V193, P698, DOI 10.1086/499820; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Pantaleo G, 1997, RES IMMUNOL, V148, P417, DOI 10.1016/S0923-2494(97)82875-1; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Rathore A, 2008, J CLIN IMMUNOL, V28, P50, DOI 10.1007/s10875-007-9131-x; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Tang NLS, 2007, NAT GENET, V39, P690, DOI 10.1038/ng0607-692; Wang Hui, 2008, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V25, P542; Wang XiaoHui, 2010, China Tropical Medicine, V10, P273; Wichukchinda N, 2007, AIDS RES HUM RETROV, V23, P686, DOI 10.1089/aid.2006.0212; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xu LJ, 2010, J CLIN IMMUNOL, V30, P402, DOI 10.1007/s10875-010-9376-7; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zhao G.L., 2008, CHIN J AIDS STU, V14, P21; Zhao Jin, 2008, Zhonghua Yufang Yixue Zazhi, V42, P901; Zhi LT, 2007, NAT GENET, V39, P691, DOI [10.1038/ng0607-692, 10.1038/ng0607-691]	36	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42972	10.1371/journal.pone.0042972	http://dx.doi.org/10.1371/journal.pone.0042972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957026	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800018
J	Dehbi, M; Uzzaman, T; Baturcam, E; Eldali, A; Ventura, W; Bouchama, A				Dehbi, Mohammed; Uzzaman, Taher; Baturcam, Engin; Eldali, Abdelmoneim; Ventura, Wilhelmina; Bouchama, Abderrezak			Toll-Like Receptor 4 and High-Mobility Group Box 1 Are Critical Mediators of Tissue Injury and Survival in a Mouse Model for Heatstroke	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; ISCHEMIA-REPERFUSION INJURY; LUNG INJURY; LIVER ISCHEMIA; HEAT-STROKE; PROTEIN; MICE; RELEASE; BABOON; DAMAGE	The molecular mechanisms that initiate the inflammatory response in heatstroke and their relation with tissue injury and lethality are not fully elucidated. We examined whether endogenous ligands released by damaged/stressed cells such as high-mobility group box 1 (HMGB1) signaling through Toll-like receptor 4 (TLR4) may play a pathogenic role in heatstroke. Mutant TLR4-defective (C3H/HeJ) and wild type (C3H/HeOuJ) mice were subjected to heat stress in an environmental chamber pre-warmed at 43.5 degrees C until their core temperature reached 42.7 degrees C, which was taken as the onset of heatstroke. The animals were then allowed to recover passively at ambient temperature. A sham-heated group served as a control. Mutant mice displayed more histological liver damage and higher mortality compared with wild type mice (73% vs. 27%, respectively, P < 0.001). Compared to wild type mice, mutant mice exhibited earlier plasma release of markers of systemic inflammation such as HMGB1 (206 +/- 105 vs. 63 +/- 21 ng/ml; P = 0.0018 and 209 +/- 100 vs. 46 +/- 32 ng/ml; P < 0.0001), IL-6 (144 +/- 40 vs. 46 +/- 20 pg/ml; P<0.001 and 184 +/- 21 vs. 84 +/- 54 pg/ml; P = 0.04), and IL-1 beta (27 +/- 4 vs. 1.7 +/- 2.3 pg/ml; P < 0.0001 at 1 hour). Both strains of mice displayed early release of HMGB1 into the circulation upstream of IL-1 beta and IL-6 responses which remained elevated up to 24 h. Specific inhibition of HMGB1 activity with DNA-binding A Box (600 mu g/mouse) protected the mutant mice against the lethal effect of heat stress (60% A Box vs. 18% GST protein, P = 0.04). These findings suggest a protective role for the TLR4 in the host response to severe heat stress. They also suggest that HMGB1 is an early mediator of inflammation, tissue injury and lethality in heatstroke in the presence of defective TLR4 signaling.	[Bouchama, Abderrezak] King Abdullah Int Med Res Ctr, Dept Expt Med, Riyadh, Saudi Arabia; [Dehbi, Mohammed; Uzzaman, Taher; Baturcam, Engin] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Faisal Specialist Hospital & Research Center	Dehbi, M (corresponding author), Dasman Diabet Inst, Dept Biomed Res, Biochem & Mol Biol Unit, Dasman, Kuwait.	mohammed.dehbi@dasmaninstitute.org		BOUCHAMA, abderrezak/0000-0003-3089-5936	King Faisal Specialist Hospital & Research Centre (KFSHRC) [RAC 2060 013]	King Faisal Specialist Hospital & Research Centre (KFSHRC)	This study was supported by a research grant (RAC 2060 013) from King Faisal Specialist Hospital & Research Centre (KFSHRC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2010, ANN REV IMMUNOL; BIANCHI L, 1972, HUM PATHOL, V3, P237, DOI 10.1016/S0046-8177(72)80077-7; BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640; Bouchama A, 2005, SHOCK, V24, P332, DOI 10.1097/01.shk.0000180620.44435.9c; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bouchama A, 2008, ARTERIOSCL THROM VAS, V28, P1318, DOI 10.1161/ATVBAHA.107.161737; Bouchama A, 2007, SHOCK, V27, P578, DOI 10.1097/01.shk.0000246903.40142.aa; Chen CM, 2006, CRIT CARE MED, V34, P1960, DOI 10.1097/01.CCM.0000224231.01533.B1; Hagiwara S, 2010, SHOCK, V34, P402, DOI 10.1097/SHK.0b013e3181d492e4; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Leon LR, 2010, AM J PHYSIOL-REG I, V299, pR241, DOI 10.1152/ajpregu.00309.2009; Leon Lisa R, 2010, Front Biosci (Schol Ed), V2, P916; Leon LR, 2005, AM J PHYSIOL-REG I, V288, pR197, DOI 10.1152/ajpregu.00046.2004; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Lin MT, 1997, AM J PHYSIOL-HEART C, V273, pH2072, DOI 10.1152/ajpheart.1997.273.4.H2072; Liu CC, 2000, J PHYSIOL-LONDON, V527, P333, DOI 10.1111/j.1469-7793.2000.t01-1-00333.x; Makranz C, 2011, EUR J APPL PHYSIOL, V111, P2359, DOI 10.1007/s00421-011-1863-x; MALAMUD N, 1946, Mil Surg, V99, P397; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Roberts GT, 2008, ARTERIOSCL THROM VAS, V28, P1130, DOI 10.1161/ATVBAHA.107.158709; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zanotti G, 2009, AM J PHYSIOL-LUNG C, V297, pL52, DOI 10.1152/ajplung.90406.2008; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834	37	23	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44100	10.1371/journal.pone.0044100	http://dx.doi.org/10.1371/journal.pone.0044100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962600	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600028
J	Feinkohl, I; Sattar, N; Welsh, P; Reynolds, RM; Deary, IJ; Strachan, MWJ; Price, JF				Feinkohl, Insa; Sattar, Naveed; Welsh, Paul; Reynolds, Rebecca M.; Deary, Ian J.; Strachan, Mark W. J.; Price, Jackie F.		Edinburgh Type 2 Diabet Study Inve	Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LEFT-VENTRICULAR DYSFUNCTION; CONGESTIVE-HEART-FAILURE; MINI-MENTAL-STATE; HOSPITAL ANXIETY; ARTERY-DISEASE; PLASMA-LEVELS; RISK-FACTORS; IMPAIRMENT; ADULTS	Background: Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Methodology and Principal Findings: Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (beta -0.09, 95% CI -0.13 to -0.03, p = 0.004 and beta 0.08, 95% CI 0.04 to 0.12, p < 0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression >= 8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (beta -0.02, 95% CI 20.07 to 0.03, p > 0.05 for 'g'; beta 0.03, 95% CI 20.02 to 0.07, p. 0.05 for depression scores). Conclusion: Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions.	[Feinkohl, Insa; Price, Jackie F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Sattar, Naveed; Welsh, Paul] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Reynolds, Rebecca M.] Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Psychol Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Strachan, Mark W. J.] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Glasgow; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Feinkohl, I (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	I.Feinkohl@sms.ed.ac.uk; Jackie.Price@ed.ac.uk	Reynolds, Rebecca M/C-3044-2008; Deary, Ian J/C-6297-2009; Welsh, Paul/H-5249-2019	Reynolds, Rebecca M/0000-0001-6226-8270; Deary, Ian J/0000-0002-1733-263X; Welsh, Paul/0000-0002-7970-3643; Price, Jackie/0000-0003-3251-3970	Medical Research Council; Chief Scientist Office of the Scottish Executive; Pfizer plc; British Heart Foundation [FS/10/005/28147] Funding Source: researchfish; Medical Research Council [G0500877, G0700704B] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09/01PhD] Funding Source: researchfish; Chief Scientist Office [CZG/2/478, CZB/4/582] Funding Source: researchfish; MRC [G0500877] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Executive; Pfizer plc(Pfizer); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The ET2DS is funded by the Medical Research Council, the Chief Scientist Office of the Scottish Executive and Pfizer plc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Almeida OP, 2011, ARQ NEURO-PSIQUIAT, V59, P324; Andersen NH, 2005, DIABETIC MED, V22, P188, DOI 10.1111/j.1464-5491.2004.01396.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326; Bankier B, 2009, J PSYCHOSOM RES, V66, P189, DOI 10.1016/j.jpsychores.2008.09.010; Bekelman DB, 2007, J CARD FAIL, V13, P643, DOI 10.1016/j.cardfail.2007.05.005; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bourdel-Marchasson I, 2010, DIABETES METAB, V36, P173, DOI 10.1016/j.diabet.2010.03.001; Bunevicius R, 2006, CLIN CARDIOL, V29, P170, DOI 10.1002/clc.4960290409; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Castleberry C, 2010, J AM COLL CARDIOL, V55; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Curb JD, 1996, ARTERIOSCL THROM VAS, V16, P1495, DOI 10.1161/01.ATV.16.12.1495; Daniels LB, 2009, CIRCULATION, V120, pS542; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2004, INTELLIGENCE, V32, P113, DOI 10.1016/j.intell.2003.06.001; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gunstad J, 2006, AM J CARDIOL, V98, P538, DOI 10.1016/j.amjcard.2006.02.062; Hayashi C, 2004, DIABETES RES CLIN PR, V66, P269, DOI 10.1016/j.diabres.2004.03.013; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Jankowska EA, 2010, EUR J HEART FAIL, V12, P966, DOI 10.1093/eurjhf/hfq108; Kerola T, 2010, ANN MED, V42, P207, DOI 10.3109/07853891003652542; Kondziella D, 2009, NEUROREPORT, V20, P825, DOI 10.1097/WNR.0b013e328326f82f; Luciano M, 2009, PSYCHOSOM MED, V71, P404, DOI 10.1097/PSY.0b013e3181a24fb9; Magnusson M, 2004, DIABETES CARE, V27, P1929, DOI 10.2337/diacare.27.8.1929; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Mauro F, 2007, ARCH MED RES, V38, P234, DOI 10.1016/j.arcmed.2006.10.004; Muller-Tasch T, 2007, J CARD FAIL, V13, P818, DOI 10.1016/j.cardfail.2007.07.008; Naito J, 2009, GERIATR GERONTOL INT, V9, P242, DOI 10.1111/j.1447-0594.2009.00526.x; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Nilsson K, 2010, CLIN BIOCHEM, V43, P1282, DOI 10.1016/j.clinbiochem.2010.08.011; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Politi P, 2007, NEUROSCI LETT, V417, P322, DOI 10.1016/j.neulet.2007.02.056; Price Jackie F, 2008, BMC Endocr Disord, V8, P18, DOI 10.1186/1472-6823-8-18; Reijmer YD, 2010, DIABETES-METAB RES, V26, P507, DOI 10.1002/dmrr.1112; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Suwa M, 2009, INT J CARDIOL, V136, P351, DOI 10.1016/j.ijcard.2008.04.099; Thomas SA, 2008, CRIT CARE NURSE, V28, P40; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Vaes B, 2009, J AM GERIATR SOC, V57, P823, DOI 10.1111/j.1532-5415.2009.02218.x; van den Broek KC, 2011, AM J CARDIOL, V107, P723, DOI 10.1016/j.amjcard.2010.10.055; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P56, DOI 10.1016/j.jacc.2011.02.041; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuccala G, 1997, J NEUROL NEUROSUR PS, V63, P509, DOI 10.1136/jnnp.63.4.509	50	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44569	10.1371/journal.pone.0044569	http://dx.doi.org/10.1371/journal.pone.0044569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22973461	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000308577600069
J	Gianesin, K; Freguja, R; Carmona, F; Zanchetta, M; Del Bianco, P; Malacrida, S; Montagna, M; Rampon, O; Giaquinto, C; De Rossi, A				Gianesin, Ketty; Freguja, Riccardo; Carmona, Francesco; Zanchetta, Marisa; Del Bianco, Paola; Malacrida, Sandro; Montagna, Marco; Rampon, Osvalda; Giaquinto, Carlo; De Rossi, Anita			The Role of Genetic Variants of stromal Cell-Derived Factor 1 in Pediatric HIV-1 Infection and Disease Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-DEFICIENCY; CORECEPTOR USAGE; CCR5; CHILDREN; RECEPTOR; POLYMORPHISM; RESISTANCE; GENOTYPE; ENTRY	Stromal cell-Derived Factor 1 (SDF1) is the natural ligand of CXCR4, the coreceptor of HIV-1 X4 viruses. This study investigated the role of the single nucleotide polymorphism (SNP) rs1801157 (NM_000609.5:c.*519G>A) of the SDF1 gene in the natural history of mother-to-child transmission of HIV-1 and disease progression of HIV-1-infected children. The study was conducted in 428 children born to HIV-1-seropositive mothers, who had not undergone antiretroviral therapy (ART) during pregnancy, and in 120 HIV-1-infected children for whom the end-point was the onset of AIDS or the initiation of ART; 16 children developed early AIDS (<24 months of life), 13 from 24 to 84 months of age, and 14 had late AIDS (>84 months). The rs1801157 SNP was not associated with risk of perinatal infection in any genetic models tested. By contrast, this SNP influenced disease progression in a time-dependent manner. rs1801157 GA heterozygous children had a higher risk of late AIDS (HR = 6.3, 95% CI 1.9-20.7, p = 0.002) than children with the rs1801157 GG genotype. Children were studied for viral coreceptor usage at birth, after 84 months of age and/or at AIDS onset. While R5 viruses using CCR5 coreceptor were predominant at birth (94%) and at early AIDS (85%), viruses using CXCR4 coreceptor emerged during the course of infection and were detected in 49% of children older than 84 months and in 62% of late AIDS. The rs1801157 SNP did not influence the emergence of R5X4 viruses, but children with the rs1801157 GA genotype and R5XA viruses were at significantly higher risk of late AIDS than children with rs1801157 GG genotype (OR = 8.0, 95% CI 1.2-52.2, p=0.029). Our results indicate that the rs1801157 SNP does not influence perinatal infection, but impacts disease progression. This effect is time-dependent and linked to the coreceptor-usage of viral variants that undergo evolution during the course of HIV-1 infection.	[Gianesin, Ketty; Freguja, Riccardo; De Rossi, Anita] Univ Padua, Sect Oncol & Immunol, AIDS Reference Ctr, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Carmona, Francesco; Zanchetta, Marisa; Del Bianco, Paola; Montagna, Marco; De Rossi, Anita] IRCCS, Ist Oncol Veneto, Padua, Italy; [Malacrida, Sandro] Univ Padua, Dept Neurosci, Padua, Italy; [Rampon, Osvalda; Giaquinto, Carlo] Univ Padua, Dept Pediat, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua	Gianesin, K (corresponding author), Univ Padua, Sect Oncol & Immunol, AIDS Reference Ctr, Dept Surg Oncol & Gastroenterol, Padua, Italy.	anita.derossi@unipd.it	De Rossi, A./L-3128-2015; De Rossi, Anita/Q-4845-2019; Giaquinto, Carlo/AAB-5016-2020; montagna, marco/E-2225-2012; Del Bianco, Paola/F-4655-2014	De Rossi, A./0000-0001-6435-7509; De Rossi, Anita/0000-0001-6435-7509; montagna, marco/0000-0002-4929-2150; Del Bianco, Paola/0000-0002-6597-0265; Malacrida, Sandro/0000-0002-4775-3857; GIAQUINTO, CARLO/0000-0001-9365-0413	PENTA Foundation	PENTA Foundation	The financial support for this research was received from the PENTA foundation. RF was supported by the PENTA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Cavarelli M, 2010, AIDS, V24, P2521, DOI 10.1097/QAD.0b013e32833d7d8c; Cavarelli M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003292; Clevestig P, 2005, AIDS RES HUM RETROV, V21, P371, DOI 10.1089/aid.2005.21.371; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2005, J INFECT DIS, V192, P1597, DOI 10.1086/496893; De Rossi A, 2007, CURR OPIN HIV AIDS, V2, P399, DOI 10.1097/COH.0b013e3282ced163; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEMARTINO M, 1994, LANCET, V343, P191; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; DEROSSI A, 1991, AIDS, V5, P15, DOI 10.1097/00002030-199101000-00002; DeRossi A, 1996, J CLIN INVEST, V97, P323, DOI 10.1172/JCI118419; DEROSSI A, 1992, AIDS, V6, P1117, DOI 10.1097/00002030-199210000-00008; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Garcia-Moruja C, 2009, CURR HIV RES, V7, P384, DOI 10.2174/157016209788680543; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; John GC, 2000, J VIROL, V74, P5736, DOI 10.1128/JVI.74.12.5736-5739.2000; Katz DA, 2010, INT J IMMUNOGENET, V37, P301, DOI 10.1111/j.1744-313X.2010.00924.x; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Koning FA, 2005, ANTIVIR THER, V10, P231; LIDINJANSSON G, 1994, PEDIATRICS, V94, P815; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu SJ, 2011, CURR HIV RES, V9, P112, DOI 10.2174/157016211795569113; Low AJ, 2007, AIDS, V21, pF19, DOI 10.1097/QAD.0b013e3282ef81ea; Mahajan SD, 2010, BIOCHEM BIOPH RES CO, V396, P348, DOI 10.1016/j.bbrc.2010.04.095; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; NEWELL ML, 1994, J GERONTOL B-PSYCHOL, V343, P1464; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ometto L, 2001, J INFECT DIS, V183, P814, DOI 10.1086/318828; Ometto L, 1999, AIDS RES HUM RETROV, V15, P1441, DOI 10.1089/088922299309955; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Petersen DC, 2005, JAIDS-J ACQ IMM DEF, V40, P521, DOI 10.1097/01.qai.0000186360.42834.28; PIZZO PA, 1995, J ACQ IMMUN DEF SYND, V8, P30; Poveda E, 2010, HIV AIDS-RES PALLIAT, V2, P51; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Repits J, 2005, J GEN VIROL, V86, P2859, DOI 10.1099/vir.0.81111-0; Ricci E, 2009, JAIDS-J ACQ IMM DEF, V51, P13, DOI 10.1097/QAI.0b013e31819df249; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; Ruiz-Mateos E, 2011, ANTIMICROB AGENTS CH, V55, P4664, DOI 10.1128/AAC.00753-11; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; Salvatori F, 1997, J VIROL, V71, P4694, DOI 10.1128/JVI.71.6.4694-4706.1997; Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Singh KK, 2003, J INFECT DIS, V188, P1461, DOI 10.1086/379038; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Tiensiwakul P, 2004, INTERVIROLOGY, V47, P87, DOI 10.1159/000077831; Tresoldi E, 2002, J INFECT DIS, V185, P696, DOI 10.1086/339004; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44460	10.1371/journal.pone.0044460	http://dx.doi.org/10.1371/journal.pone.0044460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962615	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600058
J	Veresoglou, SD; Thornton, B; Menexes, G; Mamolos, AP; Veresoglou, DS				Veresoglou, Stavros D.; Thornton, Barry; Menexes, George; Mamolos, Andreas P.; Veresoglou, Demetrios S.			Soil Fertilization Leads to a Decline in Between-Samples Variability of Microbial Community delta C-13 Profiles in a Grassland Fertilization Experiment	PLOS ONE			English	Article							ORGANIC-MATTER; STABLE-ISOTOPES; CARBON ISOTOPES; C-13 CONTENT; FATTY-ACIDS; NITROGEN; TEMPERATE; BIOMASS; BACTERIAL; MINERALIZATION	Gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) was used to measure the C-13/C-12 ratios of PLFAs at natural abundance levels from a temperate grassland nitrogen (N) and phosphorus (P) factorial fertilization experiment in northern Greece. In each plot two rhizosphere samples were derived centred around individual Agrostis capillaris and Prunella vulgaris plants. It was hypothesized that the isotopic signal of microbes that preferentially feed on recalcitrant litter such as fungi would be modified by fertilization more strongly than that of opportunistic microbes using labile C. Microbial community delta C-13 was affected by both P and N fertilization regime and plant species identity. However, we have been unable to detect significant nutrient effects on individual groups of microbes when analyzed separately in contrast to our original hypothesis. Intra-treatment variability, as evaluated from Hartley's F-max tests in the five first PCA components axes as well as the size of the convex hulls in PCA scoreplots and Mahalanobis distances, was considerably higher in the non-fertilized controls. Moreover, a significant relationship was established between the change in PLFA abundances and their respective changes in delta C-13 for the aggregate of samples and those simultaneously fertilized with N and P. We conclude that use of compound specific isotope analysis in the absence of labelling represents a valuable and overlooked tool in obtaining an insight of microbial community functioning.	[Veresoglou, Stavros D.; Mamolos, Andreas P.; Veresoglou, Demetrios S.] Aristotle Univ Thessaloniki, Fac Agr, Lab Ecol & Environm Protect, GR-54006 Thessaloniki, Greece; [Thornton, Barry] James Hutton Inst, Environm & Biochem Sci Grp, Craigiebuckler, Aberdeen, Scotland; [Menexes, George] Aristotle Univ Thessaloniki, Sch Agr, Agron Lab, GR-54006 Thessaloniki, Greece; [Veresoglou, Stavros D.] Free Univ Berlin, Berlin, Germany	Aristotle University of Thessaloniki; James Hutton Institute; Aristotle University of Thessaloniki; Free University of Berlin	Veresoglou, SD (corresponding author), Aristotle Univ Thessaloniki, Fac Agr, Lab Ecol & Environm Protect, GR-54006 Thessaloniki, Greece.	seby31@zeroone.net	Mamolos, Andreas/D-5301-2011; Veresoglou, Stavros D/D-5087-2011; Menexes, George/N-8603-2015	Mamolos, Andreas/0000-0002-1052-337X; Veresoglou, Stavros D/0000-0001-6387-4109; Menexes, George/0000-0002-1034-7345	Chloros Trust	Chloros Trust	The project was partially funded through a PhD studentship to SDV by the Chloros Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Berg B, 2002, PLANT SOIL, V242, P83, DOI 10.1023/A:1019637807021; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1; BLAIR N, 1985, APPL ENVIRON MICROB, V50, P996, DOI 10.1128/AEM.50.4.996-1001.1985; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Emmett BA, 1999, WATER AIR SOIL POLL, V116, P65, DOI 10.1023/A:1005209622313; Entry JA, 2000, BIOL FERT SOILS, V31, P436, DOI 10.1007/s003749900191; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281, DOI 10.1071/PP9860281; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Garten CT, 2000, ECOLOGY, V81, P1108, DOI 10.1890/0012-9658(2000)081[1108:CCOFSC]2.0.CO;2; GLEIXNER G, 1993, PLANT PHYSIOL, V102, P1287, DOI 10.1104/pp.102.4.1287; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; HARTLEY HO, 1950, BIOMETRIKA, V37, P271, DOI 10.1093/biomet/37.3-4.271; Hobbie EA, 2004, NEW PHYTOL, V164, P515, DOI 10.1111/j.1469-8137.2004.01187.x; Islam K, 2005, GEODERMA, V128, P249, DOI 10.1016/j.geoderma.2005.04.007; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Kroppenstedt R. M., 1992, PROKARYOTES, V2, P1139; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Lloyd J, 1999, FUNCT ECOL, V13, P439, DOI 10.1046/j.1365-2435.1999.00350.x; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Mamolos AP, 2011, ECOL RES, V26, P583, DOI 10.1007/s11284-011-0817-4; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Ngao J., 2011, BIOGEOSCIENCES DISCU, V8, P51, DOI DOI 10.5194/BGD-8-51-2011; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Palojarvi A., 2006, MICROBIOLOGICAL METH, P204; Paterson E, 2008, SOIL BIOL BIOCHEM, V40, P1103, DOI 10.1016/j.soilbio.2007.12.003; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Penny KI, 1996, APPL STAT-J ROY ST C, V45, P73, DOI 10.2307/2986224; R Core Team, 2018, R LANG ENV STAT COMP; Rodwell JS, 2000, BRIT PLANT COMMUNITI; Ruess L, 2005, ECOLOGY, V86, P2075, DOI 10.1890/04-1399; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SCHNYDER H, 1992, PLANTA, V187, P128, DOI 10.1007/BF00201634; Staddon PL, 2004, TRENDS ECOL EVOL, V19, P148, DOI 10.1016/j.tree.2003.12.003; Tiunov AV, 2007, BIOL BULL+, V34, P395, DOI 10.1134/S1062359007040127; Veresoglou SD, 2011, PLANT SOIL, V344, P187, DOI 10.1007/s11104-011-0739-5; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Wallenstein MD, 2006, FOREST ECOL MANAG, V222, P459, DOI 10.1016/j.foreco.2005.11.002; Weast R.C., 1975, HDB CHEM PHYS; WEDIN DA, 1995, ECOLOGY, V76, P1383, DOI 10.2307/1938142; Werth M, 2010, SOIL BIOL BIOCHEM, V42, P1372, DOI 10.1016/j.soilbio.2010.04.009; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Zhang CLL, 2002, CURR OPIN BIOTECH, V13, P25, DOI 10.1016/S0958-1669(02)00280-X	58	5	5	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44203	10.1371/journal.pone.0044203	http://dx.doi.org/10.1371/journal.pone.0044203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962602	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600030
J	Meloni, D; Davidse, A; Langeveld, JPM; Varello, K; Casalone, C; Corona, C; Balkema-Buschmann, A; Groschup, MH; Ingravalle, F; Bozzetta, E				Meloni, Daniela; Davidse, Aart; Langeveld, Jan P. M.; Varello, Katia; Casalone, Cristina; Corona, Cristiano; Balkema-Buschmann, Anne; Groschup, Martin H.; Ingravalle, Francesco; Bozzetta, Elena			EU-Approved Rapid Tests for Bovine Spongiform Encephalopathy Detect Atypical Forms: A Study for Their Sensitivities	PLOS ONE			English	Article							BSE-AFFECTED CATTLE; PRION PROTEIN; TRANSMISSION; PRP	Since 2004 it become clear that atypical bovine spongiform encephalopthies (BSEs) exist in cattle. Whenever their detection has relied on active surveillance plans implemented in Europe since 2001 by rapid tests, the overall and inter-laboratory performance of these diagnostic systems in the detection of the atypical strains has not been studied thoroughly to date. To fill this gap, the present study reports on the analytical sensitivity of the EU-approved rapid tests for atypical L-and H-type and classical BSE in parallel. Each test was challenged with two dilution series, one created from a positive pool of the three BSE forms according to the EURL standard method of homogenate preparation (50% w/v) and the other as per the test kit manufacturer's instructions. Multilevel logistic models and simple logistic models with the rapid test as the only covariate were fitted for each BSE form analyzed as directed by the test manufacturer's dilution protocol. The same schemes, but excluding the BSE type, were then applied to compare test performance under the manufacturer's versus the water protocol. The IDEXX HerdChek (R) BSE-scrapie short protocol test showed the highest sensitivity for all BSE forms. The IDEXX (R) HerdChek BSE-scrapie ultra short protocol, the Prionics (R) - Check WESTERN and the AJ Roboscreen (R) BetaPrion tests showed similar sensitivities, followed by the Roche (R) PrionScreen, the Bio-Rad (R) TeSeE (TM) SAP and the Prionics (R) - Check PrioSTRIP in descending order of analytical sensitivity. Despite these differences, the limit of detection of all seven rapid tests against the different classes of material set within a 2 log(10) range of the best-performing test, thus meeting the European Food Safety Authority requirement for BSE surveillance purposes. These findings indicate that not many atypical cases would have been missed surveillance since 2001 which is important for further epidemiological interpretations of the sporadic character of atypical forms.	[Meloni, Daniela; Varello, Katia; Casalone, Cristina; Corona, Cristiano; Ingravalle, Francesco; Bozzetta, Elena] Ctr Referenza Nazl Encefalopatie Anim, Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Davidse, Aart; Langeveld, Jan P. M.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Balkema-Buschmann, Anne; Groschup, Martin H.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Insel Riems, Germany	IZS Piemonte Liguria e Valle D'aosta; Wageningen University & Research; Friedrich Loeffler Institute	Meloni, D (corresponding author), Ctr Referenza Nazl Encefalopatie Anim, Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy.	elena.bozzetta@izsto.it	Bozzetta, Elena Maria/K-7580-2016; Casalone, Cristina/J-6763-2018	Casalone, Cristina/0000-0001-5271-832X; Varello, Katia/0000-0002-0486-2121				Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 1998, OFFICIAL J EUROPEA L, VL 122, P59; [Anonymous], 1999, OFFICIAL J EUROPEA L, VL 147, P1; [Anonymous], PRION CHECK WESTERN; [Anonymous], PRION CHECK LIA BSE; [Anonymous], BETAPRION BSE EIA TE; [Anonymous], PRIONSCREEN TEST; [Anonymous], PRION CHECK PRIOSTRI; [Anonymous], 2005, EFSA J, V48, P1; [Anonymous], IDEXX HERDCHECK BOV; [Anonymous], 2003, OPINION SCI STEERING; [Anonymous], 2010, EFSA J, V8, P1591; [Anonymous], 2010, OFFICIAL J EUROPEA L, VL 279, P10; [Anonymous], TESEE PUR DET SAP TE; [Anonymous], 2009, EFSA J, V7, P1436; [Anonymous], ENF SCI; Armstrong BK, 2001, PRINCIPLE EXPOSURE M; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Baron T, 2006, LANCET, V367, P297, DOI 10.1016/S0140-6736(06)68060-4; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Breyer J, 2012, VET MICROBIOL, DOI [10.1016/j.vet-mic.2011.12.008, DOI 10.1016/J.VET-MIC.2011.12.008]; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Dobly A, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-26; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; EFSA (European Food Safety Authority), 2007, EFSA J, V208, P1; Everest SJ, 2006, J GEN VIROL, V87, P471, DOI 10.1099/vir.0.81539-0; Fleiss J.L., 2013, STAT METHODS RATES P; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kittelberger R, 2012, EMERG INFECT DIS, V18, P890, DOI 10.3201/eid1805.111824; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Langeveld JPM, 2011, J CLIN MICROBIOL, V49, P3026, DOI 10.1128/JCM.01102-11; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981; Ono F, 2011, JPN J INFECT DIS, V64, P81; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Polak MP, 2012, VET J, V191, P128, DOI 10.1016/j.tvjl.2010.12.019; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Seuberlich T, 2012, EMERG INFECT DIS, V18, P158, DOI 10.3201/eid1801.111225; Szklo M, 2006, EPIDEMIOLOGY BASICS; Webster K, 2009, DETERMINATION ANAL S; WILESMITH JW, 1988, VET REC, V123, P638; Wolfang P, 2004, FIELD TRIAL 7 NEW RA	50	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43133	10.1371/journal.pone.0043133	http://dx.doi.org/10.1371/journal.pone.0043133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984410	Green Published, gold			2022-12-27	WOS:000308638700012
J	Voss-Bohme, A				Voss-Boehme, Anja			Multi-Scale Modeling in Morphogenesis: A Critical Analysis of the Cellular Potts Model	PLOS ONE			English	Article							DIFFERENTIAL ADHESION; REARRANGEMENT; CELLS	Cellular Potts models (CPMs) are used as a modeling framework to elucidate mechanisms of biological development. They allow a spatial resolution below the cellular scale and are applied particularly when problems are studied where multiple spatial and temporal scales are involved. Despite the increasing usage of CPMs in theoretical biology, this model class has received little attention from mathematical theory. To narrow this gap, the CPMs are subjected to a theoretical study here. It is asked to which extent the updating rules establish an appropriate dynamical model of intercellular interactions and what the principal behavior at different time scales characterizes. It is shown that the longtime behavior of a CPM is degenerate in the sense that the cells consecutively die out, independent of the specific interdependence structure that characterizes the model. While CPMs are naturally defined on finite, spatially bounded lattices, possible extensions to spatially unbounded systems are explored to assess to which extent spatio-temporal limit procedures can be applied to describe the emergent behavior at the tissue scale. To elucidate the mechanistic structure of CPMs, the model class is integrated into a general multiscale framework. It is shown that the central role of the surface fluctuations, which subsume several cellular and intercellular factors, entails substantial limitations for a CPM's exploitation both as a mechanistic and as a phenomenological model.	Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany	Technische Universitat Dresden	Voss-Bohme, A (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany.	anja.voss-boehme@tu-dresden.de	Voss-Böhme, Anja/O-6869-2017	Voss-Böhme, Anja/0000-0001-6510-8694	German Federal Ministry of Education and Research (Virtual Liver Network)	German Federal Ministry of Education and Research (Virtual Liver Network)	This study was supported by the German Federal Ministry of Education and Research (Virtual Liver Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168102; [Anonymous], 2000, INTRO MARKOV CHAINS, DOI DOI 10.1007/978-1-4612-1590-5_8; Balter A, 2007, SINGLE CELL BASED MO, P151, DOI [DOI 10.1007/978-3-7643-8123-3_7, 10.1007/978-3-7643-8123-3_7]; Bremaud P., 1975, MARKOV CHAINS GIBBS, V19, P91, DOI DOI 10.1007/978-1-4757-3124-8; COX JT, 1990, PROBAB THEORY REL, V85, P195, DOI 10.1007/BF01277982; De Masi A., 1991, MATH METHODS HYDRODY; Deroulers C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031917; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; Harrison NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022700; Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kafer J, 2006, PLOS COMPUT BIOL, V2, P518, DOI 10.1371/journal.pcbi.0020056; Kohn-Luque A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024175; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; LIGGETT TM, 1999, STOCHASTIC INTERACTI; Madras N., 2002, FIELDS I MONOGRAPHS; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; MARTINS ML, 1991, PHYS REV LETT, V66, P2045, DOI 10.1103/PhysRevLett.66.2045; Merks RMH, 2009, MATH MODEL NAT PHENO, V4, P149, DOI 10.1051/mmnp/20094406; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; NAGAI T, 1988, J PHYS SOC JPN, V57, P2221, DOI 10.1143/JPSJ.57.2221; Nakajima A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033035; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Sandersius SA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045007; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Simpson MJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041901; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; Starruss J, 2007, J STAT PHYS, V128, P269, DOI 10.1007/s10955-007-9298-9; Starruss J, COMMUNICATION; Suzuki Y, 1991, TOKYO J MATH, V14, P61; Szabo A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046007; Turner S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021910; Varadhan SRS, 1997, ASIAN J MATH, V1, P623; Voss-Bohme A, 2010, J THEOR BIOL, V263, P419, DOI 10.1016/j.jtbi.2009.12.011; Voss-Bohme A, 2009, MARK P REL FIELDS, V15, P441; WELIKY M, 1990, DEVELOPMENT, V109, P373; Zajac M, 2003, J THEOR BIOL, V222, P247, DOI 10.1016/S0022-5193(03)00033-X; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024999	44	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42852	10.1371/journal.pone.0042852	http://dx.doi.org/10.1371/journal.pone.0042852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984409	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700011
J	Bruni, I; De Mattia, F; Martellos, S; Galimberti, A; Savadori, P; Casiraghi, M; Nimis, PL; Labra, M				Bruni, Ilaria; De Mattia, Fabrizio; Martellos, Stefano; Galimberti, Andrea; Savadori, Paolo; Casiraghi, Maurizio; Nimis, Pier Luigi; Labra, Massimo			DNA Barcoding as an Effective Tool in Improving a Digital Plant Identification System: A Case Study for the Area of Mt. Valerio, Trieste (NE Italy)	PLOS ONE			English	Article							PLASTID RBCL; MATK; TAXONOMY; WILL	Background: Identification keys are decision trees which require the observation of one or more morphological characters of an organism at each step of the process. While modern digital keys can overcome several constraints of classical paper-printed keys, their performance is not error-free. Moreover, identification cannot be always achieved when a specimen lacks some morphological features (i.e. because of season, incomplete development or miss-collecting). DNA barcoding was proven to have great potential in plant identification, while it can be ineffective with some closely related taxa, in which the relatively brief evolutionary distance did not produce differences in the core-barcode sequences. Methodology/Principal Findings: In this paper, we investigated how the DNA barcoding can support the modern digital approaches to the identification of organisms, using as a case study a local flora, that of Mt. Valerio, a small hill near the centre of Trieste (NE Italy). The core barcode markers (plastidial rbcL and matK), plus the additional trnH-psbA region, were used to identify vascular plants specimens. The usefulness of DNA barcoding data in enhancing the performance of a digital identification key was tested on three independent simulated scenarios. Conclusions/Significance: Our results show that the core barcode markers univocally identify most species of our local flora (96%). The trnH-psbA data improve the discriminating power of DNA barcoding among closely related plant taxa. In the multiparametric digital key, DNA barcoding data improves the identification success rate; in our simulation, DNA data overcame the absence of some morphological features, reaching a correct identification for 100% of the species. FRIDA, the software used to generate the digital key, has the potential to combine different data sources: we propose to use this feature to include molecular data as well, creating an integrated identification system for plant biodiversity surveys.	[Bruni, Ilaria; De Mattia, Fabrizio; Galimberti, Andrea; Savadori, Paolo; Casiraghi, Maurizio; Labra, Massimo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlant Lab, Milan, Italy; [Martellos, Stefano; Nimis, Pier Luigi] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy	University of Milano-Bicocca; University of Trieste	Bruni, I (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, ZooPlant Lab, Piazza Sci 2, Milan, Italy.	massimo.labra@unimib.it	Casiraghi, Maurizio/E-7273-2011; Labra, Massimo/J-2372-2012; Galimberti, Andrea/ABF-7019-2020; Savadori, paolo/A-8769-2019	Casiraghi, Maurizio/0000-0002-2733-2094; Labra, Massimo/0000-0003-1065-5804; Galimberti, Andrea/0000-0003-3140-3024; Savadori, paolo/0000-0001-8606-4694; Martellos, Stefano/0000-0001-5201-8948; Bruni, Ilaria/0000-0002-9947-0963	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR) [20089BZYAH]	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR) grant 20089BZYAH with the project entitled "Tassonomia integrata per lo studio della biodiversita vegetale: DNA barcoding e analisi morfologiche". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Arif IA, 2010, INT J MOL SCI, V11, P2079, DOI 10.3390/ijms11052079; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Biemont C, 2010, HEREDITY, V105, P1, DOI 10.1038/hdy.2010.66; Brach AR, 2011, ANN MO BOT GARD, V98, P297, DOI 10.3417/2010035; Brach AR, 2005, TAXON, V54, P1041, DOI 10.2307/25065490; Bridgeman P., 1927, LOGIC MODERN PHYS; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Conti F., 2005, ANNOTATED CHECKLIST; Conti F, 2007, NATURA VICENTINA, V10, p[2006, 5]; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Dallwitz M.J., 2002, GLOBAL BIOL INFORM I, P23; Dallwitz MJ, 1995, USERS GUIDE INTKEY P; De Mattia F, 2011, FOOD RES INT, V44, P693, DOI 10.1016/j.foodres.2010.12.032; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; Fazekas AJ, 2010, BIOTECHNIQUES, V48, P277, DOI 10.2144/000113369; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Hagedorn G, 2010, TOOLS IDENTIFYING BI, P59; Hagedorn G, 2010, TOOLS IDENTIFYING BI, P13; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Martellos S, 2010, TAXON, V59, P922, DOI 10.1002/tax.593020; Naciri Y, 2010, MOL ECOL RESOUR, V10, P728, DOI 10.1111/j.1755-0998.2009.02816.x; Newmaster SG, 2009, INT J COMPUT APPL T, V35, P50, DOI 10.1504/IJCAT.2009.024595; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nimis PL, 2009, ECO MONT, V1, P61, DOI 10.1553/ecomont2s61; Ren H, 2011, J SYST EVOL, V49, P411, DOI 10.1111/j.1759-6831.2011.00152.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stace CA, 2005, TAXON, V54, P999, DOI 10.2307/25065484; Stevenson RD, 2003, CONSERV ECOL, V7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x	46	45	46	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43256	10.1371/journal.pone.0043256	http://dx.doi.org/10.1371/journal.pone.0043256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970123	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400004
J	Grimston, SK; Watkins, MP; Brodt, MD; Silva, MJ; Civitelli, R				Grimston, Susan K.; Watkins, Marcus P.; Brodt, Michael D.; Silva, Matthew J.; Civitelli, Roberto			Enhanced Periosteal and Endocortical Responses to Axial Tibial Compression Loading in Conditional Connexin43 Deficient Mice	PLOS ONE			English	Article							BONE-FORMATION; MOUSE TIBIA; INTERCELLULAR COMMUNICATION; OSTEOBLAST DIFFERENTIATION; PARATHYROID-HORMONE; CORTICAL BONE; BETA-CATENIN; IN-VIVO; INCREASES; NETWORKS	The gap junction protein, connexin43 (Cx43) is involved in mechanotransduction in bone. Recent studies using in vivo models of conditional Cx43 gene (Gja1) deletion in the osteogenic linage have generated inconsistent results, with Gja1 ablation resulting in either attenuated or enhanced response to mechanical load, depending upon the skeletal site examined or the type of load applied. To gain further insights on Cx43 and mechanotransduction, we examined bone formation response at both endocortical and periosteal surfaces in 2-month-old mice with conditional Gja1 ablation driven by the Dermo1 promoter (cKO). Relative to wild type (WT) littermates, it requires a larger amount of compressive force to generate the same periosteal strain in cKO mice. Importantly, cKO mice activate periosteal bone formation at a lower strain level than do WT mice, suggesting an increased sensitivity to mechanical load in Cx43 deficiency. Consistently, trabecular bone mass also increases in mutant mice upon load, while it decreases in WT. On the other hand, bone formation actually decreases on the endocortical surface in WT mice upon application of axial mechanical load, and this response is also accentuated in cKO mice. These changes are associated with increase of Cox-2 in both genotypes and further decrease of Sost mRNA in cKO relative to WT bones. Thus, the response of bone forming cells to mechanical load differs between trabecular and cortical components, and remarkably between endocortical and periosteal envelopes. Cx43 deficiency enhances both the periosteal and endocortical response to mechanical load applied as axial compression in growing mice.	[Grimston, Susan K.; Watkins, Marcus P.; Civitelli, Roberto] Washington Univ St Louis, Dept Internal Med, Div Bone & Mineral Dis, St Louis, MO USA; [Brodt, Michael D.; Silva, Matthew J.] Washington Univ St Louis, Dept Orthoped Surg, St Louis, MO USA; [Grimston, Susan K.; Watkins, Marcus P.; Brodt, Michael D.; Silva, Matthew J.; Civitelli, Roberto] Washington Univ St Louis, Musculoskeletal Res Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Grimston, SK (corresponding author), Washington Univ St Louis, Dept Internal Med, Div Bone & Mineral Dis, St Louis, MO USA.	Sgrimsto@dom.wustl.edu	Civitelli, Roberto/AAA-8260-2019; Watkins, Marcus/V-8817-2019	Civitelli, Roberto/0000-0003-4076-4315; Watkins, Marcus/0000-0002-1224-3478; Silva, Matthew/0000-0001-7375-4522	National Institutes of Health/National Institute of Arthritis and Musculoskeletal Skin Diseases [AR041255, AR047867, P30AR057235]; Barnes Jewish Hospital Foundation; Zealand; Novartis; Amgen; Eli-Lilly; Pfizer; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047867, R01AR041255, R29AR041255, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal Skin Diseases; Barnes Jewish Hospital Foundation; Zealand; Novartis(Novartis); Amgen(Amgen); Eli-Lilly(Eli Lilly); Pfizer(Pfizer); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal Skin Diseases grants AR041255 (RC), AR047867 (MJS), P30AR057235 (Washington University Core Center for Musculoskeletal Biology and Medicine) and funds from the Barnes Jewish Hospital Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Roberto Civitelli has a material transfer agreement with Zealand Pharma (Glostrup, Denmark) for the use of gap junction-modifying peptides but receives no honoraria or research funds from Zealand. He receives consultant fees from Novartis and Amgen, grant support from Eli-Lilly and Pfizer, and owns stock of Eli-Lilly, Merck, and Amgen. All other authors state they have no conflict of interest. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Christiansen BA, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2917435; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; FOLDES J, 1990, J BONE MINER RES, V5, P1063; Forwood MR, 1996, J BONE MINER RES, V11, P1688; Fritton JC, 2008, J BONE MINER RES, V23, P663, DOI [10.1359/jbmr.080104, 10.1359/JBMR.080104]; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Gluhak-Heinrich J, 2006, CELL COMMUN ADHES, V13, P115, DOI 10.1080/15419060600634619; Grimston SK, 2011, J BONE MINER RES; Grimston SK, 2008, J BONE MINER RES, V23, P879, DOI [10.1359/jbmr.080222, 10.1359/JBMR.080222]; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Mahajan G, 2011, AUST NZ J OBSTET GYN, V51, P403, DOI 10.1111/j.1479-828X.2011.01337.x; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Salazar V, 2011, 33 ANN M AM SOC BON; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Silva MJ, 2005, ANAT REC PART A, V283A, P380, DOI 10.1002/ar.a.20171; Stains JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-222; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165; Wyatt S S, 2001, Australas Radiol, V45, P369, DOI 10.1046/j.1440-1673.2001.00941.x; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023516	35	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44222	10.1371/journal.pone.0044222	http://dx.doi.org/10.1371/journal.pone.0044222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970183	gold, Green Submitted, Green Published			2022-12-27	WOS:000308748400012
J	Lin, CM; Lin, SM; Chung, FT; Lin, HC; Lee, KY; Huang, CD; Kuo, CH; Liu, CY; Wang, CH; Kuo, HP				Lin, Chieh-Mo; Lin, Shu-Min; Chung, Fu-Tsai; Lin, Horng-Chyuan; Lee, Kang-Yun; Huang, Chien-Da; Kuo, Chih-Hsi; Liu, Chien-Ying; Wang, Chun-Hua; Kuo, Han-Pin			Amplified Mycobacterium Tuberculosis Direct Test for Diagnosing Tuberculous Pleurisy-A Diagnostic Accuracy Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ACID AMPLIFICATION TESTS; PULMONARY TUBERCULOSIS; BIOPSY SPECIMENS; EFFUSION; PCR	Background: The study was designed to investigate the clinical usefulness of Amplified Mycobacterium Tuberculosis Direct (AMTD) tests for diagnosing TB pleurisy. Methods: One hundred and fifty-two patients for whom the exclusion of tuberculous pleural effusion was necessary were retrospectively analyzed. Results: The sensitivity of AMTD in diagnosing pleural TB was 36.4% (20 of 55). Combining sputum and pleural effusion AFB smear, pleural biopsy, and AMTD test of pleural effusion increased sensitivity to 82.5% (33/40). There were significantly higher percentages of neutrophils in the pleural effusion in the positive than in the negative AMTD group (38.0 +/- 6.7% vs. 11.1 +/- 3.7%, p<0.001). Patients with symptom duration <18 days prior to pleural effusion studies had more positive AMTD tests than those with symptom >18 days (70% vs. 31.4%; OR 5.09; 95% CI 1.54-16.79; p = 0.011). Conclusions: Combining AMTD tests with conventional diagnostic methods offer good sensitivity for pleural TB diagnosis. Patients in the early course of the disease are better candidates for AMTD tests.	[Lin, Chieh-Mo] Chang Gung Mem Hosp, Chiayi Branch, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Lin, Shu-Min; Chung, Fu-Tsai; Lin, Horng-Chyuan; Lee, Kang-Yun; Huang, Chien-Da; Kuo, Chih-Hsi; Liu, Chien-Ying; Wang, Chun-Hua; Kuo, Han-Pin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Pulm Dis Res Ctr,Dept Thorac Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, CM (corresponding author), Chang Gung Mem Hosp, Chiayi Branch, Div Pulm & Crit Care Med, Chiayi, Taiwan.	smlin100@gmail.com	Wang, Chun-Hua/V-9861-2019; Huang, Chien-Da/AAY-3771-2021; Wang, Chun-Hua/C-1488-2016	Wang, Chun-Hua/0000-0002-3514-9353; Huang, Chien-Da/0000-0002-4999-6019	Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPG 391291]	Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Linkou, Taiwan	This project is supported by the Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Linkou, Taiwan (grant no. CMRPG 391291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PF, 1989, J IMMUNOL, V142, P1114; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Bradley SP, 1996, AM J RESP CRIT CARE, V153, P1606, DOI 10.1164/ajrccm.153.5.8630609; BUENO CE, 1990, ARCH INTERN MED, V150, P1190, DOI 10.1001/archinte.1990.00390180034005; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; Catanzaro A, 1997, AM J RESP CRIT CARE, V155, P1804, DOI 10.1164/ajrccm.155.5.9154896; Cheng VCC, 2005, EUR J CLIN MICROBIOL, V24, P711, DOI 10.1007/s10096-005-0039-1; Cohen RA, 1998, AM J RESP CRIT CARE, V157, P156, DOI 10.1164/ajrccm.157.1.97-06043; Conaty SJ, 2005, J INFECTION, V50, P187, DOI 10.1016/j.jinf.2004.03.010; DEWIT D, 1992, TUBERCLE LUNG DIS, V73, P262, DOI 10.1016/0962-8479(92)90130-C; Johansen IS, 2002, EUR J CLIN MICROBIOL, V21, P455, DOI 10.1007/s10096-002-0737-x; Liam C K, 2000, Respirology, V5, P33, DOI 10.1046/j.1440-1843.2000.00223.x; Light R W, 1999, Curr Opin Pulm Med, V5, P245, DOI 10.1097/00063198-199907000-00012; Lin MT, 2009, RESP MED, V103, P820, DOI 10.1016/j.rmed.2008.12.023; Lin SM, 2010, J THORAC CARDIOV SUR, V139, P1554, DOI 10.1016/j.jtcvs.2010.02.019; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Mitarai S, 2000, INT J TUBERC LUNG D, V4, P871; Moon JW, 2005, CLIN INFECT DIS, V41, P660, DOI 10.1086/432474; Neves DD, 2007, BRAZ J INFECT DIS, V11, P83, DOI 10.1590/S1413-86702007000100019; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Ruiz-Manzano J, 2000, CHEST, V118, P648, DOI 10.1378/chest.118.3.648; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; 1996, MMWR MORB MORTAL WKL, V45, P950	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44842	10.1371/journal.pone.0044842	http://dx.doi.org/10.1371/journal.pone.0044842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970318	gold, Green Submitted, Green Published			2022-12-27	WOS:000308748400033
J	Huang, RZ; Gao, HC; Zhang, L; Jia, JM; Liu, X; Zheng, P; Ma, LH; Li, WJ; Deng, J; Wang, X; Yang, L; Wang, MJ; Xie, P				Huang, Rongzhong; Gao, Hongchang; Zhang, Liang; Jia, Jianmin; Liu, Xia; Zheng, Peng; Ma, Lihua; Li, Wenjuan; Deng, Jing; Wang, Xiao; Yang, Liu; Wang, Mingju; Xie, Peng			Borna Disease Virus Infection Perturbs Energy Metabolites and Amino Acids in Cultured Human Oligodendroglia Cells	PLOS ONE			English	Article							KETOGLUTARATE GLUTAMATE EXCHANGE; CENTRAL-NERVOUS-SYSTEM; TCA CYCLE; NMR; GLYCOLYSIS; PYRUVATE; LACTATE; BRAIN; RATS; DISORDERS	Background: Borna disease virus is a neurotropic, non-cytolytic virus that has been widely employed in neuroscientific research. Previous studies have revealed that metabolic perturbations are associated with Borna disease viral infection. However, the pathophysiological mechanism underlying its mode of action remains unclear. Methodology: Human oligodendroglia cells infected with the human strain Borna disease virus Hu-H1 and non-infected matched control cells were cultured in vitro. At day 14 post-infection, a proton nuclear magnetic resonance-based metabonomic approach was used to differentiate the metabonomic profiles of 28 independent intracellular samples from Borna disease virus-infected cells (n = 14) and matched control cells (n = 14). Partial least squares discriminant analysis was performed to demonstrate that the whole metabonomic patterns enabled discrimination between the two groups, and further statistical testing was applied to determine which individual metabolites displayed significant differences between the two groups. Findings: Metabonomic profiling revealed perturbations in 23 metabolites, 19 of which were deemed individually significant: nine energy metabolites (a-glucose, acetate, choline, creatine, formate, myo-inositol, nicotinamide adenine dinucleotide, pyruvate, succinate) and ten amino acids (aspartate, glutamate, glutamine, glycine, histidine, isoleucine, phenylalanine, threonine, tyrosine, valine). Partial least squares discriminant analysis demonstrated that the whole metabolic patterns enabled statistical discrimination between the two groups. Conclusion: Borna disease viral infection perturbs the metabonomic profiles of several metabolites in human oligodendroglia cells cultured in vitro. The findings suggest that Borna disease virus manipulates the host cell's metabolic network to support viral replication and proliferation.	[Huang, Rongzhong; Zhang, Liang; Liu, Xia; Zheng, Peng; Ma, Lihua; Deng, Jing; Wang, Mingju; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Gao, Hongchang; Jia, Jianmin] Wenzhou Med Coll, Dept Pharm, Wenzhou, Zhejiang, Peoples R China; [Huang, Rongzhong; Zhang, Liang; Liu, Xia; Zheng, Peng; Ma, Lihua; Li, Wenjuan; Deng, Jing; Wang, Xiao; Yang, Liu; Wang, Mingju; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Huang, Rongzhong; Zhang, Liang; Liu, Xia; Zheng, Peng; Ma, Lihua; Li, Wenjuan; Deng, Jing; Wang, Xiao; Yang, Liu; Wang, Mingju; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China	Chongqing Medical University; Wenzhou Medical University; Chongqing Medical University	Huang, RZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [30900456, 21175099]; Natural Science Foundation Project of Chongqing (CSTC) [2008BB5238, 2010BB5393]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300), the National Natural Science Foundation of China (Grant No. 30900456 and 21175099), and the Natural Science Foundation Project of Chongqing (CSTC, 2008BB5238 and 2010BB5393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, ENDOCRINE, V28, P295, DOI 10.1385/ENDO:28:3:295; Akhtar SN, 2007, NMR BIOMED, V20, P422, DOI 10.1002/nbm.1099; BACZKO K, 1988, J INFECT DIS, V158, P144, DOI 10.1093/infdis/158.1.144; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Benjamini Y, 2001, ANN STAT, V29, P1165; Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; Bode L, 1996, MOL PSYCHIATR, V1, P200; Clemente R, 2009, J VIROL, V83, P2655, DOI 10.1128/JVI.02206-08; de la Torre JC, 2000, VIRUS TAXONOMY, V10, P531; delaTorre JC, 1996, VIRUS RES, V44, P33, DOI 10.1016/0168-1702(96)01338-X; DITTRICH W, 1989, BIOL PSYCHIAT, V26, P818, DOI 10.1016/0006-3223(89)90122-4; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Feschotte C, 2010, NATURE, V463, P39, DOI 10.1038/463039a; FLECK MW, 1993, J NEUROSCI, V13, P3944; Gosztonyi G, 2001, CURR TOP MICROBIOL, V253, P121; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hornig M, 2012, MOL PSYCHIATR, V17, P486, DOI 10.1038/mp.2011.179; Hornig M, 2001, CURR TOP MICROBIOL, V253, P157; Ibrahim MS, 2002, J VIROL, V76, P3873, DOI 10.1128/JVI.76.8.3873-3880.2002; Kohno T, 1999, J VIROL, V73, P760, DOI 10.1128/JVI.73.1.760-766.1999; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Li Q, 2009, EUR J NEUROL, V16, P399, DOI 10.1111/j.1468-1331.2008.02516.x; Li YH, 2008, BRAIN RES, V1190, P49, DOI 10.1016/j.brainres.2007.11.006; Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108; LOU HC, 1994, ACTA PAEDIATR, V83, P86, DOI 10.1111/j.1651-2227.1994.tb13461.x; Ludwig H, 1993, Arch Virol Suppl, V7, P111; LUDWIG H, 1988, PROG MED VIROL, V35, P107; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; MASON GF, 1992, J CEREBR BLOOD F MET, V12, P434, DOI 10.1038/jcbfm.1992.61; MULLER CE, 1995, ACTA NEUROPATHOL, V89, P438, DOI 10.1007/BF00307649; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Ovanesov MV, 2007, J NEUROVIROL, V13, P185, DOI 10.1080/13550280701258415; PAULI G, 1985, VIRUS RES, V2, P29, DOI 10.1016/0168-1702(85)90057-7; Pletnikov MV, 2000, DEV BRAIN RES, V119, P179, DOI 10.1016/S0165-3806(99)00168-6; Qian J, 2010, ANTIVIR RES, V87, P249, DOI 10.1016/j.antiviral.2010.05.011; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Solbrig MV, 2003, PHARMACOL BIOCHEM BE, V74, P777, DOI 10.1016/S0091-3057(03)00019-4; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; TILTON WM, 1991, J LAB CLIN MED, V118, P146; Utrilla J, 2009, J IND MICROBIOL BIOT, V36, P1057, DOI 10.1007/s10295-009-0589-9; Zhang CX, 2005, J NEUROVIROL, V11, P256, DOI 10.1080/13550280590952781	46	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44665	10.1371/journal.pone.0044665	http://dx.doi.org/10.1371/journal.pone.0044665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970281	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000042
J	Zhang, LJ; Tao, BB; Wang, MJ; Jin, HM; Zhu, YC				Zhang, Li-Jia; Tao, Bei-Bei; Wang, Ming-Jie; Jin, Hui-Ming; Zhu, Yi-Chun			PI3K p110 alpha Isoform-Dependent Rho GTPase Rac1 Activation Mediates H2S-Promoted Endothelial Cell Migration via Actin Cytoskeleton Reorganization	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HYDROGEN-SULFIDE; ADHERENS JUNCTIONS; PROTEIN-KINASE; PHOSPHORYLATION; H2S; ANGIOGENESIS; MOTILITY; VASORELAXANT; INFLAMMATION	Hydrogen sulfide (H2S) is now considered as the third gaseotransmitter, however, the signaling pathways that modulate the biomedical effect of H2S on endothelial cells are poorly defined. In the present study, we found in human endothelial cells that H2S increased cell migration rates and induced a marked reorganization of the actin cytoskeleton, which was prevented by depletion of Rac1. Pharmacologic inhibiting vascular endothelial growth factor receptor (VEGFR) and phosphoinositide 3-kinase (PI3K) both blunted the activation of Rac1 and the promotion of cell migration induced by H2S. Moreover, H2S-induced Rac1 activation was selectively dependent on the presence of the PI3K p110 alpha isoform. Activated Rac1 by H2S thus in turn resulted in the phosphorylation of the F-actin polymerization modulator, cofilin. Additionally, inhibiting of extracellular signal-regulated kinase (ERK) decreased the augmented cell migration rate by H2S, but had no effect on Rac1 activation. These results indicate that Rac1 conveys the H2S signal to microfilaments inducing rearrangements of actin cytoskeleton that regulates cell migration. VEGFR-PI3K was found to be upstream pathway of Rac1, while cofilin acted as a downstream effector of Rac1. ERK was also shown to be involved in the action of H2S on endothelial cell migration, but independently of Rac1.	[Zhang, Li-Jia; Tao, Bei-Bei; Wang, Ming-Jie; Jin, Hui-Ming; Zhu, Yi-Chun] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	Fudan University	Zhang, LJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China.	yczhu@shmu.edu.cn		Zhu, Yichun/0000-0002-0873-2957	Ministry of Science and Technology of China [2010CB912601, 2009ZX09303-006]; National Natural Science Foundation of China [30825016, 30971064, 81000045]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology (2010CB912601 and 2009ZX09303-006) of China and the National Natural Science Foundation of China (30825016, 30971064, 81000045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Cain RJ, 2010, J CELL BIOL, V188, P863, DOI 10.1083/jcb.200907135; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hegde Akhil, 2011, Inflammation & Allergy Drug Targets, V10, P118; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Kimura H, 2010, AMINO ACIDS; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Yang G, 2011, AM J PATHOL; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang W, 2005, J PHYSIOL-LONDON, V569, P519, DOI 10.1113/jphysiol.2005.097642; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	47	26	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44590	10.1371/journal.pone.0044590	http://dx.doi.org/10.1371/journal.pone.0044590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970259	Green Submitted, Green Published, gold			2022-12-27	WOS:000308462000033
J	Green, DM; Penman, DJ; Migaud, H; Bron, JE; Taggart, JB; McAndrew, BJ				Green, Darren M.; Penman, David J.; Migaud, Herve; Bron, James E.; Taggart, John B.; McAndrew, Brendan J.			The Impact of Escaped Farmed Atlantic Salmon (Salmo salar L.) on Catch Statistics in Scotland	PLOS ONE			English	Article							WILD SALMON; SIMULATED ESCAPE; FISH; SEA; POPULATION; PREVALENCE; NORWAY; ORIGIN; AUTUMN; RIVERS	In Scotland and elsewhere, there are concerns that escaped farmed Atlantic salmon (Salmo salar L.) may impact on wild salmon stocks. Potential detrimental effects could arise through disease spread, competition, or inter-breeding. We investigated whether there is evidence of a direct effect of recorded salmon escape events on wild stocks in Scotland using anglers' counts of caught salmon (classified as wild or farmed) and sea trout (Salmo trutta L.). This tests specifically whether documented escape events can be associated with reduced or elevated escapes detected in the catch over a five-year time window, after accounting for overall variation between areas and years. Alternate model frameworks were somewhat inconsistent, however no robust association was found between documented escape events and higher proportion of farm-origin salmon in anglers' catch, nor with overall catch size. A weak positive correlation was found between local escapes and subsequent sea trout catch. This is in the opposite direction to what would be expected if salmon escapes negatively affected wild fish numbers. Our approach specifically investigated documented escape events, contrasting with earlier studies examining potentially wider effects of salmon farming on wild catch size. This approach is more conservative, but alleviates some potential sources of confounding, which are always of concern in observational studies. Successful analysis of anglers' reports of escaped farmed salmon requires high data quality, particularly since reports of farmed salmon are a relatively rare event in the Scottish data. Therefore, as part of our analysis, we reviewed studies of potential sensitivity and specificity of determination of farmed origin. Specificity estimates are generally high in the literature, making an analysis of the form we have performed feasible.	[Green, Darren M.; Penman, David J.; Migaud, Herve; Bron, James E.; Taggart, John B.; McAndrew, Brendan J.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	University of Stirling	Green, DM (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	darren.green@stir.ac.uk	Bron, James E/B-6231-2018; Migaud, Herve/C-5647-2009; Green, Darren/I-6436-2012	Bron, James E/0000-0003-3544-0519; Migaud, Herve/0000-0002-5404-7512; Green, Darren/0000-0001-9026-5675; Taggart, John/0000-0002-3843-9663	Scottish Salmon Producers' Organisation (SSPO)	Scottish Salmon Producers' Organisation (SSPO)	This work was supported by funding from the Scottish Salmon Producers' Organisation (SSPO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Butler JRA, 2005, FISHERIES MANAG ECOL, V12, P149, DOI 10.1111/j.1365-2400.2005.00437.x; Butler JRA, 2003, SALMON AT THE EDGE, P93, DOI 10.1002/9780470995495.ch9; Carr JW, 2006, ICES J MAR SCI, V63, P1263, DOI 10.1016/j.icesjms.2006.03.020; Crozier William Walter, 1998, Fisheries Management and Ecology, V5, P23, DOI 10.1046/j.1365-2400.1998.00054.x; Fiske P, 2006, ICES J MAR SCI, V63, P1182, DOI 10.1016/j.icesjms.2006.04.006; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Friedland KD, 2009, ICES J MAR SCI, V66, P289, DOI 10.1093/icesjms/fsn210; GART JJ, 1966, J ROY STAT SOC B, V28, P164; Hansen LP, 2010, FISHERIES MANAG ECOL, V17, P28, DOI 10.1111/j.1365-2400.2009.00709.x; Hansen LP, 1997, ICES J MAR SCI, V54, P152, DOI 10.1006/jmsc.1996.0178; Hansen LP, 1999, ICES J MAR SCI, V56, P200, DOI 10.1006/jmsc.1998.0437; ICES, 2010, ORAL HLTH STATUS ORA; Jacobsen JA, 2001, FISH RES, V52, P169, DOI 10.1016/S0165-7836(00)00255-1; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Jonsson B, 2006, ICES J MAR SCI, V63, P1162, DOI 10.1016/j.icesjms.2006.03.004; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Marine Scotland, 2012, SCOTT SALM SEA TROUT; Marine Scotland, 2012, IMPR CONT FISH FARM; Marine Scotland, 2011, SCOTLANDS MARINE ATL; Morris MRJ, 2008, CAN J FISH AQUAT SCI, V65, P2807, DOI 10.1139/F08-181; Olsen RE, 2010, AQUACULT ENV INTERAC, V1, P167, DOI 10.3354/aei00015; Skilbrei OT, 2006, ICES J MAR SCI, V63, P1190, DOI 10.1016/j.icesjms.2006.05.005; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P107, DOI 10.3354/aei00011; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P147, DOI 10.3354/aei00017; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P117, DOI 10.3354/aei00013; Strathspey Angling Improvement Association, 2012, MEMB PERM RUL COND C; Thorstad E.B., 2008, 36 NINA; Todd C, 2007, J PLANKTON RES, V29, pi67; Van Zwol JA, 2012, ECOL FRESHW FISH, V21, P533, DOI 10.1111/j.1600-0633.2012.00573.x; Walker AM, 2006, ICES J MAR SCI, V63, P1201, DOI 10.1016/j.icesjms.2006.04.018; WEBB JH, 1991, AQUACULTURE, V98, P97, DOI 10.1016/0044-8486(91)90375-H	32	14	14	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43560	10.1371/journal.pone.0043560	http://dx.doi.org/10.1371/journal.pone.0043560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970132	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400014
J	Hanson, MA; Herwig, BR; Zimmer, KD; Fieberg, J; Vaughn, SR; Wright, RG; Younk, JA				Hanson, Mark A.; Herwig, Brian R.; Zimmer, Kyle D.; Fieberg, John; Vaughn, Sean R.; Wright, Robert G.; Younk, Jerry A.			Comparing Effects of Lake- and Watershed-Scale Influences on Communities of Aquatic Invertebrates in Shallow Lakes	PLOS ONE			English	Article							STRUCTURING FISH ASSEMBLAGES; FRESH-WATER; PRAIRIE WETLANDS; LAND-USE; TROPHIC INTERACTIONS; SPECIES COMPOSITION; FATHEAD MINNOWS; MACROPHYTES; LANDSCAPE; ECOSYSTEMS	Constraints on lake communities are complex and are usually studied by using limited combinations of variables derived from measurements within or adjacent to study waters. While informative, results often provide limited insight about magnitude of simultaneous influences operating at multiple scales, such as lake- vs. watershed-scale. To formulate comparisons of such contrasting influences, we explored factors controlling the abundance of predominant aquatic invertebrates in 75 shallow lakes in western Minnesota, USA. Using robust regression techniques, we modeled relative abundance of Amphipoda, small and large cladocera, Corixidae, aquatic Diptera, and an aggregate taxon that combined Ephemeroptera-Trichoptera-Odonata (ETO) in response to lake-and watershed-scale characteristics. Predictor variables included fish and submerged plant abundance, linear distance to the nearest wetland or lake, watershed size, and proportion of the watershed in agricultural production. Among-lake variability in invertebrate abundance was more often explained by lake-scale predictors than by variables based on watershed characteristics. For example, we identified significant associations between fish presence and community type and abundance of small and large cladocera, Amphipoda, Diptera, and ETO. Abundance of Amphipoda, Diptera, and Corixidae were also positively correlated with submerged plant abundance. We observed no associations between lake-watershed variables and abundance of our invertebrate taxa. Broadly, our results seem to indicate preeminence of lake-level influences on aquatic invertebrates in shallow lakes, but historical land-use legacies may mask important relationships.	[Hanson, Mark A.] Minnesota Dept Nat Resources, Wetland Wildlife Populat & Res Grp, Bemidji, MN 56601 USA; [Herwig, Brian R.; Younk, Jerry A.] Minnesota Dept Nat Resources, Div Fish & Wildlife Fisheries Res, Bemidji, MN USA; [Zimmer, Kyle D.] Univ St Thomas, Dept Biol, St Paul, MN USA; [Fieberg, John] Minnesota Dept Nat Resources, Biometr Unit, Forest Lake, MN USA; [Vaughn, Sean R.] Minnesota Dept Nat Resources, Div Waters, Cambridge, MN USA; [Wright, Robert G.] Minnesota Dept Nat Resources, Wildlife GIS Unit, Forest Lake, MN USA	University of St Thomas Minnesota	Hanson, MA (corresponding author), Minnesota Dept Nat Resources, Wetland Wildlife Populat & Res Grp, Bemidji, MN 56601 USA.	mark.alan.hanson@state.mn.us	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021	Section of Fisheries, Minnesota Department of Natural Resources; Section of Wildlife, Minnesota Department of Natural Resources; University of St. Thomas, Department of Biology	Section of Fisheries, Minnesota Department of Natural Resources; Section of Wildlife, Minnesota Department of Natural Resources; University of St. Thomas, Department of Biology	Funding for this research was provided by Sections of Fisheries and Wildlife, Minnesota Department of Natural Resources and University of St. Thomas, Department of Biology. The funders had no role in design, analysis, decision to publish, or preparation of the manuscript.	ALMENDINGER JC, 2000, LANDTYPE ASS LAKE ST; Arbuckle KE, 2001, LIMNOL OCEANOGR, V46, P970, DOI 10.4319/lo.2001.46.4.0970; Baron JS, 2004, U COUNCIL WATER RESO, V127, P2; BERGMAN E, 1994, ECOLOGY, V75, P1233, DOI 10.2307/1937449; Blann KL, 2009, CRIT REV ENV SCI TEC, V39, P909, DOI 10.1080/10643380801977966; Brett MT, 1996, P NATL ACAD SCI USA, V93, P7723, DOI 10.1073/pnas.93.15.7723; BRONMARK C, 1992, ECOLOGY, V73, P1662, DOI 10.2307/1940018; Burks RL, 2006, ECOL STUD-ANAL SYNTH, V191, P37; Burton TM, 1999, WETLANDS, V19, P869, DOI 10.1007/BF03161789; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Davison AC, 1997, BOOTSTRAP METHODS TH; Deppe E, 1992, WISCONSIN DEP NATURA, V32; DETENBECK NE, 1993, LANDSCAPE ECOL, V8, P39, DOI 10.1007/BF00129866; Dodson SI, 2005, ECOL APPL, V15, P1191, DOI 10.1890/04-1494; Environmental Systems Research Institute Inc, 2007, WHATS NEW ARCGIS 9 2; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Euliss NH, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P471; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Fox J., 1997, APPL REGRESSION LINE; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; Friederichs SJ, 2011, OIKOS, V120, P756, DOI 10.1111/j.1600-0706.2010.19244.x; Gernes M.C., 2002, INDEXES BIOL INTEGRI; Gleason RA, 2003, WETLANDS, V23, P26, DOI 10.1672/0277-5212(2003)023[0026:EOSLOE]2.0.CO;2; Hanson MA, 2005, WETLANDS, V25, P764, DOI 10.1672/0277-5212(2005)025[0764:BIADOE]2.0.CO;2; HANSON MA, 1995, WETLANDS, V15, P167, DOI 10.1007/BF03160670; HANSON MA, 1994, CAN J FISH AQUAT SCI, V51, P1180, DOI 10.1139/f94-117; Hartzell D, 2007, WETLANDS, V27, P794, DOI 10.1672/0277-5212(2007)27[794:ACONAC]2.0.CO;2; HEISKARY S A, 1988, Lake and Reservoir Management, V4, P1; Hershey AE, 1999, BIOSCIENCE, V49, P887, DOI 10.2307/1313648; Herwig BR, 2007, ECOL FRESHW FISH, V16, P282, DOI 10.1111/j.1600-0633.2006.00220.x; Herwig BR, 2010, WETLANDS, V30, P609, DOI 10.1007/s13157-010-0037-7; Hobbs WO, 2012, ECOL APPL, V22, P1483, DOI 10.1890/11-1485.1; Hutchinson MG, 2000, ANUDEM SOFTWARE; JACKSON DA, 1989, ECOLOGY, V70, P1472, DOI 10.2307/1938206; Jackson LJ, 2011, AQUAT CONSERV, V21, P219, DOI 10.1002/aqc.1183; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Jones JI, 2003, ECOLOGY, V84, P2155, DOI 10.1890/02-0422; Kratz TK, 1997, FRESHWATER BIOL, V37, P209, DOI 10.1046/j.1365-2427.1997.00149.x; Lamberti GA, 2010, J N AM BENTHOL SOC, V29, P245, DOI 10.1899/08-166.1; Magnuson JJ, 1998, ECOLOGY, V79, P2941, DOI 10.1890/0012-9658(1998)079[2941:IVEITA]2.0.CO;2; Maronna RA, 2000, J STAT PLAN INFER, V89, P197, DOI 10.1016/S0378-3758(99)00208-6; MARTIN TH, 1992, OECOLOGIA, V89, P476, DOI 10.1007/BF00317152; MAZUMDER A, 1994, ECOLOGY, V75, P1141, DOI 10.2307/1939437; MCPEEK MA, 1990, ECOLOGY, V71, P83, DOI 10.2307/1940249; Mehner T, 2010, LIMNOL OCEANOGR, V55, P203, DOI 10.4319/lo.2010.55.1.0203; Meijer ML, 1999, HYDROBIOLOGIA, V408, P13, DOI 10.1023/A:1017045518813; Moore AA, 2005, ECOL APPL, V15, P1169, DOI 10.1890/04-1484; Moss B., 1996, GUIDE RESTORATION NU; NORTHCOTE TG, 1988, CAN J FISH AQUAT SCI, V45, P361, DOI 10.1139/f88-044; Potthoff AJ, 2008, J APPL ECOL, V45, P1170, DOI 10.1111/j.1365-2664.2008.01493.x; Prince Hugh C., 1997, WETLANDS AM MIDWEST; R Development Core Team, 2012, R LANG ENV STAT COMP; RAHEL FJ, 1984, ECOLOGY, V65, P1276, DOI 10.2307/1938333; Ramstack JM, 2004, CAN J FISH AQUAT SCI, V61, P561, DOI [10.1139/f04-015, 10.1139/F04-015]; Rennie MD, 2005, CAN J FISH AQUAT SCI, V62, P2088, DOI 10.1139/F05-123; Riera JL, 2000, FRESHWATER BIOL, V43, P301, DOI 10.1046/j.1365-2427.2000.00567.x; ROBINSON CLK, 1989, CAN J FISH AQUAT SCI, V46, P81, DOI 10.1139/f89-012; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2003, P NATL ACAD SCI USA, V100, P4040, DOI 10.1073/pnas.0737918100; Scheffer M., 2004, ECOLOGY SHALLOW LAKE; Schilling EG, 2009, BIOL CONSERV, V142, P3030, DOI 10.1016/j.biocon.2009.08.003; Schilling EG, 2009, FRESHWATER BIOL, V54, P181, DOI 10.1111/j.1365-2427.2008.02096.x; Simons AM, 2011, FISHES MINNESOTA INF; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Soininen J, 2012, ECOL APPL, V22, P624, DOI 10.1890/11-1126.1; Soranno PA, 2009, INT VER THEOR ANGEW, V30, P695; Spens J, 2007, J APPL ECOL, V44, P1127, DOI 10.1111/j.1365-2664.2007.01382.x; Stewart RE, 1971, BUREAU SPORT FISHERI, V92; SWANSON GA, 1978, PROG FISH CULT, V40, P73, DOI 10.1577/1548-8659(1978)40[73:FTFCLA]2.0.CO;2; SWANSON GA, 1978, J WILDLIFE MANAGE, V42, P670, DOI 10.2307/3800841; TIMMS RM, 1984, LIMNOL OCEANOGR, V29, P472, DOI 10.4319/lo.1984.29.3.0472; TONN WM, 1982, ECOLOGY, V63, P1149, DOI 10.2307/1937251; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; Vanni MJ, 2006, ECOLOGY, V87, P1696, DOI 10.1890/0012-9658(2006)87[1696:NCBFSR]2.0.CO;2; Vaughn S. R., 2010, DNR WATERSHED DELINE; Verant ML, 2007, FRESHWATER BIOL, V52, P1968, DOI 10.1111/j.1365-2427.2007.01820.x; Wang J, 2007, ROBUST INSIGHTFUL RO; Wissinger SA, 1999, INVERTEBRATES IN FRESHWATER WETLANDS OF NORTH AMERICA, P1043; Zimmer KD, 2003, CAN J FISH AQUAT SCI, V60, P721, DOI 10.1139/F03-060; Zimmer KD, 2002, FRESHWATER BIOL, V47, P2071, DOI 10.1046/j.1365-2427.2002.00952.x; Zimmer KD, 2000, CAN J FISH AQUAT SCI, V57, P76, DOI 10.1139/cjfas-57-1-76; Zimmer KD, 2001, ECOSYSTEMS, V4, P346, DOI 10.1007/s10021-001-0016-1; Zimmer KD, 2009, ECOSYSTEMS, V12, P843, DOI 10.1007/s10021-009-9262-4	89	16	17	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44644	10.1371/journal.pone.0044644	http://dx.doi.org/10.1371/journal.pone.0044644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970275	Green Published, gold			2022-12-27	WOS:000308458400100
J	Jiang, N; Zhang, XS; Zheng, XF; Chen, D; Siu, KS; Wang, HM; Ichim, TE; Quan, D; McAlister, V; Chen, GH; Min, WP				Jiang, Nan; Zhang, Xusheng; Zheng, Xiufen; Chen, Di; Siu, Kingsun; Wang, Hongmei; Ichim, Thomas E.; Quan, Douglas; McAlister, Vivian; Chen, Guihua; Min, Wei-Ping			A Novel In Vivo siRNA Delivery System Specifically Targeting Liver Cells for Protection of ConA-Induced Fulminant Hepatitis	PLOS ONE			English	Article							SMALL INTERFERING RNA; GENE-EXPRESSION; B-VIRUS; RECEPTOR; INHIBITION; REDUCTION; LIPOSOMES; MECHANISM; APOPTOSIS; CASPASE-8	Background: Fulminant hepatitis progresses to acute liver failure (ALF) when the extent of hepatocyte death exceeds the liver's regenerative capacity. Although small interfering RNA (siRNA) appears promising in animal models of hepatitis, the approach is limited by drawbacks associated with systemic administration of siRNA. The aim of this study is to develop a hepatocyte-specific delivery system of siRNA for treatment of fulminant hepatitis. Methodology/Principal Findings: Galactose-conjugated liposome nano-particles (Gal-LipoNP) bearing siRNA was prepared, and the particle size and zeta potential of Gal-LipoNP/siRNA complexes were measured. The distribution, cytotoxicity and gene silence efficiency were studied in vivo in a concanavalin A (ConA)-induced hepatitis model. C57BL/6 mice were treated with Gal-LipoNP Fas siRNA by i.v. injection 72 h before ConA challenge, and hepatocyte injury was evaluated using serum alanine transferase (ALT) and aspartate transaminase (AST) levels, as well as liver histopathology and TUNEL-positive hepatocytes. The galactose-ligated liposomes were capable of encapsulating >96% siRNA and exhibited a higher stability than naked siRNA in plasma. Hepatocyte-specific targeting was confirmed by in vivo delivery experiment, in which the majority of Gal-LipoNP-siRNA evaded nuclease digestion and accumulated in the liver as soon as 6 h after administration. In vivo gene silencing was significant in the liver after treatment of Gal-Lipo-siRNA. In the ConA-induced hepatitis model, serum levels of ALT and AST were significantly reduced in mice treated with Gal-lipoNP-siRNA as compared with control mice. Additionally, tissue histopathology and apoptosis showed an overall reduction of injury in the Gal-LipoNP siRNA-treated mice. Conclusions/Significance: This study is the first to our knowledge to demonstrate reduction of hepatic injury by liver-specific induction of RNA interference using Gal-LipoNP Fas siRNA, highlighting a novel RNAi-based therapeutic potential in many liver diseases.	[Jiang, Nan; Zhang, Xusheng; Zheng, Xiufen; Chen, Di; Siu, Kingsun; Quan, Douglas; McAlister, Vivian; Min, Wei-Ping] London Hlth Sci Ctr, Multiorgan Transplant Program, London, ON, Canada; [Jiang, Nan; Zhang, Xusheng; Zheng, Xiufen; Chen, Di; Siu, Kingsun; Quan, Douglas; McAlister, Vivian; Min, Wei-Ping] Univ Western Ontario, Dept Surg Pathol & Oncol, London, ON, Canada; [Jiang, Nan; Chen, Guihua] Sun Yat Sen Univ, Transplantat Res Inst, Affiliated Hosp 3, Liver Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Hongmei; Min, Wei-Ping] Nanchang Univ, Jiangxi Prov Inst Med Sci, Nanchang, Peoples R China; [Wang, Hongmei; Min, Wei-Ping] Nanchang Univ, Sch Med, Nanchang, Peoples R China; [Ichim, Thomas E.] Medistem Labs, San Diego, CA USA	London Health Sciences Centre; Western University (University of Western Ontario); Sun Yat Sen University; Nanchang University; Nanchang University	Min, WP (corresponding author), Univ Hosp C9 136, 339 Windermere Rd, London, ON N6A 5A5, Canada.	weiping.min@uwo.ca	JIANG, NAN/AHB-1945-2022; McAlister, Vivian/B-9881-2008	McAlister, Vivian/0000-0002-2479-6862	Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; National Nature Science Foundation of China [81160286]; CIHR Strategic Training Program in Cancer Research; Department of Surgery Institute Scientist, University of Western Ontario; Major State Basic Research Development Program (973 Program) of China [2009CB522404]; National 12th Five-Year Science and Technology Plan major projects of China [2012ZX10002017-005]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); CIHR Strategic Training Program in Cancer Research(Canadian Institutes of Health Research (CIHR)); Department of Surgery Institute Scientist, University of Western Ontario; Major State Basic Research Development Program (973 Program) of China(National Basic Research Program of China); National 12th Five-Year Science and Technology Plan major projects of China	This study was supported by the Canadian Institute of Health Research, the Heart and Stroke Foundation of Canada, and a grant from National Nature Science Foundation of China (No. 81160286). DC was supported by the CIHR Strategic Training Program in Cancer Research. WM is a recipient of Department of Surgery Institute Scientist, University of Western Ontario. NJ was supported by the grants from the Major State Basic Research Development Program (973 Program) of China (No. 2009CB522404), National 12th Five-Year Science and Technology Plan major projects of China (No. 2012ZX10002017-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Akhtar S, 2007, ADV DRUG DELIVER REV, V59, P164, DOI 10.1016/j.addr.2007.03.010; Gabizon A, 1999, BIOCONJUGATE CHEM, V10, P289, DOI 10.1021/bc9801124; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Grzelinski M, 2006, HUM GENE THER, V17, P751, DOI 10.1089/hum.2006.17.751; Hughes J, 2010, METHODS MOL BIOL, V605, P445, DOI 10.1007/978-1-60327-360-2_31; Kawakami S, 2007, DRUG METAB PHARMACOK, V22, P142, DOI 10.2133/dmpk.22.142; Kim M, 2006, VIRUS RES, V122, P1, DOI 10.1016/j.virusres.2006.05.003; Lacronique V, 1996, NAT MED, V2, P80, DOI 10.1038/nm0196-80; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024740; Moschos SA, 2007, BIOCONJUGATE CHEM, V18, P1450, DOI 10.1021/bc070077d; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Plank C, 1999, HUM GENE THER, V10, P319, DOI 10.1089/10430349950019101; Rauschhuber C, 2008, J GENE MED, V10, P878, DOI 10.1002/jgm.1207; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Rothdiener M, 2010, J CONTROL RELEASE, V144, P251, DOI 10.1016/j.jconrel.2010.02.020; Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356; Santel A, 2006, GENE THER, V13, P1222, DOI 10.1038/sj.gt.3302777; Sass DA, 2005, LIVER TRANSPLANT, V11, P594, DOI 10.1002/lt.20435; Scherr M, 2003, OLIGONUCLEOTIDES, V13, P353, DOI 10.1089/154545703322617032; Schroeder A, 2010, J INTERN MED, V267, P9, DOI 10.1111/j.1365-2796.2009.02189.x; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Tagami A, 2003, HEPATO-GASTROENTEROL, V50, P443; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; van de Water FM, 2006, DRUG METAB DISPOS, V34, P1393, DOI 10.1124/dmd.106.009555; Vaquero Javier, 2003, Curr Gastroenterol Rep, V5, P39, DOI 10.1007/s11894-003-0008-8; Wagner E, 1999, ADV DRUG DELIVER REV, V38, P279, DOI 10.1016/S0169-409X(99)00033-2; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Wu SY, 2009, AAPS J, V11, P639, DOI 10.1208/s12248-009-9140-1; Yano J, 2004, CLIN CANCER RES, V10, P7721, DOI 10.1158/1078-0432.CCR-04-1049; Ying RS, 2007, ANTIVIR RES, V73, P24, DOI 10.1016/j.antiviral.2006.05.022; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zheng XF, 2009, CIRCULATION, V120, P1099, DOI 10.1161/CIRCULATIONAHA.108.787390; Zheng XF, 2009, BLOOD, V113, P2646, DOI 10.1182/blood-2008-04-151191	38	30	30	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44138	10.1371/journal.pone.0044138	http://dx.doi.org/10.1371/journal.pone.0044138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970170	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400038
J	Sun, LG; Zhou, X; Wang, YH; Cheng, WH; Jia, N				Sun, Liguang; Zhou, Xin; Wang, Yuhong; Cheng, Wenhan; Jia, Nan			Identification of Paleo-Events Recorded in the Yellow Sea Sediments by Sorting Coefficient of Grain Size	PLOS ONE			English	Article							CHINESE LOESS; RIVER; MUD	Identification of natural and anthropogenic events in the past is important for studying their patterns and mechanisms; and sensitive proxies in marine sediments are more reliable for identifying these events than those in terrestrial sediments, which are usually disturbed by human activities. Since the main source materials for the sediments in the Northern Yellow Sea Mud are transported by the Yellow River, sedimentary characteristics can be used to reconstruct the historical events that occurred in the Yellow River Valley. In the present study, by analyzing sorting coefficient of grain size in a 250-year sediment core from the Northern Yellow Sea Mud, we identified several major historical events: the Haiyuan Earthquake in AD 1920 and several times of relocation of the Yellow River estuary. The proxy has the potential of detecting and reconstructing historical events; in combination with historical archives, they also provide an accurate dating method.	[Sun, Liguang; Zhou, Xin; Cheng, Wenhan; Jia, Nan] Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Peoples R China; [Sun, Liguang; Zhou, Xin; Cheng, Wenhan; Jia, Nan] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Peoples R China; [Wang, Yuhong] Ningbo Univ, Adv Management Res Ctr, Ningbo 315211, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Ningbo University	Sun, LG (corresponding author), Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Peoples R China.	slg@ustc.edu.cn		Zhou, Xin/0000-0003-2640-6431	National Basic Research Program of China [2010CB428902]	National Basic Research Program of China(National Basic Research Program of China)	This study is supported by the National Basic Research Program of China (2010CB428902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; Central Meteorological Bureau of China, 1981, YEARL CHARTS DRYN WE; Close U., 1922, NATL GEOGR MAG, V41, P445; D'Arrigo R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022271; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Gao W, 1997, J SEDIMENT RES, P1; [郭其蕴 Guo Qiyun], 2004, [大气科学, Chinese Journal of Atmospheric Sciences], V28, P206; KUKLA G, 1987, QUATERNARY SCI REV, V6, P191, DOI 10.1016/0277-3791(87)90004-7; [李凤业 Li Fengye], 2002, [海洋与湖沼, Oceanolgia et Limnologia Sinica], V33, P364; [刘健 Liu Jian], 2007, [第四纪研究, Quaternary Sciences], V27, P1031; Liu TS, 1998, ANNU REV EARTH PL SC, V26, P111, DOI 10.1146/annurev.earth.26.1.111; Luo C.Z., 1996, FLOODS CHINA; Peng SZ, 2001, SCI CHINA SER D, V44, P261, DOI 10.1007/BF02911995; [齐君 Qi Jun], 2004, [海洋地质与第四纪地质, Marine Geology & Quaternary Geology], V24, P9; Qiao SQ, 2011, CONT SHELF RES, V31, P1336, DOI 10.1016/j.csr.2011.05.007; Shen S.X., 1996, OCEANLOLGIA LIMNOLOG, V27, P518; Shi CX, 2005, GEOGR ANN A, V87A, P461, DOI 10.1111/j.0435-3676.2005.00271.x; Sun Y, 2006, PALAEOGEOGR PALAEOCL, V241, P129, DOI 10.1016/j.palaeo.2006.06.018; Tang K, 1994, YELLOW RIVER, P13; The Ministry of Water Resources of the People's Republic of China, 2010, SPEC RIV SED B 2009; Trask P. D., 1932, ORIGIN ENV SOURCE SE; Xiang R, 2006, SCI CHINA SER D, V49, P604, DOI 10.1007/s11430-006-0604-1; Xiao SB, 2005, CHINESE SCI BULL, V50, P466, DOI 10.1360/03wd0571; Xie Z, 2011, J HOHAI U PHILOS SOC, V13, P15; Yang WF, 2009, MAR POLLUT BULL, V58, P923, DOI 10.1016/j.marpolbul.2009.03.019; Yang ZS, 2007, MAR GEOL, V240, P169, DOI 10.1016/j.margeo.2007.02.008; ZHANG J, 1990, J HYDROL, V120, P203, DOI 10.1016/0022-1694(90)90150-V; Zhang Z., 1995, GEO J, V36, P269, DOI DOI 10.1007/BF00813183	28	8	8	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44725	10.1371/journal.pone.0044725	http://dx.doi.org/10.1371/journal.pone.0044725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970299	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400114
J	Chen, XJ; Min, DH; Yasir, TA; Hu, YG				Chen, Xiaojie; Min, Donghong; Yasir, Tauqeer Ahmad; Hu, Yin-Gang			Genetic Diversity, Population Structure and Linkage Disequilibrium in Elite Chinese Winter Wheat Investigated with SSR Markers	PLOS ONE			English	Article							LENGTH POLYMORPHISMS; MOLECULAR DIVERSITY; BREAD WHEAT; DNA	To ascertain genetic diversity, population structure and linkage disequilibrium (LD) among a representative collection of Chinese winter wheat cultivars and lines, 90 winter wheat accessions were analyzed with 269 SSR markers distributed throughout the wheat genome. A total of 1,358 alleles were detected, with 2 to 10 alleles per locus and a mean genetic richness of 5.05. The average genetic diversity index was 0.60, with values ranging from 0.05 to 0.86. Of the three genomes of wheat, ANOVA revealed that the B genome had the highest genetic diversity (0.63) and the D genome the lowest (0.56); significant differences were observed between these two genomes (P<0.01). The 90 Chinese winter wheat accessions could be divided into three subgroups based on STRUCTURE, UPGMA cluster and principal coordinate analyses. The population structure derived from STRUCTURE clustering was positively correlated to some extent with geographic eco-type. LD analysis revealed that there was a shorter LD decay distance in Chinese winter wheat compared with other wheat germplasm collections. The maximum LD decay distance, estimated by curvilinear regression, was 17.4 cM (r(2)>0.1), with a whole genome LD decay distance of approximately 2.2 cM (r(2)>0.1, P<0.001). Evidence from genetic diversity analyses suggest that wheat germplasm from other countries should be introduced into Chinese winter wheat and distant hybridization should be adopted to create new wheat germplasm with increased genetic diversity. The results of this study should provide valuable information for future association mapping using this Chinese winter wheat collection.	[Chen, Xiaojie; Min, Donghong; Yasir, Tauqeer Ahmad; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hu, Yin-Gang] NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	cxj2638@163.com; huyingang@nwsuaf.edu.cn			Ministry of Science and Technology [2006AA100201, 2006AA100223]; Ministry of Education, P.R. China [B12007]; ACIAR Project of Australia [CIM/2005/111]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, P.R. China(Ministry of Education, China); ACIAR Project of Australia(Australian Ctr Intl Agr Res)	This work was financially supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223) of the Ministry of Science and Technology, and the 111 Project (B12007) of Ministry of Education, P.R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKAYA MS, 1992, GENETICS, V132, P1131; Alheit KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-235; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Barrett BA, 1998, CROP SCI, V38, P1261, DOI 10.2135/cropsci1998.0011183X003800050025x; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Dreisigacker S, 2004, CROP SCI, V44, P381, DOI 10.2135/cropsci2004.0381; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garris AJ, 2003, GENETICS, V165, P759; Hao CY, 2006, SCI CHINA SER C, V49, P218, DOI 10.1007/s11427-006-0218-z; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Horvath A, 2009, THEOR APPL GENET, V119, P1523, DOI 10.1007/s00122-009-1153-8; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Rambaut A., 2009, FIGTREE VERSION 1 3; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1	33	86	91	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44510	10.1371/journal.pone.0044510	http://dx.doi.org/10.1371/journal.pone.0044510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957076	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800069
J	Ng, SYL; Chow, BKC; Kasamatsu, J; Kasahara, M; Lee, LTO				Ng, Stephanie Y. L.; Chow, Billy K. C.; Kasamatsu, Jun; Kasahara, Masanori; Lee, Leo T. O.			Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today's Highly Diversified Forms	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; ADENYLATE-CYCLASE; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; VPAC(1) RECEPTOR; BINDING-SITES; AMINO-ACIDS; HYPOTHALAMIC POLYPEPTIDE; HISTIDINE-ISOLEUCINE	VIP and PACAP are pleiotropic peptides belonging to the secretin superfamily of brain-gut peptides and interact specifically with three receptors (VPAC(1), PAC(1) and VPAC(2)) from the class II B G protein-coupled receptor family. There is immense interest regarding their molecular evolution which is often described closely alongside gene and/or genome duplications. Despite the wide array of information available in various vertebrates and one invertebrate the tunicate, their evolutionary origins remain unresolved. Through searches of genome databases and molecular cloning techniques, the first lamprey VIP/PACAP ligands and VPAC receptors are identified from the Japanese lamprey. In addition, two VPAC receptors (VPACa/b) are identified from inshore hagfish and ligands predicted for sea lamprey. Phylogenetic analyses group these molecules into their respective PHI/VIP, PRP/PACAP and VPAC receptor families and show they resemble ancestral forms. Japanese lamprey VIP/PACAP peptides synthesized were tested with the hagfish VPAC receptors. hfVPACa transduces signal via both adenylyl cylase and phospholipase C pathways, whilst hfVPACb was only able to transduce through the calcium pathway. In contrast to the widespread distribution of VIP/PACAP ligands and receptors in many species, the agnathan PACAP and VPAC receptors were found almost exclusively in the brain. In situ hybridisation further showed their abundance throughout the brain. The range of VIP/PACAP ligands and receptors found are highly useful, providing a glimpse into the evolutionary events both at the structural and functional levels. Though representative of ancestral forms, the VIP/PACAP ligands in particular have retained high sequence conservation indicating the importance of their functions even early in vertebrate evolution. During these nascent stages, only two VPAC receptors are likely responsible for eliciting functions before evolving later into specific subtypes post-Agnatha. We also propose VIP and PACAP's first functions to predominate in the brain, evolving alongside the central nervous system, subsequently establishing peripheral functions.	[Ng, Stephanie Y. L.; Chow, Billy K. C.; Lee, Leo T. O.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Kasamatsu, Jun; Kasahara, Masanori] Hokkaido Univ, Dept Pathol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 060, Japan	University of Hong Kong; Hokkaido University	Ng, SYL (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	ltolee2@hku.hk	Kasahara, Masanori/G-7651-2011; Lee, Leo T.O./AAB-1581-2021; Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Government Research Grants Council [7686/08M, HKU6/CRF/11G]; Committee on Research and Conference [11159073]	Hong Kong Government Research Grants Council(Hong Kong Research Grants Council); Committee on Research and Conference	The present study was supported by the Hong Kong Government Research Grants Council Grants, 7686/08M to LTOL, HKU6/CRF/11G to BKCC and the Committee on Research and Conference Grants 11159073 to LTOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ben-Shlomo I, 2005, MOL ENDOCRINOL, V19, P1097, DOI 10.1210/me.2004-0451; Bentley P., 1998, COMP VERTEBRATE ENDO; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Bourgault S, 2008, P 30 EUR PEPT S, P352; CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Cardoso JCR, 2007, PEPTIDES, V28, P1902, DOI 10.1016/j.peptides.2007.05.016; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; CAUVIN A, 1990, PEPTIDES, V11, P773, DOI 10.1016/0196-9781(90)90194-A; CHAKDER S, 1993, J PHARMACOL EXP THER, V266, P392; Chow BKC, 1997, GEN COMP ENDOCR, V105, P176, DOI 10.1006/gcen.1996.6818; Colbert E.H., 2001, COLBERTS EVOLUTION V, V5; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; GOTTSCHALL PE, 1990, ENDOCRINOLOGY, V127, P272, DOI 10.1210/endo-127-1-272; GOTTSCHALL PE, 1991, FASEB J, V5, P194, DOI 10.1096/fasebj.5.2.1848519; Gourlet P, 1996, REGUL PEPTIDES, V62, P125, DOI 10.1016/0167-0115(96)00010-9; Gourlet P, 1998, EUR J PHARMACOL, V348, P95, DOI 10.1016/S0014-2999(98)00133-2; Gozes I, 1999, CURR MED CHEM, V6, P1019; Gozes I, 1999, P NATL ACAD SCI USA, V96, P4143, DOI 10.1073/pnas.96.7.4143; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; HOLLAND PWH, 1994, DEVELOPMENT, P125; Holmgren S, 2001, BRAIN RES BULL, V55, P723, DOI 10.1016/S0361-9230(01)00556-1; HOSOYA M, 1993, BIOCHEM BIOPH RES CO, V194, P133, DOI 10.1006/bbrc.1993.1795; Hoyle CHV, 1998, REGUL PEPTIDES, V73, P1, DOI 10.1016/S0167-0115(97)01073-2; Igarashi H, 2002, J PHARMACOL EXP THER, V301, P37, DOI 10.1124/jpet.301.1.37; Igarashi H, 2002, J PHARMACOL EXP THER, V303, P445, DOI 10.1124/jpet.102.038075; INAGAKI N, 1994, P NATL ACAD SCI USA, V91, P2679, DOI 10.1073/pnas.91.7.2679; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Langer I, 2005, CELL SIGNAL, V17, P17, DOI 10.1016/j.cellsig.2004.05.009; Lee LTO, 2007, P NATL ACAD SCI USA, V104, P2133, DOI 10.1073/pnas.0611008104; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Matsuda K, 1998, PEPTIDES, V19, P1489, DOI 10.1016/S0196-9781(98)00091-6; McRory J, 1997, ENDOCRINOLOGY, V138, P2380, DOI 10.1210/en.138.6.2380; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Montero M, 2000, J MOL ENDOCRINOL, V25, P157, DOI 10.1677/jme.0.0250157; MORROW JA, 1993, FEBS LETT, V329, P99, DOI 10.1016/0014-5793(93)80202-6; Nachtergael I, 2003, BIOCHEM J, V370, P1003, DOI 10.1042/BJ20020811; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Nicole P, 1998, J PHARMACOL EXP THER, V284, P744; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; ODONNELL M, 1991, J BIOL CHEM, V266, P6389; Ohno S., 1970, P1; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; Onoue S, 1999, BIOMED RES-TOKYO, V20, P219, DOI 10.2220/biomedres.20.219; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Pisegna JR, 1996, J BIOL CHEM, V271, P17267, DOI 10.1074/jbc.271.29.17267; ROBBERECHT P, 1992, MOL PHARMACOL, V42, P347; ROBBERECHT P, 1992, EUR J BIOCHEM, V207, P239, DOI 10.1111/j.1432-1033.1992.tb17043.x; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Schafer H, 1999, REGUL PEPTIDES, V79, P83, DOI 10.1016/S0167-0115(98)00147-5; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; SUDA K, 1992, NEUROSCI LETT, V137, P19, DOI 10.1016/0304-3940(92)90288-I; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; SVOBODA M, 1993, BIOCHEM BIOPH RES CO, V195, P881, DOI 10.1006/bbrc.1993.2127; Tams JW, 2001, J MOL NEUROSCI, V17, P325, DOI 10.1385/JMN:17:3:325; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tse DLY, 2002, ENDOCRINOLOGY, V143, P1327, DOI 10.1210/en.143.4.1327; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; VANDERMEERS A, 1992, EUR J BIOCHEM, V208, P815, DOI 10.1111/j.1432-1033.1992.tb17252.x; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wu S, 2008, J MOL ENDOCRINOL, V41, P343, DOI 10.1677/JME-08-0083	72	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44691	10.1371/journal.pone.0044691	http://dx.doi.org/10.1371/journal.pone.0044691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957100	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800093
J	Corsi, DJ; Subramanian, SV; McKee, M; Li, W; Swaminathan, S; Lopez-Jaramillo, P; Avezum, A; Lear, SA; Dagenais, G; Rangarajan, S; Teo, K; Yusuf, S; Chow, CK				Corsi, Daniel J.; Subramanian, S. V.; McKee, Martin; Li, Wei; Swaminathan, Sumathi; Lopez-Jaramillo, Patricio; Avezum, Alvaro; Lear, Scott A.; Dagenais, Gilles; Rangarajan, Sumathy; Teo, Koon; Yusuf, Salim; Chow, Clara K.			Environmental Profile of a Community's Health (EPOCH): An Ecometric Assessment of Measures of the Community Environment Based on Individual Perception	PLOS ONE			English	Article							SOCIETAL INFLUENCES; INCOME COUNTRIES; NEIGHBORHOODS; MULTILEVEL; RESPONSES; SCIENCE; DISEASE; MODELS; MIDDLE; PURE	Background: Public health research has turned towards examining upstream, community-level determinants of cardiovascular disease risk factors. Objective measures of the environment, such as those derived from direct observation, and perception-based measures by residents have both been associated with health behaviours. However, current methods are generally limited to objective measures, often derived from administrative data, and few instruments have been evaluated for use in rural areas or in low-income countries. We evaluate the reliability of a quantitative tool designed to capture perceptions of community tobacco, nutrition, and social environments obtained from interviews with residents in communities in 5 countries. Methodology/Principal Findings: Thirteen measures of the community environment were developed from responses to questionnaire items from 2,360 individuals residing in 84 urban and rural communities in 5 countries (China, India, Brazil, Colombia, and Canada) in the Environmental Profile of a Community's Health (EPOCH) study. Reliability and other properties of the community-level measures were assessed using multilevel models. High reliability (>0.80) was demonstrated for all community-level measures at the mean number of survey respondents per community (n = 28 respondents). Questionnaire items included in each scale were found to represent a common latent factor at the community level in multilevel factor analysis models. Conclusions/Significance: Reliable measures which represent aspects of communities potentially related to cardiovascular disease (CVD)/risk factors can be obtained using feasible sample sizes. The EPOCH instrument is suitable for use in different settings to explore upstream determinants of CVD/risk factors.	[Corsi, Daniel J.; Rangarajan, Sumathy; Teo, Koon; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Li, Wei] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Swaminathan, Sumathi] St Johns Res Inst, Bangalore, Karnataka, India; [Lopez-Jaramillo, Patricio] Univ Santander, Res Direct, Fdn Oftalmol Santander Clin Carlos Arila Lulle, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Santander, Sch Med, Bucaramanga, Colombia; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chow, Clara K.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	McMaster University; Population Health Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; St. John's National Academy of Health Sciences; St. John's Research Institute; Universidad Industrial de Santander; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Simon Fraser University; Laval University; George Institute for Global Health; University of Sydney; University of Sydney	Corsi, DJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.	daniel.corsi@phri.ca	Avezum, Alvaro AA/K-6137-2016; Corsi, Daniel J/S-4689-2018; Swaminathan, Sumathi/AGI-7678-2022; McKee, Marc D/E-2187-2011; Avezum, Alvaro/AAP-7687-2020; McKee, Martin/E-6673-2018	Avezum, Alvaro AA/0000-0002-3073-6890; Corsi, Daniel J/0000-0001-7063-3354; McKee, Marc D/0000-0001-8349-965X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; McKee, Martin/0000-0002-0121-9683; Yusuf, Salim/0000-0003-4776-5601; Teo, Koon/0000-0002-3731-0956	Hamilton Health Sciences New Investigator Grant [08158]; Heart and Stroke Foundation of Ontario Pilot Project Grant [PLP6567]; Colombian Institute for Science and Technology [6566-04-18062]	Hamilton Health Sciences New Investigator Grant; Heart and Stroke Foundation of Ontario Pilot Project Grant; Colombian Institute for Science and Technology	This work was supported by a Hamilton Health Sciences New Investigator Grant [#08158 to CC, SY] and a Heart and Stroke Foundation of Ontario Pilot Project Grant [#PLP6567]. Data collection in Colombia was partly supported by the Colombian Institute for Science and Technology [#6566-04-18062 to PLJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne WJ, 2012, MCMC ESTIMATION MLWI; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Day K, 2006, AM J PREV MED, V30, P144, DOI 10.1016/j.amepre.2005.09.017; Eriksen M P, 1999, Nicotine Tob Res, V1 Suppl 1, pS79; Gelman A., 2007, DATA ANAL USING REGR; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Kawachi I., 2003, NEIGHBORHOODS HLTH; Leckie G., 2011, RUNMLWIN STATA MODUL; Rasbash J., 2010, MLWIN VERSION 2 20; Raudenbush S. W., 2003, NEIGHBORHOODS HLTH; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Smedslund G, 2004, TOB CONTROL, V13, P197, DOI 10.1136/tc.2002.002915; Subramanian S.V., 2003, NEIGHBORHOODS HLTH; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thomson G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-64; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	21	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44410	10.1371/journal.pone.0044410	http://dx.doi.org/10.1371/journal.pone.0044410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973446	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000308577600050
J	Jung, JJ; Tiwari, A; Inamdar, SM; Thomas, CP; Goel, A; Choudhury, A				Jung, Jae-Joon; Tiwari, Ajit; Inamdar, Shivangi M.; Thomas, Christie P.; Goel, Apollina; Choudhury, Amit			Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; REGULATED EXOCYTOSIS; ENDOCYTIC PATHWAYS; ANGIOGENIC FACTORS; GOLGI TRANSPORT; COAT PROTEINS; PREECLAMPSIA; TRAFFICKING; CELLS	The soluble form of vascular endothelial growth factor receptor 1 (sVEGFR-1/sFlt1) is generated by alternative splicing of the FLT1 gene. Secretion of sFlt1 from endothelial cells plays an important role in blood vessel sprouting and morphogenesis. However, excess sFlt1 secretion is associated with diseases such as preeclampsia and chronic kidney disease. To date, the secretory transport process involved in the secretion of sFlt1 is poorly understood. In the present study, we investigated the itinerary of sFlt1 trafficking along the secretory pathway. To understand the timecourse of sFlt1 secretion, endothelial cells stably expressing sFlt1 were metabolically radiolabeled with [S-35]-methionine and cysteine. Our results indicate that after initial synthesis the levels of secreted [S-35]-sFlt1 in the extracellular medium peaks at 8 hours. Treatment with brefeldin A (BFA), a drug which blocks trafficking between the endoplasmic reticulum (ER) and the Golgi complex, inhibited extracellular release of sFlt1 suggesting that ER to Golgi and intra-Golgi trafficking of sFlt1 are essential for its secretion. Furthermore, we show that ectopic expression of dominant-negative mutant forms of Arf1, Arf6, and Rab11 as well as siRNA-mediated knockdown of these GTPases block secretion of sFlt1 during normoxic and hypoxic conditions suggesting role for these small GTPases. This work is the first to report role of regulatory proteins involved in sFlt1 trafficking along the secretory pathway and may provide insights and new molecular targets for the modulation of sFlt-1 release during physiological and pathological conditions.	[Jung, Jae-Joon; Tiwari, Ajit; Inamdar, Shivangi M.; Choudhury, Amit] Univ Iowa, Dept Anat, Iowa City, IA 52242 USA; [Jung, Jae-Joon; Tiwari, Ajit; Inamdar, Shivangi M.; Choudhury, Amit] Univ Iowa, Dept Cell Biol, Iowa City, IA USA; [Choudhury, Amit] Univ Iowa, Dept Orthopaed, Iowa City, IA USA; [Choudhury, Amit] Univ Iowa, Dept Rehabil, Iowa City, IA USA; [Thomas, Christie P.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Goel, Apollina] Univ Iowa, Dept Radiat Oncol, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Jung, JJ (corresponding author), Univ Iowa, Dept Anat, Iowa City, IA 52242 USA.	amit-choudhury@uiowa.edu	Jung, Jae-Joon/I-2186-2014	Thomas, Christie/0000-0002-5989-9685	National Institutes of Health, National Heart, Lung, and Blood Institute [HL089599]; NATIONAL CANCER INSTITUTE [R01CA127958] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090053] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from National Institutes of Health, National Heart, Lung, and Blood Institute (HL089599 to AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Al-Awar O, 2000, MOL CELL BIOL, V20, P5998, DOI 10.1128/MCB.20.16.5998-6007.2000; Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Charnock-Jones DS, 2002, J ANAT, V200, P607, DOI 10.1046/j.1469-7580.2002.00063.x; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lippincott-Schwartz J, 1998, HISTOCHEM CELL BIOL, V109, P449, DOI 10.1007/s004180050247; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pau E, 2006, HUM REPROD, V21, P1453, DOI 10.1093/humrep/del005; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roeckl W, 1998, EXP CELL RES, V241, P161, DOI 10.1006/excr.1998.4039; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Yang CZ, 1999, J BIOL CHEM, V274, P25297, DOI 10.1074/jbc.274.36.25297	66	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44572	10.1371/journal.pone.0044572	http://dx.doi.org/10.1371/journal.pone.0044572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962618	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600070
J	Martin, N; Ruddick, A; Arthur, GK; Wan, HD; Woodman, L; Brightling, CE; Jones, DJL; Pavord, ID; Bradding, P				Martin, Neil; Ruddick, Andrew; Arthur, Greer K.; Wan, Heidi; Woodman, Lucy; Brightling, Christopher E.; Jones, Don J. L.; Pavord, Ian D.; Bradding, Peter			Primary Human Airway Epithelial Cell-Dependent Inhibition of Human Lung Mast Cell Degranulation	PLOS ONE			English	Article							PRO-RESOLVING MEDIATORS; LIPOXIN A(4) RECEPTOR; SMOOTH-MUSCLE; LIPID MEDIATORS; BRONCHIAL EPITHELIUM; ASTHMA PATHOGENESIS; SYSTEMS-APPROACH; INFLAMMATION; RESOLUTION; EXPRESSION	Introduction: Chronic mast cell activation is a characteristic feature of asthma. BEAS-2B human airway epithelial cells (AEC) profoundly inhibit both constitutive and IgE-dependent human lung mast cell (HLMC) histamine release. The aim of this study was to examine the regulation of HLMC degranulation by primary AEC from healthy and asthmatic subjects, and investigate further the inhibitory mechanism. Methods: HLMC were co-cultured with both BEAS-2B and primary AEC grown as monolayers or air-liquid interface (ALI) cultures. Results: Both constitutive and IgE-dependent HLMC histamine release were attenuated by BEAS-2B, primary AEC monolayers and ALI cultures. This occurred in the absence of HLMC-AEC contact indicating the presence of a soluble factor. Unlike healthy ALI AEC, asthmatic ALI-AEC did not significantly reduce constitutive histamine release. AEC inhibitory activity was transferable in primary AEC monolayer supernatant, but less active than with Transwell co-culture, suggesting that the inhibitory factor was labile. The AEC inhibitory effects were attenuated by both AEC wounding and pertussis toxin, indicating the involvement of a G(0)/G(i) receptor coupled mechanism. Solid phase extraction of lipids (<10 kDa) removed the AEC inhibitory activity. The lipid derivatives resolvin D1 and D2 and lipoxin A(4) attenuated HLMC histamine release in a dose-dependent fashion but were not detectable in co-culture supernatants. Conclusions: Primary AEC suppress HLMC constitutive and IgE-dependent histamine secretion through the release of a soluble, labile lipid mediator(s) that signals through the G(0)/G(i) receptor coupled mechanism. Manipulation of this interaction may have a significant therapeutic role in asthma.	[Martin, Neil; Ruddick, Andrew; Arthur, Greer K.; Wan, Heidi; Woodman, Lucy; Brightling, Christopher E.; Pavord, Ian D.; Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Jones, Don J. L.] Univ Leicester, RKCSB, Leicester, Leics, England	University of Leicester; University of Leicester	Martin, N (corresponding author), Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England.	nmartin@doctors.org.uk		brightling, chris/0000-0002-9345-4903; Arthur, Greer/0000-0002-4849-4076; Bradding, Peter/0000-0001-8403-0319; Pavord, Ian/0000-0002-4288-5973	European Regional Development Fund, ERDF [05567]; Defence Postgraduate Medical Deanery; National Institute for Health Research [NF-SI-0510-10157] Funding Source: researchfish	European Regional Development Fund, ERDF; Defence Postgraduate Medical Deanery; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was conducted in laboratories partially funded by European Regional Development Fund, ERDF #05567. NM was partially funded by the Defence Postgraduate Medical Deanery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; AUSTEN KF, 1987, DRUGS, V33, P10, DOI 10.2165/00003495-198700331-00004; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Bonnans C, 2006, AM J PATHOL, V168, P1064, DOI 10.2353/ajpath.2006.051056; Bonnans C, 2007, BIOMED PHARMACOTHER, V61, P261, DOI 10.1016/j.biopha.2007.02.016; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; Bradding P, 2003, CURR OPIN ALLERGY CL, V3, P45, DOI 10.1097/01.all.0000053267.39029.fd; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; CHRISTIE PE, 1992, AM REV RESPIR DIS, V145, P1281, DOI 10.1164/ajrccm/145.6.1281; Crivellato E, 2003, ANAT REC PART A, V274A, P778, DOI 10.1002/ar.a.10095; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Duffy SM, 2008, EUR J IMMUNOL, V38, P2548, DOI 10.1002/eji.200738106; FINOTTO S, 1994, CLIN EXP IMMUNOL, V95, P343; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Henry PJ, 2005, J PHARMACOL EXP THER, V314, P995, DOI 10.1124/jpet.105.086124; Hirasawa N, 1997, CELL SIGNAL, V9, P305, DOI 10.1016/S0898-6568(96)00189-1; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Holgate ST, 2010, DISCOV MED, V9, P439; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Hsieh FH, 2005, P NATL ACAD SCI USA, V102, P14380, DOI 10.1073/pnas.0503948102; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Mitchell D, 2007, J BIOL CHEM, V282, P15606, DOI 10.1074/jbc.M611004200; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; NG CF, 1989, ADV PROSTAG THROMB L, V19, P128; NG CF, 1989, BIOCHIM BIOPHYS ACTA, V1004, P332, DOI 10.1016/0005-2760(89)90081-7; Peden DB, 1997, AM J PHYSIOL-LUNG C, V272, pL1181, DOI 10.1152/ajplung.1997.272.6.L1181; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Ruiz-Gutierrez V, 2000, J CHROMATOGR A, V885, P321, DOI 10.1016/S0021-9673(00)00181-3; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Schafer D, 1996, THORAX, V51, P919, DOI 10.1136/thx.51.9.919; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, PROSTAG LEUKOTR ESS, V79, P157, DOI 10.1016/j.plefa.2008.09.012; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Tahan F, 2008, J ASTHMA, V45, P161, DOI 10.1080/02770900701847068; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Yang W, 2006, ALLERGY, V61, P569, DOI 10.1111/j.1398-9995.2006.01041.x	43	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43545	10.1371/journal.pone.0043545	http://dx.doi.org/10.1371/journal.pone.0043545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970103	Green Published, Green Submitted, gold			2022-12-27	WOS:000308044800036
J	Basu, S; Stuckler, D; Vellakkal, S; Ebrahim, S				Basu, Sanjay; Stuckler, David; Vellakkal, Sukumar; Ebrahim, Shah			Dietary Salt Reduction and Cardiovascular Disease Rates in India: A Mathematical Model	PLOS ONE			English	Article							BLOOD-PRESSURE; HEALTH; HYPERTENSION; METAANALYSIS; POPULATION; SODIUM; PREVENTION; STRATEGIES; COSTS	Background: Reducing salt intake has been proposed to prevent cardiovascular disease in India. We sought to determine whether salt reductions would be beneficial or feasible, given the worry that unrealistically large reductions would be required, worsening iodine deficiency and benefiting only urban subpopulations. Methods and Results: Future myocardial infarctions (MI) and strokes in India were predicted with a Markov model simulating men and women aged 40 to 69 in both urban and rural locations, incorporating the risk reduction from lower salt intake. If salt intake does not change, we expect similar to 8.3 million MIs (95% CI: 6.9-9.6 million), 830,000 strokes (690,000-960,000) and 2.0 million associated deaths (1.5-2.4 million) per year among Indian adults aged 40 to 69 over the next three decades. Reducing intake by 3 g/day over 30 years (-0.1 g/year, 25% reduction) would reduce annual MIs by 350,000 (a 4.6% reduction; 95% CI: 320,000-380,000), strokes by 48,000 (-6.5%; 13,000-83,000) and deaths by 81,000 (-4.9%; 59,000-100,000) among this group. The largest decline in MIs would be among younger urban men, but the greatest number of averted strokes would be among rural men, and nearly one-third of averted strokes and one-fifth of averted MIs would be among rural women. Only under a highly pessimistic scenario would iodine deficiency increase (by < 0.0001%, similar to 1600 persons), since inadequate iodized salt access-not low intake of iodized salt-is the major cause of deficiency and would be unaffected by dietary salt reduction. Conclusions: Modest reductions in salt intake could substantially reduce cardiovascular disease throughout India.	[Basu, Sanjay] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Stuckler, David] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England; [Vellakkal, Sukumar; Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England	Stanford University; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Basu, S (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	basus@stanford.edu	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0002-0594-1454; Stuckler, David/0000-0002-1288-8401; Vellakkal, Sukumar/0000-0003-2635-1944	University of California San Francisco Clinical and Translational Science Institute; Wellcome Trust strategic award [084674/Z/08/Z]	University of California San Francisco Clinical and Translational Science Institute(University of California System); Wellcome Trust strategic award(Wellcome Trust)	SB is supported by an award from the University of California San Francisco Clinical and Translational Science Institute. The South Asia Network for Chronic Disease (SE, SV) is supported by a Wellcome Trust strategic award 084674/Z/08/Z. No specific funding was received by DS for this research. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AGR RES SERV, 2008, NUTR INT FOOD MEAN A; [Anonymous], 1989, J Hum Hypertens, V3, P279; [Anonymous], 2011, TIMES INDIA; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Campbell N, 2012, B WORLD HEALTH ORGAN, V90, P73, DOI 10.2471/BLT.11.092080; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Elliott P, 2007, DIET PHYS ACTIVITY; Food Standards Agency, 2008, DIET SOD LEV SURV; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Indrayan A., 2005, FORECASTING VASCULAR; International Institute for Population Sciences, 2007, NAT FAM HLTH SURV; International Institute for Population Sciences, 2000, NAT FAM HLTH SURV; Kato N, 2012, HYPERTENS RES, V35, P574, DOI 10.1038/hr.2012.44; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; Ministry of Women and Child Development, 2007, IOD DEF DIS; Moyer M, 2011, ITS TIME END WAR SAL; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Organization WH, 2009, GLOB HLTH RISKS MORT; Pandav C S, 1982, Indian J Pediatr, V49, P259, DOI 10.1007/BF02830764; Panel on Dietary Reference Intakes for Electrolytes and Water, 2005, DIET REF INT WAT POT; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Radhika G, 2007, J Assoc Physicians India, V55, P405; Registrar-General of India, 2011, CENS DAT; Reinagel M, 2010, SELF MAGAZINE; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shah B, 2010, ASSESSMENT BURDEN NO; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; The R Foundation for Statistical Computing, 2011, MSTAT PACK; The Salt Institute, 2011, ISS FOC; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; WHO, 2007, SALT VEH FORT; WHO Forum on Reducing Salt Intake in Populations, 2007, WHO FOR TECHN M 5 7; World Health Organisation, 2011, STRAT MON EV POP SOD; World Health Organization, 2011, WHO STUD GLOB AGEING; World Health Organization, 2011, STUD GLOB AGEING AD; World Health Organization, 2010, GLOB MORT DAT; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	48	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44037	10.1371/journal.pone.0044037	http://dx.doi.org/10.1371/journal.pone.0044037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970159	Green Published, gold			2022-12-27	WOS:000308458400030
J	Hughes, CML; Seegelke, C; Spiegel, MA; Oehmichen, C; Hammes, J; Schack, T				Hughes, Charmayne M. L.; Seegelke, Christian; Spiegel, Marnie Ann; Oehmichen, Corinna; Hammes, Julia; Schack, Thomas			Corrections in Grasp Posture in Response to Modifications of Action Goals	PLOS ONE			English	Article							SELECTIVE PERTURBATION; PREHENSION MOVEMENTS; VISUAL INPUT; OBJECT; REACH; COMPONENTS; KINEMATICS	There is ample evidence that people plan their movements to ensure comfortable final grasp postures at the end of a movement. The end-state comfort effect has been found to be a robust constraint during unimanual movements, and leads to the inference that goal-postures are represented and planned prior to movement initiation. The purpose of this study was to examine whether individuals make appropriate corrections to ensure comfortable final goal postures when faced with an unexpected change in action goal. Participants reached for a horizontal cylinder and placed the left or right end of the object into the target disk. As soon as the participant began to move, a secondary stimuli was triggered, which indicated whether the intended action goal had changed or not. Confirming previous research, participants selected initial grasp postures that ensured end-state comfort during non-perturbed trials. In addition, participants made appropriate online corrections to their reach-to-grasp movements to ensure end-state comfort during perturbed trials. Corrections in grasp posture occurred early or late in the reach-to-grasp phase. The results indicate that individuals plan their movements to afford comfort at the end of the movement, and that grasp posture planning is controlled via both feedforward and feedback mechanisms.	[Hughes, Charmayne M. L.; Seegelke, Christian; Spiegel, Marnie Ann; Oehmichen, Corinna; Hammes, Julia; Schack, Thomas] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany; [Hughes, Charmayne M. L.; Seegelke, Christian; Schack, Thomas] Res Inst Cognit & Robot, CoR Lab, Bielefeld, Germany; [Hughes, Charmayne M. L.; Spiegel, Marnie Ann; Schack, Thomas] Ctr Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Hughes, Charmayne M. L.] Tech Univ Munich, Dept Sport & Hlth Sci, Inst Movement Sci, Munich, Germany	University of Bielefeld; Technical University of Munich	Hughes, CML (corresponding author), Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp, D-33615 Bielefeld, Germany.	charmayne.hughes@tum.de	Seegelke, Christian/AAH-9410-2019	Seegelke, Christian/0000-0001-9624-6395	German Research Foundation (DFG) [EC 277]; Honda Research Institute Europe	German Research Foundation (DFG)(German Research Foundation (DFG)); Honda Research Institute Europe	This research was funded by the German Research Foundation (DFG; EC 277). CS gratefully acknowledges the financial support from Honda Research Institute Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Armbruster C, 2006, MOTOR CONTROL, V10, P311, DOI 10.1123/mcj.10.4.311; BENNETT KMB, 1995, PSYCHOL AGING, V10, P204, DOI 10.1037/0882-7974.10.2.204; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; Castiello U, 1998, EXP BRAIN RES, V120, P31, DOI 10.1007/s002210050375; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; Dragovic M, 2004, ACTA NEUROPSYCHIATR, V16, P212, DOI 10.1111/j.0924-2708.2004.00087.x; Elsinger CL, 2003, EXP BRAIN RES, V152, P499, DOI 10.1007/s00221-003-1573-7; Fecteau JH, 2001, CAN J EXP PSYCHOL, V55, P104, DOI 10.1037/h0087357; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; Gibson J.J., 1977, PERCEIVING ACTING KN, V1, P67, DOI [DOI 10.2307/1421838, 10.4324/9781315740218]; Gibson J.J., 1966, SENSES CONSIDERED PE; Heath M, 1998, CAN J EXP PSYCHOL, V52, P163, DOI 10.1037/h0087289; Hwang EJ, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S09; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; ROSENBAUM DA, 1990, ATTENTION PERFORM, V8, P321; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; STELMACH GE, 1994, J MOTOR BEHAV, V26, P178, DOI 10.1080/00222895.1994.9941672; VANSONDEREN JF, 1988, EXP BRAIN RES, V71, P320, DOI 10.1007/BF00247492; WEIR PL, 1991, J MOTOR BEHAV, V23, P192, DOI 10.1080/00222895.1991.10118362; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; ZELAZNIK HN, 1983, J MOTOR BEHAV, V15, P217	31	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43015	10.1371/journal.pone.0043015	http://dx.doi.org/10.1371/journal.pone.0043015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970119	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400006
J	Maling, N; Hashemiyoon, R; Foote, KD; Okun, MS; Sanchez, JC				Maling, Nicholas; Hashemiyoon, Rowshanak; Foote, Kelly D.; Okun, Michael S.; Sanchez, Justin C.			Increased Thalamic Gamma Band Activity Correlates with Symptom Relief following Deep Brain Stimulation in Humans with Tourette's Syndrome	PLOS ONE			English	Article							CM-PF COMPLEX; RESPONSIVE CORTICAL STIMULATION; BEHAVIORAL SPECTRUM; VISUAL-CORTEX; OSCILLATIONS; SYNCHRONIZATION; INFORMATION; DISORDERS; MECHANISM; NEURONS	Tourette syndrome (TS) is an idiopathic, childhood-onset neuropsychiatric disorder, which is marked by persistent multiple motor and phonic tics. The disorder is highly disruptive and in some cases completely debilitating. For those with severe, treatment-refractory TS, deep brain stimulation (DBS) has emerged as a possible option, although its mechanism of action is not fully understood. We performed a longitudinal study of the effects of DBS on TS symptomatology while concomitantly examining neurophysiological dynamics. We present the first report of the clinical correlation between the presence of gamma band activity and decreased tic severity. Local field potential recordings from five subjects implanted in the centromedian nucleus (CM) of the thalamus revealed a temporal correlation between the power of gamma band activity and the clinical metrics of symptomatology as measured by the Yale Global Tic Severity Scale and the Modified Rush Tic Rating Scale. Additional studies utilizing short-term stimulation also produced increases in gamma power. Our results suggest that modulation of gamma band activity in both long-term and short-term DBS of the CM is a key factor in mitigating the pathophysiology associated with TS.	[Maling, Nicholas] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Hashemiyoon, Rowshanak; Sanchez, Justin C.] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; [Foote, Kelly D.] Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Sanchez, Justin C.] Univ Miami, Neurosci Program, Miami, FL USA; [Sanchez, Justin C.] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA	State University System of Florida; University of Florida; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Miami; University of Miami	Maling, N (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	jcsanchez@miami.edu		Foote, Kelly/0000-0002-2436-4138; Okun, Michael/0000-0002-6247-9358; Maling, Nicholas/0000-0001-6204-375X	United States National Institutes of Health [5R21NS072897, R34MH080764]; University of Florida; Neuropace, Mountainview, CA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH080764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072897] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); Neuropace, Mountainview, CA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by United States National Institutes of Health grants 5R21NS072897 (Multi-PI Sanchez and Okun) and R34MH080764 (PI: Okun). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would also like to acknowledge the donation of devices to the NIH sponsored study by Neuropace, Mountainview, CA. We would like to recognize the important feedback given on this project by Dana Mason, Stacy Merritt, Kyle Rizer, David Greene, Martha Morrell, Brent Wingeier, and Rosana Estellar.	Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1000, DOI 10.1016/j.clinph.2005.12.028; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63; Bront-Stewart H, 2011, DYNAMICAL NEUROSCIEN; Cavanna AE, 2009, J NEUROPSYCH CLIN N, V21, P13, DOI 10.1176/appi.neuropsych.21.1.13; Cheung MYC, 2007, MOVEMENT DISORD, V22, P1743, DOI 10.1002/mds.21599; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Eapen Valsamma, 2008, Prim Care Companion J Clin Psychiatry, V10, P103; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Frank MC, 2011, J NEUROL SCI, V310, P276, DOI 10.1016/j.jns.2011.06.032; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goetz CG, 1999, MOVEMENT DISORD, V14, P502, DOI 10.1002/1531-8257(199905)14:3<502::AID-MDS1020>3.0.CO;2-G; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hariz MI, 2010, EUR J NEUROSCI, V32, P1128, DOI 10.1111/j.1460-9568.2010.07415.x; Hashemiyoon R, 1996, COMPUTATIONAL NEUROS; HASSLER R, 1970, REV NEUROL, V123, P89; Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273; Jankovic J, 2011, MOVEMENT DISORD, V26, P1149, DOI 10.1002/mds.23618; Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8; Kurlan R, 2002, NEUROLOGY, V59, P414, DOI 10.1212/WNL.59.3.414; Leckman JF, 2006, J CHILD PSYCHOL PSYC, V47, P537, DOI 10.1111/j.1469-7610.2006.01620.x; Leckman JF, 2010, J CHILD ADOL PSYCHOP, V20, P237, DOI 10.1089/cap.2009.0118; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Marceglia S, 2010, MOVEMENT DISORD, V25, P300, DOI 10.1002/mds.22982; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; McNaught KS, 2011, NAT REV NEUROL, V7, P667, DOI 10.1038/nrneurol.2011.167; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Minamimoto T, 2009, BRAIN RES BULL, V78, P75, DOI 10.1016/j.brainresbull.2008.08.013; Mink JW, 2006, MOVEMENT DISORD, V21, P1831, DOI 10.1002/mds.21039; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nadasdy Z, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.006.2009; Okun MS, 2012, TRIAL SCHEDULED DEEP; Piedad JCP, 2012, NEUROSURGERY, V71, P173, DOI 10.1227/NEU.0b013e3182535a00; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Porta M, 2009, EUR NEUROL, V62, P264, DOI 10.1159/000235595; Raeva S N, 2006, Neurosci Behav Physiol, V36, P287, DOI 10.1007/s11055-006-0015-y; Robertson MM, 2009, J PSYCHOSOM RES, V67, P475, DOI 10.1016/j.jpsychores.2009.07.010; Robertson MM, 2012, ARCH DIS CHILD ED PR; Sassi M, 2011, ACTA NEUROCHIR, V153, P639, DOI 10.1007/s00701-010-0803-6; Savica R, 2012, MAYO CLIN PROC, V87, P59, DOI 10.1016/j.mayocp.2011.08.005; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Servello D, 2009, J NEUROL, V256, P1533, DOI 10.1007/s00415-009-5159-6; Steeves TDL, 2010, ANN NEUROL, V67, P170, DOI 10.1002/ana.21809; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Sun FT, 2008, NEUROTHERAPEUTICS, V5, P68, DOI 10.1016/j.nurt.2007.10.069; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Temel Y, 2004, MOVEMENT DISORD, V19, P3, DOI 10.1002/mds.10649; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Wanderer S, 2012, J DEV BEHAV PEDIATR, V33, P124, DOI 10.1097/DBP.0b013e31823f6933	63	77	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44215	10.1371/journal.pone.0044215	http://dx.doi.org/10.1371/journal.pone.0044215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970181	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400047
J	Norambuena, J; Flores, R; Cardenas, JP; Quatrini, R; Chavez, R; Levican, G				Norambuena, Javiera; Flores, Rodrigo; Cardenas, Juan P.; Quatrini, Raquel; Chavez, Renato; Levican, Gloria			Thiol/Disulfide System Plays a Crucial Role in Redox Protection in the Acidophilic Iron-Oxidizing Bacterium Leptospirillum ferriphilum	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; THIOREDOXIN REDUCTASE; HELICOBACTER-PYLORI; CCMG PROTEIN; THIOL; MECHANISMS; FERROOXIDANS; RESISTANCE; EXPRESSION	Thiol/disulfide systems are involved in the maintenance of the redox status of proteins and other molecules that contain thiol/disulfide groups. Leptospirillum ferriphilum DSM14647, an acidophilic bacterium that uses Fe2+ as electron donor, and withstands very high concentrations of iron and other redox active metals, is a good model to study how acidophiles preserve the thiol/disulfide balance. We studied the composition of thiol/disulfide systems and their role in the oxidative stress response in this extremophile bacterium. Bioinformatic analysis using genomic data and enzymatic assays using protein extracts from cells grown under oxidative stress revealed that the major thiol/disulfide system from L. ferriphilum are a cytoplasmic thioredoxin system (composed by thioredoxins Trx and thioredoxin reductase TR), periplasmic thiol oxidation system (DsbA/DsbB) and a c-type cytochrome maturation system (DsbD/DsbE). Upon exposure of L. ferriphilum to reactive oxygen species (ROS)-generating compounds, transcriptional activation of the genes encoding Trxs and the TR enzyme, which results in an increase of the corresponding activity, was observed. Altogether these data suggest that the thioredoxin-based thiol/disulfide system plays an important role in redox protection of L. ferriphilum favoring the survival of this microorganism under extreme environmental oxidative conditions.	[Norambuena, Javiera; Flores, Rodrigo; Chavez, Renato; Levican, Gloria] Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Lab Microbiol Basica & Aplicada, Santiago, Chile; [Cardenas, Juan P.; Quatrini, Raquel] Fdn Ciencia & Vida, Lab Ecofisiol Microbiana, Santiago, Chile	Universidad de Santiago de Chile	Levican, G (corresponding author), Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Lab Microbiol Basica & Aplicada, Santiago, Chile.	gloria.levican@usach.cl	Quatrini, Raquel/S-4099-2019; Levican, Gloria/R-5191-2019; Quatrini, Raquel/GSD-7689-2022; Quatrini, Raquel/N-1801-2013; Cardenas, Juan Pablo/AAB-2469-2020	Quatrini, Raquel/0000-0003-2600-2605; Levican, Gloria/0000-0002-1275-7399; Quatrini, Raquel/0000-0003-2600-2605; Cardenas, Juan Pablo/0000-0001-6715-7270; Norambuena, Javiera/0000-0002-2992-4907; Chavez, Renato/0000-0003-1754-3610	Fondecyt [11085045, 1100887]; Innova [08CM01-03]; Dicyt-Usach from the Government of Chile	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Innova; Dicyt-Usach from the Government of Chile	This work was supported by Fondecyt grants No11085045 (GL) and 1100887 (RQ), Innova 08CM01-03 (RQ) and Dicyt-Usach (GL, RC) from the Government of Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ES, 2001, CURR PROTOC TOXICOL, V7, P41; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Boylan JA, 2006, MOL MICROBIOL, V59, P475, DOI 10.1111/j.1365-2958.2005.04963.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Cerda O, 2003, FEMS MICROBIOL LETT, V224, P175, DOI 10.1016/S0378-1097(03)00423-3; Cortes A, 2011, 19 INT BIOH S, P354; Di Matteo A, 2010, PROTEINS, V78, P2213, DOI 10.1002/prot.22733; Dressaire C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S18; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Levican G, 2012, J MOL MICROB BIOTECH, V22, P94, DOI 10.1159/000338105; Levican G, 2007, P NATL ACAD SCI USA, V104, P3135, DOI 10.1073/pnas.0611611104; Li B, 2010, BIORESOURCE TECHNOL, V101, P9811, DOI 10.1016/j.biortech.2010.07.043; Li KY, 2003, ARCH MICROBIOL, V180, P484, DOI 10.1007/s00203-003-0620-x; Li Q, 2001, BIOL CHEM, V382, P1679, DOI 10.1515/BC.2001.203; Lim Hye Won, 1995, Journal of Biochemistry and Molecular Biology, V28, P17; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Nieto PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-63; Osorio H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-203; Pedone E, 2010, CELL MOL LIFE SCI, V67, P3797, DOI 10.1007/s00018-010-0449-9; Pillay CS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-15; Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Rigobello MP, 2004, BIOCHEM PHARMACOL, V67, P689, DOI 10.1016/j.bcp.2003.09.038; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rodrigues VD, 2010, PROCESS BIOCHEM, V45, P914, DOI 10.1016/j.procbio.2010.02.018; Ruddock LW, 1999, CURR BIOL, V9, pR400, DOI 10.1016/S0960-9822(99)80253-X; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Yarzabal A, 2002, FEMS MICROBIOL LETT, V209, P189, DOI 10.1016/S0378-1097(02)00514-1; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	63	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44576	10.1371/journal.pone.0044576	http://dx.doi.org/10.1371/journal.pone.0044576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970253	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400089
J	Sartoretto, JL; Hermann, K; Shiroto, T; Sartoretto, SM; Pluth, MD; Lippard, SJ; Michel, T				Sartoretto, Juliano L.; Kalwa, Hermann; Shiroto, Takashi; Sartoretto, Simone M.; Pluth, Michael D.; Lippard, Stephen J.; Michel, Thomas			Role of Ca2+ in the Control of H2O2-Modulated Phosphorylation Pathways Leading to eNOS Activation in Cardiac Myocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; HYDROGEN-PEROXIDE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HEART-FAILURE; CONTRACTION; MECHANISMS; EXPRESSION; ISOFORMS	Nitric oxide (NO) and hydrogen peroxide (H2O2) play key roles in physiological and pathological responses in cardiac myocytes. The mechanisms whereby H2O2-modulated phosphorylation pathways regulate the endothelial isoform of nitric oxide synthase (eNOS) in these cells are incompletely understood. We show here that H2O2 treatment of adult mouse cardiac myocytes leads to increases in intracellular Ca2+ ([Ca2+](i)), and document that activity of the L-type Ca2+ channel is necessary for the H2O2-promoted increase in sarcomere shortening and of [Ca2+](i). Using the chemical NO sensor Cu-2(FL2E), we discovered that the H2O2-promoted increase in cardiac myocyte NO synthesis requires activation of the L-type Ca2+ channel, as well as phosphorylation of the AMP-activated protein kinase (AMPK), and mitogen-activated protein kinase kinase 1/2 (MEK1/2). Moreover, H2O2-stimulated phosphorylations of eNOS, AMPK, MEK1/2, and ERK1/2 all depend on both an increase in [Ca2+](i) as well as the activation of protein kinase C (PKC). We also found that H2O2-promoted cardiac myocyte eNOS translocation from peripheral membranes to internal sites is abrogated by the L-type Ca2+ channel blocker nifedipine. We have previously shown that kinase Akt is also involved in H2O2-promoted eNOS phosphorylation. Here we present evidence documenting that H2O2-promoted Akt phosphorylation is dependent on activation of the L-type Ca2+ channel, but is independent of PKC. These studies establish key roles for Ca2+- and PKC-dependent signaling pathways in the modulation of cardiac myocyte eNOS activation by H2O2.	[Sartoretto, Juliano L.; Kalwa, Hermann; Shiroto, Takashi; Sartoretto, Simone M.; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; [Pluth, Michael D.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Sartoretto, JL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Sartoretto, Simone/F-5622-2014; Kalwa, Hermann/ABG-2323-2021; Pluth, Michael/A-7222-2012	Sartoretto, Simone/0000-0002-0771-233X; Pluth, Michael/0000-0003-3604-653X; sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [HL46457, HL48743, GM36259]; Uehara Memorial Foundation; American Diabetes Association/Takeda Cardiovascular Postdoctoral Fellowship Award; FAPESP [2009/54535-7]; Fonds National de Recherche, Luxembourg; National Science Foundation [NSF CHE-0907905];  [K99GM092970]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL046457, R29HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259, K99GM092970] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0907905] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); American Diabetes Association/Takeda Cardiovascular Postdoctoral Fellowship Award(American Diabetes Association); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fonds National de Recherche, Luxembourg; National Science Foundation(National Science Foundation (NSF)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to TM) and by K99GM092970 to MDP; by a fellowship grant from the Uehara Memorial Foundation (to TS); by an American Diabetes Association/Takeda Cardiovascular Postdoctoral Fellowship Award (to JLS); by a FAPESP award 2009/54535-7 (to SMS); and by a postdoctoral fellowship from the Fonds National de Recherche, Luxembourg (to HK). SJL thanks the National Science Foundation for support of this work under grant NSF CHE-0907905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Belhassen L, 1997, J BIOL CHEM, V272, P11198; BERESEWICZ A, 1991, J MOL CELL CARDIOL, V23, P899, DOI 10.1016/0022-2828(91)90133-7; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Cain BS, 1999, J SURG RES, V81, P249, DOI 10.1006/jsre.1998.5508; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Dai DF, 2012, CARDIOVASC RES, V93, P79, DOI 10.1093/cvr/cvr274; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; KIMURA M, 1992, BRIT J PHARMACOL, V107, P488, DOI 10.1111/j.1476-5381.1992.tb12772.x; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; SAKAI K, 1983, J PHARMACOL METHOD, V10, P263; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Sartoretto JL, 2009, AM J PHYSIOL-HEART C, V297, pH1697, DOI 10.1152/ajpheart.00595.2009; SHEPHERD M, 1987, BIOCHEM MED METAB B, V38, P195, DOI 10.1016/0885-4505(87)90080-6; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Tanaka M, 2011, INTERNAL MED, V50, P2877, DOI 10.2169/internalmedicine.50.5925; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; WARD CA, 1995, J MOL CELL CARDIOL, V27, P1089, DOI 10.1016/0022-2828(95)90077-2; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yin LH, 2004, AM J PHYSIOL-HEART C, V287, pH1276, DOI 10.1152/ajpheart.01120.2003	31	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44627	10.1371/journal.pone.0044627	http://dx.doi.org/10.1371/journal.pone.0044627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970272	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400097
J	Spoida, K; Distler, C; Trampe, AK; Hoffmann, KP				Spoida, Katharina; Distler, Claudia; Trampe, Anne-Kathrin; Hoffmann, Klaus-Peter			Blocking Retinal Chloride Co-Transporters KCC2 and NKCC: Impact on Direction Selective ON and OFF Responses in the Rat's Nucleus of the Optic Tract	PLOS ONE			English	Article							DORSAL TERMINAL NUCLEUS; STARBURST AMACRINE CELLS; GANGLION-CELLS; OPTOKINETIC NYSTAGMUS; CORTICAL PROJECTIONS; STRIATE CORTEX; MECHANISMS; COTRANSPORTERS; SYSTEM; UNITS	In the present study we investigated in vivo the effects of pharmacological manipulation of retinal processing on the response properties of direction selective retinal slip cells in the nucleus of the optic tract and dorsal terminal nucleus (NOT-DTN), the key visuomotor interface in the pathway underlying the optokinetic reflex. Employing a moving visual stimulus consisting of either a large dark or light edge we could differentiate direction selective ON and OFF responses in retinal slip cells. To disclose the origin of the retinal slip cells' unexpected OFF response we selectively blocked the retinal ON channels and inactivated the visual cortex by cooling. Cortical cooling had no effect on the direction selectivity of the ON or the OFF response in NOT-DTN retinal slip cells. Blockade of the retinal ON channel with APB led to a loss of the ON and, to a lesser degree, of the OFF response and a reduction in direction selectivity. Subsequent blocking of GABA receptors in the retina with picrotoxin unmasked a vigorous albeit direction unselective OFF response in the NOT-DTN. Disturbing the retinal chloride homeostasis by intraocular injections of bumetanide or furosemide led to a loss of direction selectivity in both the NOT-DTN's ON and the OFF response due to a reduced response in the neuron's preferred direction under bumetanide as well as under furosemide and a slightly increased response in the null direction under bumetanide. Our results indicate that the direction specificity of retinal slip cells in the NOT-DTN of the rat strongly depends on direction selective retinal input which depends on intraretinal chloride homeostasis. On top of the well established input from ON center direction selective ganglion cells we could demonstrate an equally effective input from the retinal OFF system to the NOT-DTN.	[Spoida, Katharina; Distler, Claudia; Trampe, Anne-Kathrin; Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Bochum, Germany	Ruhr University Bochum	Spoida, K (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	kphoffm@gmail.com		Spoida, Katharina/0000-0002-4132-0655	ZEN grant from Hertie Foundation	ZEN grant from Hertie Foundation	K.-P. Hoffmann was supported by a ZEN grant from the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert JM, 2009, J PHYSIOL-LONDON, V587, P4481, DOI 10.1113/jphysiol.2009.173344; Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1991, VISUAL NEUROSCI, V7, P431, DOI 10.1017/S095252380000972X; Bai X, 2009, NEUROSCIENCE, V162, P184, DOI 10.1016/j.neuroscience.2009.04.060; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; BONAVENTURE N, 1992, VISION RES, V32, P601, DOI 10.1016/0042-6989(92)90176-J; BUHL EH, 1986, J COMP NEUROL, V253, P163, DOI 10.1002/cne.902530204; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; COLLEWIJN H, 1975, BRAIN RES, V100, P489, DOI 10.1016/0006-8993(75)90154-7; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Distler C, 2011, OXFORD HDB EYE MOVEM, P65; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; GRASSE KL, 1990, VISUAL NEUROSCI, V4, P605, DOI 10.1017/S0952523800005800; GRASSE KL, 1984, EXP BRAIN RES, V55, P69; Harvey RJ, 1997, VISION RES, V37, P1615, DOI 10.1016/S0042-6989(96)00292-1; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; HOFFMANN KP, 1985, EXP BRAIN RES, V59, P395; HOFFMANN KP, 1991, J COMP NEUROL, V313, P707, DOI 10.1002/cne.903130413; HOLLANDER H, 1979, J COMP NEUROL, V184, P783, DOI 10.1002/cne.901840410; Hoshi H, 2011, J COMP NEUROL, V519, P2509, DOI 10.1002/cne.22678; Ibbotson MR, 2002, EXP BRAIN RES, V147, P80, DOI 10.1007/s00221-002-1215-5; Ibbotson MR, 2001, J NEUROPHYSIOL, V86, P997, DOI 10.1152/jn.2001.86.2.997; Kanjhan R, 2010, NEUROSCI LETT, V483, P105, DOI 10.1016/j.neulet.2010.07.071; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; KLAUER S, 1990, EXP BRAIN RES, V83, P178; KNAPP AG, 1988, J NEUROPHYSIOL, V60, P1010, DOI 10.1152/jn.1988.60.3.1010; Kogo N, 1998, J NEUROSCI, V18, P2673; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; LUI F, 1994, J COMP NEUROL, V344, P598, DOI 10.1002/cne.903440408; Miller RF, 2008, INVEST OPHTH VIS SCI, V49, P5184, DOI 10.1167/iovs.08-2456; Moore BD, 2011, NEURON, V71, P812, DOI 10.1016/j.neuron.2011.06.025; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Reymond E, 1990, P AUST NEUROSCI ASS, V1, P122; ROSENBERG AF, 1991, J NEUROPHYSIOL, V65, P1022, DOI 10.1152/jn.1991.65.5.1022; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SCHMIDT M, 1993, J COMP NEUROL, V330, P147, DOI 10.1002/cne.903300202; Sha O., 2006, Neuroembryology and Aging, V4, P183, DOI 10.1159/000118928; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Taylor WR, 2002, J NEUROSCI, V22, P7712; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VOLCHAN E, 1989, EXP BRAIN RES, V78, P380; Yang G, 1990, P AUST NEUROSCI ASS, V1, P142; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; YUCEL YH, 1989, VISUAL NEUROSCI, V2, P357, DOI 10.1017/S0952523800002169; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020	61	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44724	10.1371/journal.pone.0044724	http://dx.doi.org/10.1371/journal.pone.0044724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970298	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400113
J	Hermann, A; Kupper, Y; Schmitz, A; Walter, B; Vaitl, D; Hennig, J; Stark, R; Tabbert, K				Hermann, Andrea; Kuepper, Yvonne; Schmitz, Anja; Walter, Bertram; Vaitl, Dieter; Hennig, Juergen; Stark, Rudolf; Tabbert, Katharina			Functional Gene Polymorphisms in the Serotonin System and Traumatic Life Events Modulate the Neural Basis of Fear Acquisition and Extinction	PLOS ONE			English	Article							TRANSPORTER GENE; AMYGDALA; ANXIETY; DISORDERS; ETIOLOGY; 5-HTTLPR; METAANALYSIS; ASSOCIATION; ACTIVATION; DEPRESSION	Fear acquisition and extinction are crucial mechanisms in the etiology and maintenance of anxiety disorders. Moreover, they might play a pivotal role in conveying the influence of genetic and environmental factors on the development of a (more or less) stronger proneness for, or resilience against psychopathology. There are only few insights in the neurobiology of genetically and environmentally based individual differences in fear learning and extinction. In this functional magnetic resonance imaging study, 74 healthy subjects were investigated. These were invited according to 5-HTTLPR/rs25531 (S+ vs. LALA; triallelic classification) and TPH2 (G(-703) T) (T+ vs. T-) genotype. The aim was to investigate the influence of genetic factors and traumatic life events on skin conductance responses (SCRs) and neural responses (amygdala, insula, dorsal anterior cingulate cortex (dACC) and ventromedial prefrontal cortex (vmPFC)) during acquisition and extinction learning in a differential fear conditioning paradigm. Fear acquisition was characterized by stronger late conditioned and unconditioned responses in the right insula in 5-HTTLPR S-allele carriers. During extinction traumatic life events were associated with reduced amygdala activation in S-allele carriers vs. non-carriers. Beyond that, T-allele carriers of the TPH2 (G(2703) T) polymorphism with a higher number of traumatic life events showed enhanced responsiveness in the amygdala during acquisition and in the vmPFC during extinction learning compared with non-carriers. Finally, a combined effect of the two polymorphisms with higher responses in S-and T-allele carriers was found in the dACC during extinction. The results indicate an increased expression of conditioned, but also unconditioned fear responses in the insula in 5-HTTLPR S-allele carriers. A combined effect of the two polymorphisms on dACC activation during extinction might be associated with prolonged fear expression. Gene-by-environment interactions in amygdala and vmPFC activation may reflect a neural endophenotype translating genetic and adverse environmental influences into vulnerability for or resilience against developing affective psychopathology.	[Hermann, Andrea; Walter, Bertram; Stark, Rudolf] Univ Giessen, Dept Psychotherapy & Syst Neurosci, Giessen, Germany; [Hermann, Andrea; Walter, Bertram; Vaitl, Dieter; Stark, Rudolf; Tabbert, Katharina] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany; [Kuepper, Yvonne; Schmitz, Anja; Hennig, Juergen] Univ Giessen, Dept Psychol, Sect Differential Psychol & Personal Res, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Hermann, A (corresponding author), Univ Giessen, Dept Psychotherapy & Syst Neurosci, Giessen, Germany.	andrea.hermann@psychol.uni-giessen.de	Walter, Bertram/AAD-4695-2021					Alexander N, 2012, BIOL PSYCHIAT, V72, P49, DOI 10.1016/j.biopsych.2012.01.030; Alexander N, 2009, PSYCHONEUROENDOCRINO, V34, P1294, DOI 10.1016/j.psyneuen.2009.03.017; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Bockting CLH, 2013, MOL PSYCHIATR, V18, P744, DOI 10.1038/mp.2012.92; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Bryant RA, 2010, BIOL PSYCHIAT, V67, P1217, DOI 10.1016/j.biopsych.2010.03.016; Canli T, 2005, J NEURAL TRANSM, V112, P1479, DOI 10.1007/s00702-005-0391-4; Canli T, 2008, BIOL PSYCHOL, V79, P118, DOI 10.1016/j.biopsycho.2008.01.004; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eley TC, 2012, MOL PSYCHIATR, V17, P236, DOI 10.1038/mp.2011.132; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hautzinger M, 2006, BECK DEPRESSION INVE, VII; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Jacob CP, 2010, EUR ARCH PSY CLIN N, V260, P317, DOI 10.1007/s00406-009-0079-0; Klucken T, 2013, HUM BRAIN MAPP, V34, P2549, DOI 10.1002/hbm.22085; Klucken T, 2013, SOC COGN AFFECT NEUR, V8, P318, DOI 10.1093/scan/nss005; Klumpers F, 2012, BIOL PSYCHOL, V89, P277, DOI 10.1016/j.biopsycho.2011.10.018; Knight DC, 2004, COGN AFFECT BEHAV NE, V4, P317, DOI 10.3758/CABN.4.3.317; Laux L., 1981, STATE TRAIT ANXIETY; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Linnman C, 2012, AM J PSYCHIAT, V169, P415, DOI 10.1176/appi.ajp.2011.10121780; Lonsdorf TB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.36; Lonsdorf TB, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-99; Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Nobile M, 2009, J CHILD PSYCHOL PSYC, V50, P317, DOI 10.1111/j.1469-7610.2008.01958.x; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; PROKASY WF, 1967, J EXP PSYCHOL, V73, P247, DOI 10.1037/h0024108; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reuter M, 2007, INT J NEUROPSYCHOPH, V10, P401, DOI 10.1017/S1461145706007073; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Walter B, 2003, NEUROIMAGE, V19; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	61	41	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44352	10.1371/journal.pone.0044352	http://dx.doi.org/10.1371/journal.pone.0044352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957066	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800059
J	Hsu, SM; Wu, CH; Lee, JH; Hsieh, YJ; Yu, CY; Liao, YJ; Kuo, LC; Liang, JA; Huang, DYC				Hsu, Shih-Ming; Wu, Chin-Hui; Lee, Jeng-Hung; Hsieh, Ya-Ju; Yu, Chun-Yen; Liao, Yi-Jen; Kuo, Li-Cheng; Liang, Ji-An; Huang, David Y. C.			A Study on the Dose Distributions in Various Materials from an Ir-192 HDR Brachytherapy Source	PLOS ONE			English	Article							MONTE-CARLO; GLASS DOSIMETER; GAMMA-RAYS; ANISOTROPY; RECOMMENDATIONS; VERIFICATION; ATTENUATION; DIODE; I-125; TLD	Dose distributions of Ir-192 HDR brachytherapy in phantoms simulating water, bone, lung tissue, water-lung and bone-lung interfaces using the Monte Carlo codes EGS4, FLUKA and MCNP4C are reported. Experiments were designed to gather point dose measurements to verify the Monte Carlo results using Gafchromic film, radiophotoluminescent glass dosimeter, solid water, bone, and lung phantom. The results for radial dose functions and anisotropy functions in solid water phantom were consistent with previously reported data (Williamson and Li). The radial dose functions in bone were affected more by depth than those in water. Dose differences between homogeneous solid water phantoms and solid water-lung interfaces ranged from 0.6% to 14.4%. The range between homogeneous bone phantoms and bone-lung interfaces was 4.1% to 15.7%. These results support the understanding in dose distribution differences in water, bone, lung, and their interfaces. Our conclusion is that clinical parameters did not provide dose calculation accuracy for different materials, thus suggesting that dose calculation of HDR treatment planning systems should take into account material density to improve overall treatment quality.	[Hsu, Shih-Ming] China Med Univ Hosp, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wu, Chin-Hui] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu, Taiwan; [Lee, Jeng-Hung] Inst Nucl Energy Res, Div Hlth Phys, Longtan, Taiwan; [Hsieh, Ya-Ju] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Yu, Chun-Yen; Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Liao, Yi-Jen] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Kuo, Li-Cheng] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Huang, David Y. C.] Rockville Ctr, Fac Mem Sloan Kettering Canc Ctr Rockville Ctr, New York, NY USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Tsing Hua University; Institute of Nuclear Energy Research - Taiwan; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Memorial Sloan Kettering Cancer Center	Hsu, SM (corresponding author), China Med Univ Hosp, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	huangd@mskcc.org		Hsieh, Ya Ju/0000-0003-2082-9345; Kuo, Li Cheng/0000-0003-3740-7085	China Medical University and Hospital [CMU99-N1-08-1, CMU99-N1-08-2, DMR-98-102]	China Medical University and Hospital(China Medical University)	This work was supported by Grant Nos. CMU99-N1-08-1&2 and DMR-98-102 from the China Medical University and Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki F, 2003, MED PHYS, V30, P1976, DOI 10.1118/1.1587451; Chiu-Tsao ST, 2004, MED PHYS, V31, P201, DOI 10.1118/1.1637733; Hoshi Y, 2000, J RADIAT RES, V41, P129, DOI 10.1269/jrr.41.129; Hsu SM, 2008, MED PHYS, V35, P5558, DOI 10.1118/1.3005478; Karaiskos P, 1998, MED PHYS, V25, P1975, DOI 10.1118/1.598371; Kassas B, 2006, J APPL CLIN MED PHYS, V7, P28, DOI 10.1120/jacmp.v7i3.2293; Kirov AS, 1995, PHYS MED BIOL, V40, P2015, DOI 10.1088/0031-9155/40/12/002; MEISBERGER LL, 1968, RADIOLOGY, V90, P953, DOI 10.1148/90.5.953; MEREDITH WJ, 1966, BRIT J RADIOL, V39, P280, DOI 10.1259/0007-1285-39-460-280; Mishra V, 1997, MED PHYS, V24, P751, DOI 10.1118/1.597983; MULLERRUNKEL R, 1994, MED PHYS, V21, P1131, DOI 10.1118/1.597339; NATH R, 1990, MED PHYS, V17, P1032, DOI 10.1118/1.596584; NATH R, 1993, MED PHYS, V20, P1465, DOI 10.1118/1.597110; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Niroomand-Rad A, 1998, MED PHYS, V25, P2093, DOI 10.1118/1.598407; Pantelis E, 2005, INT J RADIAT ONCOL, V61, P1596, DOI 10.1016/j.ijrobp.2004.12.065; Sharma SD, 2004, PHYS MED BIOL, V49, P4065, DOI 10.1088/0031-9155/49/17/016; Taylor REP, 2008, MED PHYS, V35, P4933, DOI 10.1118/1.2987676; Tsuda Masayuki, 2000, Igaku Butsuri, V20, P131; Wang RQ, 1996, MED PHYS, V23, P1459, DOI 10.1118/1.597728; WILLIAMSON JF, 1995, MED PHYS, V22, P809, DOI 10.1118/1.597483	21	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44528	10.1371/journal.pone.0044528	http://dx.doi.org/10.1371/journal.pone.0044528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957078	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800071
J	Rivera-Serrano, EE; Rodriguez-Welsh, MF; Hicks, GR; Rojas-Pierce, M				Rivera-Serrano, Efrain E.; Rodriguez-Welsh, Maria F.; Hicks, Glenn R.; Rojas-Pierce, Marcela			A Small Molecule Inhibitor Partitions Two Distinct Pathways for Trafficking of Tonoplast Intrinsic Proteins in Arabidopsis	PLOS ONE			English	Article							AUXIN EFFLUX CARRIER; STORAGE VACUOLE; PLANT-CELLS; GOLGI-APPARATUS; IN-VIVO; ENDOSOMAL TRAFFICKING; SECRETORY PATHWAY; PLASMA-MEMBRANE; MECHANISMS; TRANSPORT	Tonoplast intrinsic proteins (TIPs) facilitate the membrane transport of water and other small molecules across the plant vacuolar membrane, and members of this family are expressed in specific developmental stages and tissue types. Delivery of TIP proteins to the tonoplast is thought to occur by vesicle-mediated traffic from the endoplasmic reticulum to the vacuole, and at least two pathways have been proposed, one that is Golgi-dependent and another that is Golgi-independent. However, the mechanisms for trafficking of vacuolar membrane proteins to the tonoplast remain poorly understood. Here we describe a chemical genetic approach to unravel the mechanisms of TIP protein targeting to the vacuole in Arabidopsis seedlings. We show that members of the TIP family are targeted to the vacuole via at least two distinct pathways, and we characterize the bioactivity of a novel inhibitor that can differentiate between them. We demonstrate that, unlike for TIP1;1, trafficking of markers for TIP3;1 and TIP2;1 is insensitive to Brefeldin A in Arabidopsis hypocotyls. Using a chemical inhibitor that may target this BFA-insensitive pathway for membrane proteins, we show that inhibition of this pathway results in impaired root hair growth and enhanced vacuolar targeting of the auxin efflux carrier PIN2 in the dark. Our results indicate that the vacuolar targeting of PIN2 and the BFA-insensitive pathway for tonoplast proteins may be mediated in part by common mechanisms.	[Rivera-Serrano, Efrain E.; Rodriguez-Welsh, Maria F.; Rojas-Pierce, Marcela] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Hicks, Glenn R.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Hicks, Glenn R.] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of North Carolina; North Carolina State University; University of California System; University of California Riverside; University of California System; University of California Riverside	Rivera-Serrano, EE (corresponding author), N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA.	mrojasp@ncsu.edu		Rivera-Serrano, Efrain E./0000-0002-1039-7182; Rojas-Pierce, Marcela/0000-0003-1051-1827	NC State Initiative for Maximizing Student Diversity (IMSD) program; U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; North Carolina State University; National Science Foundation [IOS-0951616]; North Carolina Space Grant New Investigators Program award	NC State Initiative for Maximizing Student Diversity (IMSD) program; U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; North Carolina State University; National Science Foundation(National Science Foundation (NSF)); North Carolina Space Grant New Investigators Program award	ERS was supported by the NC State Initiative for Maximizing Student Diversity (IMSD) program and a U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship. This work was supported by start-up funds from North Carolina State University, a grant for the National Science Foundation (IOS-0951616) and North Carolina Space Grant New Investigators Program award to MRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bolte S, 2011, PLANT CELL PHYSIOL, V52, P1142, DOI 10.1093/pcp/pcr065; Bottanelli F, 2011, PLANT CELL; Brandizzi F, 2002, PLANT CELL, V14, P1077, DOI 10.1105/tpc.000620; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Di Sansebastiano GP, 2001, PLANT PHYSIOL, V126, P78, DOI 10.1104/pp.126.1.78; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Drakakaki G, 2011, P NATL ACAD SCI USA, V108, P17850, DOI 10.1073/pnas.1108581108; Drakakaki G, 2009, PLANT SIGNAL BEHAV, V4, P57, DOI 10.4161/psb.4.1.7314; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Frigerio L, 2008, TRAFFIC, V9, P1564, DOI 10.1111/j.1600-0854.2008.00776.x; Fuji K, 2007, PLANT CELL, V19, P597, DOI 10.1105/tpc.106.045997; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Gattolin S, 2010, BIOCHEM SOC T, V38, P769, DOI 10.1042/BST0380769; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; GOMEZ L, 1993, PLANT CELL, V5, P1113, DOI 10.1105/tpc.5.9.1113; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Hunter PR, 2007, PLANT PHYSIOL, V145, P1371, DOI 10.1104/pp.107.103945; Hwang I, 2008, PLANT PHYSIOL, V148, P673, DOI 10.1104/pp.108.124925; Isayenkov S, 2011, PLANT CELL, V23, P756, DOI 10.1105/tpc.110.081463; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jauh GY, 1999, PLANT CELL, V11, P1867, DOI 10.1105/tpc.11.10.1867; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Lam SK, 2009, PLANT J, V60, P865, DOI 10.1111/j.1365-313X.2009.04007.x; Laxmi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001510; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Olbrich A, 2007, PLANT PHYSIOL, V145, P1383, DOI 10.1104/pp.107.108985; Paris N, 1996, CELL, V85, P563, DOI 10.1016/S0092-8674(00)81256-8; Park M, 2004, PLANT PHYSIOL, V134, P625, DOI 10.1104/pp.103.030635; Reyes FC, 2011, CURR OPIN PLANT BIOL, V14, P666, DOI 10.1016/j.pbi.2011.07.009; Reyes FC, 2011, PLANT CELL, V23, P769, DOI 10.1105/tpc.110.082156; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Richter S, 2009, TRAFFIC, V10, P819, DOI 10.1111/j.1600-0854.2009.00916.x; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Rojo E, 2001, DEV CELL, V1, P303, DOI 10.1016/S1534-5807(01)00024-7; Rojo E, 2008, PLANT PHYSIOL, V147, P1493, DOI 10.1104/pp.108.124552; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Surpin M, 2004, NAT REV MOL CELL BIO, V5, P100, DOI 10.1038/nrm1311; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tyrrell M, 2007, PLANT J, V51, P1099, DOI 10.1111/j.1365-313X.2007.03206.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Wolfenstetter S, 2012, PLANT CELL; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Yao HY, 2011, CURR OPIN PLANT BIOL, V14, P571, DOI 10.1016/j.pbi.2011.06.009; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang Y, 2010, SEX PLANT REPROD, V23, P87, DOI 10.1007/s00497-009-0118-z; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zheng HQ, 2011, PLANT PHYSIOL, V155, P2023, DOI 10.1104/pp.110.170159	72	31	31	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44735	10.1371/journal.pone.0044735	http://dx.doi.org/10.1371/journal.pone.0044735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957103	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800096
J	Sato, N; Suzuki, N; Sasaki, A; Aizawa, E; Obayashi, T; Kanazawa, M; Mizuno, T; Kano, M; Aoki, M; Fukudo, S				Sato, Naoko; Suzuki, Naoki; Sasaki, Ayaka; Aizawa, Emiko; Obayashi, Takeshi; Kanazawa, Motoyori; Mizuno, Tomoko; Kano, Michiko; Aoki, Masashi; Fukudo, Shin			Corticotropin-Releasing Hormone Receptor 1 Gene Variants in Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; ENTERIC NERVOUS-SYSTEM; ADULT DEPRESSION; CHILDHOOD MALTREATMENT; ANXIETY BEHAVIOR; SEX-DIFFERENCES; CRF1 RECEPTOR; EXPRESSION; BRAIN; STRESS	Background: Corticotropin-releasing hormone (CRH) acts mainly via the CRH receptor 1 (CRH-R1) and plays a crucial role in the stress-induced pathophysiology of irritable bowel syndrome (IBS). Several studies have demonstrated that variants of the CRH-R1 gene carry a potential risk for depression, but evidence for an association between CRH-R1 genotypes and IBS is lacking. We tested the hypothesis that genetic polymorphisms and haplotypes of CRH-R1 moderate the IBS phenotype and negative emotion in IBS patients. Methods: A total of 103 patients with IBS and 142 healthy controls participated in the study. Three single-nucleotide polymorphisms of the CRH-R1 gene (rs7209436, rs242924, and rs110402) were genotyped. Subjects' emotional states were evaluated using the Perceived-Stress Scale, the State-Trait Anxiety Inventory, and the Self-rating Depression Scale. Results: The TT genotype of rs7209436 (P = 0.01) and rs242924 (P = 0.02) was significantly more common in patients with IBS than in controls. Total sample analysis showed significant association between bowel pattern (normal, diarrhea, constipation, or mixed symptoms) and the T allele of rs7209436 (P = 0.008), T allele of rs242924 (P = 0.019), A allele of rs110402 (P = 0.047), and TAT haplocopies (P = 0.048). Negative emotion was not associated with the examined CRH-R1 SNPs. Conclusion: These findings suggest that genetic polymorphisms and the CRH-R1 haplotypes moderate IBS and related bowel patterns. There was no clear association between CRH-R1 genotypes and negative emotion accompanying IBS. Further studies on the CRH system are therefore warranted.	[Sato, Naoko; Sasaki, Ayaka; Aizawa, Emiko; Kanazawa, Motoyori; Mizuno, Tomoko; Kano, Michiko; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Obayashi, Takeshi] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Human & Life Sci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Sato, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.	sfukudo@med.tohoku.ac.jp	Suzuki, Naoki/J-6331-2019; Kano, Michiko/K-6527-2013; Fukudo, Shin/J-4813-2014; Obayashi, Takeshi/E-9663-2011	Suzuki, Naoki/0000-0001-8880-8554; Obayashi, Takeshi/0000-0002-3106-722X	Ministry of Education, Science, and Culture of Japan; Ministry of Health, Welfare, and Labor of Japan; Grants-in-Aid for Scientific Research [24114005, 22590646] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouin M, 2002, GASTROENTEROLOGY, V122, P1771, DOI 10.1053/gast.2002.33601; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brunton PJ, 2011, STRESS, V14, P634, DOI 10.3109/10253890.2011.604750; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DeYoung CG, 2011, J CHILD PSYCHOL PSYC, V52, P898, DOI 10.1111/j.1469-7610.2011.02404.x; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; FUKUDO S, 1993, J CLIN GASTROENTEROL, V17, P133, DOI 10.1097/00004836-199309000-00009; Fukudo S, 2012, PHYSL GASTROINTESTIN, P795; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Grammatopoulos DK, 2012, BRIT J PHARMACOL, V166, P85, DOI 10.1111/j.1476-5381.2011.01631.x; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hsu DT, 2012, J NEUROSCI, V32, P3253, DOI 10.1523/JNEUROSCI.5533-11.2012; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Kageyama K, 2009, ENDOCR J, V56, P335, DOI 10.1507/endocrj.K09E-075; Kanazawa M, 2004, DIGEST DIS SCI, V49, P1046, DOI 10.1023/B:DDAS.0000034570.52305.10; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Liu SM, 2006, J COMP NEUROL, V494, P63, DOI 10.1002/cne.20781; Liu SM, 2005, J COMP NEUROL, V481, P284, DOI 10.1002/cne.20370; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Markovic D, 2009, TRENDS BIOCHEM SCI, V34, P443, DOI 10.1016/j.tibs.2009.06.002; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Miyata K, 1998, AM J PHYSIOL-GASTR L, V274, pG827, DOI 10.1152/ajpgi.1998.274.5.G827; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; MONNIKES H, 1993, GASTROENTEROLOGY, V104, P716; Muramatsu Y, 2000, PEPTIDES, V21, P1799, DOI 10.1016/S0196-9781(00)00335-1; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; Papiol S, 2007, J AFFECT DISORDERS, V104, P83, DOI 10.1016/j.jad.2007.02.017; Pisarchik A, 2001, FASEB J, V15, P2754, DOI 10.1096/fj.01-0487fje; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Saito K, 2005, GASTROENTEROLOGY, V129, P1533, DOI 10.1053/j.gastro.2005.07.053; Seino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032913; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Sterrenburg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028128; Tayama J, 2007, NEUROGASTROENT MOTIL, V19, P471, DOI 10.1111/j.1365-2982.2007.00903.x; Tyrka AR, 2009, BIOL PSYCHIAT, V66, P681, DOI 10.1016/j.biopsych.2009.05.012; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1; Zmijewski MA, 2009, J CELL PHYSIOL, V218, P593, DOI 10.1002/jcp.21632; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	53	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42450	10.1371/journal.pone.0042450	http://dx.doi.org/10.1371/journal.pone.0042450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957021	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800013
J	Hause, RJ; Leung, KK; Barkinge, JL; Ciaccio, MF; Chuu, CP; Jones, RB				Hause, Ronald J., Jr.; Leung, Kin K.; Barkinge, John L.; Ciaccio, Mark F.; Chuu, Chih-pin; Jones, Richard B.			Comprehensive Binary Interaction Mapping of SH2 Domains via Fluorescence Polarization Reveals Novel Functional Diversification of ErbB Receptors	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; BINDING; SRC; GENE; RECRUITMENT; EXPRESSION; SITES; PHOSPHOPEPTIDES; OVEREXPRESSION; SELECTIVITY	First-generation interaction maps of Src homology 2 (SH2) domains with receptor tyrosine kinase (RTK) phosphosites have previously been generated using protein microarray (PM) technologies. Here, we developed a large-scale fluorescence polarization (FP) methodology that was able to characterize interactions between SH2 domains and ErbB receptor phosphosites with higher fidelity and sensitivity than was previously achieved with PMs. We used the FP assay to query the interaction of synthetic phosphopeptides corresponding to 89 ErbB receptor intracellular tyrosine sites against 93 human SH2 domains and 2 phosphotyrosine binding (PTB) domains. From 358,944 polarization measurements, the affinities for 1,405 unique biological interactions were determined, 83% of which are novel. In contrast to data from previous reports, our analyses suggested that ErbB2 was not more promiscuous than the other ErbB receptors. Our results showed that each receptor displays unique preferences in the affinity and location of recruited SH2 domains that may contribute to differences in downstream signaling potential. ErbB1 was enriched versus the other receptors for recruitment of domains from RAS GEFs whereas ErbB2 was enriched for recruitment of domains from tyrosine and phosphatidyl inositol phosphatases. ErbB3, the kinase inactive ErbB receptor family member, was predictably enriched for recruitment of domains from phosphatidyl inositol kinases and surprisingly, was enriched for recruitment of domains from tyrosine kinases, cytoskeletal regulatory proteins, and RHO GEFs but depleted for recruitment of domains from phosphatidyl inositol phosphatases. Many novel interactions were also observed with phosphopeptides corresponding to ErbB receptor tyrosines not previously reported to be phosphorylated by mass spectrometry, suggesting the existence of many biologically relevant RTK sites that may be phosphorylated but below the detection threshold of standard mass spectrometry procedures. This dataset represents a rich source of testable hypotheses regarding the biological mechanisms of ErbB receptors.	[Hause, Ronald J., Jr.; Barkinge, John L.; Jones, Richard B.] Univ Chicago, Comm Genet Gen & Syst Biol, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Hause, Ronald J., Jr.; Leung, Kin K.; Barkinge, John L.; Ciaccio, Mark F.; Jones, Richard B.] Univ Chicago, Inst Genom & Syst Biol, Gwen & Jules Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Leung, Kin K.; Jones, Richard B.] Univ Chicago, Comm Canc Biol, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Ciaccio, Mark F.; Jones, Richard B.] Univ Chicago, Comm Cellular & Mol Physiol, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chuu, Chih-pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Chuu, Chih-pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan	University of Chicago; University of Chicago; University of Chicago; University of Chicago; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Hause, RJ (corresponding author), Univ Chicago, Comm Genet Gen & Syst Biol, Ben May Dept Canc Res, Chicago, IL 60637 USA.	rbjones@uchicago.edu	Chuu, Chih-Pin/B-1086-2010; Chuu, Chih-Pin/N-6697-2019	Hause, Ronald/0000-0002-5229-7366	Cancer Research Foundation; Illinois Department of Health; National Institutes of Health Postdoctoral Cardiovascular Training Grant; NIH Cancer Biology Postdoctoral Training Grant; NIH Cancer Biology Predoctoral Training grant; NIH Genetics and Regulation Predoctoral Training Grant; NIH Systems Biology of Oxygen Predoctoral Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	Cancer Research Foundation; Illinois Department of Health; National Institutes of Health Postdoctoral Cardiovascular Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Biology Postdoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Biology Predoctoral Training grant; NIH Genetics and Regulation Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Systems Biology of Oxygen Predoctoral Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the Cancer Research Foundation and The Illinois Department of Health. Additional support was provided by National Institutes of Health Postdoctoral Cardiovascular Training Grant (JB), NIH Cancer Biology Postdoctoral Training Grant (CPC), NIH Cancer Biology Predoctoral Training grant (KKL), NIH Genetics and Regulation Predoctoral Training Grant (RJH), and NIH Systems Biology of Oxygen Predoctoral Training Grant (MFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; FELDER S, 1993, MOL CELL BIOL, V13, P1449, DOI 10.1128/MCB.13.3.1449; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ji QS, 1999, MOL CELL BIOL, V19, P4961; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaimachnikov NP, 2009, FEBS J, V276, P4102, DOI 10.1111/j.1742-4658.2009.07117.x; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; LEMMON MA, 1994, BIOCHEMISTRY-US, V33, P5070, DOI 10.1021/bi00183a010; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Lubman OY, 2003, J MOL BIOL, V328, P655, DOI 10.1016/S0022-2836(03)00344-9; Lynch BA, 1997, ANAL BIOCHEM, V247, P77, DOI 10.1006/abio.1997.2042; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PANAYOTOU G, 1993, MOL CELL BIOL, V13, P3567, DOI 10.1128/MCB.13.6.3567; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Ritz C, 2005, J STAT SOFTW, V12, P1; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Shalloway D, 1997, TRENDS CELL BIOL, V7, P215; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	55	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44471	10.1371/journal.pone.0044471	http://dx.doi.org/10.1371/journal.pone.0044471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973453	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600059
J	He, L; Ding, H; Wang, JH; Zhou, Y; Li, L; Yu, YH; Huang, L; Jia, WH; Zeng, MS; Yun, JP; Luo, RZ; Zheng, M				He, Li; Ding, Hui; Wang, Jian-Hua; Zhou, Yun; Li, Li; Yu, Yan-Hong; Huang, Long; Jia, Wei-Hua; Zeng, Musheng; Yun, Jing-Ping; Luo, Rong-Zhen; Zheng, Min			Overexpression of Karyopherin 2 in Human Ovarian Malignant Germ Cell Tumor Correlates with Poor Prognosis	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; BREAST-CANCER; DIAGNOSTIC UTILITY; GENETIC-ANALYSIS; EXPRESSION; ALPHA-2; KPNA2; CYTOGENETICS; TERATOMAS; SURVIVAL	Background: The aim of this study was to identify a biomarker useful in the diagnosis and therapy of ovarian malignant germ cell tumor (OMGCT). Methods: The karyopherin 2 (KPNA2) expression in OMGCT and normal ovarian tissue was determined by standard gene microarray assays, and further validated by a quantitative RT-PCR and immunohistochemistry. The correlation between KPNA2 expression in OMGCT and certain clinicopathological features were analyzed. Expression of SALL4, a stem cell marker, was also examined in comparison with KPNA2. Results: KPNA2 was found to be over-expressed by approximately eight-fold in yolk sac tumors and immature teratomas compared to normal ovarian tissue by microarray assays. Overexpression was detected in yolk sac tumors, immature teratomas, dysgerminomas, embryonal carcinomas, mature teratomas with malignant transformation and mixed ovarian germ cell tumors at both the transcription and translation levels. A positive correlation between KPNA2 and SALL4 expression at both the transcription level (R = 0.5120, P = 0.0125), and the translation level (R = 0.6636, P<0.0001), was presented. Extensive expression of KPNA2 was positively associated with pathologic type, recurrence and uncontrolled, ascitic fluid presence, suboptimal cytoreductive surgery necessity, resistance/refraction to initial chemotherapy, HCG level and SALL4 level in OMGCT patients. KPNA2 was found to be an independent factor for 5-year disease-free survival (DFS) of OMGCT (P = 0.02). The 5-year overall survival (OS) and DFS rate for KPNA2-low expression patients (88% and 79%, n = 48) were significantly higher than the OS and DFS rate for KPNA2-high expression patients (69% and 57.1%, n = 42)(P = 0.0151, P = 0.0109, respectively). The 5-year OS and DFS rate for SALL4-low expression patients (84% and 74%, n = 62) was marginally significantly higher than the high expression patients (78.6% and 71.4%, n = 28)(P = 0.0519, P = 0.0647, respectively). Conclusions: KPNA2 is a potential candidate molecular marker and important prognostic marker in OMGCT patients.	[He, Li; Ding, Hui; Zhou, Yun; Huang, Long; Jia, Wei-Hua; Zeng, Musheng; Zheng, Min] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [He, Li; Ding, Hui; Zhou, Yun; Huang, Long; Zheng, Min] Sun Yat Sen Univ, Dept Gynecol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jing-Ping; Luo, Rong-Zhen] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jian-Hua] Second Peoples Hosp Guangdong Prov, Dept Chest, Guangzhou, Guangdong, Peoples R China; [Li, Li] Sun Yat Sen Univ, Dept Gynecol, Huang Pu Dist Hosp, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Yan-Hong] So Med Univ, Dept Obstet & Gynecol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	He, L (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zheng_min_2006@yahoo.com.cn	Yu, Yan/GYV-4514-2022		National Natural Science Foundation of China [81171948]; Science and Technology Planning Project of Guangdong Province [2009B030801018]; Research Fund of State Key Laboratory of Oncology in Southern China [030041060004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Research Fund of State Key Laboratory of Oncology in Southern China	This study was supported by grants from the National Natural Science Foundation of China (grant 81171948), the Science and Technology Planning Project of Guangdong Province (grant 2009B030801018) and the Research Fund of State Key Laboratory of Oncology in Southern China (No. 030041060004) to Dr. Min Zheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade R, 2003, CHROMOSOMA, V112, P87, DOI 10.1007/s00412-003-0247-3; Bjerggaard JJ, 2011, EURO UROL, V59, P841; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Dorr S, 2001, HUM GENET, V109, P479, DOI 10.1007/s004390100605; Faulkner SW, 2000, GYNECOL ONCOL, V77, P283, DOI 10.1006/gyno.2000.5762; Fischer N, 1997, J BIOL CHEM, V272, P3999, DOI 10.1074/jbc.272.7.3999; GERSHENSON DM, 1993, CANCER-AM CANCER SOC, V71, P1581, DOI 10.1002/cncr.2820710425; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; HOFFNER L, 1992, CANCER GENET CYTOGEN, V62, P58, DOI 10.1016/0165-4608(92)90040-F; KING ME, 1990, INT J GYNECOL PATHOL, V9, P178, DOI 10.1097/00004347-199004000-00009; Kraggerud SM, 2000, CANCER RES, V60, P3025; Kwon JS, 2010, J CLIN ONCOL, V28, P675, DOI 10.1200/JCO.2008.21.4684; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Liu AJ, 2010, AM J SURG PATHOL, V34, P697, DOI 10.1097/PAS.0b013e3181db84aa; Mei KY, 2009, MODERN PATHOL, V22, P1628, DOI 10.1038/modpathol.2009.148; Menon U, 2007, HUM REPROD, V22, P1573, DOI 10.1093/humrep/dem055; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; odriguez E, 1995, CAN GENET CYTO, V82, P62; Quinn JE, 2009, GYNECOL ONCOL, V113, P134, DOI 10.1016/j.ygyno.2008.12.015; Richards WE, 1999, GYNECOL ONCOL, V75, P468, DOI 10.1006/gyno.1999.5645; Riopel MA, 1998, CANCER RES, V58, P3105; Smith HO, 2006, OBSTET GYNECOL, V107, P1075, DOI 10.1097/01.AOG.0000216004.22588.ce; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SPELEMAN F, 1990, CANCER GENET CYTOGEN, V45, P49, DOI 10.1016/0165-4608(90)90065-I; SURTI U, 1990, AM J HUM GENET, V47, P635; Teng SC, 2006, J MOL HISTOL, V37, P293, DOI 10.1007/s10735-006-9032-y; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Trinh DT, 2012, J OBSTET GYNAECOL RE, V38, P841, DOI 10.1111/j.1447-0756.2011.01798.x; Umegaki N, 2007, J INVEST DERMATOL, V127, P1456, DOI 10.1038/sj.jid.5700716; Umezu Tomokazu, 2008, Nagoya J Med Sci, V70, P29; Valarmathi Mani T, 2004, Hum Mutat, V23, P205, DOI 10.1002/humu.9213; van Echten J, 1998, INT J CANCER, V77, P217, DOI 10.1002/(SICI)1097-0215(19980717)77:2<217::AID-IJC8>3.0.CO;2-T; Wang CI, 2011, INT J CANCER, V128, P2364, DOI 10.1002/ijc.25568; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce	38	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e42992	10.1371/journal.pone.0042992	http://dx.doi.org/10.1371/journal.pone.0042992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962582	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600009
J	Kornej, J; Reinhardt, C; Kosiuk, J; Arya, A; Hindricks, G; Adams, V; Husser, D; Bollmann, A				Kornej, Jelena; Reinhardt, Claudia; Kosiuk, Jedrzej; Arya, Arash; Hindricks, Gerhard; Adams, Volker; Husser, Daniela; Bollmann, Andreas			Response of High-Sensitive C-Reactive Protein to Catheter Ablation of Atrial Fibrillation and Its Relation with Rhythm Outcome	PLOS ONE			English	Article							ELECTRICAL CARDIOVERSION; HS-CRP; INFLAMMATION; RECURRENCE; ELEVATION; PERPETUATION; ASSOCIATION; PERSISTENCE; EXPRESSION	Aims: This study investigated the possible association between hs-CRP as well as hs-CRP changes and rhythm outcome after AF catheter ablation. Methods: We studied 68 consecutive patients with AF undergoing catheter ablation. hs-CRP levels were measured using commercially available assays before and 6 months after catheter ablation. Serial 7-day Holter ECGs were used to detect AF recurrences. Results: Early AF recurrence (ERAF, within one week) was observed in 38%, while late AF recurrence (LRAF, between 3 and 6 months) occurred in 18% of the patients. None of the baseline clinical or echocardiographic variables was predictive of ERAF or LRAF. Baseline hs-CRP measured 2.07 +/- 1.1 mu g/ml and was not associated with ERAF and LRAF. At 6 months, hs-CRP levels were comparable with baseline values (2.14 +/- 1.19 mu g/ml, p = 0.409) and were also not related with LRAF. However, patients with LRAF showed an hs-CRP increase from 2.03 +/- 0.61 to 2.62 +/- 1.52 mu g/ml (p = 0.028). Patients with an hs-CRP change in the upper tertile (>0.2 mu g/ml) had LRAF in 32% as opposed to 11% (p = 0.042) in patients in the lower (<-0.3 mu g/ml) or intermediate (20.3-0.2 mu g/ml) tertile. Conclusions: Changes in hs-CRP but not baseline hs-CRP are associated with rhythm outcome after AF catheter ablation. This finding points to a link between an inflammatory response and AF recurrence in this setting.	[Kornej, Jelena; Kosiuk, Jedrzej; Arya, Arash; Hindricks, Gerhard; Husser, Daniela; Bollmann, Andreas] Ctr Heart, Dept Electrophysiol, Leipzig, Germany; [Reinhardt, Claudia; Adams, Volker] Ctr Heart, Dept Cardiol, Leipzig, Germany	Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heart Center Leipzig GMBH; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kornej, J (corresponding author), Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	jelena.kornej@gmx.de		Kosiuk, Jedrzej/0000-0002-7856-1372	Volkswagen Foundation, Germany [I/81545]	Volkswagen Foundation, Germany(Volkswagen)	This study was supported in part by a grant from the Volkswagen Foundation, Germany to Dr. Husser [grant number I/81545]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo M, 2006, INT J CARDIOL, V108, P326, DOI 10.1016/j.ijcard.2005.05.017; Anderson JL, 2004, AM J CARDIOL, V94, P1255, DOI 10.1016/j.amjcard.2004.07.108; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Eitel C, 2010, HEART RHYTHM, V7, P157, DOI 10.1016/j.hrthm.2009.10.003; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Henningsen KMA, 2009, SCAND J CLIN LAB INV, V69, P425, DOI 10.1080/00365510802676848; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Joshi MS, 2012, CARDIOVASC PATHOL; Kallergis EM, 2008, HEART, V94, P200, DOI 10.1136/hrt.2006.108688; Korantzopoulos P, 2005, INT J CLIN PRACT, V59, P881, DOI 10.1111/j.1368-5031.2005.00569.x; Kourliouros A, 2009, AM HEART J, V157, P243, DOI 10.1016/j.ahj.2008.10.009; Lellouche N, 2009, EUROPACE, V11, P662, DOI 10.1093/europace/eup077; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; Lin YJ, 2010, AM J CARDIOL, V105, P495, DOI 10.1016/j.amjcard.2009.10.019; Liu J, 2010, PACING CLIN ELECTROP, P1540; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Malouf JF, 2005, J AM COLL CARDIOL, V46, P1284, DOI 10.1016/j.jacc.2005.06.053; McCabe JM, 2008, PACE, V31, P1146, DOI 10.1111/j.1540-8159.2008.01155.x; Nakamura Y, 2003, THROMB RES, V111, P137, DOI 10.1016/S0049-3848(03)00405-5; Narducci ML, 2011, EUROPACE, P29; Psychari SN, 2005, AM J CARDIOL, V95, P764, DOI 10.1016/j.amjcard.2004.11.032; Rotter M, 2006, J AM COLL CARDIOL, V47, P1231, DOI 10.1016/j.jacc.2005.12.038; Stein A, 2008, EUROPACE, V10, P444, DOI 10.1093/europace/eun041; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Watanabe T, 2005, HEART VESSELS, V20, P45, DOI 10.1007/s00380-004-0800-x	30	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44165	10.1371/journal.pone.0044165	http://dx.doi.org/10.1371/journal.pone.0044165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957001	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500051
J	Matthews, SB; Santra, M; Mensack, MM; Wolfe, P; Byrne, PF; Thompson, HJ				Matthews, Shawna B.; Santra, Meenakshi; Mensack, Meghan M.; Wolfe, Pamela; Byrne, Patrick F.; Thompson, Henry J.			Metabolite Profiling of a Diverse Collection of Wheat Lines Using Ultraperformance Liquid Chromatography Coupled with Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; CLASSIFICATION; REDUCTION; ORIGINS; LIPIDS; WILD	Genetic differences among major types of wheat are well characterized; however, little is known about how these distinctions affect the small molecule profile of the wheat seed. Ethanol/water (65% v/v) extracts of seed from 45 wheat lines representing 3 genetically distinct classes, tetraploid durum (Triticum turgidum subspecies durum) (DW) and hexaploid hard and soft bread wheat (T. aestivum subspecies aestivum) (BW) were subjected to ultraperformance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC-TOF-MS). Discriminant analyses distinguished DW from BW with 100% accuracy due to differences in expression of nonpolar and polar ions, with differences attributed to sterol lipids/fatty acids and phospholipids/glycerolipids, respectively. Hard versus soft BW was distinguished with 100% accuracy by polar ions, with differences attributed to heterocyclic amines and polyketides versus phospholipid ions, respectively. This work provides a foundation for identification of metabolite profiles associated with desirable agronomic and human health traits and for assessing how environmental factors impact these characteristics.	[Matthews, Shawna B.; Santra, Meenakshi; Thompson, Henry J.] Colorado State Univ, Canc Prevent Lab, Ft Collins, CO 80523 USA; [Matthews, Shawna B.; Santra, Meenakshi; Thompson, Henry J.] Colorado State Univ, Dept Hort, Ft Collins, CO 80523 USA; [Matthews, Shawna B.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Mensack, Meghan M.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Wolfe, Pamela] Univ Colorado, Colorado Biostat Consortium, Denver, CO 80202 USA; [Byrne, Patrick F.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; University of Colorado System; University of Colorado Denver; Colorado State University	Matthews, SB (corresponding author), Colorado State Univ, Canc Prevent Lab, Ft Collins, CO 80523 USA.	henry.thompson@colostate.edu	Byrne, Patrick/AFP-4228-2022		Colorado Wheat Administrative Committee; Colorado Wheat Research Foundation	Colorado Wheat Administrative Committee; Colorado Wheat Research Foundation	This work was supported in part by a grant from the Colorado Wheat Administrative Committee and Colorado Wheat Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanino C, 2002, ANAL CHIM ACTA, V454, P315, DOI 10.1016/S0003-2670(01)01548-3; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2011, BBA-MOL CELL BIOL L, V1811, P637, DOI 10.1016/j.bbalip.2011.06.009; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gabrielsson J, 2006, CHEMOMETR INTELL LAB, V84, P153, DOI 10.1016/j.chemolab.2006.03.013; Gooding M. J., 2009, WHEAT CHEM TECHNOLOG, V4th, P19; Heldt H.-W., 2005, PLANT BIOCH; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kopka J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-109; Luque-Garcia JL, 2003, TRAC-TREND ANAL CHEM, V22, P41, DOI 10.1016/S0165-9936(03)00102-X; MAPLESTONE RA, 1992, GENE, V115, P151, DOI 10.1016/0378-1119(92)90553-2; Mensack MM, 2010, J AGR FOOD CHEM, V58, P6697, DOI 10.1021/jf1007538; Morrison D. F., 1990, MULTIVARIATE STAT ME; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ohm J.-B., 2009, WHEAT CHEM TECHNOLOG, P363; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Reynolds MP, 2002, FAO PLANT PRODUCTION, P567; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sumner Lloyd W, 2007, EXS, V97, P195; Thompson MD, 2012, CARCINOGENESIS, V33, P226, DOI 10.1093/carcin/bgr247; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tuominen LK, 2009, METHODS MOL BIOL, V547, P373, DOI 10.1007/978-1-60327-287-2_30; Tushar, 2008, DATA MIN KNOWL DISC, P98; US Census Bureau, 2011, INT DAT BAS; Villagrasa M, 2006, J AGR FOOD CHEM, V54, P1009, DOI 10.1021/jf050898h; Wiklund S., 2008, UMETRICS; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Williams PC, 1993, WORLD WHEAT GRAIN OI; Williams PC, 1993, WORLD WHEAT GRAIN OI, V2; Wrigley, 2009, WHEAT CHEM TECHNOLOG, P1, DOI [10.1016/B978-1-891127-55-7.50008-2, DOI 10.1016/B978-1-891127-55-7.50008-2]	37	33	33	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44179	10.1371/journal.pone.0044179	http://dx.doi.org/10.1371/journal.pone.0044179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957002	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500053
J	Smith, LR; Chambers, HG; Subramaniam, S; Lieber, RL				Smith, Lucas R.; Chambers, Henry G.; Subramaniam, Shankar; Lieber, Richard L.			Transcriptional Abnormalities of Hamstring Muscle Contractures in Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; MEDIAL GASTROCNEMIUS; SPASTIC DIPLEGIA; GENE ONTOLOGY; STIFFNESS; HYPOEXTENSIBILITY; DIFFERENTIATION; ARCHITECTURE	Cerebral palsy (CP) is an upper motor neuron disease that results in a spectrum of movement disorders. Secondary to the neurological lesion, muscles from patients with CP are often spastic and form debilitating contractures that limit range of motion and joint function. With no genetic component, the pathology of skeletal muscle in CP is a response to aberrant complex neurological input in ways that are not fully understood. This study was designed to gain further understanding of the skeletal muscle response in CP using transcriptional profiling correlated with functional measures to broadly investigate muscle adaptations leading to mechanical deficits. Biospsies were obtained from both the gracilis and semitendinosus muscles from a cohort of patients with CP (n = 10) and typically developing patients (n = 10) undergoing surgery. Biopsies were obtained to define the unique expression profile of the contractures and passive mechanical testing was conducted to determine stiffness values in previously published work. Affymetrix HG-U133A 2.0 chips (n = 40) generated expression data, which was validated for selected transcripts using quantitative real-time PCR. Chips were clustered based on their expression and those from patients with CP clustered separately. Significant genes were determined conservatively based on the overlap of three summarization algorithms (n = 1,398). Significantly altered genes were analyzed for over-representation among gene ontologies and muscle specific networks. The majority of altered transcripts were related to increased extracellular matrix expression in CP and a decrease in metabolism and ubiquitin ligase activity. The increase in extracellular matrix products was correlated with mechanical measures demonstrating the importance in disability. These data lay a framework for further studies and development of novel therapies.	[Smith, Lucas R.; Subramaniam, Shankar; Lieber, Richard L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Chambers, Henry G.] Rady Childrens Hosp, Dept Orthoped Surg, San Diego, CA USA; [Chambers, Henry G.; Lieber, Richard L.] Univ Calif San Diego, Dept Orthoped Surg, La Jolla, CA 92093 USA; [Lieber, Richard L.] US Dept Vet Affairs, Med Ctr, San Diego, CA USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs	Smith, LR (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	rlieber@ucsd.edu	Smith, Lucas R/S-2157-2018	Smith, Lucas R/0000-0002-7610-4231; Lieber, Richard/0000-0002-7203-4520	National Institutes of Health [AR057393]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [grant number AR057393]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache CE, 2003, CURR ORTHOPAED, V17, P88, DOI 10.1054/cuor.2003.0328; Barrett RS, 2010, DEV MED CHILD NEUROL, V52, P794, DOI 10.1111/j.1469-8749.2010.03686.x; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Booth CM, 2001, DEV MED CHILD NEUROL, V43, P314, DOI 10.1017/S0012162201000597; Brown CA, 2011, J HUMAN GENETICS; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Clavet H, 2008, CAN MED ASSOC J, V178, P691, DOI 10.1503/cmaj.071056; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crenna P, 1998, NEUROSCI BIOBEHAV R, V22, P571, DOI 10.1016/S0149-7634(97)00046-8; Ducomps C, 2003, ACTA PHYSIOL SCAND, V178, P215, DOI 10.1046/j.1365-201X.2003.01109.x; Dzienkowski R C, 1996, Nurse Pract, V21, P45, DOI 10.1097/00006205-199602000-00004; Dzienkowski RC, 1996, NURSE PRACT, V21, P51; Dzienkowski RC, 1996, NURSE PRACT, V21, P60; Dzienkowski RC, 1996, NURSE PRACT, V21, P57; Elder GCB, 2003, DEV MED CHILD NEUROL, V45, P542, DOI 10.1111/j.1469-8749.2003.tb00954.x; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Graham HK, 2003, J BONE JOINT SURG BR, V85B, P157, DOI 10.1302/0301620X.85B2.14066; Hankins GDV, 2003, OBSTET GYNECOL, V102, P628, DOI 10.1016/S0029-7844(03)00574-X; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Ivanhoe CB, 2004, AM J PHYS MED REHAB, V83, pS3, DOI 10.1097/01.PHM.0000141125.28611.3E; Kim WH, 2011, DEV MED CHILD NEUROL, V53, P68, DOI [10.1111/j.1469-8749.2010.03777.x, 10.1111/j.1469-8749.2011.04006.x]; Klebanov L, 2007, NAT BIOTECHNOL, V25, P24, DOI 10.1038/nbt0107-25; Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7; Kovanen V, 2002, EXERC SPORT SCI REV, V30, P20, DOI 10.1097/00003677-200201000-00005; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lieber RL, 2002, MUSCLE NERVE, V25, P265, DOI 10.1002/mus.10036; Lin JP, 2011, DEV MED CHILD NEUROL, V53, P7, DOI 10.1111/j.1469-8749.2010.03843.x; Lorentzen J, 2010, CLIN NEUROPHYSIOL; Malaiya R, 2007, J ELECTROMYOGR KINES, V17, P657, DOI 10.1016/j.jelekin.2007.02.009; Maraldi NM, 2011, ADV ENZYME REGUL, V51, P246, DOI 10.1016/j.advenzreg.2010.09.006; Mohagheghi AA, 2008, DEV MED CHILD NEUROL, V50, P44, DOI 10.1111/j.1469-8749.2007.02008.x; Mohagheghi AA, 2007, CLIN BIOMECH, V22, P718, DOI 10.1016/j.clinbiomech.2007.03.004; Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com; Neagoe C, 2003, J MUSCLE RES CELL M, V24, P175, DOI 10.1023/A:1026053530766; Olive M, 2008, NEUROMUSCULAR DISORD, V18, P929, DOI 10.1016/j.nmd.2008.07.009; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pohl M, 2007, BRAIN INJURY, V21, P421, DOI 10.1080/02699050701311109; Ponten EM, 2007, J NEUROL SCI, V253, P25, DOI 10.1016/j.jns.2006.11.006; Reddihough DS, 2003, AUST J PHYSIOTHER, V49, P7, DOI 10.1016/S0004-9514(14)60183-5; Rose J, 2005, DEV MED CHILD NEUROL, V47, P329, DOI 10.1017/S0012162205000629; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCELSI R, 1984, ACTA NEUROPATHOL, V62, P324, DOI 10.1007/BF00687615; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Shortland AP, 2002, DEV MED CHILD NEUROL, V44, P158, DOI 10.1017/S0012162201001864; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Smith LR, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-44; Stackhouse SK, 2005, MUSCLE NERVE, V31, P594, DOI 10.1002/mus.20302; TARDIEU C, 1982, ARCH PHYS MED REHAB, V63, P97; TARDIEU G, 1982, ARCH PHYS MED REHAB, V63, P103; Theroux MC, 2002, ANESTHESIOLOGY, V96, P330, DOI 10.1097/00000542-200202000-00017; Tilton Ann H, 2006, NeuroRx, V3, P217, DOI 10.1016/j.nurx.2006.01.008; TSAY HJ, 1989, J CELL BIOL, V108, P1523, DOI 10.1083/jcb.108.4.1523; Verrotti A, 2006, PEDIATR NEUROL, V34, P1, DOI 10.1016/j.pediatrneurol.2005.05.001; Yeargin-Allsopp M, 2008, PEDIATRICS, V121, P547, DOI 10.1542/peds.2007-1270; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	63	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2012	7	8							e40686	10.1371/journal.pone.0040686	http://dx.doi.org/10.1371/journal.pone.0040686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AN	22956992	Green Published, Green Submitted, gold			2022-12-27	WOS:000307824300004
J	Lio, P; Angelini, C; De Feis, I; Nguyen, VA				Lio, Pietro; Angelini, Claudia; De Feis, Italia; Viet-Anh Nguyen			Statistical Approaches to Use a Model Organism for Regulatory Sequences Annotation of Newly Sequenced Species	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; SCHIZOSACCHAROMYCES-POMBE; CANDIDA-ALBICANS; CELL-CYCLE; HUMAN GENOME; SITES; YEAST; GENE; EXPRESSION; IDENTIFICATION	A major goal of bioinformatics is the characterization of transcription factors and the transcriptional programs they regulate. Given the speed of genome sequencing, we would like to quickly annotate regulatory sequences in newly-sequenced genomes. In such cases, it would be helpful to predict sequence motifs by using experimental data from closely related model organism. Here we present a general algorithm that allow to identify transcription factor binding sites in one newly sequenced species by performing Bayesian regression on the annotated species. First we set the rationale of our method by applying it within the same species, then we extend it to use data available in closely related species. Finally, we generalise the method to handle the case when a certain number of experiments, from several species close to the species on which to make inference, are available. In order to show the performance of the method, we analyse three functionally related networks in the Ascomycota. Two gene network case studies are related to the G2/M phase of the Ascomycota cell cycle; the third is related to morphogenesis. We also compared the method with MatrixReduce and discuss other types of validation and tests. The first network is well known and provides a biological validation test of the method. The two cell cycle case studies, where the gene network size is conserved, demonstrate an effective utility in annotating new species sequences using all the available replicas from model species. The third case, where the gene network size varies among species, shows that the combination of information is less powerful but is still informative. Our methodology is quite general and could be extended to integrate other high-throughput data from model organisms.	[Lio, Pietro; Viet-Anh Nguyen] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Angelini, Claudia; De Feis, Italia] CNR, Ist Applicaz Calcolo Mauro Picone, I-80125 Naples, Italy	University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Lio, P (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	pl219@cam.ac.uk	DEFEIS, ITALIA/N-7506-2015; Angelini, Claudia/J-4106-2012; Angelini, Claudia/AAL-2555-2020; P. Lió, Pietro Lio/AAV-3358-2021	DEFEIS, ITALIA/0000-0002-3694-8202; Angelini, Claudia/0000-0001-8350-8464; P. Lió, Pietro Lio/0000-0002-0540-5053	Italian Flagships Project "Epigenomics"	Italian Flagships Project "Epigenomics"	We acknowledge the Schizosaccharomyces Japonicus Sequencing Project at Broad Institute of Harvard and MIT (http://www.broad.mit.edu). Claudia Angelini and Italia De Feis acknowledge the Italian Flagships Project "Epigenomics", that partially supported the research.	Angelini C, 2010, LECT NOTES COMPUTER, V6160, P367; Angelini C, 2008, AIP CONF PROC, V1028, P277, DOI 10.1063/1.2965094; Angelini C, 2007, LECT NOTES COMPUT SC, V4447, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blanco E, 2006, NUCLEIC ACIDS RES, V34, pD63, DOI 10.1093/nar/gkj116; Brown CT, 2008, METHOD CELL BIOL, V87, P337, DOI 10.1016/S0091-679X(08)00218-5; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Conlon EM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-247; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Geuten K, 2007, SYSTEMATIC BIOL, V56, P609, DOI 10.1080/10635150701499563; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; McAuliffe JD, 2005, P NATL ACAD SCI USA, V102, P7900, DOI 10.1073/pnas.0502790102; MINEHART PL, 1992, J BACTERIOL, V174, P1828, DOI 10.1128/jb.174.6.1828-1836.1992; Mulhern SM, 2006, EUKARYOT CELL, V5, P2001, DOI 10.1128/EC.00155-06; Ndamukong I, 2006, THESIS GOTTINGEN; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nguyen VA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S14; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Pardi F, 2005, PLOS GENET, V1, P672, DOI 10.1371/journal.pgen.0010071; Piazza F, 2005, PHYSICA A, V347, P472, DOI 10.1016/j.physa.2004.08.038; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Robertson AG, 2005, NUCLEIC ACIDS RES, V1, pD68; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Song Y, 2008, MOL BIOL CELL, V19, P5456, DOI 10.1091/mbc.E08-03-0272; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tadesse MG, 2004, BIOINFORMATICS, V20, P2553, DOI 10.1093/bioinformatics/bth282; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WEEMS JJ, 1992, CLIN INFECT DIS, V14, P756, DOI 10.1093/clinids/14.3.756; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	43	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42489	10.1371/journal.pone.0042489	http://dx.doi.org/10.1371/journal.pone.0042489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984403	gold, Green Submitted, Green Published			2022-12-27	WOS:000308638700006
J	McLachlan, SM; Aliesky, HA; Chen, CR; Chong, G; Rapoport, B				McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Chong, Gao; Rapoport, Basil			Breaking Tolerance in Transgenic Mice Expressing the Human TSH Receptor A-Subunit: Thyroiditis, Epitope Spreading and Adjuvant as a 'Double Edged Sword'	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; MURINE GRAVES-DISEASE; T-CELLS; HYPERTHYROIDISM; ADENOVIRUS; ANTIBODY; MOUSE; IMMUNIZATION; AUTOANTIBODIES; INSIGHT	Transgenic mice with the human thyrotropin-receptor (TSHR) A-subunit targeted to the thyroid are tolerant of the transgene. In transgenics that express low A-subunit levels (Lo-expressors), regulatory T cell (Treg) depletion using anti-CD25 before immunization with adenovirus encoding the A-subunit (A-sub-Ad) breaks tolerance, inducing extensive thyroid lymphocytic infiltration, thyroid damage and antibody spreading to other thyroid proteins. In contrast, no thyroiditis develops in Hi-expressor transgenics or wild-type mice. Our present goal was to determine if thyroiditis could be induced in Hi-expressor transgenics using a more potent immunization protocol: Treg depletion, priming with Complete Freund's Adjuvant (CFA)+A-subunit protein and further Treg depletions before two boosts with A-sub-Ad. As controls, anti-CD25 treated Hi- and Lo-expressors and wild-type mice were primed with CFA+ mouse thyroglobulin (Tg) or CFA alone before Asub-Ad boosting. Thyroiditis developed after CFA+ A-subunit protein or Tg and A-sub-Ad boosting in Lo-expressor transgenics but Hi-expressors (and wild-type mice) were resistant to thyroiditis induction. Importantly, in Lo-expressors, thyroiditis was associated with the development of antibodies to the mouse TSHR downstream of the A-subunit. Unexpectedly, we observed that the effect of bacterial products on the immune system is a "double-edged sword''. On the one hand, priming with CFA (mycobacteria emulsified in oil) plus A-subunit protein broke tolerance to the A-subunit in Hi-expressor transgenics leading to high TSHR antibody levels. On the other hand, prior treatment with CFA in the absence of A-subunit protein inhibited responses to subsequent immunization with A-sub-Ad. Consequently, adjuvant activity arising in vivo after bacterial infections combined with a protein autoantigen can break self-tolerance but in the absence of the autoantigen, adjuvant activity can inhibit the induction of immunity to autoantigens (like the TSHR) displaying strong self-tolerance.	[McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Chong, Gao; Rapoport, Basil] Cedars Sinai Res Inst, Thyroid Autoimmune Dis Unit, Los Angeles, CA USA; [McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Chong, Gao; Rapoport, Basil] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	McLachlan, SM (corresponding author), Cedars Sinai Res Inst, Thyroid Autoimmune Dis Unit, Los Angeles, CA USA.	mclachlans@cshs.org			National Institutes of Health [DK54684, DK19289]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289, R01DK054684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK54684 (SMM) and DK19289 (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chazenbalk GD, 1999, J CLIN ENDOCR METAB, V84, P702, DOI 10.1210/jc.84.2.702; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Chen CR, 2006, THYROID, V16, P427, DOI 10.1089/thy.2006.16.427; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; Chen CR, 2004, ENDOCRINOLOGY, V145, P228, DOI 10.1210/en.2003-1134; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; Misharin AV, 2009, ENDOCRINOLOGY, V150, P3944, DOI 10.1210/en.2009-0181; Misharin AV, 2009, ENDOCRINOLOGY, V150, P2948, DOI 10.1210/en.2008-1690; Mizutori Y, 2008, CLIN EXP IMMUNOL, V154, P305, DOI 10.1111/j.1365-2249.2008.03769.x; MORRIS JC, 1993, J BIOL CHEM, V268, P10900; Nagayama Y, 2007, THYROID, V17, P981, DOI 10.1089/thy.2007.0161; Pichurin P, 2001, ENDOCRINOLOGY, V142, P3530, DOI 10.1210/en.142.8.3530; Pichurin PN, 2006, J IMMUNOL, V176, P668, DOI 10.4049/jimmunol.176.1.668; Pichurin PN, 2004, CLIN EXP IMMUNOL, V135, P391, DOI 10.1111/j.1365-2249.2004.02399.x; Saitoh O, 2006, ENDOCRINOLOGY, V147, P2417, DOI 10.1210/en.2005-1024; Saitoh O, 2007, ENDOCRINOLOGY, V148, P6040, DOI 10.1210/en.2007-0300; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schwarz-Lauer L, 2003, ENDOCRINOLOGY, V144, P1718, DOI 10.1210/en.2002-0069; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; YAMAMOTO M, 1978, ENDOCRINOLOGY, V103, P2011, DOI 10.1210/endo-103-6-2011	22	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43517	10.1371/journal.pone.0043517	http://dx.doi.org/10.1371/journal.pone.0043517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970131	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000003
J	Porretta, D; Mastrantonio, V; Bellini, R; Somboon, P; Urbanelli, S				Porretta, Daniele; Mastrantonio, Valentina; Bellini, Romeo; Somboon, Pradya; Urbanelli, Sandra			Glacial History of a Modern Invader: Phylogeography and Species Distribution Modelling of the Asian Tiger Mosquito Aedes albopictus	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; GENETIC DIVERSITY; PENINSULAR MALAYSIA; DIPTERA-CULICIDAE; SOUTHEAST-ASIA; PLEISTOCENE; REFUGIA; TEMPERATE; INSIGHTS	Background: The tiger mosquito, Aedes albopictus, is one of the 100 most invasive species in the world and a vector of human diseases. In the last 30 years, it has spread from its native range in East Asia to Africa, Europe, and the Americas. Although this modern invasion has been the focus of many studies, the history of the species' native populations remains poorly understood. Here, we aimed to assess the role of Pleistocene climatic changes in shaping the current distribution of the species in its native range. Methodology/Principal Findings: We investigated the phylogeography, historical demography, and species distribution of Ae. albopictus native populations at the Last Glacial Maximum (LGM). Individuals from 16 localities from East Asia were analyzed for sequence variation at two mitochondrial genes. No phylogeographic structure was observed across the study area. Demographic analyses showed a signature of population expansion that started roughly 70,000 years BP. The occurrence of a continuous and climatically suitable area comprising Southeast China, Indochinese Peninsula, and Sundaland during LGM was indicated by species distribution modelling. Conclusions/Significance: Our results suggest an evolutionary scenario in which, during the last glacial phase, Ae. albopictus did not experience a fragmentation phase but rather persisted in interconnected populations and experienced demographic growth. The wide ecological flexibility of the species probably played a crucial role in its response to glacial-induced environmental changes. Currently, there is little information on the impact of Pleistocene climatic changes on animal species in East Asia. Most of the studies focused on forest-associated species and suggested cycles of glacial fragmentation and post-glacial expansion. The case of Ae. albopictus, which exhibits a pattern not previously observed in the study area, adds an important piece to our understanding of the Pleistocene history of East Asian biota.	[Porretta, Daniele] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Mastrantonio, Valentina; Urbanelli, Sandra] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy; [Bellini, Romeo] Agr & Environm Ctr G Nicoli, Crevalcore, Italy; [Somboon, Pradya] Chiang Mai Univ, Dept Parasitol, Chiang Mai, Thailand	Tuscia University; Sapienza University Rome; Chiang Mai University	Porretta, D (corresponding author), Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy.	daniele.porretta@uniroma1.it	Somboon, Pradya/AAL-3458-2020; URBANELLI, Sandra/N-8821-2016	MASTRANTONIO, VALENTINA/0000-0001-7701-4716; URBANELLI, Sandra/0000-0003-1183-0344; Somboon, Pradya/0000-0002-0760-4363	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356; Armistead JS, 2008, J MED ENTOMOL, V45, P629, DOI 10.1603/0022-2585(2008)45[629:ILCBAA]2.0.CO;2; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bellwood P, 1999, CAMBRIDGE HIST SE AS, V1, P61; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bisconti R, 2011, MOL ECOL, V20, P5313, DOI 10.1111/j.1365-294X.2011.05363.x; BLACK WC, 1988, HEREDITY, V61, P439, DOI 10.1038/hdy.1988.136; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burns EL, 2007, CONSERV GENET, V8, P17, DOI 10.1007/s10592-006-9143-8; Campbell P, 2006, MOL ECOL, V15, P29, DOI 10.1111/j.1365-294X.2005.02769.x; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Chen Hong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P491; de la Roque S, 2008, REV SCI TECH OIE, V27, P339, DOI 10.20506/rst.27.2.1807; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fu YX, 1997, GENETICS, V147, P915; Fuchs J, 2008, J BIOGEOGR, V35, P565, DOI 10.1111/j.1365-2699.2007.01811.x; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Hasumi H., 2004, K 1 COUPLED MODEL MI; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Innes JB, 2009, QUATERNARY SCI REV, V28, P2277, DOI 10.1016/j.quascirev.2009.04.010; Iyengar A, 2005, MOL ECOL, V14, P2281, DOI 10.1111/j.1365-294X.2005.02582.x; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Jones MK, 2009, SCIENCE, V324, P730, DOI 10.1126/science.1172082; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Lawing AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028554; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Morgan K, 2011, MOL ECOL, V20, P4533, DOI 10.1111/j.1365-294X.2011.05268.x; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; NEI M, 1978, GENETICS, V89, P583; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pope KO, 2008, J BIOGEOGR, V35, P1, DOI 10.1111/j.1365-2699.2007.01797.x; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Porretta D, 2011, J BIOGEOGR, V38, P20, DOI 10.1111/j.1365-2699.2010.02385.x; Porretta D, 2011, 59 ANN M ENT SOC AM; Porretta D, 2010, 20 ANN M IT SOC EC R; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quante M, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P9, DOI 10.1007/978-3-540-92160-8_2; Rai N, 2001, INTERNET ARCHEOLOGY; Rambaut A., 2007, TRACER V1 4; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Su YC, 2007, J BIOGEOGR, V34, P177, DOI 10.1111/j.1365-2699.2006.01617.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teacher AGF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-214; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Urbanelli S, 2005, 14 ANN M IT SOC EC T; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; Vidya TNC, 2009, P ROY SOC B-BIOL SCI, V276, P893, DOI 10.1098/rspb.2008.1494; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Yu G, 2007, PALAEOGEOGR PALAEOCL, V250, P167, DOI 10.1016/j.palaeo.2007.03.010; Zarowiecki M, 2011, J BIOGEOGR, V38, P1422, DOI 10.1111/j.1365-2699.2011.02477.x	90	65	70	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44515	10.1371/journal.pone.0044515	http://dx.doi.org/10.1371/journal.pone.0044515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970238	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400082
J	Shen, J; Terry, MB; Liao, YY; Gurvich, I; Wang, Q; Senie, RT; Santella, RM				Shen, Jing; Terry, Mary Beth; Liao, Yuyan; Gurvich, Irina; Wang, Qiao; Senie, Ruby T.; Santella, Regina M.			Genetic Variation in Telomere Maintenance Genes, Telomere Length and Breast Cancer Risk	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; NEW-YORK SITE; SISTERS DISCORDANT; BLOOD-CELLS; ASSOCIATION; WOMEN; STRESS; VARIANTS; OBESITY; LOCUS	Background: Telomeres at the ends of eukaryotic chromosomes play a critical role in maintaining the integrity and stability of the genome and participate in the initiation of DNA damage/repair responses. Methods: We performed a case-control study to evaluate the role of three SNPs (TERT-07, TERT-54 and POT1-03) in telomere maintenance genes previously found to be significantly associated with breast cancer risk. We used sister-sets obtained from the New York site of the Breast Cancer Family Registry (BCFR). Among the 313 sister-sets, there were 333 breast cancer cases and 409 unaffected sisters who were evaluated in the current study. We separately applied conditional logistic regression and generalized estimating equations (GEE) models to evaluate associations between the three SNPs and breast cancer risk within sister-sets. We examined the associations between genotype, covariates and telomere length among unaffected sisters using a GEE model. Results: We found no significant associations between the three SNPs in telomere maintenance genes and breast cancer risk by both conditional logistic regression and GEE models, nor were these SNPs significantly related to telomere length. Among unaffected sisters, shortened telomeres were statistically significantly correlated with never hormone replacement therapy (HRT) use. Increased duration of HRT use was significantly associated with reduced telomere length. The means of telomere length were 0.77 (SD = 0.35) for never HRT use, 0.67 (SD = 0.29) for HRT use <5yrs and 0.59 (SD = 0.24) for HRT use >= 5yrs after adjusting for age of blood donation and race and ethnicity. Conclusions: We found that exogenous hormonal exposure was inversely associated with telomere length. No significant associations between genetic variants and telomere length or breast cancer risk were observed. These findings provide initial evidence to understand hormonal exposure in the regulation of telomere length and breast cancer risk but need replication in prospective studies.	[Shen, Jing; Gurvich, Irina; Wang, Qiao; Santella, Regina M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Terry, Mary Beth; Liao, Yuyan; Senie, Ruby T.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University	Shen, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	js2182@columbia.edu		Terry, Mary Beth/0000-0002-4106-5033	Breast Cancer Research Foundation; Women At Risk (WAR); National Institutes of Health [R03 CA125768, U01 CA69398, P30 CA13696, P30 ES009089]; National Cancer Institute, National Institutes of Health under RFA through Columbia University [U01 CA69398, CA-06-503]; NATIONAL CANCER INSTITUTE [P30CA013696, R03CA125768, U01CA069398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Women At Risk (WAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health under RFA through Columbia University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by awards from the Breast Cancer Research Foundation, Women At Risk (WAR) and National Institutes of Health grants R03 CA125768, U01 CA69398, P30 CA13696 and P30 ES009089. This work was also supported by the National Cancer Institute, National Institutes of Health under RFA # CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Columbia University (U01 CA69398). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Choi JE, 2009, CANCER EPIDEM BIOMAR, V18, P2773, DOI 10.1158/1055-9965.EPI-09-0323; Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Heaphy CM, 2011, MODERN PATHOL, V24, P194, DOI 10.1038/modpathol.2010.198; Hoxha M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-41; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kennedy DO, 2005, JNCI-J NATL CANCER I, V97, P127, DOI 10.1093/jnci/dji013; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Lin J, 2011, BRAIN RES, V1379, P224, DOI 10.1016/j.brainres.2010.10.033; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Machella N, 2008, CARCINOGENESIS, V29, P1367, DOI 10.1093/carcin/bgn140; Meeker AK, 2004, J MAMMARY GLAND BIOL, V9, P285, DOI 10.1023/B:JOMG.0000048775.04140.92; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pavanello S, 2010, CARCINOGENESIS, V31, P216, DOI 10.1093/carcin/bgp278; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Savage SA, 2007, BRIT J CANCER, V97, P832, DOI 10.1038/sj.bjc.6603934; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Shen J, 2010, CANCER EPIDEM BIOMAR, V19, P219, DOI 10.1158/1055-9965.EPI-09-0771; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Varadi V, 2009, EUR J CANCER, V45, P3008, DOI 10.1016/j.ejca.2009.08.012; Varadi V, 2009, CANCER GENET CYTOGEN, V190, P71, DOI 10.1016/j.cancergencyto.2008.12.006; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zheng YL, 2010, BREAST CANCER RES TR, V120, P769, DOI 10.1007/s10549-009-0440-z; Zipprich J, 2009, CANCER RES, V69, P2966, DOI 10.1158/0008-5472.CAN-08-3418	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44308	10.1371/journal.pone.0044308	http://dx.doi.org/10.1371/journal.pone.0044308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970196	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400055
J	Patisaul, HB; Sullivan, AW; Radford, ME; Walker, DM; Adewale, HB; Winnik, B; Coughlin, JL; Buckley, B; Gore, AC				Patisaul, Heather B.; Sullivan, Alana W.; Radford, Meghan E.; Walker, Deena M.; Adewale, Heather B.; Winnik, Bozena; Coughlin, Janis L.; Buckley, Brian; Gore, Andrea C.			Anxiogenic Effects of Developmental Bisphenol A Exposure Are Associated with Gene Expression Changes in the Juvenile Rat Amygdala and Mitigated by Soy	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ELEVATED PLUS-MAZE; SEX-DIFFERENCES; INTACT MALE; GESTATIONAL EXPOSURE; LACTATIONAL TRANSFER; FEMALE RATS; ANXIETY; OXYTOCIN; BEHAVIOR	Early life exposure to Bisphenol A (BPA), a component of polycarbonate plastics and epoxy resins, alters sociosexual behavior in numerous species including humans. The present study focused on the ontogeny of these behavioral effects beginning in adolescence and assessed the underlying molecular changes in the amygdala. We also explored the mitigating potential of a soy-rich diet on these endpoints. Wistar rats were exposed to BPA via drinking water (1 mg/L) from gestation through puberty, and reared on a soy-based or soy-free diet. A group exposed to ethinyl estradiol (50 mg/L) and a soy-free diet was used as a positive estrogenic control. Animals were tested as juveniles or adults for anxiety-like and exploratory behavior. Assessment of serum BPA and genistein (GEN), a soy phytoestrogen, confirmed that internal dose was within a human-relevant range. BPA induced anxiogenic behavior in juveniles and loss of sexual dimorphisms in adult exploratory behavior, but only in the animals reared on the soy-free diet. Expression analysis revealed a suite of genes, including a subset known to mediate sociosexual behavior, associated with BPA-induced juvenile anxiety. Notably, expression of estrogen receptor beta (Esr2) and two melanocortin receptors (Mc3r, Mc4r) were downregulated. Collectively, these results show that behavioral impacts of BPA can manifest during adolescence, but wane in adulthood, and may be mitigated by diet. These data also reveal that, because ERb and melanocortin receptors are crucial to their function, oxytocin/vasopressin signaling pathways, which have previously been linked to human affective disorders, may underlie these behavioral outcomes.	[Patisaul, Heather B.; Sullivan, Alana W.; Radford, Meghan E.; Adewale, Heather B.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Patisaul, Heather B.; Sullivan, Alana W.; Radford, Meghan E.; Adewale, Heather B.] N Carolina State Univ, Keck Ctr Behav Sci, Raleigh, NC 27695 USA; [Walker, Deena M.; Gore, Andrea C.] Univ Texas Austin, Inst Neurosci, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Walker, Deena M.; Gore, Andrea C.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Winnik, Bozena; Coughlin, Janis L.] Joint Inst Rutgers Univ & Univ Med & Dent New Jer, Joint Grad Program Toxicol, Piscataway, NJ USA; [Buckley, Brian] Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Patisaul, HB (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	hbpatisa@ncsu.edu	Walker, Deena/GOE-5789-2022	Rebuli, Meghan/0000-0003-1918-2257; Gore, Andrea/0000-0001-5549-6793	National Institute of Environmental Health Sciences (NIEHS) [ES16001, ES05022, ES018139, ES07784, ES020662]; National Institutes on Aging [AG034813]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, T32ES007148, P30ES007784, RC1ES018139, R01ES016001, R01ES020662, R21ES021233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034813] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by the National Institute of Environmental Health Sciences (NIEHS) grants ES16001 to HBP; ES05022 to BB; and ES018139, ES07784, and ES020662 to ACG; and National Institutes on Aging grant AG034813 to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Brown NM, 2001, LAB INVEST, V81, P735, DOI 10.1038/labinvest.3780282; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Cederroth CR, 2010, MOL CELL ENDOCRINOL, V321, P152, DOI 10.1016/j.mce.2010.02.011; Choleris E, 2006, GENES BRAIN BEHAV, V5, P528, DOI 10.1111/j.1601-183X.2006.00203.x; Cooper JE, 2011, CHEMOSPHERE, V85, P943, DOI 10.1016/j.chemosphere.2011.06.060; Cooper S, 2006, TOXICOL SCI, V91, P631, DOI 10.1093/toxsci/kfj171; Coughlin JL, 2011, ANAL BIOANAL CHEM, V401, P995, DOI 10.1007/s00216-011-5151-8; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Dixon RA, 2002, PHYTOCHEMISTRY, V60, P205, DOI 10.1016/S0031-9422(02)00116-4; Doerge DR, 2010, TOXICOL LETT, V199, P372, DOI 10.1016/j.toxlet.2010.09.022; Doerge DR, 2006, REPROD TOXICOL, V21, P307, DOI 10.1016/j.reprotox.2005.09.007; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Donner J, 2008, BIOL PSYCHIAT, V64, P672, DOI 10.1016/j.biopsych.2008.06.002; Rodriguez-Landa JF, 2009, PROG NEURO-PSYCHOPH, V33, P367, DOI 10.1016/j.pnpbp.2008.12.024; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Fujimoto T, 2006, BRAIN RES, V1068, P49, DOI 10.1016/j.brainres.2005.11.028; Gabor CS, 2012, BEHAV NEUROSCI, V126, P97, DOI 10.1037/a0026464; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Hohoff C, 2009, J NEURAL TRANSM, V116, P679, DOI 10.1007/s00702-009-0215-z; Hovatta I, 2008, ANN MED, V40, P92, DOI 10.1080/07853890701747096; IMHOF JT, 1993, BEHAV BRAIN RES, V56, P177, DOI 10.1016/0166-4328(93)90036-P; JAKUBOWSKI M, 1991, ENDOCRINOLOGY, V128, P2702, DOI 10.1210/endo-128-6-2702; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Jones DC, 2008, BIOCHEM PHARMACOL, V76, P569, DOI 10.1016/j.bcp.2008.05.010; Kabuto H, 2004, LIFE SCI, V74, P2931, DOI 10.1016/j.lfs.2003.07.060; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kauffman AS, 2010, J NEUROENDOCRINOL, V22, P682, DOI 10.1111/j.1365-2826.2010.02030.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim J, 2011, ENDOCRINOLOGY, V152, P2020, DOI 10.1210/en.2010-1498; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Landgraf R, 2002, BEHAV GENET, V32, P301, DOI 10.1023/A:1020258104318; Lephart ED, 2004, ILAR J, V45, P443, DOI 10.1093/ilar.45.4.443; Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P9372, DOI 10.1021/es202507f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Lund TD, 2001, BRAIN RES, V913, P180, DOI 10.1016/S0006-8993(01)02793-7; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Martel MM, 2009, HORM BEHAV, V55, P465, DOI 10.1016/j.yhbeh.2009.02.004; McCARRISON R., 1933, INDIAN JOUR MED RES, V21, P179; McCarthy MM, 1997, MOL MED TODAY, V3, P269, DOI 10.1016/S1357-4310(97)01058-7; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miyawaki J, 2007, J ATHEROSCLER THROMB, V14, P245, DOI 10.5551/jat.E486; Muhlhauser A, 2009, BIOL REPROD, V80, P1066, DOI 10.1095/biolreprod.108.074815; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Nakagami A, 2009, PSYCHONEUROENDOCRINO, V34, P1189, DOI 10.1016/j.psyneuen.2009.03.005; Nomura M, 2002, MOL BRAIN RES, V109, P84, DOI 10.1016/S0169-328X(02)00525-9; Osterlund MK, 2005, ENDOCRINE, V28, P235, DOI 10.1385/ENDO:28:3:235; Palanza P, 2008, ENVIRON RES, V108, P150, DOI 10.1016/j.envres.2008.07.023; Patisaul HB, 2005, BEHAV NEUROSCI, V119, P587, DOI 10.1037/0735-7044.119.2.587; Patisaul HB, 2003, J NEUROENDOCRINOL, V15, P787, DOI 10.1046/j.1365-2826.2003.01061.x; Patisaul HB, 2008, HORM BEHAV, V53, P580, DOI 10.1016/j.yhbeh.2008.01.008; Patisaul HB, 2010, FRONT NEUROENDOCRIN, V31, P400, DOI 10.1016/j.yfrne.2010.03.003; Patisaul HB, 2009, HORM BEHAV, V55, P319, DOI 10.1016/j.yhbeh.2008.11.004; Pelayo S, 2012, AQUAT TOXICOL, V110, P114, DOI 10.1016/j.aquatox.2011.12.016; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Sabatier N, 2003, J NEUROSCI, V23, P10351; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott V, 2011, ENDOCRINOLOGY, V152, P3862, DOI 10.1210/en.2011-1181; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sullivan AW, 2011, HORM BEHAV, V60, P185, DOI 10.1016/j.yhbeh.2011.04.006; Thigpen JE, 1999, LAB ANIM SCI, V49, P530; Todaka E, 2005, ENVIRON RES, V99, P195, DOI 10.1016/j.envres.2004.11.006; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Walker DM, 2009, ENDOCRINOLOGY, V150, P2308, DOI 10.1210/en.2008-1396; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Zhang YK, 2011, EPIGENETICS-US, V6, P888, DOI 10.4161/epi.6.7.16315	93	86	89	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43890	10.1371/journal.pone.0043890	http://dx.doi.org/10.1371/journal.pone.0043890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957036	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800028
J	Zhang, YC; Zhang, QY; Sammul, M				Zhang, Yunchun; Zhang, Qiaoying; Sammul, Marek			Physiological Integration Ameliorates Negative Effects of Drought Stress in the Clonal Herb Fragaria orientalis	PLOS ONE			English	Article							HYDROGEN-PEROXIDE METABOLISM; UV-B RADIATION; WATER TRANSLOCATION; PSAMMOCHLOA-VILLOSA; LIPID-PEROXIDATION; OXIDATIVE STRESS; INTERCONNECTED RAMETS; ANTIOXIDANT ENZYMES; SAND BURIAL; PLANT	Clonal growth allows plants to spread horizontally and to establish ramets in sites of contrasting resource status. If ramets remain physiologically integrated, clones in heterogeneous environments can act as cooperative systems - effects of stress on one ramet can be ameliorated by another connected ramet inhabiting benign conditions. But little is known about the effects of patch contrast on physiological integration of clonal plants and no study has addressed its effects on physiological traits like osmolytes, reactive oxygen intermediates and antioxidant enzymes. We examined the effect of physiological integration on survival, growth and stress indicators such as osmolytes, reactive oxygen intermediates (ROIs) and antioxidant enzymes in a clonal plant, Fragaria orientalis, growing in homogenous and heterogeneous environments differing in patch contrast of water availability (1 homogeneous (no contrast) group; 2 low contrast group; 3 high contrast group). Drought stress markedly reduced the survival and growth of the severed ramets of F. orientalis, especially in high contrast treatments. Support from a ramet growing in benign patch considerably reduced drought stress and enhanced growth of ramets in dry patches. The larger the contrast between water availability, the larger the amount of support the depending ramet received from the supporting one. This support strongly affected the growth of the supporting ramet, but not to an extent to cause increase in stress indicators. We also found indication of costs related to maintenance of physiological connection between ramets. Thus, the net benefit of physiological integration depends on the environment and integration between ramets of F. orientalis could be advantageous only in heterogeneous conditions with a high contrast.	[Zhang, Yunchun; Sammul, Marek] Estonian Univ Life Sci, Inst Agr & Environm Sci, Dept Bot, Tartu, Estonia; [Zhang, Yunchun; Zhang, Qiaoying] Shandong Polytech Univ, Jinan, Shandong, Peoples R China; [Zhang, Qiaoying] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia	Estonian University of Life Sciences; Qilu University of Technology; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Zhang, YC (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Dept Bot, Tartu, Estonia.	yunchunzhang@163.com		Zhang, Yunchun/0000-0001-8259-5850	ERMOS Postdoctoral Research Grants [ERMOS 11]; Estonian Science Foundation [8745]; National Natural Science Foundation of China [31170502]	ERMOS Postdoctoral Research Grants; Estonian Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by ERMOS Postdoctoral Research Grants (ERMOS 11), grant no 8745 from the Estonian Science Foundation and the National Natural Science Foundation of China (31170502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain-Lhout F, 2001, PLANT SOIL, V230, P175, DOI 10.1023/A:1010387610098; ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1990, AM J BOT, V77, P1648, DOI 10.2307/2444496; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BECANA M, 1986, PLANT PHYSIOL, V82, P1169, DOI 10.1104/pp.82.4.1169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Cavalcanti FR, 2004, NEW PHYTOL, V163, P563, DOI 10.1111/j.1469-8137.2004.01139.x; Chen JS, 2011, ACTA OECOL, V37, P355, DOI 10.1016/j.actao.2011.04.002; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; CHOWDHURY SR, 1985, PHYSIOL PLANTARUM, V65, P476, DOI 10.1111/j.1399-3054.1985.tb08676.x; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; Costa H, 2002, PLANT SCI, V162, P939, DOI 10.1016/S0168-9452(02)00051-1; de Kroon H, 1998, OECOLOGIA, V116, P38, DOI 10.1007/s004420050561; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; DHERTEFELDT T, 1994, SPEC FEAT VEGET SCI, V4, P167; Dong M, 1999, PLANT ECOL, V141, P53, DOI 10.1023/A:1009875000149; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; Ederli L, 2004, PHYSIOL PLANTARUM, V121, P66, DOI 10.1111/j.0031-9317.2004.00295.x; Ekmekci Y, 2005, PESTIC BIOCHEM PHYS, V83, P69, DOI 10.1016/j.pestbp.2005.03.012; EPSTEIN E, 1972, P412; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; EVANS JP, 1991, OECOLOGIA, V86, P268, DOI 10.1007/BF00317540; Fazeli F, 2007, BIOL PLANTARUM, V51, P98, DOI 10.1007/s10535-007-0020-1; Gomez S, 2006, OECOLOGIA, V147, P461, DOI 10.1007/s00442-005-0293-z; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Guan WB, 2004, P 5 NAT S CONS SUST, P288; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2010, ECOL RES, V25, P967, DOI 10.1007/s11284-010-0724-0; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jain M, 2001, PLANT CELL REP, V20, P463, DOI 10.1007/s002990100353; Jonsdottir IS, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P109; JONSDOTTIR IS, 1990, NEW PHYTOL, V114, P419, DOI 10.1111/j.1469-8137.1990.tb00409.x; JONSDOTTIR IS, 1989, OIKOS, V54, P211, DOI 10.2307/3565269; KATO M, 1987, CAN J BOT, V65, P729, DOI 10.1139/b87-097; KELLY CK, 1995, EVOL ECOL, V9, P575, DOI 10.1007/BF01237656; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Koubek T, 2008, EVOL ECOL, V22, P449, DOI 10.1007/s10682-007-9219-z; LAU RR, 1988, ECOLOGY, V69, P215, DOI 10.2307/1943177; Li CL, 2003, FLORA CHINA, P337; Li L., 1998, Plant Growth Regulation, V24, P55, DOI 10.1023/A:1005954532397; Liu CC, 2011, ACTA PHYSIOL PLANT, V33, P93, DOI 10.1007/s11738-010-0520-z; Liu FH, 2007, FLORA, V202, P106, DOI 10.1016/j.flora.2006.05.004; Liu RH, 2012, PLANT SPEC BIOL, V27, P210, DOI 10.1111/j.1442-1984.2011.00346.x; Mao SY, 2009, PHYSIOL PLANTARUM, V137, P225, DOI 10.1111/j.1399-3054.2009.01275.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; Matlaga DP, 2009, AM J BOT, V96, P431, DOI 10.3732/ajb.0800164; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mizuki I, 2009, J FOREST RES-JPN, V14, P95, DOI 10.1007/s10310-008-0106-4; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noda H, 2004, ECOL RES, V19, P331, DOI 10.1111/j.1440-1703.2004.00642.x; ONG CK, 1979, ANN BOT-LONDON, V43, P147, DOI 10.1093/oxfordjournals.aob.a085619; Opik H., 2005, PHYSL FLOWERING PLAN, DOI [10.1017/CBO9781139164450, DOI 10.1017/CBO9781139164450]; Pinto ME, 1999, J PHOTOCH PHOTOBIO B, V48, P200, DOI 10.1016/S1011-1344(99)00031-7; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; Prakash J, 2009, SCI HORTIC-AMSTERDAM, V120, P288, DOI 10.1016/j.scienta.2008.11.016; Prochazkova D, 2001, PLANT SCI, V161, P765, DOI 10.1016/S0168-9452(01)00462-9; Ren A., 1999, J DESERT RES, V19, P30; Roiloa SR, 2012, ECOL RES, V27, P95, DOI 10.1007/s11284-011-0876-6; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; Sankar B, 2007, COLLOID SURFACE B, V60, P229, DOI 10.1016/j.colsurfb.2007.06.016; Savini G, 2008, PHYSIOL PLANTARUM, V134, P421, DOI 10.1111/j.1399-3054.2008.01145.x; SLADE AJ, 1987, OECOLOGIA, V73, P425, DOI 10.1007/BF00385260; Sohrabi Y, 2012, SYMBIOSIS, V56, P5, DOI 10.1007/s13199-012-0152-8; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; Stuefer JF, 2004, EVOL ECOL, V18, P647, DOI 10.1007/s10682-004-5148-2; Sun XL, 2010, AFR J BIOTECHNOL, V9, P5503; Uzilday B, 2012, PLANT SCI, V182, P59, DOI 10.1016/j.plantsci.2011.03.015; van Kleunen M, 1999, OIKOS, V85, P135, DOI 10.2307/3546799; Wang JC, 2011, POL J ECOL, V59, P455; Wang YH, 2011, J ARID ENVIRON, V75, P974, DOI 10.1016/j.jaridenv.2011.04.019; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Yang F, 2009, BIOL PLANTARUM, V53, P511, DOI 10.1007/s10535-009-0092-1; Yang Y, 2007, PHOTOSYNTHETICA, V45, P613, DOI 10.1007/s11099-007-0106-1; Yin GH, 2012, J FOOD AGRIC ENVIRON, V10, P853; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2004, NEW PHYTOL, V162, P697, DOI 10.1111/j.1469-8137.2004.01073.x; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Zhang CY, 2003, ACTA BOT SIN, V45, P1210; Zhang YC, 2008, BOT STUD, V49, P373; Zhang YC, 2009, ECOL RES, V24, P617, DOI 10.1007/s11284-008-0533-x; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314; Zhuang L, 2006, J INTEGR PLANT BIOL, V48, P520, DOI 10.1111/j.1744-7909.2006.00238.x	91	11	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44221	10.1371/journal.pone.0044221	http://dx.doi.org/10.1371/journal.pone.0044221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957054	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800046
J	Lee, MJ; Lee, JK; Choi, JW; Lee, CS; Sim, JH; Cho, CH; Lee, KH; Cho, IH; Chung, MH; Kim, HR; Ye, SK				Lee, Min Jeoung; Lee, Jin-Ku; Choi, Ji Won; Lee, Chang-Seok; Sim, Ji Hyun; Cho, Chung-Hyun; Lee, Kwang-Ho; Cho, Ik-Hyun; Chung, Myung-Hee; Kim, Hang-Rae; Ye, Sang-Kyu			Interleukin-6 Induces S100A9 Expression in Colonic Epithelial Cells through STAT3 Activation in Experimental Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CALCIUM-BINDING PROTEINS; INTESTINAL INFLAMMATION; MULTIPLE-SCLEROSIS; COLORECTAL-CANCER; CROHNS-DISEASE; SERUM-LEVELS; IL-6; MRP14; NEUTROPHILS	Background: Intestinal epithelium is essential for maintaining normal intestinal homeostasis; its breakdown leads to chronic inflammatory pathologies, such as inflammatory bowel diseases (IBDs). Although high concentrations of S100A9 protein and interleukin-6 (IL-6) are found in patients with IBD, the expression mechanism of S100A9 in colonic epithelial cells (CECs) remains elusive. We investigated the role of IL-6 in S100A9 expression in CECs using a colitis model. Methods: IL-6 and S100A9 expression, signal transducer and activator of transcription 3 (STAT3) phosphorylation, and infiltration of immune cells were analyzed in mice with dextran sulfate sodium (DSS)-induced colitis. The effects of soluble gp130-Fc protein (sgp130Fc) and S100A9 small interfering (si) RNA (si-S100A9) on DSS-induced colitis were evaluated. The molecular mechanism of S100A9 expression was investigated in an IL-6-treated Caco-2 cell line using chromatin immunoprecipitation assays. Results: IL-6 concentrations increased significantly in the colon tissues of DSS-treated mice. sgp130Fc or si-S100A9 administration to DSS-treated mice reduced granulocyte infiltration in CECs and induced the down-regulation of S100A9 and colitis disease activity. Treatment with STAT3 inhibitors upon IL-6 stimulation in the Caco-2 cell line demonstrated that IL-6 mediated S100A9 expression through STAT3 activation. Moreover, we found that phospho-STAT3 binds directly to the S100A9 promoter. S100A9 may recruit immune cells into inflamed colon tissues. Conclusions: Elevated S100A9 expression in CECs mediated by an IL-6/STAT3 signaling cascade may play an important role in the development of colitis.	[Lee, Min Jeoung; Lee, Jin-Ku; Choi, Ji Won; Lee, Chang-Seok; Cho, Chung-Hyun; Chung, Myung-Hee; Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Lee, Min Jeoung; Lee, Jin-Ku; Choi, Ji Won; Lee, Chang-Seok; Cho, Chung-Hyun; Chung, Myung-Hee; Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Sim, Ji Hyun; Kim, Hang-Rae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Lee, Kwang-Ho] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Dept Anat, Coll Oriental Med, Seoul, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Inst Oriental Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Kyung Hee University	Lee, MJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul, South Korea.	hangrae2@snu.ac.kr; sangkyu@snu.ac.kr	Ye, Sang Kyu/J-2768-2012; Kim, Hang-Rae/J-5448-2012; Cho, Ik-Hyun/A-9348-2014; Cho, Chung-Hyun/H-7286-2012	Kim, Hang-Rae/0000-0002-3983-6193; Lee, Jin-Ku/0000-0003-0263-3234	National Research & Development (R&D) Program for Cancer Control; Ministry of Health & Welfare, Republic of Korea [1020160, 0720540]; National Research Foundation (NRF); Ministry of Education, Science and Technology [2010-0027827, 2011-0010571]	National Research & Development (R&D) Program for Cancer Control; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation (NRF); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by grants from the National Research & Development (R&D) Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1020160 and 0720540 to SK Ye) and from National Research Foundation (NRF), Ministry of Education, Science and Technology (2010-0027827 and 2011-0010571 to SK Ye). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bogumil T, 1998, NEUROSCI LETT, V247, P195, DOI 10.1016/S0304-3940(98)00263-8; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; COOPER HS, 1993, LAB INVEST, V69, P238; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frosch M, 2005, EXP DERMATOL, V14, P259, DOI 10.1111/j.0906-6705.2005.00271.x; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Garud Sagar, 2009, Therap Adv Gastroenterol, V2, P99, DOI 10.1177/1756283X09102329; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Jin XL, 2010, GUT, V59, P186, DOI 10.1136/gut.2008.151175; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katz AB, 1999, J INVEST DERMATOL, V112, P818, DOI 10.1046/j.1523-1747.1999.00572.x; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KURUTO R, 1990, J BIOCHEM, V108, P650, DOI 10.1093/oxfordjournals.jbchem.a123257; Li C, 2004, BREAST CANCER RES TR, V87, P123, DOI 10.1023/B:BREA.0000041594.36418.f6; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; LUGERING N, 1995, DIGESTION, V56, P406, DOI 10.1159/000201267; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Montufar-Solis D, 2006, J IMMUNOL METHODS, V308, P251, DOI 10.1016/j.jim.2005.10.008; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Neurath MF, 2001, TRENDS IMMUNOL, V22, P21, DOI 10.1016/S1471-4906(00)01798-1; Newton RA, 1998, J IMMUNOL, V160, P1427; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; PANJA A, 1993, J EXP MED, V178, P1115, DOI 10.1084/jem.178.3.1115; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rammes A, 1997, J BIOL CHEM, V272, P9496; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rose-John S, 2009, CURR PHARM DESIGN, V15, P2095, DOI 10.2174/138161209788489140; ROTH J, 1993, BLOOD, V82, P1875; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Soliman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015044; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; SUZUKI Y, 1990, LIFE SCI, V47, P2193, DOI 10.1016/0024-3205(90)90149-L; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Umehara Y, 2006, HEPATO-GASTROENTEROL, V53, P879; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; WILKINSON MM, 1988, J CELL SCI, V91, P221	63	25	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e38801	10.1371/journal.pone.0038801	http://dx.doi.org/10.1371/journal.pone.0038801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962574	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600001
J	Kang, S; Kim, CU; Gu, XL; Owens, RM; van Rijn, SJ; Boonyaleepun, V; Mao, YX; Springer, TA; Jin, MM				Kang, Sungkwon; Kim, Chae Un; Gu, Xiaoling; Owens, Roisin M.; van Rijn, Sarah J.; Boonyaleepun, Vanissra; Mao, Yuxin; Springer, Timothy A.; Jin, Moonsoo M.			Complex Structure of Engineered Modular Domains Defining Molecular Interaction between ICAM-1 and Integrin LFA-1	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CRYSTAL-STRUCTURE; I-DOMAIN; CONFORMATIONAL REGULATION; RHINOVIRUS SEROTYPES; A-DOMAIN; RECEPTOR; EXPRESSION; RECOGNITION; EVOLUTION	Intermolecular contacts between integrin LFA-1 (alpha(L)beta(2)) and ICAM-1 derive solely from the integrin alpha(L) I domain and the first domain (D1) of ICAM-1. This study presents a crystal structure of the engineered complex of the aL I domain and ICAM-1 D1. Previously, we engineered the I domain for high affinity by point mutations that were identified by a directed evolution approach. In order to examine alpha(L) I domain allostery between the C-terminal alpha 7-helix (allosteric site) and the metal-ion dependent adhesion site (active site), we have chosen a high affinity variant without mutations directly influencing either the position of the alpha 7-helix or the active sites. In our crystal, the alpha(L) I domain was found to have a high affinity conformation to D1 with its alpha 7-helix displaced downward away from the binding interface, recapitulating a current understanding of the allostery in the I domain and its linkage to neighboring domains of integrins in signaling. To enable soluble D1 of ICAM-1 to fold on its own, we also engineered D1 to be functional by mutations, which were found to be those that would convert hydrogen bond networks in the solvent-excluded core into vdW contacts. The backbone structure of the beta-sandwich fold and the epitope for I domain binding of the engineered D1 were essentially identical to those of wild-type D1. Most deviations in engineered D1 were found in the loops at the N-terminal region that interacts with human rhinovirus (HRV). Structural deviation found in engineered D1 was overall in agreement with the function of engineered D1 observed previously, i.e., full capacity binding to alpha(L) I domain but reduced interaction with HRV.	[Kang, Sungkwon; Gu, Xiaoling; Owens, Roisin M.; van Rijn, Sarah J.; Boonyaleepun, Vanissra; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Kim, Chae Un] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Mao, Yuxin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Cornell University; Cornell University; Cornell University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	mj227@cornell.edu	Owens, Roisin/O-4371-2019; Kim, Chae Un/D-2956-2014	Owens, Roisin/0000-0001-7856-2108; Mao, Yuxin/0000-0002-5064-1397	National Institutes of Health (NIH) [R21 AI079532]; National Science Foundation (NSF); NIH [GM103485]; NSF award [DMR-0936384]; Macromolecular Diffraction at CHESS (MacCHESS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF award(National Science Foundation (NSF)); Macromolecular Diffraction at CHESS (MacCHESS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a grant (R21 AI079532) from the National Institutes of Health (NIH). This work is also based upon research conducted at CHESS, which is supported by the National Science Foundation (NSF) and the NIH. The authors acknowledge NSF award DMR-0936384 and the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by the award GM103485 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; Bella J, 2000, Pharm Acta Helv, V74, P291, DOI 10.1016/S0031-6865(99)00056-4; Buitrago D, 2011, ANN SURG ONCOL; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen XY, 2011, BIOMATERIALS, V32, P7651, DOI 10.1016/j.biomaterials.2011.06.030; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hadfield AT, 1997, STRUCTURE, V5, P427, DOI 10.1016/S0969-2126(97)00199-8; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; KELLY CP, 1992, AM J PHYSIOL, V263, pG864, DOI 10.1152/ajpgi.1992.263.6.G864; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON H, 1994, CLIN IMMUNOL IMMUNOP, V72, P129, DOI 10.1006/clin.1994.1116; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens RM, 2010, J BIOL CHEM, V285, P15906, DOI 10.1074/jbc.M110.104349; Roland CL, 2010, EXP BIOL MED, V235, P263, DOI 10.1258/ebm.2009.009215; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TOMITA Y, 1990, INT J CANCER, V46, P1001, DOI 10.1002/ijc.2910460609; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44124	10.1371/journal.pone.0044124	http://dx.doi.org/10.1371/journal.pone.0044124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956999	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500048
J	Duprez, DA; Neuhaus, J; Kuller, LH; Tracy, R; Belloso, W; De Wit, S; Drummond, F; Lane, HC; Ledergerber, B; Lundgren, J; Nixon, D; Paton, NI; Prineas, RJ; Neaton, JD				Duprez, Daniel A.; Neuhaus, Jacqueline; Kuller, Lewis H.; Tracy, Russell; Belloso, Waldo; De Wit, Stephane; Drummond, Fraser; Lane, H. Clifford; Ledergerber, Bruno; Lundgren, Jens; Nixon, Daniel; Paton, Nicholas I.; Prineas, Ronald J.; Neaton, James D.		INSIGHT SMART Study Grp	Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; D-DIMER; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC DISEASE; RISK; BIOMARKERS; DEATH; INTERLEUKIN-6; THROMBOSIS; EVENTS	Background: The SMART study was a trial of intermittent use of antiretroviral therapy (ART) (drug conservation [DC]) versus continuous use of ART (viral suppression [VS]) as a strategy to reduce toxicities, including cardiovascular disease (CVD) risk. We studied the predictive value of high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6) and D-dimer with CVD morbidity and mortality in HIV-infected patients who were enrolled in SMART beyond other measured CVD risk factors. Methods: A blood sample was available in 5098 participants who were enrolled in the SMART study for the measurement of IL-6, hsCRP and D-dimer. Hazard ratios (HR) with 95% CI for CVD events were estimated for each quartile (Q) for each biomarker vs the 1st quartile and for 1 SD higher levels. For both treatment groups combined, unadjusted and adjusted HRs were determined using Cox regression models. Results: There were 252 participants who had a CVD event over a median follow-up of 29 months. Adjusted HRs (95% CI) for CVD for Q4 vs Q1 were 4.65 (2.61, 8.29), 2.10 (1.40, 3.16), and 2.14 (1.38, 3.33) for IL-6, hsCRP and D-dimer, respectively. Associations were similar for the DC and VS treatment groups (interaction p-values were >0.30). The addition of the three biomarkers to a model that included baseline covariates significantly improved model fit (p<0.001). Area under the curve (AUC) estimates improved with inclusion of the three biomarkers in a model that included baseline covariates corresponding to other CVD risk factors and HIV factors (0.741 to 0.771; p<0.001 for difference). Conclusions: In HIV-infected individuals, IL-6, hsCRP and D-dimer are associated with an increased risk of CVD independent of other CVD risk factors. Further research is needed to determine whether these biomarkers can be used to improve CVD risk prediction among HIV positive individuals.	[Duprez, Daniel A.; Neuhaus, Jacqueline; Neaton, James D.] Univ Minnesota, Minneapolis, MN 55455 USA; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Tracy, Russell] Univ Vermont, Burlington, VT USA; [Belloso, Waldo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [De Wit, Stephane] St Pierre Hosp, Brussels, Belgium; [Drummond, Fraser] Univ New S Wales, Fac Med, Kirby Inst, Sydney, NSW, Australia; [Lane, H. Clifford] NIAID, NIH, Bethesda, MD 20892 USA; [Ledergerber, Bruno] Univ Zurich, Univ Zurich Hosp, Zurich, Switzerland; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark; [Nixon, Daniel] Virginia Commonwealth Univ, Richmond, VA USA; [Paton, Nicholas I.] MRC, Clin Trials Unit, London, England; [Prineas, Ronald J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont; Hospital Italiano de Buenos Aires; University of Buenos Aires; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Kirby Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Zurich; University Zurich Hospital; University of Copenhagen; Virginia Commonwealth University; Medical Research Council Clinical Trials Unit; Wake Forest University; Wake Forest Baptist Medical Center	Duprez, DA (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	dupre007@umn.edu	Ledergerber, Bruno/B-5656-2009; Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019; Lundgren, Jens/AAE-6876-2019	Ledergerber, Bruno/0000-0002-6881-4401; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Lundgren, Jens/0000-0001-8901-7850	NIAD, United States National Institutes of Health [UO1AI068641, U01AI042170, U01AI046362]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042170, U01AI068641, ZIAAI000585, U01AI046362] Funding Source: NIH RePORTER; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish	NIAD, United States National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Support for this work was provided by NIAD, United States National Institutes of Health grants UO1AI068641, U01AI042170, and U01AI046362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2010, HIV MED, V11, P608, DOI 10.1111/j.1468-1293.2010.00835.x; Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Baker JV, 2010, CURR OPIN HIV AIDS, V5, P511, DOI 10.1097/COH.0b013e32833ed7ec; Blum A, 2005, CLIN CARDIOL, V28, P149, DOI 10.1002/clc.4960280311; Calmy A, 2009, ANTIVIR THER, V14, P165; Chambless LE, 2006, STAT MED, V25, P3474, DOI 10.1002/sim.2299; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Folsom AR, 2009, AM J HEMATOL, V84, P349, DOI 10.1002/ajh.21429; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grinspoon S. K., 2008, Circulation, V118, P198, DOI 10.1161/CIRCULATIONAHA.107.189622; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Karpatkin S, 2002, THROMB HAEMOSTASIS, V88, P389; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Phillips AN, 2008, ANTIVIR THER, V13, P177; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Shen YMP, 2004, CLIN APPL THROMB-HEM, V10, P277, DOI 10.1177/107602960401000311; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Soliman EZ, 2011, J ELECTROCARDIOL, V44, P779, DOI 10.1016/j.jelectrocard.2010.10.027; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084	38	386	388	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44454	10.1371/journal.pone.0044454	http://dx.doi.org/10.1371/journal.pone.0044454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970224	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400019
J	McLeish, MJ; Beukman, G; van Noort, S; Wossler, TC				McLeish, Michael J.; Beukman, Gary; van Noort, Simon; Wossler, Theresa C.			Host-Plant Species Conservatism and Ecology of a Parasitoid Fig Wasp Genus (Chalcidoidea; Sycoryctinae; Arachonia)	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; APPARENT COMPETITION; GLOBAL PATTERNS; TROPHIC LEVELS; SPECIATION; COMMUNITY; DIVERSIFICATION; POLLINATORS; HYMENOPTERA; EVOLUTION	Parasitoid diversity in terrestrial ecosystems is enormous. However, ecological processes underpinning their evolutionary diversification in association with other trophic groups are still unclear. Specialisation and interdependencies among chalcid wasps that reproduce on Ficus presents an opportunity to investigate the ecology of a multi-trophic system that includes parasitoids. Here we estimate the host-plant species specificity of a parasitoid fig wasp genus that attacks the galls of non-pollinating pteromalid and pollinating agaonid fig wasps. We discuss the interactions between parasitoids and the Ficus species present in a forest patch of Uganda in context with populations in Southern Africa. Haplotype networks are inferred to examine intraspecific mitochondrial DNA divergences and phylogenetic approaches used to infer putative species relationships. Taxonomic appraisal and putative species delimitation by molecular and morphological techniques are compared. Results demonstrate that a parasitoid fig wasp population is able to reproduce on at least four Ficus species present in a patch. This suggests that parasitoid fig wasps have relatively broad host-Ficus species ranges compared to fig wasps that oviposit internally. Parasitoid fig wasps did not recruit on all available host plants present in the forest census area and suggests an important ecological consequence in mitigating fitness trade-offs between pollinator and Ficus reproduction. The extent to which parasitoid fig wasps exert influence on the pollination mutualism must consider the fitness consequences imposed by the ability to interact with phenotypes of multiple Ficus and fig wasps species, but not equally across space and time.	[McLeish, Michael J.] Chinese Acad & Sci, Plant Geog Lab, Xishuangbanna Trop Bot Gardens, Mengla, Yunnan, Peoples R China; [Beukman, Gary; Wossler, Theresa C.] Univ Stellenbosch, Dept Bot & Zool, DST NRF Ctr Excellence Invas Biol, Matieland, South Africa; [van Noort, Simon] Iziko S African Museum, Nat Hist Dept, Cape Town, South Africa; [van Noort, Simon] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; National Research Foundation - South Africa; Stellenbosch University; University of Cape Town	McLeish, MJ (corresponding author), Chinese Acad & Sci, Plant Geog Lab, Xishuangbanna Trop Bot Gardens, Mengla, Yunnan, Peoples R China.	michaelm@xtbg.org.cn	van Noort, Simon/C-4006-2017	van Noort, Simon/0000-0001-6930-9741; Wossler, Theresa/0000-0003-3725-6133	Claude Leon Foundation; START secretariat; South African National Research Foundation [GUN 61497]; National Research Foundation [IFR2009090800013]; Centre for Invasion Biology	Claude Leon Foundation; START secretariat; South African National Research Foundation(National Research Foundation - South Africa); National Research Foundation; Centre for Invasion Biology	This work supported by the Claude Leon Foundation and START secretariat and by a South African National Research Foundation grant GUN 61497. This material is partially supported financially by the National Research Foundation, Ref. no. IFR2009090800013 and the Centre for Invasion Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDURAHIMAN UC, 1978, ENTOMON, V3, P181; [Anonymous], 2014, TRACER V1 6; AVISE JC, 1990, OXFORD SURVEYS EVOLU, V7, P43; Berg C.C., 1992, AFRICAN FIG TREES FI; BOUCEK Z, 1981, Tijdschrift voor Entomologie, V124, P149; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; Buffington M. L., 2005, American Entomologist, V51, P50; Buffington Matthew, 2008, American Entomologist, V54, P222; Burrows J., 2003, FIGS SO S CENTRAL AF; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compton S., 1988, Antenna, V12, P102; COMPTON SG, 1988, ECOLOGY, V69, P1302, DOI 10.2307/1941288; COMPTON SG, 1992, P K NED AKAD WETENSC, V95, P423; Compton Stephen G., 2005, Acta Societatis Zoologicae Bohemicae, V69, P37; Compton SG, 2009, AFR NAT HIST, V5, P9; Compton Stephen G., 1994, P343; CONNOR EF, 2001, ENCY BIODIVERSITY, V5, P297; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cornille A, 2012, P ROY SOC B-BIOL SCI, V279, P1731, DOI 10.1098/rspb.2011.1972; Cronin JT, 2007, ECOLOGY, V88, P2966, DOI 10.1890/07-0070.1; Cronin JT, 2005, P ROY SOC B-BIOL SCI, V272, P2225, DOI 10.1098/rspb.2005.3286; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DRUMMOND AJ, 2003, BEAST VERSION 1 4 8; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; Fellowes MDE, 1999, BEHAV ECOL SOCIOBIOL, V46, P95, DOI 10.1007/s002650050597; Fenoglio MS, 2010, ECOL ENTOMOL, V35, P594, DOI 10.1111/j.1365-2311.2010.01218.x; Fill A, 2012, ECOL ENTOMOL, V37, P43, DOI 10.1111/j.1365-2311.2011.01333.x; Forister ML, 2011, BIOTROPICA, V43, P270, DOI 10.1111/j.1744-7429.2010.00702.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Ghara M, 2010, ECOL ENTOMOL, V35, P139, DOI 10.1111/j.1365-2311.2010.01176.x; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; HAWKINS BA, 1992, J ANIM ECOL, V61, P361, DOI 10.2307/5328; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; HOLT RD, 1993, AM NAT, V142, P623, DOI 10.1086/285561; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; Jackson AP, 2008, SYMBIOSIS, V45, P57; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; Kerr Peter H., 2008, American Entomologist, V54, P198; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Laing J, 1937, J ANIM ECOL, V6, P298, DOI 10.2307/1186; LASALLE J, 1991, REDIA, V74, P313; Marussich WA, 2007, MOL ECOL, V16, P1925, DOI 10.1111/j.1365-294X.2007.03278.x; McLeish MJ, 2010, MOL ECOL, V19, P1483, DOI 10.1111/j.1365-294X.2010.04583.x; McLeish M, 2011, NEW PHYTOL, V191, P210, DOI 10.1111/j.1469-8137.2011.03683.x; McLeish MJ, 2010, MOL PHYLOGENET EVOL, V57, P122, DOI 10.1016/j.ympev.2010.05.025; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Niogret J, 2009, ECOL ENTOMOL, V34, P763, DOI 10.1111/j.1365-2311.2009.01131.x; PATINO S, 1995, NEW PHYTOL, V129, P125, DOI 10.1111/j.1469-8137.1995.tb03016.x; Peng YQ, 2005, ECOL ENTOMOL, V30, P70, DOI 10.1111/j.0307-6946.2005.00650.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Proffit M, 2007, J ANIM ECOL, V76, P296, DOI 10.1111/j.1365-2656.2007.01213.x; R Core Team, 2020, R LANG ENV STAT COMP; Royer PD, 2011, J ECOL, V99, P714, DOI 10.1111/j.1365-2745.2011.01804.x; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; TAJIMA F, 1983, GENETICS, V105, P437; Tzeng HY, 2008, SYMBIOSIS, V45, P129; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; van Noort S., 2003, FIGS S SOUTH CENTRAL, P12; van Noort Simon, 1999, P299; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; WARE AB, 1994, J CHEM ECOL, V20, P785, DOI 10.1007/BF02059613; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; West SA, 1996, J BIOGEOGR, V23, P447, DOI 10.1111/j.1365-2699.1996.tb00006.x; Wiebes J. T., 1966, Zoologische Mededeelingen Leiden, V41, P151	84	13	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44804	10.1371/journal.pone.0044804	http://dx.doi.org/10.1371/journal.pone.0044804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970309	Green Submitted, Green Published, gold			2022-12-27	WOS:000308748400030
J	Su, YF; Shyu, YC; Shen, CKJ; Hwang, J				Su, Yee-Fun; Shyu, Yu-Chiau; Shen, Che-Kun James; Hwang, Jaulang			Phosphorylation-Dependent SUMOylation of the Transcription Factor NF-E2	PLOS ONE			English	Article							ERYTHROLEUKEMIA CELL-DIFFERENTIATION; LEUCINE-ZIPPER PROTEIN; SUMO MODIFICATION; GENE-EXPRESSION; TOPOISOMERASE-I; REPRESSION; PATHWAYS; KINASE; JUN	Nuclear factor erythroid-derived 2 (NF-E2), a heterodimer composed of p45 and p18, is a transcriptional activator in hematopoietic progenitors. The transcriptional activity of NF-E2 is not only upregulated by SUMOylation but also stimulated by the cAMP-dependent protein kinase A (PKA). However, the relationship between SUMOylation and phosphorylation in the activation of NF-E2 is unclear. In the present studies, we have demonstrated that PKA enhances NF-E2 SUMOylation in an in vitro system using purified proteins, suggesting a possible mechanism for PKA-dependent activation of the NF-E2 transcription factor through SUMOylation.	[Su, Yee-Fun; Shen, Che-Kun James; Hwang, Jaulang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Hwang, Jaulang] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Shyu, Yu-Chiau] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Shyu, Yu-Chiau] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei City Hospital	Su, YF (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	jaulang@tmu.edu.tw		Shyu, Yu-Chiau/0000-0003-1747-2226	National Science Council in Taiwan [NSC98-2311-B-001-008-MY3]; Institute of Molecular Biology; Academia Sinica, National Science Council	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Institute of Molecular Biology; Academia Sinica, National Science Council(Ministry of Science and Technology, TaiwanAcademia Sinica - Taiwan)	This work was supported by grants from the National Science Council in Taiwan (NSC98-2311-B-001-008-MY3) and Institute of Molecular Biology (to JH), Academia Sinica, National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp=7), and Institute of Molecular Biology (http://www.imb.sinica.edu.tw/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Chen TY, 2000, APPL MICROBIOL BIOT, V53, P558, DOI 10.1007/s002530051657; GARINGO AD, 1995, J BIOL CHEM, V270, P9169, DOI 10.1074/jbc.270.16.9169; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goerttler PS, 2005, BRIT J HAEMATOL, V129, P138, DOI 10.1111/j.1365-2141.2005.05416.x; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nagai T, 1998, J BIOL CHEM, V273, P5358, DOI 10.1074/jbc.273.9.5358; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44608	10.1371/journal.pone.0044608	http://dx.doi.org/10.1371/journal.pone.0044608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970264	Green Submitted, gold, Green Published			2022-12-27	WOS:000308748400025
J	Acharya, P; Chaubey, S; Grover, M; Tatu, U				Acharya, Pragyan; Chaubey, Shweta; Grover, Manish; Tatu, Utpal			An Exported Heat Shock Protein 40 Associates with Pathogenesis-Related Knobs in Plasmodium falciparum Infected Erythrocytes	PLOS ONE			English	Article							MEMBRANE PROTEIN-1; MAURERS CLEFTS; MALARIA; CYTOADHERENCE; TRAFFICKING; VIRULENCE; REVEALS; DOMAINS; SURFACE; FAMILY	Cell surface structures termed knobs are one of the most important pathogenesis related protein complexes deployed by the malaria parasite Plasmodium falciparum at the surface of the infected erythrocyte. Despite their relevance to the disease, their structure, mechanisms of traffic and their process of assembly remain poorly understood. In this study, we have explored the possible role of a parasite-encoded Hsp40 class of chaperone, namely PFB0090c/PF3D7_0201800 (KAHsp40) in protein trafficking in the infected erythrocyte. We found the gene coding for PF3D7_0201800 to be located in a chromosomal cluster together with knob components KAHRP and PfEMP3. Like the knob components, KAHsp40 too showed the presence of PEXEL motif required for transport to the erythrocyte compartment. Indeed, sub-cellular fractionation and immunofluorescence analysis (IFA) showed KAHsp40 to be exported in the erythrocyte cytoplasm in a stage dependent manner localizing as punctuate spots in the erythrocyte periphery, distinctly from Maurer's cleft, in structures which could be the reminiscent of knobs. Double IFA analysis revealed co-localization of PF3D7_0201800 with the markers of knobs (KAHRP, PfEMP1 and PfEMP3) and components of the PEXEL translocon (Hsp101, PTEX150). KAHsp40 was also found to be in a complex with KAHRP, PfEMP3 and Hsp101 as confirmed by co-immunoprecipitation assay. Our results suggest potential involvement of a parasite encoded Hsp40 in chaperoning knob assembly in the erythrocyte compartment.	[Acharya, Pragyan; Chaubey, Shweta; Grover, Manish; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Acharya, P (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in		Tatu, Utpal/0000-0003-0404-8872; GROVER, MANISH/0000-0002-1625-7930	European Union MALSIG Grant [223044]	European Union MALSIG Grant	European Union MALSIG Grant;223044,http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/178_en.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Aikawa M, 1996, EXP PARASITOL, V84, P339, DOI 10.1006/expr.1996.0122; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Khattab A, 2006, TRAFFIC, V7, P1654, DOI 10.1111/j.1600-0854.2006.00494.x; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Saridaki T, 2008, CELL MICROBIOL, V10, P2483, DOI 10.1111/j.1462-5822.2008.01223.x; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172	28	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44605	10.1371/journal.pone.0044605	http://dx.doi.org/10.1371/journal.pone.0044605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970262	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000308462000036
J	Zhang, Y; Zhao, ZH; Chen, CTA; Tang, K; Su, JQ; Jiao, NZ				Zhang, Yao; Zhao, Zihao; Chen, Chen-Tung Arthur; Tang, Kai; Su, Jianqiang; Jiao, Nianzhi			Sulfur Metabolizing Microbes Dominate Microbial Communities in Andesite-Hosted Shallow-Sea Hydrothermal Systems	PLOS ONE			English	Article							DEEP-SEA; EPSILON-PROTEOBACTERIA; DIVERSITY; QUALITY; VENTS; WATER; RNA; DNA	To determine microbial community composition, community spatial structure and possible key microbial processes in the shallow-sea hydrothermal vent systems off NE Taiwan's coast, we examined the bacterial and archaeal communities of four samples collected from the water column extending over a redoxocline gradient of a yellow and four from a white hydrothermal vent. Ribosomal tag pyrosequencing based on DNA and RNA showed statistically significant differences between the bacterial and archaeal communities of the different hydrothermal plumes. The bacterial and archaeal communities from the white hydrothermal plume were dominated by sulfur-reducing Nautilia and Thermococcus, whereas the yellow hydrothermal plume and the surface water were dominated by sulfide-oxidizing Thiomicrospira and Euryarchaeota Marine Group II, respectively. Canonical correspondence analyses indicate that methane (CH4) concentration was the only statistically significant variable that explains all community cluster patterns. However, the results of pyrosequencing showed an essential absence of methanogens and methanotrophs at the two vent fields, suggesting that CH4 was less tied to microbial processes in this shallow-sea hydrothermal system. We speculated that mixing between hydrothermal fluids and the sea or meteoric water leads to distinctly different CH4 concentrations and redox niches between the yellow and white vents, consequently influencing the distribution patterns of the free-living Bacteria and Archaea. We concluded that sulfur-reducing and sulfide-oxidizing chemolithoautotrophs accounted for most of the primary biomass synthesis and that microbial sulfur metabolism fueled microbial energy flow and element cycling in the shallow hydrothermal systems off the coast of NE Taiwan.	[Zhang, Yao; Zhao, Zihao; Tang, Kai; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Chen, Chen-Tung Arthur] Natl Sun Yat Sen Univ, Inst Marine Geol & Chem, Kaohsiung, Taiwan; [Su, Jianqiang] Chinese Acad Sci, Key Lab Urban Environm & Hlth, Inst Urban Environm, Xiamen, Peoples R China	Xiamen University; National Sun Yat Sen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhang, Y (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	yaozhang@xmu.edu.cn; jiao@xmu.edu.cn	CAS, KLUEH-Cooperation/E-1148-2017; chen, chen/GRY-7085-2022; Chen, Chen-Tung Arthur/C-8901-2011; Su, Jian-Qiang/C-2388-2009; CHEN, CHEN/HDM-6657-2022; CAS, KLUEH/T-5743-2019	Chen, Chen-Tung Arthur/0000-0002-5170-6471; Su, Jian-Qiang/0000-0003-1875-249X; 	National Natural Science Foundation of China (NSFC) Projects [41176095, 91028001, 41023007]; New Century Excellent Talents (NCET) Plan	National Natural Science Foundation of China (NSFC) Projects(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents (NCET) Plan(Program for New Century Excellent Talents in University (NCET))	This research was supported by the National Natural Science Foundation of China (NSFC) Projects 41176095, 91028001 and 41023007, and the New Century Excellent Talents (NCET) Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000362; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DeLong EF, 2006, P NATL ACAD SCI USA, V103, P6417, DOI 10.1073/pnas.0602079103; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gaidos E, 2011, ENVIRON MICROBIOL, V13, P1138, DOI 10.1111/j.1462-2920.2010.02392.x; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Leps J, 2003, MULTIVARIATE ANAL EC; Li Z-X, 2009, SCI DEV, V437, P40; [刘长华 LIU Chang-hua], 2010, [海洋科学, Marine Sciences], V34, P61; [刘长华 LIU Changhua], 2007, [海洋科学, Marine Sciences], V31, P61; Longnecker K, 2001, FEMS MICROBIOL ECOL, V35, P287, DOI 10.1111/j.1574-6941.2001.tb00814.x; Maugeri TL, 2010, CHEM ECOL, V26, P285, DOI 10.1080/02757541003693250; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; NOVITSKY JA, 1986, APPL ENVIRON MICROB, V52, P504, DOI 10.1128/AEM.52.3.504-509.1986; Opatkiewicz AD, 2009, FEMS MICROBIOL ECOL, V70, P413, DOI 10.1111/j.1574-6941.2009.00747.x; PAI SC, 1990, ANAL CHIM ACTA, V232, P345, DOI 10.1016/S0003-2670(00)81252-0; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith JL, 2008, INT J SYST EVOL MICR, V58, P1598, DOI 10.1099/ijs.0.65435-0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SWINNERTON JW, 1967, J GAS CHROMATOGR, V5, P570, DOI 10.1093/chromsci/5.11.570; Takail K, 2006, GEOPHYS MONOGR SER, V166, P185; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1989, HYDROBIOLOGIA, V184, P169, DOI 10.1007/BF02392953; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Yang LY, 2012, MAR CHEM, V128, P64, DOI 10.1016/j.marchem.2011.10.003; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zeng Z-G, 2007, SCI CHINA SER D, V37, P1134	43	107	110	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44593	10.1371/journal.pone.0044593	http://dx.doi.org/10.1371/journal.pone.0044593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970260	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000034
J	Das, A; Dey, N; Ghosh, A; Das, S; Chattopadhyay, DJ; Chatterjee, IB				Das, Archita; Dey, Neekkan; Ghosh, Arunava; Das, Shovanendu; Chattopadhyay, Dhruba J.; Chatterjee, Indu B.			Molecular and Cellular Mechanisms of Cigarette Smoke-Induced Myocardial Injury: Prevention by Vitamin C	PLOS ONE			English	Article							OXIDATIVE STRESS; SIGNALING PATHWAYS; HEART-FAILURE; TOBACCO-SMOKE; ASCORBIC-ACID; APOPTOSIS; ISCHEMIA; DISEASE; DAMAGE; BENZOSEMIQUINONE	Background: Cardiovascular disease (CVD) remains one of the major killers in modern society. One strong risk factor of CVD is cigarette smoking that causes myocardial injury and leads to the genesis of pathological cardiovascular events. However, the exact toxic component(s) of cigarette smoke (CS) and its molecular and cellular mechanisms for causing myocardial injury leading to heart damage and its prevention are largely unknown. Methodology/Principal Findings: Using a guinea pig model, here we show that chronic exposure to CS produces myocardial injury that is prevented by vitamin C. Male guinea pigs were fed either vitamin C-deficient (0.5 mg/day) or vitamin C-sufficient (15 mg/day) diet and subjected to CS exposure from 5 Kentucky Research cigarettes (3R4F)/day (6 days/week) in a smoke chamber up to 8 weeks. Pair-fed sham controls were subjected to air exposure instead of CS exposure under similar conditions. Myocardial injury was produced in CS-exposed marginal vitamin C-deficient guinea pigs as evidenced by release of cardiac Troponin-T and I in the serum, oxidative stress, inflammation, apoptosis, thrombosis and collagen deposition in the myocardium. Treatment of rat cardiomyocyte cells (H9c2) in vitro and guinea pigs in vivo with p-benzoquinone (p-BQ) in amounts derived from CS revealed that p-BQ was a major factor responsible for CS-induced myocardial damage. A moderately large dose of vitamin C (15 mg/day) prevented CS/p-BQ-induced myocardial injury. Population based studies indicated that plasma vitamin C levels of smokers without disease were significantly lower (p = 0,0000) than that of non-smokers. Vitamin C levels of CS-related cardiovascular patients were further lower (p = 0.0000) than that of smokers without disease. Conclusions/Significance: The results indicate that dietary supplementation of vitamin C may be a novel and simple therapy for the prevention of pathological cardiovascular events in habitual smokers.	[Das, Archita; Dey, Neekkan; Ghosh, Arunava; Chattopadhyay, Dhruba J.; Chatterjee, Indu B.] Univ Coll Sci Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Dept Biotechnol, Kolkata, India; [Das, Shovanendu] VLCC Hlth Care, Kolkata, India	University of Calcutta	Das, A (corresponding author), Univ Coll Sci Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Dept Biotechnol, Kolkata, India.	ibc123@rediffmail.com	DAS, ARCHITA/ABD-5437-2020; Ghosh, Arunava/I-5939-2019	Ghosh, Arunava/0000-0001-9550-1366; Dey, Neekkan/0000-0002-4042-7215	Juthika Research Foundation of Calcutta University, Department of Biotechnology, Government of West Bengal; Council of Scientific and Industrial Research, Government of India	Juthika Research Foundation of Calcutta University, Department of Biotechnology, Government of West Bengal; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Juthika Research Foundation of Calcutta University, Department of Biotechnology, Government of West Bengal and Council of Scientific and Industrial Research, Government of India. Indu B. Chatterjee is INSA (Indian National Science Academy) Honorary Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21; Barbieri SS, 2011, CARDIOVASC RES, V90, P475, DOI 10.1093/cvr/cvr032; Bernhard D, 2007, CURR MED CHEM, V14, P1703; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; CHAKRABARTY S, 1992, MOL CELL BIOCHEM, V111, P41; CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Chatterjee IB, 2005, US Patent, Patent No. [6,929,012, 6929012, 6,929, 012]; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Csordas A, 2008, BIOMARK INSIGHTS, V3, P127; Das A., 2011, PLOS ONE, V6; Das A, 2010, CHEM RES TOXICOL, V23, P1054, DOI 10.1021/tx1000442; Dept of Health and Human Services, 2005, DHHS PUBL, P89; Dey N, 2011, J ONCOL, V2011, DOI 10.1155/2011/561862; Dey N, 2010, J BIOSCIENCES, V35, P217, DOI 10.1007/s12038-010-0026-2; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Ghosh A, 2012, TOXICOLOGY, V292, P78, DOI 10.1016/j.tox.2011.11.014; Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com; Gilles S, 2003, CARDIOVASC RES, V60, P608, DOI 10.1016/j.cardiores.2003.08.016; Giovino GA, 2007, AM J PREV MED, V33, pS318, DOI 10.1016/j.amepre.2007.09.008; Guaiquil VH, 2004, FREE RADICAL BIO MED, V37, P1419, DOI 10.1016/j.freeradbiomed.2004.06.041; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Khanna AK, 2011, LEGALITY TARGETED KI, P1; Kim H, 2009, J IMMUNOL, V182; LEHR HA, 1994, P NATL ACAD SCI USA, V91, P7688, DOI 10.1073/pnas.91.16.7688; Lu L, 2000, AM J PHYSIOL-HEART C, V279, pH601, DOI 10.1152/ajpheart.2000.279.2.H601; McCully JD, 2004, AM J PHYSIOL-HEART C, V286, pH1923, DOI 10.1152/ajpheart.00935.2003; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; NIKI E, 1991, AM J CLIN NUTR, V54, pS1119, DOI 10.1093/ajcn/54.6.1119s; O'Brien PJ, 2008, TOXICOLOGY, V245, P206, DOI 10.1016/j.tox.2007.12.006; Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5; Panda KChatterjeeIB, 2007, ENCY VITAMIN E, P883; Preston AM, 2003, AM J CLIN NUTR, V77, P167, DOI 10.1093/ajcn/77.1.167; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Saraste A, 1997, CIRCULATION, V95, P320; SCHECTMAN G, 1989, AM J PUBLIC HEALTH, V79, P158, DOI 10.2105/AJPH.79.2.158; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Stewart B. W., 2003, WORLD CANC REPORT, P21; SULLIVAN AB, 1976, J PHYS CHEM-US, V80, P2671, DOI 10.1021/j100565a010; Takano H, 2003, ANTIOXID REDOX SIGN, V5, P789, DOI 10.1089/152308603770380098; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Valkonen MM, 2000, FREE RADICAL BIO MED, V28, P428, DOI 10.1016/S0891-5849(99)00260-9; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; White William B, 2007, Prev Cardiol, V10, P1, DOI 10.1111/j.1520-037X.2007.06050.x; WINNIFORD MD, 1986, CIRCULATION, V73, P662, DOI 10.1161/01.CIR.73.4.662; Wright JL, 2002, CHEST, V121, p188S, DOI 10.1378/chest.121.5_suppl.188S; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	53	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44151	10.1371/journal.pone.0044151	http://dx.doi.org/10.1371/journal.pone.0044151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970172	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400039
J	Kim, KT; Carroll, AP; Mashkani, B; Cairns, MJ; Small, D; Scott, RJ				Kim, Kyu-Tae; Carroll, Adam P.; Mashkani, Baratali; Cairns, Murray J.; Small, Donald; Scott, Rodney J.			MicroRNA-16 Is Down-Regulated in Mutated FLT3 Expressing Murine Myeloid FDC-P1 Cells and Interacts with Pim-1	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; CONSTITUTIVELY ACTIVATED FLT3; KINASE INHIBITOR; TYROSINE KINASE; MIR-16 TARGETS; IN-VITRO; LEUKEMIA; GENE; CANCER; MECHANISMS	Activating mutations in the receptor tyrosine kinase FLT3 are one of the most frequent somatic mutations in acute myeloid leukemia (AML). Internal tandem duplications of the juxtamembrane region of FLT3 (FLT3/ITD) constitutively activate survival and proliferation pathways, and are associated with a poor prognosis in AML. We suspected that alteration of small non-coding microRNA ( miRNA) expression in these leukemia cells is involved in the transformation process and used miRNA microarrays to determine the miRNA signature from total RNA harvested from FLT3/ITD expressing FDC-P1 cells (FD-FLT3/ITD). This revealed that a limited set of miRNAs appeared to be affected by expression of FLT3/ITD compared to the control group consisting of FDC-P1 parental cells transfected with an empty vector (FD-EV). Among differentially expressed miRNAs, we selected miR-16, miR-21 and miR-223 to validate the microarray data by quantitative real-time RT-PCR showing a high degree of correlation. We further analyzed miR-16 expression with FLT3 inhibitors in FLT3/ITD expressing cells. MiR-16 was found to be one of most significantly down-regulated miRNAs in FLT3/ITD expressing cells and was up-regulated upon FLT3 inhibition. The data suggests that miR-16 is acting as a tumour suppressor gene in FLT3/ITD-mediated leukemic transformation. Whilst miR-16 has been reported to target multiple mRNAs, computer models from public bioinformatic resources predicted a potential regulatory mechanism between miR-16 and Pim-1 mRNA. In support of this interaction, miR-16 was shown to suppress Pim-1 reporter gene expression. Further, our data demonstrated that over-expression of miR-16 mimics suppressed Pim-1 expression in FD-FLT3/ITD cells suggesting that increased miR-16 expression contributes to depletion of Pim-1 after FLT3 inhibition and that miR-16 repression may be associated with up-regulated Pim-1 in FLT3/ITD expressing cells.	[Kim, Kyu-Tae; Carroll, Adam P.; Mashkani, Baratali; Cairns, Murray J.; Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Small, Donald] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Small, Donald] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	University of Newcastle; Johns Hopkins University; Johns Hopkins University	Kim, KT (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	kyutae.kim@gmail.com	, Ali/R-6528-2019; Scott, Rodney J/B-2827-2013	, Ali/0000-0002-7606-5455; Scott, Rodney J/0000-0001-7724-3404; Cairns, Murray/0000-0003-2490-2538	University of Newcastle [10.21001]; Hunter Medical Research Institute [10.81531]	University of Newcastle; Hunter Medical Research Institute	This study was supported by funds from the University of Newcastle (grant number: 10.21001) and the Hunter Medical Research Institute (grant number: 10.81531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; BIRG F, 1992, BLOOD, V80, P2584; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Calin GA, 2006, LEUKEMIA RES, V30, P653, DOI 10.1016/j.leukres.2005.10.017; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carow CE, 1996, BLOOD, V87, P1089, DOI 10.1182/blood.V87.3.1089.bloodjournal8731089; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enjeti Anoop Kumar, 2004, Hematol J, V5, P419, DOI 10.1038/sj.thj.6200544; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; Fathi AT, 2012, LEUKEMIA RES, V36, P224, DOI 10.1016/j.leukres.2011.07.011; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Flamant S, 2010, HAEMATOL-HEMATOL J, V95, P1325, DOI 10.3324/haematol.2009.020636; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Frost MJ, 2002, MOL CANCER THER, V1, P1115; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kim KT, 2007, BRIT J HAEMATOL, V138, P603, DOI 10.1111/j.1365-2141.2007.06696.x; Kim KT, 2006, BRIT J HAEMATOL, V134, P500, DOI 10.1111/j.1365-2141.2006.06225.x; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lawrie CH, 2007, BRIT J HAEMATOL, V137, P503, DOI 10.1111/j.1365-2141.2007.06611.x; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Li L, 2007, BRIT J HAEMATOL, V137, P64, DOI 10.1111/j.1365-2141.2007.06525.x; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Mashkani B, 2010, BIOORGAN MED CHEM, V18, P1789, DOI 10.1016/j.bmc.2010.01.056; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Nakao M, 1996, LEUKEMIA, V10, P1911; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Roberts KG, 2007, MOL CANCER THER, V6, P1159, DOI 10.1158/1535-7163.MCT-06-0641; Rosnet O, 1996, LEUKEMIA, V10, P238; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; SHOUNAN Y, 1995, EXP HEMATOL, V23, P492; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thomas M, 2011, ONCOGENE; Tse KF, 2002, LEUKEMIA, V16, P2027, DOI 10.1038/sj.leu.2402674; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vu HA, 2009, BIOCHEM BIOPH RES CO, V383, P308, DOI 10.1016/j.bbrc.2009.03.157; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Yendamuri S, 2009, LEUKEMIA, V23, P1257, DOI 10.1038/leu.2008.382; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; Young SM, 2006, CELL SIGNAL, V18, P608, DOI 10.1016/j.cellsig.2005.06.005; Zhang X, 2011, ONCOGENE; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	81	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44546	10.1371/journal.pone.0044546	http://dx.doi.org/10.1371/journal.pone.0044546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970245	Green Published, gold			2022-12-27	WOS:000308458400087
J	Laco, MN; Cortes, L; Travis, SM; Paulson, HL; Rego, AC				Laco, Mario N.; Cortes, Luisa; Travis, Sue M.; Paulson, Henry L.; Cristina Rego, A.			Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; DEUBIQUITINATING ENZYME ATAXIN-3; NON-EXPANDED ATAXIN-3; NUCLEAR-LOCALIZATION; STRUCTURAL DETERMINANTS; POLYGLUTAMINE DISEASES; UBIQUITIN CHAINS; GENE-PRODUCT; CELL-NUCLEUS; HHR23A	Alterations in the ubiquitin-proteasome system (UPS) have been reported in several neurodegenerative disorders characterized by protein misfolding and aggregation, including the polylgutamine diseases. Machado-Joseph disease (MJD) or Spinocerebellar Ataxia type 3 is caused by a polyglutamine-encoding CAG expansion in the ATXN3 gene, which encodes a 42 kDa deubiquitinating enzyme (DUB), ataxin-3. We investigated ataxin-3 deubiquitinating activity and the functional relevance of ataxin-3 interactions with two proteins previously described to interact with ataxin-3, hHR23A and valosin-containing protein (VCP/p97). We confirmed ataxin-3 affinity for both hHR23A and VCP/p97. hHR23A and ataxin-3 were shown to co-localize in discrete nuclear foci, while VCP/p97 was primarily cytoplasmic. hHR23A and VCP/p97 recombinant proteins were added, separately or together, to normal and expanded ataxin-3 in in vitro deubiquitination assays to evaluate their influence on ataxin-3 activity. VCP/p97 was shown to be an activator specifically of wild-type ataxin-3, exhibiting no effect on expanded ataxin-3, In contrast, we observed no significant alterations in ataxin-3 enzyme kinetics or substrate preference in the presence of hHR23A alone or in combination with VCP. Based on our results we propose a model where ataxin-3 normally functions with its interactors to specify the cellular fate of ubiquitinated proteins.	[Laco, Mario N.; Cortes, Luisa; Cristina Rego, A.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Laco, Mario N.; Cristina Rego, A.] Univ Coimbra, Fac Med, Coimbra, Portugal; [Travis, Sue M.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Paulson, Henry L.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA	Universidade de Coimbra; Universidade de Coimbra; University of Iowa; University of Michigan System; University of Michigan	Laco, MN (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	henryp@umich.edu; acrego@cnc.cj.uc.pt	Cortes, Luisa/F-7349-2014; Rego, Ana Cristina/AAH-2606-2020; Rego, Ana Cristina C/L-4272-2014	Cortes, Luisa/0000-0001-5292-4369; Rego, Ana Cristina C/0000-0003-0700-3776; Noro Laco, Mario/0000-0003-4823-3340	NINDS NIH HHS [R01 NS038712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antony PMA, 2009, NEUROBIOL DIS, V36, P280, DOI 10.1016/j.nbd.2009.07.020; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chen L, 2006, FEBS LETT, V580, P3401, DOI 10.1016/j.febslet.2006.05.012; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dalal S, 2001, CELL, V104, P5, DOI 10.1016/S0092-8674(01)00186-6; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Evert BO, 2003, J NEUROPATH EXP NEUR, V62, P1006, DOI 10.1093/jnen/62.10.1006; Evert BO, 2001, J NEUROSCI, V21, P5389, DOI 10.1523/JNEUROSCI.21-15-05389.2001; Fei EK, 2007, BIOCHEM BIOPH RES CO, V357, P487, DOI 10.1016/j.bbrc.2007.03.160; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hsieh HC, 2005, BIOCHEM BIOPH RES CO, V335, P181, DOI 10.1016/j.bbrc.2005.07.067; Kang Y, 2007, J MOL BIOL, V369, P168, DOI 10.1016/j.jmb.2007.03.008; Kuhlbrodt K, 2011, NAT CELL BIOL, V13, P273, DOI 10.1038/ncb2200; Macedo-Ribeiro S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005834; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Mazzucchelli S, 2009, INT J BIOCHEM CELL B, V41, P2485, DOI 10.1016/j.biocel.2009.08.003; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Paulson HL, 2007, SEMIN NEUROL, V27, P133, DOI 10.1055/s-2007-971172; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Scharf A, 2007, HISTOCHEM CELL BIOL, V127, P591, DOI 10.1007/s00418-006-0266-2; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; Takeshita Y, 2011, NEUROREPORT, V22, P232, DOI 10.1097/WNR.0b013e32834505f4; Tao Rui-Song, 2008, Neurosci Bull, V24, P271, DOI 10.1007/s12264-008-0605-5; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	64	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43563	10.1371/journal.pone.0043563	http://dx.doi.org/10.1371/journal.pone.0043563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970133	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400015
J	Latreille, J; Kesse-Guyot, E; Malvy, D; Andreeva, V; Galan, P; Tschachler, E; Hercberg, S; Guinot, C; Ezzedine, K				Latreille, Julie; Kesse-Guyot, Emmanuelle; Malvy, Denis; Andreeva, Valentina; Galan, Pilar; Tschachler, Erwin; Hercberg, Serge; Guinot, Christiane; Ezzedine, Khaled			Dietary Monounsaturated Fatty Acids Intake and Risk of Skin Photoaging	PLOS ONE			English	Article							ANTIOXIDANT VITAMINS; METABOLIC SYNDROME; OLIVE OIL; MECHANISMS; SU.VI.MAX; WOMEN; PREVENTION; MINERALS; TRIAL; FOOD	Background: Intake of monounsaturated fatty acids has been reported to reduce oxidative stress, insulin resistance and related inflammatory processes and may thus protect from skin photoaging. The objective of this study was to investigate the association between the risk of photoaging, monounsaturated fatty acids intake and the sources of monounsaturated fatty acids. Methodology/Principal Findings: A cross sectional study was conducted within the framework of the SUVIMAX cohort. The survey included 1264 women and 1655 men aged between 45 and 60 years old. Dietary monounsaturated fatty acids intakes were estimated by dietary source through at least ten 24-h diet records completed during the first 2.5 years of the follow-up period. Severity of facial skin photoaging was graded by trained investigators at baseline during a clinical examination using a 6-grade scale illustrated by photographs. A lower risk of severe photoaging was associated with higher intakes of monounsaturated fatty acids from olive oil in both sexes. Strikingly, no association was found with intake of monounsaturated fatty acids from animal sources whether from dairy products, meat or processed meat. Conclusion/Significance: These findings support the beneficial effect of dietary olive oil or healthy diet habits associated with olive oil consumption on the severity of facial photoaging.	[Latreille, Julie; Tschachler, Erwin; Guinot, Christiane] CERIES Res Ctr Human Skin Founded CHANEL, Neuilly Sur Seine, France; [Latreille, Julie; Kesse-Guyot, Emmanuelle; Malvy, Denis; Andreeva, Valentina; Galan, Pilar; Hercberg, Serge; Ezzedine, Khaled] Univ Paris 13, Ctr Res Human Nutr Ile France, INRA, INSERM,U1125,CNAM,UMR U557, Paris, France; [Malvy, Denis] Hop St Andre, Dept Internal Med & Trop Dis, Bordeaux, France; [Tschachler, Erwin] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93009 Bobigny, France; [Guinot, Christiane] Univ Tours, Comp Sci Lab, Tours, France; [Ezzedine, Khaled] Hop St Andre, Dept Dermatol, Bordeaux, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; CHU Bordeaux; Medical University of Vienna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite de Tours; CHU Bordeaux	Latreille, J (corresponding author), CERIES Res Ctr Human Skin Founded CHANEL, Neuilly Sur Seine, France.	julie.latreille@ceries-lab.com	Andreeva, Valentina/F-2680-2017; MALVY, Denis/T-7930-2019; HERCBERG, Serge/B-4429-2008; Serge, Hercberg/F-3038-2017; Kesse-Guyot, Emmanuelle/F-2692-2017; Ezzedine, Khaled/F-2716-2017; Pilar, Galan/F-2908-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/ABH-7347-2020	Andreeva, Valentina/0000-0001-9480-5210; HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Ezzedine, Khaled/0000-0002-5468-4589; Pilar, Galan/0000-0003-1706-3107; Tschachler, Erwin/0000-0002-0248-1798				ARNAULT N, 2006, TABLE COMPOSITION AL; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Bergouignan A, 2009, PROG LIPID RES, V48, P128, DOI 10.1016/j.plipres.2009.02.004; Black HS, 1998, MUTAT RES-FUND MOL M, V422, P185, DOI 10.1016/S0027-5107(98)00191-2; CESARINI JP, 1988, PIGM CELL RES, V1, P223, DOI 10.1111/j.1600-0749.1988.tb00420.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cosgrove MC, 2007, AM J CLIN NUTR, V86, P1225, DOI 10.1093/ajcn/86.4.1225; Ezzedine K, 2008, J EUR ACAD DERMATOL, V22, P186, DOI 10.1111/j.1468-3083.2007.02367.x; Farage M.A., 2010, TXB AGING SKIN, V1st ed., P949; Favier JC, 1995, REPERTOIRE GEN ALIME; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Guinot C, 2001, SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, P1099; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; IRELAND J, 2002, REPERTOIRE GEN ALIME, V2; LARNIER C, 1994, BRIT J DERMATOL, V130, P167, DOI 10.1111/j.1365-2133.1994.tb02895.x; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; Malvy DJM, 2000, J AM ACAD DERMATOL, V42, P47, DOI 10.1016/S0190-9622(00)90008-2; Mennen LI, 2002, EUR J CLIN NUTR, V56, P659, DOI 10.1038/sj.ejcn.1601374; Ministry of Agriculture FaF, 2004, FATT AC SUPPL MCCANC; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nagata C, 2010, BRIT J NUTR, V103, P1493, DOI 10.1017/S0007114509993461; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Puizina-Ivic N, 2008, ACTA DERMATOVEN ALP, V17, P47; Purba MB, 2001, J AM COLL NUTR, V20, P71, DOI 10.1080/07315724.2001.10719017; Quiles JL, 2006, NUTR REV, V64, pS31, DOI 10.1111/j.1753-4887.2006.tb00261.x; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Sies H, 2004, ANNU REV NUTR, V24, P173, DOI 10.1146/annurev.nutr.24.012003.132320; USDA, 2003, NAT NUTR DAT STAND R; Viola P, 2009, CLIN DERMATOL, V27, P159, DOI 10.1016/j.clindermatol.2008.01.008; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001	38	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44490	10.1371/journal.pone.0044490	http://dx.doi.org/10.1371/journal.pone.0044490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970231	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400077
J	Lee, CK; Herbold, CW; Polson, SW; Wommack, KE; Williamson, SJ; McDonald, IR; Cary, SC				Lee, Charles K.; Herbold, Craig W.; Polson, Shawn W.; Wommack, K. Eric; Williamson, Shannon J.; McDonald, Ian R.; Cary, S. Craig			Groundtruthing Next-Gen Sequencing for Microbial Ecology-Biases and Errors in Community Structure Estimates from PCR Amplicon Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; RARE BIOSPHERE; BACTERIAL DIVERSITY; SPECIES RICHNESS; ARCTIC-OCEAN; AMPLIFICATION; PRIMERS; HETERODUPLEXES; DIVERGENCE; ALIGNMENT	Analysis of microbial communities by high-throughput pyrosequencing of SSU rRNA gene PCR amplicons has transformed microbial ecology research and led to the observation that many communities contain a diverse assortment of rare taxa-a phenomenon termed the Rare Biosphere. Multiple studies have investigated the effect of pyrosequencing read quality on operational taxonomic unit (OTU) richness for contrived communities, yet there is limited information on the fidelity of community structure estimates obtained through this approach. Given that PCR biases are widely recognized, and further unknown biases may arise from the sequencing process itself, a priori assumptions about the neutrality of the data generation process are at best unvalidated. Furthermore, post-sequencing quality control algorithms have not been explicitly evaluated for the accuracy of recovered representative sequences and its impact on downstream analyses, reducing useful discussion on pyrosequencing reads to their diversity and abundances. Here we report on community structures and sequences recovered for in vitro-simulated communities consisting of twenty 16S rRNA gene clones tiered at known proportions. PCR amplicon libraries of the V3-V4 and V6 hypervariable regions from the in vitro-simulated communities were sequenced using the Roche 454 GS FLX Titanium platform. Commonly used quality control protocols resulted in the formation of OTUs with >1% abundance composed entirely of erroneous sequences, while over-aggressive clustering approaches obfuscated real, expected OTUs. The pyrosequencing process itself did not appear to impose significant biases on overall community structure estimates, although the detection limit for rare taxa may be affected by PCR amplicon size and quality control approach employed. Meanwhile, PCR biases associated with the initial amplicon generation may impose greater distortions in the observed community structure.	[Lee, Charles K.; Herbold, Craig W.; McDonald, Ian R.; Cary, S. Craig] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Polson, Shawn W.] Univ Delaware, Ctr Bioinformat & Computat Biol, Delaware Biotechnol Inst, Newark, DE USA; [Polson, Shawn W.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Wommack, K. Eric] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Polson, Shawn W.; Wommack, K. Eric] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Wommack, K. Eric; Cary, S. Craig] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA; [Williamson, Shannon J.] J Craig Venter Inst, San Diego, CA USA	University of Waikato; University of Delaware; University of Delaware; University of Delaware; University of Delaware; University of Delaware; J. Craig Venter Institute	Lee, CK (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	caryc@waikato.ac.nz	Lee, Charles/AAC-9417-2019; McDonald, Ian R/A-4851-2008; Herbold, Craig W./S-4397-2018; Polson, Shawn W./B-7696-2011	Lee, Charles/0000-0002-6562-4733; McDonald, Ian R/0000-0002-4847-6492; Herbold, Craig W./0000-0003-3479-0197; Polson, Shawn W./0000-0002-3398-6932; Cary, Stephen/0000-0002-2876-2387	Office of Science (BER); U.S. Department of Energy [De-FC02-02ER63453]; National Science Foundation [MCB-0731916, ANT-0739648, ANT-0229836]; New Zealand Marsden Fund [UOW0802, UOW1003]	Office of Science (BER)(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported by grants from the Office of Science (BER), U.S. Department of Energy (Cooperative Agreement No. De-FC02-02ER63453) and the National Science Foundation to KEW, SJW, and SCC (MCB-0731916) and SCC (ANT-0739648 and ANT-0229836). The New Zealand Marsden Fund provided financial support for CWH, IRM, SCC (UOW0802), and CKL (UOW1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ashby MN, 2007, APPL ENVIRON MICROB, V73, P4532, DOI 10.1128/AEM.02956-06; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bragg L, 2012, FAST HIGH SPECIFICIT, P1; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hugenholtz P, 2001, ENV MOL MICROBIOLOGY; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kurata S, 2004, APPL ENVIRON MICROB, V70, P7545, DOI 10.1128/AEM.70.12.7545-7549.2004; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rueckert A, 2007, LIMNOL OCEANOGR-METH, V5, P474, DOI 10.4319/lom.2007.5.474; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tiao G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1645; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Youssef NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012414; Zinger L, 2009, ISME J, V3, P850, DOI 10.1038/ismej.2009.20	62	115	118	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44224	10.1371/journal.pone.0044224	http://dx.doi.org/10.1371/journal.pone.0044224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970184	Green Published, gold			2022-12-27	WOS:000308458400049
J	Reis, LA; Borges, FT; Simoes, MJ; Borges, AA; Sinigaglia-Coimbra, R; Schor, N				Reis, Luciana A.; Borges, Fernanda T.; Simoes, Manuel J.; Borges, Andrea A.; Sinigaglia-Coimbra, Rita; Schor, Nestor			Bone Marrow-Derived Mesenchymal Stem Cells Repaired but Did Not Prevent Gentamicin-Induced Acute Kidney Injury through Paracrine Effects in Rats	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; POSTISCHEMIC KIDNEY; STROMAL CELLS; NEPHROTOXICITY; DIFFERENTIATION; CONTRIBUTE; PROTECT; MICE	This study evaluated the effects of bone marrow-derived mesenchymal stem cells (BMSCs) or their conditioned medium (CM) on the repair and prevention of Acute Kidney Injury (AKI) induced by gentamicin (G). Animals received daily injections of G up to 20 days. On the 10th day, injections of BMSCs, CM, CM+trypsin, CM+RNase or exosome-like microvesicles extracted from the CM were administered. In the prevention groups, the animals received the BMSCs 24 h before or on the 5th day of G treatment. Creatinine (Cr), urea (U), FENa and cytokines were quantified. The kidneys were evaluated using hematoxylin/eosin staining and immunohystochemistry. The levels of Cr, U and FENa increased during all the periods of G treatment. The BMSC transplantation, its CM or exosome injections inhibited the increase in Cr, U, FENa, necrosis, apoptosis and also increased cell proliferation. The pro-inflammatory cytokines decreased while the anti-inflammatory cytokines increased compared to G. When the CM or its exosomes were incubated with RNase (but not trypsin), these effects were blunted. The Y chromosome was not observed in the 24-h prevention group, but it persisted in the kidney for all of the periods analyzed, suggesting that the injury is necessary for the docking and maintenance of BMSCs in the kidney. In conclusion, the BMSCs and CM minimized the G-induced renal damage through paracrine effects, most likely through the RNA carried by the exosome-like microvesicles. The use of the CM from BMSCs can be a potential therapeutic tool for this type of nephrotoxicity, allowing for the avoidance of cell transplantations.	[Reis, Luciana A.; Borges, Fernanda T.; Schor, Nestor] UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil; [Simoes, Manuel J.] UNIFESP EPM, Dept Morphol, Histol & Biol Struct Div, Sao Paulo, Brazil; [Borges, Andrea A.; Sinigaglia-Coimbra, Rita] UNIFESP EPM, Elect Microscopy Ctr, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Reis, LA (corresponding author), UNIFESP EPM, Dept Med, Div Nephrol, Sao Paulo, Brazil.	nestor@nefro.epm.br	Sinigaglia, Rita de Cássia/C-9155-2012; Simoes, Manuel J/H-2642-2014; Schor, Nestor/K-4364-2013; Borges, Fernanda Teixeira/Y-3439-2018; Borges, Andrea A/F-2416-2012; Batista, Marcelo/K-4305-2013	Sinigaglia, Rita de Cássia/0000-0001-8747-6316; Simoes, Manuel J/0000-0003-2770-8618; Borges, Fernanda Teixeira/0000-0002-9790-0915; Borges, Andrea/0000-0002-0606-8511	Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq); Financiadora de Estudos e Projetos (FINEP); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao Oswaldo Ramos (FOR); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq), Financiadora de Estudos e Projetos (FINEP), Fundacao Oswaldo Ramos (FOR), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 1995, GEN PHARMACOL, V26, P1477, DOI 10.1016/0306-3623(95)00049-6; BAYLIS C, 1977, KIDNEY INT, V12, P344, DOI 10.1038/ki.1977.121; BENNETT WM, 1986, CLIN NEPHROL, V25, pS126; Bergmeyer H. U., 1985, METHOD ENZYMAT AN, V9, P449; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cao HL, 2010, BIOTECHNOL LETT, V32, P725, DOI 10.1007/s10529-010-0207-y; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Herrera MB, 2004, INT J MOL MED, V14, P1035; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; O'Driscoll Lorraine, 2005, Cancer Genomics & Proteomics, V2, P43; Ohshima K, 1997, PLOS ONE, V5; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rentsch J, 1996, FEBS LETT, V379, P55, DOI 10.1016/0014-5793(95)01485-3; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; SCHOR N, 1981, KIDNEY INT, V19, P288, DOI 10.1038/ki.1981.19; SOLEZ K, 1974, KIDNEY INT, V6, P24, DOI 10.1038/ki.1974.74; 최용, 2010, Childhood Kidney diseases, V14, P32; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Villanueva S, 2011, CLIN SCI, V121, P489, DOI 10.1042/CS20110108; Zhang B, 2007, KIDNEY INT, V72, P37, DOI 10.1038/sj.ki.5002242	33	199	212	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44092	10.1371/journal.pone.0044092	http://dx.doi.org/10.1371/journal.pone.0044092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970165	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400034
J	Beconi, M; Aziz, O; Matthews, K; Moumne, L; O'Connell, C; Yates, D; Clifton, S; Pett, H; Vann, J; Crowley, L; Haughan, AF; Smith, DL; Woodman, B; Bates, GP; Brookfield, F; Burli, RW; McAllister, G; Dominguez, C; Munoz-Sanjuan, I; Beaumont, V				Beconi, Maria; Aziz, Omar; Matthews, Kim; Moumne, Lara; O'Connell, Catherine; Yates, Dawn; Clifton, Steven; Pett, Hannah; Vann, Julie; Crowley, Lynsey; Haughan, Alan F.; Smith, Donna L.; Woodman, Ben; Bates, Gillian P.; Brookfield, Fred; Buerli, Roland W.; McAllister, George; Dominguez, Celia; Munoz-Sanjuan, Ignacio; Beaumont, Vahri			Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HUNTINGTONS-DISEASE MUTATION; FRIEDREICH ATAXIA; TRANSGENIC MICE; MOUSE MODEL; HYDROXAMIC ACID; MOTOR DEFICITS; REPEAT; ACETYLATION; GENE	Histone deacetylase (HDAC) inhibitors have received considerable attention as potential therapeutics for a variety of cancers and neurological disorders. Recent publications on a class of pimelic diphenylamide HDAC inhibitors have highlighted their promise in the treatment of the neurodegenerative diseases Friedreich's ataxia and Huntington's disease, based on efficacy in cell and mouse models. These studies' authors have proposed that the unique action of these compounds compared to hydroxamic acid-based HDAC inhibitors results from their unusual slow-on/slow-off kinetics of binding, preferentially to HDAC3, resulting in a distinctive pharmacological profile and reduced toxicity. Here, we evaluate the HDAC subtype selectivity, cellular activity, absorption, distribution, metabolism and excretion (ADME) properties, as well as the central pharmacodynamic profile of one such compound, HDACi 4b, previously described to show efficacy in vivo in the R6/2 mouse model of Huntington's disease. Based on our data reported here, we conclude that while the in vitro selectivity and binding mode are largely in agreement with previous reports, the physicochemical properties, metabolic and p-glycoprotein (Pgp) substrate liability of HDACi 4b render this compound suboptimal to investigate central Class I HDAC inhibition in vivo in mouse per oral administration. A drug administration regimen using HDACi 4b dissolved in drinking water was used in the previous proof of concept study, casting doubt on the validation of CNS HDAC3 inhibition as a target for the treatment of Huntington's disease. We highlight physicochemical stability and metabolic issues with 4b that are likely intrinsic liabilities of the benzamide chemotype in general.	[Beconi, Maria; Dominguez, Celia; Munoz-Sanjuan, Ignacio; Beaumont, Vahri] CHDI Management CHDI Fdn Inc, Los Angeles, CA USA; [Aziz, Omar; Matthews, Kim; O'Connell, Catherine; Yates, Dawn; Clifton, Steven; Pett, Hannah; Vann, Julie; Crowley, Lynsey; Haughan, Alan F.; Buerli, Roland W.; McAllister, George] BioFocus, Saffron Walden, Essex, England; [Moumne, Lara; Smith, Donna L.; Woodman, Ben; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Brookfield, Fred] Evotec UK Ltd, Abingdon, Oxon, England	University of London; King's College London; Evotec	Beconi, M (corresponding author), CHDI Management CHDI Fdn Inc, Los Angeles, CA USA.	vahri.beaumont@chdifoundation.org	; Bates, Gillian/E-1146-2012	Beaumont, Vahri/0000-0002-6488-2175; Bates, Gillian/0000-0002-4041-6305	CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. This work was funded and conducted through fee-for-service contract research on behalf of CHDI Foundation, with the exception of the pharmacodynamic evaluation of 4b that was conducted by King's College London investigators 4, in collaboration with and funded by CHDI Foundation.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Francis JW, 1998, P NATL ACAD SCI USA, V95, P6492, DOI 10.1073/pnas.95.11.6492; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marmolino D, 2009, CEREBELLUM, V8, P245, DOI 10.1007/s12311-008-0084-2; Mielcarek M, 2011, PLOS ONE IN PRESS; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Muraglia E, 2008, BIOORG MED CHEM LETT, V18, P6083, DOI 10.1016/j.bmcl.2008.09.076; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili Ghazaleh, 2006, Current Alzheimer Research, V3, P403, DOI 10.2174/156720506778249407; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Soragni E, 2011, METHODS MOL BIOL, V793, P495, DOI 10.1007/978-1-61779-328-8_32; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010	44	31	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44498	10.1371/journal.pone.0044498	http://dx.doi.org/10.1371/journal.pone.0044498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973455	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600062
J	Han, T; Abdel-Motal, UM; Chang, DK; Sui, JH; Muvaffak, A; Campbell, J; Zhu, Q; Kupper, TS; Marasco, WA				Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Muvaffak, Asli; Campbell, James; Zhu, Quan; Kupper, Thomas S.; Marasco, Wayne A.			Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma	PLOS ONE			English	Article							CHEMOKINE RECEPTORS CCR4; SEZARY-SYNDROME; ANTITUMOR-ACTIVITY; MYCOSIS-FUNGOIDES; ANTIBODY; EXPRESSION; ALEMTUZUMAB; THERAPY; LYMPHOCYTES; MICE	Background: Although several therapeutic options have become available for patients with Cutaneous T-cell Lymphoma (CTCL), no therapy has been curative. Recent studies have demonstrated that CTCL cells overexpress the CC chemokine receptor 4 (CCR4). Methodology/Principal Findings: In this study, a xenograft model of CTCL was established and a recombinant adenoassociated viral serotype 8 (AAV8) vector expressing a humanized single-chain variable fragment (scFv)-Fc fusion (scFvFc or "minibody'') of anti-CCR4 monoclonal antibody (mAb) h1567 was evaluated for curative treatment. Human CCR4(+) tumor-bearing mice treated once with intravenous infusion of AAV8 virions encoding the h1567 (AAV8-h1567) minibody showed anti-tumor activity in vivo and increased survival. The AAV8-h1567 minibody notably increased the number of tumor-infiltrating Ly-6G(+) Fc gamma RIIIa(CD16A)(+) murine neutrophils in the tumor xenografts over that of AAV8-control minibody treated mice. Furthermore, in CCR4(+) tumor-bearing mice co-treated with AAV8-h1567 minibody and infused with human peripheral blood mononuclear cells (PBMCs), marked tumor infiltration of human CD16A(+) CD56(+) NK cells was observed. The h1567 minibody also induced in vitro ADCC activity through both mouse neutrophils and human NK cells. Conclusions/Significance: Overall, our data demonstrate that the in vivo anti-tumor activity of h1567 minibody is mediated, at least in part, through CD16A(+) immune effector cell ADCC mechanisms. These data further demonstrate the utility of the AAV-minibody gene transfer system in the rapid evaluation of candidate anti-tumor mAbs and the potency of h1567 as a potential novel therapy for CTCL.	[Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Muvaffak, Asli; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Campbell, James; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Dept Dermatol,Med Sch, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Han, T (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	tkupper@partners.org; wayne_marasco@dfci.harvard.edu	Kupper, Thomas/O-4962-2019	Marasco, Wayne/0000-0003-3764-4611; SUI, JIANHUA/0000-0002-1272-9662	Skin Cancer Score project [2P50CA093683]; National Institutes of Health (NIH) [1K01AI073861]; NIH [AI058804]; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058804, K01AI073861] Funding Source: NIH RePORTER	Skin Cancer Score project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by Skin Cancer Score project 2P50CA093683 to TSK, JC and WAM; by National Institutes of Health (NIH) grant 1K01AI073861 to TH; and by NIH grant AI058804 to QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinari L, 2008, LEUKEMIA RES, V32, P1299, DOI 10.1016/j.leukres.2007.11.009; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Berney T, 2001, TRANSPLANTATION, V72, P133, DOI 10.1097/00007890-200107150-00026; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Collaco RF, 1999, GENE, V238, P397, DOI 10.1016/S0378-1119(99)00347-9; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Deckert PM, 2009, CURR DRUG TARGETS, V10, P158, DOI 10.2174/138945009787354502; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Gupta P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-72; HADLEY AG, 1992, IMMUNOLOGY, V76, P446; Ishida T, 2012, J CLIN ONCOL; Ito A, 2009, CANCER IMMUNOL IMMUN, V58, P1195, DOI 10.1007/s00262-008-0632-0; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Kim YH, 2007, BLOOD, V109, P4655, DOI 10.1182/blood-2006-12-062877; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Li BH, 2010, CANCER RES, V70, P6293, DOI 10.1158/0008-5472.CAN-10-0009; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Marasco WA, 2005, NAT BIOTECHNOL, V23, P551, DOI 10.1038/nbt0505-551; Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Presta Leonard G., 2002, Current Pharmaceutical Biotechnology, V3, P237, DOI 10.2174/1389201023378256; Querfeld C, 2009, LEUKEMIA LYMPHOMA, V50, P1969, DOI 10.3109/10428190903216770; Repp R, 2011, J IMMUNOL METHODS; Selvaraj P, 2004, IMMUNOL RES, V29, P219, DOI 10.1385/IR:29:1-3:219; Siders WM, 2010, LEUKEMIA LYMPHOMA, V51, P1293, DOI 10.3109/10428191003777963; Sokolowska-Wojdyo M, 2005, BRIT J DERMATOL, V152, P258, DOI 10.1111/J.1365-2133.2004.06325.X; Sui JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000197; Ure UB, 2007, EUR J DERMATOL, V17, P525; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Vermeer MH, 2002, MODERN PATHOL, V15, P838, DOI 10.1097/01.MP.0000021006.53593.B0; Wang J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-50; WASIK MA, 1994, AM J PATHOL, V144, P1089; Watanabe Y, 2010, ORAL SURG ORAL MED O, V109, P744, DOI 10.1016/j.tripleo.2009.12.015; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wu CS, 2008, KAOHSIUNG J MED SCI, V24, P577, DOI 10.1016/S1607-551X(09)70019-1; Wu XS, 2009, J INVEST DERMATOL, V129, P1115, DOI 10.1038/jid.2009.45; Xu XC, 2000, CANCER RES, V60, P4475; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Yamanaka K, 2005, CLIN CANCER RES, V11, P5748, DOI 10.1158/1078-0432.CCR-04-2514; Yawalkar N, 2003, BLOOD, V102, P4059, DOI 10.1182/blood-2003-04-1044	50	27	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44455	10.1371/journal.pone.0044455	http://dx.doi.org/10.1371/journal.pone.0044455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973452	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600057
J	Rapoport, BI; Turicchia, L; Wattanapanitch, W; Davidson, TJ; Sarpeshkar, R				Rapoport, Benjamin I.; Turicchia, Lorenzo; Wattanapanitch, Woradorn; Davidson, Thomas J.; Sarpeshkar, Rahul			Efficient Universal Computing Architectures for Decoding Neural Activity	PLOS ONE			English	Article							BRAIN-MACHINE INTERFACES; HIPPOCAMPAL PLACE CELLS; KALMAN FILTER; PROSTHETIC DEVICES; ENERGY-EFFICIENT; CONTROL SIGNALS; POPULATION; STIMULATOR; MOVEMENT; ALGORITHMS	The ability to decode neural activity into meaningful control signals for prosthetic devices is critical to the development of clinically useful brain-machine interfaces (BMIs). Such systems require input from tens to hundreds of brain-implanted recording electrodes in order to deliver robust and accurate performance; in serving that primary function they should also minimize power dissipation in order to avoid damaging neural tissue; and they should transmit data wirelessly in order to minimize the risk of infection associated with chronic, transcutaneous implants. Electronic architectures for brain-machine interfaces must therefore minimize size and power consumption, while maximizing the ability to compress data to be transmitted over limited-bandwidth wireless channels. Here we present a system of extremely low computational complexity, designed for real-time decoding of neural signals, and suited for highly scalable implantable systems. Our programmable architecture is an explicit implementation of a universal computing machine emulating the dynamics of a network of integrate-and-fire neurons; it requires no arithmetic operations except for counting, and decodes neural signals using only computationally inexpensive logic operations. The simplicity of this architecture does not compromise its ability to compress raw neural data by factors greater than 10(5). We describe a set of decoding algorithms based on this computational architecture, one designed to operate within an implanted system, minimizing its power consumption and data transmission bandwidth; and a complementary set of algorithms for learning, programming the decoder, and postprocessing the decoded output, designed to operate in an external, nonimplanted unit. The implementation of the implantable portion is estimated to require fewer than 5000 operations per second. A proof-of-concept, 32-channel field-programmable gate array (FPGA) implementation of this portion is consequently energy efficient. We validate the performance of our overall system by decoding electrophysiologic data from a behaving rodent.	[Rapoport, Benjamin I.] Harvard Univ, Sch Med, MD Ph D Program, Boston, MA 02115 USA; [Rapoport, Benjamin I.; Turicchia, Lorenzo; Wattanapanitch, Woradorn; Sarpeshkar, Rahul] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Rapoport, Benjamin I.] Harvard Univ, Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Davidson, Thomas J.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Stanford University	Rapoport, BI (corresponding author), Harvard Univ, Sch Med, MD Ph D Program, Boston, MA 02115 USA.	rahuls@mit.edu	Rapoport, Benjamin/ABF-2332-2021	Davidson, Thomas/0000-0003-0836-6333	National Institutes of Health [NS056140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant NS056140 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actel Corporation, 2009, IGLOO LOW POW FLASH; Arfin SK, 2012, IEEE T BIOMED CIRC S, V6, P1, DOI 10.1109/TBCAS.2011.2166072; Baker MW, 2007, IEEE T BIOMED CIRC S, V1, P28, DOI 10.1109/TBCAS.2007.893180; Bengio Y, 2007, PROG BRAIN RES, V165, P521, DOI 10.1016/S0079-6123(06)65033-4; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 1998, J NEUROSCI, V18, P7411; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Eliasmith C, 2003, NEURAL ENG, P112; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Ghovanloo M, 2007, IEEE T CIRCUITS SYST, V54, P71; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holleman J, 2007, P ANN INT IEEE EMBS, P3930, DOI 10.1109/IEMBS.2007.4353193; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Japkowicz N., 2011, EVALUATING LEARNING, DOI 10.1017/CBO9780511921803; Kelly SK, 2011, IEEE T BIOMED CIRC S, V5, P20, DOI 10.1109/TBCAS.2010.2076384; Koyama S, 2010, J COMPUT NEUROSCI, V29, P73, DOI 10.1007/s10827-009-0196-9; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Madisetti V., 2009, DIGITAL SIGNAL PROCE; Mandal S, 2008, IEEE T BIOMED CIRC S, V2, P301, DOI 10.1109/TBCAS.2008.2005295; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mohseni P, 2005, IEEE T NEUR SYS REH, V13, P263, DOI 10.1109/TNSRE.2005.853625; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Narasimhan K, 2004, NAT NEUROSCI, V7, P425, DOI 10.1038/nn0504-425; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsson RH, 2005, IEEE J SOLID-ST CIRC, V40, P2796, DOI 10.1109/JSSC.2005.858479; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Patil PG, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.5.FOCUS.JULY09.INTRO; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Rapoport B, 2011, SYSTEM CIRCUIT DESIG, P216; RAPOPORT BI, 2009, EMBC 2009 ANN INT C, P4214; Rizk M, 2009, MED BIOL ENG COMPUT, V47, P955, DOI 10.1007/s11517-009-0451-2; Salanova V, 2007, CURR NEUROL NEUROSCI, V7, P315, DOI 10.1007/s11910-007-0048-9; Sanchez JC, 2005, IEEE T NEUR SYS REH, V13, P213, DOI 10.1109/TNSRE.2005.847382; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Sarma SV, 2010, IEEE T BIO-MED ENG, V57, P1297, DOI 10.1109/TBME.2009.2039213; Sarpeshkar R, 2008, IEEE T BIOMED CIRC S, V2, P173, DOI 10.1109/TBCAS.2008.2003198; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya M, 2003, BIOL CYBERN, V88, P219, DOI 10.1007/s00422-002-0374-6; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Shire DB, 2009, IEEE T BIO-MED ENG, V56, P2502, DOI 10.1109/TBME.2009.2021401; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Tarsy MD, 2008, CURR CLIN NEUROL, P1, DOI 10.1007/978-1-59745-360-8; Theogarajan LS, 2008, IEEE J SOLID-ST CIRC, V43, P2322, DOI 10.1109/JSSC.2008.2004331; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wattanapanitch W, 2011, IEEE T BIOMED CIRC S, V5, P592, DOI 10.1109/TBCAS.2011.2163404; Wattanapanitch W, 2007, IEEE T BIOMED CIRC S, V1, P136, DOI 10.1109/TBCAS.2007.907868; Wolfram S., 2002, NEW KIND SCI; Wu W, 2004, P ANN INT IEEE EMBS, V26, P4126; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Wu W, 2008, IEEE T NEUR SYS REH, V16, P213, DOI 10.1109/TNSRE.2008.922679	59	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e42492	10.1371/journal.pone.0042492	http://dx.doi.org/10.1371/journal.pone.0042492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984404	Green Published, gold, Green Submitted			2022-12-27	WOS:000308738500006
J	Van Colen, C; Debusschere, E; Braeckman, U; Van Gansbeke, D; Vincx, M				Van Colen, Carl; Debusschere, Elisabeth; Braeckman, Ulrike; Van Gansbeke, Dirk; Vincx, Magda			The Early Life History of the Clam Macoma balthica in a High CO2 World	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; AMORPHOUS CALCIUM-CARBONATE; NEAR-FUTURE LEVELS; OCEAN ACIDIFICATION; LARVAL DEVELOPMENT; ELEVATED PCO(2); BIVALVE; FERTILIZATION; SEDIMENT; PH	This study investigated the effects of experimentally manipulated seawater carbonate chemistry on several early life history processes of the Baltic tellin (Macoma balthica), a widely distributed bivalve that plays a critical role in the functioning of many coastal habitats. We demonstrate that ocean acidification significantly depresses fertilization, embryogenesis, larval development and survival during the pelagic phase. Fertilization and the formation of a D-shaped shell during embryogenesis were severely diminished: successful fertilization was reduced by 11% at a 0.6 pH unit decrease from present (pH 8.1) conditions, while hatching success was depressed by 34 and 87%, respectively at a 0.3 and 0.6 pH unit decrease. Under acidified conditions, larvae were still able to develop a shell during the post-embryonic phase, but higher larval mortality rates indicate that fewer larvae may metamorphose and settle in an acidified ocean. The cumulative impact of decreasing seawater pH on fertilization, embryogenesis and survival to the benthic stage is estimated to reduce the number of competent settlers by 38% for a 0.3 pH unit decrease, and by 89% for a 0.6 pH unit decrease from present conditions. Additionally, slower growth rates and a delayed metamorphosis at a smaller size were indicative for larvae developed under acidified conditions. This may further decline the recruit population size due to a longer subjection to perturbations, such as predation, during the pelagic phase. In general, early life history processes were most severely compromised at similar to pH 7.5, which corresponds to seawater undersaturated with respect to aragonite. Since recent models predict a comparable decrease in pH in coastal waters in the near future, this study indicates that future populations of Macoma balthica are likely to decline as a consequence of ongoing ocean acidification.	[Van Colen, Carl; Debusschere, Elisabeth; Braeckman, Ulrike; Van Gansbeke, Dirk; Vincx, Magda] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium	Ghent University	Van Colen, C (corresponding author), Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium.	carl.vancolen@ugent.be	Braeckman, Ulrike/AAJ-4801-2021	Braeckman, Ulrike/0000-0002-7558-6363; Debusschere, Elisabeth/0000-0002-5595-0295	Flemish Fund for Scientific Research FWO [1.2.380.11.N]; Ghent University [BOF-GOA 01GA1911W]	Flemish Fund for Scientific Research FWO(FWO); Ghent University(Ghent University)	CVC is a postdoctoral fellow of the Flemish Fund for Scientific Research FWO (1.2.380.11.N). Additional financial support for this study came from the special research fund of Ghent University through project BOF-GOA 01GA1911W. The funder had no role in study design, data collection and analysis.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; [Anonymous], 2007, CO2SYS XLS CALCULATO; Bos OG, 2007, MAR ECOL PROG SER, V330, P155, DOI 10.3354/meps330155; Bos OG, 2006, MAR ECOL PROG SER, V320, P207, DOI 10.3354/meps320207; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Gattuso J.P., 2010, GUIDE BEST PRACTICES; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Gould MC, 2003, MICROSC RES TECHNIQ, V61, P379, DOI 10.1002/jemt.10351; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hendriks IE, 2010, ESTUAR COAST SHELF S, V89, P186, DOI 10.1016/j.ecss.2010.06.007; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hiddink JG, 2002, J EXP MAR BIOL ECOL, V269, P223, DOI 10.1016/S0022-0981(02)00002-3; His E, 1997, WATER RES, V31, P351, DOI 10.1016/S0043-1354(96)00244-8; HOLLAND AF, 1987, ESTUARIES, V10, P227, DOI 10.2307/1351851; Honkoop PJC, 1999, MAR ECOL PROG SER, V180, P297, DOI 10.3354/meps180297; JOHNSON CH, 1981, J CELL BIOL, V89, P284, DOI 10.1083/jcb.89.2.284; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Marinelli RL, 2003, ESTUAR COAST SHELF S, V57, P179, DOI 10.1016/S0272-7714(02)00342-6; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaud E, 2006, J EXP MAR BIOL ECOL, V337, P178, DOI 10.1016/j.jembe.2006.06.025; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; REISE K, 1983, MAR ECOL PROG SER, V12, P229, DOI 10.3354/meps012229; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Solomon S., 2007, CONTRIBUTION WORKING, P996; Struyf E, 1995, HYDROBIOLOGIA, V540, P26; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Willows RI, 1998, LIMNOL OCEANOGR, V43, P1332, DOI 10.4319/lo.1998.43.6.1332; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; ZWARTS L, 1992, MAR ECOL PROG SER, V83, P113, DOI 10.3354/meps083113	54	32	33	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44655	10.1371/journal.pone.0044655	http://dx.doi.org/10.1371/journal.pone.0044655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970279	Green Published, gold			2022-12-27	WOS:000308748400027
J	Bosman, AB; Wagenaar, J; Stegeman, A; Vernooij, H; Mevius, D				Bosman, Angela B.; Wagenaar, Jaap; Stegeman, Arjan; Vernooij, Hans; Mevius, Dik			Quantifying Antimicrobial Resistance at Veal Calf Farms	PLOS ONE			English	Article							FECAL ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; DAIRY-COWS; PIGS; SAMPLES; SUSCEPTIBILITY; HARMONIZATION; SURVEILLANCE; PRODUCTS	This study was performed to determine a sampling strategy to quantify the prevalence of antimicrobial resistance on veal calf farms, based on the variation in antimicrobial resistance within and between calves on five farms. Faecal samples from 50 healthy calves (10 calves/farm) were collected. From each individual sample and one pooled faecal sample per farm, 90 selected Escherichia coli isolates were tested for their resistance against 25 mg/L amoxicillin, 25 mg/L tetracycline, 0.5 mg/L cefotaxime, 0.125 mg/L ciprofloxacin and 8/152 mg/L trimethoprim/sulfamethoxazole (tmp/s) by replica plating. From each faecal sample another 10 selected E. coli isolates were tested for their resistance by broth microdilution as a reference. Logistic regression analysis was performed to compare the odds of testing an isolate resistant between both test methods (replica plating vs. broth microdilution) and to evaluate the effect of pooling faecal samples. Bootstrap analysis was used to investigate the precision of the estimated prevalence of resistance to each antimicrobial obtained by several simulated sampling strategies. Replica plating showed similar odds of E. coli isolates tested resistant compared to broth microdilution, except for ciprofloxacin (OR 0.29, p <= 0.05). Pooled samples showed in general lower odds of an isolate being resistant compared to individual samples, although these differences were not significant. Bootstrap analysis showed that within each antimicrobial the various compositions of a pooled sample provided consistent estimates for the mean proportion of resistant isolates. Sampling strategies should be based on the variation in resistance among isolates within faecal samples and between faecal samples, which may vary by antimicrobial. In our study, the optimal sampling strategy from the perspective of precision of the estimated levels of resistance and practicality consists of a pooled faecal sample from 20 individual animals, of which 90 isolates are tested for their susceptibility by replica plating.	[Bosman, Angela B.; Wagenaar, Jaap; Mevius, Dik] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap; Mevius, Dik] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Stegeman, Arjan; Vernooij, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Utrecht University; Wageningen University & Research; Utrecht University	Bosman, AB (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	A.B.Bosman@uu.nl	Vernooij, Johannes/J-3991-2019	Vernooij, Johannes/0000-0002-2646-9216	Ministry of Agriculture, Nature and Food Quality [3201949]; Product Board Meat and Livestock [08.30.002]	Ministry of Agriculture, Nature and Food Quality; Product Board Meat and Livestock	This study was funded by the Ministry of Agriculture, Nature and Food Quality (project nr. 3201949), and the Product Board Meat and Livestock (project nr. 08.30.002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; Aarestrup FM, 2004, J VET MED B, V51, P380, DOI 10.1111/j.1439-0450.2004.00775.x; Akwar HT, 2008, CAN J VET RES, V72, P202; [Anonymous], 2010, EFSA J; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Boerlin P, 2006, ANTIMICROBIAL RESIST, VFour, P27; Davison HC, 2000, TRENDS MICROBIOL, V8, P554, DOI 10.1016/S0966-842X(00)01873-4; Dewulf J, 2007, PREV VET MED, V78, P339, DOI 10.1016/j.prevetmed.2006.11.001; Dohoo I. R., 2009, VET EPIDEMIOLOGIC RE, V2, P584; Dunlop RH, 1998, APPL ENVIRON MICROB, V64, P366; Dunlop RH, 1999, EPIDEMIOL INFECT, V122, P485, DOI 10.1017/S0950268899002411; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Franklin A, 2001, REV SCI TECH OIE, V20, P859, DOI 10.20506/rst.20.3.1315; GOLDSTEIN EJC, 1991, ANTIMICROB AGENTS CH, V35, P560, DOI 10.1128/AAC.35.3.560; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Jakobsen L, 2010, INT J FOOD MICROBIOL, V142, P264, DOI 10.1016/j.ijfoodmicro.2010.06.025; Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576; Jordan D, 2005, AUST VET J, V83, P688, DOI 10.1111/j.1751-0813.2005.tb13051.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P145, DOI 10.1093/jac/dkg312; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; MARAN, 2009, MARAN 2009 MON ANT R; Nijsten R, 1996, J ANTIMICROB CHEMOTH, V37, P1131, DOI 10.1093/jac/37.6.1131; NIJSTEN R, 1994, EPIDEMIOL INFECT, V113, P45, DOI 10.1017/S0950268800051451; OSTERBLAD M, 1995, J CLIN MICROBIOL, V33, P3146, DOI 10.1128/JCM.33.12.3146-3149.1995; Persoons D, 2011, MICROB DRUG RESIST, V17, P513, DOI 10.1089/mdr.2011.0048; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; van den Bogaard AEJM, 2000, J ANTIMICROB CHEMOTH, V45, P663, DOI 10.1093/jac/45.5.663; Vieira AR, 2008, J ANTIMICROB CHEMOTH, V62, P535, DOI 10.1093/jac/dkn210; Villarroel A, 2006, AM J VET RES, V67, P951, DOI 10.2460/ajvr.67.6.951; Wagner BA, 2002, AM J VET RES, V63, P1662, DOI 10.2460/ajvr.2002.63.1662; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x	32	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44831	10.1371/journal.pone.0044831	http://dx.doi.org/10.1371/journal.pone.0044831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970313	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000050
J	Zhou, LX; Pelengaris, S; Abouna, S; Young, J; Epstein, D; Herold, J; Nattkemper, TW; Nakhai, H; Khan, M				Zhou, Luxian; Pelengaris, Stella; Abouna, Sylvie; Young, James; Epstein, David; Herold, Julia; Nattkemper, Tim Wilhelm; Nakhai, Hassan; Khan, Michael			Re-Expression of IGF-II Is Important for Beta Cell Regeneration in Adult Mice	PLOS ONE			English	Article							GROWTH-FACTOR-II; GLUCAGON-LIKE PEPTIDE-1; PARTIAL PANCREATECTOMY; ISLET REGENERATION; DIABETES-MELLITUS; INSULIN-RECEPTOR; PROGENITOR CELLS; MASS; PANCREAS; RAT	Background: The key factors which support re-expansion of beta cell numbers after injury are largely unknown. Insulin-like growth factor II (IGF-II) plays a critical role in supporting cell division and differentiation during ontogeny but its role in the adult is not known. In this study we investigated the effect of IGF-II on beta cell regeneration. Methodology/Principal Findings: We employed an in vivo model of 'switchable' c-Myc-induced beta cell ablation, pIns-cMycER(TAM), in which 90% of beta cells are lost following 11 days of c-Myc (Myc) activation in vivo. Importantly, such ablation is normally followed by beta cell regeneration once Myc is deactivated, enabling functional studies of beta cell regeneration in vivo. IGF-II was shown to be re-expressed in the adult pancreas of pIns-c-MycER(TAM)/IGF-II+/+ (MIG) mice, following beta cell injury. As expected in the presence of IGF-II beta cell mass and numbers recover rapidly after ablation. In contrast, in pIns-c-MycER(TAM)/IGF-II+/- (MIGKO) mice, which express no IGF-II, recovery of beta cell mass and numbers were delayed and impaired. Despite failure of beta cell number increase, MIGKO mice recovered from hyperglycaemia, although this was delayed. Conclusions/Significance: Our results demonstrate that beta cell regeneration in adult mice depends on re-expression of IGF-II, and supports the utility of using such ablation-recovery models for identifying other potential factors critical for underpinning successful beta cell regeneration in vivo. The potential therapeutic benefits of manipulating the IGF-II signaling systems merit further exploration.	[Zhou, Luxian; Abouna, Sylvie; Nakhai, Hassan] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Pelengaris, Stella; Young, James; Khan, Michael] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Epstein, David] Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England; [Herold, Julia; Nattkemper, Tim Wilhelm] Univ Bielefeld, Biodata Min Grp, D-33615 Bielefeld, Germany	University of Warwick; University of Warwick; University of Warwick; University of Bielefeld	Zhou, LX (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	Michael.Khan@warwick.ac.uk	Zhou, Luxian/CAA-2078-2022; Nattkemper, Tim W/F-3332-2017	Nattkemper, Tim W/0000-0002-7986-1158; Khan, Michael/0000-0002-8591-384X	Warwick Postgraduate Research Fellowship (WPRF); Engineering and Physical Sciences Research Council (EPSRC); Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Fund [1139383]	Warwick Postgraduate Research Fellowship (WPRF); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Fund	This project was supported by: Warwick Postgraduate Research Fellowship (WPRF), Engineering and Physical Sciences Research Council (EPSRC), Biotechnology and Biological Sciences Research Council (BBSRC), and Medical Research Fund (Registered charity number 1139383; Provided support for LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Bock T, 2004, BIOESSAYS, V26, P1156, DOI 10.1002/bies.20143; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; BROWN AL, 1986, J BIOL CHEM, V261, P3144; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Cheung L, 2010, ISLETS, V2, P37, DOI 10.4161/isl.2.1.10196; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cui HM, 2007, DIS MARKERS, V23, P105, DOI 10.1155/2007/363464; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DERCOLE AJ, 1980, DEV BIOL, V75, P315, DOI 10.1016/0012-1606(80)90166-9; Desgraz R, 2011, TRENDS ENDOCRIN MET, V22, P34, DOI 10.1016/j.tem.2010.09.004; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Drab SR, 2009, PHARMACOTHERAPY, V29, p43S, DOI 10.1592/phco.29.pt2.43S; George M, 2002, J CLIN INVEST, V109, P1153, DOI 10.1172/JCI200212969; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Herold J, 2010, COMPUT MED IMAG GRAP, V34, P446, DOI 10.1016/j.compmedimag.2009.10.004; Hill DJ, 2000, ENDOCRINOLOGY, V141, P1151, DOI 10.1210/en.141.3.1151; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; MOSES AC, 1980, P NATL ACAD SCI-BIOL, V77, P3649, DOI 10.1073/pnas.77.6.3649; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43623	10.1371/journal.pone.0043623	http://dx.doi.org/10.1371/journal.pone.0043623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970135	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000004
J	Gautam, H; Verhagen, JV				Gautam, Hari; Verhagen, Justus V.			Direct Behavioral Evidence for Retronasal Olfaction in Rats	PLOS ONE			English	Article							AIR-FLOW; ODORANT TRANSPORT; TASTE; ORTHONASAL; AVERSION; IDENTIFICATION; POTENTIATION; INTEGRATION; INTUBATION; PERCEPTION	The neuroscience of flavor perception is becoming increasingly important to understand abnormal feeding behaviors and associated chronic diseases such as obesity. Yet, flavor research has mainly depended on human subjects due to the lack of an animal model. A crucial step towards establishing an animal model of flavor research is to determine whether the animal uses the retronasal mode of olfaction, an essential element of flavor perception. We designed a go- no go behavioral task to test the rat's ability to detect and discriminate retronasal odorants. In this paradigm, tasteless aqueous solutions of odorants were licked by water-restricted head-fixed rats from a lick spout. Orthonasal contamination was avoided by employing a combination of a vacuum around the lick-spout and blowing clean air toward the nose. Flow models support the effectiveness of both approaches. The licked odorants were successfully discriminated by rats. Moreover, the tasteless odorant amyl acetate was reliably discriminated against pure distilled water in a concentration-dependent manner. The results from this retronasal odor discrimination task suggest that rats are capable of smelling retronasally. This direct behavioral evidence establishes the rat as a useful animal model for flavor research.	[Gautam, Hari; Verhagen, Justus V.] John B Pierce Lab, New Haven, CT USA; [Gautam, Hari; Verhagen, Justus V.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; The John B Pierce Laboratory, Inc; Yale University	Gautam, H (corresponding author), John B Pierce Lab, New Haven, CT USA.	jverhagen@jbpierce.org			National Institute of Health/National Institute on Deafness and Other Communication Disorders grant [R01DC009994]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009994, R01DC011286] Funding Source: NIH RePORTER	National Institute of Health/National Institute on Deafness and Other Communication Disorders grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by National Institute of Health/National Institute on Deafness and Other Communication Disorders grant R01DC009994. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeson PS, 2001, CLIN PEDIATR, V40, P567, DOI 10.1177/000992280104001006; BOUTON ME, 1986, LEARN MOTIV, V17, P115, DOI 10.1016/0023-9690(86)90006-8; BURDACH KJ, 1987, PHYSIOL BEHAV, V41, P353, DOI 10.1016/0031-9384(87)90400-8; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Frasnelli J, 2005, CHEM SENSES, V30, P575, DOI 10.1093/chemse/bji051; Gautam SH, 2009, CHEM SENSES, V34, pA43; Gautam SH, 2012, J NEUROSCI, V32, P7949, DOI 10.1523/JNEUROSCI.1413-12.2012; Gautam SH, 2010, CHEM SENSES, V35, P767, DOI 10.1093/chemse/bjq075; HEATH RB, 1989, EQUINE VET J, V21, P434, DOI 10.1111/j.2042-3306.1989.tb02190.x; Heilmann S, 2004, BEHAV NEUROSCI, V118, P412, DOI 10.1037/0735-7044.118.2.412; Holcombe S.J., 1998, AAEP P, V44, P26; Inui T, 2006, BEHAV NEUROSCI, V120, P590, DOI 10.1037/0735-7044.120.3.590; MILLER MJ, 1985, J PEDIATR-US, V107, P465, DOI 10.1016/S0022-3476(85)80535-7; MOZELL MM, 1973, SCIENCE, V181, P1247, DOI 10.1126/science.181.4106.1247; MURPHY C, 1977, SENS PROCESS, V1, P204; MURPHY C, 1980, PHYSIOL BEHAV, V24, P601, DOI 10.1016/0031-9384(80)90257-7; Negus VE, 1927, J ANAT, V62, P1; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Radostits OM, 2000, VET CLIN EXAMINATION; Rivera B, 2005, CONTEMP TOP LAB ANIM, V44, P52; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; SASAKI CT, 1977, ARCH OTOLARYNGOL, V103, P169; Schoenbaum G, 2001, J NEUROSCI METH, V106, P139, DOI 10.1016/S0165-0270(01)00341-7; Scott JW, 2007, J NEUROPHYSIOL, V97, P1941, DOI 10.1152/jn.01305.2006; Scott-Johnson PE, 2000, CHEM SENSES, V25, P761, DOI 10.1093/chemse/25.6.761; Slotnick BM, 1997, ANIM LEARN BEHAV, V25, P357, DOI 10.3758/BF03199093; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Sun BC, 2005, CHEM SENSES, V30, P693, DOI 10.1093/chemse/bji062; Veldhuizen MG, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00058; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033	34	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44781	10.1371/journal.pone.0044781	http://dx.doi.org/10.1371/journal.pone.0044781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970305	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400118
J	Nackaerts, E; Wagemans, J; Helsen, W; Swinnen, SP; Wenderoth, N; Alaerts, K				Nackaerts, Evelien; Wagemans, Johan; Helsen, Werner; Swinnen, Stephan P.; Wenderoth, Nicole; Alaerts, Kaat			Recognizing Biological Motion and Emotions from Point-Light Displays in Autism Spectrum Disorders	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL-PERCEPTION; MIRROR NEURONS; SHORT FORMS; RECOGNITION; CHILDREN; PATTERNS; SCALE; INDIVIDUALS; SUPERIOR	One of the main characteristics of Autism Spectrum Disorder (ASD) are problems with social interaction and communication. Here, we explored ASD-related alterations in 'reading' body language of other humans. Accuracy and reaction times were assessed from two observational tasks involving the recognition of 'biological motion' and 'emotions' from point-light displays (PLDs). Eye movements were recorded during the completion of the tests. Results indicated that typically developed-participants were more accurate than ASD-subjects in recognizing biological motion or emotions from PLDs. No accuracy differences were revealed on two control-tasks (involving the indication of color-changes in the moving point-lights). Group differences in reaction times existed on all tasks, but effect sizes were higher for the biological and emotion recognition tasks. Biological motion recognition abilities were related to a person's ability to recognize emotions from PLDs. However, ASD-related atypicalities in emotion recognition could not entirely be attributed to more basic deficits in biological motion recognition, suggesting an additional ASD-specific deficit in recognizing the emotional dimension of the point light displays. Eye movements were assessed during the completion of tasks and results indicated that ASD-participants generally produced more saccades and shorter fixation-durations compared to the control-group. However, especially for emotion recognition, these altered eye movements were associated with reductions in task-performance.	[Nackaerts, Evelien; Helsen, Werner; Swinnen, Stephan P.; Wenderoth, Nicole; Alaerts, Kaat] Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Grp Biomed Sci, Dept Biomed Kinesiol, Heverlee, Belgium; [Wagemans, Johan] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nackaerts, E (corresponding author), Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Grp Biomed Sci, Dept Biomed Kinesiol, Heverlee, Belgium.	Kaat.Alaerts@faber.kuleuven.be	Wagemans, Johan/M-3878-2019; Wenderoth, Nicole/D-7262-2015; Alaerts, Kaat/HGV-0661-2022	Wenderoth, Nicole/0000-0002-3246-9386; Nackaerts, Evelien/0000-0002-6580-4902; Alaerts, Kaat/0000-0001-8665-6374; Wagemans, Johan/0000-0002-7970-1541	Flanders Fund for Scientific Research (FWO) [G.0758.10]; FWO; Interuniversity Attraction Poles program of the Belgian federal government [P6/29]; Research Council of the University of Leuven [IDO/08/013]; Flemish government [METH/08/02]	Flanders Fund for Scientific Research (FWO)(FWO); FWO(FWO); Interuniversity Attraction Poles program of the Belgian federal government(Belgian Federal Science Policy Office); Research Council of the University of Leuven(KU Leuven); Flemish government(European Commission)	Support for this study was provided through grants from the Flanders Fund for Scientific Research (FWO projectsG.0758.10). KA is supported by a FWO postdoctoral Research fellowship grant. This work was also supported by Grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. This study has been conducted in collaboration with the Leuven Autism Research Consortium (LAuRes), funded by the Research Council of the University of Leuven (IDO/08/013). JW is supported by the Methusalem program of the Flemish government (METH/08/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Annaz D, 2010, DEVELOPMENTAL SCI, V13, P826, DOI 10.1111/j.1467-7687.2009.00939.x; APA, 1994, DIAGN STAT MAN MENT; Atkinson AP, 2009, NEUROPSYCHOLOGIA, V47, P3023, DOI 10.1016/j.neuropsychologia.2009.05.019; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boraston Z, 2007, J PHYSIOL-LONDON, V581, P893, DOI 10.1113/jphysiol.2007.133587; Brenner LA, 2007, J AUTISM DEV DISORD, V37, P1289, DOI 10.1007/s10803-006-0277-9; Brownlow S, 1997, PSYCHOL REC, V47, P411, DOI 10.1007/BF03395235; Catteeuw P, 2009, J SPORT EXERCISE PSY, V31, P786, DOI 10.1123/jsep.31.6.786; Chouchourelou A, 2006, SOC NEUROSCI-UK, V1, P63, DOI 10.1080/17470910600630599; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Evers K, 2011, RES AUTISM SPECT DIS, V5, P1327, DOI 10.1016/j.rasd.2011.01.004; Fan YT, 2010, J CHILD PSYCHOL PSYC, V51, P981, DOI 10.1111/j.1469-7610.2010.02269.x; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Girard TA, 2010, ASSESSMENT, V17, P400, DOI 10.1177/1073191110369763; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hubert B, 2007, J AUTISM DEV DISORD, V37, P1386, DOI 10.1007/s10803-006-0275-y; Ikeda H, 2009, PERCEPTION, V38, P1002, DOI 10.1068/p6250; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kaiser MD, 2009, PSYCHON B REV, V16, P761, DOI 10.3758/PBR.16.5.761; Keehn B, 2009, J AUTISM DEV DISORD, V39, P383, DOI 10.1007/s10803-008-0608-0; Kemner C, 1998, J AUTISM DEV DISORD, V28, P61, DOI 10.1023/A:1026015120128; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; Moore DG, 1997, BRIT J DEV PSYCHOL, V15, P401, DOI 10.1111/j.2044-835X.1997.tb00738.x; Murphy P, 2009, NEUROPSYCHOLOGIA, V47, P3225, DOI 10.1016/j.neuropsychologia.2009.07.026; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Parron C, 2008, AUTISM, V12, P261, DOI 10.1177/1362361307089520; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Perry A, 2010, SOC NEUROSCI-UK, V5, P272, DOI 10.1080/17470910903395767; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Saygin AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013491; Snow J, 2011, J INT NEUROPSYCH SOC, V17, P1021, DOI 10.1017/S1355617711000981; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; van der Geest JN, 2001, BIOL PSYCHIAT, V50, P614, DOI 10.1016/S0006-3223(01)01070-8; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	51	94	98	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44473	10.1371/journal.pone.0044473	http://dx.doi.org/10.1371/journal.pone.0044473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970227	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400075
J	Stefanowicz, D; Hackett, TL; Garmaroudi, FS; Gunther, OP; Neumann, S; Sutanto, EN; Ling, KM; Kobor, MS; Kicic, A; Stick, SM; Pare, PD; Knight, DA				Stefanowicz, Dorota; Hackett, Tillie-Louise; Garmaroudi, Farshid S.; Guenther, Oliver P.; Neumann, Sarah; Sutanto, Erika N.; Ling, Kak-Ming; Kobor, Michael S.; Kicic, Anthony; Stick, Stephen M.; Pare, Peter D.; Knight, Darryl A.			DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic Children	PLOS ONE			English	Article							LIM-DOMAIN; TRANSCRIPTIONAL REPRESSION; MICROARRAY ANALYSIS; INHALANT ALLERGEN; SIGNAL TRANSDUCER; PROSTATE-CANCER; GENE-EXPRESSION; STAT PATHWAY; ASSOCIATION; ACTIVATION	Background: Allergic inflammation is commonly observed in a number of conditions that are associated with atopy including asthma, eczema and rhinitis. However, the genetic, environmental or epigenetic factors involved in these conditions are likely to be different. Epigenetic modifications, such as DNA methylation, can be influenced by the environment and result in changes to gene expression. Objectives: To characterize the DNA methylation pattern of airway epithelial cells (AECs) compared to peripheral blood mononuclear cells (PBMCs) and to discern differences in methylation within each cell type amongst healthy, atopic and asthmatic subjects. Methods: PBMCs and AECs from bronchial brushings were obtained from children undergoing elective surgery for non-respiratory conditions. The children were categorized as atopic, atopic asthmatic, non-atopic asthmatic or healthy controls. Extracted DNA was bisulfite treated and 1505 CpG loci across 807 genes were analyzed using the Illumina GoldenGate Methylation Cancer Panel I. Gene expression for a subset of genes was performed using RT-PCR. Results: We demonstrate a signature set of CpG sites that are differentially methylated in AECs as compared to PBMCs regardless of disease phenotype. Of these, 13 CpG sites were specific to healthy controls, 8 sites were only found in atopics, and 6 CpGs were unique to asthmatics. We found no differences in the methylation status of PBMCs between disease phenotypes. In AECs derived from asthmatics compared to atopics, 8 differentially methylated sites were identified including CpGs in STAT5A and CRIP1. We demonstrate STAT5A gene expression is decreased whereas CRIP1 gene expression is elevated in the AECs from asthmatic compared to both healthy and atopic subjects. Discussion: We characterized a cell specific DNA methylation signature for AECs compared to PBMCs regardless of asthmatic or atopic status. Our data highlight the importance of understanding DNA methylation in the epithelium when studying the epithelial contribution to asthma.	[Stefanowicz, Dorota; Hackett, Tillie-Louise; Garmaroudi, Farshid S.; Pare, Peter D.; Knight, Darryl A.] Univ British Columbia, Heart & Lung Inst, James Hogg Res Ctr, Dept Med, Vancouver, BC, Canada; [Stefanowicz, Dorota; Hackett, Tillie-Louise; Garmaroudi, Farshid S.; Pare, Peter D.; Knight, Darryl A.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Hackett, Tillie-Louise; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Guenther, Oliver P.] Prevent Organ Failure Ctr Excellence, Vancouver, BC, Canada; [Neumann, Sarah; Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC, Canada; [Sutanto, Erika N.; Kicic, Anthony; Stick, Stephen M.] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Kicic, Anthony; Stick, Stephen M.] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia; [Sutanto, Erika N.; Ling, Kak-Ming; Kicic, Anthony; Stick, Stephen M.] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia; [Sutanto, Erika N.; Ling, Kak-Ming; Kicic, Anthony; Stick, Stephen M.] Univ Western Australia, Ctr Child Hlth Res, Nedlands, WA 6009, Australia; [Pare, Peter D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of British Columbia	Stefanowicz, D (corresponding author), Univ British Columbia, Heart & Lung Inst, James Hogg Res Ctr, Dept Med, Vancouver, BC, Canada.	Darryl.Knight@hli.ubc.ca	Stick, Stephen/GZG-7584-2022; Pare, Peter D/C-7425-2011; Stick, Stephen/O-5683-2014; Ling, Kak Ming/AAD-1167-2020; Stick, Stephen/AAA-5945-2021; Kicic, Anthony/ABA-1252-2021	Ling, Kak Ming/0000-0001-7743-3179; Stick, Stephen/0000-0002-5386-8482; Kicic, Anthony/0000-0002-0008-9733; Gunther, Oliver/0000-0003-1900-715X; Sutanto, Erika/0000-0002-4224-2839; Kobor, Michael/0000-0003-4140-1743	NSERC (Natural Sciences and Engineering Research Council of Canada); Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline); CIHR/IMPACT (Canadian Institutes of Health Research); Michael Smith Foundation; Tehran University of Medical Science (Iran); CIHR (Centre for Integrated Healthcare Research); NHMRC [303145, 458513]; Asthma Foundation of Western Australia; corporate office and Science and Technology at Johnson Johnson; CIHR; Canadian Lung Association; Canadian Thoracic Society; GlaxoSmithKline (GSK)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline)(Canadian Institutes of Health Research (CIHR)); CIHR/IMPACT (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Tehran University of Medical Science (Iran)(Tehran University of Medical Sciences); CIHR (Centre for Integrated Healthcare Research)(Canadian Institutes of Health Research (CIHR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of Western Australia; corporate office and Science and Technology at Johnson Johnson; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association; Canadian Thoracic Society; GlaxoSmithKline (GSK)(GlaxoSmithKline)	DS is the recipient of a NSERC (Natural Sciences and Engineering Research Council of Canada) Graduate Student Scholarship. TLH is the recipient of a Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline), CIHR/IMPACT (Canadian Institutes of Health Research) strategic training and Michael Smith Foundation post doctoral fellowships. FSG is the recipient of the Tehran University of Medical Science (Iran) Doctoral Award. DAK is the Canada Research Chair in Airway Disease and a Michael Smith Foundation for Health Research Career Investigator. SS is a NHMRC Practitioner Fellow (New Hanover Medical Research). This work is funded by CIHR (Centre for Integrated Healthcare Research), NHMRC (303145, 458513), and the Asthma Foundation of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DAK received an unrestricted educational grant from the corporate office and Science and Technology at Johnson & Johnson and TLH is the recipient of a Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline), CIHR/IMPACT (Canadian Institutes of Health Research) strategic training and Michael Smith Foundation post doctoral fellowships. The fellowship is fully paid from CIHR through partnership funding with the Canadian Lung Association, Canadian Thoracic Society and GlaxoSmithKline (GSK). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allen ML, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-51; Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Bauerschlag DO, 2011, ONCOLOGY-BASEL, V80, P12, DOI 10.1159/000327746; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Dallosso AR, 2012, ONCOGENE; Davis S, 2010, METHYLUMI HANDLE ILL; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; Esteller M, 2006, CARCINOGENESIS, V27, P1121, DOI 10.1093/carcin/bgl033; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hallquist NA, 1996, J LEUKOCYTE BIOL, V59, P172, DOI 10.1002/jlb.59.2.172; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Holgate ST, 2000, AM J RESP CRIT CARE, V162, pS113, DOI 10.1164/ajrccm.162.supplement_2.ras-12; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kagami S, 2000, BLOOD, V95, P1370, DOI 10.1182/blood.V95.4.1370.004k29_1370_1377; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kim KY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-160; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Lanningham-Foster L, 2002, AM J PHYSIOL-ENDOC M, V282, pE1197, DOI 10.1152/ajpendo.00508.2001; Latonen L, 2008, EXP CELL RES, V314, P738, DOI 10.1016/j.yexcr.2007.11.024; Li GP, 2004, CELL MOL IMMUNOL, V1, P471; Liu JB, 2002, AM J RESP CELL MOL, V27, P306, DOI 10.1165/rcmb.4850; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; Macaubas C, 1999, CLIN EXP ALLERGY, V29, P1223; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; McNamara PS, 2008, EUR RESPIR J, V32, P763, DOI 10.1183/09031936.00162507; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mullings RE, 2001, J ALLERGY CLIN IMMUN, V108, P832, DOI 10.1067/mai.2001.119554; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Shin SW, 2011, ALLERGY ASTHMA IMMUN, V3, P265, DOI 10.4168/aair.2011.3.4.265; Shin S, 2012, MOL GENET GENOMICS, V287, P361, DOI 10.1007/s00438-012-0685-9; Southam DS, 2005, J ALLERGY CLIN IMMUN, V115, P95, DOI 10.1016/j.jaci.2004.09.022; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Team R. D. C, 2011, R LANG ENV STAT COMP; Trautmann A, 2005, INT ARCH ALLERGY IMM, V138, P142, DOI 10.1159/000088436; UPHAM JW, 1995, CLIN EXP ALLERGY, V25, P634, DOI 10.1111/j.1365-2222.1995.tb01111.x; Weiskirchen R, 2003, BIOESSAYS, V25, P152, DOI 10.1002/bies.10226; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yang YW, 2008, J ALLERGY CLIN IMMUN, V121, P1393, DOI 10.1016/j.jaci.2008.02.031; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7; Zheng SS, 2011, J NUTR BIOCHEM, V22, P567, DOI 10.1016/j.jnutbio.2010.04.013; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	71	85	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44213	10.1371/journal.pone.0044213	http://dx.doi.org/10.1371/journal.pone.0044213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970180	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400046
J	Wang, YL; Hu, XW; Greshock, J; Shen, L; Yang, XJ; Shao, ZJ; Liang, S; Tanyi, JL; Sood, AK; Zhang, L				Wang, Yanling; Hu, Xiaowen; Greshock, Joel; Shen, Liang; Yang, Xiaojun; Shao, Zhongjun; Liang, Shun; Tanyi, Janos L.; Sood, Anil K.; Zhang, Lin			Genomic DNA Copy-Number Alterations of the let-7 Family in Human Cancers	PLOS ONE			English	Article							HETEROCHRONIC GENES; MICRORNA BIOGENESIS; FEEDBACK LOOP; STEM-CELLS; LIN28; EXPRESSION; TARGET; GROWTH; SUPPRESSES; REPRESSES	In human cancer, expression of the let-7 family is significantly reduced, and this is associated with shorter survival times in patients. However, the mechanisms leading to let-7 downregulation in cancer are still largely unclear. Since an alteration in copy-number is one of the causes of gene deregulation in cancer, we examined copy number alterations of the let-7 family in 2,969 cancer specimens from a high-resolution SNP array dataset. We found that there was a reduction in the copy number of let-7 genes in a cancer-type specific manner. Importantly, focal deletion of four let-7 family members was found in three cancer types: medulloblastoma (let-7a-2 and let-7e), breast cancer (let-7a-2), and ovarian cancer (let-7a-3/let-7b). For example, the genomic locus harboring let-7a-3/let-7b was deleted in 44% of the specimens from ovarian cancer patients. We also found a positive correlation between the copy number of let-7b and mature let-7b expression in ovarian cancer. Finally, we showed that restoration of let-7b expression dramatically reduced ovarian tumor growth in vitro and in vivo. Our results indicate that copy number deletion is an important mechanism leading to the downregulation of expression of specific let-7 family members in medulloblastoma, breast, and ovarian cancers. Restoration of let-7 expression in tumor cells could provide a novel therapeutic strategy for the treatment of cancer.	[Wang, Yanling; Hu, Xiaowen; Shen, Liang; Yang, Xiaojun; Shao, Zhongjun; Liang, Shun; Tanyi, Janos L.; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Greshock, Joel] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Div Surg, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center	Wang, YL (corresponding author), Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Zhang, Lin/K-8478-2012		National Institutes of Health [R01-CA142776, P50-CA83638-7951, 5K12HD000849]; Department of Defense [W81XWH-10-1-0082]; Ovarian Cancer Research Fund; China Scholarship Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142776, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund; China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA142776 (LZ), P50-CA83638-7951 Project 3 (LZ), Department of Defense Grant W81XWH-10-1-0082 (LZ), and the Ovarian Cancer Research Fund (LZ). ZS was supported by the China Scholarship Council. JT was supported by National Institutes of Health Grant 5K12HD000849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; AMBROS V, 1994, TRENDS GENET, V10, P123, DOI 10.1016/0168-9525(94)90213-5; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; King CE, 2011, ONCOGENE; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; KUMAR MS, 2008, P NATL ACAD SCI US; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meirelles K, 2012, P NATL ACAD SCI US; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Nair VS, 2012, J NATL CANC I; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang WC, 2012, CELL	65	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44399	10.1371/journal.pone.0044399	http://dx.doi.org/10.1371/journal.pone.0044399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970210	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400066
J	Chassaing, B; Srinivasan, G; Delgado, MA; Young, AN; Gewirtz, AT; Vijay-Kumar, M				Chassaing, Benoit; Srinivasan, Gayathri; Delgado, Maria A.; Young, Andrew N.; Gewirtz, Andrew T.; Vijay-Kumar, Matam			Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; BOWEL-DISEASE; INSULIN-RESISTANCE; EXPERIMENTAL COLITIS; MICE; MARKER; MOUSE; IDENTIFICATION; PATHOGENESIS; MACROPHAGES	Inflammation has classically been defined histopathologically, especially by the presence of immune cell infiltrates. However, more recent studies suggest a role for "low-grade" inflammation in a variety of disorders ranging from metabolic syndrome to cancer, which is defined by modest elevations in pro-inflammatory gene expression. Consequently, there is a need for cost-effective, non-invasive biomarkers that, ideally, would have the sensitivity to detect low-grade inflammation and have a dynamic range broad enough to reflect classic robust intestinal inflammation. Herein, we report that, for assessment of intestinal inflammation, fecal lipocalin 2 (Lcn-2), measured by ELISA, serves this purpose. Specifically, using a well-characterized mouse model of DSS colitis, we observed that fecal Lcn-2 and intestinal expression of pro-inflammatory cytokines (IL-1 beta, CXCL1, TNF alpha) are modestly but significantly induced by very low concentrations of DSS (0.25 and 0.5%), and become markedly elevated at higher concentrations of DSS (1.0 and 4.0%). As expected, careful histopathologic analysis noted only modest immune infiltrates at low DSS concentration and robust colitis at higher DSS concentrations. In accordance, increased levels of the neutrophil product myeloperoxidase (MPO) was only detected in mice given 1.0 and 4.0% DSS. In addition, fecal Lcn-2 marks the severity of spontaneous colitis development in IL-10 deficient mice. Unlike histopathology, MPO, and q-RT-PCR, the assay of fecal Lcn-2 requires only a stool sample, permits measurement over time, and can detect inflammation as early as 1 day following DSS administration. Thus, assay of fecal Lcn-2 by ELISA can function as a non-invasive, sensitive, dynamic, stable and cost-effective means to monitor intestinal inflammation in mice.	[Chassaing, Benoit; Srinivasan, Gayathri; Gewirtz, Andrew T.; Vijay-Kumar, Matam] Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Delgado, Maria A.; Young, Andrew N.; Gewirtz, Andrew T.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Delgado, Maria A.; Young, Andrew N.] Grady Med Ctr, Atlanta, GA USA	University System of Georgia; Georgia State University; Emory University	Chassaing, B (corresponding author), Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	mkumar@gsu.edu	Vijay-Kumar, Matam/Q-8988-2019; Chassaing, Benoit/R-3819-2017	Chassaing, Benoit/0000-0002-4285-769X	NIH [DK061417, DK083890]; K01 R03 [DK083275]; CCFA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061417, K01DK083275, R01DK083890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K01 R03; CCFA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK061417 and DK083890 to A. T. G. and K01 & R03 (DK083275) and CCFA Career Development award to M.V-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland E, 2002, EUR J GASTROEN HEPAT, V14, P823, DOI 10.1097/00042737-200208000-00002; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Logsdon LK, 2006, J IMMUNOL METHODS, V313, P183, DOI 10.1016/j.jim.2006.05.001; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Nielsen OH, 1999, AM J GASTROENTEROL, V94, P2923, DOI 10.1016/S0002-9270(99)00495-5; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Parikh CR, 2012, KIDNEY INT, V81, P784, DOI 10.1038/ki.2011.465; Playford RJ, 2006, GASTROENTEROLOGY, V131, P809, DOI 10.1053/j.gastro.2006.05.051; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Srinivasan G, 2012, J IMMUNOL, V189, P1911, DOI 10.4049/jimmunol.1200892; van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	32	296	303	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44328	10.1371/journal.pone.0044328	http://dx.doi.org/10.1371/journal.pone.0044328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957064	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800057
J	Limousin, D; Streiff, R; Courtois, B; Dupuy, V; Alem, S; Greenfield, MD				Limousin, Denis; Streiff, Rejane; Courtois, Brigitte; Dupuy, Virginie; Alem, Sylvain; Greenfield, Michael D.			Genetic Architecture of Sexual Selection: QTL Mapping of Male Song and Female Receiver Traits in an Acoustic Moth	PLOS ONE			English	Article							ACHROIA-GRISELLA LEPIDOPTERA; MATE CHOICE; ULTRASONIC ADVERTISEMENT; QUANTITATIVE GENETICS; LESSER WAXMOTH; WAX MOTHS; PREFERENCE; EVOLUTION; SIGNAL; LOCI	Models of indirect (genetic) benefits sexual selection predict linkage disequilibria between genes that influence male traits and female preferences, owing to non-random mate choice or physical linkage. Such linkage disequilibria can accelerate the evolution of traits and preferences to exaggerated levels. Both theory and recent empirical findings on species recognition suggest that such linkage disequilibria may result from physical linkage or pleiotropy, but very little work has addressed this possibility within the context of sexual selection. We studied the genetic architecture of sexually selected traits by analyzing signals and preferences in an acoustic moth, Achroia grisella, in which males attract females with a train of ultrasound pulses and females prefer loud songs and a fast pulse rhythm. Both male signal characters and female preferences are repeatable and heritable traits. Moreover, female choice is based largely on male song, while males do not appear to provide direct benefits at mating. Thus, some genetic correlation between song and preference traits is expected. We employed a standard crossing design between inbred lines and used AFLP markers to build a linkage map for this species and locate quantitative trait loci (QTL) that influence male song and female preference. Our analyses mostly revealed QTLs of moderate strength that influence various male signal and female receiver traits, but one QTL was found that exerts a major influence on the pulse-pair rate of male song, a critical trait in female attraction. However, we found no evidence of specific co-localization of QTLs influencing male signal and female receiver traits on the same linkage groups. This finding suggests that the sexual selection process would proceed at a modest rate in A. grisella and that evolution toward exaggerated character states may be tempered. We suggest that this equilibrium state may be more the norm than the exception among animal species.	[Limousin, Denis; Alem, Sylvain; Greenfield, Michael D.] Univ Tours, CNRS, UMR IRBI 7261, Tours, France; [Streiff, Rejane; Dupuy, Virginie] Montpellier SupAgro, INRA, UMR CBGP, IRD,CIRAD, Montferrier Sur Lez, France; [Courtois, Brigitte] UMR AGAP, CIRAD, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CIRAD; Universite de Montpellier	Limousin, D (corresponding author), INRA, UMR 1272, F-78026 Versailles, France.	michael.greenfield@univ-tours.fr	COURTOIS, Brigitte/A-4004-2009	COURTOIS, Brigitte/0000-0003-2118-7102; Greenfield, Michael D./0000-0003-1935-3423; Streiff, Rejane/0000-0002-2731-8129	Agence Nationale de la Recherche of France [ANR-07-BLAN-0113-01]; Centre National de la Recherche Scientifique (CNRS); Universite Francois Rabelais de Tours; Ministere de l'Education of France; U.S. National Science Foundation [IOB-0516634]	Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Francois Rabelais de Tours; Ministere de l'Education of France; U.S. National Science Foundation(National Science Foundation (NSF))	The project was supported financially by the Agence Nationale de la Recherche of France (contrat ANR-07-BLAN-0113-01), the Centre National de la Recherche Scientifique (CNRS), the Universite Francois Rabelais de Tours, the Ministere de l'Education of France and the U.S. National Science Foundation (grant IOB-0516634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1962, EVOLUTION, V16, P443, DOI 10.1111/j.1558-5646.1962.tb03236.x; Allison JD, 2008, J EVOLUTION BIOL, V21, P1666, DOI 10.1111/j.1420-9101.2008.01595.x; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; Boake CRB, 2005, BEHAV GENET, V35, P297, DOI 10.1007/s10519-005-3221-4; Bousquet F, 2012, P NATL ACAD SCI USA, V109, P249, DOI 10.1073/pnas.1109166108; Brandt LSE, 2004, J EVOLUTION BIOL, V17, P821, DOI 10.1111/j.1420-9101.2004.00716.x; Charmantier A, 2006, TRENDS ECOL EVOL, V21, P417, DOI 10.1016/j.tree.2006.06.001; Chenoweth SF, 2006, NAT REV GENET, V7, P681, DOI 10.1038/nrg1924; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins RD, 1999, HEREDITY, V83, P644, DOI 10.1038/sj.hdy.6885540; DUTKY S. R., 1962, PROC ENTOMOL SOC WASHINGTON, V64, P56; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fisher, 1958, GENETICAL THEORY NAT; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; GREENFIELD MD, 1983, BEHAVIOUR, V84, P287, DOI 10.1163/156853983X00534; Greig EI, 2004, BEHAVIOUR, V141, P799, DOI 10.1163/1568539042265626; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Jang Y, 1997, J INSECT BEHAV, V10, P87, DOI 10.1007/BF02765476; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Jia FY, 2001, J INSECT BEHAV, V14, P19, DOI 10.1023/A:1007893411662; Jia FY, 1997, P ROY SOC B-BIOL SCI, V264, P1057, DOI 10.1098/rspb.1997.0146; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kunike G., 1930, Zeitschrift fuer Angewandte Entomologie, V16, P304; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Limousin D, 2009, J EXP BIOL, V212, P4091, DOI 10.1242/jeb.035345; LOFSTEDT C, 1989, GENETICS, V123, P553; Midamegbe A, 2011, MOL ECOL, V20, P1414, DOI 10.1111/j.1365-294X.2011.05035.x; Morris MR, 1996, ANIM BEHAV, V52, P1193, DOI 10.1006/anbe.1996.0267; Muranty H, 1996, HEREDITY, V76, P156, DOI 10.1038/hdy.1996.23; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Reinhold K, 1998, ANIM BEHAV, V55, P905, DOI 10.1006/anbe.1997.0594; Ritchie MG, 2005, ANIM BEHAV, V70, P849, DOI 10.1016/j.anbehav.2005.01.018; Ritchie MG, 1998, ANIM BEHAV, V56, P713, DOI 10.1006/anbe.1998.0799; Ritchie MG, 1996, P NATL ACAD SCI USA, V93, P14628, DOI 10.1073/pnas.93.25.14628; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Rundus AS, 2011, EVOLUTION, V65, P268, DOI 10.1111/j.1558-5646.2010.01125.x; Sasabe M, 2010, MOL ECOL, V19, P5231, DOI 10.1111/j.1365-294X.2010.04883.x; Shaw KL, 2007, MOL ECOL, V16, P2879, DOI 10.1111/j.1365-294X.2007.03321.x; Shaw KL, 2011, BEHAV ECOL, V22, P1154, DOI 10.1093/beheco/arr136; Simmons LW, 2007, P NATL ACAD SCI USA, V104, P16604, DOI 10.1073/pnas.0704871104; Simmons LW, 2004, ANIM BEHAV, V68, P313, DOI 10.1016/j.anbehav.2003.12.004; Singh ND, 2012, P NATL ACAD SCI USA, V109, P5, DOI 10.1073/pnas.1118531109; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Velthuis BJ, 2005, ANIM BEHAV, V69, P1107, DOI 10.1016/j.anbehav.2004.06.032; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; Welch AM, 2003, EVOLUTION, V57, P883; Wiley C, 2012, P ROY SOC B-BIOL SCI, V279, P1203, DOI 10.1098/rspb.2011.1740; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Xu SZ, 2003, GENETICS, V165, P2259; Zhou YH, 2011, EVOL ECOL, V25, P307, DOI 10.1007/s10682-010-9421-2	71	17	18	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44554	10.1371/journal.pone.0044554	http://dx.doi.org/10.1371/journal.pone.0044554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957082	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800075
J	Moorthy, M; Samuel, P; Peter, JV; Vijayakumar, S; Sekhar, D; Verghese, VP; Agarwal, I; Moses, PD; Ebenezer, K; Abraham, OC; Thomas, K; Mathews, P; Mishra, AC; Lal, R; Muliyil, J; Abraham, AM				Moorthy, Mahesh; Samuel, Prasanna; Peter, John Victor; Vijayakumar, Saranya; Sekhar, Dipika; Verghese, Valsan P.; Agarwal, Indira; Moses, Prabhakar D.; Ebenezer, Kala; Abraham, Ooriapadickal Cherian; Thomas, Kurien; Mathews, Prasad; Mishra, Akhilesh C.; Lal, Renu; Muliyil, Jayaprakash; Abraham, Asha Mary			Estimation of the Burden of Pandemic(H1N1)2009 in Developing Countries: Experience from a Tertiary Care Center in South India	PLOS ONE			English	Article							INFLUENZA; VIRUS; INFECTION; MORTALITY; FEATURES	Background: The burden of the pandemic (H1N1) 2009 influenza might be underestimated if detection of the virus is mandated to diagnose infection. Using an alternate approach, we propose that a much higher pandemic burden was experienced in our institution. Methodology/Principal Findings: Consecutive patients (n = 2588) presenting to our hospital with influenza like illness (ILI) or severe acute respiratory infection (SARI) during a 1-year period (May 2009-April 2010) were prospectively recruited and tested for influenza A by real-time RT-PCR. Analysis of weekly trends showed an 11-fold increase in patients presenting with ILI/SARI during the peak pandemic period when compared with the pre-pandemic period and a significant (P < 0.001) increase in SARI admissions during the pandemic period (30+/-15.9 admissions/week) when compared with pre-pandemic (7+/-2.5) and post-pandemic periods (5+/-3.8). However, Influenza A was detected in less than one-third of patients with ILI/SARI [699 (27.0%)]; a majority of these (557/699, 79.7%) were Pandemic (H1N1) 2009 virus [A/H1N1/09]. An A/H1N1/09 positive test was correlated with shorter symptom duration prior to presentation (p = 0.03). More ILI cases tested positive for A/H1N1/09 when compared with SARI (27.4% vs. 14.6%, P = 0.037). When the entire study population was considered, A/H1N1/09 positivity was associated with lower risk of hospitalization (p < 0.0001) and ICU admission (p = 0.013) suggesting mild self-limiting illness in a majority. Conclusion/Significance: Analysis of weekly trends of ILI/SARI suggest a higher burden of the pandemic attributable to A/H1N1/09 than estimates assessed by a positive PCR test alone. The study highlights methodological consideration in the estimation of burden of pandemic influenza in developing countries using hospital-based data that may help assess the impact of future outbreaks of respiratory illnesses.	[Moorthy, Mahesh; Vijayakumar, Saranya; Sekhar, Dipika; Abraham, Asha Mary] Christian Med Coll & Hosp, Dept Clin Virol, Vellore 632004, Tamil Nadu, India; [Samuel, Prasanna] Christian Med Coll & Hosp, Dept Biostat, Vellore 632004, Tamil Nadu, India; [Verghese, Valsan P.; Agarwal, Indira; Moses, Prabhakar D.; Ebenezer, Kala] Christian Med Coll & Hosp, Dept Child Hlth, Vellore 632004, Tamil Nadu, India; [Peter, John Victor; Abraham, Ooriapadickal Cherian; Thomas, Kurien; Mathews, Prasad] Christian Med Coll & Hosp, Dept Med, Vellore 632004, Tamil Nadu, India; [Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India; [Lal, Renu] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resppiratory Dis, Atlanta, GA USA	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Centers for Disease Control & Prevention - USA	Moorthy, M (corresponding author), Christian Med Coll & Hosp, Dept Clin Virol, Vellore 632004, Tamil Nadu, India.	asha_ma@cmcvellore.ac.in	Peter, John Victor/R-7700-2019; Moorthy, Mahesh/J-4486-2019	Moorthy, Mahesh/0000-0001-6040-040X; Abraham, Asha/0000-0002-0736-1445; Vijayakumar, Saranya/0000-0002-5063-6897	Department of Health and Human Services, USA; Indian Council of Medical Research, India [5U50/CI024407-05]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U50CI024407] Funding Source: NIH RePORTER	Department of Health and Human Services, USA; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Department of Health and Human Services, USA and the Indian Council of Medical Research, India (Co-operative Agreement No. 5U50/CI024407-05). Reagents for testing were in addition supplied by the National Institute of Virology, Pune, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; [Anonymous], MMWR MORB MORTAL WKL, V59, P682; Broor S, 2011, INFLUENZA OTHER RESP; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Cutter JL, 2010, ANN ACAD MED SINGAP, V39, P273; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; John TJ, 2009, INDIAN J MED RES, V130, P101; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Moorthy M, 2011, J HOSP INFECT, V77, P365, DOI 10.1016/j.jhin.2010.12.001; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Muscatello DJ, 2010, EMERG INFECT DIS, V16, P1396, DOI 10.3201/eid1609.091723; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Siau C, 2009, SINGAP MED J, V52, P475; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Van Gageldonk-Lafeber AB, 2011, INFLUENZA OTHER RESP; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Van Kerkhove MD, 2011, INFLUENZA OTHER RESP, DOI [10.1111/j.1750-2659.2011.00249.x, DOI 10.1111/J.1750-2659.2011.00249.X.]; WHO, 2005, INT MAN CHILDH ILLN; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2009, PAT CAR CHECK LIST; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization, 2009, CLIN MAN HUM INF PAN	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41507	10.1371/journal.pone.0041507	http://dx.doi.org/10.1371/journal.pone.0041507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957015	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800007
J	Wootton, JT				Wootton, J. Timothy			Effects of Timber Harvest on River Food Webs: Physical, Chemical and Biological Responses	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; LARGE WOODY DEBRIS; STREAM ECOSYSTEM; COHO SALMON; RIPARIAN BUFFERS; NITRATE REMOVAL; ORGANIC-MATTER; FOREST; USA; PRODUCTIVITY	I compared physical, chemical and biological characteristics of nine rivers running through three timber harvest regimes to investigate the effects of land use on river ecosystems, to determine whether these corresponded to changes linked with downstream location, and to compare the response of different types of indicator variables. Physical variables changed with downstream location, but varied little with timber harvest. Most chemical variables increased strongly with timber harvest, but not with downstream location. Most biological variables did not vary systematically with either timber harvst or downstream location. Dissolved organic carbon did not vary with timber harvest or downstream location, but correlated positively with salmonid abundance. Nutrient manipulations revealed no general pattern of nutrient limitation with timber harvest or downstream location. The results suggest that chemical variables most reliably indicate timber harvest impact in these systems. The biological variables most relevant to human stakeholders were surprisingly insensitive to timber harvest, however, apparently because of decoupling from nutrient responses and unexpectedly weak responses by physical variables.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	Andrew W. Mellon Foundation; Olympic Natural Resources Center (University of Washington); Division Of Environmental Biology [0919420] Funding Source: National Science Foundation	Andrew W. Mellon Foundation; Olympic Natural Resources Center (University of Washington); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided in part by the Andrew W. Mellon Foundation (http://www.mellon.org/) and the Olympic Natural Resources Center (University of Washington; http://www.onrc.washington.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe TB, 1996, REGUL RIVER, V12, P201, DOI 10.1002/(SICI)1099-1646(199603)12:2/3<201::AID-RRR390>3.0.CO;2-A; Bernot MJ, 2010, FRESHWATER BIOL, V55, P1874, DOI 10.1111/j.1365-2427.2010.02422.x; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; BILBY RE, 1992, CAN J FISH AQUAT SCI, V49, P540, DOI 10.1139/f92-064; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; Cirmo CP, 1997, J HYDROL, V199, P88, DOI 10.1016/S0022-1694(96)03286-6; Collins SF, 2011, J N AM BENTHOL SOC, V30, P831, DOI 10.1899/10-164.1; Cottingham KL, 1998, ECOL APPL, V8, P508, DOI 10.2307/2641090; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; FAIRCHILD GW, 1985, ECOLOGY, V66, P465, DOI 10.2307/1940395; Fellman JB, 2009, ECOSYSTEMS, V12, P747, DOI 10.1007/s10021-009-9254-4; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.2307/3071768; Franklin J.F., 1988, US DEP AGR FOR SERV, P8; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Ganatsios HP, 2010, FOREST ECOL MANAG, V260, P1367, DOI 10.1016/j.foreco.2010.07.033; GIBEAU GG, 1989, J FRESHWATER ECOL, V5, P171, DOI 10.1080/02705060.1989.9665226; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Hall RO, 2009, LIMNOL OCEANOGR, V54, P653, DOI 10.4319/lo.2009.54.3.0653; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Helton AM, 2011, FRONT ECOL ENVIRON, V9, P229, DOI 10.1890/080211; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; Hubbart JA, 2007, FOREST SCI, V53, P169; Janisch JE, 2012, FOREST ECOL MANAG, V270, P302, DOI 10.1016/j.foreco.2011.12.035; JONES JB, 1995, J N AM BENTHOL SOC, V14, P249, DOI 10.2307/1467777; Kiffney PM, 1997, J N AM BENTHOL SOC, V16, P520, DOI 10.2307/1468141; LAMBERTI GA, 1985, FRESHWATER BIOL, V15, P21, DOI 10.1111/j.1365-2427.1985.tb00693.x; LAMBERTI GA, 1991, CAN J FISH AQUAT SCI, V48, P196, DOI 10.1139/f91-027; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Little Edward E., 1994, Advances in Limnology, V43, P217; Marks JC, 2000, OIKOS, V90, P20, DOI 10.1034/j.1600-0706.2000.900103.x; MAYER LM, 1980, LIMNOL OCEANOGR, V25, P12, DOI 10.4319/lo.1980.25.1.0012; McHenry ML, 1998, CAN J FISH AQUAT SCI, V55, P1395, DOI 10.1139/cjfas-55-6-1395; MONTGOMERY DR, 1995, WATER RESOUR RES, V31, P1097, DOI 10.1029/94WR03285; Montgomery DR, 1996, NATURE, V381, P587, DOI 10.1038/381587a0; Mulholland PJ, 2009, LIMNOL OCEANOGR, V54, P666, DOI 10.4319/lo.2009.54.3.0666; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Ralf SC, 1994, CAN J FISH AQUAT SCI, V51, P37; SCHINDLER DW, 1985, SCIENCE, V228, P1395, DOI 10.1126/science.228.4706.1395; Snyder EB, 2002, CAN J FISH AQUAT SCI, V59, P564, DOI 10.1139/F02-021; Swank WT, 2001, FOREST ECOL MANAG, V143, P163, DOI 10.1016/S0378-1127(00)00515-6; TANG SM, 1995, ENVIRON MANAGE, V19, P741, DOI 10.1007/BF02471956; Tank JL, 2003, FRESHWATER BIOL, V48, P1031, DOI 10.1046/j.1365-2427.2003.01067.x; TAYLOR RL, 1986, WATER RESOUR BULL, V22, P629; TUCHMAN ML, 1980, HYDROBIOLOGIA, V75, P73, DOI 10.1007/BF00006564; Turner MG, 1996, ECOL APPL, V6, P1150, DOI 10.2307/2269599; *UNESCO, 1994, IOC MAN GUID, V29; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; WARNING R H, 1979, Science (Washington D C), V204, P1380; Webster J. R., 1992, RIVER CONSERVATION M, P231; Webster JR, 2007, J N AM BENTHOL SOC, V26, P375, DOI 10.1899/06-095.1; Wigington PJ, 1998, J AM WATER RESOUR AS, V34, P1035, DOI 10.1111/j.1752-1688.1998.tb04152.x; Wootton JT, 1996, P NATL ACAD SCI USA, V93, P13855, DOI 10.1073/pnas.93.24.13855; WOOTTON JT, 1993, P NATL ACAD SCI USA, V90, P1384, DOI 10.1073/pnas.90.4.1384; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; YEAKLEY JA, 1994, WATER AIR SOIL POLL, V77, P229, DOI 10.1007/BF00478421	59	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43561	10.1371/journal.pone.0043561	http://dx.doi.org/10.1371/journal.pone.0043561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957030	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800022
J	Thiel, WH; Bair, T; Peek, AS; Liu, XY; Dassie, J; Stockdale, KR; Behlke, MA; Miller, FJ; Giangrande, PH				Thiel, William H.; Bair, Thomas; Peek, Andrew S.; Liu, Xiuying; Dassie, Justin; Stockdale, Katie R.; Behlke, Mark A.; Miller, Francis J., Jr.; Giangrande, Paloma H.			Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection	PLOS ONE			English	Article							IN-VITRO SELECTION; SYSTEMATIC EVOLUTION; DNA LIGANDS; GROWTH; SELEX; INHIBITION; BINDING; MOLECULES; SEQUENCES; PROTEINS	Background: The broad applicability of RNA aptamers as cell-specific delivery tools for therapeutic reagents depends on the ability to identify aptamer sequences that selectively access the cytoplasm of distinct cell types. Towards this end, we have developed a novel approach that combines a cell-based selection method (cell-internalization SELEX) with high-throughput sequencing (HTS) and bioinformatics analyses to rapidly identify cell-specific, internalization-competent RNA aptamers. Methodology/Principal Findings: We demonstrate the utility of this approach by enriching for RNA aptamers capable of selective internalization into vascular smooth muscle cells (VSMCs). Several rounds of positive (VSMCs) and negative (endothelial cells; ECs) selection were performed to enrich for aptamer sequences that preferentially internalize into VSMCs. To identify candidate RNA aptamer sequences, HTS data from each round of selection were analyzed using bioinformatics methods: (1) metrics of selection enrichment; and (2) pairwise comparisons of sequence and structural similarity, termed edit and tree distance, respectively. Correlation analyses of experimentally validated aptamers or rounds revealed that the best cell-specific, internalizing aptamers are enriched as a result of the negative selection step performed against ECs. Conclusions and Significance: We describe a novel approach that combines cell-internalization SELEX with HTS and bioinformatics analysis to identify cell-specific, cell-internalizing RNA aptamers. Our data highlight the importance of performing a pre-clear step against a non-target cell in order to select for cell-specific aptamers. We expect the extended use of this approach to enable the identification of aptamers to a multitude of different cell types, thereby facilitating the broad development of targeted cell therapies.	[Thiel, William H.; Bair, Thomas; Liu, Xiuying; Dassie, Justin; Stockdale, Katie R.; Miller, Francis J., Jr.; Giangrande, Paloma H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Peek, Andrew S.] Roche Mol Syst, San Francisco, CA USA; [Behlke, Mark A.] Integrated DNA Technol, Coralville, IA USA; [Giangrande, Paloma H.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA	University of Iowa; Roche Holding; University of Iowa	Thiel, WH (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	paloma-giangrande@uiowa.edu	Miller Jr, Francis/N-7312-2015; Miller, Francis J/F-3801-2017	Miller Jr, Francis/0000-0001-5822-0549; Miller, Francis J/0000-0001-5822-0549; Behlke, Mark/0000-0002-4218-857X; Thiel, William/0000-0002-2372-2925	National Institutes of Health [NIH 1RO1 CA138503-01, 1R21DE019953-01, NIH 2 T32 HL007121-36]; Mary Kay Ash Foundation [MKACF 001-09]; American Heart Association [AHA 11POST7620018]; NATIONAL CANCER INSTITUTE [R01CA138503] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Kay Ash Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding to PHG (National Institutes of Health, NIH 1RO1 CA138503-01 and 1R21DE019953-01; Mary Kay Ash Foundation, MKACF 001-09) and WHT (National Institutes of Health, NIH 2 T32 HL007121-36 and American Heart Association, AHA 11POST7620018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Berezhnoy A., 2012, MOL THER; BINKLEY J, 1995, NUCLEIC ACIDS RES, V23, P3198, DOI 10.1093/nar/23.16.3198; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2010, TRENDS BIOTECHNOL, V28, P517, DOI 10.1016/j.tibtech.2010.07.005; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Charlton J, 1997, BIOCHEMISTRY-US, V36, P3018, DOI 10.1021/bi962669h; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Giangrande PH, 2007, P NATL ACAD SCI USA, V104, P12988, DOI 10.1073/pnas.0704754104; GIVER L, 1993, GENE, V137, P19, DOI 10.1016/0378-1119(93)90246-Y; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Guo KT, 2008, INT J MOL SCI, V9, P668, DOI 10.3390/ijms9040668; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Homann M, 1999, NUCLEIC ACIDS RES, V27, P2006, DOI 10.1093/nar/27.9.2006; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; JELLINEK D, 1993, P NATL ACAD SCI USA, V90, P11227, DOI 10.1073/pnas.90.23.11227; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003; Kraus E, 1998, J IMMUNOL, V160, P5209; Kubik MF, 1997, J IMMUNOL, V159, P259; Layzer JM, 2007, OLIGONUCLEOTIDES, V17, P1, DOI 10.1089/oli.2006.0059; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Li L, 2009, ANAL BIOANAL CHEM, V393, P2051, DOI 10.1007/s00216-009-2640-0; Liu YM, 2009, J NEUROCHEM, V108, P147, DOI 10.1111/j.1471-4159.2008.05748.x; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lupold SE, 2002, CANCER RES, V62, P4029; Mallikaratchy P, 2006, CHEM COMMUN, P3229, DOI 10.1039/b604778e; Martell RE, 2002, MOL THER, V6, P30, DOI 10.1006/mthe.2002.0624; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Meyer C, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/904750; Mi J, 2005, BIOCHEM BIOPH RES CO, V338, P956, DOI 10.1016/j.bbrc.2005.10.043; Mi J, 2010, NAT CHEM BIOL, V6, P22, DOI [10.1038/NCHEMBIO.277, 10.1038/nchembio.277]; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Rockey WM, 2011, NUCLEIC ACID THER, V21, P299, DOI 10.1089/nat.2011.0313; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; Schutze T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1108; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shamah SM, 2008, ACCOUNTS CHEM RES, V41, P130, DOI 10.1021/ar700142z; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Theis MG, 2004, P NATL ACAD SCI USA, V101, P11221, DOI 10.1073/pnas.0402901101; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; Thiel KW, 2012, NUCL ACIDS RES; Thiel WH, 2011, NUCLEIC ACID THER, V21, P253, DOI 10.1089/nat.2011.0288; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wullner U, 2008, CURR CANCER DRUG TAR, V8, P554, DOI 10.2174/156800908786241078; Zimmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009169; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	64	84	90	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43836	10.1371/journal.pone.0043836	http://dx.doi.org/10.1371/journal.pone.0043836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962591	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600019
J	Zakir, HM; Mostafeezur, RM; Suzuki, A; Hitomi, S; Suzuki, I; Maeda, T; Seo, K; Yamada, Y; Yamamura, K; Lev, S; Binshtok, AM; Iwata, K; Kitagawa, J				Zakir, Hossain Md; Mostafeezur, Rahman Md; Suzuki, Akiko; Hitomi, Suzuro; Suzuki, Ikuko; Maeda, Takeyasu; Seo, Kenji; Yamada, Yoshiaki; Yamamura, Kensuke; Lev, Shaya; Binshtok, Alexander M.; Iwata, Koichi; Kitagawa, Junichi			Expression of TRPV1 Channels after Nerve Injury Provides an Essential Delivery Tool for Neuropathic Pain Attenuation	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; INFERIOR ALVEOLAR NERVE; GENE-EXPRESSION; SCHWANN-CELLS; SCIATIC-NERVE; DIFFERENTIAL CHANGES; NOCICEPTIVE NEURONS; POTASSIUM CHANNELS; NUCLEUS CAUDALIS; SENSORY NEURONS	Increased expression of the transient receptor potential vanilloid 1 (TRPV1) channels, following nerve injury, may facilitate the entry of QX-314 into nociceptive neurons in order to achieve effective and selective pain relief. In this study we hypothesized that the level of QX-314/capsaicin (QX-CAP) - induced blockade of nocifensive behavior could be used as an indirect in-vivo measurement of functional expression of TRPV1 channels. We used the QX-CAP combination to monitor the functional expression of TRPV1 in regenerated neurons after inferior alveolar nerve (IAN) transection in rats. We evaluated the effect of this combination on pain threshold at different time points after IAN transection by analyzing the escape thresholds to mechanical stimulation of lateral mental skin. At 2 weeks after IAN transection, there was no QX-CAP mediated block of mechanical hyperalgesia, implying that there was no functional expression of TRPV1 channels. These results were confirmed immunohistochemically by staining of regenerated trigeminal ganglion (TG) neurons. This suggests that TRPV1 channel expression is an essential necessity for the QX-CAP mediated blockade. Furthermore, we show that 3 and 4 weeks after IAN transection, application of QX-CAP produced a gradual increase in escape threshold, which paralleled the increased levels of TRPV1 channels that were detected in regenerated TG neurons. Immunohistochemical analysis also revealed that non-myelinated neurons regenerated slowly compared to myelinated neurons following IAN transection. We also show that TRPV1 expression shifted towards myelinated neurons. Our findings suggest that nerve injury modulates the TRPV1 expression pattern in regenerated neurons and that the effectiveness of QX-CAP induced blockade depends on the availability of functional TRPV1 receptors in regenerated neurons. The results of this study also suggest that the QX-CAP based approach can be used as a new behavioral tool to detect dynamic changes in TRPV1 expression, in various pathological conditions.	[Zakir, Hossain Md; Mostafeezur, Rahman Md; Yamada, Yoshiaki; Yamamura, Kensuke; Kitagawa, Junichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Physiol, Dept Oral Biol Sci, Niigata, Japan; [Suzuki, Akiko; Maeda, Takeyasu] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Anat, Dept Oral Biol Sci, Niigata, Japan; [Hitomi, Suzuro; Suzuki, Ikuko; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Seo, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Anesthesiol, Dept Oral Biol Sci, Niigata, Japan; [Lev, Shaya; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Sch Med, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Lev, Shaya; Binshtok, Alexander M.] Hebrew Univ Jerusalem, Sch Med, Ctr Res Pain, IL-91010 Jerusalem, Israel	Niigata University; Niigata University; Nihon University; Niigata University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zakir, HM (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Physiol, Dept Oral Biol Sci, Niigata, Japan.	kitagawa@dent.niigata-u.ac.jp	Rahman, Mostafeezur/N-2738-2013; Hossain, Mohammad Zakir/H-1668-2013	Hossain, Mohammad Zakir/0000-0002-6621-8737; Kitagawa, Junichi/0000-0001-6471-9960; Binshtok, Alexander/0000-0002-3620-8116	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23592730, 22659367]; Grants-in-Aid for Scientific Research [23592730, 23390418] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid for Scientific Research Kakenhi 23592730 and 22659367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; BIANCHI CP, 1967, J PHARMACOL EXP THER, V157, P388; Biggs JE, 2007, EUR J PAIN, V11, P192, DOI 10.1016/j.ejpain.2006.02.004; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2011, INT REV NEUROBIOL, V97, P143, DOI 10.1016/B978-0-12-385198-7.00006-0; BISBY MA, 1986, BRAIN RES, V365, P85, DOI 10.1016/0006-8993(86)90725-0; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143; CARTER DA, 1987, J NEUROL SCI, V80, P163, DOI 10.1016/0022-510X(87)90152-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Fukuoka T, 2002, PAIN, V99, P111, DOI 10.1016/S0304-3959(02)00067-2; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868, DOI 10.1152/jn.2001.86.6.2868; Jabbar S, 2007, J COMP NEUROL, V501, P400, DOI 10.1002/cne.21256; Kanai Y, 2005, NEUROPHARMACOLOGY, V49, P977, DOI 10.1016/j.neuropharm.2005.05.003; Kim DS, 2001, MOL BRAIN RES, V96, P151, DOI 10.1016/S0169-328X(01)00285-6; Kim HY, 2008, J PAIN, V9, P280, DOI 10.1016/j.jpain.2007.11.013; Kim HY, 2010, PAIN, V150, P29, DOI 10.1016/j.pain.2010.02.016; Kitagawa J, 2005, J NEUROPHYSIOL, V93, P3594, DOI 10.1152/jn.01075.2004; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; KOERBER HR, 1994, J NEUROSCI, V14, P3655; Koerber HR, 1999, J NEUROPHYSIOL, V81, P1636, DOI 10.1152/jn.1999.81.4.1636; Kury P, 2001, CURR OPIN NEUROL, V14, P635, DOI 10.1097/00019052-200110000-00013; LISNEY SJW, 1987, J NEUROL SCI, V80, P289, DOI 10.1016/0022-510X(87)90163-8; Liu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029395; Lozeron P, 2004, J NEUROSCI METH, V138, P225, DOI 10.1016/j.jneumeth.2004.04.012; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Matsumoto M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-25; Michael GJ, 1999, J NEUROSCI, V19, P1844; Miki K, 1998, NEUROSCIENCE, V82, P1243; Nakagawa K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-9; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; NOGUCHI K, 1994, J NEUROSCI RES, V37, P596, DOI 10.1002/jnr.490370506; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Oaklander AL, 2004, ANN NEUROL, V55, P639, DOI 10.1002/ana.20048; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Obata K, 2003, PAIN, V101, P65, DOI 10.1016/S0304-3959(02)00296-8; OBRIEN RD, 1967, FED PROC, V26, P1056; Okamoto M, 2001, J PHYSIOL-LONDON, V532, P241, DOI 10.1111/j.1469-7793.2001.0241g.x; PRICE DD, 1976, J NEUROPHYSIOL, V39, P936, DOI 10.1152/jn.1976.39.5.936; RITCHIE JM, 1965, J PHARMACOL EXP THER, V150, P152; RITCHIE JM, 1965, J PHARMACOL EXP THER, V150, P160; Robinson PP, 2004, J OROFAC PAIN, V18, P287; Ruocco I, 2000, J COMP NEUROL, V422, P287, DOI 10.1002/(SICI)1096-9861(20000626)422:2<287::AID-CNE9>3.0.CO;2-E; Saito K, 2008, J NEUROPHYSIOL, V99, P2251, DOI 10.1152/jn.00794.2007; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smith DS, 1997, J NEUROSCI, V17, P646; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Vilceanu D, 2010, J PAIN, V11, P588, DOI 10.1016/j.jpain.2009.09.018; WOOLF CJ, 1992, J NEUROSCI, V12, P3999; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xie WJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-46; Youn SH, 1997, BRAIN RES, V752, P161, DOI 10.1016/S0006-8993(96)01451-5; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	65	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44023	10.1371/journal.pone.0044023	http://dx.doi.org/10.1371/journal.pone.0044023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962595	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600023
J	de Bruin, M; Viechtbauer, W				de Bruin, Marijn; Viechtbauer, Wolfgang			The Meaning of Adherence When Behavioral Risk Patterns Vary: Obscured Use- and Method-Effectiveness in HIV-Prevention Trials	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; MALE CIRCUMCISION; SOUTH-AFRICA; INFECTION; WOMEN; MEN; METAANALYSIS; PREVALENCE; EFFICACY; KISUMU	Background: Recently promising trials of innovative biomedical approaches to prevent HIV transmission have been reported. Participants' non-adherence to the prevention methods complicates the analyses and interpretation of trial results. The influence of variable sexual behaviors within and between participants of trials further obscures matters. Current methodological and statistical approaches in HIV-prevention studies, as well as ongoing debates on contradictory trial results, may fail to accurately address these topics. Methodology/Principal Findings: Through developing a cumulative probability model of infection within HIV prevention trials, we demonstrate how adherence and sexual behavior patterns impact the overall estimate of effectiveness, the effectiveness of prevention methods as a function of adherence, and conclusions about methods' true effectiveness. Applying the model to summary-level data from the CAPRISA trial, we observe markedly different values for the true method effectiveness of the microbicide, and show that if the gel would have been tested among women with slightly different sexual behavior patterns, conclusions might well have been that the gel is not effective. Conclusions/Significance: Relative risk and adherence analyses in HIV prevention trials overlook the complex interplay between adherence and sexual behavior patterns. Consequently, they may not provide accurate estimates of use-and method-effectiveness. Moreover, trial conclusions are contingent upon the predominant sexual behavior pattern of participants and cannot be directly generalized to other contexts. We recommend researchers to (re) examine their data and use the cumulative probability model to estimate the true method effectiveness, which might contribute to resolving current questions about contradictory trial results. Moreover, we suggest taking into account the issues raised in the design of future trials and in population models estimating the impact of large-scale dissemination of prevention methods. Comprehension of the topics described will help readers to better interpret (apparently contradictory) trial outcomes.	[de Bruin, Marijn] Wageningen Univ, Dept Commun Sci, Wageningen, Netherlands; [Viechtbauer, Wolfgang] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands	Wageningen University & Research; Maastricht University	de Bruin, M (corresponding author), Wageningen Univ, Dept Commun Sci, Wageningen, Netherlands.	marijn.debruin@wur.nl	Viechtbauer, Wolfgang/M-1549-2013; de Bruin, Marijn/X-8418-2018	Viechtbauer, Wolfgang/0000-0003-3463-4063; de Bruin, Marijn/0000-0003-3100-6803				[Anonymous], COCHRANE DATABASE SY; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; HARTER JG, 1991, ANN NY ACAD SCI, V618, P563, DOI 10.1111/j.1749-6632.1991.tb27276.x; Holtgrave D, 1997, AIDS BEHAV, V1, P169, DOI DOI 10.1023/B:AIBE.0000002977.08417.5E; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lagakos SW, 2008, METHODOLOGICAL CHALL; Mattson CL, 2010, AIDS BEHAV, V14, P162, DOI 10.1007/s10461-008-9423-z; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; PINKERTON SD, 1998, HDB EC EVALUATION HI, P13; Pinkerton SD, 2010, EVALUATION REV, V34, P19, DOI 10.1177/0193841X09353534; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011600; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011632; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Shisana O, 2009, S AFRICAN NATL HIV P; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Turner AN, 2009, J CLIN EPIDEMIOL, V62, P759, DOI 10.1016/j.jclinepi.2008.07.011; UNAIDS, 2010, REP GLOB AIDS EP; Urquhart J, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_A.8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vickerman P, 2008, JAIDS-J ACQ IMM DEF, V48, P460, DOI 10.1097/QAI.0b013e31817aebd6; Vrijens B, 1997, CONTROL CLIN TRIALS, V18, P187, DOI 10.1016/S0197-2456(96)00235-8; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44029	10.1371/journal.pone.0044029	http://dx.doi.org/10.1371/journal.pone.0044029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22970107	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300043
J	Hoef-Emden, K				Hoef-Emden, Kerstin			Pitfalls of Establishing DNA Barcoding Systems in Protists: The Cryptophyceae as a Test Case	PLOS ONE			English	Article							GENUS CRYPTOMONAS CRYPTOPHYCEAE; INTERNAL TRANSCRIBED SPACERS; MOLECULAR PHYLOGENY; PLASTID GENOME; SPECIES DELIMITATION; MITOCHONDRIAL GENOME; INTRAGENOMIC VARIATION; EVOLUTIONARY RATES; SEQUENCE ALIGNMENT; RDNA PHYLOGENY	A DNA barcode is a preferrably short and highly variable region of DNA supposed to facilitate a rapid identification of species. In many protistan lineages, a lack of species-specific morphological characters hampers an identification of species by light or electron microscopy, and difficulties to perform mating experiments in laboratory cultures also do not allow for an identification of biological species. Thus, testing candidate barcode markers as well as establishment of accurately working species identification systems are more challenging than in multicellular organisms. In cryptic species complexes the performance of a potential barcode marker can not be monitored using morphological characters as a feedback, but an inappropriate choice of DNA region may result in artifactual species trees for several reasons. Therefore a priori knowledge of the systematics of a group is required. In addition to identification of known species, methods for an automatic delimitation of species with DNA barcodes have been proposed. The Cryptophyceae provide a mixture of systematically well characterized as well as badly characterized groups and are used in this study to test the suitability of some of the methods for protists. As species identification method the performance of blast in searches against badly to well-sampled reference databases has been tested with COI-5P and 59-partial LSU rDNA (domains A to D of the nuclear LSU rRNA gene). In addition the performance of two different methods for automatic species delimitation, fixed thresholds of genetic divergence and the general mixed Yule-coalescent model (GMYC), have been examined. The study demonstrates some pitfalls of barcoding methods that have to be taken care of. Also a best-practice approach towards establishing a DNA barcode system in protists is proposed.	Univ Cologne, Inst Bot, Cologne Bioctr, Cologne, Germany	University of Cologne	Hoef-Emden, K (corresponding author), Univ Cologne, Inst Bot, Cologne Bioctr, Gyrhofstr 15, Cologne, Germany.	kerstin.hoef-emden@uni-koeln.de			German Research Foundation [HO 2015/5]	German Research Foundation(German Research Foundation (DFG))	Funding provided by German Research Foundation grant no. HO 2015/5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Anderson I, 1998, BIOINFORMATICS, V14, P349, DOI 10.1093/bioinformatics/14.4.349; Auinger BM, 2008, APPL ENVIRON MICROB, V74, P2505, DOI 10.1128/AEM.01803-07; Barraclough TG, 2012, BARRALAB WEBSITE DES; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bass D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-162; Ben Ali A, 1999, NUCLEIC ACIDS RES, V27, P2825; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Bock C, 2011, J PHYCOL, V47, P638, DOI 10.1111/j.1529-8817.2011.00989.x; Boenigk J, 2006, APPL ENVIRON MICROB, V72, P5159, DOI 10.1128/AEM.00601-06; Boenigk J, 2012, EUR J PROTISTOL, V48, P96, DOI 10.1016/j.ejop.2011.11.004; Boyer SL, 2011, J N AM BENTHOL SOC, V30, P182, DOI 10.1899/10-004.1; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Butcher RW, 1967, INTRO ACCOUNT SMAL 4; Caisova L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-262; Chantangsi C, 2007, INT J SYST EVOL MICR, V57, P2412, DOI 10.1099/ijs.0.64865-0; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clay BL, 1999, PROTIST, V150, P297, DOI 10.1016/S1434-4610(99)70031-3; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Cote CA, 2002, RNA, V8, P786, DOI 10.1017/S1355838202023063; D'Alelio D, 2009, PROTIST, V160, P9, DOI 10.1016/j.protis.2008.07.001; Deane JA, 2002, J PHYCOL, V38, P1236, DOI 10.1046/j.1529-8817.2002.01250.x; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Drummond AJ, MOL BIOL EVOL; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Esselstyn JA, 2012, P R SOC B; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; Feliner GN, 2004, ANN BOT-LONDON, V93, P189, DOI 10.1093/aob/mch027; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Feuchtmayr H, 2012, FRESHWATER BIOL, V57, P331, DOI 10.1111/j.1365-2427.2011.02671.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Gontcharov AA, 2011, PROTIST, V162, P253, DOI 10.1016/j.protis.2010.08.003; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILL DRA, 1986, PHYCOLOGIA, V25, P521, DOI 10.2216/i0031-8884-25-4-521.1; Hirst MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028158; Hoef-Emden K, 2002, J MOL EVOL, V55, P161, DOI 10.1007/s00239-002-2313-5; Hoef-Emden K, 2003, PROTIST, V154, P371, DOI 10.1078/143446103322454130; Hoef-Emden K, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-56; Hoef-Emden K, 2008, J PHYCOL, V44, P985, DOI 10.1111/j.1529-8817.2008.00530.x; Hoef-Emden K, 2007, PHYCOLOGIA, V46, P402, DOI 10.2216/06-83.1; Hoef-Emden Kerstin, 2007, Protist, V158, P135, DOI 10.1016/j.protis.2007.02.001; Howe AT, 2011, PROTIST, V162, P332, DOI 10.1016/j.protis.2010.10.002; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Inagaki Y, 2004, SYST BIOL, V53, P582, DOI 10.1080/10635150490468756; Kies L, 1967, MITT STAATSINST ALLG, V12, P35; Kim E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-215; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klaveness D., 1988, P105; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lane CE, 2008, J PHYCOL, V44, P439, DOI 10.1111/j.1529-8817.2008.00486.x; Lara E, 2009, ENVIRON MICROBIOL, V11, P47, DOI 10.1111/j.1462-2920.2008.01737.x; Lawley B, 2004, APPL ENVIRON MICROB, V70, P5963, DOI 10.1128/AEM.70.10.5963-5972.2004; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Ledergerber C, 2011, BRIEF BIOINFORM, V12, P489, DOI 10.1093/bib/bbq077; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Masuda I, 2011, HARMFUL ALGAE, V10, P130, DOI 10.1016/j.hal.2010.08.004; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nitsche F, 2011, J EUKARYOT MICROBIOL, V58, P452, DOI 10.1111/j.1550-7408.2011.00572.x; Oudot-le Secq MP, 2002, EUR J PHYCOL, V37, P163, DOI 10.1017/S0967026202003542; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell JR, 2011, MOL ECOL, V20, P655, DOI 10.1111/j.1365-294X.2010.04964.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; PROVASOLI L, 1957, ARCH MIKROBIOL, V25, P392, DOI 10.1007/BF00446694; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rambaut A., 2007, FIGTREE V1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shalchian-Tabrizi K, 2008, ENVIRON MICROBIOL, V10, P2635, DOI 10.1111/j.1462-2920.2008.01685.x; Shalchian-Tabrizi K, 2011, J EUKARYOT MICROBIOL, V58, P315, DOI 10.1111/j.1550-7408.2011.00547.x; SLATKIN M, 1991, GENETICS, V129, P555; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Stock A, 2012, EXTREMOPHILES, V16, P21, DOI 10.1007/s00792-011-0401-4; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Vralstad T, 2011, MOL ECOL, V20, P2873, DOI 10.1111/j.1365-294X.2011.05149.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; WARIS H, 1953, PHYSIOL PLANTARUM, V6, P538, DOI 10.1111/j.1399-3054.1953.tb08411.x; Watson SB, 1997, LIMNOL OCEANOGR, V42, P487, DOI 10.4319/lo.1997.42.3.0487; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang Z, 1996, MOL BIOL EVOL, V10, P1396; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhao P, 2011, FUNGAL DIVERS, V46, P183, DOI 10.1007/s13225-010-0064-y	152	23	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43652	10.1371/journal.pone.0043652	http://dx.doi.org/10.1371/journal.pone.0043652			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22970104	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500072
J	Ou, XF; Zhang, YH; Xu, CM; Lin, XY; Zang, Q; Zhuang, TT; Jiang, LL; von Wettstein, D; Liu, B				Ou, Xiufang; Zhang, Yunhong; Xu, Chunming; Lin, Xiuyun; Zang, Qi; Zhuang, Tingting; Jiang, Lili; von Wettstein, Diter; Liu, Bao			Transgenerational Inheritance of Modified DNA Methylation Patterns and Enhanced Tolerance Induced by Heavy Metal Stress in Rice (Oryza sativa L.)	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; HERITABLE ALTERATION; GENOME; PLANTS; HYPOMETHYLATION; MEMORY; DEMETHYLATION; ACTIVATION; RESPONSES	Background: DNA methylation is sensitive and responsive to stressful environmental conditions. Nonetheless, the extent to which condition-induced somatic methylation modifications can impose transgenerational effects remains to be fully understood. Even less is known about the biological relevance of the induced epigenetic changes for potentially altered well-being of the organismal progenies regarding adaptation to the specific condition their progenitors experienced. Methodology/Principal Findings: We analyzed DNA methylation pattern by gel-blotting at genomic loci representing transposable elements and protein-coding genes in leaf-tissue of heavy metal-treated rice (Oryza sativa) plants (S0), and its three successive organismal generations. We assessed expression of putative genes involved in establishing and/or maintaining DNA methylation patterns by reverse transcription (RT)-PCR. We measured growth of the stressed plants and their unstressed progenies vs. the control plants. We found (1) relative to control, DNA methylation patterns were modified in leaf-tissue of the immediately treated plants, and the modifications were exclusively confined to CHG hypomethylation; (2) the CHG-demethylated states were heritable via both maternal and paternal germline, albeit often accompanying further hypomethylation; (3) altered expression of genes encoding for DNA methyltransferases, DNA glycosylase and SWI/SNF chromatin remodeling factor (DDM1) were induced by the stress; (4) progenies of the stressed plants exhibited enhanced tolerance to the same stress their progenitor experienced, and this transgenerational inheritance of the effect of condition accompanying heritability of modified methylation patterns. Conclusions/Significance: Our findings suggest that stressful environmental condition can produce transgenerational epigenetic modifications. Progenies of stressed plants may develop enhanced adaptability to the condition, and this acquired trait is inheritable and accord with transmission of the epigenetic modifications. We suggest that environmental induction of heritable modifications in DNA methylation provides a plausible molecular underpinning for the still contentious paradigm of inheritance of acquired traits originally put forward by Jean-Baptiste Lamarck more than 200 years ago.	[Ou, Xiufang; Zhang, Yunhong; Xu, Chunming; Zang, Qi; Zhuang, Tingting; Jiang, Lili; Liu, Bao] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China; [Ou, Xiufang; Zhang, Yunhong; Xu, Chunming; Zang, Qi; Zhuang, Tingting; Jiang, Lili; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Lin, Xiuyun] Jilin Acad Agr Sci, Changchun, Peoples R China; [von Wettstein, Diter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Sch Mol Biol, Pullman, WA 99164 USA	Northeast Normal University - China; Northeast Normal University - China; Jilin Academy of Agricultural Sciences; Washington State University; Washington State University	Ou, XF (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China.	diter@wsu.edu; baoliu@nenu.edu.cn	Kuznetsov, Aleksey A/M-6859-2015	Xu, Chunming/0000-0002-0986-0993; Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	National Natural Science Foundation of China [30990243]; Programme for Introducing Talents to Universities [B07017]; Young Faculty Incubation Project of NENU [09QNJJ21]; National Institutes of Health [1R01 GM 080749-01A2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme for Introducing Talents to Universities; Young Faculty Incubation Project of NENU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of China (No. 30990243), the Programme for Introducing Talents to Universities (B07017), a Young Faculty Incubation Project of NENU (No. 09QNJJ21), and National Institutes of Health grant 1R01 GM 080749-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2011, MOL PLANT, V4, P1014, DOI 10.1093/mp/ssr022; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT SIGNAL BEHAV, V5, P995, DOI [10.4161/psb.5.8.12227, 10.1371/journal.pone.0009514]; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; BRECKLE CW, 1991, PLANT ROOTS HIDDEN H, P351; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jablonka E., 1995, EPIGENETIC INHERITAN; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Jullien PE, 2010, TRENDS GENET, V26, P394, DOI 10.1016/j.tig.2010.06.001; Kakutani T, 1999, GENETICS, V151, P831; Kidwell K.K., 1992, SIMPLE PLANT DNA ISO; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee S, 2007, PLANT PHYSIOL, V145, P831, DOI 10.1104/pp.107.102236; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu ZL, 2004, THEOR APPL GENET, V109, P200, DOI 10.1007/s00122-004-1618-8; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Luna E, 2012, PLANT SIGNAL BEHAV, V7, P615, DOI 10.4161/psb.20155; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Polle A, 1993, SIGNIFICANCE ANTIOXI; Rahavi MR, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00091; Rangwala SH, 2004, CURR OPIN GENET DEV, V14, P686, DOI 10.1016/j.gde.2004.09.009; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Vanyushin BF, 2009, DNA METHYLATION PLAN; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7	51	112	124	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e41143	10.1371/journal.pone.0041143	http://dx.doi.org/10.1371/journal.pone.0041143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984395	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700002
J	Harrington, JM; Scelsi, C; Hartel, A; Jones, NG; Engstler, M; Capewell, P; MacLeod, A; Hajduk, S				Harrington, John M.; Scelsi, Chris; Hartel, Andreas; Jones, Nicola G.; Engstler, Markus; Capewell, Paul; MacLeod, Annette; Hajduk, Stephen			Novel African Trypanocidal Agents: Membrane Rigidifying Peptides	PLOS ONE			English	Article							TRYPANOSOME LYTIC FACTOR; SIGNAL PEPTIDES; CELL-SURFACE; PROTEIN; BRUCEI; ENVIRONMENT; BILAYERS; BINDING; PROBES; DEPTH	The bloodstream developmental forms of pathogenic African trypanosomes are uniquely susceptible to killing by small hydrophobic peptides. Trypanocidal activity is conferred by peptide hydrophobicity and charge distribution and results from increased rigidity of the plasma membrane. Structural analysis of lipid-associated peptide suggests a mechanism of phospholipid clamping in which an internal hydrophobic bulge anchors the peptide in the membrane and positively charged moieties at the termini coordinate phosphates of the polar lipid headgroups. This mechanism reveals a necessary phenotype in bloodstream form African trypanosomes, high membrane fluidity, and we suggest that targeting the plasma membrane lipid bilayer as a whole may be a novel strategy for the development of new pharmaceutical agents. Additionally, the peptides we have described may be valuable tools for probing the biosynthetic machinery responsible for the unique composition and characteristics of African trypanosome plasma membranes.	[Harrington, John M.; Scelsi, Chris; Hajduk, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Hartel, Andreas; Jones, Nicola G.; Engstler, Markus] Univ Wurzburg, Dept Cell & Dev Biol, Theodor Boveri Inst, Wurzburg, Germany; [Capewell, Paul; MacLeod, Annette] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University System of Georgia; University of Georgia; University of Wurzburg; University of Glasgow	Harrington, JM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Jones, Nicola/AAP-5835-2021; Capewell, Paul/R-1935-2017	Jones, Nicola/0000-0003-3384-0156; Capewell, Paul/0000-0002-8803-5034; Hartel, Andreas/0000-0002-2693-4472	National Institutes Health [AI039033]; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039033, R01AI039033] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research reported in this manuscript was supported in large part by National Institutes Health grant AI039033 to Stephen L. Hajduk. John M. Harrington was supported by an individual National Research Service Award from the National Institute of Allergy and Infectious Disease and a T32 training grant from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHUPIN V, 1995, BIOCHEMISTRY-US, V34, P11617, DOI 10.1021/bi00036a038; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Gehrig S, 2008, INT J MOL MED, V22, P411, DOI 10.3892/ijmm_00000037; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harrington JM, 2010, J BIOL CHEM, V285, P28659, DOI 10.1074/jbc.M110.151886; JONES JD, 1994, BIOPHYS J, V67, P1534, DOI 10.1016/S0006-3495(94)80627-7; Jones TW, 2001, TRENDS PARASITOL, V17, P99, DOI 10.1016/S1471-4922(00)01777-3; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; Morrison LJ, 2009, CELL MICROBIOL, V11, P1724, DOI 10.1111/j.1462-5822.2009.01383.x; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Raper J, 1999, INFECT IMMUN, V67, P1910; Shiflett AM, 2007, J EUKARYOT MICROBIOL, V54, P18, DOI 10.1111/j.1550-7408.2006.00228.x; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; Vignini A, 2011, DIABETES-METAB RES, V27, P277, DOI 10.1002/dmrr.1173; Voglino L, 1999, BIOCHEMISTRY-US, V38, P7509, DOI 10.1021/bi990099q; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7	27	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44384	10.1371/journal.pone.0044384	http://dx.doi.org/10.1371/journal.pone.0044384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970207	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000308462000019
J	Moriguchi, Y; Shinohara, I				Moriguchi, Yusuke; Shinohara, Ikuko			My Neighbor: Children's Perception of Agency in Interaction with an Imaginary Agent	PLOS ONE			English	Article							BIOLOGICAL MOTION; COMPANIONS; FANTASY; DISTINCTION; MONSTERS; REALITY; AUTISM; KINDS; MIND	Children may treat an invisible entity as a live and thinking entity, known as an imaginary companion (IC). Some researchers suggest that this is simply pretend play, but it is possible that children experience agency in their interactions with ICs. Given the literature on cognitive science and social brain research, we hypothesize that young children may have an agent-perception system that responds to an invisible agent by which they may experience realistic agency in their interactions with ICs. In this study, children were introduced to an invisible agent and an invisible stone. However, they assigned biological and psychological properties to the agent but not the stone. The tendency of assigning such properties was stronger in children with ICs than in those without ICs. These results contribute to our understanding of cognitive and neural development in typical and atypical children.	[Moriguchi, Yusuke] Joetsu Univ Educ, Dept Sch Educ, Joetsu, Japan; [Moriguchi, Yusuke] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Shinohara, Ikuko] Aichi Shukutoku Univ, Dept Psychol, Nagakute, Aichi, Japan	Joetsu University Education; Japan Science & Technology Agency (JST); Aichi Shukutoku University	Moriguchi, Y (corresponding author), Joetsu Univ Educ, Dept Sch Educ, Joetsu, Japan.	moriguchi@juen.ac.jp		Moriguchi, Yusuke/0000-0002-9002-7834	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This research was supported by grants from the Japan Science and Technology Agency, recursory Research for Embryonic Science and Technology program to the first author (http://www.jst.go.jp/kisoken/presto/index_e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltaxe C., 1977, J PEDIATR PSYCHOL, V2, P176, DOI [10.1093/jpepsy/2.4.176, DOI 10.1093/JPEPSY/2.4.176]; Barrett JL, 2001, CHILD DEV, V72, P50, DOI 10.1111/1467-8624.00265; Bouldin P, 2001, BRIT J DEV PSYCHOL, V19, P99, DOI 10.1348/026151001165985; Boyer P., 2002, RELIG EXPLAINED EVOL; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Carlson SM, 2005, MERRILL PALMER QUART, V51, P93, DOI 10.1353/mpq.2005.0003; Carter EJ, 2006, SOC NEUROSCI-UK, V1, P396, DOI 10.1080/17470910601041382; DeLoache JS, 2004, SCIENCE, V304, P1027, DOI 10.1126/science.1093567; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gelman R., 1983, DEV SYMBOLIC THOUGHT, P297; Gleason TR, 2000, DEV PSYCHOL, V36, P419, DOI 10.1037//0012-1649.36.4.419; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Guthrie Stewart, 1995, FACES CLOUDS NEW THE; Harris P.L., 2000, WORK IMAGINATION; HARRIS PL, 1991, BRIT J DEV PSYCHOL, V9, P105, DOI 10.1111/j.2044-835X.1991.tb00865.x; Jipson JL, 2007, CHILD DEV, V78, P1675, DOI 10.1111/j.1467-8624.2007.01095.x; McGuire D., 2006, MENTAL WELLNESS ADUL; Piaget Jean, 1929, CHILDS CONCEPTION WO; Roby AC, 2008, DEVELOPMENTAL SCI, V11, P531, DOI 10.1111/j.1467-7687.2008.00699.x; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; Sharon T, 2004, BRIT J DEV PSYCHOL, V22, P293, DOI 10.1348/026151004323044627; Sigman M, 1999, MONOGR SOC RES CHILD, V64, P1, DOI 10.1111/1540-5834.00002; SPRINGER K, 1991, CHILD DEV, V62, P767, DOI 10.2307/1131176; Svendsen M, 1934, ARCH NEURO PSYCHIATR, V32, P985, DOI 10.1001/archneurpsyc.1934.02250110073006; Taylor M, 1997, CHILD DEV, V68, P436, DOI 10.1111/j.1467-8624.1997.tb01950.x; TAYLOR M, 1993, DEV PSYCHOL, V29, P276, DOI 10.1037/0012-1649.29.2.276; Taylor M., 1999, IMAGINARY COMPANIONS; Tshuji H, 1992, PIANISSIMO; Ueno K., 2008, PVT R KAIGAGOI HATTA; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x; WOOLLEY JD, 1993, CHILD DEV, V64, P1; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	32	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44463	10.1371/journal.pone.0044463	http://dx.doi.org/10.1371/journal.pone.0044463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970225	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000022
J	Charlson, ES; Bittinger, K; Chen, J; Diamond, JM; Li, HZ; Collman, RG; Bushman, FD				Charlson, Emily S.; Bittinger, Kyle; Chen, Jun; Diamond, Joshua M.; Li, Hongzhe; Collman, Ronald G.; Bushman, Frederic D.			Assessing Bacterial Populations in the Lung by Replicate Analysis of Samples from the Upper and Lower Respiratory Tracts	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; FIBEROPTIC BRONCHOSCOPY; QUANTITATIVE ASPIRATION; NOSOCOMIAL PNEUMONIA; DIVERSITY; OROPHARYNGEAL; CULTURE; BRUSH; COLONIZATION; PSEUDOMONAS	Microbes of the human respiratory tract are important in health and disease, but accurate sampling of the lung presents challenges. Lung microbes are commonly sampled by bronchoscopy, but to acquire samples the bronchoscope must pass through the upper respiratory tract, which is rich in microbes. Here we present methods to identify authentic lung microbiota in bronchoalveolar lavage (BAL) fluid that contains substantial oropharyngeal admixture. We studied clinical BAL samples from six selected subjects with potential heavy lung colonization. A single sample of BAL fluid was obtained from each subject along with contemporaneous oral wash (OW) to sample the oropharynx, and then DNA was extracted from three separate aliquots of each. Bacterial 16S rDNA sequences were amplified and products analyzed by 454 pyrosequencing. By comparing replicates, we were able to specify the depth of sequencing needed to reach a 95% chance of identifying a bacterial lineage of a given proportion-for example, at a depth of 5,000 tags, OTUs of proportion 0.3% or greater would be called with 95% confidence. We next constructed a single-sided outlier test that allowed lung-enriched organisms to be quantified against a background of oropharyngeal admixture, and assessed improvements available with replicate sequence analysis. This allowed identification of lineages enriched in lung in some BAL specimens. Finally, using samples from healthy volunteers collected at multiple sites in the upper respiratory tract, we show that OW provides a reasonable but not perfect surrogate for bacteria carried into to the lung by a bronchoscope. These methods allow identification of microbes that can replicate in the lung despite the background due to oropharyngeal microbes derived from aspiration and bronchoscopic carry-over.	[Charlson, Emily S.; Bittinger, Kyle; Collman, Ronald G.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Charlson, Emily S.; Diamond, Joshua M.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Charlson, ES (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	collmanr@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Bittinger, Kyle/ABG-2342-2020	Bushman, Frederic/0000-0003-4740-4056; Collman, Ronald/0000-0002-0508-3701	National Institutes of Health [U01 HL98957]; National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) T32: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grants [(T32) (NIAID) 5T32AI060516 - 06]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, T32AI060516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) T32: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grants; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Lung Human Microbiome Project Grant U01 HL98957 from the National Institutes of Health to R. G. C. and F. D. B., and E. S. C. was supported by National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) T32: Ruth L. Kirschstein National Research Service Award Institutional Research Training Grants (T32) (NIAID) 5T32AI060516 - 06 "Microbial Pathogenesis and Genomics." The authors also acknowledge the Penn Genome Frontiers Institute and the Penn Center for AIDS Research (AI045008) and a grant with the Pennsylvania Department of Health; the Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; BARTLETT JG, 1976, AM REV RESPIR DIS, V114, P73; Beal M, 2004, LARYNGOSCOPE, V114, P965, DOI 10.1097/00005537-200406000-00002; Bousbia S, 2010, EMERG INFECT DIS, V16, P258, DOI 10.3201/eid1602.090610; CANTRAL DE, 1993, AM J MED, V95, P601, DOI 10.1016/0002-9343(93)90356-T; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; JORDAN GW, 1976, J INFECT DIS, V134, P428, DOI 10.1093/infdis/134.5.428; KIRKPATRICK MB, 1989, AM REV RESPIR DIS, V139, P546, DOI 10.1164/ajrccm/139.2.546; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Nadkarni MA, 2012, EUR J CLIN MICROBIOL; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; ORTQVIST A, 1990, CHEST, V97, P576, DOI 10.1378/chest.97.3.576; PANG JA, 1989, LUNG, V167, P261, DOI 10.1007/BF02714955; PECORA DV, 1963, NEW ENGL J MED, V269, P664, DOI 10.1056/NEJM196309262691304; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robinson Joan, 2004, Paediatr Child Health, V9, P21; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Souweine B, 1998, CRIT CARE MED, V26, P236, DOI 10.1097/00003246-199802000-00017; Spasenovski T, 2009, DIAGN MICR INFEC DIS, V63, P261, DOI 10.1016/j.diagmicrobio.2008.11.011; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940	44	101	103	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e42786	10.1371/journal.pone.0042786	http://dx.doi.org/10.1371/journal.pone.0042786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970118	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400005
J	Chen, H; Xia, CA; Deng, Y; Wen, B; Wang, W; Xiong, SQ; Ruan, L; Tan, WJ				Chen, Hong; Xia Chuai; Deng, Yao; Wen, Bo; Wang, Wen; Xiong, Shaoqing; Ruan, Li; Tan, Wenjie			Optimisation of Prime-Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; T-CELL RESPONSES; NEUTRALIZING EPITOPES; INFECTION; COMBINATION; LAMIVUDINE; SUPPRESSION; MECHANISMS; INDUCTION; POXVIRUS	Background: A therapeutic vaccine for chronic hepatitis B virus (HBV) infection that enhances virus-specific cellular immune responses is urgently needed. The "prime-boost" regimen is a widely used vaccine strategy against many persistence infections. However, few reports have addressed this strategy applying for HBV therapeutic vaccine development. Methodology/Principal Findings: To develop an effective HBV therapeutic vaccine, we constructed a recombinant vaccinia virus (Tiantan) containing the S+PreS1 fusion antigen (RVJSS1) combined with the HBV particle-like subunit vaccine HBVSS1 to explore the most effective prime-boost regimen against HBV. The immune responses to different prime-boost regimens were assessed in C57BL/C mice by ELISA, ELISpot assay and Intracellular cytokine staining analysis. Among the combinations tested, an HBV protein particle vaccine priming and recombinant vaccinia virus boosting strategy accelerated specific seroconversion and produced high antibody (anti-PreS1, anti-S antibody) titres as well as the strongest multi-antigen (PreS1, and S)-specific cellular immune response. HBSS1 protein prime/RVJSS1 boost immunization was also generated more significant level of both CD4+ and CD8+ T cell responses for Th1 cytokines (TNF-alpha and IFN-gamma). Conclusions: The HBSS1 protein-vaccine prime plus RVJSS1 vector boost elicits specific antibody as well as CD4 and CD8 cells secreting Th1-like cytokines, and these immune responses may be important parameters for the future HBV therapeutic vaccines.	[Chen, Hong; Xia Chuai; Deng, Yao; Wen, Bo; Wang, Wen; Ruan, Li; Tan, Wenjie] Chinese Ctr Dis Control & Prevent, Biotech Ctr Viral Dis Emergency, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xia Chuai] Hebei Med Univ, Dept Microbiol, Shijiazhuang, Peoples R China; [Wen, Bo] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Xiong, Shaoqing] Beijing Univ Technol, Sch Life Sci & Bioengn, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; Jilin University; Beijing University of Technology	Chen, H (corresponding author), Chinese Ctr Dis Control & Prevent, Biotech Ctr Viral Dis Emergency, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	tanwj28@yahoo.cn			China Mega-projects of Science Research for the RD of New Drugs [2009ZX09102-237]	China Mega-projects of Science Research for the RD of New Drugs	The present study was supported by the China Mega-projects of Science Research for the R&D of New Drugs (No. 2009ZX09102-237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, VACCINE, V27, P88, DOI 10.1016/j.vaccine.2008.10.031; Bertoletti Antonio, 2009, Expert Rev Gastroenterol Hepatol, V3, P561, DOI 10.1586/egh.09.48; Bremer CM, 2011, J HEPATOL, V55, P29, DOI 10.1016/j.jhep.2010.10.019; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chen H, 2011, CLIN VACCINE IMMUNOL, V18, P1789, DOI 10.1128/CVI.05113-11; Chen Hong, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P95; Chen Hong, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P74; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Chisari FV, 1997, J CLIN INVEST, V99, P1472, DOI 10.1172/JCI119308; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Franco A, 1997, J IMMUNOL, V159, P2001; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GU S, 1991, Chinese Medical Sciences Journal, V6, P241; Hemachandra A, 2010, HUM VACCINES, V6, P835, DOI 10.4161/hv.6.10.12635; Horiike N, 2005, J CLIN VIROL, V32, P156, DOI 10.1016/j.jcv.2004.07.004; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liu MA, 2010, CURR OPIN MOL THER, V12, P86; Maeng CY, 2000, VIROLOGY, V270, P9, DOI 10.1006/viro.2000.0250; Mancini-Bourgine M, 2004, HEPATOLOGY, V40, P874, DOI 10.1002/hep.20408; Mehrizi AA, 2011, PARASITE IMMUNOL, V33, P594, DOI 10.1111/j.1365-3024.2011.01331.x; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; NEURATH AR, 1989, VACCINE, V7, P234; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Pol S, 1994, J GERONTOL B-PSYCHOL, V343, P1460; QIAO M, 1994, VIROLOGY, V201, P356, DOI 10.1006/viro.1994.1301; Radcliffe JN, 2006, J IMMUNOL, V177, P6626, DOI 10.4049/jimmunol.177.10.6626; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribas A, 2011, CLIN CANCER RES, V17, P2987, DOI 10.1158/1078-0432.CCR-10-3272; RUAN L, 1992, CHINESE J VIROL, V8, P101; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sjogren MH, 2005, AM J MED, V118, P34, DOI 10.1016/j.amjmed.2005.07.012; [田淑芳 Tian Shufang], 2002, [病毒学报, Chinese Journal of Virology], V18, P312; TSAO H, 1988, J VIROL, V62, P4832, DOI 10.1128/JVI.62.12.4832-4834.1988; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; WEN YM, 1995, LANCET, V345, P1575, DOI 10.1016/S0140-6736(95)91126-X; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	40	18	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43730	10.1371/journal.pone.0043730	http://dx.doi.org/10.1371/journal.pone.0043730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970140	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400018
J	Cohen, A; Ross, L; Nachman, I; Bar-Nun, S				Cohen, Aviv; Ross, Liron; Nachman, Iftach; Bar-Nun, Shoshana			Aggregation of PolyQ Proteins Is Increased upon Yeast Aging and Affected by Sir2 and Hsf1: Novel Quantitative Biochemical and Microscopic Assays	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; AGE-OF-ONSET; NEURONAL INTRANUCLEAR INCLUSIONS; GENOME-WIDE ANALYSIS; CAG-REPEAT LENGTH; HUNTINGTONS-DISEASE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CAENORHABDITIS-ELEGANS; POLYGLUTAMINE-EXPANSION	Aging-related neurodegenerative disorders, such as Parkinson's, Alzheimer's and Huntington's diseases, are characterized by accumulation of protein aggregates in distinct neuronal cells that eventually die. In Huntington's disease, the protein huntingtin forms aggregates, and the age of disease onset is inversely correlated to the length of the protein's polyglutamine tract. Using quantitative assays to estimate microscopically and capture biochemically protein aggregates, here we study in Saccharomyces cerevisiae aging-related aggregation of GFP-tagged, huntingtin-derived proteins with different polyQ lengths. We find that the short 25Q protein never aggregates whereas the long 103Q version always aggregates. However, the mid-size 47Q protein is soluble in young logarithmically growing yeast but aggregates as the yeast cells enter the stationary phase and age, allowing us to plot an "aggregation timeline". This aging-dependent aggregation was associated with increased cytotoxicity. We also show that two aging-related genes, SIR2 and HSF1, affect aggregation of the polyQ proteins. In Delta sir2 strain the aging-dependent aggregation of the 47Q protein is aggravated, while overexpression of the transcription factor Hsf1 attenuates aggregation. Thus, the mid-size 47Q protein and our quantitative aggregation assays provide valuable tools to unravel the roles of genes and environmental conditions that affect aging-related aggregation.	[Cohen, Aviv; Ross, Liron; Nachman, Iftach; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Cohen, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il	Nachman, Iftach/E-6750-2010; Nachman, Iftach/AAK-2051-2020	Nachman, Iftach/0000-0002-4667-0398; 	Chief Scientist Office of the Ministry of Health, Israel [3-3211]; Israel Science Foundation [384/11]; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Chief Scientist Office of the Ministry of Health, Israel; Israel Science Foundation(Israel Science Foundation); Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Initial stages of this study were supported by a grant from the Chief Scientist Office of the Ministry of Health, Israel (grant no. 3-3211 to SB) and later by a grant from The Israel Science Foundation (grant no. 384/11 to SB). IN is supported in part by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beam M, 2012, J BIOL CHEM; BENZVI A, 2009, P NATL ACAD SCI US; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen QH, 2005, BIOGERONTOLOGY, V6, P1, DOI 10.1007/s10522-004-7379-6; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Garigan D, 2002, GENETICS, V161, P1101; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Giorgini F, 2009, METHODS MOL BIOL, V548, P161, DOI 10.1007/978-1-59745-540-4_9; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harper PS, 1991, HUNTINGTONS DIS, P281; HEDREEN JC, 1995, J NEUROPATH EXP NEUR, V54, P105, DOI 10.1097/00005072-199501000-00013; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Monteiro JP, 2011, PROTEIN PEPTIDE LETT, V18, P167; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Ohtsuka H, 2011, MOL GENET GENOMICS, V285, P67, DOI 10.1007/s00438-010-0588-6; Outeiro TF, 2004, J MOL NEUROSCI, V23, P49, DOI 10.1385/JMN:23:1-2:049; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sherman MY, 2003, NEUROMOL MED, V4, P133, DOI 10.1385/NMM:4:1-2:133; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Suopanki J, 2006, J NEUROCHEM, V96, P870, DOI 10.1111/j.1471-4159.2005.03620.x; Swinnen E, 2011, BIOCHEM SOC T, V39, P1476, DOI 10.1042/BST0391476; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Taylor R.C., 2011, COLD SPRING HARB PER, V3; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CL, 2008, GENETICS, V180, P1955, DOI 10.1534/genetics.108.094516; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	86	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44785	10.1371/journal.pone.0044785	http://dx.doi.org/10.1371/journal.pone.0044785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970306	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400119
J	Ibanez, IL; Bracalente, C; Notcovich, C; Tropper, I; Molinari, BL; Policastro, LL; Duran, H				Ibanez, Irene L.; Bracalente, Candelaria; Notcovich, Cintia; Tropper, Ivanna; Molinari, Beatriz L.; Policastro, Lucia L.; Duran, Hebe			Phosphorylation and Subcellular Localization of p27Kip1 Regulated by Hydrogen Peroxide Modulation in Cancer Cells	PLOS ONE			English	Article							PERSISTENT OXIDATIVE STRESS; KINASE INHIBITOR P27(KIP1); RIBOSOMAL S6 KINASE; REACTIVE OXYGEN; CYCLE PROGRESSION; CYTOPLASMIC LOCALIZATION; PHASE-TRANSITION; REDOX REGULATION; NUCLEAR EXPORT; MELANOMA-CELLS	The Cyclin-dependent kinase inhibitor 1B (p27Kip1) is a key protein in the decision between proliferation and cell cycle exit. Quiescent cells show nuclear p27Kip1, but this protein is exported to the cytoplasm in response to proliferating signals. We recently reported that catalase treatment increases the levels of p27Kip1 in vitro and in vivo in a murine model. In order to characterize and broaden these findings, we evaluated the regulation of p27Kip1 by hydrogen peroxide (H2O2) in human melanoma cells and melanocytes. We observed a high percentage of p27Kip1 positive nuclei in melanoma cells overexpressing or treated with exogenous catalase, while non-treated controls showed a cytoplasmic localization of p27Kip1. Then we studied the levels of p27Kip1 phosphorylated (p27p) at serine 10 (S10) and at threonine 198 (T198) because phosphorylation at these sites enables nuclear exportation of this protein, leading to accumulation and stabilization of p27pT198 in the cytoplasm. We demonstrated by western blot a decrease in p27pS10 and p27pT198 levels in response to H2O2 removal in melanoma cells, associated with nuclear p27Kip1. Melanocytes also exhibited nuclear p27Kip1 and lower levels of p27pS10 and p27pT198 than melanoma cells, which showed cytoplasmic p27Kip1. We also showed that the addition of H2O2 (0.1 mu M) to melanoma cells arrested in G1 by serum starvation induces proliferation and increases the levels of p27pS10 and p27pT198 leading to cytoplasmic localization of p27Kip1. Nuclear localization and post-translational modifications of p27Kip1 were also demonstrated by catalase treatment of colorectal carcinoma and neuroblastoma cells, extending our findings to these other human cancer types. In conclusion, we showed in the present work that H2O2 scavenging prevents nuclear exportation of p27Kip1, allowing cell cycle arrest, suggesting that cancer cells take advantage of their intrinsic pro-oxidant state to favor cytoplasmic localization of p27Kip1.	[Ibanez, Irene L.; Bracalente, Candelaria; Notcovich, Cintia; Policastro, Lucia L.; Duran, Hebe] Comis Nacl Energia Atom, Dept Micro & Nanotecnol, San Martin, Argentina; [Ibanez, Irene L.; Bracalente, Candelaria; Molinari, Beatriz L.; Policastro, Lucia L.; Duran, Hebe] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Tropper, Ivanna; Duran, Hebe] Univ Nacl San Martin, Escuela Ciencia & Tecnol, San Martin, Argentina; [Molinari, Beatriz L.] Comis Nacl Energia Atom, Dept Radiobiol, San Martin, Argentina	Comision Nacional de Energia Atomica (CNEA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA)	Ibanez, IL (corresponding author), Comis Nacl Energia Atom, Dept Micro & Nanotecnol, San Martin, Argentina.	irenuliz@yahoo.com; hduran@cnea.gov.ar		Duran, Hebe/0000-0001-6691-7792; Ibanez, Irene Laura/0000-0003-3619-2529	National Agency for Scientific and Technological Promotion (ANPCyT), Argentina [PICT 2007-01628, PICT 05-14330]	National Agency for Scientific and Technological Promotion (ANPCyT), Argentina(ANPCyT)	This work was partially supported by grants from the National Agency for Scientific and Technological Promotion (ANPCyT), Argentina (PICT 2007-01628 and PICT 05-14330) and the non-profit organization Fundacion Florencio Fiorini. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Bottini C, 2009, INT J ONCOL, V34, P69, DOI 10.3892/ijo_00000130; Brar SS, 2001, AM J PHYSIOL-CELL PH, V280, pC659, DOI 10.1152/ajpcell.2001.280.3.C659; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Chen DH, 2003, CANCER RES, V63, P6626; Chen GD, 2011, CANCER EPIDEM BIOMAR, V20, P2212, DOI 10.1158/1055-9965.EPI-11-0472; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Gidanian S, 2008, PHOTOCHEM PHOTOBIOL, V84, P556, DOI 10.1111/j.1751-1097.2008.00309.x; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Ibanez IL, 2011, BREAKTHROUGHS MELANO, P1; Ibanez IL, 2011, CANCER LETT, V305, P58, DOI 10.1016/j.canlet.2011.02.026; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Laurent A, 2005, CANCER RES, V65, P948; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; MCCORD JM, 1995, P SOC EXP BIOL MED, V209, P112; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Menon SG, 2003, CANCER RES, V63, P2109; Nacusi LP, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-11; Onumah OE, 2009, FREE RADICAL BIO MED, V46, P1658, DOI 10.1016/j.freeradbiomed.2009.03.018; Picardo M, 1996, J INVEST DERMATOL, V107, P322, DOI 10.1111/1523-1747.ep12363163; Policastro L, 2004, MOL CARCINOGEN, V39, P103, DOI 10.1002/mc.20001; Policastro LL, 2009, MOL THER, V17, P1355, DOI 10.1038/mt.2009.103; POSO H, 1984, J BIOL CHEM, V259, P2307; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	64	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44502	10.1371/journal.pone.0044502	http://dx.doi.org/10.1371/journal.pone.0044502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970236	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400081
J	McDonald, AC; Denny, L; Wang, CH; Tsai, WY; Wright, TC; Kuhn, L				McDonald, Alicia C.; Denny, Lynette; Wang, Chunhui; Tsai, Wei-Yann; Wright, Thomas C., Jr.; Kuhn, Louise			Distribution of High-Risk Human Papillomavirus Genotypes among HIV-Negative Women with and without Cervical Intraepithelial Neoplasia in South Africa	PLOS ONE			English	Article							PARTICLE VACCINE; HPV INFECTION; YOUNG-WOMEN; CANCER; PREVALENCE; POPULATION; CYTOLOGY; TYPE-16; DNA; METAANALYSIS	Objective: Large studies describing the profile of high-risk Human papillomavirus (hrHPV) genotypes among women in sub-Saharan Africa are lacking. Here we describe the prevalence and distribution of hrHPV genotypes among HIV-negative women in South Africa, with and without cervical intraepithelial neoplasia (CIN). Methods: We report data on 8,050 HIV-negative women, aged 17-65 years, recruited into three sequential studies undertaken in Cape Town, South Africa. Women had no history of previous cervical cancer screening. Cervical samples were tested for hrHPV DNA using the Hybrid Capture 2 (HC2) assay and all positive samples were genotyped using a PCR-based assay (Line Blot). Women underwent colposcopy and biopsy/endocervical curettage to determine CIN status. The prevalence and distribution of specific hrHPV genotypes were examined by age and CIN status. Results: Overall, 20.7% (95% CI, 19.9-21.6%) of women were hrHPV-positive by HC2, with women with CIN having the highest rates of positivity. Prevalence decreased with increasing age among women without CIN; but, a bimodal age curve was observed among women with CIN. HPV 16 and 35 were the most common hrHPV genotypes in all age and CIN groups. HPV 45 became more frequent among older women with CIN grade 2 or 3 (CIN2,3). Younger women (17-29 years) had more multiple hrHPV genotypes overall and in each cervical disease group than older women (40-65 years). Conclusion: HPV 16, 35, and 45 were the leading contributors to CIN 2,3. The current HPV vaccines could significantly reduce HPV-related cervical disease; however, next generation vaccines that include HPV 35 and 45 would further reduce cervical disease in this population.	[McDonald, Alicia C.; Kuhn, Louise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Denny, Lynette] Univ Cape Town, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa; [Wang, Chunhui; Wright, Thomas C., Jr.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; [Tsai, Wei-Yann] Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA	Columbia University; University of Cape Town; Columbia University; Columbia University	McDonald, AC (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	lk24@columbia.edu			Bill and Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention	Bill and Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention	The study reported here was funded by the Bill and Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention. The funders had no role in the study design data collection and analysis, decision to publish or preparation of the manuscript.	Agarossi A, 2009, J MED VIROL, V81, P529, DOI 10.1002/jmv.21347; Allan B, 2008, J CLIN MICROBIOL, V46, P740, DOI 10.1128/JCM.01981-07; [Anonymous], 2007, IARC MON EV CARC RIS; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Castle PE, 2011, J CLIN MICROBIOL, V49, P3029, DOI 10.1128/JCM.00422-11; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Coutlee F, 2006, J CLIN MICROBIOL, V44, P1998, DOI 10.1128/JCM.00104-06; Cox JT, 2006, CURR OPIN OBSTET GYN, V18, pS5, DOI 10.1097/01.gco.0000216315.72572.fb; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Ferlay J, 2010, IARC CANCERBASE, V10; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hamlin-Douglas LK, 2008, CANCER EPIDEM BIOMAR, V17, P3141, DOI 10.1158/1055-9965.EPI-08-0625; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jeronimo J, 2007, AM J OBSTET GYNECOL, V197, p[47, e41]; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Ortiz M, 2006, J CLIN MICROBIOL, V44, P1428, DOI 10.1128/JCM.44.4.1428-1434.2006; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Said HM, 2009, J CLIN VIROL, V44, P318, DOI 10.1016/j.jcv.2009.02.001; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Serwadda D, 1999, J INFECT DIS, V180, P1316, DOI 10.1086/315026; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Stoler MH, 2012, AM J CLIN PATHOL, V137, P295, DOI 10.1309/AJCPGW1V2BBWMOCX; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Womack SD, 2000, INT J CANCER, V85, P206, DOI 10.1002/(SICI)1097-0215(20000115)85:2%3C206::AID-; Zhang Q, 2007, INT J CANCER, V120, P351, DOI 10.1002/ijc.22172	38	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44332	10.1371/journal.pone.0044332	http://dx.doi.org/10.1371/journal.pone.0044332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970201	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400059
J	Raju, M; Santhoshkumar, P; Sharma, KK				Raju, Murugesan; Santhoshkumar, Puttur; Sharma, K. Krishna			alpha A-Crystallin-Derived Mini-Chaperone Modulates Stability and Function of Cataract Causing alpha AG98R-Crystallin	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; MOLECULAR CHAPERONE; ARGININE HYDROCHLORIDE; CONGENITAL CATARACT; SYNTHETIC PEPTIDE; EYE LENS; MUTATION; MUTANT; CRYAA	Background: A substitution mutation in human alpha A-crystallin (alpha AG98R) is associated with autosomal dominant cataract. The recombinant mutant alpha AG98R protein exhibits altered structure, substrate-dependent chaperone activity, impaired oligomer stability and aggregation on prolonged incubation at 37 degrees C. Our previous studies have shown that alpha A-crystallin-derived mini-chaperone (DFVIFLDVKHFSPEDLTVK) functions like a molecular chaperone by suppressing the aggregation of denaturing proteins. The present study was undertaken to determine the effect of alpha A-crystallin-derived mini-chaperone on the stability and chaperone activity of alpha AG98R-crystallin. Methodology/Principal Findings: Recombinant alpha AG98R was incubated in presence and absence of mini-chaperone and analyzed by chromatographic and spectrometric methods. Transmission electron microscope was used to examine the effect of mini-chaperone on the aggregation propensity of mutant protein. Mini-chaperone containing photoactive benzoylphenylalanine was used to confirm the interaction of mini-chaperone with alpha AG98R. The rescuing of chaperone activity in mutanta-crystallin (alpha AG98R) by mini-chaperone was confirmed by chaperone assays. We found that the addition of the mini-chaperone during incubation of alpha AG98R protected the mutant crystallin from forming larger aggregates that precipitate with time. The mini-chaperone-stabilized alpha AG98R displayed chaperone activity comparable to that of wild-type alpha A-crystallin. The complexes formed between mini-alpha A-alpha AG98R complex and ADH were more stable than the complexes formed between alpha AG98R and ADH. Western-blotting and mass spectrometry confirmed the binding of mini-chaperone to mutant crystallin. Conclusion/Significance: These results demonstrate that mini-chaperone stabilizes the mutant alpha A-crystallin and modulates the chaperone activity of alpha AG98R. These findings aid in our understanding of how to design peptide chaperones that can be used to stabilize mutant alpha A-crystallins and preserve the chaperone function.	[Raju, Murugesan; Santhoshkumar, Puttur; Sharma, K. Krishna] Univ Missouri, Columbia Sch Med, Dept Ophthalmol, Columbia, MO 65211 USA; [Sharma, K. Krishna] Univ Missouri, Columbia Sch Med, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Raju, M (corresponding author), Univ Missouri, Columbia Sch Med, Dept Ophthalmol, Columbia, MO 65211 USA.	sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278	United States National Institutes of Health [EY 011981, EY 021011]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011981, R21EY021011] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY 011981 and EY 021011 from the United States National Institutes of Health (http://www.nih.gov/) and an unrestricted grant-in-aid from Research to Prevent Blindness to the Department of Ophthalmology (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bhattacharyya J, 2001, J PEPT RES, V57, P428, DOI 10.1034/j.1399-3011.2001.00871.x; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; DEJONG WW, 1984, EUR J BIOCHEM, V141, P131; Dorman G, 1998, Acta Pharm Hung, V68, P95; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Girault S, 1996, EUR J BIOCHEM, V240, P215, DOI 10.1111/j.1432-1033.1996.0215h.x; GRAW J, 1984, EXP EYE RES, V39, P37, DOI 10.1016/0014-4835(84)90112-X; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; HAWKINS JW, 1987, HUM GENET, V76, P375, DOI 10.1007/BF00272448; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, INT J BIOL MACROMOL, V22, P263, DOI 10.1016/S0141-8130(98)00024-5; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Kumar RS, 2000, J PEPT RES, V56, P157, DOI 10.1034/j.1399-3011.2000.00785.x; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Murugesan R, 2007, MOL VIS, V13, P2301; Pal J, 1998, OPHTHALMIC RES, V30, P271, DOI 10.1159/000055484; Rajaraman K, 2001, FEBS LETT, V497, P118, DOI 10.1016/S0014-5793(01)02451-6; Raju M, 2011, MOL VIS, V17, P7; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Reddy GB, 2001, BIOCHEM BIOPH RES CO, V282, P712, DOI 10.1006/bbrc.2001.4642; Santhiya S, 2006, MOL VIS, V12, P768; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; SHARMA KK, 1995, EXP EYE RES, V61, P413; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Singh D, 2006, MOL VIS, V12, P1372; Sreelakshmi Y, 2001, J PROTEIN CHEM, V20, P123, DOI 10.1023/A:1011077307262; Srinivas V, 2005, MOL VIS, V11, P249; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178	46	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44077	10.1371/journal.pone.0044077	http://dx.doi.org/10.1371/journal.pone.0044077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970163	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400033
J	Sommer, IE; Clos, M; Meijering, AL; Diederen, KMJ; Eickhoff, SB				Sommer, Iris E.; Clos, Mareike; Meijering, Anne Lotte; Diederen, Kelly M. J.; Eickhoff, Simon B.			Resting State Functional Connectivity in Patients with Chronic Hallucinations	PLOS ONE			English	Article							AUDITORY VERBAL HALLUCINATIONS; GLOBAL SIGNAL; BRAIN; SCHIZOPHRENIA; NETWORKS; CORTEX; OSCILLATIONS; ACTIVATIONS; PERCEPTION; SYMPTOMS	Auditory verbal hallucinations (AVH) are not only among the most common but also one of the most distressing symptoms of schizophrenia. Despite elaborate research, the underlying brain mechanisms are as yet elusive. Functional MRI studies have associated the experience of AVH with activation of bilateral language-related areas, in particular the right inferior frontal gyrus (rIFG) and the left superior temporal gyrus (lSTG). While these findings helped to understand the neural underpinnings of hearing voices, they provide little information about possible brain mechanisms that predispose a person to experience AVH, i.e. the traits to hallucinate. In this study, we compared resting state connectivity between 49 psychotic patients with chronic AVH and 49 matched controls using the rIFG and the lSTG as seed regions, to identify functional brain systems underlying the predisposition to hallucinate. The right parahippocampal gyrus showed increased connectivity with the rIFG in patients as compared to controls. Reduced connectivity with the rIFG in patients was found for the right dorsolateral prefrontal cortex. Reduced connectivity with the lSTG in patients was identified in the left frontal operculum as well as the parietal opercular area. Connectivity between the lSTG and the left hippocampus was also reduced in patients and showed a negative correlation with the severity of hallucinations. Concluding, we found aberrant connectivity between the seed regions and medial temporal lobe structures which have a prominent role in memory retrieval. Moreover, we found decreased connectivity between language-related areas, indicating aberrant integration in this system potentially including corollary discharge mechanisms.	[Sommer, Iris E.; Meijering, Anne Lotte; Diederen, Kelly M. J.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Sommer, Iris E.; Meijering, Anne Lotte; Diederen, Kelly M. J.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [Clos, Mareike; Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med, INM 1, INM 22, Julich, Germany; [Eickhoff, Simon B.] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Eickhoff, Simon B.] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Helmholtz Association; Research Center Julich; RWTH Aachen University; Heinrich Heine University Dusseldorf	Sommer, IE (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands.	I.Sommer@umcutrecht.nl	sommer, iris E/D-1190-2014; Eickhoff, Simon B./K-2061-2013	sommer, iris E/0000-0002-2682-5313; Eickhoff, Simon B./0000-0001-6363-2759; Sommer, Iris/0000-0001-5597-3262; Clos, Mareike/0000-0002-1611-9474; Diederen, Kelly/0000-0002-9619-6583	NWO/ZonMW (Dutch Scientific Research Organization) [40-00703-97-270]; NWO/ZonMW Innovation Impulse (VIDI) [017.106.301]	NWO/ZonMW (Dutch Scientific Research Organization)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); NWO/ZonMW Innovation Impulse (VIDI)	This work was supported by NWO/ZonMW (Dutch Scientific Research Organization) Clinical Fellowship [40-00703-97-270] and by NWO/ZonMW Innovation Impulse (VIDI) [017.106.301]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2007, INT REV PSYCHIATR, V19, P409, DOI 10.1080/09540260701486498; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Badcock Johanna C, 2005, Cogn Neuropsychiatry, V10, P125, DOI 10.1080/13546800344000363; Bandettini PA, 2008, HUM BRAIN MAPP, V29, P737, DOI 10.1002/hbm.20607; Bartsch T, 2011, P NATL ACAD SCI USA, V108, P17562, DOI 10.1073/pnas.1110266108; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bellec P, 2006, NEUROIMAGE, V29, P1231, DOI 10.1016/j.neuroimage.2005.08.044; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Copolov DL, 2003, PSYCHIAT RES-NEUROIM, V122, P139, DOI 10.1016/S0925-4927(02)00121-X; de Weijer AD, 2011, SCHIZOPHR RES, V130, P68, DOI 10.1016/j.schres.2011.05.010; de Weijer AD, 2013, HUM BRAIN MAPP, V34, P626, DOI 10.1002/hbm.21463; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2011, NEUROIMAGE, V57, P938, DOI 10.1016/j.neuroimage.2011.05.021; Ford JM, 2005, INT J PSYCHOPHYSIOL, V58, P179, DOI 10.1016/j.ijpsycho.2005.01.014; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gavrilescu M, 2010, PSYCHOL MED, V40, P1149, DOI 10.1017/S0033291709991632; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hoffman RE, 2008, BRIT J PSYCHIAT, V193, P424, DOI 10.1192/bjp.bp.107.040501; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hunter MD, 2010, NEUROIMAGE, V53, P611, DOI 10.1016/j.neuroimage.2010.06.053; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sommer IEC, 2007, SCHIZOPHR RES, V93, P406, DOI 10.1016/j.schres.2007.03.020; Sommer IE, 2010, PSYCHOPATHOLOGY, V43, P137, DOI 10.1159/000277003; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Vercammen A, 2010, BIOL PSYCHIAT, V67, P912, DOI 10.1016/j.biopsych.2009.11.017; Vercammen A, 2010, SCHIZOPHRENIA BULL, V36, P151, DOI 10.1093/schbul/sbn063; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P741, DOI 10.1093/schbul/sbq144; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005	43	72	73	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43516	10.1371/journal.pone.0043516	http://dx.doi.org/10.1371/journal.pone.0043516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970130	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400013
J	Zhu, CB; Wang, C; Chen, LL; Ma, GL; Zhang, SC; Su, L; Tian, JJ; Gai, ZT				Zhu, Cheng-Bao; Wang, Can; Chen, Li-Li; Ma, Guo-Liang; Zhang, Shi-Cai; Su, Liang; Tian, Jian-Jun; Gai, Zhong-Tao			Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma	PLOS ONE			English	Article							PLASMA YKL-40; CANCER; EXPRESSION; BIOMARKER	Background: Transcatheter arterial chemoembolization (TACE) is the most widely used treatment option for unresectable hepatocellular carcinoma (HCC). Elevated serum YKL-40 level has been shown to predict poor prognosis in HCC patients undergoing resection. This study was designed to validate the prognostic significance of serum YKL-40 in patients with HCC undergoing TACE treatment. Methods: Serum YKL-40 level was determined by enzyme-linked immunosorbent assay. Overall survival (OS) was evaluated with the Kaplan-Meier method and compared by the log-rank test. Multivariate study with Cox proportional hazard model was used to evaluate independent prognostic variables of OS. Results: The median pretreatment serum YKL-40 in HCC patients with was significantly higher than that in healthy controls (P < 0.001). The YKL-40 could predict survival precisely either in a dichotomized or continuous fashion (P < 0.001 and P = 0.001, respectively). Multivariate Cox regression analysis indicated that serum YKL-40 was an independent prognostic factor for OS in HCC patients (P = 0.001). In further stratified analyses, YKL-40 could discriminate the outcomes of patients with low and high alpha-fetoprotein (AFP) level (P = 0.006 and 0.016, respectively). Furthermore, the combination of serum YKL-40 and AFP had more capacity to predict patients' outcomes. Conclusions: Serum YKL-40 was demonstrated to be an independent prognostic biomarker in HCC patients treated with TACE. Our results need confirmation in an independent study.	[Zhu, Cheng-Bao; Tian, Jian-Jun] Shandong Univ, Jinan Infect Dis Hosp, Dept Clin Lab, Jinan 250100, Peoples R China; [Wang, Can; Su, Liang; Gai, Zhong-Tao] Shandong Univ, Jinan Infect Dis Hosp, Dept Hepatol, Jinan 250100, Peoples R China; [Chen, Li-Li] Second Peoples Hosp Jinan, Dept Traditonal Chinese Med Ophthalmol, Jinan, Shandong, Peoples R China; [Ma, Guo-Liang] Peoples Hosp Laiwu, Dept Clin Lab, Laiwu, Shandong, Peoples R China; [Zhang, Shi-Cai] Tumour Hosp Taian, Dept Clin Lab, Tai An, Shandong, Peoples R China	Shandong University; Shandong University	Zhu, CB (corresponding author), Shandong Univ, Jinan Infect Dis Hosp, Dept Clin Lab, Jinan 250100, Peoples R China.	tjjjcyy@126.com; gztjcyy@126.com			research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University)	research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University)	This study was supported by a research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Cha C, 2002, J CLIN GASTROENTEROL, V35, pS130, DOI 10.1097/00004836-200211002-00009; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Johansen JS, 2006, DAN MED BULL, V53, P172; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Johansen JS, 2009, J CLIN ONCOL, V27, P572, DOI 10.1200/JCO.2008.18.8367; Kazakova Maria H, 2009, Folia Med (Plovdiv), V51, P5; Lata Ewelina, 2010, Pol Merkur Lekarski, V28, P505; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng SY, 2010, INT J CANCER, V112, P44; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; Ryder SD, 2003, GUT, V52, pIII1, DOI 10.1136/gut.52.suppl_3.iii1; Schwartz M, 2004, GASTROENTEROLOGY, V127, pS268, DOI 10.1053/j.gastro.2004.09.041; Shackel NA, 2003, HEPATOLOGY, V38, P577, DOI 10.1053/jhep.2003.50376; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Xiao XQ, 2011, HEPATOB PANCREAT DIS, V10, P605, DOI 10.1016/S1499-3872(11)60103-3; Yang JD, 2010, GUT LIVER, V4, P537, DOI 10.5009/gnl.2010.4.4.537; Zhu CB, 2012, ANN SURG ONCOL, V19, P817, DOI 10.1245/s10434-011-2026-3	23	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44648	10.1371/journal.pone.0044648	http://dx.doi.org/10.1371/journal.pone.0044648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970277	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400101
J	Beiki, AH; Saboor, S; Ebrahimi, M				Beiki, Amir H.; Saboor, Saba; Ebrahimi, Mansour			A New Avenue for Classification and Prediction of Olive Cultivars Using Supervised and Unsupervised Algorithms	PLOS ONE			English	Article							OLEA-EUROPAEA L.; GENETIC DIVERSITY; ENZYME THERMOSTABILITY; FEATURE-SELECTION; SP-NOV.; SEQUENCE; FEATURES; IDENTIFICATION; MARKER; OIL	Various methods have been used to identify cultivares of olive trees; herein we used different bioinformatics algorithms to propose new tools to classify 10 cultivares of olive based on RAPD and ISSR genetic markers datasets generated from PCR reactions. Five RAPD markers (OPA0a21, OPD16a, OP01a1, OPD16a1 and OPA0a8) and five ISSR markers (UBC841a4, UBC868a7, UBC841a14, U12BC807a and UBC810a13) selected as the most important markers by all attribute weighting models. K-Medoids unsupervised clustering run on SVM dataset was fully able to cluster each olive cultivar to the right classes. All trees (176) induced by decision tree models generated meaningful trees and UBC841a4 attribute clearly distinguished between foreign and domestic olive cultivars with 100% accuracy. Predictive machine learning algorithms (SVM and Naive Bayes) were also able to predict the right class of olive cultivares with 100% accuracy. For the first time, our results showed data mining techniques can be effectively used to distinguish between plant cultivares and proposed machine learning based systems in this study can predict new olive cultivars with the best possible accuracy.	[Beiki, Amir H.; Ebrahimi, Mansour] Univ Qom, Dept Biol, Sch Basic Sci, Qom, Iran; [Beiki, Amir H.; Ebrahimi, Mansour] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Saboor, Saba] IKIU, Fac Engn & Technol, Dept Agr Biotechnol, Qazvin, Iran	Imam Khomeini International University	Beiki, AH (corresponding author), Univ Qom, Dept Biol, Sch Basic Sci, Qom, Iran.	mansour@future.org	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021; ebrahimi, mansour/D-9950-2011	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; 	IKIU; Bioinformatics Research Group, GRC, University of Qom	IKIU; Bioinformatics Research Group, GRC, University of Qom	The authors greatly appreciate support from IKIU and Bioinformatics Research Group, GRC, University of Qom.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Alonso-Salces RM, 2010, J AGR FOOD CHEM, V58, P5586, DOI 10.1021/jf903989b; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Bakhtiarizadeh MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027118; Banilas G, 2003, GENOME, V46, P370, DOI [10.1139/g03-011, 10.1139/G03-011]; Baseri S, 2011, ADV STUDIES BIOL, V3, P181; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Biedermann A, 2012, FORENSIC SCI INT-GEN, V6, P147, DOI 10.1016/j.fsigen.2011.06.009; Bijanzadeh E, 2010, AUST J CROP SCI, V4, P402; Corrado G, 2009, GENOME, V52, P692, DOI [10.1139/G09-044, 10.1139/g09-044]; Dabbou S, 2010, CHEM BIODIVERS, V7, P1801, DOI 10.1002/cbdv.200900385; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; Ebrahimie E, 2010, NEW BIOTECHNOL, V27, pS43, DOI 10.1016/j.nbt.2010.01.063; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Elbeaino T, 2011, VIRUS RES, V161, P198, DOI 10.1016/j.virusres.2011.07.022; Ercisli S, 2011, BIOCHEM GENET, V49, P555, DOI 10.1007/s10528-011-9430-z; Fernandez MF, 2012, INT J ANDROL, V35, P1, DOI 10.1111/j.1365-2605.2010.01131.x; Freire-Aradas A, 2012, FORENSIC SCI INT-GEN, V6, P341, DOI 10.1016/j.fsigen.2011.07.010; Garcia-Gonzalez DL, 2010, J AGR FOOD CHEM, V58, P12899, DOI 10.1021/jf1031313; Georis J, 2000, PROTEIN SCI, V9, P466; Guzman E, 2012, TALANTA, V93, P94, DOI 10.1016/j.talanta.2012.01.053; Habashy HO, 2011, BREAST CANCER RES TR, V128, P315, DOI 10.1007/s10549-010-1073-y; Hameed U, 2012, GENET MOL RES, V11, P1195, DOI 10.4238/2012.May.8.1; HELFERT RH, 1987, AM J ANAT, V179, P55, DOI 10.1002/aja.1001790108; Hosseinzadeh F, 2012, PLOS ONE IN PRESS; Jimenez-Diaz RM, 2011, PHYTOPATHOLOGY, V101, P304, DOI 10.1094/PHYTO-07-10-0176; Kumla S, 2012, MOL BIOL REP, V39, P5201, DOI 10.1007/s11033-011-1317-x; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mishra D, 2011, ADV EXP MED BIOL, V696, P91, DOI 10.1007/978-1-4419-7046-6_10; Montemurro F, 2009, BIORESOURCE TECHNOL, V100, P2969, DOI 10.1016/j.biortech.2009.01.038; Nisiotou AA, 2010, INT J SYST EVOL MICR, V60, P1219, DOI 10.1099/ijs.0.012955-0; Owen CA, 2005, THEOR APPL GENET, V110, P1169, DOI 10.1007/s00122-004-1861-z; Pafundo S, 2005, J AGR FOOD CHEM, V53, P6995, DOI 10.1021/jf050775x; Perez-Jimenez F, 2000, MED CLIN-BARCELONA, V114, P219, DOI 10.1016/S0025-7753(00)71250-4; Randhawa GJ, 2012, J AOAC INT, V95, P186, DOI 10.5740/jaoacint.10-429; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; Riaz S, 2012, GENET MOL RES, V11, P440, DOI 10.4238/2012.February.24.3; Rjiba I, 2010, CHEM BIODIVERS, V7, P649, DOI 10.1002/cbdv.200900092; Rojas AM, 2004, INT J SYST EVOL MICR, V54, P2217, DOI 10.1099/ijs.0.02924-0; Sesli M, 2010, GENET MOL RES, V9, P966, DOI 10.4238/vol9-2gmr783; Sheridan H, 2012, J ETHNOPHARMACOL, V140, P482, DOI 10.1016/j.jep.2012.01.050; Simon M, 2012, PLANT J, V69, P1094, DOI 10.1111/j.1365-313X.2011.04852.x; Simopoulos AP, 2001, J NUTR, V131, p3065S, DOI 10.1093/jn/131.11.3065S; Talhinhas P, 2005, APPL ENVIRON MICROB, V71, P2987, DOI 10.1128/AEM.71.6.2987-2998.2005; Vietina M, 2011, J SCI FOOD AGR, V91, P1381, DOI 10.1002/jsfa.4317; Vitale S, 2011, PHYTOPATHOLOGY, V101, P679, DOI 10.1094/PHYTO-04-10-0120; Xu R, 2010, ARTIF INTELL MED, V48, P91, DOI 10.1016/j.artmed.2009.06.001; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	56	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44164	10.1371/journal.pone.0044164	http://dx.doi.org/10.1371/journal.pone.0044164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957050	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800042
J	Dykstra, AR; Koh, CK; Braida, LD; Tramo, MJ				Dykstra, Andrew R.; Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude			Dissociation of Detection and Discrimination of Pure Tones following Bilateral Lesions of Auditory Cortex	PLOS ONE			English	Article							SOUND LEVEL DEPENDENCE; RESPONSE PROPERTIES; FUNCTIONAL-ANATOMY; FMRI ACTIVATION; HESCHLS GYRUS; INTENSITY; FREQUENCY; BRAIN; DEACTIVATION; LOCALIZATION	It is well known that damage to the peripheral auditory system causes deficits in tone detection as well as pitch and loudness perception across a wide range of frequencies. However, the extent to which to which the auditory cortex plays a critical role in these basic aspects of spectral processing, especially with regard to speech, music, and environmental sound perception, remains unclear. Recent experiments indicate that primary auditory cortex is necessary for the normally-high perceptual acuity exhibited by humans in pure-tone frequency discrimination. The present study assessed whether the auditory cortex plays a similar role in the intensity domain and contrasted its contribution to sensory versus discriminative aspects of intensity processing. We measured intensity thresholds for pure-tone detection and pure-tone loudness discrimination in a population of healthy adults and a middle-aged man with complete or near-complete lesions of the auditory cortex bilaterally. Detection thresholds in his left and right ears were 16 and 7 dB HL, respectively, within clinically-defined normal limits. In contrast, the intensity threshold for monaural loudness discrimination at 1 kHz was 6.5 +/- 2.1 dB in the left ear and 6.5 +/- 1.9 dB in the right ear at 40 dB sensation level, well above the means of the control population (left ear: 1.6 +/- 0.22 dB; right ear: 1.7 +/- 0.19 dB). The results indicate that auditory cortex lowers just-noticeable differences for loudness discrimination by approximately 5 dB but is not necessary for tone detection in quiet. Previous human and Old-world monkey experiments employing lesion-effect, neurophysiology, and neuroimaging methods to investigate the role of auditory cortex in intensity processing are reviewed.	[Dykstra, Andrew R.; Braida, Louis D.; Tramo, Mark Jude] MIT, Harvard Mit Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA; [Dykstra, Andrew R.; Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude] Massachusetts Gen Hosp, Dept Neurol, Inst Mus & Brain Sci, Auditory Neurosci Program, Boston, MA 02114 USA; [Dykstra, Andrew R.; Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude] Harvard Univ, Sch Med, Boston, MA USA; [Koh, Christine K.; Braida, Louis D.; Tramo, Mark Jude] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Dykstra, AR (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA.	Andrew.Dykstra@med.uni-heidelberg.de			NIH [DC03328, DC006353, DC00117, T32-DC00038]; Harvard-MIT Division of Health Sciences and Technology; Institute for Music and Brain Science	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-MIT Division of Health Sciences and Technology; Institute for Music and Brain Science	This work was supported by NIH (http://www.nih.gov/) DC03328, DC006353, DC00117, T32-DC00038, The Harvard-MIT Division of Health Sciences and Technology (http://hst.mit.edu/index.jsp), and The Institute for Music and Brain Science (http://www.brainmusic.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baran Jane A, 2004, J Am Acad Audiol, V15, P106, DOI 10.3766/jaaa.15.2.2; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Baru A, 1972, NEUROPSYCHOLOGY EVER, P1; Belin P, 1998, J NEUROSCI, V18, P6388; Bendor D, 2008, J NEUROPHYSIOL, V100, P888, DOI 10.1152/jn.00884.2007; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; DIVENYI PL, 1989, BRAIN LANG, V37, P290, DOI 10.1016/0093-934X(89)90020-5; Hall DA, 2001, J ACOUST SOC AM, V109, P1559, DOI 10.1121/1.1345697; Harrington I, 2003, INTENSITY DISCRIMINA; Hart HC, 2003, HEARING RES, V179, P104, DOI 10.1016/S0378-5955(03)00100-X; Hart HC, 2002, HEARING RES, V171, P177, DOI 10.1016/S0378-5955(02)00498-7; HODGSON WR, 1967, J SPEECH HEAR DISORD, V32, P39, DOI 10.1044/jshd.3201.39; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jerger J, 1969, Acta Otolaryngol Suppl, V258, P1; JERGER J, 1972, J SPEECH HEAR DISORD, V37, P523, DOI 10.1044/jshd.3704.523; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; King AJ, 2007, HEARING RES, V229, P106, DOI 10.1016/j.heares.2007.01.001; Lasota KJ, 2003, J COMPUT ASSIST TOMO, V27, P213, DOI 10.1097/00004728-200303000-00018; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; MARSHALL L, 1986, J SPEECH HEAR RES, V29, P82, DOI 10.1044/jshr.2901.82; MASTERTON RB, 1974, ANNU REV PSYCHOL, V25, P277, DOI 10.1146/annurev.ps.25.020174.001425; MENDEZ MF, 1988, J NEUROL NEUROSUR PS, V51, P1, DOI 10.1136/jnnp.51.1.1; MILLEN SJ, 1995, LARYNGOSCOPE, V105, P1305, DOI 10.1288/00005537-199512000-00008; Milner B, 1962, LATERALITY EFFECTS A, P177; Mohr CM, 1999, J ACOUST SOC AM, V105, P2738, DOI 10.1121/1.426942; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Moore DR, 2001, CURR BIOL, V11, pR782, DOI 10.1016/S0960-9822(01)00477-8; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Musiek FE, 1993, NEUROAUDIOLOGY CASE; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Neff WD, 1975, HDB SENSORY PHYSIOLO, P307; PARKER S, 1980, PERCEPT PSYCHOPHYS, V28, P398, DOI 10.3758/BF03204883; RABINOWITZ WM, 1976, J ACOUST SOC AM, V59, P1506, DOI 10.1121/1.381000; RAPIN I, 1966, ELECTROEN CLIN NEURO, V21, P335, DOI 10.1016/0013-4694(66)90039-3; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Rybalko N, 2010, BEHAV BRAIN RES, V209, P123, DOI 10.1016/j.bbr.2010.01.028; Sigalovsky IS, 2006, NEUROIMAGE, V32, P1524, DOI 10.1016/j.neuroimage.2006.05.023; Sigalovsky IS, 2006, HEARING RES, V215, P67, DOI 10.1016/j.heares.2006.03.002; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; STROMINGER NL, 1980, PHYSIOL BEHAV, V24, P1149, DOI 10.1016/0031-9384(80)90062-1; Swisher LP, 1967, CORTEX, V3, P179; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Thaerig S, 2008, INT J PSYCHOPHYSIOL, V67, P235, DOI 10.1016/j.ijpsycho.2007.06.007; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; Tramo MJ, 2002, J NEUROPHYSIOL, V87, P122, DOI 10.1152/jn.00104.1999; Tramo MJ, 1994, PSYCHOPHYSICAL MEASU; Watkins PV, 2008, NAT NEUROSCI, V11, P1259, DOI 10.1038/nn.2201; Watkins PV, 2011, HEARING RES, V275, P30, DOI 10.1016/j.heares.2010.11.011; Watkins PV, 2011, CEREB CORTEX, V21, P178, DOI 10.1093/cercor/bhq079; Woods DL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00155; Woods DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005183; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Yost W A., 2006, FUNDAMENTALS HEARING	60	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44602	10.1371/journal.pone.0044602	http://dx.doi.org/10.1371/journal.pone.0044602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957087	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800080
J	Ferreira, PA; Ruela-de-Sousa, RR; Queiroz, KCS; Souza, ACS; Milani, R; Pilli, RA; Peppelenbosch, MP; den Hertog, J; Ferreira, CV				Ferreira, Paula A.; Ruela-de-Sousa, Roberta R.; Queiroz, Karla C. S.; Souza, Ana Carolina S.; Milani, Renato; Pilli, Ronaldo Aloise; Peppelenbosch, Maikel P.; den Hertog, Jeroen; Ferreira, Carmen V.			Knocking Down Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) Reverts Chemoresistance through Inactivation of Src and Bcr-Abl Proteins	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; CANCER; ACTIVATION; KINASES; CELLS	The development of multidrug resistance (MDR) limits the efficacy of continuous chemotherapeutic treatment in chronic myelogenous leukemia (CML). Low molecular weight protein tyrosine phosphatase (LMW-PTP) is up-regulated in several cancers and has been associated to poor prognosis. This prompted us to investigate the involvement of LMW-PTP in MDR. In this study, we investigated the role of LMW-PTP in a chemoresistant CML cell line, Lucena-1. Our results showed that LMW-PTP is highly expressed and 7-fold more active in Lucena-1 cells compared to K562 cells, the non-resistant cell line. Knocking down LMW-PTP in Lucena-1 cells reverted chemoresistance to vincristine and imatinib mesylate, followed by a decrease of Src and Bcr-Abl phosphorylation at the activating sites, inactivating both kinases. On the other hand, overexpression of LMW-PTP in K562 cells led to chemoresistance to vincristine. Our findings describe, for the first time, that LMW-PTP cooperates with MDR phenotype, at least in part, through maintaining Src and Bcr-Abl kinases in more active statuses. These findings suggest that inhibition of LMW-PTP may be a useful strategy for the development of therapies for multidrug resistant CML.	[Ferreira, Paula A.; Ruela-de-Sousa, Roberta R.; Milani, Renato; Ferreira, Carmen V.] Univ Campinas UNICAMP, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil; [Ruela-de-Sousa, Roberta R.; Queiroz, Karla C. S.] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol & Med, NL-1105 AZ Amsterdam, Netherlands; [Queiroz, Karla C. S.; Peppelenbosch, Maikel P.] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Souza, Ana Carolina S.] Univ Fed ABC, Sao Paulo, Brazil; [Pilli, Ronaldo Aloise] Univ Campinas UNICAMP, Inst Chem, Dept Organ Chem, Sao Paulo, Brazil; [den Hertog, Jeroen] Hubrecht Inst, Utrecht, Netherlands	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Universidade Federal do ABC (UFABC); Universidade Estadual de Campinas; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Ferreira, PA (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Biochem, Lab Bioassays & Signal Transduct, Sao Paulo, Brazil.	carmenv@unicamp.br	de Souza Galvão, Ana Carolina Santos/B-8114-2014; Milani, Renato/G-1037-2010; Pilli, Ronaldo/V-3380-2019; Souza, Ana Carolina Santos/B-8122-2014; Santos, Ana Carolina/GWR-2410-2022; Ruela de Sousa, Roberta/C-6825-2012; Peppelenbosch, Maikel P./U-5304-2019; Queiroz, Karla/L-6438-2014	de Souza Galvão, Ana Carolina Santos/0000-0003-1748-3494; Milani, Renato/0000-0002-6902-6589; Ruela de Sousa, Roberta/0000-0002-3762-2247; Pilli, Ronaldo/0000-0002-5919-7763; Peppelenbosch, Maikel/0000-0001-9112-6028	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - http://fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Boehrer S, 2011, CELL CYCLE, V10, P3168, DOI 10.4161/cc.10.18.16599; Chen SY, 2008, ARCH DERMATOL RES, V300, P195, DOI 10.1007/s00403-008-0829-2; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Daley G, 1990, SCIENCE; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Kikawa KD, 2002, J BIOL CHEM, V277, P39274, DOI 10.1074/jbc.M207127200; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Mahon F, 2008, CANC RES; Malentacchi F, 2005, BIOCHEM BIOPH RES CO, V334, P875, DOI 10.1016/j.bbrc.2005.06.176; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Ren MQ, 2011, CANCER RES, V71, P7312, DOI 10.1158/0008-5472.CAN-11-1109; RENZI NL, 1983, J CHROMATOGR, V278, P179, DOI 10.1016/S0378-4347(00)84771-4; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Ruela-de-Sousa RR, 2010, BBA-REV CANCER, V1806, P287, DOI 10.1016/j.bbcan.2010.07.007; Rumjanek VM, 2001, AN ACAD BRAS CIENC, V73, P57, DOI 10.1590/S0001-37652001000100007; Souza ACS, 2009, CELL MOL LIFE SCI, V66, P1140, DOI 10.1007/s00018-008-8501-8; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125	23	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44312	10.1371/journal.pone.0044312	http://dx.doi.org/10.1371/journal.pone.0044312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957062	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800055
J	Spittal, MJ; Pirkis, J; Miller, M; Studdert, DM				Spittal, Matthew J.; Pirkis, Jane; Miller, Matthew; Studdert, David M.			Declines in the Lethality of Suicide Attempts Explain the Decline in Suicide Deaths in Australia	PLOS ONE			English	Article							CHOKING GAME; EPIDEMIOLOGY; RATES	Background: To investigate the epidemiology of a steep decrease in the incidence of suicide deaths in Australia. Methods: National data on suicide deaths and deliberate self-harm for the period 1994-2007 were obtained from the Australian Institute of Health and Welfare. We calculated attempt and death rates for five major methods and the lethality of these methods. Negative binomial regression was used to estimate the size and significance of method-specific time-trends in attempts and lethality. Results: Hanging, motor vehicle exhaust and firearms were the most lethal methods, and together accounted for 72% of all deaths. The lethality of motor vehicle exhaust attempts decreased sharply (RR = 0.94 per year, 95% CI 0.93-0.95) while the motor vehicle exhaust attempt rate changed little; this combination of motor vehicle exhaust trends explained nearly half of the overall decline in suicide deaths. Hanging lethality also decreased sharply (RR = 0.96 per year, 95% CI 0.956-0.965) but large increases in hanging attempts negated the effect on death rates. Firearm lethality changed little while attempts decreased. Conclusion: Declines in the lethality of suicide attempts-especially attempts by motor vehicle exhaust and hanging-explain the remarkable decline in deaths by suicide in Australia since 1997.	[Spittal, Matthew J.; Pirkis, Jane; Studdert, David M.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Miller, Matthew] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Studdert, David M.] Univ Melbourne, Melbourne Law Sch, Melbourne, Vic, Australia	University of Melbourne; Harvard University; Harvard T.H. Chan School of Public Health; University of Melbourne	Spittal, MJ (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia.	m.spittal@unimelb.edu.au	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Spittal, Matthew/0000-0002-2841-1536	National Health and Medical Research Council [1006610]; Federation Fellowship from the Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Federation Fellowship from the Australian Research Council(Australian Research Council)	This work is supported by the National Health and Medical Research Council [grant number 1006610] and Federation Fellowship (to DS) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2011, CAUS DEATH AUSTR 200; Australian Bureau of Statistics, 2011, AUSTR DEM STAT; Australian Institute of Health and Welfare, 2010, STAT TERR GRIM GEN R; Begg S, 2011, BURDEN DIS INJURY AU; Brennan C, 2006, CRISIS, V27, P119, DOI 10.1027/0227-5910.27.3.119; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chen VCH, 2009, SOC PSYCH PSYCH EPID, V44, P1005, DOI 10.1007/s00127-009-0021-9; Elnour AA, 2008, INJURY PREV, V14, P39, DOI 10.1136/ip.2007.016246; Gunnell D, 2005, INT J EPIDEMIOL, V34, P433, DOI 10.1093/ije/dyh398; Gunnell D, 1997, J EPIDEMIOL COMMUN H, V51, P175, DOI 10.1136/jech.51.2.175; Harriss L, 2005, BRIT J PSYCHIAT, V186, P470, DOI [10.1192/bjp.l87.5.470, DOI 10.1192/BJP.187.5.470]; Horesh N, 2012, J AFFECT DISORDERS, V136, P286, DOI 10.1016/j.jad.2011.11.035; Klonsky ED, 2007, J CLIN PSYCHOL, V63, P1045, DOI 10.1002/jclp.20412; Kreisfeld R, 1999, INJURY DEATHS AUSTR; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Kutner M., 2005, APPL LINEAR STAT MOD; Leigh A, 2010, AM LAW ECON REV, V12, P509, DOI 10.1093/aler/ahq013; Macnab AJ, 2009, INJURY PREV, V15, P45, DOI 10.1136/ip.2008.018523; Miller M, 2004, ANN EMERG MED, V43, P723, DOI 10.1016/j.annemergmed.2004.01.018; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Routley VH, 1998, MED J AUSTRALIA, V168, P65, DOI 10.5694/j.1326-5377.1998.tb126713.x; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; StataCorp, 2011, STAT REL 12; Studdert DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000210; Toblin RL, 2008, J SAFETY RES, V39, P445, DOI 10.1016/j.jsr.2008.06.002; World Health Organization, 2008, DIS INJ COUNTR EST; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2012, SUIC PREV SUPRE; Yip PSF, 2012, INJURY PREV, V18, P187, DOI 10.1136/injuryprev-2011-040177	29	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44565	10.1371/journal.pone.0044565	http://dx.doi.org/10.1371/journal.pone.0044565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001MC	22957084	Green Published, gold			2022-12-27	WOS:000308463800077
J	Wagner, BG; Blower, S				Wagner, Bradley G.; Blower, Sally			Universal Access to HIV Treatment versus Universal 'Test and Treat': Transmission, Drug Resistance & Treatment Costs	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; MALE CIRCUMCISION; SAN-FRANCISCO; PREVENTION; STRATEGY; EPIDEMICS; GROWTH; UGANDA; CURB	In South Africa (SA) universal access to treatment for HIV-infected individuals in need has yet to be achieved. Currently similar to 1 million receive treatment, but an additional 1.6 million are in need. It is being debated whether to use a universal 'test and treat' (T&T) strategy to try to eliminate HIV in SA; treatment reduces infectivity and hence transmission. Under a T&T strategy all HIV-infected individuals would receive treatment whether in need or not. This would require treating 5 million individuals almost immediately and providing treatment for several decades. We use a validated mathematical model to predict impact and costs of: (i) a universal T&T strategy and (ii) achieving universal access to treatment. Using modeling the WHO has predicted a universal T&T strategy in SA would eliminate HIV within a decade, and (after 40 years) cost similar to$10 billion less than achieving universal access. In contrast, we predict a universal T&T strategy in SA could eliminate HIV, but take 40 years and cost similar to$12 billion more than achieving universal access. We determine the difference in predictions is because the WHO has under-estimated survival time on treatment and ignored the risk of resistance. We predict, after 20 years, similar to 2 million individuals would need second-line regimens if a universal T&T strategy is implemented versus similar to 1.5 million if universal access is achieved. Costs need to be realistically estimated and multiple evaluation criteria used to compare 'treatment as prevention' with other prevention strategies. Before implementing a universal T&T strategy, which may not be sustainable, we recommend striving to achieve universal access to treatment as quickly as possible. We predict achieving universal access to treatment would be a very effective 'treatment as prevention' approach and bring the HIV epidemic in SA close to elimination, preventing similar to 4 million infections after 20 years and similar to 11 million after 40 years.	[Wagner, Bradley G.; Blower, Sally] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wagner, BG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	sblower@mednet.ucla.edu			National Institutes of Health [RO1 AI041935, R21 AI086701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935, R21AI086701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants RO1 AI041935 and R21 AI086701 website: www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Dodd PJ, 2009, EXAMINING PROMISE HI, P1; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Statistics South Africa, 2010, MID POP EST 2010; Thigpen MC, 2012, N ENGL J MED; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Wagner B, 2010, LANCET, V376, P953, DOI 10.1016/S0140-6736(10)61442-0; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782	23	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41212	10.1371/journal.pone.0041212	http://dx.doi.org/10.1371/journal.pone.0041212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957012	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800004
J	Yeh, SP; Liao, YM; Lo, WJ; Lin, CL; Bai, LY; Lin, CY; Hsieh, CY; Chang, YC; Huang, YT; Chiu, CF				Yeh, Su-Peng; Liao, Yu-Min; Lo, Wen-Jyi; Lin, Chiao-Lin; Bai, Li-Yuan; Lin, Chen-Yuan; Hsieh, Ching-Yun; Chang, Yu-Chien; Huang, Yu-Ting; Chiu, Chang-Fang			Kinetics of T Helper Subsets and Associated Cytokines Correlate Well with the Clinical Activity of Graft-Versus-Host Disease	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; INTERFERON-GAMMA; B-CELLS; PLASMA CYTOKINES; SERUM-LEVELS; IFN-GAMMA; TH2 CELLS; IL-10; INTERLEUKIN-10	Background: CD4(+) interferon (IFN)-gamma(+) T cell (Th1) and CD4(+) interleukin (IL)-4(+) T cell (Th2) polarizations are crucial in the pathogenesis of graft-versus-host disease (GVHD). However, this hypothesis is largely based on animal experiments of Parent-into-F1 GVHD model. The causal relationship between kinetics of Th1, Th2 and associated cytokines and the clinical activity of GVHD in a real world situation remains unknown. Methodology: Peripheral blood was collected every week prospectively from Day 0 to Day 210 (patients without GVHD) or Day 300 (patients with chronic GVHD) after allogeneic peripheral blood stem cell transplantation in consecutive 27 patients. The frequencies of Th1 and Th2 within CD4(+) T cells were determined by flow cytometry and pplasma IFN-gamma, IL-12, IL-4, and IL-10 were determined by ELISA. Principal Findings: Kinetics of Th1, Th2 frequency, and the plasma IL-10 and IFN-gamma more commonly coincided with, rather than predicted, the activity of GVHD. These markers are significantly higher when acute or chronic GVHD developed. The kinetics of IL-10 is especially correlated well with the activity of GVHD during clinical course of immunosuppressive treatment. For patients with hepatic GVHD, there is a positive correlation between plasma IL-10 levels and the severity of hepatic injury. The frequency of Th2 is also significant higher in acute GVHD and tends to be higher in chronic GVHD. Interestingly, there is a very good positive correlation between the frequency of Th1 and Th2 (r = 0.951, p< 0.001). The plasma level of IL-4 and IL-12 are not associated with the activity of GVHD. Conclusions: The frequency of Th1, Th2 within CD4(+) T cells and plasma IL-10 and IFN-gamma are good biomarkers of GVHD. Plasma IL-10 can also be used to monitor the therapeutic responsiveness. Furthermore, both Th1 and Th2 likely contribute to the pathogenesis of GVHD.	[Yeh, Su-Peng; Lo, Wen-Jyi; Lin, Chiao-Lin; Chang, Yu-Chien; Huang, Yu-Ting] China Med Univ Hosp, Dept Med Res, Stem Cell Res Lab, Taichung, Taiwan; [Yeh, Su-Peng; Liao, Yu-Min; Bai, Li-Yuan; Lin, Chen-Yuan; Hsieh, Ching-Yun; Chiu, Chang-Fang] China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan; [Yeh, Su-Peng; Bai, Li-Yuan; Chiu, Chang-Fang] China Med Univ, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Yeh, SP (corresponding author), China Med Univ Hosp, Dept Med Res, Stem Cell Res Lab, Taichung, Taiwan.	supengyeh@gmail.com			Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence [DOH-100-TD-C-111-005]; China Medical University Hospital [DMR 93-016]	Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence; China Medical University Hospital	This work was supported in part by the research grant from Taiwan Department of Health, China Medical University Hospital Cancer Research of Excellence (DOH-100-TD-C-111-005) and research grant from China Medical University Hospital (DMR 93-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abdallah AN, 1997, HEMATOL CELL THER, V39, P27, DOI 10.1007/s00282-997-0027-2; ALLEN RD, 1993, EUR J IMMUNOL, V23, P333, DOI 10.1002/eji.1830230205; ANTIN JH, 1992, BLOOD, V80, P2964; Bucher C, 2009, BLOOD, V114, P5375, DOI 10.1182/blood-2009-05-221135; Chik KW, 2003, J PEDIAT HEMATOL ONC, V25, P960, DOI 10.1097/00043426-200312000-00011; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; DEWIT D, 1993, J IMMUNOL, V150, P361; FOWLER DH, 1994, J IMMUNOL, V152, P1004; FOWLER DH, 1994, BLOOD, V84, P3540; Frohlich A, 2007, BLOOD, V109, P2023, DOI 10.1182/blood-2006-05-021600; Fujii N, 2006, INT J MOL MED, V17, P881; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hanash AM, 2011, BLOOD, V118, P446, DOI 10.1182/blood-2010-07-294785; Holler E, 2000, BONE MARROW TRANSPL, V25, P237, DOI 10.1038/sj.bmt.1702126; IMAMURA M, 1994, BONE MARROW TRANSPL, V13, P745; Kayaba H, 2000, J ALLERGY CLIN IMMUN, V106, pS40, DOI 10.1067/mai.2000.106060; KERNAN NA, 1986, BLOOD, V68, P770; Korngold B, 1978, J EXP MED, V148, P1687; Krenger W, 1996, TRANSPLANTATION, V62, P1278, DOI 10.1097/00007890-199611150-00018; MACNEIL IA, 1990, J IMMUNOL, V145, P4167; Min CK, 2001, BONE MARROW TRANSPL, V28, P935, DOI 10.1038/sj.bmt.1703258; Miura Y, 2002, BLOOD, V100, P2650, DOI 10.1182/blood-2002-01-0176; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morel PA, 1998, CRIT REV IMMUNOL, V18, P275, DOI 10.1615/CritRevImmunol.v18.i4.10; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakamura H, 2000, J ALLERGY CLIN IMMUN, V106, pS45, DOI 10.1067/mai.2000.106774; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Remberger M, 2003, EUR J HAEMATOL, V70, P384, DOI 10.1034/j.1600-0609.2003.00078.x; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Sakata N, 2001, BONE MARROW TRANSPL, V27, P1153, DOI 10.1038/sj.bmt.1703060; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Tanaka J, 1997, BONE MARROW TRANSPL, V19, P571, DOI 10.1038/sj.bmt.1700708; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Visentainer JEL, 2003, EXP HEMATOL, V31, P1044, DOI 10.1016/j.exphem.2003.08.005; Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203; Yeh S-P, 2006, HAEMATOLOGICA S1, V91, pa0309	43	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44416	10.1371/journal.pone.0044416	http://dx.doi.org/10.1371/journal.pone.0044416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957070	Green Submitted, gold, Green Published			2022-12-27	WOS:000308463800063
J	Devauges, V; Marquer, C; Lecart, S; Cossec, JC; Potier, MC; Fort, E; Suhling, K; Leveque-Fort, S				Devauges, Viviane; Marquer, Catherine; Lecart, Sandrine; Cossec, Jack-Christophe; Potier, Marie-Claude; Fort, Emmanuel; Suhling, Klaus; Leveque-Fort, Sandrine			Homodimerization of Amyloid Precursor Protein at the Plasma Membrane: A homoFRET Study by Time-Resolved Fluorescence Anisotropy Imaging	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LIVING CELLS; FRET MICROSCOPY; GXXXG MOTIFS; LIVE CELLS; A-BETA; APP; POLARIZATION; SPECTROSCOPY; DIMERIZATION	Classical FRET (Forster Resonance Energy Transfer) using two fluorescent labels (one for the donor and another one for the acceptor) is not efficient for studying the homodimerization of a protein as only half of the homodimers formed can be identified by this technique. We thus resorted to homoFRET detected by time-resolved Fluorescence Anisotropy IMaging (tr-FAIM). To specifically image the plasma membrane of living cells, an original combination of tr-FAIM and Total Internal Reflection Fluorescence Lifetime Imaging Microscope (TIRFLIM) was implemented. The correcting factor accounting for the depolarization due to the high numerical aperture (NA) objective, mandatory for TIRF microscopy, was quantified on fluorescein solutions and on HEK293 cells expressing enhanced Green Fluorescence Protein (eGFP). Homodimerization of Amyloid Precursor Protein (APP), a key mechanism in the etiology of Alzheimer's disease, was measured on this original setup. We showed, both in epifluorescence and under TIRF excitation, different energy transfer rates associated with the homodimerization of wild type APP-eGFP or of a mutated APP-eGFP, which forms constitutive dimers. This original set-up thus offers promising prospects for future studies of protein homodimerization in living cells in control and pathological conditions.	[Devauges, Viviane; Leveque-Fort, Sandrine] Univ Paris 11, Inst Sci Mol Orsay, CNRS UMR 8214, Orsay, France; [Devauges, Viviane] Univ Paris 11, Lab Charles Fabry, CNRS UMR 8501, Inst Opt, Palaiseau, France; [Devauges, Viviane; Lecart, Sandrine; Leveque-Fort, Sandrine] Univ Paris 11, Ctr Photon Biomed, CLUPS LUMAT FR2764, Orsay, France; [Marquer, Catherine; Cossec, Jack-Christophe; Potier, Marie-Claude] CNRS UMR 7225, CRICM UPMC, INSERM UMR S975, Paris, France; [Fort, Emmanuel] Univ Paris Diderot, Inst Langevin, ESPCI ParisTech, UMR 7587, Paris, France; [Suhling, Klaus] Kings Coll London, Dept Phys, London WC2R 2LS, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; University of London; King's College London	Devauges, V (corresponding author), Univ Paris 11, Inst Sci Mol Orsay, CNRS UMR 8214, Orsay, France.	sandrine.leveque-fort@u-psud.fr	Fort, Emmanuel/C-4981-2012	Cossec, Jack-Christophe/0000-0002-0836-1009; Leveque-Fort, Sandrine/0000-0002-9218-3363; suhling, klaus/0000-0001-8797-5430; Potier, Marie-Claude/0000-0003-2462-7150	Ministere de la Recherche; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche; Fondation Institut du Cerveau et de la Moelle; BBSRC [BB/D011086/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011086/1] Funding Source: researchfish	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Institut du Cerveau et de la Moelle; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Viviane Devauges was the recipient of a fellowship from the Ministere de la Recherche. Jack-Christophe Cossec had a fellowship from Ministere de la Recherche and Fondation pour la Recherche Medicale. This work was supported by a grant from Agence Nationale de la Recherche. The authors are also grateful to the Fondation Institut du Cerveau et de la Moelle for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Asada-Utsugi M, 2011, J NEUROCHEM, V119, P354, DOI 10.1111/j.1471-4159.2011.07364.x; AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Blandin P, 2009, APPL OPTICS, V48, P553, DOI 10.1364/AO.48.000553; Chan FTS, 2011, CHEMPHYSCHEM, V12, P500, DOI 10.1002/cphc.201000833; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; Fisz JJ, 2007, J PHYS CHEM A, V111, P8606, DOI 10.1021/jp072113b; Fisz JJ, 2009, J PHYS CHEM A, V113, P3505, DOI 10.1021/jp811117a; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Godfrey TM, 1953, GLYCEROL; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; KOSHIOKA M, 1995, APPL SPECTROSC, V49, P224, DOI 10.1366/0003702953963652; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Marquer C, 2011, FASEB J, P1; Marquer C, 2010, BIOL CELL, V102, P409, DOI 10.1042/BC20090171; Matthews DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033231; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Smith TA, 2005, REV FLUORESCENCE, V2, P245; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Suhling K, 2004, OPT LETT, V29, P584, DOI 10.1364/OL.29.000584; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tramier M, 2000, BIOPHYS J, V78, P2614, DOI 10.1016/S0006-3495(00)76806-8; Valeur B, 2002, MOL FLUORESCENCE; Visser NV, 1999, J FLUORESC, V9, P251, DOI 10.1023/A:1022515902867; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yan YL, 2003, METHOD ENZYMOL, V360, P561; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; Yum K, 2009, NANO LETT, V9, P2193, DOI 10.1021/nl901047u	45	25	25	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44434	10.1371/journal.pone.0044434	http://dx.doi.org/10.1371/journal.pone.0044434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973448	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600052
J	Mikic, A				Mikic, Aleksandar			Origin of the Words Denoting Some of the Most Ancient Old World Pulse Crops and Their Diversity in Modern European Languages	PLOS ONE			English	Article							NEOLITHIC PERIOD; PLANT REMAINS; AGRICULTURE; CULTIVATION; CONTINUITY; HISTORY	This preliminary research was aimed at finding the roots in various Eurasian proto-languages directly related to pulses and giving the words denoting the same in modern European languages. Six Proto-Indo-European roots were indentified, namely arnk(')- ('a leguminous plant'), *bhabh- ('field bean'), *ereg(w)[h]- ('a kernel of leguminous plant', 'pea'), ghArs- ('a leguminous plant'), *kek- ('pea') and *lent- ('lentil'). No Proto-Uralic root was attested save hypothetically *kaca ('pea'), while there were two Proto-Altaic roots, *bokrV ('pea') and *ziabsa ('lentil'). The Proto-Caucasianx root *qira denoted pea, while another one, *howl(a) ('bean', 'lentil') and the Proto-Basque root *ilha-r ('pea', 'bean', 'vetch') could have a common Proto-Sino-Caucasian ancestor, *hVwlV ('bean') within the hypothetic Dene-Caucasian language superfamily. The Modern Maltese preserved the memory of two Proto-Semitic roots, *'adas- ('lentil') and *pul- ('field bean'). The presented results prove that the most ancient Eurasian pulse crops were well-known and extensively cultivated by the ancestors of all modern European nations. The attested lexicological continuum witnesses the existence of a millennia-long links between the peoples of Eurasia to their mutual benefit. This research is meant to encourage interdisciplinary concerted actions between plant scientists dealing with crop evolution and biodiversity, archaeobotanists and language historians.	Inst Field & Vegetable Crops, Novi Sad, Serbia		Mikic, A (corresponding author), Inst Field & Vegetable Crops, Novi Sad, Serbia.	aleksandar.mikich@gmail.com	Mikich, Aleksandar/AAG-7286-2019	Mikich, Aleksandar/0000-0002-9105-2855	SEE-ERA.NET Plus programme of the European Union [ERA 168/01]; Ministry of Education and Science of the Republic of Serbia [TR-31024]	SEE-ERA.NET Plus programme of the European Union; Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This research is a contribution to the projects Evolution of Human Languages at the Santa Fe Institute, ERA 168/01 SEELEGUMES within FP7-supported SEE-ERA.NET Plus programme of the European Union and TR-31024 of the Ministry of Education and Science of the Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Aura JE, 2005, VEG HIST ARCHAEOBOT, V14, P542, DOI 10.1007/s00334-005-0002-1; Bakels C, 2002, VEG HIST ARCHAEOBOT, V11, P3, DOI 10.1007/s003340200000; Bakels C, 1999, VEG HIST ARCHAEOBOT, V8, P71, DOI 10.1007/BF02042844; Bengtson J, 2007, BASQUE ETYMOLOGY TOW; Cavalli-Sforza LL, 1986, AFRICAN PYGMIES; Cupina B., 2004, ACTA AGR SERB, V17, P451; Farrand W.R., 1999, DEPOSITIONAL HIST FR; Georg S, 1999, J LINGUIST, V35, P65, DOI 10.1017/S0022226798007312; Gimbutas M., 1997, J INDO EUROPEAN STUD, DOI DOI 10.1073/pnas.1813608115; Gombocz Z, 1912, MEMOIRES SOC FINNOOU; Hovsepyan R, 2008, VEG HIST ARCHAEOBOT, V17, pS63, DOI 10.1007/s00334-008-0158-6; Huurre M, 2003, SUOMEN MAATALOUDEN H, P38; Janhunen J., 2009, QUASQUICENTENNIAL FI, P57; Jovanovic Z., 2011, Ratarstvo i Povrtarstvo, V48, P227; Karg S, 2002, VEG HIST ARCHAEOBOT, V11, P169, DOI 10.1007/s003340200018; Kohler-Schneider M, 2009, VEG HIST ARCHAEOBOT, V18, P61, DOI 10.1007/s00334-007-0129-3; Krell K, 1998, ARCHAEOLOGY LANGUAGE, VII; Ljustina M., 2010, Ratarstvo i Povrtarstvo, V47, P457; Lockwood W B, 1977, INDO EUROPEAN PHILOL; Lytkin V. I., 1970, KRATKII ETIMOLOGICHE; Macbain A., 1911, ETYMOLOGICAL DICT GA; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; Marinova E, 2008, VEG HIST ARCHAEOBOT, V17, pS73, DOI 10.1007/s00334-008-0159-5; Medovic A., 2011, Ratarstvo i Povrtarstvo, V48, P219; Medovic A, 2010, 5 INT FOOD LEG RES C, P161; Mihailovic V, 2010, RATAR POVRT FIELD VE, P4743; Mikic A., 2008, Modern variety breeding for present and future needs. Proceedings of the 18th EUCARPIA general congress, Valencia, Spain, 9-12 September, 2008, P193; Mikic A., 2009, Pisum Genetics, V41, P29; Mikic A., 2011, Ratarstvo i Povrtarstvo, V48, P233; Mikic A., 2010, J LENTIL RES, V4, P15; Mikic A., 2009, GRAIN LEGUM, V51, P34; Mikic A, 2011, INDOGER FORSCH, V116, P60; Mikic Aleksandar, 2007, 6 EUR C GRAIN LEG LI, P122; Mikic-Vragolic M., 2007, RATARSTVO POVRTARSTV, V44, P91; Militarev A, 2006, SEMITIC ETYMOLOGY TO; Miller NF, 1999, VEG HIST ARCHAEOBOT, V8, P13, DOI 10.1007/BF02042837; Nikolaev S. L., 1994, N CAUCASIAN ETYMOLOG; Nikolayev SL, 2007, INDO EUROPEAN ETYMOL; Pokorny Julius, 1959, INDOGERMANISCHES ETY; Price G, 1998, ENCY LANGUAGES EUROP; Rosch M, 1998, VEG HIST ARCHAEOBOT, V7, P109, DOI 10.1007/BF01373928; Rottoli M, 2009, VEG HIST ARCHAEOBOT, V18, P91, DOI 10.1007/s00334-007-0139-1; Ruhlen M, 1998, DENE CAUCASIAN NEW L; Sillasoo U, 2009, VEG HIST ARCHAEOBOT, V18, P315, DOI 10.1007/s00334-008-0210-6; Starostin S, 2007, SINO CAUCASIAN ETYMO; Starostin S., 2003, ETYMOLOGICAL DICT AL; Starostin S, 2005, URALIC ETYMOLOGY TOW; Stika HP, 2008, VEG HIST ARCHAEOBOT, V17, pS139, DOI 10.1007/s00334-008-0171-9; Stoddard FL, 2009, AGR FOOD SCI, V18, P191, DOI 10.2137/145960609790059578; Tanno K, 2006, VEG HIST ARCHAEOBOT, V15, P197, DOI 10.1007/s00334-005-0027-5; Tolar T, 2010, VEG HIST ARCHAEOBOT, V19, P53, DOI 10.1007/s00334-009-0221-y; VANZEIST W, 1995, VEG HIST ARCHAEOBOT, V4, P179, DOI 10.1007/BF00203936; Vasmer Max, 1953, RUSSISCHES ETYMOLOGI, VI; Vorren KD, 2005, VEG HIST ARCHAEOBOT, V14, P161, DOI 10.1007/s00334-005-0016-8; Welmoed A, 2008, VEGET HIST ARCHAE S1, V17, pS131; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Zeven A.C, 1975, DICT CULTIVATED PLAN; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44512	10.1371/journal.pone.0044512	http://dx.doi.org/10.1371/journal.pone.0044512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	002ZJ	22973458	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600065
J	Peer, N; Steyn, K; Lombard, C; Lambert, EV; Vythilingum, B; Levitt, NS				Peer, Nasheeta; Steyn, Krisela; Lombard, Carl; Lambert, Estelle V.; Vythilingum, Bavanisha; Levitt, Naomi S.			Rising Diabetes Prevalence among Urban-Dwelling Black South Africans	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; COHERENCE; SENSE; MANAGEMENT; OBESITY; BURDEN	Objective: To examine the prevalence of and the association of psychosocial risk factors with diabetes in 25-74-year-old black Africans in Cape Town in 2008/09 and to compare the prevalence with a 1990 study. Research Design and Methods: A randomly selected cross-sectional sample had oral glucose tolerance tests. The prevalence of diabetes (1998 WHO criteria), other cardiovascular risk factors and psychosocial measures, including sense of coherence (SOC), locus of control and adverse life events, were determined. The comparison of diabetes prevalence between this and a 1990 study used the 1985 WHO diabetes criteria. Results: There were 1099 participants, 392 men and 707 women (response rate 86%). The age-standardised (SEGI) prevalence of diabetes was 13.1% (95% confidence interval (CI) 11.0-15.1), impaired glucose tolerance (IGT) 11.2% (9.2-13.1) and impaired fasting glycaemia 1.2% (0.6-1.9). Diabetes prevalence peaked in 65-74-year-olds (38.6%). Among diabetic participants, 57.9% were known and 38.6% treated. Using 1985 WHO criteria, age-standardised diabetes prevalence was higher by 53% in 2008/09 (12.2% (10.2-14.2)) compared to 1990 (8.0% (5.8-10.3)) and IGT by 67% (2008/09: 11.7% (9.8-13.7); 1990: 7.0% (4.9-9.1)). In women, older age (OR: 1.05, 95% CI: 1.03-1.08, p<0.001), diabetes family history (OR: 3.13, 95% CI: 1.92-5.12, p<0.001), higher BMI (OR: 1.44, 95% CI: 1.20-1.82, p = 0.001), better quality housing (OR: 2.08, 95% CI: 1.01-3.04, p = 0.047) and a lower SOC score (<= 40) was positively associated with diabetes (OR: 2.57, 95% CI: 1.37-4.80, p = 0.003). Diabetes was not associated with the other psychosocial measures in women or with any psychosocial measure in men. Only older age (OR: 1.05, 95% CI: 1.02-1.08, p = 0.002) and higher BMI (OR: 1.10, 95% CI: 1.04-1.18, p = 0.003) were significantly associated with diabetes in men. Conclusions: The current high prevalence of diabetes in urban-dwelling South Africans, and the likelihood of further rises given the high rates of IGT and obesity, is concerning. Multi-facetted diabetes prevention strategies are essential to address this burden.	[Peer, Nasheeta] MRC, Chron Dis Lifestyle Unit, Durban, South Africa; [Steyn, Krisela; Levitt, Naomi S.] Univ Cape Town, Dept Med, Chron Dis Initiat Africa, ZA-7925 Cape Town, South Africa; [Lombard, Carl] MRC, Biostat Unit, Durban, South Africa; [Lambert, Estelle V.] Univ Cape Town, MRC, Unit Exercise Sci & Sports Med, ZA-7925 Cape Town, South Africa; [Vythilingum, Bavanisha] Univ Cape Town, Dept Psychiat, ZA-7925 Cape Town, South Africa; [Levitt, Naomi S.] Univ Cape Town, Dept Med, Div Endocrinol & Diabet, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Peer, N (corresponding author), MRC, Chron Dis Lifestyle Unit, Durban, South Africa.	naomi.levitt@uct.ac.za	Lambert, Estelle/ABF-1268-2020	Lambert, Estelle/0000-0003-4315-9153; Levitt, Naomi/0000-0001-6480-8066; Peer, Nasheeta/0000-0003-2131-8344; Lombard, Carl/0000-0002-2136-6533	Servier Laboratories (South Africa); Medical Research Council of South Africa; Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham Hospital/Harvard University	Servier Laboratories (South Africa); Medical Research Council of South Africa(South African Medical Research Council); Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council; Brigham Hospital/Harvard University	This study was funded by an unrestricted grant from Servier Laboratories (South Africa), the Medical Research Council of South Africa, the Initiative for Cardiovascular Health Research in Developing Countries (IC Health) Foundation Council and Brigham Hospital/Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 1982, IARC PUBL, P671; Berger GMB, 2000, S AFR MED J, V90, P164; Bonita R, 2002, SURVEILLANCE RISK FA; Botha KF, 2002, J HEALTH PSYCHOL, V7, P519, DOI 10.1177/1359105302007005672; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Christensen DL, 2009, DIABETES RES CLIN PR, V84, P303, DOI 10.1016/j.diabres.2009.03.007; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1997, DIABETES CARE, V20, P1183; Joint WHO-FAO Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases, 2003, DIET NUTR PREV CHRON; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kouvonen AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-46; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; LEVITT NS, 1993, DIABETES CARE, V16, P601, DOI 10.2337/diacare.16.4.601; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197; Motala AA, 2008, DIABETES CARE, V31, P1783, DOI 10.2337/dc08-0212; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; South African Medical Association and Lipid and Atherosclerosis Society of Southern Africa Working Group, 2000, S AFR MED J, V90, P176; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 1985, DIAB MELL REP WHO ST; World Health Organization (WHO) Department of Non-communicable Diseases, 2002, GLOB PHYS ACT QUEST	29	134	135	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43336	10.1371/journal.pone.0043336	http://dx.doi.org/10.1371/journal.pone.0043336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962583	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600010
J	Rah, B; Amin, H; Yousuf, K; Khan, S; Jamwal, G; Mukherjee, D; Goswami, A				Rah, Bilal; Amin, Hina; Yousuf, Khalid; Khan, Sheema; Jamwal, Gayatri; Mukherjee, Debaraj; Goswami, Anindya			A Novel MMP-2 Inhibitor 3-azidowithaferin A (3-azidoWA) Abrogates Cancer Cell Invasion and Angiogenesis by Modulating Extracellular Par-4	PLOS ONE			English	Article							COMPOUND WITHAFERIN-A; TUMOR-CELL; MATRIX METALLOPROTEINASES; GELATINASE-A; APOPTOSIS; EXPRESSION; ACTIVATION; WITHANOLIDES; TRAFFICKING; METASTASIS	Background: Withaferin A, which is a naturally derived steroidal lactone, has been found to prevent angiogenesis and metastasis in diverse tumor models. It has also been recognized by different groups for prominent anti-carcinogenic roles. However, in spite of these studies on withanolides, their detailed anti-metastatic mechanism of action remained unknown. The current study has poised to address the machinery involved in invasion regulation by stable derivative of Withaferin A, 3-azido Withaferin A (3-azidoWA) in human cervical HeLa and prostate PC-3 cells. Methods and Principal Findings: Sub-toxic concentration of 3-azidowithaferin A (3-azido WA) inhibited cancer cell motility and invasion in wound healing and Boyden chamber invasion by suppressing MMP-2 activity in gelatin zymography and its expression has proved to be a major obstacle in chemo-sensitivity. We have uncovered a novel mechanism of 3-azidoWA induced extracellular pro-apoptotic candidate tumor suppressor Par-4 protein stimulation in conditioned media and also noticed a concomitant marked reduction in pAkt and pERK signaling by immunoblot analysis. Furthermore, our zymography results suggest 3-azidoWA induced MMP-2 inhibition was mediated through secretory Par-4. The inhibition of apoptosis by 3-azidoWA could not restore MMP-2 gelatinase activity. In addition to this, our in vivo animal experiments data showed 3-azidoWA abrogated neovascularisation in dose dependent manner in mouse Matrigel plug assay. Conclusion/Significance: For this report, we found that 3-azidoWA suppressed motility and invasion of HeLa and PC-3 cells in MMP-2 dependent manner. Our in vitro result strongly suggests that sub-toxic doses of 3-azidoWA enhanced the secretion of extracellular Par-4 that abolished secretory MMP-2 expression and activity. Depletion of secretory Par-4 restored MMP-2 expression and invasion capability of HeLa and PC-3 cells. Further, our findings implied that 3-azidoWA attenuated internal phospho-ERK and phospho-Akt expression in a dose dependent manner might play a key role in inhibition of mouse angiogenesis by 3-azidoWA.	[Rah, Bilal; Amin, Hina; Khan, Sheema; Jamwal, Gayatri; Goswami, Anindya] Indian Inst Integrat Med CSIR, Canc Pharmacol Div, Mol Signal Transduct Lab, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Rah, B (corresponding author), Indian Inst Integrat Med CSIR, Canc Pharmacol Div, Mol Signal Transduct Lab, Jammu, India.	agoswami@iiim.ac.in						ANBALAGAN K, 1984, BIOCHEM MED METAB B, V31, P236, DOI 10.1016/0006-2944(84)90028-0; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Banerji A, 2004, CANCER LETT, V211, P235, DOI 10.1016/j.canlet.2004.02.007; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Boehrer S, 2006, LEUKEMIA RES, V30, P597, DOI 10.1016/j.leukres.2005.09.003; Brand K, 2000, CANCER RES, V60, P5723; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chakraborty M, 2001, CANCER RES, V61, P7255; Chen Pin-Shern, 2011, PLoS One, V6, pe20164, DOI 10.1371/journal.pone.0020164; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Chetty C, 2006, MOL CANCER THER, V5, P2289, DOI 10.1158/1535-7163.MCT-06-0169; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Goswami A, 2005, MOL CELL, V20, P33, DOI 10.1016/j.molcel.2005.08.016; Hanemaaijer R, 2000, INT J CANCER, V86, P204, DOI 10.1002/(SICI)1097-0215(20000415)86:2<204::AID-IJC9>3.0.CO;2-6; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim MM, 2006, FEBS LETT, V580, P2661, DOI 10.1016/j.febslet.2006.04.015; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kour K, 2009, INT IMMUNOPHARMACOL, V9, P1137, DOI 10.1016/j.intimp.2009.05.011; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mitsiades N, 2001, EXPERT OPIN INV DRUG, V10, P1075, DOI 10.1517/13543784.10.6.1075; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Prakash J, 2002, NUTR CANCER, V42, P91, DOI 10.1207/S15327914NC421_12; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; SHOHAT B., 1967, CANCER CHEMOTHER REP, V51, P271; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stearns M, 1996, ONCOL RES, V8, P69; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; SUDHIR S, 1986, PLANTA MED, P61, DOI 10.1055/s-2007-969072; WEISSENBERG M, 1977, J CHEM SOC PERK T 1, P795, DOI 10.1039/p19770000795; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yousuf SK, 2011, STEROIDS, V76, P1213, DOI 10.1016/j.steroids.2011.05.012; Zhen MC, 2006, ACTA PHARMACOL SIN, V27, P1600, DOI 10.1111/j.1745-7254.2006.00439.x; Zucker S, 2009, CANCER BIOL THER, V8, P2371, DOI 10.4161/cbt.8.24.10353	51	76	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44039	10.1371/journal.pone.0044039	http://dx.doi.org/10.1371/journal.pone.0044039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962598	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600026
J	Stavropoulos, I; Khaldi, N; Davey, NE; O'Brien, K; Martin, F; Shields, DC				Stavropoulos, Ilias; Khaldi, Nora; Davey, Norman E.; O'Brien, Kevin; Martin, Finian; Shields, Denis C.			Protein Disorder and Short Conserved Motifs in Disordered Regions Are Enriched near the Cytoplasmic Side of Single-Pass Transmembrane Proteins	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CASEIN KINASE-II; EUKARYOTIC LINEAR MOTIFS; SYNAPTOTAGMIN GENES; ENERGY CONTENT; DOMAIN; PHOSPHORYLATION; DISCOVERY; RECEPTOR; INTERNALIZATION	Intracellular juxtamembrane regions of transmembrane proteins play pivotal roles in cell signalling, mediated by protein-protein interactions. Disordered protein regions, and short conserved motifs within them, are emerging as key determinants of many such interactions. Here, we investigated whether disorder and conserved motifs are enriched in the juxtamembrane area of human single-pass transmembrane proteins. Conserved motifs were defined as short disordered regions that were much more conserved than the adjacent disordered residues. Human single-pass proteins had higher mean disorder in their cytoplasmic segments than their extracellular parts. Some, but not all, of this effect reflected the shorter length of the cytoplasmic tail. A peak of cytoplasmic disorder was seen at around 30 residues from the membrane. We noted a significant increase in the incidence of conserved motifs within the disordered regions at the same location, even after correcting for the extent of disorder. We conclude that elevated disorder within the cytoplasmic tail of many transmembrane proteins is likely to be associated with enrichment for signalling interactions mediated by conserved short motifs.	[Stavropoulos, Ilias; Khaldi, Nora; O'Brien, Kevin; Shields, Denis C.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Stavropoulos, Ilias; Khaldi, Nora; O'Brien, Kevin; Shields, Denis C.] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Stavropoulos, Ilias; Khaldi, Nora; O'Brien, Kevin; Martin, Finian; Shields, Denis C.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Martin, Finian] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Davey, Norman E.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Khaldi, Nora] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University College Dublin; University College Dublin; University College Dublin; University College Dublin; European Molecular Biology Laboratory (EMBL); University of California System; University of California Davis	Stavropoulos, I (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	denis.shields@ucd.ie	Davey, Norman E/D-5362-2013	Davey, Norman/0000-0001-6988-4850; Shields, Denis/0000-0003-4015-2474	Irish Research Council for Science, Engineering and Technology (IRCSET) Graduate Education Research Programme; Science Foundation Ireland [PI 08/IN.1/B1864]	Irish Research Council for Science, Engineering and Technology (IRCSET) Graduate Education Research Programme(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by the Irish Research Council for Science, Engineering and Technology (IRCSET) Graduate Education Research Programme (http://bioinformatics.ucd.ie/PhD), and by Science Foundation Ireland (PI 08/IN.1/B1864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002341; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Craxton M, 2001, GENOMICS, V77, P43, DOI 10.1006/geno.2001.6619; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Davey N. E., 2011, MOL BIOSYST; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; Fukuda M, 2003, J BIOCHEM, V133, P641, DOI 10.1093/jb/mvg082; Fukuda M, 2000, J BIOCHEM, V128, P637, DOI 10.1093/oxfordjournals.jbchem.a022796; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Hanyaloglu AC, 2001, J BIOL CHEM, V276, P18066, DOI 10.1074/jbc.M009275200; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; Michael S, 2008, BIOINFORMATICS, V24, P453, DOI 10.1093/bioinformatics/btm624; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Richards JP, 1996, J BIOL CHEM, V271, P13716, DOI 10.1074/jbc.271.23.13716; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Van Roey K, 2012, CURR OPIN STRUC BIOL, V22, P378, DOI 10.1016/j.sbi.2012.03.004	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44389	10.1371/journal.pone.0044389	http://dx.doi.org/10.1371/journal.pone.0044389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962613	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600045
J	Pierre, MD; Bravi, CM; Motti, JMB; Fuku, N; Tanaka, M; Llop, E; Bonatto, SL; Moraga, M				de Saint Pierre, Michelle; Bravi, Claudio M.; Motti, Josefina M. B.; Fuku, Noriyuki; Tanaka, Masashi; Llop, Elena; Bonatto, Sandro L.; Moraga, Mauricio			An Alternative Model for the Early Peopling of Southern South America Revealed by Analyses of Three Mitochondrial DNA Haplogroups	PLOS ONE			English	Article							MTDNA VARIATION; CONTROL REGION; AMERINDIAN POPULATIONS; GENETIC CONTINUITY; EXTINCT ABORIGINES; SEQUENCE VARIATION; MONTE-VERDE; DIVERSITY; GENOME; EVOLUTIONARY	After several years of research, there is now a consensus that America was populated from Asia through Beringia, probably at the end of the Pleistocene. But many details such as the timing, route(s), and origin of the first settlers remain uncertain. In the last decade genetic evidence has taken on a major role in elucidating the peopling of the Americas. To study the early peopling of South America, we sequenced the control region of mitochondrial DNA from 300 individuals belonging to indigenous populations of Chile and Argentina, and also obtained seven complete mitochondrial DNA sequences. We identified two novel mtDNA monophyletic clades, preliminarily designated B2l and C1b13, which together with the recently described D1g sub-haplogroup have locally high frequencies and are basically restricted to populations from the extreme south of South America. The estimated ages of D1g and B2l, about,15,000 years BP, together with their similar population dynamics and the high haplotype diversity shown by the networks, suggests that they probably appeared soon after the arrival of the first settlers and agrees with the dating of the earliest archaeological sites in South America (Monte Verde, Chile, 14,500 BP). One further sub-haplogroup, D4h3a5, appears to be restricted to Fuegian-Patagonian populations and reinforces our hypothesis of the continuity of the current Patagonian populations with the initial founders. Our results indicate that the extant native populations inhabiting South Chile and Argentina are a group which had a common origin, and suggest a population break between the extreme south of South America and the more northern part of the continent. Thus the early colonization process was not just an expansion from north to south, but also included movements across the Andes.	[de Saint Pierre, Michelle] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [de Saint Pierre, Michelle; Llop, Elena; Moraga, Mauricio] Univ Chile, Fac Med, ICBM, Programa Genet Humana, Santiago 7, Chile; [Bravi, Claudio M.; Motti, Josefina M. B.] CCT CONICET La Plata, Inst Multidisciplinario Biol Celular IMBICE, Lab Genet Mol Poblac, La Plata, Argentina; [Fuku, Noriyuki; Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Itabashi Ku, Tokyo, Japan; [Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Genom & Mol Biol Lab, Porto Alegre, RS, Brazil; [Moraga, Mauricio] Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile	Universidad de Chile; Universidad de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Tokyo Metropolitan Institute of Gerontology; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidad de Chile	Pierre, MD (corresponding author), Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile.	mmoraga@med.uchile.cl	de Saint Pierre, Michelle/K-3894-2015; Bonatto, Sandro L/A-1240-2010	de Saint Pierre, Michelle/0000-0001-6516-5314; Bonatto, Sandro L/0000-0002-0064-467X; Fuku, Noriyuki/0000-0001-7792-5835	FONDECYT, Chile [11060442, 1100643]; FONCyT PICT, Argentina [32450, 715]; CONICYT, Chile [24090072]; Doctoral fellowship CONICET, Argentina; Grants-in-Aid for Scientific Research [22240072] Funding Source: KAKEN	FONDECYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONCyT PICT, Argentina(ANPCyTFONCyT); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Doctoral fellowship CONICET, Argentina; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Research grants: FONDECYT #11060442 and 1100643, Chile; FONCyT PICT 2005 #32450 and PICT 2008 #715, Argentina. Ph.D, students: MSP: Doctoral fellowship and Thesis Support Research Scholarship #24090072 from CONICYT, Chile; JMBM: Doctoral fellowship CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Barbieri C, 2011, AM J HUM BIOL, V23, P89, DOI 10.1002/ajhb.21107; Barbosa ABG, 2008, J FORENSIC SCI, V53, P142, DOI 10.1111/j.1556-4029.2007.00619.x; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Bechis MA, 2010, PIEZAS ETNOHISTORIA; Bengoa J, 2008, HIST ANTIGUOS MAPUCH; Bert F, 2004, ANN HUM BIOL, V31, P9, DOI 10.1080/03014460310001616464; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Bobillo MC, 2010, INT J LEGAL MED, V124, P263, DOI 10.1007/s00414-009-0366-3; Cooper JM, 1917, BUREAU AM ETHNOLOGY, V93; Corella A, 2007, ANN HUM BIOL, V34, P34, DOI 10.1080/03014460601075819; Costa HA, 2010, J FORENSIC LEG MED, V17, P247, DOI 10.1016/j.jflm.2010.02.011; Dillehay TD, 2005, P NATL ACAD SCI USA, V102, P17241, DOI 10.1073/pnas.0508583102; DILLEHAY TD, 1988, NATURE, V332, P150, DOI 10.1038/332150a0; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2007, SCIENCE, V316, P1890, DOI 10.1126/science.1141395; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Easton RD, 1996, AM J HUM GENET, V59, P213; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fehren-Schmitz L, 2010, AM J PHYS ANTHROPOL, V141, P208, DOI 10.1002/ajpa.21135; Forster P, 1996, AM J HUM GENET, V59, P935; Fuselli S, 2003, MOL BIOL EVOL, V20, P1682, DOI 10.1093/molbev/msg188; Garcia F, 2006, AM J PHYS ANTHROPOL, V129, P473, DOI 10.1002/ajpa.20297; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; GINTHER C, 1993, EXS, V67, P211; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gomez-Carballa A, 2012, AM J PHYS ANTHROPOL, V147, P78, DOI 10.1002/ajpa.21629; Hartmann A, 2008, VALIDATION MICROARRA; Hernandez I, 1995, INDIOS ARGENTINA; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Hunley KL, 2002, THESIS U MICHIGAN AN; Irwin J, 2007, INT J LEGAL MED, V121, P377, DOI 10.1007/s00414-006-0128-4; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2009, AM J PHYS ANTHROPOL, V140, P80, DOI 10.1002/ajpa.21037; Kolman CJ, 1997, GENETICS, V147, P1289; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Lander N, 2008, Forensic Sci Int Genet, V2, pe61, DOI 10.1016/j.fsigen.2007.12.009; Lewis CM, 2007, HUM BIOL, V79, P159, DOI 10.1353/hub.2007.0031; Lewis CM, 2005, AM J PHYS ANTHROPOL, V127, P351, DOI 10.1002/ajpa.20102; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Manriquez V, 2004, POBLACIONES CHILENAS, P19; Marrero AR, 2007, AM J PHYS ANTHROPOL, V132, P301, DOI 10.1002/ajpa.20515; Massone M., 1987, SERIE CIENCIAS SOCIA, V17, P47; Melton PE, 2007, AM J PHYS ANTHROPOL, V133, P753, DOI 10.1002/ajpa.20581; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Meyer S, 1999, GENETICS, V152, P1103; Miotti L, 1995, CURRENT RES PLEISTOC, V12, P37; Moraga M, 2010, MAGALLANIA, V38, P103, DOI 10.4067/S0718-22442010000200006; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Museo Chileno de Arte Precolombino, 1997, CHIL ANT CHIL PREH; ORQUERA LA, 1987, J WORLD PREHIST, V1, P333, DOI 10.1007/BF00974880; Palencia L, 2010, INT J LEGAL MED, V124, P331, DOI 10.1007/s00414-010-0464-2; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pinotti L, 2001, SIN EMBARGO EXISTIMO; Prieto L, 2011, FORENSIC SCI INT-GEN, V5, P146, DOI 10.1016/j.fsigen.2010.10.013; Ribeiro-dos-Santos AKC, 2000, HUM HERED, V51, P79, DOI 10.1159/000022962; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sala A, 2010, HUM BIOL, V82, P433, DOI 10.3378/027.082.0406; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006882; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Schmitt R, 2004, ANN HUM BIOL, V31, P87, DOI 10.1080/03014460310001602063; Shinoda K, 2006, AM J PHYS ANTHROPOL, V131, P98, DOI 10.1002/ajpa.20408; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Spicer Edward H., 1962, CYCLES CONQUEST IMPA; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; TORRONI A, 1993, AM J HUM GENET, V53, P563; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; Vona G, 2005, AM J PHYS ANTHROPOL, V127, P361, DOI 10.1002/ajpa.20070; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007	92	68	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43486	10.1371/journal.pone.0043486	http://dx.doi.org/10.1371/journal.pone.0043486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970129	Green Published, gold			2022-12-27	WOS:000308748400005
J	McDole, T; Nulton, J; Barott, KL; Felts, B; Hand, C; Hatay, M; Lee, H; Nadon, MO; Nosrat, B; Salamon, P; Bailey, B; Sandin, SA; Vargas-Angel, B; Youle, M; Zgliczynski, BJ; Brainard, RE; Rohwer, F				McDole, Tracey; Nulton, James; Barott, Katie L.; Felts, Ben; Hand, Carol; Hatay, Mark; Lee, Hochul; Nadon, Marc O.; Nosrat, Bahador; Salamon, Peter; Bailey, Barbara; Sandin, Stuart A.; Vargas-Angel, Bernardo; Youle, Merry; Zgliczynski, Brian J.; Brainard, Russell E.; Rohwer, Forest			Assessing Coral Reefs on a Pacific-Wide Scale Using the Microbialization Score	PLOS ONE			English	Article							NORTHERN LINE ISLANDS; FISH-ASSEMBLAGE; BASE-LINES; BACTERIA; PHYTOPLANKTON; ECOSYSTEMS; ENRICHMENT; STRESSORS; IMPACTS; ECOLOGY	The majority of the world's coral reefs are in various stages of decline. While a suite of disturbances (overfishing, eutrophication, and global climate change) have been identified, the mechanism(s) of reef system decline remain elusive. Increased microbial and viral loading with higher percentages of opportunistic and specific microbial pathogens have been identified as potentially unifying features of coral reefs in decline. Due to their relative size and high per cell activity, a small change in microbial biomass may signal a large reallocation of available energy in an ecosystem; that is the microbialization of the coral reef. Our hypothesis was that human activities alter the energy budget of the reef system, specifically by altering the allocation of metabolic energy between microbes and macrobes. To determine if this is occurring on a regional scale, we calculated the basal metabolic rates for the fish and microbial communities at 99 sites on twenty-nine coral islands throughout the Pacific Ocean using previously established scaling relationships. From these metabolic rate predictions, we derived a new metric for assessing and comparing reef health called the microbialization score. The microbialization score represents the percentage of the combined fish and microbial predicted metabolic rate that is microbial. Our results demonstrate a strong positive correlation between reef microbialization scores and human impact. In contrast, microbialization scores did not significantly correlate with ocean net primary production, local chla concentrations, or the combined metabolic rate of the fish and microbial communities. These findings support the hypothesis that human activities are shifting energy to the microbes, at the expense of the macrobes. Regardless of oceanographic context, the microbialization score is a powerful metric for assessing the level of human impact a reef system is experiencing.	[McDole, Tracey; Barott, Katie L.; Hatay, Mark; Nosrat, Bahador; Youle, Merry; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Nulton, James; Felts, Ben; Hand, Carol; Lee, Hochul; Salamon, Peter; Bailey, Barbara] San Diego State Univ, Dept Math & Comp Sci, San Diego, CA 92182 USA; [Vargas-Angel, Bernardo; Brainard, Russell E.] NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Sandin, Stuart A.; Zgliczynski, Brian J.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Nadon, Marc O.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Nadon, Marc O.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	California State University System; San Diego State University; California State University System; San Diego State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Miami; University of Hawaii System; University of Hawaii Manoa	McDole, T (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tsmcdole@yahoo.com	Rohwer, Forest/AAC-5315-2019	Rohwer, Forest/0000-0003-1548-5429; Barott, Katie/0000-0001-7371-4870	National Science Foundation (NSF) [OCE-0927415]; CIFAR [LTRDTD62207]	National Science Foundation (NSF)(National Science Foundation (NSF)); CIFAR(Canadian Institute for Advanced Research (CIFAR))	This work was supported by National Science Foundation (NSF) (OCE-0927415) and a grant from CIFAR (LTRDTD62207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], P 5 BERK S MATH STAT; Arias-Gonzalez JE, 1997, CORAL REEFS, V16, P231; Atkins P., 2007, 4 LAWS DRIVE UNIVERS; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; BJORNSEN PK, 1986, APPL ENVIRON MICROB, V51, P1199; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; BROCK RE, 1982, B MAR SCI, V32, P269; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; FROESE R, 1994, NETH J SEA RES, V32, P235, DOI 10.1016/0077-7579(94)90001-9; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOHNSON C, 1995, MAR ECOL PROG SER, V126, P123, DOI 10.3354/meps126123; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kelly LW, 2011, ISME J; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kulbicki M, 2005, CYBIUM, V29, P235; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith VH, 2006, LIMNOL OCEANOGR, V51, P377, DOI 10.4319/lo.2006.51.1_part_2.0377; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Strickland JDH, 1965, FISH RES BOARD CAN, V125; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Turgeon DD, 2008, STATE CORAL REEF ECO; Vargas-Angel B, 2011, B MAR SCI, V87, P623, DOI 10.5343/bms.2010.1095; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876	46	48	49	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43233	10.1371/journal.pone.0043233	http://dx.doi.org/10.1371/journal.pone.0043233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970122	Green Submitted, gold, Green Published			2022-12-27	WOS:000308462000001
J	Olechnowicz, SWZ; Fedele, AO; Peet, DJ				Olechnowicz, Sam W. Z.; Fedele, Anthony O.; Peet, Daniel J.			Hypoxic Induction of the Regulator of G-Protein Signalling 4 Gene Is Mediated by the Hypoxia-Inducible Factor Pathway	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; ENDOTHELIAL GROWTH-FACTOR; HUMAN NEUROBLASTOMA-CELLS; PAS DOMAIN PROTEIN-1; END RULE PATHWAY; TRANSCRIPTION FACTOR; FACTOR (HIF)-1-ALPHA; FACTOR-I; TRANSACTIVATION DOMAIN; PROLYL HYDROXYLATION	The transcriptional response to hypoxia is largely dependent on the Hypoxia Inducible Factors (HIF-1 and HIF-2) in mammalian cells. Many target genes have been characterised for these heterodimeric transcription factors, yet there is evidence that the full range of HIF-regulated genes has not yet been described. We constructed a TetON overexpression system in the rat pheochromocytoma PC-12 cell line to search for novel HIF and hypoxia responsive genes. The Rgs4 gene encodes the Regulator of G-Protein Signalling 4 (RGS4) protein, an inhibitor of signalling from G-protein coupled receptors, and dysregulation of Rgs4 is linked to disease states such as schizophrenia and cardiomyopathy. Rgs4 was found to be responsive to HIF-2 alpha overexpression, hypoxic treatment, and hypoxia mimetic drugs in PC-12 cells. Similar responses were observed in human neuroblastoma cell lines SK-N-SH and SK-N-BE(2) C, but not in endothelial cells, where Rgs4 transcript is readily detected but does not respond to hypoxia. Furthermore, this regulation was found to be dependent on transcription, and occurs in a manner consistent with direct HIF transactivation of Rgs4 transcription. However, no HIF binding site was detectable within 32 kb of the human Rgs4 gene locus, leading to the possibility of regulation by long-distance genomic interactions. Further research into Rgs4 regulation by hypoxia and HIF may result in better understanding of disease states such as schizophrenia, and also shed light on the other roles of HIF yet to be discovered.	[Olechnowicz, Sam W. Z.; Peet, Daniel J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Olechnowicz, Sam W. Z.; Peet, Daniel J.] Univ Adelaide, ARC Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia; [Fedele, Anthony O.] SA Pathol, LDRU, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; SA Pathology	Olechnowicz, SWZ (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	daniel.peet@adelaide.edu.au	Olechnowicz, Sam/I-3082-2014; Peet, Daniel/AAE-6698-2020	Olechnowicz, Sam/0000-0001-7879-7708; Peet, Daniel/0000-0002-6085-8936	ARC Special Centre for the Molecular Genetics of Development (CMGD); National Health and Medical Research Council of Australia (NHMRC)	ARC Special Centre for the Molecular Genetics of Development (CMGD)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the ARC Special Centre for the Molecular Genetics of Development (CMGD, http://www.cmgd.adelaide.edu.au) and the National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; AUGUSTIT.G, 1969, P NATL ACAD SCI USA, V64, P311, DOI 10.1073/pnas.64.1.311; Barrett JM, 2011, MICROCIRCULATION, V18, P583, DOI 10.1111/j.1549-8719.2011.00119.x; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P351, DOI 10.1093/oxfordjournals.schbul.a033458; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Ho GY, 2007, PHARMACOLOGY, V79, P114, DOI 10.1159/000098097; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin Y, 2009, J BIOL CHEM, V284, P23436, DOI 10.1074/jbc.M109.032664; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King M, 2010, MOL GENET GENOMICS, V284, P425, DOI 10.1007/s00438-010-0579-7; Konietzny R, 2009, ANN NY ACAD SCI, V1177, P74, DOI 10.1111/j.1749-6632.2009.05029.x; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Mosser DD, 1997, BIOTECHNIQUES, V22, P150, DOI 10.2144/97221rr02; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Muller PY, 2001, BIOTECHNIQUES, V31, P1306, DOI 10.2144/01316bc01; Murray RM, 2008, EUR NEUROPSYCHOPHARM, V18, pS129, DOI 10.1016/j.euroneuro.2008.04.002; Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Nomoto S, 1997, BIOCHEM BIOPH RES CO, V241, P281, DOI 10.1006/bbrc.1997.7802; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt-Kastner R, 2012, MOL PSYCHIAT; Schmidt-Kastner R, 2006, SCHIZOPHR RES; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sowter HM, 2003, CANCER RES, V63, P6130; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Tejkalova H, 2007, PHYSIOL RES, V56, P815, DOI 10.33549/physiolres.931056; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Zhang SA, 1998, J MOL CELL CARDIOL, V30, P269, DOI 10.1006/jmcc.1997.0591	71	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44564	10.1371/journal.pone.0044564	http://dx.doi.org/10.1371/journal.pone.0044564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970249	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000029
J	Ayer, A; Fellermeier, S; Fife, C; Li, SS; Smits, G; Meyer, AJ; Dawes, IW; Perrone, GG				Ayer, Anita; Fellermeier, Sina; Fife, Christopher; Li, Simone S.; Smits, Gertien; Meyer, Andreas J.; Dawes, Ian W.; Perrone, Gabriel G.			A Genome-Wide Screen in Yeast Identifies Specific Oxidative Stress Genes Required for the Maintenance of Sub-Cellular Redox Homeostasis	PLOS ONE			English	Article							DISULFIDE RELAY SYSTEM; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE-REDUCTASE; OXIDIZED GLUTATHIONE; THIOREDOXIN; EXPRESSION; GLUTAREDOXIN; MITOCHONDRIA; PEROXISOMES; INVOLVEMENT	Maintenance of an optimal redox environment is critical for appropriate functioning of cellular processes and cell survival. Despite the importance of maintaining redox homeostasis, it is not clear how the optimal redox potential is sensed and set, and the processes that impact redox on a cellular/organellar level are poorly understood. The genetic bases of cellular redox homeostasis were investigated using a green fluorescent protein (GFP) based redox probe, roGFP2 and a pH sensitive GFP-based probe, pHluorin. The use of roGFP2, in conjunction with pHluorin, enabled determination of pH-adjusted sub-cellular redox potential in a non-invasive and real-time manner. A genome-wide screen using both the non-essential and essential gene collections was carried out in Saccharomyces cerevisiae using cytosolic-roGFP2 to identify factors essential for maintenance of cytosolic redox state under steady-state conditions. 102 genes of diverse function were identified that are required for maintenance of cytosolic redox state. Mutations in these genes led to shifts in the half-cell glutathione redox potential by 75-10 mV. Interestingly, some specific oxidative stress-response processes were identified as over-represented in the data set. Further investigation of the role of oxidative stress-responsive systems in sub-cellular redox homeostasis was conducted using roGFP2 constructs targeted to the mitochondrial matrix and peroxisome and E-GSH was measured in cells in exponential and stationary phase. Analyses allowed for the identification of key redox systems on a sub-cellular level and the identification of novel genes involved in the regulation of cellular redox homeostasis.	[Ayer, Anita; Fellermeier, Sina; Fife, Christopher; Li, Simone S.; Dawes, Ian W.] Univ New S Wales, Sydney, NSW, Australia; [Smits, Gertien] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Meyer, Andreas J.] Univ Bonn, INRES Chem Signalling, Bonn, Germany; [Perrone, Gabriel G.] Univ Western Sydney, Penrith, NSW 1797, Australia	University of New South Wales Sydney; University of Amsterdam; University of Bonn; Western Sydney University	Ayer, A (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	i.dawes@unsw.edu.au	Smits, Gertien J./I-4327-2014; Meyer, Andreas J/C-4734-2013	Smits, Gertien J./0000-0002-8439-7791; Meyer, Andreas J/0000-0001-8144-4364; Li, Simone S/0000-0002-0073-3656; Ayer, Anita/0000-0002-7073-2835	Australian Postgraduate Award; Australian Research Council; Unilever; Deutsche Forschungsgemeinschaft [ME1567/5-1]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council); Unilever(Unilever); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by Australian Postgraduate Award (to AA) and a Discovery grant from the Australian Research Council (to IWD and GGP). Work in GJS's lab was partially funded by Unilever and work in AJM's laboratory was funded by the Deutsche Forschungsgemeinschaft (grant ME1567/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Brace JL, 2005, YEAST, V22, P641, DOI 10.1002/yea.1235; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Charizanis C, 1999, MOL GEN GENET, V262, P437, DOI 10.1007/s004380051103; DAIGNANFORNIER B, 1994, MOL GEN GENET, V243, P575, DOI 10.1007/BF00284206; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Galeote VA, 2007, CURR GENET, V52, P55, DOI 10.1007/s00294-007-0136-z; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kataya ARA, 2010, PLANT SIGNAL BEHAV, V5, P171, DOI 10.4161/psb.5.2.10527; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KIM JH, 1991, MOL CELL BIOL, V11, P3894, DOI 10.1128/MCB.11.8.3894; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MULLER EGD, 1995, ARCH BIOCHEM BIOPHYS, V318, P356, DOI 10.1006/abbi.1995.1240; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Tsujimoto Y, 2000, J BACTERIOL, V182, P5121, DOI 10.1128/JB.182.18.5121-5126.2000; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wheeler GL, 2002, MOL MICROBIOL, V46, P545, DOI 10.1046/j.1365-2958.2002.03174.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	58	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44278	10.1371/journal.pone.0044278	http://dx.doi.org/10.1371/journal.pone.0044278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970195	gold, Green Published			2022-12-27	WOS:000308458400054
J	Chen, J; Kwong, DLW; Zhu, CL; Chen, LL; Dong, SS; Zhang, LY; Tian, J; Qi, CB; Cao, TT; Wong, AMG; Kong, KL; Li, Y; Liu, M; Fu, L; Guan, XY				Chen, Juan; Kwong, Dora Lai-Wan; Zhu, Cai-Lei; Chen, Lei-Lei; Dong, Sui-Sui; Zhang, Li-Yi; Tian, Jun; Qi, Chu-Bo; Cao, Ting-Ting; Wong, Alissa Michelle Go; Kong, Kar-Lok; Li, Yan; Liu, Ming; Fu, Li; Guan, Xin-Yuan			RBMS3 at 3p24 Inhibits Nasopharyngeal Carcinoma Development via Inhibiting Cell Proliferation, Angiogenesis, and Inducing Apoptosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EPSTEIN-BARR-VIRUS; BETA-CATENIN; C-MYC; IN-VIVO; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CDK INHIBITORS; POOR-PROGNOSIS; RAS ONCOGENES	Deletion of the short arm of chromosome 3 is one of the most frequent genetic alterations in many solid tumors including nasopharyngeal carcinoma (NPC), suggesting the existence of one or more tumor suppressor genes (TSGs) within the frequently deleted region. A putative TSG RBMS3 (RNA binding motif, single stranded interacting protein 3), located at 3p24-p23, has been identified in our previous study. Here, we reported that downregulation of RBMS3 was detected in 3/3 NPC cell lines and 13/15 (86.7%) primary NPC tissues. Functional studies using both overexpression and suppression systems demonstrated that RBMS3 has a strong tumor suppressive role in NPC. The tumor suppressive mechanism of RBMS3 was associated with its role in cell cycle arrest at the G1/S checkpoint by upregulating p53 and p21, downregulating cyclin E and CDK2, and the subsequent inhibition of Rb-ser780. Further analysis demonstrated that RBMS3 had a pro-apoptotic role in a mitochondrial-dependent manner via activation of caspase-9 and PARP. Finally, RBMS3 inhibited microvessel formation, which may be mediated by down-regulation of MMP2 and beta-catenin and inactivation of its downstream targets, including cyclin-D1, c-Myc, MMP7, and MMP9. Taken together, our findings define a function for RBMS3 as an important tumor suppressor gene in NPC.	[Chen, Juan; Kwong, Dora Lai-Wan; Zhu, Cai-Lei; Chen, Lei-Lei; Dong, Sui-Sui; Zhang, Li-Yi; Cao, Ting-Ting; Wong, Alissa Michelle Go; Kong, Kar-Lok; Liu, Ming; Fu, Li; Guan, Xin-Yuan] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Chen, Juan] Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, Yan; Fu, Li; Guan, Xin-Yuan] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Jun] Huazhong Univ Sci & Technol, Dept Biochem & Mol Biol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Qi, Chu-Bo] Hubei Canc Hosp, Dept Pathol, Wuhan, Peoples R China	University of Hong Kong; Huazhong University of Science & Technology; Sun Yat Sen University; Huazhong University of Science & Technology	Chen, J (corresponding author), Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk; gracelfu@hkucc.hku.hk	Fu, Li/F-7182-2010; /A-3639-2009	Fu, Li/0000-0003-2643-6278; Wong, Alissa/0000-0001-7858-1368; LIU, MING/0000-0003-3222-8715; /0000-0003-1874-9805; Chen, Polly Leilei/0000-0002-1987-3878	National Natural Science Foundation of China [30700820, 30772475, 30971606]; National Key Sci-Tech Special Project of China [2008ZX10002-022]; Hong Kong UGC Area of Excellent Scheme [AoE/M-06/08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Hong Kong UGC Area of Excellent Scheme	This work was supported by grants from the National Natural Science Foundation of China (30700820, 30772475 and 30971606), the National Key Sci-Tech Special Project of China (2008ZX10002-022), and the Hong Kong UGC Area of Excellent Scheme (AoE/M-06/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Carnero A, 1998, CURR TOP MICROBIOL, V227, P43; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Claudio PP, 2001, CANCER RES, V61, P462; Fan CS, 2000, HUM PATHOL, V31, P169, DOI 10.1016/S0046-8177(00)80216-6; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Fox SB, 2001, METH MOLEC MED, V46, P29, DOI 10.1385/1-59259-143-4:029; Fritz D, 2007, J MOL BIOL, V371, P585, DOI 10.1016/j.jmb.2007.06.006; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hoshino I, 2007, ONCOL REP, V18, P867; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Hui ABY, 1998, CANCER GENET CYTOGEN, V101, P83, DOI 10.1016/S0165-4608(97)00231-8; Hui ABY, 2002, INT J ONCOL, V20, P467; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jeannel D, 1999, CANCER SURV, V33, P125; Kraemer M, 1999, CELL GROWTH DIFFER, V10, P193; Kwong D, 2004, HUM PATHOL, V35, P309, DOI 10.1016/j.humpath.2003.10.020; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li Y, 2011, CANCER RES, V71, P6106, DOI 10.1158/0008-5472.CAN-10-4291; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo JL, 1997, CHINESE MED J-PEKING, V110, P229; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; Penkov D, 2000, GENE, V243, P27, DOI 10.1016/S0378-1119(99)00515-6; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; PORTER MJ, 1994, ACTA OTO-LARYNGOL, V114, P105, DOI 10.3109/00016489409126025; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Qiu GH, 2008, J HEPATOL, V48, P433, DOI 10.1016/j.jhep.2007.11.015; RAK J, 1995, CANCER RES, V55, P4575; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vokes EE, 1997, LANCET, V350, P1087, DOI 10.1016/S0140-6736(97)07269-3; Wang XH, 2010, ONCOL REP, V24, P1093, DOI 10.3892/or_00000960; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	52	18	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44636	10.1371/journal.pone.0044636	http://dx.doi.org/10.1371/journal.pone.0044636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957092	Green Published, gold			2022-12-27	WOS:000308463800085
J	Greenblatt, MB; Vbranac, V; Tivey, T; Tsang, K; Tager, AM; Aliprantis, AO				Greenblatt, Matthew B.; Vbranac, Vladimir; Tivey, Trevor; Tsang, Kelly; Tager, Andrew M.; Aliprantis, Antonios O.			Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; INTERFERON-GAMMA; IMMUNE-RESPONSES; MICE; TRANSPLANTATION; BLOOD; CELLS; CHAIN; ACTIVATION; EXPRESSION	Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells in vivo and facilitate disease models not normally possible in laboratory animals. Here we describe a form of GVHD that develops in NOD/SCID mice reconstituted with human fetal bone marrow, liver and thymus (NS BLT mice). The skin, lungs, gastrointestinal tract and parotid glands are affected with progressive inflammation and sclerosis. Although all mice showed involvement of at least one organ site, the incidence of overt clinical disease was approximately 35% by 22 weeks after reconstitution. The use of hosts lacking the IL2 common gamma chain (NOD/SCID/gamma c(-/-)) delayed the onset of disease, but ultimately did not affect incidence. Genetic analysis revealed that particular donor HLA class I alleles influenced the risk for the development of GVHD. At a cellular level, GVHD is associated with the infiltration of human CD4+ T cells into the skin and a shift towards Th1 cytokine production. GVHD also induced a mixed M1/M2 polarization phenotype in a dermal murine CD11b+, MHC class II+ macrophage population. The presence of xenogenic GVHD in BLT mice both presents a major obstacle in the use of humanized mice and an opportunity to conduct preclinical studies on GVHD in a humanized model.	[Greenblatt, Matthew B.; Tsang, Kelly; Aliprantis, Antonios O.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] Harvard Univ, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Massachusetts Gen Hosp,Med Sch, Charlestown, MA USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] MIT, Ragon Inst Massachusetts Gen Hosp, Charlestown, MA USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] Harvard, Charlestown, MA USA; [Vbranac, Vladimir; Tivey, Trevor; Tager, Andrew M.] Harvard Univ, Div Aids, Sch Med, Charlestown, MA USA; [Aliprantis, Antonios O.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Aliprantis, Antonios O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greenblatt, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	aaliprantis@partners.org		Tivey, Trevor/0000-0003-2124-5528	Scleroderma Research Foundation; National Institute of Allergy and Infectious Diseases [P30AI060354, P01AI078897]; Ragon Institute of MGH; Massachusetts Institute of Technology; Harvard; Burroughs Wellcome Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K08AR054859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Scleroderma Research Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute of MGH; Massachusetts Institute of Technology; Harvard; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Scleroderma Research Foundation (ww.srfcure.org) to AOA. The Massachusetts General Hospital (MGH) Humanized Mouse Program was supported by P30AI060354 and P01AI078897 from National Institute of Allergy and Infectious Diseases, and a platform award from the Ragon Institute of MGH, Massachusetts Institute of Technology and Harvard. AOA holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is supported by K08AR054859 from National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Denton PW, 2011, AIDS REV, V13, P135; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Greenblatt MB, 2012, AM J PATHOL; Gregoire-Gauthier J, 2011, STEM CELLS DEV; Gupta V, 2009, BIOL BLOOD MARROW TR, V15, P864, DOI 10.1016/j.bbmt.2009.03.023; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Juchem KW, 2011, BLOOD, V118, P6209, DOI 10.1182/blood-2011-01-330035; Kalscheuer H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003481; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Khanna D, 2009, ARTHRITIS RHEUM-US, V60, P1102, DOI 10.1002/art.24380; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Littera R, 2012, BRIT J HAEMATOL, V156, P118, DOI 10.1111/j.1365-2141.2011.08923.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Murphy WJ, 1998, J CLIN INVEST, V102, P1742, DOI 10.1172/JCI3906; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Olesen R, 2011, J REPROD IMMUNOL, V88, P195, DOI 10.1016/j.jri.2010.11.005; Papp G, 2012, CLIN IMMUNOL, V142, P150, DOI 10.1016/j.clim.2011.09.014; Petersdorf EW, 2006, SEMIN HEMATOL, V43, P11, DOI 10.1053/j.seminhematol.2005.09.002; Ruzek MC, 2004, ARTHRITIS RHEUM, V50, P1319, DOI 10.1002/art.20160; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sora F, 2002, EXP HEMATOL, V30, P279, DOI 10.1016/S0301-472X(01)00793-7; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tsiakalou V, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-20; Verlinden S F, 1998, Stem Cells, V16 Suppl 1, P205; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Zhang BJ, 2009, J CELL MOL MED, V13, P1043, DOI 10.1111/j.1582-4934.2008.00347.x; Zimmermann N, 2005, AM J RESP CELL MOL, V32, P428, DOI 10.1165/rcmb.2004-0269OC	45	103	110	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44664	10.1371/journal.pone.0044664	http://dx.doi.org/10.1371/journal.pone.0044664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957096	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800089
J	Spampanato, J; Sullivan, RK; Turpin, FR; Bartlett, PF; Sah, P				Spampanato, Jay; Sullivan, Robert K.; Turpin, Fabrice R.; Bartlett, Perry F.; Sah, Pankaj			Properties of Doublecortin Expressing Neurons in the Adult Mouse Dentate Gyrus	PLOS ONE			English	Article							GENERATED GRANULE CELLS; ENHANCED SYNAPTIC PLASTICITY; HIPPOCAMPAL PYRAMIDAL CELLS; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL MATURATION; DENDRITIC SPINES; NR2A SUBUNIT; NEUROGENESIS; RECEPTOR; RAT	The dentate gyrus is a neurogenic zone where neurons continue to be born throughout life, mature and integrate into the local circuitry. In adults, this generation of new neurons is thought to contribute to learning and memory formation. As newborn neurons mature, they undergo a developmental sequence in which different stages of development are marked by expression of different proteins. Doublecortin (DCX) is an early marker that is expressed in immature granule cells that are beginning migration and dendritic growth but is turned off before neurons reach maturity. In the present study, we use a mouse strain in which enhanced green fluorescent protein (EGFP) is expressed under the control of the DCX promoter. We show that these neurons have high input resistances and some cells can discharge trains of action potentials. In mature granule cells, action potentials are followed by a slow afterhyperpolarization that is absent in EGFP-positive neurons. EGFP-positive neurons had a lower spine density than mature neurons and stimulation of either the medial or lateral perforant pathway activated dual component glutamatergic synapses that had both AMPA and NMDA receptors. NMDA receptors present at these synapses had slow kinetics and were blocked by ifenprodil, indicative of high GluN2B subunit content. These results show that EGFP-positive neurons in the DCX-EGFP mice are functionally immature both in their firing properties and excitatory synapses.	[Spampanato, Jay; Sullivan, Robert K.; Turpin, Fabrice R.; Bartlett, Perry F.; Sah, Pankaj] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Spampanato, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	Pankaj.Sah@uq.edu.au	Bartlett, Perry/F-3813-2012; Sah, Pankaj/C-8175-2009; Sullivan, Robert KP/A-8639-2012; Turpin, Fabrice/G-1717-2011	Sullivan, Robert KP/0000-0003-3414-2448; Sah, Pankaj/0000-0001-5063-1589; Spampanato, Jay/0000-0003-3968-0608	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (NH&MRC) and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Delaney AJ, 2012, J NEUROPHYSIOL, V107, P1571, DOI 10.1152/jn.01066.2011; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Flint AC, 1997, J NEUROSCI, V17, P2469; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Liu XS, 2000, BRAIN RES, V856, P202, DOI 10.1016/S0006-8993(99)02421-X; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Stocca G, 2008, J PHYSIOL-LONDON, V586, P3795, DOI 10.1113/jphysiol.2008.155739; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Ye GL, 2005, DEV BRAIN RES, V155, P26, DOI 10.1016/j.devbrainres.2004.12.002; Ye GL, 2000, DEV BRAIN RES, V124, P33, DOI 10.1016/S0165-3806(00)00103-6; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; ZAFIROV S, 1994, J COMP NEUROL, V345, P472, DOI 10.1002/cne.903450312; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158; Zhao SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012506; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	50	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41029	10.1371/journal.pone.0041029	http://dx.doi.org/10.1371/journal.pone.0041029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957010	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800002
J	Dillon, LM; Hida, A; Garcia, S; Prolla, TA; Moraes, CT				Dillon, Lloye M.; Hida, Aline; Garcia, Sofia; Prolla, Tomas A.; Moraes, Carlos T.			Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; MICE; MYOPATHY	Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated receptors (PPARs) and PPAR gamma coactivator-1 alpha (PGC-1 alpha) pathways have been shown to improve mitochondrial function and energy metabolism. The mitochondrial DNA (mtDNA) mutator mouse is a mouse model of aging that harbors a proofreading-deficient mtDNA polymerase gamma. These mice develop many features of premature aging including hair loss, anemia, osteoporosis, sarcopenia and decreased lifespan. They also have increased mtDNA mutations and marked mitochondrial dysfunction. We found that mutator mice treated with bezafibrate for 8-months had delayed hair loss and improved skin and spleen aging-like phenotypes. Although we observed an increase in markers of fatty acid oxidation in these tissues, we did not detect a generalized increase in mitochondrial markers. On the other hand, there were no improvements in muscle function or lifespan of the mutator mouse, which we attributed to the rodent-specific hepatomegaly associated with fibrate treatment. These results showed that despite its secondary effects in rodent's liver, bezafibrate was able to improve some of the aging phenotypes in the mutator mouse. Because the associated hepatomegaly is not observed in primates, long-term bezafibrate treatment in humans could have beneficial effects on tissues undergoing chronic bioenergetic-related degeneration.	[Dillon, Lloye M.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Hida, Aline; Garcia, Sofia; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Miami; University of Miami; University of Wisconsin System; University of Wisconsin Madison	Dillon, LM (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Moraes, Carlos/AAT-3818-2021	Dillon, Lloye/0000-0002-5118-1126	U.S. Public Health Service (PHS) [AG036871, EY010804, NS079965]; Muscular Dystrophy Association; Florida Biomedical Research Foundation; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871] Funding Source: NIH RePORTER	U.S. Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); Muscular Dystrophy Association(Muscular Dystrophy Association); Florida Biomedical Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The U.S. Public Health Service (PHS) grants AG036871, EY010804, NS079965; the Muscular Dystrophy Association and the Florida Biomedical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Cheung MC, 2009, J SURG RES, V153, P326, DOI 10.1016/j.jss.2008.05.002; De Souza AT, 2006, TOXICOL SCI, V92, P578, DOI 10.1093/toxsci/kfl019; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608; Djouadi F, 2011, CELL METAB, V14, P715, DOI 10.1016/j.cmet.2011.11.003; Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x; Harries MJ, 2009, J INVEST DERMATOL, V129, P1066, DOI 10.1038/jid.2008.425; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Johri A, 2012, HUM MOL GENET, V21, P1124, DOI 10.1093/hmg/ddr541; Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; OIKARINEN A, 1994, PHOTODERMATOL PHOTO, V10, P47; Pickrell AM, 2011, J NEUROSCI, V31, P9895, DOI 10.1523/JNEUROSCI.6223-10.2011; Smaldone S, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-8; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482	23	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44335	10.1371/journal.pone.0044335	http://dx.doi.org/10.1371/journal.pone.0044335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962610	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600038
J	Pendleton, L; Donato, DC; Murray, BC; Crooks, S; Jenkins, WA; Sifleet, S; Craft, C; Fourqurean, JW; Kauffman, JB; Marba, N; Megonigal, P; Pidgeon, E; Herr, D; Gordon, D; Baldera, A				Pendleton, Linwood; Donato, Daniel C.; Murray, Brian C.; Crooks, Stephen; Jenkins, W. Aaron; Sifleet, Samantha; Craft, Christopher; Fourqurean, James W.; Kauffman, J. Boone; Marba, Nuria; Megonigal, Patrick; Pidgeon, Emily; Herr, Dorothee; Gordon, David; Baldera, Alexis			Estimating Global "Blue Carbon" Emissions from Conversion and Degradation of Vegetated Coastal Ecosystems	PLOS ONE			English	Article							MANGROVE FOREST DISTRIBUTIONS; DYNAMICS; METHANE; SEQUESTRATION; CONSERVATION; ESTUARY; BIOMASS; SOILS	Recent attention has focused on the high rates of annual carbon sequestration in vegetated coastal ecosystems-marshes, mangroves, and seagrasses-that may be lost with habitat destruction ('conversion'). Relatively unappreciated, however, is that conversion of these coastal ecosystems also impacts very large pools of previously-sequestered carbon. Residing mostly in sediments, this 'blue carbon' can be released to the atmosphere when these ecosystems are converted or degraded. Here we provide the first global estimates of this impact and evaluate its economic implications. Combining the best available data on global area, land-use conversion rates, and near-surface carbon stocks in each of the three ecosystems, using an uncertainty-propagation approach, we estimate that 0.15-1.02 Pg (billion tons) of carbon dioxide are being released annually, several times higher than previous estimates that account only for lost sequestration. These emissions are equivalent to 3-19% of those from deforestation globally, and result in economic damages of $US 6-42 billion annually. The largest sources of uncertainty in these estimates stems from limited certitude in global area and rates of land-use conversion, but research is also needed on the fates of ecosystem carbon upon conversion. Currently, carbon emissions from the conversion of vegetated coastal ecosystems are not included in emissions accounting or carbon market protocols, but this analysis suggests they may be disproportionally important to both. Although the relevant science supporting these initial estimates will need to be refined in coming years, it is clear that policies encouraging the sustainable management of coastal ecosystems could significantly reduce carbon emissions from the land-use sector, in addition to sustaining the well-recognized ecosystem services of coastal habitats.	[Pendleton, Linwood; Murray, Brian C.; Jenkins, W. Aaron; Gordon, David] Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA; [Donato, Daniel C.] Univ Wisconsin, Ecosyst & Landscape Ecol Lab, Madison, WI USA; [Crooks, Stephen] ESA Phillip Williams & Associates, San Francisco, CA USA; [Sifleet, Samantha] US EPA, Res Triangle Pk, NC 27711 USA; [Craft, Christopher] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA; [Fourqurean, James W.] Florida Int Univ, Dept Biol Sci, N Miami, FL USA; [Fourqurean, James W.] Florida Int Univ, SE Environm Res Ctr, N Miami, FL USA; [Kauffman, J. Boone] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Kauffman, J. Boone] Ctr Int Forest Res, Bogor, Indonesia; [Marba, Nuria] Mediterranean Inst Adv Studies, Dept Global Change Res, Esporles, Illes Balears, Spain; [Megonigal, Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Pidgeon, Emily] Conservat Int, Arlington, VA USA; [Herr, Dorothee] Int Union Conservat Nat, Washington, DC USA; [Baldera, Alexis] Ocean Conservancy, Baton Rouge, LA USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; United States Environmental Protection Agency; Indiana University System; Indiana University Bloomington; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Oregon State University; CGIAR; Center for International Forestry Research (CIFOR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Smithsonian Institution; Smithsonian Environmental Research Center; Conservation International	Pendleton, L (corresponding author), Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA.	ddonato@wisc.edu	Marba, Nuria/H-8136-2015; Fourqurean, James/AAY-9611-2020; Marbà, Nuria/N-8143-2019; Fourqurean, James/B-4606-2008	Marba, Nuria/0000-0002-8048-6789; Fourqurean, James/0000-0002-0811-8500; Marbà, Nuria/0000-0002-8048-6789; Fourqurean, James/0000-0002-0811-8500; Megonigal, Patrick/0000-0002-2018-7883	Linden Trust for Conservation; Roger and Victoria Sant	Linden Trust for Conservation; Roger and Victoria Sant	Funding for this effort was provided by the Linden Trust for Conservation (lindentrust.org) and Roger and Victoria Sant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2011, ENVIRON SCI POLICY, V14, P462, DOI 10.1016/j.envsci.2011.02.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; CHARPY-ROUBAUD C, 1990, Marine Microbial Food Webs, V4, P31; Chen CTA, 2009, DEEP-SEA RES PT II, V56, P578, DOI 10.1016/j.dsr2.2009.01.001; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Climate Focus, 2011, BLUE CARB POL OPT AS; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crooks S, 2011, REGULATING CLIMATE C; Deverel S, 2010, SAN FRANCISCO ESTUAR, V8, P1, DOI [10.15447/sfews.2010v8iss2art1, DOI 10.15447/SFEWS.2010V8ISS2ART1]; Donato DC, 2012, J ENVIRON MANAGE, V97, P89, DOI 10.1016/j.jenvman.2011.12.004; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Doucet A, 2001, STAT ENG IN, P3; Drever J. I., 1988, GEOCHEMISTRY NATURAL; Duarte C.M., 2005, AQUATIC ECOSYSTEMS T; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Giri C, 2008, J BIOGEOGR, V35, P519, DOI 10.1111/j.1365-2699.2007.01806.x; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Giri C, 2008, SENSORS-BASEL, V8, P2104, DOI 10.3390/s8042104; GOLLEY F, 1962, ECOLOGY, V43, P9, DOI 10.2307/1932034; Gordon D, 2011, 1111 NI EP; Granek E, 2008, ESTUAR COAST SHELF S, V80, P555, DOI 10.1016/j.ecss.2008.09.012; Green E.P., 2003, WORLD ATLAS SEAGRASS; Herr D., 2011, BLUE CARBON POLICY F; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; IPCC, 2007, CLIM CHANG 2007 ASS; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Krithika K, 2008, CURR SCI INDIA, V94, P218; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Morgan PA, 2002, RESTOR ECOL, V10, P461, DOI 10.1046/j.1526-100X.2002.01037.x; Murdiyarso D, 2010, P NATL ACAD SCI USA, V107, P19655, DOI 10.1073/pnas.0911966107; Murray B. C., 2011, Green payments for blue carbon: economic incentives for protecting threatened coastal habitats; Nellemann C., 2009, BLUE CARBON RAPID RE; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pearson TRH, 2007, GEN TECHNICAL REPORT; Pidgeon E, 2009, MANAGEMENT NATURAL C; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Sjoling S, 2005, ESTUAR COAST SHELF S, V63, P397, DOI 10.1016/j.ecss.2004.12.002; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Strangmann A, 2008, BIOL FERT SOILS, V44, P511, DOI 10.1007/s00374-007-0233-7; Sweetman AK, 2010, BIOGEOSCIENCES, V7, P2129, DOI 10.5194/bg-7-2129-2010; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; *UN FAO, 2007, WORLDS MANGR 1980 20; UNFCCC, 2011, DEC CMP 7 LAND US LA; UNFCCC (United Nations Forum Convention on Climate Change, 2011, DRAFT DEC CP 17 GUID; United States Government (USG), 2010, 12866 USG USEPA; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vichkovitten T, 2005, J EXP MAR BIOL ECOL, V316, P183, DOI 10.1016/j.jembe.2004.11.002; Walker, 2005, SOURCEBOOK LAND USE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Yu OT, 2009, ENVIRON CONSERV, V36, P312, DOI 10.1017/S0376892910000184	65	788	818	57	675	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43542	10.1371/journal.pone.0043542	http://dx.doi.org/10.1371/journal.pone.0043542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962585	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600013
J	Vaishnavi, K; Saxena, N; Shah, N; Singh, R; Manjunath, K; Uthayakumar, M; Kanaujia, SP; Kaul, SC; Sekar, K; Wadhwa, R				Vaishnavi, Kirti; Saxena, Nishant; Shah, Navjot; Singh, Rumani; Manjunath, Kavyashree; Uthayakumar, M.; Kanaujia, Shankar P.; Kaul, Sunil C.; Sekar, Kanagaraj; Wadhwa, Renu			Differential Activities of the Two Closely Related Withanolides, Withaferin A and Withanone: Bioinformatics and Experimental Evidences	PLOS ONE			English	Article							CANCER-CELLS; COMPOUND WITHAFERIN; DNA-REPLICATION; TERMINAL REGION; DOWN-REGULATION; LEAF EXTRACT; IN-VIVO; KAPPA-B; P53; APOPTOSIS	Background and Purpose: Withanolides are naturally occurring chemical compounds. They are secondary metabolites produced via oxidation of steroids and structurally consist of a steroid-backbone bound to a lactone or its derivatives. They are known to protect plants against herbivores and have medicinal value including anti-inflammation, anti-cancer, adaptogenic and anti-oxidant effects. Withaferin A (Wi-A) and Withanone (Wi-N) are two structurally similar withanolides isolated from Withania somnifera, also known as Ashwagandha in Indian Ayurvedic medicine. Ashwagandha alcoholic leaf extract (i-Extract), rich in Wi-N, was shown to kill cancer cells selectively. Furthermore, the two closely related purified phytochemicals, Wi-A and Wi-N, showed differential activity in normal and cancer human cells in vitro and in vivo. We had earlier identified several genes involved in cytotoxicity of i-Extract in human cancer cells by loss-of-function assays using either siRNA or randomized ribozyme library. Methodology/Principal Findings: In the present study, we have employed bioinformatics tools on four genes, i.e., mortalin, p53, p21 and Nrf2, identified by loss-of-function screenings. We examined the docking efficacy of Wi-N and Wi-A to each of the four targets and found that the two closely related phytochemicals have differential binding properties to the selected cellular targets that can potentially instigate differential molecular effects. We validated these findings by undertaking parallel experiments on specific gene responses to either Wi-N or Wi-A in human normal and cancer cells. We demonstrate that Wi-A that binds strongly to the selected targets acts as a strong cytotoxic agent both for normal and cancer cells. Wi-N, on the other hand, has a weak binding to the targets; it showed milder cytotoxicity towards cancer cells and was safe for normal cells. The present molecular docking analyses and experimental evidence revealed important insights to the use of Wi-A and Wi-N for cancer treatment and development of new anti-cancer phytochemical cocktails.	[Vaishnavi, Kirti; Manjunath, Kavyashree; Uthayakumar, M.; Kanaujia, Shankar P.; Sekar, Kanagaraj] Indian Inst Sci, Supercomp Educ & Res Ctr, Bangalore 560012, Karnataka, India; [Saxena, Nishant; Shah, Navjot; Singh, Rumani; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Saxena, Nishant; Shah, Navjot; Singh, Rumani] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan	Indian Institute of Science (IISC) - Bangalore; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Vaishnavi, K (corresponding author), Indian Inst Sci, Supercomp Educ & Res Ctr, Bangalore 560012, Karnataka, India.	sekar@physics.iisc.ernet.in; renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; Manjunath, Kavyashree/0000-0002-1838-5362; Kanaujia, Shankar/0000-0001-9179-5723	JSPS (Japan); DST (India); Honjo International Scholarship Foundation, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Scholarship, Japan	JSPS (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DST (India)(Department of Science & Technology (India)); Honjo International Scholarship Foundation, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Scholarship, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by JSPS (Japan)-DST (India) Bilateral Project Grant. N. Saxena is supported by Honjo International Scholarship Foundation, Japan. N. Shah is supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Scholarship, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2010, EVID-BASED COMPL ALT, V7, P177, DOI 10.1093/ecam/nem184; Adams JD, 2002, ALTERN THER HEALTH M, V8, P18; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Cheung CT, 2011, CELL DEATH DIFFER, V18, P589, DOI 10.1038/cdd.2010.129; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; DEVI P U, 1992, Indian Journal of Experimental Biology, V30, P169; DEVI PU, 1995, CANCER LETT, V95, P189, DOI 10.1016/0304-3835(95)03892-Z; Devi PU, 1996, INT J RADIAT BIOL, V69, P193, DOI 10.1080/095530096146020; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; GAO R, 2010, TISS CULT RES COMMUN, V29, P147; Grover A, 2012, INT J BIOCHEM CELL B, V44, P496, DOI 10.1016/j.biocel.2011.11.021; Grover A, 2011, BIOCHEM BIOPH RES CO, V404, P498, DOI 10.1016/j.bbrc.2010.12.010; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S15; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HARPER JW, 1993, CELL, V75, P805; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2001, NEOPLASIA, V3, P110, DOI 10.1038/sj.neo.7900139; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kaul Z, 2007, ANN NY ACAD SCI, V1100, P368, DOI 10.1196/annals.1395.040; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Mishra L C, 2000, Altern Med Rev, V5, P334; Mizukoshi E, 2001, BIOCHEM BIOPH RES CO, V280, P1203, DOI 10.1006/bbrc.2001.4225; Mulabagal V, 2009, PHYTOTHER RES, V23, P987, DOI 10.1002/ptr.2736; Nakabayashi K, 1997, EXP CELL RES, V235, P345, DOI 10.1006/excr.1997.3678; Nakajima H, 2011, PHYTOTHER RES, V25, P1398, DOI 10.1002/ptr.3552; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Ran QT, 2001, EXP CELL RES, V263, P156, DOI 10.1006/excr.2000.5068; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wadhwa R, 2000, CANCER RES, V60, P6818; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015	53	71	71	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44419	10.1371/journal.pone.0044419	http://dx.doi.org/10.1371/journal.pone.0044419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973447	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308577600051
J	Huang, CC; Orvis, GD; Wang, Y; Behringer, RR				Huang, Cheng-Chiu; Orvis, Grant D.; Wang, Ying; Behringer, Richard R.			Stromal-to-Epithelial Transition during Postpartum Endometrial Regeneration	PLOS ONE			English	Article							STEM-CELLS; REPRODUCTIVE-TRACT; CANCER; IDENTIFICATION; POPULATION; EXPRESSION; REGRESSION; ESTROGEN; PTEN	Endometrium is the inner lining of the uterus which is composed of epithelial and stromal tissue compartments enclosed by the two smooth muscle layers of the myometrium. In women, much of the endometrium is shed and regenerated each month during the menstrual cycle. Endometrial regeneration also occurs after parturition. The cellular mechanisms that regulate endometrial regeneration are still poorly understood. Using genetic fate-mapping in the mouse, we found that the epithelial compartment of the endometrium maintains its epithelial identity during the estrous cycle and postpartum regeneration. However, whereas the stromal compartment maintains its identity during homeostatic cycling, after parturition a subset of stromal cells differentiates into epithelium that is subsequently maintained. These findings identify potential progenitor cells within the endometrial stromal compartment that produce long-term epithelial tissue during postpartum endometrial regeneration.	[Huang, Cheng-Chiu; Behringer, Richard R.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Huang, Cheng-Chiu; Orvis, Grant D.; Wang, Ying; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Huang, Cheng-Chiu; Wang, Ying; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Orvis, Grant D.; Behringer, Richard R.] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Huang, CC (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	rrb@mdanderson.org			National Institutes of Health (NIH) [HD030284]; Ben F. Love Endowment; Kleberg Foundation; National Cancer Institute [CA09299]; NIH [CA16672]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030284, R37HD030284] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009299, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ben F. Love Endowment; Kleberg Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant HD030284, the Ben F. Love Endowment, and the Kleberg Foundation to RRB. GDO was supported by National Cancer Institute T32 grant CA09299. Veterinary resources were supported by NIH grant CA16672. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Daikoku T, 2011, GYNECOL ONCOL, V122, P424, DOI 10.1016/j.ygyno.2011.04.022; Dharma S. J., 2001, Indian Journal of Experimental Biology, V39, P218; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Garry R, 2010, BJOG-INT J OBSTET GY, V117, P1175, DOI 10.1111/j.1471-0528.2010.02630.x; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; HE WW, 1993, DEV DYNAM, V196, P133, DOI 10.1002/aja.1001960207; Hu FF, 2010, REPROD SCI, V17, P629, DOI 10.1177/1933719110369180; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Legue E, 2010, METHOD ENZYMOL, V477, P153, DOI 10.1016/S0076-6879(10)77010-5; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Memarzadeh S, 2010, P NATL ACAD SCI USA, V107, P17298, DOI 10.1073/pnas.1012548107; Miller C, 1998, DEVELOPMENT, V125, P3201; Rasweiler John J., 2000, P157, DOI 10.1016/B978-012195670-7/50006-0; Roy A, 2011, NAT REV ENDOCRINOL, V7, P517, DOI 10.1038/nrendo.2011.79; Sipos F, 2012, WORLD J GASTROENTERO, V18, P601, DOI 10.3748/wjg.v18.i7.601; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanwar PS, 2011, CANCER RES, V71, P1584, DOI 10.1158/0008-5472.CAN-10-3166; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200	38	72	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e44285	10.1371/journal.pone.0044285	http://dx.doi.org/10.1371/journal.pone.0044285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970108	Green Submitted, Green Published, gold			2022-12-27	WOS:000308044800102
J	Ma, XY; Xi, L; Luo, DF; Liu, RH; Li, S; Liu, Y; Fan, LS; Ye, SM; Yang, WH; Yang, SH; Meng, L; Zhou, JF; Wang, SX; Ma, D				Ma, Xiangyi; Xi, Ling; Luo, Danfeng; Liu, Ronghua; Li, Shu; Liu, Yan; Fan, Liangsheng; Ye, Shuangmei; Yang, Wanhua; Yang, Shuhong; Meng, Li; Zhou, Jianfeng; Wang, Shixuan; Ma, Ding			Anti-Tumor Effects of the Peptide TMTP1-GG-(D)(KLAKLAK)(2) on Highly Metastatic Cancers (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							PROSTATE; PROTEIN; INHIBITOR; TARGET; CELLS	The treatment of cancer such as oligonucleotides or peptides requires efficient delivery systems. A novel peptide, TMTP1, previously derived and identified in our laboratory showed remarkable ability to target highly metastatic tumors both in vitro and in vivo, even at the early stage of occult metastasis foci. TMTP1 moderately inhibited tumor cell viability, although not enough to deem it an efficient killer of tumor cells. In this study, we sought to enhance the anti-tumor activity of TMTP1. To do this, we fused it to an antimicrobial peptide, (D)(KLAKLAK)(2), and termed the resulting peptide TMTP1-DKK. We found that TMTP1-DKK could trigger rapid apoptosis in human prostate and gastric cancer cells through both the mitochondrial-induced apoptosis pathway and the death receptor pathway. Furthermore, direct injection of TMTP1-DKK into mice with prostate and gastric xenograft cancers resulted in reduction of tumor volumes and a significant delay in tumor progression and metastasis in vivo. These results suggest that TMTP1-DKK may serve as a powerful therapeutic agent for metastatic tumors.	[Ma, Xiangyi; Xi, Ling; Luo, Danfeng; Liu, Ronghua; Li, Shu; Liu, Yan; Fan, Liangsheng; Ye, Shuangmei; Yang, Wanhua; Yang, Shuhong; Meng, Li; Zhou, Jianfeng; Wang, Shixuan; Ma, Ding] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Ma, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	sxwang@tjh.tjmu.edu.cn; dma@tjh.tjmu.edu.cn	meng, li/GVT-2063-2022; Luo, Danfeng/AAH-9140-2020		National Science Foundation of China [30973472, 81001006, 30973148]; Major Innovation Medicine program [2009ZX09103-738, 2009ZX09103-739, 2009ZX09103-740]; "973" Program of China [2009CB521808]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Innovation Medicine program; "973" Program of China(National Basic Research Program of China)	Funding was provided by the National Science Foundation of China (No.30973472; 81001006; 30973148), Major Innovation Medicine program (2009ZX09103-738; 2009ZX09103-739; 2009ZX09103-740), and the "973" Program of China (No. 2009CB521808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Brissette R, 2006, CURR OPIN DRUG DISC, V9, P363; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Copp BR, 2007, NAT PROD REP, V24, P278, DOI 10.1039/b513520f; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; FURUKAWA T, 1993, CANCER RES, V53, P1204; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Hu SJ, 2006, BIOCHEM BIOPH RES CO, V341, P964, DOI 10.1016/j.bbrc.2006.01.047; Landon Linda A, 2004, Curr Drug Discov Technol, V1, P113, DOI 10.2174/1570163043335108; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li G, 2007, BIOMARKERS, V12, P214, DOI 10.1080/13547500601068192; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Oman TJ, 2011, NAT CHEM BIOL, V7, P78, DOI 10.1038/NCHEMBIO.509; Presti JC, 2007, NAT CLIN PRACT UROL, V4, P505, DOI 10.1038/ncpuro0887; Ren WH, 2004, CANCER RES, V64, P6645, DOI 10.1158/0008-5472.CAN-04-1084; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Samoylova T. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P9, DOI 10.2174/187152006774755492; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang N, 2006, CANCER RES, V66, P3062, DOI 10.1158/0008-5472.CAN-05-2638; Warshamana-Greene GS, 2005, CLIN CANCER RES, V11, P1563, DOI 10.1158/1078-0432.CCR-04-1544; Yan M, 2005, LAB ANIM COMP MED, V25, P72; Yan M, 2005, SHANGHAI LAB ANIM SC, V25, P8; Yang WH, 2008, CLIN CANCER RES, V14, P5494, DOI 10.1158/1078-0432.CCR-08-0233; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang XY, 2009, CANCER RES, V69, P6506, DOI 10.1158/0008-5472.CAN-08-4721; Zhu W, 1995, Zhonghua Bing Li Xue Za Zhi, V24, P136	33	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42685	10.1371/journal.pone.0042685	http://dx.doi.org/10.1371/journal.pone.0042685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984407	Green Published, gold, Green Submitted			2022-12-27	WOS:000308638700009
J	Schwarz, J; Proff, J; Havemeier, A; Ladwein, M; Rottner, K; Barlag, B; Pich, A; Tatge, H; Just, I; Gerhard, R				Schwarz, Janett; Proff, Julia; Haevemeier, Anika; Ladwein, Markus; Rottner, Klemens; Barlag, Britta; Pich, Andreas; Tatge, Helma; Just, Ingo; Gerhard, Ralf			Serine-71 Phosphorylation of Rac1 Modulates Downstream Signaling	PLOS ONE			English	Article							SMALL GTPASE; RHO-GTPASES; DISSOCIATION INHIBITORS; KAPPA-B; PROTEINS; BINDING; KINASE; CDC42; ACTIVATION; PROGRESSION	The Rho GTPases Rac1 and Cdc42 regulate a variety of cellular functions by signaling to different signal pathways. It is believed that the presence of a specific effector at the location of GTPase activation determines the route of downstream signaling. We previously reported about EGF-induced Ser-71 phosphorylation of Rac1/Cdc42. By using the phosphomimetic S71E-mutants of Rac1 and Cdc42 we investigated the impact of Ser-71 phosphorylation on binding to selected effector proteins. Binding of the constitutively active (Q61L) variants of Rac1 and Cdc42 to their specific interaction partners Sra-1 and N-WASP, respectively, as well as to their common effector protein PAK was abrogated when Ser-71 was exchanged to glutamate as phosphomimetic substitution. Interaction with their common effector proteins IQGAP1/2/3 or MRCK alpha was, however, hardly affected. This ambivalent behaviour was obvious in functional assays. In contrast to Rac1 Q61L, phosphomimetic Rac1 Q61L/S71E was not able to induce increased membrane ruffling. Instead, Rac1 Q61L/S71E allowed filopodia formation, which is in accordance with abrogation of the dominant Sra-1/Wave signalling pathway. In addition, in contrast to Rac1 transfected cells Rac1 S71E failed to activate PAK1/2. On the other hand, Rac1 Q61L/S71E was as effective in activation of NF-kappaB as Rac1 Q61L, illustrating positive signal transduction of phosphorylated Rac1. Together, these data suggest that phosphorylation of Rac1 and Cdc42 at serine-71 represents a reversible mechanism to shift specificity of GTPase/effector coupling, and to preferentially address selected downstream pathways.	[Schwarz, Janett; Proff, Julia; Barlag, Britta; Pich, Andreas; Tatge, Helma; Just, Ingo; Gerhard, Ralf] Hannover Med Sch, Dept Toxicol, D-3000 Hannover, Germany; [Haevemeier, Anika] Hannover Med Sch, Dept Virol, D-3000 Hannover, Germany; [Ladwein, Markus; Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, Braunschweig, Germany; [Rottner, Klemens] Univ Bonn, Inst Genet, Bonn, Germany	Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bonn	Schwarz, J (corresponding author), Hannover Med Sch, Dept Toxicol, D-3000 Hannover, Germany.	Gerhard.ralf@mh-hannover.de		Rottner, Klemens/0000-0003-4244-4198	Deutsche Forschungsgemeinschaft [SFB621, B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by the Deutsche Forschungsgemeinschaft, SFB621, project B5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fukata M, 1999, J CELL SCI, V112, P4491; Geny B, 2009, CELL MICROBIOL, V11, P1102, DOI 10.1111/j.1462-5822.2009.01314.x; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2003, J BIOL CHEM IN PRESS, V278; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pietrek M, 2010, J VIROL, V84, P8231, DOI 10.1128/JVI.01696-09; PRIGMORE E, 1995, J BIOL CHEM, V270, P10717, DOI 10.1074/jbc.270.18.10717; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Schoentaube J, 2009, CELL MICROBIOL, V11, P1816, DOI 10.1111/j.1462-5822.2009.01373.x; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Tu H, 1999, MOL CELL BIOL, V19, P602; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	39	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44358	10.1371/journal.pone.0044358	http://dx.doi.org/10.1371/journal.pone.0044358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970203	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400015
J	Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Rohban, R; Etchart, N; Fruehwirth, M; Beham-Schmid, C; Andreeff, M; Strunk, D				Hofmann, Nicole A.; Ortner, Anna; Jacamo, Rodrigo O.; Reinisch, Andreas; Schallmoser, Katharina; Rohban, Rokhsareh; Etchart, Nathalie; Fruehwirth, Margareta; Beham-Schmid, Christine; Andreeff, Michael; Strunk, Dirk			Oxygen Sensing Mesenchymal Progenitors Promote Neo-Vasculogenesis in a Humanized Mouse Model In Vivo	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; COLONY-FORMING CELLS; UMBILICAL-CORD BLOOD; ENDOTHELIAL-CELLS; BONE-MARROW; TUMOR ANGIOGENESIS; GENE-EXPRESSION; STROMAL CELLS; STEM-CELLS; THERAPY	Despite insights into the molecular pathways regulating hypoxia-induced gene expression, it is not known which cell types accomplish oxygen sensing during neo-vasculogenesis. We have developed a humanized mouse model of endothelial and mesenchymal progenitor co-transplantation to delineate the cellular compartments responsible for hypoxia response during vasculogenesis. Mesenchymal stem/progenitor cells (MSPCs) accumulated nuclear hypoxia-inducible transcription factor (HIF)-1 alpha earlier and more sensitively than endothelial colony forming progenitor cells (ECFCs) in vitro and in vivo. Hypoxic ECFCs showed reduced function in vitro and underwent apoptosis within 24h in vivo when used without MSPCs. Surprisingly, only in MSPCs did pharmacologic or genetic inhibition of HIF-1 alpha abrogate neo-vasculogenesis. HIF deletion in ECFCs caused no effect. ECFCs could be rescued from hypoxia-induced apoptosis by HIF-competent MSPCs resulting in the formation of patent perfused human vessels. Several angiogenic factors need to act in concert to partially substitute mesenchymal HIF-deficiency. Results demonstrate that ECFCs require HIF-competent vessel wall progenitors to initiate vasculogenesis in vivo and to bypass hypoxia-induced apoptosis. We describe a novel mechanistic role of MSPCs as oxygen sensors promoting vasculogenesis thus underscoring their importance for the development of advanced cellular therapies.	[Hofmann, Nicole A.; Ortner, Anna; Reinisch, Andreas; Schallmoser, Katharina; Rohban, Rokhsareh; Etchart, Nathalie; Fruehwirth, Margareta; Strunk, Dirk] Med Univ Graz, Stem Cell Res Unit, Graz, Austria; [Jacamo, Rodrigo O.; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Reinisch, Andreas; Etchart, Nathalie; Fruehwirth, Margareta; Strunk, Dirk] Med Univ Graz, Dept Hematol & Stem Cell Transplantat, Graz, Austria; [Schallmoser, Katharina] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria; [Beham-Schmid, Christine] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center; Medical University of Graz; Medical University of Graz; Medical University of Graz	Hofmann, NA (corresponding author), Med Univ Graz, Stem Cell Res Unit, Graz, Austria.	dirk.strunk@medunigraz.at	Schallmoser, Katharina/V-4734-2017; Strunk, Dirk/V-4598-2017	Schallmoser, Katharina/0000-0002-7204-0058; Strunk, Dirk/0000-0003-1810-867X; Reinisch, Andreas/0000-0001-9333-7689	Austrian Research Foundation (FFG) [N211-NAN]; Adult Stem Cell Research Foundation (TASCRF); Medical University of Graz	Austrian Research Foundation (FFG)(Austrian Science Fund (FWF)); Adult Stem Cell Research Foundation (TASCRF); Medical University of Graz	This work was supported by the Austrian Research Foundation (FFG, grant N211-NAN; DS), the Adult Stem Cell Research Foundation (TASCRF) and a young investigator starting grant of the Medical University of Graz (AR). NAH, AO, AR and RR are fellows of the PhD program Molecular Medicine at the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen Y, 2012, BLOOD, V119, P4971, DOI 10.1182/blood-2011-11-389957; Cheng G, 2011, BLOOD, V118, P4740, DOI 10.1182/blood-2011-02-338426; Demidova-Rice TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032146; Dimmeler S, 2008, ARTERIOSCL THROM VAS, V28, P208, DOI 10.1161/ATVBAHA.107.155317; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Greenberger S, 2010, NEW ENGL J MED, V362, P1005, DOI 10.1056/NEJMoa0903036; Hofmann Nicole A, 2009, J Vis Exp, DOI 10.3791/1524; Hofmann Nicole A, 2012, Methods Mol Biol, V879, P381, DOI 10.1007/978-1-61779-815-3_23; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Li SH, 2008, MOL CANCER THER, V7, P3729, DOI 10.1158/1535-7163.MCT-08-0074; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Mackman N, 2011, ARTERIOSCL THROM VAS, V31, P2364, DOI 10.1161/ATVBAHA.111.236703; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Melero-Martin JM, 2010, TISSUE ENG PT A, V16, P2457, DOI [10.1089/ten.tea.2010.0024, 10.1089/ten.TEA.2010.0024]; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Reinisch A, 2007, REGEN MED, V2, P371, DOI 10.2217/17460751.2.4.371; Reinisch Andreas, 2009, J Vis Exp, DOI 10.3791/1525; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928; Schallmoser K, 2008, TISSUE ENG PT C-METH, V14, P185, DOI 10.1089/ten.tec.2008.0060; Schallmoser Katharina, 2009, J Vis Exp, DOI 10.3791/1523; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Strunk D, 2005, TRANSFUSION, V45, P315, DOI 10.1111/j.1537-2995.2005.04056.x; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Templin C, 2012, CIRCULATION IN PRESS; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zhou WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027460	57	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44468	10.1371/journal.pone.0044468	http://dx.doi.org/10.1371/journal.pone.0044468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970226	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000023
J	Hong, HX; Xu, L; Liu, J; Jones, WD; Su, ZQ; Ning, BT; Perkins, R; Ge, WG; Miclaus, K; Zhang, L; Park, K; Green, B; Han, T; Fang, H; Lambert, CG; Vega, SC; Lin, SM; Jafari, N; Czika, W; Wolfinger, RD; Goodsaid, F; Tong, WD; Shi, LM				Hong, Huixiao; Xu, Lei; Liu, Jie; Jones, Wendell D.; Su, Zhenqiang; Ning, Baitang; Perkins, Roger; Ge, Weigong; Miclaus, Kelci; Zhang, Li; Park, Kyunghee; Green, Bridgett; Han, Tao; Fang, Hong; Lambert, Christophe G.; Vega, Silvia C.; Lin, Simon M.; Jafari, Nadereh; Czika, Wendy; Wolfinger, Russell D.; Goodsaid, Federico; Tong, Weida; Shi, Leming			Technical Reproducibility of Genotyping SNP Arrays Used in Genome-Wide Association Studies	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENETIC VARIANT; HAPMAP SAMPLES; BREAST-CANCER; RISK LOCI; DISEASE; ALGORITHM; GWAS; INCONSISTENCIES; REPLICATION	During the last several years, high-density genotyping SNP arrays have facilitated genome-wide association studies (GWAS) that successfully identified common genetic variants associated with a variety of phenotypes. However, each of the identified genetic variants only explains a very small fraction of the underlying genetic contribution to the studied phenotypic trait. Moreover, discordance observed in results between independent GWAS indicates the potential for Type I and II errors. High reliability of genotyping technology is needed to have confidence in using SNP data and interpreting GWAS results. Therefore, reproducibility of two widely genotyping technology platforms from Affymetrix and Illumina was assessed by analyzing four technical replicates from each of the six individuals in five laboratories. Genotype concordance of 99.40% to 99.87% within a laboratory for the sample platform, 98.59% to 99.86% across laboratories for the same platform, and 98.80% across genotyping platforms was observed. Moreover, arrays with low quality data were detected when comparing genotyping data from technical replicates, but they could not be detected according to venders' quality control (QC) suggestions. Our results demonstrated the technical reliability of currently available genotyping platforms but also indicated the importance of incorporating some technical replicates for genotyping QC in order to improve the reliability of GWAS results. The impact of discordant genotypes on association analysis results was simulated and could explain, at least in part, the irreproducibility of some GWAS findings when the effect size (i.e. the odds ratio) and the minor allele frequencies are low.	[Hong, Huixiao; Xu, Lei; Perkins, Roger; Ge, Weigong; Tong, Weida; Shi, Leming] US FDA, Ctr Excellence Bioinformat, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Liu, Jie; Ning, Baitang; Green, Bridgett] US FDA, Div Personalized Nutr & Med, Natl Ctr Toxicol Res, Jefferson, AR USA; [Jones, Wendell D.] Express Anal Inc, Durham, NC USA; [Su, Zhenqiang; Fang, Hong] US FDA, ICF Int Co, Natl Ctr Toxicol Res, Jefferson, AR USA; [Miclaus, Kelci; Czika, Wendy; Wolfinger, Russell D.] SAS Inst Inc, Cary, NC USA; [Zhang, Li; Goodsaid, Federico] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Park, Kyunghee] Samsung Adv Inst Technol, Yongin Si Gyeonggi Do, South Korea; [Han, Tao] US FDA, Ctr Excellence Genom, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Lambert, Christophe G.] Golden Helix Inc, Bozeman, MT USA; [Vega, Silvia C.] Microsoft Corp, Rosetta BioSoftware, Hlth Solut Grp, Seattle, WA USA; [Lin, Simon M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); SAS Institute Inc; US Food & Drug Administration (FDA); Samsung; US Food & Drug Administration (FDA); Microsoft; Northwestern University	Hong, HX (corresponding author), US FDA, Ctr Excellence Bioinformat, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	huixiao.hong@fda.hhs.gov; leming.shi@fda.hhs.gov	Jones, Wendell/AAM-4831-2021; Shi, Leming/B-3150-2010; Lambert, Christophe/AAH-4448-2021; Su, Zhenqiang/H-3914-2012	Shi, Leming/0000-0002-7143-2033; Lambert, Christophe/0000-0003-1994-2893; Jones, Wendell/0000-0002-9676-5387; Hong, Huixiao/0000-0001-8087-3968; Ning, Baitang/0000-0003-0798-0331	Expression Analysis, Inc; Golden Helix Inc	Expression Analysis, Inc; Golden Helix Inc	The authors have read the journal's policy and have the following conflicts: Wendell Jones is a paid employee of Expression Analysis, Inc; Wendy Czika, Kelci Miclaus and Russell D. Wolfinger are employed by SAS Institute Inc; Zhenqiang Su and Hong Fang are employed by ICF International Company at NCTR/FDA (National Center for Toxicological Research/Food and Drug Administration); Christophe G. Lambert is a paid employee of Golden Helix Inc; Silvia Vega has been employed by Rosetta BioSoftware and for Microsoft Corp. in the last five years but at present has no competing interests. All other authors have no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hong H, 2010, PHARMACOGENOMICS J, V10, P364, DOI 10.1038/tpj.2010.24; Hong H., 2009, BATCH EFFECTS NOISE, P191; Hong HX, 2010, J GENET, V89, P55, DOI 10.1007/s12041-010-0011-4; Hong HX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S17; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lyssenko V, 2009, CURR OPIN LIPIDOL, V20, P87, DOI 10.1097/MOL.0b013e32832923af; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P324, DOI 10.1038/tpj.2010.46; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P336, DOI 10.1038/tpj.2010.36; Pearson TA, 2008, JAMA-J AM MED ASSOC, V82, P411; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pfeufer A, 2007, NAT GENET       0527, V42, P153; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang L, 2010, PHARMACOGENOMICS J, V10, P347, DOI 10.1038/tpj.2010.27	42	38	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44483	10.1371/journal.pone.0044483	http://dx.doi.org/10.1371/journal.pone.0044483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970228	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000024
J	Keating, SCJ; Thomas, AA; Flecknell, PA; Leach, MC				Keating, Stephanie C. J.; Thomas, Aurelie A.; Flecknell, Paul A.; Leach, Matthew C.			Evaluation of EMLA Cream for Preventing Pain during Tattooing of Rabbits: Changes in Physiological, Behavioural and Facial Expression Responses	PLOS ONE			English	Article							LIDOCAINE-PRILOCAINE CREAM; LABORATORY-ANIMALS; EUTECTIC MIXTURE; LOCAL-ANESTHESIA; LAPAROTOMY; RATS; CARPROFEN; SKIN; BUPRENORPHINE; ANALGESIA	Background: Ear tattooing is a routine procedure performed on laboratory, commercial and companion rabbits for the purpose of identification. Although this procedure is potentially painful, it is usually performed without the provision of analgesia, so compromising animal welfare. Furthermore, current means to assess pain in rabbits are poor and more reliable methods are required. The objectives of this study were to assess the physiological and behavioural effects of ear tattooing on rabbits, evaluate the analgesic efficacy of topical local anaesthetic cream application prior to this procedure, and to develop a scale to assess pain in rabbits based on changes in facial expression. Methodology/Principal Findings: In a crossover study, eight New Zealand White rabbits each underwent four different treatments of actual or sham ear tattooing, with and without prior application of a topical local anaesthetic (lidocaine/prilocaine). Changes in immediate behaviour, heart rate, arterial blood pressure, serum corticosterone concentrations, facial expression and home pen behaviours were assessed. Changes in facial expression were examined to develop the Rabbit Grimace Scale in order to assess acute pain. Tattooing without EMLA cream resulted in significantly greater struggling behaviour and vocalisation, greater facial expression scores of pain, higher peak heart rate, as well as higher systolic and mean arterial blood pressure compared to all other treatments. Physiological and behavioural changes following tattooing with EMLA cream were similar to those in animals receiving sham tattoos with or without EMLA cream. Behavioural changes 1 hour post-treatment were minimal with no pain behaviours identifiable in any group. Serum corticosterone responses did not differ between sham and tattoo treatments. Conclusions: Ear tattooing causes transient and potentially severe pain in rabbits, which is almost completely prevented by prior application of local anaesthetic cream. The Rabbit Grimace Scale developed appears to be a reliable and accurate way to assess acute pain in rabbits.	[Keating, Stephanie C. J.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Thomas, Aurelie A.; Flecknell, Paul A.; Leach, Matthew C.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thomas, Aurelie A.; Flecknell, Paul A.; Leach, Matthew C.] Newcastle Univ, Comparat Biol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Guelph; Newcastle University - UK; Newcastle University - UK	Keating, SCJ (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada.	Matthew.Leach@Newcastle.ac.uk		Flecknell, Paul/0000-0002-1075-1129	Swedish Board of Agriculture; NC3Rs; BBSRC; National Centre for the Replacement [G1100563/1] Funding Source: researchfish	Swedish Board of Agriculture; NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement	Ms. Keating was supported by the Swedish Board of Agriculture, Dr. Leach was supported by the NC3Rs (www.nc3rs.org.uk), and the BBSRC (www.bbsrc.ac.uk). The animals used in this study were donated by Harlan UK (www.harlan.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Rabbit Breeders Association, 2012, INSTR REG; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; BJERRING P, 1990, BRIT J ANAESTH, V64, P173, DOI 10.1093/bja/64.2.173; Brodbelt DC, 2008, VET ANAESTH ANALG, V35, P365, DOI 10.1111/j.1467-2995.2008.00397.x; Donovan John, 2006, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0105s73; FLECKNELL PA, 1990, LAB ANIM-UK, V24, P142, DOI 10.1258/002367790780890121; FLECKNELL PA, 1994, LAB ANIM-UK, V28, P222, DOI 10.1258/002367794780681660; GOODACRE TEE, 1988, BRIT J PLAST SURG, V41, P533, DOI 10.1016/0007-1226(88)90013-6; HIRVONEN J, 1991, PHARMACEUT RES, V8, P933, DOI 10.1023/A:1015824100788; HOLMES HS, 1994, DERMATOL CLIN, V12, P817, DOI 10.1016/S0733-8635(18)30145-1; Kasanen IHE, 2011, LAB ANIM-UK, V45, P154, DOI 10.1258/la.2011.010113; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; LILES JH, 1994, J VET PHARMACOL THER, V17, P284, DOI 10.1111/j.1365-2885.1994.tb00247.x; Martin TJ, 2004, ANESTHESIOLOGY, V101, P191, DOI 10.1097/00000542-200407000-00030; MROZEK M, 1995, LAB ANIM, V29, P339, DOI 10.1258/002367795781088298; National Research Council, 2009, REC ALL PAIN LAB AN; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; RYLANDER E, 1990, OBSTET GYNECOL, V75, P302; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Shaikh FM, 2009, DERMATOL SURG, V35, P948, DOI 10.1111/j.1524-4725.2009.01160.x; SMITH M, 1990, BRIT J ANAESTH, V65, P240, DOI 10.1093/bja/65.2.240; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; TADDIO A, 1994, J PEDIATR-US, V124, P643, DOI 10.1016/S0022-3476(05)83150-6; Wahlgren CF, 2000, J AM ACAD DERMATOL, V42, P584, DOI 10.1016/S0190-9622(00)90169-5; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	31	168	170	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44437	10.1371/journal.pone.0044437	http://dx.doi.org/10.1371/journal.pone.0044437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970216	gold, Green Submitted, Green Published			2022-12-27	WOS:000308462000020
J	Rogers, H; Lambers, JHR; Miller, R; Tewksbury, JJ				Rogers, Haldre; Lambers, Janneke Hille Ris; Miller, Ross; Tewksbury, Joshua J.			'Natural experiment' Demonstrates Top-Down Control of Spiders by Birds on a Landscape Level	PLOS ONE			English	Article							NIGHTINGALE REED-WARBLER; INSECTIVOROUS BIRDS; MARIANA SWIFTLET; TROPHIC CASCADE; NATIONAL-PARK; NEST SITES; WHITE-EYE; ORB WEBS; BEHAVIOR; ISLAND	The combination of small-scale manipulative experiments and large-scale natural experiments provides a powerful approach for demonstrating the importance of top-down trophic control on the ecosystem scale. The most compelling natural experiments have come from studies examining the landscape-scale loss of apex predators like sea otters, wolves, fish and land crabs. Birds are dominant apex predators in terrestrial systems around the world, yet all studies on their role as predators have come from small-scale experiments; the top-down impact of bird loss on their arthropod prey has yet to be examined at a landscape scale. Here, we use a unique natural experiment, the extirpation of insectivorous birds from nearly all forests on the island of Guam by the invasive brown tree snake, to produce the first assessment of the impacts of bird loss on their prey. We focused on spiders because experimental studies showed a consistent top-down effect of birds on spiders. We conducted spider web surveys in native forest on Guam and three nearby islands with healthy bird populations. Spider web densities on the island of Guam were 40 times greater than densities on islands with birds during the wet season, and 2.3 times greater during the dry season. These results confirm the general trend from manipulative experiments conducted in other systems however, the effect size was much greater in this natural experiment than in most manipulative experiments. In addition, bird loss appears to have removed the seasonality of spider webs and led to larger webs in at least one spider species in the forests of Guam than on nearby islands with birds. We discuss several possible mechanisms for the observed changes. Overall, our results suggest that effect sizes from smaller-scale experimental studies may significantly underestimate the impact of bird loss on spider density as demonstrated by this large-scale natural experiment.	[Rogers, Haldre; Lambers, Janneke Hille Ris; Tewksbury, Joshua J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Miller, Ross] Univ Guam, Western Pacific Trop Res Ctr, Mangilao, GU USA	University of Washington; University of Washington Seattle; University of Guam	Rogers, H (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	haldre@rice.edu		Rogers, Haldre/0000-0003-4763-5006; Tewksbury, Joshua/0000-0002-9786-1477	Budweiser Conservation Scholarship through the National Fish and Wildlife Foundation; University of Washington Department of Biology Giles Award; Howard Hughes Medical Institute undergraduate research fellowship; National Science Foundation Graduate Research Fellowship; National Science Foundation [DEB-0816465]; United States Department of Agriculture National Research Initiative [2008-03106]	Budweiser Conservation Scholarship through the National Fish and Wildlife Foundation; University of Washington Department of Biology Giles Award; Howard Hughes Medical Institute undergraduate research fellowship(Howard Hughes Medical Institute); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA))	This study was funded by the Budweiser Conservation Scholarship through the National Fish and Wildlife Foundation (HR), the University of Washington Department of Biology Giles Award (HR), Howard Hughes Medical Institute undergraduate research fellowship (to field assistant TK), National Science Foundation Graduate Research Fellowship (HR), National Science Foundation DEB-0816465, and United States Department of Agriculture National Research Initiative 2008-03106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidon FA, 2004, WILSON BULL, V116, P342, DOI 10.1676/04-037; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Beschta RL, 2005, ECOLOGY, V86, P391, DOI 10.1890/04-0964; Blackledge TA, 1999, BEHAV ECOL, V10, P372, DOI 10.1093/beheco/10.4.372; Blackledge TA, 2007, BIOL LETTERS, V3, P456, DOI 10.1098/rsbl.2007.0218; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Camp RJ, 2009, BIRD CONSERV INT, V19, P323, DOI 10.1017/S0959270909008417; Craig RJ, 1996, WILSON BULL, V108, P246; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Gruner DS, 2005, BIOL INVASIONS, V7, P541, DOI 10.1007/s10530-004-2509-2; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Guard C.P., 2003, CREATION 50 YEAR RAI; Gunnarsson B, 2007, J ARACHNOL, V35, P509, DOI 10.1636/RT07-64.1; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; Jenkins JM., 1983, NATIVE FOREST BIRDS; Kerr Alexander M., 1993, Pacific Science, V47, P328; Lander M.A., 2004, RAINFALL CLIMATOLOGY; Li DQ, 2004, ANIM BEHAV, V67, P309, DOI 10.1016/j.anbehav.2003.06.011; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; MARSHALL JOE T., 1949, CONDOR, V51, P200, DOI 10.2307/1364563; MARSHALL SD, 1989, WILSON BULL, V101, P472; Mooney KA, 2006, J ANIM ECOL, V75, P350, DOI 10.1111/j.1365-2656.2006.01054.x; Mooney KA, 2007, ECOLOGY, V88, P2005, DOI 10.1890/06-1095.1; Mosher SM, 2002, WILSON BULL, V114, P1, DOI 10.1676/0043-5643(2002)114[0001:DONEAN]2.0.CO;2; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reichel JD, 2007, WILSON J ORNITHOL, V119, P686, DOI 10.1676/06-132.1; ROBINSON MH, 1974, PAC INSECTS, V16, P117; RODDA G H, 1992, Pacific Science, V46, P46; Sagarin R, 2010, FRONT ECOL ENVIRON, V8, P379, DOI 10.1890/090001; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; SCHOENER TW, 1987, SCIENCE, V236, P949, DOI 10.1126/science.236.4804.949; SCHOENER TW, 1995, SCIENCE, V267, P1811, DOI 10.1126/science.267.5205.1811; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sekercioglu CH, 2002, BIOL CONSERV, V107, P229, DOI 10.1016/S0006-3207(02)00097-6; SPILLER DA, 1990, OECOLOGIA, V83, P150, DOI 10.1007/BF00317746; STINSON CM, 1994, J FIELD ORNITHOL, V65, P65; Terborgh J., 2010, TROPHIC CASCADES PRE; Valdez EW, 2011, PAC SCI, V65, P301, DOI 10.2984/65.3.301; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Van Bael SA, 2005, OECOLOGIA, V145, P658, DOI 10.1007/s00442-005-0134-0; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x	52	51	54	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43446	10.1371/journal.pone.0043446	http://dx.doi.org/10.1371/journal.pone.0043446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970126	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000002
J	Crawford, AO; Hamerton, I; Cavalli, G; Howlin, BJ				Crawford, Alasdair O.; Hamerton, Ian; Cavalli, Gabriel; Howlin, Brendan J.			Quantifying the Effect of Polymer Blending through Molecular Modelling of Cyanurate Polymers	PLOS ONE			English	Article							LINKED EPOXY-RESIN; INITIO FORCE-FIELD; CYANATE ESTER; DYNAMICS SIMULATION; MECHANICAL-PROPERTIES; COMPUTER-SIMULATIONS; DIFFUSION; POLYSILOXANES; COMPOSITES; POLYIMIDES	Modification of polymer properties by blending is a common practice in the polymer industry. We report here a study of blends of cyanurate polymers by molecular modelling that shows that the final experimentally determined properties can be predicted from first principles modelling to a good degree of accuracy. There is always a compromise between simulation length, accuracy and speed of prediction. A comparison of simulation times shows that 125ps of molecular dynamics simulation at each temperature provides the optimum compromise for models of this size with current technology. This study opens up the possibility of computer aided design of polymer blends with desired physical and mechanical properties.	[Crawford, Alasdair O.; Hamerton, Ian; Cavalli, Gabriel; Howlin, Brendan J.] Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England	University of Surrey	Crawford, AO (corresponding author), Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Hamerton, Ian/AAV-8918-2021; Cavalli, Gabriel/B-7207-2009; Cavalli, Gabriel/ABE-2401-2020; Howlin, Brendan J/F-3343-2011	Hamerton, Ian/0000-0003-3113-0345; Cavalli, Gabriel/0000-0002-2856-1956; Cavalli, Gabriel/0000-0002-2856-1956; Howlin, Brendan J/0000-0002-9398-7152	Lonza AG	Lonza AG	The authors thank Lonza AG for funding this work in the form of a PhD studentship (AOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, MAT STUD; Allington RD, 2003, POLYMER, V44, P793, DOI 10.1016/S0032-3861(02)00707-3; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Auhl R, 2003, J CHEM PHYS, V119, P12718, DOI 10.1063/1.1628670; Crawford AO, 2012, REACT FUNCT POLYM, V72, P596, DOI 10.1016/j.reactfunctpolym.2012.05.012; Fan HB, 2007, POLYMER, V48, P2174, DOI 10.1016/j.polymer.2007.02.007; Fried JR, 2001, COMPUT THEOR POLYM S, V11, P273, DOI 10.1016/S1089-3156(00)00021-0; Gou J, COMPUTATIONAL MAT SC, V31, P225; Gou JH, 2004, COMP MATER SCI, V31, P225, DOI 10.1016/j.commatsci.2004.03.002; Grujicic M, 2007, APPL SURF SCI, V253, P3009, DOI 10.1016/j.apsusc.2006.06.050; Guenthner AJ, 2012, MACROMOLECULES, V45, P211, DOI 10.1021/ma202513h; Hall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042928; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; Hamerton I, 2006, REACT FUNCT POLYM, V66, P21, DOI 10.1016/j.reactfunctpolym.2005.07.018; Hamerton I., 1994, CHEM TECHNOLOGY CYAN; Hofmann D, 2000, COMPUT THEOR POLYM S, V10, P419, DOI 10.1016/S1089-3156(00)00007-6; Karad SK, 2002, COMPOS PART A-APPL S, V33, P1665, DOI 10.1016/S1359-835X(02)00176-8; Lin YC, 2005, CHEM PHYS LETT, V412, P322, DOI 10.1016/j.cplett.2005.07.022; MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Nair CPR, 2001, ADV POLYM SCI, V155, P1; Nair CPR, 1999, J APPL POLYM SCI, V74, P2737; Neyertz S, 2006, J MEMBRANE SCI, V280, P517, DOI 10.1016/j.memsci.2006.02.011; Pan R, 2007, COMP MATER SCI, V39, P887, DOI 10.1016/j.commatsci.2006.10.019; Parinello M., 1981, J APPL PHYS, V52, P7182; Pavel D, 2005, POLYMER, V46, P6135, DOI 10.1016/j.polymer.2005.05.085; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Ren H, 2007, POLYMER, V48, P887, DOI 10.1016/j.polymer.2006.12.016; Rigby D, 1997, POLYM INT, V44, P311, DOI 10.1002/(SICI)1097-0126(199711)44:3<311::AID-PI880>3.0.CO;2-H; Rui P., 2007, COMP MATER SCI, V39, P887; Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v; Sun H, 1997, SPECTROCHIM ACTA A, V53, P1301, DOI 10.1016/S1386-1425(97)00013-9; Tack JL, 2008, J MOL GRAPH MODEL, V26, P1269, DOI 10.1016/j.jmgm.2007.12.001; Tao QS, 2004, POLYMER, V45, P3505, DOI 10.1016/j.polymer.2004.03.043; Wu CF, 2007, POLYMER, V48, P5802, DOI 10.1016/j.polymer.2007.07.019; Wu CF, 2006, POLYMER, V47, P6004, DOI 10.1016/j.polymer.2006.06.025	36	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44487	10.1371/journal.pone.0044487	http://dx.doi.org/10.1371/journal.pone.0044487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970230	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400076
J	Ekvall, MK; Hansson, LA				Ekvall, Mattias K.; Hansson, Lars-Anders			Differences in Recruitment and Life-History Strategy Alter Zooplankton Spring Dynamics Under Climate-Change Conditions	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; RESTING STAGES; LAKE PLANKTON; DIAPAUSE; EVENTS; EGGS; TEMPERATURE; TERMINATION; INDUCTION; EMERGENCE	In recent decades temperature elevation has been the focus of many studies on climate change, including effects on planktonic communities, but few studies have examined the effects of increased water color ("brownification"). Since these changes are likely to occur simultaneously, it is important to investigate their potential interactive effects. Accordingly, we performed a mesocosm experiment where we combined a 3 degrees C increase in temperature with a doubling in water color to study how these factors affect zooplankton. In particular, we looked at recruitment of cladocerans and copepods from the sediment in spring, as well as their establishment in the water column. Our results show that an elevated temperature will have considerable effects on recruitment as well as on pelagic abundances of both cladocerans and copepods, whereas increases in water color will have less effects on the recruitment and pelagic establishment. But more importantly, the proportion of cladocerans in the water column, relative to copepods, increased at higher temperature, suggesting that cladocerans benefit more from elevated temperatures than copepods do. Overall, these results likely stem from the combined effect of changes in recruitment and differences in life history between copepods and cladocerans. Taking a wider outlook, this suggests that future climate warming will change the dominance pattern of zooplankton communities in spring, and, in accordance with the experimental data, we here show that cladocerans are more abundant than copepods in natural lake ecosystems during warmer rather than cooler years.	[Ekvall, Mattias K.; Hansson, Lars-Anders] Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden	Lund University	Ekvall, MK (corresponding author), Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden.	mattias.ekvall@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022	Hansson, Lars-Anders/0000-0002-3035-1317	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR) through Centre for Animal Movement Research (CAnMove) [349-2007-8690]	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR) through Centre for Animal Movement Research (CAnMove)(Swedish Research Council)	The project was financed by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and the Swedish Research Council (VR) through the Centre for Animal Movement Research (CAnMove) through the Linnaeus grant 349-2007-8690. The study was performed within the framework of the Interreg IV A European union project Algae Be Gone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Alekseev VR, 1996, HYDROBIOLOGIA, V320, P15, DOI 10.1007/BF00016801; Caceres CE, 2001, FRESHWATER BIOL, V46, P1179, DOI 10.1046/j.1365-2427.2001.00737.x; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Daniel C, 2005, AQUAT MICROB ECOL, V38, P113, DOI 10.3354/ame038113; DEMEESTER L, 1993, FRESHWATER BIOL, V30, P219; Dussart BH, 1995, COPEPODA INTRO COPEP; ELGMORK K, 1981, HOLARCTIC ECOL, V4, P278; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Gerten D, 2002, FRESHWATER BIOL, V47, P2163, DOI 10.1046/j.1365-2427.2002.00970.x; Graham MD, 2009, LIMNOL OCEANOGR, V54, P2481, DOI 10.4319/lo.2009.54.6_part_2.2481; Graneli W, 2012, ENCY LAKES RESERVOIR; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Gyllstrom M, 2004, ARCH HYDROBIOL, V161, P81, DOI 10.1127/0003-9136/2004/0161-0081; Hairston NG, 2000, FRESHWATER BIOL, V45, P133; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hongve D, 2004, AQUAT SCI, V66, P231, DOI 10.1007/s00027-004-0708-7; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; MAIER G, 1990, HYDROBIOLOGIA, V206, P11, DOI 10.1007/BF00018965; Nicolle A, 2012, FRESHWATER BIOL, V57, P684, DOI 10.1111/j.1365-2427.2012.02733.x; Scheffer M, 2001, LIMNOL OCEANOGR, V46, P1780, DOI 10.4319/lo.2001.46.7.1780; SCHWARTZ SS, 1987, FRESHWATER BIOL, V17, P373, DOI 10.1111/j.1365-2427.1987.tb01057.x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stahl-Delbanco A, 2003, J PLANKTON RES, V25, P1099, DOI 10.1093/plankt/25.9.1099; Straile D, 2000, GLOBAL CHANGE BIOL, V6, P663, DOI 10.1046/j.1365-2486.2000.00350.x; STROSS RG, 1966, ECOLOGY, V47, P368, DOI 10.2307/1932977; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Vandekerkhove J, 2005, FRESHWATER BIOL, V50, P96, DOI 10.1111/j.1365-2427.2004.01312.x; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965	33	22	25	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44614	10.1371/journal.pone.0044614	http://dx.doi.org/10.1371/journal.pone.0044614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970267	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400095
J	Whitworth, WC; Hamilton, LR; Goodwin, DJ; Barrera, C; West, KB; Racster, L; Daniels, LJ; Chuke, SO; Campbell, BH; Bohanon, J; Jaffar, AT; Drane, W; Maserang, D; Mazurek, GH				Whitworth, William C.; Hamilton, Lanette R.; Goodwin, Donald J.; Barrera, Carlos; West, Kevin B.; Racster, Laura; Daniels, Laura J.; Chuke, Stella O.; Campbell, Brandon H.; Bohanon, Jamaria; Jaffar, Atheer T.; Drane, Wanzer; Maserang, David; Mazurek, Gerald H.			Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; INTERFERON-GAMMA RESPONSES; HEALTH-CARE WORKERS; RELEASE ASSAYS; REPRODUCIBILITY; CONVERSIONS; GUIDELINES	Background: The QuantiFERON (R)-TB Gold In-Tube test (QFT-GIT) is a viable alternative to the tuberculin skin test (TST) for detecting Mycobacterium tuberculosis infection. However, within-subject variability may limit test utility. To assess variability, we compared results from the same subjects when QFT-GIT enzyme-linked immunosorbent assays (ELISAs) were performed in different laboratories. Methods: Subjects were recruited at two sites and blood was tested in three labs. Two labs used the same type of automated ELISA workstation, 8-point calibration curves, and electronic data transfer. The third lab used a different automated ELISA workstation, 4-point calibration curves, and manual data entry. Variability was assessed by interpretation agreement and comparison of interferon-gamma (IFN-gamma) measurements. Data for subjects with discordant interpretations or discrepancies in TB Response >0.05 IU/mL were verified or corrected, and variability was reassessed using a reconciled dataset. Results: Ninety-seven subjects had results from three labs. Eleven (11.3%) had discordant interpretations and 72 (74.2%) had discrepancies >0.05 IU/mL using unreconciled results. After correction of manual data entry errors for 9 subjects, and exclusion of 6 subjects due to methodological errors, 7 (7.7%) subjects were discordant. Of these, 6 (85.7%) had all TB Responses within 0.25 IU/mL of the manufacturer's recommended cutoff. Non-uniform error of measurement was observed, with greater variation in higher IFN-gamma measurements. Within-subject standard deviation for TB Response was as high as 0.16 IU/mL, and limits of agreement ranged from -0.46 to 0.43 IU/mL for subjects with mean TB Response within 0.25 IU/mL of the cutoff. Conclusion: Greater interlaboratory variability was associated with manual data entry and higher IFN-gamma measurements. Manual data entry should be avoided. Because variability in measuring TB Response may affect interpretation, especially near the cutoff, consideration should be given to developing a range of values near the cutoff to be interpreted as "borderline," rather than negative or positive.	[Whitworth, William C.; Daniels, Laura J.; Chuke, Stella O.; Campbell, Brandon H.; Mazurek, Gerald H.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; [Hamilton, Lanette R.; Barrera, Carlos] Tripler Army Med Ctr, Dept Med, Honolulu, HI 96859 USA; [Goodwin, Donald J.; Racster, Laura; Bohanon, Jamaria; Jaffar, Atheer T.] USAF, Sch Aerosp Med, Epidemiol Serv Branch, Brooks City Base, TX USA; [West, Kevin B.] Wilford Hall USAF Med Ctr, Reid Clin, Dept Occupat Med TB Prevent Deployment Med, Lackland AFB, TX 78236 USA; [Daniels, Laura J.; Bohanon, Jamaria; Jaffar, Atheer T.] CDC Fdn, Atlanta, GA USA; [Chuke, Stella O.] Northrop Grumman Informat Syst Sect, Atlanta, GA USA; [Drane, Wanzer] Univ S Carolina, Columbia, SC 29208 USA; [Maserang, David] USAF, Sch Aerosp Med, Appl Technol Ctr, Brooks City Base, TX USA	Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Defense; United States Air Force	Whitworth, WC (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	wcw2@cdc.gov			United States Air Force (USAF)	United States Air Force (USAF)	The United States Air Force (USAF) funded this study as part of a larger project assessing reproducibility of the QuantiFERON-TB Gold In-Tube tests. The USAF and the Centers for Disease Control and Prevention (CDC) reviewed the study design, data collection methods, and analysis plans prior to approval. The USAF, U. S. Army, and CDC cleared the manuscript for publication according to established guidelines. No outside funders had a role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Atkinson G, 2000, SPORTS MED, V30, P375, DOI 10.2165/00007256-200030050-00005; Baker CA, 2009, AM J TROP MED HYG, V80, P628, DOI 10.4269/ajtmh.2009.80.628; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Belknap R, 2009, AM J RESP CRIT CARE, V179; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM., 2006, SHOULD I CALCULATE W; Cellestis, 2009, QUANTIFERON TB GOLD; Costa JT, 2010, REV PORT PNEUMOL, V16, P211, DOI 10.1016/S0873-2159(15)30022-2; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P1146; Lu L, 2007, NE SAS USERS GROUP 2; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262; Pollock NR, 2009, INFECT CONT HOSP EP, V30, P392, DOI 10.1086/596606; Powell RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020061; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Zwerling AA, 2009, AM J RESP CRIT CARE, V179; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	34	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43790	10.1371/journal.pone.0043790	http://dx.doi.org/10.1371/journal.pone.0043790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970142	Green Published, gold			2022-12-27	WOS:000308458400019
J	Xu, D; Zhang, BJ; Liang, G; Ping, J; Kou, H; Li, XJ; Xiong, J; Hu, DC; Chen, LB; Magdalou, J; Wang, H				Xu, Dan; Zhang, Benjian; Liang, Gai; Ping, Jie; Kou, Hao; Li, Xiaojun; Xiong, Jie; Hu, Dongcai; Chen, Liaobin; Magdalou, Jacques; Wang, Hui			Caffeine-Induced Activated Glucocorticoid Metabolism in the Hippocampus Causes Hypothalamic-Pituitary-Adrenal Axis Inhibition in Fetal Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; INTRAUTERINE GROWTH RESTRICTION; GENE-EXPRESSION; MINERALOCORTICOID RECEPTOR; ENVIRONMENTAL EPIGENOMICS; PRENATAL OVEREXPOSURE; EPIGENETIC MECHANISMS; INSULIN SENSITIVITY; PROTEIN-A; CORTISOL	Epidemiological investigations have shown that fetuses with intrauterine growth retardation (IUGR) are susceptible to adult metabolic syndrome. Clinical investigations and experiments have demonstrated that caffeine is a definite inducer of IUGR, as children who ingest caffeine-containing food or drinks are highly susceptible to adult obesity and hypertension. Our goals for this study were to investigate the effect of prenatal caffeine ingestion on the functional development of the fetal hippocampus and the hypothalamic-pituitary-adrenal (HPA) axis and to clarify an intrauterine HPA axis-associated neuroendocrine alteration induced by caffeine. Pregnant Wistar rats were intragastrically administered 20, 60, and 180 mg/kg.d caffeine from gestational days 11-20. The results show that prenatal caffeine ingestion significantly decreased the expression of fetal hypothalamus corticotrophin-releasing hormone. The fetal adrenal cortex changed into slight and the expression of fetal adrenal steroid acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme (P450scc), as well as the level of fetal adrenal endogenous corticosterone (CORT), were all significantly decreased after caffeine treatment. Moreover, caffeine ingestion significantly increased the levels of maternal and fetal blood CORT and decreased the expression of placental 11 beta-hydroxysteroid dehydrogenase-2 (11 beta-HSD-2). Additionally, both in vivo and in vitro studies show that caffeine can downregulate the expression of fetal hippocampal 11b-HSD-2, promote the expression of 11 beta-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor (GR), and enhance DNA methylation within the hippocampal 11b-HSD-2 promoter. These results suggest that prenatal caffeine ingestion inhibits the development of the fetal HPA axis, which may be associated with the fetal overexposure to maternal glucocorticoid and activated glucocorticoid metabolism in the fetal hippocampus. These results will be beneficial in elucidating the developmental toxicity of caffeine and in exploring the fetal origin of adult HPA axis dysfunction and metabolic syndrome susceptibility for offspring with IUGR induced by caffeine.	[Xu, Dan; Zhang, Benjian; Liang, Gai; Ping, Jie; Kou, Hao; Li, Xiaojun; Xiong, Jie; Wang, Hui] Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430072, Peoples R China; [Xu, Dan; Ping, Jie; Wang, Hui] Wuhan Univ, Res Ctr Food & Drug Evaluat, Wuhan 430072, Peoples R China; [Hu, Dongcai; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan 430072, Peoples R China; [Magdalou, Jacques] Univ Nancy, Fac Med, CNRS, UMR 7561, Vandoeuvre Les Nancy, France	Wuhan University; Wuhan University; Wuhan University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Xu, D (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430072, Peoples R China.	wanghui19@whu.edu.cn	Hu, Dongcai/F-2375-2014; Zhang, Benjian/ABC-1130-2020	Hu, Dongcai/0000-0002-1239-7215; 	National Natural Science Foundation of China [30830112, 81072709, 812 2]; Chinese Ministry of Education [V200801]; Hubei Province Science Foundation for Innovation Group of China [2009CDA079]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110141120055]; Postdoctoral Science Foundation of China [20110491196]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Hubei Province Science Foundation for Innovation Group of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30830112, 81072709, and 812 2), the Key Grant Project of the Chinese Ministry of Education (No. V200801), the Hubei Province Science Foundation for Innovation Group of China (No. 2009CDA079), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20110141120055) and the Postdoctoral Science Foundation of China (No. 20110491196). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Baserga M, 2010, AM J PHYSIOL-REG I, V299, pR334, DOI 10.1152/ajpregu.00122.2010; Boylan SM, 2008, BRIT J NUTR, V100, P875, DOI 10.1017/S0007114508939842; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Brown RW, 1996, ENDOCRINOLOGY, V137, P794, DOI 10.1210/en.137.2.794; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cayetanot F, 2009, RESP PHYSIOL NEUROBI, V168, P92, DOI 10.1016/j.resp.2009.04.024; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Chen M, 2007, EXP TOXICOL PATHOL, V59, P245, DOI 10.1016/j.etp.2007.05.007; Christian MS, 2001, TERATOLOGY, V64, P51, DOI 10.1002/tera.1047; Cohen M S, 1982, Drug Ther, P165; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Diaz R, 1998, J NEUROSCI, V18, P2570; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Fowden AL, 2005, EARLY HUM DEV, V81, P723, DOI 10.1016/j.earlhumdev.2005.06.007; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Da Silveira VMF, 2008, REV SAUDE PUBL, V42, P10, DOI 10.1590/S0034-89102008000100002; Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323; Henriquez-Hernandez LA, 2007, J PHARMACOL EXP THER, V320, P695, DOI 10.1124/jpet.106.113209; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Huang J, 2012, CLIN EXP PHARMACOL P, V39, P357, DOI 10.1111/j.1440-1681.2012.05676.x; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johren O, 2007, BRAIN RES, V1184, P160, DOI 10.1016/j.brainres.2007.09.036; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Kjaer SL, 2011, PHYSIOL BEHAV, V102, P444, DOI 10.1016/j.physbeh.2010.12.015; Kjaer SL, 2010, BRAIN RES, V1320, P106, DOI 10.1016/j.brainres.2010.01.008; Kuczkowski KM, 2007, CURR OPIN OBSTET GYN, V19, P578, DOI 10.1097/GCO.0b013e3282f1bf17; Liang G, 2011, EXP TOXICOL PATHOL, V63, P607, DOI 10.1016/j.etp.2010.04.015; Lin A S, 1997, Depress Anxiety, V5, P21, DOI 10.1002/(SICI)1520-6394(1997)5:1<21::AID-DA4>3.3.CO;2-A; Liu YS, 2012, TOXICOL APP IN PRESS; Lopez-Bermejo A, 2004, CLIN ENDOCRINOL, V60, P256, DOI 10.1046/j.1365-2265.2004.01977.x; Marret S, 1997, BRAIN RES, V773, P213, DOI 10.1016/S0006-8993(97)00938-4; McNeil CJ, 2007, REPRODUCTION, V133, P653, DOI 10.1530/rep.1.01198; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; Morrow AL, 2001, INT REV NEUROBIOL, V46, P349; Neitzke U, 2008, PLACENTA, V29, P246, DOI 10.1016/j.placenta.2007.11.014; Owen D, 2005, J NEUROENDOCRINOL, V17, P220, DOI 10.1111/j.1365-2826.2005.01294.x; Pettenuzzo LF, 2008, PHYSIOL BEHAV, V95, P295, DOI 10.1016/j.physbeh.2008.06.003; Ping J, 2012, CHEM-BIOL INTERACT, V195, P68, DOI 10.1016/j.cbi.2011.11.001; Radosavljevic Tatjana, 2005, Med Pregl, V58, P558, DOI 10.2298/MPNS0512558R; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reichardt HM, 1996, MOL MED, V2, P735, DOI 10.1007/BF03401657; Seckl JR, 1997, FRONT NEUROENDOCRIN, V18, P49, DOI 10.1006/frne.1996.0143; Thayer P S, 1975, CRC Crit Rev Toxicol, V3, P345, DOI 10.3109/10408447509079863; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Wan Shun-Lun, 2002, Shengli Xuebao, V54, P473; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2009, SEMIN FETAL NEONAT M, V14, P143, DOI 10.1016/j.siny.2008.12.002; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WILKINSON JM, 1993, DEV BRAIN RES, V75, P193, DOI 10.1016/0165-3806(93)90023-4; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Xu D, 2011, ENVIRON TOXICOL PHAR, V32, P356, DOI 10.1016/j.etap.2011.08.003; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303	61	94	103	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44497	10.1371/journal.pone.0044497	http://dx.doi.org/10.1371/journal.pone.0044497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970234	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400080
J	Heath, JP; Montevecchi, WA; Esler, D				Heath, Joel P.; Montevecchi, William A.; Esler, Daniel			A Method for Quantifying Consistency in Animal Distributions Using Survey Data	PLOS ONE			English	Article							HABITAT SELECTION; ECOLOGY; DISPERSAL; PHILOPATRY; LANDSCAPES; DENSITY; QUALITY; SCALES; BIRDS; PREY	The degree of consistency with which groups of animals use the landscape is determined by a variety of ecological processes that influence their movements and patterns of habitat use. We developed a technique termed Distributional Consistency that uses survey data of unmarked individuals to quantify temporal consistency in their spatial distribution, while accounting for changes in population size. Distributional consistency is quantified by comparing the observed distribution patterns to all theoretically possible distribution patterns of observed individuals, leading to a proportional score between 0 and 1, reflecting increasingly consistent use of sites within a region. The technique can be applied to survey data for any taxa across a range of spatial and temporal scales. We suggest ways in which distributional consistency could provide inferences about the dispersal and habitat decisions of individuals, and the scales at which these decisions operate. Distributional consistency integrates spatial and temporal processes to quantify an important characteristic of different habitats and their use by populations, which in turn will be particularly useful in complimenting and interpreting other ecological measures such as population density and stability. The technique can be applied to many existing data sets to investigate and evaluate a range of important ecological questions using simple survey data.	[Heath, Joel P.] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Montevecchi, William A.] Mem Univ Newfoundland, Cognit & Behav Ecol Programme, St John, NF, Canada; [Esler, Daniel] Simon Fraser Univ, Ctr Wildlife Ecol, Delta, BC, Canada	University of British Columbia; Memorial University Newfoundland; Simon Fraser University	Heath, JP (corresponding author), Univ British Columbia, Dept Math, Vancouver, BC, Canada.	heath.joel@gmail.com			Memorial University of Newfoundland graduate fellowship; National Sciences and Engineering Research Council of Canada (NSERC) PGS-B Fellowship	Memorial University of Newfoundland graduate fellowship; National Sciences and Engineering Research Council of Canada (NSERC) PGS-B Fellowship	Funding to JPH was provided by a Memorial University of Newfoundland graduate fellowship and a National Sciences and Engineering Research Council of Canada (NSERC) PGS-B Fellowship (www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson Michael G., 1992, P365; Clark RG, 2004, CONDOR, V106, P717, DOI 10.1650/7644; Davoren GK, 2003, MAR ECOL PROG SER, V256, P229, DOI 10.3354/meps256229; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Heath JP, 2006, CAN J ZOOL, V84, P855, DOI 10.1139/Z06-059; Heath JP, 2006, OIKOS, V115, P573; Heath JP, 2001, THESIS MEMORIAL U NE; Jones WT, 1988, ECOLOGY, V69, P1475; Kendall WL, 2004, CONDOR, V106, P720, DOI 10.1650/7630; Kirk M, 2008, OECOLOGIA, V155, P859, DOI 10.1007/s00442-007-0947-0; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Newton I., 1998, POPULATION LIMITATIO; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Schneider D. C., 1994, QUANTITATIVE ECOLOGY; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SKEEL MA, 1983, CAN J ZOOL, V61, P218, DOI 10.1139/z83-027; Sokal R.R., 2012, BIOMETRY; Sutherland W.J., 1996, OXFORD SERIES ECOLOG; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; White G.C., 1990, ANAL WILDLIFE RADIO; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; [No title captured]	28	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44353	10.1371/journal.pone.0044353	http://dx.doi.org/10.1371/journal.pone.0044353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957067	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000308463800060
J	Picardi, E; Gallo, A; Galeano, F; Tomaselli, S; Pesole, G				Picardi, Ernesto; Gallo, Angela; Galeano, Federica; Tomaselli, Sara; Pesole, Graziano			A Novel Computational Strategy to Identify A-to-I RNA Editing Sites by RNA-Seq Data: De Novo Detection in Human Spinal Cord Tissue	PLOS ONE			English	Article							MESSENGER-RNA; PARALLEL DNA; INOSINE RNA; TRANSCRIPT; DIVERSIFICATION; IDENTIFICATION; DIVERSITY; EVOLUTION; ADENOSINE; REVEALS	RNA editing is a post-transcriptional process occurring in a wide range of organisms. In human brain, the A-to-I RNA editing, in which individual adenosine (A) bases in pre-mRNA are modified to yield inosine (I), is the most frequent event. Modulating gene expression, RNA editing is essential for cellular homeostasis. Indeed, its deregulation has been linked to several neurological and neurodegenerative diseases. To date, many RNA editing sites have been identified by next generation sequencing technologies employing massive transcriptome sequencing together with whole genome or exome sequencing. While genome and transcriptome reads are not always available for single individuals, RNA-Seq data are widespread through public databases and represent a relevant source of yet unexplored RNA editing sites. In this context, we propose a simple computational strategy to identify genomic positions enriched in novel hypothetical RNA editing events by means of a new two-steps mapping procedure requiring only RNA-Seq data and no a priori knowledge of RNA editing characteristics and genomic reads. We assessed the suitability of our procedure by confirming A-to-I candidates using conventional Sanger sequencing and performing RNA-Seq as well as whole exome sequencing of human spinal cord tissue from a single individual.	[Picardi, Ernesto; Pesole, Graziano] Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, Bari, Italy; [Picardi, Ernesto; Pesole, Graziano] CNR, Ist Biomembrane & Bioenerget, I-70126 Bari, Italy; [Gallo, Angela; Galeano, Federica; Tomaselli, Sara] Osped Pediat Bambino Gesu, IRCCS, Oncohaematol Dept, RNA Editing Lab, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); IRCCS Bambino Gesu	Picardi, E (corresponding author), Univ Bari, Dipartimento Biosci Biotecnol & Sci Farmacol, Bari, Italy.	graziano.pesole@uniba.it	Pesole, Graziano/E-9051-2014; Gallo, Angela/AAA-5003-2020; Pesole, Graziano/C-1408-2009; Pesole, Graziano/K-5283-2019; Picardi, Ernesto/A-5863-2015; Gallo, Angela/E-7837-2011	Pesole, Graziano/0000-0003-3663-0859; Gallo, Angela/0000-0003-0297-1807; Pesole, Graziano/0000-0003-3663-0859; Picardi, Ernesto/0000-0002-6549-0114; Gallo, Angela/0000-0003-0297-1807	Ministero dell'Istruzione, Universita e Ricerca" (MIUR, Italy): "Laboratorio Internazionale di Bioinformatica", "Laboratorio di Bioinformatica per la Biodiversita Molecolare" [DM19410]; Consiglio Nazionale delle Ricerche: Flagship Project "Epigen"; PNR-CNR; Center of Excellence in Genomics (CEGBA, Italy); Italian Research Foundation for amyotrophic lateral sclerosis (AriSLA); Italian Ministry for Foreign Affairs (Italy-Israel actions)	Ministero dell'Istruzione, Universita e Ricerca" (MIUR, Italy): "Laboratorio Internazionale di Bioinformatica", "Laboratorio di Bioinformatica per la Biodiversita Molecolare"; Consiglio Nazionale delle Ricerche: Flagship Project "Epigen"; PNR-CNR; Center of Excellence in Genomics (CEGBA, Italy); Italian Research Foundation for amyotrophic lateral sclerosis (AriSLA); Italian Ministry for Foreign Affairs (Italy-Israel actions)	This work was supported by "Ministero dell'Istruzione, Universita e Ricerca" (MIUR, Italy): "Laboratorio Internazionale di Bioinformatica", "Laboratorio di Bioinformatica per la Biodiversita Molecolare" (Project DM19410), "PRIN 2009"; Consiglio Nazionale delle Ricerche: Flagship Project "Epigen", PNR-CNR Aging Program 2012-2014, the Center of Excellence in Genomics (CEGBA, Italy), Italian Research Foundation for amyotrophic lateral sclerosis (AriSLA), and by Italian Ministry for Foreign Affairs (Italy-Israel actions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2011, GENOME RES; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chepelev I, 2012, METHODS MOL BIOL, V815, P91, DOI 10.1007/978-1-61779-424-7_8; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Irimia M, 2012, RNA BIOL, V9, P12, DOI 10.4161/rna.9.1.18387; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Martelli PL, 2011, NUCLEIC ACIDS RES, V39, pD80, DOI 10.1093/nar/gkq1073; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2007, REDIDB RNA EDITING D; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Picardi E, 2011, BIOINFORMATICS, V27, P1311, DOI 10.1093/bioinformatics/btr117; Picardi E, 2011, MITOCHONDRION, V11, P360, DOI 10.1016/j.mito.2010.10.005; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wulff BE, 2010, WIRES RNA, V1, P90, DOI 10.1002/wrna.10; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915	49	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44184	10.1371/journal.pone.0044184	http://dx.doi.org/10.1371/journal.pone.0044184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957051	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800043
J	Ramos-Sevillano, E; Rodriguez-Sosa, C; Cafini, F; Gimenez, MJ; Navarro, A; Sevillano, D; Alou, L; Garcia, E; Aguilar, L; Yuste, J				Ramos-Sevillano, Elisa; Rodriguez-Sosa, Cinthya; Cafini, Fabio; Gimenez, Maria-Jose; Navarro, Ana; Sevillano, David; Alou, Luis; Garcia, Ernesto; Aguilar, Lorenzo; Yuste, Jose			Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains	PLOS ONE			English	Article							C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; MOUSE SEPSIS MODEL; STAPHYLOCOCCUS-AUREUS; 2 PARTS; PHAGOCYTOSIS; CHILDREN; PATHWAY; DISEASE; POLYSACCHARIDES	Background: Specific antibodies mediate humoral and cellular protection against invading pathogens such as Streptococcus pneumoniae by activating complement mediated immunity, promoting phagocytosis and stimulating bacterial clearance. The emergence of pneumococcal strains with high levels of antibiotic resistance is of great concern worldwide and a serious threat for public health. Methodology/Principal Findings: Flow cytometry was used to determine whether complement-mediated immunity against three antibiotic-resistant S. pneumoniae clinical isolates is enhanced in the presence of sub-inhibitory concentrations of cefditoren and ceftriaxone. The binding of acute phase proteins such as C-reactive protein and serum amyloid P component, and of complement component C1q, to pneumococci was enhanced in the presence of serum plus either of these antibiotics. Both antibiotics therefore trigger the activation of the classical complement pathway against S. pneumoniae. C3b deposition was also increased in the presence of specific anti-pneumococcal antibodies and sub-inhibitory concentrations of cefditoren and ceftriaxone confirming that the presence of these antibiotics enhances complement-mediated immunity to S. pneumoniae. Conclusions/Significance: Using cefditoren and ceftriaxone to promote the binding of acute phase proteins and C1q to pneumococci, and to increase C3b deposition, when anti-pneumococcal antibodies are present, might help reduce the impact of antibiotic resistance in S. pneumoniae infections.	[Ramos-Sevillano, Elisa; Garcia, Ernesto; Yuste, Jose] CSIC, Ctr Invest Biol, Madrid, Spain; [Ramos-Sevillano, Elisa; Garcia, Ernesto; Yuste, Jose] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Rodriguez-Sosa, Cinthya; Navarro, Ana; Yuste, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Cafini, Fabio; Gimenez, Maria-Jose; Sevillano, David; Alou, Luis; Aguilar, Lorenzo] Univ Complutense, Fac Med, Dept Microbiol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complutense University of Madrid	Ramos-Sevillano, E (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	jyuste@isciii.es	Alou, Luis/B-8170-2011; Cafini, Fabio/AAA-7938-2020; YUSTE, JOSE/ABG-9851-2020; Gimenez, Maria Jose/GXF-2237-2022; Sevillano, David/G-5661-2010; Sevillano, Elisa Ramos/J-4824-2016	Alou, Luis/0000-0002-0859-008X; Cafini, Fabio/0000-0002-5442-1674; Gimenez, Maria Jose/0000-0003-0830-4095; Sevillano, Elisa Ramos/0000-0003-0803-2755; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; YUSTE, JOSE/0000-0001-7996-0837; Sevillano Fernandez, David/0000-0003-0212-2194	Direccion General de Investigacion Cientifica y Tecnica [SAF2009-10824]; ISCIII [MPY 1350/10]; Tedec-Meiji Farma S.A. (Madrid, Spain); FPU fellowship from Ministerio de Ciencia e Innovacion; MAEC-AECID	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII(Instituto de Salud Carlos III); Tedec-Meiji Farma S.A. (Madrid, Spain); FPU fellowship from Ministerio de Ciencia e Innovacion; MAEC-AECID	This work was supported by grants SAF2009-10824 from Direccion General de Investigacion Cientifica y Tecnica, MPY 1350/10 from ISCIII and an unrestricted educational grant from Tedec-Meiji Farma S.A. (Madrid, Spain). Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) is an initiative of the ISCIII. E.R-S. was supported by an FPU fellowship from Ministerio de Ciencia e Innovacion and C. R-S was supported by a fellowship from MAEC-AECID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2004, CHEST, V125, P1335, DOI 10.1378/chest.125.4.1335; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Cafini F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012041; Casal J, 2002, ANTIMICROB AGENTS CH, V46, P1340, DOI 10.1128/AAC.46.5.1340-1344.2002; DARVEAU RP, 1990, J INFECT DIS, V162, P914, DOI 10.1093/infdis/162.4.914; Du Clos TW, 2001, CURR OPIN INFECT DIS, V14, P289, DOI 10.1097/00001432-200106000-00007; FENOLL A, 1991, REV INFECT DIS, V13, P56; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jansen WTM, 2004, INDIAN J MED RES, V119, P7; Johnson Heather L., 1999, Journal of Microbiology Immunology and Infection, V32, P73; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Jung E, 1998, AM J MED SCI, V315, P307, DOI 10.1097/00000441-199805000-00004; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Labro MT, 2000, CLIN MICROBIOL REV, V13, P615, DOI 10.1128/CMR.13.4.615-650.2000; McCullers JA, 2001, FRONT BIOSCI-LANDMRK, V6, pD877, DOI 10.2741/McCullers; MILATOVIC D, 1983, EUR J CLIN MICROBIOL, V2, P414, DOI 10.1007/BF02013898; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; Mold C, 2001, J IMMUNOL, V166, P1200, DOI 10.4049/jimmunol.166.2.1200; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Soriano F, 2008, J ANTIMICROB CHEMOTH, V62, P1234, DOI 10.1093/jac/dkn392; Subrt N, 2011, J ANTIMICROB CHEMOTH, V66, P979, DOI 10.1093/jac/dkr043; Thomas-Rudolph D, 2007, J IMMUNOL, V178, P7283, DOI 10.4049/jimmunol.178.11.7283; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; VANDAM JEG, 1990, ANTON LEEUW INT J G, V58, P1; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WILLIAMS P, 1987, ANTIMICROB AGENTS CH, V31, P758, DOI 10.1128/AAC.31.5.758; Yuste J, 2002, CLIN EXP IMMUNOL, V128, P411, DOI 10.1046/j.1365-2249.2002.01860.x; Yuste J, 2001, J ANTIMICROB CHEMOTH, V48, P594, DOI 10.1093/jac/48.4.594; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	38	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44135	10.1371/journal.pone.0044135	http://dx.doi.org/10.1371/journal.pone.0044135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957048	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800040
J	Chu, K; Cortier, H; Maldonado, F; Mashant, T; Ford, N; Trelles, M				Chu, Kathryn; Cortier, Hilde; Maldonado, Fernando; Mashant, Tshiteng; Ford, Nathan; Trelles, Miguel			Cesarean Section Rates and Indications in Sub-Saharan Africa: A Multi-Country Study from Medecins sans Frontieres	PLOS ONE			English	Article							DELIVERY; CARE	Objectives: The World Health Organization considers Cesarean section rates of 5-15% to be the optimal range for targeted provision of this life saving intervention. However, access to safe Cesarean section in resource-limited settings is much lower, estimated at 1-2% reported in sub-Saharan Africa. This study reports Cesarean sections rates and indications in Democratic Republic of Congo, Burundi, and Sierra Leone, and describe the main parameters associated with maternal and early neonatal mortality. Methods: Women undergoing Cesarean section from August 1 2010 to January 31 2011 were included in this prospective study. Logistic regression was used to model determinants of maternal and early neonatal mortality. Results: 1276 women underwent a Cesarean section, giving a frequency of 6.2% (range 4.1-16.8%). The most common indications were obstructed labor (399, 31%), poor presentation (233, 18%), previous Cesarean section (184, 14%), and fetal distress (128, 10%), uterine rupture (117, 9%) and antepartum hemorrhage (101, 8%). Parity >6 (adjusted odds ratio [aOR] = 8.6, P = 0.015), uterine rupture (aOR = 20.5; P = .010), antepartum hemorrhage (aOR = 13.1; P = .045), and pre-eclampsia/eclampsia (aOR = 42.9; P = .017) were associated with maternal death. Uterine rupture (aOR = 6.6, P < 0.001), anterpartum hemorrhage (aOR = 3.6, P < 0.001), and cord prolapse (aOR = 2.7, P = 0.017) were associated with early neonatal death. Conclusions: This study demonstrates that target Cesarean section rates can be achieved in sub-Saharan Africa. Identifying the common indications for Cesarean section and associations with mortality can target improvements in antenatal services and emergency obstetric care.	[Chu, Kathryn; Ford, Nathan] Med Sans Frontieres, Johannesburg, South Africa; [Chu, Kathryn] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Chu, Kathryn] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA; [Cortier, Hilde; Trelles, Miguel] Med Sans Frontieres, Dept Med, Brussels, Belgium; [Maldonado, Fernando] Med Sans Frontieres, Kinshasa, DEM REP CONGO; [Mashant, Tshiteng] Med Sans Frontieres, Bujumbura, Burundi; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	Johns Hopkins University; Johns Hopkins University; Doctors Without Borders; University of Cape Town	Chu, K (corresponding author), Med Sans Frontieres, Johannesburg, South Africa.	kathryn.chu@joburg.msf.org						[Anonymous], 1985, LANCET, V2, P436; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Dolea C., 2003, GLOBAL BURDEN OBSTRU; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Guise JM, 2004, OBSTET GYNECOL, V103, P420, DOI 10.1097/01.AOG.0000116259.41678.f1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Koonin L M, 1997, MMWR CDC Surveill Summ, V46, P17; Okonta P I, 2002, J Obstet Gynaecol, V22, P626, DOI 10.1080/0144361021000020394; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Stanton C, 2008, BIRTH-ISS PERINAT C, V35, P204, DOI 10.1111/j.1523-536X.2008.00241.x; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Weil O, 1999, LANCET, V354, P940, DOI 10.1016/S0140-6736(99)02369-7; WHO, 2010, TRENDS MAT MORT 1990	15	74	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44484	10.1371/journal.pone.0044484	http://dx.doi.org/10.1371/journal.pone.0044484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962616	gold, Green Published			2022-12-27	WOS:000308577600061
J	Xia, HP; Ooi, LLPJ; Hui, KM				Xia, Hongping; Ooi, London Lucien P. J.; Hui, Kam M.			MiR-214 Targets beta-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							E-CADHERIN; MICRORNA EXPRESSION; UP-REGULATION; PROTEIN EZH2; CANCER; GROWTH; CELLS; REPRESSION; IDENTIFICATION; ASSOCIATION	The down-regulation of miR-214 has previously been observed in human hepatocellular carcinoma (HCC). Here, we demonstrated the down-regulation of miR-214 is associated with cell invasion, stem-like traits and early recurrence of HCC. Firstly, we validated the suppression of miR-214 in human HCC by real-time quantitative RT-PCR (qRT-PCR) in 20 paired tumor and non-tumor liver tissues of HCC patients and 10 histologically normal liver tissues from colorectal cancer patients with liver metastases. Further qRT-PCR analysis of 50 HCC tissues from an independent cohort of HCC patients of whom 29 with early recurrent disease (<2 years) and 21 with late recurrent disease demonstrated that the suppression of miR-214 was significantly more suppressed in samples from HCC patients with early recurrent disease compared those from patients with no recurrence. Re-expression of miR-214 significantly suppressed the growth of HCC cells in vitro and reduced their tumorigenicity in vivo. The enhancer of zeste homologue 2 (EZH2) and beta-catenin (CTNNB1) was identified as two potential direct downstream targets of miR-214 through bioinformatics analysis and experimentally validated the miRNA-target interactions with a dual-firefly luciferase reporter assay. In corroborate with this, both EZH2 and CTNNB1 are found to be significantly overexpressed in human HCC biopsies. Since EZH2 can regulate CTNNB1, CTNNB1 can also be an indirect target of miR-214 through EZH2. Silencing EZH2 or CTNNB1 expression suppressed the growth and invasion of HCC cells and induced E-cadherin (CDH1), known to inhibit cell invasion and metastasis. Furthermore, the silencing of miR-214 or overexpression of EZH2 increased EpCAM(+) stem-like cells through the activation of CTNNB1. Interestingly, the up-regulation of EZH2, CTNNB1 and the down-regulation of CDH1 in HCC patients correlated with early recurrent disease and can be an independent predictor of poor survival. Therefore, miR-214 can directly or indirectly target CTNNB1 to modulate the beta-catenin signaling pathway in HCC.	[Xia, Hongping; Hui, Kam M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Bek Chai Heah Lab Canc Genom, Singapore, Singapore; [Ooi, London Lucien P. J.] Singapore Gen Hosp, Dept Surg Oncol, Singapore 0316, Singapore; [Hui, Kam M.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Hui, Kam M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Hui, Kam M.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Xia, HP (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Bek Chai Heah Lab Canc Genom, Singapore, Singapore.	cmrhkm@nccs.com.sg	Ooi, London Lucien/AGK-1395-2022; XIA, HONGPING/AAK-7100-2020		National Medical Research Council; Biomedical Research Council of Singapore; Singapore Millennium Foundation	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was supported by by grants from the National Medical Research Council, Biomedical Research Council of Singapore and The Singapore Millennium Foundation, http://www.nmrc.gov.sg/content/nmrc_internet/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar-Eli M, 2011, EMBO J, V30, P1880, DOI 10.1038/emboj.2011.132; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Law PTY, 2011, J GASTROEN HEPATOL, V26, P437, DOI 10.1111/j.1440-1746.2010.06512.x; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Oishi N, 2011, INT J BIOL SCI, V7, P517, DOI 10.7150/ijbs.7.517; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pei YF, 2009, ACTA BIOCH BIOPH SIN, V41, P1, DOI 10.1093/abbs/gmn001; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang SM, 2011, CLIN CANCER RES, V17, P6040, DOI 10.1158/1078-0432.CCR-11-0557; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469	48	129	134	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44206	10.1371/journal.pone.0044206	http://dx.doi.org/10.1371/journal.pone.0044206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962603	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600031
J	Weber, A; Prokazov, Y; Zuschratter, W; Hauser, MJB				Weber, Andre; Prokazov, Yury; Zuschratter, Werner; Hauser, Marcus J. B.			Desynchronisation of Glycolytic Oscillations in Yeast Cell Populations	PLOS ONE			English	Article							SYNCHRONIZATION; MECHANISM; RHYTHM; WAVES; ONSET	Glycolytic oscillations of intact yeast cells of the strain Saccharomyces carlsbergensis were investigated at both the levels of cell populations and of individual cells. Individual cells showed glycolytic oscillations even at very low cell densities (e. g. 1.0 x 10(5) cells/ml). By contrast, the collective behaviour on the population level was cell density-dependent: at high cell densities it is oscillatory, but below the threshold density of 1.0 x 10(6) cells/ml the collective dynamics becomes quiescent. We demonstrate that the transition in the collective dynamics is caused by the desynchronisation of the oscillations of individual cells. This is characteristic for a Kuramoto transition. Spatially resolved measurements at low cell densities revealed that even cells that adhere to their neighbours oscillated with their own, independent frequencies and phases.	[Weber, Andre; Hauser, Marcus J. B.] Univ Magdeburg, Inst Expt Phys, Biophys Grp, D-39106 Magdeburg, Germany; [Weber, Andre; Prokazov, Yury; Zuschratter, Werner] Leibniz Inst Neurobiol, Special Lab Electron & Laserscanning Microscopy, Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Weber, A (corresponding author), Univ Magdeburg, Inst Expt Phys, Biophys Grp, D-39106 Magdeburg, Germany.	marcus.hauser@physik.uni-magdeburg.de		Hauser, Marcus/0000-0003-2105-3446	Bundesministerium fur Bildung und Forschung [13N10077]; Deutsche Forschungsgemeinschaft [DFG SFB 854 TPZ]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support by the Bundesministerium fur Bildung und Forschung (grant number 13N10077) and the Deutsche Forschungsgemeinschaft (DFG SFB 854 TPZ) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; AON MA, 1992, J GEN MICROBIOL, V138, P2219, DOI 10.1099/00221287-138-10-2219; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Bolyo J, 2010, BIOPHYS CHEM, V153, P54, DOI 10.1016/j.bpc.2010.10.004; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; DUYSENS LNM, 1957, BIOCHIM BIOPHYS ACTA, V24, P19, DOI 10.1016/0006-3002(57)90141-5; Gehrmann E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021913; GHOSH A, 1964, BIOCHEM BIOPH RES CO, V16, P174, DOI 10.1016/0006-291X(64)90357-2; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Henson MA, 2002, BIOCHEM J, V368, P433, DOI 10.1042/BJ20021051; HESS B, 1968, H-S Z PHYSIOL CHEM, V349, P1567, DOI 10.1515/bchm2.1968.349.2.1567; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Kim JR, 2010, J CELL SCI, V123, P537, DOI 10.1242/jcs.060061; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Kuramoto Y, 2002, NONLINEAR DYNAMICS C; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Pikovsky A, 2004, SYNCHRONIZATION UNIV; Poulsen AK, 2007, BIOPHYS CHEM, V125, P275, DOI 10.1016/j.bpc.2006.08.009; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Avila GMR, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/60007; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Richard P, 1996, EUR J BIOCHEM, V235, P238, DOI 10.1111/j.1432-1033.1996.00238.x; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P3473, DOI 10.1073/pnas.262796299; Schutze J, 2011, BIOPHYS J, V100, P809, DOI 10.1016/j.bpj.2010.12.3704; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; Stark J, 2007, IMMUNOL REV, V216, P213; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Stumpf K, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/48001; Su Y, 2011, J MATH BIOL, V63, P557, DOI 10.1007/s00285-010-0381-5; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; Vitali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015820; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Winfree AT., 1980, GEOMETRY BIOL TIME; Wolf J, 2000, BIOCHEM J, V345, P321, DOI 10.1042/0264-6021:3450321; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	43	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43276	10.1371/journal.pone.0043276	http://dx.doi.org/10.1371/journal.pone.0043276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984417	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700017
J	Gao, P; Peterson, YK; Smith, RA; Smith, CD				Gao, Peng; Peterson, Yuri K.; Smith, Ryan A.; Smith, Charles D.			Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID METABOLISM; DIACYLGLYCEROL KINASES; THERAPEUTIC TARGETS; ANTITUMOR-ACTIVITY; HUMAN LEUKEMIA; TUMOR-CELLS; SPHINGOSINE-1-PHOSPHATE	Sphingosine kinases (SKs) are promising new therapeutic targets for cancer because they regulate the balance between proapoptotic ceramides and mitogenic sphingosine-1-phosphate. The functions of the two SK isoenzymes, SK1 and SK2, are not redundant, with genetic ablation of SK2 having more pronounced anticancer effects than removal of SK1. Although several small molecule inhibitors of SKs have been described in the literature, detailed characterization of their molecular and cellular pharmacology, particularly their activities against human SK1 and SK2, have not been completed. Computational modeling of the putative active sites of SK1 and SK2 suggests structural differences that might allow isozyme-selective inhibitors. Therefore, we characterized several SK-inhibitory compounds which revealed differential inhibitory effects on SK1 and SK2 as follows: SKI-II and ABC294735 are SK1/2-dual inhibitors; CB5468139 is a SK1-selective inhibitor; and ABC294640 is a SK2-selective inhibitor. We examined the effects of the SK inhibitors on several biochemical and phenotypic processes in A498 kidney adenocarcinoma cells. The SK2-selective inhibitor ABC294640 demonstrated the most pronounced effects on SK1 and SK2 mRNA expression, decrease of S1P levels, elevation of ceramide levels, cell cycle arrest, and inhibition of proliferation, migration and invasion. ABC294640 also down-regulated the expression or activation of several signaling proteins, including STAT3, AKT, ERK, p21, p53 and FAK. These effects were equivalent or superior to responses to the SK1/2-dual inhibitors. Overall, these results suggest that inhibition of SK2 results in stronger anticancer effects than does inhibition of SK1 or both SK1 and SK2.	[Gao, Peng; Peterson, Yuri K.; Smith, Charles D.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Smith, Ryan A.; Smith, Charles D.] Apogee Biotechnol Corp, Hummelstown, PA USA	Medical University of South Carolina	Gao, P (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	smithchd@musc.edu			National Institutes of Health [R01 CA122226]; NATIONAL CANCER INSTITUTE [R01CA122226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 CA122226 to Charles D. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antoon JW, 2010, ENDOCRINOLOGY, V151, P5124, DOI 10.1210/en.2010-0420; Bakali HMA, 2007, J BIOL CHEM, V282, P19644, DOI 10.1074/jbc.M604852200; Beljanski V, 2011, INVEST NEW DRUG, V29, P1132, DOI 10.1007/s10637-010-9452-0; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; ENDO K, 1991, CANCER RES, V51, P1613; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; French KJ, 2003, CANCER RES, V63, P5962; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hengst JA, 2010, BIOORG MED CHEM LETT, V20, P7498, DOI 10.1016/j.bmcl.2010.10.005; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; IGARASHI Y, 1989, BIOCHEMISTRY-US, V28, P6796, DOI 10.1021/bi00443a002; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kennedy AJ, 2011, J MED CHEM, V54, P3524, DOI 10.1021/jm2001053; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Ogretmen B, 2006, FEBS LETT, V580, P5467, DOI 10.1016/j.febslet.2006.08.052; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Ren SY, 2010, CELL PHYSIOL BIOCHEM, V26, P97, DOI 10.1159/000315110; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; SCHAAP D, 1994, BIOCHEM J, V304, P661, DOI 10.1042/bj3040661; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Sweeney EA, 1996, INT J CANCER, V66, P358, DOI 10.1002/(SICI)1097-0215(19960503)66:3<358::AID-IJC16>3.0.CO;2-7; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; TamiyaKoizumi K, 1997, BIOCHEM MOL BIOL INT, V41, P1179; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Xiang YB, 2009, BIOORG MED CHEM LETT, V19, P6119, DOI 10.1016/j.bmcl.2009.09.022; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	55	87	92	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44543	10.1371/journal.pone.0044543	http://dx.doi.org/10.1371/journal.pone.0044543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970244	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400021
J	Goldman, AD; Baross, JA; Samudrala, R				Goldman, Aaron David; Baross, John A.; Samudrala, Ram			The Enzymatic and Metabolic Capabilities of Early Life	PLOS ONE			English	Article							PROTEIN FOLD ARCHITECTURE; UNIVERSAL COMMON ANCESTOR; PHYLOGENOMIC ANALYSIS; ZINC-SULFIDE; EVOLUTION; ORIGIN; PROTEOMES; WORLD; NETWORKS; ANNOTATION	We introduce the concept of metaconsensus and employ it to make high confidence predictions of early enzyme functions and the metabolic properties that they may have produced. Several independent studies have used comparative bioinformatics methods to identify taxonomically broad features of genomic sequence data, protein structure data, and metabolic pathway data in order to predict physiological features that were present in early, ancestral life forms. But all such methods carry with them some level of technical bias. Here, we cross-reference the results of these previous studies to determine enzyme functions predicted to be ancient by multiple methods. We survey modern metabolic pathways to identify those that maintain the highest frequency of metaconsensus enzymes. Using the full set of modern reactions catalyzed by these metaconsensus enzyme functions, we reconstruct a representative metabolic network that may reflect the core metabolism of early life forms. Our results show that ten enzyme functions, four hydrolases, three transferases, one oxidoreductase, one lyase, and one ligase, are determined by metaconsensus to be present at least as late as the last universal common ancestor. Subnetworks within central metabolic processes related to sugar and starch metabolism, amino acid biosynthesis, phospholipid metabolism, and CoA biosynthesis, have high frequencies of these enzyme functions. We demonstrate that a large metabolic network can be generated from this small number of enzyme functions.	[Goldman, Aaron David] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Baross, John A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Baross, John A.; Samudrala, Ram] Univ Washington, Ctr Astrobiol & Early Evolut, Seattle, WA 98195 USA; [Samudrala, Ram] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goldman, AD (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	adg@princeton.edu			National Science Foundation Integrative Graduate Education and Research Traineeship through the Center for Astrobiology and Early Evolution at the University of Washington; Helen Whitely Graduate Fellowship Award through the Department of Microbiology at the University of Washington; National Science Foundation's Career Award [DBI-0217241]; NATIONAL LIBRARY OF MEDICINE [DP1LM011509] Funding Source: NIH RePORTER	National Science Foundation Integrative Graduate Education and Research Traineeship through the Center for Astrobiology and Early Evolution at the University of Washington; Helen Whitely Graduate Fellowship Award through the Department of Microbiology at the University of Washington; National Science Foundation's Career Award; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was primarily supported by the National Science Foundation Integrative Graduate Education and Research Traineeship through the Center for Astrobiology and Early Evolution at the University of Washington and the Helen Whitely Graduate Fellowship Award through the Department of Microbiology at the University of Washington. Additional funding came from the National Science Foundation's Career Award DBI-0217241. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becerra A, 2007, ANNU REV ECOL EVOL S, V38, P361, DOI 10.1146/annurev.ecolsys.38.091206.095825; Benson DA, 2010, NUCL ACIDS RES; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Caetano-Anolles G, 2005, J MOL EVOL, V60, P484, DOI 10.1007/s00239-004-0221-6; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Cody GD, 2004, ANNU REV EARTH PL SC, V32, P569, DOI 10.1146/annurev.earth.32.101802.120225; De Duve C., 1995, VITAL DUST ORIGIN EV; Delaye L, 2005, PHYS LIFE REV, V2, P47, DOI 10.1016/j.plrev.2004.12.002; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Doolittle FW, 1999, LOGIC CIRCUITS CARBO, V284, P2124; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Goldman AD, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-15; Goldman AD, 2012, EVOLUTION PROTEIN RE, P207; Goldman AD, 2012, OXYTRICHA MODERN ANA, DOI [10.1016/j.tig.2012.03.010, DOI 10.1016/J.TIG.2012.03.010]; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Jadhav VR, 2002, BIOCHEMISTRY-US, V41, P723, DOI 10.1021/bi011803h; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Lazcano A, 1999, J MOL EVOL, V49, P424, DOI 10.1007/PL00006565; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; McDermott J, 2003, NUCLEIC ACIDS RES, V31, P3736, DOI 10.1093/nar/gkg550; Mulkidjanian AY, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-26; Mulkidjanian AY, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-27; Petrey D, 2009, P NATL ACAD SCI USA, V106, P17377, DOI 10.1073/pnas.0907971106; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Rao RP, 2008, PROSTAG OTH LIPID M, V85, P1, DOI 10.1016/j.prostaglandins.2007.10.002; Sadowski M, 2010, J STRUCT BI IN PRESS; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Shimizu M, 2008, J BIOCHEM, V144, P383, DOI 10.1093/jb/mvn073; Srinivasan V, 2009, BIOL BULL-US, V216, P126; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Theobald DL, 2010, NATURE, V465, P219, DOI 10.1038/nature09014; van der Gulik P, 2009, J THEOR BIOL, V261, P531, DOI 10.1016/j.jtbi.2009.09.004; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Wang ML, 2006, COMPLEXITY, V12, P27, DOI 10.1002/cplx.20141; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	54	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e39912	10.1371/journal.pone.0039912	http://dx.doi.org/10.1371/journal.pone.0039912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970111	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400001
J	Ross, PD; Polson, L; Grosbras, MH				Ross, Patrick D.; Polson, Louise; Grosbras, Marie-Helene			Developmental Changes in Emotion Recognition from Full-Light and Point-Light Displays of Body Movement	PLOS ONE			English	Article							BIOLOGICAL MOTION DISPLAYS; FACIAL EXPRESSION; AMYGDALA RESPONSE; PERCEPTION; CHILDREN; CHILDHOOD; NETWORKS; BODIES; FACES	To date, research on the development of emotion recognition has been dominated by studies on facial expression interpretation; very little is known about children's ability to recognize affective meaning from body movements. In the present study, we acquired simultaneous video and motion capture recordings of two actors portraying four basic emotions (Happiness Sadness, Fear and Anger). One hundred and seven primary and secondary school children (aged 4-17) and 14 adult volunteers participated in the study. Each participant viewed the full-light and point-light video clips and was asked to make a forced-choice as to which emotion was being portrayed. As a group, children performed worse than adults for both point-light and full-light conditions. Linear regression showed that both age and lighting condition were significant predictors of performance in children. Using piecewise regression, we found that a bilinear model with a steep improvement in performance until 8.5 years of age, followed by a much slower improvement rate through late childhood and adolescence best explained the data. These findings confirm that, like for facial expression, adolescents' recognition of basic emotions from body language is not fully mature and seems to follow a non-linear development. This is in line with observations of non-linear developmental trajectories for different aspects of human stimuli processing (voices and faces), perhaps suggesting a shift from one perceptual or cognitive strategy to another during adolescence. These results have important implications to understanding the maturation of social cognition.	[Ross, Patrick D.; Polson, Louise; Grosbras, Marie-Helene] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Ross, PD (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	p.ross@psy.gla.ac.uk	Ross, Patrick/I-3031-2012; Ross, Paddy/S-6999-2019; Grosbras, Marie-Helene/C-7371-2009	Ross, Paddy/0000-0001-8481-2070; Grosbras, Marie-Helene/0000-0002-9807-6307	UK ESRC [ES/E020933/1]; ESCR DTC [ES/J500136/1]	UK ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESCR DTC	This study was partly funded by the UK ESRC grant ES/E020933/1 and the ESCR DTC grant ES/J500136/1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaz D, 2010, DEVELOPMENTAL SCI, V13, P826, DOI 10.1111/j.1467-7687.2009.00939.x; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Boone RT, 1998, DEV PSYCHOL, V34, P1007, DOI 10.1037/0012-1649.34.5.1007; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Sonneville LMJ, 2002, J CLIN EXP NEUROPSYC, V24, P200, DOI 10.1076/jcen.24.2.200.989; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; FELLEMAN ES, 1983, DEV PSYCHOL, V19, P405, DOI 10.1037/0012-1649.19.3.405; FLIN RH, 1980, DEV PSYCHOL, V16, P373, DOI 10.1037/0012-1649.16.4.373; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Freire A, 2006, PERCEPTION, V35, P647, DOI 10.1068/p5403; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOSSELIN P, 1995, J PERS SOC PSYCHOL, V68, P83, DOI 10.1037/0022-3514.68.1.83; Guyer AE, 2008, J COGNITIVE NEUROSCI, V20, P1565, DOI 10.1162/jocn.2008.20114; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Hill H, 2000, PSYCHOL SCI, V11, P223, DOI 10.1111/1467-9280.00245; Jansson LC, 1974, DEV DEDUCTIVE REASON; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; Kuhlmeier VA, 2010, INFANCY, V15, P83, DOI 10.1111/j.1532-7078.2009.00003.x; Lagerlof I, 2009, EUR J DEV PSYCHOL, V6, P409, DOI 10.1080/17405620701438475; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; MANN VA, 1979, J EXP CHILD PSYCHOL, V27, P153, DOI 10.1016/0022-0965(79)90067-5; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; MCDONNELL R., 2009, ACM T APPL PERCEPT, V6, p[14, 1, 11]; McGivern RF, 2002, BRAIN COGNITION, V50, P73, DOI 10.1016/S0278-2626(02)00012-X; Pavlova M, 2001, PERCEPTION, V30, P925, DOI 10.1068/p3157; Peelen MV, 2009, DEVELOPMENTAL SCI, V12, pF16, DOI 10.1111/j.1467-7687.2009.00916.x; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Van Meel J, 1993, EMPIR STUD ARTS, V11, P117, DOI DOI 10.2190/V69N-VB0T-A9Q3-TJ04; Wade AM, 2006, J APPL STAT, V33, P297, DOI 10.1080/02664760500445756; WALK RD, 1984, B PSYCHONOMIC SOC, V22, P437; Yoon JMD, 2009, CHILD DEV, V80, P1069, DOI 10.1111/j.1467-8624.2009.01317.x	45	41	42	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44815	10.1371/journal.pone.0044815	http://dx.doi.org/10.1371/journal.pone.0044815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970310	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000308748400031
J	Ehrentraut, SF; Dorr, A; Ehrentraut, H; Lohner, R; Lee, SH; Hoeft, A; Baumgarten, G; Knuefermann, P; Boehm, O; Meyer, R				Ehrentraut, Stefan Felix; Doerr, Anne; Ehrentraut, Heidi; Lohner, Ralph; Lee, Sun-Hee; Hoeft, Andreas; Baumgarten, Georg; Knuefermann, Pascal; Boehm, Olaf; Meyer, Rainer			Vascular Dysfunction following Polymicrobial Sepsis: Role of Pattern Recognition Receptors	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; NITRIC-OXIDE; CD14-DEFICIENT MICE; INNATE IMMUNITY; CECAL LIGATION; ANIMAL-MODELS; LIPOPOLYSACCHARIDE; INFLAMMATION; TOLL-LIKE-RECEPTOR-9; CONTRACTILITY	Aims: Aim was to elucidate the specific role of pattern recognition receptors in vascular dysfunction during polymicrobial sepsis (colon ascendens stent peritonitis, CASP). Methods and Results: Vascular contractility of C57BL/6 (wildtype) mice and mice deficient for Toll-like receptor 2/4/9 (TLR2-D, TLR4-D, TLR9-D) or CD14 (CD14-D) was measured 18 h following CASP. mRNA expression of pro-(Tumor Necrosis Factor-alpha (TNF alpha), Interleukin (IL)-1 beta, IL-6) and anti-inflammatory cytokines (IL-10) and of vascular inducible NO-Synthase (iNOS) was determined using RT-qPCR. Wildtype mice exhibited a significant loss of vascular contractility after CASP. This was aggravated in TLR2-D mice, blunted in TLR4-D animals and abolished in TLR9-D and CD14-D animals. TNF-alpha expression was significantly up-regulated after CASP in wildtype and TLR2-D animals, but not in mice deficient for TLR4, -9 or CD14. iNOS was significantly up-regulated in TLR2-D animals only. TLR2-D animals showed significantly higher levels of TLR4, -9 and CD14. Application of H154-ODN, a TLR9 antagonist, attenuated CASP-induced cytokine release and vascular dysfunction in wildtype mice. Conclusions: Within our model, CD14 and TLR9 play a decisive role for the development of vascular dysfunction and thus can be effectively antagonized using H154-ODN. TLR2-D animals are more prone to polymicrobial sepsis, presumably due to up-regulation of TLR4, 9 and CD14.	[Ehrentraut, Stefan Felix; Ehrentraut, Heidi; Hoeft, Andreas; Baumgarten, Georg; Knuefermann, Pascal; Boehm, Olaf] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany; [Doerr, Anne; Lohner, Ralph; Lee, Sun-Hee; Meyer, Rainer] Univ Bonn, Inst Physiol 2, Bonn, Germany	University of Bonn; University of Bonn	Ehrentraut, SF (corresponding author), Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany.	Rainer.Meyer@ukb.uni-bonn.de	Meyer, Rainer/H-5871-2013	Ehrentraut, Stefan/0000-0001-5747-6737	Else-Kroner-Fresenius-Stiftung [P46/08//A22/08]	Else-Kroner-Fresenius-Stiftung	Part of the project has been funded through a grant to Pascal Knuefermann, Georg Baumgarten and Rainer Meyer by the Else-Kroner-Fresenius-Stiftung (P46/08//A22/08); www.ekfs.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Araujo AV, 2011, VASC PHARMACOL, V54, P44, DOI 10.1016/j.vph.2010.12.002; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Baumgarten G, 2006, SHOCK, V25, P43, DOI 10.1097/01.shk.0000196498.57306.a6; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cowan DB, 2000, AM J PHYSIOL-HEART C, V279, pH619, DOI 10.1152/ajpheart.2000.279.2.H619; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Ehrentraut S, 2007, ARTERIOSCL THROM VAS, V27, P2170, DOI 10.1161/ATVBAHA.107.146100; Ehrentraut S, 2011, SHOCK, V36, P613, DOI 10.1097/SHK.0b013e318235805f; Grandel U, 2000, CIRCULATION, V102, P2758, DOI 10.1161/01.CIR.102.22.2758; Ha TZ, 2010, AM J PHYSIOL-HEART C, V298, pH984, DOI 10.1152/ajpheart.01109.2009; Hall E, 2005, REGUL PEPTIDES, V131, P34, DOI 10.1016/j.regpep.2005.06.006; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Loh G, 2008, ENVIRON MICROBIOL, V10, P709, DOI 10.1111/j.1462-2920.2007.01493.x; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Perera PY, 1997, J IMMUNOL, V158, P4422; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vromen A, 1996, SHOCK, V6, P248, DOI 10.1097/00024382-199610000-00004; Wang CH, 2004, FUND CLIN PHARMACOL, V18, P679, DOI 10.1111/j.1472-8206.2004.00293.x; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Yamada H, 2002, J IMMUNOL, V169, P5590, DOI 10.4049/jimmunol.169.10.5590; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e; Zou L, 2010, CRIT CARE MED, V38, P1335, DOI 10.1097/CCM.0b013e3181d99e67	39	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44531	10.1371/journal.pone.0044531	http://dx.doi.org/10.1371/journal.pone.0044531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970242	Green Submitted, Green Published, gold			2022-12-27	WOS:000308462000027
J	Bayfield, OW; Chen, CS; Patterson, AR; Luan, WS; Smits, C; Gollnick, P; Antson, AA				Bayfield, Oliver W.; Chen, Chao-Sheng; Patterson, Andrea R.; Luan, Weisha; Smits, Callum; Gollnick, Paul; Antson, Alfred A.			Trp RNA-Binding Attenuation Protein: Modifying Symmetry and Stability of a Circular Oligomer	PLOS ONE			English	Article							MOLECULAR-GRAPHICS; TRAP; DNA; TRANSLOCATION; REFINEMENT; MUTANT; MOTOR	Background: Subunit number is amongst the most important structural parameters that determine size, symmetry and geometry of a circular protein oligomer. The L-tryptophan biosynthesis regulator, TRAP, present in several Bacilli, is a good model system for investigating determinants of the oligomeric state. A short segment of C-terminal residues defines whether TRAP forms an 11-mer or 12-mer assembly. To understand which oligomeric state is more stable, we examine the stability of several wild type and mutant TRAP proteins. Methodology/Principal Findings: Among the wild type B. stearothermophilus, B. halodurans and B. subtilis TRAP, we find that the former is the most stable whilst the latter is the least. Thermal stability of all TRAP is shown to increase with L-tryptophan concentration. We also find that mutant TRAP molecules that are truncated at the C-terminus - and hence induced to form 12-mers, distinct from their 11-mer wild type counterparts - have increased melting temperatures. We show that the same effect can be achieved by a point mutation S72N at a subunit interface, which leads to exclusion of C-terminal residues from the interface. Our findings are supported by dye-based scanning fluorimetry, CD spectroscopy, and by crystal structure and mass spectrometry analysis of the B. subtilis S72N TRAP. Conclusions/Significance: We conclude that the oligomeric state of a circular protein can be changed by introducing a point mutation at a subunit interface. Exclusion (or deletion) of the C-terminus from the subunit interface has a major impact on properties of TRAP oligomers, making them more stable, and we argue that the cause of these changes is the altered oligomeric state. The more stable TRAP oligomers could be used in potential applications of TRAP in bionanotechnology.	[Bayfield, Oliver W.; Chen, Chao-Sheng; Luan, Weisha; Smits, Callum; Antson, Alfred A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Patterson, Andrea R.; Gollnick, Paul] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	University of York - UK; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bayfield, OW (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	fred.antson@york.ac.uk	Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Bayfield, Oliver William/0000-0003-1421-7780	Engineering and Physical Sciences Research Council; Department of Chemistry Vacation Bursary Scheme; Wild Fund awards; National Science Foundation Molecular and Cellular Biology [1019960]; Wellcome Trust [081916]; Div Of Molecular and Cellular Bioscience [1019960] Funding Source: National Science Foundation	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Chemistry Vacation Bursary Scheme; Wild Fund awards; National Science Foundation Molecular and Cellular Biology(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Engineering and Physical Sciences Research Council studentship 2011 and the Department of Chemistry Vacation Bursary Scheme 2011 to OWB, Wild Fund awards to C-SC and WL, by National Science Foundation Molecular and Cellular Biology grant 1019960 to PG and by the Wellcome Trust fellowship 081916 to AAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chen CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025296; Chen XP, 1999, J MOL BIOL, V289, P1003, DOI 10.1006/jmbi.1999.2834; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Heddle JG, 2007, SMALL, V3, P1950, DOI 10.1002/smll.200700400; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Li PTX, 2004, J MOL BIOL, V335, P707, DOI 10.1016/j.jmb.2003.11.002; Malay AD, 2011, BIOCHEM J, V434, P427, DOI 10.1042/BJ20101813; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; McElroy CA, 2006, BIOCHEMISTRY-US, V45, P7844, DOI 10.1021/bi0526074; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Miranda FF, 2009, SMALL, V5, P2077, DOI 10.1002/smll.200900667; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]	30	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44309	10.1371/journal.pone.0044309	http://dx.doi.org/10.1371/journal.pone.0044309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970197	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400056
J	Kim, YJ; Yeu, SY; Park, BS; Koh, HJ; Song, JT; Seo, HS				Kim, Yeon Jeong; Yeu, Song Yion; Park, Bong Soo; Koh, Hee-Jong; Song, Jong Tae; Seo, Hak Soo			Protein Disulfide Isomerase-Like Protein 1-1 Controls Endosperm Development through Regulation of the Amount and Composition of Seed Proteins in Rice	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM; AMYLOPECTIN BIOSYNTHESIS; STORAGE PROTEINS; STARCH; MUTATIONS; GENE; QUALITY; ACCUMULATION	Protein disulfide isomerase (PDI) is a chaperone protein involved in oxidative protein folding by acting as a catalyst and assisting folding in the endoplasmic reticulum (ER). A genome database search showed that rice contains 19 PDI-like genes. However, their functions are not clearly identified. This paper shows possible functions of rice PDI-like protein 1-1 (PDIL1-1) during seed development. Seeds of the T-DNA insertion PDIL1-1 mutant, PDIL1-1D, identified by genomic DNA PCR and western blot analysis, display a chalky phenotype and a thick aleurone layer. Protein content per seed was significantly lower and free sugar content higher in PDIL1-1D mutant seeds than in the wild type. Proteomic analysis of PDIL1-1D mutant seeds showed that PDIL1-1 is post-translationally regulated, and its loss causes accumulation of many types of seed proteins including glucose/starch metabolism-and ROS (reactive oxygen species) scavenging-related proteins. In addition, PDIL1-1 strongly interacts with the cysteine protease OsCP1. Our data indicate that the opaque phenotype of PDIL1-1D mutant seeds results from production of irregular starch granules and protein body through loss of regulatory activity for various proteins involved in the synthesis of seed components.	[Kim, Yeon Jeong; Park, Bong Soo; Koh, Hee-Jong; Seo, Hak Soo] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Seoul, South Korea; [Yeu, Song Yion] Seoul Natl Univ, Sch Agr Biotechnol, Seoul, South Korea; [Koh, Hee-Jong; Seo, Hak Soo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea; [Seo, Hak Soo] Seoul Natl Univ, BioMAX Inst, Seoul, South Korea; [Song, Jong Tae] Kyungpook Natl Univ, Sch Appl Biosci, Taegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University	Kim, YJ (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Seoul, South Korea.	seohs@snu.ac.kr		Song, Jong Tae/0000-0002-2052-6582	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ008123]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008123), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENBACH SB, 1981, VIROLOGY, V112, P25, DOI 10.1016/0042-6822(81)90608-5; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; CAI H, 1994, J BIOL CHEM, V269, P24550; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Dinges JR, 2001, PLANT PHYSIOL, V125, P1406, DOI 10.1104/pp.125.3.1406; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Gallant DJ, 1997, CARBOHYD POLYM, V32, P177, DOI 10.1016/S0144-8617(97)00008-8; Han XH, 2012, J EXP BOT, V63, P121, DOI 10.1093/jxb/err262; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Jacquot JP, 2002, BIOCHEM PHARMACOL, V64, P1065, DOI 10.1016/S0006-2952(02)01177-2; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Kawakatsu T, 2010, PLANT PHYSIOL, V154, P1842, DOI 10.1104/pp.110.164343; Kim YJ, 2010, J KOREAN SOC APPL BI, V53, P508, DOI 10.3839/jksabc.2010.077; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kossmann J, 2000, CRIT REV PLANT SCI, V19, P171, DOI 10.1016/S0735-2689(00)80002-7; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MILES MJ, 1985, CARBOHYD RES, V135, P271, DOI 10.1016/S0008-6215(00)90778-X; MIZUNO K, 1993, J BIOL CHEM, V268, P19084; Muntz K, 1998, PLANT MOL BIOL, V38, P77, DOI 10.1023/A:1006020208380; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 1996, PHYSIOL PLANTARUM, V97, P491, DOI [10.1111/j.1399-3054.1996.tb00508.x, 10.1034/j.1399-3054.1996.970311.x]; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Onda Y, 2011, PLANT CELL, V23, P210, DOI 10.1105/tpc.110.079509; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; PUIG A, 1994, J BIOL CHEM, V269, P7764; SATOH H, 1981, JPN J BREED, V31, P316; Satoh-Cruz M, 2010, PLANT CELL PHYSIOL, V51, P1581, DOI 10.1093/pcp/pcq098; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson DB, 2000, CARBOHYD POLYM, V43, P223, DOI 10.1016/S0144-8617(00)00150-8; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSAI CY, 1978, BIOCHEM GENET, V16, P883, DOI 10.1007/BF00483740; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Wakasa Y, 2011, PLANT J, V65, P675, DOI 10.1111/j.1365-313X.2010.04453.x; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wong JH, 2003, FEBS LETT, V547, P151, DOI 10.1016/S0014-5793(03)00696-3; Yasuda H, 2009, PLANT CELL PHYSIOL, V50, P1532, DOI 10.1093/pcp/pcp098; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	54	43	46	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44493	10.1371/journal.pone.0044493	http://dx.doi.org/10.1371/journal.pone.0044493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970232	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400078
J	Tan, KW; Jobichen, C; Ong, TC; Gao, YF; Tiong, YS; Wong, KN; Chew, FT; Sivaraman, J; Mok, YK				Tan, Kang Wei; Jobichen, Chacko; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung			Crystal Structure of Der f 7, a Dust Mite Allergen from Dermatophagoides farinae	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY BINDING; X-RAY-DIFFRACTION; AMINO-ACID; MOLECULAR-CLONING; PROTEIN; SYSTEM; IGE; SENSITIVITY; EXPRESSION; ALIGNMENT	Background: Der f 7 is the group 7 allergen from the dust mite Dermatophagoides farinae, homologous to the major allergen Der p 7 from D. pteronyssinus. Monoclonal antibody that bind to residues Leu48 and Phe50 was found to inhibit IgE binding to residue Asp159, which is important for the cross-reactivity between Der f 7 and Der p 7. Methodology/Principal Findings: Here, we report the crystal structure of Der f 7 that shows an elongated and curved molecule consisting of two anti-parallel beta-sheets - one 4-stranded and the other 5-stranded - that wrap around a long C-terminal helix. The overall fold of Der f 7 is similar to Der p 7 but key difference was found in the beta 1-beta 2 loop region. In Der f 7, Leu48 and Phe50 are in close proximity to Asp159, explaining why monoclonal antibody binding to Leu48 and Phe50 can inhibit IgE binding to Asp159. Both Der f 7 and Der p 7 bind weakly to polymyxin B via a similar binding site that is formed by the N-terminal helix, the 4-stranded beta-sheet and the C-terminal helix. The thermal stability of Der f 7 is significantly lower than that of Der p 7, and the stabilities of both allergens are highly depend on pH. Conclusion/Significance: Der f 7 is homologous to Der p 7 in terms of the amino acid sequence and overall 3D structure but with significant differences in the region proximal to the IgE epitope and in thermal stability. The crystal structure of Der f 7 provides a basis for studying the function and allergenicity of this group of allergens.	[Tan, Kang Wei; Jobichen, Chacko; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Tan, KW (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsmokh@nus.edu.sg	Mok, Yu Keung/H-8019-2012; Jobichen, Chacko/AAR-7637-2020; Jobichen, Chacko/D-1978-2014; Chew, Fook Tim/E-7259-2010	Mok, Yu Keung/0000-0002-2829-4878; Jobichen, Chacko/0000-0001-5927-1815; Chew, Fook Tim/0000-0003-1337-5146; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council [04/1/21/19/315]; National Medical Research Council of Singapore [NMRC/1150/2008]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This study was supported by grants from the Biomedical Research Council (04/1/21/19/315) and the National Medical Research Council (NMRC/1150/2008) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Cabrera AR, 2009, J INSECT PHYSIOL, V55, P1079, DOI 10.1016/j.jinsphys.2009.08.007; Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1; Chou H, 2011, MOL IMMUNOL, V48, P2130, DOI 10.1016/j.molimm.2011.07.004; Cui YB, 2010, J MED ENTOMOL, V47, P868, DOI 10.1603/ME09180; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; DOWNING AS, 1990, EXP APPL ACAROL, V9, P123, DOI 10.1007/BF01198990; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goddard T. D., SPARKY 3; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Kidon MI, 2011, PEDIAT ALLERG IMM-UK, V22, P202, DOI 10.1111/j.1399-3038.2010.01094.x; Kleiger G, 2000, J MOL BIOL, V299, P1019, DOI 10.1006/jmbi.2000.3805; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; SHEN HD, 1993, CLIN EXP ALLERGY, V23, P934, DOI 10.1111/j.1365-2222.1993.tb00278.x; SHEN HD, 1995, CLIN EXP ALLERGY, V25, P1000, DOI 10.1111/j.1365-2222.1995.tb00403.x; Shen HD, 1996, CLIN EXP ALLERGY, V26, P308, DOI 10.1111/j.1365-2222.1996.tb00096.x; Shen HD, 1997, CLIN EXP ALLERGY, V27, P824, DOI 10.1046/j.1365-2222.1997.650890.x; Shen HD, 2011, IMMUNOL CELL BIOL, V89, P225, DOI 10.1038/icb.2010.77; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Tan KW, 2011, ACTA CRYSTALLOGR F, V67, P1612, DOI 10.1107/S174430911103836X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wheeler TT, 2002, BBA-GENE STRUCT EXPR, V1579, P92, DOI 10.1016/S0167-4781(02)00508-0; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	37	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44850	10.1371/journal.pone.0044850	http://dx.doi.org/10.1371/journal.pone.0044850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970319	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400124
J	Zhang, LX; Xie, JP; Patel, M; Bakhtyar, A; Ehrlich, GD; Ahmed, A; Earl, J; Marrs, CF; Clemans, D; Murphy, TF; Gilsdorf, JR				Zhang, Lixin; Xie, Jingping; Patel, Mayuri; Bakhtyar, Arsala; Ehrlich, Garth D.; Ahmed, Azad; Earl, Josh; Marrs, Carl F.; Clemans, Daniel; Murphy, Timothy F.; Gilsdorf, Janet R.			Nontypeable Haemophilus influenzae Genetic Islands Associated with Chronic Pulmonary Infection	PLOS ONE			English	Article							COMPARATIVE GENOMICS; RESPIRATORY-TRACT; OTITIS-MEDIA; MULTIPLE STRAINS; DISEASE; IDENTIFICATION; COLONIZATION; COMMENSAL; VIRULENCE; BACTERIA	Background: Haemophilus influenzae (Hi) colonizes the human respiratory tract and is an important pathogen associated with chronic obstructive pulmonary disease (COPD). Bacterial factors that interact with the human host may be important in the pathogenesis of COPD. These factors, however, have not been well defined. The overall goal of this study was to identify bacterial genetic elements with increased prevalence among H. influenzae strains isolated from patients with COPD compared to those isolated from the pharynges of healthy individuals. Methodology/Principal Findings: Four nontypeable H. influenzae (NTHi) strains, two isolated from the airways of patients with COPD and two from a healthy individual, were subjected to whole genome sequencing using 454 FLX Titanium technology. COPD strain-specific genetic islands greater than 500 bp in size were identified by in silico subtraction. Open reading frames residing within these islands include known Hi virulence genes such as lic2b, hgbA, iga, hmw1 and hmw2, as well as genes encoding urease and other enzymes involving metabolic pathways. The distributions of seven selected genetic islands were assessed among a panel of 421 NTHi strains of both disease and commensal origins using a Library-on-a-Slide high throughput dot blot DNA hybridization procedure. Four of the seven islands screened, containing genes that encode a methyltransferase, a dehydrogenase, a urease synthesis enzyme, and a set of unknown short ORFs, respectively, were more prevalent in COPD strains than in colonizing strains with prevalence ratios ranging from 1.21 to 2.85 (p <= 0.0002). Surprisingly, none of these sequences show increased prevalence among NTHi isolated from the airways of patients with cystic fibrosis. Conclusions/Significance: Our data suggest that specific bacterial genes, many involved in metabolic functions, are associated with the ability of NTHi strains to survive in the lower airways of patients with COPD.	[Zhang, Lixin; Xie, Jingping; Marrs, Carl F.; Gilsdorf, Janet R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Patel, Mayuri; Bakhtyar, Arsala; Gilsdorf, Janet R.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Ehrlich, Garth D.; Ahmed, Azad; Earl, Josh] Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Clemans, Daniel] Eastern Michigan Univ, Dept Biol, Ypsilanti, MI 48197 USA; [Murphy, Timothy F.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dept Microbiol, Div Infect Dis,Dept Med, Buffalo, NY 14260 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Drexel University; Drexel University; Eastern Michigan University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhang, LX (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	lxzhang@umich.edu	Zhang, Li/GWM-7501-2022	Ehrlich, Garth/0000-0003-1140-6594; Murphy, Timothy/0000-0002-3496-2641	National Institutes of Health [RO1 HL083893, DC05840, R15 HL071526, AI19641]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083893, R15HL071526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study is supported in part by National Institutes of Health grants RO1 HL083893 and DC05840 (JG), R15 HL071526 (DLC), AI19641 (TFM) and by the Department of Veterans Affairs (TFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012617; Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman NH, 2003, INFECT IMMUN, V71, P1098, DOI 10.1128/IAI.71.3.1098-1108.2003; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Boucher Y, 2001, CURR OPIN MICROBIOL, V4, P285, DOI 10.1016/S1369-5274(00)00204-6; Campos JM, 1999, MANUAL CLIN MICROBIO, P604; Davis GS, 2011, J CLIN MICROBIOL, V49, P2594, DOI 10.1128/JCM.02509-10; Dhooge I, 2000, INT J PEDIATR OTORHI, V54, P7, DOI 10.1016/S0165-5876(00)00321-9; Ecevit IZ, 2004, J CLIN MICROBIOL, V42, P3065, DOI 10.1128/JCM.42.7.3065-3072.2004; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Farjo RS, 2004, PEDIATR INFECT DIS J, V23, P41, DOI 10.1097/01.inf.0000106981.89572.d1; Fernaays MM, 2006, INFECT IMMUN, V74, P5860, DOI 10.1128/IAI.00796-06; Fernaays MM, 2006, INFECT IMMUN, V74, P3366, DOI 10.1128/IAI.01904-05; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Harb OS, 1998, INFECT IMMUN, V66, P1898, DOI 10.1128/IAI.66.5.1898-1903.1998; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07; Kilian M., 2005, BERGEYS MANUAL SYSTE, V2B, P883; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Minino AM, 2011, NATL VITAL STAT REP, V59, P1; MOLLER LVM, 1995, J INFECT DIS, V172, P1388, DOI 10.1093/infdis/172.5.1388; Munson RS, 2004, INFECT IMMUN, V72, P3002, DOI 10.1128/IAI.72.5.3002-3010.2004; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Murphy TF, 2002, DRUG AGING, V19, P761, DOI 10.2165/00002512-200219100-00005; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nakamura S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001247; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Qu J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-162; Sachs G, 2006, J MEMBRANE BIOL, V212, P71, DOI 10.1007/s00232-006-0867-7; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; SAMUELSON A, 1995, J CLIN MICROBIOL, V33, P2027, DOI 10.1128/JCM.33.8.2027-2031.1995; Sandstedt SA, 2008, J MICROBIOL METH, V75, P369, DOI 10.1016/j.mimet.2008.06.023; Sandstedt SA, 2010, J CLIN MICROBIOL, V48, P2565, DOI 10.1128/JCM.02453-09; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schoolnik GK, 2002, CURR OPIN MICROBIOL, V5, P20, DOI 10.1016/S1369-5274(02)00280-1; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Seale TW, 2006, INFECT IMMUN, V74, P6213, DOI 10.1128/IAI.00744-06; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; SmithVaughan HC, 1996, EPIDEMIOL INFECT, V116, P177, DOI 10.1017/S0950268800052419; St Sauver J, 2000, EMERG INFECT DIS, V6, P622, DOI 10.3201/eid0606.000611; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; TROTTIER S, 1989, J CLIN MICROBIOL, V27, P2175, DOI 10.1128/JCM.27.10.2175-2179.1989; Vitovski S, 2002, JAMA-J AM MED ASSOC, V287, P1699, DOI 10.1001/jama.287.13.1699; Weiser LN, 2000, TRENDS MICROBIOL, V8, P433, DOI 10.1016/S0966-842X(00)01839-4; Whitby PW, 2006, J BACTERIOL, V188, P5640, DOI 10.1128/JB.00417-06; Whitby PW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-6; Whittam TS, 2002, CURR OPIN GENET DEV, V12, P719, DOI 10.1016/S0959-437X(02)00361-1; Wilson R, 2001, EUR RESPIR J, V17, P995, DOI 10.1183/09031936.01.17509950; Wong SMS, 2011, INFECT IMMUN, V79, P1971, DOI 10.1128/IAI.01269-10; Xie JP, 2006, J CLIN MICROBIOL, V44, P4316, DOI 10.1128/JCM.01331-06; Zhang LX, 2005, BIOTECHNIQUES, V39, P640, DOI 10.2144/000112038; Zhang LX, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-12	64	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44730	10.1371/journal.pone.0044730	http://dx.doi.org/10.1371/journal.pone.0044730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970300	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400115
J	Bae, YK; Sung, JY; Kim, YN; Kim, S; Hong, KM; Kim, HT; Choi, MS; Kwon, JY; Shim, J				Bae, Young-Ki; Sung, Jee Young; Kim, Yong-Nyun; Kim, Sunshin; Hong, Kyeong Man; Kim, Heung Tae; Choi, Min Sung; Kwon, Jae Young; Shim, Jaegal			An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs	PLOS ONE			English	Article							CELL LUNG-CANCER; CAENORHABDITIS-ELEGANS; TYROSINE KINASE; GEFITINIB-RESISTANCE; ACQUIRED-RESISTANCE; VULVAL DEVELOPMENT; CLINICAL-RESPONSE; RECEPTOR; MUTATIONS; ENCODES	The epidermal growth factor receptor (EGFR) is a well-established target for cancer treatment. EGFR tyrosine kinase (TK) inhibitors, such as gefinitib and erlotinib, have been developed as anti-cancer drugs. Although non-small cell lung carcinoma with an activating EGFR mutation, L858R, responds well to gefinitib and erlotinib, tumors with a doubly mutated EGFR, T790M-L858R, acquire resistance to these drugs. The C. elegans EGFR homolog LET-23 and its downstream signaling pathway have been studied extensively to provide insight into regulatory mechanisms conserved from C. elegans to humans. To develop an in vivo screening system for potential cancer drugs targeting specific EGFR mutants, we expressed three LET-23 chimeras in which the TK domain was replaced with either the human wild-type TK domain (LET-23:: hEGFR-TK), a TK domain with the L858R mutation (LET-23:: hEGFR-TK[L858R]), or a TK domain with the T790M-L858R mutations (LET23:: hEGFR-TK[T790M-L858R]) in C. elegans vulval cells using the let-23 promoter. The wild-type hEGFR-TK chimeric protein rescued the let-23 mutant phenotype, and the activating mutant hEGFR-TK chimeras induced a multivulva (Muv) phenotype in a wild-type C. elegans background. The anti-cancer drugs gefitinib and erlotinib suppressed the Muv phenotype in LET23:: hEGFR-TK[L858R]-expressing transgenic animals, but not in LET-23:: hEGFR-TK[T790M-L858R] transgenic animals. As a pilot screen, 8,960 small chemicals were tested for Muv suppression, and AG1478 (an EGFR-TK inhibitor) and U0126 (a MEK inhibitor) were identified as potential inhibitors of EGFR-mediated biological function. In conclusion, transgenic C. elegans expressing chimeric LET-23:: hEGFR-TK proteins are a model system that can be used in mutation-specific screens for new anti-cancer drugs.	[Bae, Young-Ki; Kim, Yong-Nyun; Shim, Jaegal] Natl Canc Ctr, Comparat Biomed Res Branch, Goyang Si, Gyeonggi Do, South Korea; [Sung, Jee Young] Natl Canc Ctr, Pediat Oncol Res Branch, Goyang Si, Gyeonggi Do, South Korea; [Kim, Sunshin] Natl Canc Ctr, New Expt Therapeut Branch, Goyang Si, Gyeonggi Do, South Korea; [Hong, Kyeong Man] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Goyang Si, Gyeonggi Do, South Korea; [Kim, Heung Tae] Natl Canc Ctr, Ctr Lung Canc, Goyang Si, Gyeonggi Do, South Korea; [Choi, Min Sung; Kwon, Jae Young] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU)	Bae, YK (corresponding author), Natl Canc Ctr, Comparat Biomed Res Branch, Goyang Si, Gyeonggi Do, South Korea.	jaegal@ncc.re.kr			National Cancer Center of South Korea [NCC-1110060]; NIH National Center for Research Resources (NCRR)	National Cancer Center of South Korea; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was solely supported by a research grant from the National Cancer Center (NCC-1110060) of South Korea (www.ncc.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Korea Chemical Bank of KRICT for providing 7,680 chemicals. Some nematode strains including let-23, let-60, lin-15, JJ1136, PS4657 and PS3352 used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Cappuzzo F, 2006, ANN ONCOL, V17, P1120, DOI 10.1093/annonc/mdl077; Chang C, 1999, CANCER METAST REV, V18, P203, DOI 10.1023/A:1006317206443; CLARK SG, 1994, GENETICS, V137, P987; Dengg Marlene, 2004, Journal of Pharmacological and Toxicological Methods, V50, P209, DOI 10.1016/j.vascn.2004.04.002; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gonzalez-Perez Vanessa, 2010, J Mol Signal, V5, P2, DOI 10.1186/1750-2187-5-2; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; HARA M, 1995, P NATL ACAD SCI USA, V92, P3333, DOI 10.1073/pnas.92.8.3333; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inoue T, 2005, P NATL ACAD SCI USA, V102, P4972, DOI 10.1073/pnas.0408122102; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kim TH, 2011, FEBS LETT, V585, P121, DOI 10.1016/j.febslet.2010.11.020; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Labouesse Michel, 2006, WormBook, P1; Lackner MR, 2005, CANCER CELL, V7, P325, DOI 10.1016/j.ccr.2005.03.024; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Uchida A, 2007, CANCER SCI, V98, P357, DOI 10.1111/j.1349-7006.2007.00387.x; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; Wong KK, 2009, RECENT PAT ANTI-CANC, V4, P28, DOI 10.2174/157489209787002461; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	43	14	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42441	10.1371/journal.pone.0042441	http://dx.doi.org/10.1371/journal.pone.0042441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957020	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800012
J	Fillon, SA; Harris, JK; Wagner, BD; Kelly, CJ; Stevens, MJ; Moore, W; Fang, R; Schroeder, S; Masterson, JC; Robertson, CE; Pace, NR; Ackerman, SJ; Furuta, GT				Fillon, Sophie A.; Harris, J. Kirk; Wagner, Brandie D.; Kelly, Caleb J.; Stevens, Mark J.; Moore, Wendy; Fang, Rui; Schroeder, Shauna; Masterson, Joanne C.; Robertson, Charles E.; Pace, Norman R.; Ackerman, Steven J.; Furuta, Glenn T.			Novel Device to Sample the Esophageal Microbiome-The Esophageal String Test	PLOS ONE			English	Article							ENTEROTEST DUODENAL CAPSULE; INFLAMMATORY BOWEL DISEASES; BARRETTS-ESOPHAGUS; BARCODED PRIMERS; DISTAL ESOPHAGUS; BACTERIAL BIOTA; DIVERSITY; INFECTIONS; DIAGNOSIS; TWINS	A growing number of studies implicate the microbiome in the pathogenesis of intestinal inflammation. Previous work has shown that adults with esophagitis related to gastroesophageal reflux disease have altered esophageal microbiota compared to those who do not have esophagitis. In these studies, sampling of the esophageal microbiome was accomplished by isolating DNA from esophageal biopsies obtained at the time of upper endoscopy. The aim of the current study was to identify the esophageal microbiome in pediatric individuals with normal esophageal mucosa using a minimally invasive, capsule-based string technology, the Enterotest (TM). We used the proximal segment of the Enterotest string to sample the esophagus, and term this the "Esophageal String Test" (EST). We hypothesized that the less invasive EST would capture mucosal adherent bacteria present in the esophagus in a similar fashion as mucosal biopsy. EST samples and mucosal biopsies were collected from children with no esophageal inflammation (n = 15) and their microbiome composition determined by 16S rRNA gene sequencing. Microbiota from esophageal biopsies and ESTs produced nearly identical profiles of bacterial genera and were different from the bacterial contents of samples collected from the nasal and oral cavity. We conclude that the minimally invasive EST can serve as a useful device for study of the esophageal microbiome.	[Fillon, Sophie A.; Kelly, Caleb J.; Moore, Wendy; Schroeder, Shauna; Masterson, Joanne C.; Furuta, Glenn T.] Univ Colorado Denver, Sect Gastroenterol Hepatol & Nutr,Dept Pediat, Gastrointestinal Eosinophil Dis Program,Sch Med, Childrens Hosp Colordo,Digest Hlth Inst,Mucosal I, Aurora, CO USA; [Harris, J. Kirk; Stevens, Mark J.] Univ Colorado Denver, Sch Med, Dept Pediat, Div Pulmonol, Aurora, CO USA; [Wagner, Brandie D.; Fang, Rui] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, Boulder, CO USA; [Ackerman, Steven J.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fillon, SA (corresponding author), Univ Colorado Denver, Sect Gastroenterol Hepatol & Nutr,Dept Pediat, Gastrointestinal Eosinophil Dis Program,Sch Med, Childrens Hosp Colordo,Digest Hlth Inst,Mucosal I, Aurora, CO USA.	sophie.fillon@ucdenver.edu		Wagner, brandie/0000-0002-2745-0103; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202; Kelly, Caleb/0000-0003-4861-1479	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI [UL1 RR025780, KL2 RR025779]; American Partnership For Eosinophilic Disorders (APFED); Campaign Urging Research for Eosinophilic Diseases (CURED); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025779, UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI; American Partnership For Eosinophilic Disorders (APFED); Campaign Urging Research for Eosinophilic Diseases (CURED); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors recognize the support of REDCap for subjects' database supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant Number UL1 RR025780. This work was supported by the American Partnership For Eosinophilic Disorders (APFED) Junior Faculty HOPE Research Grant (SF); National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant Number KL2 RR025779 (SF) and UL1 RR025780 (GTF) and the Campaign Urging Research for Eosinophilic Diseases (CURED) (SJA/GTF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dahlen G, 2009, PERIODONTOL 2000, V49, P13, DOI 10.1111/j.1600-0757.2008.00295.x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gagliardi D, 1998, Dis Esophagus, V11, P248; GOLDSMID JM, 1978, MED J AUSTRALIA, V1, P519, DOI 10.5694/j.1326-5377.1978.tb112594.x; GRACEY M, 1977, ARCH DIS CHILD, V52, P74, DOI 10.1136/adc.52.1.74; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2010, APPL ENV MICROBIOL; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kopanski Z, 1996, Eur J Med Res, V1, P520; Lawson R Daniel, 2010, Curr Gastroenterol Rep, V12, P259, DOI 10.1007/s11894-010-0111-6; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Leong RWL, 2003, WORLD J GASTROENTERO, V9, P309, DOI 10.3748/wjg.v9.i2.309; Macfarlane S, 2007, CLIN INFECT DIS, V45, P29, DOI 10.1086/518578; Michail S, 2011, INFLAMM BOWEL DIS; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Norder Grusell E, 2012, DIS ESOPHAGUS; Osias GL, 2004, DIGEST DIS SCI, V49, P228, DOI 10.1023/B:DDAS.0000017443.44802.4b; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pajecki D, 2002, J GASTROINTEST SURG, V6, P723, DOI 10.1016/S1091-255X(02)00028-8; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Pei ZH, 2005, WORLD J GASTROENTERO, V11, P7277, DOI 10.3748/wjg.v11.i46.7277; THOMAS GE, 1974, S AFR MED J, V48, P2219; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046	36	66	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42938	10.1371/journal.pone.0042938	http://dx.doi.org/10.1371/journal.pone.0042938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957025	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308463800017
J	Freeman, MC; Trinies, V; Boisson, S; Mak, G; Clasen, T				Freeman, Matthew C.; Trinies, Victoria; Boisson, Sophie; Mak, Gregory; Clasen, Thomas			Promoting Household Water Treatment through Women's Self Help Groups in Rural India: Assessing Impact on Drinking Water Quality and Equity	PLOS ONE			English	Article							POINT-OF-USE; DEVELOPING-COUNTRIES; MICROBIOLOGICAL EFFECTIVENESS; INTERVENTIONS; DIARRHEA; HEALTH; COST	Household water treatment, including boiling, chlorination and filtration, has been shown effective in improving drinking water quality and preventing diarrheal disease among vulnerable populations. We used a case-control study design to evaluate the extent to which the commercial promotion of household water filters through microfinance institutions to women's self-help group (SHG) members improved access to safe drinking water. This pilot program achieved a 9.8% adoption rate among women targeted for adoption. Data from surveys and assays of fecal contamination (thermotolerant coliforms, TTC) of drinking water samples (source and household) were analyzed from 281 filter adopters and 247 non-adopters exposed to the program; 251 non-SHG members were also surveyed. While adopters were more likely than non-adopters to have children under 5 years, they were also more educated, less poor, more likely to have access to improved water supplies, and more likely to have previously used a water filter. Adopters had lower levels of fecal contamination of household drinking water than non-adopters, even among those non-adopters who treated their water by boiling or using traditional ceramic filters. Nevertheless, one-third of water samples from adopter households exceeded 100 TTC/100ml (high risk), and more than a quarter of the filters had no stored treated water available when visited by an investigator, raising concerns about correct, consistent use. In addition, the poorest adopters were less likely to see improvements in their water quality. Comparisons of SHG and non-SHG members suggest similar demographic characteristics, indicating SHG members are an appropriate target group for this promotion campaign. However, in order to increase the potential for health gains, future programs will need to increase uptake, particularly among the poorest households who are most susceptible to disease morbidity and mortality, and focus on strategies to improve the correct, consistent and sustained use of these water treatment products.	[Freeman, Matthew C.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Ctr Global Safe Water, Atlanta, GA 30322 USA; [Freeman, Matthew C.; Boisson, Sophie; Clasen, Thomas] London Sch Hyg & Trop Med, Environm Hlth Grp, Fac Infect Dis, London WC1, England; [Trinies, Victoria; Mak, Gregory] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth, New York, NY USA	Emory University; Rollins School Public Health; University of London; London School of Hygiene & Tropical Medicine; Columbia University	Freeman, MC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Ctr Global Safe Water, Atlanta, GA 30322 USA.	mcfreem@emory.edu	Freeman, Matthew/ABE-6245-2020	Freeman, Matthew/0000-0002-1517-2572; Trinies, Victoria/0000-0002-7863-7509	Hindustan Level Limited	Hindustan Level Limited	This study was funded by Hindustan Level Limited, the maker of the Pureit water filter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA- American Public Health Association, 2005, AM PUBL HLTH ASS STA, V21; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030955, 10.1371/journal.pone.0036735]; Clasen T, 2009, SCALING HOUSEHOLD WA; Clasen T, 2008, AM J TROP MED HYG, V79, P407, DOI 10.4269/ajtmh.2008.79.407; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Clasen T, 2006, TROP MED INT HEALTH, V11, P1399, DOI 10.1111/j.1365-3156.2006.01699.x; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Freeman MC, 2011, AM J TROP MED HYG, V84, P370, DOI 10.4269/ajtmh.2011.10-0361; Freeman MC, 2009, J WATER HEALTH, V7, P527, DOI 10.2166/wh.2009.063; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Indian Council of Medical Research (ICMR), 2006, ETH GUID BIOM RES HU; Khan A, 2008, STUDY PROTOCOL EVALU; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; National Environmental Engineering Research Institute, 2004, POT WAT QUAL ASS SOM; PATH, 2011, PRIV SECT HWTS POU; Properzi F, 2010, STOCKH WORLD WAT C S; Pruss-Ustun A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-7; Trinies V, 2011, J WATER SANIT HYG DE, V1, P224, DOI 10.2166/washdev.2011.127; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 1993, GUID DRINK WAT QUAL; WHO UNICEF, 2010, PROGR SAN DRINK WAT; WHO/UNICEF Joint Monitoring Program for Water Supply and Sanitation, 2012, EST US IMPR DRINK WA; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	29	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44068	10.1371/journal.pone.0044068	http://dx.doi.org/10.1371/journal.pone.0044068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957043	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800035
J	Gupta, S; Marcel, N; Talwar, S; Garg, M; Indulaxmi, R; Perumalsamy, LR; Sarin, A; Shivashankar, GV				Gupta, Soumya; Marcel, Nimi; Talwar, Shefali; Garg, Megha; Indulaxmi, R.; Perumalsamy, Lakshmi R.; Sarin, Apurva; Shivashankar, G. V.			Developmental Heterogeneity in DNA Packaging Patterns Influences T-Cell Activation and Transmigration	PLOS ONE			English	Article							KAPPA-B ACTIVATION; STEM-CELLS; GENOMIC ORGANIZATION; GENE-EXPRESSION; CHROMATIN; DIFFERENTIATION; PLASTICITY; PROTEINS; DYNAMICS; NUCLEOSOME	Cellular differentiation programs are accompanied by large-scale changes in nuclear organization and gene expression. In this context, accompanying transitions in chromatin assembly that facilitates changes in gene expression and cell behavior in a developmental system are poorly understood. Here, we address this gap and map structural changes in chromatin organization during murine T-cell development, to describe an unusual heterogeneity in chromatin organization and associated functional correlates in T-cell lineage. Confocal imaging of DNA assembly in cells isolated from bone marrow, thymus and spleen reveal the emergence of heterogeneous patterns in DNA organization in mature T-cells following their exit from the thymus. The central DNA pattern dominated in immature precursor cells in the thymus whereas both central and peripheral DNA patterns were observed in naive and memory cells in circulation. Naive T-cells with central DNA patterns exhibited higher mechanical pliability in response to compressive loads in vitro and transmigration assays in vivo, and demonstrated accelerated expression of activation-induced marker CD69. T-cell activation was characterized by marked redistribution of DNA assembly to a central DNA pattern and increased nuclear size. Notably, heterogeneity in DNA patterns recovered in cells induced into quiescence in culture, suggesting an internal regulatory mechanism for chromatin reorganization. Taken together, our results uncover an important component of plasticity in nuclear organization, reflected in chromatin assembly, during T-cell development, differentiation and transmigration.	[Gupta, Soumya; Marcel, Nimi; Talwar, Shefali; Garg, Megha; Indulaxmi, R.; Perumalsamy, Lakshmi R.; Sarin, Apurva; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Gupta, Soumya; Talwar, Shefali; Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Gupta, Soumya; Talwar, Shefali; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Marcel, Nimi] Manipal Univ, Dept Hlth Sci, Manipal, Karnataka, India; [Garg, Megha] Univ Mysore, Dept Biotechnol, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); National University of Singapore; National University of Singapore; Manipal Academy of Higher Education (MAHE); University of Mysore	Gupta, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	dbsgvs@nus.edu.sg			Nanoscience Initiative Grant from Department of Science and Technology, India; MechanoBiology Institute at National University of Singapore; Department of Biotechnology, India; Swarnajayanti Grant from Department of Science and Technology, India; Council of Scientific and Industrial Research	Nanoscience Initiative Grant from Department of Science and Technology, India; MechanoBiology Institute at National University of Singapore(National University of Singapore); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Swarnajayanti Grant from Department of Science and Technology, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	We thank the Nanoscience Initiative and Swarnajayanti Grants from the Department of Science and Technology, India, MechanoBiology Institute at National University of Singapore and Department of Biotechnology, India for funding. ST and LRP were funded by the Council of Scientific and Industrial Research, and MG was funded by Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; Blazquez MV, 1999, AIDS RES HUM RETROV, V15, P1209, DOI 10.1089/088922299310304; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mehta IS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r5; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Purushothaman D, 2009, J EXP MED, V206, P1515, DOI 10.1084/jem.20082851; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Shivashankar GV, 2010, METHOD CELL BIOL, V98, pXIII, DOI 10.1016/S0091-679X(10)98019-9; Shu L, 2006, BLOOD CELL MOL DIS, V37, P64, DOI 10.1016/j.bcmd.2006.04.002; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Wang ZF, 1996, GENOME RES, V6, P688, DOI 10.1101/gr.6.8.688; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Wilson CB, 2006, CURR OPIN IMMUNOL, V18, P143, DOI 10.1016/j.coi.2006.01.013	40	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43718	10.1371/journal.pone.0043718	http://dx.doi.org/10.1371/journal.pone.0043718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957031	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308463800023
J	Wurster, CM; Robertson, J; Westcott, DA; Dryden, B; Zazzo, A; Bird, MI				Wurster, Christopher M.; Robertson, Jack; Westcott, David A.; Dryden, Bart; Zazzo, Antoine; Bird, Michael I.			Utilization of Sugarcane Habitat by Feral Pig (Sus scrofa) in Northern Tropical Queensland: Evidence from the Stable Isotope Composition of Hair	PLOS ONE			English	Article							DIETARY CARBON TURNOVER; RAIN-FORESTS; PATTERNS; MANAGEMENT; MIGRATION; DIGGINGS; CO2	Feral pigs (Sus scrofa) are an invasive species that disrupt ecosystem functioning throughout their introduced range. In tropical environments, feral pigs are associated with predation and displacement of endangered species, modification of habitat, and act as a vector for the spread of exotic vegetation and disease. Across many parts of their introduced range, the diet of feral pigs is poorly known. Although the remote location and difficult terrain of far north Queensland makes observing feral pig behavior difficult, feral pigs are perceived to seek refuge in World Heritage tropical rainforests and seasonally 'crop raid' into lowland sugarcane crops. Thus, identifying how feral pigs are using different components of the landscape is important to the design of management strategies. We used the stable isotope composition of captured feral pigs to determine the extent of rainforest and sugarcane habitat usage. Recently grown hair (basal hair) from feral pigs captured in remote rainforest indicated pigs met their dietary needs solely within this habitat. Stable carbon and nitrogen isotope values of basal hair from feral pigs captured near sugarcane plantations were more variable, with some individuals estimated to consume over 85% of their diet within a sugarcane habitat, while a few consumed as much as 90% of their diet from adjacent forested environments. We estimated whether feral pigs switch habitats by sequentially sampling delta C-13 and delta N-15 values of long tail hair from a subset of seven captured animals, and demonstrate that four of these individuals moved between habitats. Our results indicate that feral pigs utilize both sugarcane and forest habitats, and can switch between these resources.	[Wurster, Christopher M.; Robertson, Jack; Bird, Michael I.] James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia; [Wurster, Christopher M.; Robertson, Jack; Bird, Michael I.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Westcott, David A.] Commonwealth Sci & Ind Res Org CSIRO Ecosyst Sci, Atherton, Qld, Australia; [Dryden, Bart] Terrain Nat Resource Management, Innisfail, Qld, Australia; [Zazzo, Antoine] CNRS, UMR 7209, Paris, France; [Zazzo, Antoine] Museum Natl Hist Nat, F-75231 Paris, France	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	Wurster, CM (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia.	christopher.wurster@jcu.edu.au	Westcott, David A/G-5559-2010; zazzo, Antoine/H-1697-2011; Wurster, Christopher M/A-1983-2011; Bird, Michael/G-5364-2010	zazzo, Antoine/0000-0001-7608-2207; Bird, Michael/0000-0003-1801-8703; Wurster, Christopher/0000-0002-2866-5798	Australian Government's Marine and Tropical Science Fund; Terrain Natural Resource Management (NRM) Ltd.; Austrailia Research Council [FF0883221]	Australian Government's Marine and Tropical Science Fund(Australian Government); Terrain Natural Resource Management (NRM) Ltd.; Austrailia Research Council	Funding for this work was provided by the Australian Government's Marine and Tropical Science Fund, Terrain Natural Resource Management (NRM) Ltd., and Austrailia Research Council Federation fellowship to MB (FF0883221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BD and Terrain NRM provided samples and information critical to this study, but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, on the analysis, interpretations.	Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bird MI, 1997, GLOBAL BIOGEOCHEM CY, V11, P313, DOI 10.1029/97GB01197; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Cerling TE, 2004, PALAEOGEOGR PALAEOCL, V206, P367, DOI 10.1016/j.palaeo.2004.01.013; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Cowled BD, 2008, CONSERV GENET, V9, P211, DOI 10.1007/s10592-007-9331-1; Ehleringer J.R., 2002, ENCY GLOBAL ENV CHAN, V2, P186; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Hilbert D. W., 2008, LIVING DYNAMIC TROPI, P107; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Laurance WF, 1997, WILDLIFE RES, V24, P579, DOI 10.1071/WR96029; Mitchell J, 2007, WILDLIFE RES, V34, P597, DOI 10.1071/WR06064; Mitchell J, 2007, WILDLIFE RES, V34, P603, DOI 10.1071/WR06065; Mitchell J, 2009, WILDLIFE RES, V36, P110, DOI 10.1071/WR06066; Pavlov P, 1995, J MOUNTAIN ECOLOGY, V3, P148; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Spain A, 1997, BIOL FERT SOILS, V24, P118, DOI 10.1007/s003740050218; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Sponheimer M, 2007, KOEDOE AFRICAN PROTE, V46, P101; Stork NE, 2008, LIVING DYNAMIC TROPI, P4, DOI DOI 10.1002/9781444300321; The State of Queensland DoPIaF, 2008, PR083564 STAT QUEENS; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; WINTER J W, 1987, Proceedings of the Royal Society of Queensland, V98, P41; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110; Zazzo A, 2008, RAPID COMMUN MASS SP, V22, P2937, DOI 10.1002/rcm.3693	31	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43538	10.1371/journal.pone.0043538	http://dx.doi.org/10.1371/journal.pone.0043538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957029	gold, Green Published, Green Accepted			2022-12-27	WOS:000308463800021
J	Neal-McKinney, JM; Lu, X; Duong, T; Larson, CL; Call, DR; Shah, DH; Konkel, ME				Neal-McKinney, Jason M.; Lu, Xiaonan; Tri Duong; Larson, Charles L.; Call, Douglas R.; Shah, Devendra H.; Konkel, Michael E.			Production of Organic Acids by Probiotic Lactobacilli Can Be Used to Reduce Pathogen Load in Poultry	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI COLONIZATION; COMPETITIVE-EXCLUSION BACTERIA; GARLIC ALLIUM-SATIVUM; INFRARED-SPECTROSCOPY; BROILER-CHICKENS; IDENTIFICATION; MILK; SALMONELLA; TAXONOMY; PRIMALAC	Probiotic Lactobacillus can be used to reduce the colonization of pathogenic bacteria in food animals, and therefore reduce the risk of foodborne illness to consumers. As a model system, we examined the mechanism of protection conferred by Lactobacillus species to inhibit C. jejuni growth in vitro and reduce colonization in broiler chickens. Possible mechanisms for the reduction of pathogens by lactobacilli include: 1) stimulation of adaptive immunity; 2) alteration of the cecal microbiome; and, 3) production of inhibitory metabolites, such as organic acids. The Lactobacillus species produced lactic acid at concentrations sufficient to kill C. jejuni in vitro. We determined that lactic acid produced by Lactobacillus disrupted the membrane of C. jejuni, as judged by biophotonics. The spectral features obtained using Fourier-transform infrared (FTIR) and Raman spectroscopy techniques were used to accurately predict bacterial viability and differentiate C. jejuni samples according to lactic acid treatment. FT-IR spectral features of C. jejuni and Lactobacillus grown in co-culture revealed that the metabolism was dominated by Lactobacillus prior to the killing of C. jejuni. Based on our results, the development of future competitive exclusion strategies should include the evaluation of organic acid production.	[Neal-McKinney, Jason M.; Lu, Xiaonan; Tri Duong; Larson, Charles L.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Call, Douglas R.; Shah, Devendra H.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Washington State University	Neal-McKinney, JM (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	konkel@vetmed.wsu.edu	Shah, Devendra H./S-4965-2016; Duong, Tri/B-5594-2012; Duong, Tri/F-9458-2019	Shah, Devendra H./0000-0001-6365-7868; Duong, Tri/0000-0002-4803-8564; Konkel, Michael/0000-0002-8950-0903	National Institutes of Health (NIH) [R56 AI088518-01A1]; United States Department of Agriculture, National Institute of Food and Agriculture [2011-67015-30772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI088518] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from funds awarded to MEK from the National Institutes of Health (NIH, Award Number R56 AI088518-01A1) and from the United States Department of Agriculture, National Institute of Food and Agriculture (Award Number 2011-67015-30772). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qadiri HM, 2008, J DAIRY SCI, V91, P950, DOI 10.3168/jds.2007-0618; Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; BAREFOOT SF, 1993, J DAIRY SCI, V76, P2366, DOI 10.3168/jds.S0022-0302(93)77574-8; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Berndtson E, 1996, PREV VET MED, V26, P167, DOI 10.1016/0167-5877(95)01008-4; Byrd J. A., 2005, Food safety control in the poultry industry, P310; Chaveerach P, 2002, POULTRY SCI, V81, P621, DOI 10.1093/ps/81.5.621; Chen HC, 2001, APPL ENVIRON MICROB, V67, P848, DOI 10.1128/AEM.67.2.848-851.2001; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Corry JEL, 2001, J APPL MICROBIOL, V90, p96S, DOI 10.1046/j.1365-2672.2001.01358.x; Davis GS, 2002, POULTRY SCI, V81, P755, DOI 10.1093/ps/81.6.755; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Ding W, 2005, J FOOD PROTECT, V68, P2295, DOI 10.4315/0362-028X-68.11.2295; Dobson AE, 2007, J APPL MICROBIOL, V103, P1766, DOI 10.1111/j.1365-2672.2007.03417.x; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Friedman C.R., 2000, CAMPYLOBACTER, P121; Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; Hakkinen M, 1999, BRIT POULTRY SCI, V40, P619, DOI 10.1080/00071669986990; Jacobs-Reitsma W, 2008, CAMPYLOBACTER, 3RD EDITION, P627; Koenen ME, 2004, BRIT POULTRY SCI, V45, P355, DOI 10.1080/00071660410001730851; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Lu XN, 2011, APPL ENVIRON MICROB, V77, P5257, DOI 10.1128/AEM.02845-10; Lu XN, 2011, J AGR FOOD CHEM, V59, P6376, DOI 10.1021/jf200953z; Lu XN, 2011, J AGR FOOD CHEM, V59, P5215, DOI 10.1021/jf201254f; Lu XN, 2011, FOOD BIOPROCESS TECH, V4, P919, DOI 10.1007/s11947-011-0516-8; Maniatis T., 1982, MOL CLONING; Mead GC, 1995, EPIDEMIOL INFECT, V115, P495, DOI 10.1017/S0950268800058659; Mercenier A, 2003, CURR PHARM DESIGN, V9, P175, DOI 10.2174/1381612033392224; Morishita TY, 1997, AVIAN DIS, V41, P850, DOI 10.2307/1592338; Nachamkin I., 2000, CAMPYLOBACTER, P155; Nava G. M., 2005, Animal Health Research Reviews, V6, P105, DOI 10.1079/AHR2005103; Nazef L, 2008, POULTRY SCI, V87, P329, DOI 10.3382/ps.2007-00282; Neal-McKinney JM, 2010, MOL MICROBIOL, V76, P918, DOI 10.1111/j.1365-2958.2010.07144.x; Nicolaou N, 2011, ANAL CHEM, V83, P5681, DOI 10.1021/ac2008256; Ogawa T, 2006, BRIT J NUTR, V95, P430, DOI 10.1079/BJN20051629; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; ROBINSON DA, 1981, BRIT MED J, V282, P1584, DOI 10.1136/bmj.282.6276.1584; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SCHOENI JL, 1992, APPL ENVIRON MICROB, V58, P664, DOI 10.1128/AEM.58.2.664-670.1992; SCHOENI JL, 1994, APPL ENVIRON MICROB, V60, P1191, DOI 10.1128/AEM.60.4.1191-1197.1994; Stern NJ, 2006, ANTIMICROB AGENTS CH, V50, P3111, DOI 10.1128/AAC.00259-06; Stern NJ, 2001, POULTRY SCI, V80, P156, DOI 10.1093/ps/80.2.156; Stiles ME, 1997, INT J FOOD MICROBIOL, V36, P1, DOI 10.1016/S0168-1605(96)01233-0; Talebi A, 2008, AVIAN PATHOL, V37, P509, DOI 10.1080/03079450802356995; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang GD, 2007, J FOOD PROTECT, V70, P867, DOI 10.4315/0362-028X-70.4.867; Zhao T, 2006, J FOOD PROTECT, V69, P762, DOI 10.4315/0362-028X-69.4.762; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	53	153	159	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43928	10.1371/journal.pone.0043928	http://dx.doi.org/10.1371/journal.pone.0043928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962594	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600022
J	Schauer, D; Starlinger, P; Reiter, C; Jahn, N; Zajc, P; Buchberger, E; Bachleitner-Hofmann, T; Bergmann, M; Stift, A; Gruenberger, T; Brostjan, C				Schauer, Dominic; Starlinger, Patrick; Reiter, Christian; Jahn, Nikolaus; Zajc, Philipp; Buchberger, Elisabeth; Bachleitner-Hofmann, Thomas; Bergmann, Michael; Stift, Anton; Gruenberger, Thomas; Brostjan, Christine			Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; HUMAN PERIPHERAL-BLOOD; GROWTH-FACTOR-BETA; GAMMA-RIII CD16; GENE-EXPRESSION; INDUCTION; SUBSETS; SEPSIS; ANGIOPOIETIN-2; IDENTIFICATION	We have conducted the first study to determine the diagnostic potential of the CD14++CD16+ intermediate monocytes as compared to the pro-angiogenic subset of CD14++CD16+TIE2+ TIE2-expressing monocytes (TEMs) in cancer. These monocyte populations were investigated by flow cytometry in healthy volunteers (N = 32) and in colorectal carcinoma patients with localized (N = 24) or metastatic (N = 37) disease. We further determined blood levels of cytokines associated with monocyte regulation. The results revealed the intermediate monocyte subset to be significantly elevated in colorectal cancer patients and to show the highest frequencies in localized disease. Multivariate regression analysis identified intermediate monocytes as a significant independent variable in cancer prediction. With a cut-off value at 0.37% (intermediate monocytes of total leukocytes) the diagnostic sensitivity and specificity ranged at 69% and 81%, respectively. In contrast, TEM levels were elevated in localized cancer but did not differ significantly between groups and none of the cytokines correlated with monocyte subpopulations. Of interest, in vitro analyses supported the observation that intermediate monocytes were more potently induced by primary as opposed to metastatic cancer cells which may relate to the immunosuppressive milieu established in the advanced stage of metastatic disease. In conclusion, intermediate monocytes as compared to TIE2-expressing monocytes are a more sensitive diagnostic indicator of colorectal cancer.	[Schauer, Dominic; Starlinger, Patrick; Reiter, Christian; Jahn, Nikolaus; Zajc, Philipp; Buchberger, Elisabeth; Bachleitner-Hofmann, Thomas; Bergmann, Michael; Stift, Anton; Gruenberger, Thomas; Brostjan, Christine] Med Univ Vienna, Dept Surg, Gen Hosp, Vienna, Austria	Medical University of Vienna	Schauer, D (corresponding author), Med Univ Vienna, Dept Surg, Gen Hosp, Vienna, Austria.	Christine.Brostjan@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022; Gruenberger, Thomas/ABA-1661-2020	Gruenberger, Thomas/0000-0002-2671-0540; Starlinger, Patrick/0000-0002-4666-5337; Stift, Anton/0000-0002-7243-8138; Bergmann, Michael/0000-0001-8529-1166; Bachleitner-Hofmann, Thomas/0000-0002-4201-8247; Brostjan, Christine/0000-0003-1462-5397	Medical Scientific Fund of the Mayor of the City of Vienna [8064]	Medical Scientific Fund of the Mayor of the City of Vienna	This work was supported by the Medical Scientific Fund of the Mayor of the City of Vienna (http://www.wien.gv.at/gesundheit/einrichtungen/medwiss-fonds/) by grant no. 8064 issued to T. Gruenberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Feng AL, 2011, CLIN EXP IMMUNOL, V164, P57, DOI 10.1111/j.1365-2249.2011.04321.x; FINGERLE G, 1993, BLOOD, V82, P3170; Goede V, 2012, CANCER INVEST, V30, P225, DOI 10.3109/07357907.2011.636114; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744; Herra CM, 1996, J MED MICROBIOL, V44, P135, DOI 10.1099/00222615-44-2-135; Hristov M, 2009, CYTOM PART A, V75A, P848, DOI 10.1002/cyto.a.20772; Kruger M, 1996, IMMUNOLOGY, V87, P162; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; MUNN DH, 1989, J EXP MED, V170, P511, DOI 10.1084/jem.170.2.511; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nijziel MR, 2000, AM J HEMATOL, V64, P282, DOI 10.1002/1096-8652(200008)64:4<282::AID-AJH8>3.0.CO;2-2; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; SALEH MN, 1995, BLOOD, V85, P2910, DOI 10.1182/blood.V85.10.2910.bloodjournal85102910; Schaaf B, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-12; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; SCHMID I, 1995, CYTOMETRY, V22, P103, DOI 10.1002/cyto.990220205; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Subimerb C, 2010, CLIN EXP IMMUNOL, V161, P471, DOI 10.1111/j.1365-2249.2010.04200.x; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tsujimoto H, 2004, J ENDOTOXIN RES, V10, P229, DOI 10.1179/096805104225005814; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; WONG HL, 1991, J IMMUNOL, V147, P1843; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	40	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44450	10.1371/journal.pone.0044450	http://dx.doi.org/10.1371/journal.pone.0044450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973451	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600056
J	Tomar, D; Khan, T; Singh, RR; Mishra, S; Gupta, S; Surolia, A; Salunke, DM				Tomar, Divya; Khan, Tarique; Singh, Rajiv Ranjan; Mishra, Satyendra; Gupta, Sarika; Surolia, Avadhesha; Salunke, Dinakar M.			Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; HUMAN-SERUM PREALBUMIN; FORMATION INHIBITORS; CRYSTAL-STRUCTURES; X-RAY; PROTEIN; STABILIZATION; REFINEMENT; DISEASE; DESIGN	Background: Transthyretin (TTR) is a homotetrameric serum and cerebrospinal fluid protein that transports thyroxine (T4) and retinol by binding to retinol binding protein. Rate-limiting tetramer dissociation and rapid monomer misfolding and disassembly of TTR lead to amyloid fibril formation in different tissues causing various amyloid diseases. Based on the current understanding of the pathogenesis of TTR amyloidosis, it is considered that the inhibition of amyloid fibril formation by stabilization of TTR in native tetrameric form is a viable approach for the treatment of TTR amyloidosis. Methodology and Principal Findings: We have examined interactions of the wtTTR with a series of compounds containing various substitutions at biphenyl ether skeleton and a novel compound, previously evaluated for binding and inhibiting tetramer dissociation, by x-ray crystallographic approach. High resolution crystal structures of five ligands in complex with wtTTR provided snapshots of negatively cooperative binding of ligands in two T4 binding sites besides characterizing their binding orientations, conformations, and interactions with binding site residues. In all complexes, the ligand has better fit and more potent interactions in first T4 site i.e. (AC site) than the second T4 site (BD site). Together, these results suggest that AC site is a preferred ligand binding site and retention of ordered water molecules between the dimer interfaces further stabilizes the tetramer by bridging a hydrogen bond interaction between Ser117 and its symmetric copy. Conclusion: Novel biphenyl ether based compounds exhibit negative-cooperativity while binding to two T4 sites which suggests that binding of only single ligand molecule is sufficient to inhibit the TTR tetramer dissociation.	[Tomar, Divya; Khan, Tarique; Salunke, Dinakar M.] Natl Inst Immunol, Struct Biol Unit, New Delhi 110067, India; [Singh, Rajiv Ranjan; Gupta, Sarika] Natl Inst Immunol, Mol Sci Lab, New Delhi 110067, India; [Mishra, Satyendra; Surolia, Avadhesha] Natl Inst Immunol, Ctr Mol Med, New Delhi 110067, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Salunke, Dinakar M.] Reg Ctr Biotechnol, Gurgaon, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology	Tomar, D (corresponding author), Natl Inst Immunol, Struct Biol Unit, New Delhi 110067, India.	surolia@mbu.iisc.ernet.in; dmsalunke@rcb.res.in	Mishra, Satyendra/AAT-8827-2021	Singh, Rajiv Ranjan/0000-0002-1819-2165	Departments of Biotechnology and Science & Technology, Ministry of Science & Technology, Government of India; Department of Biotechnology, Government of India	Departments of Biotechnology and Science & Technology, Ministry of Science & Technology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grants from the Departments of Biotechnology and Science & Technology, Ministry of Science & Technology, Government of India. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dinakar M Salunke and Avadhesha Surolia are the JC Bose National Fellows of the Department of Science and Technology, Government of India. We acknowledge BM14 project from Department of Biotechnology, Government of India for support.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Benson MD, 1989, METABOLIC BASIS INHE, P2439; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLAKE CCF, 1971, J MOL BIOL, V61, P217, DOI 10.1016/0022-2836(71)90218-X; BRANCH WT, 1972, ARCH BIOCHEM BIOPHYS, V152, P144, DOI 10.1016/0003-9861(72)90202-0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHENG SY, 1977, BIOCHEMISTRY-US, V16, P3707, DOI 10.1021/bi00635a031; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Gupta S, 2007, J MED CHEM, V50, P5589, DOI 10.1021/jm0700159; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; Johnson SM, 2009, J MED CHEM, V52, P1115, DOI 10.1021/jm801347s; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006290; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Sekijima Y, 2001, AMYLOID, V8, P257, DOI 10.3109/13506120108993822; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Wiseman RL, 2005, J AM CHEM SOC, V127, P5540, DOI 10.1021/ja042929f	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43522	10.1371/journal.pone.0043522	http://dx.doi.org/10.1371/journal.pone.0043522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973437	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308577600012
J	Joyce, G; Williams, KJ; Robb, M; Noens, E; Tizzano, B; Shahrezaei, V; Robertson, BD				Joyce, Graham; Williams, Kerstin J.; Robb, Matthew; Noens, Elke; Tizzano, Barbara; Shahrezaei, Vahid; Robertson, Brian D.			Cell Division Site Placement and Asymmetric Growth in Mycobacteria	PLOS ONE			English	Article							ACTINOMYCETE CORYNEBACTERIUM-GLUTAMICUM; PENICILLIN-BINDING PROTEINS; TO-POLE OSCILLATION; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; WALL SYNTHESIS; LOCALIZATION; DIVIVA; TUBERCULOSIS; SMEGMATIS	Mycobacteria are members of the actinomycetes that grow by tip extension and lack apparent homologues of the known cell division regulators found in other rod-shaped bacteria. Previous work using static microscopy on dividing mycobacteria led to the hypothesis that these cells can grow and divide asymmetrically, and at a wide range of sizes, in contrast to the cell growth and division patterns observed in the model rod-shaped organisms. In this study, we test this hypothesis using livecell time-lapse imaging of dividing Mycobacterium smegmatis labelled with fluorescent PBP1a, to probe peptidoglycan synthesis and label the cell septum. We demonstrate that the new septum is placed accurately at mid-cell, and that the asymmetric division observed is a result of differential growth from the cell tips, with a more than 2-fold difference in growth rate between fast and slow growing poles. We also show that the division site is not selected at a characteristic cell length, suggesting this is not an important cue during the mycobacterial cell cycle.	[Joyce, Graham; Williams, Kerstin J.; Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England; [Robb, Matthew; Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Noens, Elke; Tizzano, Barbara] DESY, European Mol Biol Lab, D-2000 Hamburg, Germany	Imperial College London; Imperial College London; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Joyce, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England.	b.robertson@imperial.ac.uk	Noens, Elke/A-6742-2015; Noens, Elke/H-3556-2012	Robertson, Brian D./0000-0001-5785-5307; Shahrezaei, Vahid/0000-0002-4013-5458	Biotechnology and Biological Sciences Research Council; European Union's Seventh Framework Programme (FP7) [241587]; MRC [MR/J006874/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union's Seventh Framework Programme (FP7); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	G.J. was supported by a studentship from the Biotechnology and Biological Sciences Research Council. B.T. and E.N. are supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Dahl JL, 2004, FEMS MICROBIOL LETT, V240, P15, DOI 10.1016/j.femsle.2004.09.004; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hartmans S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P889, DOI 10.1007/0-387-30743-5_33; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Joyce Graham, 2011, BMC Res Notes, V4, P73, DOI 10.1186/1756-0500-4-73; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Pedersen LB, 1999, J BACTERIOL, V181, P3201, DOI 10.1128/JB.181.10.3201-3211.1999; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Singh B, 2010, ANTON LEEUW INT J G, V98, P165, DOI 10.1007/s10482-010-9446-0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P55, DOI 10.1007/BF00451499; UDOU T, 1982, J BACTERIOL, V151, P1035, DOI 10.1128/JB.151.2.1035-1039.1982; Valbuena N, 2007, MOL MICROBIOL, V66, P643, DOI 10.1111/j.1365-2958.2007.05943.x; WEIBULL C, 1953, J BACTERIOL, V66, P688, DOI 10.1128/JB.66.6.688-695.1953; WEIDEL W, 1960, J GEN MICROBIOL, V22, P158, DOI 10.1099/00221287-22-1-158; Whitman W., 2015, SOLIRUBROBACTERACEAE, DOI [10.1002/9781118960608.fbm00055, DOI 10.1002/9781118960608.FBM00055]; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	51	61	63	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44582	10.1371/journal.pone.0044582	http://dx.doi.org/10.1371/journal.pone.0044582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970255	gold, Green Submitted, Green Published			2022-12-27	WOS:000308748400024
J	Uyttendaele, I; Lavens, D; Catteeuw, D; Lemmens, I; Bovijn, C; Tavernier, J; Peelman, F				Uyttendaele, Isabel; Lavens, Delphine; Catteeuw, Dominiek; Lemmens, Irma; Bovijn, Celia; Tavernier, Jan; Peelman, Frank			Random Mutagenesis MAPPIT Analysis Identifies Binding Sites for Vif and Gag in Both Cytidine Deaminase Domains of Apobec3G	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HIV-1 REVERSE TRANSCRIPTION; MULTIPLE SEQUENCE ALIGNMENT; VIRION INFECTIVITY FACTOR; INTERACTOME NETWORK; ANTIVIRAL ACTIVITY; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; FUNCTIONAL IMPLICATIONS; INTERACTION TRAP	The mammalian two-hybrid system MAPPIT allows the detection of protein-protein interactions in intact human cells. We developed a random mutagenesis screening strategy based on MAPPIT to detect mutations that disrupt the interaction of one protein with multiple protein interactors simultanously. The strategy was used to detect residues of the human cytidine deaminase Apobec3G that are important for its homodimerization and its interaction with the HIV-1 Gag and Vif proteins. The strategy is able to identify the previously described head-to-head homodimerization interface in the N-terminal domain of Apobec3G. Our analysis further detects two new potential interaction surfaces in the N- and C-terminal domain of Apobec3G for interaction with Vif and Gag or for Apobec3G dimerization.	[Uyttendaele, Isabel; Lavens, Delphine; Catteeuw, Dominiek; Lemmens, Irma; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] VIB, Dept Med Prot Res, Ghent, Belgium; [Uyttendaele, Isabel; Lavens, Delphine; Catteeuw, Dominiek; Lemmens, Irma; Bovijn, Celia; Tavernier, Jan; Peelman, Frank] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Uyttendaele, I (corresponding author), VIB, Dept Med Prot Res, Ghent, Belgium.	jan.tavernier@vib-ugent.be; frank.peelman@vib-ugent.be	Tavernier, Jan/AAG-3636-2019		Fund of Scientific Research (FWO) Grant [G.0747.10N]; Interuniversitary Attraction Poles [P6:28]; Ghent University Methusalem grant	Fund of Scientific Research (FWO) Grant; Interuniversitary Attraction Poles; Ghent University Methusalem grant	This work is supported by the Fund of Scientific Research (FWO, www.fwo.be) Grant (G.0747.10N), Interuniversitary Attraction Poles (P6:28) (http://www.belspo.be/belspo iap/index_en.stm) and a Ghent University Methusalem grant (http://www.ugent.be/en/research/topresearch methusalem_laureates.htm/). DL and IL are postdoctoral fellows of the Fund of Scientific Research (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Daggett KA, 2009, ACS CHEM BIOL, V4, P109, DOI 10.1021/cb800271f; de Vries SJ, 2010, PROTEINS, V78, P3242, DOI 10.1002/prot.22814; Dhayalan A, 2008, J MOL BIOL, V376, P1091, DOI 10.1016/j.jmb.2007.12.032; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Gooch BD, 2008, VIROLOGY, V379, P118, DOI 10.1016/j.virol.2008.06.013; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2009, P NATL ACAD SCI USA, V106, P19539, DOI 10.1073/pnas.0906652106; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khan MA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-99; Kim JY, 2012, METHODS MOL BIOL, V812, P209, DOI 10.1007/978-1-61779-455-1_12; Kundrotas PJ, 2008, INT J BIOL MACROMOL, V43, P198, DOI 10.1016/j.ijbiomac.2008.05.004; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Lemmens I, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng075; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Lickfeld M, 2011, YEAST, V28, P535, DOI 10.1002/yea.1856; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Liu J, 2012, PROTEIN ENG DES SEL, V25, P67, DOI 10.1093/protein/gzr060; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poussu E, 2004, PROTEINS, V54, P681, DOI 10.1002/prot.10467; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Stefan N, 2011, J MOL BIOL, V413, P826, DOI 10.1016/j.jmb.2011.09.016; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tavernier J, 2002, CLIN EXP ALLERGY, V32, P1397, DOI 10.1046/j.1365-2745.2002.01520.x; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004; Yep A, 2008, P NATL ACAD SCI USA, V105, P5733, DOI 10.1073/pnas.0709657105; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027	91	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44143	10.1371/journal.pone.0044143	http://dx.doi.org/10.1371/journal.pone.0044143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970171	Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400011
J	Zhang, MY; Yuan, TT; Li, JJ; Borges, AR; Watkins, JD; Guenaga, J; Yang, Z; Wang, YP; Wilson, R; Li, YX; Polonis, VR; Pincus, SH; Ruprecht, RM; Dimitrov, DS				Zhang, Mei-Yun; Yuan, Tingting; Li, Jingjing; Borges, Andrew Rosa; Watkins, Jennifer D.; Guenaga, Javier; Yang, Zheng; Wang, Yanping; Wilson, Richard; Li, Yuxing; Polonis, Victoria R.; Pincus, Seth H.; Ruprecht, Ruth M.; Dimitrov, Dimiter S.			Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; CRYSTAL-STRUCTURE; PHAGE LIBRARY; POTENT; CELL; RECOGNIZES; EFFICACY; EPITOPE; IMMUNOTOXINS	Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine immunogen design. Here we report a novel human monoclonal antibody (mAb), designated m43, which co-targets the gp120 and gp41 subunits of the HIV-1 envelope glycoprotein (Env). M43 bound to recombinant gp140 s from various primary isolates, to membrane-associated Envs on transfected cells and HIV-1 infected cells, as well as to recombinant gp120 s and gp41 fusion intermediate structures containing N-trimer structure, but did not bind to denatured recombinant gp140 s and the CD4 binding site (CD4bs) mutant, gp120 D368R, suggesting that the m43 epitope is conformational and overlaps the CD4bs on gp120 and the N-trimer structure on gp41. M43 neutralized 34% of the HIV-1 primary isolates from different clades and all the SHIVs tested in assays based on infection of peripheral blood mononuclear cells (PBMCs) by replication-competent virus, but was less potent in cell line-based pseudovirus assays. In contrast to CD4, m43 did not induce Env conformational changes upon binding leading to exposure of the coreceptor binding site, enhanced binding of mAbs 2F5 and 4E10 specific for the membrane proximal external region (MPER) of gp41 Envs, or increased gp120 shedding. The overall modest neutralization activity of m43 is likely due to the limited binding of m43 to functional Envs which could be increased by antibody engineering if needed. M43 may represent a new class of bnAbs targeting conformational epitopes overlapping structures on both gp120 and gp41. Its novel epitope and possibly new mechanism(s) of neutralization could helpdesign improved vaccine immunogens and candidate therapeutics.	[Zhang, Mei-Yun; Yuan, Tingting; Li, Jingjing; Yang, Zheng] Univ Hong Kong, AIDS Inst, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Mei-Yun; Yuan, Tingting; Li, Jingjing; Yang, Zheng] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Borges, Andrew Rosa] Henry M Jackson Fdn, Dept Vaccine Res, US Mil HIV Res Program, Rockville, MD USA; [Watkins, Jennifer D.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Watkins, Jennifer D.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Guenaga, Javier; Wilson, Richard; Li, Yuxing] Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Wang, Yanping; Dimitrov, Dimiter S.] NCI, CCRNP, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Polonis, Victoria R.] Walter Reed Army Inst Res, Div Retrovirol, US Mil HIV Res Program, Rockville, MD USA; [Pincus, Seth H.] Childrens Hosp, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	University of Hong Kong; University of Hong Kong; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, MY (corresponding author), Univ Hong Kong, AIDS Inst, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	zhangmy@hku.hk		Yang, Zheng/0000-0003-0217-6694	Intramural Research Program of the University of Hong Kong; Hong Kong Research Grants Council (RGC) General Research Fund (GRF) grant [785210]; National Institutes of Health (NIH) [R37 AI034266, P01 AI048240]; Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH; Bill and Melinda Gates Foundation; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R37AI034266] Funding Source: NIH RePORTER	Intramural Research Program of the University of Hong Kong; Hong Kong Research Grants Council (RGC) General Research Fund (GRF) grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the University of Hong Kong, and by Hong Kong Research Grants Council (RGC) General Research Fund (GRF) grant #785210 to MYZ, National Institutes of Health (NIH) R37 AI034266 and P01 AI048240 to RMR, and by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH, and the Bill and Melinda Gates Foundation to DSD. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chapal N, 2000, J IMMUNOL, V164, P4162, DOI 10.4049/jimmunol.164.8.4162; Chapal N, 2001, ENDOCRINOLOGY, V142, P4740, DOI 10.1210/en.142.11.4740; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dreyer K, 1999, AIDS RES HUM RETROV, V15, P1563, DOI 10.1089/088922299309856; Gauduin MC, 1998, J VIROL, V72, P3475, DOI 10.1128/JVI.72.4.3475-3478.1998; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Krowicka H, 2008, AIDS RES HU IN PRESS; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Louis JM, 2005, J MOL BIOL, V353, P945, DOI 10.1016/j.jmb.2005.09.044; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; McLellan JS, 2011, CARBON NANOTUBES LON; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; PINCUS SH, 1991, J IMMUNOL, V146, P4315; PINCUS SH, 1990, J INFECT DIS, V162, P1233, DOI 10.1093/infdis/162.6.1233; Pincus SH, 2003, J IMMUNOL, V170, P2236, DOI 10.4049/jimmunol.170.4.2236; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Siddappa NB, 2009, J VIROL, V83, P1422, DOI 10.1128/JVI.02066-08; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2011, CARBON NANOTUBES LON; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2008, J VIROL, V82, P6869, DOI 10.1128/JVI.00033-08; Zhang MY, 2006, J IMMUNOL METHODS, V317, P21, DOI 10.1016/j.jim.2006.09.016; Zhang Mei-Yun, 2009, V525, P175, DOI 10.1007/978-1-59745-554-1_9; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	50	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44241	10.1371/journal.pone.0044241	http://dx.doi.org/10.1371/journal.pone.0044241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970187	Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400013
J	Daugela, L; Nusgen, N; Walier, M; Oldenburg, J; Schwaab, R; El-Maarri, O				Daugela, Laurynas; Nuesgen, Nicole; Walier, Maja; Oldenburg, Johannes; Schwaab, Rainer; El-Maarri, Osman			Measurements of DNA Methylation at Seven Loci in Various Tissues of CD1 Mice	PLOS ONE			English	Article							IP-RP-HPLC; ACTIVE-DEMETHYLATION; CPG SITES; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; GENOME; AGE; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; WIDESPREAD	In humans, considerable variation in methylation at single loci and repetitive elements in various cells and tissues is observed. Recently, several inter- and intra-tissue correlations for DNA methylation have been reported. To investigate the extent and reproducibility of such correlations, we investigated inter- and intra-tissue methylation correlations among seven different loci in 9 different tissues in a population of 100 healthy seven-week-old CD1 outbred mice. We used a highly quantitative approach to measure methylation levels to high accuracy at two single loci in the alpha-actin and myosine light chain promoters, at three differentially methylated regions of the Peg3, Snrpn and Lit1 genes associated with imprinted loci, and at two repetitive elements in the Line-1 and IAP-LTR genes in the various tissues. In this population of mice, methylation at several loci was sex-associated and intra-tissue correlations among the studied loci were observed for brain and spleen. Inter-tissue correlations were rarely observed. To investigate method-dependent experimental variability, we re-analyzed the same spleen and tongue samples using SIRPH and pyrosequencing methods and reconfirmed intra-tissue correlations for spleen and sex-associated correlations for DNA methylation for tongue. When we repeated DNA methylation measurements for a second mouse population raised under similar conditions three months later, we did not detect sex-associated or intra-tissues correlations. Additional studies that examine large numbers of loci may be required to further understand the factors that influence stability of DNA methylation.	[Daugela, Laurynas; Nuesgen, Nicole; Oldenburg, Johannes; Schwaab, Rainer; El-Maarri, Osman] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany; [Walier, Maja] Univ Bonn, IMBIE, Bonn, Germany	University of Bonn; University of Bonn	Daugela, L (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.	osman.elmaarri@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	Oldenburg, Johannes/0000-0002-1585-4100; El-Maarri, Osman/0000-0002-6859-5819				Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bartolomei MS, 2011, COLD SPRING HARB PER; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Buchner A, 1996, CONSCIOUS COGN, V5, P581, DOI 10.1006/ccog.1996.0034; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dauksa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037509; El-Maarri O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e25; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri Osman, 2004, Methods Mol Biol, V287, P195; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Harrison J, 1998, ANAL BIOCHEM, V264, P129, DOI 10.1006/abio.1998.2833; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	42	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44585	10.1371/journal.pone.0044585	http://dx.doi.org/10.1371/journal.pone.0044585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970256	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000032
J	Rodriguez-Bano, J; Mingorance, J; Fernandez-Romero, N; Serrano, L; Lopez-Cerero, L; Pascual, A				Rodriguez-Bano, Jesus; Mingorance, Jesus; Fernandez-Romero, Natalia; Serrano, Lara; Lopez-Cerero, Lorena; Pascual, Alvaro		ESBL-REIPI Grp	Virulence Profiles of Bacteremic Extended-Spectrum beta-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features	PLOS ONE			English	Article							ADHESIN-ENCODING OPERONS; MOLECULAR CHARACTERISTICS; STRAINS; COMMUNITY; GENOTYPE; CLONE; IDENTIFICATION; RESISTANCE; PHYLOGENY; DIVERSITY	There is scarce data about the importance of phylogroups and virulence factors (VF) in bloodstream infections (BSI) caused by extended-spectrum beta-lactamase-producing Escherichia coli (ESBLEC). A prospective multicenter Spanish cohort including 191 cases of BSI due to ESBLEC was studied. Phylogroups and 25 VF genes were investigated by PCR. ESBLEC were classified into clusters according to their virulence profiles. The association of phylogropus, VF, and clusters with epidemiological features were studied using multivariate analysis. Overall, 57.6%, 26.7%, and 15.7% of isolates belonged to A/B1, D and B2 phylogroups, respectively. By multivariate analysis (adjusted OR [95% CI]), virulence cluster C2 was independently associated with urinary tract source (5.05 [0.96-25.48]); cluster C4 with sources other than urinary of biliary tract (2.89 [1.05-7.93]), and cluster C5 with BSI in non-predisposed patients (2.80 [0.99-7.93]). Isolates producing CTX-M-9 group ESBLs and from phylogroup D predominated among cluster C2 and C5, while CTX-M-1 group of ESBL and phylogroup B2 predominantes among C4 isolates. These results suggest that host factors and previous antimicrobial use were more important than phylogroup or specific VF in the occurrence of BSI due to ESBLEC. However, some associations between virulence clusters and some specific epidemiological features were found.	[Rodriguez-Bano, Jesus; Serrano, Lara; Lopez-Cerero, Lorena; Pascual, Alvaro] Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain; [Rodriguez-Bano, Jesus] Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Madrid, Spain; [Mingorance, Jesus; Fernandez-Romero, Natalia] Univ Seville, Dept Med, Seville, Spain; [Pascual, Alvaro] Univ Seville, Dept Microbiol, Seville, Spain	Hospital Universitario Virgen Macarena; Hospital Universitario La Paz; University of Sevilla; University of Sevilla	Rodriguez-Bano, J (corresponding author), Hosp Univ Virgen Macarena, Unidad Clin Enfermedades Infecciosas & Microbiol, Seville, Spain.	jesusrb@us.es	Rodríguez-Baño, Jesús/F-2453-2011; Pascual, Alvaro/Y-5854-2018; Mingorance, Jesus/B-7562-2009; Cisneros, José Miguel/ABI-6103-2020; López-Cerero, Lorena/D-3524-2019	Rodríguez-Baño, Jesús/0000-0001-6732-9001; Pascual, Alvaro/0000-0002-8672-5891; Mingorance, Jesus/0000-0001-6173-5711; Cisneros, José Miguel/0000-0001-5001-672X; López-Cerero, Lorena/0000-0001-8950-4384; Gijon, Paloma/0000-0002-5011-1927; Gimenez, Montserrat/0000-0001-8841-810X	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF; Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Fondo de Investigacion Sanitaria [070190, 10/02021, 10/01955, 10/00795]; Junta de Andalucia [0048/2008, CTS-5259]; Merck; Wyeth; Roche; Pfizer	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe" ERDF(European Commission); Spanish Network for Research in Infectious Diseases; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia); Merck(Merck & Company); Wyeth(Wyeth); Roche(Roche Holding); Pfizer(Pfizer)	This study was funded by the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for Research in Infectious Diseases (REIPI RD06/0008), Fondo de Investigacion Sanitaria (grants 070190, 10/02021, 10/01955, and 10/00795), and Junta de Andalucia (grants 0048/2008, and CTS-5259). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: J. Rodriguez-Bano has been a consultant for Wyeth, Merck, and Pfizer, has served as speaker for Wyeth, Merck, Pfizer, Astra-Zeneca and GlaxoSmithKline, and has received research support from Merck and Wyeth. J. Mingorance has received research support from Roche and Pfizer. A. Pascual has been a consultant for Merck and Pfizer, has served as speaker for Wyeth, Astra-Zeneca, Merck, and Pfizer and has received research support from Merck and Pfizer and Wyeth. All other authors had no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ananias M, 2008, BRAZ J MED BIOL RES, V41, P877, DOI 10.1590/S0100-879X2008001000008; [Anonymous], 2009, PERFORMANCE STANDARD, V19; Bert F, 2010, J CLIN MICROBIOL, V48, P2709, DOI 10.1128/JCM.00516-10; Bidet P, 2007, APPL ENVIRON MICROB, V73, P2373, DOI 10.1128/AEM.02341-06; Blanco M, 1997, RES MICROBIOL, V148, P745, DOI 10.1016/S0923-2508(97)82450-3; Brisse S, 2012, J CLIN MICR IN PRESS; Bukh AS, 2009, J ANTIMICROB CHEMOTH, V64, P163, DOI 10.1093/jac/dkp156; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Cooke NM, 2010, J CLIN MICROBIOL, V48, P1099, DOI 10.1128/JCM.02017-09; Courpon-Claudinon A, 2011, CLIN MICROBIOL INFEC, V17, P557, DOI 10.1111/j.1469-0691.2010.03298.x; Girardeau JP, 2003, J CLIN MICROBIOL, V41, P218, DOI 10.1128/JCM.41.1.218-226.2003; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2002, J INFECT DIS, V185, P1439, DOI 10.1086/340506; Johnson JR, 2001, INFECT IMMUN, V69, P5363, DOI 10.1128/IAI.69.9.5363-5374.2001; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Karkkainen UM, 1998, J MICROBIOL METH, V34, P23, DOI 10.1016/S0167-7012(98)00065-7; Lavigne JP, 2006, CLIN MICROBIOL INFEC, V12, P1199, DOI 10.1111/j.1469-0691.2006.01536.x; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; LEBOUGUENEC C, 1992, J CLIN MICROBIOL, V30, P1189, DOI 10.1128/JCM.30.5.1189-1193.1992; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; Moreno E, 2005, DIAGN MICR INFEC DIS, V53, P93, DOI 10.1016/j.diagmicrobio.2005.05.015; Moreno E, 2006, ENFERM INFEC MICR CL, V24, P483, DOI 10.1157/13092463; Nakano M, 2001, FEMS MICROBIOL LETT, V205, P71, DOI 10.1016/S0378-1097(01)00442-6; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Russo TA, 2001, INFECT IMMUN, V69, P6209, DOI 10.1128/IAI.69.10.6209-6216.2001; Sannes MR, 2004, J INFECT DIS, V190, P2121, DOI 10.1086/425984; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; Wang MC, 2002, CLIN INFECT DIS, V35, P1161, DOI 10.1086/343828; YAMAMOTO S, 1995, FEMS IMMUNOL MED MIC, V12, P85, DOI 10.1111/j.1574-695X.1995.tb00179.x	36	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44238	10.1371/journal.pone.0044238	http://dx.doi.org/10.1371/journal.pone.0044238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970186	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000015
J	Acestor, N; Cooksey, R; Newton, PN; Menard, D; Guerin, PJ; Nakagawa, J; Christophel, E; Gonzalez, IJ; Bell, D				Acestor, Nathalie; Cooksey, Richard; Newton, Paul N.; Menard, Didier; Guerin, Philippe J.; Nakagawa, Jun; Christophel, Eva; Gonzalez, Iveth J.; Bell, David			Mapping the Aetiology of Non-Malarial Febrile Illness in Southeast Asia through a Systematic Review-Terra Incognita Impairing Treatment Policies	PLOS ONE			English	Article							KHAMMOUANE PROVINCE; SCRUB TYPHUS; INFECTIONS; FEVER; LAOS	Background: An increasing use of point of care diagnostic tests that exclude malaria, coupled with a declining malaria burden in many endemic countries, is highlighting the lack of ability of many health systems to manage other causes of febrile disease. A lack of knowledge of distribution of these pathogens, and a lack of screening and point-of-care diagnostics to identify them, prevents effective management of these generally treatable contributors to disease burden. While prospective data collection is vital, an untapped body of knowledge already exists in the published health literature. Methods: Focusing on the Mekong region of Southeast Asia, published data from 1986 to 2011 was screened to for frequency of isolation of pathogens implicated in aetiology of non-malarial febrile illness. Eligibility criteria included English-language peer-reviewed studies recording major pathogens for which specific management is likely to be warranted. Of 1,252 identified papers, 146 met inclusion criteria and were analyzed and data mapped. Results: Data tended to be clustered around specific areas where research institutions operate, and where resources to conduct studies are greater. The most frequently reported pathogen was dengue virus (n = 70), followed by Orientia tsutsugamushi and Rickettsia species (scrub typhus/murine typhus/spotted fever group n = 58), Leptospira spp. (n = 35), Salmonella enterica serovar Typhi and Paratyphi (enteric fever n = 24), Burkholderia pseudomallei (melioidosis n = 14), and Japanese encephalitis virus (n = 18). Wide tracts with very little published data on aetiology of fever are apparent. Discussion and Conclusions: This mapping demonstrates a very heterogeneous distribution of information on the causes of fever in the Mekong countries. Further directed data collection to address gaps in the evidence-base, and expansion to a global database of pathogen distribution, is readily achievable, and would help define wider priorities for research and development to improve syndromic management of fever, prioritize diagnostic development, and guide empirical therapy.	[Acestor, Nathalie; Bell, David] FIND, Malaria Acute Febrile Syndrome Programme, Geneva, Switzerland; [Cooksey, Richard; Newton, Paul N.; Guerin, Philippe J.] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Cooksey, Richard; Newton, Paul N.] Univ Oxford, Churchill Hosp, WorldWide Antimalarial Resistance Network, Oxford, England; [Newton, Paul N.] Mahosot Hosp, Microbiol Lab, Wellcome Trust Mahosot Oxford Trop Med Res Collab, Lao PDR, Viangchan, Laos; [Menard, Didier] Pasteur Inst Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Nakagawa, Jun; Christophel, Eva] WHO Reg Off Western Pacific, Manila, Philippines	Foundation For Innovative New Diagnostics; University of Oxford; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); Mahidol Oxford Tropical Medicine Research Unit (MORU); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; WHO Western Pacific Regional Office; World Health Organization	Acestor, N (corresponding author), FIND, Malaria Acute Febrile Syndrome Programme, Geneva, Switzerland.	david.bell@finddiagnostics.org	Guerin, Philippe/AAH-8873-2021; Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495; Guerin, Philippe/0000-0002-6008-2963; Newton, Paul/0000-0002-4608-6431	United Kingdom Department For International Development (DFID); Wellcome Trust of Great Britain; French Ministry of Foreign Affairs; Bill and Melinda Gates Foundation; DFID	United Kingdom Department For International Development (DFID); Wellcome Trust of Great Britain(Wellcome Trust); French Ministry of Foreign Affairs; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); DFID	FIND was supported by the United Kingdom Department For International Development (DFID). Paul Newton is supported by the Wellcome Trust of Great Britain. Didier Menard is supported by the French Ministry of Foreign Affairs. WWARN is supported by the Bill and Melinda Gates Foundation and DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; [Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], STAYING COURS MAL RE; Black RE, 2010, J GERONTOL B, P11; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Blacksell SD, 2010, AM J TROP MED HYG, V83, P365, DOI 10.4269/ajtmh.2010.09-0534; Blacksell SD, 2010, CLIN VACCINE IMMUNOL, V17, P263, DOI 10.1128/CVI.00448-08; Chanta Chulapong, 2005, Journal of the Medical Association of Thailand, V88, P1867; Corwin A, 1999, CLIN INFECT DIS, V29, P940, DOI 10.1086/520468; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Ha DQ, 2000, EMERG INFECT DIS, V6, P422; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hiscox A, 2010, AM J TROP MED HYG, V83, P1166, DOI 10.4269/ajtmh.2010.09-0480; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; *MALERA CONS GROUP, 2011, PLOS MED, V0008; McGready R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000888; Mediannikov O, 2010, PLOS NEGL TROP DIS, V4; Pagnarith Y, 2010, AM J TROP MED HYG, V82, P1106, DOI 10.4269/ajtmh.2010.10-0030; Paris DH, 2008, CLIN EXP IMMUNOL, V153, P63, DOI 10.1111/j.1365-2249.2008.03673.x; Peacock SJ, 2008, T ROY SOC TROP MED H, V102, P5, DOI 10.1016/j.trstmh.2007.06.004; Phyo AP, 2012, J GERONTOL B-PSYCHOL, V2012, P5; Policy Cures, 2011, NEGL DIS RES DEV IS; Shirayama Y, 2008, T ROY SOC TROP MED H, V102, P743, DOI 10.1016/j.trstmh.2008.05.014; Shirayama Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-217; Sirichote P, 2010, SE ASIAN J TROP MED, V41, P1405; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2011, GLOB BURD DIS; WWARN, 2012, WORLDW ANT RES NETW	33	90	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44269	10.1371/journal.pone.0044269	http://dx.doi.org/10.1371/journal.pone.0044269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970193	gold, Green Published			2022-12-27	WOS:000308458400053
J	Blokland, YM; Farquhar, JDR; Mourisse, J; Scheffer, GJ; Lerou, JGC; Bruhn, J				Blokland, Yvonne M.; Farquhar, Jason D. R.; Mourisse, Jo; Scheffer, Gert J.; Lerou, Jos G. C.; Bruhn, Jorgen			Towards a Novel Monitor of Intraoperative Awareness: Selecting Paradigm Settings for a Movement-Based Brain-Computer Interface	PLOS ONE			English	Article							GENERAL-ANESTHESIA; MOTOR IMAGERY; SET	During 0.1-0.2% of operations with general anesthesia, patients become aware during surgery. Unfortunately, pharmacologically paralyzed patients cannot seek attention by moving. Their attempted movements may however induce detectable EEG changes over the motor cortex. Here, methods from the area of movement-based brain-computer interfacing are proposed as a novel direction in anesthesia monitoring. Optimal settings for development of such a paradigm are studied to allow for a clinically feasible system. A classifier was trained on recorded EEG data of ten healthy non-anesthetized participants executing 3-second movement tasks. Extensive analysis was performed on this data to obtain an optimal EEG channel set and optimal features for use in a movement detection paradigm. EEG during movement could be distinguished from EEG during non-movement with very high accuracy. After a short calibration session, an average classification rate of 92% was obtained using nine EEG channels over the motor cortex, combined movement and post-movement signals, a frequency resolution of 4 Hz and a frequency range of 8-24 Hz. Using Monte Carlo simulation and a simple decision making paradigm, this translated into a probability of 99% of true positive movement detection within the first two and a half minutes after movement onset. A very low mean false positive rate of <0.01% was obtained. The current results corroborate the feasibility of detecting movement-related EEG signals, bearing in mind the clinical demands for use during surgery. Based on these results further clinical testing can be initiated.	[Blokland, Yvonne M.; Mourisse, Jo; Scheffer, Gert J.; Lerou, Jos G. C.; Bruhn, Jorgen] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [Blokland, Yvonne M.; Farquhar, Jason D. R.; Bruhn, Jorgen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Blokland, YM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands.	Y.Blokland@anes.umcn.nl	Scheffer, G.J./H-8086-2014; Bruhn, Jörgen/H-3703-2012; Mourisse, J.M.J./L-4531-2015; Farquhar, Jason/D-2285-2010; wilson, nozaspi/H-9769-2012; Lerou, J.G.C./L-4488-2015	Farquhar, Jason/0000-0002-8560-0712; Lerou, Jos/0000-0003-4006-292X	Netherlands Organisation for Scientific Research (NWO) [91710346]; BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This work was supported by VIDI grant number 91710346 from the Netherlands Organisation for Scientific Research (NWO) and the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2011, NEW ENGL J MED, V365, P591, DOI 10.1056/NEJMoa1100403; Bishop C. M, 2006, PATTERN RECOGNITION; Blokland Y, 2011, P 5 INT BRAIN COMP I, P300; Errando CL, 2008, BRIT J ANAESTH, V101, P178, DOI 10.1093/bja/aen144; Ghoneim MM, 2009, ANESTH ANALG, V108, P527, DOI 10.1213/ane.0b013e318193c634; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Kent CD, 2009, CURR OPIN ANESTHESIO, V22, P782, DOI 10.1097/ACO.0b013e3283326986; Leslie K, 2010, MINERVA ANESTESIOL, V76, P624; Long JY, 2010, COGN NEURODYNAMICS, V4, P207, DOI 10.1007/s11571-010-9114-0; Mooney C.Z., 1997, MONTE CARLO SIMULATI; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Nikulin VV, 2008, NEUROPSYCHOLOGIA, V46, P727, DOI 10.1016/j.neuropsychologia.2007.10.008; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Qian K, 2010, CLIN NEUROPHYSIOL, V121, P1304, DOI 10.1016/j.clinph.2010.03.001; Reuderink B, 2011, P 33 C EMBS IEEE 201; Sandin RH, 2000, LANCET, V355, P707, DOI 10.1016/S0140-6736(99)11010-9; Sannelli C, 2010, BRAIN TOPOGR, V23, P186, DOI 10.1007/s10548-010-0135-0; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Stoica P, 1997, INTRO SPECTRAL ANAL, V51; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; Whitlock EL, 2011, ANESTHESIOLOGY, V115, P1209, DOI 10.1097/ALN.0b013e3182395dcb; Xu L, 2009, ACTA ANAESTH SCAND, V53, P873, DOI 10.1111/j.1399-6576.2009.02016.x; Zhang L, 2010, J MED SYST, V34, P51, DOI 10.1007/s10916-008-9215-z; Zhu J, 2005, J COMPUT GRAPH STAT, V14, P185, DOI 10.1198/106186005X25619	29	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44336	10.1371/journal.pone.0044336	http://dx.doi.org/10.1371/journal.pone.0044336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970202	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400060
J	Bossard, C; Busson, M; Vindrieux, D; Gaudin, F; Machelon, R; Brigitte, M; Jacquard, C; Pillon, A; Balaguer, P; Balabanian, K; Lazennec, G				Bossard, Carine; Busson, Muriel; Vindrieux, David; Gaudin, Francoise; Machelon, Veronique; Brigitte, Madly; Jacquard, Carine; Pillon, Arnaud; Balaguer, Patrick; Balabanian, Karl; Lazennec, Gwendal			Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer	PLOS ONE			English	Article							MENOPAUSAL HORMONE-THERAPY; ER-BETA; CELL-LINE; ALPHA; EXPRESSION; PROTEASOME; PROLIFERATION; TRANSCRIPTION; CARCINOMA; GROWTH	Ovarian cancer is the gynecological cancer exhibiting the highest morbidity and improvement of treatments is still required. Previous studies have shown that Estrogen-receptor beta (ER beta) levels decreased along with ovarian carcinogenesis. Here, we present evidence that reintroduction of ER beta in BG-1 epithelial ovarian cancer cells, which express ER alpha, leads in vitro to a decrease of basal and estradiol-promoted cell proliferation. ER beta reduced the frequency of cells in S phase and increased the one of cells in G2/M phase. At the molecular level, we found that ER beta downregulated total retinoblastoma (Rb), phosphorylated Rb and phospho-AKT cellular content as well as cyclins D1 and A2. In addition, ER beta had a direct effect on ER alpha, by strongly inhibiting its expression and activity, which could explain part of the anti-proliferative action of ER beta. By developing a novel preclinical model of ovarian cancer based on a luminescent orthotopic xenograft in athymic Nude mice, we further revealed that ER beta expression reduces tumor growth and the presence of tumor cells in sites of metastasis, hence resulting in improved survival of mice. Altogether, these findings unveil a potential tumor-suppressor role of ER beta in ovarian carcinogenesis, which could be of potential clinical relevance for the selection of the most appropriate treatment for patients.	[Bossard, Carine; Busson, Muriel; Vindrieux, David; Brigitte, Madly; Jacquard, Carine; Lazennec, Gwendal] Univ Montpellier I, INSERM, U844, F-34091 Montpellier, France; [Gaudin, Francoise; Machelon, Veronique; Balabanian, Karl] Univ Paris 11, UMR S996, INSERM, LERMIT, Clamart, France; [Pillon, Arnaud; Balaguer, Patrick] IRCM, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Bossard, C (corresponding author), Univ Montpellier I, INSERM, U844, F-34091 Montpellier, France.	Gwendal.Lazennec@inserm.fr	Balabanian, Karl/S-6250-2019; Balaguer, Patrick/I-2973-2016; Balabanian, Karl/I-2990-2016	Balabanian, Karl/0000-0002-0534-3198; Balabanian, Karl/0000-0002-0534-3198; Jacquard, Carine/0000-0003-0972-8455; Lazennec, Gwendal/0000-0002-8522-1763; Vindrieux, David/0000-0002-4713-5768	ARC (Association pour la Recherche contre le Cancer) [3582]; Ligue Nationale Contre le Cancer; FRM (Fondation pour la Recherche Medicale); HFSP fellowship; Agence Nationale de la Recherche (ANR) [2010 JCJC 1104 01]; Universite Paris-Sud; Institut National de la Sante et de la Recherche Medicale (INSERM); Ligue Nationale Contre le Cancer (Comite Val d'Oise); ANR (Investissements dAvenir)	ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); HFSP fellowship; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Universite Paris-Sud; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (Comite Val d'Oise)(Institut National du Cancer (INCA) France); ANR (Investissements dAvenir)(French National Research Agency (ANR))	This work was supported by grants from ARC (Association pour la Recherche contre le Cancer, Grant No. 3582) (http://www.arc-cancer.net), The Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net). Muriel Busson was supported by FRM (Fondation pour la Recherche Medicale) (http://www.frm.org). DV was a recipient of the Ligue Nationale contre le Cancer. CB was supported by a HFSP fellowship (http://www.hfsp.org/). The K. B. lab is supported by the Agence Nationale de la Recherche (ANR, grant number 2010 JCJC 1104 01) (http://www.agence-nationale-recherche.fr/), the Universite Paris-Sud, the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Ligue Nationale Contre le Cancer (Comite Val d'Oise), and is a member of the Laboratory of Excellence LERMIT (Laboratory of Excellence in Research on Medication and Innovative Therapeutics) supported by a grant from ANR (Investissements dAvenir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Baldwin WS, 1998, IN VITRO CELL DEV-AN, V34, P649; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; BERAL V, 1988, LANCET, V2, P1331; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Burges A, 2010, ARCH GYNECOL OBSTET, V281, P511, DOI 10.1007/s00404-009-1185-y; Chan KKL, 2008, OBSTET GYNECOL, V111, P144, DOI 10.1097/01.AOG.0000296715.07705.e9; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Couse JF, 2000, J STEROID BIOCHEM, V74, P287, DOI 10.1016/S0960-0760(00)00105-9; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; De Stefano I, 2011, GYNECOL ONCOL, V122, P573, DOI 10.1016/j.ygyno.2011.05.025; Deligeoroglou E, 2003, ANN NY ACAD SCI, V997, P199, DOI 10.1196/annals.1290.023; Drummond AE, 2010, J ENDOCRINOL, V205, P15, DOI 10.1677/JOE-09-0379; Duong V, 2006, ONCOGENE, V25, P1799, DOI 10.1038/sj.onc.1209102; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Halon A, 2011, ANTICANCER RES, V31, P711; HATCH KD, 1991, CANCER, V68, P269, DOI 10.1002/1097-0142(19910715)68:2<269::AID-CNCR2820680209>3.0.CO;2-O; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; LANGDON SP, 1988, CANCER RES, V48, P6166; Lazennec G, 2006, CANCER LETT, V231, P151, DOI 10.1016/j.canlet.2005.01.021; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Licznar A, 2003, FEBS LETT, V553, P445, DOI 10.1016/S0014-5793(03)01090-1; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lucas A, 2003, BIOCHEM BIOPH RES CO, V309, P1011, DOI 10.1016/j.bbrc.2003.08.101; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020703; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Pillon A, 2005, ANAL BIOCHEM, V340, P295, DOI 10.1016/j.ab.2005.02.032; Pujol P, 1998, CANCER RES, V58, P5367; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rosenfeld CS, 2001, REPRODUCTION, V122, P215, DOI 10.1530/rep.0.1220215; Rossing MA, 2007, CANCER EPIDEM BIOMAR, V16, P2548, DOI 10.1158/1055-9965.EPI-07-0550; Rutherford T, 2000, OBSTET GYNECOL, V96, P417, DOI 10.1016/S0029-7844(00)00917-0; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Suzuki F, 2008, CANCER SCI, V99, P2365, DOI 10.1111/j.1349-7006.2008.00988.x; Treeck O, 2007, J ENDOCRINOL, V193, P421, DOI 10.1677/JOE-07-0087; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Yap OWS, 2009, ANTICANCER RES, V29, P139	54	77	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44787	10.1371/journal.pone.0044787	http://dx.doi.org/10.1371/journal.pone.0044787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970307	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400120
J	Feitosa, E; Adati, RD; Hansson, P; Malmsten, M				Feitosa, Eloi; Adati, Renata D.; Hansson, Per; Malmsten, Martin			Thermal and Structural Behavior of Dioctadecyldimethylammonium Bromide Dispersions Studied by Differential Scanning Calorimetry and X-Ray Scattering	PLOS ONE			English	Article							PHASE-TRANSITION; VESICLES; CHLORIDE; DODAB	Dioctadecyldimethylammonium bromide (DODAB) is a double chain cationic lipid, which assembles as bilayer structures in aqueous solution. The precise structures formed depend on, e.g., lipid concentration and temperature. We here combine differential scanning calorimetry (DSC) and X-ray scattering (SAXS and WAXS) to investigate the thermal and structural behavior of up to 120 mM DODAB in water within the temperature range 1-70 degrees C. Below 1 mM, this system is dominated by unilamellar vesicles (ULVs). Between 1 and 65 mM, ULVs and multilamellar structures (MLSs) co-exist, while above 65 mM, the MLSs are the preferred structure. Depending on temperature, DSC and X-ray data show that the vesicles can be either in the subgel (SG), gel, or liquid crystalline (LC) state, while the MLSs (with lattice distance d = 36.7 angstrom) consist of interdigitated lamellae in the SG state, and ULVs in the LC state (no Bragg peak). Critical temperatures related to the thermal transitions of these bilayer structures obtained in the heating and cooling modes are reported, together with the corresponding transition enthalpies.	[Feitosa, Eloi; Hansson, Per; Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Adati, Renata D.] Sao Paulo State Univ, Dept Phys, Sao Jose Do Rio Preto, Brazil	Uppsala University; Universidade Estadual Paulista	Feitosa, E (corresponding author), Uppsala Univ, Dept Pharm, Uppsala, Sweden.	eloi@ibilce.unesp.br	ADATI, RENATA DANIELLE/AAC-9284-2021	Adati, Renata/0000-0003-0443-591X; Feitosa, Eloi/0000-0002-1141-9494	FAPESP [2011/00796-4, 2011/07414-0]; Swedish Research Council [2009-3009]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by FAPESP (www.fapesp.br), grants 2011/00796-4 and 2011/07414-0. Swedish Research Council (http://www.vr.se/) (2009-3009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreleiro PCA, 2000, J PHYS CHEM B, V104, P7795, DOI 10.1021/jp000636c; Benatti CR, 2001, CHEM PHYS LIPIDS, V111, P93, DOI 10.1016/S0009-3084(01)00134-7; BLANDAMER MJ, 1992, J CHEM SOC FARADAY T, V88, P3431, DOI 10.1039/ft9928803431; Brito RO, 2005, CHEM PHYS LIPIDS, V137, P18, DOI 10.1016/j.chemphyslip.2005.05.001; Coppola L, 2009, J COLLOID INTERF SCI, V338, P550, DOI 10.1016/j.jcis.2009.06.054; Cullity B.D., 1967, ELEMENTS XRAY DIFFRA; Dong YD, 2011, INT J PHARMACEUT, V417, P101, DOI 10.1016/j.ijpharm.2011.01.022; Feitosa E, 2006, CHEM PHYS LIPIDS, V140, P66, DOI 10.1016/j.chemphyslip.2006.01.005; Feitosa E, 2004, PROG COLL POL SCI S, V128, P163, DOI 10.1007/b97125; Feitosa E, 2000, CHEM PHYS LIPIDS, V105, P201, DOI 10.1016/S0009-3084(00)00127-4; Feitosa E, 2012, STRUCTURAL ORG UNPUB; Feitosa E, 2012, REVERSIBILITY UNPUB; Feitosa E, 2009, COLLOID POLYM SCI, V287, P591, DOI 10.1007/s00396-009-2008-1; Furuike S, 1999, BIOPHYS J, V77, P2015, DOI 10.1016/S0006-3495(99)77042-6; Lopes A, 2008, J COLLOID INTERF SCI, V322, P582, DOI 10.1016/j.jcis.2008.03.015; Saveyn P, 2009, SOFT MATTER, V5, P1735, DOI 10.1039/b821387a; Tanford C., 1991, HYDROPHOBIC EFFECT F, V2nd; Wu FG, 2011, LANGMUIR, V27, P2349, DOI 10.1021/la1049474	18	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44702	10.1371/journal.pone.0044702	http://dx.doi.org/10.1371/journal.pone.0044702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970291	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400106
J	Ruiz, JD; Martinez, C; Anderson, K; Gross, M; Lang, NP; Garcia-Martin, E; Agundez, JAG				Ruiz, Jhon D.; Martinez, Carmen; Anderson, Kristin; Gross, Myron; Lang, Nicholas P.; Garcia-Martin, Elena; Agundez, Jose A. G.			The Differential Effect of NAT2 Variant Alleles Permits Refinement in Phenotype Inference and Identifies a Very Slow Acetylation Genotype	PLOS ONE			English	Article							N-ACETYLTRANSFERASES; POLYMORPHISMS; CAFFEINE; RISK; ASSOCIATIONS; CONCORDANCE; METABOLISM; GENES	Indirect evidences suggest that acetylation phenotype categories are heterogeneous and that subcategories, related to specific NAT2 variant alleles might exist. We analyzed the in vivo acetylation phenotype and genotype in 504 north-American subjects of Caucasian origin. The analyses of the SNPs rs1801280 and rs1799930 allowed the discrimination of five categories with different acetylation status within the study population. These categories are related to the distinct effect of NAT2 alleles on the acetylation status in vivo and to the occurrence of a gene-dose effect. These five phenotype categories, from higher to lower acetylation capacity, correspond to the genotypes NAT2*4/*4, NAT2*4/*5 or *4/*6, NAT2*5/*5, NAT2*5/*6 and NAT2*6/*6 (p <= 0.001 for all comparisons). The NAT2*6/*6 genotype correspond to a phenotype category of very-slow acetylators. The refinement in phenotype prediction may help to identify risks associated to phenotype subcategories, and warrants the re-analysis of previous studies that may have overlooked phenotype subcategory-specific risks.	[Ruiz, Jhon D.; Martinez, Carmen; Agundez, Jose A. G.] Univ Extremadura, Sch Med, Dept Pharmacol, Badajoz, Spain; [Anderson, Kristin] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Gross, Myron] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Lang, Nicholas P.] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA; [Garcia-Martin, Elena] Univ Extremadura, Sch Biol Sci, Dept Biochem & Mol Biol, Caceres, Spain; [Ruiz, Jhon D.; Martinez, Carmen; Agundez, Jose A. G.] Univ Extremadura, Sch Med, Dept Pharmacol, Caceres, Spain	Universidad de Extremadura; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Arkansas System; University of Arkansas Medical Sciences; Universidad de Extremadura; Universidad de Extremadura	Ruiz, JD (corresponding author), Univ Extremadura, Sch Med, Dept Pharmacol, Badajoz, Spain.	jagundez@unex.es	Ruiz, Jhon D/Q-1887-2016; García-Martin, Elena/H-9828-2016; Agúndez, José A. G./A-5503-2008	Ruiz, Jhon D/0000-0003-4410-4349; García-Martin, Elena/0000-0002-8094-046X; Agúndez, José A. G./0000-0001-6895-9160	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS PS09/00943, PS09/00469, RETICS RD07/0064/0016]; Junta de Extremadura, Spain [GR10068]; European Union	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; European Union(European Commission)	Financial support provided by FIS PS09/00943, PS09/00469, and RETICS RD07/0064/0016 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain, and GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2008, CURR DRUG METAB, V9, P520, DOI 10.2174/138920008784892083; Agundez JAG, 2008, CLIN CHEM, V54, P1390, DOI 10.1373/clinchem.2008.105569; Agundez JAG, 2008, CURR DRUG METAB, V9, P463, DOI 10.2174/138920008784892146; Agundez JAG, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00002; Anderson KE, 2005, CANCER EPIDEM BIOMAR, V14, P2261, DOI 10.1158/1055-9965.EPI-04-0514; Anderson KE, 2002, MUTAT RES-FUND MOL M, V506, P225, DOI 10.1016/S0027-5107(02)00169-0; Andrade RJ, 2009, CURR DRUG METAB, V10, P956, DOI 10.2174/138920009790711805; Bartsch H, 1998, EUR J CANCER PREV, V7, P215, DOI 10.1097/00008469-199806000-00006; Bolt HM, 2005, ARCH TOXICOL, V79, P196, DOI 10.1007/s00204-004-0622-8; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Cascorbi I, 1999, DRUG METAB REV, V31, P489, DOI 10.1081/DMR-100101932; EVANS DAP, 1960, AM REV RESPIR DIS, V82, P853; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; Gross M, 1999, CANCER EPIDEM BIOMAR, V8, P683; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Leiro-Fernandez V, 2011, INT J TUBERC LUNG D, V15, P1403, DOI 10.5588/ijtld.10.0648; MCQUILKIN SH, 1995, CANCER EPIDEM BIOMAR, V4, P139; Miners JO, 1996, GEN PHARMACOL-VASC S, V27, P245, DOI 10.1016/0306-3623(95)02014-4; Moslehi R, 2006, PHARMACOGENOMICS, V7, P819, DOI 10.2217/14622416.7.6.819; Selinski S, 2011, PHARMACOGENET GENOM, V21, P673, DOI 10.1097/FPC.0b013e3283493a23; TANG BK, 1987, CLIN PHARMACOL THER, V42, P509, DOI 10.1038/clpt.1987.189; Walraven JM, 2008, CURR DRUG METAB, V9, P471, DOI 10.2174/138920008784892065; Zhang JJ, 2011, INT J MOL EPIDEMIOL, V2, P236	25	36	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44629	10.1371/journal.pone.0044629	http://dx.doi.org/10.1371/journal.pone.0044629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970273	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400098
J	Sarkisian, MR; Siebzehnrubl, D				Sarkisian, Matthew R.; Siebzehnrubl, Dorit			Abnormal Levels of Gadd45alpha in Developing Neocortex Impair Neurite Outgrowth	PLOS ONE			English	Article							DAMAGE-INDUCIBLE GENE; GROWTH ARREST; VALPROIC ACID; ANIMAL-MODEL; IN-VIVO; DNA; EXPRESSION; GADD45-ALPHA; MIGRATION; ACTIVATION	To better understand the short and long-term effects of stress on the developing cerebral cortex, it is necessary to understand how early stress response genes protect or permanently alter cells. One family of highly conserved, stress response genes is the growth arrest and DNA damage-45 (Gadd45) genes. The expression of these genes is induced by a host of genotoxic, drug, and environmental stressors. Here we examined the impact of altering the expression of Gadd45alpha (Gadd45a), a member of the Gadd45 protein family that is expressed throughout the developing cortices of mice and humans. To manipulate levels of Gadd45a protein in developing mouse cortex, we electroporated cDNA plasmids encoding either Gadd45a or Gadd45a shRNA to either overexpress or knockdown Gadd45a levels in the developing cortices of mice, respectively. The effects of these manipulations were assessed by examining the fates and morphologies of the labeled neurons. Gadd45a overexpression both in vitro and in vivo significantly impaired the morphology of neurons, decreasing neurite complexity, inducing soma hypertrophy and increasing cell death. Knockdown of Gadd45a partially inhibited neuronal migration and reduced neurite complexity, an effect that was reversed in the presence of an shRNA-resistant Gadd45a. Finally, we found that shRNA against MEKK4, a direct target of Gadd45a, also stunted neurite outgrowth. Our findings suggest that the expression of Gadd45a in normal, developing brain is tightly regulated and that treatments or environmental stimuli that alter its expression could produce significant changes in neuronal circuitry development.	[Sarkisian, Matthew R.; Siebzehnrubl, Dorit] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Sarkisian, MR (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA.	matt.sarkisian@mbi.ufl.edu			McKnight Brain Research Foundation; Evelyn F. and William L. McKnight Brain Institute at the University of Florida; University of Florida	McKnight Brain Research Foundation; Evelyn F. and William L. McKnight Brain Institute at the University of Florida; University of Florida(University of Florida)	This work was supported by funds from the McKnight Brain Research Foundation and the Evelyn F. and William L. McKnight Brain Institute at the University of Florida (to M. R. S.) and a University of Florida Opportunity Fund Award (to M. R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Chang QS, 2007, CANCER RES, V67, P6146, DOI 10.1158/0008-5472.CAN-07-0867; Chen ZX, 2002, CANCER LETT, V188, P127, DOI 10.1016/S0304-3835(02)00322-1; Chiou SK, 2009, APOPTOSIS, V14, P1341, DOI 10.1007/s10495-009-0399-6; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Friedlander DR, 1998, J NEUROBIOL, V37, P291, DOI 10.1002/(SICI)1097-4695(19981105)37:2<291::AID-NEU8>3.0.CO;2-F; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Henshall DC, 1999, J NEUROCHEM, V73, P1573, DOI 10.1046/j.1471-4159.1999.0731573.x; Hocevar Z, 2012, J ULTRAS MED, V31, P923, DOI 10.7863/jum.2012.31.6.923; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Huang HS, 2010, MOL CELL NEUROSCI, V44, P282, DOI 10.1016/j.mcn.2010.03.014; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Kuwagata M, 2009, INT J DEV NEUROSCI, V27, P399, DOI 10.1016/j.ijdevneu.2009.01.006; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; Patterson AD, 2006, BIRTH DEFECTS RES A, V76, P129, DOI 10.1002/bdra.20217; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Saffary R, 2011, J NEUROSCI, V31, P1427, DOI 10.1523/JNEUROSCI.4854-10.2011; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sytnikova YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014500; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yang C, 2011, CANCER CHEMOTH PHARM, V67, P439, DOI 10.1007/s00280-010-1344-7; Yochum CL, 2008, BRAIN RES, V1203, P126, DOI 10.1016/j.brainres.2008.01.055; Zhang YD, 2009, MOL CARCINOGEN, V48, P454, DOI 10.1002/mc.20483; Zhu RL, 1997, NEUROSCIENCE, V81, P707, DOI 10.1016/S0306-4522(97)00205-4	38	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44207	10.1371/journal.pone.0044207	http://dx.doi.org/10.1371/journal.pone.0044207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970179	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400045
J	Song, XL; Wang, X				Song, Xiaolan; Wang, Xiao			Mind Wandering in Chinese Daily Lives - An Experience Sampling Study	PLOS ONE			English	Article							REPETITIVE THOUGHT; DEFAULT NETWORK; DAILY-LIFE; KANE 2010; CONSCIOUSNESS; PSYCHOLOGY; ATTENTION; FUTURE; MEMORY; BRAIN	Mind wandering has recently received extensive research because it reveals an important characteristic of our consciousness: conscious experience can arise internally and involuntarily. As the first attempt to examine mind wandering in a non-western population, the present study used experience-sampling method to collect the daily momentary mind wandering episodes in a Chinese sample. The results showed that mind wandering was also a ubiquitous experience among the Chinese population, and, instead of emerging out of nowhere, it was often elicited by external or internal cues. Furthermore, most of the mind wandering episodes involved prospective thinking and were closely related to one's personal life. Finally, the frequency of mind wandering was influenced by some contextual factors. These results taken together suggest that mind wandering plays an important role in helping people to maintain a continuous feeling of "self" and to prepare them to cope with the upcoming events.	[Song, Xiaolan; Wang, Xiao] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China	Zhejiang Normal University	Song, XL (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China.	xlsong@zjnu.cn			Humanities and Social Sciences Fund of the Ministry of Education of P.R. China [10YJCXLX040]; Zhejiang Provincial Social Sciences Foundation [11ZJQN076YB]; Research Fund of Zhejiang Department of Education [Z200908972]; Program for Innovative Research Team of Zhejiang Normal University [PIRT0809]	Humanities and Social Sciences Fund of the Ministry of Education of P.R. China; Zhejiang Provincial Social Sciences Foundation; Research Fund of Zhejiang Department of Education; Program for Innovative Research Team of Zhejiang Normal University	This research was supported by the grants as follows: 1. Humanities and Social Sciences Fund of the Ministry of Education of P.R. China (10YJCXLX040); 2. Zhejiang Provincial Social Sciences Foundation (11ZJQN076YB); 3. Research Fund of Zhejiang Department of Education (Z200908972); 4. The Program for Innovative Research Team of Zhejiang Normal University (PIRT0809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars BJ, 2010, PSYCHOL BULL, V136, P208, DOI 10.1037/a0018726; Baars BJ, 1998, COGNITIVE THEORY CON; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Ball CT, 2006, APPL COGNITIVE PSYCH, V20, P1167, DOI 10.1002/acp.1264; Berntsen D, 1996, APPL COGNITIVE PSYCH, V10, P435, DOI 10.1002/(SICI)1099-0720(199610)10:5<435::AID-ACP408>3.0.CO;2-L; Berntsen D, 2008, CONSCIOUS COGN, V17, P1093, DOI 10.1016/j.concog.2008.03.001; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; D'Argembeau A, 2011, APPL COGNITIVE PSYCH, V25, P96, DOI 10.1002/acp.1647; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Fredrickson BL, 2003, AM SCI, V91, P330, DOI 10.1511/2003.4.330; GIAMBRA LM, 1993, EXP GERONTOL, V28, P485, DOI 10.1016/0531-5565(93)90073-M; GIAMBRA LM, 1995, CONSCIOUS COGN, V4, P1, DOI 10.1006/ccog.1995.1001; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kim U, 2000, J CROSS CULT PSYCHOL, V31, P63, DOI 10.1177/0022022100031001006; Klinger E. C., 1999, THOUGHT FLOW PROPERT, P29; Kvavilashvili L, 2004, COGNITIVE PSYCHOL, V48, P47, DOI 10.1016/S0010-0285(03)00115-4; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; Metcalfe J, 2005, EPISODIC MEMORY AUTO, P3; Nezlek JB, 2001, PERS SOC PSYCHOL B, V27, P771, DOI 10.1177/0146167201277001; Nisbett RE, 2003, GEOGRAPHHY THOUGHT A; Schooler JW, 2002, TRENDS COGN SCI, V6, P339, DOI 10.1016/S1364-6613(02)01949-6; Scollon CN., 2003, J HAPPINESS STUD, V4, P5, DOI [10.1023/A:1023605205115, DOI 10.1023/A:1023605205115]; Smallwood J, 2004, CONSCIOUS COGN, V13, P789, DOI 10.1016/j.concog.2004.07.004; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Smallwood J, 2011, CONSCIOUSNE IN PRESS; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2011, COGNITION EMOTION, V25, P1481, DOI 10.1080/02699931.2010.545263; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; VERSACE R, 1993, PERCEPT MOTOR SKILL, V76, P851, DOI 10.2466/pms.1993.76.3.851; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Watkins ER, 2010, PSYCHOL BULL, V136, P198, DOI 10.1037/a0018563	43	121	124	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44423	10.1371/journal.pone.0044423	http://dx.doi.org/10.1371/journal.pone.0044423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001MC	22957071	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800064
J	Holmuhamedov, EL; Oberlin, A; Short, K; Terzic, A; Jahangir, A				Holmuhamedov, Ekhson L.; Oberlin, Andrew; Short, Kevin; Terzic, Andre; Jahangir, Arshad			Cardiac Subsarcolemmal and Interfibrillar Mitochondria Display Distinct Responsiveness to Protection by Diazoxide	PLOS ONE			English	Article							SENSITIVE K+ CHANNELS; CHROMAFFIN-CELL STIMULATION; AGING RAT-HEART; OXIDATIVE-PHOSPHORYLATION; PERMEABILITY TRANSITION; MYOCARDIAL-ISCHEMIA; ENERGY-PRODUCTION; INTERMYOFIBRILLAR MITOCHONDRIA; INTRAMITOCHONDRIAL CA2+; 2 POPULATIONS	Objective: Cardiac subsarcolemmal (SSM) and interfibrillar (IFM) mitochondrial subpopulations possess distinct biochemical properties and differ with respect to their protein and lipid compositions, capacities for respiration and protein synthesis, and sensitivity to metabolic challenge, yet their responsiveness to mitochondrially active cardioprotective therapeutics has not been characterized. This study assessed the differential responsiveness of the two mitochondrial subpopulations to diazoxide, a cardioprotective agent targeting mitochondria. Methods: Mitochondrial subpopulations were freshly isolated from rat ventricles and their morphologies assessed by electron microscopy and enzymatic activities determined using standard biochemical protocols with a plate reader. Oxidative phosphorylation was assessed from State 3 respiration using succinate as a substrate. Calcium dynamics and the status of Ca2+-dependent mitochondrial permeability transition (MPT) pore and mitochondrial membrane potential were assessed using standard Ca2+ and TPP+ ion-selective electrodes. Results: Compared to IFM, isolated SSM exhibited a higher sensitivity to Ca2+ overload-mediated inhibition of adenosine triphosphate (ATP) synthesis with decreased ATP production (from 375 +/- 25 to 83 +/- 15 nmol ATP/min/mg protein in SSM, and from 875 +/- 39 to 583 +/- 45 nmol ATP/min/mg protein in IFM). In addition, SSM exhibited reduced Ca2+-accumulating capacity as compared to IFM (230 +/- 13 vs. 450 +/- 46 nmol Ca2+/mg protein in SSM and IFM, respectively), suggestive of increased Ca2+ sensitivity of MPT pore opening. Despite enhanced susceptibility to stress, SSM were more responsive to the protective effect of diazoxide (100 mM) against Ca2+ overload-mediated inhibition of ATP synthesis (67% vs. 2% in SSM and IFM, respectively). Conclusion: These results provide evidence for the distinct sensitivity of cardiac SSM and IFM toward Ca2+-dependent metabolic stress and the protective effect of diazoxide on mitochondrial energetics.	[Holmuhamedov, Ekhson L.; Jahangir, Arshad] Aurora Univ Wisconsin, Ctr Integrat Res Cardiovasc Aging, Med Grp, Aurora Hlth Care, Milwaukee, WI USA; [Oberlin, Andrew; Terzic, Andre; Jahangir, Arshad] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Short, Kevin] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Holmuhamedov, EL (corresponding author), Aurora Univ Wisconsin, Ctr Integrat Res Cardiovasc Aging, Med Grp, Aurora Hlth Care, Milwaukee, WI USA.	arshad.jahangir@aurora.org	Jahangir, Arshad/M-7916-2016; Holmuhamedov, Ekhson L/P-5228-2016; Short, Kevin R/AAC-2553-2020	Holmuhamedov, Ekhson L/0000-0002-0809-350X; Short, Kevin R/0000-0001-6704-9587	National Heart, Lung, and Blood Institute [HL089542-04, HL101240-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089542, R01HL101240] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute (HL089542-04 and HL101240-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 2003, CIRC RES, V92, P195, DOI 10.1161/01.RES.0000051862.16691.F9; Argaud L, 2004, CARDIOVASC RES, V61, P115, DOI 10.1016/j.cardiores.2003.11.003; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; Dos Santos P, 2002, AM J PHYSIOL-HEART C, V283, pH284, DOI 10.1152/ajpheart.00034.2002; DUAN JM, 1989, CAN J PHYSIOL PHARM, V67, P704, DOI 10.1139/y89-114; DUAN JM, 1989, MOL CELL BIOCHEM, V90, P47; FERRARI R, 1993, BASIC RES CARDIOL, V88, P495, DOI 10.1007/BF00795415; Fryer RM, 2000, AM J PHYSIOL-HEART C, V278, pH305, DOI 10.1152/ajpheart.2000.278.1.H305; Gallitelli MF, 1999, J PHYSIOL-LONDON, V518, P433, DOI 10.1111/j.1469-7793.1999.0433p.x; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Gross GJ, 1999, CIRC RES, V84, P973, DOI 10.1161/01.RES.84.9.973; Grover GJ, 2000, J MOL CELL CARDIOL, V32, P677, DOI 10.1006/jmcc.2000.1111; He ZH, 1997, J PHYSIOL-LONDON, V501, P125, DOI 10.1111/j.1469-7793.1997.125bo.x; Holmuhamedov EL, 2004, FEBS LETT, V568, P167, DOI 10.1016/j.febslet.2004.05.031; Holmuhamedov EL, 1999, J PHYSIOL-LONDON, V519, P347, DOI 10.1111/j.1469-7793.1999.0347m.x; Holmuhamedov EL, 1998, AM J PHYSIOL-HEART C, V275, pH1567, DOI 10.1152/ajpheart.1998.275.5.H1567; Holmuhamedov EL, 2001, MOL CELL BIOCHEM, V220, P135, DOI 10.1023/A:1010894427373; Hoppel CL, 2009, INT J BIOCHEM CELL B, V41, P1949, DOI 10.1016/j.biocel.2009.05.004; Hoppel CL, 2002, BIOGERONTOLOGY, V3, P41, DOI 10.1023/A:1015251212039; Jahangir A, 2001, MECH AGEING DEV, V122, P1073, DOI 10.1016/S0047-6374(01)00242-1; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kavazis AN, 2008, AM J PHYSIOL-HEART C, V294, pH928, DOI 10.1152/ajpheart.01231.2007; Kavazis AN, 2009, AM J PHYSIOL-HEART C, V297, pH144, DOI 10.1152/ajpheart.01278.2008; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; MCCORMACK JG, 1989, MOL CELL BIOCHEM, V89, P121; MCCORMACK JG, 1993, BIOCHEM SOC T, V21, P793, DOI 10.1042/bst0210793; MCMILLINWOOD J, 1980, BIOCHIM BIOPHYS ACTA, V591, P251, DOI 10.1016/0005-2728(80)90157-7; Minners J, 2007, MOL CELL BIOCHEM, V294, P11, DOI 10.1007/s11010-005-9066-6; MIYATA H, 1992, CIRC RES, V71, P605, DOI 10.1161/01.RES.71.3.605; Montero M, 2001, EUR J NEUROSCI, V13, P2247, DOI 10.1046/j.0953-816x.2001.01602.x; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Ozcan C, 2001, J THORAC CARDIOV SUR, V121, P298, DOI 10.1067/mtc.2001.111421; PALMER JW, 1977, J BIOL CHEM, V252, P8731; PALMER JW, 1986, AM J PHYSIOL, V250, pH741, DOI 10.1152/ajpheart.1986.250.5.H741; PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7; PIPER HM, 1985, J MOL CELL CARDIOL, V17, P885, DOI 10.1016/S0022-2828(85)80102-4; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Ruiz-Meana M, 2006, CARDIOVASC RES, V71, P715, DOI 10.1016/j.cardiores.2006.06.019; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; Sato T, 2000, BASIC RES CARDIOL, V95, P285, DOI 10.1007/s003950070047; Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4; Tanonaka K, 1999, J PHARMACOL EXP THER, V291, P710; TUENADEGOMEZPUYOU M, 1980, BIOCHIM BIOPHYS ACTA, V592, P396, DOI 10.1016/0005-2728(80)90087-0; Williamson CL, 2010, AM J PHYSIOL-HEART C, V298, pH633, DOI 10.1152/ajpheart.00668.2009	58	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44667	10.1371/journal.pone.0044667	http://dx.doi.org/10.1371/journal.pone.0044667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973464	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600076
J	Lee, SJ; Lee, EJ; Kim, SK; Jeong, P; Cho, YH; Yun, SJ; Kim, S; Kim, GY; Choi, YH; Cha, EJ; Kim, WJ; Moon, SK				Lee, Se-Jung; Lee, Eo-Jin; Kim, Seon-Kyu; Jeong, Pildu; Cho, Young-Hwa; Yun, Seok Joong; Kim, Sangtae; Kim, Gi-Young; Choi, Yung Hyun; Cha, Eun-Jong; Kim, Wun-Jae; Moon, Sung-Kwon			Identification of Pro-Inflammatory Cytokines Associated with Muscle Invasive Bladder Cancer; The Roles of IL-5, IL-20, and IL-28A	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; IV COLLAGENASE GENE; SIGNAL-TRANSDUCTION; MATRIX-METALLOPROTEINASE-9 EXPRESSION; MATRIX METALLOPROTEINASES; ANTITUMOR-ACTIVITY; HUMAN EOSINOPHILS; TUMOR-CELLS; MECHANISM; PATHWAY	We used gene expression profiling to identify inflammatory cytokines that correlate with bladder cancer development. Gene expression profiles of the tissue samples were investigated using cDNA microarrays that contained 103 non-muscle invasive bladder cancers (NMIBC), 62 muscle invasive bladder cancers (MIBC), 58 samples of histologically normal-looking surrounding tissues, and 10 normal, healthy subjects who served as the control cohort for comparison. We grouped the data-sets according to biological characterizations and focused on immune response genes with at least 2-fold differential expression in MIBC vs. controls. The experimental data-set identified 36 immune-related genes that were significantly altered in MIBC samples. In addition, 10 genes were up-regulated and 26 genes were down-regulated in MIBC samples compared with the normal tissues. Among the 10 up-regulated molecules examined, the capacity for both wound-healing migration and invasion was enhanced in response to IL-5, IL-20, and IL-28A in bladder cancer cell lines (253J and EJ cells), compared with untreated cells. The expression levels of IL-5, IL-20, and IL-28A were increased in patients with MIBC. All 3 cytokines and their receptors were produced in bladder cancer cell lines, as determined by real-time PCR, immunoblot analysis and confocal immunofluorescence. Up-regulation of MMP-2 and MMP-9 was found after IL-5, IL-20, and IL-28A stimulation in both cell types. Moreover, an EMSA assay showed that treatment with IL-5, IL-20, and IL-28A induced activation of the transcription factors NF-kappa B and AP-1 that regulate the MMP-9 promoter. Finally, activation of MAPK and Jak-Stat signaling was observed after the addition of IL-5, IL-20, and IL-28A to bladder cancer cells. This study suggests the presence of specific inflammatory cytokine (IL-5, IL-20, and IL-28A)-mediated association in bladder cancer development. All 3 cytokines may be important new molecular targets for the modulation of migration and invasion in bladder cancer.	[Lee, Se-Jung; Lee, Eo-Jin; Kim, Sangtae; Moon, Sung-Kwon] Chungju Natl Univ, Dept Biotechnol, Chungju, Chungbuk, South Korea; [Lee, Se-Jung] Chung Ang Univ, Dept Food Sci & Technol, Ansung, South Korea; [Cho, Young-Hwa] Juseong Univ, Juseong Gene Therapy R&D Ctr, Chungbuk, South Korea; [Kim, Gi-Young] Jeju Natl Univ, Dept Marine Life Sci, Immunobiol Lab, Cheju, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Pusan, South Korea; [Lee, Se-Jung; Lee, Eo-Jin; Jeong, Pildu; Yun, Seok Joong; Kim, Wun-Jae; Moon, Sung-Kwon] Chungbuk Natl Univ, Dept Urol, Coll Med, Chungbuk, Chungbuk, South Korea; [Kim, Seon-Kyu] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Cha, Eun-Jong] Chungbuk Natl Univ, Dept Biomed Engn, Cheongju, South Korea	Chung Ang University; Jeju National University; Dong-Eui University; Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University	Lee, SJ (corresponding author), Chungju Natl Univ, Dept Biotechnol, Chungju, Chungbuk, South Korea.	wjkim@chungbuk.ac.kr; sumoon66@dreamwiz.com		Kim, Seon-Kyu/0000-0002-4176-5187; Yun, Seok-Joong/0000-0001-7737-4746	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0001736]; Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100651-1011-0000200]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2010-0001736) and the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100651-1011-0000200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 1998, AM J PHYSIOL-CELL PH, V275, pC623, DOI 10.1152/ajpcell.1998.275.3.C623; Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Bianco FJ, 1998, CLIN CANCER RES, V4, P3011; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Bohle A, 2003, J UROLOGY, V170, P964, DOI 10.1097/01.ju.0000073852.24341.4a; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brumatti G, 2010, CELL MOL LIFE SCI, V67, P1619, DOI 10.1007/s00018-010-0288-8; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; Coffer PJ, 1998, BLOOD, V91, P2547, DOI 10.1182/blood.V91.7.2547.2547_2547_2557; DAVIES B, 1993, CANCER RES, V53, P5365; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Gerhards S, 2001, UROLOGY, V57, P675, DOI 10.1016/S0090-4295(00)01087-6; Goswami B, 2008, INT J GYNECOL CANCER, V18, P591, DOI 10.1111/j.1525-1438.2007.01089.x; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; Inoue K, 2000, CANCER RES, V60, P2290; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lee CF, 2004, J UROLOGY, V171, P1343, DOI 10.1097/01.ju.0000103924.93206.93; Li CG, 2010, CANCER CHEMOTH PHARM, V66, P981, DOI 10.1007/s00280-010-1336-7; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; LIOTTA LA, 1986, CANCER RES, V46, P1; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Matsumoto K, 2011, HUM GENE THER, V22, P1423, DOI 10.1089/hum.2011.013; Mitra AP, 2009, CANCER METAST REV, V28, P317, DOI 10.1007/s10555-009-9196-5; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Moses MA, 1998, CANCER RES, V58, P1395; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; PAZDRAK K, 1995, J IMMUNOL, V155, P397; PAZDRAK K, 1995, J EXP MED, V181, P1827, DOI 10.1084/jem.181.5.1827; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Saban Marcia R, 2006, BMC Physiol, V6, P1, DOI 10.1186/1472-6793-6-1; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sato S, 1994, J EXP MED; Satyam A, 2011, UROL ONCOL-SEMIN ORI, V29, P58, DOI 10.1016/j.urolonc.2009.06.002; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; TYAGI P, 2009, INT UROL NEPHROL; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wegenka UM, 2010, CYTOKINE GROWTH F R, V21, P353, DOI 10.1016/j.cytogfr.2010.08.001; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xu WF, 2004, INT IMMUNOPHARMACOL, V4, P627, DOI 10.1016/j.intimp.2004.01.006; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	62	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e40267	10.1371/journal.pone.0040267	http://dx.doi.org/10.1371/journal.pone.0040267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962576	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600003
J	Moulton, EA; Becerra, L; Rosenthal, P; Borsook, D				Moulton, Eric A.; Becerra, Lino; Rosenthal, Perry; Borsook, David			An Approach to Localizing Corneal Pain Representation in Human Primary Somatosensory Cortex	PLOS ONE			English	Article							EYE BLINKING; INNERVATION; FMRI; ACTIVATION; NERVES; EOG	The cornea has been a focus of animal electrophysiological research for decades, but little is known regarding its cortical representation in the human brain. This study attempts to localize the somatotopic representation of the cornea to painful stimuli in human primary somatosensory cortex using functional magnetic resonance imaging (fMRI). In this case study, a subject was imaged at 3T while bright light was presented in a block-design, which either produced pain and blinking (during photophobia) or blinking alone (after recovery from photophobia). Pain and blinking produced precisely localized activations in primary somatosensory cortex and primary motor cortex. These results indicate that noxious stimulation of the cornea can produce somatotopic activation in primary somatosensory cortex. This finding opens future avenues of research to evaluate the relationship between corneal pain and central brain mechanisms relating to the development of chronic pain conditions, such as dry eye-like symptoms.	[Moulton, Eric A.; Becerra, Lino; Borsook, David] Harvard Univ, Massachusetts Gen Hosp, Sch Med,McLean Hosp, Ctr Pain & Brain,Childrens Hosp Boston,PAIN Grp, Boston, MA 02114 USA; [Rosenthal, Perry] Boston Fdn Sight, Needham, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts General Hospital; McLean Hospital	Moulton, EA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,McLean Hosp, Ctr Pain & Brain,Childrens Hosp Boston,PAIN Grp, Boston, MA 02114 USA.	eric.moulton@childrens.harvard.edu	Moulton, Eric/AAF-8225-2019	Moulton, Eric/0000-0002-7959-8441	National Institute on Drug Abuse [DA024289]; Neurological Institute of Neurological Disorders and Stroke [NS064050]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Neurological Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a K01 grant from the National Institute on Drug Abuse (DA024289) to EAM and a K24 grant from the Neurological Institute of Neurological Disorders and Stroke (NS064050) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2011, HUM BRAIN MAPP, V32, P624, DOI 10.1002/hbm.21050; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Belmonte Carlos, 2004, Ocul Surf, V2, P248; BERGMANSON JPG, 1977, EXP EYE RES, V24, P225, DOI 10.1016/0014-4835(77)90160-9; Chung JY, 2006, NEUROSCI LETT, V395, P196, DOI 10.1016/j.neulet.2005.10.094; Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Gong SZ, 2005, BRAIN RES, V1047, P177, DOI 10.1016/j.brainres.2005.04.045; Kato M, 2003, NEUROIMAGE, V19, P1260, DOI 10.1016/S1053-8119(03)00223-4; LELE PP, 1959, EXP NEUROL, V1, P334, DOI 10.1016/0014-4886(59)90025-1; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Moulton EA, 2009, PAIN, V145, P358, DOI 10.1016/j.pain.2009.07.018; Moulton EA, 2009, HUM BRAIN MAPP, V30, P757, DOI 10.1002/hbm.20541; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1950, CEREBRAL CORTEX MAN; Rosenthal P, 2012, OCUL SURF, V10, P2, DOI 10.1016/j.jtos.2012.01.002; TERENGHI G, 1985, J COMP NEUROL, V233, P506, DOI 10.1002/cne.902330410; Xu YX, 2011, J NEUROPHYSIOL, V106, P71, DOI 10.1152/jn.00668.2010; Yoon HW, 2005, NEUROSCI LETT, V381, P26, DOI 10.1016/j.neulet.2005.01.077	19	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44643	10.1371/journal.pone.0044643	http://dx.doi.org/10.1371/journal.pone.0044643			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973463	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600074
J	Zelinka, CP; Scott, MA; Volkov, L; Fischer, AJ				Zelinka, Christopher P.; Scott, Melissa A.; Volkov, Leo; Fischer, Andy J.			The Reactivity, Distribution and Abundance of Non-Astrocytic Inner Retinal Glial (NIRG) Cells Are Regulated by Microglia, Acute Damage, and IGF1	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULLER GLIA; CHICKEN RETINA; COMMON PROGENITOR; GANGLION-CELLS; OCULAR GROWTH; QUAIL RETINA; OPTIC-NERVE; RAT RETINA; IN-VIVO	Recent studies have described a novel type of glial cell that is scattered across the inner layers of the avian retina and possibly the retinas of primates. These cells have been termed Non-astrocytic Inner Retinal Glial (NIRG) cells. These cells are stimulated by insulin-like growth factor 1 (IGF1) to proliferate, migrate distally into the retina, and become reactive. These changes in glial activity correlate with increased susceptibility of retinal neurons and Muller glia to excitotoxic damage. The purpose of this study was to further study the NIRG cells in retinas treated with IGF1 or acute damage. In response to IGF1, the reactivity, proliferation and migration of NIRG cells persists through 3 days after treatment. At 7 days after treatment, the numbers and distribution of NIRG cells returns to normal, suggesting that homeostatic mechanisms are in place within the retina to maintain the numbers and distribution of these glial cells. By comparison, IGF1-induced microglial reactivity persists for at least 7 days after treatment. In damaged retinas, we find a transient accumulation of NIRG cells, which parallels the accumulation of reactive microglia, suggesting that the reactivity of NIRG cells and microglia are linked. When the microglia are selectively ablated by the combination of interleukin 6 and clodronate-liposomes, the NIRG cells down-regulate transitin and perish within the following week, suggesting that the survival and phenotype of NIRG cells are somehow linked to the microglia. We conclude that the abundance, reactivity and retinal distribution of NIRG cells can be dynamic, are regulated by homoestatic mechanisms and are tethered to the microglia.	[Zelinka, Christopher P.; Scott, Melissa A.; Volkov, Leo; Fischer, Andy J.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zelinka, CP (corresponding author), Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA.	fischer.412@osu.edu	Fischer, Andy J./AFF-1827-2022; Fischer, Andy J./AAE-9817-2022; Fischer, Andrew J/E-3061-2011	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405; 	National Institutes of Health [EY016043-05]; NATIONAL EYE INSTITUTE [R01EY016043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a grant (EY016043-05) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Boije H, 2010, DEV DYNAM, V239, P1858, DOI 10.1002/dvdy.22309; Bredariol ASD, 2001, J COMP NEUROL, V441, P58, DOI 10.1002/cne.1397; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fischer AJ, 2006, J COMP NEUROL, V496, P479, DOI 10.1002/cne.20937; Fischer AJ, 2002, DEV BIOL, V251, P367, DOI 10.1006/dbio.2002.0813; Fischer AJ, 2004, MOL VIS, V10, P973; Fischer AJ, 1999, VISION RES, V39, P685, DOI 10.1016/S0042-6989(98)00178-3; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 1998, VISUAL NEUROSCI, V15, P1089, DOI 10.1017/S0952523898156080; Fischer AJ, 2008, DEV BIOL, V317, P196, DOI 10.1016/j.ydbio.2008.02.023; Fischer AJ, 2007, J COMP NEUROL, V503, P538, DOI 10.1002/cne.21404; Fischer AJ, 2011, INVEST OPHTH VIS SCI, V52, P7705, DOI 10.1167/iovs.11-8330; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Fischer AJ, 2010, GLIA, V58, P633, DOI 10.1002/glia.20950; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Francke M, 2001, J NEUROCYTOL, V30, P131, DOI 10.1023/A:1011987107034; Fujita Y, 2001, TISSUE CELL, V33, P129, DOI 10.1054/tice.2000.0152; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Ghai K, 2009, J NEUROCHEM, V111, P1, DOI 10.1111/j.1471-4159.2009.06270.x; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hayes S, 2007, DEV BIOL, V312, P300, DOI 10.1016/j.ydbio.2007.09.046; Ide CF, 1996, PROG BRAIN RES, V108, P365, DOI 10.1016/S0079-6123(08)62552-2; Kido N, 2001, BRAIN RES, V910, P153, DOI 10.1016/S0006-8993(01)02706-8; KOHSAKA S, 1980, J NEUROCHEM, V34, P662, DOI 10.1111/j.1471-4159.1980.tb11195.x; Lamas M, 2005, INVEST OPHTH VIS SCI, V46, P3570, DOI 10.1167/iovs.04-1398; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Magnus T, 2002, J NEUROPATH EXP NEUR, V61, P760, DOI 10.1093/jnen/61.9.760; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Marin-Teva JL, 1998, GLIA, V22, P31, DOI 10.1002/(SICI)1098-1136(199801)22:1<31::AID-GLIA4>3.0.CO;2-B; Mascarelli F, 1991, GROWTH FACTORS, V4, P81, DOI 10.3109/08977199109000260; MORGAN IG, 1981, NEUROSCI LETT, V24, P255, DOI 10.1016/0304-3940(81)90167-1; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Murphy M, 1997, PROG NEUROBIOL, V52, P355, DOI 10.1016/S0301-0082(97)00020-8; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; NARANG HK, 1977, NATURE, V266, P858, DOI 10.1038/266855a0; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Rompani SB, 2010, J NEUROSCI, V30, P4970, DOI 10.1523/JNEUROSCI.3456-09.2010; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Stanke JJ, 2010, INVEST OPHTH VIS SCI, V51, P2208, DOI 10.1167/iovs.09-4447; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Torrado J., 2003, Current Pharmaceutical Biotechnology, V4, P123, DOI 10.2174/1389201033489865; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Won MH, 2000, MICROSC RES TECHNIQ, V50, P151, DOI 10.1002/1097-0029(20000715)50:2<151::AID-JEMT7>3.0.CO;2-5; WYSE JPH, 1981, ACTA NEUROPATHOL, V54, P203, DOI 10.1007/BF00687743; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072	56	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44477	10.1371/journal.pone.0044477	http://dx.doi.org/10.1371/journal.pone.0044477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973454	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600060
J	Chen, LX; Ren, YL; Lin, JQ; Liu, XM; Pang, X; Lin, JQ				Chen, Linxu; Ren, Yilin; Lin, Jianqun; Liu, Xiangmei; Pang, Xin; Lin, Jianqiang			Acidithiobacillus caldus Sulfur Oxidation Model Based on Transcriptome Analysis between the Wild Type and Sulfur Oxygenase Reductase Defective Mutant	PLOS ONE			English	Article							PARACOCCUS-PANTOTROPHUS; THIOBACILLUS-CALDUS; GENOME SEQUENCE; FERROOXIDANS; GENE; IRON; PURIFICATION; EXPRESSION; RHODANESE; BACTERIA	Background: Acidithiobacillus caldus (A. caldus) is widely used in bio-leaching. It gains energy and electrons from oxidation of elemental sulfur and reduced inorganic sulfur compounds (RISCs) for carbon dioxide fixation and growth. Genomic analyses suggest that its sulfur oxidation system involves a truncated sulfur oxidation (Sox) system (omitting SoxCD), non-Sox sulfur oxidation system similar to the sulfur oxidation in A. ferrooxidans, and sulfur oxygenase reductase (SOR). The complexity of the sulfur oxidation system of A. caldus generates a big obstacle on the research of its sulfur oxidation mechanism. However, the development of genetic manipulation method for A. caldus in recent years provides powerful tools for constructing genetic mutants to study the sulfur oxidation system. Results: An A. caldus mutant lacking the sulfur oxygenase reductase gene (sor) was created and its growth abilities were measured in media using elemental sulfur (S-0) and tetrathionate (K2S4O6) as the substrates, respectively. Then, comparative transcriptome analysis (microarrays and real-time quantitative PCR) of the wild type and the Delta sor mutant in S-0 and K2S4O6 media were employed to detect the differentially expressed genes involved in sulfur oxidation. SOR was concluded to oxidize the cytoplasmic elemental sulfur, but could not couple the sulfur oxidation with the electron transfer chain or substrate-level phosphorylation. Other elemental sulfur oxidation pathways including sulfur diooxygenase (SDO) and heterodisulfide reductase (HDR), the truncated Sox pathway, and the S4I pathway for hydrolysis of tetrathionate and oxidation of thiosulfate in A. caldus are proposed according to expression patterns of sulfur oxidation genes and growth abilities of the wild type and the mutant in different substrates media. Conclusion: An integrated sulfur oxidation model with various sulfur oxidation pathways of A. caldus is proposed and the features of this model are summarized.	[Chen, Linxu; Lin, Jianqun; Liu, Xiangmei; Pang, Xin; Lin, Jianqiang] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Ren, Yilin] Shandong Normal Univ, Sch Life Sci, Jinan, Peoples R China	Shandong University; Shandong Normal University	Chen, LX (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	jianqunlin@sdu.edu.cn	Lin, Jianqiang/ABC-6345-2021	, Linxu/0000-0001-6620-6798	National Basic Research Program [2010CB630902, 2004CB619202]; National Natural Science Foundation [31070034]; Knowledge Innovation Program of CAS of China [2AKSCX2-YW-JS401]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of CAS of China	This research was supported by the National Basic Research Program (http://www.973.gov.cn)(2010CB630902, 2004CB619202), the National Natural Science Foundation (http://www.nsfc.gov.cn)(31070034), and the Knowledge Innovation Program of CAS (http://www.cas.cn)(2AKSCX2-YW-JS401) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billaut-Laden I, 2006, TOXICOLOGY, V225, P1, DOI 10.1016/j.tox.2006.04.054; Bugaytsova Z, 2004, EUR J BIOCHEM, V271, P272, DOI 10.1046/j.1432-1033.2003.03926.x; BUONFIGLIO V, 1993, FEMS MICROBIOL REV, V11, P43, DOI 10.1016/0168-6445(93)90022-2; Cabrejos ME, 1999, FEMS MICROBIOL LETT, V175, P223, DOI 10.1111/j.1574-6968.1999.tb13624.x; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Chen LX, 2010, J MICROBIOL BIOTECHN, V20, P39, DOI 10.4014/jmb.0905.05023; Chen ZW, 2007, APPL MICROBIOL BIOT, V74, P688, DOI 10.1007/s00253-006-0691-0; Dahl Christiane, 2006, V1, P21, DOI 10.1007/7171_002; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; Dopson M, 1999, APPL ENVIRON MICROB, V65, P36; Edwards KJ, 2000, ENVIRON MICROBIOL, V2, P324, DOI 10.1046/j.1462-2920.2000.00111.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gardner MN, 2000, J APPL MICROBIOL, V89, P185, DOI 10.1046/j.1365-2672.2000.01117.x; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hallberg KB, 1996, J BACTERIOL, V178, P6, DOI 10.1128/jb.178.1.6-11.1996; Hallberg KB, 1996, APPL ENVIRON MICROB, V62, P4243, DOI 10.1128/AEM.62.11.4243-4246.1996; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Huan H, 2009, STUDY SPECIATION TRA; JIN SM, 1992, APPL ENVIRON MICROB, V58, P429, DOI 10.1128/AEM.58.1.429-430.1992; Kamimura K, 1999, MICROBIOS, V99, P7; KLETZIN A, 1992, J BACTERIOL, V174, P5854, DOI 10.1128/jb.174.18.5854-5859.1992; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; KLETZIN A, 1989, J BACTERIOL, V171, P1638, DOI 10.1128/jb.171.3.1638-1643.1989; Liu XM, 2007, J MICROBIOL BIOTECHN, V17, P162; [刘缨 Liu Ying], 2004, [微生物学报, Acta Microbiologica Sinica], V44, P382; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangold S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00017; MEULENBERG R, 1992, ARCH MICROBIOL, V157, P161, DOI 10.1007/BF00245285; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Okibe N, 2003, APPL ENVIRON MICROB, V69, P1936, DOI 10.1128/AEM.69.4.1936-1943.2003; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Rainey FA, 1999, INT J SYST BACTERIOL, V49, P645, DOI 10.1099/00207713-49-2-645; Ramirez P, 2004, APPL ENVIRON MICROB, V70, P4491, DOI 10.1128/AEM.70.8.4491-4498.2004; Rawlings DE, 1998, J IND MICROBIOL BIOT, V20, P268, DOI 10.1038/sj.jim.2900522; Rohwerder T, 2007, ENG LIFE SCI, V7, P301, DOI 10.1002/elsc.200720204; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; SCHRADER JA, 1988, J BACTERIOL, V170, P3915, DOI 10.1128/jb.170.9.3915-3923.1988; Steudel R, 2000, CHEM SULFUR CYCLE; Sugio T, 2005, P 16 INT BIOH S CAP, P25; Sun CW, 2003, EXTREMOPHILES, V7, P131, DOI 10.1007/s00792-002-0304-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urich T, 2004, BIOCHEM J, V381, P137, DOI 10.1042/BJ20040003; Valdes J, 2008, HYDROMETALLURGY, V94, P180, DOI 10.1016/j.hydromet.2008.05.039; Valdes J, 2009, J BACTERIOL, V191, P5877, DOI 10.1128/JB.00843-09; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van Zyl LJ, 2008, APPL ENVIRON MICROB, V74, P5686, DOI 10.1128/AEM.01235-08; Wakai S, 2004, BIOSCI BIOTECH BIOCH, V68, P2519, DOI 10.1271/bbb.68.2519; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006	58	70	75	11	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e39470	10.1371/journal.pone.0039470	http://dx.doi.org/10.1371/journal.pone.0039470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984393	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500001
J	Engels, S; Hein, CM; Lefeldt, N; Prior, H; Mouritsen, H				Engels, Svenja; Hein, Christine Maira; Lefeldt, Nele; Prior, Helmut; Mouritsen, Henrik			Night-Migratory Songbirds Possess a Magnetic Compass in Both Eyes	PLOS ONE			English	Article							PHOTORECEPTOR-BASED MAGNETORECEPTION; POLARIZED-LIGHT CUES; VISUAL LATERALIZATION; CLUSTER-N; ORIENTATION; BIRDS; CRYPTOCHROME; BRAIN; MODEL; CALIBRATION	Previous studies on European robins, Erithacus rubecula, and Australian silvereyes, Zosterops lateralis, had suggested that magnetic compass information is being processed only in the right eye and left brain hemisphere of migratory birds. However, recently it was demonstrated that both garden warblers, Sylvia borin, and European robins have a magnetic compass in both eyes. These results raise the question if the strong lateralization effect observed in earlier experiments might have arisen from artifacts or from differences in experimental conditions rather than reflecting a true all-or-none lateralization of the magnetic compass in European robins. Here we show that (1) European robins having only their left eye open can orient in their seasonally appropriate direction both during autumn and spring, i.e. there are no strong lateralization differences between the outward journey and the way home, that (2) their directional choices are based on the standard inclination compass as they are turned 180 degrees when the inclination is reversed, and that (3) the capability to use the magnetic compass does not depend on monocular learning or intraocular transfer as it is already present in the first tests of the birds with only one eye open.	[Engels, Svenja; Hein, Christine Maira; Lefeldt, Nele; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensor Anim Nav, D-2900 Oldenburg, Germany; [Engels, Svenja; Hein, Christine Maira; Lefeldt, Nele; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-2900 Oldenburg, Germany; [Prior, Helmut] Goethe Univ Frankfurt, Inst Psychol, Frankfurt, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Goethe University Frankfurt	Engels, S (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensor Anim Nav, D-2900 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839	Volkswagen-Stiftung; Deutsche Forschungsgemeinschaft [FOR 701, Pr 489/4-2]; Heinz Neumuller Stiftung	Volkswagen-Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinz Neumuller Stiftung	This work was supported by the Volkswagen-Stiftung (Lichtenberg-Professorship grant to HM), the Deutsche Forschungsgemeinschaft (FOR 701 grant to HM; Pr 489/4-2 to HP) and the Heinz Neumuller Stiftung (SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; Chernetsov N, 2008, CURR BIOL, V18, P188, DOI 10.1016/j.cub.2008.01.018; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; COWAN WM, 1963, PROC R SOC SER B-BIO, V158, P232, DOI 10.1098/rspb.1963.0045; Diekamp B, 2002, BEHAV BRAIN RES, V136, P103, DOI 10.1016/S0166-4328(02)00106-7; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Freire R, 2010, J EXP BIOL, V213, P3423, DOI 10.1242/jeb.047613; Gagliardo A, 2005, EUR J NEUROSCI, V22, P2549, DOI 10.1111/j.1460-9568.2005.04444.x; Gagliardo A, 2005, EUR J NEUROSCI, V22, P189, DOI 10.1111/j.1460-9568.2005.04204.x; Gunturkun O, 1997, NEUROREPORT, V8, pR3; Hart NS, 2000, CURR BIOL, V10, P115, DOI 10.1016/S0960-9822(00)00297-9; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MCGILL JI, 1966, J ANAT, V100, P5; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mouritsen H, 1998, ANIM BEHAV, V55, P1311, DOI 10.1006/anbe.1997.0696; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Mouritsen H, 2009, J ORNITHOL, V150, P713, DOI 10.1007/s10336-009-0421-3; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; Muheim R, 2006, SCIENCE, V313, P837, DOI 10.1126/science.1129709; Muheim R, 2009, J EXP BIOL, V212, P3466, DOI 10.1242/jeb.032771; PERDECK A. C., 1958, ARDEA, V46, P1; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Prior H, 2002, J EXP BIOL, V205, P1795; Prior H, 2006, MOL BIOL INTELL UNIT, P75; Rattenborg NC, 2006, NATURWISSENSCHAFTEN, V93, P413, DOI 10.1007/s00114-006-0120-3; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Rogers LJ, 2008, BEHAV BRAIN RES, V186, P66, DOI 10.1016/j.bbr.2007.07.029; Rogers LJ, 2002, COMP VERTEBRATE LATE; SCHULTEN K, 1978, BIOPHYS J, V24, P295, DOI 10.1016/S0006-3495(78)85378-8; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Skiba M, 2000, BRAIN LANG, V73, P254, DOI 10.1006/brln.2000.2306; Solov'yov IA, 2010, BIOPHYS J, V99, P40, DOI 10.1016/j.bpj.2010.03.053; Ulrich C, 1999, BEHAV BRAIN RES, V104, P169, DOI 10.1016/S0166-4328(99)00062-5; Wiltschko R, 2005, CURR BIOL, V15, P1518, DOI 10.1016/j.cub.2005.07.037; Wiltschko R, 2010, CURR ZOOL, V56, P265, DOI 10.1093/czoolo/56.3.265; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2003, AUST J ZOOL, V51, P597, DOI 10.1071/ZO03022; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 2007, J ORNITHOL, V148, pS61, DOI 10.1007/s10336-007-0233-2; Wiltschko W, 2011, NATURE, V471, pE12, DOI 10.1038/nature09876; Wilzeck C, 2010, J R SOC INTERFACE, V7, pS235, DOI 10.1098/rsif.2009.0436.focus; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	63	23	23	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43271	10.1371/journal.pone.0043271	http://dx.doi.org/10.1371/journal.pone.0043271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984416	Green Submitted, gold, Green Published			2022-12-27	WOS:000308738500008
J	Flechas, SV; Sarmiento, C; Cardenas, ME; Medina, EM; Restrepo, S; Amezquita, A				Flechas, Sandra V.; Sarmiento, Carolina; Cardenas, Martha E.; Medina, Edgar M.; Restrepo, Silvia; Amezquita, Adolfo			Surviving Chytridiomycosis: Differential Anti-Batrachochytrium dendrobatidis Activity in Bacterial Isolates from Three Lowland Species of Atelopus	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; POPULATION DECLINES; CUTANEOUS BACTERIA; SKIN BACTERIA; DISEASE; FROG; SALAMANDER; INFECTION; PERSISTENCE; EXTINCTION	In the Neotropics, almost every species of the stream-dwelling harlequin toads (genus Atelopus) have experienced catastrophic declines. The persistence of lowland species of Atelopus could be explained by the lower growth rate of Batrachochytrium dendrobatidis (Bd) at temperatures above 25 degrees C. We tested the complementary hypothesis that the toads' skin bacterial microbiota acts as a protective barrier against the pathogen, perhaps delaying or impeding the symptomatic phase of chytridiomycosis. We isolated 148 cultivable bacterial strains from three lowland Atelopus species and quantified the anti-Bd activity through antagonism assays. Twenty-six percent (38 strains representing 12 species) of the bacteria inhibited Bd growth and just two of them were shared among the toad species sampled in different localities. Interestingly, the strongest anti-Bd activity was measured in bacteria isolated from A. elegans, the only species that tested positive for the pathogen. The cutaneous bacterial microbiota is thus likely a fitness-enhancing trait that may (adaptation) or not (exaptation) have appeared because of natural selection mediated by chytridiomycosis. Our findings reveal bacterial strains for development of local probiotic treatments against chytridiomycosis and also shed light on the mechanisms behind the frog-bacteria-pathogen interaction.	[Flechas, Sandra V.; Sarmiento, Carolina; Cardenas, Martha E.; Medina, Edgar M.; Restrepo, Silvia; Amezquita, Adolfo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia	Universidad de los Andes (Colombia)	Flechas, SV (corresponding author), Univ Los Andes, Dept Biol Sci, Bogota, Colombia.	s-flecha@uniandes.edu.co	Sarmiento, Carolina/ABF-3966-2020	Sarmiento, Carolina/0000-0002-8575-7170; Flechas, Sandra/0000-0002-3967-5991; Cardenas, Martha/0000-0002-2009-4126; Medina, Edgar M./0000-0002-5518-5933; Amezquita, Adolfo/0000-0001-7320-1143; Restrepo, Silvia/0000-0001-9016-1040	Association of Zoos and Aquariums [CEF 08-836]; US Fish and Wildlife Service [96200-0-G228)]	Association of Zoos and Aquariums; US Fish and Wildlife Service(US Fish & Wildlife Service)	This work was supported by the Association of Zoos and Aquariums (grant CEF 08-836) and US Fish and Wildlife Service (grant 96200-0-G228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amphibia Web, 2012, INF AMPH BIOL CONS; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boopathy R, 1998, CURR MICROBIOL, V37, P127, DOI 10.1007/s002849900350; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; COOPER EL, 1992, CRYOBIOLOGY, V29, P616, DOI 10.1016/0011-2240(92)90066-B; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Daszak P, 2004, HERPETOL J, V14, P201; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dierckx P., 1993, CURVE SURFACE FITTIN; Drummond A., 2011, GENEIOUS V5 5; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P1; Flechas SV, ECOHEALTH IN PRESS, DOI [10.007/s10393-10012-10771-10399, DOI 10.1007/S10393-10012-10771-10399]; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Hof C, 2011, CARBON NANOTUBES LON, V480, P519; IUCN, 2012, IUCN RED LIST THREAT; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2003, CONSERV BIOL, V37, P222, DOI [10.1046/j.1523-1739.2003.01623.x, DOI 10.1046/J.1523-1739.2003.01623.X]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2010, ECOHEALTH, V7, P185, DOI 10.1007/s10393-010-0327-9; McKenzie VJ, 2011, ISME J, V2011, P1; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Rahman KSM, 2003, BIORESOURCE TECHNOL, V90, P159, DOI 10.1016/S0960-8524(03)00114-7; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Rueda-Almonacid JV, 2005, RANAS ARLEQUINES, P158; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Vredenburg V.T., 2011, FUNGAL DIS EMERGING, P342; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; Woodhams DC, 2008, ECOHEALTH, V5, P268, DOI 10.1007/s10393-008-0190-0	58	63	64	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44832	10.1371/journal.pone.0044832	http://dx.doi.org/10.1371/journal.pone.0044832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970314	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400032
J	De Kimpe, L; Bennis, A; Zwart, R; van Haastert, ES; Hoozemans, JJM; Scheper, W				De Kimpe, Line; Bennis, Anna; Zwart, Rob; van Haastert, Elise S.; Hoozemans, Jeroen J. M.; Scheper, Wiep			Disturbed Ca2+ Homeostasis Increases Glutaminyl Cyclase Expression; Connecting Two Early Pathogenic Events in Alzheimer's Disease In Vitro	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PYROGLUTAMATE A-BETA; INTRACELLULAR CALCIUM; C-FOS; LEAK; STORES; CELLS; DYSREGULATION; MOBILIZATION; HYPOTHESIS	A major neuropathological hallmark of Alzheimer's disease (AD) is the deposition of aggregated beta amyloid (A beta) peptide in the senile plaques. Ab is a peptide of 38-43 amino acids and its accumulation and aggregation plays a key role early in the disease. A large fraction of beta amyloid is N-terminally truncated rendering a glutamine that can subsequently be cyclized into pyroglutamate (pE). This makes the peptide more resistant to proteases, more prone to aggregation and increases its neurotoxicity. The enzyme glutaminyl cyclase (QC) catalyzes this conversion of glutamine to pE. In brains of AD patients, the expression of QC is increased in the earliest stages of pathology, which may be an important event in the pathogenesis. In this study we aimed to investigate the regulatory mechanism underlying the upregulation of QC expression in AD. Using differentiated SK-N-SH as a neuronal cell model, we found that neither the presence of A beta peptides nor the unfolded protein response, two early events in AD, leads to increased QC levels. In contrast, we demonstrated increased QC mRNA levels and enzyme activity in response to another pathogenic factor in AD, perturbed intracellular Ca2+ homeostasis. The QC promoter contains a putative binding site for the Ca2+ dependent transcription factors c-fos and c-jun. C-fos and c-jun are induced by the same Ca2+-related stimuli as QC and their upregulation precedes QC expression. We show that in the human brain QC is predominantly expressed by neurons. Interestingly, the Ca2+-dependent regulation of both c-fos and QC is not observed in non-neuronal cells. Our results indicate that perturbed Ca2+ homeostasis results in upregulation of QC selectively in neuronal cells via Ca2+-dependent transcription factors. This suggests that disruption of Ca2+ homeostasis may contribute to the formation of the neurotoxic pE A beta peptides in Alzheimer's disease.	[De Kimpe, Line; Bennis, Anna; Zwart, Rob; Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [van Haastert, Elise S.; Hoozemans, Jeroen J. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	De Kimpe, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.scheper@amc.uva.nl	Scheper, Wiep/AAI-7323-2020	Hoozemans, Jeroen/0000-0002-2888-8967; Scheper, Wiep/0000-0002-1431-4559	European Commission as part of the 6th Framework Program (EDAR) [37670]; 7th Framework program (NAD) [212043]; Internationale Stichting Alzheimer Onderzoek Nederland (ISAO) [07506]; Netherlands Organisation for Scientific Research (NWO) [836.05.060]	European Commission as part of the 6th Framework Program (EDAR); 7th Framework program (NAD); Internationale Stichting Alzheimer Onderzoek Nederland (ISAO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the European Commission as part of the 6th Framework Program (EDAR, contract # 37670) and the 7th Framework program (NAD, grant agreement # 212043), Internationale Stichting Alzheimer Onderzoek Nederland (ISAO #07506) and the Netherlands Organisation for Scientific Research (NWO; Meervoud Grant #836.05.060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Chafekar SM, 2008, CURR ALZHEIMER RES, V5, P469, DOI 10.2174/156720508785908883; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Chung KC, 2001, J BIOL CHEM, V276, P2132, DOI 10.1074/jbc.M007492200; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; De Kimpe L, 2010, CURR MED CHEM, V17, P198, DOI 10.2174/092986710790149765; De Kimpe L, 2013, AGE, V35, P673, DOI 10.1007/s11357-012-9403-0; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Gissel C, 1997, J NEUROCHEM, V69, P2538; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MOORE WC, 1991, NEUROREPORT, V2, P124, DOI 10.1097/00001756-199103000-00003; MORI H, 1992, J BIOL CHEM, V267, P17082; MUALLEM S, 1990, J BIOL CHEM, V265, P2011; Murchison D, 2007, AGING CELL, V6, P297, DOI 10.1111/j.1474-9726.2007.00293.x; PRESTON SF, 1992, CELL CALCIUM, V13, P303, DOI 10.1016/0143-4160(92)90065-Z; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sajan Farrah D, 2007, Am J Alzheimers Dis Other Demen, V22, P319, DOI 10.1177/1533317507302447; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Supnet C, 2011, CELL CALCIUM, V50, P303, DOI 10.1016/j.ceca.2011.05.013; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toescu EC, 2010, CELL CALCIUM, V47, P158, DOI 10.1016/j.ceca.2009.11.013; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707	46	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44674	10.1371/journal.pone.0044674	http://dx.doi.org/10.1371/journal.pone.0044674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970285	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000043
J	Hahm, ER; Chandra-Kuntal, K; Desai, D; Amin, S; Singh, SV				Hahm, Eun-Ryeong; Chandra-Kuntal, Kumar; Desai, Dhimant; Amin, Shantu; Singh, Shivendra V.			Notch Activation Is Dispensable for D, L-Sulforaphane-Mediated Inhibition of Human Prostate Cancer Cell Migration	PLOS ONE			English	Article							NF-KAPPA-B; PHENETHYL ISOTHIOCYANATE; CYCLE ARREST; APOPTOSIS; PATHWAY; CHEMOPREVENTION; CONSTITUENT; EXPRESSION; GROWTH; MICE	D, L-Sulforaphane (SFN), a synthetic racemic analog of broccoli constituent L-sulforaphane, is a highly promising cancer chemopreventive agent with in vivo efficacy against chemically-induced as well as oncogene-driven cancer in preclinical rodent models. Cancer chemopreventive effect of SFN is characterized by G(2)/M phase cell cycle arrest, apoptosis induction, and inhibition of cell migration and invasion. Moreover, SFN inhibits multiple oncogenic signaling pathways often hyperactive in human cancers, including nuclear factor-kappa B, Akt, signal transducer and activator of transcription 3, and androgen receptor. The present study was designed to determine the role of Notch signaling, which is constitutively active in many human cancers, in anticancer effects of SFN using prostate cancer cells as a model. Exposure of human prostate cancer cells (PC-3, LNCaP, and/or LNCaP-C4-2B) to SFN as well as its naturally-occurring thio-, sulfinyl-, and sulfonyl-analogs resulted in cleavage (activation) of Notch1, Notch2, and Notch4, which was accompanied by a decrease in levels of full-length Notch forms especially at the 16- and 24-hour time points. The SFN-mediated cleavage of Notch isoforms was associated with its transcriptional activation as evidenced by RBP-Jk-, HES-1A/B- and HEY-1 luciferase reporter assays. Migration of PC-3 and LNCaP cells was decreased significantly by RNA interference of Notch1 and Notch2, but not Notch4. Furthermore, SFN-mediated inhibition of PC-3 and LNCaP cell migration was only marginally affected by knockdown of Notch1 and Notch2. Strikingly, SFN administration to Transgenic Adenocarcinoma of Mouse Prostate transgenic mice failed to increase levels of cleaved Notch1, cleaved Notch2, and HES-1 proteins in vivo in prostatic intraepithelial neoplasia, well-differentiated carcinoma or poorly-differentiated prostate cancer lesions. These results indicate that Notch activation is largely dispensable for SFN-mediated inhibition of cell migration, which should be viewed as a therapeutic advantage as Notch activation is frequent in human prostate cancers.	[Hahm, Eun-Ryeong; Chandra-Kuntal, Kumar; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Hahm, Eun-Ryeong; Chandra-Kuntal, Kumar; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Desai, Dhimant; Amin, Shantu] Penn State Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hahm, ER (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	singhs@upmc.edu			National Cancer Institute [CA115498-07, P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA115498] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by the National Cancer Institute grant CA115498-07. This research used a tissue and research pathology facility supported by a grant from the National Cancer Institute (P30 CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Bertl E, 2006, MOL CANCER THER, V5, P575, DOI 10.1158/1535-7163.MCT-05-0324; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Conaway CC, 2005, CANCER RES, V65, P8548, DOI 10.1158/0008-5472.CAN-05-0237; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Keum YS, 2009, PHARM RES-DORDR, V26, P2324, DOI 10.1007/s11095-009-9948-5; Kim SH, 2012, BREAST CANC IN PRESS; Kim SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026615; Kim SH, 2009, MOL CANCER THER, V8, P1946, DOI 10.1158/1535-7163.MCT-09-0104; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Singh SV, 2012, CARCINOGENE IN PRESS; Tan XL, 2010, J NUTR, V140, P1404, DOI 10.3945/jn.110.121905; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147	38	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44957	10.1371/journal.pone.0044957	http://dx.doi.org/10.1371/journal.pone.0044957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970326	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000056
J	Liu, SP; Harn, HJ; Chien, YJ; Chang, CH; Hsu, CY; Fu, RH; Huang, YC; Chen, SY; Shyu, WC; Lin, SZ				Liu, Shih-Ping; Harn, Horng-Jyh; Chien, Ying-Jiun; Chang, Cheng-Hsuan; Hsu, Chien-Yu; Fu, Ru-Huei; Huang, Yu-Chuen; Chen, Shih-Yin; Shyu, Woei-Cherng; Lin, Shinn-Zong			n-Butylidenephthalide (BP) Maintains Stem Cell Pluripotency by Activating Jak2/Stat3 Pathway and Increases the Efficiency of iPS Cells Generation	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; SIGNAL TRANSDUCER GP130; ANGELICA-SINENSIS; HUMAN FIBROBLASTS; SELF-RENEWAL; BRAIN-TUMOR; IN-VITRO; STAT3; DIFFERENTIATION; INTERLEUKIN-6	In 2006, induced pluripotent stem (iPS) cells were generated from somatic cells by introducing Oct4, Sox2, c-Myc and Klf4. The original process was inefficient; maintaining the pluripotency of embryonic stem (ES) and iPS cell cultures required an expensive reagent-leukemia induced factor (LIF). Our goal is to find a pure compound that not only maintains ES and iPS cell pluripotency, but also increases iPS cell generation efficiency. From 15 candidate compounds we determined that 10 mu g/ml n-Butylidenephthalide (BP), an Angelica sinensis extract, triggers the up-regulation of Oct4 and Sox2 gene expression levels in MEF cells. We used ES and iPS cells treated with different concentrations of BP to test its usefulness for maintaining stem cell pluripotency. Results indicate higher expression levels of several stem cell markers in BP-treated ES and iPS cells compared to controls that did not contain LIF, including alkaline phosphatase, SSEA1, and Nanog. Embryoid body formation and differentiation results confirm that BP containing medium culture was capable of maintaining ES cell pluripotency after six time passage. Microarray analysis data identified PPAR, ECM, and Jak-Stat signaling as the top three deregulated pathways. We subsequently determined that phosphorylated Jak2 and phosphorylated Stat3 protein levels increased following BP treatment and suppressed with the Jak2 inhibitor, AG490. The gene expression levels of cytokines associated with the Jak2-Stat3 pathway were also up-regulated. Last, we used pou5f1-GFP MEF cells to test iPS generation efficiency following BP treatment. Our data demonstrate the ability of BP to maintain stem cell pluripotency via the Jak2-Stat3 pathway by inducing cytokine expression levels, at the same time improving iPS generation efficiency.	[Liu, Shih-Ping; Chien, Ying-Jiun; Chang, Cheng-Hsuan; Hsu, Chien-Yu] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Liu, Shih-Ping; Fu, Ru-Huei; Shyu, Woei-Cherng; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Harn, Horng-Jyh] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Fu, Ru-Huei] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan; [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Liu, SP (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	spliu@mail.cmu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020	Liu, Shih-Ping/0000-0002-5803-4460; Fu, Ru-Huei/0000-0001-9367-1759	Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; National Science Council [NSC 101-2314-B-039-009-MY2]; China Medical University [CMU99-COL-45]	Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University)	The authors wish to thank the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004), National Science Council plan (NSC 101-2314-B-039-009-MY2) and China Medical University (CMU99-COL-45) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Lee CM, 2006, TOXICOL APPL PHARM, V214, P126, DOI 10.1016/j.taap.2005.12.020; Lin PC, 2008, J NEUROCHEM, V106, P1017, DOI 10.1111/j.1471-4159.2008.05432.x; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Liu SP, 2011, CELL TRANSPLANT, V20, P15, DOI 10.3727/096368910X532828; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; METCALF D, 1991, INT J CELL CLONING, V9, P95, DOI 10.1002/stem.5530090201; Mo CQ, 2010, CELL SIGNAL, V22, P495, DOI 10.1016/j.cellsig.2009.11.003; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tejedo JR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.57; Tsai NM, 2005, CLIN CANCER RES, V11, P3475, DOI 10.1158/1078-0432.CCR-04-1827; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Wang Haiyan, 1998, Zhongguo Zhongyao Zazhi, V23, P167; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240	34	19	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44024	10.1371/journal.pone.0044024	http://dx.doi.org/10.1371/journal.pone.0044024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970157	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000011
J	Nagano, K; Hasegawa, Y; Abiko, Y; Yoshida, Y; Murakami, Y; Yoshimura, F				Nagano, Keiji; Hasegawa, Yoshiaki; Abiko, Yuki; Yoshida, Yasuo; Murakami, Yukitaka; Yoshimura, Fuminobu			Porphyromonas gingivalis FimA Fimbriae: Fimbrial Assembly by fimA Alone in the fim Gene Cluster and Differential Antigenicity among fimA Genotypes	PLOS ONE			English	Article							ANAEROBE BACTEROIDES-GINGIVALIS; COMPLETE GENOME SEQUENCE; OUTER-MEMBRANE PROTEINS; ORAL ANAEROBE; STRAIN W83; VIRULENCE; EXPRESSION; COMPONENTS; PERIODONTITIS; IDENTIFICATION	The periodontal pathogen Porphyromonas gingivalis colonizes largely through FimA fimbriae, composed of polymerized FimA encoded by fimA. fimA exists as a single copy within the fim gene cluster (fim cluster), which consists of seven genes: fimX, pgmA and fimA-E. Using an expression vector, fimA alone was inserted into a mutant from which the whole fim cluster was deleted, and the resultant complement exhibited a fimbrial structure. Thus, the genes of the fim cluster other than fimA were not essential for the assembly of FimA fimbriae, although they were reported to influence FimA protein expression. It is known that there are various genotypes for fimA, and it was indicated that the genotype was related to the morphological features of FimA fimbriae, especially the length, and to the pathogenicity of the bacterium. We next complemented the fim cluster-deletion mutant with fimA genes cloned from P. gingivalis strains including genotypes I to V. All genotypes showed a long fimbrial structure, indicating that FimA itself had nothing to do with regulation of the fimbrial length. In FimA fimbriae purified from the complemented strains, types I, II, and III showed slightly higher thermostability than types IV and V. Antisera of mice immunized with each purified fimbria principally recognized the polymeric, structural conformation of the fimbriae, and showed low cross-reactivity among genotypes, indicating that FimA fimbriae of each genotype were antigenically different. Additionally, the activity of a macrophage cell line stimulated with the purified fimbriae was much lower than that induced by Escherichia coli lipopolysaccharide.	[Nagano, Keiji; Abiko, Yuki; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi 464, Japan; [Hasegawa, Yoshiaki; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci, Gifu, Japan	Aichi Gakuin University; Asahi University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	Strategic Research AGU-Platform Formation; Aichi Health Promotion Foundation; Grants-in-Aid for Scientific Research [22791783] Funding Source: KAKEN	Strategic Research AGU-Platform Formation; Aichi Health Promotion Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Strategic Research AGU-Platform Formation, Aichi Health Promotion Foundation, and Furukawa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2010, BIOCHEM BIOPH RES CO, V398, P86, DOI 10.1016/j.bbrc.2010.06.040; DICKINSON DP, 1988, J BACTERIOL, V170, P1658, DOI 10.1128/jb.170.4.1658-1665.1988; Enersen M., 2011, J ORAL MICROBIOL, V3, P8487, DOI [10.3402/jom.v3i0.8487, DOI 10.3402/J0M.V3I0.8487]; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Hajishengallis G, 2004, IMMUNOL INVEST, V33, P157, DOI 10.1081/IMM-120030917; Hongo H, 1999, MICROBIOL IMMUNOL, V43, P937, DOI 10.1111/j.1348-0421.1999.tb03354.x; Inaba H, 2008, ORAL MICROBIOL IMMUN, V23, P29, DOI 10.1111/j.1399-302X.2007.00386.x; Ito HO, 2003, BIOCHEM BIOPH RES CO, V308, P770, DOI 10.1016/S0006-291X(03)01466-9; Kato T, 2007, CELL MICROBIOL, V9, P753, DOI 10.1111/j.1462-5822.2006.00825.x; Kuboniwa M, 2010, PERIODONTOL 2000, V54, P136, DOI 10.1111/j.1600-0757.2010.00352.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LEE JY, 1991, INFECT IMMUN, V59, P383, DOI 10.1128/IAI.59.1.383-389.1991; Masuda T, 2006, APPL ENVIRON MICROB, V72, P3458, DOI 10.1128/AEM.72.5.3458-3467.2006; Moon JH, 2012, FEMS IMMUNOL MED MIC, V64, P425, DOI 10.1111/j.1574-695X.2011.00889.x; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; MURAKAMI Y, 1993, BIOCHEM BIOPH RES CO, V192, P826, DOI 10.1006/bbrc.1993.1489; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909, DOI 10.1128/JCM.38.5.1909-1914.2000; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishikawa K, 2004, MOL MICROBIOL, V54, P546, DOI 10.1111/j.1365-2958.2004.04291.x; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Ogawa T, 2002, EUR J IMMUNOL, V32, P2543, DOI 10.1002/1521-4141(200209)32:9<2543::AID-IMMU2543>3.0.CO;2-2; Perez-Chaparro PJ, 2009, ORAL MICROBIOL IMMUN, V24, P423, DOI 10.1111/j.1399-302X.2009.00519.x; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Shoji M, 2010, CAN J MICROBIOL, V56, P959, DOI [10.1139/W10-084, 10.1139/w10-084]; SUZUKI Y, 1988, J GEN MICROBIOL, V134, P2713; Umeda JE, 2006, ORAL MICROBIOL IMMUN, V21, P415, DOI 10.1111/j.1399-302X.2006.00312.x; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Watanabe K, 1996, MICROBIOL IMMUNOL, V40, P725, DOI 10.1111/j.1348-0421.1996.tb01133.x; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; YOSHIMURA F, 1993, INFECT IMMUN, V61, P5181, DOI 10.1128/IAI.61.12.5181-5189.1993; YOSHIMURA F, 1987, MICROBIOL IMMUNOL, V31, P935, DOI 10.1111/j.1348-0421.1987.tb03154.x; YOSHIMURA F, 1985, J BACTERIOL, V163, P730, DOI 10.1128/JB.163.2.730-734.1985; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984; Zheng C, 2011, MOL ORAL MICROBIOL, V26, P388, DOI 10.1111/j.2041-1014.2011.00626.x	42	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43722	10.1371/journal.pone.0043722	http://dx.doi.org/10.1371/journal.pone.0043722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970139	Green Submitted, gold, Green Published			2022-12-27	WOS:000308462000005
J	Oswald, DJ; Lee, A; Trinidad, M; Chi, C; Ren, RY; Rich, CB; Trinkaus-Randall, V				Oswald, Duane J.; Lee, Albert; Trinidad, Monique; Chi, Cheryl; Ren, Ruiyi; Rich, Celeste B.; Trinkaus-Randall, Vickery			Communication between Corneal Epithelial Cells and Trigeminal Neurons Is Facilitated by Purinergic (P2) and Glutamatergic Receptors	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; V PYRAMIDAL NEURONS; NMDA RECEPTORS; CALCIUM WAVES; ATP RELEASE; SPINAL-CORD; CA2+ WAVES; ACTIVATION; MIGRATION; P2X(2)	Previously, we demonstrated that nucleotides released upon mechanical injury to corneal epithelium activate purinergic (P2) receptors resulting in mobilization of a Ca2+ wave. However, the tissue is extensively innervated and communication between epithelium and neurons is critical and not well understood. Therefore, we developed a co-culture of primary trigeminal neurons and human corneal limbal epithelial cells. We demonstrated that trigeminal neurons expressed a repertoire of P2Yand P2X receptor transcripts and responded to P2 agonists in a concentration-dependent manner. Mechanical injuries to epithelia in the co-cultures elicited a Ca2+ wave that mobilized to neurons and was attenuated by Apyrase, an ectonucleotidase. To elucidate the role of factors released from each cell type, epithelial and neuronal cells were cultured, injured, and the wound media from one cell type was collected and added to the other cell type. Epithelial wound media generated a rapid Ca2+ mobilization in neuronal cells that was abrogated in the presence of Apyrase, while neuronal wound media elicited a complex response in epithelial cells. The rapid Ca2+ mobilization was detected, which was abrogated with Apyrase, but it was followed by Ca2+ waves that occurred in cell clusters. When neuronal wound media was preincubated with a cocktail of N-methyl-D-aspartate (NMDA) receptor inhibitors, the secondary response in epithelia was diminished. Glutamate was detected in the neuronal wound media and epithelial expression of NMDA receptor subunit transcripts was demonstrated. Our results indicate that corneal epithelia and neurons communicate via purinergic and NMDA receptors that mediate the wound response in a highly orchestrated manner.	[Oswald, Duane J.; Lee, Albert; Ren, Ruiyi; Rich, Celeste B.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Oswald, Duane J.; Lee, Albert; Ren, Ruiyi; Rich, Celeste B.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University; Boston University	Oswald, DJ (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	vickery@bu.edu		Ren, Ruiyi/0000-0001-5785-2165; Trinkaus-Randall, Vickery/0000-0002-8573-9108	National Institutes of Health/Nuclear Energy Institute [EY06000]; Mass Lions Foundation; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE [R01EY006000] Funding Source: NIH RePORTER	National Institutes of Health/Nuclear Energy Institute; Mass Lions Foundation; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health/Nuclear Energy Institute EY06000, General support to the Department from the Mass Lions Foundation and the New England Corneal Transplant Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; BELMONTE C, 1981, J PHYSIOL-LONDON, V321, P355, DOI 10.1113/jphysiol.1981.sp013989; BELMONTE C, 1991, J PHYSIOL-LONDON, V437, P709, DOI 10.1113/jphysiol.1991.sp018621; BEUERMAN RW, 1980, EXP NEUROL, V69, P196, DOI 10.1016/0014-4886(80)90154-5; BLEEHEN T, 1978, BRIT J PHARMACOL, V62, P573, DOI 10.1111/j.1476-5381.1978.tb07764.x; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Boucher I, 2011, AM J PATHOL, V178, P1092, DOI 10.1016/j.ajpath.2010.11.060; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 1980, Prog Biochem Pharmacol, V16, P141; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cajal SRY, 1999, TEXTURE OF THE NERVOUS SYSTEM OF MAN AND THE VERTEBRATES, VOL I, P1; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1991, CELL CALCIUM, V12, P185, DOI 10.1016/0143-4160(91)90020-F; Danjo Y, 1998, J CELL SCI, V111, P3323; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Ding SH, 2000, J PHYSIOL-LONDON, V522, P199, DOI 10.1111/j.1469-7793.2000.t01-1-00199.x; GALLAR J, 1993, J PHYSIOL-LONDON, V468, P609, DOI 10.1113/jphysiol.1993.sp019791; GARCIAHIRSCHFELD J, 1994, EXP EYE RES, V59, P597, DOI 10.1006/exer.1994.1145; GARCIAHIRSCHFELD J, 1995, NEUROSCIENCE, V67, P235, DOI 10.1016/0306-4522(95)00055-N; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; ISHIDA N, 1984, ARCH OPHTHALMOL-CHIC, V102, P1380; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; Klepeis VE, 2001, J CELL SCI, V114, P4185; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Langford MP, 2010, CURR EYE RES, V35, P202, DOI 10.3109/02713680903461489; Luthardt J, 2003, NEUROCHEM INT, V42, P161, DOI 10.1016/S0197-0186(02)00069-4; Mankus C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028541; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Nakamura M, 1997, EXP EYE RES, V65, P321, DOI 10.1006/exer.1997.0345; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; Ortinau S, 2003, J NEUROSCI, V23, P4996; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Pintor J, 2004, OPHTHAL PHYSL OPT, V24, P186, DOI 10.1111/j.1475-1313.2004.00182.x; POZO MA, 1993, J NEUROPHYSIOL, V70, P2370, DOI 10.1152/jn.1993.70.6.2370; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reigada D, 2006, J PHYSIOL-LONDON, V575, P707, DOI 10.1113/jphysiol.2006.114439; Schultz R O, 1983, Trans Am Ophthalmol Soc, V81, P107; Song QH, 2003, CELL TISSUE RES, V312, P203, DOI 10.1007/s00441-002-0693-x; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; VAUGHAN RB, 1966, J CELL SCI, V1, P407; VINORES SA, 1995, EXP EYE RES, V60, P385, DOI 10.1016/S0014-4835(05)80095-8; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Wilson SE, 2001, AM J OPHTHALMOL, V132, P405, DOI 10.1016/S0002-9394(01)00995-3; Wirkner K, 2002, NEUROPHARMACOLOGY, V42, P476, DOI 10.1016/S0028-3908(01)00199-X; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; ZIESKE JD, 1986, INVEST OPHTH VIS SCI, V27, P1; ZIESKE JD, 1989, J CELL BIOL, V109, P571, DOI 10.1083/jcb.109.2.571	66	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44574	10.1371/journal.pone.0044574	http://dx.doi.org/10.1371/journal.pone.0044574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970252	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000031
J	Bedke, N; Sammut, D; Green, B; Kehagia, V; Dennison, P; Jenkins, G; Tatler, A; Howarth, PH; Holgate, ST; Davies, DE				Bedke, Nicole; Sammut, David; Green, Ben; Kehagia, Valia; Dennison, Patrick; Jenkins, Gisli; Tatler, Amanda; Howarth, Peter H.; Holgate, Stephen T.; Davies, Donna E.			Transforming Growth Factor-Beta Promotes Rhinovirus Replication in Bronchial Epithelial Cells by Suppressing the Innate Immune Response	PLOS ONE			English	Article							IN-VITRO; ASTHMA; EXPRESSION; ACTIVATION; MECHANISMS; INFECTION; PROTEINS; AIRWAYS; EXACERBATIONS; INFLAMMATION	Rhinovirus (RV) infection is a major cause of asthma exacerbations which may be due to a deficient innate immune response in the bronchial epithelium. We hypothesized that the pleiotropic cytokine, TGF-beta, influences interferon (IFN) production by primary bronchial epithelial cells (PBECs) following RV infection. Exogenous TGF-beta(2) increased RV replication and decreased IFN protein secretion in response to RV or double-stranded RNA (dsRNA). Conversely, neutralizing TGF-beta antibodies decreased RV replication and increased IFN expression in response to RV or dsRNA. Endogenous TGF-beta(2) levels were higher in conditioned media of PBECs from asthmatic donors and the suppressive effect of anti-TGF-beta on RV replication was significantly greater in these cells. Basal SMAD-2 activation was reduced when asthmatic PBECs were treated with anti-TGF-beta and this was accompanied by suppression of SOCS-1 and SOCS-3 expression. Our results suggest that endogenous TGF-beta contributes to a suppressed IFN response to RV infection possibly via SOCS-1 and SOCS-3.	[Bedke, Nicole; Sammut, David; Green, Ben; Kehagia, Valia; Dennison, Patrick; Howarth, Peter H.; Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Dennison, Patrick; Howarth, Peter H.; Holgate, Stephen T.; Davies, Donna E.] Southampton Univ Hosp, Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton, Hants, England; [Jenkins, Gisli; Tatler, Amanda] Univ Nottingham, City Hosp Nottingham, Nottingham NG7 2RD, England	University of Southampton; University of Southampton; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Bedke, N (corresponding author), Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	donnad@soton.ac.uk	tatler, amanda/I-2620-2019; Davies, Donna E/H-2993-2012; Jenkins, Gisli/R-8143-2017; Sammut, David/AAM-9164-2021	tatler, amanda/0000-0002-4644-4614; Jenkins, Gisli/0000-0002-7929-2119; Davies, Donna/0000-0002-5117-2991; Howarth, Peter/0000-0003-0619-7927	Medical Research Council (United Kingdom) Capacity Building Studentship; Medical Research Council [G0501506]; Asthma, Allergy & Inflammation Research Charity; MRC [G0900453, G0501506] Funding Source: UKRI; Medical Research Council [G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [10/020] Funding Source: researchfish	Medical Research Council (United Kingdom) Capacity Building Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma, Allergy & Inflammation Research Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This work was supported by a Medical Research Council (United Kingdom) Capacity Building Studentship to NB, Medical Research Council grant (G0501506) and the Asthma, Allergy & Inflammation Research Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; AUBERT JD, 1994, THORAX, V49, P225, DOI 10.1136/thx.49.3.225; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; BRANDES ME, 1991, J IMMUNOL, V147, P1600; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Fox SW, 2003, J IMMUNOL, V170, P3679, DOI 10.4049/jimmunol.170.7.3679; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Harada M, 2007, AM J RESP CELL MOL, V36, P491, DOI 10.1165/rcmb.2006-0090OC; Hatsushika K, 2007, CLIN EXP ALLERGY, V37, P1165, DOI 10.1111/j.1365-2222.2007.02768.x; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMARRE J, 1990, LAB INVEST, V62, P545; McCann KL, 2007, J VIROL, V81, P2880, DOI 10.1128/JVI.02583-06; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Thomas BJ, 2009, AM J RESP CELL MOL, V41, P339, DOI 10.1165/rcmb.2008-0316OC; Torrego A, 2007, THORAX, V62, P307, DOI 10.1136/thx.2006.063487; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WAKEFIELD LM, 1990, J CLIN INVEST, V86, P1976, DOI 10.1172/JCI114932; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Zhang SL, 1999, LAB INVEST, V79, P395	38	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44580	10.1371/journal.pone.0044580	http://dx.doi.org/10.1371/journal.pone.0044580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970254	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308458400090
J	Giordano, S; Lee, J; Darley-Usmar, VM; Zhang, JH				Giordano, Samantha; Lee, Jisun; Darley-Usmar, Victor M.; Zhang, Jianhua			Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; MITOCHONDRIAL COMPLEX-I; NEUROBLASTOMA SH-SY5Y CELLS; PARKINSONS-DISEASE; DOPAMINE TRANSPORTER; HYDROGEN-PEROXIDE; CYTOTOXIC AGENTS; VITRO MODEL; NDI1 GENE; WILD-TYPE	Parkinson's disease is characterized by dopaminergic neurodegeneration and is associated with mitochondrial dysfunction. The bioenergetic susceptibility of dopaminergic neurons to toxins which induce Parkinson's like syndromes in animal models is then of particular interest. For example, rotenone, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its active metabolite 1-methyl-4-phenylpyridinium (MPP+), and 6-hydroxydopamine (6-OHDA), have been shown to induce dopaminergic cell death in vivo and in vitro. Exposure of animals to these compounds induce a range of responses characteristics of Parkinson's disease, including dopaminergic cell death, and Reactive Oxygen Species (ROS) production. Here we test the hypothesis that cellular bioenergetic dysfunction caused by these compounds correlates with induction of cell death in differentiated dopaminergic neuroblastoma SH-SY5Y cells. At increasing doses, rotenone induced significant cell death accompanied with caspase 3 activation. At these concentrations, rotenone had an immediate inhibition of mitochondrial basal oxygen consumption rate (OCR) concomitant with a decrease of ATP-linked OCR and reserve capacity, as well as a stimulation of glycolysis. MPP+ exhibited a different behavior with less pronounced cell death at doses that nearly eliminated basal and ATP-linked OCR. Interestingly, MPP+, unlike rotenone, stimulated bioenergetic reserve capacity. The effects of 6-OHDA on bioenergetic function was markedly less than the effects of rotenone or MPP+ at cytotoxic doses, suggesting a mechanism largely independent of bioenergetic dysfunction. These studies suggest that these dopaminergic neurotoxins induce cell death through distinct mechanisms and differential effects on cellular bioenergetics.	[Giordano, Samantha; Lee, Jisun; Darley-Usmar, Victor M.; Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Zhang, Jianhua] Birmingham VA Med Ctr, Dept Vet Affairs, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Giordano, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Birmingham, AL 35294 USA.	zhanja@uab.edu	; Lee, Junyoung/D-5463-2012	Darley-Usmar, Victor/0000-0001-8921-7086; Lee, Junyoung/0000-0001-6689-2759; Zhang, Jianhua/0000-0002-2128-9574	United States National Institutes of Health [NIH-ES/HL10167, NIH-DK75865]; VA merit award;  [NIH-NS064090];  [P30 DK079337];  [P30 AR50948];  [S10 RR19231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075865, R56DK075865, P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064090] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA merit award(US Department of Veterans Affairs); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States National Institutes of Health NIH-ES/HL10167, and NIH-DK75865 (to VM DU); NIH-NS064090 and a VA merit award (to JZ). MPP+ mass spectrometry was supported by P30 DK079337, P30 AR50948 and S10 RR19231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; ANDREW R, 1993, NEUROCHEM RES, V18, P1175, DOI 10.1007/BF00978370; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Bove J., 2011, NEUROSCIENCE; Brand MD, 2011, BIOCHEM J, V437, P575; Brill LB, 2003, EXP NEUROL, V181, P25, DOI 10.1016/S0014-4886(02)00045-6; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Chen S, 2008, FEBS LETT, V582, P603, DOI 10.1016/j.febslet.2008.01.028; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; COHEN G, 1974, J BIOL CHEM, V249, P2447; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; CURTIUS HC, 1974, J CHROMATOGR, V99, P529, DOI 10.1016/S0021-9673(00)90882-3; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9; Dranka B.P., 2012, J NEUROCHEM; Dranka BP, 2011, FREE RADIC BIOL MED; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x; Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004; Fasano M, 2006, J NEUROCHEM, V96, P909, DOI 10.1111/j.1471-4159.2005.03638.x; Glinka Y, 1997, J NEURAL TRANSM-SUPP, P55; Glinka Y, 1996, J NEUROCHEM, V66, P2004; GLINKA YY, 1995, EUR J PHARM-ENVIRON, V292, P329, DOI 10.1016/0926-6917(95)90040-3; GLUCK MR, 1994, J NEUROCHEM, V63, P655; HEIKKILA R, 1972, MOL PHARMACOL, V8, P241; Higgins DS, 1996, J NEUROSCI, V16, P3807; Jameson GNL, 2004, ORG BIOMOL CHEM, V2, P2346, DOI 10.1039/b408044k; Jaworska-Feil L, 2010, NEUROPEPTIDES, V44, P495, DOI 10.1016/j.npep.2010.08.004; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Kobayashi H, 2008, FREE RADICAL RES, V42, P651, DOI 10.1080/10715760802270334; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; LINDAHL PE, 1960, NATURE, V187, P784, DOI 10.1038/187784a0; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Linert W, 1996, BBA-MOL BASIS DIS, V1316, P160, DOI 10.1016/0925-4439(96)00020-8; Lopes FM, 2012, NEUROTOX RES, V22, P138, DOI 10.1007/s12640-012-9311-1; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; MURPHY MP, 1995, BIOCHEM J, V306, P359, DOI 10.1042/bj3060359; Nakaso K, 2008, NEUROSCI LETT, V432, P146, DOI 10.1016/j.neulet.2007.12.034; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; OFORI S, 1989, J PHARMACOL EXP THER, V251, P258; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Parker WD, 1998, AM J HUM GENET, V62, P758, DOI 10.1086/301812; PIFL C, 1993, J NEUROSCI, V13, P4246, DOI 10.1523/jneurosci.13-10-04246.1993; Poltl D., 2011, NEUROTOXICOLOGY; PORTER CC, 1963, J PHARMACOL EXP THER, V140, P308; PORTER CC, 1965, J PHARMACOL EXP THER, V150, P17; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; RAMSAY RR, 1986, J BIOL CHEM, V261, P7585; RAMSAY RR, 1987, ARCH BIOCHEM BIOPHYS, V259, P645, DOI 10.1016/0003-9861(87)90531-5; RAMSAY RR, 1991, BIOCHEM J, V273, P481, DOI 10.1042/bj2730481; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sherer TB, 2002, J NEUROSCI, V22, P7006; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; SINGER TP, 1993, ADV NEUROL, V60, P300; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674; Swerdlow RH, 1999, BIOCHEM BIOPH RES CO, V261, P701, DOI 10.1006/bbrc.1999.1095; Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Verhaar R, 2012, NEUROBIOL DIS, V45, P839, DOI 10.1016/j.nbd.2011.10.012; VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x; Wernicke C, 2010, PHARMACOL REP, V62, P649, DOI 10.1016/S1734-1140(10)70322-4; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	90	121	122	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44610	10.1371/journal.pone.0044610	http://dx.doi.org/10.1371/journal.pone.0044610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970265	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400093
J	von Neuhoff, N; Oumeraci, T; Wolf, T; Kollewe, K; Bewerunge, P; Neumann, B; Brors, B; Bufler, J; Wurster, U; Schlegelberger, B; Dengler, R; Zapatka, M; Petri, S				von Neuhoff, Nils; Oumeraci, Tonio; Wolf, Thomas; Kollewe, Katja; Bewerunge, Peter; Neumann, Boris; Brors, Benedikt; Bufler, Johannes; Wurster, Ulrich; Schlegelberger, Brigitte; Dengler, Reinhard; Zapatka, Marc; Petri, Susanne			Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; BUNINA BODIES; CHROMOGRANIN PEPTIDES; EL-ESCORIAL; DISEASE; IMMUNOREACTIVITY; DEMENTIA; GENE; ALS; IDENTIFICATION	Background: Amyotrophic lateral sclerosis (ALS) is a fatal disorder of the motor neuron system with poor prognosis and marginal therapeutic options. Current clinical diagnostic criteria are based on electrophysiological examination and exclusion of other ALS-mimicking conditions. Neuroprotective treatments are, however, most promising in early disease stages. Identification of disease-specific CSF biomarkers and associated biochemical pathways is therefore most relevant to monitor disease progression, response to neuroprotective agents and to enable early inclusion of patients into clinical trials. Methods and Findings: CSF from 35 patients with ALS diagnosed according to the revised El Escorial criteria and 23 age-matched controls was processed using paramagnetic bead chromatography for protein isolation and subsequently analyzed by MALDI-TOF mass spectrometry. CSF protein profiles were integrated into a Random Forest model constructed from 153 mass peaks. After reducing this peak set to the top 25%, a classifier was built which enabled prediction of ALS with high accuracy, sensitivity and specificity. Further analysis of the identified peptides resulted in a panel of five highly sensitive ALS biomarkers. Upregulation of secreted phosphoprotein 1 in ALS-CSF samples was confirmed by univariate analysis of ELISA and mass spectrometry data. Further quantitative validation of the five biomarkers was achieved in an 80-plex Multiple Reaction Monitoring mass spectrometry assay. Conclusions: ALS classification based on the CSF biomarker panel proposed in this study could become a valuable predictive tool for early clinical risk stratification. Of the numerous CSF proteins identified, many have putative roles in ALS-related metabolic processes, particularly in chromogranin-mediated secretion signaling pathways. While a stand-alone clinical application of this classifier will only be possible after further validation and a multicenter trial, it could be readily used to complement current ALS diagnostics and might also provide new insights into the pathomechanisms of this disease in the future.	[von Neuhoff, Nils; Oumeraci, Tonio; Wolf, Thomas; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany; [Wolf, Thomas; Bewerunge, Peter; Brors, Benedikt; Zapatka, Marc] German Canc Res Ctr, Res Program Struct & Funct Genom, Div Theoret Bioinformat, INF 580, D-6900 Heidelberg, Germany; [Kollewe, Katja; Bufler, Johannes; Wurster, Ulrich; Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Neumann, Boris] Proteome Factory AG, Berlin, Germany	Hannover Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School	von Neuhoff, N (corresponding author), Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany.	neuhoff.nils.von@mh-hannover.de	Zapatka, Marc/G-9896-2013; Brors, Benedikt/E-5620-2013; Petri, Susanne/AID-7665-2022	Zapatka, Marc/0000-0001-8287-5967; Brors, Benedikt/0000-0001-5940-3101; 				Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Bartolomucci A, 2010, NEUROSCIENCE, V170, P289, DOI 10.1016/j.neuroscience.2010.06.057; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Bos IWM, 2006, NEUROCHEM INT, V48, P306, DOI 10.1016/j.neuint.2005.09.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brettschneider J, 2008, NEUROCHEM RES, V33, P2358, DOI 10.1007/s11064-008-9742-5; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Cho HJ, 2009, MOL CELLS, V27, P105, DOI 10.1007/s10059-009-0011-5; Findeisen P, 2009, J CLIN ONCOL, V27, P2199, DOI 10.1200/JCO.2008.18.0554; GEORGE PM, 1989, CLIN CHEM, V35, P179; GOLLIN PA, 1992, NEUROREPORT, V3, P201, DOI 10.1097/00001756-199202000-00020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Li X., PROCESS CIPHERGEN SE; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Marksteiner J, 2000, ACTA NEUROPATHOL, V100, P205, DOI 10.1007/s004010000239; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; OKAMOTO K, 1993, NEUROSCI LETT, V162, P125, DOI 10.1016/0304-3940(93)90576-7; Okamoto K, 2008, NEUROPATHOLOGY, V28, P109, DOI 10.1111/j.1440-1789.2007.00873.x; Ono S, 2000, ACTA NEUROL SCAND, V102, P47, DOI 10.1034/j.1600-0404.2000.102001047.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Pendyala G, 2009, J PROTEOME RES, V8, P2253, DOI 10.1021/pr800854t; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; Ranganathan S, 2007, AMYOTROPH LATERAL SC, V8, P373, DOI 10.1080/17482960701549681; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Schrott-Fischer A, 2009, REGUL PEPTIDES, V152, P13, DOI 10.1016/j.regpep.2008.07.009; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sussmuth SD, 2008, CURR MED CHEM, V15, P1788, DOI 10.2174/092986708785133031; Sugaya K, 1998, NEUROBIOL AGING, V19, P351, DOI 10.1016/S0197-4580(98)00072-4; Sun L, 2011, J RHEUMATOL, V38, P454, DOI 10.3899/jrheum.100550; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Therneau TM, 2009, RPART RECURSIVE PART, P45; THOMPSON EJ, 1995, J NEUROL NEUROSUR PS, V59, P349, DOI 10.1136/jnnp.59.4.349; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; TU GF, 1992, AM J PHYSIOL, V263, pR195, DOI 10.1152/ajpregu.1992.263.1.R195; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Wada M, 1999, ACTA NEUROPATHOL, V98, P150, DOI 10.1007/s004010051063; Wilson KE, 2004, J NEUROL NEUROSUR PS, V75, P529, DOI 10.1136/jnnp.2003.026260; Wilson ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015133; Wootz H, 2006, NEUROSCIENCE, V143, P419, DOI 10.1016/j.neuroscience.2006.07.048; Wuolikainen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017947; Xu L, 2005, NEUROBIOL DIS, V18, P152, DOI 10.1016/j.nbd.2004.08.012; Yang YR, 2008, CELL MOL NEUROBIOL, V28, P737, DOI 10.1007/s10571-007-9257-7; Zhao Zhong, 2008, Int J Med Sci, V5, P92	57	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44401	10.1371/journal.pone.0044401	http://dx.doi.org/10.1371/journal.pone.0044401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970211	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400067
J	Hu, G; Horswell, R; Wang, YJ; Li, W; Besse, J; Xiao, K; Chen, HL; Keller, JN; Heymsfield, SB; Ryan, DH; Katzmarzyk, PT				Hu, Gang; Horswell, Ronald; Wang, Yujie; Li, Wei; Besse, Jay; Xiao, Ke; Chen, Honglei; Keller, Jeffrey N.; Heymsfield, Steven B.; Ryan, Donna H.; Katzmarzyk, Peter T.			Body Mass Index and the Risk of Dementia among Louisiana Low Income Diabetic Patients	PLOS ONE			English	Article							AGED FINNISH MEN; TO-HIP RATIO; IGF-I LEVELS; PHYSICAL-ACTIVITY; LATE-LIFE; WAIST CIRCUMFERENCE; CARDIOMETABOLIC RISK; FOLLOW-UP; OBESITY; ASSOCIATION	Background: The association between obesity and dementia risk remains debatable and no studies have assessed this association among diabetic patients. The aim of our study was to investigate the association between body mass index (BMI) and dementia risk among middle and low income diabetic patients. Methodology/Principal Findings: The sample included 44,660 diabetic patients (19,618 white and 25,042 African American) 30 to 96 years of age without a history of dementia in the Louisiana State University Hospital-Based Longitudinal Study. During a mean follow-up period of 3.9 years, 388 subjects developed incident dementia. The age-and sex-adjusted hazards ratios (HRs) for incident dementia at different levels of BMI (<= 25, 25-26.9, 27-29.9, 30-34.9, and >= 35 kg/m(2)) were 1.00, 0.53 (95% CI 0.34-0.83), 0.29 (0.18-0.45), 0.37 (0.25-0.56), and 0.31 (0.21-0.48) (P-trend<0.001) in white diabetic patients, and 1.00, 1.00 (95% CI 0.62-1.63), 0.62 (0.39-0.98), 0.56 (0.36-0.86), and 0.65 (0.43-1.01) (P-trend = 0.029) in African American diabetic patients. Further adjustment for other confounding factors affected the results only slightly. There was a significant interaction between race and BMI on dementia risk (chi(2) = 5.52, 1df, p<0.025), such that the association was stronger in white patients. In stratified analyses, the multivariate-adjusted inverse association between BMI and risk of dementia was present in subjects aged 55-64 years, 65-74 years, and >= 75 years, in men and women, in non-smokers and smokers, and in subjects with different types of health insurance. Conclusions/Significance: Higher baseline BMI was associated with a lower risk of dementia among diabetic patients, and this association was stronger among white than among African American diabetic patients.	[Hu, Gang; Horswell, Ronald; Wang, Yujie; Li, Wei; Keller, Jeffrey N.; Heymsfield, Steven B.; Ryan, Donna H.; Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Horswell, Ronald; Besse, Jay; Xiao, Ke] Louisiana State Univ, Div Hlth Care Serv, Baton Rouge, LA 70803 USA; [Wang, Yujie] Louisiana State Univ, Sch Human Ecol, Ctr Agr, Baton Rouge, LA 70803 USA; [Xiao, Ke] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hu, G (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	gang.hu@pbrc.edu	Katzmarzyk, Peter T/N-1974-2017; Heymsfield, Steven B/N-1968-2017; Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017; Keller, Jeffrey N/N-1975-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Heymsfield, Steven B/0000-0003-1127-9425; Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017; Chen, Honglei/0000-0003-3446-7779; Ryan, Donna/0000-0001-8374-2277; keller, jeffrey/0000-0002-9892-7423	Louisiana State University's Improving Clinical Outcomes Network (LSU ICON); Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences [Z01-ES-101986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER	Louisiana State University's Improving Clinical Outcomes Network (LSU ICON); Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Louisiana State University's Improving Clinical Outcomes Network (LSU ICON), and Dr. Chen was supported by the Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences (Z01-ES-101986). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; COX DR, 1972, J R STAT SOC B, V34, P187; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2012, J ALZHEIMERS DIS, V28, P162, DOI 10.3233/JAD-2011-110917; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; Hu G, 2006, NEUROLOGY, V67, P1955, DOI 10.1212/01.wnl.0000247052.18422.e5; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; Hu G, 2011, DIABETES CARE, V34, P1415, DOI 10.2337/dc10-2019; Hu G, 2010, CIRCULATION, V121, P237, DOI 10.1161/CIRCULATIONAHA.109.887893; Hughes Elizabeth, 2010, Morbidity and Mortality Weekly Report, V59, P1; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; Kamogawa K, 2010, DEMENT GERIATR COGN, V30, P432, DOI 10.1159/000321985; Kanaya AM, 2011, DIABETES CARE, V34, P930, DOI 10.2337/dc10-1964; Katzmarzyk PT, 2010, AM J CLIN NUTR, V91, P7, DOI 10.3945/ajcn.2009.28136; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Li W, 2011, DIABETES RES CLIN PR, V94, P262, DOI 10.1016/j.diabres.2011.08.010; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okereke O, 2007, NEUROBIOL AGING, V28, P135, DOI 10.1016/j.neurobiolaging.2005.10.012; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Power BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017902; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Wang YJ, 2012, J WOMENS HEALTH, V21, P628, DOI 10.1089/jwh.2011.3318; Wang YJ, 2012, J WOMENS HEALTH, V21, P319, DOI 10.1089/jwh.2011.2838; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586; YAMAMOTO H, 1993, ENDOCR J, V40, P41, DOI 10.1507/endocrj.40.41	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44537	10.1371/journal.pone.0044537	http://dx.doi.org/10.1371/journal.pone.0044537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001MC	22957079	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800072
J	Hinterleitner, R; Gruber, T; Pfeifhofer-Obermair, C; Lutz-Nicoladoni, C; Tzankov, A; Schuster, M; Penninger, JM; Loibner, H; Lametschwandtner, G; Wolf, D; Baier, G				Hinterleitner, Reinhard; Gruber, Thomas; Pfeifhofer-Obermair, Christa; Lutz-Nicoladoni, Christina; Tzankov, Alexander; Schuster, Manfred; Penninger, Josef M.; Loibner, Hans; Lametschwandtner, Guenther; Wolf, Dominik; Baier, Gottfried			Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model	PLOS ONE			English	Article							GENE-THERAPY; CUTTING EDGE; CELLS; CANCER; IMMUNOTHERAPY; CD28; COSTIMULATION; AUTOIMMUNITY; ACTIVATION; REGRESSION	The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We recently showed that adoptive cell transfer (ACT) of cblb(-/-) CD8(+) T cells enhances dendritic cell (DC) immunization-mediated anti-tumor effects in immune-competent recipients. However, translation of cblb targeting to clinically applicable concepts requires that inhibition of cblb activity be transient and reversible. Here we provide experimental evidence that inhibition of cblb using chemically synthesized siRNA has such potential. Silencing cblb expression by ex vivo siRNA transfection of polyclonal CD8(+) T cells prior to ACT increased T cell tumor infiltration, significantly delayed tumor outgrowth, and increased survival rates of tumor-bearing mice. As shown by ex vivo recall assays, cblb silencing resulted in significant augmentation of intratumoral T cell cytokine response. ACT of cblb-silenced polyclonal CD8(+) T cells combined with DC-based tumor vaccines predominantly mediated anti-tumor immune responses, whereas no signs of autoimmunity could be detected. Importantly, CBLB silencing in human CD8(+) T cells mirrored the effects observed for cblb-silenced and cblb-deficient murine T cells. Our data validate the concept of enhanced anti-tumor immunity by repetitive ACT of ex vivo cblb siRNA-silenced hyper-reactive CD8(+) T cells as add-on adjuvant therapy to augment the efficacy of existing cancer immunotherapy regimens in clinical practice.	[Hinterleitner, Reinhard; Gruber, Thomas; Pfeifhofer-Obermair, Christa; Lutz-Nicoladoni, Christina; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria; [Lutz-Nicoladoni, Christina; Wolf, Dominik] Tyrolean Canc Res Inst, Lab Tumor Immunol, Innsbruck, Austria; [Tzankov, Alexander] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Schuster, Manfred; Loibner, Hans; Lametschwandtner, Guenther] Apeiron Biol AG, Vienna, Austria; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Wolf, Dominik] Med Univ Bonn, Dept Hematol & Oncol, Bonn, Germany	Medical University of Innsbruck; University of Basel; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Bonn	Hinterleitner, R (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria.	Gottfried.Baier@i-med.ac.at	Tzankov, Alexandar/H-5656-2019; Penninger, Josef M/I-6860-2013; Hinterleitner, Reinhard/N-7091-2019	Tzankov, Alexandar/0000-0002-1100-3819; Penninger, Josef M/0000-0002-8194-3777; Baier, Gottfried/0000-0002-2085-8325; Gruber, Thomas/0000-0002-5796-7090; Pfeifhofer-Obermair, Christa/0000-0002-9942-6540	FWF Austrian Science Fund [SFB021, T264-B13, P22207]; Austrian Federal Ministries BMVIT/BMWFJ via FFG; Tiroler Zukunftsstiftung/Standortagentur Tirol; Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H.; Swiss Kamillo Eisner-Foundation [CH-6052 Hergiswil]; Tiroler Landeskrankenanstalten GmbH; Krebshilfe-KG Tirol; MFF-Tirol; Austrian Science Fund (FWF) [T 264, P 22207] Funding Source: researchfish	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministries BMVIT/BMWFJ via FFG; Tiroler Zukunftsstiftung/Standortagentur Tirol; Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H.; Swiss Kamillo Eisner-Foundation; Tiroler Landeskrankenanstalten GmbH; Krebshilfe-KG Tirol; MFF-Tirol; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund (SFB021, T264-B13, and P22207), the COMET Center ONCOTYROL funded by the Austrian Federal Ministries BMVIT/BMWFJ (via FFG) and the Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT), Apeiron Biologics Forschungs-und Entwicklungsgesellschaft m.b.H., the Swiss Kamillo Eisner-Foundation (CH-6052 Hergiswil), the Tiroler Landeskrankenanstalten GmbH, the Krebshilfe-KG Tirol, and MFF-Tirol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bouwhuis MG, 2011, CURR OPIN ONCOL, V23, P170, DOI 10.1097/CCO.0b013e328341edff; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Coccoris M, 2010, EXPERT OPIN BIOL TH, V10, P547, DOI 10.1517/14712591003614756; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kawakami Y, 1997, IMMUNOL RES, V16, P313, DOI 10.1007/BF02786397; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Li DD, 2004, J IMMUNOL, V173, P7135, DOI 10.4049/jimmunol.173.12.7135; Loeser S, 2007, CELL CYCLE, V6, P2478, DOI 10.4161/cc.6.20.4797; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Lutz-Nicoladoni C, 2011, IMMUNOL CELL BIOL; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Sondak VK, 2011, NAT REV DRUG DISCOV, V10, P411, DOI 10.1038/nrd3463; Stoitzner P, 2010, IMMUNOL CELL BIOL, V88, P431, DOI 10.1038/icb.2010.31; Stromnes IM, 2010, J CLIN INVEST, V120, P3722, DOI 10.1172/JCI41991; Thara E, 2011, MATURITAS; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thoeni G, 2005, J IMMUNOL, V174, P7584, DOI 10.4049/jimmunol.174.12.7584; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wolf D, 2006, MINI-REV MED CHEM, V6, P509, DOI 10.2174/138955706776876230; Yang TM, 2009, CANCER IMMUNOL IMMUN, V58, P1867, DOI 10.1007/s00262-009-0698-3	35	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44295	10.1371/journal.pone.0044295	http://dx.doi.org/10.1371/journal.pone.0044295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962608	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600036
J	Zheng, MH; Shi, KQ; Fan, YC; Liu, WY; Lin, XF; Li, LF; Chen, YP				Zheng, Ming-Hua; Shi, Ke-Qing; Fan, Yu-Chen; Liu, Wen-Yue; Lin, Xian-Feng; Li, Ling-Fei; Chen, Yong-Ping			Upper Limits of Normal for Serum Alanine Aminotransferase Levels in Chinese Han Population	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CHRONIC HEPATITIS-B; RISK; COHORT	Background and Objectives: Serum alanine aminotransferase (ALT) activity is the most common tool for the assessment of liver diseases. However, it is not clear whether the current normal ALT range really discriminate patients with or without liver diseases. The present study was to establish a new normal range of ALT and examine its ability to identify patients with hepatitis B or nonalcoholic fatty liver disease (NAFLD) in Chinese Han population. Methods: 53037 adults were included in this study from January 1st 2008 to August 31st 2010. The 95th percentile of ALT in population with relative low risk factors for liver diseases was set as the new upper limits of normal ALT in gender-specific manner. Results: The 95th percentile levels at low risk factors for liver diseases were achieved at 35 U/L for men and 23 U/L for women. The concordance statistics for detection were 0.873 (95% CI: 0.865-0.881) for HBV and 0.932 (95% CI: 0.927-0.937) for NAFLD in men while 0.857 (95% CI: 0.850-0.864) for HBV and 0.909 (95% CI: 0.903-0.915) for NAFLD in women. The median sensitivity of the current used ALT upper limit (40 U/L) was 6.6% for HBV and 29.7% for NAFLD and median specificity was 98.7% for men and 99.4% for women. Using our new-derived thresholds, the sensitivities ranged from 35.3% to 61.1% and the specificities were 94.8% for men and 94.6% for women. Conclusions: Our results suggest that upper limits of ALT 35 U/L for men and 23 U/L for women in Chinese Han population. Re-consideration of normal limits of ALT should be recommended.	[Zheng, Ming-Hua; Shi, Ke-Qing; Liu, Wen-Yue; Lin, Xian-Feng; Li, Ling-Fei; Chen, Yong-Ping] Wenzhou Med Coll, Dept Infect & Liver Dis, Liver Res Ctr, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zheng, Ming-Hua; Shi, Ke-Qing; Chen, Yong-Ping] Wenzhou Med Coll, Inst Hepatol, Wenzhou, Peoples R China; [Fan, Yu-Chen] Shandong Univ, Dept Hepatol, Qilu Hosp, Jinan, Peoples R China; [Liu, Wen-Yue; Lin, Xian-Feng; Li, Ling-Fei] Wenzhou Med Coll, Sch Clin Med Sci 1, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Shandong University; Wenzhou Medical University	Zheng, MH (corresponding author), Wenzhou Med Coll, Dept Infect & Liver Dis, Liver Res Ctr, Affiliated Hosp 1, Wenzhou, Peoples R China.	blueman1320@163.com	Lin, Xianfeng/ABA-2917-2020; Zheng, Ming-Hua/H-5584-2019; Fan, Yu-Chen/A-8035-2013; Shi, KeQing/A-3411-2009; Shi, Keqing/GZK-5146-2022	Zheng, Ming-Hua/0000-0003-4984-2631; Fan, Yu-Chen/0000-0003-1621-8007; Shi, KeQing/0000-0002-5070-3834; Shi, Keqing/0000-0002-5070-3834; Fan, Yu-Chen/0000-0002-9126-679X; Liu, Wen-yue/0000-0003-1454-7077	National Science and Technology Major Project of China [2012ZX10002004]; Scientific Research Foundation of Wenzhou, Zhejiang Province, China [H20090014, Y20090269]; Health Bureau of Zhejiang Province [2010KYB070]; Research Foundation of Education Bureau of Zhejiang Province [Y201009942]; Project of New Century 551 Talent Nurturing in Wenzhou	National Science and Technology Major Project of China; Scientific Research Foundation of Wenzhou, Zhejiang Province, China; Health Bureau of Zhejiang Province; Research Foundation of Education Bureau of Zhejiang Province; Project of New Century 551 Talent Nurturing in Wenzhou	This work was supported by grants from National Science and Technology Major Project of China (2012ZX10002004), Scientific Research Foundation of Wenzhou, Zhejiang Province, China (H20090014, Y20090269), Health Bureau of Zhejiang Province (2010KYB070), Research Foundation of Education Bureau of Zhejiang Province (Y201009942) and Project of New Century 551 Talent Nurturing in Wenzhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boppidi H, 2008, POSTGRAD MED, V120, pE01; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Schwimmer JB, 2010, GASTROENTEROLOGY, V138, P1357, DOI 10.1053/j.gastro.2009.12.052; Singal AK, 2010, HEPATOLOGY, V52, p506A; Van der Poorten D, 2007, HEPATOLOGY, V46, P1750, DOI 10.1002/hep.21918; Wong VWS, 2009, ALIMENT PHARM THER, V29, P387, DOI 10.1111/j.1365-2036.2008.03896.x; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; [World Health Organization Western Pacific Region Force IAftSoOIOT], 2000, AS PAC PERSP RED OB; Yang Yue, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P879; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136	23	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43736	10.1371/journal.pone.0043736	http://dx.doi.org/10.1371/journal.pone.0043736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962588	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600016
J	Chaillon, A; Braibant, M; Hue, S; Bencharif, S; Enard, D; Moreau, A; Samri, A; Agut, H; Barin, F				Chaillon, Antoine; Braibant, Martine; Hue, Stephane; Bencharif, Samia; Enard, David; Moreau, Alain; Samri, Assia; Agut, Henri; Barin, Francis			Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection	PLOS ONE			English	Article							LONG-TERM NONPROGRESSORS; DISEASE PROGRESSION; GLYCOSYLATION SITES; HUMORAL IMMUNITY; 2G12 RECOGNIZES; SHIV CHALLENGE; GLYCAN SHIELD; C INFECTION; SUBTYPE-B; ENVELOPE	Background: The evolution of HIV-1 and its immune escape to autologous neutralizing antibodies (Nabs) during the acute/early phases of infection have been analyzed in depth in many studies. In contrast, little is known about neither the longterm evolution of the virus in patients who developed broadly Nabs (bNabs) or the mechanism of escape in presence of these bNabs. Results: We have studied the viral population infecting a long term non progressor HIV-1 infected patient who had developed broadly neutralizing antibodies toward all tier 2/3 viruses (6 clades) tested, 9 years after infection, and was then followed up over 7 years. The autologous neutralization titers of the sequential sera toward env variants representative of the viral population significantly increased during the follow-up period. The most resistant pseudotyped virus was identified at the last visit suggesting that it represented a late emerging escape variant. We identified 5 amino acids substitutions that appeared associated with escape to broadly neutralizing antibodies. They were V319I/S, R/K355T, R/W429G, Q460E and G/T463E, in V3, C3 and V5 regions. Conclusion: This study showed that HIV-1 may continue to evolve in presence of both broadly neutralizing antibodies and increasing autologous neutralizing activity more than 10 years post-infection.	[Chaillon, Antoine; Braibant, Martine; Bencharif, Samia; Moreau, Alain; Barin, Francis] Univ Tours, Inserm UMR 966, Tours, France; [Chaillon, Antoine; Barin, Francis] CHU Bretonneau, Virol Lab, F-37044 Tours, France; [Hue, Stephane] UCL, Ctr Med Mol Virol, London, England; [Enard, David] Ecole Normale Super, Lab Ecol & Evolut CNRS UMR 7625, F-75231 Paris, France; [Samri, Assia] Univ Paris 06, Hop La Pitie Salpetriere, IFR 113, Inserm UMRS 945, Paris, France; [Agut, Henri] Univ Paris 06, DETIV ER1, Hop La Pitie Salpetriere, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Chaillon, A (corresponding author), Univ Tours, Inserm UMR 966, Tours, France.	francis.barin@univ-tours.fr	Chaillon, Antoine/GNH-6121-2022; chaillon, antoine/GNH-1623-2022	Enard, David/0000-0003-2634-8016; Hue, Stephane/0000-0002-8580-6905	Agence Nationale de Recherche sur le SIDA et les hepatites (ANRS, Paris, France)	Agence Nationale de Recherche sur le SIDA et les hepatites (ANRS, Paris, France)(ANRS)	This work was supported by the Agence Nationale de Recherche sur le SIDA et les hepatites (ANRS, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barin F, 2004, J INFECT DIS, V189, P322, DOI 10.1086/380099; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Braibant M, 2008, JAIDS-J ACQ IMM DEF, V47, P274, DOI 10.1097/QAI.0b013e318162cac2; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Braibant M, 2010, VIROLOGY, V405, P81, DOI 10.1016/j.virol.2010.05.026; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Bunnik EM, 2009, VIROLOGY, V390, P348, DOI 10.1016/j.virol.2009.05.028; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Chaillon A, 2011, J VIROL, V85, P3642, DOI 10.1128/JVI.02424-10; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edo-Matas D, 2010, VIROLOGY, V405, P492, DOI 10.1016/j.virol.2010.06.029; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Joos B, 2007, J INFECT DIS, V196, P313, DOI 10.1086/518935; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kirchherr JL, 2011, VIROLOGY, V409, P163, DOI 10.1016/j.virol.2010.09.031; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; van Gils MJ, 2011, J VIROL, V85, P8443, DOI 10.1128/JVI.05214-11; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Varela M, J VIROL; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu X, 2010, SCIENCE; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	83	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44163	10.1371/journal.pone.0044163	http://dx.doi.org/10.1371/journal.pone.0044163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957000	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000308206500050
J	Hill, V; Zozio, T; Sadikalay, S; Viegas, S; Streit, E; Kallenius, G; Rastogi, N				Hill, Veronique; Zozio, Thierry; Sadikalay, Syndia; Viegas, Sofia; Streit, Elisabeth; Kallenius, Gunilla; Rastogi, Nalin			MLVA Based Classification of Mycobacterium tuberculosis Complex Lineages for a Robust Phylogeographic Snapshot of Its Worldwide Molecular Diversity	PLOS ONE			English	Article							DIRECT REPEAT LOCUS; HUMAN GENETIC HISTORY; Y-CHROMOSOME; SPACER OLIGONUCLEOTIDES; EVOLUTIONARY SCENARIO; IS6110 TRANSPOSITION; GLOBAL DISSEMINATION; EPIDEMIOLOGY; POLYMORPHISM; IDENTIFICATION	Multiple-locus variable-number tandem repeat analysis (MLVA) is useful to establish transmission routes and sources of infections for various microorganisms including Mycobacterium tuberculosis complex (MTC). The recently released SITVITWEB database contains 12-loci Mycobacterial Interspersed Repetitive Units - Variable Number of Tandem DNA Repeats (MIRU-VNTR) profiles and spoligotype patterns for thousands of MTC strains; it uses MIRU International Types (MIT) and Spoligotype International Types (SIT) to designate clustered patterns worldwide. Considering existing doubts on the ability of spoligotyping alone to reveal exact phylogenetic relationships between MTC strains, we developed a MLVA based classification for MTC genotypic lineages. We studied 6 different subsets of MTC isolates encompassing 7793 strains worldwide. Minimum spanning trees (MST) were constructed to identify major lineages, and the most common representative located as a central node was taken as the prototype defining different phylogenetic groups. A total of 7 major lineages with their respective prototypes were identified: Indo-Oceanic/MIT57, East Asian and African Indian/MIT17, Euro American/MIT116, West African-I/MIT934, West African-II/MIT664, M. bovis/MIT49, M. canettii/MIT60. Further MST subdivision identified an additional 34 sublineage MIT prototypes. The phylogenetic relationships among the 37 newly defined MIRU-VNTR lineages were inferred using a classification algorithm based on a bayesian approach. This information was used to construct an updated phylogenetic and phylogeographic snapshot of worldwide MTC diversity studied both at the regional, sub-regional, and country level according to the United Nations specifications. We also looked for IS6110 insertional events that are known to modify the results of the spoligotyping in specific circumstances, and showed that a fair portion of convergence leading to the currently observed bias in phylogenetic classification of strains may be traced back to the presence of IS6110. These results shed new light on the evolutionary history of the pathogen in relation to the history of peopling and human migration.	[Hill, Veronique; Zozio, Thierry; Sadikalay, Syndia; Streit, Elisabeth; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranatl TB Reference Lab, Abymes, France; [Viegas, Sofia] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital	Hill, V (corresponding author), Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranatl TB Reference Lab, Abymes, France.	nrastogi@pasteur-guadeloupe.fr	Källenius, Gunilla/AGZ-3956-2022; RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Kallenius, Gunilla/0000-0002-8921-0551	European Social Funds through the Regional Council of Guadeloupe; International Network of the Pasteur Institutes	European Social Funds through the Regional Council of Guadeloupe; International Network of the Pasteur Institutes	Veronique Hill was awarded a Ph.D. fellowship by the European Social Funds through the Regional Council of Guadeloupe. The project was partially financed by the International Network of the Pasteur Institutes. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Alexander DC, 2003, ANTIMICROB AGENTS CH, V47, P3208, DOI 10.1128/AAC.47.10.3208-3213.2003; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Asgharzadeh M, 2011, INFECT GENET EVOL, V11, P124, DOI 10.1016/j.meegid.2010.09.013; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2004, J CLIN MICROBIOL, V42, P5053, DOI 10.1128/JCM.42.11.5053-5057.2004; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caimi K, 2001, J CLIN MICROBIOL, V39, P1067, DOI 10.1128/JCM.39.3.1067-1072.2001; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fang Z, 1998, J BACTERIOL, V180, P2102, DOI 10.1128/JB.180.8.2102-2109.1998; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Filliol I, 2000, J CLIN MICROBIOL, V38, P1231, DOI 10.1128/JCM.38.3.1231-1234.2000; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Lari N, 2001, J MED MICROBIOL, V50, P805, DOI 10.1099/0022-1317-50-9-805; Legrand E, 2001, J CLIN MICROBIOL, V39, P1595, DOI 10.1128/JCM.39.4.1595-1599.2001; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Rao KR, 2005, J CLIN MICROBIOL, V43, P5978, DOI 10.1128/JCM.43.12.5978-5982.2005; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Renfrew C, 2010, CURR BIOL, V20, pR162, DOI 10.1016/j.cub.2009.11.056; ROBERTS DE, 1991, GENETICS, V128, P37; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sampson SL, 2003, J BACTERIOL, V185, P2856, DOI 10.1128/JB.185.9.2856-2866.2003; Schurch AC, 2011, J CLIN MICROBIOL, V49, P1318, DOI 10.1128/JCM.01848-10; Sola Christophe, 2005, Infection Genetics and Evolution, V5, P145, DOI 10.1016/j.meegid.2004.08.003; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van der Zanden AGM, 2002, J CLIN MICROBIOL, V40, P4628, DOI 10.1128/JCM.40.12.4628-4639.2002; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Viegas SO, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-195	48	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e41991	10.1371/journal.pone.0041991	http://dx.doi.org/10.1371/journal.pone.0041991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984400	Green Submitted, Green Published, gold			2022-12-27	WOS:000308638700003
J	Bauer, L; Langer, R; Becker, K; Hapfelmeier, A; Ott, K; Novotny, A; Hofler, H; Keller, G				Bauer, Lukas; Langer, Rupert; Becker, Karen; Hapfelmeier, Alexander; Ott, Katja; Novotny, Alexander; Hoefler, Heinz; Keller, Gisela			Expression Profiling of Stem Cell-Related Genes in Neoadjuvant-Treated Gastric Cancer: A NOTCH2, GSK3B and beta-catenin Gene Signature Predicts Survival	PLOS ONE			English	Article							BREAST-CANCER; SELF-RENEWAL; MARKERS; CHEMOTHERAPY; CARCINOMAS; REGRESSION; PATTERNS; TUMOR; PHOSPHORYLATION; CARCINOGENESIS	Cancer stem cell (CSC) based gene expression signatures are associated with prognosis in various tumour types and CSCs are suggested to be particularly drug resistant. The aim of our study was first, to determine the prognostic significance of CSC-related gene expression in residual tumour cells of neoadjuvant-treated gastric cancer (GC) patients. Second, we wished to examine, whether expression alterations between pre- and post-therapeutic tumour samples exist, consistent with an enrichment of drug resistant tumour cells. The expression of 44 genes was analysed in 63 formalin-fixed, paraffin embedded tumour specimens with partial tumour regression (10-50% residual tumour) after neoadjuvant chemotherapy by quantitative real time PCR low-density arrays. A signature of combined GSK3B(high), beta-catenin (CTNNB1)(high) and NOTCH2(low) expression was strongly correlated with better patient survival (p < 0.001). A prognostic relevance of these genes was also found analysing publically available gene expression data. The expression of 9 genes was compared between pretherapeutic biopsies and post-therapeutic resected specimens. A significant post-therapeutic increase in NOTCH2, LGR5 and POU5F1 expression was found in tumours with different tumour regression grades. No significant alterations were observed for GSK3B and CTNNB1. Immunohistochemical analysis demonstrated a chemotherapy-associated increase in the intensity of NOTCH2 staining, but not in the percentage of NOTCH2. Taken together, the GSK3B, CTNNB1 and NOTCH2 expression signature is a novel, promising prognostic parameter for GC. The results of the differential expression analysis indicate a prominent role for NOTCH2 and chemotherapy resistance in GC, which seems to be related to an effect of the drugs on NOTCH2 expression rather than to an enrichment of NOTCH2 expressing tumour cells.	[Bauer, Lukas; Langer, Rupert; Becker, Karen; Hoefler, Heinz; Keller, Gisela] Tech Univ Munich, Inst Pathol, Munich, Germany; [Ott, Katja] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany; [Novotny, Alexander] Tech Univ Munich, Dept Surg, Munich, Germany; [Hapfelmeier, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany; [Hoefler, Heinz] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bauer, L (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	gisela.keller@lrz.tum.de	Langer, Rupert/AAU-1174-2021; Hapfelmeier, Alexander/I-9966-2019	Langer, Rupert/0000-0001-9491-3609; Hapfelmeier, Alexander/0000-0001-6765-6352	Deutsche Krebshilfe Mildred Scheel Stiftung [108524]	Deutsche Krebshilfe Mildred Scheel Stiftung(Deutsche Krebshilfe)	The study was supported by the Deutsche Krebshilfe Mildred Scheel Stiftung, grant number 108524 to GK and KB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Becker K, 2011, ANN SURG, V253, P934, DOI 10.1097/SLA.0b013e318216f449; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Espinosa I, 2011, MODERN PATHOL, V24, P846, DOI 10.1038/modpathol.2011.12; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Grabsch H, 2001, HISTOPATHOLOGY, V39, P141, DOI 10.1046/j.1365-2559.2001.01177.x; Groth C, 2012, SEMIN CELL DEV BIOL; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Li Da-Wei, 2007, Ai Zheng, V26, P1183; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lordick Florian, 2005, Gastric Cancer, V8, P78, DOI 10.1007/s10120-005-0321-z; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Nabais S, 2003, INT J SURG PATHOL, V11, P1, DOI 10.1177/106689690301100102; Napieralski R, 2005, CLIN CANCER RES, V11, P3025, DOI 10.1158/1078-0432.CCR-04-1605; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Ott Katja, 2003, Gastric Cancer, V6, P159, DOI 10.1007/s10120-003-0245-4; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rocco A, 2012, J CELL PHYSIOL, V227, P2686, DOI 10.1002/jcp.23013; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Saikawa Y, 2010, GASTRIC CANCER, V13, P11, DOI 10.1007/s10120-009-0537-4; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuhmacher CP, 2001, CANCER-AM CANCER SOC, V91, P918, DOI 10.1002/1097-0142(20010301)91:5<918::AID-CNCR1081>3.3.CO;2-N; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Takebe N, 2010, CLIN CANCER RES, V16, P3106, DOI 10.1158/1078-0432.CCR-09-2934; Tseng YC, 2011, MOL CARCINOG; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vries RGJ, 2010, MOL ONCOL, V4, P373, DOI 10.1016/j.molonc.2010.05.001; Wakamatsu Y, 2012, PATHOL INT, V62, P112, DOI 10.1111/j.1440-1827.2011.02760.x; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zhao YD, 2008, CANCER INFORM, V6, P9	51	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44566	10.1371/journal.pone.0044566	http://dx.doi.org/10.1371/journal.pone.0044566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970250	gold, Green Submitted, Green Published			2022-12-27	WOS:000308748400023
J	Gale, CR; Cooper, R; Craig, L; Elliott, J; Kuh, D; Richards, M; Starr, JM; Whalley, LJ; Deary, IJ				Gale, Catharine R.; Cooper, Rachel; Craig, Leone; Elliott, Jane; Kuh, Diana; Richards, Marcus; Starr, John M.; Whalley, Lawrence J.; Deary, Ian J.		HALCyon Study Team	Cognitive Function in Childhood and Lifetime Cognitive Change in Relation to Mental Wellbeing in Four Cohorts of Older People	PLOS ONE			English	Article							1946 BIRTH COHORT; SOCIOECONOMIC DETERMINANTS; EARLY ADULTHOOD; INTELLIGENCE; AGE; ABILITY; HEALTH; PERSONALITY; DISORDERS; HAPPINESS	Background: Poorer cognitive ability in youth is a risk factor for later mental health problems but it is largely unknown whether cognitive ability, in youth or in later life, is predictive of mental wellbeing. The purpose of this study was to investigate whether cognitive ability at age 11 years, cognitive ability in later life, or lifetime cognitive change are associated with mental wellbeing in older people. Methods: We used data on 8191 men and women aged 50 to 87 years from four cohorts in the HALCyon collaborative research programme into healthy ageing: the Aberdeen Birth Cohort 1936, the Lothian Birth Cohort 1921, the National Child Development Survey, and the MRC National Survey for Health and Development. We used linear regression to examine associations between cognitive ability at age 11, cognitive ability in later life, and lifetime change in cognitive ability and mean score on the Warwick Edinburgh Mental Wellbeing Scale and meta-analysis to obtain an overall estimate of the effect of each. Results: People whose cognitive ability at age 11 was a standard deviation above the mean scored 0.53 points higher on the mental wellbeing scale (95% confidence interval 0.36, 0.71). The equivalent value for cognitive ability in later life was 0.89 points (0.72, 1.07). A standard deviation improvement in cognitive ability in later life relative to childhood ability was associated with 0.66 points (0.39, 0.93) advantage in wellbeing score. These effect sizes equate to around 0.1 of a standard deviation in mental wellbeing score. Adjustment for potential confounding and mediating variables, primarily the personality trait neuroticism, substantially attenuated these associations. Conclusion: Associations between cognitive ability in childhood or lifetime cognitive change and mental wellbeing in older people are slight and may be confounded by personality trait differences.	[Gale, Catharine R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Gale, Catharine R.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Cooper, Rachel; Kuh, Diana; Richards, Marcus] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Whalley, Lawrence J.] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Elliott, Jane] Univ London, Inst Educ, Ctr Longitudinal Studies, London WC1N 1AZ, England; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland	University of Southampton; University of Edinburgh; University of London; University College London; University of Aberdeen; University of London; University College London; UCL Institute of Education; University of Edinburgh	Gale, CR (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.	crg@mrc.soton.ac.uk	whalley, lawrence j/E-9019-2011; Cooper, Rachel/ABE-3768-2021; Kuh, Diana/L-6019-2014; Gale, Catharine R/B-1653-2012; Deary, Ian J/C-6297-2009	Cooper, Rachel/0000-0003-3370-5720; Kuh, Diana/0000-0001-7386-2857; Deary, Ian J/0000-0002-1733-263X; Elliott, Jane/0000-0003-2683-0099; Gale, Catharine/0000-0002-3361-8638; Richards, Marcus/0000-0001-9191-2192	New Dynamics of Ageing (NDA) programme [RES-353-25-0001]; joint seven-year initiative of five UK Research Councils; NDA grant; Wellcome Trust career development award; Biotechnology and Biological Sciences Research Council; Chief Scientist Office of the Scottish Executive Health Department; Economic and Social Research Council grant for the Centre for Longitudinal Studies Resource Centre [RES-579-47-0001]; Medical Research Council; Biotechnology Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative; ESRC [ES/G00773X/1] Funding Source: UKRI; MRC [MC_UP_A620_1015, MC_U123092720, MC_U123092722, G0700704] Funding Source: UKRI; Economic and Social Research Council [ES/G00773X/1, ES/G040923/1] Funding Source: researchfish; Medical Research Council [MC_U123092722, G0700704, G0700704B, U1475000002, MC_U123092720, MC_UP_A620_1015] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish	New Dynamics of Ageing (NDA) programme; joint seven-year initiative of five UK Research Councils; NDA grant; Wellcome Trust career development award(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Chief Scientist Office of the Scottish Executive Health Department; Economic and Social Research Council grant for the Centre for Longitudinal Studies Resource Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology Sciences Research Council; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The HALCyon collaborative research programme is funded by the New Dynamics of Ageing (NDA) programme (RES-353-25-0001), a joint seven-year initiative of five UK Research Councils. RC is supported by this NDA grant. Follow-up of the Aberdeen Birth Cohort 1936 was supported by a Wellcome Trust career development award to LW. The Lothian Birth Cohort 1921 was funded by the Biotechnology and Biological Sciences Research Council and the Chief Scientist Office of the Scottish Executive Health Department. The National Child Development Study (NCDS) is funded as part of the Economic and Social Research Council grant for the Centre for Longitudinal Studies Resource Centre (RES-579-47-0001). The National Survey for Health and Development is funded by the Medical Research Council. The Centre for Cognitive Ageing and Cognitive Epidemiology is funded by the Biotechnology Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the Medical Research Council and the University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; Austin EJ, 2002, PERS INDIV DIFFER, V32, P1391, DOI 10.1016/S0191-8869(01)00129-5; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Djapo N, 2011, PERS INDIV DIFFER, V51, P63, DOI 10.1016/j.paid.2011.03.014; Douglas J. W. B., 1964, HOME SCH STUDY ABILI; Gale CR, 2010, J GERONTOL B-PSYCHOL, V65, P50, DOI 10.1093/geronb/gbp082; Gale CR, 2010, EPIDEMIOLOGY, V21, P70, DOI 10.1097/EDE.0b013e3181c17da8; Gale CR, 2009, INTELLIGENCE, V37, P592, DOI 10.1016/j.intell.2008.09.002; Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410; Goldberg LR, 2001, INT PERSONALITY ITEM; Gow AJ, 2005, BMJ-BRIT MED J, V331, P141, DOI 10.1136/bmj.38531.675660.F7; Gow AJ, 2005, PERS INDIV DIFFER, V39, P317, DOI 10.1016/j.paid.2005.01.011; Gow AJ, 2012, PSYCHOL AGING, V27, P250, DOI 10.1037/a0024144; Gow AJ, 2011, PSYCHOL AGING, V26, P232, DOI 10.1037/a0021072; Hatch SL, 2007, SOC SCI MED, V64, P2285, DOI 10.1016/j.socscimed.2007.02.027; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jokela M, 2011, ANN EPIDEMIOL, V21, P489, DOI 10.1016/j.annepidem.2011.01.008; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Kaplan GA, 2008, ANN EPIDEMIOL, V18, P531, DOI 10.1016/j.annepidem.2008.03.006; Keyes C.L.M, 2002, PROMOTING POSITIVE C, V4, P257; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Koster A, 2005, ANN EPIDEMIOL, V15, P564, DOI 10.1016/j.annepidem.2005.02.008; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Kurland BF, 2006, J AM GERIATR SOC, V54, P1846, DOI 10.1111/j.1532-5415.2006.00970.x; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Louis VV, 2002, J FAM ISSUES, V23, P986, DOI 10.1177/019251302237300; Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x; Martin LT, 2007, INT J EPIDEMIOL, V36, P769, DOI 10.1093/ije/dym063; Matthews G, 2003, PERSONALITY TRAITS, P58; Nettle D, 2003, BRIT J PSYCHOL, V94, P551, DOI 10.1348/000712603322503097; OKUN MA, 1984, INT J AGING HUM DEV, V19, P111, DOI 10.2190/QGJN-0N81-5957-HAQD; Pintner R, 1937, ASPECTS PERSONALITY; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Raven JC, 1977, MANUAL RAVENS PROGR; Rowe J.W., 1998, SUCCESSFUL AGING MAC; Salthouse TA, 2001, INTELLIGENCE, V29, P93, DOI 10.1016/S0160-2896(00)00040-4; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Stewart ME, 2005, PERS INDIV DIFFER, V38, P1085, DOI 10.1016/j.paid.2004.07.007; Subramanian SV, 2005, J EPIDEMIOL COMMUN H, V59, P664, DOI 10.1136/jech.2004.025742; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Waldstein SR, 2001, MED NEUROPSYCHOLOGY; Wechsler D, 1987, WMS R WECHSLER MEMOR; World Health Organization, 2004, PROM MENT HLTH CONC; ZAUTRA A, 1984, INT J AGING HUM DEV, V19, P95, DOI 10.2190/A9RB-7D02-G77K-M3N6	52	35	35	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44860	10.1371/journal.pone.0044860	http://dx.doi.org/10.1371/journal.pone.0044860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970320	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000308748400034
J	Villa, E; Vukotic, R; Camma, C; Petta, S; Di Leo, A; Gitto, S; Turola, E; Karampatou, A; Losi, L; Bernabucci, V; Cenci, A; Tagliavini, S; Baraldi, E; De Maria, N; Gelmini, R; Bertolini, E; Rendina, M; Francavilla, A				Villa, Erica; Vukotic, Ranka; Camma, Calogero; Petta, Salvatore; Di Leo, Alfredo; Gitto, Stefano; Turola, Elena; Karampatou, Aimilia; Losi, Luisa; Bernabucci, Veronica; Cenci, Annamaria; Tagliavini, Simonetta; Baraldi, Enrica; De Maria, Nicola; Gelmini, Roberta; Bertolini, Elena; Rendina, Maria; Francavilla, Antonio		Research Network Women Hepatology	Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C	PLOS ONE			English	Article							LIVER FIBROSIS; STELLATE CELLS; PROGRESSION; ESTRADIOL; TESTOSTERONE; ACTIVATION; THERAPY; BENEFIT	Introduction: Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis depends on the increase of fibrosis, whose progression is twice as rapid in men as in women. Aim of the study was to evaluate the effects of reproductive stage on fibrosis severity in women and to compare these findings with age-matched men. Materials and Methods: A retrospective study of 710 consecutive patients with biopsy-proven chronic hepatitis C was conducted, using data from a clinical database of two tertiary Italian care centers. Four age-matched groups of men served as controls. Data about demographics, biochemistry, liver biopsy and ultrasonography were analyzed. Contributing factors were assessed by multivariate logistic regression analysis. Results: Liver fibrosis was more advanced in the early menopausal than in the fully reproductive (P<0.0001) or premenopausal (P = 0.042) group. Late menopausal women had higher liver fibrosis compared with the other groups (fully reproductive, P<0.0001; premenopausal, P = <0.0001; early menopausal, P = 0.052). Multivariate analyses showed that male sex was independently associated with more severe fibrosis in the groups corresponding to premenopausal (P = 0.048) and early menopausal (P = 0.004) but not late menopausal pairs. In women, estradiol/testosterone ratio decreased markedly in early (vs. reproductive age: P = 0.002 and vs. premenopausal: P<0.0001) and late menopause (vs. reproductive age: P = 0.001; vs. premenopausal: P<0.0001). In men age-matched with menopausal women, estradiol/testosterone ratio instead increased (reproductive age group vs. early: P = 0.002 and vs. late M: P = 0.001). Conclusions: The severity of fibrosis in women worsens in parallel with increasing estrogen deprivation and estradiol/testosterone ratio decrease. Our data provide evidence why fibrosis progression is discontinuous in women and more linear and severe in men, in whom aging-associated estradiol/testosterone ratio increase occurs too late to noticeably influence the inflammatory process leading to fibrosis.	[Villa, Erica; Vukotic, Ranka; Gitto, Stefano; Turola, Elena; Karampatou, Aimilia; Bernabucci, Veronica; De Maria, Nicola; Bertolini, Elena] Azienda Osped Univ, Dept Gastroenterol, Modena, Italy; [Villa, Erica; Vukotic, Ranka; Gitto, Stefano; Turola, Elena; Karampatou, Aimilia; Bernabucci, Veronica; De Maria, Nicola; Bertolini, Elena] Univ Modena & Reggio Emilia, Modena, Italy; [Camma, Calogero; Petta, Salvatore] Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy; [Di Leo, Alfredo; Rendina, Maria] Univ Bari, Dept Gastroenterol, I-70124 Bari, Italy; [Losi, Luisa] Azienda Osped Univ, Dept Pathol, Modena, Italy; [Cenci, Annamaria; Tagliavini, Simonetta; Baraldi, Enrica] NOCSAE, Dept Clin Pathol, Modena, Italy; [Gelmini, Roberta] Azienda Osped Univ, Dept Gen Surg, Modena, Italy; [Francavilla, Antonio] Ist Ricovero & Cura Saverio de Bellis, Castellana Grotte, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; University of Palermo; Universita degli Studi di Bari Aldo Moro; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Saverio de Bellis	Villa, E (corresponding author), Azienda Osped Univ, Dept Gastroenterol, Modena, Italy.	erica.villa@unimore.it	Gelmini, Roberta/J-8234-2016; Gelmini, Roberta/F-7184-2017; Gitto, Stefano/J-9922-2018; Villa, Erica/A-7576-2012; GELMINI, Roberta/N-6881-2019	Gelmini, Roberta/0000-0002-8471-710X; Gelmini, Roberta/0000-0002-8471-710X; Gitto, Stefano/0000-0002-8042-6508; Villa, Erica/0000-0001-6388-7022; GELMINI, Roberta/0000-0002-8471-710X; Di Leo, Alfredo/0000-0003-2026-1200; Petta, Salvatore/0000-0002-0822-9673; CAMMA', CALOGERO/0000-0002-9224-1914; Elena, Turola/0000-0002-1810-8648	Merck & Co (Whitehouse Station, NJ, USA)	Merck & Co (Whitehouse Station, NJ, USA)(Merck & Company)	The study was supported by an unrestricted grant by Merck & Co (Whitehouse Station, NJ, USA). The funding source had no role in the design of the study; collection, analysis, and interpretation of the data; drafting of the manuscript or decision to submit the manuscript for publication.; The study was supported by an unrestricted grant by Merck & Co (Whitehouse Station, NJ, USA). The funding source had no role in the design of the study; collection, analysis, and interpretation of the data; drafting of the manuscript or decision to submit the manuscript for publication. Corresponding Author is serving as Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Conte D, 2000, HEPATOLOGY, V31, P751, DOI 10.1002/hep.510310328; Deuffic-Burban S, 2002, J VIRAL HEPATITIS, V9, P114, DOI 10.1046/j.1365-2893.2002.00340.x; Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Hoefs JC, 2011, GASTROENTEROLOGY, V141, P900, DOI 10.1053/j.gastro.2011.06.007; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2; La Marca A, 2009, HUM REPROD, V24, P2264, DOI 10.1093/humrep/dep210; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; Miyaaki H, 2011, INTERNAL MED, V50, P1137, DOI 10.2169/internalmedicine.50.4447; Petta S, 2010, HEPATOLOGY, V52, P1543, DOI 10.1002/hep.23859; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Riggs RM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.004; Rogers A, 2001, BONE, V29, P30, DOI 10.1016/S8756-3282(01)00468-9; SAS Technical Report SAS/STAS software, 1992, SAS TECHN REP SAS ST, V7; Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; Shimizu I, 2001, INTERNAL MED, V40, P100, DOI 10.2169/internalmedicine.40.100; Sweeting MJ, 2006, J CLIN EPIDEMIOL, V59, P144, DOI 10.1016/j.jclinepi.2005.06.008; van Disseldorp J, 2008, J CLIN ENDOCR METAB, V93, P2129, DOI 10.1210/jc.2007-2093; Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027; White DL, 2012, HEPATOLOGY, V55, P759, DOI 10.1002/hep.24618; Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307; Yen T, 2003, J CLIN GASTROENTEROL, V36, P47, DOI 10.1097/00004836-200301000-00015	29	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44624	10.1371/journal.pone.0044624	http://dx.doi.org/10.1371/journal.pone.0044624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970270	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400026
J	Shen, XP; He, Z; Li, HD; Yao, C; Zhang, Y; He, L; Li, S; Huang, J; Guo, Z				Shen, Xiaopei; He, Zheng; Li, Hongdong; Yao, Chen; Zhang, Yang; He, Lang; Li, Shan; Huang, Jian; Guo, Zheng			Distinct Functional Patterns of Gene Promoter Hypomethylation and Hypermethylation in Cancer Genomes	PLOS ONE			English	Article							FALSE DISCOVERY RATE; DNA METHYLATION; EPIGENETIC REGULATION; EXPRESSION; DISEASE; DEMETHYLATION; INFLAMMATION; MECHANISMS; RECEPTORS; REVEALS	Background: Aberrant DNA methylation plays important roles in carcinogenesis. However, the functional significance of genome-wide hypermethylation and hypomethylation of gene promoters in carcinogenesis currently remain unclear. Principal Findings: Based on genome-wide methylation data for five cancer types, we showed that genes with promoter hypermethylation were highly consistent in function across different cancer types, and so were genes with promoter hypomethylation. Functions related to "developmental processes" and "regulation of biology processes" were significantly enriched with hypermethylated genes but were depleted of hypomethylated genes. In contrast, functions related to "cell killing" and "response to stimulus", including immune and inflammatory response, were associated with an enrichment of hypomethylated genes and depletion of hypermethylated genes. We also observed that some families of cytokines secreted by immune cells, such as IL10 family cytokines and chemokines, tended to be hypomethylated in various cancer types. These results provide new hints for understanding the distinct functional roles of genome-wide hypermethylation and hypomethylation of gene promoters in carcinogenesis. Conclusions: Genes with promoter hypermethylation and hypomethylation are highly consistent in function across different cancer types, respectively, but these two groups of genes tend to be enriched in different functions associated with cancer. Especially, we speculate that hypomethylation of gene promoters may play roles in inducing immunity and inflammation disorders in precancerous conditions, which may provide hints for improving epigenetic therapy and immunotherapy of cancer.	[Shen, Xiaopei; He, Zheng; Li, Hongdong; Yao, Chen; Zhang, Yang; He, Lang; Li, Shan; Huang, Jian; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; Harbin Medical University	Shen, XP (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Shen, Xiaopei/B-2773-2017; Zhang, Yang/CAG-6008-2022; Huang, Jian/G-8437-2011; Zhang, Yang/ACU-6405-2022	Shen, Xiaopei/0000-0002-0004-4228; Zhang, Yang/0000-0002-1317-120X; Huang, Jian/0000-0003-3282-8892; 	National Natural Science Foundation of China [30970668, 31100901, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (30970668, 31100901, 81071646 and 91029717), Excellent Youth Foundation of Heilongjiang Province (JC200808): http://www.nsfc.gov.cn/and http://jj.hljkj.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Cash HL, 2011, INT J CANC; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cooke J, 2012, INFLAMM BOWEL DIS; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; J Wang, 2011, BRIEF BIOINFORM; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim EH, 2010, ONCOGENE, V29, P4725, DOI 10.1038/onc.2010.223; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Qiu WL, 2012, AM J RESP CRIT CARE, V185, P373, DOI 10.1164/rccm.201108-1382OC; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Son KS, 2010, BREAST, V19, P484, DOI 10.1016/j.breast.2010.05.011; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Wang ZQ, 2006, INT J CANCER, V118, P1436, DOI 10.1002/ijc.21499; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029686; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; [邹金凤 Zou Jinfeng], 2012, [生物物理学报, Acta Biophysica Sinica], V28, P232	50	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44822	10.1371/journal.pone.0044822	http://dx.doi.org/10.1371/journal.pone.0044822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970311	Green Submitted, Green Published, gold			2022-12-27	WOS:000308462000049
J	Maira-Litran, T; Bentancor, LV; Bozkurt-Guzel, C; O'Malley, JM; Cywes-Bentley, C; Pier, GB				Maira-Litran, Tomas; Bentancor, Leticia V.; Bozkurt-Guzel, Cagla; O'Malley, Jennifer M.; Cywes-Bentley, Colette; Pier, Gerald B.			Synthesis and Evaluation of a Conjugate Vaccine Composed of Staphylococcus aureus Poly-N-Acetyl-Glucosamine and Clumping Factor A	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; PROTECTIVE EFFICACY; FACTOR-A; ANTIBODIES; FIBRINOGEN; VIRULENCE; QUANTITATION	The increasing frequency, severity and antimicrobial resistance of Staphylococcus aureus infections has made the development of immunotherapies against this pathogen more urgent than ever. Previous immunization attempts using monovalent antigens resulted in at best partial levels of protection against S. aureus infection. We therefore reasoned that synthesizing a bivalent conjugate vaccine composed of two widely expressed antigens of S. aureus would result in additive/synergetic activities by antibodies to each vaccine component and/or in increased strain coverage. For this we used reductive amination, to covalently link the S. aureus antigens clumping factor A (ClfA) and deacetylated poly-N-beta-(1-6)-acetyl-glucosamine (dPNAG). Mice immunized with 1, 5 or 10 mu g of the dPNAG-ClfA conjugate responded in a dose-dependent manner with IgG to dPNAG and ClfA, whereas mice immunized with a mixture of ClfA and dPNAG developed significantly lower antibody titers to ClfA and no antibodies to PNAG. The dPNAG-ClfA vaccine was also highly immunogenic in rabbits, rhesus monkeys and a goat. Moreover, affinity-purified, antibodies to ClfA from dPNAG-ClfA immune serum blocked the binding of three S. aureus strains to immobilized fibrinogen. In an opsonophagocytic assay (OPKA) goat antibodies to dPNAG-ClfA vaccine, in the presence of complement and polymorphonuclear cells, killed S. aureus Newman and, to a lower extent, S. aureus Newman Delta clfA. A PNAG-negative isogenic mutant was not killed. Moreover, PNAG antigen fully inhibited the killing of S. aureus Newman by antisera to dPNAG-ClfA vaccine. Finally, mice passively vaccinated with goat antisera to dPNAG-ClfA or dPNAG-diphtheria toxoid conjugate had comparable levels of reductions of bacteria in the blood 2 h after infection with three different S. aureus strains as compared to mice given normal goat serum. In conclusion, ClfA is an immunogenic carrier protein that elicited anti-adhesive antibodies that fail to augment the OPK and protective activities of antibodies to the PNAG cell surface polysaccharide.	[Maira-Litran, Tomas; Bentancor, Leticia V.; Bozkurt-Guzel, Cagla; O'Malley, Jennifer M.; Cywes-Bentley, Colette; Pier, Gerald B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Maira-Litran, T (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA.	tmaira@rics.bwh.harvard.edu	Pier, Gerald/AAO-2692-2021; guzel, cagla bozkurt/AAD-6086-2020	Pier, Gerald/0000-0002-9112-2331; Cywes Bentley, Colette/0000-0002-6301-0930	National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI46706, AI057159, U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046706, U54AI057159, R21AI046706] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases numbers AI46706 (GBP) and AI057159, a component of Award Number U54 AI057159. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Domanski PJ, 2005, INFECT IMMUN, V73, P5229, DOI 10.1128/IAI.73.8.5229-5232.2005; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Lee JC, 1997, INFECT IMMUN, V65, P4146, DOI 10.1128/IAI.65.10.4146-4151.1997; Lowy F, 2005, HARRISONS PRINCIPLES; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Risley AL, 2007, J INFECT DIS, V196, P919, DOI 10.1086/520932; SMITH RL, 1979, ANAL BIOCHEM, V98, P478, DOI 10.1016/0003-2697(79)90170-2; Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200	24	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43813	10.1371/journal.pone.0043813	http://dx.doi.org/10.1371/journal.pone.0043813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970144	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400021
J	Platania, CBM; Salomone, S; Leggio, GM; Drago, F; Bucolo, C				Platania, Chiara Bianca Maria; Salomone, Salvatore; Leggio, Gian Marco; Drago, Filippo; Bucolo, Claudio			Homology Modeling of Dopamine D-2 and D-3 Receptors: Molecular Dynamics Refinement and Docking Evaluation	PLOS ONE			English	Article							LOWERS INTRAOCULAR-PRESSURE; PROTEIN-COUPLED RECEPTORS; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; D3 RECEPTOR; IONIC LOCK; BINDING; AGONIST; LIGAND; SITES	Dopamine (DA) receptors, a class of G-protein coupled receptors (GPCRs), have been targeted for drug development for the treatment of neurological, psychiatric and ocular disorders. The lack of structural information about GPCRs and their ligand complexes has prompted the development of homology models of these proteins aimed at structure-based drug design. Crystal structure of human dopamine D-3 (hD(3)) receptor has been recently solved. Based on the hD(3) receptor crystal structure we generated dopamine D-2 and D-3 receptor models and refined them with molecular dynamics (MD) protocol. Refined structures, obtained from the MD simulations in membrane environment, were subsequently used in molecular docking studies in order to investigate potential sites of interaction. The structure of hD(3) and hD(2L) receptors was differentiated by means of MD simulations and D-3 selective ligands were discriminated, in terms of binding energy, by docking calculation. Robust correlation of computed and experimental K-i was obtained for hD(3) and hD(2L) receptor ligands. In conclusion, the present computational approach seems suitable to build and refine structure models of homologous dopamine receptors that may be of value for structure-based drug discovery of selective dopaminergic ligands.	[Platania, Chiara Bianca Maria; Salomone, Salvatore; Leggio, Gian Marco; Drago, Filippo; Bucolo, Claudio] Catania Univ, Sect Pharmacol & Biochem, Dept Clin & Mol Biomed, Catania, Italy	University of Catania	Platania, CBM (corresponding author), Catania Univ, Sect Pharmacol & Biochem, Dept Clin & Mol Biomed, Catania, Italy.	claudio.bucolo@unict.it	Drago, Francesco/H-7563-2019; Leggio, Gian Marco/AHE-1151-2022; Drago, Filippo/AAC-5090-2022; Platania, Chiara BM/AHE-1140-2022; Drago, Filippo/K-5619-2018	Leggio, Gian Marco/0000-0002-7280-4871; Platania, Chiara Bianca Maria/0000-0002-8630-5993; Bucolo, Claudio/0000-0002-4879-4140; Salomone, Salvatore/0000-0001-5307-6103; Leggio, Gian Marco/0000-0003-4440-3373; Drago, Filippo/0000-0003-2887-5223	International Ph.D. Program in Neuropharmacology, University of Catania, Italy;  [PON01-00110]	International Ph.D. Program in Neuropharmacology, University of Catania, Italy; 	This work was supported in part by a National grant PON01-00110. Dr. Chiara B. M. Platania was supported by the International Ph.D. Program in Neuropharmacology, University of Catania, Italy. The authors wish to thank the "Consorzio Cometa'' [http://www.consorzio-cometa.it/] for the computational hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bettinetti L, 2002, J MED CHEM, V45, P4594, DOI 10.1021/jm025558r; Bucolo C, 2011, BIOCHEM PHARMACOL, V83, P680; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chen PC, 2009, J NEUROCHEM, V110, P1180, DOI 10.1111/j.1471-4159.2009.06209.x; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chu E, 2000, J PHARMACOL EXP THER, V293, P710; CHUMPRADIT S, 1993, J MED CHEM, V36, P4308, DOI 10.1021/jm00078a021; CHUMPRADIT S, 1994, J MED CHEM, V37, P4245, DOI 10.1021/jm00050a021; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diaz J, 2000, J NEUROSCI, V20, P8677; GEYER O, 1987, J OCUL PHARMACOL, V3, P291, DOI 10.1089/jop.1987.3.291; Ghosh B, 2010, J MED CHEM, V53, P1023, DOI 10.1021/jm901184n; GLASE SA, 1995, J MED CHEM, V38, P3132, DOI 10.1021/jm00016a016; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kortagere S, 2011, BIOCHEM PHARMACOL, V81, P157, DOI 10.1016/j.bcp.2010.08.026; Kuzhikandathil EV, 2012, PHARM RES; LANDWEHRMEYER B, 1993, MOL BRAIN RES, V18, P187, DOI 10.1016/0169-328X(93)90188-U; Lape M, 2010, BIOPHYS CHEM, V150, P88, DOI 10.1016/j.bpc.2010.01.011; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Levant B, 1997, PHARMACOL REV, V49, P231; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Lopez L, 2010, CHEMMEDCHEM, V5, P1300, DOI 10.1002/cmdc.201000101; MALMBERG A, 1994, MOL PHARMACOL, V46, P299; MARTIN PL, 1993, J PHARMACOL EXP THER, V267, P1342; MEKKI QA, 1983, LANCET, V1, P1250; MIERAU J, 1995, EUR J PHARM-MOLEC PH, V290, P29, DOI 10.1016/0922-4106(95)90013-6; Millan MJ, 2000, SYNAPSE, V35, P79, DOI 10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Obiol-Pardo C, 2011, PROTEINS, V79, P1695, DOI 10.1002/prot.23021; OGIDIGBEN M, 1993, J PHARMACOL EXP THER, V267, P822; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ortega R, 2011, BIOORG MED CHEM LETT, V21, P2670, DOI 10.1016/j.bmcl.2010.12.083; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POTTER DE, 1987, J OCUL PHARMACOL, V3, P309, DOI 10.1089/jop.1987.3.309; Potter DE, 1998, PHARMACOLOGY, V57, P249, DOI 10.1159/000028249; Reynolds NA, 2005, CNS DRUGS, V19, P973, DOI 10.2165/00023210-200519110-00006; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scheideler MA, 1997, EUR J PHARMACOL, V339, P261, DOI 10.1016/S0014-2999(97)01372-1; Scheller D, 2009, N-S ARCH PHARMACOL, V379, P73, DOI 10.1007/s00210-008-0341-4; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Tadori Y, 2011, EUR J PHARMACOL, V666, P43, DOI 10.1016/j.ejphar.2011.05.050; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tschammer N, 2011, J MED CHEM, V54, P2477, DOI 10.1021/jm101639t; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Yap BK, 2012, J MOL MODELING; Yap BK, 2012, J MOL MODEL; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563	65	59	61	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44316	10.1371/journal.pone.0044316	http://dx.doi.org/10.1371/journal.pone.0044316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970199	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400058
J	Smith, KF; Schmidt, V; Rosen, GE; Amaral-Zettler, L				Smith, Katherine F.; Schmidt, Victor; Rosen, Gail E.; Amaral-Zettler, Linda			Microbial Diversity and Potential Pathogens in Ornamental Fish Aquarium Water	PLOS ONE			English	Article							VIBRIO-CHOLERAE; PLESIOMONAS-SHIGELLOIDES; FRESH-WATER; LEGIONELLA-PNEUMOPHILA; LEGIONNAIRES-DISEASE; HIGH-THROUGHPUT; RARE BIOSPHERE; UNITED-STATES; VULNIFICUS; INFECTION	Ornamental fishes are among the most popular and fastest growing categories of pets in the United States (U. S.). The global scope and scale of the ornamental fish trade and growing popularity of pet fish in the U. S. are strong indicators of the myriad economic and social benefits the pet industry provides. Relatively little is known about the microbial communities associated with these ornamental fishes or the aquarium water in which they are transported and housed. Using conventional molecular approaches and next generation high-throughput amplicon sequencing of 16S ribosomal RNA gene hypervariable regions, we characterized the bacterial community of aquarium water containing common goldfish (Carassius auratus) and Chinese algae eaters (Gyrinocheilus aymonieri) purchased from seven pet/aquarium shops in Rhode Island and identified the presence of potential pathogens. Our survey identified a total of 30 phyla, the most common being Proteobacteria (52%), Bacteroidetes (18%) and Planctomycetes (6%), with the top four phyla representing >80% of all sequences. Sequences from our water samples were most closely related to eleven bacterial species that have the potential to cause disease in fishes, humans and other species: Coxiella burnetii, Flavobacterium columnare, Legionella birminghamensis, L. pneumophila, Vibrio cholerae, V. mimicus. V. vulnificus, Aeromonas schubertii, A. veronii, A. hydrophila and Plesiomonas shigelloides. Our results, combined with evidence from the literature, suggest aquarium tank water harboring ornamental fish are an understudied source for novel microbial communities and pathogens that pose potential risks to the pet industry, fishes in trade, humans and other species.	[Smith, Katherine F.; Schmidt, Victor; Rosen, Gail E.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Schmidt, Victor; Amaral-Zettler, Linda] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Rosen, Gail E.] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA; [Amaral-Zettler, Linda] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University; Marine Biological Laboratory - Woods Hole; Columbia University; Brown University	Smith, KF (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	amaral@mbl.edu			Brown University Office of the Vice President of Research SEED grant	Brown University Office of the Vice President of Research SEED grant	A Brown University Office of the Vice President of Research SEED grant to KFS and LAZ entitled "Tracking disease spread through the wildlife trade: New techniques to identify infectious microbes in aquarium fishes" funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler Linda, 2010, P223; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Blokesch M, 2007, PLOS PATHOG, V3, P733, DOI 10.1371/journal.ppat.0030081; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Broza M, 2005, ENVIRON MICROBIOL, V7, P576, DOI 10.1111/j.1462-2920.2005.00745.x; Bunge J, 2011, BIOCOMPUT-PAC SYM, P121; Campos E, 1996, APPL ENVIRON MICROB, V62, P1141, DOI 10.1128/AEM.62.4.1141-1144.1996; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casati S, 2010, CLIN MICROBIOL INFEC, V16, P945, DOI 10.1111/j.1469-0691.2009.03009.x; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Crump BC, 2012, ISME J, V6, P1629, DOI 10.1038/ismej.2012.9; de Magny GC, 2011, APPL ENVIRON MICROB, V77, P6125, DOI 10.1128/AEM.01472-10; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Drummond A., 2011, GENEIOUS V5 5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Filler G, 2000, J CLIN MICROBIOL, V38, P469; Gobin I, 2009, REV MED MICROBIOL, V20, P1, DOI 10.1097/MRM.0b013e32832e82da; Gonzalez-Rey C, 2000, FEMS IMMUNOL MED MIC, V29, P107, DOI 10.1016/S0928-8244(00)00194-2; Greig JE, 2004, MED J AUSTRALIA, V180, P566, DOI 10.5694/j.1326-5377.2004.tb06093.x; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Howden BP, 2003, INTERN MED J, V33, P484, DOI 10.1046/j.1445-5994.2003.00422.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Iijima S, 2009, MICROB BIOTECHNOL, V2, P361, DOI 10.1111/j.1751-7915.2009.00097.x; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jermyn WS, 2005, MICROBIOL-SGM, V151, P311, DOI 10.1099/mic.0.27621-0; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; KAM KM, 1995, PUBLIC HEALTH, V109, P389, DOI 10.1016/S0033-3506(95)80012-3; KAYSNER CA, 1987, APPL ENVIRON MICROB, V53, P1344, DOI 10.1128/AEM.53.6.1344-1348.1987; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kunttu H, 2010, THESIS U JYVASKYLA; Levin RE, 2008, FOOD BIOTECHNOL, V22, P189, DOI 10.1080/08905430802043339; Lim LC, 2003, AQUAC RES, V34, P923, DOI 10.1046/j.1365-2109.2003.00946.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macri D, 2008, VET RES COMMUN, V32, pS215, DOI 10.1007/s11259-008-9157-4; Marco-Noales E, 2001, APPL ENVIRON MICROB, V67, P4717, DOI 10.1128/AEM.67.10.4717-4725.2001; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Olivares-Fuster O, 2007, SYST APPL MICROBIOL, V30, P624, DOI 10.1016/j.syapm.2007.07.003; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Pfeffer CS, 2003, APPL ENVIRON MICROB, V69, P3526, DOI 10.1128/AEM.69.6.3526-3531.2003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raja K., 2006, RES J MICROBIOL, V5, P448; REDDACLIFF GL, 1993, J FISH DIS, V16, P517, DOI 10.1111/j.1365-2761.1993.tb00887.x; Rodolakis A, 2006, SMALL RUMINANT RES, V62, P121, DOI 10.1016/j.smallrumres.2005.07.038; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Senderovich Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008607; Shotts Jr E, 1984, DISTRIBUTION BIOL MA; Sindermann C, 1991, B MAR SCI, V4, P745; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; TRUST TJ, 1974, APPL MICROBIOL, V28, P35, DOI 10.1128/AEM.28.1.35-40.1974; University of Florida IFAS Extension website, AER INF FISH 2009; University of Florida IFAS Extension website, VIBR INF FISH 2009; VANDAMME LR, 1980, APPL ENVIRON MICROB, V39, P475, DOI 10.1128/AEM.39.3.475-479.1980; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; WADSTROM T, 1991, INT J FOOD MICROBIOL, V12, P303, DOI 10.1016/0168-1605(91)90144-E; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weir M, 2012, EPIDEMIOL INFECT, V140, P192, DOI 10.1017/S0950268811001798; WILKINSON HW, 1987, J CLIN MICROBIOL, V25, P2120, DOI 10.1128/JCM.25.11.2120-2122.1987	72	33	33	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e39971	10.1371/journal.pone.0039971	http://dx.doi.org/10.1371/journal.pone.0039971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970112	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400001
J	Turan, JM; Steinfeld, RL; Onono, M; Bukusi, EA; Woods, M; Shade, SB; Washington, S; Marima, R; Penner, J; Ackers, ML; Mbori-Ngacha, D; Cohen, CR				Turan, Janet M.; Steinfeld, Rachel L.; Onono, Maricianah; Bukusi, Elizabeth A.; Woods, Meghan; Shade, Starley B.; Washington, Sierra; Marima, Reson; Penner, Jeremy; Ackers, Marta L.; Mbori-Ngacha, Dorothy; Cohen, Craig R.			The Study of HIV and Antenatal Care Integration in Pregnancy in Kenya: Design, Methods, and Baseline Results of a Cluster-Randomized Controlled Trial	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SINGLE-DOSE NEVIRAPINE; REPRODUCTIVE HEALTH; SCALING-UP; RURAL KENYA; PREVENTION; SERVICES; IMPLEMENTATION; PROGRAM	Background: Despite strong evidence for the effectiveness of anti-retroviral therapy for improving the health of women living with HIV and for the prevention of mother-to-child transmission (PMTCT), HIV persists as a major maternal and child health problem in sub-Saharan Africa. In most settings antenatal care (ANC) services and HIV treatment services are offered in separate clinics. Integrating these services may result in better uptake of services, reduction of the time to treatment initiation, better adherence, and reduction of stigma. Methodology/Principal Findings: A prospective cluster randomized controlled trial design was used to evaluate the effects of integrating HIV treatment into ANC clinics at government health facilities in rural Kenya. Twelve facilities were randomized to provide either fully integrated services (ANC, PMTCT, and HIV treatment services all delivered in the ANC clinic) or non-integrated services (ANC clinics provided ANC and basic PMTCT services and referred clients to a separate HIV clinic for HIV treatment). During June 2009-March 2011, 1,172 HIV-positive pregnant women were enrolled in the study. The main study outcomes are rates of maternal enrollment in HIV care and treatment, infant HIV testing uptake, and HIV-free infant survival. Baseline results revealed that the intervention and control cohorts were similar with respect to socio-demographics, male partner HIV testing, sero-discordance of the couple, obstetric history, baseline CD4 count, and WHO Stage. Challenges faced while conducting this trial at low-resource rural health facilities included frequent staff turnover, stock-outs of essential supplies, transportation challenges, and changes in national guidelines. Conclusions/Significance: This is the first randomized trial of ANC and HIV service integration to be conducted in rural Africa. It is expected that the study will provide critical evidence regarding the implementation and effectiveness of this service delivery strategy, with important implications for programs striving to eliminate vertical transmission of HIV and improve maternal health.	[Turan, Janet M.] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [Turan, Janet M.; Steinfeld, Rachel L.; Bukusi, Elizabeth A.; Woods, Meghan; Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Onono, Maricianah; Bukusi, Elizabeth A.; Penner, Jeremy] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Shade, Starley B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Washington, Sierra] Albert Einstein Coll Med, Dept OBGYN & Womens Hlth, Bronx, NY USA; [Marima, Reson] Aga Khan Univ Hosp, Nairobi, Kenya; [Ackers, Marta L.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Mbori-Ngacha, Dorothy] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; Centers for Disease Control & Prevention - USA; University of Nairobi	Turan, JM (corresponding author), Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA.	jmturan@uab.edu		Turan, Janet/0000-0002-7802-6206	CDC [5U2GPS001913-02]; U.S. National Institute of Mental Health [K01MH081777]; Nyanza Provincial Ministries of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH081777] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Nyanza Provincial Ministries of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research described was supported as a Public Health Evaluation by the President's Emergency Plan for AIDS Relief (PEPFAR)/U.S. Centers for Disease Control and Prevention (CDC). The study was funded under the CDC cooperative agreement number 5U2GPS001913-02. The funders had no role in data collection and analysis. The manuscript has received CDC clearance for journal submission. The first author's time working on this study was partially supported by Award Number K01MH081777 from the U.S. National Institute of Mental Health. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U. S. Centers for Disease Control and Prevention or the U. S. National Institutes of Health.; We thank the Kenyan women who participated in the study. We acknowledge the important logistical support of the KEMRI-UCSF Collaborative Group and especially Family AIDS Care and Education Services (FACES). We gratefully acknowledge the Director of KEMRI, the Director of KEMRI's Centre for Microbiology, and the Nyanza Provincial Ministries of Health for their support in conducting this research. We also thank John Oguda, Peter Manwari, George O'chieng, Pheobe Anyango, Kevin Owuor, Cinthia Blat, Jayne Kulzer, Nicole Schmidt, Katie Schwartz, Lisa Dillabaugh, and Benard Otieno for their important contributions to this research.	[Anonymous], SOFTW DES AN CLUST R; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Barker PM, 2011, JAIDS-J ACQ IMM DEF, V56, pE45, DOI 10.1097/QAI.0b013e3181fdbf20; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Brickley DB, 2011, AIDS CARE, V23, P303, DOI 10.1080/09540121.2010.507746; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Car LT, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008741.pub2; Church K, 2010, AIDS, V24, P189, DOI 10.1097/QAD.0b013e328333aeb3; Dabis F, 2005, AIDS, V19, P309; Delvaux T, 2008, TROP MED INT HEALTH, V13, P970, DOI 10.1111/j.1365-3156.2008.02105.x; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Etiebet MA, 2004, AIDS CARE, V16, P37, DOI 10.1080/09540120310001633958; FACES, 2010, PPCT PROGR REP; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Freedman LP, 2011, JAIDS-J ACQ IMM DEF, V57, pS80, DOI 10.1097/QAI.0b013e31821dba2d; Horwood C, 2010, TROP MED INT HEALTH, V15, P992, DOI 10.1111/j.1365-3156.2010.02576.x; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kennedy CE, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-26; Kenya Ministry of Public Health and Sanitation Kenya Ministry of Medical Services, 2010, NAT REC PREV MOTH CH; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kulzer JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-8; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lehman DA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000169; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; McIntyre J, 2008, CURR OPIN HIV AIDS, V3, P139, DOI 10.1097/COH.0b013e3282f5242a; Ministry of Public Health and Sanitation [Kenya] Ministry of Medical Services [Kenya], 2009, NAT REPR HLTH HIV AI; Mofenson LM, 2010, NEW ENGL J MED, V362, P2316, DOI 10.1056/NEJMe1004406; National AIDS and STI Control Programme of the Ministry of Health, 2005, AIDS KEN; Pangaea Global AIDS Foundation`, 2009, REPORT EXPERT CONSUL; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Ranson MK, 2006, CAN J PUBLIC HEALTH, V97, P72, DOI 10.1007/BF03405220; Simba D, 2010, INT J HEALTH PLAN M, V25, P17, DOI 10.1002/hpm.950; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Torpey K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-29; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; UN General Assembly Special Session on HIV and AIDS (UNGASS), 2010, COUNTR REP; UNICEF UNAIDS WHO UNFPA, 2009, CHILDR AIDS 4 STOCKT; van der Merwe K, 2006, JAIDS-J ACQ IMM DEF, V43, P577; Vo BN, 2012, AIDS CARE, V24, P1442, DOI 10.1080/09540121.2011.652357; Vo BN, 2011, AIDS CARE, DOI 09540121.2011.652357; Welty TK, 2005, JAIDS-J ACQ IMM DEF, V40, P486, DOI 10.1097/01.qai.0000163196.36199.89; WHO/UNAIDS/UNICEF, 2009, UN ACC SCAL HIV PRIO; Winestone LE, 2012, GLOB PUBLIC HEALTH, V7, P149, DOI 10.1080/17441692.2011.621964	48	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44181	10.1371/journal.pone.0044181	http://dx.doi.org/10.1371/journal.pone.0044181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970177	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400043
J	van Bokhorst-van de Veen, M; van Swam, I; Wels, M; Bron, PA; Kleerebezem, M				van Bokhorst-van de Veen, Hermien; van Swam, Iris; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel			Congruent Strain Specific Intestinal Persistence of Lactobacillus plantarum in an Intestine-Mimicking In Vitro System and in Human Volunteers	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; PROBIOTIC LACTOBACILLI; CLUSTER-ANALYSIS; LIFE-STYLE; IDENTIFICATION; GENES; SURVIVAL; COLONIZATION; DIVERSITY; BACTERIA	Background: An important trait of probiotics is their capability to reach their intestinal target sites alive to optimally exert their beneficial effects. Assessment of this trait in intestine-mimicking in vitro model systems has revealed differential survival of individual strains of a species. However, data on the in situ persistence characteristics of individual or mixtures of strains of the same species in the gastrointestinal tract of healthy human volunteers have not been reported to date. Methodology/Principal Findings: The GI-tract survival of individual L. plantarum strains was determined using an intestine mimicking model system, revealing substantial inter-strain differences. The obtained data were correlated to genomic diversity of the strains using comparative genome hybridization (CGH) datasets, but this approach failed to discover specific genetic loci that explain the observed differences between the strains. Moreover, we developed a next-generation sequencing-based method that targets a variable intergenic region, and employed this method to assess the in vivo GI-tract persistence of different L. plantarum strains when administered in mixtures to healthy human volunteers. Remarkable consistency of the strain-specific persistence curves were observed between individual volunteers, which also correlated significantly with the GI-tract survival predicted on basis of the in vitro assay. Conclusion: The survival of individual L. plantarum strains in the GI-tract could not be correlated to the absence or presence of specific genes compared to the reference strain L. plantarum WCFS1. Nevertheless, in vivo persistence analysis in the human GI-tract confirmed the strain-specific persistence, which appeared to be remarkably similar in different healthy volunteers. Moreover, the relative strain-specific persistence in vivo appeared to be accurately and significantly predicted by their relative survival in the intestine-mimicking in vitro assay, supporting the use of this assay for screening of strain-specific GI persistence.	[van Bokhorst-van de Veen, Hermien; van Swam, Iris; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [van Bokhorst-van de Veen, Hermien; van Swam, Iris; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [van Bokhorst-van de Veen, Hermien; Kleerebezem, Michiel] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands; [Wels, Michiel] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat CMBI 260, NL-6525 ED Nijmegen, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; Wageningen University & Research; Radboud University Nijmegen	van Bokhorst-van de Veen, M (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Peter.Bron@nizo.com	Kleerebezem, Michiel/AAT-2078-2021; van Bokhorst-van de Veen, Hermien/K-2111-2013	van Bokhorst-van de Veen, Hermien/0000-0003-4159-5955; Kleerebezem, Michiel/0000-0001-8552-2235				Ahrne S, 1998, J APPL MICROBIOL, V85, P88; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brigidi P, 2003, INT J FOOD MICROBIOL, V81, P203, DOI 10.1016/S0168-1605(02)00245-3; Bringel F, 2005, INT J SYST EVOL MICR, V55, P1629, DOI 10.1099/ijs.0.63333-0; Bron PA, 2007, J APPL MICROBIOL, V103, P1424, DOI 10.1111/j.1365-2672.2007.03376.x; Bron PA, 2006, J APPL MICROBIOL, V100, P728, DOI 10.1111/j.1365-2672.2006.02891.x; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Bron PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038720; Bron PA, 2011, FOOD MICROBIOL FOOD, P369, DOI 10.1007/978-0-387-92771-8_16; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CORAZZIARI E, 1987, J CLIN GASTROENTEROL, V9, P427, DOI 10.1097/00004836-198708000-00014; Corcoran BM, 2007, MICROBIOL-SGM, V153, P291, DOI 10.1099/mic.0.28966-0; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Goodman AL, 2011, NAT PROTOC, V6, P1969, DOI 10.1038/nprot.2011.417; Hutt P, 2011, BENEF MICROBES, V2, P79, DOI 10.3920/BM2010.0023; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Klingberg TD, 2006, INT J FOOD MICROBIOL, V109, P157, DOI 10.1016/j.ijfoodmicro.2006.01.014; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Marteau P, 1997, J DAIRY SCI, V80, P1031, DOI 10.3168/jds.S0022-0302(97)76027-2; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Mills S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S19; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Molly K, 1996, MICROB ECOL HEALTH D, V9, P79, DOI 10.1002/(SICI)1234-987X(199603)9:2<79::AID-MEH415>3.3.CO;2-V; Pitino L, 2010, FOOD MICROBIOL, V27, P1121, DOI 10.1016/j.fm.2010.07.019; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Smith TJ, 2011, J AM COLL NUTR, V30, P259, DOI 10.1080/07315724.2011.10719968; Stevens MJA, 2010, APPL ENVIRON MICROB, V76, P3748, DOI 10.1128/AEM.00073-10; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; TURNBULL GK, 1988, DIS COLON RECTUM, V31, P190, DOI 10.1007/BF02552545; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; van Bokhorst-van de Veen H, 2011, APPL ENVIRON MICROB, V77, P5247, DOI 10.1128/AEM.00515-11; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Verdenelli MC, 2011, LETT APPL MICROBIOL, V52, P596, DOI 10.1111/j.1472-765X.2011.03042.x; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; Wels M, 2011, MICROB BIOTECHNOL, V4, P333, DOI 10.1111/j.1751-7915.2010.00217.x; WOLF BW, 1995, MICROB ECOL HEALTH D, V8, P41, DOI 10.3109/08910609509141381; Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060	55	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44588	10.1371/journal.pone.0044588	http://dx.doi.org/10.1371/journal.pone.0044588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970257	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400091
J	Brazhe, NA; Treiman, M; Brazhe, AR; Find, NL; Maksimov, GV; Sosnovtseva, OV				Brazhe, Nadezda A.; Treiman, Marek; Brazhe, Alexey R.; Find, Ninett L.; Maksimov, Georgy V.; Sosnovtseva, Olga V.			Mapping of Redox State of Mitochondrial Cytochromes in Live Cardiomyocytes Using Raman Microspectroscopy	PLOS ONE			English	Article							SELF-ORGANIZING MAPS; ELECTRON-TRANSFER; CELLS; REPERFUSION; SPECTRA; DISEASE; COMPLEX	This paper presents a nonivasive approach to study redox state of reduced cytochromes c, c1 and b of complexes II and III in mitochondria of live cardiomyocytes by means of Raman microspectroscopy. For the first time with the proposed approach we perform studies of rod- and round-shaped cardiomyocytes, representing different morphological and functional states. Raman mapping and cluster analysis reveal that these cardiomyocytes differ in the amounts of reduced cytochromes c, c1 and b. The rod- shaped cardiomyocytes possess uneven distribution of reduced cytochromes c, c1 and b in cell center and periphery. Moreover, by means of Raman spectroscopy we demonstrated the decrease in the relative amounts of reduced cytochromes c, c1 and b in the rod-shaped cardiomyocytes caused by H2O2-induced oxidative stress before any visible changes. Results of Raman mapping and time-dependent study of reduced cytochromes of complexes II and III and cytochrome c in cardiomyocytes are in a good agreement with our fluorescence indicator studies and other published data.	[Brazhe, Nadezda A.; Brazhe, Alexey R.; Maksimov, Georgy V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Brazhe, Nadezda A.; Treiman, Marek; Find, Ninett L.; Sosnovtseva, Olga V.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Treiman, Marek; Find, Ninett L.] Danish Natl Fdn, Res Ctr Heart Arrhythmia, Copenhagen, Denmark	Lomonosov Moscow State University; University of Copenhagen	Brazhe, NA (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia.	olga@sund.ku.dk	Maksimov, Georgy V/B-4396-2016; Sosnovtseva, Olga/H-5115-2016; Brazhe, Nadezda/K-1369-2015; Brazhe, Alexey/G-9635-2016	Maksimov, Georgy V/0000-0002-7377-0773; Sosnovtseva, Olga/0000-0001-7334-9869; Brazhe, Alexey/0000-0002-1495-4652	Danish Council for Independent Research \ Natural Sciences; Danish National Research Foundation for Heart Arrhythmia; Novo Nordisk Foundation; A. and E. Danielsen's Foundation	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation for Heart Arrhythmia(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A. and E. Danielsen's Foundation	Support for this work came from The Danish Council for Independent Research vertical bar Natural Sciences (to N.A.B. and O.V.S.). M. T and N.L.F. were supported by The Danish National Research Foundation for Heart Arrhythmia, The Novo Nordisk Foundation and the A. and E. Danielsen's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR F, 1977, FEBS LETT, V80, P195, DOI 10.1016/0014-5793(77)80438-9; ADAR F, 1974, ARCH BIOCHEM BIOPHYS, V165, P570, DOI 10.1016/0003-9861(74)90284-7; Akao M, 2003, CIRC RES, V92, P186, DOI 10.1161/01.RES.0000051861.21316.E9; ARGADE PV, 1986, BIOPHYS J, V50, P613, DOI 10.1016/S0006-3495(86)83500-7; Bacao F, 2005, LECT NOTES COMPUT SC, V3516, P476; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Berezhna S, 2003, BIOCHEMISTRY-US, V42, P6149, DOI 10.1021/bi027387y; Borchert GH, 2008, AM J PHYSIOL-HEART C, V294, pH1948, DOI 10.1152/ajpheart.01209.2007; Brazhe NA, 2009, BIOPHYS J, V97, P3206, DOI 10.1016/j.bpj.2009.09.029; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Christensen MLM, 2008, ANAL BIOCHEM, V378, P25, DOI 10.1016/j.ab.2008.03.042; Delfino I, 2005, BIOPHYS CHEM, V113, P41, DOI 10.1016/j.bpc.2004.07.006; Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201; Hendgen-Cotta UB, 2010, J EXP BIOL, V213, P2734, DOI 10.1242/jeb.041178; Huang YS, 2005, BIOCHEMISTRY-US, V44, P10009, DOI 10.1021/bi050179w; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; MIKI T, 1994, J BIOL CHEM, V269, P1827; Mitchell P, 1977, Annu Rev Biochem, V46, P996, DOI 10.1146/annurev.bi.46.070177.005024; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls D., 2002, BIOENERGETICS; Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; PAPA S, 1981, BIOCHEM J, V194, P395, DOI 10.1042/bj1940395; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; VANDERHEIDE RS, 1986, AM J PATHOL, V125, P55; Viola HM, 2010, J MOL CELL CARDIOL, V49, P875, DOI 10.1016/j.yjmcc.2010.07.015; Ward MW, 2000, J NEUROSCI, V20, P7208; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	34	64	64	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41990	10.1371/journal.pone.0041990	http://dx.doi.org/10.1371/journal.pone.0041990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957018	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800010
J	Cousijn, J; Goudriaan, AE; Ridderinkhof, KR; van den Brink, W; Veltman, DJ; Wiers, RW				Cousijn, Janna; Goudriaan, Anna E.; Ridderinkhof, K. Richard; van den Brink, Wim; Veltman, Dick J.; Wiers, Reinout W.			Approach-Bias Predicts Development of Cannabis Problem Severity in Heavy Cannabis Users: Results from a Prospective FMRI Study	PLOS ONE			English	Article							AUTOMATIC ACTION-TENDENCIES; NICOTINE DEPENDENCE; SMOKING CUES; ALCOHOL CUES; AVOIDANCE; CORTEX	A potentially powerful predictor for the course of drug (ab) use is the approach-bias, that is, the pre-reflective tendency to approach rather than avoid drug-related stimuli. Here we investigated the neural underpinnings of cannabis approach and avoidance tendencies. By elucidating the predictive power of neural approach-bias activations for future cannabis use and problem severity, we aimed at identifying new intervention targets. Using functional Magnetic Resonance Imaging (fMRI), neural approach-bias activations were measured with a Stimulus Response Compatibility task (SRC) and compared between 33 heavy cannabis users and 36 matched controls. In addition, associations were examined between approach-bias activations and cannabis use and problem severity at baseline and at six-month follow-up. Approach-bias activations did not differ between heavy cannabis users and controls. However, within the group of heavy cannabis users, a positive relation was observed between total lifetime cannabis use and approach-bias activations in various fronto-limbic areas. Moreover, approach-bias activations in the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) independently predicted cannabis problem severity after six months over and beyond session-induced subjective measures of craving. Higher DLPFC/ACC activity during cannabis approach trials, but lower activity during cannabis avoidance trials were associated with decreases in cannabis problem severity. These findings suggest that cannabis users with deficient control over cannabis action tendencies are more likely to develop cannabis related problems. Moreover, the balance between cannabis approach and avoidance responses in the DLPFC and ACC may help identify individuals at-risk for cannabis use disorders and may be new targets for prevention and treatment.	[Cousijn, Janna; Ridderinkhof, K. Richard; Wiers, Reinout W.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cousijn, Janna; Goudriaan, Anna E.; van den Brink, Wim; Veltman, Dick J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam Inst Addict Res, NL-1105 AZ Amsterdam, Netherlands; [Ridderinkhof, K. Richard] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Veltman, Dick J.] Vriie Univ, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Cousijn, J (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	j.cousijn@gmail.com	Wiers, Reinout/AAB-4008-2021	Wiers, Reinout/0000-0002-4312-9766; Cousijn, Janna/0000-0002-7699-2582	Netherlands Organization for Scientific Research - Health Research and Development, ZON-Mw [31180002]; Amsterdam Brain Imaging Platform; National Science Foundation (N.W.O.) [453.008.001]	Netherlands Organization for Scientific Research - Health Research and Development, ZON-Mw; Amsterdam Brain Imaging Platform; National Science Foundation (N.W.O.)(Netherlands Organization for Scientific Research (NWO)National Science Foundation (NSF))	This research was supported by a grant from the Netherlands Organization for Scientific Research - Health Research and Development, ZON-Mw grant # 31180002, awarded to A. E. Goudriaan, D.J. Veltman, and W. van den Brink. Scanning costs were partly funded by a grant of the Amsterdam Brain Imaging Platform to J. Cousijn. R. W. Wiers is supported by National Science Foundation (N.W.O.) Vici grant 453.008.001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SJ, 2003, DRUG ALCOHOL REV, V22, P309, DOI 10.1080/0959523031000154454; Bachman JG, 2002, DECLINE SUBSTANCE US; Bennett A, 2008, MONOGRAPH SERIES, P171; Berkman ET, 2010, J COGNITIVE NEUROSCI, V22, P1970, DOI 10.1162/jocn.2009.21317; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Bradley B, 2004, BEHAV PHARMACOL, V15, P29, DOI 10.1097/00008877-200402000-00004; Chiew KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017635; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cousijn J, 2013, ADDICT BIOL, V18, P570, DOI 10.1111/j.1369-1600.2011.00417.x; Cousijn J, 2012, NEUROIMAGE, V59, P3845, DOI 10.1016/j.neuroimage.2011.09.046; Cousijn J, 2011, ADDICTION, V106, P1667, DOI 10.1111/j.1360-0443.2011.03475.x; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Field M, 2005, ALCOHOL ALCOHOLISM, V40, P504, DOI 10.1093/alcalc/agh213; Field M, 2008, J BEHAV THER EXP PSY, V39, P209, DOI 10.1016/j.jbtep.2007.06.001; Field M, 2006, DRUG ALCOHOL DEPEN, V85, P75, DOI 10.1016/j.drugalcdep.2006.03.018; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heishman SJ, 2009, DRUG ALCOHOL DEPEN, V102, P35, DOI 10.1016/j.drugalcdep.2008.12.010; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mogg K, 2005, PSYCHOPHARMACOLOGY, V180, P333, DOI 10.1007/s00213-005-2158-x; Ostafin BD, 2006, PSYCHOL ADDICT BEHAV, V20, P322, DOI 10.1037/0893-164X.20.3.322; Palfai TP, 2003, BEHAV RES THER, V41, P1149, DOI 10.1016/S0005-7967(03)00018-4; Perkonigg A, 2008, ADDICTION, V103, P439, DOI 10.1111/j.1360-0443.2007.02064.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Roelofs K, 2009, SOC COGN AFFECT NEUR, V4, P50, DOI 10.1093/scan/nsn036; ROESE NJ, 1993, PSYCHOL BULL, V114, P363, DOI 10.1037/0033-2909.114.2.363; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schlund MW, 2011, BEHAV BRAIN RES, V225, P437, DOI 10.1016/j.bbr.2011.07.054; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; Schulenberg JE, 2005, J DRUG ISSUES, V35, P255, DOI 10.1177/002204260503500203; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; United Nations Office on Drugs and Crime, 2009, UNODC WORLD DRUG REP; Volman I, 2011, CEREB CORTEX, V21, P2282, DOI 10.1093/cercor/bhr001; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	46	59	59	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42394	10.1371/journal.pone.0042394	http://dx.doi.org/10.1371/journal.pone.0042394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957019	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800011
J	Gevins, A; Chan, CS; Sam-Vargas, L				Gevins, Alan; Chan, Cynthia S.; Sam-Vargas, Lita			Towards Measuring Brain Function on Groups of People in the Real World	PLOS ONE			English	Article							PATTERN-RECOGNITION; EEG; PERFORMANCE; ARTIFACT	In three studies, EEGs from three groups of participants were recorded during progressively more real world situations after drinking alcoholic beverages that brought breath alcohol contents near the limit for driving in California 30 minutes after drinking. A simple equation that measured neurophysiological effects of alcohol in the first group of 15 participants performing repetitive cognitive tasks was applied to a second group of 15 operating an automobile driving simulator, and to a third group of 10 ambulatory people recorded simultaneously during a cocktail party. The equation derived from the first group quantified alcohol's effect by combining measures of higher frequency (beta) and lower frequency (theta) power into a single score. It produced an Area Under the Receiver Operator Characteristic Curve of .73 (p<.05; 67% sensitivity in recognizing alcohol and 87% specificity in recognizing placebo). Applying the same equation to the second group operating the driving simulator, AUC was .95, (p<.0001; 93% sensitivity and 73% specificity), while for the cocktail party group AUC was .87 (p<.01; 80% sensitivity and 80% specificity). EEG scores were significantly related to breath alcohol content in all studies. Some individuals differed markedly from the overall response evident in their respective groups. The feasibility of measuring the neurophysiological effect of a psychoactive substance from an entire group of ambulatory people at a cocktail party suggests that future studies may be able to fruitfully apply brain function measures derived under rigorously controlled laboratory conditions to assess drug effects on groups of people interacting in real world situations.	[Gevins, Alan; Chan, Cynthia S.; Sam-Vargas, Lita] San Francisco Brain Res Inst & SAM Technol, San Francisco, CA USA		Gevins, A (corresponding author), San Francisco Brain Res Inst & SAM Technol, San Francisco, CA USA.	alan@sfbri.org			National Institute of Mental Health [R43MH071865]; National Institute of Neurological Diseases and Strokes [R44NS048815]; National Institute of Alcoholism and Alcohol Abuse [R44AA014824]; United States Air Force Research Laboratory [FA8650-05-C-6553]; U.S. Federal Government; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS048815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R44AA014824] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Diseases and Strokes; National Institute of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); United States Air Force Research Laboratory(United States Department of DefenseUS Air Force Research Laboratory); U.S. Federal Government; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding came from the National Institute of Mental Health R43MH071865, National Institute of Neurological Diseases and Strokes R44NS048815, National Institute of Alcoholism and Alcohol Abuse R44AA014824, and the United States Air Force Research Laboratory FA8650-05-C-6553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The authors are employed by the San Francisco Brain Research Institute & SAM Technology which are 100% supported by competing research grants from the U.S. Federal Government. Alan Gevins is the founder and owner of this private research laboratory which has been operating independently of the University of California San Francisco School of Medicine since 1980. The organization only performs research and offers no services or products. None of the authors perform consulting work. It is very unlikely that any corporation, investor, etc. would find it commercially worthwhile to buy or license the technologies that the authors have made to do their research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Begleiter H, 1972, BIOL ALCOHOL, V2, P308; Cacioppo JT, 2011, ANN NY ACAD SCI, V1224, P162, DOI 10.1111/j.1749-6632.2010.05858.x; COHEN HL, 1993, NEUROPSYCHOPHARMACOL, V8, P365, DOI 10.1038/npp.1993.36; Du, 1994, IEEE 7 SP WORKSH STA, P433; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V73, P179, DOI 10.1016/0013-4694(89)90118-1; FINK M, 1984, NEUROPSYCHOBIOLOGY, V12, P173, DOI 10.1159/000118132; Friel PN, 1999, J STUD ALCOHOL, V60, P555, DOI 10.15288/jsa.1999.60.555; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Gevins A, 1999, AVIAT SPACE ENVIR MD, V70, P1018; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; Gevins A, 2002, NEUROPSYCHOPHARMACOL, V26, P27, DOI 10.1016/S0893-133X(01)00300-1; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Gevins A., 2009, A Sandoval-US Patent, Patent No. [7551952, 7, 551, 952]; Gevins A, 2011, J PSYCHOPHARMACOL, V25, P1062, DOI 10.1177/0269881110388334; Gevins A, 2011, CLIN NEUROPHYSIOL, V122, P114, DOI 10.1016/j.clinph.2010.06.010; Gevins A, 2011, DEMENT GERIATR COGN, V31, P7, DOI 10.1159/000322108; GEVINS AS, 1983, SCIENCE, V220, P97, DOI 10.1126/science.6828886; GEVINS AS, 1990, ELECTROEN CLIN NEURO, V76, P339, DOI 10.1016/0013-4694(90)90035-I; GEVINS AS, 1984, IEEE T BIO-MED ENG, V31, P833, DOI 10.1109/TBME.1984.325246; GEVINS AS, 1987, SCIENCE, V235, P580, DOI 10.1126/science.3810158; GEVINS AS, 1980, IEEE T PATTERN ANAL, V2, P383, DOI 10.1109/TPAMI.1980.6592360; GEVINS AS, 1979, SCIENCE, V203, P665, DOI 10.1126/science.760212; GEVINS AS, 1977, ELECTROEN CLIN NEURO, V43, P31, DOI 10.1016/0013-4694(77)90192-4; GEVINS AS, 1977, ELECTROEN CLIN NEURO, V42, P267, DOI 10.1016/0013-4694(77)90035-9; GEVINS AS, 1981, SCIENCE, V213, P918, DOI 10.1126/science.7256287; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; HERMANN WM, 1982, ELECTROENCEPHALOGRAP; Ilan AB, 2001, ALCOHOL, V25, P137, DOI 10.1016/S0741-8329(01)00191-4; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lehmann D, 1988, STATISTICS TOPOGRAPH, P27; LUKAS SE, 1986, PHARMACOL BIOCHEM BE, V25, P889, DOI 10.1016/0091-3057(86)90403-X; Mackie R.R., 1977, VIGILANCE PP, P537; Makeig S, 1996, ADV NEUR IN, V8, P145; Mitchell JP, 2008, CURR DIR PSYCHOL SCI, V17, P142, DOI 10.1111/j.1467-8721.2008.00564.x; RAMAEKERS JG, 1992, EUR J CLIN PHARMACOL, V42, P363; Smith ME, 2001, HUM FACTORS, V43, P366, DOI 10.1518/001872001775898287; STENBERG G, 1994, J STUD ALCOHOL, V55, P645, DOI 10.15288/jsa.1994.55.645; Tou J. T., 1974, PATTERN RECOGN	44	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44676	10.1371/journal.pone.0044676	http://dx.doi.org/10.1371/journal.pone.0044676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957099	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800092
J	Guinot, G; Adnet, S; Cappetta, H				Guinot, Guillaume; Adnet, Sylvain; Cappetta, Henri			An Analytical Approach for Estimating Fossil Record and Diversification Events in Sharks, Skates and Rays	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; CARTILAGINOUS FISHES; TAXONOMIC DIVERSITY; CHONDRICHTHYES; PHYLOGENY; ELASMOBRANCHS; EXTINCTION; EVOLUTION; TRAJECTORIES; BOUNDARY	Background: Modern selachians and their supposed sister group (hybodont sharks) have a long and successful evolutionary history. Yet, although selachian remains are considered relatively common in the fossil record in comparison with other marine vertebrates, little is known about the quality of their fossil record. Similarly, only a few works based on specific time intervals have attempted to identify major events that marked the evolutionary history of this group. Methodology/Principal Findings: Phylogenetic hypotheses concerning modern selachians' interrelationships are numerous but differ significantly and no consensus has been found. The aim of the present study is to take advantage of the range of recent phylogenetic hypotheses in order to assess the fit of the selachian fossil record to phylogenies, according to two different branching methods. Compilation of these data allowed the inference of an estimated range of diversity through time and evolutionary events that marked this group over the past 300 Ma are identified. Results indicate that with the exception of high taxonomic ranks (orders), the selachian fossil record is by far imperfect, particularly for generic and post-Triassic data. Timing and amplitude of the various identified events that marked the selachian evolutionary history are discussed. Conclusion/Significance: Some identified diversity events were mentioned in previous works using alternative methods (Early Jurassic, mid-Cretaceous, K/T boundary and late Paleogene diversity drops), thus reinforcing the efficiency of the methodology presented here in inferring evolutionary events. Other events (Permian/Triassic, Early and Late Cretaceous diversifications; Triassic/Jurassic extinction) are newly identified. Relationships between these events and paleoenvironmental characteristics and other groups' evolutionary history are proposed.	[Guinot, Guillaume; Adnet, Sylvain; Cappetta, Henri] Univ Montpellier 2, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Guinot, G (corresponding author), Univ Montpellier 2, Inst Sci Evolut Montpellier, Montpellier, France.	guillaume.guinot@univ-montp2.fr		Guinot, Guillaume/0000-0003-3363-6972	French Agence Nationale de la Recherche: ANR-PALASIAFRICA Program (ANR-ERC) [ANR-08-JCJC-0017]	French Agence Nationale de la Recherche: ANR-PALASIAFRICA Program (ANR-ERC)(French National Research Agency (ANR))	This research was supported by the French Agence Nationale de la Recherche: ANR-PALASIAFRICA Program (ANR-08-JCJC-0017, ANR-ERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arnason U, 2001, ZOOL SCR, V30, P249, DOI 10.1046/j.1463-6409.2001.00067.x; BENTON MJ, 1994, GEOLOGY, V22, P111, DOI 10.1130/0091-7613(1994)022<0111:TTQOTF>2.3.CO;2; Benton MJ, 2000, NATURE, V403, P534, DOI 10.1038/35000558; Bock WJ, 2004, J ZOOL SYST EVOL RES, V42, P178, DOI 10.1111/j.1439-0469.2004.00276.x; Cappetta, 1987, MEM SOC GEOL FR, V150, P113; Cappetta H., 1987, Handbook of Paleoichthyology, V3B, P1; Cappetta H., 2012, HDB PALEOICHTHYOLOGY; Cappetta H, 1993, FOSS REC, V2, P593; Cappetta H, 2006, FOSSILIUM CATALOGUS; Cavin L, 2007, PALAEOGEOGR PALAEOCL, V245, P353, DOI 10.1016/j.palaeo.2006.08.010; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Cuny G, 1999, GEOBIOS-LYON, V32, P193, DOI 10.1016/S0016-6995(99)80032-1; de Carvalho Marcelo R., 1996, P9; de Carvalho MR, 1996, INTERRELATIONSHIPS F, V3, P35; Douady CJ, 2003, MOL PHYLOGENET EVOL, V26, P215, DOI 10.1016/S1055-7903(02)00333-0; ERWIN DH, 1987, EVOLUTION, V41, P1177, DOI 10.1111/j.1558-5646.1987.tb02459.x; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Forey PL, 2004, PHILOS T R SOC B, V359, P639, DOI 10.1098/rstb.2003.1453; Ginter M., 2010, HDB PALEOICHTHYOLOGY, P168; Heinicke Matthew P., 2009, P320; Human BA, 2006, MOL PHYLOGENET EVOL, V39, P384, DOI 10.1016/j.ympev.2005.09.009; Ivanov Alexander, 2005, Revista Brasileira de Paleontologia, V8, P127; Kiessling W, 2007, PALAEOGEOGR PALAEOCL, V244, P201, DOI 10.1016/j.palaeo.2006.06.029; Kriwet J, 2004, PALAEOGEOGR PALAEOCL, V214, P181, DOI 10.1016/j.palaeo.2004.02.049; Kriwet J, 2009, P ROY SOC B-BIOL SCI, V276, P945, DOI 10.1098/rspb.2008.1441; Lloyd GT, 2012, SYST BIOL, V61, P80, DOI 10.1093/sysbio/syr076; Maisey, 1989, AM MUS NOVIT, V2931, P1; MAISEY JG, 2004, MESOZOIC FISHES, V3, P17; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; Naylor Gavin J.P., 2005, P1; Naylor Gavin J.P., 1994, American Museum Novitates, V3109, P1; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Noubhani A, 2010, HIST BIOL, V22, P71, DOI 10.1080/08912961003707349; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; SHIRAI S, 1992, COPEIA, P505; Shirai Shigeru, 1996, P9, DOI 10.1016/B978-012670950-6/50003-5; Thies D., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P333; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Underwood CJ, 2006, PALEOBIOLOGY, V32, P215, DOI 10.1666/04069.1; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Wilga CD, 2007, INTEGR COMP BIOL, V47, P55, DOI 10.1093/icb/icm029; Winchell CJ, 2004, MOL PHYLOGENET EVOL, V31, P214, DOI 10.1016/j.ympev.2003.07.010; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	51	42	44	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44632	10.1371/journal.pone.0044632	http://dx.doi.org/10.1371/journal.pone.0044632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957091	Green Published, gold			2022-12-27	WOS:000308463800084
J	Thayanithy, V; Park, C; Sarver, AL; Kartha, RV; Korpela, DM; Graef, AJ; Steer, CJ; Modiano, JF; Subramanian, S				Thayanithy, Venugopal; Park, ChangWon; Sarver, Aaron L.; Kartha, Reena V.; Korpela, Derek M.; Graef, Ashley J.; Steer, Clifford J.; Modiano, Jaime F.; Subramanian, Subbaya			Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines	PLOS ONE			English	Article							VALPROIC ACID; MICRORNA EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; AMPLIFICATION; INHIBITION; MODULATION; ACTIVATION; APOPTOSIS; CLUSTER	Downregulation of microRNAs (miRNAs) at the 14q32 locus stabilizes the expression of cMYC, thus significantly contributing to osteosarcoma (OS) pathobiology. Here, we show that downregulation of 14q32 miRNAs is epigenetically regulated. The predicted promoter regions of miRNA clusters at 14q32 locus showed no recurrent patterns of differential methylation, but Saos2 cells showed elevated histone deacetylase (HDAC) activity. Treatment with 4-phenylbutyrate increased acetylation of histones associated with 14q32 miRNAs, but interestingly, robust restoration of 14q32 miRNA expression, attenuation of cMYC expression, and induction of apoptosis required concomitant treatment with 5-Azacytidine, an inhibitor of DNA methylation. These events were associated with genome-wide gene expression changes including induction of proapoptotic genes and downregulation of cell cycle genes. Comparable effects were achieved in human and canine OS cells using the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) and the DNA methylation inhibitor Zebularine (Zeb), with significantly more pronounced cytotoxicity in cells whose molecular phenotypes were indicative of aggressive biological behavior. These results suggested that the combination of these chromatin-modifying drugs may be a useful adjuvant in the treatment of rapidly progressive OS.	[Thayanithy, Venugopal; Subramanian, Subbaya] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Park, ChangWon; Steer, Clifford J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Sarver, Aaron L.; Modiano, Jaime F.; Subramanian, Subbaya] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Kartha, Reena V.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Korpela, Derek M.; Graef, Ashley J.; Modiano, Jaime F.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Thayanithy, V (corresponding author), Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	subree@umn.edu	Kartha, Reena/AAG-3969-2021; Fiumefreddo, Andrea/T-2977-2019; Thayanithy, Venugopal/C-2777-2013; MODIANO, JAIME/K-3583-2019	Kartha, Reena/0000-0002-1692-1539; MODIANO, JAIME/0000-0001-6398-7648; Subramanian, Subbaya/0000-0002-2544-480X	University of Minnesota Academic Health Center; Masonic Cancer Center, University of Minnesota; Wyckoff Rein in Sarcoma Foundation; AKC Canine Health Foundation; Van Sloun Foundation; Kate Koogler Canine Cancer Fund	University of Minnesota Academic Health Center; Masonic Cancer Center, University of Minnesota(University of Minnesota System); Wyckoff Rein in Sarcoma Foundation; AKC Canine Health Foundation; Van Sloun Foundation; Kate Koogler Canine Cancer Fund	This study was supported by a grant from the University of Minnesota Academic Health Center, by a translational research grant from the Masonic Cancer Center, University of Minnesota, and by grants from the Wyckoff Rein in Sarcoma Foundation, the AKC Canine Health Foundation, the Van Sloun Foundation, and the Kate Koogler Canine Cancer Fund (JFM and SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Al-Romaih K, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-14; BOGENMANN E, 1987, CANCER RES, V47, P3808; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carraway HE, 2007, J CLIN ONCOL, V25, P1955, DOI 10.1200/JCO.2006.09.8293; Catalano MG, 2006, J ENDOCRINOL, V191, P465, DOI 10.1677/joe.1.06970; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; Imai T, 2003, ONCOGENE, V22, P9231, DOI 10.1038/sj.onc.1207184; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kim MS, 2003, CANCER RES, V63, P7291; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; LADANYI M, 1993, DIAGN MOL PATHOL, V2, P163, DOI 10.1097/00019606-199303000-00024; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marulanda German A, 2008, Cancer Control, V15, P13; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Moriarty B, 2011, C GEN ENG SING; Munster P, 2007, J CLIN ONCOL, V25, P1979, DOI 10.1200/JCO.2006.08.6165; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sarver A, 2011, PREFECT POLICE F PEC; Sarver AL, 2010, LAB INVEST, V90, P753, DOI 10.1038/labinvest.2010.53; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Thomas R, 2005, GENOME RES, V15, P1831, DOI 10.1101/gr.3825705; Thomas R, 2009, CHROMOSOME RES, V17, P365, DOI 10.1007/s10577-009-9028-z; Watanabe K, 2005, CELL DEATH DIFFER, V12, P10, DOI 10.1038/sj.cdd.4401507; Wittenburg LA, 2011, CANCER CHEMOTH PHARM, V67, P83, DOI 10.1007/s00280-010-1287-z; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	42	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43720	10.1371/journal.pone.0043720	http://dx.doi.org/10.1371/journal.pone.0043720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957032	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800024
J	Yanai, S; Semba, Y; Endo, S				Yanai, Shuichi; Semba, Yuki; Endo, Shogo			Remarkable Changes in Behavior and Physiology of Laboratory Mice after the Massive 2011 Tohoku Earthquake in Japan	PLOS ONE			English	Article							CHRONIC UNPREDICTABLE STRESS; SYNAPTIC PLASTICITY; WATER MAZE; RATS; MEMORY; CORTICOSTERONE; BRAIN; HIPPOCAMPUS; ENVIRONMENT; AMYGDALA	A devastating earthquake and tsunami hit Japan on March 11, 2011, followed by several long and intense aftershocks. Laboratory mice housed in the Tokyo, located approximately 330 km south of this earthquake's epicenter, displayed remarkable changes in a variety of behaviors and physiological measures. Although unusual pre-earthquake behaviors have been previously reported in laboratory animals, little is known about behavioral and physiological changes that occur after a great earthquake. In the present study, the effects of Tohoku earthquake on mice behavior were investigated. "Earthquake-experienced" mice displayed a marked increase in food consumption without gaining body weight in response to the earthquake. They also displayed enhanced anxiety, and in a formal fear memory task, showed significantly greater tone-and context-dependent conditioned freezing. Water maze performance of earthquake-experienced mice showed the quicker acquisition of the task, faster swim speed and longer swim distance than the naive mice. Serum corticosterone levels were elevated compared to the naive mice, indicating that the earthquake and aftershocks were stressful for the mice. These results demonstrate that great earthquakes strongly affect mouse behaviors and physiology. Although the effects of a variety of experimental manipulations on mouse behaviors in disease models or in models of higher cognitive functions have been extensively examined, researchers need to be aware how natural phenomena, such as earthquakes and perhaps other natural environmental factors, influence laboratory animal behaviors and physiology.	[Yanai, Shuichi; Semba, Yuki; Endo, Shogo] Tokyo Metropolitan Inst Gerontol, Aging Regulat Res Grp, Itabashi Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology	Yanai, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Aging Regulat Res Grp, Itabashi Ku, Tokyo, Japan.	sendo@tmig.or.jp		Yanai, Shuichi/0000-0002-4604-5525	Naito Foundation; MEXT of Japan; Japan Foundation for Aging and Health	Naito Foundation(Naito Memorial Foundation); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Aging and Health	This work was supported in part by the Naito Foundation, MEXT of Japan (www.mext.go.jp), and Japan Foundation for Aging and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Artiga AI, 2007, PHYSIOL BEHAV, V91, P424, DOI 10.1016/j.physbeh.2007.04.001; Baldwin AL, 2007, J AM ASSOC LAB ANIM, V46, P45; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Chen LL, 2010, EXP BIOL MED, V235, P1216, DOI 10.1258/ebm.2010.010042; CONRAD CD, 1993, J NEUROSCI, V13, P2582, DOI 10.1523/JNEUROSCI.13-06-02582.1993; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Dell'Osso L, 2011, J AFFECT DISORDERS, V131, P79, DOI 10.1016/j.jad.2010.11.023; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Gouirand AM, 2005, PHYSIOL BEHAV, V86, P21, DOI 10.1016/j.physbeh.2005.06.027; Grant RA, 2011, INT J ENV RES PUB HE, V8, P1936, DOI 10.3390/ijerph8061936; Haile CN, 2001, PSYCHOPHARMACOLOGY, V154, P213, DOI 10.1007/s002130000650; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JHANWARUNIYAL M, 1986, BRAIN RES, V368, P404, DOI 10.1016/0006-8993(86)90591-3; Kirschvink JL, 2000, B SEISMOL SOC AM, V90, P312, DOI 10.1785/0119980114; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kotozaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034612; Kyutoku Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031014; LEIBOWITZ SF, 1986, FASEB J, V45, P1396; Li YH, 2009, BIOELECTROMAGNETICS, V30, P613, DOI 10.1002/bem.20520; Lilly MM, 2010, VIOLENCE VICTIMS, V25, P604, DOI 10.1891/0886-6708.25.5.604; Lubbers ME, 2007, BEHAV BRAIN RES, V180, P107, DOI 10.1016/j.bbr.2007.02.021; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Naeem F, 2011, J AFFECT DISORDERS, V130, P268, DOI 10.1016/j.jad.2010.10.035; Nguyen L, 2011, INT J GROUP PSYCHOTH, V61, P27, DOI 10.1521/ijgp.2011.61.1.26; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Pankevich DE, 2008, OBESITY, V16, P1539, DOI 10.1038/oby.2008.221; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Robinaugh DJ, 2011, J TRAUMA STRESS, V24, P483, DOI 10.1002/jts.20656; ROLAND CR, 1986, NEUROENDOCRINOLOGY, V42, P296, DOI 10.1159/000124455; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Sanford LD, 2010, SLEEP, V33, P621, DOI 10.1093/sleep/33.5.621; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Trull FL, 1999, SCIENCE, V284, P1463, DOI 10.1126/science.284.5419.1463; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Yokoi S, 2003, BIOELECTROMAGNETICS, V24, P289, DOI 10.1002/bem.10108	44	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44475	10.1371/journal.pone.0044475	http://dx.doi.org/10.1371/journal.pone.0044475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957073	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800066
J	Chen, CA; Carolan, PC; Annes, JP				Chen, Chen Amy; Carolan, Peter C.; Annes, Justin P.			In Vivo Screening for Secreted Proteins That Modulate Glucose Handling Identifies Interleukin-6 Family Members as Potent Hypoglycemic Agents	PLOS ONE			English	Article							SLEEPING-BEAUTY TRANSPOSASE; TYPE-2 DIABETES-MELLITUS; BETA-CELL FAILURE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-TRANSFER; PLASMID DNA; TNF-ALPHA; DELIVERY; OBESITY	Diabetes is a disease of abnormal glucose homeostasis characterized by chronic hyperglycemia and a broad array of consequent organ damage. Because normal glucose homeostasis is maintained by a complex interaction between behavior (feeding and physical activity) and metabolic activity that is modulated by inter-organ signaling through secreted factors, disease modeling in vitro is necessarily limited. In contrast, in vivo studies allow complex metabolic phenotypes to be studied but present a barrier to high throughput studies. Here we present the development of a novel in vivo screening platform that addresses this primary limitation of in vivo experimentation. Our platform leverages the large secretory capacity of the liver and the hepatocyte transfection technique of hydrodynamic tail vein injection to achieve supraphysiologic blood levels of secreted proteins. To date, the utility of hydrodynamic transfection has been limited by the deleterious impact of the variable transfection efficiency inherent to this technique. We overcome this constraint by co-transfection of a secreted luciferase cDNA whose product can be easily monitored in the blood of a living animal and used as a surrogate marker for transfection efficiency and gene expression levels. To demonstrate the utility of our strategy, we screened 248 secreted proteins for the ability to enhance glucose tolerance. Surprisingly, interleukin-6 and several of its family members but not other well-recognized insulin sensitizing agents were identified as potent hypoglycemic factors. We propose this experimental system as a powerful and flexible in vivo screening platform for identifying genes that modulate complex behavioral and metabolic phenotypes.	[Chen, Chen Amy] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Carolan, Peter C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Annes, Justin P.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Harvard University; Harvard University; Massachusetts General Hospital; Stanford University	Chen, CA (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	jannes@stanford.edu		Annes, Justin/0000-0001-8431-3589	National Institutes of Health [DK084206, U01DK072505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084206, U01DK072505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants DK084206 and U01DK072505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2003, DIABETES CARE, V26, P2860, DOI 10.2337/diacare.26.10.2860; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bell JB, 2010, MOL THER, V18, P1796, DOI 10.1038/mt.2010.152; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Higuchi N, 2003, GENE THER, V10, P1297, DOI 10.1038/sj.gt.3301988; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; JHALA U, 1994, LIFE SCI, V54, P413, DOI 10.1016/0024-3205(94)00699-7; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu H, 2005, CIRCULATION, V111, P1593, DOI 10.1161/01.CIR.0000160348.75918.CA; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Miao CH, 2005, ADV GENET, V54, P143, DOI 10.1016/S0065-2660(05)54007-0; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Porter MH, 2002, J LAB CLIN MED, V139, P140, DOI 10.1067/mlc.2002.121552; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; SOWA R, 1990, DIABETOLOGIA, V33, P118, DOI 10.1007/BF00401051; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tong PCY, 2008, DIABETES RES CLIN PR, V82, P346, DOI 10.1016/j.diabres.2008.09.006; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xia Y, 1999, J CLIN INVEST, V103, P1309, DOI 10.1172/JCI5823; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210	50	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44600	10.1371/journal.pone.0044600	http://dx.doi.org/10.1371/journal.pone.0044600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962620	gold, Green Published, Green Submitted			2022-12-27	WOS:000308577600073
J	Flores, GE; Henley, JB; Fierer, N				Flores, Gilberto E.; Henley, Jessica B.; Fierer, Noah			A Direct PCR Approach to Accelerate Analyses of Human-Associated Microbial Communities	PLOS ONE			English	Article							GUT MICROBIOME; DIVERSITY; SEQUENCES; AGE	Since the composition of the human microbiome is highly variable both within and between individuals, researchers are increasingly reliant on high-throughput molecular approaches to identify linkages between the composition of these communities and human health. While new sequencing technologies have made it increasingly feasible to analyze large numbers of human-associated samples, the extraction of DNA from samples often remains a bottleneck in the process. Here we tested a direct PCR approach using the Extract-N-Amp Plant PCR Kit to accelerate the 16S rRNA gene-based analyses of human-associated bacterial communities, directly comparing this method to a more commonly-used approach whereby DNA is first extracted and purified from samples using a series of steps prior to PCR amplification. We used both approaches on replicate samples collected from each of five body habitats (tongue surface, feces, forehead skin, underarm skin, and forearm skin) from four individuals. With the exception of the tongue samples, there were few significant differences in the estimates of taxon richness or phylogenetic diversity obtained using the two approaches. Perhaps more importantly, there were no significant differences between the methods in their ability resolve body habitat differences or inter-individual differences in bacterial community composition and the estimates of the relative abundances of individual taxa were nearly identical with the two methods. Overall, the two methods gave very similar results and the direct PCR approach is clearly advantageous for many studies exploring the diversity and composition of human-associated bacterial communities given that large numbers of samples can be processed far more quickly and efficiently.	[Flores, Gilberto E.; Henley, Jessica B.; Fierer, Noah] Univ Colorado, NOAA, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Flores, GE (corresponding author), Univ Colorado, NOAA, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	noah.fierer@colorado.edu		FIERER, NOAH/0000-0002-6432-4261; Flores, Gilberto/0000-0002-3338-611X	National Science Foundation; Alfred P. Sloan Foundation	National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported by grants to N.F. from the National Science Foundation and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Caporaso J.G., 2012, ISME J; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gorley C.K., 2006, GETTING STARTED PRIM; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035294; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	38	53	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44563	10.1371/journal.pone.0044563	http://dx.doi.org/10.1371/journal.pone.0044563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962617	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600068
J	Goncalves, RM; Scopel, KKG; Bastos, MS; Ferreira, MU				Goncalves, Raquel M.; Scopel, Kezia K. G.; Bastos, Melissa S.; Ferreira, Marcelo U.			Cytokine Balance in Human Malaria: Does Plasmodium vivax Elicit More Inflammatory Responses than Plasmodium falciparum?	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTORS; UNCOMPLICATED MALARIA; DISEASE SEVERITY; DENDRITIC CELLS; TNF RECEPTORS; T-CELLS; CORRELATE; IMMUNITY; THROMBOCYTOPENIA; INTERLEUKIN-10	Background: The mechanisms by which humans regulate pro-and anti-inflammatory responses on exposure to different malaria parasites remains unclear. Although Plasmodium vivax usually causes a relatively benign disease, this parasite has been suggested to elicit more host inflammation per parasitized red blood cell than P. falciparum. Methodology/Principal Findings: We measured plasma concentrations of seven cytokines and two soluble tumor necrosis factor (TNF)-alpha receptors, and evaluated clinical and laboratory outcomes, in Brazilians with acute uncomplicated infections with P. vivax (n = 85), P. falciparum (n = 30), or both species (n = 12), and in 45 asymptomatic carriers of low-density P. vivax infection. Symptomatic vivax malaria patients, compared to those infected with P. falciparum or both species, had more intense paroxysms, but they had no clear association with a pro-inflammatory imbalance. To the contrary, these patients had higher levels of the regulatory cytokine interleukin (IL)-10, which correlated positively with parasite density, and elevated IL-10/TNF-alpha, IL-10/interferon (IFN)-gamma, IL-10/IL-6 and sTNFRII/TNF-alpha ratios, compared to falciparum or mixed-species malaria patient groups. Vivax malaria patients had the highest levels of circulating soluble TNF-alpha receptor sTNFRII. Levels of regulatory cytokines returned to normal values 28 days after P. vivax clearance following chemotherapy. Finally, asymptomatic carriers of low P. vivax parasitemias had substantially lower levels of both inflammatory and regulatory cytokines than did patients with clinical malaria due to either species. Conclusions: Controlling fast-multiplying P. falciparum blood stages requires a strong inflammatory response to prevent fulminant infections, while reducing inflammation-related tissue damage with early regulatory cytokine responses may be a more cost-effective strategy in infections with the less virulent P. vivax parasite. The early induction of regulatory cytokines may be a critical mechanism protecting vivax malaria patients from severe clinical complications.	[Goncalves, Raquel M.; Scopel, Kezia K. G.; Bastos, Melissa S.; Ferreira, Marcelo U.] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil; [Scopel, Kezia K. G.] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Immunol, Inst Biol Sci, Juiz De Fora, Brazil	Universidade de Sao Paulo; Universidade Federal de Juiz de Fora	Goncalves, RM (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.	muferrei@usp.br	Ferreira, Marcelo U/G-8289-2011	Ferreira, Marcelo U/0000-0002-5293-9090	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; FAPESP [07/52771-0, 08/50645-0, 10/52146-0]; CNPq [470195/2008-8, 474529/2010-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RMG receives a scholarship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and MUF is a senior investigator supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. This work was supported by FAPESP (research grants 07/52771-0, 08/50645-0, and 10/52146-0 to MUF) and CNPq (research grants 470195/2008-8 and 474529/2010-0 to MUF and KKGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; Akanmori BD, 2000, EUR CYTOKINE NETW, V11, P113; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Andrade BB, 2010, MALARIA J, V9, P9; Andrade BB, 2010, J IMMUNOL, V185, P1196, DOI 10.4049/jimmunol.0904179; Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650; Andrade BB, 2011, MEM I OSWALDO CRUZ, V106, P70, DOI 10.1590/S0074-02762011000900009; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Cox-Singh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020541; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; DELORON P, 1994, EUR CYTOKINE NETW, V5, P331; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; Grell M, 1996, J INFLAMM, V47, P8; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007; Hemmer CJ, 2006, TROP MED INT HEALTH, V11, P817, DOI 10.1111/j.1365-3156.2006.01635.x; Hugosson E, 2004, PARASITE IMMUNOL, V26, P111, DOI 10.1111/j.0141-9838.2004.00678.x; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2010, ACTA TROP, V113, P263, DOI 10.1016/j.actatropica.2009.11.009; Karunaweera ND, 1998, AM J TROP MED HYG, V58, P204, DOI 10.4269/ajtmh.1998.58.204; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; KERN P, 1993, J INFECT DIS, V168, P1340, DOI 10.1093/infdis/168.5.1340; KERN P, 1992, J INFECT DIS, V166, P930, DOI 10.1093/infdis/166.4.930; KREMSNER PG, 1995, AM J TROP MED HYG, V53, P532, DOI 10.4269/ajtmh.1995.53.532; Langhorne J, 2004, IMMUNOL REV, V201, P35, DOI 10.1111/j.0105-2896.2004.00182.x; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McKenzie FE, 2006, CLIN INFECT DIS, V42, P1713, DOI 10.1086/504330; Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Fernandes AAM, 2008, CLIN VACCINE IMMUNOL, V15, P650, DOI 10.1128/CVI.00475-07; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Perkins DJ, 2000, J INFECT DIS, V182, P988, DOI 10.1086/315762; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Rodriguez-Morales AJ, 2005, CLIN INFECT DIS, V41, P130, DOI 10.1086/430837; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Yeo TW, 2010, J INFECT DIS, V202, P109, DOI 10.1086/653211; Zeyrek FY, 2006, PARASITE IMMUNOL, V28, P201, DOI 10.1111/j.1365-3024.2006.00822.x	52	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44394	10.1371/journal.pone.0044394	http://dx.doi.org/10.1371/journal.pone.0044394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973442	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600046
J	Oommen, S; Francois, M; Kawasaki, M; Murrell, M; Kawasaki, K; Porntaveetus, T; Ghafoor, S; Young, NJ; Okamatsu, Y; McGrath, J; Koopman, P; Sharpe, PT; Ohazama, A				Oommen, Shelly; Francois, Mathias; Kawasaki, Maiko; Murrell, Melanie; Kawasaki, Katsushige; Porntaveetus, Thantrira; Ghafoor, Sarah; Young, Neville J.; Okamatsu, Yoshimasa; McGrath, John; Koopman, Peter; Sharpe, Paul T.; Ohazama, Atsushi			Cytoplasmic Plaque Formation in Hemidesmosome Development Is Dependent on SoxF Transcription Factor Function	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; EPIDERMAL BASEMENT-MEMBRANE; MOLECULAR-ORGANIZATION; PYLORIC ATRESIA; CELL-MIGRATION; GROWTH-FACTOR; INTEGRIN; MICE; MUTATIONS; ADHESION	Hemidesmosomes are composed of intricate networks of proteins, that are an essential attachment apparatus for the integrity of epithelial tissue. Disruption leads to blistering diseases such as epidermolysis bullosa. Members of the Sox gene family show dynamic and diverse expression patterns during development and mutation analyses in humans and mice provide evidence that they play a remarkable variety of roles in development and human disease. Previous studies have established that the mouse mutant ragged-opossum (Ra-op) expresses a dominant-negative form of the SOX18 transcription factor that interferes with the function of wild type SOX18 and of the related SOXF-subgroup proteins SOX7 and -17. Here we show that skin and oral mucosa in homozygous Ra-op mice display extensive detachment of epithelium from the underlying mesenchymal tissue, caused by tearing of epithelial cells just above the plasma membrane due to hemidesmosome disruption. In addition, several hemidesmosome proteins expression were found to be dysregulated in the Ra-op mice. Our data suggest that SOXF transcription factors play a role in regulating formation of cytoplasmic plaque protein assembly, and that disrupted SOXF function results in epidermolysis bullosa-like skin phenotypes.	[Oommen, Shelly; Kawasaki, Maiko; Kawasaki, Katsushige; Porntaveetus, Thantrira; Ghafoor, Sarah; Sharpe, Paul T.; Ohazama, Atsushi] Kings Coll London, Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [Oommen, Shelly; Kawasaki, Maiko; Kawasaki, Katsushige; Porntaveetus, Thantrira; Ghafoor, Sarah; Sharpe, Paul T.; Ohazama, Atsushi] Kings Coll London, Biomed Res Ctr, Inst Dent, London WC2R 2LS, England; [Francois, Mathias; Murrell, Melanie; Young, Neville J.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Okamatsu, Yoshimasa; Ohazama, Atsushi] Showa Univ, Sch Dent, Dept Periodontol, Tokyo 142, Japan; [McGrath, John] Kings Coll London, Genet Skin Dis Grp, St Johns Inst Dermatol, Div Skin Sci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of Queensland; Showa University; University of London; King's College London	Oommen, S (corresponding author), Kings Coll London, Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England.	atsushi.2.ohazama@kcl.ac.uk	Koopman, Peter A/C-9416-2009; McGrath, John/N-3529-2019; francois, mathias/A-9604-2014; Porntaveetus, Thantrira/ABF-6854-2020	Koopman, Peter A/0000-0001-6939-0914; francois, mathias/0000-0002-9846-6882; Sharpe, Paul/0000-0003-2116-9561; porntaveetus, thantrira/0000-0003-0145-9801	Europen Orthodontic Society; Higher Education of Pakistan; JSPS; Medical Research Council [MR/J006742/1] Funding Source: researchfish	Europen Orthodontic Society; Higher Education of Pakistan(Higher Education Commission of Pakistan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AO is an Research Councils UK (RCUK) Fellow. TP is supported by W J B Houston Research Scholarship (Europen Orthodontic Society). SG is supported by Higher Education of Pakistan under the scheme Overseas Scholarship Phase II (Batch2). KK is supported by JSPS International Program for Young Researcher Overseas Visits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; CARTER TC, 1954, J HERED, V45, P151; CHAN FL, 1994, MICROSC RES TECHNIQ, V28, P48, DOI 10.1002/jemt.1070280106; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; DiPersio CM, 2000, J CELL SCI, V113, P3051; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Downes M, 2001, TRENDS CARDIOVAS MED, V11, P318, DOI 10.1016/S1050-1738(01)00131-1; Eger A, 1997, J CELL SCI, V110, P1307; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Ghohestani RF, 2001, CLIN DERMATOL, V19, P551, DOI 10.1016/S0738-081X(00)00175-9; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; HOSKING B, 2008, INBORN ERRORS DEV, P883; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Huber M, 2002, J INVEST DERMATOL, V118, P185, DOI 10.1046/j.0022-202x.2001.01617.x; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jonkman MF, 2002, J INVEST DERMATOL, V119, P1275, DOI 10.1046/j.1523-1747.2002.19609.x; KURPAKUS MA, 1991, J CELL BIOL, V115, P1737, DOI 10.1083/jcb.115.6.1737; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Masunaga T, 2006, CONNECT TISSUE RES, V47, P55, DOI 10.1080/03008200600584157; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; McMillan JR, 1996, ARCH DERMATOL RES, V288, P91, DOI 10.1007/s004030050029; Morita K, 2003, EXP DERMATOL, V12, P289, DOI 10.1034/j.1600-0625.2003.120309.x; Nakamura H, 2005, J MOL DIAGN, V7, P28, DOI 10.1016/S1525-1578(10)60005-0; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; POTTS AJ, 1994, EXP CELL RES, V212, P2, DOI 10.1006/excr.1994.1111; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Tennenbaum T, 1996, CELL GROWTH DIFFER, V7, P615; Tucker AS, 1999, DEVELOPMENT, V126, P51; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Uitto J, 2004, AM J MED GENET C, V131C, P61, DOI 10.1002/ajmg.c.30035; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Walko G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002396; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Werner ME, 2007, J BIOL CHEM, V282, P5560, DOI 10.1074/jbc.M603669200	49	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43857	10.1371/journal.pone.0043857	http://dx.doi.org/10.1371/journal.pone.0043857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962592	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600020
J	Bonmassar, G; Fujimoto, K; Golby, AJ				Bonmassar, Giorgio; Fujimoto, Kyoko; Golby, Alexandra J.			PTFOS: Flexible and Absorbable Intracranial Electrodes for Magnetic Resonance Imaging	PLOS ONE			English	Article							FLIP-ANGLE; ARTIFACTS; STIMULATION; IMPLANTS; SIGNALS	Intracranial electrocortical recording and stimulation can provide unique knowledge about functional brain anatomy in patients undergoing brain surgery. This approach is commonly used in the treatment of medically refractory epilepsy. However, it can be very difficult to integrate the results of cortical recordings with other brain mapping modalities, particularly functional magnetic resonance imaging (fMRI). The ability to integrate imaging and electrophysiological information with simultaneous subdural electrocortical recording/stimulation and fMRI could offer significant insight for cognitive and systems neuroscience as well as for clinical neurology, particularly for patients with epilepsy or functional disorders. However, standard subdural electrodes cause significant artifact in MRI images, and concerns about risks such as cortical heating have generally precluded obtaining MRI in patients with implanted electrodes. We propose an electrode set based on polymer thick film organic substrate (PTFOS), an organic absorbable, flexible and stretchable electrode grid for intracranial use. These new types of MRI transparent intracranial electrodes are based on nano-particle ink technology that builds on our earlier development of an EEG/fMRI electrode set for scalp recording. The development of MRI-compatible recording/stimulation electrodes with a very thin profile could allow functional mapping at the individual subject level of the underlying feedback and feed forward networks. The thin flexible substrate would allow the electrodes to optimally contact the convoluted brain surface. Performance properties of the PTFOS were assessed by MRI measurements, finite difference time domain (FDTD) simulations, micro-volt recording, and injecting currents using standard electrocortical stimulation in phantoms. In contrast to the large artifacts exhibited with standard electrode sets, the PTFOS exhibited no artifact due to the reduced amount of metal and conductivity of the electrode/trace ink and had similar electrical properties to a standard subdural electrode set. The enhanced image quality could enable routine MRI exams of patients with intracranial electrode implantation and could also lead to chronic implantation solutions.	[Bonmassar, Giorgio; Fujimoto, Kyoko] Harvard Univ, Sch Med, Massachusetts Gen Hosp, AA Martinos Ctr, Charlestown, MA USA; [Golby, Alexandra J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg & Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bonmassar, G (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, AA Martinos Ctr, Charlestown, MA USA.	giorgio@nmr.mgh.harvard.edu		Fujimoto, Kyoko/0000-0002-0087-1397	Center for Integration of Medicine and Innovative Technology for the award [CIMIT 07-153]; National Institutes of Health [R43NS071988 (NINDS), R01EB006385 (NIBIB), R01NS037462 (NINDS), P41RR14075 (NCRR), P41EB015898 (NCRR), P41RR019703 (NIBIB)]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019703, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015898, R01EB006385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS071988, R01NS037462] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology for the award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Center for Integration of Medicine and Innovative Technology for the award # CIMIT 07-153 (www.cimit.org). Furthermore, this project was supported by the National Institutes of Health through grant numbers: R43NS071988 (NINDS), R01EB006385 (NIBIB), R01NS037462 (NINDS), P41RR14075 (NCRR), P41EB015898 (NCRR) and P41RR019703 (NIBIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTRASSE CL, 1988, IEEE T BIO-MED ENG, V35, P870, DOI 10.1109/10.7294; Bartels LW, 2002, MAGNET RESON MED, V47, P171, DOI 10.1002/mrm.10004; Bennett LH, 1996, J APPL PHYS, V79, P4712, DOI 10.1063/1.361649; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Bhavaraju NC, 2002, MAGN RESON IMAGING, V20, P351, DOI 10.1016/S0730-725X(02)00506-4; Bonmassar G, 2001, HUM BRAIN MAPP, V14, P108, DOI 10.1002/hbm.1045; Bonmassar Giorgio, 2010, Int J Bioelectromagn, V12, P32; CAMACHO CR, 1995, JMRI-J MAGN RESON IM, V5, P75, DOI 10.1002/jmri.1880050115; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Davis LM, 1999, EPILEPSY RES, V35, P95, DOI 10.1016/S0920-1211(99)00007-8; Dziedzic A, 1998, J PHYS D APPL PHYS, V31, P2091, DOI 10.1088/0022-3727/31/17/003; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ferrier CH, 2006, EPILEPSIA, V47, P1477, DOI 10.1111/j.1528-1167.2006.00619.x; Finelli DA, 1997, AM J NEURORADIOL, V18, P147; Gilleo K, 1996, POLYM THICK FILM, Vxvi, P421; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Graf H, 2005, MAGN RESON IMAGING, V23, P493, DOI 10.1016/j.mri.2004.12.009; Hartwig V, 2011, MAGN RESON IMAGING, V29, P717, DOI 10.1016/j.mri.2011.01.004; Kay S. M., 1993, FUNDAMENTALS STAT SI; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li W, 2009, PROC IEEE MICR ELECT, P248, DOI 10.1109/MEMSYS.2009.4805365; MALKO JA, 1989, RADIOLOGY, V173, P563, DOI 10.1148/radiology.173.2.2798891; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP, Vxiii, P1309; Purdon PL, 2008, J NEUROSCI METH, V175, P165, DOI 10.1016/j.jneumeth.2008.07.017; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schueler BA, 1999, JMRI-J MAGN RESON IM, V9, P596, DOI 10.1002/(SICI)1522-2586(199904)9:4<596::AID-JMRI14>3.0.CO;2-T; SHELLOCK FG, 1990, RADIOLOGY, V175, P586; SIEGFRIED J, 1985, APPL NEUROPHYSIOL, V48, P408; Silberbusch MA, 1998, AM J NEURORADIOL, V19, P1089; Smith SW, 1997, SCI ENG GUIDE DIGITA, Vxiv, P626; Suarez RO, 2009, EPILEPSY BEHAV, V16, P288, DOI 10.1016/j.yebeh.2009.07.034; Szelenyi A, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09237; Vasios CE, 2006, NEUROIMAGE, V33, P1082, DOI 10.1016/j.neuroimage.2006.07.038; Voskerician G, 2005, IEEE SENS J, V5, P1147, DOI 10.1109/JSEN.2005.857877; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zumsteg D, 2005, CLIN NEUROPHYSIOL, V116, P2810, DOI 10.1016/j.clinph.2005.08.009	39	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41187	10.1371/journal.pone.0041187	http://dx.doi.org/10.1371/journal.pone.0041187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984396	Green Submitted, Green Published, gold			2022-12-27	WOS:000308738500002
J	Bonizzoni, M; Afrane, Y; Dunn, WA; Atieli, FK; Zhou, GF; Zhong, DB; Li, J; Githeko, A; Yan, GY				Bonizzoni, Mariangela; Afrane, Yaw; Dunn, William Augustine; Atieli, Francis K.; Zhou, Goufa; Zhong, Daibin; Li, Jun; Githeko, Andrew; Yan, Guiyun			Comparative Transcriptome Analyses of Deltamethrin-Resistant and - Susceptible Anopheles gambiae Mosquitoes from Kenya by RNA-Seq	PLOS ONE			English	Article							MALARIA VECTOR; INSECTICIDE RESISTANCE; KNOCKDOWN RESISTANCE; PYRETHROID RESISTANCE; GENE-EXPRESSION; REDUCED SUSCEPTIBILITY; PERMETHRIN RESISTANCE; R CONSENSUS; KDR; POPULATIONS	Malaria causes more than 300 million clinical cases and 665,000 deaths each year, and the majority of the mortality and morbidity occurs in sub-Saharan Africa. Due to the lack of effective vaccines and wide-spread resistance to antimalarial drugs, mosquito control is the primary method of malaria prevention and control. Currently, malaria vector control relies on the use of insecticides, primarily pyrethroids. The extensive use of insecticides has imposed strong selection pressures for resistance in the mosquito populations. Consequently, resistance to pyrethroids in Anopheles gambiae, the main malaria vector in sub-Saharan Africa, has become a major obstacle for malaria control. A key element of resistance management is the identification of resistance mechanisms and subsequent development of reliable resistance monitoring tools. Field-derived An. gambiae from Western Kenya were phenotyped as deltamethrin-resistant or -susceptible by the standard WHO tube test, and their expression profile compared by RNA-seq. Based on the current annotation of the An. gambiae genome, a total of 1,093 transcripts were detected as significantly differentially accumulated between deltamethrin-resistant and susceptible mosquitoes. These transcripts are distributed over the entire genome, with a large number mapping in QTLs previously linked to pyrethorid resistance, and correspond to heat-shock proteins, metabolic and transport functions, signal transduction activities, cytoskeleton and others. The detected differences in transcript accumulation levels between resistant and susceptible mosquitoes reflect transcripts directly or indirectly correlated with pyrethroid resistance. RNA-seq data also were used to perform a de-novo Cufflinks assembly of the An. gambiae genome.	[Bonizzoni, Mariangela; Zhou, Goufa; Zhong, Daibin; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA; [Afrane, Yaw; Dunn, William Augustine; Githeko, Andrew] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Atieli, Francis K.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Dunn, William Augustine] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Li, Jun] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of California System; University of California Irvine; Kenya Medical Research Institute; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Oklahoma System; University of Oklahoma - Norman	Bonizzoni, M (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	mbonizzo@uci.edu	bonizzoni, mariangela/AAM-9035-2021; Zhong, Daibin/GRF-0564-2022	bonizzoni, mariangela/0000-0003-0568-8564; Dunn, Augustine/0000-0002-8683-1459	National Institutes of Health [R21 AI098652-01, R01 AI050243, D43 TW001505, R25 TW008125]; FOGARTY INTERNATIONAL CENTER [D43TW001505, R25TW008125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098652, R01AI050243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by National Institutes of Health grants R21 AI098652-01, R01 AI050243, D43 TW001505 and R25 TW008125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Benoit JB, 2011, P NATL ACAD SCI USA, V108, P8026, DOI 10.1073/pnas.1105195108; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butler D, 2011, NATURE, V475, P19, DOI 10.1038/475019a; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Christian RN, 2011, PESTIC BIOCHEM PHYS, V99, P140, DOI 10.1016/j.pestbp.2010.11.010; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Dvorak Z, 2005, CURR DRUG METAB, V6, P545, DOI 10.2174/138920005774832623; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; John R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-92; Kamalaveni K, 2001, PEST MANAG SCI, V57, P1151, DOI 10.1002/ps.395; Khambay BPS., 2010, INSECT CONTROL BIOL, P1; Li T, 2011, 2011 ESA ANN M; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Neira-Oviedo M, 2011, INSECT MOL BIOL, V20, P141, DOI 10.1111/j.1365-2583.2010.01053.x; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2004, INSECT MOL BIOL, V13, P379, DOI 10.1111/j.0962-1075.2004.00495.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Rund SSC, 2011, P NATL ACAD SCI USA, V108, pE421, DOI 10.1073/pnas.1100584108; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sim C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-231; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; STELZER KJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P361, DOI 10.1016/0005-2736(85)90310-4; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 1998, WHOCDSCPCMALI9812; Willis J.H., 2005, P79; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; World Health Organization, 2005, MAL CONTR TOD CURR W; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Zhong D, 2011, 60 ASTMH M	70	64	71	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44607	10.1371/journal.pone.0044607	http://dx.doi.org/10.1371/journal.pone.0044607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970263	gold, Green Published			2022-12-27	WOS:000308462000037
J	Li, WQ; Shao, M; Zhong, WG; Yang, J; Okada, K; Yamane, H; Zhang, L; Wang, G; Wang, D; Xiao, SS; Chang, SS; Qian, GL; Liu, FQ				Li, Wenqi; Shao, Min; Zhong, Weigong; Yang, Jie; Okada, Kazunori; Yamane, Hisakazu; Zhang, Lei; Wang, Guang; Wang, Dong; Xiao, Shanshan; Chang, Shanshan; Qian, Guoliang; Liu, Fengquan			Ectopic Expression of Hrf1 Enhances Bacterial Resistance via Regulation of Diterpene Phytoalexins, Silicon and Reactive Oxygen Species Burst in Rice	PLOS ONE			English	Article							HARPIN-ENCODING GENE; DISEASE RESISTANCE; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; MAGNAPORTHE-GRISEA; BLAST FUNGUS; DEFENSE RESPONSES; DROUGHT TOLERANCE; ERWINIA-AMYLOVORA; BOTRYTIS-CINEREA	Harpin proteins as elicitor derived from plant gram negative bacteria such as Xanthomonas oryzae pv. oryzae (Xoo), Erwinia amylovora induce disease resistance in plants by activating multiple defense responses. However, it is unclear whether phytoalexin production and ROS burst are involved in the disease resistance conferred by the expression of the harpin(Xoo) protein in rice. In this article, ectopic expression of hrf1 in rice enhanced resistance to bacterial blight. Accompanying with the activation of genes related to the phytoalexin biosynthesis pathway in hrf1-transformed rice, phytoalexins quickly and consistently accumulated concurrent with the limitation of bacterial growth rate. Moreover, the hrf1-transformed rice showed an increased ability for ROS scavenging and decreased hydrogen peroxide (H2O2) concentration. Furthermore, the localization and relative quantification of silicon deposition in rice leaves was detected by scanning electron microscopy (SEM) and energy-dispersive X-ray spectrometer (EDS). Finally, the transcript levels of defense response genes increased in transformed rice. These results show a correlation between Xoo resistance and phytoalexin production, H2O2, silicon deposition and defense gene expression in hrf1-transformed rice. These data are significant because they provide evidence for a better understanding the role of defense responses in the incompatible interaction between bacterial disease and hrf1-transformed plants. These data also supply an opportunity for generating nonspecific resistance to pathogens.	[Li, Wenqi; Shao, Min; Zhang, Lei; Wang, Guang; Wang, Dong; Xiao, Shanshan; Chang, Shanshan; Qian, Guoliang; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Li, Wenqi; Shao, Min; Zhang, Lei; Wang, Guang; Wang, Dong; Xiao, Shanshan; Chang, Shanshan; Qian, Guoliang; Liu, Fengquan] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Zhong, Weigong; Yang, Jie] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China; [Okada, Kazunori; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan	Nanjing Agricultural University; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; University of Tokyo	Li, WQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	fqliu20011@sina.com			Major Program of National Transgenic Biology New Varieties Breeding from the Ministry of Agriculture of China [2009ZX08001-005B]; National High Technology Research and Development Program from the Ministry of Science and Technology of China [2008AA10Z108, 2007AA10Z188]	Major Program of National Transgenic Biology New Varieties Breeding from the Ministry of Agriculture of China; National High Technology Research and Development Program from the Ministry of Science and Technology of China(National High Technology Research and Development Program of China)	This work was supported by grants from the Major Program of National Transgenic Biology New Varieties Breeding from the Ministry of Agriculture of China (grant no. 2009ZX08001-005B), and the National High Technology Research and Development Program from the Ministry of Science and Technology of China (grant nos. 2008AA10Z108 and 2007AA10Z188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Dayakar BV, 2003, PLANT MOL BIOL, V51, P913, DOI 10.1023/A:1023061303755; Dillon VM, 1997, PHYTOCHEMISTRY, V44, P599, DOI 10.1016/S0031-9422(96)00619-X; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Gupta A, 2008, FEMS MICROBIOL LETT, V278, P22, DOI 10.1111/j.1574-6968.2007.00937.x; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; Hayasaka T, 2008, PHYTOPATHOLOGY, V98, P1038, DOI 10.1094/PHYTO-98-9-1038; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Huo R, 2010, TRANSGENIC RES, V19, P841, DOI 10.1007/s11248-010-9365-x; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Kim JA, 2009, MOL CELLS, V28, P431, DOI 10.1007/s10059-009-0161-5; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; KOGA J, 1995, TETRAHEDRON, V51, P7907, DOI 10.1016/0040-4020(95)00423-6; KUC J, 1995, ANNU REV PHYTOPATHOL, V33, P275, DOI 10.1146/annurev.py.33.090195.001423; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Pavli OI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017306; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Rodrigues FA, 2004, PHYTOPATHOLOGY, V94, P177, DOI 10.1094/PHYTO.2004.94.2.177; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Sohn S, 2007, MOL CELLS, V24, P232; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Sun WC, 2010, EUR J PLANT PATHOL, V128, P39, DOI 10.1007/s10658-010-9625-x; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Umemura K, 2003, BIOSCI BIOTECH BIOCH, V67, P899, DOI 10.1271/bbb.67.899; VANETTEN HD, 1989, ANNU REV PHYTOPATHOL, V27, P143, DOI 10.1146/annurev.py.27.090189.001043; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wen W, 2001, ACTA PHYTOPATHOL SIN, V31, P296; [闻伟刚 Wen Weigang], 2003, [农业生物技术学报, Journol of Agricultural Biotechnology], V11, P192; Zhang L, 2011, J EXP BOT, V62, P4229, DOI 10.1093/jxb/err131; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	45	9	10	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43914	10.1371/journal.pone.0043914	http://dx.doi.org/10.1371/journal.pone.0043914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970151	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400025
J	Shapiro, RS; Zaas, AK; Betancourt-Quiroz, M; Perfect, JR; Cowen, LE				Shapiro, Rebecca S.; Zaas, Aimee K.; Betancourt-Quiroz, Marisol; Perfect, John R.; Cowen, Leah E.			The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; ADENYLYL-CYCLASE; HYPHAL GROWTH; KINASE; IDENTIFICATION; EPIDEMIOLOGY; VIRULENCE; EVOLUTION; PATHWAY; CDC37	The molecular chaperone Hsp90 orchestrates regulatory circuitry governing fungal morphogenesis, biofilm development, drug resistance, and virulence. Hsp90 functions in concert with co-chaperones to regulate stability and activation of client proteins, many of which are signal transducers. Here, we characterize the first Hsp90 co-chaperone in the leading human fungal pathogen, Candida albicans. We demonstrate that Sgt1 physically interacts with Hsp90, and that it governs C. albicans morphogenesis and drug resistance. Genetic depletion of Sgt1 phenocopies depletion of Hsp90, inducing yeast to filament morphogenesis and invasive growth. Sgt1 governs these traits by bridging two morphogenetic regulators: Hsp90 and the adenylyl cyclase of the cAMP-PKA signaling cascade, Cyr1. Sgt1 physically interacts with Cyr1, and depletion of either Sgt1 or Hsp90 activates cAMP-PKA signaling, revealing the elusive link between Hsp90 and the PKA signaling cascade. Sgt1 also mediates tolerance and resistance to the two most widely deployed classes of antifungal drugs, azoles and echinocandins. Depletion of Sgt1 abrogates basal tolerance and acquired resistance to azoles, which target the cell membrane. Depletion of Sgt1 also abrogates tolerance and resistance to echinocandins, which target the cell wall, and renders echinocandins fungicidal. Though Sgt1 and Hsp90 have a conserved impact on drug resistance, the underlying mechanisms are distinct. Depletion of Hsp90 destabilizes the client protein calcineurin, thereby blocking crucial responses to drug-induced stress; in contrast, depletion of Sgt1 does not destabilize calcineurin, but blocks calcineurin activation in response to drug-induced stress. Sgt1 influences not only morphogenesis and drug resistance, but also virulence, as genetic depletion of C. albicans Sgt1 leads to reduced kidney fungal burden in a murine model of systemic infection. Thus, our characterization of the first Hsp90 co-chaperone in a fungal pathogen establishes C. albicans Sgt1 as a global regulator of morphogenesis and drug resistance, providing a new target for treatment of life-threatening fungal infections.	[Shapiro, Rebecca S.; Cowen, Leah E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Zaas, Aimee K.; Betancourt-Quiroz, Marisol; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Zaas, Aimee K.; Perfect, John R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	University of Toronto; Duke University; Duke University	Shapiro, RS (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	leah.cowen@utoronto.ca	Shapiro, Rebecca/I-9247-2019	Shapiro, Rebecca/0000-0002-7119-8865; Betancourt Quiroz, Marisol/0000-0002-6920-9182; Cowen, Leah/0000-0001-5797-0110	Natural Sciences and Engineering Research Council of Canada (NSERC) CGS-D Award; Public Health Service [R01-AI73896]; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Ministry of Research and Innovation Early Researcher Award; Canada Research Chair in Microbial Genomics and Infectious Disease; Canadian Institutes of Health Research Grant [MOP-86452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073896] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC) CGS-D Award; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RSS is supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) CGS-D Award; JRP by Public Health Service Grants R01-AI73896; LEC by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, by a Ministry of Research and Innovation Early Researcher Award, by a Canada Research Chair in Microbial Genomics and Infectious Disease, and by Canadian Institutes of Health Research Grant MOP-86452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Bachewich C, 2003, MOL BIOL CELL, V14, P2163, DOI 10.1091/mbc.02-05-0076; Bahn YS, 2003, MOL MICROBIOL, V50, P391, DOI 10.1046/j.1365-2958.2003.03692.x; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Burt ET, 2003, ANN CLIN LAB SCI, V33, P86; Calderone RA., 2002, CANDIDA CANDIDIASIS; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; Fang HM, 2006, MOL MICROBIOL, V61, P484, DOI 10.1111/j.1365-2958.2006.05248.x; Flom GA, 2012, CURR GENET, V58, P149, DOI 10.1007/s00294-012-0373-7; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Krueger KE, 2004, MICROBIOL-SGM, V150, P229, DOI 10.1099/mic.0.26792-0; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Robbins N, 2010, FUNGAL GENET BIOL, V47, P81, DOI 10.1016/j.fgb.2009.07.004; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Senn H, 2012, MOL BIOL CELL, V23, P268, DOI 10.1091/mbc.E11-08-0729; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	72	63	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44734	10.1371/journal.pone.0044734	http://dx.doi.org/10.1371/journal.pone.0044734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970302	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400116
J	Fang, EF; Zhang, CZY; Zhang, L; Wong, JH; Chan, YS; Pan, WL; Dan, XL; Yin, CM; Cho, CH; Ng, TB				Fang, Evandro Fei; Zhang, Chris Zhi Yi; Zhang, Lin; Wong, Jack Ho; Chan, Yau Sang; Pan, Wen Liang; Dan, Xiu Li; Yin, Cui Ming; Cho, Chi Hin; Ng, Tzi Bun			Trichosanthin Inhibits Breast Cancer Cell Proliferation in Both Cell Lines and Nude Mice by Promotion of Apoptosis	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEIN; RICIN-A-CHAIN; ANTITUMOR-ACTIVITY; MOMORDICA-CHARANTIA; HIV DISEASE; IN-VITRO; ANTI-HIV; ABORTIFACIENT; REPLICATION; MECHANISMS	Breast cancer ranks as a common and severe neoplasia in women with increasing incidence as well as high risk of metastasis and relapse. Translational and laboratory-based clinical investigations of new/novel drugs are in progress. Medicinal plants are rich sources of biologically active natural products for drug development. The 27-kDa trichosanthin (TCS) is a ribosome inactivating protein purified from tubers of the Chinese herbal plant Trichosanthes kirilowii Maximowicz (common name Tian Hua Fen). In this study, we extended the potential medicinal applications of TCS from HIV, ferticide, hydatidiform moles, invasive moles, to breast cancer. We found that TCS manifested anti-proliferative and apoptosis-inducing activities in both estrogen-dependent human MCF-7 cells and estrogen-independent MDA-MB-231 cells. Flow cytometric analysis disclosed that TCS induced cell cycle arrest. Further studies revealed that TCS-induced tumor cell apoptosis was attributed to activation of both caspase-8 and caspase-9 regulated pathways. The subsequent events including caspase-3 activation, and increased PARP cleavage. With regard to cell morphology, stereotypical apoptotic features were observed. Moreover, in comparison with control, TCS-treated nude mice bearing MDA-MB-231 xenograft tumors exhibited significantly reduced tumor volume and tumor weight, due to the potent effect of TCS on tumor cell apoptosis as determined by the increase of caspase-3 activation, PARP cleavage, and DNA fragmentation using immunohistochemistry. Considering the clinical efficacy and relative safety of TCS on other human diseases, this work opens up new therapeutic avenues for patients with estrogen-dependent and/or estrogen-independent breast cancers.	[Fang, Evandro Fei; Zhang, Lin; Wong, Jack Ho; Chan, Yau Sang; Pan, Wen Liang; Dan, Xiu Li; Yin, Cui Ming; Cho, Chi Hin; Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Zhang, Chris Zhi Yi] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chris Zhi Yi] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University	Fang, EF (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	fangfei1030@yahoo.com.cn; b021770@mailserv.cuhk.edu.hk	Zhang, Chris Zhiyi/F-9862-2013; Fang, Evandro Fei/AAV-4653-2020; Fang, Evandro Fei/AAC-5511-2019; ZHANG, Lin/O-9109-2015; Cho, Chi Hin/C-6543-2014	ZHANG, Lin/0000-0003-1634-3780; Cho, Chi Hin/0000-0002-7658-3260; WONG, Jack/0000-0002-9732-986X; Fang, Evandro Fei/0000-0003-0355-7202				Balunas MJ, 2006, CHEM BIODIVERS, V3, P897, DOI 10.1002/cbdv.200690092; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Baselga J, 2011, N ENGL J MED; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; BYERS VS, 1990, AIDS, V4, P1189, DOI 10.1097/00002030-199012000-00002; BYERS VS, 1994, AIDS RES HUM RETROV, V10, P413, DOI 10.1089/aid.1994.10.413; Cai YC, 2011, CELL MOL IMMUNOL, V8, P359, DOI 10.1038/cmi.2011.12; Chan WL, 2000, BIOCHEM BIOPH RES CO, V270, P453, DOI 10.1006/bbrc.2000.2441; Chan WL, 2002, TOXICOLOGY, V177, P245, DOI 10.1016/S0300-483X(02)00226-3; CHAN WY, 1993, INT J FERTIL, V38, P99; Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326; Fang EF, 2011, CURR MED CHEM, V18, P4410; Fang EF, 2011, CURR MOL MED, V11, P417; Fang E. F, 2011, CANC PREV RES PHILA; Fang EF, CANC LETT IN PRESS; Fang EF, 2011, APOPTOSIS; Fang EF, 2012, CANCER PREV RES, V5, P109, DOI 10.1158/1940-6207.CAPR-11-0203; Fang EF, 2011, BBA-REV CANCER, V1815, P65, DOI 10.1016/j.bbcan.2010.09.001; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; He DX, 2010, BIOCHEM BIOPH RES CO, V402, P670, DOI 10.1016/j.bbrc.2010.10.080; He DX, 2011, MOL IMMUNOL, V48, P2000, DOI 10.1016/j.molimm.2011.06.217; Ho CY, 2005, CANCER BIOL THER, V4, P638, DOI 10.4161/cbt.4.6.1721; Hou X, 2011, CANC RES; Huang PL, 1999, BIOCHEM BIOPH RES CO, V262, P615, DOI 10.1006/bbrc.1999.1213; Jiang QS, 2011, MOL BIOL REP, V38, P2863, DOI 10.1007/s11033-010-0432-4; Jiao YZ, 2010, BIOCHEM BIOPH RES CO, V391, P1579, DOI 10.1016/j.bbrc.2009.12.006; Jin Y C, 1990, Shengzhi Yu Biyun, V10, P34; KAHN JO, 1994, ANTIMICROB AGENTS CH, V38, P260, DOI 10.1128/AAC.38.2.260; Komatsu N, 2000, J BIOCHEM-TOKYO, V128, P463, DOI 10.1093/oxfordjournals.jbchem.a022775; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Ledford H, 2010, NATURE, V468, P608, DOI 10.1038/468608a; Lee-Huang S, 2000, ANTICANCER RES, V20, P653; Li CT, 2010, PHARM BIOL, V48, P1302, DOI 10.3109/13880201003789432; Li J, 2007, BBA-GEN SUBJECTS, V1770, P1169, DOI 10.1016/j.bbagen.2007.04.007; Li J, 2007, BBA-GEN SUBJECTS, V1770, P63, DOI 10.1016/j.bbagen.2006.07.011; Li M, 2010, ANAT REC, V293, P986, DOI 10.1002/ar.21142; Li M, 2010, LIFE SCI, V86, P10, DOI 10.1016/j.lfs.2009.10.016; MARAGANORE JM, 1987, J BIOL CHEM, V262, P11628; MCGRATH MS, 1989, P NATL ACAD SCI USA, V86, P2844, DOI 10.1073/pnas.86.8.2844; Roy HK, 2004, MOL CANCER THER, V3, P1159; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Sha O, 2010, TOXICOL IN VITRO, V24, P1176, DOI 10.1016/j.tiv.2010.02.014; Shaw PC, 2005, TOXICON, V45, P683, DOI 10.1016/j.toxicon.2004.12.024; Wang P, 2007, LIFE SCI, V81, P1130, DOI 10.1016/j.lfs.2007.08.016; WANG QC, 1991, CANCER RES, V51, P3353; Xiang DJ, REPROD SCI IN PRESS; Zhang CZY, 2011, APOPTOSIS, V16, P683, DOI 10.1007/s10495-011-0597-x; Zhang CY, 2001, BIOCHEM J, V355, P653, DOI 10.1042/bj3550653; ZHANG XJ, 1986, NATURE, V321, P477	52	57	64	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41592	10.1371/journal.pone.0041592	http://dx.doi.org/10.1371/journal.pone.0041592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957017	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800009
J	Li, PP; Zhou, JJ; Meng, M; Madhavan, R; Peng, HB				Li, Pan P.; Zhou, Jie J.; Meng, Min; Madhavan, Raghavan; Peng, H. Benjamin			Reciprocal Regulation of Axonal Filopodia and Outgrowth during Neuromuscular Junction Development	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; P75 NEUROTROPHIN RECEPTOR; CULTURED MUSCLE-CELLS; IN-VIVO; DENDRITIC FILOPODIA; ACETYLCHOLINE-RECEPTORS; NEURITE OUTGROWTH; SYNAPSE FORMATION; CORTICAL-NEURONS	Background: The assembly of the vertebrate neuromuscular junction (NMJ) is initiated when nerve and muscle first contact each other by filopodial processes which are thought to enable close interactions between the synaptic partners and facilitate synaptogenesis. We recently reported that embryonic Xenopus spinal neurons preferentially extended filopodia towards cocultured muscle cells and that basic fibroblast growth factor (bFGF) produced by muscle activated neuronal FGF receptor 1 (FGFR1) to induce filopodia and favor synaptogenesis. Intriguingly, in an earlier study we found that neurotrophins (NTs), a different set of target-derived factors that act through Trk receptor tyrosine kinases, promoted neuronal growth but hindered presynaptic differentiation and NMJ formation. Thus, here we investigated how bFGF-and NT-signals in neurons jointly elicit presynaptic changes during the earliest stages of NMJ development. Methodology/Principal Findings: Whereas forced expression of wild-type TrkB in neurons reduced filopodial extension and triggered axonal outgrowth, expression of a mutant TrkB lacking the intracellular kinase domain enhanced filopodial growth and slowed axonal advance. Neurons overexpressing wild-type FGFR1 also displayed more filopodia than control neurons, in accord with our previous findings, and, notably, this elevation in filopodial density was suppressed when neurons were chronically treated from the beginning of the culture period with BDNF, the NT that specifically activates TrkB. Conversely, inhibition by BDNF of NMJ formation in nerve-muscle cocultures was partly reversed by the overexpression of bFGF in muscle. Conclusions: Our results suggest that the balance between neuronal FGFR1- and TrkB-dependent filopodial assembly and axonal outgrowth regulates the establishment of incipient NMJs.	[Li, Pan P.; Zhou, Jie J.; Meng, Min; Madhavan, Raghavan; Peng, H. Benjamin] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Li, PP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.	penghb@ust.hk	Li, Pan/Y-6619-2019; meng, meng/GWZ-7461-2022	Li, Pan/0000-0001-6084-6348; 	Hong Kong GRF [662311]; HKUST [RPC11SC10]	Hong Kong GRF(Hong Kong Research Grants Council); HKUST	This work was supported by Hong Kong GRF grant 662311 and HKUST grant RPC11SC10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ANDERSON MJ, 1984, J CELL BIOL, V99, P1769, DOI 10.1083/jcb.99.5.1769; ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; Araki T, 2000, J NEUROCHEM, V74, P659, DOI 10.1046/j.1471-4159.2000.740659.x; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chen G, 2012, MOL BIOL CE IN PRESS, V23; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; DAI ZS, 1995, J NEUROSCI, V15, P5466; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Fagan AM, 1996, J NEUROSCI, V16, P6208; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; Fiala JC, 1998, J NEUROSCI, V18, P8900; Frade JM, 1996, NATURE, V383, P166; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Hartmann M, 2004, J CELL SCI, V117, P5803, DOI 10.1242/jcs.01511; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Ketschek A, 2010, J NEUROSCI, V30, P12185, DOI 10.1523/JNEUROSCI.1740-10.2010; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Li PP, 2011, MOL BIOL CELL, V22, P2480, DOI 10.1091/mbc.E11-03-0198; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Madhavan R, 2006, J NEUROBIOL, V66, P134, DOI 10.1002/neu.20206; Madhavan R, 2006, J NEUROBIOL, V66, P1511, DOI 10.1002/neu.20320; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Peng HB, 2003, J NEUROSCI, V23, P5050; PENG HB, 1995, J NEUROSCI, V15, P3027; PENG HB, 1991, NEURON, V6, P237; PENG HB, 1991, METHOD CELL BIOL, V36, P511; Rimer M, 2007, J NEUROSCI RES, V85, P1827, DOI 10.1002/jnr.21237; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Seebach BS, 1999, J NEUROPHYSIOL, V81, P2398, DOI 10.1152/jn.1999.81.5.2398; Strochlic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029976; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; TAPLEY P, 1992, ONCOGENE, V7, P371; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; WONG V, 1993, EUR J NEUROSCI, V5, P466, DOI 10.1111/j.1460-9568.1993.tb00513.x; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yuen EC, 1999, EXP NEUROL, V159, P297, DOI 10.1006/exnr.1999.7148; Zhang B, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-7; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zhou H, 1997, MOL CELL NEUROSCI, V10, P56, DOI 10.1006/mcne.1997.0638; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	63	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44759	10.1371/journal.pone.0044759	http://dx.doi.org/10.1371/journal.pone.0044759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957106	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800099
J	Sun, YY; Zhu, ZH; Wang, RX; Sun, YN; Xu, TJ				Sun, Yueyan; Zhu, Zhihuang; Wang, Rixin; Sun, Yuena; Xu, Tianjun			Miiuy Croaker Transferrin Gene and Evidence for Positive Selection Events Reveal Different Evolutionary Patterns	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; VIBRIO-ANGUILLARUM; SERUM TRANSFERRIN; LIVER TRANSFERRIN; MESSENGER-RNA; CDNA	Transferrin (TF) is a protein that plays a central role in iron metabolism. This protein is associated with the innate immune system, which is responsible for disease defense responses after bacterial infection. The clear link between TF and the immune defense mechanism has led researchers to consider TF as a candidate gene for disease resistance. In this study, the Miichthys miiuy (miiuy croaker) TF gene (MIMI-TF) was cloned and characterized. The gene structure consisted of a coding region of 2070 nucleotides divided into 17 exons, as well as a non-coding region that included 16 introns and spans 6757 nucleotides. The deduced MIMI-TF protein consisted of 689 amino acids that comprised a signal peptide and two lobes (Nand C-lobes). MIMI-TF expression was significantly up-regulated after infection with Vibrio anguillarum. A series of model tests implemented in the CODEML program showed that TF underwent a complex evolutionary process. Branch-site models revealed that vertebrate TF was vastly different from that of invertebrates, and that the TF of the ancestors of aquatic and terrestrial organisms underwent different selection pressures. The site models detected 10 positively selected sites in extant TF genes. One site was located in the cleft between the N1 and N2 domains and was expected to affect the capability of TF to bind to or release iron indirectly. In addition, eight sites were found near the TF exterior. Two of these sites, which could have evolved from the competition for iron between pathogenic bacteria and TF, were located in potential pathogen-binding domains. Our results could be used to further investigate the function of TF and the selective mechanisms involved.	[Sun, Yueyan; Zhu, Zhihuang; Wang, Rixin; Sun, Yuena; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China	Zhejiang Ocean University	Sun, YY (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China.	tianjunxu@163.com	Xu, Tianjun/G-2545-2013		Nation Nature Science Foundation of China [31001120]; Zhejiang Provincial Natural Science Foundation of China [Y3100013, Y12C030014]	Nation Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by Nation Nature Science Foundation of China (31001120) and Zhejiang Provincial Natural Science Foundation of China (Y3100013, Y12C030014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; BALDWIN GS, 1988, NUCLEIC ACIDS RES, V16, P8720, DOI 10.1093/nar/16.17.8720; BANFIELD DK, 1991, BIOCHIM BIOPHYS ACTA, V1089, P262, DOI 10.1016/0167-4781(91)90021-D; BARTFELD NS, 1990, J BIOL CHEM, V265, P21684; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; CARPENTER MA, 1993, BIOCHIM BIOPHYS ACTA, V1173, P230, DOI 10.1016/0167-4781(93)90186-H; Ciuraszkiewicz J, 2007, ACTA BIOCHIM POL, V54, P175, DOI 10.18388/abp.2007_3284; Ciuraszklewicz J, 2007, GENE, V396, P28, DOI 10.1016/j.gene.2007.02.018; DenovanWright EM, 1996, COMP BIOCHEM PHYS B, V113, P269, DOI 10.1016/0305-0491(95)02023-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ford MJ, 1999, MOL ECOL, V8, P1055, DOI 10.1046/j.1365-294x.1999.00651.x; Ford MJ, 2001, MOL BIOL EVOL, V18, P639, DOI 10.1093/oxfordjournals.molbev.a003844; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; HIRONO I, 1995, J MAR BIOTECHNOL, V2, P193; HUEBERS HA, 1982, J COMP PHYSIOL, V148, P101, DOI 10.1007/BF00688893; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JAMIESON A, 1990, ANIM GENET, V21, P295, DOI 10.1111/j.1365-2052.1990.tb03239.x; JAMROZ RC, 1993, P NATL ACAD SCI USA, V90, P1320, DOI 10.1073/pnas.90.4.1320; JELTSCH JM, 1982, EUR J BIOCHEM, V122, P291, DOI 10.1111/j.1432-1033.1982.tb05879.x; Kvingedal Ane M., 1993, Molecular Marine Biology and Biotechnology, V2, P233; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Lee J, 1995, FISH PATHOLOGY, V30; Lee JY, 1998, MOL MAR BIOL BIOTECH, V7, P287; Liu H, 2010, FISH SHELLFISH IMMUN, V28, P159, DOI 10.1016/j.fsi.2009.10.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEHR TM, 1989, IRON CARRIERS IRON P; Lou B., 2004, CHIN J MOD FISH, V6, P11; MARTINEZ JL, 1990, FEMS MICROBIOL LETT, V75, P45, DOI 10.1016/0378-1097(90)90522-R; Mikawa N, 1996, MOL MAR BIOL BIOTECH, V5, P225; MOSKAITIS JE, 1990, NUCLEIC ACIDS RES, V18, P6135, DOI 10.1093/nar/18.20.6135; Mount D. W., 2001, BIOINFORMATICS SEQUE; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Retzer MD, 1999, MOL MICROBIOL, V32, P111, DOI 10.1046/j.1365-2958.1999.01331.x; ROED KH, 1995, FISH SHELLFISH IMMUN, V5, P71, DOI 10.1016/S1050-4648(05)80008-7; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Taboy CH, 2001, J BIOL CHEM, V276, P2719, DOI 10.1074/jbc.M004763200; Tange N, 1997, MOL MAR BIOL BIOTECH, V6, P351; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORANZO AE, 1990, DIS AQUAT ORGAN, V9, P73, DOI 10.3354/dao009073; Xu TJ, 2008, FISH SHELLFISH IMMUN, V25, P213, DOI 10.1016/j.fsi.2008.05.007; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Xu TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023823; YANG FM, 1984, P NATL ACAD SCI-BIOL, V81, P2752, DOI 10.1073/pnas.81.9.2752; Yang L, 2004, MOL BIOL EVOL, V21, P1264, DOI 10.1093/molbev/msh121; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337; Zak O, 2002, BIOCHEMISTRY-US, V41, P1647, DOI 10.1021/bi015868w	54	32	34	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43936	10.1371/journal.pone.0043936	http://dx.doi.org/10.1371/journal.pone.0043936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957037	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800029
J	Wang, YJ; Wang, JF; Ping, J; Yu, Y; Wang, Y; Lian, P; Li, X; Li, YX; Hao, P				Wang, Ya-Jun; Wang, Jing-Fang; Ping, Jie; Yu, Yao; Wang, Ying; Lian, Peng; Li, Xuan; Li, Yi-Xue; Hao, Pei			Computational Studies on the Substrate Interactions of Influenza A Virus PB2 Subunit	PLOS ONE			English	Article							CAP-BINDING-PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; M2 PROTON CHANNEL; MESSENGER-RNA; STRUCTURAL BASIS; DRUG-RESISTANCE; RECOGNITION; STACKING; OSELTAMIVIR; MECHANISM	Influenza virus, which spreads around the world in seasonal epidemics and leads to large numbers of deaths every year, has several ribonucleoproteins in the central core of the viral particle. These viral ribonucleoproteins can specifically bind the conserved 39 and 59 caps of the viral RNAs with responsibility for replication and transcription of the viral RNA in the nucleus of infected cells. A fundamental question of most importance is that how the cap-binding proteins in the influenza virus discriminates between capped RNAs and non-capped ones. To get an answer, we performed molecular dynamics simulations and free energy calculations on the influenza A virus PB2 subunit, an important component of the RNP complexes, with a cap analog m7GTP. Our calculations showed that some key residues in the active site, such as Arg355, His357, Glu361 as well as Gln406, could offer significant hydrogen bonding and hydrophobic interactions with the guanine ring of the cap analog m7GTP to form an aromatic sandwich mechanism for the cap recognition and positioning in the active site. Subsequently, we applied this idea to a virtual screening procedure and identified 5 potential candidates that might be inhibitors against the PB2 subunit. Interestingly, 2 candidates Cpd1 and Cpd2 have been already reported to have inhibitory activities to the influenza virus cap-binding proteins. Further calculation also showed that they had comparatively higher binding affinities to the PB2 subunit than that of m7GTP. We believed that our findings could give an atomic insight into the deeper understanding of the cap recognition and binding mechanism, providing useful information for searching or designing novel drugs against influenza viruses.	[Wang, Ya-Jun; Wang, Jing-Fang; Ping, Jie; Wang, Ying; Lian, Peng] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China; [Wang, Jing-Fang; Yu, Yao; Li, Xuan; Li, Yi-Xue; Hao, Pei] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Li, Yi-Xue] Chinese Acad Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Yu, Yao; Li, Xuan] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Hao, Pei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, YJ (corresponding author), Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China.	jfwang8113@sjtu.edu.cn; phao@sibs.ac.cn	Wang, Jingfang/Q-2597-2018; Lian, Peng/L-3862-2013	Wang, Jingfang/0000-0002-1355-5481; Hao, Pei/0000-0002-1498-7059	National Basic Research Program of China (973 Program) [2012CB517900]; National Key Basic Research Program [30800210]; National Natural Science Foundation of China [90913009]; Shanghai Pujiang Scholarship Program [10PJ1408000]; Doctoral Program Foundation of Institutions of Higher Education of China [20110073120078]; China Postdoctoral Science Foundation [20110490068]; SA-SIBS scholarship Program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Scholarship Program(Shanghai Pujiang Program); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SA-SIBS scholarship Program	This work was supported by the grants from the National Basic Research Program of China (973 Program, No. 2012CB517900), National Key Basic Research Program (No. 30800210), National Natural Science Foundation of China (Major Program, No. 90913009), Shanghai Pujiang Scholarship Program (No. 10PJ1408000), Doctoral Program Foundation of Institutions of Higher Education of China (No. 20110073120078), and China Postdoctoral Science Foundation (No. 20110490068). The authors gratefully acknowledge the support of SA-SIBS scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Borroso L, 2005, ANTIVIR THER, V10, P901; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Chen Y, 2010, CHEM BIOL DRUG DES, V75, P295, DOI 10.1111/j.1747-0285.2009.00935.x; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DARZYNKIEWICZ E, 1989, BIOPHYS CHEM, V33, P289, DOI 10.1016/0301-4622(89)80030-4; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Hooker L, 2003, BIOCHEMISTRY-US, V42, P6234, DOI 10.1021/bi027081r; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; ISHIDA T, 1988, NUCLEIC ACIDS RES, V16, P6175, DOI 10.1093/nar/16.13.6175; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lamb RA, 1993, ANNU REV BIOCHEM, V52, P467; Lee RV, 2007, LANCET INFECT DIS, V7, P760, DOI 10.1016/S1473-3099(07)70270-0; Leung TWC, 2009, J CLIN VIROL, V46, P298, DOI 10.1016/j.jcv.2009.08.004; Li J, 2011, J CHEM INF MODEL, V51, P3217, DOI 10.1021/ci2004016; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pielak RM, 2010, PROTEIN CELL, V1, P246, DOI 10.1007/s13238-010-0025-y; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Qin F, 2011, PHYS CHEM CHEM PHYS, V13, P1407, DOI 10.1039/c0cp00701c; Qin F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3224126; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Stolarski R, 1996, BBA-PROTEIN STRUCT M, V1293, P97, DOI 10.1016/0167-4838(95)00232-4; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1075, P181, DOI 10.1016/0304-4165(91)90249-G; Wang JF, 2012, J MOL MODEL, V18, P2717, DOI 10.1007/s00894-011-1295-x; Wang JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031048; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang J, 2008, BIOPHYS J, V95, P5037, DOI 10.1529/biophysj.108.131672; Wang NX, 2009, PROTEIN SCI, V18, P707, DOI 10.1002/pro.77; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Zeng QK, 2009, BIOTECHNOL LETT, V31, P1025, DOI 10.1007/s10529-009-9980-x	58	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44079	10.1371/journal.pone.0044079	http://dx.doi.org/10.1371/journal.pone.0044079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957044	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800036
J	Zavareh, RB; Sukhai, MA; Hurren, R; Gronda, M; Wang, XM; Simpson, CD; Maclean, N; Zih, F; Ketela, T; Swallow, CJ; Moffat, J; Rose, DR; Schachter, H; Schimmer, AD; Dennis, JW				Zavareh, Reza Beheshti; Sukhai, Mahadeo A.; Hurren, Rose; Gronda, Marcela; Wang, Xiaoming; Simpson, Craig D.; Maclean, Neil; Zih, Francis; Ketela, Troy; Swallow, Carol J.; Moffat, Jason; Rose, David R.; Schachter, Harry; Schimmer, Aaron D.; Dennis, James W.			Suppression of Cancer Progression by MGAT1 shRNA Knockdown	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE V; ASPARAGINE-LINKED OLIGOSACCHARIDES; TUMOR-CELLS; TRANSCRIPTIONAL REGULATION; ADVANCED MALIGNANCIES; ENZYMATIC BASIS; GROWTH; MICE; SWAINSONINE; INHIBITION	Oncogenic signaling promotes tumor invasion and metastasis, in part, by increasing the expression of tri- and tetra-branched N-glycans. The branched N-glycans bind to galectins forming a multivalent lattice that enhances cell surface residency of growth factor receptors, and focal adhesion turnover. N-acetylglucosaminyltransferase I (MGAT1), the first branching enzyme in the pathway, is required for the addition of all subsequent branches. Here we have introduced MGAT1 shRNA into human HeLa cervical and PC-3-Yellow prostate tumor cells lines, generating cell lines with reduced transcript, enzyme activity and branched N-glycans at the cell surface. MGAT1 knockdown inhibited HeLa cell migration and invasion, but did not alter cell proliferation rates. Swainsonine, an inhibitor of alpha-mannosidase II immediately downstream of MGAT1, also inhibited cell invasion and was not additive with MGAT1 shRNA, consistent with a common mechanism of action. Focal adhesion and microfilament organization in MGAT1 knockdown cells also indicate a less motile phenotype. In vivo, MGAT1 knockdown in the PC-3-Yellow orthotopic prostate cancer xenograft model significantly decreased primary tumor growth and the incidence of lung metastases. Our results demonstrate that blocking MGAT1 is a potential target for anti-cancer therapy.	[Zavareh, Reza Beheshti; Sukhai, Mahadeo A.; Hurren, Rose; Gronda, Marcela; Wang, Xiaoming; Maclean, Neil; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Zavareh, Reza Beheshti; Sukhai, Mahadeo A.; Hurren, Rose; Gronda, Marcela; Wang, Xiaoming; Maclean, Neil; Schimmer, Aaron D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Simpson, Craig D.; Zih, Francis; Swallow, Carol J.; Dennis, James W.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Ketela, Troy; Moffat, Jason] Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Schachter, Harry] Univ Toronto, Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Waterloo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Zavareh, RB (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada.	aaron.schimmer@utoronto.ca; dennis@lunenfeld.ca	Moffat, Jason/AAC-1110-2020; Zavareh, Reza Beheshti/D-8118-2016; Dennis, James/E-7268-2013	Moffat, Jason/0000-0002-5663-8586; Zavareh, Reza Beheshti/0000-0002-3345-408X; Schimmer, Aaron/0000-0003-4023-3899	Canadian Institutes of Health Research (CIHR) [MOP-62975]; Canada Research Chair (CRC) [950-202079]; Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (CRC)(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Research was supported by grants from the Canadian Institutes of Health Research (CIHR) (MOP-62975) and Canada Research Chair (CRC) (950-202079) to JWD, and Canadian Institutes of Health Research (CIHR) to ADS, who is a CIHR Clinician Scientist and a Leukemia and Lymphoma Society Scholar in Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunelleschi S, 2002, CURR PHARM DESIGN, V8, P1959, DOI 10.2174/1381612023393530; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cheung P, 2007, GLYCOBIOLOGY, V17, P767, DOI 10.1093/glycob/cwm037; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; DENNIS JW, 1990, CANCER RES, V50, P1867; FERNANDES B, 1991, CANCER RES, V51, P718; Glinsky GV, 2006, CELL CYCLE, V5, P191, DOI 10.4161/cc.5.2.2320; GOSS PE, 1994, CANCER RES, V54, P1450; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Granovsky M, 2000, NAT MED, V6, P306; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Seelentag WKF, 1998, CANCER RES, V58, P5559; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Takamatsu S, 1999, CANCER RES, V59, P3949; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Xu GW, 2008, APOPTOSIS, V13, P413, DOI 10.1007/s10495-007-0175-4; YAGEL S, 1989, INT J CANCER, V44, P685, DOI 10.1002/ijc.2910440422; YAMASHITA K, 1985, J BIOL CHEM, V260, P3963; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833	38	29	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43721	10.1371/journal.pone.0043721	http://dx.doi.org/10.1371/journal.pone.0043721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957033	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800025
J	Aguado-Fraile, E; Ramos, E; Saenz-Morales, D; Conde, E; Blanco-Sanchez, I; Stamatakis, K; del Peso, L; Cuppen, E; Brune, B; Garcia Bermejo, ML				Aguado-Fraile, Elia; Ramos, Edurne; Saenz-Morales, David; Conde, Elisa; Blanco-Sanchez, Ignacio; Stamatakis, Konstantinos; del Peso, Luis; Cuppen, Edwin; Bruene, Bernhard; Garcia Bermejo, Maria Laura			miR-127 Protects Proximal Tubule Cells against Ischemia/Reperfusion: Identification of Kinesin Family Member 3B as miR-127 Target	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; ACUTE-KIDNEY-INJURY; EPITHELIAL-CELLS; EXPRESSION; MICRORNAS; PATHOPHYSIOLOGY; RAT; TRANSCRIPTION; HYDROXYLASES	Ischemia/reperfusion (I/R) is at the basis of renal transplantation and acute kidney injury. Molecular mechanisms underlying proximal tubule response to I/R will allow the identification of new therapeutic targets for both clinical settings. microRNAs have emerged as crucial and tight regulators of the cellular response to insults including hypoxia. Here, we have identified several miRNAs involved in the response of the proximal tubule cell to I/R. Microarrays and RT-PCR analysis of proximal tubule cells submitted to I/R mimicking conditions in vitro demonstrated that miR-127 is induced during ischemia and also during reperfusion. miR-127 is also modulated in a rat model of renal I/R. Interference approaches demonstrated that ischemic induction of miR-127 is mediated by Hypoxia Inducible Factor-1alpha (HIF-1 alpha) stabilization. Moreover, miR-127 is involved in cell-matrix and cell-cell adhesion maintenance, since overexpression of miR-127 maintains focal adhesion complex assembly and the integrity of tight junctions. miR-127 also regulates intracellular trafficking since miR-127 interference promotes dextran-FITC uptake. In fact, we have identified the Kinesin Family Member 3B (KIF3B), involved in cell trafficking, as a target of miR-127 in rat proximal tubule cells. In summary, we have described a novel role of miR-127 in cell adhesion and its regulation by HIF-1 alpha. We also identified for the first time KIF3B as a miR-127 target. Both, miR-127 and KIF3B appear as key mediators of proximal epithelial tubule cell response to I/R with potential al application in renal ischemic damage management.	[Aguado-Fraile, Elia; Ramos, Edurne; Saenz-Morales, David; Conde, Elisa; Blanco-Sanchez, Ignacio; Garcia Bermejo, Maria Laura] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Dept Pathol, Madrid, Spain; [Stamatakis, Konstantinos] Ctr Biol Mol Severo Ochoa CBM SO CSIC UAM, Dept Cell Biol & Immunol, Madrid, Spain; [del Peso, Luis] Hosp La Paz IdiPAZ, HIV Unit, Dept Biochem, Madrid, Spain; [del Peso, Luis] CSIC UAM, Inst Biomed Res Alberto Sols, Madrid, Spain; [Cuppen, Edwin] Hubrecht Inst, Genome Biol Grp, Utrecht, Netherlands; [Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Frankfurt, Germany; [Garcia Bermejo, Maria Laura] Alcala Univ, Dept Physiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Goethe University Frankfurt; Universidad de Alcala	Aguado-Fraile, E (corresponding author), Inst Ramon & Cajal Invest Sanitaria IRYCIS, Dept Pathol, Madrid, Spain.	mgarciab.hrc@salud.madrid.org	Cuppen, Edwin/H-2389-2016; MORENO, ELISA CONDE/H-7853-2017; García-Bermejo, María Laura/E-1542-2015; Conde-Moreno, Elisa/AAG-2295-2021; Stamatakis, Konstantinos/A-6596-2017; Cuppen, Edwin/F-5696-2011; del Peso, Luis/K-9391-2014	Cuppen, Edwin/0000-0002-0400-9542; MORENO, ELISA CONDE/0000-0002-3751-9602; García-Bermejo, María Laura/0000-0002-8167-2276; Conde-Moreno, Elisa/0000-0002-3751-9602; Stamatakis, Konstantinos/0000-0001-9934-3502; Cuppen, Edwin/0000-0002-0400-9542; del Peso, Luis/0000-0003-4014-5688; Ramos, Edurne/0000-0001-5388-0281	Instituto de Salud Carlos III; Ayuda Intramural Fundacion para la Investigacion en Biomedicina del Hospital Universitario Ramon y Cajal [122/2009];  [FIS PS09/02183]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ayuda Intramural Fundacion para la Investigacion en Biomedicina del Hospital Universitario Ramon y Cajal; 	This work was supported by grant FIS PS09/02183 funding by Instituto de Salud Carlos III and Ayuda Intramural Fundacion para la Investigacion en Biomedicina del Hospital Universitario Ramon y Cajal 122/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Crosby ME, 2005, CURR PHARM DESIGN, V15, P3861; Duangtum N, 2011, BIOCHEM BIOPH RES CO, V413, P69, DOI 10.1016/j.bbrc.2011.08.050; Fasanaro P, 2010, PHARMACOL THERAPEUT, V125, P92, DOI 10.1016/j.pharmthera.2009.10.003; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim Gene H, 2011, Pulm Circ, V1, P347, DOI 10.4103/2045-8932.87300; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leucci E, 2010, INT J CANCER, V126, P1316, DOI 10.1002/ijc.24655; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Lujambio A, 2010, ONCOGENE, V29, P6390, DOI 10.1038/onc.2010.361; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Saenz-Morales D, 2006, EXP CELL RES, V312, P3711, DOI 10.1016/j.yexcr.2006.05.024; Saenz-Morales D, 2010, KIDNEY INT, V77, P781, DOI 10.1038/ki.2010.10; Saenz-Morales D, 2009, CELL PHYSIOL BIOCHEM, V23, P285, DOI 10.1159/000218175; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005	47	61	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44305	10.1371/journal.pone.0044305	http://dx.doi.org/10.1371/journal.pone.0044305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962609	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600037
J	Lacroix, R; McKemey, AR; Raduan, N; Wee, LK; Ming, WH; Ney, TG; Rahidah, AAS; Salman, S; Subramaniam, S; Nordin, O; Hanum, ATN; Angamuthu, C; Mansor, SM; Lees, RS; Naish, N; Scaife, S; Gray, P; Labbe, G; Beech, C; Nimmo, D; Alphey, L; Vasan, SS; Lim, LH; Wasi, AN; Murad, S				Lacroix, Renaud; McKemey, Andrew R.; Raduan, Norzahira; Wee, Lim Kwee; Ming, Wong Hong; Ney, Teoh Guat; Rahidah, Siti A. A.; Salman, Sawaluddin; Subramaniam, Selvi; Nordin, Oreenaiza; Hanum, Norhaida A. T.; Angamuthu, Chandru; Mansor, Suria Marlina; Lees, Rosemary S.; Naish, Neil; Scaife, Sarah; Gray, Pam; Labbe, Genevieve; Beech, Camilla; Nimmo, Derric; Alphey, Luke; Vasan, Seshadri S.; Lim, Lee Han; Wasi, Nazni A.; Murad, Shahnaz			Open Field Release of Genetically Engineered Sterile Male Aedes aegypti in Malaysia	PLOS ONE			English	Article							MOSQUITO-BORNE DISEASES; TRANSGENIC MOSQUITOS; DISPERSAL; FITNESS; POPULATION; RESISTANCE; DOMINANT; SURVIVAL; COMPETITION; RECAPTURE	Background: Dengue is the most important mosquito-borne viral disease. In the absence of specific drugs or vaccines, control focuses on suppressing the principal mosquito vector, Aedes aegypti, yet current methods have not proven adequate to control the disease. New methods are therefore urgently needed, for example genetics-based sterile-male-release methods. However, this requires that lab-reared, modified mosquitoes be able to survive and disperse adequately in the field. Methodology/Principal Findings: Adult male mosquitoes were released into an uninhabited forested area of Pahang, Malaysia. Their survival and dispersal was assessed by use of a network of traps. Two strains were used, an engineered 'genetically sterile' (OX513A) and a wild-type laboratory strain, to give both absolute and relative data about the performance of the modified mosquitoes. The two strains had similar maximum dispersal distances (220 m), but mean distance travelled of the OX513A strain was lower (52 vs. 100 m). Life expectancy was similar (2.0 vs. 2.2 days). Recapture rates were high for both strains, possibly because of the uninhabited nature of the site. Conclusions/Significance: After extensive contained studies and regulatory scrutiny, a field release of engineered mosquitoes was safely and successfully conducted in Malaysia. The engineered strain showed similar field longevity to an unmodified counterpart, though in this setting dispersal was reduced relative to the unmodified strain. These data are encouraging for the future testing and implementation of genetic control strategies and will help guide future field use of this and other engineered strains.	[Lacroix, Renaud; Raduan, Norzahira; Vasan, Seshadri S.] Oxitec Sendirian Berhad, Kuala Lumpur, Wilayah Perseku, Malaysia; [Lacroix, Renaud; McKemey, Andrew R.; Naish, Neil; Scaife, Sarah; Gray, Pam; Labbe, Genevieve; Beech, Camilla; Nimmo, Derric; Alphey, Luke] Oxitec Ltd, Oxford, England; [Raduan, Norzahira; Wee, Lim Kwee; Ming, Wong Hong; Ney, Teoh Guat; Rahidah, Siti A. A.; Salman, Sawaluddin; Subramaniam, Selvi; Nordin, Oreenaiza; Hanum, Norhaida A. T.; Angamuthu, Chandru; Mansor, Suria Marlina; Vasan, Seshadri S.; Lim, Lee Han; Wasi, Nazni A.] Inst Med Res, Med Entomol Unit, Kuala Lumpur 50588, Wilayah Perseku, Malaysia; [Lees, Rosemary S.; Vasan, Seshadri S.] Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Kementerian Kesihatan Malaysia; Universiti Malaya; University of Oxford	Lacroix, R (corresponding author), Oxitec Sendirian Berhad, Kuala Lumpur, Wilayah Perseku, Malaysia.	Luke.Alphey@oxitec.com; leehl@imr.gov.my	Lees, Rosemary Susan/H-3425-2019	Lees, Rosemary Susan/0000-0002-4232-9125; Labbe, Genevieve/0000-0002-1015-8579; Alphey, Luke/0000-0002-2916-3802; Beech, Camilla/0000-0001-8348-9566	National Institutes of Health from the Ministry of Health, Malaysia [JPP-IMR 06-053]; Oxitec Ltd.	National Institutes of Health from the Ministry of Health, Malaysia; Oxitec Ltd.	This study was supported by a grant from the National Institutes of Health from the Ministry of Health, Malaysia (code: JPP-IMR 06-053). Oxitec Ltd. provided salary and other support for the research program of those authors employed by the company (as noted in the author list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2004, J ECON ENTOMOL, V97, P1181, DOI 10.1603/0022-0493(2004)097[1181:PFOTSO]2.0.CO;2; Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2007, J ECON ENTOMOL, V100, P1642, DOI 10.1603/0022-0493(2007)100[1642:MIRBMR]2.0.CO;2; Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384; Alphey N, 2011, J THEOR BIOL, V270, P42, DOI 10.1016/j.jtbi.2010.11.016; Alphey N, 2009, J ECON ENTOMOL, V102, P717, DOI 10.1603/029.102.0233; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Bargielowski I, 2012, VECTOR-BORNE ZOONOT, V12, P1053, DOI 10.1089/vbz.2012.0994; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Chee Y.C., 2005, REPORT EXPERT PANEL; Clements A.N., 1999, BIOL MOSQUITOES SENS; Coleman PG, 2004, TROP MED INT HEALTH, V9, P433, DOI 10.1111/j.1365-3156.2004.01225.x; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Dyck V.A., 2006, STERILE INSECT TECHN; Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kongmee M, 2010, J MED ENTOMOL, V47, P1092, DOI 10.1603/ME10046; Lambrechts L, 2008, TRENDS PARASITOL, V24, P4, DOI 10.1016/j.pt.2007.09.009; Lee H. L., 1992, Mosquito Borne Diseases Bulletin, V9, P9; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Lee HL, 2009, DENGUE B, V33; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; MORRIS CD, 1991, J AM MOSQUITO CONTR, V7, P608; Nazni W. A., 2009, Dengue Bulletin, V33, P124; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tee AS, 1997, GUIDELINES USE OVITR, P6; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; WHO/TDR, 2009, DENG GUID DIAGN TREA; WHO-TDR 2006, 2006, SCI WORK GROUP REP D; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	57	168	177	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e42771	10.1371/journal.pone.0042771	http://dx.doi.org/10.1371/journal.pone.0042771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970102	Green Submitted, gold, Green Published			2022-12-27	WOS:000308044800011
J	Makeyev, AV; Enkhmandakh, B; Hong, SH; Joshi, P; Shin, DG; Bayarsaihan, D				Makeyev, Aleksandr V.; Enkhmandakh, Badam; Hong, Seung-Hyun; Joshi, Pujan; Shin, Dong-Guk; Bayarsaihan, Dashzeveg			Diversity and Complexity in Chromatin Recognition by TFII-I Transcription Factors in Pluripotent Embryonic Stem Cells and Embryonic Tissues	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; FAMILY TARGET GENES; BINDING PROTEIN; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; ELEMENT; GENOME; MEMBER; BEN	GTF2I and GTF2IRD1 encode a family of closely related transcription factors TFII-I and BEN critical in embryonic development. Both genes are deleted in Williams-Beuren syndrome, a complex genetic disorder associated with neurocognitive, craniofacial, dental and skeletal abnormalities. Although genome-wide promoter analysis has revealed the existence of multiple TFII-I binding sites in embryonic stem cells (ESCs), there was no correlation between TFII-I occupancy and gene expression. Surprisingly, TFII-I recognizes the promoter sequences enriched for H3K4me3/K27me3 bivalent domain, an epigenetic signature of developmentally important genes. Moreover, we discovered significant differences in the association between TFII-I and BEN with the cis-regulatory elements in ESCs and embryonic craniofacial tissues. Our data indicate that in embryonic tissues BEN, but not the highly homologous TFII-I, is primarily recruited to target gene promoters. We propose a "feed-forward model" of gene regulation to explain the specificity of promoter recognition by TFII-I factors in eukaryotic cells.	[Makeyev, Aleksandr V.; Enkhmandakh, Badam; Bayarsaihan, Dashzeveg] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev,Sch Dent, Farmington, CT USA; [Hong, Seung-Hyun; Joshi, Pujan; Shin, Dong-Guk] Univ Connecticut, Sch Engn, Storrs, CT USA	University of Connecticut; University of Connecticut	Makeyev, AV (corresponding author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev,Sch Dent, Farmington, CT USA.	dashzeveg@uchc.edu			National Institutes of Health (NIH) [K02 DE18412, R01DE017205]; State of Connecticut Stem Cell Initiative [09-SCB-UCHC, 06SCC04]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017205, K02DE018412] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut Stem Cell Initiative; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (NIH) grants K02 DE18412 and R01DE017205 and State of Connecticut Stem Cell Initiative 09-SCB-UCHC to DB. The work by SH, PJ and DG was supported in part by the funding from State of Connecticut Stem Cell Initiative (Project No. 06SCC04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Bayarsaihan D, 2012, J CELL BIOCHEM, V113, P3056, DOI 10.1002/jcb.24202; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Chimge NO, 2012, J CELL BIOCHEM, V113, P1122, DOI 10.1002/jcb.23441; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Enkhmandakh B, 2004, GENE EXPR PATTERNS, V4, P25, DOI 10.1016/S1567-133X(03)00155-8; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kambere MB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S2; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lazebnik MB, 2008, J BIOL CHEM, V283, P11078, DOI 10.1074/jbc.C800049200; Li QR, 2011, MOL CELLULAR PROTOMI, V10, pM110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Makeyev AV, 2011, CLEFT PALATE-CRAN J, V48, P109, DOI 10.1597/09-093; Makeyev AV, 2009, BIOCHEM BIOPH RES CO, V386, P554, DOI 10.1016/j.bbrc.2009.06.045; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Ogura Y, 2006, GENES CELLS, V11, P373, DOI 10.1111/j.1365-2443.2006.00952.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Salbaum JM, 2010, BIRTH DEFECTS RES A, V88, P601, DOI 10.1002/bdra.20680; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003	38	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44443	10.1371/journal.pone.0044443	http://dx.doi.org/10.1371/journal.pone.0044443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970219	Green Submitted, Green Published, gold			2022-12-27	WOS:000308748400018
J	Pellissier, G; Yazdanpanah, Y; Adehossi, E; Tosini, W; Madougou, B; Ibrahima, K; Lolom, I; Legac, S; Rouveix, E; Champenois, K; Rabaud, C; Bouvet, E				Pellissier, Gerard; Yazdanpanah, Yazdan; Adehossi, Eric; Tosini, William; Madougou, Boubacar; Ibrahima, Kaza; Lolom, Isabelle; Legac, Sylvie; Rouveix, Elisabeth; Champenois, Karen; Rabaud, Christian; Bouvet, Elisabeth			Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger	PLOS ONE			English	Article							B-VIRUS INFECTION; HEPATITIS-B; BLOOD; PREVALENCE; RISK; MANAGEMENT; EXPOSURES; SURGEONS; MARKERS; AFRICA	Background: Exposure to hepatitis B virus (HBV) remains a serious risk to healthcare workers (HCWs) in endemic developing countries owing to the strong prevalence of HBV in the general and hospital populations, and to the high rate of occupational blood exposure. Routine HBV vaccination programs targeted to high-risk groups and especially to HCWs are generally considered as a key element of prevention strategies. However, the high rate of natural immunization among adults in such countries where most infections occur perinatally or during early childhood must be taken into account. Methodology/Principal Findings: We conducted a cross sectional study in 207 personnel of 4 occupational groups (medical, paramedical, cleaning staff, and administrative) in Niamey's National Hospital, Niger, in order to assess the prevalence of HBV markers, to evaluate susceptibility to HBV infection, and to identify personnel who might benefit from vaccination. The proportion of those who declared a history of occupational blood exposure ranged from 18.9% in the administrative staff to 46.9% in paramedical staff. Only 7.2% had a history of vaccination against HBV with at least 3 injections. Ninety two percent were anti-HBc positive. When we focused on170 HCWs, only 12 (7.1%) showed no biological HBV contact. Twenty six were HBsAg positive (15,3%; 95% confidence interval: 9.9%-20.7%) of whom 8 (32%) had a viral load >2000 IU/ml. Conclusions/Significance: The very small proportion of HCWs susceptible to HBV infection in our study and other studies suggests that in a global approach to prevent occupational infection by bloodborne pathogens, a universal hepatitis B vaccination of HCWs is not priority in these settings. The greatest impact on the risk will most likely be achieved by focusing efforts on primary prevention strategies to reduce occupational blood exposure. HBV screening in HCWs and treatment of those with chronic HBV infection should be however considered.	[Pellissier, Gerard; Tosini, William; Lolom, Isabelle; Legac, Sylvie; Rouveix, Elisabeth; Rabaud, Christian; Bouvet, Elisabeth] Fac Med Paris VII Bichat, Grp Etud Risque Exposit Soignants Agents Infect G, Paris, France; [Yazdanpanah, Yazdan; Legac, Sylvie; Bouvet, Elisabeth] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Yazdanpanah, Yazdan; Champenois, Karen] ATIP Avenir Inserm Modelisat Aide Decis & Cout Ef, Lille, France; [Adehossi, Eric; Madougou, Boubacar; Ibrahima, Kaza] Hop Natl Niamey, Dept Med, Niamey, Niger; [Madougou, Boubacar] GIP ESTHER, Niamey, Niger; [Madougou, Boubacar] GIP ESTHER, Paris, France; [Lolom, Isabelle] Hop Bichat Claude Bernard, AP HP, Unite Hyg & Lutte Infect Nosocomiale, F-75877 Paris 18, France; [Rouveix, Elisabeth] Entraide Sante 92, Vaucresson, France; [Rouveix, Elisabeth] Hop Ambroise Pare, AP HP, Med Serv, Boulogne, France; [Rabaud, Christian] Ctr Hosp Univ, Serv Malad Infect, Nancy, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU de Nancy	Pellissier, G (corresponding author), Fac Med Paris VII Bichat, Grp Etud Risque Exposit Soignants Agents Infect G, Paris, France.	gerard.pellissier@geres.org	Pellissier, Gerard/AAE-9058-2020	Pellissier, Gerard/0000-0002-3872-4536	French Ministries of Health and Co-operation	French Ministries of Health and Co-operation	Financial assistance for this study was obtained from the Public Interest Group ESTHER created by the French Ministries of Health and Co-operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Barrigar DL, 2001, BMC MED ETHICS, V2, P4, DOI DOI 10.1186/1472-6939-2-4; Belo AC, 2000, E AFR MED J, V77, P283; Beltrami EM, 2000, CLIN MICROBIOL REV, V13, P385, DOI 10.1128/CMR.13.3.385-407.2000; Beutels P, 2001, HEALTH ECON, V10, P751, DOI 10.1002/hec.625; Bonanni P, 2001, VACCINE, V19, P2389, DOI 10.1016/S0264-410X(00)00460-6; Braka F, 2006, VACCINE, V24, P6930, DOI 10.1016/j.vaccine.2006.08.029; Burnett RJ, 2011, VACCINE, V29, P4293, DOI 10.1016/j.vaccine.2011.03.001; De Schryver A, 2011, EUR J PUBLIC HEALTH, V21, P338, DOI 10.1093/eurpub/ckq122; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; GERBERDING JL, 1995, NEW ENGL J MED, V332, P444, DOI 10.1056/NEJM199502163320707; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hou Jinlin, 2005, Int J Med Sci, V2, P50; KANE M, 1995, VACCINE, V13, pS47; Kesieme Emeka B, 2011, Hepat Res Treat, V2011, P157089, DOI 10.1155/2011/157089; Kim SR, 2011, HEPAT MON, V11, P601, DOI 10.5812/kowsar.1735143X.657; Mahoney FJ, 1999, CLIN MICROBIOL REV, V12, P351, DOI 10.1128/CMR.12.2.351; Mamadou S, 2010, ANN U ABDOU MOUMOUNI, V11, P28; Mamadou S, 2009, J SOC BIOL CLIN, V013, P42; Mamadou S, 2012, HIV AIDS-RES PALLIAT, V4, P1, DOI 10.2147/HIV.S27881; Mast EE, 1999, VACCINE, V17, P1730, DOI 10.1016/S0264-410X(98)00415-0; Ngatu NR, 2012, AM J INFECT CONTROL, V40, P68, DOI 10.1016/j.ajic.2011.01.021; Olubuyide IO, 1997, QJM-MON J ASSOC PHYS, V90, P417, DOI 10.1093/qjmed/90.6.417; Phillips EK, 2007, INFECT CONT HOSP EP, V28, P1334, DOI 10.1086/522681; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; ROMIEU I, 1989, J MED VIROL, V27, P282, DOI 10.1002/jmv.1890270405; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; SOUBIRAN G, 1987, T ROY SOC TROP MED H, V81, P998, DOI 10.1016/0035-9203(87)90376-2; SOUBIRAN G, 1984, ANN INST PASTEUR VIR, V135, P213, DOI 10.1016/S0769-2617(84)80057-X; Suckling RM, 2006, J HOSP INFECT, V64, P271, DOI 10.1016/j.jhin.2006.06.024; Tarantola A, 2005, J HOSP INFECT, V60, P276, DOI 10.1016/j.jhin.2004.11.025; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Wiersma Steven T, 2011, Liver Int, V31, P755, DOI 10.1111/j.1478-3231.2010.02373.x; World Health Organization, 2008, HEP B; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Ziraba AK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-191	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44442	10.1371/journal.pone.0044442	http://dx.doi.org/10.1371/journal.pone.0044442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970218	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000021
J	Barnett, L; Platisa, J; Popovic, M; Pieribone, VA; Hughes, T				Barnett, Lauren; Platisa, Jelena; Popovic, Marko; Pieribone, Vincent A.; Hughes, Thomas			A Fluorescent, Genetically-Encoded Voltage Probe Capable of Resolving Action Potentials	PLOS ONE			English	Article							MEMBRANE VOLTAGE; NEURAL ACTIVITY; SENSING DOMAIN; PROTEIN; CA2+; INDICATORS; INSERTION; KINETICS; SENSORS; DESIGN	There is a pressing need in neuroscience for genetically-encoded, fluorescent voltage probes that can be targeted to specific neurons and circuits to allow study of neural activity using fluorescent imaging. We created 90 constructs in which the voltage sensing portion (S1-S4) of Ciona intestinalis voltage sensitive phosphatase (CiVSP) was fused to circularly permuted eGFP. This led to ElectricPk, a probe that is an order of magnitude faster (taus similar to 1-2 ms) than any currently published fluorescent protein-based voltage probe. ElectricPk can follow the rise and fall of neuronal action potentials with a modest decrease in fluorescence intensity (similar to 0.7% Delta F/F). The probe has a nearly linear fluorescence/membrane potential response to both hyperpolarizing and depolarizing steps. This is the first probe based on CiVSP that captures the rapid movements of the voltage sensor, suggesting that voltage probes designed with circularly permuted fluorescent proteins may have some advantages.	[Barnett, Lauren; Hughes, Thomas] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Platisa, Jelena; Pieribone, Vincent A.] John B Pierce Lab Inc, New Haven, CT USA; [Platisa, Jelena] Univ Belgrade, Fac Phys Chem, Belgrade, Serbia; [Popovic, Marko; Pieribone, Vincent A.] Yale Univ, Sch Med, New Haven, CT USA	Montana State University System; Montana State University Bozeman; Yale University; The John B Pierce Laboratory, Inc; University of Belgrade; Yale University	Barnett, L (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	vpieribo@jbpierce.org	Platisa, Jelena/R-3785-2017; Platisa, Jelena/P-4987-2019	Platisa, Jelena/0000-0003-4813-609X; Platisa, Jelena/0000-0003-4813-609X; Hughes, Thomas/0000-0002-8430-070X; Pieribone, Vincent/0000-0002-5836-5454	NINDS [U24NS057631, ARRA U24NS057631-03S1]; NIH [ARRA-R01NS065110]; John B. Pierce Laboratory, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS065110, R01NS065110, U24NS057631] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John B. Pierce Laboratory, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported as an NINDS funded U24 consortium to produce voltage sensors for the neuroscience community (U24NS057631, ARRA U24NS057631-03S1). Consortium members include: Randall Stewart (National Institutes of Health [NIH] Program Officer) and the laboratories of Lawrence B. Cohen, Thomas Hughes, Ehud Isacoff, Thomas Knopfel, Vincent A. Pieribone, and Brian Salzberg. This project was also supported by NIH grant ARRA-R01NS065110 and by The John B. Pierce Laboratory, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baker BJ, 2008, BRAIN CELL BIOL, V36, P53, DOI 10.1007/s11068-008-9026-7; Baker BJ, 2012, J NEUROSCI METH, V208, P190, DOI 10.1016/j.jneumeth.2012.05.016; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Gautam Sunita Ghimire, 2009, Front Neuroeng, V2, P14, DOI 10.3389/neuro.16.014.2009; Jin L, 2012, NEURON IN PRESS; Jin L, 2011, J NEUROSCI METH, V199, P1, DOI 10.1016/j.jneumeth.2011.03.028; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Lundby A, 2010, EUR BIOPHYS J BIOPHY, V39, P1625, DOI 10.1007/s00249-010-0620-0; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Perron A, 2009, CHEM BIOL, V16, P1268, DOI 10.1016/j.chembiol.2009.11.014; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Villalba-Galea CA, BIOPHYSICAL J, V96, P19; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	24	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43454	10.1371/journal.pone.0043454	http://dx.doi.org/10.1371/journal.pone.0043454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970127	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400011
J	Mezrich, JD; Nguyen, LP; Kennedy, G; Nukaya, M; Fechner, JH; Zhang, XJ; Xing, YN; Bradfield, CA				Mezrich, Joshua D.; Nguyen, Linh P.; Kennedy, Greg; Nukaya, Manabu; Fechner, John H.; Zhang, Xiaoji; Xing, Yongna; Bradfield, Christopher A.			SU5416, a VEGF Receptor Inhibitor and Ligand of the AHR, Represents a New Alternative for Immunomodulation	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; SMALL-MOLECULE INHIBITOR; AROMATIC-HYDROCARBONS; INDOLEAMINE 2,3-DIOXYGENASE; TUMOR ANGIOGENESIS; GENE-EXPRESSION; DENDRITIC CELLS; IN-VITRO	The experimental compound SU5416 went as far as Phase III clinical trials as an anticancer agent, putatively because of its activity as a VEGFR-2 inhibitor, but showed poor results. Here, we show that SU5416 is also an aryl hydrocarbon receptor (AHR) agonist with unique properties. Like TCDD, SU5416 favors induction of indoleamine 2,3 dioxygenase (IDO) in immunologically relevant populations such as dendritic cells in an AHR-dependent manner, leading to generation of regulatory T-cells in vitro. These characteristics lead us to suggest that SU5416 may be an ideal clinical agent for treatment of autoimmune diseases and prevention of transplant rejection, two areas where regulatory ligands of the AHR have shown promise. At the same time, AHR agonism might represent a poor characteristic for an anticancer drug, as regulatory T-cells can inhibit clearance of cancer cells, and activation of the AHR can lead to upregulation of xenobiotic metabolizing enzymes that might influence the half-lives of co-administered chemotherapeutic agents. Not only does SU5416 activate the human AHR with a potency approaching 2,3,7,8-tetrachlorodibenzo-p-dioxin, but it also activates polymorphic murine receptor isoforms (encoded by the Ahr(d) and Ahr(b1) alleles) with similar potency, a finding that has rarely been described and may have implications in identifying true endogenous ligands of this receptor.	[Mezrich, Joshua D.; Kennedy, Greg; Nukaya, Manabu; Fechner, John H.; Zhang, Xiaoji] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA; [Nguyen, Linh P.] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Xing, Yongna; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Mezrich, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA.	Mezrich@surgery.wisc.edu	Fechner, John/C-5962-2016	Fechner, John/0000-0002-8220-7237; Nukaya, Manabu/0000-0002-6204-0978	Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; National Institutes of Environmental Health Services Grant [R37ES005703]; National Cancer Institute [P30CA014520]; American Society of Nephrology; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005703, R01ES005703, K08ES017283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER	Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health; National Institutes of Environmental Health Services Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Nephrology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 1UL1RR025011 from the Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health (JDM), National Institutes of Environmental Health Services Grant R37ES005703 (CAB), National Cancer Institute Grant P30CA014520 (CAB). JDM is a John Merrill Grant Scholar of the American Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2010, TOXICOL MECH METHOD, V20, P159, DOI 10.3109/15376511003690307; BRADFIELD CA, 1988, MOL PHARMACOL, V34, P229; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cao YH, 2009, FRONT BIOSCI-LANDMRK, V14, P3962, DOI [10.2741/3504, 10.2735/3504]; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Edelbauer M, 2010, BLOOD, V116, P1980, DOI 10.1182/blood-2009-11-252460; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050; Fong TAT, 1999, CANCER RES, V59, P99; Carvalho JF, 2007, J CLIN IMMUNOL, V27, P246, DOI 10.1007/s10875-007-9083-1; Fury MG, 2007, INVEST NEW DRUG, V25, P165, DOI 10.1007/s10637-006-9011-x; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARPER PA, 1991, MOL PHARMACOL, V40, P818; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Ishimaru N, 2009, J IMMUNOL, V182, P6576, DOI 10.4049/jimmunol.0802289; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; KARENLAMPI SO, 1988, J BIOL CHEM, V263, P10111; KENNEDY SW, 1994, ANAL BIOCHEM, V222, P217, DOI 10.1006/abio.1994.1476; Kieran MW, 2009, PEDIATR BLOOD CANCER, V52, P169, DOI 10.1002/pbc.21873; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Munn DH, 2005, BLOOD, V105, P2618, DOI 10.1182/blood-2005-01-0122; NIWA A, 1975, ARCH BIOCHEM BIOPHYS, V166, P559, DOI 10.1016/0003-9861(75)90420-8; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Overmoyer B, 2007, CLIN CANCER RES, V13, P5862, DOI 10.1158/1078-0432.CCR-07-0688; Pauly SK, 2012, TOXICOL ENVIRON CHEM, V94, P1175, DOI 10.1080/02772248.2012.688546; POLAND A, 1986, J BIOL CHEM, V261, P6352; POLAND A, 1987, MOL PHARMACOL, V32, P471; POSTLIND H, 1993, TOXICOL APPL PHARM, V118, P255, DOI 10.1006/taap.1993.1031; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Roscoe WA, 2009, J NEUROIMMUNOL, V209, P6, DOI 10.1016/j.jneuroim.2009.01.009; Rushing SR, 2002, ARCH BIOCHEM BIOPHYS, V403, P189, DOI 10.1016/S0003-9861(02)00233-3; Sanderson JT, 1996, TOXICOL APPL PHARM, V137, P316, DOI 10.1006/taap.1996.0086; SCHMIDT JV, 1993, J BIOL CHEM, V268, P22203; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Singer K, 2011, CANC IMMUNOL IMMUNOT; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Thackaberry E A, 2002, Cardiovasc Toxicol, V2, P263, DOI 10.1385/CT:2:4:263; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156; Walisser JA, 2004, P NATL ACAD SCI USA, V101, P16677, DOI 10.1073/pnas.0404379101; Walisser JA, 2004, J BIOL CHEM, V279, P16326, DOI 10.1074/jbc.M400784200; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117	64	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44547	10.1371/journal.pone.0044547	http://dx.doi.org/10.1371/journal.pone.0044547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970246	Green Published, gold			2022-12-27	WOS:000308458400088
J	Peterson, MN; Hartis, B; Rodriguez, S; Green, M; Lepczyk, CA				Peterson, M. Nils; Hartis, Brett; Rodriguez, Shari; Green, Matthew; Lepczyk, Christopher A.			Opinions from the Front Lines of Cat Colony Management Conflict	PLOS ONE			English	Article							DOMESTIC CATS; WILDLIFE; PREDATION; ATTITUDES; GENDER; RIGHTS	Outdoor cats represent a global threat to terrestrial vertebrate conservation, but management has been rife with conflict due to differences in views of the problem and appropriate responses to it. To evaluate these differences we conducted a survey of opinions about outdoor cats and their management with two contrasting stakeholder groups, cat colony caretakers (CCCs) and bird conservation professionals (BCPs) across the United States. Group opinions were polarized, for both normative statements (CCCs supported treating feral cats as protected wildlife and using trap neuter and release [TNR] and BCPs supported treating feral cats as pests and using euthanasia) and empirical statements. Opinions also were related to gender, age, and education, with females and older respondents being less likely than their counterparts to support treating feral cats as pests, and females being less likely than males to support euthanasia. Most CCCs held false beliefs about the impacts of feral cats on wildlife and the impacts of TNR (e. g., 9% believed feral cats harmed bird populations, 70% believed TNR eliminates cat colonies, and 18% disagreed with the statement that feral cats filled the role of native predators). Only 6% of CCCs believed feral cats carried diseases. To the extent the beliefs held by CCCs are rooted in lack of knowledge and mistrust, rather than denial of directly observable phenomenon, the conservation community can manage these conflicts more productively by bringing CCCs into the process of defining data collection methods, defining study/management locations, and identifying common goals related to caring for animals.	[Peterson, M. Nils; Hartis, Brett; Rodriguez, Shari] N Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Green, Matthew] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Lepczyk, Christopher A.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Hawaii System; University of Hawaii Manoa	Peterson, MN (corresponding author), N Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	nils_peterson@ncsu.edu		Green, Matthew/0000-0001-6802-0524; Peterson, Nils/0000-0002-4246-1206	National Science Foundation; United States Forest Service's Urban Long Term Research Area program	National Science Foundation(National Science Foundation (NSF)); United States Forest Service's Urban Long Term Research Area program	This project was supported in part by the National Science Foundation and United States Forest Service's Urban Long Term Research Area program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alley Cat Allies, 2008, CATS CAMP TRAP NEUT, P1; American Bird Conservancy, 2004, MAN CAT COL WRONG SO; Audubon Society of Portland, 2007, CATS WILDL, P1; Barrows PL, 2004, JAVMA-J AM VET MED A, V225, P1365, DOI 10.2460/javma.2004.225.1365; Bernard HR, 2011, RES METHODS ANTHR; Bernstein M, 2005, ANNU REV SOCIOL, V31, P47, DOI 10.1146/annurev.soc.29.010202.100054; Brown KM, 2007, LAND USE POLICY, V24, P633, DOI 10.1016/j.landusepol.2006.02.004; Cain B, 2012, NEWS OBSERVER; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Chen XD, 2011, ENVIRON CONSERV, V38, P45, DOI 10.1017/S037689291000086X; CHURCHER PB, 1987, J ZOOL, V212, P439, DOI 10.1111/j.1469-7998.1987.tb02915.x; Clayton S., 2005, ANAL SOC ISS PUB POL, V5, P87, DOI DOI 10.1111/J.1530-2415.2005.00057.X; COLEMAN JS, 1993, WILDLIFE SOC B, V21, P381; Dauphine N., 2011, WILDLIFE PROFESSIONA, V5, P50; Dauphine N, 2009, P 4 INT PARTN FLIGHT, P205; Farnworth MJ, 2011, J APPL ANIM WELF SCI, V14, P59, DOI 10.1080/10888705.2011.527604; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fitzgerald B.M., 1988, P123; Georgia Ornithological Society, 2011, GEORG ORN SOC POS ST; Goldschmidt-Rotschild BV, 1976, REV SUISSE ZOOL, V83, P723; Greenwood D. J., 1998, INTRO ACTION RES SOC; HATLEY PJ, 2003, FERAL CAT COLONIES F; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Herzog Jr H. A., 1991, ANTHROZO, V4, p184?191, DOI [10.2752/089279391787057170, DOI 10.2752/089279391787057170]; Hess S. C., 2011, WILDLIFE PROFESSIONA, V5, P66; KARMEL TS, 1987, J AM STAT ASSOC, V82, P52, DOI 10.2307/2289124; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Kendall HA, 2006, RURAL SOCIOL, V71, P399, DOI 10.1526/003601106778070617; Lauber TB, 2007, SOC NATUR RESOUR, V20, P119, DOI 10.1080/08941920601052362; Lepczyk C.A., 2011, WILDL PROF, V5, P68; Lepczyk CA, 2005, WISCONSIN STATE 0319; Lepczyk CA, 2010, CONSERV BIOL, V24, P627, DOI 10.1111/j.1523-1739.2009.01426.x; Longcore T, 2009, CONSERV BIOL, V23, P887, DOI 10.1111/j.1523-1739.2009.01174.x; Lord LK, 2008, JAVMA-J AM VET MED A, V232, P1159, DOI 10.2460/javma.232.8.1159; Loyd K. A. T., 2010, Human Dimensions of Wildlife, V15, P262, DOI 10.1080/10871209.2010.491846; Loyd KAT, 2010, ECOL SOC, V15; Manfredo MJ, 2009, SOC SCI QUART, V90, P407, DOI 10.1111/j.1540-6237.2009.00624.x; Moore C., 2003, MEDIATION PROCESS PR; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; O'Brien SJ, 2007, SCI AM, V297, P68, DOI 10.1038/scientificamerican0707-68; Peek CW, 1996, GENDER SOC, V10, P464, DOI 10.1177/089124396010004007; Peterson MN, 2008, LANDSCAPE URBAN PLAN, V86, P126, DOI 10.1016/j.landurbplan.2008.01.003; Reid J. R. W., 2000, SURVEY BUFF BANDED R; Schmidt PM, 2007, J WILDLIFE MANAGE, V71, P915, DOI 10.2193/2006-066; SEXTON NR, 2011, HUM DIMENS WILDL, V16, P154, DOI DOI 10.1080/10871209.2011.572142; Stoskopf MK, 2004, JAVMA-J AM VET MED A, V225, P1361, DOI 10.2460/javma.2004.225.1361; Topp L, 2004, DRUG ALCOHOL DEPEN, V73, P33, DOI 10.1016/j.drugalcdep.2003.09.001; van Heezik Y, 2010, ORYX, V44, P153, DOI 10.1017/S003060531000027X; Vaske J.J., 2011, HUM DIMENS WILDL, V16, P200, DOI DOI 10.1080/10871209.2011.571230; Willis G.B, 2004, COGNITIVE INTERVIEWI	50	59	60	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44616	10.1371/journal.pone.0044616	http://dx.doi.org/10.1371/journal.pone.0044616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970269	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400096
J	Shirreffs, A; Lee, DP; Henry, J; Golden, MR; Stekler, JD				Shirreffs, Alexandra; Lee, David P.; Henry, Jsani; Golden, Matthew R.; Stekler, Joanne D.			Understanding Barriers to Routine HIV Screening: Knowledge, Attitudes, and Practices of Healthcare Providers in King County, Washington	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; UNITED-STATES; TESTING RECOMMENDATIONS; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; PERSONS AWARE; VIRUS; PREVENTION; SETTINGS; TRANSMISSION	Objective: In 2006, the Centers for Disease Control and Prevention (CDC) recommended routine HIV screening in healthcare settings for persons between 13 and 64 years old. In 2010, the Washington Administrative Code (WAC) was changed to align testing rules with these recommendations. We designed this survey to ascertain the current state of HIV testing and barriers to routine screening in King County, Washington. Methods: Between March 23 and April 16, 2010, a convenience sample of healthcare providers completed an online survey. Providers answered true-false and multiple choice questions about national recommendations and the WAC, policies in their primary clinical settings, and their personal HIV testing practices. Providers were asked to agree or disagree whether commonly reported barriers limited their implementation of routine HIV screening. Results: Although 76% of the 221 respondents knew that the CDC recommended routine HIV screening for persons regardless of their risk, 99 (45%) providers reported that their primary clinical setting had a policy to target testing based on patient risk factors. Forty-four (20%) providers reported that their primary clinical setting had a policy of routine HIV screening, 54 (25%) reported no official policy, and 15 (7%) did not know whether a policy existed. Only 11 (5%) providers offer HIV testing to all patients at initial visits. When asked about barriers to routine screening, 57% of providers agreed that perception that their patient population is low risk limits the number of HIV tests they perform. Only 26 (13%) providers agreed that concern about reimbursement posed a barrier to testing. Conclusions: Most providers participating in this survey continue to target HIV testing, despite knowledge of national recommendations. Efforts are still needed to educate providers and policymakers, clarify the recent WAC revisions, and implement structural changes in order to increase HIV testing in Washington State.	[Shirreffs, Alexandra; Henry, Jsani] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Lee, David P.; Golden, Matthew R.; Stekler, Joanne D.] Univ Washington, Dept Med, Seattle, WA USA; [Golden, Matthew R.; Stekler, Joanne D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Henry, Jsani; Golden, Matthew R.; Stekler, Joanne D.] Publ Hlth Seattle & King Cty, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shirreffs, A (corresponding author), Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.	golden@u.washington.edu; jstekler@uw.edu	Golden, Matthew/AAE-4314-2020		National Institute of Health [K23 AI65243]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065243] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Stekler was supported by National Institute of Health grant K23 AI65243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRQ, 2007, AHRQ PUB; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P661; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1550; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; Goetz MB, 2009, J GEN INTERN MED, V24, P1275, DOI 10.1007/s11606-009-1120-8; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; HIV/AIDS Epidemiology Unit Public Health-Seattle & King County and the Infectious Disease and Reproductive Health Assessment Unit Washington State Department of Health, 2009, HIV AIDS EP REP 1 HA, V74; Hutchinson AB, 2011, AIDS EDUC PREV, V23, P58, DOI 10.1521/aeap.2011.23.3_supp.58; Jain CL, 2009, AIDS PATIENT CARE ST, V23, P167, DOI 10.1089/apc.2008.0130; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Neff S, 2011, JAMA-J AM MED ASSOC, V305, P1767, DOI 10.1001/jama.2011.564; Ogbuanu IU, 2009, AM J PUBLIC HEALTH, V99, pS111, DOI 10.2105/AJPH.2006.104323; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; The Voluntary HIV-1 Counseling and Testing Efficacy Study Group, 2000, J GERONTOL B-PSYCHOL, V356, P103; Wolf LE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001005; 2002, MMWR MORB MORTAL WKL, V51, P1013; 2008, MMWR MORB MORTAL WKL, V57, P1073	27	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44417	10.1371/journal.pone.0044417	http://dx.doi.org/10.1371/journal.pone.0044417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970215	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400069
J	Carter, MQ; Xue, K; Brandl, MT; Liu, FF; Wu, LY; Louie, JW; Mandrell, RE; Zhou, JZ				Carter, Michelle Q.; Xue, Kai; Brandl, Maria T.; Liu, Feifei; Wu, Liyou; Louie, Jacqueline W.; Mandrell, Robert E.; Zhou, Jizhong			Functional Metagenomics of Escherichia coli O157:H7 Interactions with Spinach Indigenous Microorganisms during Biofilm Formation	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SEA OIL PLUME; MICROBIAL COMMUNITIES; EPIPHYTIC BACTERIA; LETTUCE; GEOCHIP; O157-H7; PHYLLOSPHERE; MICROARRAY; DIVERSITY	The increase in foodborne outbreaks worldwide attributed to fresh fruit and vegetables suggests that produce may serve as an ecological niche for enteric pathogens. Here we examined the interaction of E. coli O157:H7 (EcO157) with spinach leaf indigenous microorganisms during co-colonization and establishment of a mixed biofilm on a stainless steel surface. Stainless steel surface was selected to mimic the surface of produce-processing equipment, where retention of foodborne pathogens such as EcO157 could serve as a potential source for transmission. We observed a positive effect of spinach-associated microbes on the initial attachment of EcO157, but an antagonistic effect on the EcO157 population at the later stage of biofilm formation. Metagenomic analyses of the biofilm community with the GeoChip revealed an extremely diverse community (gene richness, 23409; Shannon-Weiner index H, 9.55). Presence of EcO157 in the mixed biofilm resulted in a significant decrease in the community alpha-diversity (t test, P<0.05), indicating a putative competition between the pathogen and indigenous spinach microbes. The decrease in the beta-diversity of the EcO157-inoculated biofilm at 48 h (ANOVA, P<0.05) suggested a convergent shift in functional composition in response to EcO157 invasion. The success of EcO157 in the mixed biofilm is likely associated with its metabolic potential in utilizing spinach nutrients: the generation time of EcO157 in spinach lysates at 28 degrees C is similar to 38 min, which is comparable to that in rich broth. The significant decrease in the abundance of many genes involved in carbon, nitrogen, and phosphorus cycling in the EcO157-inoculated biofilms (t test, P<0.05) further support our conclusion that competition for essential macronutrients is likely the primary interaction between the EcO157 and indigenous spinach-biofilm species.	[Carter, Michelle Q.; Brandl, Maria T.; Louie, Jacqueline W.; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA; [Xue, Kai; Liu, Feifei; Wu, Liyou; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Zhou, Jizhong] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Carter, MQ (corresponding author), ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA.	michelle.carter@ars.usda.gov	Liu, Feifei/AAP-9241-2021; 吴, 昊/AAB-1620-2020; Mandrell, Robert E/O-9814-2018	Liu, Feifei/0000-0003-1966-8759; Carter, Michelle Qiu/0000-0002-0710-7420; Xue, Kai/0000-0002-5990-4448	ENIGMA through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy [DE-AC02-05CH11231]; United States Department of Agriculture, (USDA-ARS CRIS) [5325-42000-046-00D]	ENIGMA through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy; United States Department of Agriculture, (USDA-ARS CRIS)	We thank J. D. Van Nostrand for technical support and Y. Deng for discussion on data analysis. The GeoChips and associated computational pipelines used in this study were supported by ENIGMA through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.; This work was supported by United States Department of Agriculture, (USDA-ARS CRIS project 5325-42000-046-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brand MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025553; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Castonguay MH, 2006, RES MICROBIOL, V157, P471, DOI 10.1016/j.resmic.2005.10.003; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Edwards JL, 2010, GENES, V1, P15; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Hill MO, 1980, VEGETATION, V42, P12; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Klayman BJ, 2009, ENVIRON SCI TECHNOL, V43, P2105, DOI 10.1021/es802218q; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G., 2011, Diversity, V3, P721, DOI 10.3390/d3040721; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V153, P351, DOI 10.1016/j.ijfoodmicro.2011.11.026; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Mandrell R. E., 2009, Microbial safety of fresh produce, P5; Mueller RS, 2011, ENVIRON MICROBIOL, V13, P2279, DOI 10.1111/j.1462-2920.2011.02486.x; Rivas L, 2007, J MICROBIOL METH, V69, P44, DOI 10.1016/j.mimet.2006.11.014; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Villanueva-Suarez MJ, 2003, J AGR FOOD CHEM, V51, P5950, DOI 10.1021/jf021010h; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	33	40	45	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44186	10.1371/journal.pone.0044186	http://dx.doi.org/10.1371/journal.pone.0044186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957052	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800044
J	Diskin, S; Chen, WS; Cao, ZY; Gyawali, S; Gong, HY; Soza, A; Gonzalez, A; Panjwani, N				Diskin, Shiri; Chen, Wei-Sheng; Cao, Zhiyi; Gyawali, Smita; Gong, Haiyan; Soza, Andrea; Gonzalez, Alfonso; Panjwani, Noorjahan			Galectin-8 Promotes Cytoskeletal Rearrangement in Trabecular Meshwork Cells through Activation of Rho Signaling	PLOS ONE			English	Article							AQUEOUS-HUMOR OUTFLOW; OPEN-ANGLE GLAUCOMA; KINASE INHIBITOR; PROTEIN-KINASE; BETA(1) INTEGRIN; CYTOCHALASIN-B; ADHESION; FACILITY; FIBRONECTIN; EXPRESSION	Purpose: The trabecular meshwork (TM) cell-matrix interactions and factors that influence Rho signaling in TM cells are thought to play a pivotal role in the regulation of aqueous outflow. The current study was designed to evaluate the role of a carbohydrate-binding protein, galectin-8 (Gal8), in TM cell adhesion and Rho signaling. Methods: Normal human TM cells were assayed for Gal8 expression by immunohistochemistry and Western blot analysis. To assess the role of Gal8 in TM cell adhesion and Rho signaling, the cell adhesion and spreading assays were performed on Gal8-coated culture plates in the presence and the absence of anti-beta(1) integrin antibody and Rho and Rho-kinase inhibitors. In addition, the effect of Gal8-mediated cell-matrix interactions on TM cell cytoskeleton arrangement and myosin light chain 2 (MLC2) phosphorylation was examined. Principal Findings: We demonstrate here that Gal8 is expressed in the TM and a function-blocking anti-beta(1) integrin antibody inhibits the adhesion and spreading of TM cells to Gal8-coated wells. Cell spreading on Gal8 substratum was associated with the accumulation of phosphorylated myosin light chain and the formation of stress fibers that was inhibited by the Rho inhibitor, C3 transferase, as well as by the Rho-kinase inhibitor, Y27632. Conclusions/Significance: The above findings present a novel function for Gal8 in activating Rho signaling in TM cells. This function may allow Gal8 to participate in the regulation of aqueous outflow.	[Diskin, Shiri; Chen, Wei-Sheng; Panjwani, Noorjahan] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Cao, Zhiyi; Gyawali, Smita; Panjwani, Noorjahan] Tufts Univ, New England Eye Ctr, Boston, MA 02111 USA; [Cao, Zhiyi; Gyawali, Smita; Panjwani, Noorjahan] Tufts Univ, Dept Ophthalmol, Boston, MA 02111 USA; [Gong, Haiyan] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Soza, Andrea; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Fac Med, Ctr Regulac Celular & Patol, Santiago, Chile; [Soza, Andrea; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac, Fac Ciencias Biol, Santiago, Chile; [Soza, Andrea; Gonzalez, Alfonso] Millennium Inst Fundamental & Appl Biol, Santiago, Chile; [Panjwani, Noorjahan] Tufts Univ, Dept Biochem, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Boston University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Tufts University	Diskin, S (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.	Noorjahan.Panjwani@tufts.edu		Gong, Haiyan/0000-0002-7204-5019; Soza, Andrea/0000-0003-3783-5231	National Institutes of Health [R03EY015168, P30EY13078]; Research to Prevent Blindness; FONDECYT (National Fund for Scientific and Technological Development) [1050715]; FONDAP (Fund for Advanced Research in Priority Areas (Centers of Excellence FONDAP) [19800001]; NATIONAL EYE INSTITUTE [P30EY013078, R03EY015168, R01EY007088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); FONDECYT (National Fund for Scientific and Technological Development)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP (Fund for Advanced Research in Priority Areas (Centers of Excellence FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R03EY015168 (N.P.), a core grant for vision research P30EY13078, Mass Lions Eye Research fund and a grant from Research to Prevent Blindness. A. G. was funded by Grants FONDECYT (National Fund for Scientific and Technological Development) #1050715 and FONDAP (Fund for Advanced Research in Priority Areas (Centers of Excellence FONDAP) #19800001. New England Eye Center (NEEC) is not a company. It is a nonprofit physician group dedicated to providing patients with an unprecedented level of care and responsive service. NEEC is the Ophthalmology Department of Tufts University School of Medcine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Barry ST, 1996, CELL ADHES COMMUN, V4, P387, DOI 10.3109/15419069709004456; Bidon N, 2001, INT J MOL MED, V8, P245; CAIXIA S, 1991, CELL IMMUNOL, V138, P216, DOI 10.1016/0008-8749(91)90146-3; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Dallabrida SM, 2000, BLOOD, V95, P2586, DOI 10.1182/blood.V95.8.2586.008k04_2586_2592; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Diskin S, 2009, GLYCOBIOLOGY, V19, P29, DOI 10.1093/glycob/cwn100; Filla MS, 2011, INVEST OPHTH VIS SCI, V52, P2952, DOI 10.1167/iovs.10-6618; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Kaibuchi K, 1999, Prog Mol Subcell Biol, V22, P23; KAUFMAN PL, 1982, INVEST OPHTH VIS SCI, V23, P646; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Levy Y, 2006, GLYCOBIOLOGY, V16, P463, DOI 10.1093/glycob/cwj097; Ni HY, 1998, CELL ADHES COMMUN, V5, P257, DOI 10.3109/15419069809040296; Pal Z, 2012, BIOCH BIOPHYS ACTA; Peterson JA, 2000, INVEST OPHTH VIS SCI, V41, P1749; POLANSKY JR, 1994, PRINCIPLES PRACTICE, P226; Rao PV, 2005, EXP EYE RES, V80, P197, DOI 10.1016/j.exer.2004.08.029; Rao PV, 2005, MOL VIS, V11, P288; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; Shiokawa S, 1999, BIOL REPROD, V60, P1468, DOI 10.1095/biolreprod60.6.1468; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; Summers L, 2009, MOL CELL NEUROSCI, V41, P148, DOI 10.1016/j.mcn.2009.02.007; Tian BH, 2005, EXP EYE RES, V80, P215, DOI 10.1016/j.exer.2004.09.002; Tian BH, 1998, ARCH OPHTHALMOL-CHIC, V116, P633, DOI 10.1001/archopht.116.5.633; Tian BH, 1999, EXP EYE RES, V68, P649, DOI 10.1006/exer.1998.0647; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Vittitow JL, 2002, MOL VIS, V8, P32; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; Williams RD, 2011, AM J OPHTHALMOL, V152, P834, DOI 10.1016/j.ajo.2011.04.012; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Zhou LL, 1996, INVEST OPHTH VIS SCI, V37, P104	43	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44400	10.1371/journal.pone.0044400	http://dx.doi.org/10.1371/journal.pone.0044400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973445	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600049
J	Jiang, SZ; Yang, ZW; Li, WJ; Li, XJ; Wang, YF; Zhang, JB; Xu, CH; Chen, PJ; Hou, JL; McCrae, MA; Chen, XM; Zhuang, H; Lu, FM				Jiang, Suzhen; Yang, Ziwei; Li, Weijie; Li, Xiaojun; Wang, Yongfeng; Zhang, Jiangbo; Xu, Chunhui; Chen, Pei-Jer; Hou, Jinlin; McCrae, Malcolm A.; Chen, Xiangmei; Zhuang, Hui; Lu, Fengmin			Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; INSERTIONAL MUTAGENESIS; WOODCHUCK HEPATITIS; GENE; ACTIVATION; EXPRESSION; MUTANTS; DNA	To examine the role of hepatitis B virus (HBV) integration in hepatocarcinogenesis, a systematic comparative study of both tumor and their corresponding non-tumor derived tissue has been conducted in a cohort of 60 HBV associated hepatocellular carcinoma (HCC) patients. By using Alu-polymerase chain reaction (PCR) and ligation-mediated PCR, 233 viral-host junctions mapped across all human chromosomes at random, no difference between tumor and non-tumor tissue was observed, with the exception of fragile sites (P = 0.0070). HBV insertions in close proximity to cancer related genes such as hTERT were found in this study, however overall they were rare events. No direct correlation between chromosome aberrations and the number of HBV integration events was found using a sensitive array-based comparative genomic hybridization (aCGH) assay. However, a positive correlation was observed between the status of several tumor suppressor genes (TP53, RB1, CDNK2A and TP73) and the number of chromosome aberrations (r = 0.6625, P = 0.0003). Examination of the viral genome revealed that 43% of inserts were in the preC/C region and 57% were in the HBV X gene. Strikingly, approximately 24% of the integrations examined had a breakpoint in a short 15 nt viral genome region (1820-1834 nt). As a consequence, all of the confirmed X gene insertions were C-terminal truncated, losing their growth-suppressive domain. However, the same pattern of X gene C-terminal truncation was found in both tumor and non-tumor derived samples. Furthermore, the integrated viral sequences in both groups had a similar low frequency of C1653T, T1753V and A1762T/G1764A mutations. The frequency and patterns of HBV insertions were similar between tumor and their adjacent non-tumor samples indicating that the majority of HBV DNA integration events are not associated with hepatocarcinogenesis.	[Jiang, Suzhen; Yang, Ziwei; Li, Weijie; Li, Xiaojun; Wang, Yongfeng; Zhang, Jiangbo; Xu, Chunhui; Chen, Xiangmei; Zhuang, Hui; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Jiang, Suzhen; Hou, Jinlin] So Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Jiang, Suzhen] Linyi Peoples Hosp, Dept Infect Dis, Linyi, Shandong, Peoples R China; [Chen, Pei-Jer] Natl Taiwan Univ & Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [McCrae, Malcolm A.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Chen, Xiangmei; Zhuang, Hui; Lu, Fengmin] Peking Univ, Ctr Infect Dis, Beijing 100871, Peoples R China	Peking University; Southern Medical University - China; National Taiwan University; National Taiwan University Hospital; University of Warwick; Peking University	Jiang, SZ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	xm_chen6176@bjmu.edu.cn; Lu.fengmin@hsc.pku.edu.cn		Chen, Pei-Jer/0000-0001-8316-3785; Chen, Xiangmei/0000-0003-0302-6866	National S & T Major Project for Infectious Diseases [2012ZX10004-904, 2012ZX10002-007]	National S & T Major Project for Infectious Diseases	This work was supported by the National S & T Major Project for Infectious Diseases (Grant no. 2012ZX10004-904; and 2012ZX10002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruni R, 1999, VIROLOGY, V257, P483, DOI 10.1006/viro.1999.9678; EDMAN JC, 1980, NATURE, V286, P535, DOI 10.1038/286535a0; ENRIETTO PJ, 1983, ADV CANCER RES, V39, P269, DOI 10.1016/S0065-230X(08)61037-4; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; FOUREL G, 1990, NATURE, V347, P294, DOI 10.1038/347294a0; Guerrero RB, 2005, J HEPATOL, V42, P760, DOI 10.1016/j.jhep.2005.02.005; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Jacob JR, 2004, HEPATOLOGY, V39, P1008, DOI 10.1002/hep.20106; Jiang Z, 2012, GENOME RES; Lei YH, 2012, ONCOL REP, V27, P151, DOI 10.3892/or.2011.1489; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10; Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4; Minami M, 2005, ONCOGENE, V24, P4340, DOI 10.1038/sj.onc.1208628; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Nakajima T, 2004, MODERN PATHOL, V17, P722, DOI 10.1038/modpathol.3800115; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Tamori A, 2005, CLIN CANCER RES, V11, P5821, DOI 10.1158/1078-0432.CCR-04-2055; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang Y, 2004, ONCOGENE, V23, P142, DOI 10.1038/sj.onc.1206889; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD; Zhong S, 2000, J VIRAL HEPATITIS, V7, P115	27	60	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e40363	10.1371/journal.pone.0040363	http://dx.doi.org/10.1371/journal.pone.0040363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962577	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600004
J	Watanabe, TM; Tsukasaki, Y; Fujita, H; Ichimura, T; Saitoh, T; Akira, S; Yanagida, T				Watanabe, Tomonobu M.; Tsukasaki, Yoshikazu; Fujita, Hideaki; Ichimura, Taro; Saitoh, Tatsuya; Akira, Shizuo; Yanagida, Toshio			Distinct Modulated Pupil Function System for Real-Time Imaging of Living Cells	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; RESOLUTION LIMIT; PLASMA-MEMBRANE; E-CADHERIN; DYNAMICS; EB1; RECONSTRUCTION; MECHANISMS; RECEPTORS; AUTOPHAGY	Optical microscopy is one of the most contributive tools for cell biology in the past decades. Many microscopic techniques with various functions have been developed to date, i.e., phase contrast microscopy, differential interference contrast (DIC) microscopy, confocal microscopy, two photon microscopy, superresolution microscopy, etc. However, person who is in charge of an experiment has to select one of the several microscopic techniques to achieve an experimental goal, which makes the biological assay time-consuming and expensive. To solve this problem, we have developed a microscopic system with various functions in one instrument based on the optical Fourier transformation with a lens system for detection while focusing on applicability and user-friendliness for biology. The present instrument can arbitrarily modulate the pupil function with a micro mirror array on the Fourier plane of the optical pathway for detection. We named the present instrument DiMPS (Distinct optical Modulated Pupil function System). The DiMPS is compatible with conventional fluorescent probes and illumination equipment, and gives us a Fourier-filtered image, a pseudo-relief image, and a deep focus depth. Furthermore, DiMPS achieved a resolution enhancement (pseudo-superresolution) of 110 nm through the subtraction of two images whose pupil functions are independently modulated. In maximum, the spatial and temporal resolution was improved to 120 nm and 2 ms, respectively. Since the DiMPS is based on relay optics, it can be easily combined with another microscopic instrument such as confocal microscope, and provides a method for multi-color pseudo-superresolution. Thus, the DiMPS shows great promise as a flexible optical microscopy technique in biological research fields.	[Watanabe, Tomonobu M.; Tsukasaki, Yoshikazu; Fujita, Hideaki; Ichimura, Taro; Yanagida, Toshio] RIKEN Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Fujita, Hideaki; Saitoh, Tatsuya; Akira, Shizuo; Yanagida, Toshio] Osaka Univ, World Premier Int Res Ctr Initiat, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan; [Watanabe, Tomonobu M.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	RIKEN; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Watanabe, TM (corresponding author), RIKEN Quantitat Biol Ctr QBiC, 6-2-3 Furuedai, Suita, Osaka, Japan.	yanagida@fbs.osaka-u.ac.jp	Ichimura, Taro/E-2792-2010; Watanabe, Tomonobu/J-4812-2013; Akira, Shizuo/C-3134-2009; Fujita, Hideaki/B-7633-2008	Ichimura, Taro/0000-0002-3740-3634; Fujita, Hideaki/0000-0003-3430-5681; Watanabe, Tomonobu/0000-0002-2420-4230	Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23370072] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grant, PRESTO, from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Abrahamsson S, 2006, PROC SPIE, V6090, DOI 10.1117/12.647022; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; CAMPOS J, 1989, J MOD OPTIC, V36, P733, DOI 10.1080/09500348914550821; Chtcheglova LA, 2007, BIOPHYS J, V93, pL11, DOI 10.1529/biophysj.107.109751; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; COX IJ, 1982, J OPT SOC AM, V72, P1287, DOI 10.1364/JOSA.72.001287; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Ellinger P, 1940, BIOL REV CAMB PHILOS, V15, P323, DOI 10.1111/j.1469-185X.1940.tb00761.x; FILLER AS, 1964, J OPT SOC AM, V54, P762, DOI 10.1364/JOSA.54.000762; Fujita K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228105; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; HARTMAN JS, 1981, APPL OPTICS, V20, P2665, DOI 10.1364/AO.20.002665; Heintzmann R, 2003, MICRON, V34, P293, DOI 10.1016/S0968-4328(03)00054-4; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HOFFMAN R, 1975, APPL OPTICS, V14, P1169, DOI 10.1364/AO.14.001169; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Matsumoto B, 2002, METHOD CELL BIOL, V70, P52; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sako Y, 2003, NAT CELL BIOL, pSS1, DOI 10.1038/nrm1193; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Seebach J, 2007, CARDIOVASC RES, V75, P596, DOI 10.1016/j.cardiores.2007.04.017; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang Yu-li, 2003, Methods Cell Biol, V72, P337, DOI 10.1016/S0091-679X(03)72016-0; Watanabe TM, 2007, BIOCHEM BIOPH RES CO, V359, P1, DOI 10.1016/j.bbrc.2007.04.168; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345	49	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44028	10.1371/journal.pone.0044028	http://dx.doi.org/10.1371/journal.pone.0044028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962597	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600025
J	Chauvey, V; Hatwell, Y; Verine, B; Kaminski, G; Gentaz, E				Chauvey, Valerie; Hatwell, Yvette; Verine, Bertrand; Kaminski, Gwenael; Gentaz, Edouard			Lexical References to Sensory Modalities in Verbal Descriptions of People and Objects by Congenitally Blind, Late Blind and Sighted Adults	PLOS ONE			English	Article							COGNITION; CHILDREN	Background: Some previous studies have revealed that while congenitally blind people have a tendency to refer to visual attributes ('verbalism'), references to auditory and tactile attributes are scarcer. However, this statement may be challenged by current theories claiming that cognition is linked to the perceptions and actions from which it derives. Verbal productions by the blind could therefore differ from those of the sighted because of their specific perceptual experience. The relative weight of each sense in oral descriptions was compared in three groups with different visual experience Congenitally blind (CB), late blind (LB) and blindfolded sighted (BS) adults. Methodology/Principal Findings: Participants were asked to give an oral description of their mother and their father, and of four familiar manually-explored objects. The number of visual references obtained when describing people was relatively high, and was the same in the CB and BS groups ("verbalism" in the CB). While references to touch were scarce in all groups, the CB referred to audition more frequently than the LB and the BS groups. There were, by contrast, no differences between groups in descriptions of objects, and references to touch dominated the other modalities. Conclusion/Significance: The relative weight of each modality varies according to the cognitive processes involved in each task. Long term memory, internal representations and information acquired through social communication, are at work in the People task, seem to favour visual references in both the blind and the sighted, whereas the congenitally blind also refer often to audition. By contrast, the perceptual encoding and working memory at work in the Objects task enhance sensory references to touch in a similar way in all groups. These results attenuate the impact of verbalism in blindness, and support (albeit moderately) the idea that the perceptual experience of the congenitally blind is to some extent reflected in their cognition.	[Chauvey, Valerie; Hatwell, Yvette; Gentaz, Edouard] Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France; [Verine, Bertrand] Univ Montpellier 3, CNRS, UMR 5267, Lab Praxiling, F-34032 Montpellier, France; [Kaminski, Gwenael] Univ Toulouse Le Mirail, CNRS, UMR 5263, Lab CLLE LTC, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Montpellier; Universite Paul-Valery; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Bordeaux-Montaigne	Chauvey, V (corresponding author), Univ Pierre Mendes France, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France.	Edouard.Gentaz@upmf-grenoble.fr	Kaminski, Gwenael/G-6394-2010; Kaminski, Gwenael/AAA-4214-2021	Kaminski, Gwenael/0000-0001-5300-5655; Kaminski, Gwenael/0000-0001-5300-5655	Federation des Aveugles de France (FAF) [075128]	Federation des Aveugles de France (FAF)	Funding came from Federation des Aveugles de France (FAF)http://www.faf.asso.fr/, Grant numbers No075128 (obtained by BV). The funders had no role in study design, data collection and analysis, decision to publish or preparation if the manuscript.	ANDERSON DW, 1981, J VISUAL IMPAIR BLIN, V75, P165; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Burlingham D, 1961, PSYCHOANALYTIC STUDY, V26, P121; Cutsforth T. D., 1932, TEACHERS FORUM, V25, P86; Cutsforth T.D., 1951, BLIND SCH SOC PSYCHO, P2013; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Eardley AF, 2006, MEMORY, V14, P925, DOI 10.1080/09658210600859582; Gentaz E, 2009, MAIN TOUCHER CERVEAU; Harley RK, 1963, AM FDN BLIND RES SER; Hatwell Y., 2003, PSYCHOL COGNITIVE CE; HATWELL Y, 2003, TOUCHING KNOWING; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Millar S, 1997, READING TOUCH; Miller S., 1983, LANG ACQUIS, P167; NOLAN CY, 1960, NEW OUTLOOK BLIND, V54, P100; Rosel J, 2005, J VISUAL IMPAIR BLIN, V99, P413, DOI 10.1177/0145482X0509900704; Sanchez MT, 2012, IMAGINATION COGNITIO, V31, P113; Vinter A, CHILD CARE IN PRESS; Von Tetzchner S., 1980, INT J PSYCHOLINGUIST, V7-3, P49; Warren D. H., 1994, BLINDNESS CHILDREN I; Warren D. H., 1984, BLINDNESS EARLY CHIL; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	23	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44020	10.1371/journal.pone.0044020	http://dx.doi.org/10.1371/journal.pone.0044020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956997	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500044
J	Jost, T; Lacroix, C; Braegger, CP; Chassard, C				Jost, Ted; Lacroix, Christophe; Braegger, Christian P.; Chassard, Christophe			New Insights in Gut Microbiota Establishment in Healthy Breast Fed Neonates	PLOS ONE			English	Article							FORMULA-FED INFANTS; INTESTINAL MICROBIOTA; BACTERIAL COMMUNITIES; FECAL MICROFLORA; HUMAN-MILK; FLORA; BIFIDOBACTERIA; LACTOBACILLI; DELIVERY; LIFE	The establishment of a pioneer gut microbiota is increasingly recognized as a crucial stage in neonatal development influencing health throughout life. While current knowledge is mainly based on either culture or molecular analysis of feces, we opted for a comprehensive approach complementing culture with state-of-the-art molecular methods. The bacterial composition in feces from seven healthy vaginally-delivered, breast-fed neonates was analyzed at day 4-6, 9-14 and 25-30 postnatal, using culture, 16S rRNA gene sequencing of isolates, quantitative PCR and pyrosequencing. Anaerobes outnumbered facultative anaerobes in all seven neonates within the first days of life, owing to high levels of Bifidobacterium and unexpectedly also Bacteroides, which were inversely correlated. Four neonates harboured maternal Bacteroides levels, comprising typical adult species, throughout the neonatal period, while in three only subdominant levels were detected. In contrast, the major adult type butyrate producing anaerobic populations, Roseburia and Faecalibacterium, remained undetectable during the neonatal period. The presence of Bacteroidetes as pioneer bacteria in the majority of neonates studied demonstrates that adult-type strict anaerobes may reach adult-like population densities within the first week of life. Consequently the switch from facultative to strict anaerobes may occur earlier than previously assumed in breast fed neonates, and the establishment of the major butyrate-producing populations may be limited by other factors than the absence of anaerobic conditions. The impact of breast milk components on the timing of establishment of anaerobic pioneer bacteria, as well as opportunistic pathogens should be further studied in regard to priming of the gut-associated immune system and consequences on later health.	[Jost, Ted; Lacroix, Christophe; Chassard, Christophe] ETH, Lab Food Biotechnol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Braegger, Christian P.] Univ Childrens Hosp Zurich, Div Gastroenterol & Nutr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University Children's Hospital Zurich	Jost, T (corresponding author), ETH, Lab Food Biotechnol, Inst Food Nutr & Hlth, Schmelzbergstr, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016; Braegger, Christian Peter/ABC-9884-2021	Lacroix, Christophe/0000-0003-4360-2020; Ravel, Jacques/0000-0002-0851-2233; Braegger, Christian/0000-0001-8069-9875	Nestle Nutrition (Vevey, Switzerland); Nestec (Lausanne, Switzerland); Swiss Foundation for Nutrition Research (SFEFS) (Zurich, Switzerland)	Nestle Nutrition (Vevey, Switzerland)(Nestle SA); Nestec (Lausanne, Switzerland); Swiss Foundation for Nutrition Research (SFEFS) (Zurich, Switzerland)	This research was supported by Nestle Nutrition (Vevey, Switzerland), Nestec (Lausanne, Switzerland) and the Swiss Foundation for Nutrition Research (SFEFS) (Zurich, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adlerberth I, 2008, NESTLE NUTR WORKS SE, V62, P13, DOI 10.1159/000146245; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BEERENS H, 1991, APPL ENVIRON MICROB, V57, P2418, DOI 10.1128/AEM.57.8.2418-2419.1991; BENNO Y, 1984, MICROBIOL IMMUNOL, V28, P975, DOI 10.1111/j.1348-0421.1984.tb00754.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Dai D, 1999, Adv Pediatr, V46, P353; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edwards CA, 2002, BRIT J NUTR, V88, pS11, DOI [10.1079/BJN2002625, 10.1079/BJNBJN2002580]; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Greer JB, 2011, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00168; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hartemink R, 1997, J MICROBIOL METH, V29, P77, DOI 10.1016/S0167-7012(97)00025-0; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; MACFARLANE GT, 1990, J APPL BACTERIOL, V68, P179, DOI 10.1111/j.1365-2672.1990.tb02564.x; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mitsou EK, 2008, ANAEROBE, V14, P94, DOI 10.1016/j.anaerobe.2007.11.002; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; SAARINEN UM, 1995, LANCET, V346, P1065, DOI 10.1016/S0140-6736(95)91742-X; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Steer Toni E, 2004, Curr Issues Intest Microbiol, V5, P23; TANNOCK GW, 1990, J CLIN MICROBIOL, V28, P1225, DOI 10.1128/JCM.28.6.1225-1228.1990; Vael C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-68; Vaughan EE, 2002, ANTON LEEUW INT J G, V82, P341, DOI 10.1023/A:1020672724450; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; YOSHIOKA H, 1983, PEDIATRICS, V72, P317	50	203	211	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44595	10.1371/journal.pone.0044595	http://dx.doi.org/10.1371/journal.pone.0044595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957008	Green Published, gold			2022-12-27	WOS:000308206500079
J	Zeng, LL; Liu, L; Liu, YD; Shen, H; Li, YM; Hu, DW				Zeng, Ling-Li; Liu, Li; Liu, Yadong; Shen, Hui; Li, Yaming; Hu, Dewen			Antidepressant Treatment Normalizes White Matter Volume in Patients with Major Depression	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVATION; ILLNESS-DURATION; CINGULATE CORTEX; DISORDER; NETWORKS; ABNORMALITIES; 1ST-EPISODE; REDUCTION	Objective: To investigate white matter volume abnormalities in patients with major depression and the effects of antidepressant treatment on white matter volume. Method: Magnetic resonance imaging (MRI) was performed on 32 treatment-naive depressed patients, 17 recovered patients who had received antidepressant treatment and subsequently achieved clinical recovery and 34 matched controls. Results: Relative to the healthy controls, the treatment-naive depressed patients showed increased white matter volumes in the left dorsolateral prefrontal cortex (DLPFC) and left putamen and reduced white matter volumes in the left cerebellum posterior lobe and left inferior parietal lobule. For the treatment-naive patients, the length in months of the current depressive episode was positively correlated with the white matter volumes in both the left DLPFC and left putamen. In the recovered patients, the differences in white matter volume were no longer statistically significant relative to healthy controls. No significant difference was found in the total white matter volume among the three groups. Conclusions: This study demonstrates that there were alterations in the white matter volumes of depressed patients, which might disrupt the neural circuits that are involved in emotional and cognitive function and thus contribute to the pathophysiology of depression. The finding of the significant correlations between refractoriness and the white matter volumes in the left DLPFC and left putamen combined with the finding that antidepressant treatment normalized the white matter volume of recovered patients, suggests that a quantitative, structural MRI measurement could act as a potential biomarker in depression therapy for individual subjects.	[Zeng, Ling-Li; Liu, Yadong; Shen, Hui; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Liu, Li] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Li, Yaming] China Med Univ, Affiliated Hosp 1, Dept Nucl Med, Shenyang, Liaoning, Peoples R China	National University of Defense Technology - China; China Medical University; China Medical University	Zeng, LL (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	lllyy2003@163.com; dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015	Zeng, Ling-Li/0000-0002-0515-256X	National Basic Research Program of China [2011CB707802]; National Science Foundation of China [60835005, 61003202]; Hunan Provincial Innovation Foundation for Postgraduate [CX2011B015]; National University of Defense Technology [B110304]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation for Postgraduate; National University of Defense Technology	This work was supported by the National Basic Research Program of China (Grant No. 2011CB707802), National Science Foundation of China (Grant Nos. 60835005, 61003202), Hunan Provincial Innovation Foundation for Postgraduate (Grant No. CX2011B015), and Graduate Innovation Fund of National University of Defense Technology (Grant No. B110304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; APA, 2000, DIAGN STAT MAN MENT; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; First M.B., 2016, STRUCTURED CLIN INTE; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Guy W, 1976, ECDEU ASSESSMENT MAN; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hu DW, 2008, CEREBELLUM, V7, P304, DOI 10.1007/s12311-008-0031-2; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Potter GG, 2007, NEUROPSYCHOPHARMACOL, V32, P2135, DOI 10.1038/sj.npp.1301339; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schlosser RGM, 2008, NEUROIMAGE, V43, P645, DOI 10.1016/j.neuroimage.2008.08.002; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Steingard RJ, 2002, BIOL PSYCHIAT, V52, P413, DOI 10.1016/S0006-3223(02)01393-8; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Vasic N, 2009, PSYCHOL MED, V39, P977, DOI 10.1017/S0033291708004443; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	44	44	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44248	10.1371/journal.pone.0044248	http://dx.doi.org/10.1371/journal.pone.0044248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957005	Green Published, gold, Green Submitted			2022-12-27	WOS:000308206500057
J	Cabeza-Arvelaiz, Y; Schiestl, RH				Cabeza-Arvelaiz, Yofre; Schiestl, Robert H.			Transcriptome Analysis of a Rotenone Model of Parkinsonism Reveals Complex I-Tied and -Untied Toxicity Mechanisms Common to Neurodegenerative Diseases	PLOS ONE			English	Article							DNA-DAMAGE-RESPONSE; CELL-CYCLE ARREST; ENDOPLASMIC-RETICULUM STRESS; HUMAN NEUROBLASTOMA-CELLS; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; INDUCED APOPTOSIS; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; SH-SY5Y CELLS	The pesticide rotenone, a neurotoxin that inhibits the mitochondrial complex I, and destabilizes microtubules (MT) has been linked to Parkinson disease (PD) etiology and is often used to model this neurodegenerative disease (ND). Many of the mechanisms of action of rotenone are posited mechanisms of neurodegeneration; however, they are not fully understood. Therefore, the study of rotenone-affected functional pathways is pertinent to the understanding of NDs pathogenesis. This report describes the transcriptome analysis of a neuroblastoma (NB) cell line chronically exposed to marginally toxic and moderately toxic doses of rotenone. The results revealed a complex pleiotropic response to rotenone that impacts a variety of cellular events, including cell cycle, DNA damage response, proliferation, differentiation, senescence and cell death, which could lead to survival or neurodegeneration depending on the dose and time of exposure and cell phenotype. The response encompasses an array of physiological pathways, modulated by transcriptional and epigenetic regulatory networks, likely activated by homeostatic alterations. Pathways that incorporate the contribution of MT destabilization to rotenone toxicity are suggested to explain complex I-independent rotenone-induced alterations of metabolism and redox homeostasis. The postulated mechanisms involve the blockage of mitochondrial voltage-dependent anions channels (VDACs) by tubulin, which coupled with other rotenone-induced organelle dysfunctions may underlie many presumed neurodegeneration mechanisms associated with pathophysiological aspects of various NDs including PD, AD and their variant forms. Thus, further investigation of such pathways may help identify novel therapeutic paths for these NDs.	[Cabeza-Arvelaiz, Yofre] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Cabeza-Arvelaiz, Yofre] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Environm Hlth Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Cabeza-Arvelaiz, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.	yofrecabeza@gmail.com	Cao, Pengxiu/I-5378-2012		PHS [U54 ES12078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012078] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by PHS grantU54 ES12078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Armstrong JS, 2001, BIOCHEM BIOPH RES CO, V289, P973, DOI 10.1006/bbrc.2001.6054; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Basu SS, 2011, CHEM RES TOXICOL, V24, P1630, DOI 10.1021/tx200366j; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bhattacharya R, 2008, CELL MOTIL CYTOSKEL, V65, P708, DOI 10.1002/cm.20292; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Boutros R, 2005, EXP CELL RES, V310, P152, DOI 10.1016/j.yexcr.2005.07.009; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Burns MP, 2010, BBA-MOL CELL BIOL L, V1801, P853, DOI 10.1016/j.bbalip.2010.03.004; Cabeza-Arvelaiz Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-83; Caldwell CM, 2009, ADV EXP MED BIOL, V656, P51, DOI 10.1007/978-1-4419-1145-2_5; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Chaves RS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-144; Chen MHJ, 2006, NEUROSCI LETT, V397, P69, DOI 10.1016/j.neulet.2005.12.011; Chen YM, 2011, CELL CYCLE, V10, P655, DOI 10.4161/cc.10.4.14814; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; CICCARONE V, 1989, CANCER RES, V49, P219; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cortellino S, 2003, P NATL ACAD SCI USA, V100, P15071, DOI 10.1073/pnas.2334585100; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; Deasy BM, 2003, STEM CELLS, V21, P536, DOI 10.1634/stemcells.21-5-536; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; Dimri GP, 1996, BIOL SIGNAL, V5, P154; Doles J, 2010, CANCER RES, V70, P1033, DOI 10.1158/0008-5472.CAN-09-2113; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Esteves AR, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.005.2009; Fu Z, 2009, J CLIN INVEST, V119, P2714, DOI 10.1172/JCI37405; Fujiuchi N, 2004, J BIOL CHEM, V279, P20339, DOI 10.1074/jbc.M400344200; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Ganguly A, 2011, ONCOTARGET, V2, P368, DOI 10.18632/oncotarget.250; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Gomez-Santos C, 2005, BRAIN RES BULL, V65, P87, DOI 10.1016/j.brainresbull.2004.11.008; Goncalves AP, 2011, BBA-MOL CELL RES, V1813, P492, DOI 10.1016/j.bbamcr.2011.01.006; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x; Greene JG, 2008, NEUROSCIENCE, V152, P198, DOI 10.1016/j.neuroscience.2007.11.029; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; HARA E, 1994, J BIOL CHEM, V269, P2139; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Helmbold H, 2009, ONCOGENE, V28, P3456, DOI 10.1038/onc.2009.222; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Hoglinger GU, 2003, J NEUROCHEM, V84, P491, DOI 10.1046/j.1471-4159.2003.01533.x; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inden M, 2011, BIOL PHARM BULL, V34, P92, DOI 10.1248/bpb.34.92; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Jobe EM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00059; Jun JI, 2005, ONCOGENE, V24, P688, DOI 10.1038/sj.onc.1208186; Kawabe J, 2006, BIOCHEM BIOPH RES CO, V342, P164, DOI 10.1016/j.bbrc.2006.01.125; Kitamura Y, 2002, NEUROSCI LETT, V333, P25, DOI 10.1016/S0304-3940(02)00964-3; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; LASORELLA A, 1995, CANCER RES, V55, P4711; Lee JJ, 2008, BIOCHEM BIOPH RES CO, V371, P33, DOI 10.1016/j.bbrc.2008.03.149; Lesniak W, 2011, CLIN EPIGENETICS, V2, P77, DOI 10.1007/s13148-011-0023-9; Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litvan I, 2007, J NEUROPATH EXP NEUR, V66, P251, DOI 10.1097/nen.0b013e3180415e42; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Matson DR, 2011, MOL INTERV, V11, P141, DOI 10.1124/mi.11.2.12; Mazzio E, 2003, NEUROSCI LETT, V337, P77, DOI 10.1016/S0304-3940(02)01327-7; Molina-Jimenez MF, 2005, TOXICOL APPL PHARM, V209, P214, DOI 10.1016/j.taap.2005.04.009; Muller GA, 2012, NUCLEIC ACIDS RES, V40, P1561, DOI 10.1093/nar/gkr793; Murzik U, 2008, MOL BIOL CELL, V19, P2926, DOI 10.1091/mbc.E07-11-1167; Newhouse K, 2004, TOXICOL SCI, V79, P137, DOI 10.1093/toxsci/kfh089; Nishiyama H, 2001, ONCOGENE, V20, P2956, DOI 10.1038/sj.onc.1204432; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Ohtsuka T, 2004, ONCOGENE, V23, P5405, DOI 10.1038/sj.onc.1207693; Ovadi J, 2005, IUBMB LIFE, V57, P765, DOI 10.1080/15216540500381101; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pelegrini AL, 2010, MUTAGENESIS, V25, P447, DOI 10.1093/mutage/geq026; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Qin Q, 2011, CELL RES; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Ramirez OA, 2011, BIOL RES, V44, P17, DOI 10.4067/S0716-97602011000100004; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; REED JC, 1991, CANCER RES, V51, P6529; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; RETTIG WJ, 1987, CANCER RES, V47, P1383; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2011, BIOCH BIOPHYS ACTA; Russell P, 2012, ONCOGENE, V31, P2450, DOI 10.1038/onc.2011.431; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Salaun P, 2008, ADV EXP MED BIOL, V617, P41; Samantaray S, 2007, NEUROSCIENCE, V146, P741, DOI 10.1016/j.neuroscience.2007.01.056; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Sharma S, 2011, NUCL ACIDS RES; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sherer TB, 2002, J NEUROSCI, V22, P7006; Sherer TB, 2001, BRAIN RES, V891, P94, DOI 10.1016/S0006-8993(00)03203-0; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Silva DFF, 2011, J ALZHEIMERS DIS, V26, P565, DOI 10.3233/JAD-2011-110423; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; Tikunov A, 2010, ARCH BIOCHEM BIOPHYS, V495, P174, DOI 10.1016/j.abb.2010.01.008; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Tsang WY, 2008, CELL CYCLE, V7, P702, DOI 10.4161/cc.7.6.5611; TSOKOS M, 1987, AM J PATHOL, V128, P484; Tumurbaatar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014711; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; Ullrich C, 2009, NEUROCHEM RES, V34, P2147, DOI 10.1007/s11064-009-0014-9; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Wainwright LJ, 2001, P NATL ACAD SCI USA, V98, P9396, DOI 10.1073/pnas.161288698; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Xiong K, 2007, EXP BRAIN RES, V181, P435, DOI 10.1007/s00221-007-0943-y; Yuan YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022354; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhovmer A, 2010, THESCIENTIFICWORLDJO, V10, P633, DOI 10.1100/tsw.2010.46; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	164	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44700	10.1371/journal.pone.0044700	http://dx.doi.org/10.1371/journal.pone.0044700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970289	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000046
J	Christian, SL; Zu, D; Licursi, M; Komatsu, Y; Pongnopparat, T; Codner, DA; Hirasawa, K				Christian, Sherri L.; Zu, Dong; Licursi, Maria; Komatsu, Yumiko; Pongnopparat, Theerawat; Codner, Dianne A.; Hirasawa, Kensuke			Suppression of IFN-Induced Transcription Underlies IFN Defects Generated by Activated Ras/MEK in Human Cancer Cells	PLOS ONE			English	Article							INTERFERON-ALPHA RESISTANCE; RAS SIGNALING PATHWAY; ANTIVIRAL RESPONSE; INDUCIBLE GENES; TUMOR-CELLS; MICROARRAY EXPERIMENTS; NEGATIVE REGULATION; ONCOLYTIC VIRUS; RIG-I; KINASE	Certain oncolytic viruses exploit activated Ras signaling in order to replicate in cancer cells. Constitutive activation of the Ras/MEK pathway is known to suppress the effectiveness of the interferon (IFN) antiviral response, which may contribute to Ras-dependent viral oncolysis. Here, we identified 10 human cancer cell lines (out of 16) with increased sensitivity to the anti-viral effects of IFN-alpha after treatment with the MEK inhibitor U0126, suggesting that the Ras/MEK pathway underlies their reduced sensitivity to IFN. To determine how Ras/MEK suppresses the IFN response in these cells, we used DNA microarrays to compare IFN-induced transcription in IFN-sensitive SKOV3 cells, moderately resistant HT1080 cells, and HT1080 cells treated with U0126. We found that 267 genes were induced by IFN in SKOV3 cells, while only 98 genes were induced in HT1080 cells at the same time point. Furthermore, the expression of a distinct subset of IFN inducible genes, that included RIGI, GBP2, IFIT2, BTN3A3, MAP2, MMP7 and STAT2, was restored or increased in HT1080 cells when the cells were co-treated with U0126 and IFN. Bioinformatic analysis of the biological processes represented by these genes revealed increased representation of genes involved in the anti-viral response, regulation of apoptosis, cell differentiation and metabolism. Furthermore, introduction of constitutively active Ras into IFN sensitive SKOV3 cells reduced their IFN sensitivity and ability to activate IFN-induced transcription. This work demonstrates for the first time that activated Ras/MEK in human cancer cells induces downregulation of a specific subset of IFN-inducible genes.	[Christian, Sherri L.; Zu, Dong; Licursi, Maria; Komatsu, Yumiko; Pongnopparat, Theerawat; Codner, Dianne A.; Hirasawa, Kensuke] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Christian, SL (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	sherri.christian@mun.ca; kensuke@mun.ca		Christian, Sherri/0000-0002-4289-4386	Canadian Institutes for Health Research [MOP74429, ROP99020]; Beatrice Hunter Cancer Research Institute; Cancer Research Training Program, Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; Cancer Research Training Program, Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	This work was supported by Canadian Institutes for Health Research (www.cihr-irsc.gc.ca), grant numbers MOP74429 and ROP99020. SLC was supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by the Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR (www.bhcri.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Battcock SA, 2006, J VIROL, V80, P4422, DOI 10.1128/JVI.80.9.4422-4430.2006; Bergmann M, 2001, CANCER RES, V61, P8188; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cascallo M, 2003, CANCER RES, V63, P5544; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Christian SL, 2009, J VIROL, V83, P6717, DOI 10.1128/JVI.02213-08; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Cully M, 2008, CELL, V133, P1292, DOI 10.1016/j.cell.2008.06.020; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dehmelt L, 2005, GENOME BIOL, V6; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; GOLDSTEIN D, 1986, CANCER RES, V46, P4315; GOLDSTEIN D, 1988, CA-CANCER J CLIN, V38, P258, DOI 10.3322/canjclin.38.5.258; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Guo Z, 2005, J IMMUNOL, V175, P7407, DOI 10.4049/jimmunol.175.11.7407; Hirasawa K, 2002, CANCER RES, V62, P1696; Hirasawa K, 2003, J VIROL, V77, P5649, DOI 10.1128/JVI.77.10.5649-5656.2003; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Landolfo S, 2000, Hematol J, V1, P7, DOI 10.1038/sj.thj.6200004; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; McCusker D, 1999, IMMUNOGENETICS, V49, P438, DOI 10.1007/s002510050517; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Noser JA, 2007, MOL THER, V15, P1531, DOI 10.1038/sj.mt.6300193; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Pelaez IM, 2010, INT J BIOCHEM CELL B, V42, P911, DOI 10.1016/j.biocel.2010.01.024; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puhlmann J, 2010, ONCOGENE, V29, P2205, DOI 10.1038/onc.2009.507; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Shang D, 2007, CANCER SCI, V98, P1259, DOI 10.1111/j.1349-7006.2007.00526.x; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Ward SV, 2003, VIROLOGY, V313, P553, DOI 10.1016/S0042-6822(03)00347-7; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035; Zitzmann K, 2007, CANCER RES, V67, P5025, DOI 10.1158/0008-5472.CAN-06-2575	72	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44267	10.1371/journal.pone.0044267	http://dx.doi.org/10.1371/journal.pone.0044267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970192	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000308462000016
J	Das Ghosh, D; Bhattacharjee, B; Sen, S; Premi, L; Mukhopadhyay, I; Chowdhury, RR; Roy, S; Sengupta, S				Das Ghosh, Damayanti; Bhattacharjee, Bornali; Sen, Shrinka; Premi, Laikangbam; Mukhopadhyay, Indranil; Chowdhury, Rahul Roy; Roy, Sudipta; Sengupta, Sharmila			Some Novel Insights on HPV16 Related Cervical Cancer Pathogenesis Based on Analyses of LCR Methylation, Viral Load, E7 and E2/E4 Expressions	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CPG METHYLATION; E2 PROTEIN; SEQUENCE VARIATIONS; INDIAN WOMEN; DNA; INTEGRATION; GENOME; CARCINOMA; BINDING	This study was undertaken to decipher the interdependent roles of (i) methylation within E2 binding site I and II (E2BS-I/II) and replication origin (nt 7862) in the long control region (LCR), (ii) expression of viral oncogene E7, (iii) expression of the transcript (E7-E1(boolean AND)E4) that encodes E2 repressor protein and (iv) viral load, in human papillomavirus 16 (HPV16) related cervical cancer (CaCx) pathogenesis. The results revealed over-representation (p < 0.001) of methylation at nucleotide 58 of E2BS-I among E2-intact CaCx cases compared to E2-disrupted cases. Bisulphite sequencing of LCR revealed overrepresentation of methylation at nucleotide 58 or other CpGs in E2BS-I/II, among E2-intact cases than E2-disrupted cases and lack of methylation at replication origin in case of both. The viral transcript (E7-E1(boolean AND)E4) that produces the repressor E2 was analyzed by APOT (amplification of papillomavirus oncogenic transcript)-coupled-quantitative-RT-PCR (of E7 and E4 genes) to distinguish episomal (pure or concomitant with integrated) from purely integrated viral genomes based on the ratio, E7 C-T/E4 C-T. Relative quantification based on comparative C-T (theshold cycle) method revealed 75.087 folds higher E7 mRNA expression in episomal cases over purely integrated cases. Viral load and E2 gene copy numbers were negatively correlated with E7 C-T (p = 0.007) and E2 C-T (p < 0.0001), respectively, each normalized with ACTB C-T, among episomal cases only. The k-means clustering analysis considering E7 C-T from APOT-coupled-quantitative-RT-PCR assay, in conjunction with viral load, revealed immense heterogeneity among the HPV16 positive CaCx cases portraying integrated viral genomes. The findings provide novel insights into HPV16 related CaCx pathogenesis and highlight that CaCx cases that harbour episomal HPV16 genomes with intact E2 are likely to be distinct biologically, from the purely integrated viral genomes in terms of host genes and/or pathways involved in cervical carcinogenesis.	[Das Ghosh, Damayanti; Bhattacharjee, Bornali; Premi, Laikangbam; Mukhopadhyay, Indranil] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Chowdhury, Rahul Roy] Saroj Gupta Canc Ctr & Res Inst, Dept Gynecol, Kolkata, India; [Roy, Sudipta] Suraksha Diagnost Private Ltd, Dept Pathol, Kolkata, India; [Sen, Shrinka; Sengupta, Sharmila] Natl Inst Biomed Genom, Dist Nadia, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG)	Das Ghosh, D (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.	ssg1@nibmg.ac.in		Bhattacharjee, Bornali/0000-0002-0801-1543	Department of Biotechnology, Government of India [BT/PR8014/Med/14/1220/2006]; Council of Scientific and Industrial Research, Government of India; Indian Statistical Institute; UGC	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Indian Statistical Institute; UGC(University Grants Commission, India)	This work was supported by Department of Biotechnology (Grant No. BT/PR8014/Med/14/1220/2006),r We thank Cancer Centre Welfare Home and Research Institute (Thakurpukur, South 24 Parganas, West Bengal, India), for support in sample collection; Human Genetics Unit, Indian Statistical Institute, Kolkata, India for technical support; Professor Partha P Majumder, Director, National Institute of Biomedical Genomics (NIBMG) and members of NIBMG for their co-operation and special thanks also to (i) Council of Scientific and Industrial Research, Government of India, for providing Dr. Bornali Bhattacharjee with a Fellowship (JRF and SRF) and Dr. Laikangbam Premi with a Fellowship (SRF), (ii) Indian Statistical Institute for providing Fellowships to Ms. Damayanti Das (JRF and SRF), and (iii) UGC for providing fellowship to Ms Shrinka Sen (JRF) to work on this project.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2003, INT J GYNECOL CANCER, V13, P154, DOI 10.1136/ijgc-00009577-200303000-00009; Alloul N, 1999, J GEN VIROL, V80, P29, DOI 10.1099/0022-1317-80-1-29; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997; BERUMEN J, 1994, INT J CANCER, V56, P640, DOI 10.1002/ijc.2910560506; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Bhattacharjee B, 2008, VIROLOGY, V377, P143, DOI 10.1016/j.virol.2008.04.007; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Bhattacharya P, 2007, TISSUE ANTIGENS, V70, P283, DOI 10.1111/j.1399-0039.2007.00894.x; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Das D, 2010, VIROLOGY, V402, P197, DOI 10.1016/j.virol.2010.03.030; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Gillitzer E, 2000, EMBO J, V19, P3069, DOI 10.1093/emboj/19.12.3069; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Klaes R, 1999, CANCER RES, V59, P6132; MATSUKURA T, 1989, VIROLOGY, V172, P63, DOI 10.1016/0042-6822(89)90107-4; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Sathish N, 2004, GYNECOL ONCOL, V95, P363, DOI 10.1016/j.ygyno.2004.08.025; Singh RK, 2006, INT J GYNECOL CANCER, V16, P1048, DOI 10.1111/j.1525-1438.2006.00550.x; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Sowjanya AP, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-116; Thain A, 1996, J VIROL, V70, P7233, DOI 10.1128/JVI.70.10.7233-7235.1996; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Van Tine BA, 2004, P NATL ACAD SCI USA, V101, P4030, DOI 10.1073/pnas.0306848101; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44678	10.1371/journal.pone.0044678	http://dx.doi.org/10.1371/journal.pone.0044678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970286	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400105
J	Esworthy, RS; Kim, BW; Rivas, GE; Leto, TL; Doroshow, JH; Chu, FF				Esworthy, R. Steven; Kim, Byung-Wook; Rivas, Guillermo E.; Leto, Thomas L.; Doroshow, James H.; Chu, Fong-Fong			Analysis of Candidate Colitis Genes in the Gdac1 Locus of Mice Deficient in Glutathione Peroxidase-1 and-2	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIUM; BINDING-PROTEIN; DUAL OXIDASE; CELL-CYCLE; EXPRESSION; MOUSE; RESPONSES; GPX2	Background: Mice that are deficient for glutathione peroxidases 1 and 2 (GPX) show large variations in the penetrance and severity of colitis in C57BL/6J and 129S1/SvImJ backgrounds. We mapped a locus contributing to this difference to distal chromosome 2 (similar to 119-133 mbp) and named it glutathione peroxidase-deficiency-associated colitis 1 (Gdac1). The aim of this study was to identify the best gene candidates within the Gdac1 locus contributing to the murine colitis phenotype. Method/Principal Findings: We refined the boundaries of Gdac1 to 118-125 mbp (95% confidence interval) by increasing sample size and marker density across the interval. The narrowed region contains 128 well-annotated protein coding genes but it excludes Fermt1, a human inflammatory bowel disease candidate that was within the original boundaries of Gdac1. The locus we identified may be the Cdcs3 locus mapped by others studying IL10-knockout mice. Using in silico analysis of the 128 genes, based on published colon expression data, the relevance of pathways to colitis, gene mutations, presence of non-synonymous-single-nucleotide polymorphisms (nsSNPs) and whether the nsSNPs are predicted to have an impact on protein function or expression, we excluded 42 genes. Based on a similar analysis, twenty-five genes from the remaining 86 genes were analyzed for expression-quantitative-trait loci, and another 15 genes were excluded. Conclusion/Significance: Among the remaining 10 genes, we identified Pla2g4f and Duox2 as the most likely colitis gene candidates, because GPX metabolizes PLA2G4F and DUOX2 products. Pla2g4f is a phospholipase A2 that has three potentially significant nsSNP variants and showed expression differences across mouse strains. PLA2G4F produces arachidonic acid, which is a substrate for lipoxygenases and, in turn, for GPXs. DUOX2 produces H2O2 and may control microbial populations. DUOX-1 and -2 control microbial populations in mammalian lung and in the gut of several insects and zebrafish. Dysbiosis is a phenotype that differentiates 129S1/SvImJ from C57BL/6J and may be due to strain differences in DUOX2 activity.	[Esworthy, R. Steven; Kim, Byung-Wook; Chu, Fong-Fong] Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA USA; [Leto, Thomas L.] NIAID, Host Def Lab, NIH, Rockville, MD USA; [Doroshow, James H.] NCI, NIH, Bethesda, MD 20892 USA	City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Esworthy, RS (corresponding author), Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA USA.	fchu@coh.org	Esworthy, Steve/AAN-3152-2020	Esworthy, Steve/0000-0002-4111-3349	National Institutes of Health [R01CA114569]; NATIONAL CANCER INSTITUTE [R01CA114569, ZIABC011076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by National Institutes of Health R01CA114569 (FFC)http://projectreporter.nih.gov/reporter_searchresults.cfm. No additional external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2008, J CLIN INVEST, V118, P2121, DOI 10.1172/JCI30473; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Arisawa T, 2008, HEPATO-GASTROENTEROL, V55, P394; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown JK, 2008, INT J PARASITOL, V38, P143, DOI 10.1016/j.ijpara.2007.10.002; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Castrop H, 2008, AM J PHYSIOL-RENAL, V295, pF859, DOI 10.1152/ajprenal.00106.2008; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chiba H, 2004, J BIOL CHEM, V279, P12890, DOI 10.1074/jbc.M305801200; CHU FF, 1993, J BIOL CHEM, V268, P2571; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Chu FF, 1997, BIOMED ENVIRON SCI, V10, P156; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; Dgany O, 2002, AM J HUM GENET, V71, P1467, DOI 10.1086/344781; Esworthy RS, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/986046; Esworthy RS, 2011, INFLAMM BOWEL DIS, V17, P1373, DOI 10.1002/ibd.21479; Esworthy RS, 2003, BIOL CHEM, V384, P597, DOI 10.1515/BC.2003.067; Farmer MA, 2001, P NATL ACAD SCI USA, V98, P13820, DOI 10.1073/pnas.241258698; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Fisler JS, 1997, J NUTR, V127, pS1909, DOI 10.1093/jn/127.9.1909S; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Flores MV, 2010, BIOCHEM BIOPH RES CO, V400, P164, DOI 10.1016/j.bbrc.2010.08.037; Furtado LV, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-119; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; Hesketh J, 2008, ANNU REV NUTR, V28, P157, DOI 10.1146/annurev.nutr.28.061807.155446; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim BW, 2012, FREE RADICAL BIO MED, V52, P1569, DOI 10.1016/j.freeradbiomed.2012.02.009; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kiyomitsu T, 2011, MOL CELL BIOL, V31, P998, DOI 10.1128/MCB.00815-10; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Naetar N, 2007, J CELL SCI, V120, P737, DOI 10.1242/jcs.03390; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Renella R, 2011, BLOOD, V117, P6928, DOI 10.1182/blood-2010-09-308478; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; SAVAGE DC, 1968, J EXP MED, V127, P67, DOI 10.1084/jem.127.1.67; Southgate L, 2010, NEUROGENETICS, V11, P379, DOI 10.1007/s10048-010-0243-8; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wohlgemuth S, 2009, ENVIRON MICROBIOL, V11, P1562, DOI 10.1111/j.1462-2920.2009.01883.x; Xiao H, 2009, MOL BIOL CELL, V20, P21, DOI 10.1091/mbc.E08-04-0441; Ye JHQ, 2009, WORLD J GASTROENTERO, V15, P4491, DOI 10.3748/wjg.15.4491; Zhang Y, 2007, J MED GENET, V44, P233, DOI 10.1136/jmg.2006.045765	78	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44262	10.1371/journal.pone.0044262	http://dx.doi.org/10.1371/journal.pone.0044262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970191	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400052
J	Guazzi, P; Goitre, L; Ferro, E; Cutano, V; Martino, C; Trabalzini, L; Retta, SF				Guazzi, Paolo; Goitre, Luca; Ferro, Elisa; Cutano, Valentina; Martino, Chiara; Trabalzini, Lorenza; Retta, Saverio Francesco			Identification of the Kelch Family Protein Nd1-L as a Novel Molecular Interactor of KRIT1	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; INTEGRIN ACTIVATION; RECENT INSIGHTS; ANKYRIN REPEAT; RHO KINASE; PATHOGENESIS; TALIN; BINDING; RAP1; DOMAIN	Loss-of-function mutations of the KRIT1 gene (CCM1) have been associated with the Cerebral Cavernous Malformation (CCM) disease, which is characterized by serious alterations of brain capillary architecture. The KRIT1 protein contains multiple interaction domains and motifs, suggesting that it might act as a scaffold for the assembly of functional protein complexes involved in signaling networks. In previous work, we defined structure-function relationships underlying KRIT1 intramolecular and intermolecular interactions and nucleocytoplasmic shuttling, and found that KRIT1 plays an important role in molecular mechanisms involved in the maintenance of the intracellular Reactive Oxygen Species (ROS) homeostasis to prevent oxidative cellular damage. Here we report the identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1. This interaction was discovered through yeast two-hybrid screening of a mouse embryo cDNA library, and confirmed by pull-down and co-immunoprecipitation assays of recombinant proteins, as well as by co-immunoprecipitation of endogenous proteins in human endothelial cells. Furthermore, using distinct KRIT1 isoforms and mutants, we defined the role of KRIT1 domains in the Nd1-L/KRIT1 interaction. Finally, functional assays showed that Nd1-L may contribute to the regulation of KRIT1 nucleocytoplasmic shuttling and cooperate with KRIT1 in modulating the expression levels of the antioxidant protein SOD2, opening a novel avenue for future mechanistic studies. The identification of Nd1-L as a novel KRIT1 interacting protein provides a novel piece of the molecular puzzle involving KRIT1 and suggests a potential functional cooperation in cellular responses to oxidative stress, thus expanding the framework of molecular complexes and mechanisms that may underlie the pathogenesis of CCM disease.	[Guazzi, Paolo; Ferro, Elisa; Trabalzini, Lorenza] Univ Siena, Dept Biotechnol Chem & Pharm, I-53100 Siena, Italy; [Goitre, Luca; Cutano, Valentina; Martino, Chiara; Retta, Saverio Francesco] Univ Turin, Dept Clin & Biol Sci, Orbassano, TO, Italy	University of Siena; University of Turin	Guazzi, P (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy.	francesco.retta@unito.it	Retta, Saverio Francesco/Q-4770-2019	Retta, Saverio Francesco/0000-0001-9761-2959; Trabalzini, Lorenza/0000-0002-0850-7186	MIUR (Italian Ministry of University and Research) [2004052127, 2008BP25KN]; Fondazione Telethon [GGP06222]	MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Fondazione Telethon(Fondazione TelethonEuropean Commission)	This work was supported by MIUR (Italian Ministry of University and Research, PRIN National Projects no. 2004052127 to LT and SFR, and no. 2008BP25KN to SFR) and Fondazione Telethon (grant no. GGP06222 to SFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Felbor U, 2006, ZBL NEUROCHIR, V67, P110, DOI 10.1055/s-2006-933537; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Fujimura L, 2004, CARDIOVASC RES, V64, P315, DOI 10.1016/j.cardiores.2004.07.009; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Kang M, 2001, BBA-GENE STRUCT EXPR, V1519, P167, DOI 10.1016/S0167-4781(01)00231-7; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Matsudo Y, 2006, TRANSGENIC RES, V15, P573, DOI 10.1007/s11248-006-9010-x; Ohta Y, 2010, INT J ONCOL, V36, P427, DOI 10.3892/ijo_00000516; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Retta SF, 2006, EUR J CELL BIOL, V85, P283, DOI 10.1016/j.ejcb.2005.09.007; Retta SF, 2004, GENE, V325, P63, DOI 10.1016/j.gene.2003.09.046; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Yadla S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10121; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	43	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44705	10.1371/journal.pone.0044705	http://dx.doi.org/10.1371/journal.pone.0044705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970292	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400107
J	Singh, D; Takahashi, K; Adams, JM				Singh, Dharmesh; Takahashi, Koichi; Adams, Jonathan M.			Elevational Patterns in Archaeal Diversity on Mt. Fuji	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MESOPHILIC CRENARCHAEOTA; KINGDOM CRENARCHAEOTA; PHYLOGENETIC ANALYSIS; COMMUNITY STRUCTURE; SOIL; ABUNDANCE; OXIDATION; EURYARCHAEOTA; MOUNTAINSIDES	Little is known of how archaeal diversity and community ecology behaves along elevational gradients. We chose to study Mount Fuji of Japan as a geologically and topographically uniform mountain system, with a wide range of elevational zones. PCR-amplified soil DNA for the archaeal 16 S rRNA gene was pyrosequenced and taxonomically classified against EzTaxon-e archaeal database. At a bootstrap cut-off of 80%, most of the archaeal sequences were classified into phylum Thaumarchaeota (96%) and Euryarchaeota (3.9%), with no sequences classified into other phyla. Archaeal OTU richness and diversity on Fuji showed a pronounced 'peak' in the mid-elevations, around 1500 masl, within the boreal forest zone, compared to the temperate forest zone below and the alpine fell-field and desert zones above. Diversity decreased towards higher elevations followed by a subtle increase at the summit, mainly due to an increase in the relative abundance of the group I. 1b of Thaumarchaeota. Archaeal diversity showed a strong positive correlation with soil NH4+, K and NO32. Archaeal diversity does not parallel plant diversity, although it does roughly parallel bacterial diversity. Ecological hypotheses to explain the mid diversity bulge on Fuji include intermediate disturbance effects, and the result of mid elevations combining a mosaic of upper and lower slope environments. Our findings show clearly that archaeal soil communities are highly responsive to soil environmental gradients, in terms of both their diversity and community composition. Distinct communities of archaea specific to each elevational zone suggest that many archaea may be quite finely niche-adapted within the range of soil environments. A further interesting finding is the presence of a mesophilic component of archaea at high altitudes on a mountain that is not volcanically active. This emphasizes the importance of microclimate - in this case solar heating of the black volcanic ash surface - for the ecology of soil archaea.	[Singh, Dharmesh; Adams, Jonathan M.] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151742, South Korea; [Takahashi, Koichi] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano, Japan; [Takahashi, Koichi] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 390, Japan	Seoul National University (SNU); Shinshu University; Shinshu University	Singh, D (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151742, South Korea.	jonadams@snu.ac.kr		Singh, Dharmesh/0000-0002-4251-6617	National Research Foundation (NRF); Korean government, Ministry of Education, Science and Technology (MEST) [NRF-2011-0015787]	National Research Foundation (NRF); Korean government, Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the National Research Foundation (NRF) grant funded by the Korean government, Ministry of Education, Science and Technology (MEST) (NRF-2011-0015787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu C, 2001, J APPL MICROBIOL, V90, P713, DOI 10.1046/j.1365-2672.2001.01297.x; Adams J, 2009, S-P B ENVIRON SCI; Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Angelov A, 2006, J BIOTECHNOL, V126, P3, DOI 10.1016/j.jbiotec.2006.02.017; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bintrim SB, 1997, P NATL ACAD SCI USA, V94, P277, DOI 10.1073/pnas.94.1.277; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; DeLong EF, 1998, CURR OPIN GENET DEV, V8, P649, DOI 10.1016/S0959-437X(98)80032-4; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Ehrhardt CJ, 2007, ENVIRON MICROBIOL, V9, P900, DOI 10.1111/j.1462-2920.2006.01211.x; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Friedrich MW, 2001, APPL ENVIRON MICROB, V67, P4880, DOI 10.1128/AEM.67.10.4880-4890.2001; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Huston M. A., 1994, BIOL DIVERSITY; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Jurgens G, 1997, APPL ENVIRON MICROB, V63, P803, DOI 10.1128/AEM.63.2.803-805.1997; Kan JJ, 2011, ISME J, V5, P1784, DOI 10.1038/ismej.2011.56; Kim JG, 2012, ENVIRON MICROBIOL, V14, P1528, DOI 10.1111/j.1462-2920.2012.02740.x; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KORNER C, 1986, OECOLOGIA, V69, P577, DOI 10.1007/BF00410366; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li L, 1999, MAR BIOTECHNOL, V1, P391, DOI 10.1007/PL00011793; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magurran A.E, 2004, MEASURING BIOL DIVER; Manerkar MA, 2008, MICROB ECOL, V56, P467, DOI 10.1007/s00248-008-9365-z; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; MASUZAWA T, 1991, Reports of Faculty of Science Shizuoka University, V25, P69; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Miehe G, 1994, PHYTOCOENOLOGIA, V24, P53, DOI 10.1127/phyto/24/1994/53; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; OHSAWA M, 1984, VEGETATIO, V57, P15, DOI 10.1007/BF00031929; Oline DK, 2006, MICROB ECOL, V52, P480, DOI 10.1007/s00248-006-9101-5; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Park HD, 2007, J APPL MICROBIOL, V102, P1401, DOI 10.1111/j.1365-2672.2006.03176.x; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sandaa RA, 1999, APPL ENVIRON MICROB, V65, P3293; Sarle, 1990, VARCLUS PROCEDURE SA; Schleper C, 1997, APPL ENVIRON MICROB, V63, P321, DOI 10.1128/AEM.63.1.321-323.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singh D, 2012, MICROB ECOL, V63, P429, DOI 10.1007/s00248-011-9900-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Winiger M., 1981, ERDKUNDE, V35, P248; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Zhang LM, 2009, FEMS MICROBIOL ECOL, V70, P208, DOI 10.1111/j.1574-6941.2009.00775.x	76	37	44	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44494	10.1371/journal.pone.0044494	http://dx.doi.org/10.1371/journal.pone.0044494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970233	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400079
J	Taylor, PA; Cho, KH; Lin, CP; Biswal, BB				Taylor, Paul A.; Cho, Kuan-Hung; Lin, Ching-Po; Biswal, Bharat B.			Improving DTI Tractography by including Diagonal Tract Propagation	PLOS ONE			English	Article							WHITE-MATTER; AXONAL PROJECTIONS; FIBER TRACTOGRAPHY; DIFFUSION; BRAIN; MRI; CONNECTIVITY; RECONSTRUCTION; ANISOTROPY; REDUCTION	Tractography algorithms have been developed to reconstruct likely WM pathways in the brain from diffusion tensor imaging (DTI) data. In this study, an elegant and simple means for improving existing tractography algorithms is proposed by allowing tracts to propagate through diagonal trajectories between voxels, instead of only rectilinearly to their facewise neighbors. A series of tests (using both real and simulated data sets) are utilized to show several benefits of this new approach. First, the inclusion of diagonal tract propagation decreases the dependence of an algorithm on the arbitrary orientation of coordinate axes and therefore reduces numerical errors associated with that bias (which are also demonstrated here). Moreover, both quantitatively and qualitatively, including diagonals decreases overall noise sensitivity of results and leads to significantly greater efficiency in scanning protocols; that is, the obtained tracts converge much more quickly (i.e., in a smaller amount of scanning time) to those of data sets with high SNR and spatial resolution. Importantly, the inclusion of diagonal propagation adds essentially no appreciable time of calculation or computational costs to standard methods. This study focuses on the widely-used streamline tracking method, FACT (fiber assessment by continuous tracking), and the modified method is termed "FACTID" (FACT including diagonals).	[Taylor, Paul A.; Biswal, Bharat B.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA; [Cho, Kuan-Hung; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Yang Ming Chiao Tung University	Taylor, PA (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	neon.taylor@gmail.com		Taylor, Paul/0000-0003-0488-6796	National Institutes of Health (NIH) [R01 AG032088-02]; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grant R01 AG032088-02. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Chao YP, 2008, MED ENG PHYS, V30, P989, DOI 10.1016/j.medengphy.2008.01.010; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kim M, 2006, NEUROIMAGE, V32, P1243, DOI 10.1016/j.neuroimage.2006.06.006; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Mangin JF, 2002, NMR BIOMED, V15, P481, DOI 10.1002/nbm.780; Minati L, 2007, J GERIATR PSYCH NEUR, V20, P3, DOI 10.1177/0891988706297089; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Poupon C, 2008, MAGN RESON MED, V60, P1276, DOI 10.1002/mrm.21789; Press W. H., 1992, ART SCI COMPUTING; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; REISERT M, 2009, MICCAI WORKSH DIFF M; Sherbondy A, 2005, IEEE T VIS COMPUT GR, V11, P419, DOI 10.1109/TVCG.2005.59; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X; Taylor PA, 2011, MAGN RESON IMAGING, V29, P777, DOI 10.1016/j.mri.2011.02.031; Tensaouti F., 2009, MICCAI WORKSH DIFF M; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ulug AM, 1999, AM J NEURORADIOL, V20, P1044; Ulug AM, 1997, STROKE, V28, P483, DOI 10.1161/01.STR.28.3.483; Warach S, 1997, STROKE, V28, P481; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894; Westin CF, 1999, LECT NOTES COMPUT SC, V1679, P441; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43415	10.1371/journal.pone.0043415	http://dx.doi.org/10.1371/journal.pone.0043415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970125	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400010
J	Anderson, SR; Porrill, J; Pearson, MJ; Pipe, AG; Prescott, TJ; Dean, P				Anderson, Sean R.; Porrill, John; Pearson, Martin J.; Pipe, Anthony G.; Prescott, Tony J.; Dean, Paul			An Internal Model Architecture for Novelty Detection: Implications for Cerebellar and Collicular Roles in Sensory Processing	PLOS ONE			English	Article							TRIGEMINAL GANGLION NEURONS; LOBULUS SIMPLEX PROJECTION; INFERIOR OLIVARY NEURONS; SACCADIC EYE-MOVEMENTS; ADAPTIVE-FILTER MODEL; CRUS-II PROJECTION; SUPERIOR COLLICULUS; ELECTROPHYSIOLOGICAL ANALYSIS; TACTILE AREAS; BRAIN-STEM	The cerebellum is thought to implement internal models for sensory prediction, but details of the underlying circuitry are currently obscure. We therefore investigated a specific example of internal-model based sensory prediction, namely detection of whisker contacts during whisking. Inputs from the vibrissae in rats can be affected by signals generated by whisker movement, a phenomenon also observable in whisking robots. Robot novelty-detection can be improved by adaptive noise-cancellation, in which an adaptive filter learns a forward model of the whisker plant that allows the sensory effects of whisking to be predicted and thus subtracted from the noisy sensory input. However, the forward model only uses information from an efference copy of the whisking commands. Here we show that the addition of sensory information from the whiskers allows the adaptive filter to learn a more complex internal model that performs more robustly than the forward model, particularly when the whisking-induced interference has a periodic structure. We then propose a neural equivalent of the circuitry required for adaptive novelty-detection in the robot, in which the role of the adaptive filter is carried out by the cerebellum, with the comparison of its output (an estimate of the self-induced interference) and the original vibrissal signal occurring in the superior colliculus, a structure noted for its central role in novelty detection. This proposal makes a specific prediction concerning the whisker-related functions of a region in cerebellar cortical zone A(2) that in rats receives climbing fibre input from the superior colliculus (via the inferior olive). This region has not been observed in non-whisking animals such as cats and primates, and its functional role in vibrissal processing has hitherto remained mysterious. Further investigation of this system may throw light on how cerebellar-based internal models could be used in broader sensory, motor and cognitive contexts.	[Anderson, Sean R.; Porrill, John; Prescott, Tony J.; Dean, Paul] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Pearson, Martin J.; Pipe, Anthony G.] Bristol Robot Lab, Bristol, Avon, England	University of Sheffield; University of Bristol; University of West England	Anderson, SR (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	p.dean@sheffield.ac.uk	Prescott, Tony J/A-7574-2008	Prescott, Tony J/0000-0003-4927-5390; Anderson, Sean/0000-0002-7452-5681; Pearson, Martin/0000-0002-8642-4845	European Union under Grant Biomimetic Technology for Vibrissal Active Touch (BIOTACT) [ICT-215910]; Engineering and Physical Sciences Research Council [EP/I032533/1] Funding Source: researchfish; EPSRC [EP/I032533/1] Funding Source: UKRI	European Union under Grant Biomimetic Technology for Vibrissal Active Touch (BIOTACT); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union under Grant Biomimetic Technology for Vibrissal Active Touch (BIOTACT) ICT-215910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1986, BRAIN RES, V378, P186, DOI 10.1016/0006-8993(86)90304-5; AKAIKE T, 1986, BRAIN RES, V386, P400, DOI 10.1016/0006-8993(86)90180-0; AKAIKE T, 1987, BRAIN RES, V417, P371, DOI 10.1016/0006-8993(87)90467-7; AKAIKE T, 1989, BRAIN RES, V482, P402, DOI 10.1016/0006-8993(89)91209-2; AKAIKE T, 1992, J COMP NEUROL, V320, P398, DOI 10.1002/cne.903200311; AKAIKE T, 1988, BRAIN RES, V442, P373, DOI 10.1016/0006-8993(88)91529-6; AKAIKE T, 1985, BRAIN RES, V340, P369, DOI 10.1016/0006-8993(85)90934-5; Alloway KD, 2010, J COMP NEUROL, V518, P4546, DOI 10.1002/cne.22477; Anderson SR, 2010, IEEE T ROBOT, V26, P1065, DOI 10.1109/TRO.2010.2069990; APPS R, 1990, J COMP NEUROL, V302, P236, DOI 10.1002/cne.903020205; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; Atkins MJ, 1997, J COMP NEUROL, V389, P249; Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 1999, J EXP BIOL, V202, P1339; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; BENTIVOGLIO M, 1982, EXP BRAIN RES, V46, P339; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Bosman LWJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00053; Bower J, 2003, SCI AM, V289, P50, DOI 10.1038/scientificamerican0803-48; BOWER JM, 1981, BRAIN BEHAV EVOLUT, V18, P1, DOI 10.1159/000121772; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; BRUNI C, 1974, IEEE T AUTOMAT CONTR, VAC19, P334, DOI 10.1109/TAC.1974.1100617; BUISSERETDELMAS C, 1988, NEUROSCI RES, V5, P475, DOI 10.1016/0168-0102(88)90038-7; BUISSERETDELMAS C, 1993, PROG NEUROBIOL, V40, P63, DOI 10.1016/0301-0082(93)90048-W; Cerminara NL, 2011, CEREBELLUM, V10, P484, DOI 10.1007/s12311-010-0209-2; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Curtis JC, 2006, NEURON, V50, P524, DOI 10.1016/j.neuron.2006.05.004; DEAN P, 1980, BRAIN RES, V197, P571, DOI 10.1016/0006-8993(80)91149-X; DEAN P, 1984, BRAIN RES REV, V8, P155, DOI 10.1016/0165-0173(84)90004-3; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; DEAN P, 1984, BRAIN RES REV, V8, P129, DOI 10.1016/0165-0173(84)90002-X; DEAN P, 1984, BRAIN RES REV, V8, P143, DOI 10.1016/0165-0173(84)90003-1; DEAN P, 1994, J COGNITIVE NEUROSCI, V6, P117, DOI 10.1162/jocn.1994.6.2.117; Dean P, 2002, P ROY SOC B-BIOL SCI, V269, P1895, DOI 10.1098/rspb.2002.2103; Dean P, 2011, J PHYSIOL-LONDON, V589, P3459, DOI 10.1113/jphysiol.2010.201574; Dean P, 2010, FUNCT NEUROL, V25, P173; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fox C, 2009, AUTON ROBOT, V26, P223, DOI 10.1007/s10514-009-9109-z; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; Gibson S, 2005, IEEE T AUTOMAT CONTR, V50, P1581, DOI 10.1109/TAC.2005.856664; GODSCHALK M, 1994, J PHYSIOL-LONDON, V480, P147, DOI 10.1113/jphysiol.1994.sp020348; Hartmann MJZ, 2011, ANN NY ACAD SCI, V1225, P110, DOI 10.1111/j.1749-6632.2011.06007.x; Hartmann MJZ, 2009, INTEGR COMP BIOL, V49, P681, DOI 10.1093/icb/icp107; Hemelt ME, 2008, J NEUROPHYSIOL, V100, P1245, DOI 10.1152/jn.90478.2008; Hemelt ME, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-12; HESS DT, 1982, BRAIN RES, V250, P143; Honda T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002087; HUERTA MF, 1983, J COMP NEUROL, V220, P147, DOI 10.1002/cne.902200204; HUSTON JP, 1980, BRAIN RES BULL, V5, P745, DOI 10.1016/0361-9230(80)90214-2; Imamizu H, 2010, JPN PSYCHOL RES, V52, P107, DOI 10.1111/j.1468-5884.2010.00428.x; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Iwamoto Y, 2010, EXP BRAIN RES, V204, P145, DOI 10.1007/s00221-010-2314-3; KASSEL J, 1980, BRAIN RES, V202, P291, DOI 10.1016/0006-8993(80)90142-0; Kawato M, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P409; Khatri V, 2009, J NEUROPHYSIOL, V101, P1836, DOI 10.1152/jn.90655.2008; KILPATRICK IC, 1982, NEUROSCIENCE, V7, P207, DOI 10.1016/0306-4522(82)90161-0; KIRVEL RD, 1975, J COMP PHYSIOL PSYCH, V89, P882, DOI 10.1037/h0077166; KIRVEL RD, 1974, J COMP PHYSIOL PSYCH, V87, P156, DOI 10.1037/h0036570; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Ko H, 2000, IEEE T AERO ELEC SYS, V36, P102, DOI 10.1109/7.826315; KOHONEN T, 1976, BIOL CYBERN, V21, P85, DOI 10.1007/BF01259390; KURIMOTO Y, 1995, NEUROSCI RES, V22, P57, DOI 10.1016/0168-0102(95)00874-S; Leergaard TB, 2006, EUR J NEUROSCI, V24, P2801, DOI 10.1111/j.1460-9568.2006.05150.x; Leiser SC, 2007, NEURON, V53, P117, DOI 10.1016/j.neuron.2006.10.036; Lepora NF, 2012, J R SOC INTERFACE, V9, P1517, DOI 10.1098/rsif.2011.0750; Lisberger SG, 2009, NEUROSCIENCE, V162, P763, DOI 10.1016/j.neuroscience.2009.03.059; Markou M, 2003, SIGNAL PROCESS, V83, P2499, DOI 10.1016/j.sigpro.2003.07.019; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI 10.1016/j.sigpro.2003.07.018; MARSHALL JF, 1978, EXP NEUROL, V58, P203, DOI 10.1016/0014-4886(78)90134-6; Marsland S, 2005, ROBOT AUTON SYST, V51, P191, DOI 10.1016/j.robot.2004.10.006; Marsland S, 2002, NEURAL COMPUTING SUR, V3, P1; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Medina JF, 2011, CURR OPIN NEUROBIOL, V21, P616, DOI 10.1016/j.conb.2011.05.025; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Meredith MA, 2001, NEUROSCI RES, V40, P301, DOI 10.1016/S0168-0102(01)00240-1; MIHAILOFF GA, 1985, J COMP NEUROL, V237, P251, DOI 10.1002/cne.902370209; Mitchinson B., 2011, NEUROMORPHIC BRAIN B, ppp 23; Morissette J, 1996, EXP BRAIN RES, V109, P240; Niemi-Junkola UJ, 2000, NEUROSCIENCE, V97, P565, DOI 10.1016/S0306-4522(00)00044-0; NODA H, 1991, JPN J PHYSIOL, V41, P351, DOI 10.2170/jjphysiol.41.351; Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005; PAALLYSAHO J, 1991, NEUROSCI RES, V12, P217, DOI 10.1016/0168-0102(91)90112-C; Pearson MJ, 2007, ADAPT BEHAV, V15, P223, DOI 10.1177/1059712307082089; Pearson MJ, 2011, PHILOS T R SOC B, V366, P3085, DOI 10.1098/rstb.2011.0164; Pietr MD, 2010, J NEUROPHYSIOL, V104, P2532, DOI 10.1152/jn.01039.2009; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Porrill J, 2004, P ROY SOC B-BIOL SCI, V271, P789, DOI 10.1098/rspb.2003.2658; Prescott TJ, 2009, IEEE ROBOT AUTOM MAG, V16, P42, DOI 10.1109/MRA.2009.933624; REDGRAVE P, 1981, PSYCHOPHARMACOLOGY, V75, P198, DOI 10.1007/BF00432187; Requarth T, 2011, CURR OPIN NEUROBIOL, V21, P602, DOI 10.1016/j.conb.2011.05.031; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; Roberts SJ, 1999, IEE P-VIS IMAGE SIGN, V146, P124, DOI 10.1049/ip-vis:19990428; Ruigrok TJH, 2000, J COMP NEUROL, V426, P209, DOI 10.1002/1096-9861(20001016)426:2<209::AID-CNE4>3.0.CO;2-0; Sawtell NB, 2008, J NEUROSCI, V28, P1598, DOI 10.1523/JNEUROSCI.4946-07.2008; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SHAMBES GM, 1978, BRAIN RES, V157, P123, DOI 10.1016/0006-8993(78)91000-4; Shimansky Y, 1997, LEARN MEMORY, V4, P36, DOI 10.1101/lm.4.1.36; Soetedjo R, 2008, J NEUROPHYSIOL, V100, P1949, DOI 10.1152/jn.90526.2008; Speller JM, 1996, EXP BRAIN RES, V110, P425; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; SWENSON RS, 1983, NEUROSCIENCE, V8, P259, DOI 10.1016/0306-4522(83)90064-7; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Teune TM, 2000, PROG BRAIN RES, V124, P141; Towal RB, 2008, J NEUROPHYSIOL, V100, P740, DOI 10.1152/jn.01295.2007; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Voogd J, 2006, PROG BRAIN RES, V151, P231, DOI 10.1016/S0079-6123(05)51008-2; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Voogd J, 2003, J NEUROSCI, V23, P4645; WATSON CRR, 1978, NEUROSCI LETT, V10, P77, DOI 10.1016/0304-3940(78)90015-0; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Widrow B., 1985, ADAPTIVE SIGNAL PROC; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yatim N, 1996, NEUROSCI RES, V25, P267, DOI 10.1016/0168-0102(96)01061-9; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	132	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44560	10.1371/journal.pone.0044560	http://dx.doi.org/10.1371/journal.pone.0044560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957083	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800076
J	Mosberg, JA; Gregg, CJ; Lajoie, MJ; Wang, HH; Church, GM				Mosberg, Joshua A.; Gregg, Christopher J.; Lajoie, Marc J.; Wang, Harris H.; Church, George M.			Improving Lambda Red Genome Engineering in Escherichia coli via Rational Removal of Endogenous Nucleases	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; MEDIATED RECOMBINATION; EXONUCLEASE VII; REPAIR; PURIFICATION; EFFICIENT; GENE; IDENTIFICATION; REPLICATION; CHROMOSOMES	Lambda Red recombineering is a powerful technique for making targeted genetic changes in bacteria. However, many applications are limited by the frequency of recombination. Previous studies have suggested that endogenous nucleases may hinder recombination by degrading the exogenous DNA used for recombineering. In this work, we identify ExoVII as a nuclease which degrades the ends of single-stranded DNA (ssDNA) oligonucleotides and double-stranded DNA (dsDNA) cassettes. Removing this nuclease improves both recombination frequency and the inheritance of mutations at the 39 ends of ssDNA and dsDNA. Extending this approach, we show that removing a set of five exonucleases (RecJ, ExoI, ExoVII, ExoX, and Lambda Exo) substantially improves the performance of co-selection multiplex automatable genome engineering (CoS-MAGE). In a given round of CoS-MAGE with ten ssDNA oligonucleotides, the five nuclease knockout strain has on average 46% more alleles converted per clone, 200% more clones with five or more allele conversions, and 35% fewer clones without any allele conversions. Finally, we use these nuclease knockout strains to investigate and clarify the effects of oligonucleotide phosphorothioation on recombination frequency. The results described in this work provide further mechanistic insight into recombineering, and substantially improve recombineering performance.	[Gregg, Christopher J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Mosberg, Joshua A.; Lajoie, Marc J.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Wang, Harris H.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Wang, Harris H.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University	Mosberg, JA (corresponding author), Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969	Department of Energy Genomes to Life Center [DE-FG02-03ER6344]; United States Department of Defense NDSEG; Wyss Institute for Biologically Inspired Engineering; National Institutes of Health [1DP5OD009172-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	Department of Energy Genomes to Life Center(United States Department of Energy (DOE)); United States Department of Defense NDSEG(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Department of Energy Genomes to Life Center (Grant #DE-FG02-03ER6344). M.J.L. is supported by a United States Department of Defense NDSEG Fellowship. H. H. W. is supported by the Wyss Technology Development Fellowship from the Wyss Institute for Biologically Inspired Engineering and the Director's Early Independence Award from the National Institutes of Health (Grant #1DP5OD009172-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; CHASE JW, 1974, J BIOL CHEM, V249, P4553; CHASE JW, 1974, J BIOL CHEM, V249, P4545; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEUTSCHER MP, 1969, J BIOL CHEM, V244, P3029; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JEKEL M, 1995, GENE, V154, P55, DOI 10.1016/0378-1119(94)00835-G; KULKARNI SK, 1989, GENETICS, V123, P249; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lemuth K, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-29; Li XT, 2003, NUCLEIC ACIDS RES, V31, P6674, DOI 10.1093/nar/gkg844; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Liu XP, 2010, PROTEIN SCI, V19, P967, DOI 10.1002/pro.374; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Muyrers JPP, 2000, GENE DEV, V14, P1971; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; PRASHER DC, 1983, J BIOL CHEM, V258, P6340; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; STEIN CA, 1988, NUCLEIC ACIDS RES, V16, P3209, DOI 10.1093/nar/16.8.3209; Thomason LC, 2007, PLASMID, V58, P148, DOI 10.1016/j.plasmid.2007.03.001; VALES LD, 1983, J BACTERIOL, V155, P1116, DOI 10.1128/JB.155.3.1116-1122.1983; Viswanathan M, 1999, J BIOL CHEM, V274, P30094, DOI 10.1074/jbc.274.42.30094; Wang HH, 2011, NUCLEIC ACIDS RES, V39, P7336, DOI 10.1093/nar/gkr183; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang HH, 2012, GENOME SCALE PROMOTE; Wang Y, 2008, METAB ENG, V10, P33, DOI 10.1016/j.ymben.2007.09.002; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	46	55	66	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44638	10.1371/journal.pone.0044638	http://dx.doi.org/10.1371/journal.pone.0044638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957093	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800086
J	Thurber, RV; Burkepile, DE; Correa, AMS; Thurber, AR; Shantz, AA; Welsh, R; Pritchard, C; Rosales, S				Thurber, Rebecca Vega; Burkepile, Deron E.; Correa, Adrienne M. S.; Thurber, Andrew R.; Shantz, Andrew A.; Welsh, Rory; Pritchard, Catharine; Rosales, Stephanie			Macroalgae Decrease Growth and Alter Microbial Community Structure of the Reef-Building Coral, Porites astreoides	PLOS ONE			English	Article							FIXATION ACETYLENE-REDUCTION; METAGENOMIC ANALYSIS; PRIMARY PRODUCERS; CARIBBEAN REEFS; ORGANIC-MATTER; CLIMATE-CHANGE; BACTERIA; CYANOBACTERIA; DIVERSITY; MORTALITY	With the continued and unprecedented decline of coral reefs worldwide, evaluating the factors that contribute to coral demise is of critical importance. As coral cover declines, macroalgae are becoming more common on tropical reefs. Interactions between these macroalgae and corals may alter the coral microbiome, which is thought to play an important role in colony health and survival. Together, such changes in benthic macroalgae and in the coral microbiome may result in a feedback mechanism that contributes to additional coral cover loss. To determine if macroalgae alter the coral microbiome, we conducted a field-based experiment in which the coral Porites astreoides was placed in competition with five species of macroalgae. Macroalgal contact increased variance in the coral-associated microbial community, and two algal species significantly altered microbial community composition. All macroalgae caused the disappearance of a gamma-proteobacterium previously hypothesized to be an important mutualist of P. astreoides. Macroalgal contact also triggered: 1) increases or 2) decreases in microbial taxa already present in corals, 3) establishment of new taxa to the coral microbiome, and 4) vectoring and growth of microbial taxa from the macroalgae to the coral. Furthermore, macroalgal competition decreased coral growth rates by an average of 36.8%. Overall, this study found that competition between corals and certain species of macroalgae leads to an altered coral microbiome, providing a potential mechanism by which macroalgae-coral interactions reduce coral health and lead to coral loss on impacted reefs.	[Thurber, Rebecca Vega; Burkepile, Deron E.; Correa, Adrienne M. S.; Shantz, Andrew A.; Welsh, Rory; Pritchard, Catharine; Rosales, Stephanie] Florida Int Univ, Deptartment Biol Sci, N Miami, FL USA; [Thurber, Rebecca Vega; Correa, Adrienne M. S.; Welsh, Rory; Rosales, Stephanie] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Pritchard, Catharine] Oregon Inst Marine Biol, Charleston, OR USA	State University System of Florida; Florida International University; Oregon State University; Oregon State University	Thurber, RV (corresponding author), Florida Int Univ, Deptartment Biol Sci, N Miami, FL USA.	Rebecca.Vega-Thurber@oregonstate.edu	Rosales, Stephanie/Z-4923-2019; Burkepile, Deron/F-2368-2013	Shantz, Andrew/0000-0001-5641-8914	Florida International University College of Arts and Sciences; OCE from National Science Foundation [1130786]; Division Of Ocean Sciences [1130786] Funding Source: National Science Foundation	Florida International University College of Arts and Sciences; OCE from National Science Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the Florida International University College of Arts and Sciences and grant OCE #1130786 from the National Science Foundation to DEB and RVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2011, ENVIRON MICROBIOL, P1; Barott KL, 2011, P ROYAL SOC B; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BRYLINSKY M, 1977, MAR BIOL, V39, P213, DOI 10.1007/BF00390995; Burkepile DE, 2011, CORAL REEFS, V30, P351, DOI 10.1007/s00338-011-0726-6; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; DAVIES PS, 1989, MAR BIOL, V101, P389; Ferrer LM, 1988, P 6 INT COR REEF S, V2, P1; Fine M, 2002, P ROY SOC B-BIOL SCI, V269, P1205, DOI 10.1098/rspb.2002.1983; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; HOLM S, 1979, SCAND J STAT, V6, P65; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Klaus JS, 2005, CORAL REEFS, V24, P129, DOI 10.1007/s00338-004-0447-1; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Mumby PJ, 2009, CORAL REEFS, V28, P683, DOI 10.1007/s00338-009-0501-0; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; WILLIAMS WM, 1987, MAR BIOL, V94, P531, DOI 10.1007/BF00431399; [No title captured]	57	84	85	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44246	10.1371/journal.pone.0044246	http://dx.doi.org/10.1371/journal.pone.0044246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957055	gold, Green Published			2022-12-27	WOS:000308463800047
J	Yue, K; Guduru, R; Hong, JM; Liang, P; Nair, M; Khizroev, S				Yue, Kun; Guduru, Rakesh; Hong, Jeongmin; Liang, Ping; Nair, Madhavan; Khizroev, Sakhrat			Magneto-Electric Nano-Particles for Non-Invasive Brain Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EXCITABILITY	This paper for the first time discusses a computational study of using magneto-electric (ME) nanoparticles to artificially stimulate the neural activity deep in the brain. The new technology provides a unique way to couple electric signals in the neural network to the magnetic dipoles in the nanoparticles with the purpose to enable a non-invasive approach. Simulations of the effect of ME nanoparticles for non-invasively stimulating the brain of a patient with Parkinson's Disease to bring the pulsed sequences of the electric field to the levels comparable to those of healthy people show that the optimized values for the concentration of the 20-nm nanoparticles (with the magneto-electric (ME) coefficient of 100 V cm(-1) Oe(-1) in the aqueous solution) is 3 x 10(6) particles/cc, and the frequency of the externally applied 300-Oe magnetic field is 80 Hz.	[Yue, Kun; Guduru, Rakesh; Hong, Jeongmin; Nair, Madhavan; Khizroev, Sakhrat] Florida Int Univ, Coll Engn & Comp, Ctr Nanomed, Miami, FL 33199 USA; [Nair, Madhavan; Khizroev, Sakhrat] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Miami, FL 33199 USA; [Liang, Ping] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of California System; University of California Riverside	Yue, K (corresponding author), Florida Int Univ, Coll Engn & Comp, Ctr Nanomed, Miami, FL 33199 USA.	khizroev@fiu.edu			Department of Defense (DoD) Defense Microelectronics Activity (DMEA) [H94003-09-2-0904]; National Science Foundation (NSF) [005084-002]; National Institute of Health (NIH) DA [027049]; University of California (UC) [189573]; Florida Scholars Boost Award [212400105]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027049] Funding Source: NIH RePORTER; Directorate For Engineering [1237818] Funding Source: National Science Foundation; Div Of Electrical, Commun & Cyber Sys [1102074] Funding Source: National Science Foundation	Department of Defense (DoD) Defense Microelectronics Activity (DMEA)(United States Department of Defense); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Health (NIH) DA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California (UC)(University of California System); Florida Scholars Boost Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors acknowledge financial support from Department of Defense (DoD) Defense Microelectronics Activity (DMEA) under contract # H94003-09-2-0904, National Science Foundation (NSF) award # 005084-002, National Institute of Health (NIH) DA # 027049, University of California (UC) Discovery Grant # 189573, and Florida Scholars Boost Award # 212400105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelmann L, 2000, J APPL PHYS, V87, P6636, DOI 10.1063/1.372795; BARKER AT, 1985, LANCET, V1, P1106; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Khizroev S, 2004, NANOTECHNOLOGY, V15, pR7, DOI 10.1088/0957-4484/15/3/R01; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Parekh V, 2006, NANOTECHNOLOGY, V17, P2079, DOI 10.1088/0957-4484/17/9/001; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; So RQ, 2012, J COMPUT NEUROSCI, V32, P499, DOI 10.1007/s10827-011-0366-4; Tokura Y, 2010, ADV MATER, V22, P1554, DOI 10.1002/adma.200901961; Zangen A, 2005, CLIN NEUROPHYSIOL, V116, P775, DOI 10.1016/j.clinph.2004.11.008	12	67	70	8	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44040	10.1371/journal.pone.0044040	http://dx.doi.org/10.1371/journal.pone.0044040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957042	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800034
J	Walker, TL; Vukovic, J; Koudijs, MM; Blackmore, DG; Mackay, EW; Sykes, AM; Overall, RW; Hamlin, AS; Bartlett, PF				Walker, Tara L.; Vukovic, Jana; Koudijs, Margaretha M.; Blackmore, Daniel G.; Mackay, Eirinn W.; Sykes, Alex M.; Overall, Rupert W.; Hamlin, Adam S.; Bartlett, Perry F.			Prolactin Stimulates Precursor Cells in the Adult Mouse Hippocampus	PLOS ONE			English	Article							NEURAL STEM-CELLS; NEUROGENESIS; PROLIFERATION; MITOGENESIS; PREGNANCY; NEURONS; BRAIN	In the search for ways to combat degenerative neurological disorders, neurogenesis-stimulating factors are proving to be a promising area of research. In this study, we show that the hormonal factor prolactin (PRL) can activate a pool of latent precursor cells in the adult mouse hippocampus. Using an in vitro neurosphere assay, we found that the addition of exogenous PRL to primary adult hippocampal cells resulted in an approximate 50% increase in neurosphere number. In addition, direct infusion of PRL into the adult dentate gyrus also resulted in a significant increase in neurosphere number. Together these data indicate that exogenous PRL can increase hippocampal precursor numbers both in vitro and in vivo. Conversely, PRL null mice showed a significant reduction (approximately 80%) in the number of hippocampal-derived neurospheres. Interestingly, no deficit in precursor proliferation was observed in vivo, indicating that in this situation other niche factors can compensate for a loss in PRL. The PRL loss resulted in learning and memory deficits in the PRL null mice, as indicated by significant deficits in the standard behavioral tests requiring input from the hippocampus. This behavioral deficit was rescued by direct infusion of recombinant PRL into the hippocampus, indicating that a lack of PRL in the adult mouse hippocampus can be correlated with impaired learning and memory.	[Walker, Tara L.; Vukovic, Jana; Koudijs, Margaretha M.; Blackmore, Daniel G.; Mackay, Eirinn W.; Sykes, Alex M.; Hamlin, Adam S.; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Walker, Tara L.; Overall, Rupert W.] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany	University of Queensland; Technische Universitat Dresden	Walker, TL (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	t.walker1@uq.edu.au	Bartlett, Perry/F-3813-2012; Blackmore, Daniel G/C-2450-2013; Vukovic, Jana/B-4845-2013; Overall, Rupert W/P-3102-2016; Walker, Tara/C-6242-2017	Blackmore, Daniel G/0000-0003-1153-1707; Vukovic, Jana/0000-0002-3739-1688; Overall, Rupert W/0000-0002-3882-6073; Hamlin, Adam/0000-0003-0495-1973; Walker, Tara/0000-0002-8472-0245; Mackay, Eirinn/0000-0003-1436-2259	NHMRC (National Health and Medical Research Council) Program Grant [569575]	NHMRC (National Health and Medical Research Council) Program Grant(National Health and Medical Research Council (NHMRC) of Australia)	PB was funded by a NHMRC (National Health and Medical Research Council) Program Grant (ID#569575). This work has also been supported by the Estate of Dr Clem Jones AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Larsen CM, 2008, HORM BEHAV, V53, P509, DOI 10.1016/j.yhbeh.2007.11.020; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mohammad YN, 2002, BIOCHEM CELL BIOL, V80, P475, DOI 10.1139/O02-036; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wagner K, 2009, CELL PHYSIOL BIOCHEM, V24, P397, DOI 10.1159/000257432; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007	25	65	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44371	10.1371/journal.pone.0044371	http://dx.doi.org/10.1371/journal.pone.0044371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973440	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600042
J	Chen, YH; Wu, YW; Yang, WS; Wang, SS; Lee, CM; Chou, NK; Hsu, RB; Lin, YH; Lin, MS; Ho, YL; Chen, MF				Chen, Ying-Hsien; Wu, Yen-Wen; Yang, Wei-Shiung; Wang, Shoei-Shen; Lee, Chi-Ming; Chou, Nai-Kuan; Hsu, Ron-Bin; Lin, Yen-Hung; Lin, Mao-Shin; Ho, Yi-Lwun; Chen, Ming-Fong			Relationship between Bone Mineral Density and Serum Osteoprotegerin in Patients with Chronic Heart Failure	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOSTATIN; OSTEOPOROSIS; ACTIVATION; MARKERS; MASS; MEN	Purpose: Heart failure (HF) had been reported with increased risk of hip fractures. However, the relationship between circulating biomarkers and bone mineral density (BMD) in chronic HF remained unclear. Methods: This is a cross-sectional study which recruited stable chronic HF from registry of the Heart Failure Center of National Taiwan University Hospital. Patients underwent dual-energy x-ray absorptiometry (DEXA) measurements at hip and lumbar spines and biochemical assessments including B-type natriuretic peptide (BNP-32), myostatin, follistatin and osteoprotegerin (OPG). Results: A total of 115 stable chronic HF individuals with left ventricular ejection fraction (EF) <45% (74% of male, mean age at 59) were recruited with 24 patients in NYHA class I, 73 patients in NYHA class II and 18 patients in NYHA class III. Results of BMD showed that Z scores of hip in NYHA III group (-0.12 +/- 1.15) was significantly lower than who were NYHA II (0.58 +/- 1.04). Serum OPG was significantly higher in subjects of NYHA III (9.3 +/- 4.6 pmol/l) than NYHA II (7.4 +/- 2.8 pmol/l) or NYHA I (6.8 +/- 3.6 pmol/l) groups. There's a significant negative association between log transformed serum OPG and trochanteric BMD (R = -0.299, P = 0.001), which remained significant after multivariate analysis. Conclusions: Our study demonstrated an inverse association between serum OPG and trochanteric BMD in patients with HF. OPG may be a predictor of BMD and an alternative to DEXA for identifying at risk HF patients for osteoporosis.	[Chen, Ying-Hsien; Wu, Yen-Wen; Yang, Wei-Shiung; Wang, Shoei-Shen; Lee, Chi-Ming; Chou, Nai-Kuan; Hsu, Ron-Bin; Lin, Yen-Hung; Lin, Mao-Shin; Ho, Yi-Lwun; Chen, Ming-Fong] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wang, Shoei-Shen; Chou, Nai-Kuan; Hsu, Ron-Bin] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lee, Chi-Ming] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liu City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Chen, Ying-Hsien; Wu, Yen-Wen; Yang, Wei-Shiung; Lee, Chi-Ming; Lin, Yen-Hung; Lin, Mao-Shin; Ho, Yi-Lwun; Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chen, YH (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	ylho@ntu.edu.tw	Chen, Ming/GVU-8412-2022; Lin, Yen-Hung/AAQ-1242-2020	Lin, Yen-Hung/0000-0001-8153-1441; Chou, Nai-Kuan/0000-0001-5494-7708; WU, YEN-WEN/0000-0003-1520-1166; Wang, Shoei-Shen/0000-0003-3201-4143; HO, YI-LWUN/0000-0002-8936-9570; YANG, WEI-SHIUNG/0000-0001-5087-373X	National Science Council of Taiwan [NSC 98-2314-B-002-145-MY2, NSC 99-2911-I-008-100]; Department of Health, Executive Yuan, R.O.C. [DOH 99-TD-B-111-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, R.O.C.	The work was supported by National Science Council of Taiwan [NSC 98-2314-B-002-145-MY2] to YW Wu and [NSC 99-2911-I-008-100] to YL Ho and Department of Health, Executive Yuan, R.O.C. [DOH 99-TD-B-111-001] to YL Ho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya S, 2009, ARCH GERONTOL GERIAT, V49, P250, DOI 10.1016/j.archger.2008.09.004; Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Baldini V, 2005, J Endocrinol Invest, V28, P69; Barasch E, 2009, CIRC-HEART FAIL, V2, P303, DOI 10.1161/CIRCHEARTFAILURE.108.828343; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozic B, 2010, J CARD FAIL, V16, P301, DOI 10.1016/j.cardfail.2009.12.015; Carbone L, 2010, EUR HEART J, V31, P77, DOI 10.1093/eurheartj/ehp483; Chhokar VS, 2004, AM J PHYSIOL-HEART C, V287, pH2023, DOI 10.1152/ajpheart.00477.2004; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Huang KC, 2004, CLIN ENDOCRINOL, V61, P204, DOI 10.1111/j.1365-2265.2004.02081.x; Hwang JJ, 2009, ATHEROSCLEROSIS, V204, P293, DOI 10.1016/j.atherosclerosis.2008.08.019; Jabbar S, 2011, J CLIN PATHOL; Jankowska EA, 2009, EUR J HEART FAIL, V11, P28, DOI 10.1093/eurjhf/hfn004; Jono S, 2010, J THROMB HAEMOST, V8, P1170, DOI 10.1111/j.1538-7836.2010.03833.x; Kochetkova EA, 2010, TERAPEVT ARKH, V82, P10; LEE AH, 1994, AM J MED, V96, P35, DOI 10.1016/0002-9343(94)90113-9; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lim LS, 2008, ARCH INTERN MED, V168, P735, DOI 10.1001/archinte.168.7.735; Loncar G, 2011, INT J CARDIOL; Loncar G, 2010, ENDOCRINE, V37, P148, DOI 10.1007/s12020-009-9282-z; Lyons K, 2011, CIRC HEART FAIL; Pobeha P, 2011, BONE, V48, P1008, DOI 10.1016/j.bone.2011.02.017; Roysland R, 2010, AM HEART J, V160, P286, DOI 10.1016/j.ahj.2010.05.015; Shaker OG, 2010, ANGIOLOGY, V61, P756, DOI 10.1177/0003319710370961; Shane E, 1997, AM J MED, V103, P197, DOI 10.1016/S0002-9343(97)00142-3; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Ueland T, 2011, CIRC-HEART FAIL, V4, P145, DOI 10.1161/CIRCHEARTFAILURE.110.957332; van Diepen S, 2008, CIRCULATION, V118, P1946, DOI 10.1161/CIRCULATIONAHA.108.784009; Witasp A, 2011, EUR J CLIN INVEST, V41, P498, DOI 10.1111/j.1365-2362.2010.02432.x; Zamora E, 2010, REV ESP CARDIOL, V63, P992, DOI 10.1016/S0300-8932(10)70212-8; Zittermann A, 2006, CLIN CHIM ACTA, V366, P27, DOI 10.1016/j.cca.2005.10.006	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44242	10.1371/journal.pone.0044242	http://dx.doi.org/10.1371/journal.pone.0044242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957004	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500056
J	Al-Baho, A; Serour, M; Al-Weqayyn, A; AlHilali, M; Sadek, AAA				Al-Baho, Abeer; Serour, Maleka; Al-Weqayyn, Adnan; AlHilali, Mohammed; Sadek, Ali A. A.			Clinical Audits in a Postgraduate General Practice Training Program: An Evaluation of 8 Years' Experience	PLOS ONE			English	Article							PREVALENCE; FEEDBACK	Background: Clinical audit can be of valuable assistance to any program which aims to improve the quality of health care and its delivery. Yet without a coherent strategy aimed at evaluating audits' effectiveness, valuable opportunities will be overlooked. Clinical audit projects are required as a part of the formative assessment of trainees in the Family Medicine Residency Program (FMRP) in Kuwait. This study was undertaken to draw a picture of trainees' understanding of the audit project with attention to the knowledge of audit theory and its educational significance and scrutinize the difficulties confronted during the experience. Methodology/Principal Findings: The materials included the records of 133 audits carried out by trainees and 165 post course questionnaires carried out between 2004 and 2011. They were reviewed and analyzed. The majority of audit projects were performed on diabetic (44.4%) and hypertensive (38.3%) care. Regarding audits done on diabetic care, they were carried out to assess doctors' awareness about screening for smoking status (8.6%), microalbuminuria (19.3%), hemoglobin A1c (15.5%), retinopathy (10.3%), dyslipidemia (15.8%), peripheral neuropathy (8.8%), and other problems (21.7%). As for audits concerning hypertensive care, they were carried out to assess doctors' awareness about screening for smoking status (38.0%), obesity (26.0%), dyslipidemia (12.0%), microalbuminuria (10.0%) and other problems (14.0%). More than half the participants (68.48%) who attended the audit course stated that they 'definitely agreed' about understanding the meaning of clinical audit. Most of them (75.8%) 'definitely agreed' about realizing the importance of clinical audit in improving patients' care. About half (49.7%) of them 'agreed' that they can distinguish between 'criteria' and 'standards'. Conclusion: The eight years of experience were beneficial. Trainees showed a good understanding of the idea behind auditing the services provided. They demonstrated their ability to improve the care given in health centers in which these projects were undertaken.	[Al-Baho, Abeer] Minist Hlth, Dept Hlth Promot, Kuwait, Al Kuwait, Kuwait; [Serour, Maleka; Al-Weqayyn, Adnan] Kuwait Inst Med Specializat, Family Med Residency Program, Kuwait, Al Kuwait, Kuwait; [AlHilali, Mohammed] Ain Shams Univ Hosp, Dept Internal Med, Cairo, Al Qahirah, Egypt; [Sadek, Ali A. A.] Univ Alexandria, Fac Med, Dept Publ Hlth, Alexandria, Al Eskandariyya, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Alexandria University	Al-Baho, A (corresponding author), Minist Hlth, Dept Hlth Promot, Kuwait, Al Kuwait, Kuwait.	drserour@hotmail.com	Serour, Maleka/GVT-6468-2022					Abdella N, 1998, DIABETES RES CLIN PR, V42, P187, DOI 10.1016/S0168-8227(98)00104-1; Brazil Victoria, 2004, Emerg Med Australas, V16, P348, DOI 10.1111/j.1742-6723.2004.00611.x; Campion P, 1992, Qual Health Care, V1, P114, DOI 10.1136/qshc.1.2.114; Chan S C, 2004, Med J Malaysia, V59, P609; Gagliardi AR, 2011, J CONTIN EDUC HEALTH, V31, P258, DOI 10.1002/chp.20138; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Johnston G, 2000, QUAL HEALTH CARE, V9, P23, DOI 10.1136/qhc.9.1.23; Lough JRM, 2001, MED EDUC, V35, P357, DOI 10.1046/j.1365-2923.2001.00868.x; MCKAY J, 1995, BRIT J GEN PRACT, V45, P301; McKenna H P, 1995, Nurs Stand, V9, P32; Moussa MAA, 2005, MED PRIN PRACT, V14, P87, DOI 10.1159/000083917; Moussa MAA, 2008, MED PRIN PRACT, V17, P270, DOI 10.1159/000129604; Penney G C, 1995, Qual Health Care, V4, P37, DOI 10.1136/qshc.4.1.37; Robinson S, 1996, QUAL HEALTH CARE, V5, P206, DOI 10.1136/qshc.5.4.206; Sales AE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-74; Shah NM, 2010, MED PRIN PRACT, V19, P105, DOI 10.1159/000273069; Taylor L, 2006, J PSYCHIATR MENT HLT, V13, P228, DOI 10.1111/j.1365-2850.2006.00945.x; Xyrichis A, 2008, INT J NURS STUD, V45, P140, DOI 10.1016/j.ijnurstu.2007.01.015; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	19	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43895	10.1371/journal.pone.0043895	http://dx.doi.org/10.1371/journal.pone.0043895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970146	Green Submitted, Green Published, gold			2022-12-27	WOS:000308748400008
J	Tyagi, AM; Srivastava, K; Mansoori, MN; Trivedi, R; Chattopadhyay, N; Singh, D				Tyagi, Abdul M.; Srivastava, Kamini; Mansoori, Mohd Nizam; Trivedi, Ritu; Chattopadhyay, Naibedya; Singh, Divya			Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis	PLOS ONE			English	Article							T-CELLS; BONE LOSS; RHEUMATOID-ARTHRITIS; INFLAMMATORY CYTOKINE; OSTEOCLAST FORMATION; PANCREATIC-ISLETS; INTERLEUKIN-17; DESTRUCTION; GAMMA; AGE	Th17 cells produce IL-17, and the latter promotes bone loss in collagen-induced arthritis in mice. Blocking IL-17 action in mouse model of rheumatoid arthritis reduces disease symptoms. These observations suggest that Th17 cells may be involved in the pathogenesis of bone loss. However, the role of Th17 cell in estrogen (E2) deficiency-induced bone loss is still not very clear. We investigated the effect of E2 on Th17 differentiation in vivo and IL-17 mediated regulation of osteoclast and osteoblast differentiation. Additionally, effect of IL-17 functional block under E2 deficiency-induced bone loss was studied. In murine bone marrow cells, E2 suppressed IL-17 mediated osteoclast differentiation. IL-17 inhibited formation of mineralized nodules in osteoblasts and this effect was suppressed by E2. E2 treatment to mouse calvarial osteoblasts inhibited the IL-17-induced production of osteoclastogenic cytokines and NF-kappa B translocation. In ovariectomized mice, there was increase in the number of Th17 cells, transcription factors promoting Th17 cell differentiation and circulating IL-17 levels. These effects were reversed by E2 supplementation. Treatment of neutralizing IL-17 monoclonal antibody to Ovx mice mitigated the E2 deficiency-induced trabecular bone loss and reversed the decreased osteoprotegerin-to-receptor activator of nuclear factor kappa B ligand (RANKL) transcript levels in long bones, increased osteoclast differentiation from the bone marrow precursor cells and decreased osteoblast differentiation from the bone marrow stromal cells. Our findings indicate that E2 deficiency leads to increased differentiation of Th17 cells with attendant up regulation of STAT3, ROR-gamma t and ROR-alpha and downregulation of Foxp3 which antagonizes Th17 cell differentiation. Increased IL-17 production in turn induces bone loss by increasing pro-osteoclastogenic cytokines including TNF-alpha, IL-6 and RANKL from osteoblasts and functional block of IL-17 prevents bone loss. IL-17 thus plays a critical causal role in Ovx-induced bone loss and may be considered a potential therapeutic target in pathogenesis of post menopausal osteoporosis.	[Tyagi, Abdul M.; Srivastava, Kamini; Mansoori, Mohd Nizam; Trivedi, Ritu; Chattopadhyay, Naibedya; Singh, Divya] Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Tyagi, AM (corresponding author), Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India.	divya_singh@cdri.res.in	Chattopadhyay, Naibedya/AAQ-3213-2021; Chattopadhyay, Naibedya/AAF-2058-2019; Malik, Abdul/AAX-5715-2020	Chattopadhyay, Naibedya/0000-0003-2473-0246; Malik, Abdul/0000-0001-9012-5779; SRIVASTAVA, KAMINI/0000-0002-3928-0885	Ministry of Health and Family Welfare; Council of Scientific and Industrial Research; Department of Science and Technology, Govt of India	Ministry of Health and Family Welfare; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Govt of India(Department of Science & Technology (India))	This work was supported by generous funding by the Ministry of Health and Family Welfare, Council of Scientific and Industrial Research and Department of Science and Technology, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Tyagi DS, 2011, OSTEOPOROS INT  0421, V22, pS214; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Bhargavan B, 2009, J CELL BIOCHEM, V108, P388, DOI 10.1002/jcb.22264; BIANCHI F, 1993, TISSUE CELL, V25, P817, DOI 10.1016/0040-8166(93)90030-O; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Burger HG, 2001, HORM RES, V56, P82, DOI 10.1159/000048141; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; DeSelm CJ, 2012, J CELL BIOCHEM, V113, P2895, DOI 10.1002/jcb.24165; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Garnero P, 1998, OSTEOPOROSIS INT, V8, P563, DOI 10.1007/s001980050100; Gautam AK, 2011, J NUTR BIOCHEM, V22, P318, DOI 10.1016/j.jnutbio.2010.02.010; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Goswami J, 2009, EUR J IMMUNOL, V39, P2831, DOI 10.1002/eji.200939670; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Holland JC, 2011, J ANAT, V218, P619, DOI 10.1111/j.1469-7580.2011.01376.x; Huang H, 2009, CELL DEATH DIFFER, V16, P1332, DOI 10.1038/cdd.2009.74; Kamiya S, 2007, J BONE MINER METAB, V25, P277, DOI 10.1007/s00774-007-0766-8; Kim SH, 2005, EXP BIOL MED, V230, P681; Kitami S, 2010, BIOCHIMIE, V92, P398, DOI 10.1016/j.biochi.2009.12.011; Kocic J, 2012, BBA-MOL CELL RES, V1823, P838, DOI 10.1016/j.bbamcr.2012.01.001; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 2000, EXP GERONTOL, V35, P947, DOI 10.1016/S0531-5565(00)00178-9; Kosmaczewska A, 2011, POSTEP HIG MED DOSW, V65, P397, DOI 10.5604/17322693.948971; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kozlowska E, 2007, IMMUNOLOGY, V122, P445, DOI 10.1111/j.1365-2567.2007.02667.x; Kramer JM, 2007, J PERIODONTOL, V78, P1083, DOI 10.1902/jop.2007.060392; Kumar A, 2010, PROTEOMICS, V10, P1730, DOI 10.1002/pmic.200900666; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Luo CY, 2011, CELL MOL IMMUNOL, V8, P50, DOI 10.1038/cmi.2010.54; Mainini G, 2011, CLIN EXP OBSTET GYN, V38, P355; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARCHETTI P, 1994, TRANSPLANTATION, V57, P1532; Maurya R, 2009, BIOORG MED CHEM LETT, V19, P610, DOI 10.1016/j.bmcl.2008.12.064; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Oostlander AE, 2012, J CELL BIOCHEM, V113, P260, DOI 10.1002/jcb.23352; Pacifici R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2126; Pandey R, 2010, MENOPAUSE, V17, P602, DOI 10.1097/gme.0b013e3181d0f7f0; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Sarkar S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2838; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Stamp LK, 2004, IMMUNOL CELL BIOL, V82, P1, DOI 10.1111/j.1440-1711.2004.01212.x; Tarjanyi Oktavia, 2009, Immun Ageing, V6, P8, DOI 10.1186/1742-4933-6-8; Tyagi AM, 2012, OSTEOPOROSIS INT, V23, P1151, DOI 10.1007/s00198-011-1650-x; Tyagi AM, 2010, MOL CELL ENDOCRINOL, V325, P101, DOI 10.1016/j.mce.2010.05.016; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Weitzmann MN, 2001, J BONE MINER RES, V16, P328, DOI 10.1359/jbmr.2001.16.2.328; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Won HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018168; Yago T, 2009, J CELL BIOCHEM, V108, P947, DOI 10.1002/jcb.22326; Yang W, 2011, J MOL MED, V89, P399, DOI 10.1007/s00109-010-0711-5; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Yuan FL, 2012, MOL BIOL REP, V39, P771, DOI 10.1007/s11033-011-0797-z	62	190	201	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44552	10.1371/journal.pone.0044552	http://dx.doi.org/10.1371/journal.pone.0044552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970248	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400022
J	Rothbart, MM; Hennig, RM				Rothbart, Matti Michael; Hennig, Ralf Matthias			The Steppengrille (Gryllus spec./assimilis): Selective Filters and Signal Mismatch on Two Time Scales	PLOS ONE			English	Article							AUDITORY-BEHAVIOR; SONG RECOGNITION; FEMALE CRICKETS; CALLING SONGS; ORTHOPTERA; PHONOTAXIS; WALKING	In Europe, several species of crickets are available commercially as pet food. Here we investigated the calling song and phonotactic selectivity for sound patterns on the short and long time scales for one such a cricket, Gryllus spec., available as "Gryllus assimilis", the Steppengrille, originally from Ecuador. The calling song consisted of short chirps (2-3 pulses, carrier frequency: 5.0 kHz) emitted with a pulse period of 30.2 ms and chirp rate of 0.43 per second. Females exhibited high selectivity on both time scales. The preference for pulse period peaked at 33 ms which was higher then the pulse period produced by males. Two consecutive pulses per chirp at the correct pulse period were already sufficient for positive phonotaxis. The preference for the chirp pattern was limited by selectivity for small chirp duty cycles and for chirp periods between 200 ms and 500 ms. The long chirp period of the songs of males was unattractive to females. On both time scales a mismatch between the song signal of the males and the preference of females was observed. The variability of song parameters as quantified by the coefficient of variation was below 50% for all temporal measures. Hence, there was not a strong indication for directional selection on song parameters by females which could account for the observed mismatch. The divergence of the chirp period and female preference may originate from a founder effect, when the Steppengrille was cultured. Alternatively the mismatch was a result of selection pressures exerted by commercial breeders on low singing activity, to satisfy customers with softly singing crickets. In the latter case the prominent divergence between male song and female preference was the result of domestication and may serve as an example of rapid evolution of song traits in acoustic communication systems.	[Rothbart, Matti Michael; Hennig, Ralf Matthias] Univ Berlin, Dept Biol, Berlin, Germany		Rothbart, MM (corresponding author), Univ Berlin, Dept Biol, Berlin, Germany.	matthias.hennig@biologie.hu-berlin.de			Deutsche Forschungsgemeinschaft/Sonderforschungsbereich [DFG/SFB 618, SFB 618]	Deutsche Forschungsgemeinschaft/Sonderforschungsbereich(German Research Foundation (DFG))	This study was funded by DFG/SFB 618 from Deutsche Forschungsgemeinschaft/Sonderforschungsbereich (SFB 618 - Theoretische Biologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; Anderson M, 1994, SEXUAL SELECTION; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Bradbury Jack W., 1998, pi; Deily JA, 2009, J COMP PHYSIOL A, V195, P31, DOI 10.1007/s00359-008-0379-2; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P173, DOI 10.1046/j.1463-6409.2003.00107.x; DOHERTY JA, 1985, J COMP PHYSIOL A, V156, P787, DOI 10.1007/BF00610831; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grobe B, 2012, J EXP BIOL, V215, P1681, DOI 10.1242/jeb.065466; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; Hennig RM, 2009, J COMP PHYSIOL A, V195, P971, DOI 10.1007/s00359-009-0473-0; Hennig RM, 2003, J COMP PHYSIOL A, V189, P589, DOI 10.1007/s00359-003-0438-7; HENNIG RM, 1990, J COMP PHYSIOL A, V167, P617; Huber F., 1989, CRICKET BEHAV NEUROB; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; Otte Daniel, 1992, Journal of Orthoptera Research, V1, P25; Poulet JFA, 2005, P NATL ACAD SCI USA, V102, P15665, DOI 10.1073/pnas.0505282102; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; Schmidt AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028593; Schneider E, 2012, J COMP PHYSIOL A, V198, P181, DOI 10.1007/s00359-011-0698-6; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; Trobe D, 2011, J COMP PHYSIOL A, V197, P131, DOI 10.1007/s00359-010-0589-2; Verburgt L, 2008, J COMP PHYSIOL A, V194, P79, DOI 10.1007/s00359-007-0292-0; WALKER TJ, 1975, J COMP PHYSIOL, V101, P57, DOI 10.1007/BF00660119; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weissman DB, 2009, ANN ENTOMOL SOC AM, V102, P367, DOI 10.1603/008.102.0304; Wiley C, 2012, P ROY SOC B-BIOL SCI, V279, P1203, DOI 10.1098/rspb.2011.1740; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	31	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43975	10.1371/journal.pone.0043975	http://dx.doi.org/10.1371/journal.pone.0043975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970154	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000009
J	Wen, RY; Moore, G; Shaw, PJ				Wen, Ruoyu; Moore, Graham; Shaw, Peter J.			Centromeres Cluster De Novo at the Beginning of Meiosis in Brachypodium distachyon	PLOS ONE			English	Article							BOUQUET FORMATION; SATELLITE REPEAT; DNA ELEMENT; PH1 LOCUS; CHROMOSOMES; TELOMERES; THALIANA; YEAST; RECOMBINATION; ORGANIZATION	In most eukaryotes that have been studied, the telomeres cluster into a bouquet early in meiosis, and in wheat and its relatives and in Arabidopsis the centromeres pair at the same time. In Arabidopsis, the telomeres do not cluster as a typical telomere bouquet on the nuclear membrane but are associated with the nucleolus both somatically and at the onset of meiosis. We therefore assessed whether Brachypodium distachyon, a monocot species related to cereals and whose genome is approximately twice the size of Arabidopsis thaliana, also exhibited an atypical telomere bouquet and centromere pairing. In order to investigate the occurrence of a bouquet and centromere pairing in B distachyon, we first had to establish protocols for studying meiosis in this species. This enabled us to visualize chromosome behaviour in meiocytes derived from young B distachyon spikelets in three-dimensions by fluorescent in situ hybridization (FISH), and accurately to stage meiosis based on chromatin morphology in relation to spikelet size and the timing of sample collection. Surprisingly, this study revealed that the centromeres clustered as a single site at the same time as the telomeres also formed a bouquet or single cluster.	[Wen, Ruoyu; Moore, Graham; Shaw, Peter J.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wen, RY (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	peter.shaw@jic.ac.uk	shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669	China Scholarship Council (CSC) from the Biological and Biotechnology Research Council (BBSRC) [BB/J004588/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000128] Funding Source: researchfish; BBSRC [BBS/E/J/00000128] Funding Source: UKRI	China Scholarship Council (CSC) from the Biological and Biotechnology Research Council (BBSRC); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China Scholarship Council (CSC), by grant BB/J004588/1 from the Biological and Biotechnology Research Council (BBSRC) and the John Innes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abramoff MD, 2002, IEEE T MED IMAGING, V21, P296, DOI 10.1109/TMI.2002.1000254; Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Aragon-Alcaide L, 1998, PLANT J, V14, P503, DOI 10.1046/j.1365-313X.1998.00148.x; AragonAlcaide L, 1996, CHROMOSOMA, V105, P261, DOI 10.1007/BF02524643; AragonAlcaide L, 1997, CURR BIOL, V7, P905, DOI 10.1016/S0960-9822(06)00383-6; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Colas I, 2008, P NATL ACAD SCI USA, V105, P6075, DOI 10.1073/pnas.0801521105; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; Da Ines O, 2012, PLOS GENET, V8, P245, DOI 10.1371/journal.pgen.1002636; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Greer E, 2012, PLANT CELL, V24, P152, DOI 10.1105/tpc.111.094771; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Kumekawa N, 2001, DNA RES, V8, P285, DOI 10.1093/dnares/8.6.285; Martinez-Perez E, 2003, PLANT J, V36, P21, DOI 10.1046/j.1365-313X.2003.01853.x; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; Martinez-Perez E, 2000, J CELL BIOL, V148, P233, DOI 10.1083/jcb.148.2.233; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; Mikhailova EI, 2001, J CELL SCI, V114, P1875; Miller JT, 1998, GENETICS, V150, P1615; Moore G, 2009, CURR OPIN GENET DEV, V19, P99, DOI 10.1016/j.gde.2009.02.006; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2003, GENETICS, V163, P759; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Opanowicz M, 2011, J EXP BOT, V62, P735, DOI 10.1093/jxb/erq309; Osman K, 2011, NEW PHYTOL, V190, P523, DOI 10.1111/j.1469-8137.2011.03665.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Penfold CA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002496; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Prieto P, 2004, NAT CELL BIOL, V6, P906, DOI 10.1038/ncb1168; Prieto P, 2004, CHROMOSOMA, V112, P300, DOI 10.1007/s00412-004-0274-8; Prieto P, 2007, NAT PROTOC, V2, P1831, DOI 10.1038/nprot.2007.265; Trelles-Sticken E, 1999, J CELL SCI, V112, P651; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wu JZ, 2004, PLANT CELL, V16, P967, DOI 10.1105/tpc.019273; Zhang Y, 2004, NUCLEIC ACIDS RES, V32, P2023, DOI 10.1093/nar/gkh521; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	43	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44681	10.1371/journal.pone.0044681	http://dx.doi.org/10.1371/journal.pone.0044681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970287	Green Submitted, Green Published, gold			2022-12-27	WOS:000308462000044
J	Grilo, C; Sousa, J; Ascensao, F; Matos, H; Leitao, I; Pinheiro, P; Costa, M; Bernardo, J; Reto, D; Lourenco, R; Santos-Reis, M; Revilla, E				Grilo, Clara; Sousa, Joana; Ascensao, Fernando; Matos, Hugo; Leitao, Ines; Pinheiro, Paula; Costa, Monica; Bernardo, Joao; Reto, Dyana; Lourenco, Rui; Santos-Reis, Margarida; Revilla, Eloy			Individual Spatial Responses towards Roads: Implications for Mortality Risk	PLOS ONE			English	Article							SMALL MAMMALS; TYTO-ALBA; GENE FLOW; HABITAT; HIGHWAY; MOVEMENT; FRAGMENTATION; MITIGATION; CULVERTS; BEHAVIOR	Background: Understanding the ecological consequences of roads and developing ways to mitigate their negative effects has become an important goal for many conservation biologists. Most mitigation measures are based on road mortality and barrier effects data. However, studying fine-scale individual spatial responses in roaded landscapes may help develop more cohesive road planning strategies for wildlife conservation. Methodology/Principal Findings: We investigated how individuals respond in their spatial behavior toward a highway and its traffic intensity by radio-tracking two common species particularly vulnerable to road mortality (barn owl Tyto alba and stone marten Martes foina). We addressed the following questions: 1) how highways affected home-range location and size in the immediate vicinity of these structures, 2) which road-related features influenced habitat selection, 3) what was the role of different road-related features on movement properties, and 4) which characteristics were associated with crossing events and road-kills. The main findings were: 1) if there was available habitat, barn owls and stone martens may not avoid highways and may even include highways within their home-ranges; 2) both species avoided using areas near the highway when traffic was high, but tended to move toward the highway when streams were in close proximity and where verges offered suitable habitat; and 3) barn owls tended to cross above-grade highway sections while stone martens tended to avoid crossing at leveled highway sections. Conclusions: Mortality may be the main road-mediated mechanism that affects barn owl and stone marten populations. Fine-scale movements strongly indicated that a decrease in road mortality risk can be realized by reducing sources of attraction, and by increasing road permeability through measures that promote safe crossings.	[Grilo, Clara; Sousa, Joana; Ascensao, Fernando; Matos, Hugo; Leitao, Ines; Pinheiro, Paula; Costa, Monica; Bernardo, Joao; Reto, Dyana; Santos-Reis, Margarida] Univ Lisbon, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Grilo, Clara; Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Lourenco, Rui] Univ Evora, Inst Mediterranean Agrarian & Environm Sci, Evora, Portugal	Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Evora	Grilo, C (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	claragrilo@ua.pt	Ascensão, Fernando/G-1513-2014; Lourenço, Rui/AAB-6030-2020; Santos-Reis, Margarida/H-4064-2011; Revilla, Eloy/B-5100-2008; Grilo, Clara/H-2002-2012; Lourenço, Rui/B-7148-2012; Ascensão, Fernando/ABF-9787-2021	Ascensão, Fernando/0000-0003-1704-0212; Lourenço, Rui/0000-0001-7694-0478; Revilla, Eloy/0000-0001-5534-5581; Grilo, Clara/0000-0001-9870-3115; Lourenço, Rui/0000-0001-7694-0478; Ascensão, Fernando/0000-0003-1704-0212; Santos-Reis, Margarida/0000-0002-0337-963X; Sousa, Joana/0000-0001-5102-254X	Brisa (Auto-Estradas de Portugal S.A.); Fundacao para a Ciencia e a Tecnologia [CG SFRH/BPD/64205/2009, FA SFRH/BD/38053/2007]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS]; FEDER	Brisa (Auto-Estradas de Portugal S.A.); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission)	Funding was provided by Brisa (Auto-Estradas de Portugal S.A.) and Fundacao para a Ciencia e a Tecnologia with a Post-doctoral (CG SFRH/BPD/64205/2009) and PhD grant (FA SFRH/BD/38053/2007). ER was supported by the Spanish Ministry of Science and Innovation (CGL2009-07301/BOS co-funded with FEDER funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beaudry F, 2008, BIOL CONSERV, V141, P2550, DOI 10.1016/j.biocon.2008.07.016; Bellamy PE, 2000, MAMMAL REV, V30, P131, DOI 10.1046/j.1365-2907.2000.00061.x; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Brostrom G., 2011, GLMMML GEN LINEAR MO; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Chandler D, 2011, BARL OWL; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; COLVIN BA, 1986, J FIELD ORNITHOL, V57, P200; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Eigenbrod F, 2009, ECOL SOC, V14; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Fahrig L, 2009, ECOL SOC, V14; Fajardo I., 1990, Ardeola, V37, P101; Frey C, 2011, J ORNITHOL, V152, P279, DOI 10.1007/s10336-010-0579-8; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Gomes L, 2009, ECOL RES, V24, P355, DOI 10.1007/s11284-008-0515-z; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Grilo C, 2008, BIODIVERS CONSERV, V17, P1685, DOI 10.1007/s10531-008-9374-8; Grilo C, 2011, EUR J WILDLIFE RES, V57, P707, DOI 10.1007/s10344-010-0478-6; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Langen TA, 2009, J WILDLIFE MANAGE, V73, P104, DOI 10.2193/2008-017; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Laurian C, 2008, J WILDLIFE MANAGE, V72, P1550, DOI 10.2193/2008-063; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Martinez JA, 2004, ARDEOLA, V51, P303; McDonald W, 2004, J APPL ECOL, V41, P82, DOI 10.1111/j.1365-2664.2004.00877.x; Mumme RL, 2000, CONSERV BIOL, V14, P501, DOI 10.1046/j.1523-1739.2000.98370.x; Neumann W, 2012, BIOL CONSERV, V145, P70, DOI 10.1016/j.biocon.2011.10.011; Parris KM, 2009, ECOL SOC, V14; PAYNE RS, 1971, J EXP BIOL, V54, P535; R Core Team, 2016, R FDN STAT COMP; Ramsden D.J., 2003, BARN OWLS MAJOR ROAD; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rivers James W., 1998, Kansas Ornithological Society Bulletin, V49, P43; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Roque Ines, 2004, Airo, V14, P11; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P459, DOI 10.1098/rspb.2000.1022; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Sabino-Marques H, 2011, ECOL RES, V26, P277, DOI 10.1007/s11284-010-0781-4; Santens S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025429, 10.1371/journal.pone.0025383]; Santos-Reis M, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P147; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; Seiler A, 2003, THESIS SWEDISH U AGR; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Taylor I. R, 1994, BARN OWLS PREDATOR P; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Van Renterghem T, 2012, LANDSCAPE URBAN PLAN, V105, P199, DOI 10.1016/j.landurbplan.2011.12.017; Zuberogoitia Inigo, 1998, Ardeola, V45, P47; Zuur Alain F., 2009, P1	64	66	69	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43811	10.1371/journal.pone.0043811	http://dx.doi.org/10.1371/journal.pone.0043811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970143	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400020
J	Kondo, N; Melikyan, GB				Kondo, Naoyuki; Melikyan, Gregory B.			Intercellular Adhesion Molecule 1 Promotes HIV-1 Attachment but Not Fusion to Target Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; FUNCTION-ASSOCIATED ANTIGEN-1; CD4(+) T-LYMPHOCYTES; HOST ICAM-1; ENVELOPE GLYCOPROTEIN; REPLICATION-COMPETENT; MEMBRANE-PROTEINS; TYPE-1 PARTICLES; MEDIATED FUSION	Incorporation of intercellular adhesion molecule 1 (ICAM-1) into HIV-1 particles is known to markedly enhance the virus binding and infection of cells expressing lymphocyte function-associated antigen-1 (LFA-1). At the same time, ICAM-1 has been reported to exert a less pronounced effect on HIV-1 fusion with lymphoid cells. Here we examined the role of ICAM-1/LFA-1 interactions in productive HIV-1 entry into lymphoid cells using a direct virus-cell fusion assay. ICAM-1 promoted HIV1 attachment to cells in a temperature-dependent manner. It exerted a marginal effect on virus binding in the cold, but enhanced binding up to 4-fold at physiological temperature. ICAM-1-independent attachment in the cold was readily reversible upon subsequent incubation at elevated temperature, whereas ICAM-1-bearing particles were largely retained by cells. The better virus retention resulted in a proportional increase in HIV-1 internalization and fusion, suggesting that ICAM-1 did not specifically accelerate endocytosis or fusion steps. We also measured the rates of CD4 engagement, productive endocytosis and HIV-endosome fusion using specific fusion inhibitors. These rates were virtually independent of the presence of ICAM-1 in viral particles. Importantly, irrespective of the presence of ICAM-1, HIV-1 escaped from the low temperature block, which stopped virus endocytosis and fusion, much later than from a membrane-impermeant fusion inhibitor targeting surface-accessible particles. This result, along with the complete inhibition of HIV-1 fusion by a small molecule dynamin inhibitor, implies this virus enters lymphoid cells used in this study via endocytosis and that this pathway is not altered by the viral ICAM-1. Our data highlight the role of ICAM-1 in stabilizing the HIV-1 attachment to LFA-1 expressing cells, which leads to a proportional enhancement of the receptor-mediated uptake and fusion with endosomes.	[Kondo, Naoyuki; Melikyan, Gregory B.] Emory Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA USA	Children's Healthcare of Atlanta (CHOA)	Kondo, N (corresponding author), Emory Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA USA.	gmeliki@emory.edu	Kondo, Naoyuki/W-5845-2019	Kondo, Naoyuki/0000-0002-6624-5989	National Institutes of Health [R01 GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health R01 GM054787 grant to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; BAZIL V, 1990, FOLIA BIOL-PRAGUE, V36, P41; Beausejour Y, 2004, J VIROL, V78, P11916, DOI 10.1128/JVI.78.21.11916-11925.2004; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Cabanas C, 1999, J BIOL REG HOMEOS AG, V13, P126; CAPOBIANCHI MR, 1994, J INFECT DIS, V169, P886, DOI 10.1093/infdis/169.4.886; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Ding ZM, 1999, J IMMUNOL, V163, P5029; Fortin JF, 2000, VIROLOGY, V268, P493, DOI 10.1006/viro.2000.0190; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Fortin JF, 1998, J VIROL, V72, P2105, DOI 10.1128/JVI.72.3.2105-2112.1998; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Fromentin R, 2010, VIROLOGY, V398, P168, DOI 10.1016/j.virol.2009.12.008; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; GELDERBLOM H, 1987, Z NATURFORSCH C, V42, P1328; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Henderson RB, 2001, J EXP MED, V194, P219, DOI 10.1084/jem.194.2.219; HILDRETH JEK, 1989, SCIENCE, V244, P1075, DOI 10.1126/science.2543075; Hioe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023202; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; HOXIE JA, 1987, HUM IMMUNOL, V18, P39, DOI 10.1016/0198-8859(87)90111-X; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Laudanna C, 2005, NAT IMMUNOL, V6, P429, DOI 10.1038/ni0505-429; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Losier M, 2003, CLIN IMMUNOL, V108, P111, DOI 10.1016/S1521-6616(03)00093-7; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; ORENTAS RJ, 1993, AIDS RES HUM RETROV, V9, P1157, DOI 10.1089/aid.1993.9.1157; Paquette JS, 1998, J VIROL, V72, P9329, DOI 10.1128/JVI.72.11.9329-9336.1998; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Saphire ACS, 2006, J PROTEOME RES, V5, P530, DOI 10.1021/pr050276b; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; Tardif MR, 2009, ANTIMICROB AGENTS CH, V53, P4656, DOI 10.1128/AAC.00117-09; Tardif MR, 2005, J IMMUNOL, V175, P926, DOI 10.4049/jimmunol.175.2.926; Tardif MR, 2005, J VIROL, V79, P13714, DOI 10.1128/JVI.79.21.13714-13724.2005; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; WANG SCT, 1995, J LEUKOCYTE BIOL, V57, P343, DOI 10.1002/jlb.57.2.343; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yi YJ, 1999, J VIROL, V73, P7117, DOI 10.1128/JVI.73.9.7117-7125.1999	81	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44827	10.1371/journal.pone.0044827	http://dx.doi.org/10.1371/journal.pone.0044827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970312	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400122
J	Norton, KA; Namazi, S; Barnard, N; Fujibayashi, M; Bhanot, G; Ganesan, S; Iyatomi, H; Ogawa, K; Shinbrot, T				Norton, Kerri-Ann; Namazi, Sameera; Barnard, Nicola; Fujibayashi, Mariko; Bhanot, Gyan; Ganesan, Shridar; Iyatomi, Hitoshi; Ogawa, Koichi; Shinbrot, Troy			Automated Reconstruction Algorithm for Identification of 3D Architectures of Cribriform Ductal Carcinoma In Situ	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; BORDER DETECTION; BREAST; SEGMENTATION; GROWTH; CLASSIFICATION; MORPHOGENESIS; MODEL; DCIS; VISUALIZATION	Ductal carcinoma in situ (DCIS) is a pre-invasive carcinoma of the breast that exhibits several distinct morphologies but the link between morphology and patient outcome is not clear. We hypothesize that different mechanisms of growth may still result in similar 2D morphologies, which may look different in 3D. To elucidate the connection between growth and 3D morphology, we reconstruct the 3D architecture of cribriform DCIS from resected patient material. We produce a fully automated algorithm that aligns, segments, and reconstructs 3D architectures from microscopy images of 2D serial sections from human specimens. The alignment algorithm is based on normalized cross correlation, the segmentation algorithm uses histogram equilization, Otsu's thresholding, and morphology techniques to segment the duct and cribra. The reconstruction method combines these images in 3D. We show that two distinct 3D architectures are indeed found in samples whose 2D histological sections are similarly identified as cribriform DCIS. These differences in architecture support the hypothesis that luminal spaces may form due to different mechanisms, either isolated cell death or merging fronds, leading to the different architectures. We find that out of 15 samples, 6 were found to have 'bubble-like' cribra, 6 were found to have 'tube-like' criba and 3 were 'unknown.' We propose that the 3D architectures found, 'bubbles' and 'tubes', account for some of the heterogeneity of the disease and may be prognostic indicators of different patient outcomes.	[Norton, Kerri-Ann; Namazi, Sameera; Bhanot, Gyan; Shinbrot, Troy] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA; [Norton, Kerri-Ann] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Barnard, Nicola] UMDNJ Robert Wood Johnson Med Sch, Dept Pathol, New Brunswick, NJ USA; [Fujibayashi, Mariko] Tokyo Womens Med Univ, Med Ctr E, Dept Surg Pathol, Tokyo, Japan; [Bhanot, Gyan] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Iyatomi, Hitoshi; Ogawa, Koichi] Hosei Univ, Dept Appl Informat, Tokyo, Japan; [Bhanot, Gyan; Ganesan, Shridar] UMDNJ Robert Wood Johnson, Sch Med, Canc Inst New Jersey, New Brunswick, NJ USA	Rutgers State University New Brunswick; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tokyo Women's Medical University; Institute for Advanced Study - USA; Hosei University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Norton, KA (corresponding author), Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08854 USA.	knorton4@jhmi.edu		Ogawa, Koichi/0000-0002-7137-9447	Hosei International Fund Foreign Scholars Fellowship; National Institutes of Health; New Jersey Commission on Cancer Research	Hosei International Fund Foreign Scholars Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research	This research was funded in part by the Hosei International Fund Foreign Scholars Fellowship. SG was supported by grants from the National Institutes of Health and the New Jersey Commission on Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NH, 1997, J PATHOL, V181, P374; Ando M, 2006, LECT NOTES COMPUT SC, V4046, P525, DOI 10.1007/11783237_71; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Bankhead A, 2007, J THEOR BIOL, V246, P491, DOI 10.1016/j.jtbi.2007.01.011; BARTELS PH, 1992, PATHOL RES PRACT, V188, P396, DOI 10.1016/S0344-0338(11)80026-9; Bartels PH, 1997, INT J IMAG SYST TECH, V8, P214, DOI 10.1002/(SICI)1098-1098(1997)8:2<214::AID-IMA8>3.0.CO;2-D; Celebi ME, 2007, COMPUT MED IMAG GRAP, V31, P362, DOI 10.1016/j.compmedimag.2007.01.003; Celebi ME, 2008, IEEE ENG MED BIO, P3056, DOI 10.1109/IEMBS.2008.4649848; Celebi ME, 2009, COMPUT MED IMAG GRAP, V33, P148, DOI 10.1016/j.compmedimag.2008.11.002; Chowdhury AR, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P449, DOI 10.1109/ICME.2002.1035815; Cornfield DB, 2004, CANCER, V100, P2317, DOI 10.1002/cncr.20260; Dadmanesh F, 2009, ARCH PATHOL LAB MED, V133, P26, DOI 10.1043/1543-2165-133.1.26; Davies JD, 1996, ANTICANCER RES, V16, P3971; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Diamond J, 2004, HUM PATHOL, V35, P1121, DOI 10.1016/j.humpath.2004.05.010; Eke I, 2011, RADIOTHER ONCOL, V99, P271, DOI 10.1016/j.radonc.2011.06.007; Fernandez-Aguilar S, 2005, VIRCHOWS ARCH, V447, P683, DOI 10.1007/s00428-005-0018-z; Fernandez-Gonzalez R, 2002, MICROSC RES TECHNIQ, V59, P522, DOI 10.1002/jemt.10233; Franks SJ, 2005, J THEOR BIOL, V232, P523, DOI 10.1016/j.jtbi.2004.08.032; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Going JJ, 2004, J PATHOL, V203, P538, DOI 10.1002/path.1556; Goulart R, 2002, COMPUTER AIDED MAPPI; Grin A, 2009, ARCH PATHOL LAB MED, V133, P31, DOI 10.1043/1543-2165-133.1.31; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VVolume 1; Hong LC, 1997, IEEE T NUCL SCI, V44, P1297, DOI 10.1109/23.597004; Ichihara S, 2008, VIRCHOWS ARCH, V452, P41, DOI 10.1007/s00428-007-0528-y; Iyatomi H, 2010, IEEE ENG MED BIO, P5407, DOI 10.1109/IEMBS.2010.5626500; Jaffer S, 2002, MICROSC RES TECHNIQ, V59, P92, DOI 10.1002/jemt.10180; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kurien T, 2005, J CLIN PATHOL, V58, P968, DOI 10.1136/jcp.2004.024794; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P13, DOI 10.1043/1543-2165-133.1.13; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P15, DOI 10.1043/1543-2165-133.1.15; Macklin P, 2011, J THEOR BIOL; Mai KT, 2000, HUM PATHOL, V31, P464, DOI 10.1053/hp.2000.6536; Malandain G, 2003, LECT NOTES COMPUT SC, V2732, P487; Miller NA, 2010, CANCER INFORM, V9, P209; Munro E, 2006, CURR OPIN GENET DEV, V16, P399, DOI 10.1016/j.gde.2006.06.004; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelsona TR, 2008, MED PHYS, V35, P1078, DOI 10.1118/1.2839439; Norton KA, 2010, IEEE ENG MED BIO, P5403, DOI 10.1109/IEMBS.2010.5626499; Norton KA, 2010, J THEOR BIOL, V263, P393, DOI 10.1016/j.jtbi.2009.11.024; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohtake T, 2001, CANCER-AM CANCER SOC, V91, P2263, DOI 10.1002/1097-0142(20010615)91:12<2263::AID-CNCR1257>3.0.CO;2-5; OHUCHI N, 1985, BREAST CANCER RES TR, V5, P57, DOI 10.1007/BF01807651; Otsu N, 1975, AUTOMATICA, V11, P285; Paish EC, 2009, J CLIN PATHOL, V62, P617, DOI 10.1136/jcp.2009.065219; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Rejniak KA, 2007, J THEOR BIOL, V247, P186, DOI 10.1016/j.jtbi.2007.02.019; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Shumate SD, 2009, IEEE T BIO-MED ENG, V56, P1341, DOI 10.1109/TBME.2008.2005638; Silva AS, 2010, J THEOR BIOL, V262, P601, DOI 10.1016/j.jtbi.2009.10.031; Streicher J, 1997, ANAT REC, V248, P583; Tang J, 2011, INTEGR BIOL-UK, V3, P408, DOI 10.1039/c0ib00092b; THOMPSON D, 1995, ANAL QUANT CYTOL, V17, P314; THOMPSON D, 1993, ANAL QUANT CYTOL, V15, P236; VanderSal N., 2007, 3D RECONSTRUCTION IM; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WELLINGS SR, 1973, J NATL CANCER I, V50, P1111, DOI 10.1093/jnci/50.5.1111; Wiechmann L, 2008, CANCER-AM CANCER SOC, V112, P2130, DOI 10.1002/cncr.23430; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44011	10.1371/journal.pone.0044011	http://dx.doi.org/10.1371/journal.pone.0044011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970156	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400028
J	Shirure, VS; Reynolds, NM; Burdick, MM				Shirure, Venktesh S.; Reynolds, Nathan M.; Burdick, Monica M.			Mac-2 Binding Protein Is a Novel E-Selectin Ligand Expressed by Breast Cancer Cells	PLOS ONE			English	Article							MAJOR E-SELECTIN; MAC-2-BINDING PROTEIN; TUMOR-CELLS; TRANSENDOTHELIAL MIGRATION; P-SELECTIN; ADHESION; CD44; METASTASIS; GALECTIN-1; ENDOTHELIUM	Hematogenous metastasis involves the adhesion of circulating tumor cells to vascular endothelium of the secondary site. We hypothesized that breast cancer cell adhesion is mediated by interaction of endothelial E-selectin with its glycoprotein counter-receptor(s) expressed on breast cancer cells. At a hematogenous wall shear rate, ZR-75-1 breast cancer cells specifically adhered to E-selectin expressing human umbilical vein endothelial cells when tested in parallel plate flow chamber adhesion assays. Consistent with their E-selectin ligand activity, ZR-75-1 cells expressed flow cytometrically detectable epitopes of HECA-452 mAb, which recognizes high efficiency E-selectin ligands typified by sialofucosylated moieties. Multiple E-selectin reactive proteins expressed by ZR-75-1 cells were revealed by immunoprecipitation with E-selectin chimera (E-Ig chimera) followed by Western blotting. Mass spectrometry analysis of the 72 kDa protein, which exhibited the most prominent E-selectin ligand activity, corresponded to Mac-2 binding protein (Mac-2BP), a heretofore unidentified E-selectin ligand. Immunoprecipitated Mac-2BP expressed sialofucosylated epitopes and possessed E-selectin ligand activity when tested by Western blot analysis using HECA-452 mAb and E-Ig chimera, respectively, demonstrating that Mac-2BP is a novel high efficiency E-selectin ligand. Furthermore, silencing the expression of Mac-2BP from ZR-75-1 cells by shRNA markedly reduced their adhesion to E-selectin expressing cells under physiological flow conditions, confirming the functional E-selectin ligand activity of Mac-2BP on intact cells. In addition to ZR-75-1 cells, several other E-selectin ligand positive breast cancer cell lines expressed Mac-2BP as detected by Western blot and flow cytometry, suggesting that Mac-2BP may be an E-selectin ligand in a variety of breast cancer types. Further, invasive breast carcinoma tissue showed co-localized expression of Mac-2BP and HECA-452 antigens by fluorescence microscopy, underscoring the possible role of Mac-2BP as an E-selectin ligand. In summary, breast cancer cells express Mac-2BP as a novel E-selectin ligand, potentially revealing a new prognostic and therapeutic target for breast cancer.	[Shirure, Venktesh S.; Reynolds, Nathan M.; Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH USA; [Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Biomed Engn Program, Athens, OH USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Shirure, VS (corresponding author), Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH USA.	burdick@ohio.edu	Shirure, Venktesh/M-8806-2015	Shirure, Venktesh/0000-0002-4430-2612; Burdick, Monica/0000-0003-3168-0072	seed grant from the Ohio Cancer Research Associates; United States National Institutes of Health grant [1R15CA161830-01]; National Science Foundation Major Research Instrumentation grant [1039869]; NATIONAL CANCER INSTITUTE [R15CA161830] Funding Source: NIH RePORTER	seed grant from the Ohio Cancer Research Associates; United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation grant(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a seed grant from the Ohio Cancer Research Associates (to MMB), a United States National Institutes of Health grant (1R15CA161830-01; to MMB), and a National Science Foundation Major Research Instrumentation grant (1039869; to MMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Becker R, 2008, FASEB J, V22, P3059, DOI 10.1096/fj.07-101386; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brunk DK, 1996, BIOPHYS J, V71, P2902, DOI 10.1016/S0006-3495(96)79487-0; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2001, BIOCHEM BIOPH RES CO, V284, P42, DOI 10.1006/bbrc.2001.4899; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2004, CANCER RES, V64, P5261, DOI 10.1158/0008-5472.CAN-04-0691; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; IACOBELLI S, 1993, FEBS LETT, V319, P59, DOI 10.1016/0014-5793(93)80037-U; Inohara H, 1996, CANCER RES, V56, P4530; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Kannagi R, 2001, Adv Exp Med Biol, V491, P587; Konstantopoulos K, 2011, ADV EXP MED BIOL, V705, P601, DOI 10.1007/978-1-4419-7877-6_32; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Krause T, 1999, CLIN EXP METASTAS, V17, P183, DOI 10.1023/A:1006626500852; Mannori G, 1997, AM J PATHOL, V151, P233; Marchetti A, 2002, CANCER RES, V62, P2535; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Moss MA, 2000, ANTICANCER RES, V20, P1425; Myung JH, 2011, ANAL CHEM, V83, P1078, DOI 10.1021/ac102901e; Narita, 1996, Breast Cancer, V3, P19, DOI 10.1007/BF02966958; Robertson D, 2011, METHODS MOL BIOL, V724, P69, DOI 10.1007/978-1-61779-055-3_4; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; SATO S, 1994, J BIOL CHEM, V269, P4424; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Shirure VS, 2011, BIOCHEM BIOPH RES CO, V406, P423, DOI 10.1016/j.bbrc.2011.02.061; Srirajaskanthan R, 2010, MOL CELL PROTEOMICS, V9, P656, DOI 10.1074/mcp.M900401-MCP200; Sutherland RL, 1999, HUMAN CELL CULTURE 2, VII; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Thomas SN, 2009, AM J PHYSIOL-CELL PH, V296, pC505, DOI 10.1152/ajpcell.00472.2008; Tinari N, 2001, INT J CANCER, V91, P167, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q; Tinari N, 2009, INT J CANCER, V124, P333, DOI 10.1002/ijc.23970; TOZEREN A, 1995, INT J CANCER, V60, P426; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; Wang HS, 2005, EXP CELL RES, V304, P116, DOI 10.1016/j.yexcr.2004.10.015; Wang L, 2011, MOL CARCINOGEN, V50, P58, DOI 10.1002/mc.20696; WEISS L, 1980, AM J PATHOL, V101, P101; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yin JJ, 2003, P NATL ACAD SCI USA, V100, P10954, DOI 10.1073/pnas.1830978100; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; Zou XY, 2005, AM J PHYSIOL-CELL PH, V289, pC415, DOI 10.1152/ajpcell.00289.2004	58	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44529	10.1371/journal.pone.0044529	http://dx.doi.org/10.1371/journal.pone.0044529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970241	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400085
J	Bestaven, E; Guillaud, E; Cazalets, JR				Bestaven, Emma; Guillaud, Etienne; Cazalets, Jean-Rene			Is "Circling" Behavior in Humans Related to Postural Asymmetry?	PLOS ONE			English	Article							HUMAN WALKING; SPATIAL REPRESENTATION; NONVISUAL NAVIGATION; BLIND PEDESTRIANS; PATH-INTEGRATION; CURVED PATH; ORIENTATION; LOCOMOTION; STIMULATION; MOVEMENT	In attempting to walk rectilinearly in the absence of visual landmarks, persons will gradually turn in a circle to eventually become lost. The aim of the present study was to provide insights into the possible underlying mechanisms of this behavior. For each subject (N = 15) six trajectories were monitored during blindfolded walking in a large enclosed area to suppress external cues, and ground irregularities that may elicit unexpected changes in direction. There was a substantial variability from trial to trial for a given subject and between subjects who could either veer very early or relatively late. Of the total number of trials, 50% trajectories terminated on the left side, 39% on the right side and 11% were defined as "straight". For each subject, we established a "turning score" that reflected his/her preferential side of veering. The turning score was found to be unrelated to any evident biomechanical asymmetry or functional dominance (eye, hand.). Posturographic analysis, used to assess if there was a relationship between functional postural asymmetry and veering revealed that the mean position of the center of foot pressure during balance tests was correlated with the turning score. Finally, we established that the mean position of the center of pressure was correlated with perceived verticality assessed by a subjective verticality test. Together, our results suggest that veering is related to a "sense of straight ahead" that could be shaped by vestibular inputs.	[Bestaven, Emma; Guillaud, Etienne; Cazalets, Jean-Rene] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Unite Mixte Rech 5287, Bordeaux, France; [Bestaven, Emma; Guillaud, Etienne; Cazalets, Jean-Rene] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, Unite Mixte Rech 5287, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS)	Bestaven, E (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Unite Mixte Rech 5287, Bordeaux, France.	jean-rene.cazalets@u-bordeaux2.fr	Cazalets, Jean-René/D-7851-2014; GUILLAUD, Etienne/F-3824-2014	Cazalets, Jean-René/0000-0001-9047-3933; GUILLAUD, Etienne/0000-0002-4875-1458				Amorim MA, 1997, PERCEPT PSYCHOPHYS, V59, P404, DOI 10.3758/BF03211907; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Berthoz A, 1999, CURR OPIN NEUROBIOL, V9, P708, DOI 10.1016/S0959-4388(99)00041-0; Borel L, 2004, BEHAV BRAIN RES, V150, P191, DOI 10.1016/S0166-4328(03)00257-2; Borel L, 2008, NEUROPHYSIOL CLIN, V38, P375, DOI 10.1016/j.neucli.2008.09.002; Borel L, 2001, NEUROREPORT, V12, P3137, DOI 10.1097/00001756-200110080-00031; Boyadjian A, 1999, NEUROSCI LETT, V265, P21, DOI 10.1016/S0304-3940(99)00198-6; Carroll T, 1929, 314 NAT ADV COMM AER; Cicinelli J., 1989, VEER FUNCTION PREVIE; Cohen HS, 2000, J VESTIBUL RES-EQUIL, V10, P7; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Cratty B. J., 1967, AM FDN BLIND RES B, V14, P13; Cratty B.J., 1966, PERCEPTUAL THRESHO 2; CRATTY BJ, 1965, PERCEPTUAL THRESHO 1; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Fitzpatrick RC, 1999, J PHYSIOL-LONDON, V517, P931, DOI 10.1111/j.1469-7793.1999.0931s.x; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; Glasauer S, 2002, EXP BRAIN RES, V145, P489, DOI 10.1007/s00221-002-1146-1; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Guldberg FO, 1897, Z BIOL, V35, P419; Guldberg GA, 1896, BIOL CENTRALBL, V16, P806; GUTH D, 1994, J VISUAL IMPAIR BLIN, V88, P391; GUTH D, 1995, J VISUAL IMPAIR BLIN, V89, P28; Iles JF, 2007, EXP BRAIN RES, V178, P151, DOI 10.1007/s00221-006-0721-2; Ivanenko YP, 2011, HUM MOVEMENT SCI, V30, P341, DOI 10.1016/j.humov.2010.04.001; Kallie CS, 2007, J EXP PSYCHOL HUMAN, V33, P183, DOI 10.1037/0096-1523.33.1.183; KLATZKY RL, 1990, J MOTOR BEHAV, V22, P19; Lacour M, 2006, CURR MED RES OPIN, V22, P1651, DOI 10.1185/030079906X115694; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lee SA, 2010, EXP BRAIN RES, V206, P179, DOI 10.1007/s00221-010-2349-5; Marques B, 2007, EXP BRAIN RES, V183, P457, DOI 10.1007/s00221-007-1063-4; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; Mittelstaedt ML, 2001, EXP BRAIN RES, V139, P318, DOI 10.1007/s002210100735; Mohr C, 2004, BEHAV BRAIN RES, V151, P321, DOI 10.1016/j.bbr.2003.09.006; Mohr C, 2007, LATERALITY, V12, P172, DOI 10.1080/13576500601051580; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Philbeck JW, 2001, J EXP PSYCHOL HUMAN, V27, P141, DOI 10.1037/0096-1523.27.1.141; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; Schaeffer AA, 1928, ANAT REC, V34, P115; Schafffer AA, 1928, J MORPHOL PHYSIOL, V45, P293, DOI 10.1002/jmor.1050450110; ScientificAmerican, 1893, WHY LOST PEOPL WALK; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Takei Y, 1997, EXP BRAIN RES, V115, P361, DOI 10.1007/PL00005705; TAKEMORI S, 1985, ORL-J OTO-RHIN-LARYN, V47, P76, DOI 10.1159/000275748; Vibert D, 2000, ACTA OTO-LARYNGOL, V120, P620, DOI 10.1080/000164800750000432; Vieilledent S, 2003, COGNITIVE BRAIN RES, V16, P238, DOI 10.1016/S0926-6410(02)00279-3	48	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43861	10.1371/journal.pone.0043861	http://dx.doi.org/10.1371/journal.pone.0043861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957035	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800027
J	Cheng, N; Mao, YH; Shi, YY; Tao, SH				Cheng, Nan; Mao, Yuanhui; Shi, Youyi; Tao, Shiheng			Coevolution in RNA Molecules Driven by Selective Constraints: Evidence from 5S rRNA	PLOS ONE			English	Article							DETECTING COEVOLVING POSITIONS; COMPENSATORY EVOLUTION; SECONDARY STRUCTURE; SEQUENCE EVOLUTION; MUTUAL INFORMATION; PROTEIN; SUBSTITUTIONS; COVARIATION; PREDICTION; PHYLOGENY	Understanding intra-molecular coevolution helps to elucidate various structural and functional constraints acting on molecules and might have practical applications in predicting molecular structure and interactions. In this study, we used 5S rRNA as a template to investigate how selective constraints have shaped the RNA evolution. We have observed the nonrandom occurrence of paired differences along the phylogenetic trees, the high rate of compensatory evolution, and the high TIR scores (the ratio of the numbers of terminal to intermediate states), all of which indicate that significant positive selection has driven the evolution of 5S rRNA. We found three mechanisms of compensatory evolution: Watson-Crick interaction (the primary one), complex interactions between multiple sites within a stem, and interplay of stems and loops. Coevolutionary interactions between sites were observed to be highly dependent on the structural and functional environment in which they occurred. Coevolution occurred mostly in those sites closest to loops or bulges within structurally or functionally important helices, which may be under weaker selective constraints than other stem positions. Breaking these pairs would directly increase the size of the adjoining loop or bulge, causing a partial or total structural rearrangement. In conclusion, our results indicate that sequence coevolution is a direct result of maintaining optimal structural and functional integrity.	[Cheng, Nan; Mao, Yuanhui; Tao, Shiheng] NW A&F Univ, StateKey Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Cheng, Nan; Mao, Yuanhui; Tao, Shiheng] NW A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Cheng, Nan; Tao, Shiheng] NW A&F Univ, Bioinformat Ctr, Yangling, Peoples R China; [Shi, Youyi] NW A&F Univ, Coll Sci, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Cheng, N (corresponding author), NW A&F Univ, StateKey Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	shihengt@nwsuaf.edu.cn			PhD Programs Foundation of the Ministry of Education of China [20100204110026]	PhD Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	The authors gratefully acknowledge the PhD Programs Foundation of the Ministry of Education of China (20100204110026) in ST's Lab. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmaev VR, 2000, BIOINFORMATICS, V16, P501, DOI 10.1093/bioinformatics/16.6.501; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Brown JR, 2004, BIOESSAYS, V26, P463, DOI 10.1002/bies.20030; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Chen YW, 2006, TRENDS GENET, V22, P416, DOI 10.1016/j.tig.2006.06.008; Dimmic MW, 2005, BIOINFORMATICS, V21, pI126, DOI 10.1093/bioinformatics/bti1032; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Dutheil JY, 2012, BRIEF BIOINFORM, V13, P228, DOI 10.1093/bib/bbr048; Dutheil JY, 2010, MOL BIOL EVOL, V27, P1868, DOI 10.1093/molbev/msq069; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; Huvet M, 2011, MOL BIOL EVOL, V28, P1141, DOI 10.1093/molbev/msq301; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kouvela EC, 2007, NUCLEIC ACIDS RES, V35, P5108, DOI 10.1093/nar/gkm546; Kulathinal RJ, 2004, SCIENCE, V306, P1553, DOI 10.1126/science.1100522; Kuo D, 2010, GENOME RES, V20, P1672, DOI 10.1101/gr.111765.110; Li G, 2011, MOL BIOL EVOL, V28, P911, DOI 10.1093/molbev/msq281; Marino-Ramirez L, 2006, EVOL BIOINFORM ONLIN, V2, P295; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Meer MV, 2010, NATURE, V464, P279, DOI 10.1038/nature08691; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Parsch J, 2000, GENETICS, V154, P909; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pei JM, 2006, BIOINFORMATICS, V22, P164, DOI 10.1093/bioinformatics/bti766; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savill NJ, 2001, GENETICS, V157, P399; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Snel B, 2004, GENOME RES, V14, P391, DOI 10.1101/gr.1969504; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Szymanski M, 2002, NUCLEIC ACIDS RES, V30, P176, DOI 10.1093/nar/30.1.176; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753, DOI 10.1093/oxfordjournals.molbev.a026273; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yeang CH, 2007, MOL BIOL EVOL, V24, P2119, DOI 10.1093/molbev/msm142; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44376	10.1371/journal.pone.0044376	http://dx.doi.org/10.1371/journal.pone.0044376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973441	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600043
J	Kamoi, M; Ogawa, Y; Nakamura, S; Dogru, M; Nagai, T; Obata, H; Ito, M; Kaido, M; Kawakita, T; Okada, Y; Kawakami, Y; Shimmura, S; Tsubota, K				Kamoi, Mizuka; Ogawa, Yoko; Nakamura, Shigeru; Dogru, Murat; Nagai, Toshihiro; Obata, Hiroto; Ito, Masataka; Kaido, Minako; Kawakita, Tetsuya; Okada, Yasunori; Kawakami, Yutaka; Shimmura, Shigeto; Tsubota, Kazuo			Accumulation of Secretory Vesicles in the Lacrimal Gland Epithelia Is Related to Non-Sjogren's Type Dry Eye in Visual Display Terminal Users	PLOS ONE			English	Article							REGULATED EXOCYTOSIS; OCULAR SURFACE; VAMP8/ENDOBREVIN; BLINKING; RAB3D; WORK	Previous observations in a rat model of a non-Sjogren's syndrome (non-SS) type of dry eye seen in users of visual display terminals (VDT) indicated that secretory vesicle (SV) accumulation in the lacrimal gland epithelia contributes to the condition. Here, to examine this possibility in humans, we compared the lacrimal gland histology and percent SV area in the cytoplasm of acinar epithelial cells using light microscopy and transmission electron microscopy, in patients with VDT work-related non-SS dry-eye (VDT group), SS-induced dry-eye, and autopsied normal controls. In addition, the VAMP8 (vesicle-associated membrane protein 8, an exocrine-pathway molecule) and Rab3D (mature vesicle marker) were histochemically examined in lacrimal gland tissue sections. The lacrimal gland acini were larger in the VDT group than in the SS group, and the percent SV area was significantly higher in the VDT group than in the normal controls (P = 0.021) or SS group (P = 0.004). Immunostaining revealed abnormal distributions of VAMP8 in the VDT and SS groups. Rab3D was more strongly expressed in the cytoplasm of acinar epithelial cells in the VDT group than in that of normal controls. The duration of VDT use was significantly longer in the VDT group than in the other groups. These findings suggest that excessive SV accumulation in the acinar epithelia may contribute to the reduced tear secretion in VDT users.	[Kamoi, Mizuka; Ogawa, Yoko; Nakamura, Shigeru; Dogru, Murat; Kaido, Minako; Kawakita, Tetsuya; Shimmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Nagai, Toshihiro; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Obata, Hiroto] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Saitama, Japan; [Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan	Keio University; Keio University; Jichi Medical University; National Defense Medical College - Japan; Keio University	Kamoi, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	yoko@z7.keio.jp	Okada, Yasunori/B-5550-2014; Kawakami, Yutaka/E-7429-2013; Ogawa, Yoko/AAV-1932-2021; Shimmura, Shigeto/J-4678-2013	Okada, Yasunori/0000-0001-9208-4755; Kawakami, Yutaka/0000-0003-4836-2855; Ogawa, Yoko/0000-0002-2906-9621; 	Japanese Ministry of Education, Science, Sports and Culture [24791877]; Japanese Medical Association; Grants-in-Aid for Scientific Research [24791877] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Medical Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japanese Ministry of Education, Science, Sports and Culture (no. 24791877 to Mizuka Kamoi), and the Japanese Medical Association 2010 (to Yoko Ogawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FOX RI, 1986, ARTHRITIS RHEUM-US, V29, P577, DOI 10.1002/art.1780290501; Hollander M., 1999, NONPARAMETRIC STAT M, Vsecond, P106; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Kojima T, 2011, AM J OPHTHALMOL, V152, P933, DOI 10.1016/j.ajo.2011.05.025; Kokolakis G, 2008, J IMMUNOL METHODS, V331, P140, DOI 10.1016/j.jim.2007.12.013; Lemp Michael A., 1995, CLAO Journal, V21, P221; Lemp MA, 2007, OCUL SURF, V5, P75; Nakamura S, 2005, INVEST OPHTH VIS SCI, V46, P2379, DOI 10.1167/iovs.04-1344; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Noma H, 2011, JPN J OPHTHALMOL, V55, P248, DOI 10.1007/s10384-011-0016-4; OBATA H, 1995, OPHTHALMOLOGY, V102, P678, DOI 10.1016/S0161-6420(95)30971-2; Obata H, 2006, CORNEA, V25, pS82, DOI 10.1097/01.ico.0000247220.18295.d3; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Rios JD, 2005, EXP EYE RES, V80, P477, DOI 10.1016/j.exer.2004.10.012; Rocha EM, 2008, OCUL SURF, V6, P162, DOI 10.1016/S1542-0124(12)70177-5; Sato N, 1992, J EYE, V9, P1739; Shimazaki J, 2007, ATARASHII GANKA, V24, P181; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Tsubota K, 1996, LANCET, V347, P768, DOI 10.1016/S0140-6736(96)90122-1; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang YR, 2003, J CELL SCI, V116, P2051, DOI 10.1242/jcs.00398; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009	32	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43688	10.1371/journal.pone.0043688	http://dx.doi.org/10.1371/journal.pone.0043688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962587	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600015
J	Landes, M; van Lettow, M; Bedell, R; Mayuni, I; Chan, AK; Tenthani, L; Schouten, E				Landes, Megan; van Lettow, Monique; Bedell, Richard; Mayuni, Isabell; Chan, Adrienne K.; Tenthani, Lyson; Schouten, Erik			Mortality and Health Outcomes in HIV-Infected and HIV-Uninfected Mothers at 18-20 Months Postpartum in Zomba District, Malawi	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; SCALING-UP; FOLLOW-UP; MATERNAL MORTALITY; PREGNANT-WOMEN; MORBIDITY; PREVENTION; TANZANIA	Background: Maternal morbidity and mortality among HIV-infected women is a global concern. This study compared mortality and health outcomes of HIV-infected and HIV-uninfected mothers at 18-20 months postpartum within routine prevention of mother-to-child transmission of HIV (PMTCT) services in a rural district in Malawi. Methods: A retrospective cohort study of mother-child dyads at 18-20 months postpartum in Zomba District. Data on socio-demographic characteristics, service uptake, maternal health outcomes and biometric parameters were collected. Results: 173 HIV-infected and 214 HIV-uninfected mothers were included. HIV-specific cohort mortality at 18-20 months postpartum was 42.4 deaths/1000 person-years; no deaths occurred among HIV-uninfected women. Median time to death was 11 months post-partum (range 3-19). Women ranked their health on a comparative qualitative scale; HIV-infected women perceived their health to be poorer than did HIV-uninfected women (RR 2.4; 95% CI 1.6-3.7). Perceived maternal health status was well correlated with an objective measure of functional status (Karnofsky scale; p<0.001). HIV-infected women were more likely to report minor (RR 3.8; 95% CI 2.3-6.4) and major (RR 6.2; 95% CI 2.2-17.7) signs or symptoms of disease. In multivariable analysis, HIV-infected women remained twice as likely to report poorer health [adjusted OR (aOR) 2.3; 95% CI 1.4-3.6], as did women with low BMI (aOR 2.1; 95% CI 1.1-4.0) and scoring lowest on the welfare scale (aOR 2.0; 95% CI 1.1-3.8). Conclusions: HIV-infected women show increased mortality and morbidity at 18-20 months postpartum. In our rural Malawian operational setting, where there is documented under-application of ART and poor adherence to PMTCT services, these results support attention to optimizing maternal participation in PMTCT programs.	[Landes, Megan; van Lettow, Monique; Bedell, Richard; Mayuni, Isabell; Chan, Adrienne K.] Dignitas Int, Zomba, Malawi; [Landes, Megan] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [van Lettow, Monique; Chan, Adrienne K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chan, Adrienne K.] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Tenthani, Lyson] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Schouten, Erik] Management Sci Hlth, Lilongwe, Malawi	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Landes, M (corresponding author), Dignitas Int, Zomba, Malawi.	m.vanlettow@dignitasinternational.org	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053				Ahdieh L, 2001, CLIN OBSTET GYNECOL, V44, P154, DOI 10.1097/00003081-200106000-00006; Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Brown ER, 2009, J INFECT DIS, V199, P1292, DOI 10.1086/597617; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Collin SM, 2006, AIDS CARE, V18, P812, DOI 10.1080/09540120500465061; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Coutsoudis A, 2010, AIDS, V24, P2859, DOI 10.1097/QAD.0b013e32834041b7; Erikstrup C, 2007, JAIDS-J ACQ IMM DEF, V44, P478, DOI 10.1097/QAI.0b013e318032bbcd; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Jones SA, 2005, AIDS CARE, V17, P466, DOI 10.1080/09540120412331319723; Karnofsky DA, 1949, CLIN EVALUATION CHEM, P196; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Malawi MOH, 2008, HIV SYPH SER SURV NA; Malawi National Statistics Office, 2008, POP HOUS CENS SEPT 2; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Ndekha M, 2009, TROP MED INT HEALTH, V14, P1059, DOI 10.1111/j.1365-3156.2009.02322.x; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Olagbuji BN, 2010, ARCH GYNECOL OBSTET, V281, P991, DOI 10.1007/s00404-009-1186-x; Payongayong E., 2006, SIMPLE HOUSEHOLD POV; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Stangl AL, 2011, QUAL LIFE RES; *UNAIDS, 2010, REP GLOB AIDS EP; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Walson JL, 2007, JAIDS-J ACQ IMM DEF, V46, P208, DOI 10.1097/QAI.0b013e318141fcc0; WHO/UNICEF/UNFPA/World Bank, 2007, TRENDS MAT MORT 1990; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43; Zvandasara P, 2006, JAIDS-J ACQ IMM DEF, V43, P107, DOI 10.1097/01.qai.0000229015.77569.c7	33	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44396	10.1371/journal.pone.0044396	http://dx.doi.org/10.1371/journal.pone.0044396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973443	gold, Green Published, Green Submitted			2022-12-27	WOS:000308577600047
J	Torta, DME; Vizzari, V; Castelli, L; Zibetti, M; Lanotte, M; Lopiano, L; Geminiani, G				Torta, Diana M. E.; Vizzari, Vincenzo; Castelli, Lorys; Zibetti, Maurizio; Lanotte, Michele; Lopiano, Leonardo; Geminiani, Giuliano			Impulsivities and Parkinson's Disease: Delay Aversion Is Not Worsened by Deep Brain Stimulation of the Subthalamic Nucleus	PLOS ONE			English	Article							IMPULSE CONTROL; BILATERAL STIMULATION; COGNITIVE FUNCTION; DECISION-MAKING; BASAL GANGLIA; FOLLOW-UP; STN DBS; MEDICATION; LEVODOPA; BEHAVIOR	Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) improves motor symptoms in Parkinson's disease (PD), but can exert detrimental effects on impulsivity. These effects are especially related to the inability to slow down when high-conflict choices have to be made. However, the influence that DBS has on delay aversion is still under-investigated. Here, we tested a group of 21 PD patients on and off stimulation (off medication) by using the Cambridge Gamble Task (CGT), a computerized task that allows the investigation of risk-related behaviours and delay aversion, and psychological questionnaires such as the Barratt Impulsiveness Scale (BIS), the Sensitivity to Punishment and to Reward Questionnaire (SPSRQ), and the Quick Delay Questionnaire (QDQ). We found that delay aversion scores on the CGT were no higher when patients were on stimulation as compared to when they were off stimulation. In contrast, PD patients reported feeling more impulsive in the off stimulation state, as revealed by significantly higher scores on the BIS. Higher scores on the sensitivity to punishment subscale of the SPSRQ highlighted that possible punishments influence patients' behaviours more than possible rewards. Significant correlations between delay aversion scores on the CGT and QDQ delay aversion subscale suggest that these two instruments can be used in synergy to reach a convergent validity. In conclusion, our results show that not all impulsivities are detrimentally affected by DBS of the STN and that the joint use of experimental paradigms and psychological questionnaires can provide useful insights in the study of impulsivity.	[Torta, Diana M. E.; Vizzari, Vincenzo; Castelli, Lorys; Geminiani, Giuliano] Univ Turin, Dept Psychol, Turin, Italy; [Zibetti, Maurizio; Lanotte, Michele; Lopiano, Leonardo] Univ Turin, Dept Neurosci, Turin, Italy	University of Turin; University of Turin	Torta, DME (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	diana.torta@unito.it	Lanotte, Michele M./I-2647-2012; Castelli, Lorys/G-9973-2012; Zibetti, Maurizio/B-6969-2013	Lanotte, Michele M./0000-0002-4184-028X; Castelli, Lorys/0000-0001-5009-2271; Zibetti, Maurizio/0000-0002-2939-343X; Lopiano, Leonardo/0000-0001-9098-387X; Torta, Diana/0000-0002-3499-3982	'Progetto Alfieri' research grant	'Progetto Alfieri' research grant	This research was funded by a 'Progetto Alfieri' research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 2011, MOVEMENT DISORDERS; Amanzio M, 2010, BRAIN COGNITION, V72, P337, DOI 10.1016/j.bandc.2009.10.011; Antonelli F, 2011, J NEUROL SCI, V310, P202, DOI 10.1016/j.jns.2011.06.006; Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z; Ardouin C, 2006, MOVEMENT DISORD, V21, P1941, DOI 10.1002/mds.21098; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Bandini F, 2007, PARKINSONISM RELAT D, V13, P369, DOI 10.1016/j.parkreldis.2006.07.011; Berlin HA, 2013, WORLD J BIOL PSYCHIA, V14, P121, DOI 10.3109/15622975.2011.560964; Berney A, 2007, MOVEMENT DISORD, V22, P1093, DOI 10.1002/mds.21245; Broen M, 2011, PARKINSONISM RELAT D, V17, P413, DOI 10.1016/j.parkreldis.2011.02.013; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Campbell MC, 2008, NEUROPSYCHOLOGIA, V46, P3162, DOI 10.1016/j.neuropsychologia.2008.07.012; Castelli L, 2010, PARKINSONISM RELAT D, V16, P115, DOI 10.1016/j.parkreldis.2009.08.010; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Chabardes S, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.03.010; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Clare S, 2010, ADHD-ATTEND DEFICIT, V2, P43, DOI 10.1007/s12402-010-0020-4; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dujardin K, 2001, J NEUROL, V248, P603, DOI 10.1007/s004150170139; Bermejo PE, 2010, J NEUROL, V257, P1682, DOI 10.1007/s00415-010-5603-7; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Funkiewiez A, 2003, MOVEMENT DISORD, V18, P524, DOI 10.1002/mds.10441; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Grafen A., 2002, MODERN STAT LIFE SCI; Gray J.A., 1981, MODEL PERSONALITY, P246, DOI DOI 10.1007/978-3-642-67783-0_8; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; HAERTZEN CA, 1963, PSYCHOPHARMACOLOGIA, V4, P155, DOI 10.1007/BF02584088; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Halpern CH, 2009, INT J GERIATR PSYCH, V24, P443, DOI 10.1002/gps.2149; Hershey T, 2004, NEUROLOGY, V62, P1110, DOI 10.1212/01.WNL.0000118202.19098.10; Hershey T, 2010, BRAIN, V133, P3625, DOI 10.1093/brain/awq256; Housden CR, 2010, NEUROPSYCHOPHARMACOL, V35, P2155, DOI 10.1038/npp.2010.84; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Knobel D, 2008, COGN BEHAV NEUROL, V21, P187, DOI 10.1097/WNN.0b013e318185e6e2; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lhommee E, 2012, BRAIN, V135, P1463, DOI 10.1093/brain/aws078; Lim SY, 2009, J CLIN NEUROSCI, V16, P1148, DOI 10.1016/j.jocn.2008.12.010; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Merchant H, 2008, EXP BRAIN RES, V184, P233, DOI 10.1007/s00221-007-1097-7; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Ray NJ, 2009, NEUROPSYCHOLOGIA, V47, P2828, DOI 10.1016/j.neuropsychologia.2009.06.011; Robert G, 2009, MOVEMENT DISORD, V24, P2316, DOI 10.1002/mds.22836; Rodriguez-Oroz MC, 2011, BRAIN, V134, P36, DOI 10.1093/brain/awq301; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Smeding HMM, 2007, J NEUROL NEUROSUR PS, V78, P517, DOI 10.1136/jnnp.2006.102061; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Torta DME, 2010, J NEUROL, V257, P1356, DOI 10.1007/s00415-010-5532-5; Torta DME, 2009, BRAIN COGNITION, V71, P84, DOI 10.1016/j.bandc.2009.04.003; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Volkmann J, 2007, PARKINSONISM RELAT D, V13, pS462, DOI 10.1016/S1353-8020(08)70050-6; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Wild-Wall N, 2008, NEUROSCI LETT, V442, P34, DOI 10.1016/j.neulet.2008.06.069; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2005, EUR J NEUROSCI, V21, P3107, DOI 10.1111/j.1460-9568.2005.04143.x; Witjas T, 2005, MOVEMENT DISORD, V20, P1052, DOI 10.1002/mds.20501; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Wylie SA, 2010, BRAIN, V133, P3611, DOI 10.1093/brain/awq239	68	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43261	10.1371/journal.pone.0043261	http://dx.doi.org/10.1371/journal.pone.0043261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984415	Green Published, Green Submitted, gold			2022-12-27	WOS:000308638700016
J	Pena, J; Rochat, Y				Pena, Jorge; Rochat, Yannick			Bipartite Graphs as Models of Population Structures in Evolutionary Multiplayer Games	PLOS ONE			English	Article							DIVERSITY PROMOTES; COOPERATION; EMERGENCE; NETWORKS; ORGANIZATION; ALTRUISM; DYNAMICS	By combining evolutionary game theory and graph theory, "games on graphs" study the evolutionary dynamics of frequency-dependent selection in population structures modeled as geographical or social networks. Networks are usually represented by means of unipartite graphs, and social interactions by two-person games such as the famous prisoner's dilemma. Unipartite graphs have also been used for modeling interactions going beyond pairwise interactions. In this paper, we argue that bipartite graphs are a better alternative to unipartite graphs for describing population structures in evolutionary multiplayer games. To illustrate this point, we make use of bipartite graphs to investigate, by means of computer simulations, the evolution of cooperation under the conventional and the distributed N-person prisoner's dilemma. We show that several implicit assumptions arising from the standard approach based on unipartite graphs (such as the definition of replacement neighborhoods, the intertwining of individual and group diversity, and the large overlap of interaction neighborhoods) can have a large impact on the resulting evolutionary dynamics. Our work provides a clear example of the importance of construction procedures in games on graphs, of the suitability of bigraphs and hypergraphs for computational modeling, and of the importance of concepts from social network analysis such as centrality, centralization and bipartite clustering for the understanding of dynamical processes occurring on networked population structures.	[Pena, Jorge; Rochat, Yannick] Univ Lausanne, Fac Social & Polit Sci, Inst Appl Math, Lausanne, Switzerland	University of Lausanne	Pena, J (corresponding author), Univ Basel, Fac Business & Econ, Basel, Switzerland.	jorge.pena@unibas.ch	Peña, Jorge/H-8235-2014; Peña, Jorge/GXI-0458-2022	Peña, Jorge/0000-0002-4137-1823; Rochat, Yannick/0000-0002-9588-9855				Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Birmele E, 2009, DISCRETE APPL MATH, V157, P2267, DOI 10.1016/j.dam.2008.06.052; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davis G. F., 2003, Strategic Organization, V1, P301, DOI 10.1177/14761270030013002; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Grafen A, 2007, J EVOLUTION BIOL, V20, P2278, DOI 10.1111/j.1420-9101.2007.01413.x; Grafen A, 2008, J THEOR BIOL, V252, P694, DOI 10.1016/j.jtbi.2008.01.021; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; HAMBURGER H, 1973, J MATH SOCIOL, V3, P27, DOI 10.1080/0022250X.1973.9989822; Hamilton WD, 1975, BIOSOCIAL ANTHR, P135; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Huang ZG, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50008; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Lei CA, 2010, PHYSICA A, V389, P4708, DOI 10.1016/j.physa.2010.06.002; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Maynard Smith J., 1982, pi; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Nacher JC, 2011, PHYSICA A, V390, P4636, DOI 10.1016/j.physa.2011.06.073; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak Martin A., 2007, P7; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pena J, 2012, EVOLUTION, V66, P623, DOI 10.1111/j.1558-5646.2011.01504.x; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pusch A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036120; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Viger F, 2005, EFFICIENT SIMPLE GEN; von Hippel E, 2003, ORGAN SCI, V14, P209, DOI 10.1287/orsc.14.2.209.14992; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zhang HF, 2010, PHYSICA A, V389, P1099, DOI 10.1016/j.physa.2009.11.029	76	24	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44514	10.1371/journal.pone.0044514	http://dx.doi.org/10.1371/journal.pone.0044514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970237	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400020
J	Santos, NDD; de Moura, KS; Napoleao, TH; Santos, GKN; Coelho, LCBB; Navarro, DMDF; Paiva, PMG				de Lima Santos, Nataly Diniz; de Moura, Kezia Santana; Napoleao, Thiago Henrique; Novais Santos, Geanne Karla; Breitenbach Barroso Coelho, Luana Cassandra; do Amaral Ferraz Navarro, Daniela Maria; Guedes Paiva, Patricia Maria			Oviposition-Stimulant and Ovicidal Activities of Moringa oleifera Lectin on Aedes aegypti	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI; DIPTERA-CULICIDAE; MALARIAL VECTOR; ESSENTIAL OILS; MYRACRODRUON-URUNDEUVA; LARVICIDAL ACTIVITY; SEED EXTRACT; LINN.; L.	Background: Natural insecticides against the vector mosquito Aedes aegypti have been the object of research due to their high level of eco-safety. The water-soluble Moringa oleifera lectin (WSMoL) is a larvicidal agent against A. aegypti. This work reports the effects of WSMoL on oviposition and egg hatching of A. aegypti. Methodology/Principal Findings: WSMoL crude preparations (seed extract and 0-60 protein fraction), at 0.1 mg/mL protein concentration, did not affect oviposition, while A. aegypti gravid females laid their eggs preferentially (73%) in vessels containing isolated WSMoL (0.1 mg/mL), compared with vessels containing only distilled water (control). Volatile compounds were not detected in WSMoL preparation. The hatchability of fresh eggs deposited in the solutions in the oviposition assay was evaluated. The numbers of hatched larvae in seed extract, 0-60 protein fraction and WSMoL were 45 +/- 8.7 %, 20 +/- 11 % and 55 +/- 7.5 %, respectively, significantly (p<0.05) lower than in controls containing only distilled water (75-95%). Embryos were visualized inside fresh control eggs, but not within eggs that were laid and maintained in WSMoL solution. Ovicidal activity was also assessed using stored A. aegypti eggs. The protein concentrations able to reduce the hatching rate by 50% (EC50) were 0.32, 0.16 and 0.1 mg/mL for seed extract, 0-60 protein fraction and WSMoL, respectively. The absence of hatching of stored eggs treated with WSMoL at 0.3 mg/mL (EC99) after transfer to medium without lectin indicates that embryos within the eggs were killed by WSMoL. The reduction in hatching rate of A. aegypti was not linked to decrease in bacteria population. Conclusions/Significance: WSMoL acted both as a chemical stimulant cue for ovipositing females and ovicidal agent at a given concentration. The oviposition-stimulant and ovicidal activities, combined with the previously reported larvicidal activity, make WSMoL a very interesting candidate in integrated A. aegypti control.	[de Lima Santos, Nataly Diniz; de Moura, Kezia Santana; Napoleao, Thiago Henrique; Breitenbach Barroso Coelho, Luana Cassandra; Guedes Paiva, Patricia Maria] Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, Recife, PE, Brazil; [Novais Santos, Geanne Karla; do Amaral Ferraz Navarro, Daniela Maria] Univ Fed Pernambuco, Ctr Ciencias Exatas & Nat, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Santos, NDD (corresponding author), Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, Cidade Univ, Recife, PE, Brazil.	ppaivaufpe@yahoo.com.br	Santos, Geanne K N/Q-8702-2016; Navarro, Daniela Maria do Amaral Ferraz/C-4975-2013; Paiva, Patricia Maria Guedes/S-4038-2019; Navarro, Daniela Maria do Amaral Ferraz/GXM-4019-2022; Napoleao, Thiago Henrique/P-2364-2019; Santos, Nataly/AAX-6876-2020	Navarro, Daniela Maria do Amaral Ferraz/0000-0003-0158-7221; Paiva, Patricia Maria Guedes/0000-0003-3467-708X; Napoleao, Thiago Henrique/0000-0002-0065-2602; Santos, Nataly/0000-0001-9155-6773	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [IBPG-0063.2.08/09, APQ-0653-2.08/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (IBPG-0063.2.08/09 to N.D.L.S. and APQ-0653-2.08/10 to P.M.G.P.; www.facepe.br), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (L.C.B.B.C. and P.M.G.P.; www.cnpq.br), and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; BEEHLER JW, 1994, MED VET ENTOMOL, V8, P381, DOI 10.1111/j.1365-2915.1994.tb00103.x; Benedet F, 2002, P ROY SOC B-BIOL SCI, V269, P1879, DOI 10.1098/rspb.2002.2077; BENTLEY MD, 1979, ENVIRON ENTOMOL, V8, P206, DOI 10.1093/ee/8.2.206; BING DH, 1967, P SOC EXP BIOL MED, V124, P1166; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Boyer S, 2006, CHEMOSPHERE, V65, P721, DOI 10.1016/j.chemosphere.2006.02.032; Chenniappan Kuppusamy, 2008, Entomological Research, V38, P119, DOI 10.1111/j.1748-5967.2008.00147.x; Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022; CONSOLI RAGB, 1989, MEM I OSWALDO CRUZ, V84, P47, DOI 10.1590/S0074-02761989000100009; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Elango G, 2008, PARASITOL RES, V103, P691; Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007; Ferreira RS, 2011, LETT APPL MICROBIOL, V53, P186, DOI 10.1111/j.1472-765X.2011.03089.x; FRINGS HUBERT, 1950, JOUR NEW YORK ENT SOC, V58, P133; Govindarajan M, 2008, PARASITOL RES, V102, P289, DOI [10.1007/s00436-007-0761-y, 10.1007/s00436-008-0907-6]; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P24, DOI 10.1016/S1995-7645(11)60026-6; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P176, DOI 10.1016/S1995-7645(11)60064-3; GREEN AA, 1955, METHOD ENZYMOL, V1, P67, DOI 10.1016/0076-6879(55)01014-8; Hay F. C., 2002, PRACTICAL IMMUNOLOGY, DOI DOI 10.1002/9780470757475.CH7; HUYTON PM, 1980, PHYSIOL ENTOMOL, V5, P253, DOI 10.1111/j.1365-3032.1980.tb00233.x; Kent U M, 1999, Methods Mol Biol, V115, P11; Lampman RL, 1996, J AM MOSQUITO CONTR, V12, P119; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maheswaran R, 2012, PARASITOL RES, V110, P1801, DOI 10.1007/s00436-011-2702-z; Mandal S, 2010, ASIAN PAC J TROP MED, V3, P605, DOI 10.1016/S1995-7645(10)60147-2; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moreira MF, 2007, INSECT BIOCHEM MOLEC, V37, P1249, DOI 10.1016/j.ibmb.2007.07.017; MORTENSON EARL W., 1950, MOSQUITO NEWS, V10, P211; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Napoleao TH, 2012, PARASITOL RES, V110, P609, DOI 10.1007/s00436-011-2529-7; Navarro DMAF, 2003, J APPL ENTOMOL, V127, P46, DOI 10.1046/j.1439-0418.2003.00690.x; Paiva P.M., 2010, CURR RES TECHNOL ED, V1, P396; PAIVA PMG, 1992, APPL BIOCHEM BIOTECH, V36, P113, DOI 10.1007/BF02929691; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2; Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012; Prabhu K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P124, DOI 10.1016/S2221-1691(11)60009-9; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Ramos MV, 2006, MEM I OSWALDO CRUZ, V101, P503, DOI 10.1590/S0074-02762006000500004; Regnault-Roger C, 2004, BIOPESTICIDAS ORIGEN; Ritchie SA, 2001, J AM MOSQUITO CONTR, V17, P206; Barbosa RMR, 2011, MEM I OSWALDO CRUZ, V106, P451, DOI 10.1590/S0074-02762011000400011; Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1; Rolim LADMM, 2011, J FOOD SCI, V76, pT53, DOI 10.1111/j.1750-3841.2010.01990.x; Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441; Sa RA, 2009, COMP BIOCHEM PHYS C, V149, P300, DOI 10.1016/j.cbpc.2008.08.004; Samidurai K, 2011, PARASITOL RES, V109, P1107, DOI 10.1007/s00436-011-2353-0; Sanchez-Fortun S, 2005, CHEMOSPHERE, V59, P553, DOI 10.1016/j.chemosphere.2004.12.023; Santos E, 2010, NEOTROP ENTOMOL, V39, P299, DOI 10.1590/S1519-566X2010000200023; Santos GKN, 2012, IND CROP PROD, V40, P254, DOI 10.1016/j.indcrop.2012.03.020; Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; TianFu D, 2009, J ZHEJIANG U AGR LIF, V35, P532; Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020; Warikoo R, 2011, PARASITOL RES, V109, P1125, DOI 10.1007/s00436-011-2355-y; WHO, 2009, DENG DENG HAEM FEV	58	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44840	10.1371/journal.pone.0044840	http://dx.doi.org/10.1371/journal.pone.0044840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970317	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400123
J	Maunsell, F; Brown, MB; Powe, J; Ivey, J; Woolard, M; Love, W; Simecka, JW				Maunsell, Fiona; Brown, Mary B.; Powe, Joshua; Ivey, James; Woolard, Matthew; Love, Wees; Simecka, Jerry W.			Oral Inoculation of Young Dairy Calves with Mycoplasma bovis Results in Colonization of Tonsils, Development of Otitis Media and Local Immunity	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; RESPIRATORY-TRACT; PASTEURELLA-HAEMOLYTICA; INFECTION; PNEUMONIA; HYORHINIS; DISEASE; CALF; EUSTACHITIS; PATHOGEN	Because M. bovis otitis media is an economically important problem, there is a need to understand the pathogenesis of disease, not only to improve our understanding of the factors contributing to the development of this disease but also to inform the development of improved diagnostic tests and therapy. Oral ingestion of M. bovis-contaminated milk is linked, but not definitively proven, to development of otitis media. In the current study, we demonstrate that oral ingestion of M. bovis infected colostrum can result in an ascending infection and development of otitis media. Importantly, M. bovis was found to have a previously unrecognized tendency for colonization of the tonsils of calves, which most likely contributed to the subsequent development of otitis media. In contrast, transtracheal inoculation failed to produce clinically significant upper respiratory tract disease, although did induce lower respiratory tract disease. The upper respiratory tract was the major site of M. bovis-specific B cell and mucosal IgA responses in calves inoculated by the oral route. The oral inoculation route of infection presented here is particularly suited to the study of host-pathogen interactions during initial colonization of the tonsils, expansion of infection and dissemination to the lower respiratory tract and middle ear. In addition, it could be used to investigate potential new preventative or control strategies, especially those aimed at limiting colonization of the tonsils and/or spread to the middle ear.	[Maunsell, Fiona; Brown, Mary B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Powe, Joshua] Millennium Pharmaceut Inc, Cambridge, MA USA; [Ivey, James] Univ Texas SW Med Ctr Dallas, Dept Microbiol & Immunol, Dallas, TX 75390 USA; [Woolard, Matthew] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA USA; [Love, Wees; Simecka, Jerry W.] Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	State University System of Florida; University of Florida; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Texas System; University of Texas Southwestern Medical Center Dallas; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of North Texas System; University of North Texas Health Science Center	Maunsell, F (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA.	jerry.simecka@unthsc.edu	Woolard, Matthew/AAE-1536-2020	Woolard, Matthew/0000-0002-8497-5838	UF Alumni Fellowship; residency in Anatomic Pathology at the UF College of Veterinary Medicine; USDA CREES grant [2002-35204-12362]	UF Alumni Fellowship; residency in Anatomic Pathology at the UF College of Veterinary Medicine; USDA CREES grant	FM was supported by a UF Alumni Fellowship, and JP was supported by a residency in Anatomic Pathology at the UF College of Veterinary Medicine. This work was supported by a USDA CREES grant 2002-35204-12362 to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOYE DS, 1995, J VET DIAGN INVEST, V7, P333, DOI 10.1177/104063879500700306; Ayling RD, 2004, VET REC, V155, P413, DOI 10.1136/vr.155.14.413; BENNETT RH, 1977, CORNELL VET, V67, P361; BRYS A, 1989, ARCH EXP VET MED, V43, P677; BRYS A, 1989, ARCH EXP VET MED, V43, P667; Bush TJV, 2003, VET IMMUNOL IMMUNOP, V94, P23, DOI 10.1016/S0165-2427(03)00056-4; Butler JA, 2000, J DAIRY SCI, V83, P2285, DOI 10.3168/jds.S0022-0302(00)75114-9; Cartner SC, 1998, INFECT IMMUN, V66, P3485, DOI 10.1128/IAI.66.8.3485-3491.1998; Francoz D, 2004, CAN VET J, V45, P661; Friis NF, 2002, ACTA VET SCAND, V43, P191; GOURLAY RN, 1989, VET REC, V124, P420, DOI 10.1136/vr.124.16.420; GOURLAY RN, 1985, RES VET SCI, V38, P377, DOI 10.1016/S0034-5288(18)31813-7; Hewicker-Trautwein M, 2002, VET REC, V151, P699; Hodge LM, 2002, J INFECT DIS, V186, P290, DOI 10.1086/341280; HOWARD CJ, 1980, RES VET SCI, V28, P242, DOI 10.1016/S0034-5288(18)32755-3; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; Lamm CG, 2004, J VET DIAGN INVEST, V16, P397, DOI 10.1177/104063870401600505; LOPEZ A, 1986, AM J VET RES, V47, P1283; Maeda T, 2003, J COMP PATHOL, V129, P100, DOI 10.1016/S0021-9975(03)00009-4; Miles K, 2005, VET MICROBIOL, V107, P301, DOI 10.1016/j.vetmic.2005.02.003; MORITA T, 1995, VET PATHOL, V32, P107, DOI 10.1177/030098589503200202; MORITA T, 1993, J VET MED SCI, V55, P475, DOI 10.1292/jvms.55.475; Morita T, 1999, VET PATHOL, V36, P174, DOI 10.1354/vp.36-2-174; Morita T, 1998, AM J VET RES, V59, P869; Nicholas RAJ, 2002, VACCINE, V20, P3569, DOI 10.1016/S0264-410X(02)00340-7; PFUTZNER H, 1983, ARCH EXP VET MED, V37, P445; RYAN MJ, 1983, VET PATHOL, V20, P472, DOI 10.1177/030098588302000410; Shahriar FM, 2002, CAN VET J, V43, P863; SIMECKA J W, 1989, Regional Immunology, V2, P385; SIMECKA JW, 1987, ISRAEL J MED SCI, V23, P485; Stipkovits L, 2001, VET REC, V148, P399, DOI 10.1136/vr.148.13.399; Stipkovits L, 2000, ACTA VET HUNG, V48, P387, DOI 10.1556/004.48.2000.4.2; Tschopp R, 2001, SCHWEIZ ARCH TIERH, V143, P461; van der Merwe J, 2010, INFECT IMMUN, V78, P4570, DOI 10.1128/IAI.00707-10; Walz PH, 1997, J VET DIAGN INVEST, V9, P250, DOI 10.1177/104063879700900305; Woolard MD, 2004, J IMMUNOL, V172, P6875, DOI 10.4049/jimmunol.172.11.6875	36	39	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44523	10.1371/journal.pone.0044523	http://dx.doi.org/10.1371/journal.pone.0044523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970240	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400084
J	Cao, HB; Lei, SF; Deng, HW; Wang, YP				Cao, Hongbao; Lei, Shufeng; Deng, Hong-Wen; Wang, Yu-Ping			Identification of Genes for Complex Diseases Using Integrated Analysis of Multiple Types of Genomic Data	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; BONE-RESORPTION; OSTEOPOROSIS; EXPRESSION; WOMEN; DICER; HIP	Various types of genomic data (e. g., SNPs and mRNA transcripts) have been employed to identify risk genes for complex diseases. However, the analysis of these data has largely been performed in isolation. Combining these multiple data for integrative analysis can take advantage of complementary information and thus can have higher power to identify genes (and/or their functions) that would otherwise be impossible with individual data analysis. Due to the different nature, structure, and format of diverse sets of genomic data, multiple genomic data integration is challenging. Here we address the problem by developing a sparse representation based clustering (SRC) method for integrative data analysis. As an example, we applied the SRC method to the integrative analysis of 376821 SNPs in 200 subjects (100 cases and 100 controls) and expression data for 22283 genes in 80 subjects (40 cases and 40 controls) to identify significant genes for osteoporosis (OP). Comparing our results with previous studies, we identified some genes known related to OP risk (e. g., 'THSD4', 'CRHR1', 'HSD11B1', 'THSD7A', 'BMPR1B' 'ADCY10', 'PRL', 'CA8','ESRRA', 'CALM1', 'CALM1', 'SPARC', and 'LRP1'). Moreover, we uncovered novel osteoporosis susceptible genes ('DICER1', 'PTMA', etc.) that were not found previously but play functionally important roles in osteoporosis etiology from existing studies. In addition, the SRC method identified genes can lead to higher accuracy for the diagnosis/classification of osteoporosis subjects when compared with the traditional T-test and Fisher-exact test, which further validates the proposed SRC approach for integrative analysis.	[Cao, Hongbao; Wang, Yu-Ping] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Lei, Shufeng] Soochow Univ, Coll Med, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Peoples R China; [Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA	Tulane University; Soochow University - China; Tulane University	Cao, HB (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	wyp@tulane.edu	Cao, Hongbao/G-8253-2014	Cao, Hongbao/0000-0001-9190-0511; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [1R21LM010042-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR050496] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM010042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health grant 1R21LM010042-01 (www.nlm.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger JA, 2006, IEEE ACM T COMPUT BI, V3, P2, DOI 10.1109/TCBB.2006.10; Cao HB, 2012, IEEE T NANOBIOSCI, V11, P111, DOI 10.1109/TNB.2012.2189414; COHENSOLAL ME, 1993, J CLIN ENDOCR METAB, V77, P1648, DOI 10.1210/jc.77.6.1648; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Deng FY, 2011, J BONE MINER RES, V26, P2695, DOI 10.1002/jbmr.471; Deng HW, 2002, GENET EPIDEMIOL, V22, P12, DOI 10.1002/gepi.1040; Dumble M, 2004, ANN NY ACAD SCI, V1019, P171, DOI 10.1196/annals.1297.027; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Fisher R.A., 1948, STAT TABLES BIOL AGR, V3rd edn, pp 26; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Hautaniemi S, 2004, J FRANKLIN I, V341, P77, DOI 10.1016/j.jfranklin.2003.12.005; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Jian WX, 2005, J BONE MINER METAB, V23, P181, DOI 10.1007/s00774-004-0558-3; Kobayashi T, 2006, CANCER RES, V66, P3137, DOI 10.1158/0008-5472.CAN-05-2112; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Liu PY, 2004, AM J HUM BIOL, V16, P68, DOI 10.1002/ajhb.10240; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Melton LJ, 2005, J BONE MINER RES, V20, P886, DOI 10.1359/jbmr.2005.20.5.886; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Soneson C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-191; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Xu XH, 2010, ENDOCR REV, V31, P447, DOI 10.1210/er.2009-0032; Yang HH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00192; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; ZALLONE AZ, 1984, J CELL SCI, V66, P335	35	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42755	10.1371/journal.pone.0042755	http://dx.doi.org/10.1371/journal.pone.0042755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957024	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800016
J	Latif, R; Teixeira, A; Michalek, K; Ali, MR; Schlesinger, M; Baliram, R; Morshed, SA; Davies, TF				Latif, Rauf; Teixeira, Avelino; Michalek, Krzysztof; Ali, M. Rejwan; Schlesinger, Max; Baliram, Ramkumarie; Morshed, Syed A.; Davies, Terry F.			Antibody Protection Reveals Extended Epitopes on the Human TSH Receptor	PLOS ONE			English	Article							THYROID-STIMULATING AUTOANTIBODY; HUMAN THYROTROPIN RECEPTOR; LEUCINE-RICH DOMAIN; HORMONE-RECEPTOR; CRYSTAL-STRUCTURE; HINGE REGION; MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY; GRAVES-DISEASE; BINDING	Stimulating, and some blocking, antibodies to the TSH receptor (TSHR) have conformation-dependent epitopes reported to involve primarily the leucine rich repeat region of the ectodomain (LRD). However, successful crystallization of TSHR residues 22-260 has omitted important extracellular non-LRD residues including the hinge region which connects the TSHR ectodomain to the transmembrane domain and which is involved in ligand induced signal transduction. The aim of the present study, therefore, was to determine if TSHR antibodies (TSHR-Abs) have non-LRD binding sites outside the LRD. To obtain this information we employed the method of epitope protection in which we first protected TSHR residues 1-412 with intact TSHR antibodies and then enzymatically digested the unprotected residues. Those peptides remaining were subsequently delineated by mass spectrometry. Fourteen out of 23 of the reported stimulating monoclonal TSHR-Ab crystal contact residues were protected by this technique which may reflect the higher binding energies of certain residues detected in this approach. Comparing the protected epitopes of two stimulating TSHR-Abs we found both similarities and differences but both antibodies also contacted the hinge region and the amino terminus of the TSHR following the signal peptide and encompassing cysteine box 1 which has previously been shown to be important for TSH binding and activation. A monoclonal blocking TSHR antibody revealed a similar pattern of binding regions but the residues that it contacted on the LRD were again distinct. These data demonstrated that conformationally dependent TSHR-Abs had epitopes not confined to the LRDs but also incorporated epitopes not revealed in the available crystal structure. Furthermore, the data also indicated that in addition to overlapping contact regions within the LRD, there are unique epitope patterns for each of the antibodies which may contribute to their functional heterogeneity.	[Latif, Rauf; Teixeira, Avelino] Mt Sinai Sch Med, Dept Med, Prote Lab, New York, NY 10029 USA; [Latif, Rauf; Ali, M. Rejwan; Schlesinger, Max; Baliram, Ramkumarie; Morshed, Syed A.; Davies, Terry F.] James J Peters VA Med Ctr, Thyroid Res Unit, New York, NY USA; [Michalek, Krzysztof] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Dis, Poznan, Poland	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Poznan University of Medical Sciences	Latif, R (corresponding author), Mt Sinai Sch Med, Dept Med, Prote Lab, New York, NY 10029 USA.	rauf.latif@mssm.edu	latif, rauf/AAR-1634-2020; Latif, Rauf/ABH-4394-2020	Latif, Rauf/0000-0002-4226-3728	NIH [DK069713, DK052464]; Veterans Administration Merit Award program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052464, R01DK069713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by NIH grants DK069713 and DK052464 and the Veterans Administration Merit Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2004, ENDOCRINOLOGY, V145, P5185, DOI 10.1210/en.2004-0789; Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Benjamin David C., 1996, Methods (Orlando), V9, P508, DOI 10.1006/meth.1996.0058; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chen CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031973; Cornelis S, 2001, BIOCHEMISTRY-US, V40, P9860, DOI 10.1021/bi0107389; Costagliola S, 2004, MOL ENDOCRINOL, V18, P3020, DOI 10.1210/me.2004-0231; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Couet J, 1996, J BIOL CHEM, V271, P4545; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Hamidi S, 2011, THYROID, V21, P1013, DOI 10.1089/thy.2011.0147; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Latif R, 2010, MOL ENDOCRINOL, V24, P2009, DOI 10.1210/me.2010-0001; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; Miguel RN, 2009, J MOL ENDOCRINOL, V42, P381, DOI 10.1677/JME-08-0152; Miguel RN, 2005, THYROID, V15, P746; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mizutori Y, 2009, J CLIN ENDOCR METAB, V94, P927, DOI 10.1210/jc.2008-2134; Morshed SA, 2010, ENDOCRINOLOGY, V151, P5537, DOI 10.1210/en.2010-0424; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; Oda Y, 1998, J MOL ENDOCRINOL, V20, P233, DOI 10.1677/jme.0.0200233; Parker CE, 1996, J IMMUNOL, V157, P198; Parker CE, 2002, MOL BIOTECHNOL, V20, P49, DOI 10.1385/MB:20:1:049; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Raska CS, 2003, J AM SOC MASS SPECTR, V14, P1076, DOI 10.1016/S1044-0305(03)00405-7; Raska CS, 2002, ANAL CHEM, V74, P3429, DOI 10.1021/ac0111199; RUSSO D, 1991, MOL ENDOCRINOL, V5, P1607, DOI 10.1210/mend-5-11-1607; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sanders J, 1997, BAILLIERE CLIN ENDOC, V11, P451, DOI 10.1016/S0950-351X(97)80693-3; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44669	10.1371/journal.pone.0044669	http://dx.doi.org/10.1371/journal.pone.0044669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957097	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800090
J	Schneider, PN; Slusarski, DC; Houston, DW				Schneider, Patricia N.; Slusarski, Diane C.; Houston, Douglas W.			Differential Role of Axin RGS Domain Function in Wnt Signaling during Anteroposterior Patterning and Maternal Axis Formation	PLOS ONE			English	Article							BETA-CATENIN; NEGATIVE REGULATOR; PROTEIN; ZEBRAFISH; COMPLEX; PHOSPHORYLATION; EXPRESSION; INDUCTION; MECHANISM; MESODERM	Axin is a critical component of the beta-catenin destruction complex and is also necessary for Wnt signaling initiation at the level of co-receptor activation. Axin contains an RGS domain, which is similar to that of proteins that accelerate the GTPase activity of heterotrimeric G alpha/Gna proteins and thereby limit the duration of active G-protein signaling. Although G-proteins are increasingly recognized as essential components of Wnt signaling, it has been unclear whether this domain of Axin might function in G-protein regulation. This study was performed to test the hypothesis that Axin RGS-Gna interactions would be required to attenuate Wnt signaling. We tested these ideas using an axin1 genetic mutant (masterblind) and antisense oligo knockdowns in developing zebrafish and Xenopus embryos. We generated a point mutation that is predicted to reduce Axin-Gna interaction and tested for the ability of the mutant forms to rescue Axin loss-of-function function. This Axin point mutation was deficient in binding to Gna proteins in vitro, and was unable to relocalize to the plasma membrane upon Gna overexpression. We found that the Axin point mutant construct failed to rescue normal anteroposterior neural patterning in masterblind mutant zebrafish, suggesting a requirement for G-protein interactions in this context. We also found that the same mutant was able to rescue deficiencies in maternal axin1 loss-of-function in Xenopus. These data suggest that maternal and zygotic Wnt signaling may differ in the extent of Axin regulation of G-protein signaling. We further report that expression of a membrane-localized Axin construct is sufficient to inhibit Wnt/beta-catenin signaling and to promote Axin protein turnover.	[Schneider, Patricia N.; Slusarski, Diane C.; Houston, Douglas W.] Univ Iowa, Dept Biol, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA	University of Iowa	Schneider, PN (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	douglas-houston@uiowa.edu	Schneider, Patricia N/F-4372-2017; Schneider, Patricia/ABA-9787-2020	Schneider, Patricia N/0000-0002-9745-0694; Schneider, Patricia/0000-0002-9745-0694; Slusarski, Diane/0000-0003-3793-8636	National Institutes of Health [R01 GM083999, R01 CA112369]; NATIONAL CANCER INSTITUTE [R01CA112369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM083999 to DWH and R01 CA112369 to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cha S, 2008, DEVELOPMENT; Chia IV, 2009, GENETICS, V181, P1359, DOI 10.1534/genetics.109.101055; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Houston DW, 2012, WIRES DEV BIOL, V1, P371, DOI 10.1002/wdev.29; Houston DW, 2005, DEVELOPMENT, V132, P4845, DOI 10.1242/dev.02066; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jernigan KK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000647; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2009, NATURE PRECEDINGS, P1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kofron M, 2001, DEV BIOL, V237, P183, DOI 10.1006/dbio.2001.0371; Koval A, 2010, BIOCH J; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Natochin M, 1998, J BIOL CHEM, V273, P6731, DOI 10.1074/jbc.273.12.6731; Niehrs C, 2001, INT J DEV BIOL, V45, P237; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Schneider PN, 2010, J VIS EXP, pe1864; Sive H.L., 2000, EARLY DEV XENOPUS LA, P249; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; SMITH WC, 1995, CELL, V82, P37, DOI 10.1016/0092-8674(95)90050-0; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Stemmle LN, 2006, MOL PHARMACOL, V70, P1461, DOI 10.1124/mol.106.023705; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Thisse C, 2005, ZFIN DIRECT DATA SUB; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Westerfield M, 1993, ZEBRAFISH BOOK; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44096	10.1371/journal.pone.0044096	http://dx.doi.org/10.1371/journal.pone.0044096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957046	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800038
J	Si, JJ; Yang, JL; Xue, LF; Yang, CH; Luo, YX; Shi, HS; Lu, L				Si, Jijian; Yang, Jianli; Xue, Lifen; Yang, Chenhao; Luo, Yixiao; Shi, Haishui; Lu, Lin			Activation of NF-kappa B in Basolateral Amygdala Is Required for Memory Reconsolidation in Auditory Fear Conditioning	PLOS ONE			English	Article							LONG-TERM-MEMORY; POSTTRAUMATIC-STRESS-DISORDER; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; EXPRESSION; RETRIEVAL; ALPHA; MICE; CONSOLIDATION; ACETYLATION	Posttraumatic stress disorder (PTSD) is characterized by acute and chronic changes in the stress response, manifested as conditioned fear memory. Previously formed memories that are susceptible to disruption immediately after retrieval undergo a protein synthesis-dependent process to become persistent, termed reconsolidation, a process that is regulated by many distinct molecular mechanisms that control gene expression. Increasing evidence supports the participation of the transcription factor NF-kappa B in the different phases of memory. Here, we demonstrate that inhibition of NF-kappa B in the basolateral amygdala (BLA), but not central nucleus of the amygdala, after memory reactivation impairs the retention of amygdala-dependent auditory fear conditioning (AFC). We used two independent pharmacological strategies to disrupt the reconsolidation of AFC. Bilateral intra-BLA infusion of sulfasalazine, an inhibitor of I kappa B kinase that activates NF-kappa B, and bilateral intra-BLA infusion of SN50, a direct inhibitor of the NF-kappa B DNA-binding complex, immediately after retrieval disrupted the reconsolidation of AFC. We also found that systemic pretreatment with sodium butyrate, a histone deacetylase inhibitor that enhances histone acetylation, in the amygdala rescued the disruption of reconsolidation induced by NF-kappa B inhibition in the BLA. These findings indicate that NF-kappa B activity in the BLA is required for memory reconsolidation in AFC, suggesting that NF-kappa B might be a potential pharmacotherapy target for posttraumatic stress disorder.	[Si, Jijian; Yang, Chenhao] Tianjin Med Univ, Tianjin, Peoples R China; [Si, Jijian; Yang, Jianli; Yang, Chenhao] Tianjin Mental Hlth Ctr, Tianjin, Peoples R China; [Si, Jijian; Xue, Lifen; Yang, Chenhao; Luo, Yixiao; Shi, Haishui; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Tianjin Medical University; Peking University	Si, JJ (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.	yangjianli0722@sohu.com; xiaosmile0001@sina.com			National Science Foundation of China [30870895]; Natural Science Foundation of Beijing Municipality [7091003]; Science and Technology Foundation of Tianjin Health Bureau [06KR04, 09KY02]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Science and Technology Foundation of Tianjin Health Bureau	This work was supported by grants from the National Science Foundation of China (No. 30870895 to JLY), Natural Science Foundation of Beijing Municipality (No.7091003), and Science and Technology Foundation of Tianjin Health Bureau (No.06KR04 and 09KY02 to JLY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baratti CM, 2009, BRAZ J MED BIOL RES, V42, P148, DOI 10.1590/S0100-879X2009000200001; Boccia M, 2007, J NEUROSCI, V27, P13436, DOI 10.1523/JNEUROSCI.4430-07.2007; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Izumi T, 2011, J NEUROSCI RES, V89, P773, DOI 10.1002/jnr.22592; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kasahara M, 2011, NEUROENDOCRINOL LETT, V32, P193; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sah P, 2008, NATURE, V454, P589, DOI 10.1038/454589a; Teng FYH, 2010, REV NEUROSCIENCE, V21, P299; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang JL, 2011, BEHAV BRAIN RES, V216, P592, DOI 10.1016/j.bbr.2010.08.047; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200; Yiu AP, 2011, NEUROPSYCHOPHARMACOL	41	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43973	10.1371/journal.pone.0043973	http://dx.doi.org/10.1371/journal.pone.0043973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957038	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800030
J	Xu, PX; Hooper, AM; Pickett, JA; Leal, WS				Xu, Pingxi; Hooper, Antony M.; Pickett, John A.; Leal, Walter S.			Specificity Determinants of the Silkworm Moth Sex Pheromone	PLOS ONE			English	Article							BINDING PROTEIN; SENSITIVE NEURONS; BOMBYX-MORI; RECEPTORS; ACTIVATION; RELEASE	The insect olfactory system, particularly the peripheral sensory system for sex pheromone reception in male moths, is highly selective, but specificity determinants at the receptor level are hitherto unknown. Using the Xenopus oocyte recording system, we conducted a thorough structure-activity relationship study with the sex pheromone receptor of the silkworm moth, Bombyx mori, BmorOR1. When co-expressed with the obligatory odorant receptor co-receptor (BmorOrco), BmorOR1 responded in a dose-dependent fashion to both bombykol and its related aldehyde, bombykal, but the threshold of the latter was about one order of magnitude higher. Solubilizing these ligands with a pheromone-binding protein (BmorPBP1) did not enhance selectivity. By contrast, both ligands were trapped by BmorPBP1 leading to dramatically reduced responses. The silkworm moth pheromone receptor was highly selective towards the stereochemistry of the conjugated diene, with robust response to the natural (10E, 12Z)-isomer and very little or no response to the other three isomers. Shifting the conjugated diene towards the functional group or elongating the carbon chain rendered these molecules completely inactive. In contrast, an analogue shortened by two omega carbons elicited the same or slightly higher responses than bombykol. Flexibility of the saturated C1-C9 moiety is important for function as addition of a double or triple bond in position 4 led to reduced responses. The ligand is hypothesized to be accommodated by a large hydrophobic cavity within the helical bundle of transmembrane domains.	[Xu, Pingxi; Leal, Walter S.] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Hooper, Antony M.; Pickett, John A.] Rothamsted Res, Harpenden, Herts, England	University of California System; University of California Davis; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Xu, PX (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal, Walter/0000-0002-6800-1240; Hooper, Antony/0000-0002-0780-2167; Leal Filho, Walter/0000-0002-1241-5225	National Science Foundation [0918177]; Agriculture and Food Research Initiative from the United States Department of Agriculture-National Institute for Food and Agriculture [2010-65105-20582]; National Institutes of Health [1R01AI095514-01A1]; Biotechnology and Biological Sciences Research Council of the UK (BBSRC); BBSRC [BBS/E/C/00005194, BB/J020281/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BB/J020281/1] Funding Source: researchfish; Direct For Biological Sciences [0918177] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Agriculture and Food Research Initiative from the United States Department of Agriculture-National Institute for Food and Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Science Foundation grant 0918177, Agriculture and Food Research Initiative competitive grant 2010-65105-20582 from the United States Department of Agriculture-National Institute for Food and Agriculture, and National Institutes of Health, 1R01AI095514-01A1. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hooper AM, 2009, CHEM COMMUN, P5725, DOI 10.1039/b914294k; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; KAISSLING KE, 1987, WRIGHT LECT INSECT O; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; SYED Z, 2010, P NATL ACAD SCI US; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	20	26	27	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44190	10.1371/journal.pone.0044190	http://dx.doi.org/10.1371/journal.pone.0044190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957053	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800045
J	Zhang, T; Shi, N; Bai, DS; Chen, YL; Feng, G				Zhang, Tao; Shi, Ning; Bai, Dengsha; Chen, Yinglong; Feng, Gu			Arbuscular Mycorrhizal Fungi Promote the Growth of Ceratocarpus arenarius (Chenopodiaceae) with No Enhancement of Phosphorus Nutrition	PLOS ONE			English	Article							ATRIPLEX-NUMMULARIA; JUNGGAR BASIN; DIVERSITY; PLANTS; INOCULATION; PHOSPHATE; ROOTS; COLONIZATION; ASSOCIATIONS; EPHEMERALS	The mycorrhizal status of plants in the Chenopodiaceae is not well studied with a few controversial reports. This study examined arbuscular mycorrhizal (AM) colonization and growth response of Ceratocarpus arenarius in the field and a greenhouse inoculation trial. The colonization rate of AM fungi in C. arenarius in in-growth field cores was low (around 15%). Vesicles and intraradical hyphae were present during all growth stages, but no arbuscules were observed. Sequencing analysis of the large ribosomal rDNA subunit detected four culturable Glomus species, G. intraradices, G. mosseae, G. etunicatum and G. microaggregatum together with eight unculturable species belong to the Glomeromycota in the root system of C. arenarius collected from the field. These results establish the mycotrophic status of C. arenarius. Both in the field and in the greenhouse inoculation trial, the growth of C. arenarius was stimulated by the indigenous AM fungal community and the inoculated AM fungal isolates, respectively, but the P uptake and concentration of the mycorrhizal plants did not increase significantly over the controls in both experiments. Furthermore, the AM fungi significantly increased seed production. Our results suggest that an alternative reciprocal benefit to carbon-phosphorus trade-off between AM fungi and the chenopod plant might exist in the extremely arid environment.	[Zhang, Tao; Shi, Ning; Feng, Gu] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Zhang, Tao; Shi, Ning; Feng, Gu] China Agr Univ, Ctr Resource Environm & Food Secur, Beijing 100094, Peoples R China; [Bai, Dengsha] Xinjiang Acad Agr Sci, Inst Nucl Technol & Biotechnol, Urumqi, Xinjiang, Peoples R China; [Chen, Yinglong] Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia	China Agricultural University; China Agricultural University; University of Western Australia	Zhang, T (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	fenggu@cau.edu.cn	Chen, Yinglong/D-2104-2011; Feng, Gu/K-8367-2012	Chen, Yinglong/0000-0003-0798-8683; Feng, Gu/0000-0002-1052-5009	National Science Foundation of China [30770341, 31121062]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Science Foundation of China (No. 30770341 and the Innovative Group Grant No. 31121062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera LE, 1998, REV CHIL HIST NAT, V71, P291; Aleman R, 2010, T ROY SOC SOUTH AUST, V134, P1; ALLEN MF, 1983, MYCOLOGIA, V75, P773, DOI 10.2307/3792769; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARMSTRONG KA, 1983, Q REV BIOL, V58, P234, DOI 10.1086/413230; Asghari HR, 2005, PLANT SOIL, V273, P245, DOI 10.1007/s11104-004-7942-6; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Fitter AH, 2006, NEW PHYTOL, V172, P3, DOI 10.1111/j.1469-8137.2006.01861.x; Gao Rui, 2007, Acta Botanica Yunnanica, V29, P300; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Grime JP, 1979, 20 BRIT EC SOC S LON, P123; Gutterman Yitzchak, 2002, P1; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Huang PY, 2002, SHRUB VEGETATION RES; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Johnson D, 2001, NEW PHYTOL, V152, P555, DOI 10.1046/j.0028-646X.2001.00273.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Ma Z., 1994, ARID ZONE RES, V11, P1; Manjarrez M, 2010, FUNCT PLANT BIOL, V37, P1132, DOI 10.1071/FP09248; Marschner P, 2010, SOIL MICROBIOLOGY AND SUSTAINABLE CROP PRODUCTION, P297, DOI 10.1007/978-90-481-9479-7_8; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; O'Connor PJ, 2002, NEW PHYTOL, V154, P209, DOI 10.1046/j.1469-8137.2002.00364.x; O'Connor PJ, 2001, AUST J BOT, V49, P493, DOI 10.1071/BT00014; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Pennisi E, 2004, SCIENCE, V304, P1620, DOI 10.1126/science.304.5677.1620; Plenchette C, 2005, J ARID ENVIRON, V61, P535, DOI 10.1016/j.jaridenv.2004.10.003; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; SENGUPTA A, 1990, PLANT SOIL, V122, P111, DOI 10.1007/BF02851917; Shi ZY, 2006, MYCORRHIZA, V16, P269, DOI 10.1007/s00572-006-0041-1; Shi ZY, 2007, APPL SOIL ECOL, V35, P10, DOI 10.1016/j.apsoil.2006.06.002; Smith FA, 2009, NEW PHYTOL, V182, P347, DOI 10.1111/j.1469-8137.2008.02753.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; Wang XQ, 2004, CHINESE J APPL ECOLO, V15, P556; White JA, 2008, MYCOLOGIA, V100, P6, DOI 10.3852/mycologia.100.1.6; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; WILLIAMS SE, 1974, SOIL SCI SOC AM J, V38, P962, DOI 10.2136/sssaj1974.03615995003800060034x; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	45	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41151	10.1371/journal.pone.0041151	http://dx.doi.org/10.1371/journal.pone.0041151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957011	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800003
J	Iqbal, M; Ho, HL; Petropoulos, S; Moisiadis, VG; Gibb, W; Matthews, SG				Iqbal, Majid; Ho, Hay Lam; Petropoulos, Sophie; Moisiadis, Vasilis G.; Gibb, William; Matthews, Stephen G.			Pro-Inflammatory Cytokine Regulation of P-glycoprotein in the Developing Blood-Brain Barrier	PLOS ONE			English	Article							NF-KAPPA-B; RESISTANCE PHOSPHOGLYCOPROTEIN ABCB1; NECROSIS-FACTOR-ALPHA; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; MDR1 GENE-EXPRESSION; DRUG TRANSPORTERS; DECREASED EXPRESSION; EFFLUX TRANSPORTERS; ADVANCING GESTATION; MEDIATED TRANSPORT	Placental P-glycoprotein (P-gp) acts to protect the developing fetus from exogenous compounds. This protection declines with advancing gestation leaving the fetus and fetal brain vulnerable to these compounds and potential teratogens in maternal circulation. This vulnerability may be more pronounced in pregnancies complicated by infection, which is common during pregnancy. Pro-inflammatory cytokines (released during infection) have been shown to be potent inhibitors of P-gp, but nothing is known regarding their effects at the developing blood-brain barrier (BBB). We hypothesized that P-gp function and expression in endothelial cells of the developing BBB will be inhibited by proinflammatory cytokines. We have derived brain endothelial cell (BEC) cultures from various stages of development of the guinea pig: gestational day (GD) 50, 65 (term similar to 68 days) and postnatal day (PND) 14. Once these cultures reached confluence, BECs were treated with various doses (10(0) - 10(4) pg/mL) of pro-inflammatory cytokines: interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) or tumor necrosis factor-alpha (TNF-alpha). P-gp function or abcb1 mRNA (encodes P-gp) expression was assessed following treatment. Incubation of GD50 BECs with IL-1 beta, IL-6 or TNF-alpha resulted in no change in P-gp function. GD65 BECs displayed a dose-dependent decrease in function with all cytokines tested; maximal effects at 42%, 65% and 34% with IL-1 beta, IL-6 and TNF-alpha treatment, respectively (P<0.01). Inhibition of P-gp function by IL-1 beta, IL-6 and TNF-alpha was even greater in PND14 BECs; maximal effects at 36% (P<0.01), 84% (P<0.05) and 55% (P<0.01), respectively. Cytokine-induced reductions in P-gp function were associated with decreased abcb1 mRNA expression. These data suggest that BBB P-gp function is increasingly responsive to the inhibitory effects of pro-inflammatory cytokines, with increasing developmental age. Thus, women who experience infection and take prescription medication during pregnancy may expose the developing fetal brain to greater amounts of exogenous compounds - many of which are considered potentially teratogenic.	[Iqbal, Majid; Ho, Hay Lam; Petropoulos, Sophie; Moisiadis, Vasilis G.; Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Gibb, William] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Gibb, William] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Med, Fac Med, Toronto, ON, Canada	University of Toronto; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto	Iqbal, M (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	majid.iqbal@utoronto.ca	Petropoulos, Sophie/M-3090-2017; Matthews, Stephen/R-5147-2019; Matthews, Stephen G/N-7555-2018; Petropoulos, Sophie/D-6861-2016	Matthews, Stephen/0000-0002-9654-9940; Matthews, Stephen G/0000-0002-9654-9940; Petropoulos, Sophie/0000-0003-2293-8238	Canadian Institutes for Health Research [FRN-57746]; Doctoral Research Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Doctoral Research Award	This study was funded by the Canadian Institutes for Health Research, FRN-57746; to WG and SGM and Doctoral Research Award to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P546, DOI 10.1002/pds.1235; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Babic Z, 2009, COLLEGIUM ANTROPOL, V33, P1145; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chen YH, 2005, TOXICOLOGY, V211, P242, DOI 10.1016/j.tox.2005.03.011; Davis TME, 2010, FUTURE MICROBIOL, V5, P1599, DOI 10.2217/FMB.10.113; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Ek CJ, 2010, TOXICOL LETT, V197, P51, DOI 10.1016/j.toxlet.2010.04.025; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Finney SJ, 2012, INTENS CARE MED, V38, P324, DOI 10.1007/s00134-011-2444-5; Gao XJ, 2012, PARASITOLOGY, V139, P139, DOI 10.1017/S0031182011001880; Garcia AM, 1999, AM J EPIDEMIOL, V149, P64, DOI 10.1093/oxfordjournals.aje.a009729; Agren J, 2006, SCAND J IMMUNOL, V64, P61, DOI 10.1111/j.1365-3083.2006.01779.x; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Hartmann G, 2001, INT IMMUNOPHARMACOL, V1, P189, DOI 10.1016/S0162-3109(00)00271-X; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Higa JK, 2011, CYTOKINE, V55, P18, DOI 10.1016/j.cyto.2011.02.019; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; IKEGUCHI M, 1991, DNA CELL BIOL, V10, P639, DOI 10.1089/dna.1991.10.639; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kalabis GM, 2009, CAN J PHYSIOL PHARM, V87, P973, DOI [10.1139/Y09-087, 10.1139/y09-087]; Kalitsky-Szirtes J, 2004, DRUG METAB DISPOS, V32, P20, DOI 10.1124/dmd.32.1.20; Kapoor A, 2008, BRAIN RES REV, V57, P586, DOI 10.1016/j.brainresrev.2007.06.013; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Kim-Fine S, 2012, J MATERN FETAL NEONA; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Lacroix I, 2000, LANCET, V356, P1735, DOI 10.1016/S0140-6736(00)03209-8; Lagas JS, 2009, MOL INTERV, V9, P136, DOI 10.1124/mi.9.3.7; Lamont RF, 2005, BJOG-INT J OBSTET GY, V112, P67, DOI 10.1111/j.1471-0528.2005.00589.x; Lee E, 2006, PHARMACOEPIDEM DR S, V15, P537, DOI 10.1002/pds.1241; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Loffredo CA, 2001, AM J EPIDEMIOL, V153, P529, DOI 10.1093/aje/153.6.529; Mackenzie R, 2006, AM J OBSTET GYNECOL, V194, P1234, DOI 10.1016/j.ajog.2005.06.049; Malm H, 2004, DRUG SAFETY, V27, P899, DOI 10.2165/00002018-200427120-00006; Marino T, 2010, VIRAL INFECT PREGNAN; McRae MP, 2003, DRUG METAB REV, V35, P19, DOI 10.1081/DMR-120018247; Nezic L, 2009, GEN PHYSIOL BIOPHYS, V28, P119; Nwaozuzu OM, 2003, J NEUROCHEM, V87, P1043, DOI 10.1046/j.1471-4159.2003.02061.x; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; Petropoulos S, 2010, BRAIN RES, V1357, P9, DOI 10.1016/j.brainres.2010.08.016; Petrovic V, 2010, DRUG METAB DISPOS, V38, P1760, DOI 10.1124/dmd.110.034470; Piquette-Miller M, 1998, PHARMACEUT RES, V15, P706, DOI 10.1023/A:1011962818051; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Rahmat D, 2012, INT J PHARMACEUT, V422, P40, DOI 10.1016/j.ijpharm.2011.10.024; Regidor E, 2004, OCCUP ENVIRON MED, V61, P334, DOI 10.1136/oem.2003.009043; Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121; Schumacher U, 1997, HISTOCHEM CELL BIOL, V108, P179, DOI 10.1007/s004180050159; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Shaw SY, 2008, P NATL ACAD SCI USA, V105, P7387, DOI 10.1073/pnas.0802878105; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Sukhai M, 2001, INFLAMM RES, V50, P362, DOI 10.1007/PL00000257; Sukhai Mahadeo, 2000, Molecular Cell Biology Research Communications, V4, P248, DOI 10.1006/mcbr.2001.0288; Sun M, 2006, PLACENTA, V27, P602, DOI 10.1016/j.placenta.2005.05.007; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Trickler WJ, 2005, BRAIN RES, V1048, P24, DOI 10.1016/j.brainres.2005.04.028; VANKALKEN CK, 1992, AM J PATHOL, V141, P1063; Viale M, 2011, INVEST NEW DRUG, V29, P98, DOI 10.1007/s10637-009-9340-7; Virgintino D, 2008, J NEUROPATH EXP NEUR, V67, P50, DOI 10.1097/nen.0b013e31815f65d9; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; Wang JH, 2005, J NUCL MED, V46, P1537; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Weidler M, 2000, BIOCHEM BIOPH RES CO, V276, P447, DOI 10.1006/bbrc.2000.3499; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yun HC, 2010, BACTERIAL INFECT PRE; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	75	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43022	10.1371/journal.pone.0043022	http://dx.doi.org/10.1371/journal.pone.0043022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22973436	Green Submitted, gold, Green Published			2022-12-27	WOS:000307500100052
J	Zujovic, V; Doucerain, C; Hidalgo, A; Bachelin, C; Lachapelle, F; Weissert, R; Stadelmann, C; Linington, C; Baron-Van Evercooren, A				Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Weissert, Robert; Stadelmann, Christine; Linington, Chris; Baron-Van Evercooren, Anne			Exogenous Schwann Cells Migrate, Remyelinate and Promote Clinical Recovery in Experimental Auto-Immune Encephalomyelitis	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; SKIN-DERIVED PRECURSORS; NEURAL CREST CELLS; MULTIPLE-SCLEROSIS; SPINAL-CORD; OLIGODENDROCYTE PROGENITORS; FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; MYELIN REPAIR	Schwann cell (SC) transplantation is currently being discussed as a strategy that may promote functional recovery in patients with multiple sclerosis (MS) and other inflammatory demyelinating diseases of the central nervous system (CNS). However this assumes they will not only survive but also remyelinate demyelinated axons in the chronically inflamed CNS. To address this question we investigated the fate of transplanted SCs in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in the Dark Agouti rat; an animal model that reproduces the complex inflammatory demyelinating immunopathology of MS. We now report that SCs expressing green fluorescent protein (GFP-SCs) allografted after disease onset not only survive but also migrate to remyelinate lesions in the inflamed CNS. GFP-SCs were detected more frequently in the parenchyma after direct injection into the spinal cord, than via intrathecal delivery into the cerebrospinal fluid. In both cases the transplanted cells intermingled with astrocytes in demyelinated lesions, aligned with axons and by twenty one days post transplantation had formed Pzero protein immunoreactive internodes. Strikingly, GFP-SCs transplantation was associated with marked decrease in clinical disease severity in terms of mortality; all GFP-SCs transplanted animals survived whilst 80% of controls died within 40 days of disease.	[Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Baron-Van Evercooren, Anne] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Baron-Van Evercooren, Anne] INSERM, U975, Paris, France; [Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Baron-Van Evercooren, Anne] CNRS, UMR 7225, Paris, France; [Baron-Van Evercooren, Anne] Hop La Pitie Salpetriere, AP HP, Paris, France; [Weissert, Robert] Univ Regensburg, Dept Neurol, Regensburg, Germany; [Stadelmann, Christine] Inst Neuropathol, Gottingen, Germany; [Linington, Chris] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Regensburg; University of Glasgow	Zujovic, V (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	anne.baron@upmc.fr	Violetta, Zujovic/I-8784-2017; Weissert, Robert/AAA-4791-2019; Weissert, Robert/B-2585-2009; Linington, Chris/M-4883-2019; Evercooren, Anne S Baron-Van/G-3632-2013	Violetta, Zujovic/0000-0002-6786-065X; Weissert, Robert/0000-0002-1295-1271; Baron-Van Evercooren, Anne/0000-0002-4150-2205; Stadelmann, Christine/0000-0003-1766-5458; violetta, zujovic/0000-0002-2741-6052; Linington, Christopher/0000-0002-0937-9526	European Leukodystrophy Association (ELA) Foundation; INSERM; Association Francaise contre les Myopathies (AFM); ELA Foundation	European Leukodystrophy Association (ELA) Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); ELA Foundation	This study was supported by European Leukodystrophy Association (ELA) Foundation, and INSERM. VZ and CD were recipients of fellowships from Association Francaise contre les Myopathies (AFM), and ELA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Avellana-Adalid V, 1998, EUR J NEUROSCI, V10, P291; Bachelin C, 2010, BRAIN, V133, P406, DOI 10.1093/brain/awp256; Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Fairless R, 2005, MOL CELL NEUROSCI, V28, P253, DOI 10.1016/j.mcn.2004.09.009; FEIGIN I, 1971, J NEUROPATH EXP NEUR, V30, P603, DOI 10.1097/00005072-197110000-00005; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-04.2005; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Honmou O, 1996, J NEUROSCI, V16, P3199; ITOYAMA Y, 1983, ANN NEUROL, V14, P339, DOI 10.1002/ana.410140313; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Mimouni-Rongy M, 2011, J NEUROIMMUNOL, V230, P17, DOI 10.1016/j.jneuroim.2010.08.010; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Rosner BI, 2005, EXP NEUROL, V195, P81, DOI 10.1016/j.expneurol.2005.04.003; RUTKOWSKI JL, 1995, NAT MED, V1, P80, DOI 10.1038/nm0195-80; Santos-Silva A, 2007, J NEUROSCI, V27, P7154, DOI 10.1523/JNEUROSCI.1184-07.2007; Shields SA, 2000, J NEUROSCI RES, V60, P571, DOI 10.1002/(SICI)1097-4547(20000601)60:5<571::AID-JNR1>3.0.CO;2-Q; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; VANEVERCOOREN AB, 1992, J NEUROIMMUNOL, V40, P235, DOI 10.1016/0165-5728(92)90139-C; Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Woodhoo A, 2007, BRAIN, V130, P2175, DOI 10.1093/brain/awm125; YAMAMOTO T, 1991, J NEUROL SCI, V102, P163, DOI 10.1016/0022-510X(91)90064-E; Zujovic V, 2010, STEM CELLS, V28, P470, DOI 10.1002/stem.290; Zujovic V, 2007, NEUROSCIENTIST, V13, P383, DOI 10.1177/10738584070130041001	49	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42667	10.1371/journal.pone.0042667	http://dx.doi.org/10.1371/journal.pone.0042667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984406	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000308638700008
J	Kitamoto, S; Yokoyama, S; Higashi, M; Yamada, N; Matsubara, S; Takao, S; Batra, SK; Yonezawa, S				Kitamoto, Sho; Yokoyama, Seiya; Higashi, Michiyo; Yamada, Norishige; Matsubara, Shyuichiro; Takao, Sonshin; Batra, Surinder K.; Yonezawa, Suguru			Expression of MUC17 Is Regulated by HIF1 alpha-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; DNA METHYLATION; HELICOBACTER-PYLORI; MUCIN; GENE; CONTRIBUTES; METASTASIS; PROFILES; THERAPY	MUC17 is a type 1 membrane-bound glycoprotein that is mainly expressed in the digestive tract. Recent studies have demonstrated that the aberrant overexpression of MUC17 is correlated with the malignant potential of pancreatic ductal adenocarcinomas (PDACs); however, the exact regulatory mechanism of MUC17 expression has yet to be identified. Here, we provide the first report of the MUC17 regulatory mechanism under hypoxia, an essential feature of the tumor microenvironment and a driving force of cancer progression. Our data revealed that MUC17 was significantly induced by hypoxic stimulation through a hypoxia-inducible factor 1 alpha (HIF1 alpha)-dependent pathway in some pancreatic cancer cells ( e. g., AsPC1), whereas other pancreatic cancer cells (e.g., BxPC3) exhibited little response to hypoxia. Interestingly, these low-responsive cells have highly methylated CpG motifs within the hypoxia responsive element (HRE, 5'-RCGTG-3'), a binding site for HIF1a. Thus, we investigated the demethylation effects of CpG at HRE on the hypoxic induction of MUC17. Treatment of low-responsive cells with 5-aza-2'-deoxycytidine followed by additional hypoxic incubation resulted in the restoration of hypoxic MUC17 induction. Furthermore, DNA methylation of HRE in pancreatic tissues from patients with PDACs showed higher hypomethylation status as compared to those from non-cancerous tissues, and hypomethylation was also correlated with MUC17 mRNA expression. Taken together, these findings suggested that the HIF1 alpha-mediated hypoxic signal pathway contributes to MUC17 expression, and DNA methylation of HRE could be a determinant of the hypoxic inducibility of MUC17 in pancreatic cancer cells.	[Kitamoto, Sho; Yokoyama, Seiya; Higashi, Michiyo; Yamada, Norishige; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Human Pathol, Kagoshima 890, Japan; [Matsubara, Shyuichiro; Takao, Sonshin] Kagoshima Univ, Frontier Sci Res Ctr, Kagoshima 890, Japan; [Batra, Surinder K.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	Kagoshima University; Kagoshima University; University of Nebraska System; University of Nebraska Medical Center	Kitamoto, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Human Pathol, Kagoshima 890, Japan.	syoneza@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647	Princes Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 21590399, 24701008, 239349]; Pancreas Research Foundation of Japan; Kodama Memorial Foundation, Japan; National Institutes of Health [CA78590, CA163120, CA133944, CA111294]; NATIONAL CANCER INSTITUTE [U01CA111294, R03CA133944, U54CA163120, R01CA078590] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN	Princes Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan); Kodama Memorial Foundation, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Princes Takamatsu Cancer Research Fund to S. Yonezawa; Grants-in-Aid for Scientific Research on Scientific Research (B) 23390085 to S. Yonezawa; Scientific Research (C) 21590399 to M. Higashi; Young Scientists (B) 24701008 to S. Yokoyama; Scientific Research on Priority Areas 239349 to S. Kitamoto (JSPS Fellowship) from the Ministry of Education, Science, Sports, Culture and Technology, Japan; a Pancreas Research Foundation of Japan to S. Yokoyama; and the Kodama Memorial Foundation, Japan to M. Higashi. S. Batra is supported in part by the National Institutes of Health grants (CA78590, CA163120, CA133944 and CA111294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2009, CARCINOGENESIS, V30, P214, DOI 10.1093/carcin/bgn268; Ashida S, 2002, J CANCER RES CLIN, V128, P561, DOI 10.1007/s00432-002-0374-x; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; BHASKAR KR, 1992, NATURE, V360, P458, DOI 10.1038/360458a0; Fechner G, 2007, ANTICANCER RES, V27, P4225; Gum JR, 2002, BIOCHEM BIOPH RES CO, V291, P466, DOI 10.1006/bbrc.2002.6475; Hirono S, 2010, CANCER SCI, V101, P259, DOI 10.1111/j.1349-7006.2009.01359.x; Ho SB, 2006, GASTROENTEROLOGY, V131, P1501, DOI 10.1053/j.gastro.2006.09.006; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kitamoto S, 2011, GLYCOBIOLOGY, V21, P247, DOI 10.1093/glycob/cwq155; Kitamoto S, 2010, BIOCHEM BIOPH RES CO, V397, P333, DOI 10.1016/j.bbrc.2010.05.124; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Luu Y, 2010, INT J BIOCHEM CELL B, V42, P996, DOI 10.1016/j.biocel.2010.03.001; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Moehle C, 2006, J MOL MED, V84, P1055, DOI 10.1007/s00109-006-0100-2; Moniaux N, 2006, J BIOL CHEM, V281, P23676, DOI 10.1074/jbc.M600302200; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Rossler J, 2004, J CELL BIOCHEM, V93, P153, DOI 10.1002/jcb.20133; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Senapati S, 2010, J CLIN PATHOL, V63, P702, DOI 10.1136/jcp.2010.078717; Vincent A, 2008, FASEB J, V22, P3035, DOI 10.1096/fj.07-103390; Vorwerk P, 2002, J CLIN PATHOL-MOL PA, V55, P40, DOI 10.1136/mp.55.1.40; Yamada N, 2009, BRIT J CANCER, V100, P344, DOI 10.1038/sj.bjc.6604845; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yamada N, 2010, J HEPATO-BIL-PAN SCI, V17, P844, DOI 10.1007/s00534-010-0278-0; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Yokoyama S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-67; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Zhu Y, 2010, MED ONCOLOGY	36	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44108	10.1371/journal.pone.0044108	http://dx.doi.org/10.1371/journal.pone.0044108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970168	gold, Green Published, Green Submitted			2022-12-27	WOS:000308748400010
J	Nyamweya, S; Townend, J; Zaman, A; Steele, SJ; Jeffries, D; Rowland-Jones, S; Whittle, H; Flanagan, KL; Jaye, A				Nyamweya, Samuel; Townend, John; Zaman, Akram; Steele, Sarah Jane; Jeffries, David; Rowland-Jones, Sarah; Whittle, Hilton; Flanagan, Katie L.; Jaye, Assan			Are Plasma Biomarkers of Immune Activation Predictive of HIV Progression: A Longitudinal Comparison and Analyses in HIV-1 and HIV-2 Infections?	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; VIRAL LOAD PREDICTS; T-CELL-ACTIVATION; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; SURVIVAL; MARKERS; INDIVIDUALS; RECEPTOR; LEVEL	Background: Chronic immune activation is a hallmark of HIV infection and has been associated with disease progression. Assessment of soluble biomarkers indicating immune activation provide clues into pathogenesis and hold promise for the development of point-of-care monitoring of HIV in resource-poor-settings. Their evaluation in cohort resources is therefore needed to further their development and use in HIV research. Methodology/Principal Findings: Longitudinal evaluation of beta-2 microglobulin (beta-2 m), neopterin and suPAR soluble urokinase-type plasminogen activator receptor (suPAR) was performed with archived plasma samples to predict disease progression and provided the first direct comparison of levels in HIV-1 and HIV-2 infections. At least 2095 samples from 137 HIV-1 and 198 HIV-2 subjects with starting CD4% of >= 28 and median follow up of 4 years were analysed. All biomarkers were correlated negatively to CD4% and positively to viral load and to each other. Analyses in subjects living for >= 5 years revealed increases in median beta-2 m and neopterin and decreases in CD4% over this period and the odds of death within 5 years were positively associated with baseline levels of beta-2 m and neopterin. ROC analyses strengthened the evidence of elevation of biomarkers in patients approaching death in both HIV-1 and HIV-2 infections. Regression models showed that rates of biomarker fold change accelerated from 6-8 years before death with no significant differences between biomarker levels in HIV-1 and HIV-2 at equal time points prior to death. An 'immune activation index' analysis indicative of biomarker levels at equivalent viral loads also showed no differences between the two infections. Conclusions/Significance: Our results suggest that beta-2 m and neopterin are useful tools for disease monitoring in both HIV-1 and HIV-2 infections, whereas sUPAR performed less well. Levels of immune activation per amount of virus were comparable in HIV-1 and HIV-2 infected subjects.	[Nyamweya, Samuel; Townend, John; Zaman, Akram; Jeffries, David; Whittle, Hilton; Flanagan, Katie L.; Jaye, Assan] Med Res Council UK, Banjul, Gambia; [Steele, Sarah Jane] Univ Toronto, Toronto, ON, Canada; [Rowland-Jones, Sarah] Weatherall Inst Mol Med, Oxford, England; [Zaman, Akram] Hlth Protect Agcy, Ctr Infect, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University of Oxford; Health Protection Agency	Nyamweya, S (corresponding author), Med Res Council UK, Banjul, Gambia.	ajaye@mrc.gm		Flanagan, Katie/0000-0002-1575-1953	UK Medical Research Council; Medical Research Council [MC_U190092704, MC_U190085854, MC_U190092702, MC_U137884180] Funding Source: researchfish; MRC [MC_U190085854, MC_U190092702, MC_U137884180, MC_U190092704] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirayan-Chevillard N, 2000, CLIN DIAGN LAB IMMUN, V7, P832, DOI 10.1128/CDLI.7.5.832-834.2000; ANDERSON RE, 1990, ARCH INTERN MED, V150, P73, DOI 10.1001/archinte.150.1.73; Ariyoshi K, 2000, AIDS, V14, P339, DOI 10.1097/00002030-200003100-00006; Berry N, 1998, J Hum Virol, V1, P457; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chaudhary Monica, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P259, DOI 10.1177/1545109708322302; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Giorgi JV, 1999, IMMUNOL LETT, V66, P105, DOI 10.1016/S0165-2478(98)00170-9; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Halota Waldemar, 2002, Pol Merkur Lekarski, V13, P126; Hansmann A, 2005, JAIDS-J ACQ IMM DEF, V38, P335; Hanson A, 2005, AIDS RES HUM RETROV, V21, P791, DOI 10.1089/aid.2005.21.791; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hightower Maia, 2003, Braz J Infect Dis, V7, P07, DOI 10.1590/S1413-86702003000100002; Hodges-Mameletzis I, 2011, EXPERT REV ANTI-INFE, V9, P195, DOI [10.1586/eri.10.176, 10.1586/ERI.10.176]; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jaffar S, 2005, AIDS RES HUM RETROV, V21, P560, DOI 10.1089/aid.2005.21.560; Kiepiela P, 2005, BEST PRACT RES CL OB, V19, P243, DOI 10.1016/j.bpobgyn.2004.11.002; Leligdowicz A, 2007, J CLIN INVEST, V117, P3067, DOI 10.1172/JCI32380; Leligdowicz A, 2010, J INFECT DIS, V201, P114, DOI 10.1086/648733; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Michel P, 2000, J INFECT DIS, V181, P64, DOI 10.1086/315170; Mildvan D, 2005, CLIN INFECT DIS, V40, P853, DOI 10.1086/427877; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; PIWOWAR EM, 1995, CLIN DIAGN LAB IMMUN, V2, P236, DOI 10.1128/CDLI.2.2.236-237.1995; Plesner T, 1997, STEM CELLS, V15, P398, DOI 10.1002/stem.150398; Sidenius N, 2000, BLOOD, V96, P4091; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; van der Loeff MFS, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-46; WHITTLE H, 1992, AIDS, V6, P685, DOI 10.1097/00002030-199207000-00011; Yilmaz A, 2008, JAIDS-J ACQ IMM DEF, V47, P168, DOI 10.1097/QAI.0b013e31815ace97; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	37	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44411	10.1371/journal.pone.0044411	http://dx.doi.org/10.1371/journal.pone.0044411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970212	Green Submitted, gold, Green Published			2022-12-27	WOS:000308748400016
J	Carriquiry, G; Otero, L; Gonzalez-Lagos, E; Zamudio, C; Sanchez, E; Nabeta, P; Campos, M; Echevarria, J; Seas, C; Gotuzzo, E				Carriquiry, Gabriela; Otero, Larissa; Gonzalez-Lagos, Elsa; Zamudio, Carlos; Sanchez, Eduardo; Nabeta, Pamela; Campos, Miguel; Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo			A Diagnostic Accuracy Study of Xpert (R) MTB/RIF in HIV-Positive Patients with High Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru	PLOS ONE			English	Article							XPERT MTB/RIF; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPICIN RESISTANCE; ASSAY; IMPLEMENTATION; COUNTRIES; BURDEN; TB	Background: Diagnosis of pulmonary tuberculosis (TB) among human immunodeficiency virus (HIV) patients remains complex and demands easy to perform and accurate tests. Xpert (R) MTB/RIF (MTB/RIF) is a molecular TB diagnostic test which is rapid and convenient; the test requires minimal human resources and reports results within two hours. The majority of performance studies of MTB/RIF have been performed in high HIV burden settings, thus TB diagnostic studies among HIV patients in low HIV prevalence settings such as Peru are still needed. Methodology/Principal Findings: From April 2010 to May 2011, HIV-positive patients with high clinical suspicion of TB were enrolled from two tertiary hospitals in Lima, Peru. Detection of TB by MTB/RIF was compared to a composite reference standard Lowenstein-Jensen (LJ) and liquid culture. Detection of rifampicin resistance was compared to the LJ proportion method. We included 131 patients, the median CD4 cell count was 154.5 cells/mm(3) and 45 (34.4%) had TB. For TB detection among HIV patients, sensitivity of MTB/RIF was 97.8% (95% CI 88.4-99.6) (44/45); specificity was 97.7% (95% CI 91.9-99.4) (84/86); the positive predictive value was 95.7% (95% CI 85.5-98.8) (44/46); and the negative predictive value, 98.8% (95% CI 93.6-99.8) (84/85). MTB/RIF detected 13/14 smear-negative TB cases, outperforming smear microscopy [97.8% (44/45) vs. 68.9% (31/45); p = 0.0002]. For rifampicin resistance detection, sensitivity of MTB/RIF was 100% (95% CI 61.0-100.0) (6/6); specificity was 91.0% (95% CI 76.4-96.9) (30/33); the positive predictive value was 66.7% (95% CI 35.4-87.9) (6/9); and the negative predictive value was 100% (95% CI 88.7 -100.0) (30/30). Conclusions/Significance: In HIV patients in our population with a high clinical suspicion of TB, MTB/RIF performed well for TB diagnosis and outperformed smear microscopy.	[Carriquiry, Gabriela; Gonzalez-Lagos, Elsa; Campos, Miguel; Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Carriquiry, Gabriela; Otero, Larissa; Gonzalez-Lagos, Elsa; Zamudio, Carlos; Campos, Miguel; Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Sanchez, Eduardo] Hosp Nacl Hipolito Unanue, Serv Enfermedades Infecciosas & Trop, Lima, Peru; [Nabeta, Pamela] Fdn Innovat New Diagnost, Geneva, Switzerland; [Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo] Hosp Nacl Cayetano Heredia, Dept Enfermedades Infecciosas & Trop, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Foundation For Innovative New Diagnostics	Carriquiry, G (corresponding author), Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru.	gabriela.carriquiry.c@upch.pe		Otero, Larissa/0000-0002-8348-4340; Seas, Carlos/0000-0001-7067-9141; Campos-Sanchez, Miguel/0000-0003-4650-1225; Zamudio, Carlos/0000-0001-7479-127X	Fogarty International Center at the U.S. National Institutes of Health (NIH) (Peru ICOHRTA network for AIDS/TB research) [1U2RTW007368-01A1]; FOGARTY INTERNATIONAL CENTER [U2RTW007368] Funding Source: NIH RePORTER	Fogarty International Center at the U.S. National Institutes of Health (NIH) (Peru ICOHRTA network for AIDS/TB research); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [grant number 1U2RTW007368-01A1] and received partial funding of the Belgian Cooperation through a project of institutional collaboration with the Institute of Tropical Medicine in Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, OPENEPI OPEN SOURCE; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Mathew P, 2002, J CLIN MICROBIOL, V40, P3482, DOI 10.1128/JCM.40.9.3482-3484.2002; Ministerio de Salud, 2010, ESTR SAN NAC PREV CO; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Toman K, 2004, TOMAN, P23; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wechsler S., 1997, STAT SQUARE ONE; World Health Organization, 2011, WHO PUBL	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44626	10.1371/journal.pone.0044626	http://dx.doi.org/10.1371/journal.pone.0044626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970271	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000039
J	Park, YY; Park, ES; Kim, SB; Kim, SC; Sohn, BH; Chu, IS; Jeong, W; Mills, GB; Byers, LA; Lee, JS				Park, Yun-Yong; Park, Eun Sung; Kim, Sang Bae; Kim, Sang Cheol; Sohn, Bo Hwa; Chu, In-Sun; Jeong, Woojin; Mills, Gordon B.; Byers, Lauren Averett; Lee, Ju-Seog			Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma	PLOS ONE			English	Article							BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; THYMIDYLATE SYNTHASE; SQUAMOUS-CELL; SURVIVAL; CLASSIFICATION; IDENTIFICATION; ASSOCIATION; CISPLATIN; PROFILES	Although several prognostic signatures have been developed in lung cancer, their application in clinical practice has been limited because they have not been validated in multiple independent data sets. Moreover, the lack of common genes between the signatures makes it difficult to know what biological process may be reflected or measured by the signature. By using classical data exploration approach with gene expression data from patients with lung adenocarcinoma (n = 186), we uncovered two distinct subgroups of lung adenocarcinoma and identified prognostic 193-gene gene expression signature associated with two subgroups. The signature was validated in 4 independent lung adenocarcinoma cohorts, including 556 patients. In multivariate analysis, the signature was an independent predictor of overall survival (hazard ratio, 2.4; 95% confidence interval, 1.2 to 4.8; p = 0.01). An integrated analysis of the signature revealed that E2F1 plays key roles in regulating genes in the signature. Subset analysis demonstrated that the gene signature could identify high-risk patients in early stage (stage I disease), and patients who would have benefit of adjuvant chemotherapy. Thus, our study provided evidence for molecular basis of clinically relevant two distinct two subtypes of lung adenocarcinoma.	[Park, Yun-Yong; Park, Eun Sung; Kim, Sang Bae; Sohn, Bo Hwa; Jeong, Woojin; Mills, Gordon B.; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Park, Eun Sung] Yonsei Univ, Coll Med, Inst Med Convergence, Seoul, South Korea; [Kim, Sang Bae] Univ Texas Grad Sch Biomed Sci, Houston, TX USA; [Kim, Sang Cheol; Chu, In-Sun] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Jeong, Woojin] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Byers, Lauren Averett] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University Health System; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; University of Texas System; UTMD Anderson Cancer Center	Park, YY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	jlee@mdanderson.org	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753	University of Texas MD Anderson Cancer Center; KRIBB Research Initiative Program; National Cancer Institute at National Institutes of Health CCSG [CA106672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center; KRIBB Research Initiative Program; National Cancer Institute at National Institutes of Health CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by the intramural faculty fund of The University of Texas MD Anderson Cancer Center to JSL and a grant from "KRIBB Research Initiative Program" to ISC. MD Anderson Cancer Center is partially funded by National Cancer Institute at National Institutes of Health CCSG Core Grant CA106672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Chen CW, 2011, INT J BIOL SCI, V7, P551, DOI 10.7150/ijbs.7.551; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fujiwara T, 2012, LUNG CANCER, V75, P119, DOI 10.1016/j.lungcan.2011.05.028; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gomez HL, 2006, CLIN CANCER RES, V12, P832, DOI 10.1158/1078-0432.CCR-05-0295; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hashimoto H, 2006, CANCER-AM CANCER SOC, V106, P1595, DOI 10.1002/cncr.21777; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kadara H, 2010, NEOPLASIA, V12, P499, DOI 10.1593/neo.10390; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Katz EM, 2005, NAT CLIN PRACT ONCOL, V2, P482, DOI 10.1038/ncponc0318; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Li C, 2004, ONCOGENE, V23, P9336, DOI 10.1038/sj.onc.1208114; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Neumann J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-77; Oh SC, 2012, GUT, V61, P1291, DOI 10.1136/gutjnl-2011-300812; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; PAIROLERO PC, 1984, ANN THORAC SURG, V38, P331, DOI 10.1016/S0003-4975(10)62281-3; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Selvaggi G, 2009, ONCOLOGY-NY, V23, P1133; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shih C, 1997, CANCER RES, V57, P1116; Shimokawa H, 2011, LUNG CANCER, V72, P360, DOI 10.1016/j.lungcan.2010.08.024; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Simon R, 2007, CANCER INFORM, V3, P11; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Sun ZF, 2008, J CLIN ONCOL, V26, P877, DOI 10.1200/JCO.2007.13.1516; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162	58	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44225	10.1371/journal.pone.0044225	http://dx.doi.org/10.1371/journal.pone.0044225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970185	Green Published, gold			2022-12-27	WOS:000308462000014
J	Gropeanu, RA; Baumann, H; Ritz, S; Mailander, V; Surrey, T; del Campo, A				Gropeanu, Radu A.; Baumann, Hella; Ritz, Sandra; Mailaender, Volker; Surrey, Thomas; del Campo, Aranzazu			Phototriggerable 2 ',7-Caged Paclitaxel	PLOS ONE			English	Article							MICROTUBULE DYNAMICS; TUBULIN; BINDING; TAXOL; DERIVATIVES; PRODRUGS; POLARIZATION; INHIBITION; CHEMISTRY; ANALOGS	Three different variants of photoactivatable caged paclitaxel (PTX) have been synthesized and their bioactivity was characterized in in vitro assays and in living cells. The caged PTXs contain the photoremovable chromophore 4,5-dimethoxy-2-nitrobenzyloxycarbonyl (Nvoc) attached to position C7, C2' and to both of these positions via a carbonate bond. Single caged PTXs remained biologically active even at low dosages. Double caging was necessary in order to fully inhibit its activity and to obtain a phototriggerable PTX that can be applied successfully at commonly used concentrations. Irradiation of solutions containing the double caged PTX allowed dose-dependent delivery of functional PTX. Light-triggered stabilization of microtubule assemblies in vitro and in vivo by controlled light exposure of tubulin solutions or cell cultures containing caged PTX was demonstrated. Short light exposure under a fluorescence microscope allowed controlled delivery of free PTX during imaging.	[Gropeanu, Radu A.; Ritz, Sandra; Mailaender, Volker; del Campo, Aranzazu] Max Planck Inst Polymer Res, Mainz, Germany; [Baumann, Hella; Surrey, Thomas] Lincolns Inn Fields Labs, London Res Inst, Canc Res United Kingdom, London, England; [Mailaender, Volker] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany	Max Planck Society; Cancer Research UK; University of London; University College London; Johannes Gutenberg University of Mainz	Gropeanu, RA (corresponding author), Max Planck Inst Polymer Res, Mainz, Germany.	delcampo@mpip-mainz.mpg.de	Mailänder, Volker/H-3589-2012; Mailänder, Volker/AAD-1722-2019; Surrey, Thomas/AAC-4608-2021	Mailänder, Volker/0000-0001-6583-8136; Mailänder, Volker/0000-0001-6583-8136; del Campo, Aranzazu/0000-0001-5725-2135; Surrey, Thomas/0000-0001-9082-1870	Federal Ministry of Education and Research [0312005A]; Cancer Research United Kingdom; Boehringer Ingelheim Fonds; Cancer Research UK [14256] Funding Source: researchfish	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Cancer Research United Kingdom(Cancer Research UK); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Cancer Research UK(Cancer Research UK)	AdC acknowledges financial support from the Federal Ministry of Education and Research (grant no. 0312005A). TS acknowledges financial support from Cancer Research United Kingdom. HB thanks the Boehringer Ingelheim Fonds for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Baloglu E, 2001, BIOORG MED CHEM LETT, V11, P2249, DOI 10.1016/S0960-894X(01)00453-X; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Buck KB, 2002, J NEUROSCI, V22, P9358; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Ceruti M, 2000, J CONTROL RELEASE, V63, P141, DOI 10.1016/S0168-3659(99)00198-4; del Campo A, 2005, ANGEW CHEM INT EDIT, V44, P4707, DOI 10.1002/anie.200500092; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Diaz JF, 2005, J BIOL CHEM, V280, P3928, DOI 10.1074/jbc.M407816200; Ellis-Davies GCR, 2008, CHEM REV, V108, P1603, DOI 10.1021/cr078210i; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Engelborghs Y, 2000, MOL BIOL CELL, V11, p189A; Fu Y, 2009, CURR MED CHEM, V16, P3966, DOI 10.2174/092986709789352277; Goeldner M, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P1, DOI 10.1002/3527605592; Gonzalez R. C., 2004, EDUCATION, V624, P609; Greenwald RB, 1996, J MED CHEM, V39, P424, DOI 10.1021/jm950475e; GREENWALD RB, 1995, J ORG CHEM, V60, P331, DOI 10.1021/jo00107a010; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; Han Y, 1996, BIOCHEMISTRY-US, V35, P14173, DOI 10.1021/bi960774l; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI 10.1016/j.copbio.2010.05.001; Li YK, 2000, BIOCHEMISTRY-US, V39, P616, DOI 10.1021/bi992044u; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; Morais S, 2003, ANAL BIOCHEM, V321, P44, DOI 10.1016/S0003-2697(03)00436-6; Noguchi M, 2008, BIOORGAN MED CHEM, V16, P5389, DOI 10.1016/j.bmc.2008.04.022; Petersen S, 2008, ANGEW CHEM INT EDIT, V47, P3192, DOI 10.1002/anie.200704857; Rao CS, 1998, BIOORGAN MED CHEM, V6, P2193, DOI 10.1016/S0968-0896(98)00158-8; San Miguel V, 2011, J AM CHEM SOC, V133, P5380, DOI 10.1021/ja110572j; Sengupta S, 1997, BIOCHEMISTRY-US, V36, P5179, DOI 10.1021/bi962891m; SENGUPTA S, 1995, BIOCHEMISTRY-US, V34, P11889, DOI 10.1021/bi00037a029; SENGUPTA S, 1995, MOL BIOL CELL, V6, P168; Shick AW, 2010, [No title captured], Patent No. [WO2010151073(A2), 2010151073]; Skwarczynski M, 2006, BIOORG MED CHEM LETT, V16, P4492, DOI 10.1016/j.bmcl.2006.06.030; Sun L, 2009, CHEMMEDCHEM, V4, P719, DOI 10.1002/cmdc.200900044; Wirkner M, 2011, ADV MATER, V23, P3907, DOI 10.1002/adma.201100925; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042	41	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43657	10.1371/journal.pone.0043657	http://dx.doi.org/10.1371/journal.pone.0043657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970137	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400016
J	Wang, QF; Huang, ZH; Ni, SJ; Xiao, XY; Xu, QH; Wang, LS; Huang, D; Tan, C; Sheng, WQ; Du, X				Wang, Qifeng; Huang, Zhaohui; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang			Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; SERUM; DIAGNOSIS; MARKER; CHINA	Background: Colorectal cancer (CRC) is a major cause of death worldwide. Sensitive, non-invasive diagnostic screen methods are urgently needed to improve its survival rates. Stable circulating microRNA offers unique opportunities for the early diagnosis of several diseases, including cancers. Our aim has been to find new plasma miRNAs that can be used as biomarkers for the detection of CRC. Methodology/Principal Findings: According to the results of miRNA profiling performed on pooling plasma samples form 10 CRC patients or 10 healthy controls, a panel of miRNAs (hsa-miR-10a, -19a, -22*, -24, -92a, 125a-5p, -141, -150, -188-3p, 192, -210, -221, -224*, -376a, -425*, -495, -572, -601, -720, -760 and hsa-let-7a, -7e) were deregulated in CRC plasma with fold changes.5. After large scale validation by qRT-PCR performed on another 191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants), we found that the levels of plasma miR-601 and miR-760 were significantly decreased in colorectal neoplasia (carcinomas and advanced adenomas) compared with healthy controls. ROC curve analysis showed that plasma miR-601 and miR-760 were of significant diagnostic value for advanced neoplasia. These two miRNAs together yield an AUC of 0.792 with 83.3% sensitivity and 69.1% specificity for separating CRC from normal controls, and yield an AUC of 0.683 with 72.1% sensitivity and 62.1% specificity in discriminating advanced adenomas from normal controls. Conclusions/Significance: Plasma miR-601 and miR-760 can potentially serve as promising non-invasive biomarkers for the early detection of CRC.	[Wang, Qifeng; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang] Fudan Univ, Canc Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Wang, Qifeng; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang] Fudan Univ, Shanghai Med Sch, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Qifeng; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Qifeng; Huang, Zhaohui] Suzhou Univ, Affiliated Hosp 4, Wuxi Oncol Inst, Wuxi, Jiangsu, Peoples R China; [Xu, Qinghua] Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Wang, QF (corresponding author), Fudan Univ, Canc Hosp, Dept Pathol, Shanghai 200433, Peoples R China.	dx2008cn@yahoo.com.cn	XU, Qinghua/AAZ-9641-2021; Huang, Zhaohui/S-9410-2019	XU, Qinghua/0000-0002-9380-5566; Huang, Zhaohui/0000-0002-0117-9976; Guo, Weijie/0000-0001-7167-9899	National Natural Science Foundation of China [81000867, 81071791]; Science and TechnologyCommission of Shanghai Municipality [09JC1403700, 10XD1401300]; Starting Merieux Research Grants	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and TechnologyCommission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Starting Merieux Research Grants	This study was partially supported by grants from National Natural Science Foundation of China (Grant Nos. 81000867 and 81071791), Science and TechnologyCommission of Shanghai Municipality (Grant No. 09JC1403700 and 10XD1401300), and Starting Merieux Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ANN SURG, V251, P499; Butterly LF, 2008, NEW ENGL J MED, V358, P89; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng H, PLOS ONE, V6; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; El-Maraghi RH, 2009, ACAD RADIOL, V16, P564, DOI 10.1016/j.acra.2009.01.008; Fichtlscherer S, CIRC RES, V107, P677; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Komatsu S, BR J CANC, V105, P104; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu G, MOL BIOL REP, V37, P3575; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ohdaira H, 2009, COMPUT BIOL CHEM, V33, P429, DOI 10.1016/j.compbiolchem.2009.09.003; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Shen J., 2012, PROSTATE; Shigoka M, 1992, PATHOL INT, V60, P351; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tsujiura M, BR J CANC, V102, P1174; Waldman SA, 2008, CLIN CHEM, V54, P943, DOI 10.1373/clinchem.2008.105353; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang YL, 2002, WORLD J GASTROENTERO, V8, P21, DOI 10.3748/wjg.v8.i1.21	32	207	222	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44398	10.1371/journal.pone.0044398	http://dx.doi.org/10.1371/journal.pone.0044398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970209	Green Submitted, Green Published, gold			2022-12-27	WOS:000308458400065
J	ter Riet, G; Korevaar, DA; Leenaars, M; Sterk, PJ; Van Noorden, CJF; Bouter, LM; Lutter, R; Elferink, RPO; Hooft, L				ter Riet, Gerben; Korevaar, Daniel A.; Leenaars, Marlies; Sterk, Peter J.; Van Noorden, Cornelis J. F.; Bouter, Lex M.; Lutter, Rene; Elferink, Ronald P. Oude; Hooft, Lotty			Publication Bias in Laboratory Animal Research: A Survey on Magnitude, Drivers, Consequences and Potential Solutions	PLOS ONE			English	Article							ANTIDEPRESSANT TRIALS; MEDICAL STATISTICS; REVIEWS	Context: Publication bias jeopardizes evidence-based medicine, mainly through biased literature syntheses. Publication bias may also affect laboratory animal research, but evidence is scarce. Objectives: To assess the opinion of laboratory animal researchers on the magnitude, drivers, consequences and potential solutions for publication bias. And to explore the impact of size of the animals used, seniority of the respondent, working in a for-profit organization and type of research (fundamental, pre-clinical, or both) on those opinions. Design: Internet-based survey. Setting: All animal laboratories in The Netherlands. Participants: Laboratory animal researchers. Main Outcome Measure(s): Median (interquartile ranges) strengths of beliefs on 5 and 10-point scales (1: totally unimportant to 5 or 10: extremely important). Results: Overall, 454 researchers participated. They considered publication bias a problem in animal research (7 (5 to 8)) and thought that about 50% (32-70) of animal experiments are published. Employees (n = 21) of for-profit organizations estimated that 10% (5 to 50) are published. Lack of statistical significance (4 (4 to 5)), technical problems (4 (3 to 4)), supervisors (4 (3 to 5)) and peer reviewers (4 (3 to 5)) were considered important reasons for non-publication (all on 5-point scales). Respondents thought that mandatory publication of study protocols and results, or the reasons why no results were obtained, may increase scientific progress but expected increased bureaucracy. These opinions did not depend on size of the animal used, seniority of the respondent or type of research. Conclusions: Non-publication of "negative" results appears to be prevalent in laboratory animal research. If statistical significance is indeed a main driver of publication, the collective literature on animal experimentation will be biased. This will impede the performance of valid literature syntheses. Effective, yet efficient systems should be explored to counteract selective reporting of laboratory animal research.	[ter Riet, Gerben; Korevaar, Daniel A.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Leenaars, Marlies] Radboud Univ Nijmegen, Med Ctr, Cent Anim Lab, Res Ctr 3R, NL-6525 ED Nijmegen, Netherlands; [Sterk, Peter J.; Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands; [Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Bouter, Lex M.] Vrije Univ Amsterdam, Execut Board, Amsterdam, Netherlands; [Elferink, Ronald P. Oude] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Hooft, Lotty] Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	ter Riet, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.terriet@amc.nl	Leenaars, P.P.A.M./L-4478-2015; Korevaar, Daniël A./O-5809-2019; Bouter, Lex/X-1003-2019; Sterk, P.J./AAK-8175-2020; Riet, Gerben ter/A-6943-2011	Leenaars, P.P.A.M./0000-0002-9855-708X; Bouter, Lex/0000-0002-2659-5482; Riet, Gerben ter/0000-0002-2231-7637				Bennett DA, 2004, J CLIN EPIDEMIOL, V57, P349, DOI 10.1016/j.jclinepi.2003.09.015; Bernard C., 1865, INTRO ETUDE MED EXPT; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Bracken MB, 2009, J ROY SOC MED, V102, P120, DOI 10.1258/jrsm.2008.08k033; Bracken MB, 2009, ANN EPIDEMIOL, V19, P220, DOI 10.1016/j.annepidem.2008.11.006; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Greenland S, 2007, INT J EPIDEMIOL, V36, P944, DOI 10.1093/ije/dym174; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Lemon R, 2005, BMJ-BRIT MED J, V330, P977, DOI 10.1136/bmj.330.7498.977; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Mignini Luciano E, 2006, BMC Med Res Methodol, V6, P10, DOI 10.1186/1471-2288-6-10; Ministerie van Economische Zaken Landbouw en Innovatie, 2010, RAPP NVWA ZO DOEND 2; Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126	29	64	66	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43404	10.1371/journal.pone.0043404	http://dx.doi.org/10.1371/journal.pone.0043404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957028	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800020
J	Okada, Y; Oh-Oka, K; Nakamura, Y; Ishimaru, K; Matsuoka, S; Okumura, K; Ogawa, H; Hisamoto, M; Okuda, T; Nakao, A				Okada, Yui; Oh-oka, Kyoko; Nakamura, Yuki; Ishimaru, Kayoko; Matsuoka, Shuji; Okumura, Ko; Ogawa, Hideoki; Hisamoto, Masashi; Okuda, Tohru; Nakao, Atsuhito			Dietary Resveratrol Prevents the Development of Food Allergy in Mice	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; CHOLERA-TOXIN; DENDRITIC CELLS; ORAL TOLERANCE; PATHWAY; ANTIGEN; HEALTH	Background: Resveratrol is a bioactive polyphenol enriched in red wine that exhibits many beneficial health effects via multiple mechanisms. However, it is unclear whether resveratrol is beneficial for the prevention of food allergy. This study investigated whether resveratrol inhibited the development of food allergy by using a mouse model of the disease. Methodology/Principal Findings: Mice fed standard diet or standard diet plus resveratrol were sensitized by intragastric administration of ovalbumin (OVA) and mucosal adjuvant cholera toxin (CT). Several manifestations of food allergy were then compared between the mice. The effects of resveratrol on T cells or dendritic cells were also examined by using splenocytes from OVA-specific T cell-receptor (TCR) transgenic DO11.10 mice or mouse bone marrow-derived dendritic cells (BMDCs) in vitro. We found that mice fed resveratrol showed reduced OVA-specific serum IgE production, anaphylactic reaction, and OVA-induced IL-13 and IFN-(a) over bar production from the mesenteric lymph nodes (MLNs) and spleens in comparison to the control mice, following oral sensitization with OVA plus CT. In addition, resveratrol inhibited OVA plus CT-induced IL-4, IL-13, and IFN-(a) over bar production in splenocytes from DO11.10 mice associated with inhibition of GATA-3 and T-bet expression. Furthermore, resveratrol suppressed the OVA plus CT-induced CD25 expression and IL-2 production in DO11.10 mice-splenocytes in association with decreases in CD80 and CD86 expression levels. Finally, resveratrol suppressed CT-induced cAMP elevation in association with decreases in CD80 and CD86 expression levels in BMDCs. Conclusions/Significance: Ingestion of resveratrol prevented the development of a food allergy model in mice. Given the in vitro findings, resveratrol might do so by inhibiting DC maturation and subsequent early T cell activation and differentiation via downregulation of CT-induced cAMP activation in mice. These results suggest that resveratrol may have potential for prophylaxis against food allergy.	[Okada, Yui; Oh-oka, Kyoko; Nakamura, Yuki; Ishimaru, Kayoko; Nakao, Atsuhito] Univ Yamanashi, Dept Immunol, Fac Med, Chuo Ku, Yamanashi, Japan; [Okada, Yui; Hisamoto, Masashi; Okuda, Tohru] Univ Yamanashi, Inst Enol & Viticulture, Koufu, Yamanashi, Japan; [Matsuoka, Shuji] Juntendo Univ, Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; [Okumura, Ko; Ogawa, Hideoki; Nakao, Atsuhito] Juntendo Univ, Sch Med, Dept Pathol, Atopy Res Ctr,Bunkyo Ku, Tokyo 113, Japan	University of Yamanashi; University of Yamanashi; Juntendo University; Juntendo University	Okada, Y (corresponding author), Univ Yamanashi, Dept Immunol, Fac Med, Chuo Ku, Yamanashi, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [H23]; Grants-in-Aid for Scientific Research [23790904] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (H23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blazquez AB, 2008, J IMMUNOL, V180, P4441, DOI 10.4049/jimmunol.180.7.4441; Brandtzaeg P, 2010, NAT REV GASTRO HEPAT, V7, P380, DOI 10.1038/nrgastro.2010.80; Burks AW, 2008, J ALLERGY CLIN IMMUN, V121, P1344, DOI 10.1016/j.jaci.2008.02.037; Crespo JF, 2003, ALLERGY, V58, P98, DOI 10.1034/j.1398-9995.2003.02170.x; Ela Sala A, 2009, J EXP MED, V206, P1227; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; German JB, 2000, ANNU REV NUTR, V20, P561, DOI 10.1146/annurev.nutr.20.1.561; Hamelmann E, 2008, CLIN EXP ALLERGY, V38, P233, DOI 10.1111/j.1365-2222.2007.02901.x; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Lack G, 2008, NEW ENGL J MED, V359, P1252, DOI 10.1056/NEJMcp0800871; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009; Morinaga N, 2010, TOXICON, V56, P29, DOI 10.1016/j.toxicon.2010.03.009; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Negri DRM, 2009, INFECT IMMUN, V77, P1924, DOI 10.1128/IAI.01559-08; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh A, 2011, CLIN EXP ALLERGY, V41, P1346, DOI 10.1111/j.1365-2222.2011.03773.x; Soleas GJ, 2001, ADV EXP MED BIOL, V492, P159; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Zuercher AW, 2010, CLIN EXP ALLERGY, V40, P942, DOI 10.1111/j.1365-2222.2010.03460.x	28	35	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44338	10.1371/journal.pone.0044338	http://dx.doi.org/10.1371/journal.pone.0044338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962611	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600039
J	Kumar, M; Roe, K; Nerurkar, PV; Namekar, M; Orillo, B; Verma, S; Nerurkar, VR				Kumar, Mukesh; Roe, Kelsey; Nerurkar, Pratibha V.; Namekar, Madhuri; Orillo, Beverly; Verma, Saguna; Nerurkar, Vivek R.			Impaired Virus Clearance, Compromised Immune Response and Increased Mortality in Type 2 Diabetic Mice Infected with West Nile Virus	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; BLOOD-BRAIN-BARRIER; INFLAMMATORY RESPONSE; ALPHA/BETA-INTERFERON; ADIPOSE-TISSUE; UNITED-STATES; MOUSE MODEL; IN-VITRO	Clinicoepidemiological data suggest that type 2 diabetes is associated with increased risk of West Nile virus encephalitis (WNVE). However, no experimental studies have elucidated the role of diabetes in WNV neuropathogenesis. Herein, we employed the db/db mouse model to understand WNV immunopathogenesis in diabetics. Nine-week old C57BL/6 WT and db/db mice were inoculated with WNV and mortality, virus burden in the periphery and brain, and antiviral defense responses were analyzed. db/db mice were highly susceptible to WNV disease, exhibited increased tissue tropism and mortality than the wild-type mice, and were unable to clear the infection. Increased and sustained WNV replication was observed in the serum, peripheral tissues and brain of db/db mice, and heightened virus replication in the periphery was correlated with enhanced neuroinvasion and replication of WNV in the brain. WNV infection in db/db mice was associated with enhanced inflammatory response and compromised antiviral immune response characterized by delayed induction of IFN-alpha, and significantly reduced concentrations of WNV-specific IgM and IgG antibodies. The compromised immune response in db/db mice correlated with increased viremia. These data suggest that delayed immune response coupled with failure to clear the virus leads to increased mortality in db/db mice. In conclusion, this study provides unique mechanistic insight into the immunopathogenesis of WNVE observed in diabetics and can be used to develop therapeutics for the management of WNVE among diabetic patients.	[Kumar, Mukesh; Roe, Kelsey; Namekar, Madhuri; Orillo, Beverly; Verma, Saguna; Nerurkar, Vivek R.] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Kumar, Mukesh; Roe, Kelsey; Namekar, Madhuri; Orillo, Beverly; Verma, Saguna; Nerurkar, Vivek R.] Univ Hawaii Manoa, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA; [Nerurkar, Pratibha V.] Univ Hawaii Manoa, Lab Metab Disorders & Alternat Med, Dept Mol Biosci & Bioengn, Coll Trop Agr & Human Resources, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Kumar, M (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	nerurkar@hawaii.edu	Kumar, Mukesh/N-8814-2015; Kumar, Mukesh/AAI-1046-2019; Namekar, Madhuri/AAU-9421-2021; Nerurkar, Pratibha/AAP-5734-2021; Nerurkar, Vivek R/F-5533-2011	Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875; 	Centers of Biomedical Research Excellence [P20GM103516]; National Institute of General Medicine; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Institutional funds and grant (P20GM103516) from the Centers of Biomedical Research Excellence, National Institute of General Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroug F, 2006, MAYO CLIN PROC, V81, P12, DOI 10.4065/81.1.12; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bouwman JJM, 2008, INT J OBESITY, V32, P892, DOI 10.1038/ijo.2008.36; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717; Deonarain R, 2004, CIRCULATION, V110, P3540, DOI 10.1161/01.CIR.0000136824.73458.20; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Dhurandhar NV, 1997, OBES RES, V5, P464, DOI 10.1002/j.1550-8528.1997.tb00672.x; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Garcia-Tapia D, 2007, J NEUROVIROL, V13, P130, DOI 10.1080/13550280601187185; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Khairallah M, 2007, OCUL IMMUNOL INFLAMM, V15, P435, DOI 10.1080/09273940701798488; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; LEITER EH, 1981, DIABETES, V30, P30, DOI 10.2337/diabetes.30.1.30; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nagajyothi F, 2010, J INFECT DIS, V202, P1104, DOI 10.1086/656189; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nerurkar PV, 2011, BR J NUTR, P1; O'Connor JC, 2005, J IMMUNOL, V174, P4991, DOI 10.4049/jimmunol.174.8.4991; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Sejvar JJ, 2011, VECTOR-BORNE ZOONOT, V11, P161, DOI 10.1089/vbz.2009.0086; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; TANOWITZ HB, 1988, T ROY SOC TROP MED H, V82, P90, DOI 10.1016/0035-9203(88)90272-6; Teitelbaum BA, 2007, CLIN EXP OPTOM, V90, P463, DOI 10.1111/j.1444-0938.2007.00140.x; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; WEBB SR, 1976, J EXP MED, V143, P1239, DOI 10.1084/jem.143.5.1239	52	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44682	10.1371/journal.pone.0044682	http://dx.doi.org/10.1371/journal.pone.0044682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22953001	Green Submitted, Green Published, gold			2022-12-27	WOS:000308221300105
J	Gylander, T; Hamann, A; Brouard, JS; Thomas, BR				Gylander, Tim; Hamann, Andreas; Brouard, Jean S.; Thomas, Barb R.			The Potential of Aspen Clonal Forestry in Alberta: Breeding Regions and Estimates of Genetic Gain from Selection	PLOS ONE			English	Article							SEED-TRANSFER GUIDELINES; POPULUS-TREMULOIDES; TREMBLING ASPEN; PHENOTYPIC VARIATION; NATURAL-POPULATIONS; ZONES; WOOD; REFORESTATION; DIVERSITY; GENOTYPE	Background: Aspen naturally grows in large, single-species, even-aged stands that regenerate clonally after fire disturbance. This offers an opportunity for an intensive clonal forestry system that closely emulates the natural life history of the species. In this paper, we assess the potential of genetic tree improvement and clonal deployment to enhance the productivity of aspen forests in Alberta. We further investigate geographic patterns of genetic variation in aspen and infer forest management strategies under uncertain future climates. Methodology/Principal Findings: Genetic variation among 242 clones from Alberta was evaluated in 13 common garden trials after 5-8 growing seasons in the field. Broad-sense heritabilities for height and diameter at breast height (DBH) ranged from 0.36 to 0.64, allowing 5-15% genetic gains in height and 9-34% genetic gains in DBH. Geographic partitioning of genetic variance revealed predominant latitudinal genetic differentiation. We further observed that northward movement of clones almost always resulted in increased growth relative to local planting material, while southward movement had a strong opposite effect. Conclusion/Significance: Aspen forests are an important natural resource in western Canada that is used for pulp and oriented strandboard production, accounting for similar to 40% of the total forest harvest. Moderate to high broad-sense heritabilities in growth traits suggest good potential for a genetic tree improvement program with aspen. Significant productivity gains appear possible through clonal selection from existing trials. We propose two breeding regions for Alberta, and suggest that well-tested southern clones may be used in the northern breeding region, accounting for a general warming trend observed over the last several decades in Alberta.	[Gylander, Tim; Hamann, Andreas; Thomas, Barb R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Gylander, Tim] Weyerhaeuser Co Ltd, Edmonton, AB, Canada; [Brouard, Jean S.] Isabella Point Forestry Ltd, Salt Spring Isl, BC, Canada; [Thomas, Barb R.] Alberta Pacific Forest Ind Inc, Boyle, AB, Canada	University of Alberta	Gylander, T (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	andreas.hamann@ualberta.ca		Thomas, Barb R./0000-0002-9718-9297; Hamann, Andreas/0000-0003-2046-4550	NSERC/Industry Collaborative Development Grant [CRDPJ 349100-06]; Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Forest Research Institute; Alberta-Pacific Forest Industries Inc.; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	NSERC/Industry Collaborative Development Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Forest Research Institute; Alberta-Pacific Forest Industries Inc.; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	This study was supported by an NSERC/Industry Collaborative Development Grant CRDPJ 349100-06. Government funders included the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Alberta Forest Research Institute. Industry co-sponsors included Alberta-Pacific Forest Industries Inc., Ainsworth Engineered Canada LP, Daishowa-Marubeni International Ltd., Western Boreal Aspen Corporation, and Weyerhaeuser Company Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ASRD, 2009, ALB FOR GEN RES MAN; Balatinecz JJ, 2001, FOREST CHRON, V77, P265, DOI 10.5558/tfc77265-2; BARNES BV, 1975, FOREST SCI, V21, P319; CHELIAK WM, 1982, CAN J GENET CYTOL, V24, P611, DOI 10.1139/g82-065; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dickmann DI, 1983, CULTURE POPLARS N AM; FARMER ROBERT E., 1962, FOREST SCI, V8, P403; Gray LK, 2011, ECOL APPL, V21, P1591, DOI 10.1890/10-1054.1; HAEUSSLER S, 1986, 33 MIN FOR INF SERV; Hamann A, 2000, FOREST ECOL MANAG, V136, P107, DOI 10.1016/S0378-1127(99)00284-4; Hamann A, 2011, TREE GENET GENOMES, V7, P399, DOI 10.1007/s11295-010-0341-7; HYUN JO, 1987, CAN J FOREST RES, V17, P1134, DOI 10.1139/x87-173; JELINSKI DE, 1992, AM J BOT, V79, P728, DOI 10.2307/2444937; Li BL, 1995, FOREST CHRON, V71, P720, DOI 10.5558/tfc71720-6; Lindroth RL, 2007, J CHEM ECOL, V33, P1049, DOI 10.1007/s10886-007-9281-6; Lowwood J., 1997, ENG WOOD PRODUCTS A, P12345; MANGOLD RD, 1978, SILVAE GENET, V27, P66; Marshall I.B., 1999, NATL ECOLOGICAL FRAM; Matyas C, 1990, JOINT M W FOR GEN AS; Mbogga MS, 2009, AGR FOREST METEOROL, V149, P881, DOI 10.1016/j.agrformet.2008.11.009; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; MORLEY PM, 1993, FOREST CHRON, V69, P46, DOI 10.5558/tfc69046-1; Namkoong G., 1988, TREE BREEDING PRINCI; O'Neill GA, 2004, CAN J FOREST RES, V34, P695, DOI 10.1139/X03-227; PARKER WH, 1992, CAN J FOREST RES, V22, P267, DOI 10.1139/x92-035; Peterson E.B., 1992, ECOLOGY MANAGEMENT U, P1; R Core Team, 2018, R LANG ENV STAT COMP; Rytter L, 2003, SILVA FENN, V37, P313, DOI 10.14214/sf.491; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; St Clair SB, 2010, FOREST SCI, V56, P222; Thomas BR, 1997, SILVAE GENET, V46, P317; Thomas BR, 1997, SILVAE GENET, V46, P309; YANCHUK AD, 1988, WOOD SCI TECHNOL, V22, P67, DOI 10.1007/BF00353229; YANCHUK AD, 1984, SILVAE GENET, V33, P11; Yates F., 1953, SAMPLING METHODS CEN; Yeh FC, 1995, J HERED, V86, P454, DOI 10.1093/oxfordjournals.jhered.a111620; Ying CC, 2006, FOREST ECOL MANAG, V227, P1, DOI 10.1016/j.foreco.2006.02.028; Zsuffa L, 1975, P 14 M CAN TREE IM 2, P107	40	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44303	10.1371/journal.pone.0044303	http://dx.doi.org/10.1371/journal.pone.0044303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22957006	gold, Green Published, Green Submitted			2022-12-27	WOS:000308206500059
J	Halpin, CG; Skelhorn, J; Rowe, C				Halpin, Christina G.; Skelhorn, John; Rowe, Candy			The Relationship between Sympatric Defended Species Depends upon Predators' Discriminatory Behaviour	PLOS ONE			English	Article							MULLERIAN MIMICRY; MONARCH BUTTERFLIES; STRATEGIC DECISIONS; EDUCATED PREDATORS; MUELLERIAN MIMICRY; INITIAL EVOLUTION; PREY; BIRDS; WILD; NEOPHOBIA	Toxic prey species living in the same environment have long been thought to mutually benefit from having the same warning signal by sharing the education of naive predators. In contrast, 'saturation theory' predicts that predators are physiologically limited by the amount of toxin that they can eat in a given time period. Therefore, sympatric species that contain the same toxin should mutually benefit from reduced predation even when they are visually distinct, reducing the benefits to visual mimicry. For the first time, we found that mutualism can occur between unequally defended prey that are visually distinct, although the benefits to each prey type depends on the predators' abilities and/or motivation to visually discriminate between them. Furthermore, we found that this variability in predatory behaviour had a significant impact on the benefits of mimicry for unequally defended prey. Our results demonstrate that variability in the foraging decisions of predators can have a significant effect on the benefits of shared toxicity and visual mimicry between sympatric species, and highlights the need to consider how predators exert selection pressures on models and mimics over their entire lifetimes.	[Halpin, Christina G.; Rowe, Candy] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skelhorn, John] Univ Exeter, Ctr Res Anim Behav, Exeter, Devon, England	Newcastle University - UK; University of Exeter	Halpin, CG (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	christina.halpin@ncl.ac.uk	Rowe, Candy/B-7157-2008	Rowe, Candy/0000-0001-5379-843X	BBSRC; NERC [BB/G00188X/1]; Biotechnology and Biological Sciences Research Council [BB/G00188X/1] Funding Source: researchfish; BBSRC [BB/G00188X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was co-funded by BBSRC and NERC (BB/G00188X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; Alcock A, 1970, ANIM BEHAV, V18, P592; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Barnett CA, 2012, BEHAV ECOL, V23, P418, DOI 10.1093/beheco/arr206; FINK LS, 1981, NATURE, V291, P67, DOI 10.1038/291067a0; FINK LS, 1983, BIOTROPICA, V15, P151, DOI 10.2307/2387962; GITTLEMAN JL, 1980, NATURE, V286, P149, DOI 10.1038/286149a0; Halpin CG, 2008, ANIM BEHAV, V75, P771, DOI 10.1016/j.anbehav.2007.06.009; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Kaplan G, 2001, BIRDS THEIR HABITATS; Kokko H, 2003, ECOL LETT, V6, P1068, DOI 10.1046/j.1461-0248.2003.00532.x; Krebs JR, 1996, IBIS, V138, P34; KRONENBERGER JP, 1985, BEHAV PROCESS, V11, P53, DOI 10.1016/0376-6357(85)90102-0; Lindstrom L, 2006, ANIM BEHAV, V72, P323, DOI 10.1016/j.anbehav.2005.10.015; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Marples NM, 1999, EVOL ECOL, V13, P641, DOI 10.1023/A:1011077731153; Marshall GAK, 1908, T R ENTOMOL SOC LOND, V56, P93, DOI [10.1111/j.1365-2311.1908.tb02141.x, DOI 10.1111/J.1365-2311.1908.TB02141.X]; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; MITCHELL D, 1976, J COMP PHYSIOL PSYCH, V90, P190, DOI 10.1037/h0077196; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; Pinheiro CEG, 1996, BIOL J LINN SOC, V59, P351, DOI 10.1111/j.1095-8312.1996.tb01471.x; Pinheiro CEG, 2003, BIOTROPICA, V35, P356, DOI 10.1646/02128; Poulton EB, 1890, COLORS ANIMALS; RETTENMEYER CW, 1970, ANNU REV ENTOMOL, V15, P43, DOI 10.1146/annurev.en.15.010170.000355; Rowe C, 2004, P ROY SOC B-BIOL SCI, V271, P407, DOI 10.1098/rspb.2003.2615; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Rowland HM, 2010, ECOL LETT, V13, P1494, DOI 10.1111/j.1461-0248.2010.01539.x; Rowland HM, 2010, BEHAV ECOL, V21, P851, DOI 10.1093/beheco/arq071; ROZIN P, 1968, J COMP PHYSIOL PSYCH, V66, P82, DOI 10.1037/h0025974; Sherratt TN, 2008, NATURWISSENSCHAFTEN, V95, P681, DOI 10.1007/s00114-008-0403-y; Skelhorn J, 2007, CURR BIOL, V17, P1479, DOI 10.1016/j.cub.2007.07.064; Skelhorn J, 2006, ANIM BEHAV, V72, P827, DOI 10.1016/j.anbehav.2005.12.010; Skelhorn J, 2010, P ROY SOC B-BIOL SCI, V277, P1729, DOI 10.1098/rspb.2009.2092; Skelhorn J, 2009, ANIM BEHAV, V78, P761, DOI 10.1016/j.anbehav.2009.07.006; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Speed MP, 2000, P ROY SOC B-BIOL SCI, V267, P725, DOI 10.1098/rspb.2000.1063; Speed MP, 1999, EVOL ECOL, V13, P755, DOI 10.1023/A:1010871106763; Tullberg BS, 2000, ANIM BEHAV, V59, P281, DOI 10.1006/anbe.1999.1302; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; Turner JRG, 1999, EVOL ECOL, V13, P807, DOI 10.1023/A:1010856716448	41	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44895	10.1371/journal.pone.0044895	http://dx.doi.org/10.1371/journal.pone.0044895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970323	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400035
J	Liu, B; Xu, Y; Voss, C; Qiu, FH; Zhao, MZ; Liu, YD; Nie, J; Wang, ZL				Liu, Bin; Xu, Yun; Voss, Courtney; Qiu, Fang-hua; Zhao, Ming-zhe; Liu, Yong-dong; Nie, Jing; Wang, Zi-lian			Altered Protein Expression in Gestational Diabetes Mellitus Placentas Provides Insight into Insulin Resistance and Coagulation/Fibrinolysis Pathways	PLOS ONE			English	Article							ANNEXIN-II; FIBRINOLYTIC REGULATORS; VASCULAR DYSFUNCTION; GLYCATION; BINDING; PHOSPHORYLATION; DEGRADATION; GENERATION; EXPOSURE; SURFACE	Objective: To investigate the placental proteome differences between pregnant women complicated with gestational diabetes mellitus (GDM) and those with normal glucose tolerance (NGT). Methods: We used two-dimensional electrophoresis (2DE) to separate and compare placental protein levels from GDM and NGT groups. Differentially expressed proteins between the two groups were identified by MALDI-TOF/TOF mass spectrometry and further confirmed by Western blotting. The mRNA levels of related proteins were measured by realtime RT-PCR. Immunohistochemistry (IHC) was performed to examine the cellular location of the proteins expressed in placenta villi. Results: Twenty-one protein spots were differentially expressed between GDM and NGT placenta villi in the tested samples, fifteen of which were successfully identified by mass spectrometry. The molecular functions of these differentially expressed proteins include blood coagulation, signal transduction, anti-apoptosis, ATP binding, phospholipid binding, calcium ion binding, platelet activation, and tryptophan-tRNA ligase activity. Both protein and mRNA levels of Annexin A2, Annexin A5 and 14-3-3 protein f/d were up-regulated, while the expression of the Ras-related protein Rap1A was down-regulated in the GDM placenta group. Conclusion: Placenta villi derived from GDM pregnant women exhibit significant proteome differences compared to those of NGT mothers. The identified differentially expressed proteins are mainly associated with the development of insulin resistance, transplacental transportation of glucose, hyperglucose-mediated coagulation and fibrinolysis disorders in the GDM placenta villi.	[Liu, Bin; Wang, Zi-lian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Nie, Jing] So Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China; [Xu, Yun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Voss, Courtney] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Qiu, Fang-hua; Zhao, Ming-zhe] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Prote, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yong-dong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University; Western University (University of Western Ontario); Sun Yat Sen University; Sun Yat Sen University	Liu, B (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China.	niejing@fimmu.com; zilianwang@gmail.com			Science and Technology Planning Project of Guangdong Province, China [2009B03081099]; Scholarship Award for Excellent Doctoral Student; Ministry of Education of China	Science and Technology Planning Project of Guangdong Province, China; Scholarship Award for Excellent Doctoral Student; Ministry of Education of China(Ministry of Education, China)	This work was supported by Science and Technology Planning Project of Guangdong Province, China (No. 2009B03081099, to Prof. Zi-lian Wang) and Scholarship Award for Excellent Doctoral Student (to Dr. Bin Liu and Prof. Zi-lian Wang as supervisor) granted by Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Engelke H, 2011, J PHYS CHEM B, V115, P12963, DOI 10.1021/jp2048579; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; GRUNDMANN U, 1988, P NATL ACAD SCI USA, V85, P3708, DOI 10.1073/pnas.85.11.3708; Hiden U, 2009, CURR VASC PHARMACOL, V7, P460, DOI 10.2174/157016109789043973; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Ishii H, 2001, ANN NY ACAD SCI, V947, P308; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Leach L, 2011, MICROCIRCULATION, V18, P263, DOI 10.1111/j.1549-8719.2011.00091.x; Leach L, 2009, J ANAT, V215, P69, DOI 10.1111/j.1469-7580.2009.01098.x; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; LYONS TJ, 1993, AM J CARDIOL, V71, pB26, DOI 10.1016/0002-9149(93)90142-Y; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; Mine K, 2007, PLACENTA, V28, P676, DOI 10.1016/j.placenta.2006.10.005; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; PEDERSEN J, 1977, PREGNANT DIABETIC HE; Person Maria D, 2006, J Biomol Tech, V17, P145; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Ren S, 2002, J CLIN ENDOCR METAB, V87, P286, DOI 10.1210/jc.87.1.286; Sangle GV, 2010, ENDOCRINOLOGY, V151, P4455, DOI 10.1210/en.2010-0323; Takata K, 1997, MICROSC RES TECHNIQ, V38, P145; TAMES FJ, 1992, ATHEROSCLEROSIS, V93, P237, DOI 10.1016/0021-9150(92)90260-N; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; Wilson JD., HARRISONS PRINCIPLES, V1994, P472; Xiang XQ, 2002, MOL ENDOCRINOL, V16, P552, DOI 10.1210/me.16.3.552; Zhang JY, 1998, ARTERIOSCL THROM VAS, V18, P1140, DOI 10.1161/01.ATV.18.7.1140; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w	43	36	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44701	10.1371/journal.pone.0044701	http://dx.doi.org/10.1371/journal.pone.0044701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970290	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000047
J	Yew, KH; Carpenter, C; Duncan, RS; Harrison, CJ				Yew, Kok-Hooi; Carpenter, Cory; Duncan, R. Scott; Harrison, Christopher J.			Human Cytomegalovirus Induces TLR4 Signaling Components in Monocytes Altering TIRAP, TRAM and Downstream Interferon-Beta and TNF-Alpha Expression	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GENE-EXPRESSION; CD14; LIPOPOLYSACCHARIDE; CELLS; LPS; ACTIVATION; MD-2; INFECTION; PATHWAY	Using TLR pathways, primary human cytomegalovirus (HCMV) induces innate responses including the production of inflammatory cytokines. Mounting evidence suggests that LPS recognition by TLR4/MD2/CD14 results in differential utilization of TIRAP-TRAF6 and TRAM-TRIF signaling, thereby leading to transcriptional activation of various cytokine genes. However, relative roles of the TLR4/MD2/CD14 complex and its adaptor proteins TIRAP and TRAM involved in regulating monocyte responses to HCMV are incomplete. Here, we provided evidence supporting the notion that the TLR4/MD2/CD14 complex contributes notably to HCMV-induced signaling and subsequent cytokine production in monocytes. In particular, induction of both IL-6 and IL-8 is associated with elevated TIRAP and reduced TRAM mRNA expression. The latter may serve in a compensatory pathway that yields a robust IFN response when TIRAP signaling is blocked in monocytes incubated with Toledo strain HCMV. Inhibitory studies using antisense oligonucleotides or neutralizing antibodies indicate that IL-6 induction by TLR4/MD2 complex is important for the activation of endogenous CD14 which later acts in concert or synergy with TLR4/MD2 as a factor resulting in IL-8 gene expression. We further show that exogenous recombinant CD14 can potentiate innate immune response via TLR4-dependent and possibly via TLR9-dependent pathways to promote enhanced expression/production of IL-8 and IFN-beta, respectively.	[Yew, Kok-Hooi; Carpenter, Cory; Duncan, R. Scott; Harrison, Christopher J.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Yew, Kok-Hooi; Harrison, Christopher J.] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA; [Carpenter, Cory] Kansas City Univ Med & Biosci, Kansas City, MO USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences	Yew, KH (corresponding author), Childrens Mercy Hosp, Kansas City, MO 64108 USA.	hyew@kumc.edu	Harrison, Christopher/Q-6670-2019; Duncan, Raymond/AAD-1969-2019		Katharine B. Richardson Foundation [01.4247]	Katharine B. Richardson Foundation	This work was supported by a grant from the Katharine B. Richardson Foundation (Grant No. 01.4247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Fearns C, 1997, INFECT IMMUN, V65, P4822, DOI 10.1128/IAI.65.11.4822-4831.1997; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Humar A, 1999, J INFECT DIS, V179, P484, DOI 10.1086/314602; Iwamoto GK, 1997, J INVEST MED, V45, P175; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Landmann R, 1998, INFECT IMMUN, V66, P2264, DOI 10.1128/IAI.66.5.2264-2271.1998; Murayama T, 1998, J LEUKOCYTE BIOL, V64, P62, DOI 10.1002/jlb.64.1.62; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sacre SM, 2007, J IMMUNOL, V178, P2148, DOI 10.4049/jimmunol.178.4.2148; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Watts C, 2008, NAT IMMUNOL, V9, P343, DOI 10.1038/ni0408-343; Xie XH, 2009, PEDIATR RES, V65, P156, DOI 10.1203/PDR.0b013e318191f5c6; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yew KH, 2010, MOL IMMUNOL, V47, P883, DOI 10.1016/j.molimm.2009.10.009	25	36	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44500	10.1371/journal.pone.0044500	http://dx.doi.org/10.1371/journal.pone.0044500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970235	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000026
J	Cebulla, CM; Zelinka, CP; Scott, MA; Lubow, M; Bingham, A; Rasiah, S; Mahmoud, AM; Fischer, AJ				Cebulla, Colleen M.; Zelinka, Chris P.; Scott, Melissa A.; Lubow, Martin; Bingham, Amanda; Rasiah, Stephen; Mahmoud, Ashraf M.; Fischer, Andy J.			A Chick Model of Retinal Detachment: Cone Rich and Novel	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBRILLARY ACIDIC PROTEIN; CELL NUCLEAR ANTIGEN; PROLIFERATIVE VITREORETINOPATHY; VISUAL RECOVERY; MULLER GLIA; GROUND-SQUIRREL; PHOTORECEPTOR DEGENERATION; MICE DEFICIENT; POTENTIAL ROLE	Background: Development of retinal detachment models in small animals can be difficult and expensive. Here we create and characterize a novel, cone-rich retinal detachment (RD) model in the chick. Methodology/Principal Findings: Retinal detachments were created in chicks between postnatal days 7 and 21 by subretinal injections of either saline (SA) or hyaluronic acid (HA). Injections were performed through a dilated pupil with observation via surgical microscope, using the fellow eye as a control. Immunohistochemical analyses were performed at days 1, 3, 7, 10 and 14 after retinal detachment to evaluate the cellular responses of photoreceptors, Muller glia, microglia and nonastrocytic inner retinal glia (NIRG). Cell proliferation was detected with bromodeoxyuridine (BrdU)-incorporation and by the expression of proliferating cell nuclear antigen (PCNA). Cell death was detected with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). As in mammalian models of RD, there is shortening of photoreceptor outer segments and mis-trafficking of photoreceptor opsins in areas of RD. Photoreceptor cell death was maximal 1 day after RD, but continued until 14 days after RD. Muller glia up-regulated glial fibriliary acidic protein (GFAP), proliferated, showed interkinetic nuclear migration, and migrated to the subretinal space in areas of detachment. Microglia became reactive; they up-regulated CD45, acquired amoeboid morphology, and migrated toward outer retina in areas of RD. Reactive NIRG cells accumulated in detached areas. Conclusions/Significance: Subretinal injections of SA or HA in the chick eye successfully produced retinal detachments and cellular responses similar to those seen in standard mammalian models. Given the relatively large eye size, and considering the low cost, the chick model of RD offers advantages for high-throughput studies.	[Cebulla, Colleen M.; Lubow, Martin; Bingham, Amanda; Rasiah, Stephen; Mahmoud, Ashraf M.] Ohio State Univ, Dept Ophthalmol & Visual Sci, Havener Eye Inst, Columbus, OH 43210 USA; [Zelinka, Chris P.; Scott, Melissa A.; Fischer, Andy J.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cebulla, CM (corresponding author), Ohio State Univ, Dept Ophthalmol & Visual Sci, Havener Eye Inst, Columbus, OH 43210 USA.	Colleen.Cebulla@osumc.edu	Fischer, Andy J./AAE-9817-2022; Cebulla, Colleen/E-2861-2011; Fischer, Andy J./AFF-1827-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405; Cebulla, Colleen/0000-0002-5636-4968	National Center for Research Resources [KL2RR025754]; Ohio State University Department of Ophthalmology; NICHD; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025754] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ohio State University Department of Ophthalmology; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by award number KL2RR025754 from the National Center for Research Resources and by The Ohio State University Department of Ophthalmology start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The antibody to rhodopsin (Rho 4D2) was a generous gift Dr. R. Molday, University British Columbia. The antibody to BrdU (G3G4) was developed by S.J. Kaufman and the antibody to transitin (clone EAP3) was developed by G.J. Cole; both antibodies were obtained by the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We thank Bongsu Kim for helpful technical assistance.	Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; ANDERSON DH, 1983, INVEST OPHTH VIS SCI, V24, P906; ANDERSON DH, 1986, INVEST OPHTH VIS SCI, V27, P168; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; BOWMAKER JK, 1977, VISION RES, V17, P17, DOI 10.1016/0042-6989(77)90195-X; Bruhn SL, 1996, J NEUROSCI, V16, P1430; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Cebulla CM, 2010, EXP EYE RES, V90, P521, DOI 10.1016/j.exer.2010.01.008; CHANG CJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P880, DOI 10.1001/archopht.1995.01100070054025; COOK B, 1995, INVEST OPHTH VIS SCI, V36, P990; Cuadros MA, 2006, J HISTOCHEM CYTOCHEM, V54, P727, DOI 10.1369/jhc.5A6832.2006; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Davidorf F H, 1975, Ophthalmic Surg, V6, P74; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Fischer AJ, 2011, NEUROSCIENCE, V178, P250, DOI 10.1016/j.neuroscience.2011.01.022; Fischer AJ, 2006, J COMP NEUROL, V496, P479, DOI 10.1002/cne.20937; Fischer AJ, 2004, MOL VIS, V10, P973; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Fischer AJ, 2010, GLIA, V58, P633, DOI 10.1002/glia.20950; FISHER SK, 1991, INVEST OPHTH VIS SCI, V32, P1739; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; GELLER SF, 1995, INVEST OPHTH VIS SCI, V36, P737; Ghai K, 2008, BRAIN RES, V1192, P76, DOI 10.1016/j.brainres.2007.01.105; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Gharbiya M, 2012, RETINA-J RET VIT DIS, V32, P43, DOI 10.1097/IAE.0b013e3182180114; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; Headington K, 2011, CURR EYE RES, V36, P947, DOI 10.3109/02713683.2011.587934; Hisatomi T, 2003, AM J PATHOL, V162, P1869, DOI 10.1016/S0002-9440(10)64321-0; HUI YN, 1989, AM J OPHTHALMOL, V108, P176, DOI 10.1016/0002-9394(89)90014-7; Iribarne M, 2008, AM J PATHOL, V172, P1030, DOI 10.2353/ajpath.2008.070605; Jacobs Gerald H., 2002, Documenta Ophthalmologica, V104, P119, DOI 10.1023/A:1014431701523; JACOBS GH, 1985, J COMP PHYSIOL A, V156, P503, DOI 10.1007/BF00613974; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; KROLL AJ, 1968, AM J OPHTHALMOL, V66, P410, DOI 10.1016/0002-9394(68)91524-9; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lewis GP, 2010, MOL VIS, V16, P1361; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; Lewis GP, 2005, MOL VIS, V11, P491; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; LEWIS GP, 1991, EXP EYE RES, V53, P629, DOI 10.1016/0014-4835(91)90223-2; Lewis GP, 2002, EYE, V16, P375, DOI 10.1038/sj.eye.6700202; Linberg KA, 2002, VISUAL NEUROSCI, V19, P603, DOI 10.1017/S095252380219506X; Luna G, 2009, INVEST OPHTH VIS SCI, V50, P3977, DOI 10.1167/iovs.08-2910; Mandava N, 2002, INVEST OPHTH VIS SCI, V43, P3338; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; MORRIS VB, 1970, J COMP NEUROL, V140, P359, DOI 10.1002/cne.901400308; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P1066, DOI 10.1001/archopht.1995.01100080118039; Ochrietor JD, 2010, MOL VIS, V16, P961; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; Rex TS, 2002, MOL VIS, V8, P114; Rex TS, 2002, INVEST OPHTH VIS SCI, V43, P1234; Ross WH, 2002, EYE, V16, P440, DOI 10.1038/sj.eye.6700192; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Sakai T, 2003, INVEST OPHTH VIS SCI, V44, P416, DOI 10.1167/iovs.02-0633; Salicone A, 2006, OPHTHALMOLOGY, V113, P1734, DOI 10.1016/j.ophtha.2006.03.064; Schiff WM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1161, DOI 10.1001/archopht.125.9.1161; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Thanos S, 2001, BRAIN RES REV, V35, P205, DOI 10.1016/S0165-0173(01)00049-2; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wenningmann I, 2001, MOL PHARMACOL, V60, P790	72	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44257	10.1371/journal.pone.0044257	http://dx.doi.org/10.1371/journal.pone.0044257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970190	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400051
J	Chao, MW; Chen, CH; Chang, YL; Teng, CM; Pan, SL				Chao, Min-Wu; Chen, Chun-Han; Chang, Ya-Ling; Teng, Che-Ming; Pan, Shiow-Lin			alpha-Tomatine-Mediated Anti-Cancer Activity In Vitro and In Vivo through Cell Cycle- and Caspase-Independent Pathways	PLOS ONE			English	Article							CANCER-CELLS; BCL-2 FAMILY; APOPTOSIS PROTEIN; UP-REGULATION; SURVIVIN; DEATH; LEUKEMIA; GLYCOALKALOIDS; INHIBITION; ADJUVANT	alpha-Tomatine, a tomato glycoalkaloid, has been reported to possess antibiotic properties against human pathogens. However, the mechanism of its action against leukemia remains unclear. In this study, the therapeutic potential of alpha-tomatine against leukemic cells was evaluated in vitro and in vivo. Cell viability experiments showed that alpha-tomatine had significant cytotoxic effects on the human leukemia cancer cell lines HL60 and K562, and the cells were found to be in the Annexin V-positive/propidium iodide-negative phase of cell death. In addition, alpha-tomatine induced both HL60 and K562 cell apoptosis in a cell cycle-and caspase-independent manner. alpha-Tomatine exposure led to a loss of the mitochrondrial membrane potential, and this finding was consistent with that observed on activation of the Bak and Mcl-1 short form (Mcl-1s) proteins. Exposure to alpha-tomatine also triggered the release of the apoptosis-inducing factor (AIF) from the mitochondria into the nucleus and down-regulated survivin expression. Furthermore, alpha-tomatine significantly inhibited HL60 xenograft tumor growth without causing loss of body weight in severe combined immunodeficiency (SCID) mice. Immunohistochemical test showed that the reduced tumor growth in the alpha-tomatine-treated mice was a result of increased apoptosis, which was associated with increased translocation of AIF in the nucleus and decreased survivin expression ex vivo. These results suggest that alpha-tomatine may be a candidate for leukemia treatment.	[Chao, Min-Wu; Chen, Chun-Han; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Pan, Shiow-Lin] Natl Hlth Res Inst, Dept Biotechnol & Pharmaceut Res, Miaoli, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan	Chao, MW (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	cmteng@ntu.edu.tw; apan0826@nhri.org.tw	Pan, Shiow-Lin/C-1372-2010	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan [NSC 99-2320-B400-008-MY3, NSC 99-2628-B002-024-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grants from the National Science Council of Taiwan (NSC 99-2320-B400-008-MY3) and (NSC 99-2628-B002-024-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Carter BZ, 2007, ONCOL REV, V1, P195, DOI 10.1007/s12156-008-0024-x; Carter BZ, 2003, BLOOD, V102, P4179, DOI 10.1182/blood-2003-03-0960; Chandele A, 2004, NEOPLASIA, V6, P29, DOI 10.1016/S1476-5586(04)80051-4; Croci DO, 2008, J CELL BIOCHEM, V105, P381, DOI 10.1002/jcb.21836; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Elangovan S, 2008, INT J ONCOL, V33, P833, DOI 10.3892/ijo_00000071; FONTAINE TD, 1948, ARCH BIOCHEM, V18, P467; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Holstein SA, 2001, MOL CANCER THER, V1, P141; Huang DM, 2004, EUR J PHARMACOL, V503, P17, DOI 10.1016/j.ejphar.2004.09.040; Iwasaki R, 2009, CANCER SCI, V100, P349, DOI 10.1111/j.1349-7006.2008.01046.x; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Sandrock RW, 1998, PHYTOPATHOLOGY, V88, P137, DOI 10.1094/PHYTO.1998.88.2.137; Shih YW, 2009, FOOD CHEM TOXICOL; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wrzesien-Kus A, 2004, APOPTOSIS, V9, P705, DOI 10.1023/B:APPT.0000045788.61012.b2; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yang YW, 2004, VACCINE, V22, P2316, DOI 10.1016/j.vaccine.2003.10.036; Yang YW, 2002, BIOMATERIALS, V23, P4677, DOI 10.1016/S0142-9612(02)00218-1	31	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44093	10.1371/journal.pone.0044093	http://dx.doi.org/10.1371/journal.pone.0044093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970166	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400035
J	Godwin, S; Bent, E; Borneman, J; Pereg, L				Godwin, Scott; Bent, Elizabeth; Borneman, James; Pereg, Lily			The Role of Coral-Associated Bacterial Communities in Australian Subtropical White Syndrome of Turbinaria mesenterina	PLOS ONE			English	Article							BLACK-BAND-DISEASE; JUVENILE-OYSTER-DISEASE; PLAGUE-LIKE DISEASE; SP-NOV.; ROSEOVARIUS-CRASSOSTREAE; ROSEOBACTER CLADE; CAUSATIVE AGENT; VIBRIO-SHILOI; ELKHORN CORAL; TISSUE	Australian Subtropical White Syndrome (ASWS) is an infectious, temperature dependent disease of the subtropical coral Turbinaria mesenterina involving a hitherto unknown transmissible causative agent. This report describes significant changes in the coral associated bacterial community as the disease progresses from the apparently healthy tissue of ASWS affected coral colonies, to areas of the colony affected by ASWS lesions, to the dead coral skeleton exposed by ASWS. In an effort to better understand the potential roles of bacteria in the formation of disease lesions, the effect of antibacterials on the rate of lesion progression was tested, and both culture based and culture independent techniques were used to investigate the bacterial communities associated with colonies of T. mesenterina. Culture-independent analysis was performed using the Oligonucleotide Fingerprinting of Ribosomal Genes (OFRG) technique, which allowed a library of 8094 cloned bacterial 16S ribosomal genes to be analysed. Interestingly, the bacterial communities associated with both healthy and disease affected corals were very diverse and ASWS associated communities were not characterized by a single dominant organism. Treatment with antibacterials had a significant effect on the rate of progress of disease lesions (p = 0.006), suggesting that bacteria may play direct roles as the causative agents of ASWS. A number of potential aetiological agents of ASWS were identified in both the culture-based and culture-independent studies. In the culture-independent study an Alphaproteobacterium closely related to Roseovarius crassostreae, the apparent aetiological agent of juvenile oyster disease, was found to be significantly associated with disease lesions. In the culture-based study Vibrio harveyi was consistently associated with ASWS affected coral colonies and was not isolated from any healthy colonies. The differing results of the culture based and culture-independent studies highlight the importance of using both approaches in the investigation of microbial communities.	[Godwin, Scott; Pereg, Lily] Univ New England, Sch Sci & Technol, Res Ctr Mol Biol, Armidale, NSW, Australia; [Bent, Elizabeth; Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Bent, Elizabeth] Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of New England; University of California System; University of California Riverside; University of Guelph	Godwin, S (corresponding author), Univ New England, Sch Sci & Technol, Res Ctr Mol Biol, Armidale, NSW, Australia.	lperegge@une.edu.au			University of New England, Armidale, NSW, Australia	University of New England, Armidale, NSW, Australia	This work was funded by a University Research Grant provided by the University of New England, Armidale, NSW, Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Bent E, 2006, J MICROBIOL METH, V67, P171, DOI 10.1016/j.mimet.2006.03.023; Boettcher KJ, 2000, APPL ENVIRON MICROB, V66, P3924, DOI 10.1128/AEM.66.9.3924-3930.2000; Boettcher KJ, 2005, INT J SYST EVOL MICR, V55, P1531, DOI 10.1099/ijs.0.63620-0; Borneman J, 2001, Bioinformatics, V17 Suppl 1, pS39; Bourne D, 2007, AQUACULTURE, V268, P274, DOI 10.1016/j.aquaculture.2007.04.067; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cardenas A, 2011, ISME J; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi DH, 2006, INT J SYST EVOL MICR, V56, P1869, DOI 10.1099/ijs.0.64235-0; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dalton SJ, 2006, CORAL REEFS, V25, P529, DOI 10.1007/s00338-006-0139-0; Dalton SJ, 2010, MARINE FRESHWATER RE, V61, P1; Dalton SJ, 2010, PUBLIC HEALTH 21ST C, P187; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Figueroa A, 2004, J COMPUT BIOL, V11, P887, DOI 10.1089/cmb.2004.11.887; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; HARRIOTT VJ, 1995, MAR FRESHWATER RES, V46, P457, DOI 10.1071/MF9950457; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Israely T, 2001, AQUAT MICROB ECOL, V24, P1, DOI 10.3354/ame024001; Kapley A, 2007, WORLD J MICROB BIOT, V23, P923, DOI 10.1007/s11274-006-9315-1; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koren O, 2007, MICROB ECOL, V55, P523; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; Maloy AP, 2007, AQUACULTURE, V269, P71, DOI 10.1016/j.aquaculture.2007.04.008; McCune B., 2002, ANAL ECOLOGICAL COMM; McCune B., 2006, PC ORD MULTIVARIATE; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Payne MS, 2008, J APPL MICROBIOL, V105, P340, DOI 10.1111/j.1365-2672.2008.03749.x; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2003, FEMS MICROBIOL ECOL, V43, P287, DOI 10.1016/S0168-6496(03)00025-4; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; SAR N, 1987, MICROB ECOL, V13, P193, DOI 10.1007/BF02024997; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Swofford D.L, 2002, PAUP PYLOGENETIC ANA; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Valinsky L, 2002, APPL ENVIRON MICROB, V68, P3243, DOI 10.1128/AEM.68.7.3243-3250.2002; Valinsky L, 2004, MOL MICROBIAL ECOLOG, P569; van Oppen MJH, 2009, SYMBIOSIS, V47, P1; Vattakaven T, 2006, APPL ENVIRON MICROB, V72, P6508, DOI 10.1128/AEM.00798-06; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Willis BL, 2004, CORAL HLTH DIS	66	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44243	10.1371/journal.pone.0044243	http://dx.doi.org/10.1371/journal.pone.0044243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970188	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400050
J	Hermann, M; Maeder, ML; Rector, K; Ruiz, J; Becher, B; Burki, K; Khayter, C; Aguzzi, A; Joung, JK; Buch, T; Pelczar, P				Hermann, Mario; Maeder, Morgan L.; Rector, Kyle; Ruiz, Joseph; Becher, Burkhard; Buerki, Kurt; Khayter, Cyd; Aguzzi, Adriano; Joung, J. Keith; Buch, Thorsten; Pelczar, Pawel			Evaluation of OPEN Zinc Finger Nucleases for Direct Gene Targeting of the ROSA26 Locus in Mouse Embryos	PLOS ONE			English	Article							POOL ENGINEERING OPEN; KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; RAPID GENERATION; GENOME; MICE; ZEBRAFISH; MUTAGENESIS; CLEAVAGE; CELLS	Zinc finger nucleases (ZFNs) enable precise genome modification in a variety of organisms and cell types. Commercial ZFNs were reported to enhance gene targeting directly in mouse zygotes, whereas similar approaches using publicly available resources have not yet been described. Here we report precise targeted mutagenesis of the mouse genome using Oligomerized Pool Engineering (OPEN) ZFNs. OPEN ZFN can be constructed using publicly available resources and therefore provide an attractive alternative for academic researchers. Two ZFN pairs specific to the mouse genomic locus gt(ROSA26)Sor were generated by OPEN selections and used for gene disruption and homology-mediated gene replacement in single cell mouse embryos. One specific ZFN pair facilitated non-homologous end joining (NHEJ)-mediated gene disruption when expressed in mouse zygotes. We also observed a single homologous recombination (HR)-driven gene replacement event when this ZFN pair was co-injected with a targeting vector. Our experiments demonstrate the feasibility of achieving both gene ablation through NHEJ and gene replacement by HR by using the OPEN ZFN technology directly in mouse zygotes.	[Hermann, Mario; Buerki, Kurt; Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Maeder, Morgan L.; Khayter, Cyd; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA USA; [Rector, Kyle] Transposagen Biopharmaceut Inc, Lexington, KY USA; [Becher, Burkhard; Buch, Thorsten] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Hermann, Mario; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Maeder, Morgan L.; Khayter, Cyd; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA	University of Zurich; Harvard University; Massachusetts General Hospital; University of Zurich; University of Zurich; University Zurich Hospital; Harvard University; Harvard Medical School; Technical University of Munich; Harvard University; Massachusetts General Hospital	Hermann, M (corresponding author), Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.	thorsten.buch@mikrobio.med.tum.de; pawel.pelczar@ltk.uzh.ch	Buch, Thorsten/P-1659-2019; Becher, Burkhard/ABE-4225-2020	Buch, Thorsten/0000-0002-2236-9074; Becher, Burkhard/0000-0002-1541-7867; Aguzzi, Adriano/0000-0002-0344-6708	National Institutes of Health [R01 GM088040]; Swiss National Science Foundation (SNSF), Sinergia grant [CRSI33_125073]; NCCR Neuro; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF), Sinergia grant; NCCR Neuro; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov) grant R01 GM088040 (MLM, CK, and JKJ), Swiss National Science Foundation (SNSF) (http://www.snf.ch), Sinergia grant CRSI33_125073 (AA, TB, and PP) and NCCR Neuro to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2002, GENETICS, V161, P1169; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Cade L, 2012, NUCL ACIDS RES; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Haueter S, 2010, GENESIS, V48, P151, DOI 10.1002/dvg.20598; Johansson T, 2010, GENESIS, V48, P264, DOI 10.1002/dvg.20612; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mani M, 2005, BIOCHEM BIOPH RES CO, V334, P1191, DOI 10.1016/j.bbrc.2005.07.021; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Perez-Pinera P, 2012, NUCLEIC ACIDS RES, V40, P3741, DOI 10.1093/nar/gkr1214; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	45	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e41796	10.1371/journal.pone.0041796	http://dx.doi.org/10.1371/journal.pone.0041796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970113	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000308458400002
J	Murrell, EG; Juliano, SA				Murrell, Ebony G.; Juliano, Steven A.			Competitive Abilities in Experimental Microcosms Are Accurately Predicted by a Demographic Index for R*	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; FEEDING-BEHAVIOR; LIFE-HISTORY; RESOURCE COMPETITION; SPECIES INTERACTIONS; DETRITUS TYPE; BODY-SIZE; FOOD; MOSQUITOS; AEGYPTI	Resource competition theory predicts that R*, the equilibrium resource amount yielding zero growth of a consumer population, should predict species' competitive abilities for that resource. This concept has been supported for unicellular organisms, but has not been well-tested for metazoans, probably due to the difficulty of raising experimental populations to equilibrium and measuring population growth rates for species with long or complex life cycles. We developed an index (R-index) of R* based on demography of one insect cohort, growing from egg to adult in a non-equilibrium setting, and tested whether R-index yielded accurate predictions of competitive abilities using mosquitoes as a model system. We estimated finite rate of increase (lambda') from demographic data for cohorts of three mosquito species raised with different detritus amounts, and estimated each species' R-index using nonlinear regressions of lambda' vs. initial detritus amount. All three species' R-index differed significantly, and accurately predicted competitive hierarchy of the species determined in simultaneous pairwise competition experiments. Our R-index could provide estimates and rigorous statistical comparisons of competitive ability for organisms for which typical chemostat methods and equilibrium population conditions are impractical.	[Murrell, Ebony G.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	University of Wisconsin System; University of Wisconsin Madison; Illinois State University	Murrell, EG (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	egmurre@ilstu.edu		Juliano, Steven/0000-0002-6178-4553	National Institute of Allergy and Infectious Diseases (NIAID) [R15 AI075306-01, R01-AI44793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044793, R15AI075306] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institute of Allergy and Infectious Diseases (NIAID) grants R15 AI075306-01 and R01-AI44793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chmielewski MW, 2010, ANN ENTOMOL SOC AM, V103, P734, DOI 10.1603/AN09162; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Damgaard C, 2010, J ECOL, V98, P1, DOI 10.1111/j.1365-2745.2009.01587.x; de Villemereuil PB, 2011, ECOL MODEL, V222, P419, DOI 10.1016/j.ecolmodel.2010.10.011; FISH D, 1982, ECOLOGY, V63, P283, DOI 10.2307/1938943; Frankino WA, 1999, OECOLOGIA, V120, P59, DOI 10.1007/s004420050833; Gibson DJ, 1999, J ECOL, V87, P1, DOI 10.1046/j.1365-2745.1999.00321.x; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Grover J. P., 1997, RESOURCE COMPETITION; Halaj J, 2002, ECOLOGY, V83, P3141, DOI 10.2307/3071849; Huntsman BM, 2011, FRESHWATER BIOL, V56, P1746, DOI 10.1111/j.1365-2427.2011.02609.x; Inouye BD, 2001, ECOLOGY, V82, P2696, DOI 10.2307/2679954; Ives AR, 1996, ECOLOGY, V77, P681, DOI 10.2307/2265491; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kammenga JE, 2003, OIKOS, V100, P89, DOI 10.1034/j.1600-0706.2003.12160.x; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Kaufman MG, 1999, APPL ENVIRON MICROB, V65, P2661; Kirk KL, 2002, FRESHWATER BIOL, V47, P1089, DOI 10.1046/j.1365-2427.2002.00841.x; Leisnham PT, 2009, ECOLOGY, V90, P2405, DOI 10.1890/08-1569.1; Leisnham PT, 2010, OECOLOGIA, V164, P221, DOI 10.1007/s00442-010-1624-2; LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; MacArthur R.H., 1972, pvii; McPeek MA, 1998, ECOLOGY, V79, P867, DOI 10.2307/176586; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; ROTHHAUPT KO, 1988, NATURE, V333, P660, DOI 10.1038/333660a0; Sibly RM, 2000, OIKOS, V88, P335, DOI 10.1034/j.1600-0706.2000.880212.x; SOMMER U, 1986, MAR BIOL, V91, P345, DOI 10.1007/BF00428628; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; VANDONK E, 1990, J PHYCOL, V26, P40; Vinogradova E., 2006, INT J DIPTEROL RES, V17, P3; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x; Yee DA, 2004, J VECTOR ECOL, V29, P315; Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2; Yee DA, 2011, OECOLOGIA IN PRESS; Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x; Yee DA, 2007, J MED ENTOMOL, V44, P580, DOI 10.1603/0022-2585(2007)44[580:DAIEOA]2.0.CO;2	49	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43458	10.1371/journal.pone.0043458	http://dx.doi.org/10.1371/journal.pone.0043458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970128	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400012
J	Riepl, RL; Fischer, R; Hautmann, H; Hartmann, G; Muller, TD; Tschop, M; Toepfer, M; Otto, B				Riepl, Rudolf L.; Fischer, Rainald; Hautmann, Hubert; Hartmann, Gunther; Mueller, Timo D.; Tschoep, Matthias; Toepfer, Marcell; Otto, Baerbel			Influence of Acute Exposure to High Altitude on Basal and Postprandial Plasma Levels of Gastroenteropancreatic Peptides	PLOS ONE			English	Article							EXOCRINE PANCREATIC-SECRETION; INTRADUODENAL BILE; PHYSICAL-EXERCISE; CHRONIC HYPOXIA; POLYPEPTIDE; GHRELIN; SOMATOSTATIN; LEPTIN; TAURODEOXYCHOLATE; CHOLECYSTOKININ	Acute mountain sickness (AMS) is characterized by headache often accompanied by gastrointestinal complaints that vary from anorexia through nausea to vomiting. The aim of this study was to investigate the influence of high altitude on plasma levels of gastroenteropancreatic (GEP) peptides and their association to AMS symptoms. Plasma levels of 6 GEP peptides were measured by radioimmunoassay in 11 subjects at 490 m (Munich, Germany) and, after rapid passive ascent to 3454 m (Jungfraujoch, Switzerland), over the course of three days. In a second study (n = 5), the same peptides and ghrelin were measured in subjects who consumed standardized liquid meals at these two elevations. AMS symptoms and oxygen saturation were monitored. In the first study, both fasting (morning 8 a. m.) and stimulated (evening 8 p. m.) plasma levels of pancreatic polypeptide (PP) and cholecystokinin (CCK) were significantly lower at high altitude as compared to baseline, whereas gastrin and motilin concentrations were significantly increased. Fasting plasma neurotensin was significantly enhanced whereas stimulated levels were reduced. Both fasting and stimulated plasma motilin levels correlated with gastrointestinal symptom severity (r = 0.294, p = 0.05, and r = 0.41, p = 0.006, respectively). Mean O2-saturation dropped from 96% to 88% at high altitude. In the second study, meal-stimulated integrated (= area under curve) plasma CCK, PP, and neurotensin values were significantly suppressed at high altitude, whereas integrated levels of gastrin were increased and integrated VIP and ghrelin levels were unchanged. In summary, our data show that acute exposure to a hypobaric hypoxic environment causes significant changes in fasting and stimulated plasma levels of GEP peptides over consecutive days and after a standardized meal. The changes of peptide levels were not uniform. Based on the inhibition of PP and neurotensin release a reduction of the cholinergic tone can be postulated.	[Riepl, Rudolf L.] Kreiskrankenhaus Erding, Dept Med, Erding, Germany; [Fischer, Rainald; Otto, Baerbel] Klin Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Hautmann, Hubert] Tech Univ Munich, Dept Med, Munich, Germany; [Hartmann, Gunther] Univ Hosp Bonn, Bonn, Germany; [Mueller, Timo D.; Tschoep, Matthias] Tech Univ Munich, Dept Med, Helmholtz Ctr Munich, Inst Diabet & Obes, Munich, Germany	University of Munich; Technical University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Riepl, RL (corresponding author), Kreiskrankenhaus Erding, Dept Med, Erding, Germany.	rudolf.riepl@kkh-erding.de	Hartmann, Gunther/P-7492-2017; Tschoep, Matthias H/I-5443-2014; Müller, Timo D./AAZ-4445-2020	Hartmann, Gunther/0000-0003-1021-2018; Muller, Timo/0000-0002-0624-9339; Tschoep, Matthias/0000-0002-4744-371X				Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; Bailey DM, 2001, J APPL PHYSIOL, V90, P105, DOI 10.1152/jappl.2001.90.1.105; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Benso A, 2007, EUR J ENDOCRINOL, V157, P733, DOI 10.1530/EJE-07-0355; Chaiban JT, 2008, METABOLISM, V57, P1019, DOI 10.1016/j.metabol.2007.02.011; Daniel EE, 1991, NEUROPEPTIDE FUNCTIO; Dockray GJ, 1994, GUT PEPTIDES BIOCH P, P175; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; JO N, 1987, HORM METAB RES, V19, P182, DOI 10.1055/s-2007-1011772; Jo N, 1990, Rev Gastroenterol Peru, V10, P9; JO N, 1992, REV ESP ENFERM DIG, V81, P99; KNUDTZON J, 1989, AVIAT SPACE ENVIR MD, V60, P1072; Li X, 1990, Zhonghua Nei Ke Za Zhi, V29, P8; Liddle RA., 1994, GUT PEPTIDES BIOCH P; Lippl FJ, 2010, OBESITY, V18, P675, DOI 10.1038/oby.2009.509; Mannon P, 1994, GUT PEPTIDES BIOCH P, P341; MATERIA A, 1982, ANN SURG, V196, P48, DOI 10.1097/00000658-198207000-00011; Mouats A, 1990, Reprod Nutr Dev, VSuppl 2, p219s; Poitras P, 1994, GUT PEPTIDES BIOCH P, P261; PONCET L, 1994, NEUROSCI LETT, V176, P1, DOI 10.1016/0304-3940(94)90856-7; RIEPL RL, 1994, PANCREAS, V9, P109, DOI 10.1097/00006676-199401000-00016; Riepl RL, 1996, BRIT J CLIN PHARMACO, V42, P371, DOI 10.1046/j.1365-2125.1996.42013.x; RIEPL RL, 1990, SCAND J GASTROENTERO, V25, P45, DOI 10.3109/00365529008999208; Riepl RL, 1996, ITAL J GASTROENTEROL, V28, P421; Riepl RL, 1996, EUR J MED RES, V2, P23; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Sakio H, 1980, RESP CIRC, V28, P1161; SCHWARTZ TW, 1983, GASTROENTEROLOGY, V85, P1411; Shen DY, 1998, MIL MED, V163, P120, DOI 10.1093/milmed/163.2.120; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; Shulkes A, 1994, GUT PEPTIDES BIOCH P, P371; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, ADV EXP MED BIOL, V502, P237; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Walsh JH, 1994, GUT PEPTIDES BIOCH P; Westerterp KR, 2006, EUR J GASTROEN HEPAT, V18, P1, DOI 10.1097/00042737-200601000-00001; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yang Chun-min, 2006, Zhonghua Yi Xue Za Zhi, V86, P2391	42	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44445	10.1371/journal.pone.0044445	http://dx.doi.org/10.1371/journal.pone.0044445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970220	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400071
J	Baru, AM; Untucht, C; Ganesh, V; Hesse, C; Mayer, CT; Sparwasser, T				Baru, Abdul Mannan; Untucht, Christopher; Ganesh, Venkateswaran; Hesse, Christina; Mayer, Christian T.; Sparwasser, Tim			Optimal Isolation of Functional Foxp3(+) Induced Regulatory T Cells Using DEREG Mice	PLOS ONE			English	Article							SELECTIVE DEPLETION; TH2 RESPONSES; TARGET GENES; IN-VIVO; TREG	Foxp3 reporter mice including DEREG (DEpletion of REGulatory T cells) mice have greatly helped in exploring the biology of Foxp3(+) Tregs. DEREG mice express a DTR-eGFP fusion protein under the control of a bacterial artificial chromosome (BAC)-encoded Foxp3 promoter, allowing the viable isolation and inducible depletion of Foxp3(+) Tregs. Adaptive Tregs differentiated in vitro to express Foxp3 (iTregs) are gaining high interest as potential therapeutics for inflammatory conditions such as autoimmunity, allergy and transplant rejection. However, selective isolation of Foxp3(+) iTregs with a stable phenotype still remains to be a problem, especially in the human setting. While screening for culture conditions to generate stable CD4(+) Foxp3(+) iTregs from DEREG mice, with maximum suppressive activity, we observed an unexpected dichotomy of eGFP and Foxp3 expression which is not seen in ex vivo isolated cells from DEREG mice. Further characterization of eGFP(+) Foxp3(-) cells revealed relatively lower CD25 expression and a lack of suppressive activity in vitro. Similarly, eGFP(-) cells isolated from the same cultures were not suppressive despite of a broad CD25 expression reflecting mere T cell activation. In contrast, eGFP(+) Foxp3(+) iTregs exhibited potent suppressive activity comparable to that of natural eGFP(+) Foxp3(+) Tregs, emphasizing the importance of isolating Foxp3 expressing iTregs. Interestingly, the use of plate-bound anti-CD3 and anti-CD28 or Flt3L-driven BMDC resulted in considerable resolution of the observed dichotomy. In summary, we defined culture conditions for efficient generation of eGFP(+) Foxp3(+) iTregs by use of DEREG mice. Isolation of functional Foxp3(+) iTregs using DEREG mice can also be achieved under sub-optimal conditions based on the magnitude of surface CD25 expression, in synergy with transgene encoded eGFP. Besides, the reported phenomenon may be of general interest for exploring Foxp3 gene regulation, given that Foxp3 and eGFP expression are driven from distinct Foxp3 loci and because this dichotomy preferentially occurs only under defined in vitro conditions.	[Baru, Abdul Mannan; Untucht, Christopher; Ganesh, Venkateswaran; Hesse, Christina; Mayer, Christian T.; Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, Hannover, Germany		Baru, AM (corresponding author), Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, Hannover, Germany.	Tim.Sparwasser@twincore.de	Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019	Sparwasser, Tim/0000-0001-5645-902X	Deutsche Forschungsgemeinschaft [SFB587 (Sonderforschungsbereich 587)]; Research Training Group (German Research Foundation) [GRK 1441]; German National Academic Foundation; Research Training Group [GRK 1441]; Braukmann-Wittenberg-Herz-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Training Group (German Research Foundation)(German Research Foundation (DFG)); German National Academic Foundation; Research Training Group; Braukmann-Wittenberg-Herz-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft SFB587 (Sonderforschungsbereich 587). CH was supported by Research Training Group (German Research Foundation-GRK 1441) and CTM was supported by a stipend from the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christine Jaenke for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft SFB587 (Sonderforschungsbereich 587). CH was supported by Research Training Group (GRK 1441) and CTM was supported by a stipend from the German National Academic Foundation. We would further like to thank the Cell Sorting Core Facility of the Hannover Medical School supported in part by the Braukmann-Wittenberg-Herz-Stiftung and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Berod L, 2012, MICROB BIOTECHNOL, V5, P260, DOI 10.1111/j.1751-7915.2011.00299.x; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fyhrquist N, 2012, J INVEST DERMATOL, V132, P1672, DOI 10.1038/jid.2012.40; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; MANGER B, 1987, J IMMUNOL, V139, P2755; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mayer CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00183; Mayer CT, 2012, BLOOD, V119, P1314, DOI 10.1182/blood-2011-11-392266; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Rausch S, 2009, EUR J IMMUNOL, V39, P3066, DOI 10.1002/eji.200939644; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; VANLIER RAW, 1989, IMMUNOLOGY, V68, P45; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	26	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44760	10.1371/journal.pone.0044760	http://dx.doi.org/10.1371/journal.pone.0044760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957107	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800100
J	Elvira, G; Garcia, I; Benito, M; Gallo, J; Desco, M; Penades, S; Garcia-Sanz, JA; Silva, A				Elvira, Gema; Garcia, Isabel; Benito, Marina; Gallo, Juan; Desco, Manuel; Penades, Soledad; Garcia-Sanz, Jose A.; Silva, Augusto			Live Imaging of Mouse Endogenous Neural Progenitors Migrating in Response to an Induced Tumor	PLOS ONE			English	Article							ADULT MAMMALIAN BRAIN; STEM-CELLS; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; MONOCLONAL-ANTIBODIES; MULTIPLE-SCLEROSIS; PRECURSOR CELLS; TRACKING; MRI; MODEL	Adult neurogenesis is restricted to specific brain regions. Although involved in the continuous supply of interneurons for the olfactory function, the role of neural precursors in brain damage-repair remains an open question. Aiming to in vivo identify endogenous neural precursor cells migrating towards a brain damage site, the monoclonal antibody Nilo2 recognizing cell surface antigens on neuroblasts, was coupled to magnetic glyconanoparticles (mGNPs). The Nilo2-mGNP complexes allowed, by magnetic resonance imaging in living animals, the in vivo identification of endogenous neural precursors at their niche, as well as their migration to a lesion site (induced brain tumor), which was fast (within hours) and orderly. Interestingly, the rapid migration of neuroblasts towards a damage site is a characteristic that might be exploited to precisely localize early damage events in neurodegenerative diseases. In addition, it might facilitate the study of regenerative mechanisms through the activation of endogenous neural cell precursors. A similar approach, combining magnetic glyconanoparticles linked to appropriate antibodies could be applied to flag other small cell subpopulations within the organism, track their migration, localize stem cell niches, cancer stem cells or even track metastatic cells.	[Elvira, Gema; Garcia-Sanz, Jose A.; Silva, Augusto] Ctr Invest Biol CIB CSIC, Dept Cellular & Mol Med, Madrid, Spain; [Garcia, Isabel; Gallo, Juan; Penades, Soledad] CICbiomaGUNE, Lab Glyconanotechnol, San Sebastian, Spain; [Garcia, Isabel; Penades, Soledad] CIBER BBN, San Sebastian, Spain; [Benito, Marina; Desco, Manuel] Hosp Gen Gregorio Maranon, CIBERSAM, Madrid, Spain; [Desco, Manuel] Univ Carlos III Madrid, Dept Bioengn & Aerospatial Engn, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIC biomaGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; General University Gregorio Maranon Hospital; Universidad Carlos III de Madrid	Elvira, G (corresponding author), Ctr Invest Biol CIB CSIC, Dept Cellular & Mol Med, Madrid, Spain.	asilva@cib.csic.es	Gallo, Juan/K-8476-2019; Desco, Manuel/AAD-7137-2019; Garcia-Sanz, Jose A./AAA-2956-2019; Garcia, Isabel/B-2193-2009; Vicente, Marina Benito/N-5884-2014; Garcia-Sanz, Jose A/E-7684-2011; biomaGUNE, CIC/J-9136-2014	Gallo, Juan/0000-0002-2028-3234; Desco, Manuel/0000-0003-0989-3231; Garcia-Sanz, Jose A./0000-0002-1153-6025; Garcia, Isabel/0000-0002-4101-317X; Vicente, Marina Benito/0000-0002-0661-755X; Garcia-Sanz, Jose A/0000-0002-1153-6025; biomaGUNE, CIC/0000-0001-7690-0660	CSIC [PIF200620F0041]; MICINN (Instituto de Salud Carlos III) [SAF2009-07974, RD06/0010/1010]; MICINN [CTQ2008-04638]; Department of Industry, Innovation and Technology of the Basque Country	CSIC; MICINN (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Department of Industry, Innovation and Technology of the Basque Country	This work was supported by CSIC (PIF200620F0041), MICINN (SAF2009-07974; RD06/0010/1010 from the Instituto de Salud Carlos III, CTQ2008-04638) and the Department of Industry, Innovation and Technology of the Basque Country (grant ETORTEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ben-Hur T, 2007, MAGN RESON MED, V57, P164, DOI 10.1002/mrm.21116; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; de Vries NA, 2009, CANCER TREAT REV, V35, P714, DOI 10.1016/j.ctrv.2009.08.011; Del Valle I, 2010, NEUROSCIENCE, V169, P1473, DOI 10.1016/j.neuroscience.2010.04.058; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Elvira G, 2012, J BIOMATER APPL, V26, P1069, DOI 10.1177/0885328210393294; Gallo J, 2011, BIOMATERIALS, V32, P9818, DOI 10.1016/j.biomaterials.2011.09.010; Gallo J, 2010, J MATER CHEM, V20, P10010, DOI 10.1039/c0jm01756f; Garcia I, 2011, BIOCONJUGATE CHEM, V22, P264, DOI 10.1021/bc1003923; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Martinez-Murillo R, 2007, HISTOL HISTOPATHOL, V22, P1309, DOI 10.14670/HH-22.1309; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Panizzo RA, 2009, NEUROIMAGE, V44, P1239, DOI 10.1016/j.neuroimage.2008.10.062; Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Vreys R, 2010, NEUROIMAGE, V49, P2094, DOI 10.1016/j.neuroimage.2009.10.034; Zhang ZG, 2004, NEUROIMAGE, V23, P281, DOI 10.1016/j.neuroimage.2004.05.019; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146	45	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44466	10.1371/journal.pone.0044466	http://dx.doi.org/10.1371/journal.pone.0044466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957072	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800065
J	Meslin, C; Mugnier, S; Callebaut, I; Laurin, M; Pascal, G; Poupon, A; Goudet, G; Monget, P				Meslin, Camille; Mugnier, Sylvie; Callebaut, Isabelle; Laurin, Michel; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe			Evolution of Genes Involved in Gamete Interaction: Evidence for Positive Selection, Duplications and Losses in Vertebrates	PLOS ONE			English	Article							ZONA-PELLUCIDA BINDING; SPERM-EGG BINDING; ANGIOTENSIN-CONVERTING ENZYME; FERTILIZATION IN-VITRO; CRYSTAL-STRUCTURE; ACROSOME REACTION; MOUSE FERTILIZATION; ADAPTIVE EVOLUTION; REPRODUCTIVE PROTEINS; PHYLOGENETIC ANALYSIS	Genes encoding proteins involved in sperm-egg interaction and fertilization exhibit a particularly fast evolution and may participate in prezygotic species isolation [1,2]. Some of them (ZP3, ADAM1, ADAM2, ACR and CD9) have individually been shown to evolve under positive selection [3,4], suggesting a role of positive Darwinian selection on sperm-egg interaction. However, the genes involved in this biological function have not been systematically and exhaustively studied with an evolutionary perspective, in particular across vertebrates with internal and external fertilization. Here we show that 33 genes among the 69 that have been experimentally shown to be involved in fertilization in at least one taxon in vertebrates are under positive selection. Moreover, we identified 17 pseudogenes and 39 genes that have at least one duplicate in one species. For 15 genes, we found neither positive selection, nor gene copies or pseudogenes. Genes of teleosts, especially genes involved in sperm-oolemma fusion, appear to be more frequently under positive selection than genes of birds and eutherians. In contrast, pseudogenization, gene loss and gene gain are more frequent in eutherians. Thus, each of the 19 studied vertebrate species exhibits a unique signature characterized by gene gain and loss, as well as position of amino acids under positive selection. Reflecting these clade-specific signatures, teleosts and eutherian mammals are recovered as clades in a parsimony analysis. Interestingly the same analysis places Xenopus apart from teleosts, with which it shares the primitive external fertilization, and locates it along with amniotes (which share internal fertilization), suggesting that external or internal environmental conditions of germ cell interaction may not be the unique factors that drive the evolution of fertilization genes. Our work should improve our understanding of the fertilization process and on the establishment of reproductive barriers, for example by offering new leads for experiments on genes identified as positively selected.	[Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] CNRS, UMR6175, Nouzilly, France; [Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] Univ Tours, Tours, France; [Meslin, Camille; Pascal, Geraldine; Poupon, Anne; Goudet, Ghylene; Monget, Philippe] IFCE, Nouzilly, France; [Mugnier, Sylvie] AgroSup Dijon, Dept Agron Agroequipement Elevage Environm, Dijon, France; [Callebaut, Isabelle] Univ Paris 06, IMPMC UMR 7590, Paris, France; [Laurin, Michel] Museum Natl Hist Nat, CNRS MNHN UPMC, UMR 7207, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Meslin, C (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	philippe.monget@tours.inra.fr	Laurin, Michel/B-7884-2008; Pascal, Geraldine/P-8125-2019; PASCAL, Géraldine/A-7041-2008; PASCAL, Géraldine/L-4519-2013	Laurin, Michel/0000-0003-2974-9835; Pascal, Geraldine/0000-0002-5250-6594; PASCAL, Géraldine/0000-0002-5250-6594; Poupon, Anne/0000-0003-0617-0935; Goudet, Ghylene/0000-0001-7805-6985	MENRT PhD fellowship; INRA	MENRT PhD fellowship; INRA	CM is funded by a MENRT PhD fellowship. This work was supported by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard JE, 2010, MOL BIOL EVOL, V27, P193, DOI 10.1093/molbev/msp221; BABA T, 1994, J BIOL CHEM, V269, P31845; Barraud-Lange V, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-102; Berlin S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-65; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Boissonnas CC, 2010, DEV DYNAM, V239, P773, DOI 10.1002/dvdy.22206; BOUE F, 1994, BIOL REPROD, V51, P577, DOI 10.1095/biolreprod51.4.577; Brahmaraju M, 2004, BIOCHEM BIOPH RES CO, V318, P148, DOI 10.1016/j.bbrc.2004.04.006; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Busset J, 2011, NUCLEIC ACIDS RES, V39, pW479, DOI 10.1093/nar/gkr243; Busso D, 2007, BIOL REPROD, V77, P848, DOI 10.1095/biolreprod.107.061788; Busso D, 2007, BIOL REPROD, V76, P701, DOI 10.1095/biolreprod.106.056770; Cheng GY, 2007, ASIAN J ANDROL, V9, P23, DOI 10.1111/j.1745-7262.2007.00247.x; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; Chruszcz M, 2003, J INORG BIOCHEM, V96, P386, DOI 10.1016/S0162-0134(03)00176-4; Cohen DJ, 2008, INT J DEV BIOL, V52, P737, DOI 10.1387/ijdb.072538dc; Cohen DJ, 2001, BIOL REPROD, V65, P1000, DOI 10.1095/biolreprod65.4.1000; CORNWALL GA, 1991, BIOL REPROD, V44, P913, DOI 10.1095/biolreprod44.5.913; Da Ros VG, 2008, DEV BIOL, V320, P12, DOI 10.1016/j.ydbio.2008.03.015; Deguchi E, 2007, BIOL REPROD, V77, P794, DOI 10.1095/biolreprod.107.060004; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Esther CR, 1996, LAB INVEST, V74, P953; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fujihara Y, 2010, J CELL SCI, V2010, P7; Furlong LI, 2005, FERTIL STERIL, V83, P1780, DOI 10.1016/j.fertnstert.2004.12.042; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Ganguly A, 2010, HUM REPROD, V25, P1643, DOI 10.1093/humrep/deq105; Germain D, 2009, EVOL DEV, V11, P170, DOI 10.1111/j.1525-142X.2009.00318.x; Ghosh I, 2003, MOL REPROD DEV, V64, P235, DOI 10.1002/mrd.10207; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; Glazar AI, 2009, REPROD FERT DEVELOP, V21, P293, DOI 10.1071/RD08158; Goncalves RF, 2008, ANIM REPROD SCI, V106, P188, DOI 10.1016/j.anireprosci.2007.12.019; Goncalves RF, 2007, THERIOGENOLOGY, V67, P468, DOI 10.1016/j.theriogenology.2006.08.013; Goudet G, 2008, BIOL REPROD, V78, P796, DOI 10.1095/biolreprod.107.064568; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jagadish N, 2005, J REPROD IMMUNOL, V67, P69, DOI 10.1016/j.jri.2005.06.004; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kohn MJ, 2010, FERTIL STERIL, V93, P1533, DOI 10.1016/j.fertnstert.2009.06.010; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Linfor J, 2000, J REPROD FERTIL, V120, P65, DOI 10.1530/reprod/120.1.65; Lu QX, 1997, DEVELOPMENT, V124, P4121; Maddison W., 2018, MESQUITE MODULAR SYS; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Marin-Briggiler CI, 2008, MOL HUM REPROD, V14, P561, DOI 10.1093/molehr/gan053; Marjanovic D, 2007, SYST BIOL, V56, P369, DOI 10.1080/10635150701397635; McCartney MA, 2004, MOL BIOL EVOL, V21, P732, DOI 10.1093/molbev/msh071; MIDFORD P, 2003, PDAP PACKAGE MESQUIT; Monne M, 2011, BIOL REPROD; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2007, J BIOL CHEM, V282, P17900, DOI 10.1074/jbc.M702268200; Okumura H, 2004, BIOCHEM J, V384, P191, DOI 10.1042/BJ20040299; Pasten-Hidalgo K, 2008, REPRODUCTION, V136, P41, DOI 10.1530/REP-07-0300; RANGANATHAN S, 1994, MOL REPROD DEV, V38, P69, DOI 10.1002/mrd.1080380112; Rattanachaiyanont M, 2001, MOL HUM REPROD, V7, P633, DOI 10.1093/molehr/7.7.633; Riginos C, 2003, MOL BIOL EVOL, V20, P200, DOI 10.1093/molbev/msg021; Sato Y, 2010, ENVIRON BIOL FISH, V88, P169, DOI 10.1007/s10641-010-9628-7; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Smith J, 2005, MOL REPROD DEV, V70, P133, DOI 10.1002/mrd.20197; Song XX, 2007, ASIAN AUSTRAL J ANIM, V20, P351, DOI 10.5713/ajas.2007.351; Sosnik J, 2010, J CELL PHYSIOL, V224, P575, DOI 10.1002/jcp.22211; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Studer RA, 2008, GENOME RES, V18, P1393, DOI 10.1101/gr.076992.108; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Takahashi Y, 2001, MOL BIOL CELL, V12, P809, DOI 10.1091/mbc.12.4.809; Tardif S, 2010, BIOL REPROD, V83, P464, DOI 10.1095/biolreprod.109.083238; TAYLOR CT, 1994, HUM REPROD, V9, P907, DOI 10.1093/oxfordjournals.humrep.a138615; Tengowski MW, 2001, MOL REPROD DEV, V58, P236, DOI 10.1002/1098-2795(200102)58:2&lt;236::AID-MRD13&gt;3.0.CO;2-0; Thys M, 2009, REPRODUCTION, V138, P471, DOI 10.1530/REP-09-0094; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Vacquier VD, 1997, J MOL EVOL, V44, pS15, DOI 10.1007/PL00000049; van Tuinen M, 2009, TIMETREE LIFE; Veselsky L, 1999, AM J REPROD IMMUNOL, V42, P187; Vjugina U, 2009, BIOL REPROD, V80, P833, DOI 10.1095/biolreprod.108.075275; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Weinberger H, 2009, MOL BIOL EVOL, V17, P17; WILLIAMS TA, 1994, J BIOL CHEM, V269, P29430; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; YAMASAKI N, 1995, MOL REPROD DEV, V40, P48, DOI 10.1002/mrd.1080400107; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; Yanagimachi R., 1994, P189; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Yin L, 2009, CELL MOL LIFE SCI, V66, P900, DOI 10.1007/s00018-009-8482-2; Ying XQ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-10; Yu Y, 2006, DEV BIOL, V290, P32, DOI 10.1016/j.ydbio.2005.11.003; Zhao LM, 2008, REPRODUCTION, V136, P323, DOI 10.1530/REP-07-0569; Zitta K, 2006, MOL HUM REPROD, V12, P557, DOI 10.1093/molehr/gal059; Ziv S, 2002, MOL REPROD DEV, V62, P547, DOI 10.1002/mrd.10149; Ziyyat A, 2006, J CELL SCI, V119, P416, DOI 10.1242/jcs.02730; Ziyyat A, 2005, HUM REPROD, V20, P3452, DOI 10.1093/humrep/dei241	114	36	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44548	10.1371/journal.pone.0044548	http://dx.doi.org/10.1371/journal.pone.0044548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957080	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800073
J	Zhang, YP; Deng, FY; Yang, TL; Zhang, F; Chen, XD; Shen, H; Zhu, XZ; Tian, Q; Deng, HW				Zhang, Yin-Ping; Deng, Fei-Yan; Yang, Tie-Lin; Zhang, Feng; Chen, Xiang-Ding; Shen, Hui; Zhu, Xue-Zheng; Tian, Qing; Deng, Hong-Wen			Genome-Wide Association Study Identified CNP12587 Region Underlying Height Variation in Chinese Females	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENE-EXPRESSION; 18Q DELETIONS; HUMAN STATURE; ADULT HEIGHT; C2 DOMAIN; GROWTH; UBIQUITIN; LOCI; VARIANTS	Introduction: Human height is a highly heritable trait considered as an important factor for health. There has been limited success in identifying the genetic factors underlying height variation. We aim to identify sequence variants associated with adult height by a genome-wide association study of copy number variants (CNVs) in Chinese. Methods: Genome-wide CNV association analyses were conducted in 1,625 unrelated Chinese adults and sex specific subgroup for height variation, respectively. Height was measured with a stadiometer. Affymetrix SNP6.0 genotyping platform was used to identify copy number polymorphisms (CNPs). We constructed a genomic map containing 1,009 CNPs in Chinese individuals and performed a genome-wide association study of CNPs with height. Results: We detected 10 significant association signals for height (p < 0.05) in the whole population, 9 and 11 association signals for Chinese female and male population, respectively. A copy number polymorphism (CNP12587, chr18:54081842-54086942, p = 2.41 x 10(-4)) was found to be significantly associated with height variation in Chinese females even after strict Bonferroni correction (p = 0.048). Confirmatory real time PCR experiments lent further support for CNV validation. Compared to female subjects with two copies of the CNP, carriers of three copies had an average of 8.1% decrease in height. An important candidate gene, ubiquitin-protein ligase NEDD4-like (NEDD4L), was detected at this region, which plays important roles in bone metabolism by binding to bone formation regulators. Conclusions: Our findings suggest the important genetic variants underlying height variation in Chinese.	[Zhang, Yin-Ping; Zhang, Feng] Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China; [Deng, Fei-Yan; Shen, Hui; Tian, Qing; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Yang, Tie-Lin; Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; [Yang, Tie-Lin; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Peoples R China; [Chen, Xiang-Ding; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Zhu, Xue-Zheng; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Systemat Biomed Res, Shanghai 201800, Peoples R China	Xi'an Jiaotong University; Tulane University; Xi'an Jiaotong University; Xi'an Jiaotong University; Hunan Normal University; University of Shanghai for Science & Technology	Zhang, YP (corresponding author), Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China.	cathyzh@mail.xjtu.edu.cn; hdeng2@tulane.edu	Yang, Tie-Lin/G-8365-2014	Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	National Science Foundation of China [81100628, 81000363, 31000554]; Shaanxi Province Science and Technology Foundation [2010K16-01]; Xi'an Jiaotong University, Guang hua foundation [GH0203416]; Huo Ying Dong Education Foundation, Hunan Province, Shanghai Leading Academic Discipline Project [S30501]; China Scholarship Council; Ministry of Education; NIH [R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR057049, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Foundation; Xi'an Jiaotong University, Guang hua foundation; Huo Ying Dong Education Foundation, Hunan Province, Shanghai Leading Academic Discipline Project; China Scholarship Council(China Scholarship Council); Ministry of Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were funded in part by grants from National Science Foundation of China (81100628, 81000363, 31000554), Shaanxi Province Science and Technology Foundation (2010K16-01), Xi'an Jiaotong University, Guang hua foundation (GH0203416). Huo Ying Dong Education Foundation, Hunan Province, Shanghai Leading Academic Discipline Project (S30501). The study also benefited from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973, and P50 AR055081). Yin-Ping Zhang was supported by China Scholarship Council, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Beunen G, 2000, ANN HUM BIOL, V27, P173; Boniotto M, 2004, GENET TEST, V8, P325, DOI 10.1089/gte.2004.8.325; Cody JD, 1997, AM J MED GENET, V71, P420, DOI 10.1002/(SICI)1096-8628(19970905)71:4<420::AID-AJMG9>3.3.CO;2-A; Deng HW, 2000, GENET EPIDEMIOL, V19, P160, DOI 10.1002/1098-2272(200009)19:2<160::AID-GEPI4>3.0.CO;2-H; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feenstra I, 2007, AM J MED GENET A, V143A, P1858, DOI 10.1002/ajmg.a.31850; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Garrone NF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-26; Ghidoni PD, 1997, AM J MED GENET, V69, P7, DOI 10.1002/(SICI)1096-8628(19970303)69:1<7::AID-AJMG2>3.0.CO;2-P; GonzalezRodriguez E, 1997, AM J MED GENET, V72, P399, DOI 10.1002/(SICI)1096-8628(19971112)72:4<399::AID-AJMG5>3.0.CO;2-M; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hale DE, 2000, J CLIN ENDOCR METAB, V85, P4450, DOI 10.1210/jc.85.12.4450; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Hu J, 2006, J MOL DIAGN, V8, P521, DOI 10.2353/jmoldx.2006.060001; Kanaan RA, 2006, MED SCI MONITOR, V12, pRA164; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lei SF, 2009, HUM MOL GENET, V18, P1661, DOI 10.1093/hmg/ddn405; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li MX, 2004, J HUM GENET, V49, P148, DOI 10.1007/s10038-004-0125-8; Liu SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022035; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sammalisto S, 2005, J MED GENET, V42, P932, DOI 10.1136/jmg.2005.031278; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Shmueli A, 2005, CELL, V121, P963, DOI 10.1016/j.cell.2005.06.018; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Stamoyannou L, 1997, AM J MED GENET, V72, P71, DOI 10.1002/(SICI)1096-8628(19971003)72:1<71::AID-AJMG15>3.0.CO;2-R; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; STRATHDEE G, 1995, AM J MED GENET, V59, P476, DOI 10.1002/ajmg.1320590414; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050	46	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44292	10.1371/journal.pone.0044292	http://dx.doi.org/10.1371/journal.pone.0044292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957059	gold, Green Submitted, Green Published			2022-12-27	WOS:000308463800052
J	Zheng, QX; Ren, YP; Tzekov, R; Zhang, YP; Chen, B; Hou, JP; Zhao, CH; Zhu, JL; Zhang, Y; Dai, XF; Ma, S; Li, J; Pang, JJ; Qu, J; Li, WS				Zheng, Qinxiang; Ren, Yueping; Tzekov, Radouil; Zhang, Yuanping; Chen, Bo; Hou, Jiangping; Zhao, Chunhui; Zhu, Jiali; Zhang, Ying; Dai, Xufeng; Ma, Shan; Li, Jia; Pang, Jijing; Qu, Jia; Li, Wensheng			Differential Proteomics and Functional Research following Gene Therapy in a Mouse Model of Leber Congenital Amaurosis	PLOS ONE			English	Article							CANINE MODEL; RETINAL DEGENERATION; CHILDHOOD BLINDNESS; RPE65 MUTATIONS; RESTORES VISION; PEROXIREDOXIN 6; LIGHT DAMAGE; MURINE MODEL; RAT RETINA; CELL-DEATH	Leber congenital amaurosis (LCA) is one of the most severe forms of inherited retinal degeneration and can be caused by mutations in at least 15 different genes. To clarify the proteomic differences in LCA eyes, a cohort of retinal degeneration 12 (rd12) mice, an LCA2 model caused by a mutation in the RPE65 gene, were injected subretinally with an AAV vector (scAAV5-smCBA-hRPE65) in one eye, while the contralateral eye served as a control. Proteomics were compared between untreated rd12 and normal control retinas on P14 and P21, and among treated and untreated rd12 retinas and control retinas on P42. Gene therapy in rd12 mice restored retinal function in treated eyes, which was demonstrated by electroretinography (ERG). Proteomic analysis successfully identified 39 proteins expressed differently among the 3 groups. The expression of 3 proteins involved in regulation of apoptosis and neuroptotection (alpha A crystallin, heat shock protein 70 and peroxiredoxin 6) were investigated further. Immunofluorescence, Western blot and real-time PCR confirmed the quantitative changes in their expression. Furthermore, cell culture studies suggested that peroxiredoxin 6 could act in an antioxidant role in rd12 mice. Our findings support the feasibility of gene therapy in LCA2 patients and support a role for alpha A crystallin, heat shock protein 70 and peroxiredoxin 6 in the pathogenetic mechanisms involved in LCA2 disease process.	[Zheng, Qinxiang; Ren, Yueping; Hou, Jiangping; Zhao, Chunhui; Zhu, Jiali; Zhang, Ying; Dai, Xufeng; Pang, Jijing; Qu, Jia; Li, Wensheng] Wenzhou Med Coll, Hosp Eye, Wenzhou, Peoples R China; [Tzekov, Radouil] Roskamp Inst, Sarasota, FL USA; [Zhang, Yuanping] Kunming Med Coll, Affiliated Hosp 2, Dept Ophthalmol, Kunming, Peoples R China; [Chen, Bo] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Ma, Shan; Li, Jia] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA USA; [Pang, Jijing] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Li, Wensheng] NEI, Neurobiol Neurodegenerat & Repair Lab, Retinal Cell Biol & Degenerat Sect, NIH, Bethesda, MD 20892 USA	Wenzhou Medical University; Kunming Medical University; Yale University; University of Massachusetts System; University of Massachusetts Worcester; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Zheng, QX (corresponding author), Wenzhou Med Coll, Hosp Eye, Wenzhou, Peoples R China.	jqu@wzmc.net; drlws@163.net		Tzekov, Radouil/0000-0002-3662-9818	Major Projects of the National Science and Technology of China [2009ZX09503]; Specilized Research Fund for the Doctoral Program of Higher Education [20103321110002]; Key Projects of National High-Tech R&D Program (863 Program) of China [2007AA021004]; Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical College, Wenzhou, China; NATIONAL EYE INSTITUTE [R01EY021502] Funding Source: NIH RePORTER	Major Projects of the National Science and Technology of China; Specilized Research Fund for the Doctoral Program of Higher Education; Key Projects of National High-Tech R&D Program (863 Program) of China; Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical College, Wenzhou, China; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants of Major Projects of the National Science and Technology of China (No: 2009ZX09503), Specilized Research Fund for the Doctoral Program of Higher Education (No: 20103321110002), Key Projects of National High-Tech R&D Program (863 Program) of China (No: 2007AA021004), retinal gene therapy study grants from Eye Hospital, School of Ophthalmology & Optometry, Wenzhou Medical College, Wenzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BARBE MF, 1988, SCIENCE, V241, P1817, DOI 10.1126/science.3175623; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bernstein SL, 2000, INVEST OPHTH VIS SCI, V41, P2857; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cavusoglu N, 2003, MOL CELL PROTEOMICS, V2, P494, DOI 10.1074/mcp.M300029-MCP200; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; DeLaPaz MA, 1996, CURR EYE RES, V15, P273, DOI 10.3109/02713689609007621; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DERETIC D, 1994, J BIOL CHEM, V269, P16853; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Finnegan S, 2010, MOL VIS, V16, P7; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kostic C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016588; Kubo E, 2009, LIFE SCI, V84, P857, DOI 10.1016/j.lfs.2009.03.019; Lai CM, 2004, GENET VACCINES THER, V2, P3; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Li WS, 2009, MOL VIS, V15, P267; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2003, ADV EXP MED BIOL, V533, P423; Narfstrom K, 2003, J HERED, V94, P31, DOI 10.1093/jhered/esg015; Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Siu AW, 2008, NEUROSCI LETT, V432, P193, DOI 10.1016/j.neulet.2007.12.046; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Tulsawani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-125; Tzekov RT, 2001, INVEST OPHTH VIS SCI, V42, P1319; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Wang PF, 2007, GRAEF ARCH CLIN EXP, V245, P1401, DOI 10.1007/s00417-007-0554-0; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1085, DOI 10.1167/iovs.04-0042; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	57	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44855	10.1371/journal.pone.0044855	http://dx.doi.org/10.1371/journal.pone.0044855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22953002	gold, Green Published, Green Submitted			2022-12-27	WOS:000308221300106
J	Hegde, M; Karki, SS; Thomas, E; Kumar, S; Panjamurthy, K; Ranganatha, SR; Rangappa, KS; Choudhary, B; Raghavan, SC				Hegde, Mahesh; Karki, Subhas S.; Thomas, Elizabeth; Kumar, Sujeet; Panjamurthy, Kuppusamy; Ranganatha, Somasagara R.; Rangappa, Kanchugarakoppal S.; Choudhary, Bibha; Raghavan, Sathees C.			Novel Levamisole Derivative Induces Extrinsic Pathway of Apoptosis in Cancer Cells and Inhibits Tumor Progression in Mice	PLOS ONE			English	Article							CYTOCHROME-C; CHROMOSOMAL TRANSLOCATIONS; PROSTATE-CANCER; NUCLEAR ANTIGEN; LEUKEMIC-CELLS; COLON-CANCER; P53; BCL-2; RELEASE; MITOCHONDRIA	Background: Levamisole, an imidazo(2,1-b) thiazole derivative, has been reported to be a potential antitumor agent. In the present study, we have investigated the mechanism of action of one of the recently identified analogues, 4a (2-benzyl-6-(4'-fluorophenyl)-5-thiocyanato-imidazo[2,1-b][1,3,4]thiadiazole). Materials and Methods: ROS production and expression of various apoptotic proteins were measured following 4a treatment in leukemia cell lines. Tumor animal models were used to evaluate the effect of 4a in comparison with Levamisole on progression of breast adenocarcinoma and survival. Immunohistochemistry and western blotting studies were performed to understand the mechanism of 4a action both ex vivo and in vivo. Results: We have determined the IC50 value of 4a in many leukemic and breast cancer cell lines and found CEM cells most sensitive (IC50 5 mu M). Results showed that 4a treatment leads to the accumulation of ROS. Western blot analysis showed upregulation of pro-apoptotic proteins t-BID and BAX, upon treatment with 4a. Besides, dose-dependent activation of p53 along with FAS, FAS-L, and cleavage of CASPASE-8 suggest that it induces death receptor mediated apoptotic pathway in CEM cells. More importantly, we observed a reduction in tumor growth and significant increase in survival upon oral administration of 4a (20 mg/kg, six doses) in mice. In comparison, 4a was found to be more potent than its parental analogue Levamisole based on both ex vivo and in vivo studies. Further, immunohistochemistry and western blotting studies indicate that 4a treatment led to abrogation of tumor cell proliferation and activation of apoptosis by the extrinsic pathway even in animal models. Conclusion: Thus, our results suggest that 4a could be used as a potent chemotherapeutic agent.	[Hegde, Mahesh; Thomas, Elizabeth; Panjamurthy, Kuppusamy; Ranganatha, Somasagara R.; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Karki, Subhas S.; Kumar, Sujeet] KLE Univ, Dept Pharmaceut Chem, Coll Pharm, Bangalore, Karnataka, India; [Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Choudhary, Bibha] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; K.L.E. Academy of Higher Education & Research; University of Mysore	Hegde, M (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	Kuppusamy, Panjamurthy/AAT-1518-2021; Hegde, MahesH/ABE-2057-2020; karki, subhas s/AAH-6451-2020; KUMAR, SUJEET/AAD-5081-2019; Thomas, Elizabeth/AAV-3393-2020	Kuppusamy, Panjamurthy/0000-0003-3293-7220; Hegde, MahesH/0000-0002-7853-6281; karki, subhas s/0000-0002-5599-3594; KUMAR, SUJEET/0000-0002-0833-158X; 	Lady Tata Memorial Trust, United Kingdom; Indian Institute of Science start up grant	Lady Tata Memorial Trust, United Kingdom; Indian Institute of Science start up grant	This work was supported by grant from Lady Tata Memorial Trust, United Kingdom, and Indian Institute of Science start up grant for SCR. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; ANDREANI A, 1982, ARCH PHARM, V315, P451, DOI 10.1002/ardp.19823150511; Aplan PD, 2005, BLOOD, V105, P1843, DOI 10.1182/blood-2004-12-4760; Artwohl M, 2000, BRIT J PHARMACOL, V131, P1577, DOI 10.1038/sj.bjp.0703660; ATTIA MAM, 1966, CANCER RES, V26, P1787; Bhattacharyya A, 2003, CARCINOGENESIS, V24, P75, DOI 10.1093/carcin/24.1.75; Buolamwini JK, 2000, CURR PHARM DESIGN, V6, P379, DOI 10.2174/1381612003400948; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; CHEUNG ANY, 1993, HISTOPATHOLOGY, V22, P565, DOI 10.1111/j.1365-2559.1993.tb00177.x; Chiruvella KK, 2011, INVEST NEW DRUG, V29, P583, DOI 10.1007/s10637-010-9393-7; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; Durland-Busbice S, 2002, LEUKEMIA, V16, P2165, DOI 10.1038/sj.leu.2402647; Friis Tina, 2005, Angiogenesis, V8, P25, DOI 10.1007/s10456-005-3588-0; Gadad AK, 1999, ARZNEIMITTEL-FORSCH, V49, P858; GEKELER V, 1993, MOL CELL BIOL, V13, P5020, DOI 10.1128/MCB.13.8.5020; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghosh M, 1997, CANCER LETT, V119, P7, DOI 10.1016/S0304-3835(97)00244-9; GUMINSKA M, 1986, BIOCHEM PHARMACOL, V35, P4369, DOI 10.1016/0006-2952(86)90750-1; Hazra B, 2005, TOXICOL LETT, V157, P109, DOI 10.1016/j.toxlet.2005.01.016; Huang CX, 2008, CANCER LETT, V266, P135, DOI 10.1016/j.canlet.2008.02.059; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karki SS, 2011, EUR J MED CHEM, V46, P2109, DOI 10.1016/j.ejmech.2011.02.064; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; KOVACH JS, 1992, J NATL CANCER I, V84, P515, DOI 10.1093/jnci/84.7.515; Kumagai H, 2004, CARCINOGENESIS, V25, P723, DOI 10.1093/carcin/bgh067; Kumar A, 2009, CANCER CHEMOTH PHARM, V64, P1221, DOI 10.1007/s00280-009-0992-y; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Luppi G, 1996, ANN ONCOL, V7, P412; MIYASHITA T, 1995, CELL, V80, P293; Moen MD, 2007, DRUGS, V67, P299, DOI 10.2165/00003495-200767020-00010; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nickoloff JA, 2008, CURR OPIN HEMATOL, V15, P338, DOI 10.1097/MOH.0b013e328302f711; Noaman E, 2008, CANCER LETT, V268, P348, DOI 10.1016/j.canlet.2008.04.012; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Ramanadham M, 2010, J IMMUNOTOXICOL, V7, P327, DOI 10.3109/1547691X.2010.514871; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Salem FS, 2011, VET ITAL, V47, P89; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Sharma S, 2012, MOL CARCINOG; STEVENSON HC, 1991, J CLIN ONCOL, V9, P2052, DOI 10.1200/JCO.1991.9.11.2052; Sugimoto Y, 2009, J MED CHEM, V52, P798, DOI 10.1021/jm801265e; SYMOENS J, 1978, CANCER TREAT REP, V62, P1721; Tang DG, 1997, PROSTATE, V32, P284; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vrekoussis T, 2009, ANTICANCER RES, V29, P4995; Wiebke EA, 2003, J SURG RES, V111, P63, DOI 10.1016/S0022-4804(03)00053-2; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	58	41	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e43632	10.1371/journal.pone.0043632	http://dx.doi.org/10.1371/journal.pone.0043632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970136	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000308748400007
J	Gregory, SD; Brook, BW; Goossens, B; Ancrenaz, M; Alfred, R; Ambu, LN; Fordham, DA				Gregory, Stephen D.; Brook, Barry W.; Goossens, Benoit; Ancrenaz, Marc; Alfred, Raymond; Ambu, Laurentius N.; Fordham, Damien A.			Long-Term Field Data and Climate-Habitat Models Show That Orangutan Persistence Depends on Effective Forest Management and Greenhouse Gas Mitigation	PLOS ONE			English	Article							LAND-USE CHANGE; GENETIC DIVERSITY; SPECIES RICHNESS; PROTECTED AREAS; DANUM-VALLEY; BORNEO; SABAH; MALAYSIA; POPULATION; DEFORESTATION	Background: Southeast Asian deforestation rates are among the world's highest and threaten to drive many forest-dependent species to extinction. Climate change is expected to interact with deforestation to amplify this risk. Here we examine whether regional incentives for sustainable forest management will be effective in improving threatened mammal conservation, in isolation and when combined with global climate change mitigation. Methodology/Principal Findings: Using a long time-series of orangutan nest counts for Sabah (2000-10), Malaysian Borneo, we evaluated the effect of sustainable forest management and climate change scenarios, and their interaction, on orangutan spatial abundance patterns. By linking dynamic land-cover and downscaled global climate model projections, we determine the relative influence of these factors on orangutan spatial abundance and use the resulting statistical models to identify habitat crucial for their long-term conservation. We show that land-cover change the degradation of primary forest had the greatest influence on orangutan population size. Anticipated climate change was predicted to cause reductions in abundance in currently occupied populations due to decreased habitat suitability, but also to promote population growth in western Sabah by increasing the suitability of presently unoccupied regions. Conclusions/Significance: We find strong quantitative support for the Sabah government's proposal to implement sustainable forest management in all its forest reserves during the current decade; failure to do so could result in a 40 to 80 per cent regional decline in orangutan abundance by 2100. The Sabah orangutan is just one (albeit iconic) example of a forest-dependent species that stands to benefit from sustainable forest management, which promotes conservation of existing forests.	[Gregory, Stephen D.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Gregory, Stephen D.; Brook, Barry W.; Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Gregory, Stephen D.; Brook, Barry W.; Fordham, Damien A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Goossens, Benoit] Cardiff Univ, Organisms & Environm Div, Sch Biosci, Cardiff, S Glam, Wales; [Goossens, Benoit; Ancrenaz, Marc; Ambu, Laurentius N.] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Ancrenaz, Marc] Hutan Kinabatangan Orang Utan Conservat Programme, Sandakan, Sabah, Malaysia; [Ancrenaz, Marc] Chester Zoo, N England Zool Soc, Chester, Cheshire, England; [Alfred, Raymond] Borneo Conservat Trust, Kota Kinabalu, Sabah, Malaysia	University of Adelaide; University of Adelaide; University of Adelaide; Cardiff University	Gregory, SD (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA, Australia.	stephendavidgregory@gmail.com	Goossens, Benoit R/E-8812-2010; Gregory, Stephen D/A-1471-2010; Fordham, Damien A/E-9255-2013; Brook, Barry W./G-2686-2011	Gregory, Stephen D/0000-0002-8230-0191; Fordham, Damien A/0000-0003-2137-5592; Brook, Barry W./0000-0002-2491-1517	ARC [DP1096427]; Darwin Initiative for the Survival of Species, DEFRA, UK [09-016]; Cardiff University; Apenheul Primate Park; ZooParc de Beauval; Cleveland Metroparks Zoo; Chester Zoo; Columbus Zoo; Houston Zoo; Zoo de La Palmyre; Oregon Zoo; Philadelphia Zoo; Phoenix Zoo; Saint Louis Zoo; Utah's Hogle Zoo; Woodland Park Zoo; Abraham Foundation,; Arcus Foundation; Balikpapan Orangutan Survival Foundation (NL); Shared Earth Foundation; Elephant Family Foundation; Ensemble Foundation; Mohamed bin Zayed Foundation; Shining Hope Foundation; World Women Work Foundation; WoodTiger Fund; Wildlife Conservation Network; US Fish and Wildlife Services Great Ape Conservation Fund; North England Zoological Society; Orangutan Project	ARC(Australian Research Council); Darwin Initiative for the Survival of Species, DEFRA, UK(Department for Environment, Food & Rural Affairs (DEFRA)); Cardiff University; Apenheul Primate Park; ZooParc de Beauval; Cleveland Metroparks Zoo; Chester Zoo; Columbus Zoo; Houston Zoo; Zoo de La Palmyre; Oregon Zoo; Philadelphia Zoo; Phoenix Zoo; Saint Louis Zoo; Utah's Hogle Zoo; Woodland Park Zoo; Abraham Foundation,; Arcus Foundation; Balikpapan Orangutan Survival Foundation (NL); Shared Earth Foundation; Elephant Family Foundation; Ensemble Foundation; Mohamed bin Zayed Foundation; Shining Hope Foundation; World Women Work Foundation; WoodTiger Fund; Wildlife Conservation Network; US Fish and Wildlife Services Great Ape Conservation Fund(US Fish & Wildlife Service); North England Zoological Society; Orangutan Project	This research was funded by an ARC Discovery Grant awarded to DAF and BWB (DP1096427). BG was supported by a Darwin Initiative for the Survival of Species (Grant no. 09-016, DEFRA, UK) and Cardiff University. KOCP is supported by Apenheul Primate Park, ZooParc de Beauval, Cleveland Metroparks Zoo, Chester Zoo, Columbus Zoo, Houston Zoo, Zoo de La Palmyre, Oregon Zoo, Philadelphia Zoo, Phoenix Zoo, Saint Louis Zoo, Utah's Hogle Zoo, Woodland Park Zoo, Abraham Foundation, Arcus Foundation, Balikpapan Orangutan Survival Foundation (NL), Shared Earth Foundation, Elephant Family Foundation, Ensemble Foundation, Mohamed bin Zayed Foundation, Shining Hope Foundation, World Women Work Foundation, the WoodTiger Fund, Wildlife Conservation Network, US Fish and Wildlife Services Great Ape Conservation Fund, North England Zoological Society and the Orangutan Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Alfred R., 2010, ONLINE J BIOL SCI, V10, P73; Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Bruford Michael W., 2010, Endangered Species Research, V12, P249, DOI 10.3354/esr00295; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Campbell-Smith G, 2012, J APPL ECOL, V49, P367, DOI 10.1111/j.1365-2664.2012.02109.x; Cannon CH, 2007, BIOTROPICA, V39, P747, DOI 10.1111/j.1744-7429.2007.00323.x; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; EASTMAN JR, 1995, PHOTOGRAMM ENG REM S, V61, P539; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Fordham DA, 2012, ECOGRAPHY, V35, P4, DOI 10.1111/j.1600-0587.2011.07398.x; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Hector A, 2011, PHILOS T R SOC B, V366, P3165, DOI 10.1098/rstb.2011.0174; Hill JK, 2011, PHILOS T R SOC B, V366, P3265, DOI 10.1098/rstb.2011.0050; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; MacKinnon J., 1974, SEARCH RED APE; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; O'Brien TG, 2003, ANIM CONSERV, V6, P115, DOI 10.1017/S1367943003003159; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Pyle JA, 2011, PHILOS T R SOC B, V366, P3210, DOI 10.1098/rstb.2011.0060; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Sabah Forestry Department, 2010, ANN REP 2010 SAB FOR; Shearman P, 2012, BIOL CONSERV, V151, P17, DOI 10.1016/j.biocon.2011.10.036; Singleton Ian, 2009, P205; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Takada T, 2010, LANDSCAPE ECOL, V25, P561, DOI 10.1007/s10980-009-9433-x; Tingley R, 2009, J BIOGEOGR, V36, P1656, DOI 10.1111/j.1365-2699.2009.02117.x; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X	48	20	20	3	170	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43846	10.1371/journal.pone.0043846	http://dx.doi.org/10.1371/journal.pone.0043846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970145	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000007
J	Han, NY; Liu, XW; Mu, YG				Han, Nanyu; Liu, Xuewei; Mu, Yuguang			Exploring the Mechanism of Zanamivir Resistance in a Neuraminidase Mutant: A Molecular Dynamics Study	PLOS ONE			English	Article							WELL-TEMPERED METADYNAMICS; INFLUENZA; SIMULATION; ENERGIES; VIRUSES; THREAT; PDBSUM; H5N1	It is critical to understand the molecular basis of the drug resistance of influenza viruses to efficiently treat this infectious disease. Recently, H1N1 strains of influenza A carrying a mutation of Q136K in neuraminidase were found. The new strain showed a strong Zanamivir neutralization effect. In this study, normal molecular dynamics simulations and metadynamics simulations were employed to explore the mechanism of Zanamivir resistance. The wild-type neuraminidase contained a 310 helix before the 150 loop, and there was interaction between the 150 and 430 loops. However, the helix and the interaction between the two loops were disturbed in the mutant protein due to interaction between K136 and nearby residues. Hydrogen-bond network analysis showed weakened interaction between the Zanamivir drug and E276/D151 on account of the electrostatic interaction between K136 and D151. Metadynamics simulations showed that the free energy landscape was different in the mutant than in the wild-type neuraminidase. Conformation with the global minimum of free energy for the mutant protein was different from the wild-type conformation. While the drug fit completely into the active site of the wild-type neuraminidase, it did not match the active site of the mutant variant. This study indicates that the altered hydrogen-bond network and the deformation of the 150 loop are the key factors in development of Zanamivir resistance. Furthermore, the Q136K mutation has a variable effect on conformation of different N1 variants, with conformation of the 1918 N1 variant being more profoundly affected than that of the other N1 variants studied in this paper. This observation warrants further experimental investigation.	[Han, Nanyu; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Liu, Xuewei] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Han, NY (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ygmu@ntu.edu.sg			IDA;  [NMRC/H1N1R/001/2009]	IDA; 	The support of research grants, NMRC/H1N1R/001/2009 and the IDA Cloud Computing Call for Project Proposals 2012 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Barducci A, 2010, BIOPHYS J, V98, pL44, DOI 10.1016/j.bpj.2010.01.033; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chachra R, 2008, J CHEM THEORY COMPUT, V4, P1526, DOI 10.1021/ct800068v; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Cossio P, 2010, J PHYS CHEM B, V114, P3259, DOI 10.1021/jp907464b; Crespo Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055701; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Duan S, 2011, ANTIMICROB AGENTS CH, V55, P4718, DOI 10.1128/AAC.00316-11; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Frisch G. W. T. M. J., 2009, GAUSSIAN 09; Gervasio FL, 2005, J AM CHEM SOC, V127, P2600, DOI 10.1021/ja0445950; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Micheletti C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.170601; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Oxford J, 2004, J ANTIMICROB CHEMOTH, V53, P133, DOI 10.1093/jac/dkh037; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith BJ, 2001, PROTEIN SCI, V10, P689, DOI 10.1110/ps.41801; Van Der Vries E, 2011, NEW ENGL J MED, V364, P1182; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	50	12	13	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44057	10.1371/journal.pone.0044057	http://dx.doi.org/10.1371/journal.pone.0044057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970161	Green Published, gold			2022-12-27	WOS:000308458400032
J	Stanhope, SA; Skol, AD				Stanhope, Stephen A.; Skol, Andrew D.			Improved Minimum Cost and Maximum Power Two Stage Genome-Wide Association Study Designs	PLOS ONE			English	Article							EFFICIENT; SNP	In a two stage genome-wide association study (2S-GWAS), a sample of cases and controls is allocated into two groups, and genetic markers are analyzed sequentially with respect to these groups. For such studies, experimental design considerations have primarily focused on minimizing study cost as a function of the allocation of cases and controls to stages, subject to a constraint on the power to detect an associated marker. However, most treatments of this problem implicitly restrict the set of feasible designs to only those that allocate the same proportions of cases and controls to each stage. In this paper, we demonstrate that removing this restriction can improve the cost advantages demonstrated by previous 2S-GWAS designs by up to 40%. Additionally, we consider designs that maximize study power with respect to a cost constraint, and show that recalculated power maximizing designs can recover a substantial amount of the planned study power that might otherwise be lost if study funding is reduced. We provide open source software for calculating cost minimizing or power maximizing 2S-GWAS designs.	[Stanhope, Stephen A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Skol, Andrew D.] Univ Chicago, Program Genet Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Stanhope, SA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	sstanhop@bsd.uchicago.edu						Gail MH, 2008, ANN HUM GENET, V72, P812, DOI 10.1111/j.1469-1809.2008.00467.x; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Kitamura N, 2008, J HUM GENET, V53, P390, DOI 10.1007/s10038-008-0258-2; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nguyen TT, 2009, ANN HUM GENET, V73, P638, DOI 10.1111/j.1469-1809.2009.00544.x; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pahl R, 2009, BIOSTATISTICS, V10, P297, DOI 10.1093/biostatistics/kxn036; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Scherag A, 2009, BIOMETRICS, V65, P815, DOI 10.1111/j.1541-0420.2008.01174.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Thomas D, 2004, GENET EPIDEMIOL, V27, P401, DOI 10.1002/gepi.20047; Thomas DC, 2009, STAT SCI, V24, P414, DOI 10.1214/09-STS288; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Van Steen K, 2011, STAT MED, V30, P2201, DOI 10.1002/sim.4259; Wang HS, 2006, COMPUT STAT DATA AN, V51, P457, DOI 10.1016/j.csda.2006.04.034	17	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e42367	10.1371/journal.pone.0042367	http://dx.doi.org/10.1371/journal.pone.0042367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970116	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400004
J	Ueti, MW; Mealey, RH; Kappmeyer, LS; White, SN; Kumpula-McWhirter, N; Pelzel, AM; Grause, JF; Bunn, TO; Schwartz, A; Traub-Dargatz, JL; Hendrickson, A; Espy, B; Guthrie, AJ; Fowler, WK; Knowles, DP				Ueti, Massaro W.; Mealey, Robert H.; Kappmeyer, Lowell S.; White, Stephen N.; Kumpula-McWhirter, Nancy; Pelzel, Angela M.; Grause, Juanita F.; Bunn, Thomas O.; Schwartz, Andy; Traub-Dargatz, Josie L.; Hendrickson, Amy; Espy, Benjamin; Guthrie, Alan J.; Fowler, W. Kent; Knowles, Donald P.			Re-Emergence of the Apicomplexan Theileria equi in the United States: Elimination of Persistent Infection and Transmission Risk	PLOS ONE			English	Article							PIROPLASMOSIS BABESIA-EQUI; IMIDOCARB DIPROPIONATE; BOOPHILUS-MICROPLUS; YELLOW-FEVER; HORSES; BUPARVAQUONE; EXPRESSION; RESERVOIRS; MOSQUITOS; EFFICACY	Arthropod-borne apicomplexan pathogens that cause asymptomatic persistent infections present a significant challenge due to their life-long transmission potential. Although anti-microbials have been used to ameliorate acute disease in animals and humans, chemotherapeutic efficacy for apicomplexan pathogen elimination from a persistently infected host and removal of transmission risk is largely unconfirmed. The recent re-emergence of the apicomplexan Theileria equi in U. S. horses prompted testing whether imidocarb dipropionate was able to eliminate T. equi from naturally infected horses and remove transmission risk. Following imidocarb treatment, levels of T. equi declined from a mean of 10(4.9) organisms/ml of blood to undetectable by nested PCR in 24 of 25 naturally infected horses. Further, blood transfer from treated horses that became nested PCR negative failed to transmit to naive splenectomized horses. Although these results were consistent with elimination of infection in 24 of 25 horses, T. equi-specific antibodies persisted in the majority of imidocarb treated horses. Imidocarb treatment was unsuccessful in one horse which remained infected as measured by nested PCR and retained the ability to infect a naive recipient via intravenous blood transfer. However, a second round of treatment eliminated T. equi infection. These results support the utility of imidocarb chemotherapy for assistance in the control and eradication of this tick-borne pathogen. Successful imidocarb dipropionate treatment of persistently infected horses provides a tool to aid the global equine industry by removing transmission risk associated with infection and facilitating international movement of equids between endemic and non-endemic regions.	[Ueti, Massaro W.; Kappmeyer, Lowell S.; White, Stephen N.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Ueti, Massaro W.; Mealey, Robert H.; White, Stephen N.; Kumpula-McWhirter, Nancy; Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Pelzel, Angela M.] Vet Serv, US Dept Agr Anim & Plant Hlth Inspect Serv, Western Reg Off, Ft Collins, CO USA; [Grause, Juanita F.; Bunn, Thomas O.] Vet Serv, Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Ames, IA USA; [Schwartz, Andy] Texas Anim Hlth Commiss, Austin, TX USA; [Traub-Dargatz, Josie L.] Colorado State Univ, Anim Populat Hlth Inst, Dept Clin Sci, Ft Collins, CO 80523 USA; [Hendrickson, Amy] Natl Assoc State Dept Agr, Washington, DC USA; [Espy, Benjamin] Equine Reprod, San Antonio, TX USA; [Guthrie, Alan J.] Univ Pretoria, Fac Vet Sci, Equine Res Ctr, ZA-0110 Onderstepoort, South Africa; [Fowler, W. Kent] Calif Dept Food & Agr, Sacramento, CA 95814 USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); Colorado State University; University of Pretoria; California Department of Food & Agriculture	Ueti, MW (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA USA.	massaro@vetmed.wsu.edu	Mealey, Robert/H-1454-2016; Guthrie, Alan/J-6375-2013; Kappmeyer, Lowell/AAF-2115-2020	Mealey, Robert/0000-0002-7571-1689; Guthrie, Alan/0000-0001-7729-9918; Kappmeyer, Lowell/0000-0002-4081-4995; White, Stephen N./0000-0001-9255-6054	United States Department of Agriculture-Agricultural Research Service [5348-32000-034-00D]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture-Agricultural Research Service 5348-32000-034-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LG, 1981, RES VET SCI, V31, P54, DOI 10.1016/S0034-5288(18)32521-9; Baird JK, 2003, TRENDS PARASITOL, V19, P115, DOI 10.1016/S1471-4922(03)00005-9; Bowman MC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000970; Bruning A, 1996, BRIT VET J, V152, P139, DOI 10.1016/S0007-1935(96)80070-4; Butler CM, 2008, VET PARASITOL, V151, P320, DOI 10.1016/j.vetpar.2007.11.010; Calder JAM, 1996, J CLIN MICROBIOL, V34, P2748, DOI 10.1128/JCM.34.11.2748-2755.1996; CHEEVERS WP, 1985, REV INFECT DIS, V7, P83; ERIKS IS, 1989, J CLIN MICROBIOL, V27, P279, DOI 10.1128/JCM.27.2.279-284.1989; FRERICHS WM, 1973, VET REC, V93, P73, DOI 10.1136/vr.93.3.73; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001; Gubbels MJ, 2001, PARASITOLOGY, V123, P553, DOI 10.1017/S0031182001008757; Holbrook A A, 1968, Proc Annu Meet U S Anim Health Assoc, V72, P220; Howell JM, 2007, J CLIN MICROBIOL, V45, P3155, DOI 10.1128/JCM.00766-07; Kumar S, 2003, J VET MED SCI, V65, P1171, DOI 10.1292/jvms.65.1171; KUTTLER KL, 1987, AM J VET RES, V48, P1613; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Nicolaiewsky TB, 2001, VET PARASITOL, V101, P9, DOI 10.1016/S0304-4017(01)00471-X; Palacpac NMQ, 2006, MOL BIOCHEM PARASIT, V150, P353, DOI 10.1016/j.molbiopara.2006.07.006; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Schwint ON, 2009, ANTIMICROB AGENTS CH, V53, P4327, DOI 10.1128/AAC.00404-09; Scoles GA, 2011, EMERG INFECT DIS, V17, P1903, DOI 10.3201/eid1710.101182; Short MA, 2012, JAVMA-J AM VET MED A, V240, P588, DOI 10.2460/javma.240.5.588; SIMPSON CF, 1980, AM J VET RES, V41, P267; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Stiller D, 2002, J MED ENTOMOL, V39, P667, DOI 10.1603/0022-2585-39.4.667; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Ueti MW, 2008, INFECT IMMUN, V76, P3525, DOI 10.1128/IAI.00251-08; Ueti MW, 2005, J CLIN MICROBIOL, V43, P3755, DOI 10.1128/JCM.43.8.3755-3759.2005; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197; ZAUGG JL, 1992, AM J VET RES, V53, P1396	35	39	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44713	10.1371/journal.pone.0044713	http://dx.doi.org/10.1371/journal.pone.0044713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970295	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400110
J	Zaritsky, A; Natan, S; Ben-Jacob, E; Tsarfaty, I				Zaritsky, Assaf; Natan, Sari; Ben-Jacob, Eshel; Tsarfaty, Ilan			Emergence of HGF/SF-Induced Coordinated Cellular Motility	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; COLLECTIVE MIGRATION; C-MET; CELLS; METASTASIS; MODEL; MICROENVIRONMENT; INVASION; BEHAVIOR; FORCES	Collective cell migration plays a major role in embryonic morphogenesis, tissue remodeling, wound repair and cancer invasion. Despite many decades of extensive investigations, only few analytical tools have been developed to enhance the biological understanding of this important phenomenon. Here we present a novel quantitative approach to analyze long term kinetics of bright field time-lapse wound healing. Fully-automated spatiotemporal measures and visualization of cells' motility and implicit morphology were proven to be sound, repetitive and highly informative compared to single-cell tracking analysis. We study cellular collective migration induced by tyrosine kinase-growth factor signaling (Met-Hepatocyte Growth Factor/Scatter Factor (HGF/SF)). Our quantitative approach is applied to demonstrate that collective migration of the adenocarcinoma cell lines is characterized by simple morpho-kinetics. HGF/SF induces complex morpho-kinetic coordinated collective migration: cells at the front move faster and are more spread than those further away from the wound edge. As the wound heals, distant cells gradually accelerate and enhance spread and elongation -resembling the epithelial to mesenchymal transition (EMT), and then the cells become more spread and maintain higher velocity than cells located closer to the wound. Finally, upon wound closure, front cells halt, shrink and round up (resembling mesenchymal to epithelial transition (MET) phenotype) while distant cells undergo the same process gradually. Met inhibition experiments further validate that Met signaling dramatically alters the morpho-kinetic dynamics of the healing wound. Machine-learning classification was applied to demonstrate the generalization of our findings, revealing even subtle changes in motility patterns induced by Met-inhibition. It is concluded that activation of Met-signaling induces an elaborated model in which cells lead a coordinated increased motility along with gradual differentiation-based collective cell motility dynamics. Our quantitative phenotypes may guide future investigation on the molecular and cellular mechanisms of tyrosine kinase-induced coordinate cell motility and morphogenesis in metastasis.	[Zaritsky, Assaf] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Natan, Sari; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Ben-Jacob, Eshel] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Rice University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University	Zaritsky, A (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	ilants@post.tau.ac.il		Natan, Sari/0000-0001-9419-3808; Zaritsky, Assaf/0000-0002-1477-5478; Tsarfaty, Ilan/0000-0002-5230-7093	Breast Cancer Research Foundation; Federico Foundation Grants; United States Israel Binational Science Foundation; Tauber Family Foundation; Division Of Physics [1308264] Funding Source: National Science Foundation	Breast Cancer Research Foundation; Federico Foundation Grants; United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Tauber Family Foundation; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by research grants from the Breast Cancer Research Foundation, the Federico Foundation Grants, the United States Israel Binational Science Foundation and the Tauber Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Crosswell HE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-411; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; Driscoll MK, 2012, AGING-US, V4, P119, DOI 10.18632/aging.100434; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Firon M, 2000, ONCOGENE, V19, P2386, DOI 10.1038/sj.onc.1203557; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; FU YX, 1990, CANCER RES, V50, P227; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gov NS, 2009, HFSP J, V3, P223, DOI 10.2976/1.3185785; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Inaki M, 2012, P NATL ACAD SCI USA, V109, P2027, DOI 10.1073/pnas.1115260109; Jung KH, 2012, ARCH PHARM RES, V35, P595, DOI 10.1007/s12272-012-0402-6; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loerke D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002677; Mark S, 2010, BIOPHYS J, V98, P361, DOI 10.1016/j.bpj.2009.10.022; Matsubayashi Y, 2011, J CELL SCI, V124, P1017, DOI 10.1242/jcs.080853; MCCORMACK SA, 1992, AM J PHYSIOL, V263, pG426, DOI 10.1152/ajpgi.1992.263.3.G426; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Reffay M, 2011, BIOPHYS J, V100, P2566, DOI 10.1016/j.bpj.2011.04.047; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Serra-Picamal X, 2012, NAT PHYS; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trepat X, 2011, TRENDS CELL BIOL; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Tsarfaty I, 2012, P NATL ACAD SCI USA, V109, P6790, DOI 10.1073/pnas.1202337109; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Yao D, 2011, MOL CANC RES; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zaritsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027593	51	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44671	10.1371/journal.pone.0044671	http://dx.doi.org/10.1371/journal.pone.0044671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970283	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400104
J	Imai, CM; Halldorsson, TI; Gunnarsdottir, I; Gudnason, V; Aspelund, T; Jonsson, G; Birgisdottir, BE; Thorsdottir, I				Imai, Cindy Mari; Halldorsson, Thorhallur Ingi; Gunnarsdottir, Ingibjorg; Gudnason, Vilmundur; Aspelund, Thor; Jonsson, Gudmundur; Birgisdottir, Bryndis Eva; Thorsdottir, Inga			Effect of Birth Year on Birth Weight and Obesity in Adulthood: Comparison between Subjects Born Prior to and during the Great Depression in Iceland	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CATCH-UP GROWTH; BODY-COMPOSITION; GLUCOSE-TOLERANCE; CHILDHOOD GROWTH; DUTCH FAMINE; SIZE; LIFE; POPULATION; CONSEQUENCES	Background: Many epidemiological studies have linked small size at birth to adverse adult health outcomes but the relative influence of environmental exposures is less well established. Methods: The authors investigated the impact of prenatal environmental exposure by comparing 2750 participants born before (1925-1929) and during (1930-1934) the Great Depression in Reykjavik, Iceland. Calendar year served as proxy for environmental effects. Anthropometric measurements at birth and school-age (8-13 years) were collected from national registries. Participants were medically examined as adults (33-65 years). Results: Mean birth weight, adjusted for maternal age and parity, decreased by 97 g (95% confidence interval (CI): 39, 156) for men and 70 g (95% CI: 11, 129) for women from 1925 to 1934; growth at school-age was significantly reduced for participants growing during the Depression. As adults, women prenatally exposed to the Depression had higher body mass index (Delta 0.6 kg/m(2), 95% CI: 0.2, 1.1), higher fasting blood glucose levels (Delta 0.16 mmol/L, 95% CI: 0.07, 0.23) and greater odds of being obese 1.43 (95% CI: 1.01, 2.02) compared to unexposed counterparts. Non-significant associations were observed in men. Conclusion: Reduction in birth weight due to rapid shifts in the economic environment appears to have a modest but significant association with later obesity for women while male offspring appear to be less affected by these conditions.	[Imai, Cindy Mari; Halldorsson, Thorhallur Ingi; Gunnarsdottir, Ingibjorg; Birgisdottir, Bryndis Eva; Thorsdottir, Inga] Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland; [Imai, Cindy Mari; Halldorsson, Thorhallur Ingi; Gunnarsdottir, Ingibjorg; Birgisdottir, Bryndis Eva; Thorsdottir, Inga] Univ Iceland, Fac Food Sci & Nutr, Sch Hlth Sci, Reykjavik, Iceland; [Gudnason, Vilmundur; Aspelund, Thor] Iceland Heart Assocat, Kopavogur, Iceland; [Gudnason, Vilmundur; Aspelund, Thor] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland; [Jonsson, Gudmundur] Univ Iceland, Fac Humanities, Dept Hist & Philosophy, Reykjavik, Iceland	Landspitali National University Hospital; University of Iceland; Icelandic Heart Association; University of Iceland; University of Iceland	Imai, CM (corresponding author), Landspitali Univ Hosp, Unit Nutr Res, Reykjavik, Iceland.	cmi1@hi.is	Gunnarsdottir, Ingibjorg/L-9371-2015; Aspelund, Thor/K-7022-2019; Birgisdottir, Bryndis E/M-1504-2015; Halldorsson, Tohrhallur/M-1823-2015; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Thorsdottir, Inga/M-3260-2015	Aspelund, Thor/0000-0002-7998-5433; Halldorsson, Tohrhallur/0000-0001-5115-0162; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Thorsdottir, Inga/0000-0002-2946-287X; Halldorsson, Thorhallur/0000-0002-3488-0777; Gunnarsdottir, Ingibjorg/0000-0001-9447-8627; Jonsson, Gudmundur/0000-0001-8539-3189; Birgisdottir, Bryndis Eva/0000-0002-5788-4551	University of Iceland Research Fund; Landspitali National University Hospital Research Fund	University of Iceland Research Fund; Landspitali National University Hospital Research Fund	Support was received from the University of Iceland Research Fund and Landspitali National University Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2001, BMJ-BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; BARTLEY M, 1994, BMJ-BRIT MED J, V309, P1475, DOI 10.1136/bmj.309.6967.1475; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Birgisdottir BE, 2002, AM J CLIN NUTR, V76, P399, DOI 10.1093/ajcn/76.2.399; Bjornsson B, 1941, ARBOK REYKJAVIKURBAE; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Gunnarsdottir I, 2004, EUR J CLIN NUTR, V58, P812, DOI 10.1038/sj.ejcn.1601881; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; Gunnarsdottir I, 2002, J HYPERTENS, V20, P623, DOI 10.1097/00004872-200204000-00018; Halldorsson TI, 2011, HYPERTENSION, V58, P8, DOI 10.1161/HYPERTENSIONAHA.111.170985; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Jonsson G, 1997, SOGULEGUR HAGTOLUR I; Jonsson G, 2004, EXPLORING EC GROWTH, P131; JuEnsson, 1998, SCANDINAVIAN EC HIST, V46, P24, DOI DOI 10.1080/03585522.1998.10414677; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Olafsdottir AS, 2005, BJOG-INT J OBSTET GY, V112, P424, DOI 10.1111/j.1471-0528.2005.00477.x; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Phillips DIW, 2005, DIABETES, V54, pS145, DOI 10.2337/diabetes.54.suppl_2.S145; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Portrait F, 2011, SOC SCI MED, V73, P711, DOI 10.1016/j.socscimed.2011.04.005; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Robinson R, 2001, BRIT MED J, V322, P375, DOI 10.1136/bmj.322.7283.375; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; van Abeelen AFM, 2012, AM J CLIN NUTR, V95, P179, DOI 10.3945/ajcn.111.022038; Vilbergsson S, 1997, DIABETIC MED, V14, P491, DOI 10.1002/(SICI)1096-9136(199706)14:6<491::AID-DIA365>3.0.CO;2-1; Weyer C, 2000, OBES RES, V8, P559, DOI 10.1038/oby.2000.72; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44551	10.1371/journal.pone.0044551	http://dx.doi.org/10.1371/journal.pone.0044551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957081	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800074
J	Pirone, A; Cozzi, B; Edelstein, L; Peruffo, A; Lenzi, C; Quilici, F; Antonini, R; Castagna, M				Pirone, Andrea; Cozzi, Bruno; Edelstein, Larry; Peruffo, Antonella; Lenzi, Carla; Quilici, Francesca; Antonini, Rita; Castagna, Maura			Topography of Gng2-and NetrinG2-Expression Suggests an Insular Origin of the Human Claustrum	PLOS ONE			English	Article							EXPRESSION; MONKEY; CONNECTIONS; ANATOMY; COMPLEX; CORTEX; CAT	The claustrum has been described in the forebrain of all mammals studied so far. It has been suggested that the claustrum plays a role in the integration of multisensory information: however, its detailed structure and function remain enigmatic. The human claustrum is a thin, irregular, sheet of grey matter located between the inner surface of the insular cortex and the outer surface of the putamen. Recently, the G-protein gamma2 subunit (Gng2) was proposed as a specific claustrum marker in the rat, and used to better delineate its anatomical boundaries and connections. Additional claustral markers proposed in mammals include Netrin-G2 in the monkey and latexin in the cat. Here we report the expression and distribution of Gng2 and Netrin-G2 in human post-mortem samples of the claustrum and adjacent structures. Gng2 immunoreactivity was detected in the neuropil of the claustrum and of the insular cortex but not in the putamen. A faint labelling was present also in the external and extreme capsules. Double-labelling experiments indicate that Gng2 is also expressed in glial cells. Netrin-G2 labelling was seen in neuronal cell bodies throughout the claustrum and the insular cortex but not in the medially adjacent putamen. No latexin immunoreactive element was detected in the claustrum or adjacent structures. Our results confirm that both the Gng2 and the Netrin-G2 proteins show an affinity to the claustrum and related formations also in the human brain. The presence of Gng2 and Netrin-G2 immunoreactive elements in the insular cortex, but not in the putamen, suggests a possible common ontogeny of the claustrum and insula.	[Cozzi, Bruno; Peruffo, Antonella] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Pirone, Andrea; Lenzi, Carla] Univ Pisa, Dept Physiol Sci, Pisa, Italy; [Quilici, Francesca; Antonini, Rita; Castagna, Maura] Univ Pisa, Dept Surg, Pisa, Italy	University of Padua; University of Pisa; University of Pisa	Cozzi, B (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	bruno.cozzi@unipd.it	PIRONE, ANDREA/S-7228-2019; Edelstein, Lawrence/K-6774-2012; Cozzi, Bruno/H-9618-2019	Edelstein, Lawrence/0000-0003-1885-4285; Cozzi, Bruno/0000-0002-7531-7040; PIRONE, ANDREA/0000-0001-6363-392X; Peruffo, Antonella/0000-0003-0454-9087				AMARAL DG, 1980, J COMP NEUROL, V189, P573, DOI 10.1002/cne.901890402; AMARAL DG, 1992, EXP BRAIN RES, V88, P375, DOI 10.1007/BF02259113; ARIKUNI T, 1985, Neuroscience Research, V2, P239, DOI 10.1016/0168-0102(85)90003-3; Arimatsu Y, 2009, NEUROSCIENCE, V162, P1398, DOI 10.1016/j.neuroscience.2009.05.060; Ashwell KWS, 2004, BRAIN BEHAV EVOLUT, V64, P223, DOI 10.1159/000080243; BRAND S, 1981, ANAT EMBRYOL, V162, P475, DOI 10.1007/BF00301872; CAREY RG, 1985, BRAIN RES, V329, P185, DOI 10.1016/0006-8993(85)90524-4; CARMAN JB, 1964, J NEUROL NEUROSUR PS, V27, P46, DOI 10.1136/jnnp.27.1.46; Chang-Seon M, 2006, MOL PHARM, V69, P877; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; DINOPOULOS A, 1992, J COMP NEUROL, V316, P187, DOI 10.1002/cne.903160205; Edelstein LR, 2004, CELL MOL BIOL, V50, P675; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Filimonoff I N, 1966, J Hirnforsch, V8, P503; Kowianski P, 1999, BRAIN BEHAV EVOLUT, V53, P44, DOI 10.1159/000006581; LEVAY S, 1981, J NEUROSCI, V1, P956; Mathur BN, 2009, CEREB CORTEX, V19, P2372, DOI 10.1093/cercor/bhn253; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Miyashita T, 2005, NEUROSCIENCE, V136, P487, DOI 10.1016/j.neuroscience.2005.08.025; MORYS J, 1993, BRAIN RES, V616, P176, DOI 10.1016/0006-8993(93)90207-4; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; RAE A S, 1954, Confin Neurol, V14, P211; RAE ASL, 1954, J COMP NEUROL, V100, P15, DOI 10.1002/cne.901000103; Tanne-Gariepy J, 2002, J COMP NEUROL, V454, P140, DOI 10.1002/cne.10425; Wasilewska B, 2001, Folia Morphol (Warsz), V60, P41; Watakabe A, 2009, DEV GROWTH DIFFER, V51, P343, DOI 10.1111/j.1440-169X.2008.01085.x	27	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44745	10.1371/journal.pone.0044745	http://dx.doi.org/10.1371/journal.pone.0044745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957104	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800097
J	Su, HM; Lin, TH; Hsu, PC; Chu, CY; Lee, WH; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Abnormally Low and High Ankle-Brachial Indices Are Independently Associated with Increased Left Ventricular Mass Index in Chronic Kidney Disease	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; VASCULAR-DISEASE; RISK-FACTORS; ALL-CAUSE; PREVALENCE; MORTALITY; HYPERTROPHY; ATHEROSCLEROSIS; RECOMMENDATIONS; CALCIFICATION	Abnormally low and high ankle-brachial indices (ABIs) are associated with high cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD), but the mechanisms responsible for the association are not fully known. This study is designed to assess whether there is a significant correlation between abnormal ABI and echocariographic parameters in patients with CKD stages 3-5. A total of 684 pre-dialysis CKD patients were included in the study. The ABI was measured using an ABI-form device. Patients were classified into ABI <0.9, >= 0.9 to <1.3, and >= 1.3. Clinical and echocariographic parameters were compared and analyzed. Compared with patients with ABI of >= 0.9 to <1.3, the values of left ventricular mass index (LVMI) were higher in patients with ABI <0.9 and ABI >= 1.3 (P <= 0.004). After the multivariate analysis, patients with ABI <0.9 (beta=0.099, P=0.004) and ABI >= 1.3 (beta=0.143, P<0.001) were independently associated with increased LVMI. Besides, increased LVMI (odds ratio, 1.017; 95% confidence interval, 1.002 to 1.033; P=0.031) was also significantly associated with ABI <0.9 or ABI >= 1.3. Our study in patients of CKD stages 3-5 demonstrated abnormally low and high ABIs were positively associated with LVMI. Future studies are required to determine whether increased LVMI is a causal intermediary between abnormal ABI and adverse cardiovascular outcomes in CKD.	[Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Div Cardiol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Div Nephrol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Fac Mecicine, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Div Cardiol, Dept Internal Med, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X				Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Chen JH, 2009, KAOHSIUNG J MED SCI, V25, P366, DOI 10.1016/S1607-551X(09)70529-7; Chen SC, 2012, HYPERTENS RES; Chen SC, 2012, NEPHROL DIAL TRANSPL, V27, P1064, DOI 10.1093/ndt/gfr407; Chen SC, 2012, AM J MED SCI, V343, P109, DOI 10.1097/MAJ.0b013e318223e814; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; de Albuquerque PF, 2012, ARQ BRAS CARDIOL, V98, P84, DOI 10.1590/S0066-782X2012000100013; de Vinuesa SG, 2005, KIDNEY INT, V67, pS44, DOI 10.1111/j.1523-1755.2005.09310.x; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Hasimu B, 2006, HYPERTENS RES, V29, P23, DOI 10.1291/hypres.29.23; Ix JH, 2010, J AM COLL CARDIOL, V55, P342, DOI 10.1016/j.jacc.2009.11.010; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Nardi E, 2012, HYPERTENS RES; Niederhoffer N, 1997, HYPERTENSION, V29, P999, DOI 10.1161/01.HYP.29.4.999; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; O'Hare AM, 2004, CIRCULATION, V109, P320, DOI 10.1161/01.CIR.0000114519.75433.DD; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; ORCHARD TJ, 1993, DIABETES CARE, V16, P1199, DOI 10.2337/diacare.16.8.1199; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; ROMAN MJ, 1995, J AM COLL CARDIOL, V25, P83, DOI 10.1016/0735-1097(94)00316-I; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; WEBB AT, 1993, EUR J VASCULAR SURG, V7, P523, DOI 10.1016/S0950-821X(05)80364-0; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253	37	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44732	10.1371/journal.pone.0044732	http://dx.doi.org/10.1371/journal.pone.0044732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957102	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800095
J	Zhang, JL; Chen, GW; Liu, YC; Wang, PY; Wang, X; Wan, YL; Zhu, J; Gao, HQ; Yin, J; Wang, W; Tian, ML				Zhang, Jun-Ling; Chen, Guo-Wei; Liu, Yu-Cun; Wang, Peng-Yuan; Wang, Xin; Wan, Yuan-Lian; Zhu, Jing; Gao, Hong-Qiao; Yin, Jie; Wang, Wei; Tian, Mao-Lin			Secreted Protein Acidic and Rich in Cysteine (SPARC) Suppresses Angiogenesis by Down-Regulating the Expression of VEGF and MMP-7 in Gastric Cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; GROWTH-FACTOR; PROGRESSION	Background: Secreted protein acidic and rich in cysteine (SPARC) is a glycoprotein that functions to inhibit angiogenesis, proliferation, and invasion in different types of cancer. The ability of SPARC to modulate neovascularisation is believed to be mediated in part by its ability to modulate the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). In this study, we aimed to determine the effect of SPARC expression in gastric cancer cells on proliferation and angiogenesis in vitro and in vivo. Method: We evaluated expression of SPARC in seven human gastric cancer cell lines. Then we established a stably transfected SPARC overexpressed cell line (BGC-SP) and a stably transfected SPARC knock-down cell line (HGC-sh). The effect of SPARC overexpression and SPARC silencing was studied by examining capillary formation of HUVECs in vitro and a dorsal skin-fold chamber model in vivo. Quantitative real-time PCR and western blotting were performed to detect if the expressions of VEGF and MMP-7 were modulated by SPARC expression. To further determine the effect of SPARC expression on angiogenesis in vivo, xenograft models were established and microvessel density (MVD) of different clones were detected by immunohistochemistry. Results: Endogenous SPARC overexpression inhibited the expression of VEGF and MMP-7, as well as the angiogenesis induced by BGC-SP cells. Correspondingly, SPARC silencing increased the expression of VEGF and MMP-7, as well as the angiogenesis induced by HGC-sh cells. Elevated angiogenesis induced by SPARC silencing in HGC-sh cells was decreased when VEGF was neutralised by antibodies, and MMP-7 was knocked down in vitro. Conclusion: SPARC suppresses angiogenesis of gastric cancer by down-regulating the expression of VEGF and MMP-7.	[Zhang, Jun-Ling; Chen, Guo-Wei; Liu, Yu-Cun; Wang, Peng-Yuan; Wang, Xin; Wan, Yuan-Lian; Zhu, Jing; Gao, Hong-Qiao; Yin, Jie; Wang, Wei; Tian, Mao-Lin] Peking Univ, Dept Gen Surg, Hosp 1, Beijing 100871, Peoples R China	Peking University	Zhang, JL (corresponding author), Peking Univ, Dept Gen Surg, Hosp 1, Beijing 100871, Peoples R China.	yucunliu@bjmu.edu.cn			National Natural Science Foundation of China [30901417/H1617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 30901417/H1617). http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bhoopathi P, 2010, BRIT J CANCER, V102, P530, DOI 10.1038/sj.bjc.6605538; Chen G, 2010, BRIT J CANCER, V102, P188, DOI 10.1038/sj.bjc.6605440; Chlenski A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-138; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Franke K, 2009, TRANSL ONCOL, V2, P310, DOI 10.1593/tlo.09169; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Huo N, 2002, CANCER LETT, V177, P95, DOI 10.1016/S0304-3835(01)00772-8; Jia ZC, 2012, INT J COLORECTAL DIS, V27, P437, DOI 10.1007/s00384-011-1351-0; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lau CPY, 2006, J PATHOL, V210, P459, DOI 10.1002/path.2068; Liang JF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-71; Nishizuka I, 2001, CANCER LETT, V173, P175, DOI 10.1016/S0304-3835(01)00634-6; Ordonez JL, 2005, MELANOMA RES, V15, P495, DOI 10.1097/00008390-200512000-00003; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Said N, 2007, MOL CANCER RES, V5, P1015, DOI 10.1158/1541-7786.MCR-07-0001; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Wang CS, 2004, BRIT J CANCER, V91, P1924, DOI 10.1038/sj.bjc.6602213; Wang LF, 2012, PATHOL ONCOL RES, V18, P697, DOI 10.1007/s12253-012-9497-9; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Yan M, 2004, PATHOBIOLOGY, V71, P253, DOI 10.1159/000080059; Yunker CK, 2008, INT J CANCER, V122, P2735, DOI 10.1002/ijc.23450	25	41	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44618	10.1371/journal.pone.0044618	http://dx.doi.org/10.1371/journal.pone.0044618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957090	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800083
J	Crolla, RMPH; van der Laan, L; Veen, EJ; Hendriks, Y; van Schendel, C; Kluytmans, J				Crolla, Rogier M. P. H.; van der Laan, Lijckle; Veen, Eelco J.; Hendriks, Yvonne; van Schendel, Caroline; Kluytmans, Jan			Reduction of Surgical Site Infections after Implementation of a Bundle of Care	PLOS ONE			English	Article							INTERVENTION	Background: Surgical Site Infections (SSI) are relatively frequent complications after colorectal surgery and are associated with substantial morbidity and mortality. Objective: Implementing a bundle of care and measuring the effects on the SSI rate. Design: Prospective quasi experimental cohort study. Methods: A prospective surveillance for SSI after colorectal surgery was performed in the Amphia Hospital, Breda, from January 1, 2008 until January 1, 2012. As part of a National patient safety initiative, a bundle of care consisting of 4 elements covering the surgical process was introduced in 2009. The elements of the bundle were perioperative antibiotic prophylaxis, hair removal before surgery, perioperative normothermia and discipline in the operating room. Bundle compliance was measured every 3 months in a random sample of surgical procedures. Results: Bundle compliance improved significantly from an average of 10% in 2009 to 60% in 2011. 1537 colorectal procedures were performed during the study period and 300 SSI (19.5%) occurred. SSI were associated with a prolonged length of stay (mean additional length of stay 18 days) and a significantly higher 6 months mortality (Adjusted OR: 2.71, 95% confidence interval 1.76-4.18). Logistic regression showed a significant decrease of the SSI rate that paralleled the introduction of the bundle. The adjusted Odds ratio of the SSI rate was 36% lower in 2011 compared to 2008. Conclusion: The implementation of the bundle was associated with improved compliance over time and a 36% reduction of the SSI rate after adjustment for confounders. This makes the bundle an important tool to improve patient safety.	[Crolla, Rogier M. P. H.; van der Laan, Lijckle; Veen, Eelco J.] Amphia Hosp, Dept Surg, Breda, Netherlands; [Hendriks, Yvonne; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands	Amphia Hospital; Amphia Hospital; Vrije Universiteit Amsterdam	Crolla, RMPH (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	jankluytmans@gmail.com	Crolla, Rogier/L-9847-2019	Crolla, Rogier/0000-0003-2617-1791; van der laan, lijckle/0000-0001-5631-594X				Anthony T, 2011, ARCH SURG-CHICAGO, V146, P263, DOI 10.1001/archsurg.2010.249; Berenholtz SM, 2011, INFECT CONT HOSP EP, V32, P305, DOI 10.1086/658938; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Bull A, 2011, J HOSP INFECT, V78, P297, DOI 10.1016/j.jhin.2011.03.029; de Bruijne M., 2007, ONBEDOELDE SCHADE NE; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Frederik J, 2011, NED TIJDSCHR GENEES, V155, pA3269; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Kurmann A, 2011, BRIT J SURG, V98, P1021, DOI 10.1002/bjs.7496; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115	11	80	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44599	10.1371/journal.pone.0044599	http://dx.doi.org/10.1371/journal.pone.0044599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962619	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600072
J	Zhou, XY; Liu, ZQ; Jang, F; Xiang, CN; Li, Y; He, YZ				Zhou, Xiangyu; Liu, Zhiqiang; Jang, Feng; Xiang, Chuannan; Li, Yuan; He, Yanzheng			Autocrine Sonic Hedgehog Attenuates Inflammation in Cerulein-Induced Acute Pancreatitis in Mice via Upregulation of IL-10	PLOS ONE			English	Article							DISEASED PANCREAS; DOWN-REGULATION; INTERLEUKIN-10; ACTIVATION; CANCER; CELLS; PATHWAY; INJURY; TISSUE	Hedgehog signaling plays critical roles in pancreatic oncogenesis and chronic pancreatitis, but its roles in acute pancreatitis (AP) are largely ambiguous. In this study, we provide evidence that Sonic hedgehog (Shh), but neither Desert hedgehog (Dhh) nor Indian hedgehog (Ihh), is the main protein whose expression is activated during the development of ceruleininduced acute pancreatitis in mice, and the Shh serves as an anti-inflammation factor in an autocrine manner. Blocking autocrine Shh signaling with anti-Shh neutralizing antibody aggravates the progression of acute pancreatitis. Mechanistic insight into Shh signaling activation in acute pancreatitis indicates that inflammatory stimulation activates Shh expression and secretion, and subsequently upregulates the expression and secretion of interleukin-10 (IL-10). Moreover, inhibition of Shh signaling with neutralizing antibody abolishes IL-10 production in vivo and in vitro. Molecular biological studies show that autocrine Shh signaling activates the key transcriptional factor Gli1 so that the target gene IL-10 is upregulated, leading to the protective and anti-inflammatory functions in the mouse model of acute pancreatitis. Thus, this study suggests autocrine Shh signaling functions as a protective signaling in the progression of acute pancreatitis.	[Zhou, Xiangyu; He, Yanzheng] Luzhou Med Coll, Affiliated Hosp, Dept Vasc Surg, Luzhou, Sichuan, Peoples R China; [Liu, Zhiqiang] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Div Canc Med, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Jang, Feng] Luzhou Med Coll, Affiliated Hosp, Dept Cardiol, Luzhou, Sichuan, Peoples R China; [Xiang, Chuannan] Luzhou Peoples Hosp, Dept Gen Surg, Luzhou, Sichuan, Peoples R China; [Li, Yuan] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Inst Digest Surg, Chengdu, Peoples R China	Southwest Medical University; University of Texas System; UTMD Anderson Cancer Center; Southwest Medical University; Sichuan University	He, YZ (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Vasc Surg, Luzhou, Sichuan, Peoples R China.	heyanzheng2012@gmail.com	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097	National Natural Science Foundation of China [81100272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by grants from the National Natural Science Foundation of China (81100272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Blinman TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1993, DOI 10.1152/ajpcell.2000.279.6.C1993; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Franco-Pons N, 2010, J PATHOL, V221, P175, DOI 10.1002/path.2691; Guy CD, 2011, HEPTAOLOGY; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Heiser PW, 2004, CELL CYCLE, V3, P270; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; Kawahira H, 2003, DEVELOPMENT, V130, P4871, DOI 10.1242/dev.00653; Kayed H, 2005, MOL CARCINOGEN, V42, P183, DOI 10.1002/mc.20088; Kayed H, 2003, J ENDOCRINOL, V178, P467, DOI 10.1677/joe.0.1780467; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Keceli M, 2005, J INVEST SURG, V18, P7, DOI 10.1080/08941930590905080; Kylanpaa ML, 2010, WORLD J GASTROENTERO, V16, P2867, DOI 10.3748/wjg.v16.i23.2867; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Omenetti A, 2008, AM J PHYSIOL-GASTR L, V294, pG595, DOI 10.1152/ajpgi.00543.2007; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Shifrin AL, 2005, PANCREAS, V30, P122, DOI 10.1097/01.mpa.0000151578.99413.88; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Van Dop WA, 2010, GASTROENTEROLOGY, V138, P426, DOI 10.1053/j.gastro.2009.12.013; Van Laethem JL, 1998, GUT, V43, P408, DOI 10.1136/gut.43.3.408; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Wan MH, 2012, HPB, V14, P73, DOI 10.1111/j.1477-2574.2011.00408.x; Warzecha Z, 2003, J PHYSIOL PHARMACOL, V54, P575; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zhou XY, 2009, TOHOKU J EXP MED, V217, P279, DOI 10.1620/tjem.217.279	36	31	33	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44121	10.1371/journal.pone.0044121	http://dx.doi.org/10.1371/journal.pone.0044121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956998	gold, Green Submitted, Green Published			2022-12-27	WOS:000308206500047
J	Hulgan, T; Robbins, GK; Kalams, SA; Samuels, DC; Grady, B; Shafer, R; Murdock, DG; Selph, D; Haas, DW; Pollard, RB				Hulgan, Todd; Robbins, Gregory K.; Kalams, Spyros A.; Samuels, David C.; Grady, Benjamin; Shafer, Robert; Murdock, Deborah G.; Selph, Doug; Haas, David W.; Pollard, Richard B.		AIDS Clinical Trials Grp	T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; SEQUENTIAL 3-DRUG REGIMENS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; COUNT RECOVERY; PERIPHERAL NEUROPATHY; VIROLOGICAL RESPONSE; INITIAL THERAPY; APOPTOSIS	Introduction: Mitochondrial function influences T cell dynamics and is affected by mitochondrial DNA (mtDNA) variation. We previously reported an association between African mtDNA haplogroup L2 and less robust CD4 cell recovery on antiretroviral therapy (ART) in non-Hispanic black ACTG 384 subjects. We explored whether additional T cell parameters in this cohort differed by mtDNA haplogroup. Methods: ACTG 384 randomized ART-naive subjects to two different nucleoside regimens with efavirenz, nelfinavir, or both. CD4 and CD8 memory and activation markers were available at baseline and week 48 on most subjects. mtDNA sequencing was performed on whole blood DNA, and haplogroups were determined. We studied non-Hispanic black subjects with HIV RNA <400 copies/mL at week 48. Analyses included Wilcoxon ranksum test and linear regression. Results: Data from 104 subjects were included. Major African mtDNA haplogroups included L1 (N = 25), L2 (N = 31), and L3 (N = 32). Baseline age, HIV RNA, and CD4 cells did not differ between L2 and non-L2 haplogroups. Compared to non-L2 haplogroups, L2 subjects had lower baseline activated CD4 cells (median 12% vs. 17%; p = 0.03) and tended toward lower activated CD8 cells (41% vs. 47%; p = 0.06). At 48 weeks of ART, L2 subjects had smaller decreases in activated CD4 cells (-4% vs. -11%; p = 0.01), and smaller CD4 cell increases (+95 vs. +178; p = 0.002). In models adjusting for baseline age, CD4 cells, HIV RNA, and naive-to-memory CD4 cell ratio, haplogroup L2 was associated with lower baseline (p = 0.04) and 48-week change in (p = 0.01) activated CD4 cells. Conclusions: Among ART-naive non-Hispanic blacks, mtDNA haplogroup L2 was associated with baseline and 48-week change in T cell activation, and poorer CD4 cell recovery. These data suggest mtDNA variation may influence CD4 T cell dynamics by modulating T cell activation. Further study is needed to replicate these associations and identify mechanisms.	[Hulgan, Todd; Kalams, Spyros A.; Samuels, David C.; Grady, Benjamin; Murdock, Deborah G.; Selph, Doug; Haas, David W.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Robbins, Gregory K.] Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Shafer, Robert] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Pollard, Richard B.] Univ Calif Davis, Sacramento, CA 95817 USA	Vanderbilt University; Harvard University; Massachusetts General Hospital; Stanford University; University of California System; University of California Davis	Hulgan, T (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	todd.hulgan@vanderbilt.edu	Samuels, David/C-1365-2012; Hulgan, Todd/B-3947-2014; Murdock, Deborah/C-3483-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022; Hulgan, Todd/AAG-7491-2019	Hulgan, Todd/0000-0002-3339-067X; Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Robbins, Gregory/0000-0001-7545-5817	National Institutes of Health (NIH)/National Institute of Neurological Diseases and Stroke [NS059330]; National Institute of Allergy and Infectious Diseases [U01AI068636]; National Institute of Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); Agouron/Pfizer; Bristol Myers Squibb; GlaxoSmithKline; NIH [AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, AI32782, AI27661, AI25859, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR000445]; Merck; Gilead Sciences; Schering-Plough; Boehringer-Ingelheim; National Institutes of Health [AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI069502, AI069419, AI077505, AI54999, HL087726, AI69495, 5T32GM80178, AI062435];  [AI38858]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069472, UM1AI069452, U01AI069513, UM1AI069424, UM1AI069501, UM1AI069511, P30AI054999, U01AI038858, UM1AI069471, U01AI069502, UM1AI069434, UM1AI069472, U01AI046370, UM1AI069428, U01AI069452, U01AI069477, UM1AI069513, U01AI069484, U01AI069424, UM1AI069450, UM1AI069532, U01AI069474, UM1AI069467, U01AI027661, U01AI038844, U01AI068636, U01AI069471, UM1AI069415, UM1AI069556, U01AI069501, U01AI069423, U01AI069532, U01AI034853, U01AI025859, U01AI069511, UM1AI069484, U01AI069428, U01AI069432, UM1AI069502, U01AI069495, UM1AI069465, UM1AI069432, UM1AI069495, U01AI069434, UM1AI069419, U01AI069465, U01AI069450, U01AI069415, K01AI062435, U01AI034835, U01AI069467, U01AI069556, UM1AI069474, U01AI069419, UM1AI069423, R01AI077505, UM1AI069477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059330] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Neurological Diseases and Stroke; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Agouron/Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Merck(Merck & Company); Gilead Sciences(Gilead Sciences); Schering-Plough(Merck & CompanySchering Plough Corporation); Boehringer-Ingelheim(Boehringer Ingelheim); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for the genomic sequencing was provided by the National Institutes of Health (NIH)/National Institute of Neurological Diseases and Stroke grant NS059330. The project described was also supported by Award Number U01AI068636 from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH), and National Institute of Dental and Craniofacial Research (NIDCR). AIDS Clinical Trials Group (ACTG) Study 384 was also supported by grant AI38858, and by Agouron/Pfizer, Bristol Myers Squibb, and GlaxoSmithKline. The ACTG sites contributing DNA for these analyses were funded by NIH grants AI069513, AI34835, AI069432, AI069423, AI069477, AI069501, AI069474, AI069428, AI69467, AI069415, AI32782, AI27661, AI25859, AI069495, AI069471, AI069532, AI069452, AI069450, AI069556, AI069484, AI069472, AI34853, AI069465, AI069511, AI38844, AI069424, AI069434, AI46370, AI069502, and AI069419. The ACTG Human DNA Repository is also supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1 TR000445. Additional NIH grant support included: AI077505, AI54999, HL087726, AI69495, 5T32GM80178 and AI062435. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: TH has received research support from Merck. GKR has received research support from Gilead Sciences, Schering-Plough. DWH has received research grants from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and Merck, and has served as a consultant for Boehringer-Ingelheim. AIDS Clinical Trials Group (ACTG) Study 384 was also supported in part by Agouron/Pfizer, Bristol Myers Squibb, and GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Badley AD, 2003, TRENDS PHARMACOL SCI, V24, P298, DOI 10.1016/S0165-6147(03)00125-1; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Casula M, 2007, J INFECT DIS, V196, P371, DOI 10.1086/519284; Chavan SJ, 1999, CLIN IMMUNOL, V93, P24, DOI 10.1006/clim.1999.4770; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Grady BJ, 2011, JAIDS-J ACQ IMM DEF, V58, P363, DOI 10.1097/QAI.0b013e31822c688b; Grimaldi Marina, 2005, Curr Opin Investig Drugs, V6, P1095; GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Haas DW, 2003, HIV CLIN TRIALS, V4, P287, DOI 10.1310/MUQC-QXBC-8118-BPM5; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Johnson N, 1998, CLIN EXP IMMUNOL, V113, P229; Kallianpur AR, 2006, AIDS, V20, P1503, DOI 10.1097/01.aids.0000237366.56864.3c; Karamchand L, 2008, JAIDS-J ACQ IMM DEF, V48, P381, DOI 10.1097/QAI.0b013e3181799662; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krishnan S, 2011, ONCOLOGY-BASEL, V80, P42, DOI 10.1159/000328032; Maagaard A, 2006, HIV MED, V7, P53, DOI 10.1111/j.1468-1293.2005.00336.x; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Mancuso Michelangelo, 2008, Human Genomics, V3, P71; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; Motsinger AA, 2006, PHARMACOGENET GENOM, V16, P837, DOI 10.1097/01.fpc.0000230413.97596.fa; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Nasi M, 2005, IMMUNOGENETICS, V57, P628, DOI 10.1007/s00251-005-0031-z; Nasi M, 2008, CLIN INFECT DIS, V47, P962, DOI 10.1086/591706; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Nishigaki Y, 2010, GERIATR GERONTOL INT, V10, pS221, DOI 10.1111/j.1447-0594.2010.00599.x; Peraire J, 2007, CURR HIV RES, V5, P467, DOI 10.2174/157016207781662452; Petit F, 2003, BIOCHIMIE, V85, P795, DOI 10.1016/j.biochi.2003.09.007; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; Rigato PO, 2008, CURR HIV RES, V6, P466, DOI 10.2174/157016208785861131; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Soria A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027349; Sternfeld T, 2009, HIV MED, V10, P512, DOI 10.1111/j.1468-1293.2009.00723.x; Sternfeld T, 2007, ANTIVIR THER, V12, P769; Varbanov M, 2006, AIDS REV, V8, P221; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798	61	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2012	7	8							e43803	10.1371/journal.pone.0043803	http://dx.doi.org/10.1371/journal.pone.0043803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	995WH	22970105	Green Published, gold, Green Submitted			2022-12-27	WOS:000308044800061
J	Chadha, VK; Kumar, P; Anjinappa, S; Singh, S; Narasimhaiah, S; Joshi, MV; Gupta, J; Lakshminarayana; Ramchandra, J; Velu, M; Papkianathan, S; Babu, S; Krishna, H				Chadha, Vineet K.; Kumar, Prahlad; Anjinappa, SharadaM.; Singh, Sanjay; Narasimhaiah, Somashekar; Joshi, Malathi V.; Gupta, Joydev; Lakshminarayana; Ramchandra, Jitendra; Velu, Magesh; Papkianathan, Suganthi; Babu, Suseendra; Krishna, Hemalatha			Prevalence of Pulmonary Tuberculosis among Adults in a Rural Sub-District of South India	PLOS ONE			English	Article							DECLINE; DOTS	Background: We conducted a survey to estimate point prevalence of bacteriologically positive pulmonary TB (PTB) in a rural area in South India, implementing TB program DOTS strategy since 2002. Methods: Survey was conducted among persons >= 15 years of age in fifteen clusters selected by simple random sampling; each consisting of 5-12 villages. Persons having symptoms suggestive of PTB or history of anti-TB treatment (ATT) were eligible for sputum examination by smear microscopy for Acid Fast Bacilli and culture for Mycobacterium tuberculosis; two sputum samples were collected from each eligible person. Persons with one or both sputum specimen positive on microscopy and/or culture were labeled suffering from PTB. Prevalence was estimated after imputing missing values to correct for bias introduced by incompleteness of data. In six clusters, registered persons were also screened by X-ray chest. Persons with any abnormal shadow on X-ray were eligible for sputum examination in addition to those with symptoms and ATT. Multiplication factor calculated as ratio of prevalence while using both screening tools to prevalence using symptoms screening alone was applied to entire study population to estimate prevalence corrected for non-screening by X-ray. Results: Of 71,874 residents >= 15 years of age, 63,362 (88.2%) were screened for symptoms and ATT. Of them, 5120 (8.1%) 4681 (7.4%) with symptoms and an additional 439 (0.7%) with ATT were eligible for sputum examination. Spot specimen were collected from 4850 (94.7%) and early morning sputum specimens from 4719 (92.2%). Using symptom screening alone, prevalence of smear, culture and bacteriologically positive PTB in persons >= 15 years of age was 83 (CI: 57-109), 152 (CI: 108-197) and 196 (CI : 145-246) per 100,000 population respectively. Prevalence corrected for non-screening by X-ray was 108 (CI: 82-134), 198 (CI: 153-243) and 254 (CI: 204-301) respectively. Conclusion: Observed prevalence suggests further strengthening of TB control program.	[Chadha, Vineet K.; Anjinappa, SharadaM.; Singh, Sanjay; Gupta, Joydev; Lakshminarayana; Velu, Magesh; Papkianathan, Suganthi] Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India; [Kumar, Prahlad] Natl TB Inst, Off Director, Bangalore, Karnataka, India		Chadha, VK (corresponding author), Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India.	vineet2.chadha@gmail.com			World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	Survey was undertaken with available human and capital resources already available in the institute, supplemented by funding of 11700000 Indian Rupees from World Health Organization (WHO) for supplies and additional manpower. Website of WHO India is whoindia.org/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India], 2012, REV NAT TUB CONTR PR; [Central TB Division Directorate General Health Services Ministry of Health and Family Welfare Government of India], 2012, TB IND 2012 REV NAT; Chadha VK, 2011, EPIDEMIOLOGY PULMONA, P489; Chen XY, 2004, LANCET, V364, P417; Gopi P. G., 1997, Indian Journal of Tuberculosis, V44, P171; Gopi P. G., 1999, Indian Journal of Tuberculosis, V46, P261; Gopi PG, 2006, INT J TUBERC LUNG D, V10, P343; Gothi G.D., 1974, INDIAN J TUBERC, V21, P90; GOTHI GD, 1976, INDIAN J MED RES, V64, P1150; Indian Council of Medical Research, 1959, ICMR SPECIAL REPORT, V34; Khatri GR, 2000, INT J TUBERC LUNG D, V4, P193; Manjula Datta, 2000, Indian Journal of Tuberculosis, V47, P147; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Styblo K., 1991, EPIDEMIOLOGY TUBERCU, V24; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; WHO, 2011, WHOHTMTB201017; *WHO, 1992, TUB PROGR REV IND; World Health Organization, 2012, SEATB338 WHO	20	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42625	10.1371/journal.pone.0042625	http://dx.doi.org/10.1371/journal.pone.0042625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22956993	Green Published, Green Submitted, gold			2022-12-27	WOS:000307823600020
J	Reiss, DJ; Howard, FM; Mobley, HLT				Reiss, Daniel J.; Howard, Frederick M.; Mobley, Harry L. T.			A Novel Approach for Transcription Factor Analysis Using SELEX with High-Throughput Sequencing (TFAST)	PLOS ONE			English	Article							DNA; ALIGNMENT; LIGANDS; TOOL	Background: In previous work, we designed a modified aptamer-free SELEX-seq protocol (afSELEX-seq) for the discovery of transcription factor binding sites. Here, we present original software, TFAST, designed to analyze afSELEX-seq data, validated against our previously generated afSELEX-seq dataset and a model dataset. TFAST is designed with a simple graphical interface (Java) so that it can be installed and executed without extensive expertise in bioinformatics. TFAST completes analysis within minutes on most personal computers. Methodology: Once afSELEX-seq data are aligned to a target genome, TFAST identifies peaks and, uniquely, compares peak characteristics between cycles. TFAST generates a hierarchical report of graded peaks, their associated genomic sequences, binding site length predictions, and dummy sequences. Principal Findings: Including additional cycles of afSELEX-seq improved TFAST's ability to selectively identify peaks, leading to 7,274, 4,255, and 2,628 peaks identified in two-, three-, and four-cycle afSELEX-seq. Inter-round analysis by TFAST identified 457 peaks as the strongest candidates for true binding sites. Separating peaks by TFAST into classes of worst, second-best and best candidate peaks revealed a trend of increasing significance (e-values 4.5x10(12), 2.9x10(-46), and 1.2x10(-73)) and informational content (11.0, 11.9, and 12.5 bits over 15 bp) of discovered motifs within each respective class. TFAST also predicted a binding site length (28 bp) consistent with non-computational experimentally derived results for the transcription factor PapX (22 to 29 bp). Conclusions/Significance: TFAST offers a novel and intuitive approach for determining DNA binding sites of proteins subjected to afSELEX-seq. Here, we demonstrate that TFAST, using afSELEX-seq data, rapidly and accurately predicted sequence length and motif for a putative transcription factor's binding site.	[Reiss, Daniel J.; Mobley, Harry L. T.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Reiss, Daniel J.; Howard, Frederick M.; Mobley, Harry L. T.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Reiss, DJ (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	hmobley@umich.edu		Mobley, Harry/0000-0001-9195-7665; Howard, Frederick/0000-0002-6039-1141	Public Health Service from the National Institute of Health [AI43363, AI59722, AI007528, T32 GM07863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059722, T32AI007528, R01AI043363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants (grant numbers AI43363, AI59722, AI007528 and T32 GM07863) from the National Institute of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bulyk ML, 2005, NAT BIOTECHNOL, V23, P942, DOI 10.1038/nbt0805-942; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Reiss DJ, 2011, J BIOL CHEM; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Schutze T, PLOS ONE, V6; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Stein LD, 2011, CURR PROTOC BIOINFOR; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang L, 2012, BIOTECHNOLOGY LETT; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590; Zimmermann B, 2010, METHODS, V52, P125, DOI 10.1016/j.ymeth.2010.06.004	24	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42761	10.1371/journal.pone.0042761	http://dx.doi.org/10.1371/journal.pone.0042761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22956994	Green Published, Green Submitted, gold			2022-12-27	WOS:000307284100165
J	Michel, MJ; Knouft, JH				Michel, Matt J.; Knouft, Jason H.			Niche Variability and Its Consequences for Species Distribution Modeling	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROHABITAT USE; FISH ASSEMBLAGE; EXTINCTION RISK; PREDICT	When species distribution models (SDMs) are used to predict how a species will respond to environmental change, an important assumption is that the environmental niche of the species is conserved over evolutionary time-scales. Empirical studies conducted at ecological time-scales, however, demonstrate that the niche of some species can vary in response to environmental change. We use habitat and locality data of five species of stream fishes collected across seasons to examine the effects of niche variability on the accuracy of projections from Maxent, a popular SDM. We then compare these predictions to those from an alternate method of creating SDM projections in which a transformation of the environmental data to similar scales is applied. The niche of each species varied to some degree in response to seasonal variation in environmental variables, with most species shifting habitat use in response to changes in canopy cover or flow rate. SDMs constructed from the original environmental data accurately predicted the occurrences of one species across all seasons and a subset of seasons for two other species. A similar result was found for SDMs constructed from the transformed environmental data. However, the transformed SDMs produced better models in ten of the 14 total SDMs, as judged by ratios of mean probability values at known presences to mean probability values at all other locations. Niche variability should be an important consideration when using SDMs to predict future distributions of species because of its prevalence among natural populations. The framework we present here may potentially improve these predictions by accounting for such variability.	[Michel, Matt J.; Knouft, Jason H.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Michel, MJ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	mmichel3@slu.edu		Knouft, Jason/0000-0002-3737-5696	United States National Science Foundation [DEB-0844644]	United States National Science Foundation(National Science Foundation (NSF))	This work was supported by funding from the United States National Science Foundation to JHK (DEB-0844644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Gelman A., 2007, DATA ANAL USING REGR; Gogol-Prokurat M, 2011, ECOL APPL, V21, P33, DOI 10.1890/09-1190.1; Gotelli NJ, 2013, ECOSIMR 1 00; GROSSMAN GD, 1987, J ZOOL, V212, P151, DOI 10.1111/j.1469-7998.1987.tb05121.x; Grossman GD, 1998, ECOL MONOGR, V68, P395, DOI 10.1890/0012-9615(1998)068[0395:AOISFE]2.0.CO;2; GROSSMAN GD, 1987, OECOLOGIA, V73, P501, DOI 10.1007/BF00379407; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Knouft JH, 2011, METHODS ECOL EVOL, V2, P303, DOI 10.1111/j.2041-210X.2010.00076.x; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; MATTHEWS WJ, 1994, ENVIRON BIOL FISH, V39, P381, DOI 10.1007/BF00004807; Overpeck JT, 2011, SCIENCE, V331, P700, DOI 10.1126/science.1197869; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2020, R LANG ENV STAT COMP; Rodder D, 2010, TROP ZOOL, V23, P35; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Zurell D, 2009, ECOGRAPHY, V32, P733, DOI 10.1111/j.1600-0587.2009.05810.x; [No title captured]	30	5	5	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44932	10.1371/journal.pone.0044932	http://dx.doi.org/10.1371/journal.pone.0044932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970325	Green Published, Green Submitted, gold			2022-12-27	WOS:000308748400036
J	Timoneda, O; Balcells, I; Cordoba, S; Castello, A; Sanchez, A				Timoneda, Oriol; Balcells, Ingrid; Cordoba, Sarai; Castello, Anna; Sanchez, Armand			Determination of Reference microRNAs for Relative Quantification in Porcine Tissues	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; REFERENCE GENES; EXPRESSION; IDENTIFICATION; NORMALIZATION; BIOGENESIS; IDENTIFY; MIRNAS	Relative quantification is the strategy of choice for processing RT-qPCR data in microRNAs (miRNAs) expression studies. Normalisation of relative quantification data is performed by using reference genes. In livestock species, such as pigs, the determination of reference miRNAs and the optimal number of them has not been widely studied. In this study, the stability of ten miRNAs (Ssc-let-7a, Ssc-miR-103, Ssc-miR-17-3p, Hsa-miR-25, Hsa-miR-93, Ssc-miR-106a, Ssc-miR-191, Ssc-miR-16, Ssc-miR-26a and Ssc-miR-17-5p) was investigated by RT-qPCR in different tissues (skeletal muscle, kidney, liver, ovary and uterus) and in different pig breeds (Iberian, Landrace, Large White, Meishan and Vietnamese) as variation factors. Stability values were calculated with geNorm and NormFinder algorithms obtaining high correlation between them (r(2) = 0.99). The analyses showed that tissue is an important variability factor in miRNAs expression stability whereas breed is not a determinant factor. All ten miRNAs analysed had good stability values and, therefore, can be used as reference miRNAs. When all tissues were considered, miR-93 was the most stable miRNA. Dividing data set by tissues, let-7a was the most stable in skeletal muscle and ovary, miR-17-5p in kidney, miR-26a in liver and miR-103 in uterus. Moreover, the optimal number of reference miRNAs to be used for proper normalisation data was determined. It is suggested the use of five reference miRNAs (miR-93, miR-25, miR-106a, miR-17-5p and miR-26a) in multi-tissue experimental designs and the use of three reference miRNAs as the optimal number in single tissues studies (let-7a, miR-17-5p and miR-25 in skeletal muscle; miR-17-5p, miR-93 and miR-26a in kidney, miR-26a, miR-103 and let-7a in liver, let-7a, miR-25 and miR-106a in ovary and miR-103, let-7a and miR-93 in uterus). Overall, this study provides valuable information about the porcine reference miRNAs that can be used in order to perform a proper normalisation when relative quantification by RT-qPCR studies is undertaken.	[Timoneda, Oriol; Balcells, Ingrid; Cordoba, Sarai; Castello, Anna; Sanchez, Armand] Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca AgriGen CRAG, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Timoneda, O (corresponding author), Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca AgriGen CRAG, E-08193 Barcelona, Spain.	oriol.timoneda@uab.cat	Farré, Anna Castelló/K-9637-2015; Sanchez, Armand/L-7905-2015	Farré, Anna Castelló/0000-0001-8497-6251; Sanchez, Armand/0000-0001-9160-1124; Cordoba, Sarai/0000-0002-8786-9889	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion [CSD2007-00036]; PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government;  [AGL2007-66371-C02-01];  [AGL2010-22358-C02-01]	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion; PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government; ; 	This work was supported by the projects AGL2007-66371-C02-01 and AGL2010-22358-C02-01 and by the Consolider-Ingenio 2010 program (CSD2007-00036) from Ministerio de Ciencia e Innovacion. OT is recipient of PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Curry E, 2011, THERIOGENOLOGY, V76, P1532, DOI 10.1016/j.theriogenology.2011.06.025; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Patel N, 2011, J NUCL ACIDS INVESTI, V2, pe1; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Sharkey JW, 2012, BIOMARKERS; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Stowe HM, 2012, GENE, V501, P198, DOI 10.1016/j.gene.2012.03.058; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viprey VF, 2012, ANAL BIOCHEM, V421, P566, DOI 10.1016/j.ab.2011.10.022; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009	34	42	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44413	10.1371/journal.pone.0044413	http://dx.doi.org/10.1371/journal.pone.0044413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970213	Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400017
J	Acosta, EG; Castilla, V; Damonte, EB				Acosta, Eliana G.; Castilla, Viviana; Damonte, Elsa B.			Differential Requirements in Endocytic Trafficking for Penetration of Dengue Virus	PLOS ONE			English	Article							INFECTIOUS ENTRY; EARLY ENDOSOME; JUNIN VIRUS; PATHWAY; CELLS; RAB5; TRANSFERRIN; INHIBITION; PROTEINS; FUSION	The entry of DENV into the host cell appears to be a very complex process which has been started to be studied in detail. In this report, the route of functional intracellular trafficking after endocytic uptake of dengue virus serotype 1 (DENV-1) strain HW, DENV-2 strain NGC and DENV-2 strain 16681 into Vero cells was studied by using a susceptibility to ammonium chloride assay, dominant negative mutants of several members of the family of cellular Rab GTPases that participate in regulation of transport through endosome vesicles and immunofluorescence colocalization. Together, the results presented demonstrate that in spite of the different internalization route among viral serotypes in Vero cells and regardless of the viral strain, DENV particles are first transported to early endosomes in a Rab5-dependent manner. Then a Rab7-dependent pathway guides DENV-2 16681 to late endosomes, whereas a yet unknown sorting event controls the transport of DENV-2 NGC, and most probably DENV-1 HW, to the perinuclear recycling compartments where fusion membrane would take place releasing nucleocapsid into the cytoplasm. Besides the demonstration of a different intracellular trafficking for two DENV-2 strains that shared the initial clathrin-independent internalization route, these studies proved for the first time the involvement of the slow recycling pathway for DENV-2 productive infection.	[Acosta, Eliana G.; Castilla, Viviana; Damonte, Elsa B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Virol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Acosta, EG (corresponding author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.	edamonte@qb.fcen.uba.ar			Agencia Nacional para la Promocion Cientifica y Tecnologica [PICT 985]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET-PID 0467]; Universidad de Buenos Aires, Argentina [UBACYT 00145]	Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Argentina(University of Buenos Aires)	This research was supported by Agencia Nacional para la Promocion Cientifica y Tecnologica (PICT 985), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-PID 0467) and Universidad de Buenos Aires (UBACYT 00145), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008; Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Altmeyer R, 2004, CURR PHARM DESIGN, V10, P3701, DOI 10.2174/1381612043382729; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Benmerah A, 1999, J CELL SCI, V112, P1303; Brabec M, 2006, BIOCHEM BIOPH RES CO, V348, P741, DOI 10.1016/j.bbrc.2006.07.125; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; CASTILLA V, 1994, ARCH VIROL, V136, P363, DOI 10.1007/BF01321064; Clemente R, 2009, J VIROL, V83, P10406, DOI 10.1128/JVI.00990-09; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Johns HL, 2009, J VIROL, V83, P6247, DOI 10.1128/JVI.02460-08; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; KO KK, 1979, ARCH VIROL, V62, P41, DOI 10.1007/BF01314902; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; Martinez M. Guadalupe, 2009, Biotechnology Journal, V4, P866, DOI 10.1002/biot.200800357; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; SINGH I, 1992, J VIROL, V66, P7049, DOI 10.1128/JVI.66.12.7049-7058.1992; SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	52	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44835	10.1371/journal.pone.0044835	http://dx.doi.org/10.1371/journal.pone.0044835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970315	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000051
J	Zuo, XR; Wang, Q; Cao, Q; Yu, YZ; Wang, H; Bi, LQ; Xie, WP; Wang, H				Zuo, Xiang-Rong; Wang, Qiang; Cao, Quan; Yu, Yan-Zhe; Wang, Hui; Bi, Li-Qing; Xie, Wei-Ping; Wang, Hong			Nicorandil Prevents Right Ventricular Remodeling by Inhibiting Apoptosis and Lowering Pressure Overload in Rats with Pulmonary Arterial Hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; SENSITIVE POTASSIUM CHANNELS; RIGHT-HEART-FAILURE; CARDIAC MYOCYTES; MOLECULAR-MECHANISMS; RECEPTOR BLOCKADE; OXIDATIVE STRESS; CELL-SURVIVAL; MONOCROTALINE; DYSFUNCTION	Background: Most of the deaths among patients with severe pulmonary arterial hypertension (PAH) are caused by progressive right ventricular (RV) pathological remodeling, dysfunction, and failure. Nicorandil can inhibit the development of PAH by reducing pulmonary artery pressure and RV hypertrophy. However, whether nicorandil can inhibit apoptosis in RV cardiomyocytes and prevent RV remodeling has been unclear. Methodology/Principal Findings: RV remodeling was induced in rats by intraperitoneal injection of monocrotaline (MCT). RV systolic pressure (RVSP) was measured at the end of each week after MCT injection. Blood samples were drawn for brain natriuretic peptide (BNP) ELISA analysis. The hearts were excised for histopathological, ultrastructural, immunohistochemical, and Western blotting analyses. The MCT-injected rats exhibited greater mortality and less weight gain and showed significantly increased RVSP and RV hypertrophy during the second week. These worsened during the third week. MCT injection for three weeks caused pathological RV remodeling, characterized by hypertrophy, fibrosis, dysfunction, and RV mitochondrial impairment, as indicated by increased levels of apoptosis. Nicorandil improved survival, weight gain, and RV function, ameliorated RV pressure overload, and prevented maladaptive RV remodeling in PAH rats. Nicorandil also reduced the number of apoptotic cardiomyocytes, with a concomitant increase in Bcl-2/Bax ratio. 5-hydroxydecanoate (5-HD) reversed these beneficial effects of nicorandil in MCT-injected rats. Conclusions/Significance: Nicorandil inhibits PAH-induced RV remodeling in rats not only by reducing RV pressure overload but also by inhibiting apoptosis in cardiomyocytes through the activation of mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels. The use of a mitoK(ATP) channel opener such as nicorandil for PAH-associated RV remodeling and dysfunction may represent a new therapeutic strategy for the amelioration of RV remodeling during the early stages of PAH.	[Zuo, Xiang-Rong; Wang, Qiang; Yu, Yan-Zhe; Wang, Hui; Bi, Li-Qing; Xie, Wei-Ping; Wang, Hong] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Zuo, Xiang-Rong; Cao, Quan] Nanjing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zuo, XR (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	xieweiping2002@yahoo.com; wanghong.njmu@gmail.com			National Natural Science Foundation of China (NSFC) [30971319]; "Six Talent Peak" Project of Jiangsu Province [08-B]; Open Project Program of the key discipline of Public Health Department of Jiangsu Province [XK13_200902]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); "Six Talent Peak" Project of Jiangsu Province; Open Project Program of the key discipline of Public Health Department of Jiangsu Province	This work was partially supported by the National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn, No. 30971319, HW), and by a research fund from the "Six Talent Peak" Project of Jiangsu Province (http://www.jshrss.gov.cn, No. 08-B, WX). This work was also partially supported by the grant from Open Project Program of the key discipline of Public Health Department of Jiangsu Province (www.jswst.gov.cn, No. XK13_200902, XZ). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Akao M, 2002, J AM COLL CARDIOL, V40, P803, DOI 10.1016/S0735-1097(02)02007-7; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Braun MU, 2003, CARDIOVASC RES, V59, P658, DOI 10.1016/S0008-6363(03)00470-X; Buermans HPJ, 2005, PHYSIOL GENOMICS, V21, P314, DOI 10.1152/physiolgenomics.00185.2004; Bussani R, 2003, J CLIN PATHOL, V56, P672, DOI 10.1136/jcp.56.9.672; Campian ME, 2009, J NUCL MED, V50, P1371, DOI 10.2967/jnumed.108.061366; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Eguchi Y, 2009, CIRC J, V73, P554, DOI 10.1253/circj.CJ-08-0843; Gross A, 2001, IUBMB LIFE, V52, P231, DOI 10.1080/15216540152846046; Handoko ML, 2008, PFLUG ARCH EUR J PHY, V455, P951, DOI 10.1007/s00424-007-0334-z; Hardziyenka M, 2006, J AM SOC ECHOCARDIOG, V19, P1272, DOI 10.1016/j.echo.2006.04.036; Haworth SG, 2007, EUR HEART J SUPPL, V9, pH10, DOI 10.1093/eurheartj/sum025; Henkens IR, 2007, AM J PHYSIOL-HEART C, V293, pH1300, DOI 10.1152/ajpheart.01359.2006; Hessel MHM, 2006, AM J PHYSIOL-HEART C, V291, pH2424, DOI 10.1152/ajpheart.00369.2006; HONDA M, 1992, JPN CIRC J, V56, P392, DOI 10.1253/jcj.56.392; Hongo M, 2005, J CARDIOVASC PHARM, V46, P452, DOI 10.1097/01.fjc.0000176728.74690.09; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Ikeda S, 1999, LIFE SCI, V65, P925, DOI 10.1016/S0024-3205(99)00322-7; Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913; Kret M, 2007, J CARDIOVASC PHARM T, V12, P5, DOI 10.1177/1074248406298293; Lee JK, 1999, AM J PHYSIOL-HEART C, V277, pH1725, DOI 10.1152/ajpheart.1999.277.5.H1725; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MIYAUCHI T, 1993, CIRC RES, V73, P887, DOI 10.1161/01.RES.73.5.887; Nagata K, 2003, J MOL CELL CARDIOL, V35, P1505, DOI 10.1016/j.yjmcc.2003.09.018; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; Nishikawa S, 2006, J MOL CELL CARDIOL, V40, P510, DOI 10.1016/j.yjmcc.2006.01.020; Noordegraaf AV, 2008, RHEUMATOLOGY, V47, pV42, DOI 10.1093/rheumatology/ken284; Okada M, 2009, J PHARMACOL SCI, V111, P193, DOI 10.1254/jphs.09112FP; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Rhodes CJ, 2009, PHARMACOL THERAPEUT, V121, P69, DOI 10.1016/j.pharmthera.2008.10.002; Saeed M, 2002, RADIOLOGY, V224, P830, DOI 10.1148/radiol.2243011372; Sahara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033367; Sanada S, 2002, J AM COLL CARDIOL, V40, P991, DOI 10.1016/S0735-1097(02)02057-0; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Shiina Y, 2009, INT J CARDIOL, V135, P53, DOI 10.1016/j.ijcard.2008.03.090; Simon MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/568095; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Voelkel NF, 2011, RIGHT VENTRICLE PULM, P525; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Yap LB, 2004, HEART FAIL REV, V9, P99, DOI 10.1023/B:HREV.0000046364.68371.b0	53	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44485	10.1371/journal.pone.0044485	http://dx.doi.org/10.1371/journal.pone.0044485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970229	Green Published, Green Submitted, gold			2022-12-27	WOS:000308462000025
J	Araki, J; Nishizawa, Y; Nakamura, T; Sato, T; Naito, M; Fujii, S; Mihara, M; Koshima, I				Araki, Jun; Nishizawa, Yuji; Nakamura, Tatsuo; Sato, Tomoyuki; Naito, Munekazu; Fujii, Satoshi; Mihara, Makoto; Koshima, Isao			The Development of a Canine Anorectal Autotransplantation Model Based on Blood Supply: A Preliminary Case Report	PLOS ONE			English	Article							INTESTINAL TRANSPLANTATION; FOLLOW-UP; COLON; ALLOTRANSPLANTATION; SPHINCTER; HAND	Colostomy is conventionally the only treatment for anal dysfunction. Recently, a few trials of anorectal transplantation in animals have been published; however, further development of this technique is required. Moreover, it is crucial to perform this research in dogs, which resemble humans in anorectal anatomy and biology. We designed a canine anorectal transplantation model, wherein anorectal autotransplantation was performed by anastomoses of the rectum, inferior mesenteric artery (IMA) and vein, and pudendal nerves. Resting pressure in the anal canal and anal canal pressure fluctuation were measured before and after surgery. Graft pathology was examined three days after surgery. The anal blood supply was compared with that in three beagles using indocyanine green (ICG) fluorescence angiography. The anorectal graft had sufficient arterial blood supply from the IMA; however, the graft's distal end was congested and necrotized. Functional examination demonstrated reduced resting pressure and the appearance of an irregular anal canal pressure wave after surgery. ICG angiography showed that the pudendal arteries provided more blood flow than the IMA to the anal segment. This is the first canine model of preliminary anorectal autotransplantation, and it demonstrates the possibility of establishing a transplantation model in dogs using appropriate vascular anastomoses, thus contributing to the progress of anorectal transplantation.	[Araki, Jun; Mihara, Makoto; Koshima, Isao] Univ Tokyo, Dept Plast Surg, Tokyo, Japan; [Nishizawa, Yuji; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan; [Sato, Tomoyuki] Saitama Shinkaibashi Clin, Saitama, Japan; [Naito, Munekazu] Tokyo Med Univ, Dept Anat, Tokyo, Japan; [Fujii, Satoshi] Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Div Pathol, Chiba, Japan	University of Tokyo; Kyoto University; Tokyo Medical University; National Cancer Center - Japan	Araki, J (corresponding author), Univ Tokyo, Dept Plast Surg, Tokyo, Japan.	arakij-pla@h.u-tokyo.ac.jp			Princess Takamatsu Cancer Research Fund; Kawano Masanori Memorial Foundation for Promotion of Pediatrics	Princess Takamatsu Cancer Research Fund; Kawano Masanori Memorial Foundation for Promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics)	This work was supported by grants from the Princess Takamatsu Cancer Research Fund and the Kawano Masanori Memorial Foundation for Promotion of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2011, TRANSPL P, V43, P3552, DOI 10.1016/j.transproceed.2011.08.042; Bartha I, 1995, Orv Hetil, V136, P1995; Cavadas PC, 2011, AM J TRANSPLANT, V11, P1085, DOI 10.1111/j.1600-6143.2011.03503.x; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x; Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653; Devesa J M, 2005, Tech Coloproctol, V9, P149, DOI 10.1007/s10151-005-0215-4; Eid KR, 2010, AM J TRANSPLANT, V10, P1940, DOI 10.1111/j.1600-6143.2010.03167.x; Fattah A, 2011, AM J TRANSPLANT, V11, P2762, DOI 10.1111/j.1600-6143.2011.03782.x; Galvao FHF, 2009, TECH COLOPROCTOL, V13, P55, DOI 10.1007/s10151-009-0459-5; Galvao FHF, 2012, MICROSURG, V32, P77, DOI 10.1002/micr.20958; Fishbein TM, 2009, NEW ENGL J MED, V361, P998, DOI 10.1056/NEJMra0804605; HURNY C, 1985, CA-CANCER J CLIN, V35, P170, DOI 10.3322/canjclin.35.3.170; Jones JW, 2000, NEW ENGL J MED, V343, P468, DOI 10.1056/NEJM200008173430704; Kato T, 2008, TRANSPLANTATION, V86, P293, DOI 10.1097/TP.0b013e31817ef01c; Kisu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035124; Lange MM, 2009, EJSO-EUR J SURG ONC, V35, P456, DOI 10.1016/j.ejso.2008.09.012; MCHUGH SM, 1987, GUT, V28, P1234, DOI 10.1136/gut.28.10.1234; Mihara M, 2011, HUM REPROD, V26, P3019, DOI 10.1093/humrep/der276; Miles W E, 1971, CA Cancer J Clin, V21, P361, DOI 10.3322/canjclin.21.6.361; O'Bichere A, 2000, BRIT J SURG, V87, P1534, DOI 10.1046/j.1365-2168.2000.01557.x; Petruzzo P, 2011, AM J TRANSPLANT, V11, P808, DOI 10.1111/j.1600-6143.2011.03469.x; Romano G, 2003, DIS COLON RECTUM, V46, P730, DOI 10.1007/s10350-004-6649-3; Sato T, 2005, SURGERY, V137, P8, DOI 10.1016/j.surg.2004.05.046; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; TODO S, 1994, TRANSPLANTATION, V57, P840, DOI 10.1097/00007890-199403270-00012	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44310	10.1371/journal.pone.0044310	http://dx.doi.org/10.1371/journal.pone.0044310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970198	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400057
J	Boe, CA; Knutsen, JHJ; Boye, E; Grallert, B				Boe, Cathrine A.; Knutsen, Jon Halvor J.; Boye, Erik; Grallert, Beata			Hpz1 Modulates the G1-S Transition in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CELL-CYCLE; S-PHASE; POLY(ADP-RIBOSE) POLYMERASE; UV-IRRADIATION; GENE; KINASES; ATR; ORIGINS	Here we characterize a novel protein in S. pombe. It has a high degree of homology with the Zn-finger domain of the human Poly(ADP-ribose) polymerase (PARP). Surprisingly, the gene for this protein is, in many fungi, fused with and in the same reading frame as that encoding Rad3, the homologue of the human ATR checkpoint protein. We name the protein Hpz1 (Homologue of PARP-type Zn-finger). Hpz1 does not possess PARP activity, but is important for resistance to ultraviolet light in the G1 phase and to treatment with hydroxyurea, a drug that arrests DNA replication forks in the S phase. However, we find no evidence of a checkpoint function of Hpz1. Furthermore, absence of Hpz1 results in an advancement of S-phase entry after a G1 arrest as well as earlier recovery from a hydroxyurea block. The hpz1 gene is expressed mainly in the G1 phase and Hpz1 is localized to the nucleus. We conclude that Hpz1 regulates the initiation of the S phase and may cooperate with Rad3 in this function.	[Boe, Cathrine A.; Knutsen, Jon Halvor J.; Boye, Erik; Grallert, Beata] Inst Canc Res, Dept Cell Biol, Oslo, Norway; [Boe, Cathrine A.; Knutsen, Jon Halvor J.; Boye, Erik; Grallert, Beata] Univ Oslo, Inst Mol Biosci, N-0316 Oslo, Norway	University of Oslo	Boe, CA (corresponding author), Inst Canc Res, Dept Cell Biol, Oslo, Norway.	beata.grallert@rr-research.no			Norwegian Cancer Society; Research Council of Norway; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	This work received funding from The Norwegian Cancer Society (www.kreftforeningen.no), from The Research Council of Norway (www.forskningsradet.no), and from the South-Eastern Norway Regional Health Authority (www.helse-sorost.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; AVILA MA, 1994, YEAST, V10, P1003, DOI 10.1002/yea.320100803; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Domingo-Sananes MR, 2011, PHILOS T R SOC B, V366, P3584, DOI 10.1098/rstb.2011.0087; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Feng WY, 2007, METHODS, V41, P151, DOI 10.1016/j.ymeth.2006.07.023; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Kuznetsov IB, 2006, BIOINFORMATICS, V22, P1055, DOI 10.1093/bioinformatics/btl049; Kuznetsov IB, 2008, BIOINFORMATICS, V24, P1534, DOI 10.1093/bioinformatics/btn233; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilssen EA, 2003, P NATL ACAD SCI USA, V100, P10758, DOI 10.1073/pnas.1833769100; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; REYMOND A, 1992, MOL GEN GENET, V234, P449, DOI 10.1007/BF00538705; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shechter D, 2005, CELL CYCLE, V4, P235; SKOOG L, 1971, EUR J BIOCHEM, V19, P81, DOI 10.1111/j.1432-1033.1971.tb01290.x; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Uhlmann F, 2011, PHILOS T R SOC B, V366, P3572, DOI 10.1098/rstb.2011.0082; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	54	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44539	10.1371/journal.pone.0044539	http://dx.doi.org/10.1371/journal.pone.0044539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970243	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400086
J	Katsurada, T; Kobayashi, W; Tomaru, U; Baba, T; Furukawa, S; Ishizu, A; Takeda, K; Sakamoto, N; Asaka, M; Takeda, H; Kasahara, M				Katsurada, Takehiko; Kobayashi, Waka; Tomaru, Utano; Baba, Tomohisa; Furukawa, Shigeru; Ishizu, Akihiro; Takeda, Kazuyoshi; Sakamoto, Naoya; Asaka, Masahiro; Takeda, Hiroshi; Kasahara, Masanori			Decrease of Peripheral and Intestinal NKG2A-Positive T Cells in Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NATURAL-KILLER-CELL; INHIBITORY RECEPTORS; CD94/NKG2A EXPRESSION; REGULATORY CELLS; LYMPHOCYTES; NKG2A; PATHOGENESIS; RECOGNITION; RESPONSES	To investigate the role of inhibitory natural killer receptors (iNKRs) in inflammatory bowel disease (IBD), we analyzed the expression of NKG2A, one of the iNKRs, on T cells in a mouse colitis model and human IBD. During the active phase of dextran sulfate sodium (DSS)-induced mouse colitis, the frequency of NKG2A+ T cells was significantly decreased in the peripheral blood, and increased in the intestine, suggesting the mobilization of this T cell subset to the sites of inflammation. Administration of anti-NKG2A antibody increased the number of inflammatory foci in DSS-induced colitis, suggesting the involvement of NKG2A+ T cells in this colitis model. In ulcerative colitis (UC) patients, the frequency of peripheral blood NKG2A+ T cells was significantly decreased, compared with Crohn's disease (CD) patients and healthy controls, regardless of clinical conditions such as treatment modalities and disease activity. Notably, in sharp contrast to the DSS-induced mouse colitis model, the frequency of NKG2A+ cells among intestinal T cells was also decreased in UC patients. These results suggest that inadequate local infiltration of NKG2A+ T cells may be involved in the pathogenesis of UC.	[Katsurada, Takehiko; Kobayashi, Waka; Tomaru, Utano; Baba, Tomohisa; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Katsurada, Takehiko; Kobayashi, Waka; Furukawa, Shigeru; Sakamoto, Naoya; Asaka, Masahiro; Takeda, Hiroshi] Hokkaido Univ, Grad Sch, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Juntendo University; Hokkaido University	Katsurada, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	tomaruu@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011; Takeda, Hiroshi/C-6551-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Braud VM, 2003, TRENDS IMMUNOL, V24, P162, DOI 10.1016/S1471-4906(03)00064-4; Byers AM, 2006, J IMMUNOL, V176, P6121, DOI 10.4049/jimmunol.176.10.6121; DEDOMBAL FT, 1987, GUT, V28, P474, DOI 10.1136/gut.28.4.474; Derre L, 2002, J IMMUNOL, V168, P4864, DOI 10.4049/jimmunol.168.10.4864; Eksteen B, 2008, INFLAMM BOWEL DIS, V14, P1298, DOI 10.1002/ibd.20453; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Freishtat RJ, 2005, HUM IMMUNOL, V66, P1223, DOI 10.1016/j.humimm.2006.02.005; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Hart AL, 2010, INFLAMM BOWEL DIS, V16, P1969, DOI 10.1002/ibd.21304; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Kirman I, 1996, AM J GASTROENTEROL, V91, P1789; Le Drean E, 1998, EUR J IMMUNOL, V28, P264, DOI 10.1002/(SICI)1521-4141(199801)28:01<264::AID-IMMU264>3.0.CO;2-O; Li WX, 2010, CLIN RHEUMATOL, V29, P315, DOI 10.1007/s10067-009-1322-9; Liao YH, 2006, BRIT J DERMATOL, V155, P318, DOI 10.1111/j.1365-2133.2006.07301.x; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Makita S, 2004, J IMMUNOL, V173, P3119, DOI 10.4049/jimmunol.173.5.3119; Marusina AI, 2005, J IMMUNOL, V174, P2152, DOI 10.4049/jimmunol.174.4.2152; Mingari MC, 2005, CURR OPIN IMMUNOL, V17, P312, DOI 10.1016/j.coi.2005.03.006; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Saito M, 2003, BLOOD, V102, P577, DOI 10.1182/blood-2002-09-2855; Sakai T, 1998, GASTROENTEROLOGY, V114, P1237, DOI 10.1016/S0016-5085(98)70430-5; Speiser DE, 1999, J EXP MED, V190, P775, DOI 10.1084/jem.190.6.775; Suvas S, 2006, J IMMUNOL, V176, P1703, DOI 10.4049/jimmunol.176.3.1703; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44113	10.1371/journal.pone.0044113	http://dx.doi.org/10.1371/journal.pone.0044113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970169	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400037
J	Kuscu, C; Evensen, N; Kim, D; Hu, YJ; Zucker, S; Cao, J				Kuscu, Cem; Evensen, Nikki; Kim, Deborah; Hu, You-Jun; Zucker, Stanley; Cao, Jian			Transcriptional and Epigenetic Regulation of KIAA1199 Gene Expression in Human Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; NF-KAPPA-B; DNA METHYLATION; PROMOTER HYPOMETHYLATION; GC BOX; CARCINOGENESIS; IDENTIFICATION; DEMETHYLATION; REPRESSION; DISEASE	Emerging evidence has demonstrated that upregulated expression of KIAA1199 in human cancer bodes for poor survival. The regulatory mechanism controlling KIAA1199 expression in cancer remains to be characterized. In the present study, we have isolated and characterized the human KIAA1199 promoter in terms of regulation of KIAA1199 gene expression. A 3.3 kb fragment of human genomic DNA containing the 5'-flanking sequence of the KIAA1199 gene possesses both suppressive and activating elements. Employing a deletion mutagenesis approach, a 1.4 kb proximal region was defined as the basic KIAA1199 promoter containing a TATA-box close to the transcription start site. A combination of 5'-primer extension study with 5'RACE DNA sequencing analysis revealed one major transcription start site that is utilized in the human KIAA1199 gene. Bioinformatics analysis suggested that the 1.4 kb KIAA1199 promoter contains putative activating regulatory elements, including activator protein-1(AP-1), Twist-1, and NF-kappa B sites. Sequential deletion and site-direct mutagenesis analysis demonstrated that the AP-1 and distal NF-kappa B sites are required for KIAA1199 gene expression. Further analyses using an electrophoretic mobility-shift assay and chromatin immunoprecipitation confirmed the requirement of these cis- and trans-acting elements in controlling KIAA1199 gene expression. Finally, we found that upregulated KIAA1199 expression in human breast cancer specimens correlated with hypomethylation of the regulatory region. Involvement of DNA methylation in regulation of KIAA1199 expression was recapitulated in human breast cancer cell lines. Taken together, our study unraveled the regulatory mechanisms controlling KIAA1199 gene expression in human cancer.	[Kuscu, Cem; Evensen, Nikki; Kim, Deborah; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Hu, You-Jun; Cao, Jian] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zucker, Stanley] SUNY Stony Brook, Dept Med Hematol & Oncol, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kuscu, C (corresponding author), SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu		KUSCU, CEM/0000-0001-7154-6762; Kim, Deborah/0000-0002-9388-5391	National Institutes of Health/National Cancer Institute [R01CA113553, R01CA166936]; Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113553, R01CA166936] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Institutes of Health/National Cancer Institute grants (R01CA113553 and R01CA166936) and the Carol Baldwin Breast Cancer Foundation (to JC); and a Merit Review grant from the Department of Veterans Affairs (to SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Broadbent S, 2010, J MICROBIOL METH, V81, P256, DOI 10.1016/j.mimet.2010.03.021; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Guo JH, 2006, FEBS LETT, V580, P581, DOI 10.1016/j.febslet.2005.12.076; HANADA M, 1993, BLOOD, V82, P1820; Harbeck N, 2008, J CLIN ONCOL, V26, P5036, DOI 10.1200/JCO.2007.14.1697; Hasegawa H, 2009, EXP CELL RES, V315, P1384, DOI 10.1016/j.yexcr.2009.02.019; He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123; Honda T, 2004, BRIT J CANCER, V90, P838, DOI 10.1038/sj.bjc.6601600; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Ko YG, 2010, PLACENTA, V31, P969, DOI 10.1016/j.placenta.2010.08.010; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Miyajima A, 2009, DRUG METAB PHARMACOK, V24, P269, DOI 10.2133/dmpk.24.269; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Ponticos M, 2009, NUCLEIC ACIDS RES, V37, P5378, DOI 10.1093/nar/gkp544; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; SUZUKI S, 1995, MOL ENDOCRINOL, V9, P1288, DOI 10.1210/me.9.10.1288; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Vaiopoulos AG, 2010, INT J BIOCHEM CELL B, V42, P1061, DOI 10.1016/j.biocel.2010.03.018; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zhou H, 2001, ONCOGENE, V20, P6009, DOI 10.1038/sj.onc.1204830	47	44	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44661	10.1371/journal.pone.0044661	http://dx.doi.org/10.1371/journal.pone.0044661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970280	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400102
J	McGuire, CR; Nufio, CR; Bowers, MD; Guralnick, RP				McGuire, Chris R.; Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.			Elevation-Dependent Temperature Trends in the Rocky Mountain Front Range: Changes over a 56-and 20-Year Record	PLOS ONE			English	Article							CLIMATE-CHANGE; COLORADO; SEASON; PRECIPITATION; VARIABILITY; INDICATORS; SNOWPACK; IMPACTS; REGIONS; TIME	Determining the magnitude of climate change patterns across elevational gradients is essential for an improved understanding of broader climate change patterns and for predicting hydrologic and ecosystem changes. We present temperature trends from five long-term weather stations along a 2077-meter elevational transect in the Rocky Mountain Front Range of Colorado, USA. These trends were measured over two time periods: a full 56-year record (1953-2008) and a shorter 20-year (1989-2008) record representing a period of widely reported accelerating change. The rate of change of biological indicators, season length and accumulated growing-degree days, were also measured over the 56 and 20-year records. Finally, we compared how well interpolated Parameter-elevation Regression on Independent Slopes Model (PRISM) datasets match the quality controlled and weather data from each station. Our results show that warming signals were strongest at mid-elevations over both temporal scales. Over the 56-year record, most sites show warming occurring largely through increases in maximum temperatures, while the 20-year record documents warming associated with increases in maximum temperatures at lower elevations and increases in minimum temperatures at higher elevations. Recent decades have also shown a shift from warming during springtime to warming in July and November. Warming along the gradient has contributed to increases in growing-degree days, although to differing degrees, over both temporal scales. However, the length of the growing season has remained unchanged. Finally, the actual and the PRISM interpolated yearly rates rarely showed strong correlations and suggest different warming and cooling trends at most sites. Interpretation of climate trends and their seasonal biases in the Rocky Mountain Front Range are dependent on both elevation and the temporal scale of analysis. Given mismatches between interpolated data and the directly measured station data, we caution against an over-reliance on interpolation methods for documenting local patterns of climatic change.	[McGuire, Chris R.; Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Nat Hist Museum, Boulder, CO 80309 USA; [McGuire, Chris R.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McGuire, CR (corresponding author), Univ Colorado, Nat Hist Museum, Boulder, CO 80309 USA.	nufio@colorado.edu		BOWERS, M/0000-0002-5697-888X	National Science Foundation [1543813]; University of Colorado Museum of Natural History's Walker Van Riper research grant; Chancellor's Office of the University of Colorado at Boulder; Direct For Biological Sciences [1027341] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Colorado Museum of Natural History's Walker Van Riper research grant; Chancellor's Office of the University of Colorado at Boulder; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation Grant #1543813, the University of Colorado Museum of Natural History's Walker Van Riper research grant and a post-doctoral diversity fellowship from the Chancellor's Office of the University of Colorado at Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2002, INT J CLIMATOL, V22, P1727, DOI 10.1002/joc.818; Beniston M, 1996, THEOR APPL CLIMATOL, V53, P231, DOI 10.1007/BF00871739; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; Bryant SR, 1998, J APPL ECOL, V35, P921, DOI 10.1111/j.1365-2664.1998.tb00009.x; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chase TN, 1999, J GEOPHYS RES-ATMOS, V104, P16673, DOI 10.1029/1999JD900118; Chen B, 2003, CLIM DYNAM, V20, P401, DOI 10.1007/s00382-002-0282-4; Clow DW, 2010, J CLIMATE, V23, P2293, DOI 10.1175/2009JCLI2951.1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; DEGAETANO AT, 1993, AGR FOREST METEOROL, V66, P1, DOI 10.1016/0168-1923(93)90079-W; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Diaz HF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GLO31253; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Diaz HF, 2003, CLIMATIC CHANGE, V59, P33, DOI 10.1023/A:1024460010140; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Easterling DR, 2002, B AM METEOROL SOC, V83, P1327, DOI 10.1175/1520-0477(2002)083&lt;1327:RCIFDA&gt;2.3.CO;2; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Feng S, 2004, THEOR APPL CLIMATOL, V78, P247, DOI 10.1007/s00704-004-0061-8; Fyfe JC, 1999, J CLIMATE, V12, P230, DOI 10.1175/1520-0442-12.1.230; Giorgi F, 1997, J CLIMATE, V10, P288, DOI 10.1175/1520-0442(1997)010<0288:EDOTSC>2.0.CO;2; GREENLAND D, 1989, ARCTIC ALPINE RES, V21, P380, DOI 10.2307/1551647; Guisan A, 2000, INTEGRATED ASSESSMEN, V1, P307, DOI [DOI 10.1023/A:1018912114948, 10.1023/A:1018912114948]; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; IPCC, 2007, CLIM CHANG 2007 PHYS; Kittel TG, 2002, ROCKY MOUNTAIN FUTUR; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Marr JW, 1968, DATA MOUNTAIN ENV, P181; Marr JW, 1968, DATA MOUNTAIN ENV, P169; Marr JW, 1967, DATA MOUNTAIN ENV, P110; Marr JW, 1961, ECOSYSTEMS E SLOPE F, P124; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Mix K, 2010, WATER AIR SOIL POLL, V205, P289, DOI 10.1007/s11270-009-0074-0; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pepin N, 2002, INT J CLIMATOL, V22, P311, DOI 10.1002/joc.740; Pepin N, 2000, ARCT ANTARCT ALP RES, V32, P135, DOI 10.2307/1552445; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Pepin N. C., 2005, J GEOPHYS RES ATMOSP, V110; Pielke RA, 1998, J GEOPHYS RES-ATMOS, V103, P16927, DOI 10.1029/98JD01645; Pielke RA, 2002, INT J CLIMATOL, V22, P421, DOI 10.1002/joc.706; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Ritchie J.T., 1991, AGRON MONOGR, V31, P5, DOI [10.2134/AGRONMONOGR31.C2, DOI 10.2134/AGR0NM0N0GR31.C2]; Robeson SM, 2002, CLIMATIC CHANGE, V52, P219, DOI 10.1023/A:1013088011223; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAS Institute, 1989, JMP VERS 8 02; Schlenker W, 2007, CLIMATIC CHANGE, V81, P19, DOI 10.1007/s10584-005-9008-z; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; SEGAL M, 1989, MON WEATHER REV, V117, P809, DOI 10.1175/1520-0493(1989)117<0809:TIOCAI>2.0.CO;2; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Snyder MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014431; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Stohlgren TJ, 1998, GLOBAL CHANGE BIOL, V4, P495, DOI 10.1046/j.1365-2486.1998.00182.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	61	85	86	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44370	10.1371/journal.pone.0044370	http://dx.doi.org/10.1371/journal.pone.0044370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970205	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400062
J	Satchi-Fainaro, R; Ferber, S; Segal, E; Ma, LL; Dixit, N; Ijaz, A; Hlatky, L; Abdollahi, A; Almog, N				Satchi-Fainaro, Ronit; Ferber, Shiran; Segal, Ehud; Ma, Lili; Dixit, Niharika; Ijaz, Ambreen; Hlatky, Lynn; Abdollahi, Amir; Almog, Nava			Prospective Identification of Glioblastoma Cells Generating Dormant Tumors	PLOS ONE			English	Article							ANGIOGENIC SWITCH; THERAPEUTIC TARGET; METASTATIC GROWTH; HUMAN LIPOSARCOMA; CANCER DORMANCY; IN-VIVO; MICROMETASTASES; TRANSITION; PHENOTYPE; MECHANISM	Although dormant tumors are highly prevalent within the human population, the underlying mechanisms are still mostly unknown. We have previously identified the consensus gene expression pattern of dormant tumors. Here, we show that this gene expression signature could be used for the isolation and identification of clones which generate dormant tumors. We established single cell-derived clones from the aggressive tumor-generating U-87 MG human glioblastoma cell line. Based only on the expression pattern of genes which were previously shown to be associated with tumor dormancy, we identified clones which generate dormant tumors. We show that very high expression levels of thrombospondin and high expression levels of angiomotin and insulin-like growth factor binding protein 5 (IGFBP5), together with low levels of endothelial specific marker (ESM) 1 and epithelial growth factor receptor (EGFR) characterize the clone which generates dormant U-87 MG derived glioblastomas. These tumors remained indolent both in subcutaneous and orthotopic intracranial sites, in spite of a high prevalence of proliferating cells. We further show that tumor cells which form U-87 MG derived dormant tumors have an impaired angiogenesis potential both in vitro and in vivo and have a slower invasion capacity. This work demonstrates that fast-growing tumors contain tumor cells that when isolated will form dormant tumors and serves as a proof-of-concept for the use of transcriptome profiles in the identification of such cells. Isolating the tumor cells that form dormant tumors will facilitate understanding of the underlying mechanisms of dormant micro-metastases, late recurrence, and changes in rate of tumor progression.	[Satchi-Fainaro, Ronit; Ferber, Shiran; Segal, Ehud] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Ma, Lili; Dixit, Niharika; Ijaz, Ambreen; Hlatky, Lynn; Abdollahi, Amir; Almog, Nava] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Steward Res & Specialty Projects Corp,Ctr Canc Sy, Boston, MA 02111 USA; [Abdollahi, Amir] Univ Heidelberg, Sch Med, Heidelberg, Germany; [Abdollahi, Amir] German Canc Res Ctr, Dept Radiat Oncol, D-6900 Heidelberg, Germany	Tel Aviv University; Sackler Faculty of Medicine; St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Satchi-Fainaro, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	nava.almog@tufts.edu	Dixit, Niharika/AAF-7057-2019; Satchi-Fainaro, Ronit/F-9137-2011	Satchi-Fainaro, Ronit/0000-0002-7360-7837	National Cancer Institute [U54CA149233]; Chief Scientist Office of the Ministry of Health, Israel [5145-300000]; Israel Science Foundation [1309/10]; The Swiss Bridge Award; The Israel Cancer Research Fund; NATIONAL CANCER INSTITUTE [U54CA149233] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office of the Ministry of Health, Israel; Israel Science Foundation(Israel Science Foundation); The Swiss Bridge Award; The Israel Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors wish to thank Janusz Weremowicz and Clare Lamont for assisting with animal work. The project described was supported (in part) by Award Number U54CA149233 from the National Cancer Institute (LH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This study was supported (in part) by grant no. 5145-300000 from the Chief Scientist Office of the Ministry of Health, Israel, by the Israel Science Foundation (grant No. 1309/10), The Swiss Bridge Award and The Israel Cancer Research Fund given to RSF. The authors disclose any commercial affiliations or financial interests that may be considered conflict of interest regarding this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles EG, 2001, J NATL CANCER I, V93, P1075, DOI 10.1093/jnci/93.14.1075; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANC LETT; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Hart IR, 1999, J PATHOL, V187, P91, DOI 10.1002/(SICI)1096-9896(199901)187:1<91::AID-PATH234>3.0.CO;2-J; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Quesnel B, 2008, CANCER LETT, V267, P10, DOI 10.1016/j.canlet.2008.02.055; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Segal E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005233; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Udagawa T, 2002, FASEB J, V16, P1361, DOI 10.1096/fj.01-0813com; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Uhr JW, P NATL ACAD SCI US; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x	34	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44395	10.1371/journal.pone.0044395	http://dx.doi.org/10.1371/journal.pone.0044395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970208	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400064
J	Chung, CJ; Huang, CY; Tsai, HB; Muo, CH; Chung, MC; Chang, CH; Huang, CC				Chung, Chi-Jung; Huang, Chao-Yuan; Tsai, Hung-Bin; Muo, Chih-Hsin; Chung, Mu-Chi; Chang, Chao-Hsiang; Huang, Chiu-Ching			Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CELL CARCINOMA; ARISTOLOCHIC ACID; CANCER; TRANSPLANTATION; DIALYSIS; RISK; MORTALITY; NEPHROPATHY; ASSOCIATION	Increasing evidence indicates that end-stage renal disease (ESRD) is associated with the morbidity of cancer. However, whether different dialysis modality and sex effect modify the cancer risks in ESRD patients remains unclear. A total of 3,570 newly diagnosed ESRD patients and 14,280 controls matched for age, sex, index month, and index year were recruited from the National Health Insurance Research Database in Taiwan. The ESRD status was ascertained from the registry of catastrophic illness patients. The incidence of cancer was identified through cross-referencing with the National Cancer Registry System. The Cox proportional hazards model and the Kaplan-Meier method were used for analyses. A similar twofold increase in cancer risk was observed among ESRD patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) after adjusting for other potential risk factors. Patients with the highest cancer risk, approximately fourfold increased risk, were those received renal transplants. Urothelial carcinoma (UC) had the highest incidence in HD and PD patients. However, renal cell carcinoma (RCC) had the highest incidence in the renal transplantation (RT) group. In addition, female patients undergoing RT or PD had a higher incidence of RCC and UC, respectively. Male patients under HD had both higher incidence of RCC and UC. In conclusion, different dialysis modality could modify the cancer risks in ESRD patients. We also found sex effect on genitourinary malignancy when they are under different dialysis modality.	[Chung, Chi-Jung] China Med Univ & Hosp, Dept Med Res, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Coll Publ Hlth, Taichung, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Dept Urol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Tsai, Hung-Bin] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chung, Mu-Chi] Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Chang, Chao-Hsiang] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan; [Chang, Chao-Hsiang; Huang, Chiu-Ching] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Huang, Chiu-Ching] China Med Univ & Hosp, Div Nephrol, Taichung, Taiwan; [Huang, Chiu-Ching] China Med Univ & Hosp, Kidney Inst, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chung, CJ (corresponding author), China Med Univ & Hosp, Dept Med Res, Taichung, Taiwan.	cch@mail.cmuh.org.tw	Chung, Chi-Jung/G-4755-2013; Tsai, Hung-Bin/G-3761-2011	, Mu Chi/0000-0001-5283-2886; HUANG, CHAO-YUAN/0000-0002-9322-6062; Tsai, Hung-Bin/0000-0002-0689-8339	Department of Health, Taiwan [DOH 97-HP-1101]; Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; Cancer Research Center of Excellence [DOH99-TD-C-111-001, DOH100-TD-C-111-005]; National Science Council [NSC 99-2621-M-039-001]; China Medical University Hospital	Department of Health, Taiwan; Clinical Trial and Research Center of Excellence; Cancer Research Center of Excellence; National Science Council(Ministry of Science and Technology, Taiwan); China Medical University Hospital	The study was supported in part by grants from the Department of Health, Taiwan (DOH 97-HP-1101, 2008-2010), the Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), the Cancer Research Center of Excellence (DOH99-TD-C-111-001, 2010-2011, DOH100-TD-C-111-005), the National Science Council (NSC 99-2621-M-039-001), and the China Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkeland SA, 2000, LANCET, V355, P1886, DOI 10.1016/S0140-6736(00)02298-4; BOON NA, 1984, BRIT J UROL, V56, P96, DOI 10.1111/j.1464-410X.1984.tb07172.x; Chang CH, 2009, CLIN NEPHROL, V72, P298; Chen CH, 2008, UROLOGY, V71, P1155, DOI 10.1016/j.urology.2007.11.140; CHEN KS, 1995, AM J KIDNEY DIS, V25, P694, DOI 10.1016/0272-6386(95)90544-8; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; Cosyns JP, 2001, KIDNEY INT, V59, P2164, DOI 10.1046/j.1523-1755.2001.0590062164.x; Farivar-Mohseni H, 2006, J UROLOGY, V175, P2018, DOI 10.1016/S0022-5347(06)00340-5; Fischereder M, 2008, NEPHROL DIAL TRANSPL, V23, P2457, DOI 10.1093/ndt/gfn183; Hung PH, 2011, WORLD J UROL, V29, P511, DOI 10.1007/s00345-011-0682-3; Hurst FP, 2010, TRANSPLANTATION, V90, P898, DOI 10.1097/TP.0b013e3181f30479; Hurst FP, 2011, UROLOGY, V77, P1271, DOI 10.1016/j.urology.2011.01.007; Kummer S, 2012, PEDIATR NEPHROL, V27, P1213, DOI 10.1007/s00467-011-1963-1; Lai MN, 2009, NEPHROLOGY, V14, P227, DOI 10.1111/j.1440-1797.2008.01061.x; Lee JE, 2009, J KOREAN MED SCI, V24, pS95, DOI 10.3346/jkms.2009.24.S1.S95; Li WH, 2012, NEPHROL DIAL TRANSPL, V27, P833, DOI 10.1093/ndt/gfr277; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lindsay RM, 2011, HEMODIAL INT, V15, P15, DOI 10.1111/j.1542-4758.2010.00521.x; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Nouh MAAM, 2010, BJU INT, V105, P620, DOI 10.1111/j.1464-410X.2009.08817.x; Orskov B, 2012, NEPHROL DIAL TRANSPL, V27, P1607, DOI 10.1093/ndt/gfr467; Parfrey PS, 1999, TRANSPL P, V31, P291, DOI 10.1016/S0041-1345(98)01631-5; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Sassa N, 2011, NEPHROL DIAL TRANSPL, V26, P1677, DOI 10.1093/ndt/gfq529; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Stewart JH, 2009, NEPHROL DIAL TRANSPL, V24, P3225, DOI 10.1093/ndt/gfp331; SUTHANTHIRAN M, 1994, NEW ENGL J MED, V331, P365, DOI 10.1056/NEJM199408113310606; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Yang HY, 2009, J EPIDEMIOL, V19, P17, DOI 10.2188/jea.JE20080035	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44675	10.1371/journal.pone.0044675	http://dx.doi.org/10.1371/journal.pone.0044675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957098	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800091
J	Hu, XY; Zhang, ZD; Li, N; Liu, DX; Zhang, L; He, W; Zhang, W; Li, YX; Zhu, C; Zhu, GJ; Zhang, LP; Xu, F; Wang, SH; Cao, XY; Zhao, HY; Li, Q; Zhang, XJ; Lin, JD; Zhao, SP; Li, C; Du, B				Hu, Xiaoyun; Zhang, Zhidan; Li, Na; Liu, Dexin; Zhang, Li; He, Wei; Zhang, Wei; Li, Yuexia; Zhu, Cheng; Zhu, Guijun; Zhang, Lipeng; Xu, Fang; Wang, Shouhong; Cao, Xiangyuan; Zhao, Huiying; Li, Qian; Zhang, Xijing; Lin, Jiandong; Zhao, Shuangping; Li, Chen; Du, Bin		CCCCTG	Self-Reported Use of Personal Protective Equipment among Chinese Critical Care Clinicians during 2009 H1N1 Influenza Pandemic	PLOS ONE			English	Article							INTENSIVE-CARE; CONTACT ISOLATION; INFECTION-CONTROL; UNITED-STATES; HAND HYGIENE; SARS; RECOMMENDATIONS; TRANSMISSION; IMPROVEMENT; PREVENTION	Background: Critically ill patients with 2009 H1N1 influenza are often treated in intensive care units (ICUs), representing significant risk of nosocomial transmission to critical care clinicians and other patients. Despite a large body of literature and guidelines recommending infection control practices, numerous barriers have been identified in ICUs, leading to poor compliance to the use of personal protective equipment (PPE). The use of PPE among critical care clinicians has not been extensively evaluated, especially during the pandemic influenza. This study examined the knowledge, attitudes, and self-reported behaviors, and barriers to compliance with the use of PPE among ICU healthcare workers (HCWs) during the pandemic influenza. Methodology/Principal Findings: A survey instrument consisting of 36 questions was developed and mailed to all HCWs in 21 ICUs in 17 provinces in China. A total of 733 physicians, nurses, and other professionals were surveyed, and 650 (88.7%) were included in the analysis. Fifty-six percent of respondents reported having received training program of pandemic influenza before they cared for H1N1 patients, while 77% reported to have adequate knowledge of self and patient protection. Only 18% of respondents were able to correctly identify all components of PPE, and 55% reported high compliance (>80%) with PPE use during patient care. In multivariate analysis, vaccination for 2009 H1N1 influenza, positive attitudes towards PPE use, organizational factors such as availability of PPE in ICU, and patient information of influenza precautions, as well as reprimand for noncompliance by the supervisors were associated with high compliance, whereas negative attitudes towards PPE use and violation of PPE use were independent predictors of low compliance. Conclusion/Significance: Knowledge and self-reported compliance to recommended PPE use among Chinese critical care clinicians is suboptimal. The perceived barriers should be addressed in order to close the significant gap between perception and knowledge or behavior.	[Hu, Xiaoyun; Du, Bin] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Zhang, Zhidan] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China; [Li, Na] Hainan Prov Peoples Hosp, Haikou, Peoples R China; [Liu, Dexin] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; [Zhang, Li] Capital Med Univ, Fuxing Hosp, Beijing, Peoples R China; [He, Wei] Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China; [Zhang, Wei] Kunming Med Coll, Affiliated Hosp 1, Kunming, Peoples R China; [Li, Yuexia] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhu, Cheng] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China; [Zhu, Guijun] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China; [Zhang, Lipeng] Inner Mongolia Med Coll, Affiliated Hosp, Hohhot, Peoples R China; [Xu, Fang] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Wang, Shouhong] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Cao, Xiangyuan] Ningxia Med Univ, Affiliated Hosp, Yinchuan, Peoples R China; [Zhao, Huiying] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Li, Qian] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xijing] Xijing Hosp, Xian, Peoples R China; [Lin, Jiandong] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China; [Zhao, Shuangping] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Li, Chen] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; China Medical University; Jilin University; Capital Medical University; Capital Medical University; Kunming Medical University; Zhengzhou University; Shanghai Jiao Tong University; Hebei Medical University; Inner Mongolia Medical University; Chongqing Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Ningxia Medical University; Peking University; Zhejiang Provincial People's Hospital; Air Force Military Medical University; Fujian Medical University; Central South University; Shandong University	Hu, XY (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	dubin98@gmail.com	zhao, shuangling/HCI-6255-2022; Zhu, Guangshan/E-2024-2013; Du, Bin/K-4283-2013	Du, Bin/0000-0001-6237-2895				Banach DB, 2011, INFECT CONT HOSP EP, V32, P293, DOI 10.1086/658911; Beam EL, 2011, AM J INFECT CONTROL, V39, P415, DOI 10.1016/j.ajic.2010.07.009; Bolyard EA, 1998, AM J INFECT CONTROL, V26, P289, DOI 10.1016/S0196-6553(98)80015-1; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Brunkhorst FM, 2008, CRIT CARE MED, V36, P2719, DOI 10.1097/CCM.0b013e318186b6f3; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; *CDCP, 2009 H1N1 FLU INT SI; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e3181b6fa29, 10.1097/CCM.0b013e31819d67b5]; de Vos MLG, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-52; Department of Health, 2008, PAND INFL GUID INF C; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Harriman K., 2009, Morbidity and Mortality Weekly Report, V58, P641; Huang DT, 2010, INT J QUAL HEALTH C, V22, P151, DOI 10.1093/intqhc/mzq017; Jaeger JL, 2011, INFECT CONT HOSP EP, V32, P1149, DOI 10.1086/662709; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kirkland KB, 1999, LANCET, V354, P1177, DOI 10.1016/S0140-6736(99)04196-3; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; Ma XC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-24; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; O'Boyle CA, 2001, AM J INFECT CONTROL, V29, P352, DOI 10.1067/mic.2001.18405; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Reid SM, 2011, CAN J EMERG MED, V13, P71, DOI 10.2310/8000.2011.110253; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Swaminathan A, 2007, EMERG INFECT DIS, V13, P1541, DOI 10.3201/eid1310.070033; Tai DYH, 2006, ANN ACAD MED SINGAP, V35, P374; Timen A, 2010, AM J INFECT CONTROL, V38, P726, DOI 10.1016/j.ajic.2010.03.006; Vinck L, 2011, EURO SURVEILL, V16; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization (WHO), 2009, COMMUNICATION   0425; Zilberberg MD, 2009, PLOS CURR INFLUENZA	33	29	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44723	10.1371/journal.pone.0044723	http://dx.doi.org/10.1371/journal.pone.0044723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957101	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800094
J	Moreno-Rueda, G; Redondo, T				Moreno-Rueda, Gregorio; Redondo, Tomas			Benefits of Extra Begging Fail to Compensate for Immunological Costs in Southern Shrike (Lanius meridionalis) Nestlings	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; IMMUNE-RESPONSE; NEED; GROWTH; BIRDS; PHYTOHEMAGGLUTININ; BEHAVIOR; SIGNALS	Theoretical models aimed at explaining the evolution of honest, informative begging signals employed by nestling birds to solicit food from their parents, require that dishonest signalers incur a net viability cost in order to prevent runaway escalation of signal intensity over evolutionary time. Previous attempts to determine such a cost empirically have identified two candidate physiological costs associated with exaggerated begging: a growth and an immunological cost. However, they failed to take into account the fact that those costs are potentially offset by the fact that nestlings that invest more in begging are also likely to obtain more food. In this study, we test experimentally whether a 25% increase in ingested food compensates for growth and immunological costs of extra begging in southern shrike (Lanius meridionalis) nestlings. Three nestmates matched by size were given three treatments: low begging, high begging-same food intake, and high begging-extra food intake. We found that, while a higher food intake did effectively compensate for the growth cost, it failed to compensate for the immunological cost, measured as T-cell mediated immune response against an innocuous mitogen. Thus, we show for the first time that escalated begging has an associated physiological net cost likely to affect nestling survival negatively.	[Redondo, Tomas] CSIC, Estac Biol Donana, Seville, Spain; [Moreno-Rueda, Gregorio] Univ Granada, Dept Zool, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada	Moreno-Rueda, G (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	gmr@ugr.es	Redondo, Tomás/K-8896-2014; Moreno-Rueda, Gregorio/K-7068-2014	Redondo, Tomás/0000-0002-0927-9111; Moreno-Rueda, Gregorio/0000-0002-6726-7215	Spanish Government (Ministerio de Ciencia y Tecnologia); Consejo Superior de Investigaciones Cientificas (CSIC) [201030E079]; Spanish government (Ministerio de Ciencia e Innovacion) [CGL2011-29694]	Spanish Government (Ministerio de Ciencia y Tecnologia)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); Spanish government (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	G.M.-R. was supported by the Spanish Government (Ministerio de Ciencia y Tecnologia, "Juan de la Cierva" program), and T. R. was supported by the Consejo Superior de Investigaciones Cientificas (CSIC; Proyectos Intramurales Especiales, ref. 201030E079). The study was economically supported by the Spanish government (Ministerio de Ciencia e Innovacion; project CGL2011-29694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Brilot BO, 2003, P ROY SOC B-BIOL SCI, V270, P1055, DOI 10.1098/rspb.2003.2329; Budden AE, 2001, CURR ORNITHOL, V16, P83; Budden Amber E., 2001, Ring, V22, P165; Chappell MA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P143, DOI 10.1007/0-306-47660-6_8; Clark AB, 1998, ANIM BEHAV, V56, P563, DOI 10.1006/anbe.1998.0831; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GUNTURKUN O, 1989, PHARMACOL BIOCHEM BE, V32, P415, DOI 10.1016/0091-3057(89)90172-X; Haff TM, 2011, BIOL LETTERS, V7, P493, DOI 10.1098/rsbl.2010.1125; Hernandez A, 2004, LIBRO ROJO AVES ESPA, P351; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Injidi MH, 1989, BR POULT SCI, V282, P139; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Johnstone Rufus A., 1997, P155; Kedar H, 2000, P ROY SOC B-BIOL SCI, V267, P1723, DOI 10.1098/rspb.2000.1201; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V54, P573, DOI 10.1007/s00265-003-0668-2; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin-Galvez D, 2011, J EXP BIOL, V214, P1463, DOI 10.1242/jeb.050153; Mock D. W., 1997, EVOLUTION SIBLING RI; Moreno-Rueda G, 2011, J EVOLUTION BIOL, V24, P1091, DOI 10.1111/j.1420-9101.2011.02242.x; Moreno-Rueda G, 2007, J ETHOL, V25, P215, DOI 10.1007/s10164-006-0020-1; Moreno-Rueda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040367; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Moreno-Rueda G, 2009, ACTA ORNITHOL, V44, P167, DOI 10.3161/000164509X482740; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; REDONDO T, 1992, ETHOLOGY, V92, P193; Rodriguez-Girones MA, 2001, BEHAV ECOL, V12, P269, DOI 10.1093/beheco/12.3.269; RodriguezGirones MA, 1996, P NATL ACAD SCI USA, V93, P14637, DOI 10.1073/pnas.93.25.14637; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; SOSULSKI FW, 1990, J AGR FOOD CHEM, V38, P1351, DOI 10.1021/jf00096a011; Swain BK, 2000, BRIT POULTRY SCI, V41, P83, DOI 10.1080/00071660086457; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; TRIVERS RL, 1974, AM ZOOL, V14, P249; Verhulst S, 1997, AUK, V114, P134, DOI 10.2307/4089078; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Weathers Wesley W., 1996, P461; Wolf P, 2003, J ANIM PHYSIOL AN N, V87, P122, DOI 10.1046/j.1439-0396.2003.00424.x; Wright J, 2002, EVOLUTION BEGGING	55	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44647	10.1371/journal.pone.0044647	http://dx.doi.org/10.1371/journal.pone.0044647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957095	gold, Green Published			2022-12-27	WOS:000308463800088
J	Sachs, G; Traugott, J; Nesterova, AP; Dell'Omo, G; Kummeth, F; Heidrich, W; Vyssotski, AL; Bonadonna, F				Sachs, Gottfried; Traugott, Johannes; Nesterova, Anna P.; Dell'Omo, Giacomo; Kuemmeth, Franz; Heidrich, Wolfgang; Vyssotski, Alexei L.; Bonadonna, Francesco			Flying at No Mechanical Energy Cost: Disclosing the Secret of Wandering Albatrosses	PLOS ONE			English	Article							TRACKING; WIND	Albatrosses do something that no other birds are able to do: fly thousands of kilometres at no mechanical cost. This is possible because they use dynamic soaring, a flight mode that enables them to gain the energy required for flying from wind. Until now, the physical mechanisms of the energy gain in terms of the energy transfer from the wind to the bird were mostly unknown. Here we show that the energy gain is achieved by a dynamic flight manoeuvre consisting of a continually repeated up-down curve with optimal adjustment to the wind. We determined the energy obtained from the wind by analysing the measured trajectories of free flying birds using a new GPS-signal tracking method yielding a high precision. Our results reveal an evolutionary adaptation to an extreme environment, and may support recent biologically inspired research on robotic aircraft that might utilize albatrosses' flight technique for engineless propulsion.	[Sachs, Gottfried; Traugott, Johannes] Tech Univ Munich, Inst Flight Syst Dynam, D-8046 Garching, Germany; [Nesterova, Anna P.; Bonadonna, Francesco] 5175 CNRS, UMR, Ctr Ecol Fonct & Evolut, Behav Ecol Grp, Montpellier, France; [Dell'Omo, Giacomo] Ornis ital, Rome, Italy; [Kuemmeth, Franz; Heidrich, Wolfgang] E Obs GmbH, Grunwald, Germany; [Vyssotski, Alexei L.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	Technical University of Munich; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Sachs, G (corresponding author), Tech Univ Munich, Inst Flight Syst Dynam, D-8046 Garching, Germany.	francesco.bonadonna@cefe.cnrs.fr	Bonadonna, Francesco/A-7456-2008	Bonadonna, Francesco/0000-0002-2702-5801; Chiaradia, Andre/0000-0002-6178-4211; Vyssotski, Alexei/0000-0002-9021-1471; Dell'Omo, Giacomo/0000-0002-9601-9675	Institut Polaire Francais Paul Emile Victor (IPEV) [354]; National Science Foundation [0700939]; Ornis italica	Institut Polaire Francais Paul Emile Victor (IPEV); National Science Foundation(National Science Foundation (NSF)); Ornis italica	This work was supported by Institut Polaire Francais Paul Emile Victor (IPEV, Program No. 354) A. P. Nesterova was supported by National Science Foundation International Research Fellowship (# 0700939). G. Dell'Omo was supported by Ornis italica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2012, 2009734 AIAA, V226, P1315; [Anonymous], NASA ALB DYN SOAR OP; Brooke M, 2004, ALBATROSSES PETRELS; Catry P, 2004, AUK, V121, P1208, DOI 10.1642/0004-8038(2004)121[1208:SFTBAG]2.0.CO;2; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Deittert M, 2009, J GUID CONTROL DYNAM, V32, P1446, DOI 10.2514/1.43270; Denny Mark, 2009, European Journal of Physics, V30, P75, DOI 10.1088/0143-0807/30/1/008; Hector J, 1895, T NZ I, V27, P651; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Langelaan JW, 2009, SCIENCE, V326, P1642, DOI 10.1126/science.1182497; Langelaan JW, 2008, 46 AER C AM I AER AS; Lighthill J., 1975, P423; Lindhe Norberg Ulla M., 2004, Acta Zoologica Sinica, V50, P921; Madsen J, 2006, J AVIAN BIOL, V37, P283, DOI 10.1111/j.2006.0908-8857.03555.x; Nicholas RJ, 2009, 20096112 AIAA; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; Pennycuik Colin J., 2002, Avian Science, V2, P1; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Sachs G, 2005, IBIS, V147, P1, DOI 10.1111/j.1474-919x.2004.00295.x; Stull R.B., 2003, INTRO BOUNDARY LAYER; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; TICKELL, 2000, ALBATROSSES; Traugott J., 2008, GPS WORLD, V19, P48; Traugott J., 2008, P 21 INT TECHN M SAT, P1883; Warham J., 1996, BEHAV POPULATION BIO; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	28	53	56	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41449	10.1371/journal.pone.0041449	http://dx.doi.org/10.1371/journal.pone.0041449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957014	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000308463800006
J	Chang, CM; Su, YC; Lai, NS; Huang, KY; Chien, SH; Chang, YH; Lian, WC; Hsu, TW; Lee, CC				Chang, Chun-Ming; Su, Yu-Chieh; Lai, Ning-Sheng; Huang, Kuang-Yung; Chien, Sou-Hsin; Chang, Yu-Han; Lian, Wei-Cheng; Hsu, Ta-Wen; Lee, Ching-Chih			The Combined Effect of Individual and Neighborhood Socioeconomic Status on Cancer Survival Rates	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ADVANCED PANCREATIC-CANCER; BREAST-CANCER; RADICAL PROSTATECTOMY; MULTILEVEL EVIDENCE; SOCIAL-ENVIRONMENT; ALAMEDA COUNTY; MORTALITY; RISK; DEATH	Background: This population-based study investigated the relationship between individual and neighborhood socioeconomic status (SES) and mortality rates for major cancers in Taiwan. Methods: A population-based follow-up study was conducted with 20,488 cancer patients diagnosed in 2002. Each patient was traced to death or for 5 years. The individual income-related insurance payment amount was used as a proxy measure of individual SES for patients. Neighborhood SES was defined by income, and neighborhoods were grouped as living in advantaged or disadvantaged areas. The Cox proportional hazards model was used to compare the death-free survival rates between the different SES groups after adjusting for possible confounding and risk factors. Results: After adjusting for patient characteristics (age, gender, Charlson Comorbidity Index Score, urbanization, and area of residence), tumor extent, treatment modalities (operation and adjuvant therapy), and hospital characteristics (ownership and teaching level), colorectal cancer, and head and neck cancer patients under 65 years old with low individual SES in disadvantaged neighborhoods conferred a 1.5 to 2-fold higher risk of mortality, compared with patients with high individual SES in advantaged neighborhoods. A cross-level interaction effect was found in lung cancer and breast cancer. Lung cancer and breast cancer patients less than 65 years old with low SES in advantaged neighborhoods carried the highest risk of mortality. Prostate cancer patients aged 65 and above with low SES in disadvantaged neighborhoods incurred the highest risk of mortality. There was no association between SES and mortality for cervical cancer and pancreatic cancer. Conclusions: Our findings indicate that cancer patients with low individual SES have the highest risk of mortality even under a universal health-care system. Public health strategies and welfare policies must continue to focus on this vulnerable group.	[Chang, Chun-Ming; Chien, Sou-Hsin; Hsu, Ta-Wen] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan; [Chang, Chun-Ming; Su, Yu-Chieh; Lai, Ning-Sheng; Huang, Kuang-Yung; Chien, Sou-Hsin; Hsu, Ta-Wen; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lai, Ning-Sheng; Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Rheumatol, Chiayi, Taiwan; [Chang, Yu-Han] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Lian, Wei-Cheng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chang, CM (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan.	hematcd@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Bao YH, 2007, HEALTH SERV RES, V42, P950, DOI 10.1111/j.1475-6773.2006.00638.x; Benard VB, 2008, CANCER-AM CANCER SOC, V113, P2910, DOI 10.1002/cncr.23742; Booth CM, 2010, CANCER-AM CANCER SOC, V116, P4160, DOI 10.1002/cncr.25427; Borrell LN, 2004, INT J EPIDEMIOL, V33, P398, DOI 10.1093/ije/dyh063; Boyd C, 1999, J CLIN ONCOL, V17, P2244, DOI 10.1200/JCO.1999.17.7.2244; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Brewster DH, 2001, BRIT MED J, V322, P830, DOI 10.1136/bmj.322.7290.830; Bureau of Health Promotion, 2011, CANC STAT; Castellanos EH, 2011, ONCOLOGY-NY, V25, P182; Chen VW, 1997, CANCER EPIDEM BIOMAR, V6, P1087; Chiao C, 2012, J PUBLIC HEALTH-UK, V34, P217, DOI 10.1093/pubmed/fdr069; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Engelhardt Joseph B, 2008, Home Healthc Nurse, V26, P166, DOI 10.1097/01.NHH.0000313348.85980.1e; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Griggs JJ, 2007, J CLIN ONCOL, V25, P277, DOI 10.1200/JCO.2006.08.3063; Hellenthal NJ, 2010, UROLOGY, V76, P1409, DOI 10.1016/j.urology.2010.03.024; Hook EB, 2000, AM J EPIDEMIOL, V151, P1132; Ignatius SH, 2009, J THORAC ONCOL, V4, P37, DOI 10.1097/JTO.0b013e31819140fb; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson S, 2010, ORAL ONCOL, V46, P366, DOI 10.1016/j.oraloncology.2010.02.010; Koil CE, 2003, GENET MED, V5, P364, DOI 10.1097/01.GIM.0000086477.00766.C9; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Liu CY HY, 2006, J HLTH MANAGE, P1; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; MARMOT MG, 1983, J PSYCHOSOM RES, V27, P377, DOI 10.1016/0022-3999(83)90069-7; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Paquette L, 2007, J AM COLL SURGEONS, V205, P636, DOI 10.1016/j.jamcollsurg.2007.04.043; Pu C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-166; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Roos LL, 2004, SOC SCI MED, V59, P1435, DOI 10.1016/j.socscimed.2004.01.024; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Snow AN, 2010, ADV ANAT PATHOL, V17, P394, DOI 10.1097/PAP.0b013e3181f895c1; Srougi V, 2011, INT BRAZ J UROL, V37, P507, DOI 10.1590/S1677-55382011000400010; Stojadinovic A, 2003, J AM COLL SURGEONS, V196, P954, DOI 10.1016/S1072-7515(03)00010-3; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Winkleby M, 2006, AM J PUBLIC HEALTH, V96, P2145, DOI 10.2105/AJPH.2004.060970; Yen IH, 1999, AM J EPIDEMIOL, V149, P898; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/00000658-200209000-00012; Zell JA, 2008, J CLIN ONCOL, V26, P66, DOI 10.1200/JCO.2007.12.3604	46	65	65	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e44325	10.1371/journal.pone.0044325	http://dx.doi.org/10.1371/journal.pone.0044325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	997ZH	22957007	Green Published, Green Submitted, gold			2022-12-27	WOS:000308206500060
J	Cossu, G; Boria, S; Copioli, C; Bracceschi, R; Giuberti, V; Santelli, E; Gallese, V				Cossu, Giuseppe; Boria, Sonia; Copioli, Cristiana; Bracceschi, Roberta; Giuberti, Virginia; Santelli, Erica; Gallese, Vittorio			Motor Representation of Actions in Children with Autism	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; MIRROR NEURON DYSFUNCTION; INTENTIONAL ATTUNEMENT; IMITATION; RECOGNITION; ORGANIZATION; COGNITION; DISORDER; DEFICITS; SYSTEM	Background: Children with Autistic Spectrum Disorders (ASD) are frequently hampered by motor impairment, with difficulties ranging from imitation of actions to recognition of motor intentions. Such a widespread inefficiency of the motor system is likely to interfere on the ontogeny of both motor planning and understanding of the goals of actions, thus delivering its ultimate effects on the emergence of social cognition. Methodology/Principal Findings: We investigate the organization of action representation in 15 high functioning ASD (mean age: 8.11) and in two control samples of typically developing (TD) children: the first one, from a primary school, was matched for chronological age (CA), the second one, from a kindergarten, comprised children of much younger age (CY). We used nine newly designed behavioural motor tasks, aiming at exploring three domains of motor cognition: 1) imitation of actions, 2) production of pantomimes, and 3) comprehension of pantomimes. The findings reveal that ASD children fare significantly worse than the two control samples in each of the inspected components of the motor representation of actions, be it the imitation of gestures, the self-planning of pantomimes, or the (verbal) comprehension of observed pantomimes. In the latter task, owing to its cognitive complexity, ASD children come close to the younger TD children's level of performance; yet they fare significantly worse with respect to their age-mate controls. Overall, ASD children reveal a profound damage to the mechanisms that control both production and pre-cognitive "comprehension" of the motor representation of actions. Conclusions/Significance: Our findings suggest that many of the social cognitive impairments manifested by ASD individuals are likely rooted in their incapacity to assemble and directly grasp the intrinsic goal-related organization of motor behaviour. Such impairment of motor cognition might be partly due to an early damage of the Mirror Neuron Mechanism (MNM).	[Cossu, Giuseppe; Boria, Sonia; Copioli, Cristiana; Bracceschi, Roberta; Gallese, Vittorio] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Giuberti, Virginia; Santelli, Erica] AUSL Reggio Emilia, Unita Neuropsichiat Infantile, Reggio Emilia, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Cossu, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giuseppe.cossu@unipr.it	Gallese, Vittorio/ABD-5097-2021	Gallese, Vittorio/0000-0003-4815-3607	Fondazione Monte Parma (FMP); Regione Emilia Romagna; MIUR (Ministero Italiano dell'Universita e della Ricerca); EU grants	Fondazione Monte Parma (FMP); Regione Emilia Romagna(Regione Emilia Romagna); MIUR (Ministero Italiano dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); EU grants	The study was supported by Fondazione Monte Parma (FMP), by Regione Emilia Romagna, by MIUR (Ministero Italiano dell'Universita e della Ricerca) and EU grants NESTCOM and DISCOS (to V.G.). The authors thank A.M. Dalla Vecchia for her clinical contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beall PM, 2008, J EXP CHILD PSYCHOL, V101, P206, DOI 10.1016/j.jecp.2008.04.004; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Boria S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005596; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; DEMYER MK, 1972, J AUTISM CHILD SCHIZ, V2, P264, DOI 10.1007/BF01537618; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 2006, BRAIN RES, V1079, P15, DOI 10.1016/j.brainres.2006.01.054; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P1231, DOI 10.1098/rstb.2003.1315; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Gallese V, 2012, DEV MED CHI IN PRESS; Gallese V, 2007, J AM PSYCHOANAL ASS, V55, P131, DOI 10.1177/00030651070550010601; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Grezes J, 2009, NEUROPSYCHOLOGIA, V47, P1816, DOI 10.1016/j.neuropsychologia.2009.02.021; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Ingersoll B, 2003, J AUTISM DEV DISORD, V33, P673, DOI 10.1023/B:JADD.0000006003.26667.f8; Kanner L, 1943, NERV CHILD, V2, P217; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Leighton J, 2008, NEUROPSYCHOLOGIA, V46, P1041, DOI 10.1016/j.neuropsychologia.2007.11.013; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; Martineau J, 2008, INT J PSYCHOPHYSIOL, V68, P35, DOI 10.1016/j.ijpsycho.2008.01.002; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Moll J, 2000, NEUROLOGY, V54, P1331, DOI 10.1212/WNL.54.6.1331; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Nielsen M, 2008, J EXP CHILD PSYCHOL, V101, P165, DOI 10.1016/j.jecp.2008.06.004; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Press C, 2010, NEUROPSYCHOLOGIA, V48, P3291, DOI 10.1016/j.neuropsychologia.2010.07.012; RAVEN JC, 1984, COLOURED PROGR MATRI; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G., 2000, NEW COGNITIVE NEUROS, P539; Rogers S. J., 1991, DEV PSYCHOPATHOL, V3, P137, DOI DOI 10.1017/S0954579400000043; Rogers S. J., 2006, IMITATION SOCIAL MIN, P277; Rogers SJ, 2010, DEV PSYCHOPATHOL, V22, P71, DOI 10.1017/S0954579409990277; Rubini V, 1986, WECHSLER INTELLIGENC; Sevlever M, 2010, RES DEV DISABIL, V31, P976, DOI 10.1016/j.ridd.2010.04.014; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whiten A., 1999, INTERSUBJECTIVE COMM; Williams JHG, 2004, J AUTISM DEV DISORD, V34, P285, DOI 10.1023/B:JADD.0000029551.56735.3a	51	44	45	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44779	10.1371/journal.pone.0044779	http://dx.doi.org/10.1371/journal.pone.0044779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970304	Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400029
J	Wang, F; Sun, GP; Zou, YF; Li, YY; Hao, L; Pan, FM				Wang, Fang; Sun, Guoping; Zou, Yanfeng; Li, Yuanyuan; Hao, Li; Pan, Faming			Association of microRNA-499 rs3746444 Polymorphism with Cancer Risk: Evidence from 7188 Cases and 8548 Controls	PLOS ONE			English	Article							COMMON GENETIC-VARIANTS; PRE-MICRORNAS; HEPATOCELLULAR-CARCINOMA; SUSCEPTIBILITY; METAANALYSIS; ALLELE; MIRNA	Background: Owing to inconsistent and inconclusive results, we performed a meta-analysis to derive a more precise estimation of the association between miR-499 rs3746444 polymorphism and cancer risk. Methodology/Principal Findings: A systematic search of the Pubmed, Excerpta Medica Database (Embase) and Chinese Biomedical Literature Database (CBM) databases was performed with the last search updated on May 6, 2012. The odds ratio (OR) and its 95% confidence interval (95% CI) were used to assess the strength of the association. A total of 15 independent studies including 7,188 cases and 8,548 controls were used in the meta-analysis. In the present meta-analysis, we found a significant association between miR-499 rs3746444 polymorphism and cancer risk in the overall analysis (G versus A: OR = 1.10, 95% CI 1.01-1.19, P = 0.03; GG+AG versus AA: OR = 1.15, 95% CI 1.02-1.30, P = 0.02; GG versus AG+AA: OR = 1.07, 95% CI 0.89-1.28, P = 0.50; GG versus AA: OR = 1.13, 95% CI 0.98-1.31, P = 0.09; AG versus AA: OR = 1.16, 95% CI 1.02-1.33, P = 0.03). In the subgroup analysis by ethnicity, miR-499 rs3746444 polymorphism was significantly associated with cancer risk in Asian population. In the subgroup analysis by cancer types, miR-499 rs3746444 polymorphism was significantly associated with breast cancer. Conclusions/Significance: This meta-analysis suggests a significant association between miR-499 rs3746444 polymorphism and cancer risk. Large-scale and well-designed case-control studies are necessary to validate the risk identified in the present meta-analysis.	[Wang, Fang; Sun, Guoping; Li, Yuanyuan; Hao, Li] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China; [Zou, Yanfeng; Pan, Faming] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Wang, F (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Anhui, Peoples R China.	sunguoping@ahmu.edu.cn			National Natural Science Foundation of China [81071986, 81001283, 30971530]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81071986, 81001283, 30971530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, ASIAN PAC J CANCER P, V12, P3107; Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Landi D, 2011, MUTAT RES-FUND MOL M, V717, P109, DOI 10.1016/j.mrfmmm.2010.10.002; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033987; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; MANTEL N, 1959, J NATL CANCER I, V22, P719; Min KT, 2012, MOL CARCINOGEN, V51, pE65, DOI 10.1002/mc.21849; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qiu LX, 2011, CYTOKINE, V56, P695, DOI 10.1016/j.cyto.2011.09.001; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340	36	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e45042	10.1371/journal.pone.0045042	http://dx.doi.org/10.1371/journal.pone.0045042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970328	Green Published, gold, Green Submitted			2022-12-27	WOS:000308748400038
J	Tsompanidou, E; Denham, EL; Sibbald, MJJB; Yang, XM; Seinen, J; Friedrich, AW; Buist, G; van Dijl, JM				Tsompanidou, Eleni; Denham, Emma L.; Sibbald, Mark J. J. B.; Yang, Xiao-mei; Seinen, Jolien; Friedrich, Alexander W.; Buist, Girbe; van Dijl, Jan Maarten			The Sortase A Substrates FnbpA, FnbpB, ClfA and ClfB Antagonize Colony Spreading of Staphylococcus aureus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; FIBRONECTIN-BINDING PROTEINS; I SIGNAL PEPTIDASES; SURFACE-PROTEINS; CELL-WALL; EPIDERMIDIS BIOFILMS; INDEPENDENT BIOFILM; TRANSPEPTIDASE-SRTA; FIBRINOGEN-BINDING; SORTING SIGNAL	Staphylococcus aureus is an important human pathogen that is renowned both for its rapid transmission within hospitals and the community, and for the formation of antibiotic resistant biofilms on medical implants. Recently, it was shown that S. aureus is able to spread over wet surfaces. This motility phenomenon is promoted by the surfactant properties of secreted phenol-soluble modulins (PSMs), which are also known to inhibit biofilm formation. The aim of the present studies was to determine whether any cell surface-associated S. aureus proteins have an impact on colony spreading. To this end, we analyzed the spreading capabilities of strains lacking non-essential components of the protein export and sorting machinery. Interestingly, our analyses reveal that the absence of sortase A (SrtA) causes a hyper-spreading phenotype. SrtA is responsible for covalent anchoring of various proteins to the staphylococcal cell wall. Accordingly, we show that the hyper-spreading phenotype of srtA mutant cells is an indirect effect that relates to the sortase substrates FnbpA, FnbpB, ClfA and ClfB. These surface-exposed staphylococcal proteins are known to promote biofilm formation, and cell-cell interactions. The hyper-spreading phenotype of srtA mutant staphylococcal cells was subsequently validated in Staphylococcus epidermidis. We conclude that cell wall-associated factors that promote a sessile lifestyle of S. aureus and S. epidermidis antagonize the colony spreading motility of these bacteria.	[Tsompanidou, Eleni; Denham, Emma L.; Yang, Xiao-mei; Seinen, Jolien; Friedrich, Alexander W.; Buist, Girbe; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [Tsompanidou, Eleni; Denham, Emma L.; Yang, Xiao-mei; Seinen, Jolien; Friedrich, Alexander W.; Buist, Girbe; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Sibbald, Mark J. J. B.] Univ Groningen, Dept Pharmaceut Biol, Groningen, Netherlands; [Yang, Xiao-mei] Fudan Univ, Shanghai Med Coll, Key Lab Mol Virol, Shanghai 200433, Peoples R China	University of Groningen; University of Groningen; University of Groningen; Fudan University	Tsompanidou, E (corresponding author), Univ Groningen, Dept Med Microbiol, Groningen, Netherlands.	J.M.van.dijl01@umcg.nl	van Dijl, Jan Maarten/G-1205-2013; Friedrich, Alex/ABG-9823-2020; Denham, Emma/P-3979-2014	Denham, Emma/0000-0002-5123-4099	CEU [LSHM-CT-2006-019064, LSHG-CT-2006-037469]; Top Institute Pharma project [T4-213]	CEU; Top Institute Pharma project	E. T., E. L. D., M.J.J.B.S, X.Y., G. B. and J.M.v.D. were in part supported by the CEU projects LSHM-CT-2006-019064, and LSHG-CT-2006-037469, the transnational SysMO initiative through the BACELL SysMO projects 1 and 2, and the Top Institute Pharma project T4-213. E. T. and A. W. F. were supported through the INTERREG-IVa Euregio-project Safeguard MRSAVetMed-net with reference no. 34-INTERREG IV A-II-2-05=025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Dreisbach A, 2011, PROTEOMICS, V11, P3154, DOI 10.1002/pmic.201000823; Dreisbach A, 2010, PROTEOMICS, V10, P3082, DOI 10.1002/pmic.201000062; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; George NPE, 2006, ARTERIOSCL THROM VAS, V26, P2394, DOI 10.1161/01.ATV.0000237606.90523.94; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Hanada M, 1996, FEBS LETT, V381, P25, DOI 10.1016/0014-5793(96)00066-X; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Komatsuzawa H, 2000, FEMS MICROBIOL LETT, V188, P35, DOI 10.1016/S0378-1097(00)00194-4; Kouwen TRHM, 2009, ANTIMICROB AGENTS CH, V53, P4702, DOI 10.1128/AAC.00439-09; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Meulemans L, 2007, VET MICROBIOL, V125, P333, DOI 10.1016/j.vetmic.2007.05.024; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Nandakumar R, 2005, J PROTEOME RES, V4, P250, DOI 10.1021/pr049866k; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Periasamy S, 2012, P NATL ACAD SCI US; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Savolainen K, 2001, INFECT IMMUN, V69, P3013, DOI 10.1128/IAI.69.5.3013-3020.2001; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; van Roosmalen ML, 2004, BBA-MOL CELL RES, V1694, P279, DOI 10.1016/j.bbamcr.2004.05.006; Vancraeynest D, 2004, VET MICROBIOL, V103, P241, DOI 10.1016/j.vetmic.2004.09.002; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wolz C, 1996, INFECT IMMUN, V64, P3142, DOI 10.1128/IAI.64.8.3142-3147.1996; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945	59	35	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44646	10.1371/journal.pone.0044646	http://dx.doi.org/10.1371/journal.pone.0044646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970276	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000040
J	Zhang, GC; Hu, YW; Wang, HP; Zhang, L; Bao, YX; Zhou, XM				Zhang, Guocui; Hu, Yunwen; Wang, Hongping; Zhang, Lu; Bao, Yixi; Zhou, Xiaoming			High Incidence of Multiple Viral Infections Identified in Upper Respiratory Tract Infected Children under Three Years of Age in Shanghai, China	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN METAPNEUMOVIRUS; SYNCYTIAL-VIRUS; INFLUENZA-B; NESTED-PCR; ASSAY; DIAGNOSIS; SYSTEM; SARS	Background: Upper respiratory tract infection (URTI) is a major reason for hospitalization in childhood. More than 80% of URTIs are viral. Etiological diagnosis of URTIs is important to make correct clinical decisions on treatment methods. However, data for viral spectrum of URTIs are very limited in Shanghai children. Methods: Nasopharyngeal swabs were collected from a group of 164 children aged below 3 years who were hospitalized due to acute respiratory infection from May 2009 to July 2010 in Shanghai. A VRDAL multiplex PCR for 10 common respiratory viruses was performed on collected specimens compared with the Seeplex (R) RV15 ACE Detection kit for 15 respiratory viruses. Results: Viruses were detected in 84 (51.2%) patients by VRDAL multiplex PCR, and 8 (4.9%) of cases were mixed infections. Using the Seeplex (R) RV15 ACE Detection kit, viruses were detected in 129 (78.7%) patients, 49 (29.9%) were co-infected cases. Identified viruses included 37 of human rhinovirus (22.6% of cases), 32 of influenza A virus (19.5%), 30 of parainfluenzavirus-2 (18.3%), 23 of parainfluenzavirus-3 (14.0%), 15 of human enterovirus (9.1%), 14 each of parainfluenzavirus-1, respiratory syncytial virus B and adenovirus (8.5%), 8 of coronavirus 229E/NL63 (4.9%), 6 of human bocavirus (3.7%), 5 each of influenza B virus and respiratory syncytial virus A (3.0%), 3 of parainfluenzavirus-4 (1.8%), 2 of coronavirus OC43/HKU1 (1.2%), and 1 human metapneumovirus (0.6%). Conclusions: A high frequency of respiratory infections (78.7%) and co-infections (29.9%) was detected in children with acute respiratory infection symptoms in Shanghai. The Seeplex (R) RV15 ACE detection method was found to be a more reliable high throughput tool than VRDAL method to simultaneously detect multiple respiratory viruses.	[Zhang, Guocui; Hu, Yunwen; Wang, Hongping; Zhang, Lu; Zhou, Xiaoming] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Guocui; Bao, Yixi] Chongqing Med Univ, Affiliated Hosp 2, Dept Clin Lab, Chongqing, Peoples R China	Fudan University; Chongqing Medical University	Zhang, GC (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	xmzhou@shmu.edu.cn			Chinese National R&D Programme for Key Technologies from Chinese Government, Ministry of Science and Technology [2009ZX10004-104]	Chinese National R&D Programme for Key Technologies from Chinese Government, Ministry of Science and Technology	This work was funded by Chinese National R&D Programme for Key Technologies (No. 2009ZX10004-104) from Chinese Government, Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Chan PKS, 2004, EMERG INFECT DIS, V10, P497, DOI 10.3201/eid1003.030513; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Lee N, 2007, J CLIN VIROL, V40, P333, DOI 10.1016/j.jcv.2007.08.015; Li PQ, 2008, DIAGN MICR INFEC DIS, V62, P44, DOI 10.1016/j.diagmicrobio.2008.04.017; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Roh KH, 2008, ANN CLIN LAB SCI, V38, P41; Shi WX, 2008, CHIN J HLTH LAB TECH, V18, P1263; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; [曾玫 ZENG Mei], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P527	21	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44568	10.1371/journal.pone.0044568	http://dx.doi.org/10.1371/journal.pone.0044568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970251	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000030
J	Chen, KY; Chang, SS; Chen, CYC				Chen, Kuan-Yu; Chang, Su-Sen; Chen, Calvin Yu-Chian			In Silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors from Traditional Chinese Medicine	PLOS ONE			English	Article							DRUG DISCOVERY; OBESITY; ORLISTAT; ABSORPTION; PROGRAM; PROTEIN; WEIGHT; DESIGN	Pancreatic triacylglycerol lipase (PNLIP) are primary lipases that are critical for triacylglyceride digestion in human. Since reduced metabolism of triacylglyceride might be a plausible concept for weight loss, we screened for potential PNLIP inhibitors from traditional Chinese medicine (TCM) with the aim to identify weight loss candidate compounds. TCM candidates Aurantiamide, Cnidiadin, and 2-hexadecenoic acid exhibited higher Dock Scores than the commercial drug Orlistat, and were also predicted to have inhibitory characteristics against PNLIP using constructed MLR (R-2 = 0.8664) and SVM (R-2 = 0.9030) models. Molecular dynamics indicated that the TCM-PNLIP complexes formed were stable. We identified that the PNLIP binding site has several residues that can serve as anchors, and a hydrophobic corridor that provides additional stability to the complex. Aurantiamide, Cnidiadin, and 2-hexadecenoic acid all have features that correspond to these binding site features, indicating their potential as candidates for PNLIP inhibitors. The information presented in this study may provide helpful insights to designing novel weight-control drugs.	[Chen, Kuan-Yu] China Med Univ, Dept Chinese Med, Taichung, Taiwan; [Chen, Kuan-Yu; Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan; [Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ, Beigang Hosp, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Asia University Taiwan; China Medical University Taiwan	Chen, KY (corresponding author), China Med Univ, Dept Chinese Med, Taichung, Taiwan.	ycc929@MIT.EDU	Chen, Calvin Yu-Chian/E-9402-2010	Chen, Calvin Yu-Chian/0000-0003-3306-250X; Chen, Calvin Yu-Chian/0000-0001-9213-9832	National Science Council of Taiwan [NSC 100-2325-B-039-001]; Committee on Chinese Medicine and Pharmacy [CCMP100-RD-030]; China Medical University and Asia University [DMR-101-094]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH101-TD-C111-005]; China Medical University Beigang Hospital [CMUBH R101-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy; China Medical University and Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence; China Medical University Beigang Hospital(China Medical University)	The research was supported by grants from the National Science Council of Taiwan (NSC 100-2325-B-039-001), Committee on Chinese Medicine and Pharmacy (CCMP100-RD-030), China Medical University and Asia University (DMR-101-094). This study is also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (DOH101-TD-C111-005). Partial funding is also provided by China Medical University Beigang Hospital (CMUBH R101-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borhani DW, 2012, J COMPUT AID MOL DES, V26, P15, DOI 10.1007/s10822-011-9517-y; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Chang KW, 2011, J BIOMOL STRUCT DYN, V29, P243, DOI 10.1080/073911011010524988; Chang PC, 2011, J BIOMOL STRUCT DYN, V29, P471, DOI 10.1080/07391102.2011.10507399; Chang SS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002315; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen CYC, 2009, J MOL GRAPH MODEL, V28, P261, DOI 10.1016/j.jmgm.2009.08.004; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Chen KC, 2011, CHEM BIOL DRUG DES, V78, P679, DOI 10.1111/j.1747-0285.2011.01202.x; Chen KC, 2011, MOL BIOSYST, V7, P2711, DOI 10.1039/c1mb05164d; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Hodgson J, 2001, NAT BIOTECHNOL, V19, P722, DOI 10.1038/90761; IVANCIUC O, 2007, REV COMPUTATIONAL CH, V23, P291, DOI DOI 10.1002/9780470116449.CH6; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Karamadoukis L, 2009, CLIN NEPHROL, V71, P430; Lin HY, 2008, J CHIN MED ASSOC, V71, P305, DOI 10.1016/S1726-4901(08)70127-8; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mukherjee M, 2003, J MOL CATAL B-ENZYM, V22, P369, DOI 10.1016/S1381-1177(03)00052-3; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; ROGERS D, 1994, J CHEM INF COMP SCI, V34, P854, DOI 10.1021/ci00020a020; Sampson HA, 2009, J ALLERGY CLIN IMMUN, V123, P317, DOI 10.1016/j.jaci.2008.12.1112; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Slinker BK, 2008, CIRCULATION, V117, P1732, DOI 10.1161/CIRCULATIONAHA.106.654376; Thomson ABR, 1997, METHOD ENZYMOL, V286, P3; Tsai TY, 2011, J COMPUT AID MOL DES, V25, P525, DOI 10.1007/s10822-011-9438-9; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1963, AUTOM REMOTE, V24, P774; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHO, 2010, 10 FACTS OB; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yang SC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002189; ZHI JG, 1995, J CLIN PHARMACOL, V35, P1103, DOI 10.1002/j.1552-4604.1995.tb04034.x	36	20	21	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43932	10.1371/journal.pone.0043932	http://dx.doi.org/10.1371/journal.pone.0043932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970152	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400026
J	D'Cruz, TS; Weibley, BN; Kimball, SR; Barber, AJ				D'Cruz, Travis S.; Weibley, Brittany N.; Kimball, Scot R.; Barber, Alistair J.			Post-Translational Processing of Synaptophysin in the Rat Retina Is Disrupted by Diabetes	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; MEMBRANE-PROTEIN; TRANSLATION; CELLS; EXPRESSION; BINDING; MICE; DISTRIBUTIONS; SYNAPTOPORIN; ENDOCYTOSIS	Synaptophysin, is an abundant presynaptic protein involved in synaptic vesicle recycling and neurotransmitter release. Previous work shows that its content is significantly reduced in the rat retina by streptozotocin (STZ)-diabetes. This study tested the hypothesis that STZ-diabetes alters synaptophysin protein turnover and glycosylation in the rat retina. Whole explant retinas from male Sprague-Dawley rats were used in this study. Rats were made diabetic by a single intraperitoneal STZ injection (65 mg/kg body weight in 10 mM sodium citrate, pH 4.5). mRNA translation was measured using a S-35-methionine labeling assay followed by synaptophysin immunoprecipitation and autoradiography. A pulse-chase study was used to determine the depletion of newly synthesized synaptophysin. Depletion of total synaptophysin was determined after treatment with cycloheximide. Mannose rich N-glycosylated synaptophysin was detected by treating retinal lysates with endoglycosidase H followed by immunoblot analysis. Synaptophysin mRNA translation was significantly increased after 1 month (p<0.001) and 2 months (p<0.05) of STZ-diabetes, compared to age-matched controls. Newly synthesized synaptophysin degradation was significantly accelerated in the retina after 1 and 2 months of diabetes compared to controls (p<0.05). Mannose rich glycosylated synaptophysin was significantly increased after 1 month of STZ-diabetes compared to controls (p<0.05). These data suggest that diabetes increases mRNA translation of synaptophysin in the retina, resulting in an accumulation of mannose rich glycosylated synaptophysin, a transient post-translational state of the protein. This diabetes-induced irregularity in post-translational processing could explain the accelerated degradation of retinal synaptophysin in diabetes.	[D'Cruz, Travis S.; Weibley, Brittany N.; Barber, Alistair J.] Milton S Hershey Med Ctr, Penn State Hershey Coll Med, Penn State Hershey Eye Ctr, Dept Ophthalmol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	D'Cruz, TS (corresponding author), Milton S Hershey Med Ctr, Penn State Hershey Coll Med, Penn State Hershey Eye Ctr, Dept Ophthalmol, Hershey, PA 17033 USA.	abarber@psu.edu		Barber, Alistair/0000-0003-4235-2293	American Diabetes Association [7-09-BS-09]; Juvenile Diabetes Research Foundation [1-2008-294]; PA Lions Sight Conservation Eye Research Foundation	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); PA Lions Sight Conservation Eye Research Foundation	This work was supported by the American Diabetes Association (7-09-BS-09 to AJB), Juvenile Diabetes Research Foundation (1-2008-294 to AJB), and PA Lions Sight Conservation Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BRAND SH, 1993, EMBO J, V12, P3753, DOI 10.1002/j.1460-2075.1993.tb06053.x; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; FYKSE EM, 1993, J NEUROSCI, V13, P4997; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; KIVELA T, 1989, INVEST OPHTH VIS SCI, V30, P212; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; KNAUS P, 1990, NEURON, V5, P453, DOI 10.1016/0896-6273(90)90084-S; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nag TC, 2001, J BIOSCIENCES, V26, P179, DOI 10.1007/BF02703642; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Singleton DR, 1997, J CELL SCI, V110, P2099; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Stenius K, 1995, J CELL BIOL, V131, P1801, DOI 10.1083/jcb.131.6.1801; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9	33	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44711	10.1371/journal.pone.0044711	http://dx.doi.org/10.1371/journal.pone.0044711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970294	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400109
J	Hung, MC; Lu, HM; Chen, LK; Lin, MS; Chen, CR; Yu, CJ; Wang, JD				Hung, Mei-Chuan; Lu, Hsin-Ming; Chen, Likwang; Lin, Ming-Shian; Chen, Cheng-Ren; Yu, Chong-Jen; Wang, Jung-Der			Cost per QALY (Quality-Adjusted Life Year) and Lifetime Cost of Prolonged Mechanical Ventilation in Taiwan	PLOS ONE			English	Article							OF-LIFE; HEALTH-INSURANCE; SURVIVAL; EQ-5D	Introduction: Patients who require prolonged mechanical ventilation (PMV) are increasing and producing financial burdens worldwide. This study determines the cost per QALY (quality-adjusted life year), out-of-pocket expenses, and lifetime costs for PMV patients stratified by underlying diseases and cognition levels. Methods: A nationwide sample of 50,481 patients with continual mechanical ventilation for more than 21 days was collected during 1997-2007. After stratifying the patients according to specific diagnoses, a latent class analysis (LCA) was performed to categorise PMV patients with multiple co-morbidities into several homogeneous groups. The survival functions were estimated for individual groups using the Kaplan-Meier method and extrapolated to 300 months through a semi-parametric method. The survival functions were adjusted using an EQ-5D utility value derived from a convenience sample of 142 PMV patients to estimate quality-adjusted life expectancies (QALE). Another convenience sample of 165 patients was used to estimate the out-of-pocket expenses. The lifetime expenditures paid by the single-payer National Health Insurance (NHI) system and patients' families were estimated by multiplying average monthly expenditures by the survival probabilities and summing the values over lifetime. Results: PMV therapy costs more than 100,000 U. S. dollars (USD) per QALY for all patients with poor cognition. For patients with partial cognition, PMV therapy costs less than 56,000 USD per QALY for those with liver cirrhosis, intracranial or spinal cord injuries, and 57,000-69,000 USD for patients with multiple co-morbidities under age of 65. The average lifetime cost of PMV was usually below 56,000 USD. The out-of-pocket expenses were often more than one-third of the total cost of treatment. Conclusions: PMV treatment for patients with poor cognition would cost more than 5 times Taiwan's GDP (gross domestic products), or less cost-effective. The out-of-pocket expenses for PMV provision should also be considered in policy decision.	[Hung, Mei-Chuan; Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Lu, Hsin-Ming; Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Zhunan, Miaoli County, Taiwan; [Chen, Likwang] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Ming-Shian; Chen, Cheng-Ren] Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Hung, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	jdwang121@gmail.com	Chen, Li-Kwang/E-3934-2010	Yu, Chong-Jen/0000-0001-5664-9392	National Science Council (NSC) [98-2341-B-002-129, 99-2314-B-006 -002, 101-3114-Y-006-001]; National Health Research Institutes (NHRI) in Taiwan [HD-097-PP-01, PH-098-PP-13, HD-097-PP-11, PH-098-PP-19, PH-099-PP-19]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institutes (NHRI) in Taiwan(National Health Research Institutes - Taiwan)	Supported by grants from the National Science Council (NSC, grant no. 98-2341-B-002-129, 99-2314-B-006 -002 and 101-3114-Y-006-001) and the National Health Research Institutes (NHRI, grant no. HD-097-PP-01, PH-098-PP-13, HD-097-PP-11, PH-098-PP-19, and PH-099-PP-19) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan S, 2005, QUAL LIFE RES, V14, P107, DOI 10.1007/s11136-004-1920-6; Bureau of National Health Insurance, PROSP PAYM SYST VENT; Carson SS, 2006, CURR OPIN CRIT CARE, V12, P405, DOI 10.1097/01.ccx.0000244118.08753.dc; Carson Shannon S, 2006, J Intensive Care Med, V21, P173, DOI 10.1177/0885066605282784; Cheng SH, 2008, HEALTH POLICY, V86, P288, DOI 10.1016/j.healthpol.2007.11.002; Chu PC, 2008, J FORMOS MED ASSOC, V107, P54, DOI 10.1016/S0929-6646(08)60008-X; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Cooke CR, 2012, CRIT CARE CLIN, V28, P39, DOI 10.1016/j.ccc.2011.10.004; Coucill W, 2001, MED CARE, V39, P760, DOI 10.1097/00005650-200108000-00003; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; DANIELS N, 1985, JUST HLTH CARE; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Gold MR, 1996, COST EFFECTIVENESS H; Harris J, 2005, J MED ETHICS, V31, P373, DOI 10.1136/jme.2005.012906; Hjelmgren J, 2001, Value Health, V4, P225, DOI 10.1046/j.1524-4733.2001.43040.x; Hung MC, 2011, CRIT CARE, V15, DOI 10.1186/cc10128; Hung MC, 2011, VALUE HEALTH, V14, P347, DOI 10.1016/j.jval.2010.09.006; Hung MC, 2010, QUAL LIFE RES, V19, P721, DOI 10.1007/s11136-010-9629-1; Hwang JS, 2004, QUAL LIFE RES, V13, P1, DOI 10.1023/B:QURE.0000015299.45623.38; Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4; Hwang JS, 1996, STAT MED, V15, P93, DOI 10.1002/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2; McPhail S, 2008, MED CARE, V46, P1140, DOI 10.1097/MLR.0b013e31817d69a6; Ministry of the Interior in Taiwan, GROSS DOM PROD; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; National Health Research Institute, 2012, NAT HLTH RES DAT; Needham DM, 2004, CRIT CARE MED, V32, P1504, DOI 10.1097/01.CCM.0000129972.31533.37; Orpana HM1, 2009, HLTH REPORTS, V20, P1; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Pickard AS, 2005, MED CARE, V43, P493, DOI 10.1097/01.mlr.0000160419.27642.a8; Pickard AS, 2004, STROKE, V35, P607, DOI 10.1161/01.STR.0000110984.91157.BD; WHO, COST EFF THRESH	34	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44043	10.1371/journal.pone.0044043	http://dx.doi.org/10.1371/journal.pone.0044043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970160	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400031
J	Kawanabe, Y; Takahashi, M; Jin, XJ; Abdul-Majeed, S; Nauli, AM; Sari, Y; Nauli, SM				Kawanabe, Yoshifumi; Takahashi, Maki; Jin, Xingjian; Abdul-Majeed, Shakila; Nauli, Andromeda M.; Sari, Youssef; Nauli, Surya M.			Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation	PLOS ONE			English	Article							PHOSPHODIESTERASE INHIBITOR; BASILAR ARTERY; CA2+ CHANNELS; CONTRACTION; CELLS; POLYCYSTIN-2; INVOLVEMENT; PLASMA; INFLUX; CILIA	Cilostazol is a phosphodiesterase inhibitor that has been shown to inhibit platelet activation. Endothelin is known to be the most potent endogenous growth promoting and vasoactive peptide. In patients and animal models with stroke, the level of circulating endothelin increases and complicates the recovery progress contributed by vascular constriction (an immediate pathology) and vascular proliferation (a long-term pathology). However, the effects of cilostazol on endothelin have not been explored. To demonstrate the dual-antagonizing effects of cilostazol on vasoconstriction and cell proliferation induced by endothelin, we used primary culture of mouse vascular smooth muscle cells in vitro, mouse femoral artery ex vivo, and intracranial basilar artery ex vivo. We show that the dual-inhibition effects of cilostazol are mediated by blocking endothelin-induced extracellular calcium influx. Although cilostazol does not inhibit endothelin-induced intraorganellar calcium release, blockade of extracellular calcium influx is sufficient to blunt endothelin-induced vasoconstriction. We also show that cilostazol inhibits endothelin-induced cellular proliferation by blocking extracellular calcium influx. Inhibition of cAMP-dependent protein kinase (PKA) can block anti-proliferation activity of cilostazol, confirming the downstream role of PKA in cellular proliferation. To further demonstrate the selectivity of the dual-antagonizing effects of cilostazol, we used a different phosphodiesterase inhibitor. Interestingly, sildenafil inhibits endothelin-induced vasoconstriction but not cellular proliferation in smooth muscle cells. For the first time, we show selective dual-antagonizing effects of cilostazol on endothelin. We propose that cilostazol is an excellent candidate to treat endothelin-associated diseases, such as stroke.	[Kawanabe, Yoshifumi; Takahashi, Maki; Jin, Xingjian; Abdul-Majeed, Shakila; Sari, Youssef; Nauli, Surya M.] Univ Toledo, Dept Pharmacol, Toledo, OH 43606 USA; [Nauli, Andromeda M.] E Tennessee State Univ, Dept Hlth Sci, Johnson City, TN 37614 USA	University System of Ohio; University of Toledo; East Tennessee State University	Kawanabe, Y (corresponding author), Otsu Municipal Hosp, Dept Neurosurg, Otsu, Shiga, Japan.	Surya.Nauli@UToledo.Edu	Sari, Youssef/X-5449-2018					Abdul-Majeed S, 2011, CELL MOL LIFE SCI; Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Abdul-Majeed S, 2011, HYPERTENSION, V58, P325, DOI 10.1161/HYPERTENSIONAHA.111.172080; AbouAlaiwi WA, 2011, HUM MOL GENET, V20, P354, DOI 10.1093/hmg/ddq470; AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Al-Qudah ZA, 2011, EXPERT OPIN PHARMACO, V12, P1305, DOI 10.1517/14656566.2011.576248; ALABADI JA, 1993, NEUROSURGERY, V33, P707, DOI 10.1227/00006123-199310000-00022; Chen WJ, 2011, ARTERIOSCL THROM VAS, V31, P2106, DOI 10.1161/ATVBAHA.111.230987; FUJIMORI A, 1990, LANCET, V336, P633, DOI 10.1016/0140-6736(90)93432-O; Hefke T, 2012, THORAC CARDIOV SURG, V60, P26, DOI 10.1055/s-0030-1250726; Kawanabe Y, 2005, CELL SIGNAL, V17, P911, DOI 10.1016/j.cellsig.2005.01.001; Kawanabe Y, 2002, AM J PHYSIOL-CELL PH, V282, pC330, DOI 10.1152/ajpcell.00227.2001; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kawanabe Y, 2006, J NEUROSURG, V105, P288, DOI 10.3171/jns.2006.105.2.288; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Nakamura K, 2006, J VASC RES, V43, P86, DOI 10.1159/000089723; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2003, BIOL NEONATE, V83, P123, DOI 10.1159/000067595; Nauli SM, 2000, GEN PHARMACOL-VASC S, V35, P107, DOI 10.1016/S0306-3623(01)00100-8; Nauli SM, 2001, AM J PHYSIOL-HEART C, V280, pH1019, DOI 10.1152/ajpheart.2001.280.3.H1019; Nauli SM, 2001, AM J PHYSIOL-CELL PH, V281, pC1785, DOI 10.1152/ajpcell.2001.281.6.C1785; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Sallustio F, 2010, CURR VASC PHARMACOL, V8, P363, DOI 10.2174/157016110791112331; Sanganalmath SK, 2008, CAN J PHYSIOL PHARM, V86, P180, DOI 10.1139/Y08-005; Shiraishi Y, 1998, BRIT J PHARMACOL, V123, P869, DOI 10.1038/sj.bjp.0701699; SUZUKI R, 1992, J NEUROSURG, V77, P96, DOI 10.3171/jns.1992.77.1.0096; TAKAHASHI S, 1992, J CARDIOVASC PHARM, V20, P900, DOI 10.1097/00005344-199212000-00009; TANAKA T, 1988, PHARMACOLOGY, V36, P313, DOI 10.1159/000138400; Witteveen PO, 2010, NEOPLASIA, V12, P941, DOI 10.1593/neo.10582; YAMAURA I, 1992, J NEUROSURG, V76, P99, DOI 10.3171/jns.1992.76.1.0099; ZIV I, 1992, STROKE, V23, P1014, DOI 10.1161/01.STR.23.7.1014	34	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44476	10.1371/journal.pone.0044476	http://dx.doi.org/10.1371/journal.pone.0044476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957074	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800067
J	Meyer, GF; Wong, LT; Timson, E; Perfect, P; White, MD				Meyer, Georg F.; Wong, Li Ting; Timson, Emma; Perfect, Philip; White, Mark D.			Objective Fidelity Evaluation in Multisensory Virtual Environments: Auditory Cue Fidelity in Flight Simulation	PLOS ONE			English	Article							SUPERIOR COLLICULUS NEURONS; VISUAL-MOTION SIGNALS; PSYCHOMETRIC FUNCTION; VESTIBULAR CUES; SELF-MOTION; INTEGRATION; PERFORMANCE; REALITY; DETERMINANTS; FACILITATION	We argue that objective fidelity evaluation of virtual environments, such as flight simulation, should be human-performance-centred and task-specific rather than measure the match between simulation and physical reality. We show how principled experimental paradigms and behavioural models to quantify human performance in simulated environments that have emerged from research in multisensory perception provide a framework for the objective evaluation of the contribution of individual cues to human performance measures of fidelity. We present three examples in a flight simulation environment as a case study: Experiment 1: Detection and categorisation of auditory and kinematic motion cues; Experiment 2: Performance evaluation in a target-tracking task; Experiment 3: Transferrable learning of auditory motion cues. We show how the contribution of individual cues to human performance can be robustly evaluated for each task and that the contribution is highly task dependent. The same auditory cues that can be discriminated and are optimally integrated in experiment 1, do not contribute to target-tracking performance in an in-flight refuelling simulation without training, experiment 2. In experiment 3, however, we demonstrate that the auditory cue leads to significant, transferrable, performance improvements with training. We conclude that objective fidelity evaluation requires a task-specific analysis of the contribution of individual cues.	[Meyer, Georg F.; Wong, Li Ting] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England; [Timson, Emma; Perfect, Philip; White, Mark D.] Univ Liverpool, Sch Engn, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Meyer, GF (corresponding author), Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England.	georg@liv.ac.uk	White, Mark/AAG-8761-2020	White, Mark/0000-0002-8611-9525; Meyer, Georg/0000-0002-3739-1653	Engineering and Physical Sciences Research Council [EP/K503538/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aggarwal R, 2007, ANN SURG, V246, P771, DOI 10.1097/SLA.0b013e3180f61b09; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; [Anonymous], 2008, JAR FSTD H HELICOPTE; Barnett-Cowan M, 2011, EXP BRAIN RES, V214, P27, DOI 10.1007/s00221-011-2802-0; Barnett-Cowan M, 2009, EXP BRAIN RES, V198, P221, DOI 10.1007/s00221-009-1779-4; Bell HH, 1998, INT J AVIAT PSYCHOL, V8, P223, DOI 10.1207/s15327108ijap0803_4; Berger DR, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658354; Berger DR, 2009, EXP BRAIN RES, V198, P287, DOI 10.1007/s00221-009-1767-8; Badia SBI, 2009, PRESENCE-TELEOP VIRT, V18, P277, DOI 10.1162/pres.18.4.277; Bowman DA, 2007, COMPUTER, V40, P36, DOI 10.1109/MC.2007.257; Burki-Cohen J, 2007, AIAA MOD SIM TECHN C, P6564; Calvert G., 2004, HDB MULTISENSORY PRO; Dahlstrom N, 2009, THEOR ISS ERGON SCI, V10, P305, DOI 10.1080/14639220802368864; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ferwerda JA, 2003, PROC SPIE, V5007, P290, DOI 10.1117/12.473899; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Grant P, 2007, J AIRCRAFT, V44, P927, DOI 10.2514/1.25807; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Hale KS, 2009, ERGONOMICS, V52, P187, DOI 10.1080/00140130802376000; Harrison NR, 2010, J VISION, V10, DOI 10.1167/10.14.16; Ho C., 2008, MULTISENSORY DRIVER; Hodge SJ, 2011, P 67 ANN FOR AM HEL; Jones E. R., 1985, HUMAN FACTORS ASPECT; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Lathan CE, 2002, PRESENCE-TELEOP VIRT, V11, P368, DOI 10.1162/105474602760204282; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Longridge T, 2001, P 11 INT S AV PSYCH; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Maran NJ, 2003, MED EDUC, V37, P22, DOI 10.1046/j.1365-2923.37.s1.9.x; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Meyer G, 2003, SPEECH COMMUN, V41, P429, DOI 10.1016/S0167-6393(03)00013-X; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; Padfield G, 2005, AEROSP SCI TECHNOL, V9, P400, DOI 10.1016/j.ast.2005.03.004; Padfield GD, 2003, AERONAUT J, V107, P529; Perfect P, 2011, P 37 EUR ROT FOR GAL; Perfect P, 2010, P 36 EUR ROT FOR PAR; Quick R., 1974, BIOL CYBERN, V16, P65, DOI DOI 10.1007/BF00271628; Schricker BC, 2001, PROC ANNU SIMUL SYMP, P109, DOI 10.1109/SIMSYM.2001.922122; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shapiro MJ, 2004, QUAL SAF HEALTH CARE, V13, P417, DOI 10.1136/qshc.2003.005447; Valjamae A, 2008, PRESENCE-TELEOP VIRT, V17, P43, DOI 10.1162/pres.17.1.43; Wallet G, 2010, STUD HEALTH TECHNOL, V154, P145, DOI 10.3233/978-1-60750-561-7-145; White MD, 2009, P 35 EUR ROT FOR; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; [No title captured]	49	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44381	10.1371/journal.pone.0044381	http://dx.doi.org/10.1371/journal.pone.0044381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957068	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800061
J	Pennell, MW; Sarver, BAJ; Harmon, LJ				Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.			Trees of Unusual Size: Biased Inference of Early Bursts from Large Molecular Phylogenies	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; DIVERSIFICATION RATES; EVOLUTIONARY RADIATIONS; SPECIES DELIMITATION; FOSSIL RECORD; EXTINCTION; DIVERSITY; SPECIATION; DYNAMICS; PATTERNS	An early burst of speciation followed by a subsequent slowdown in the rate of diversification is commonly inferred from molecular phylogenies. This pattern is consistent with some verbal theory of ecological opportunity and adaptive radiations. One often-overlooked source of bias in these studies is that of sampling at the level of whole clades, as researchers tend to choose large, speciose clades to study. In this paper, we investigate the performance of common methods across the distribution of clade sizes that can be generated by a constant-rate birth-death process. Clades which are larger than expected for a given constant-rate branching process tend to show a pattern of an early burst even when both speciation and extinction rates are constant through time. All methods evaluated were susceptible to detecting this false signature when extinction was low. Under moderate extinction, both the c-statistic and diversity-dependent models did not detect such a slowdown but only because the signature of a slowdown was masked by subsequent extinction. Some models which estimate time-varying speciation rates are able to detect early bursts under higher extinction rates, but are extremely prone to sampling bias. We suggest that examining clades in isolation may result in spurious inferences that rates of diversification have changed through time.	[Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies IBEST, Moscow, ID 83843 USA; [Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Pennell, Matthew W.; Sarver, Brice A. J.; Harmon, Luke J.] BEACON Ctr Study Evolut Act, E Lansing, MI USA	Idaho; University of Idaho; Idaho; University of Idaho	Pennell, MW (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies IBEST, Moscow, ID 83843 USA.	mwpennell@gmail.com		Harmon, Luke/0000-0002-4985-5750	National Science Foundation [DEB-0919499, DBI-0939454]; NSERC-PGS-M award	National Science Foundation(National Science Foundation (NSF)); NSERC-PGS-M award	LJH and MWP were funded by National Science Foundation grant DEB-0919499. MWP also received funding from a NSERC-PGS-M award. This material is based in part upon work supported by the National Science Foundation under Cooperative Agreement No. DBI-0939454. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; Bokma F, 2009, P ROY SOC B-BIOL SCI, V276, P993, DOI 10.1098/rspb.2008.1249; Brock CD, 2011, SYST BIOL, V60, P410, DOI 10.1093/sysbio/syr007; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cusimano N, 2012, SYSTEMATIC BIOL; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Davies TJ, 2004, P ROY SOC B-BIOL SCI, V271, P2195, DOI 10.1098/rspb.2004.2849; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Etienne RS, 2012, SYST BIOL, V61, P204, DOI 10.1093/sysbio/syr091; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Fordyce JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011781; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Price T, 2007, SPECIATION BIRDS; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Rosenblum EB, 2012, EVOL BIOL, V39, P255, DOI 10.1007/s11692-012-9171-x; Ruber L, 2005, EVOLUTION, V59, P1119; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stadler T, 2008, MATH BIOSCI, V216, P163, DOI 10.1016/j.mbs.2008.09.006; Weir JT, 2006, EVOLUTION, V60, P842; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	53	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43348	10.1371/journal.pone.0043348	http://dx.doi.org/10.1371/journal.pone.0043348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957027	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800019
J	Wang, L; Xiang, SY; Williams, KA; Dong, HQ; Bai, WL; Nicosia, SV; Khochbin, S; Bepler, G; Zhang, XH				Wang, Lei; Xiang, Shengyan; Williams, Kendra A.; Dong, Huiqin; Bai, Wenlong; Nicosia, Santo V.; Khochbin, Saadi; Bepler, Gerold; Zhang, Xiaohong			Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; VINORELBINE PLUS CISPLATIN; ADJUVANT CHEMOTHERAPY; ANTICANCER AGENTS; CLINICAL-TRIALS; GASTRIC-CANCER; EXPRESSION; P53; PHOSPHORYLATION; ACETYLATION	Histone deacetylase inhibitors (HDACi) are promising therapeutic agents which are currently used in combination with chemotherapeutic agents in clinical trials for cancer treatment including non-small cell lung cancer (NSCLC). However, the mechanisms underlying their anti-tumor activities remain elusive. Previous studies showed that inhibition of HDAC6 induces DNA damage and sensitizes transformed cells to anti-tumor agents such as etoposide and doxorubicin. Here, we showed that depletion of HDAC6 in two NSCLC cell lines, H292 and A549, sensitized cells to cisplatin, one of the first-line chemotherapeutic agents used to treat NSCLC. We suggested that depletion of HDAC6 increased cisplatin-induced cytotoxicity was due to the enhancement of apoptosis via activating ATR/Chk1 pathway. Furthermore, we showed that HDAC6 protein levels were positively correlated with cisplatin IC50 in 15 NSCLC cell lines. Lastly, depletion of HDAC6 in H292 xenografts rendered decreased tumor weight and volume and exhibited increased basal apoptosis compared with the controls in a xenograft mouse model. In summary, our findings suggest that HDAC6 is positively associated with cisplatin resistance in NSCLC and reveal HDAC6 as a potential novel therapeutic target for platinum refractory NSCLC.	[Wang, Lei; Xiang, Shengyan; Williams, Kendra A.; Dong, Huiqin; Bai, Wenlong; Nicosia, Santo V.; Zhang, Xiaohong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33620 USA; [Bai, Wenlong; Zhang, Xiaohong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Khochbin, Saadi] Albert Bonniot Inst, French Natl Inst Hlth & Med Res, Grenoble, France; [Bepler, Gerold] Karmanos Canc Inst, Dept Oncol, Detroit, MI USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Barbara Ann Karmanos Cancer Institute	Wang, L (corresponding author), Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33620 USA.	beplerg@karmanos.org; xzhang1@health.usf.edu	Khochbin, Saadi/M-8090-2013; Bai, Wenlong/A-8977-2013; Wang, Lei/E-3063-2012; XIANG, SHENGYAN/C-3176-2013	Khochbin, Saadi/0000-0002-0455-0857; Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559	National Cancer Institute of the National Institutes of Health [R01CA164147]; Florida James and Esther King Biomedical Program [09KN-17]; Marsha Rivkin Foundation; Ovarian Cancer Research Fund (OCRF); H. Lee Moffitt Cancer Center Lung Cancer SPORE; USF Graduate Student Success Diversity Fellowship; NATIONAL CANCER INSTITUTE [P30CA076292, P50CA119997, R01CA164147] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida James and Esther King Biomedical Program; Marsha Rivkin Foundation; Ovarian Cancer Research Fund (OCRF); H. Lee Moffitt Cancer Center Lung Cancer SPORE; USF Graduate Student Success Diversity Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Cancer Institute of the National Institutes of Health under Award Number R01CA164147, New Investigator grant (09KN-17) from Florida James and Esther King Biomedical Program, the Marsha Rivkin Foundation pilot grant, Ovarian Cancer Research Fund (OCRF), the career development grant from H. Lee Moffitt Cancer Center Lung Cancer SPORE to XZ and USF Graduate Student Success Diversity Fellowship to KAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PA, 1992, CANCER RES, V52, P1895; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hartley JM, 1999, CLIN CANCER RES, V5, P507; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamemura K, 2008, BIOCHEM BIOPH RES CO, V374, P84, DOI 10.1016/j.bbrc.2008.06.092; Kanamori Y, 1998, EUR J CANCER, V34, P1802, DOI 10.1016/S0959-8049(98)00199-3; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kigawa J, 2002, GYNECOL ONCOL, V84, P210, DOI 10.1006/gyno.2001.6488; Kim IA, 2009, RADIOTHER ONCOL, V92, P125, DOI 10.1016/j.radonc.2009.03.008; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; LONG BH, 1994, CANCER RES, V54, P4355; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Olive PL, 2009, CYTOM PART B-CLIN CY, V76B, P79, DOI 10.1002/cyto.b.20450; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; POZAROWSKI P, 2004, CURR PROTOC CELL BIO, pCH18, DOI DOI 10.1002/0471143030.CB1808S21; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Vekris A, 2004, CANCER RES, V64, P356, DOI 10.1158/0008-5472.CAN-03-2258; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhou J, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/597098; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	55	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44265	10.1371/journal.pone.0044265	http://dx.doi.org/10.1371/journal.pone.0044265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957056	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800048
J	Jung, WY; Kwon, SG; Son, M; Cho, ES; Lee, Y; Kim, JH; Kim, BW; Park, DH; Hwang, JH; Kim, TW; Park, HC; Park, BY; Choi, JS; Cho, KK; Chung, KH; Song, YM; Kim, IS; Jin, SK; Kim, DH; Lee, SW; Lee, KW; Bang, WY; Kim, CW				Jung, Won Yong; Kwon, Seul Gi; Son, Minky; Cho, Eun Seok; Lee, Yuno; Kim, Jae Hwan; Kim, Byeong-Woo; Park, Da Hye; Hwang, Jung Hye; Kim, Tae Wan; Park, Hwa Choon; Park, Beom Young; Choi, Jong-Soon; Cho, Kwang Keun; Chung, Ki Hwa; Song, Young Min; Kim, Il Suk; Jin, Sang Keun; Kim, Doo Hwan; Lee, Seung-Won; Lee, Keun Woo; Bang, Woo Young; Kim, Chul Wook			RNA-Seq Approach for Genetic Improvement of Meat Quality in Pig and Evolutionary Insight into the Substrate Specificity of Animal Carbonyl Reductases	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; GENOME; TRAITS; MUSCLE; SNPS; PHOSPHORYLATION; IDENTIFICATION; POLYMORPHISMS; VARIANTS	Changes in meat quality traits are strongly associated with alterations in postmortem metabolism which depend on genetic variations, especially nonsynonymous single nucleotide variations (nsSNVs) having critical effects on protein structure and function. To selectively identify metabolism-related nsSNVs, next-generation transcriptome sequencing (RNA-Seq) was carried out using RNAs from porcine liver, which contains a diverse range of metabolic enzymes. The multiplex SNV genotyping analysis showed that various metabolism-related genes had different nsSNV alleles. Moreover, many nsSNVs were significantly associated with multiple meat quality traits. Particularly, ch7:g.22112616A.G SNV was identified to create a single amino acid change (Thr/Ala) at the 145th residue of H1.3-like protein, very close to the putative 147th threonine phosphorylation site, suggesting that the nsSNV may affect multiple meat quality traits by affecting the epigenetic regulation of postmortem metabolism-related gene expression. Besides, one nonsynonymous variation, probably generated by gene duplication, led to a stop signal in porcine testicular carbonyl reductase (PTCR), resulting in a C-terminal (E281-A288) deletion. Molecular docking and energy minimization calculations indicated that the binding affinity of wild-type PTCR to 5 alpha-DHT, a C-21-steroid, was superior to that of C-terminal-deleted PTCR or human carbonyl reductase, which was very consistent with experimental data, reported previously. Furthermore, P284 was identified as an important residue mediating the specific interaction between PTCR and 5 alpha-DHT, and phylogenetic analysis showed that P284 is an evolutionarily conserved residue among animal carbonyl reductases, which suggests that the C-terminal tails of these reductases may have evolved under evolutionary pressure to increase the substrate specificity for C-21-steroids and facilitate metabolic adaptation. Altogether, our RNA-Seq revealed that selective nsSNVs were associated with meat quality traits that could be useful for successful marker-assisted selection in pigs and also represents a useful resource to enhance understanding of protein folding, substrate specificity, and the evolution of enzymes such as carbonyl reductase.	[Jung, Won Yong; Kwon, Seul Gi; Cho, Kwang Keun; Chung, Ki Hwa; Song, Young Min; Kim, Il Suk; Jin, Sang Keun; Kim, Doo Hwan; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Dept Anim Resources Technol, Jinju, South Korea; [Kwon, Seul Gi; Cho, Eun Seok; Kim, Jae Hwan; Park, Da Hye; Hwang, Jung Hye; Kim, Tae Wan; Cho, Kwang Keun; Chung, Ki Hwa; Song, Young Min; Kim, Il Suk; Jin, Sang Keun; Kim, Doo Hwan; Bang, Woo Young; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea; [Jung, Won Yong; Lee, Seung-Won] SeqGenesis, Taejon, South Korea; [Son, Minky; Lee, Yuno; Kim, Byeong-Woo; Lee, Keun Woo] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju, South Korea; [Son, Minky; Lee, Yuno; Lee, Keun Woo] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Jinju, South Korea; [Park, Hwa Choon] Da San Jong Don Co Ltd, Namwon, South Korea; [Cho, Eun Seok; Park, Beom Young] Natl Inst Anim Sci, RDA, Suwon, South Korea; [Choi, Jong-Soon] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Choi, Jong-Soon] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology; Gyeongsang National University; Gyeongsang National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Korea Basic Science Institute (KBSI); Chungnam National University	Jung, WY (corresponding author), Gyeongnam Natl Univ Sci & Technol, Dept Anim Resources Technol, Jinju, South Korea.	wybang@gntech.ac.kr; cwkim@gntech.ac.kr		Jung, WonYong/0000-0002-1751-8418	National Research Foundation of Korea (NRF) [2011-0022965, 2012-0008319]; Ministry of Education, Science and Technology; Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [107091-5]; Rural Development Administration, Republic of Korea [PJ0077672011]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by grants from the Priority Research Centers Program (2011-0022965) and Basic Science Research Program (2012-0008319) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, and the Technology Development Program for Agriculture and Forestry (107091-5), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. It was also carried out with the support of "Cooperative Research Program for Agriculture Science and Technology Development (PJ0077672011)" Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cherel P, 2012, J ANIM SCI, V90, P699, DOI 10.2527/jas.2011-4198; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fan B, 2010, MEAT SCI, V84, P645, DOI 10.1016/j.meatsci.2009.10.025; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Ho MR, 2011, NUCLEIC ACIDS RES, V39, pD920, DOI 10.1093/nar/gkq1197; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kobayashi K, 1996, J STEROID BIOCHEM, V59, P485, DOI 10.1016/S0960-0760(96)00137-9; Lalonde E, 2010, GENOME RES, DOI [10.1101/gr.111211.111110, DOI 10.1101/GR.111211.111110]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li X, 2009, MEAT SCI, V81, P218, DOI 10.1016/j.meatsci.2008.07.022; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; McCabe M, 2010, ADV ANIM BIOSCI, V1, P62; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakajin S, 2001, BBA-PROTEIN STRUCT M, V1550, P175, DOI 10.1016/S0167-4838(01)00285-0; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Philibert P, 2010, FERTIL STERIL, V94, P472, DOI 10.1016/j.fertnstert.2009.03.057; Ponsuksili S, 2011, J LIPID RES, V52, P668, DOI 10.1194/jlr.M013342; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sampath V, 2012, PEDIATR PULM, V47, P460, DOI 10.1002/ppul.21568; Savas Sevtap, 2006, Human Genomics, V2, P274; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Uzun A, 2007, NUCLEIC ACIDS RES, V35, pW384, DOI 10.1093/nar/gkm232; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; WERMUTH B, 1981, J BIOL CHEM, V256, P1206; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wojcik SE, 2010, CARCINOGENESIS, V31, P208, DOI 10.1093/carcin/bgp209; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wu XF, 2009, J ANDROL, V30, P46, DOI 10.2164/jandrol.108.005736; Xu DQ, 2007, LIVEST SCI, V106, P96, DOI 10.1016/j.livsci.2006.07.005; Yang JO, 2011, NUCLEIC ACIDS RES, V39, pD939, DOI 10.1093/nar/gkq957; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	49	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e42198	10.1371/journal.pone.0042198	http://dx.doi.org/10.1371/journal.pone.0042198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962580	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600007
J	Rebollo, R; Horard, B; Begeot, F; Delattre, M; Gilson, E; Vieira, C				Rebollo, Rita; Horard, Beatrice; Begeot, Flora; Delattre, Marion; Gilson, Eric; Vieira, Cristina			A Snapshot of Histone Modifications within Transposable Elements in Drosophila Wild Type Strains	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; GENOME; MELANOGASTER; GENES; EVOLUTION; RETROTRANSPOSON; DYNAMICS; OPINION; DNA; EPIGENETICS	Transposable elements (TEs) are a major source of genetic variability in genomes, creating genetic novelty and driving genome evolution. Analysis of sequenced genomes has revealed considerable diversity in TE families, copy number, and localization between different, closely related species. For instance, although the twin species Drosophila melanogaster and D. simulans share the same TE families, they display different amounts of TEs. Furthermore, previous analyses of wild type derived strains of D. simulans have revealed high polymorphism regarding TE copy number within this species. Several factors may influence the diversity and abundance of TEs in a genome, including molecular mechanisms such as epigenetic factors, which could be a source of variation in TE success. In this paper, we present the first analysis of the epigenetic status of four TE families (roo, tirant, 412 and F) in seven wild type strains of D. melanogaster and D. simulans. Our data shows intra- and inter-specific variations in the histone marks that adorn TE copies. Our results demonstrate that the chromatin state of common TEs varies among TE families, between closely related species and also between wild type strains.	[Rebollo, Rita; Vieira, Cristina] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolutive, F-69622 Villeurbanne, France; [Horard, Beatrice; Gilson, Eric] UNS, Fac Med, Inst Res Canc & Aging, CNRS UMR7284,INSERM U1081, Nice, France; [Begeot, Flora; Delattre, Marion] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Geneva	Rebollo, R (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	cristina.vieira@univ-lyon1.fr	Vieira, Cristina/Q-3137-2017	Vieira, Cristina/0000-0003-3414-3993; Rebollo, Rita/0000-0002-8138-5082; Gilson, Marion/0000-0001-7521-0799	Centre National de Recherche Scientifique (CNRS); Agence National de la Recherche [(ANR)-09-Programe Blanc-0103-01]; Swiss National Science Foundation; State of Geneva fund	Centre National de Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva fund	This work was funded by Centre National de Recherche Scientifique (CNRS), the Agence National de la Recherche (ANR)-09-Programe Blanc-0103-01, and Cible 2008 (Region Rhone Alpes) for C. Vieira's laboratory. Prof. E. Gilson is an associate member of European Union 6th framework program The Epigenome Network of Excellence (NoE), and his laboratory was funded by a European Union 6th framework program grant RISCRAD and ARECA framework program from Canceropole Lyon Auvergne Rhone Alpes. The Swiss National Science Foundation and the State of Geneva fund the work of F. Begeot and M. Delattre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestar E, 2009, CLIN REV ALLERGY IMM; Bartolome C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r22; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boulesteix M, 2006, MOL BIOL EVOL, V23, P162, DOI 10.1093/molbev/msj012; Brookfield JFY, 2006, GENETICS, V173, P1115, DOI 10.1534/genetics.104.027219; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Fablet M, 2009, FASEB J, V23, P1482, DOI 10.1096/fj.08-123513; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Granzotto A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-174; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; KAMINKER JS, 2002, GENOME BIOL, V0003; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lerat E, 2003, GENOME RES, V13, P1889, DOI 10.1101/gr.827603; Lerat E, 2009, GENOME BIOL EVOLUTIO; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Rebollo R, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-9; Rebollo R, 2010, GENE, V454, P1, DOI 10.1016/j.gene.2010.01.003; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Rigal M, 2011, BIOCH BIOPHYS ACTA; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Schulze SR, 2007, ANNU REV ENTOMOL, V52, P171, DOI 10.1146/annurev.ento.51.110104.151007; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira C, 1996, J MOL EVOL, V42, P443; Vieira C, 1999, MOL BIOL EVOL, V16, P1251, DOI 10.1093/oxfordjournals.molbev.a026215; Vieira C, 2009, GENOME DYNAM STABIL, V4, P21, DOI 10.1007/7050_2009_044; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yin H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002380; 2004, NATURE, V431, P931	43	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44253	10.1371/journal.pone.0044253	http://dx.doi.org/10.1371/journal.pone.0044253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962605	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600033
J	Simwaka, BN; Theobald, S; Willets, A; Salaniponi, FML; Nkhonjera, P; Bello, G; Squire, SB				Simwaka, Bertha Nhlema; Theobald, Sally; Willets, Annie; Salaniponi, Felix M. L.; Nkhonjera, Patnice; Bello, George; Squire, Stephen Bertel			Acceptability and Effectiveness of the Storekeeper-Based TB Referral System for TB Suspects in Sub-Districts of Lilongwe in Malawi	PLOS ONE			English	Article							TUBERCULOSIS SERVICES; HEALTH; COMMUNITY; DOCTORS; ACCESS; POOR	Background: Early access to tuberculosis diagnosis and treatment remains a challenge in developing countries. General use of informal providers such as storekeepers is common. The aim of this study was to determine the effectiveness and acceptability of a storekeeper-based referral system for TB suspects in urban settings of Lilongwe, Malawi. Methods: The referral system intervention was implemented in two sub-districts. This was evaluated using a pre and post comparison as well as comparison with a third sub-district designated as the control. The intervention included training of storekeepers to detect and refer clients with chronic cough using predesigned referral letters along with monitoring and supervision. Data from a community based chronic cough survey and an audit of health centre records were used to measure its effectiveness. Focus group discussions and in-depth interviews were carried out to document acceptability of the intervention with the different stakeholders. Results: Following the intervention, the mean patient delay appeared lower in the intervention than comparison areas (2.14 weeks (SD 5.8) vs 8.8 weeks (SD 15.1)). However, after adjusting for confounding variables this difference was not significant (p = 0.07). After the intervention the proportion of the population diagnosed with smear positive TB in the intervention sites (1.2 per 1000) was significantly higher than in the comparison area (0.6 per 1000, p < 0.01) even after adjusting for sex and age. Qualitative findings suggested that (a) the referral letters triggered health workers to ask patients to submit sputum for TB diagnosis (b) the approach may be sustainable as the referral role was linked to the livelihood of the storekeepers. Conclusion: The study suggests that the referral system with storekeepers is sustainable and effective in increasing smear positive TB case notification. Studies that assess this approach for control of other diseases along with collection of specimens by storekeepers or similar providers are needed.	[Simwaka, Bertha Nhlema; Nkhonjera, Patnice; Bello, George] Res Equ & Community Hlth Trust, Lilongwe, Malawi; [Theobald, Sally; Squire, Stephen Bertel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Willets, Annie] Wellsense Int Publ Hlth Consultants, Kilifi, Kenya; [Salaniponi, Felix M. L.] Malawi Natl TB Control Programme, Lilongwe, Malawi	Liverpool School of Tropical Medicine; University of Liverpool	Simwaka, BN (corresponding author), Res Equ & Community Hlth Trust, Lilongwe, Malawi.	bertha@africa-online.net		Theobald, Sally/0000-0002-9053-211X; Squire, Stephen/0000-0001-7173-9038	Norwegian Lung and Heart Patients Organisation (LHL); Department for International Development (DFID)	Norwegian Lung and Heart Patients Organisation (LHL); Department for International Development (DFID)	This research was funded by Norwegian Lung and Heart Patients Organisation (LHL) and Department for International Development (DFID) funded EQUI-TB Knowledge Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2000, INT J TUBERC LUNG D, V4, P1047; Kamat VR, 2010, SOC SCI MED, V71, P626, DOI 10.1016/j.socscimed.2010.04.016; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Lal SS, 2011, TROP MED INT HEALTH, V16, P685, DOI 10.1111/j.1365-3156.2011.02749.x; Malmborg R, 2006, B WORLD HEALTH ORGAN, V84, P752; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Paul V, 2004, BMJ-BRIT MED J, V329, P1117, DOI 10.1136/bmj.329.7475.1117; Perry H, 1999, SOC SCI MED, V48, P1053, DOI 10.1016/S0277-9536(98)00406-7; Ritchie J, 2004, QUALITATIVE RES PRAC, P24; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Simwaka BN, 2007, INT J TUBERC LUNG D, V11, P65; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Spencer L, 2003, QUALITATIVE RES PRAC, P199; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Thorson A, 2004, HEALTH POLICY, V68, P37, DOI 10.1016/j.healthpol.2003.07.010; Weiss M. G., 2008, International Journal of Tuberculosis and Lung Disease, V12, P825; WHO, 2010, GLOB TUB CONTR SURV; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e39746	10.1371/journal.pone.0039746	http://dx.doi.org/10.1371/journal.pone.0039746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962575	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600002
J	Wang, ZK; Zheng, J; Zhang, XJ; Peng, JJ; Liu, JY; Huang, Y				Wang, Zhikang; Zheng, Jia; Zhang, Xiaojie; Peng, Jingjing; Liu, Jinyu; Huang, Ying			Identification and Sequence Analysis of Metazoan tRNA 3 '-End Processing Enzymes tRNase Zs	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY GENE; FLEXIBLE ARM; CRYSTAL-STRUCTURE; CLEAVAGE SITE; FAMILY; DROSOPHILA; RESIDUES; END; MITOCHONDRIAL; EVOLUTION	tRNase Z is the endonuclease responsible for removing the 3'-trailer sequences from precursor tRNAs, a prerequisite for the addition of the CCA sequence. It occurs in the short (tRNase Z(S)) and long (tRNase Z(L)) forms. Here we report the identification and sequence analysis of candidate tRNase Zs from 81 metazoan species. We found that the vast majority of deuterostomes, lophotrochozoans and lower metazoans have one tRNase Z(S) and one tRNase Z L genes, whereas ecdysozoans possess only a single tRNase Z(L) gene. Sequence analysis revealed that in metazoans, a single nuclear tRNase Z(L) gene is likely to encode both the nuclear and mitochondrial forms of tRNA 39-end processing enzyme through mechanisms that include alternative translation initiation from two in-frame start codons and alternative splicing. Sequence conservation analysis revealed a variant PxKxRN motif, PxPxRG, which is located in the N-terminal region of tRNase Z(S)s. We also identified a previously unappreciated motif, AxDx, present in the C-terminal region of both tRNase Z(S)s and tRNase Z(L)s. The AxDx motif consisting mainly of a very short loop is potentially close enough to form hydrogen bonds with the loop containing the PxKxRN or PxPxRG motif. Through complementation analysis, we demonstrated the likely functional importance of the AxDx motif. In conclusion, our analysis supports the notion that in metazoans a single tRNase Z(L) has evolved to participate in both nuclear and mitochondrial tRNA 39-end processing, whereas tRNase Z(S) may have evolved new functions. Our analysis also unveils new evolutionarily conserved motifs in tRNase Zs, including the C-terminal AxDx motif, which may have functional significance.	[Wang, Zhikang; Zheng, Jia; Zhang, Xiaojie; Peng, Jingjing; Liu, Jinyu; Huang, Ying] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Huang, Y (corresponding author), Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Jiangsu, Peoples R China.	yhuang@njnu.edu.cn			National Science Foundation of China [31070703]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Nanjing Normal University [2007104XGQ0148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Nanjing Normal University	This work was supported in part by grants from the National Science Foundation of China (31070703) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/) and Nanjing Normal University (2007104XGQ0148). The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aravind L, 1999, In Silico Biol, V1, P69; Bogerd HP, 2010, MOL CELL, V37, P135, DOI 10.1016/j.molcel.2009.12.016; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Canino G, 2009, PLANT PHYSL; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Ceballos M, 2007, PROTEIN PEPTIDE LETT, V14, P137, DOI 10.2174/092986607779816050; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Diebel KW, 2010, RNA, V16, P170, DOI 10.1261/rna.1873910; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Dumont M, 2004, BBA-GENE STRUCT EXPR, V1679, P230, DOI 10.1016/j.bbaexp.2004.07.001; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fan LJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-219; Gan X, 2011, BIOCH J; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hopkinson A, 2008, RNA BIOL, V5, P104, DOI 10.4161/rna.5.2.6086; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1995, P NATL ACAD SCI USA, V92, P2662, DOI 10.1073/pnas.92.7.2662; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Levinger L, 2009, J BIOL CHEM, V284, P15685, DOI 10.1074/jbc.M900745200; Lopez Sanchez MI, 2011, CELL CYCLE, V10; Minagawa A, 2008, J MOL BIOL, V381, P289, DOI 10.1016/j.jmb.2008.05.016; Minagawa A, 2006, NUCLEIC ACIDS RES, V34, P3811, DOI 10.1093/nar/gkl517; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossmanith W, 2011, BIOCH BIOPHYS ACTA; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Xie X, 2010, INSECT BIOCH MOL BIO; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Yanaihara N, 2001, GENOMICS, V72, P169, DOI 10.1006/geno.2000.6454; Zareen N, 2006, RNA, V12, P1104, DOI 10.1261/rna.4206; Zhao W, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-272; Zhao Z, 2009, BIOCHEM J, V422, P483, DOI 10.1042/BJ20090743	59	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44264	10.1371/journal.pone.0044264	http://dx.doi.org/10.1371/journal.pone.0044264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962606	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600034
J	Yamada, T; Hara, K; Umematsu, H; Suzuki, R; Kadowaki, T				Yamada, Tomohide; Hara, Kazuo; Umematsu, Hitomi; Suzuki, Ryo; Kadowaki, Takashi			Erectile Dysfunction and Cardiovascular Events in Diabetic Men: A Meta-analysis of Observational Studies	PLOS ONE			English	Article							SILENT-MYOCARDIAL-ISCHEMIA; CORONARY-ARTERY-DISEASE; ENDOTHELIAL DYSFUNCTION; HEART-DISEASE; TYPE-2; RISK; PREVALENCE; ASSOCIATION; GUIDELINES; LIFE	Background: Several studies have shown that erectile dysfunction (ED) influences the risk of cardiovascular events (CV events). However, a meta-analysis of the overall risk of CV events associated with ED in patients with diabetes has not been performed. Methodology/Principal Findings: We searched MEDLINE and the Cochrane Library for pertinent articles (including references) published between 1951 and April 22, 2012. English language reports of original observational cohort studies and cross-sectional studies were included. Pooled effect estimates were obtained by random effects meta-analysis. A total of 3,791 CV events were reported in 3 cohort studies and 9 cross-sectional studies (covering 22,586 subjects). Across the cohort studies, the overall odds ratio (OR) of diabetic men with ED versus those without ED was 1.74 (95% confidence interval [CI]: 1.34-2.27; P<0.001) for CV events and 1.72 (95% CI: 1.5-1.98; P<0.001) for coronary heart disease (CHD). The funnel plot, Begg's test, and Egger's test did not show evidence of publication bias (all P>0.05). Moreover, meta-regression analysis found no relationship between the method used to assess ED (questionnaire or interview), mean age, mean hemoglobin A(1c), mean body mass index, or mean duration of diabetes and the risk of CV events or CHD. In the cross-sectional studies, the OR of diabetic men with ED versus those without ED was 3.39 (95% CI: 2.58-4.44; P<0.001) for CV events (N = 9), 3.43 (95% CI: 2.46-4.77; P<0.001) for CHD (N = 7), and 2.63 (95% CI: 1.41-4.91; P = 0.002) for peripheral vascular disease (N = 5). Conclusion/Significance: ED was associated with an increased risk of CV events in diabetic patients. Prevention and early detection of cardiovascular disease are important in the management of diabetes, especially in view of the rapid increase in its prevalence.	[Yamada, Tomohide; Hara, Kazuo; Umematsu, Hitomi; Suzuki, Ryo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan	University of Tokyo	Yamada, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.	thara-tky@umin.ac.jp	Suzuki, Ryo/AAA-2736-2019; Stefanadis, Christodoulos/ABH-2232-2020	Suzuki, Ryo/0000-0002-2965-6906; Stefanadis, Christodoulos/0000-0001-5974-6454				ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; Batty GD, 2010, J AM COLL CARDIOL, V56, P1908, DOI 10.1016/j.jacc.2010.04.067; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Cho NH, 2006, DIABETIC MED, V23, P198, DOI 10.1111/j.1464-5491.2005.01789.x; De Berardis G, 2005, DIABETES CARE, V28, P2637, DOI 10.2337/diacare.28.11.2637; Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fedele D, 2000, INT J EPIDEMIOL, V29, P524, DOI 10.1093/ije/29.3.524; Frantzen J, 2006, ANN EPIDEMIOL, V16, P85, DOI 10.1016/j.annepidem.2005.06.047; Garcia-Malpartida K, 2011, J SEX MED, V8, P2606, DOI 10.1111/j.1743-6109.2011.02365.x; Gazzaruso C, 2004, CIRCULATION, V110, P22, DOI 10.1161/01.CIR.0000133278.81226.C9; Gazzaruso C, 2006, INT J IMPOT RES, V18, P311, DOI 10.1038/sj.ijir.3901403; Gazzaruso C, 2008, J AM COLL CARDIOL, V51, P2040, DOI 10.1016/j.jacc.2007.10.069; Gazzaruso C, 2011, ENDOCRINE, V40, P273, DOI 10.1007/s12020-011-9523-9; Giuliano FA, 2004, UROLOGY, V64, P1196, DOI 10.1016/j.urology.2004.08.059; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Guo WB, 2010, J SEX MED, V7, P2805, DOI 10.1111/j.1743-6109.2010.01792.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Kalter-Leibovici O, 2005, DIABETES CARE, V28, P1739, DOI 10.2337/diacare.28.7.1739; Kirby M, 2005, INT J CLIN PRACT, V59, P225, DOI 10.1111/j.1742-1241.2005.00453.x; Klein R, 1996, DIABETES CARE, V19, P135, DOI 10.2337/diacare.19.2.135; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ma RCW, 2008, J AM COLL CARDIOL, V51, P2045, DOI 10.1016/j.jacc.2008.02.051; McEvoy JW, 2011, ARCH INTERN MED, V171, P1260, DOI 10.1001/archinternmed.2011.204; Montorsi P, 2005, AM J CARDIOL, V96, p19M; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Romeo JH, 2000, J UROLOGY, V163, P788, DOI 10.1016/S0022-5347(05)67805-6; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Sasaki H, 2005, DIABETES RES CLIN PR, V70, P81, DOI 10.1016/j.diabres.2005.02.018; Shiri R, 2006, INT J IMPOT RES, V18, P348, DOI 10.1038/sj.ijir.3901432; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Vlachopoulos C, 2008, CURR PHARM DESIGN, V14, P3700, DOI 10.2174/138161208786898716; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476; Yu LW, 2010, INT J ANDROL, V33, P853, DOI 10.1111/j.1365-2605.2009.01026.x	40	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43673	10.1371/journal.pone.0043673	http://dx.doi.org/10.1371/journal.pone.0043673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962586	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600014
J	Perera, S; Crewther, D; Croft, R; Keage, H; Hermens, D; Clark, CR				Perera, Sharnel; Crewther, David; Croft, Rodney; Keage, Hannah; Hermens, Daniel; Clark, C. Richard			Comorbid Externalising Behaviour in AD/HD: Evidence for a Distinct Pathological Entity in Adolescence	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; OPPOSITIONAL DEFIANT DISORDER; EEG-DEFINED SUBTYPES; RESPONSE-INHIBITION; CONDUCT DISORDER; SUSTAINED ATTENTION; POWER SPECTRA; ADHD	While the profiling of subtypes of Attention Deficit Hyperactivity Disorder (AD/HD) have been the subject of considerable scrutiny, both psychometrically and psychophysiologically, little attention has been paid to the effect of diagnoses comorbid with AD/HD on such profiles. This is despite the greater than 80% prevalence of comorbidity under the DSM-IV-TR diagnostic definitions. Here we investigate the event related potential (ERP) and psychometric profiles of Controls, AD/HD, and comorbid AD/HD (particularly AD/HD+ODD/CD) groups on six neurocognitive tasks thought to probe the constructs of selective and sustained attention, response inhibition and executive function. Data from 29 parameters extracted from a child group (age range 6 to 12; 52 Controls and 64 AD/HD) and from an adolescent group (age range 13 to 17; 79 Controls and 88 AD/HD) were reduced via a Principal Components Analysis, the 6 significant eigenvectors then used as determinants of cluster membership via a Two-Step Cluster Analysis. Two clusters were found in the analysis of the adolescent age group -a cluster dominated by Control and AD/HD participants without comorbidity, while the second cluster was dominated by AD/HD participants with externalising comorbidity (largely oppositional defiant/conduct disorder ODD/CD). A similar segregation within the child age group was not found. Further analysis of these objectively determined clusters in terms of their clinical diagnoses indicates a significant effect of ODD/CD comorbidity on a concurrent AD/HD diagnosis. We conclude that comorbid externalising behaviour in AD/HD constitutes a distinct pathological entity in adolescence.	[Perera, Sharnel; Crewther, David] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia; [Croft, Rodney] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Keage, Hannah; Clark, C. Richard] Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia; [Hermens, Daniel] Univ Sydney, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Keage, Hannah] Univ S Australia, Sch Psychol Social Work & Social Policy, Cognit Neurosci Lab, Adelaide, SA 5001, Australia	Swinburne University of Technology; University of Wollongong; Flinders University South Australia; University of Sydney; University of South Australia	Perera, S (corresponding author), Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia.	dcrewther@swin.edu.au	Perera, Sharnel/AAC-8643-2019; Keage, Hannah/C-6470-2011	Perera, Sharnel/0000-0002-0000-2431; Keage, Hannah/0000-0002-6814-4997; Hermens, Daniel/0000-0002-8570-2663; Croft, Rodney/0000-0002-5986-9136	Australian Research Council [LP0349079]; BRAINnet	Australian Research Council(Australian Research Council); BRAINnet	This study was funded under an Australian Research Council Linkage Grant (no. LP0349079) and the authors acknowledge the support of linkage partner, the Brain Resource Company (BRC) [www.brainresource.com], for use of the Brain Resource International Database (BRID). The authors also thank the individuals who gave their time to take part in the study. R. Clark holds shares (<1% of capital) in the BRC. All scientific decisions are made independent of BRC's commercial decisions via the independently operated scientific division, BRAINnet (www.brainnet.org.au), which is overseen by the independently funded Brain Dynamics Centre and scientist members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN PT, 1995, BRAIN LANG, V49, P140, DOI 10.1006/brln.1995.1025; ACKERMAN PT, 1994, J LEARN DISABIL, V27, P619, DOI 10.1177/002221949402701002; Altenmuller Eckart O, 1999, ELECTROENCEPHALOGRAP, V4, P637; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Banaschewski T, 2004, J NEURAL TRANSM, V111, P841, DOI 10.1007/s00702-003-0040-8; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barnett R, 2009, AUST NZ J PSYCHIAT, V43, P722, DOI 10.1080/00048670903001927; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Black J.T, 1992, MULTIVARIATE DATA AN; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Brookes KJ, 2008, AM J MED GENET B, V147B, P1519, DOI 10.1002/ajmg.b.30782; Brown CR, 2005, INT J PSYCHOPHYSIOL, V58, P94, DOI 10.1016/j.ijpsycho.2005.03.012; Burke JD, 2002, J AM ACAD CHILD PSY, V41, P1275, DOI 10.1097/00004583-200211000-00009; Chabot RJ, 1996, CLIN ELECTROENCEPHAL, V27, P26, DOI 10.1177/155005949602700105; Chabot RJ, 1996, BIOL PSYCHIAT, V40, P951, DOI 10.1016/0006-3223(95)00576-5; Clark CR, 2006, ARCH CLIN NEUROPSYCH, V21, P449, DOI 10.1016/j.acn.2006.06.005; Clarke AR, 2002, CLIN NEUROPHYSIOL, V113, P1036, DOI 10.1016/S1388-2457(02)00115-3; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P2098, DOI 10.1016/S1388-2457(01)00668-X; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Connor DF, 2008, J ATTEN DISORD, V12, P126, DOI 10.1177/1087054707308486; Crowe SE, 1999, J INT NEUROPSYCH SOC, V5, P1, DOI 10.1017/S1355617799511016; Decker SL, 2001, INT J NEUROSCI, V110, P43, DOI 10.3109/00207450108994220; Dimoska A, 2003, BIOL PSYCHIAT, V54, P1345, DOI 10.1016/S0006-3223(03)00703-0; Drabick DAG, 2007, J AM ACAD CHILD PSY, V46, P92, DOI 10.1097/01.chi.0000242245.00174.90; El-Sayed E, 2003, ACTA PAEDIATR, V92, P776, DOI 10.1080/08035250310002777; Elia J, 2009, PSYCHIAT RES, V170, P192, DOI 10.1016/j.psychres.2008.10.008; Gabel S, 1996, CHILD PSYCHIAT HUM D, V27, P15, DOI 10.1007/BF02353443; Gordon E, 2005, CLIN EEG NEUROSCI, V36, P64, DOI 10.1177/155005940503600205; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; HART EL, 1995, J ABNORM CHILD PSYCH, V23, P729, DOI 10.1007/BF01447474; Hay DA, 1996, AUST ED DEV PSYCHOL, V13, P69; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hermens DF, 2005, INT J PSYCHOPHYSIOL, V58, P21, DOI 10.1016/j.ijpsycho.2005.03.006; Hickie IB, 2001, MED J AUSTRALIA, V175, pS10; Hickie IB, 2001, MED J AUSTRALIA, V175, pS4; Hobbs MJ, 2007, CLIN NEUROPHYSIOL, V118, P363, DOI 10.1016/j.clinph.2006.10.013; Houghton S, 1999, J CHILD NEUROL, V14, P801, DOI 10.1177/088307389901401206; Hurtig T, 2007, EUR CHILD ADOLES PSY, V16, P362, DOI 10.1007/s00787-007-0607-2; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1065, DOI 10.1097/00004583-199708000-00014; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kadesjo B, 2001, J CHILD PSYCHOL PSYC, V42, P487, DOI 10.1017/S0021963001007090; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kuhne M, 1997, J AM ACAD CHILD PSY, V36, P1715, DOI 10.1097/00004583-199712000-00020; Lazzaro I, 1998, CLIN ELECTROENCEPHAL, V29, P37, DOI 10.1177/155005949802900111; LOISELLE DL, 1980, PSYCHOPHYSIOLOGY, V17, P193, DOI 10.1111/j.1469-8986.1980.tb00134.x; MACFARLANE J W, 1954, Publ Child Dev Univ Calif, V2, P1; Nazari MA, 2011, INT J PSYCHOPHYSIOL, V81, P230, DOI 10.1016/j.ijpsycho.2011.06.016; Newcorn JH, 2001, J AM ACAD CHILD PSY, V40, P137, DOI 10.1097/00004583-200102000-00008; Nigg JT, 2003, ANN NY ACAD SCI, V1008, P170, DOI 10.1196/annals.1301.018; Norusis M.J., 2008, SPSS 17 0 STAT PROCE; Pallant J, 2004, SPSS SURVIVAL MANUAL; Pasini A, 2007, BRAIN DEV-JPN, V29, P400, DOI 10.1016/j.braindev.2006.11.010; Paul RH, 2005, INT J NEUROSCI, V115, P1549, DOI 10.1080/00207450590957890; Paul RH, 2007, INT J NEUROSCI, V117, P549, DOI 10.1080/00207450600773665; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Raberger T, 2003, NEUROPSYCHOLOGIA, V41, P1493, DOI 10.1016/S0028-3932(03)00078-2; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Rommelse NNJ, 2009, J ABNORM CHILD PSYCH, V37, P793, DOI 10.1007/s10802-009-9312-6; SCHACHAR R, 1995, J AM ACAD CHILD PSY, V34, P639, DOI 10.1097/00004583-199505000-00016; Shi T, 2012, BRAIN DEV; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Smith JL, 2003, J CHILD PSYCHOL PSYC, V44, P1067, DOI 10.1111/1469-7610.00191; Spencer TJ, 2007, AMBUL PEDIATR, V7, P73, DOI 10.1016/j.ambp.2006.07.006; Spronk M, 2008, CLIN NEUROPHYSIOL, V119, P2738, DOI 10.1016/j.clinph.2008.09.010; Steinhausen HC, 2009, ACTA PSYCHIAT SCAND, V120, P392, DOI 10.1111/j.1600-0447.2009.01446.x; Stins JF, 2005, CHILD NEUROPSYCHOL, V11, P285, DOI 10.1080/09297040490916938; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SUGG MJ, 1994, J EXP PSYCHOL HUMAN, V20, P647, DOI 10.1037/0096-1523.20.3.647; Takeda T, 2012, RES DEV DISABIL, V33, P419, DOI 10.1016/j.ridd.2011.09.024; Tirosh E, 2006, J CHILD NEUROL, V21, P502, DOI 10.1177/08830738060210062401; Waschbusch DA, 2002, PSYCHOL BULL, V128, P118, DOI 10.1037/0033-2909.128.1.118; Watkins M., 2008, MONTE CARLO PCA PARA; WHO, 2012, ICD 10 CLASS MENT BE; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475; Zhou KX, 2008, AM J MED GENET B, V147B, P1481, DOI 10.1002/ajmg.b.30644	83	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41407	10.1371/journal.pone.0041407	http://dx.doi.org/10.1371/journal.pone.0041407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984398	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000308738500004
J	Tremblay, P; Ferrier-Pages, C; Maguer, JF; Rottier, C; Legendre, L; Grover, R				Tremblay, Pascale; Ferrier-Pages, Christine; Maguer, Jean Francois; Rottier, Cecile; Legendre, Louis; Grover, Renaud			Controlling Effects of Irradiance and Heterotrophy on Carbon Translocation in the Temperate Coral Cladocora caespitosa	PLOS ONE			English	Article							ANEMONE ANTHOPLEURA-ELEGANTISSIMA; SHADE-ADAPTED COLONIES; STYLOPHORA-PISTILLATA; SEA-ANEMONE; SYMBIOTIC CORAL; OCULINA-PATAGONICA; AIPTASIA-PALLIDA; ALGAL SYMBIONTS; ZOOXANTHELLAE; LIGHT	Temperate symbiotic corals, such as the Mediterranean species Cladocora caespitosa, live in seasonally changing environments, where irradiance can be ten times higher in summer than winter. These corals shift from autotrophy in summer to heterotrophy in winter in response to light limitation of the symbiont's photosynthesis. In this study, we determined the autotrophic carbon budget under different conditions of irradiance (20 and 120 mu mol photons m(-2) s(-1)) and feeding (fed three times a week with Artemia salina nauplii, and unfed). Corals were incubated in (HCO3-)-C-13-enriched seawater, and the fate of C-13 was followed in the symbionts and the host tissue. The total amount of carbon fixed by photosynthesis and translocated was significantly higher at high than low irradiance (ca. 13 versus 2.5-4.5 mu g cm(-2) h(-1)), because the rates of photosynthesis and carbon fixation were also higher. However, the percent of carbon translocation was similar under the two irradiances, and reached more than 70% of the total fixed carbon. Host feeding induced a decrease in the percentage of carbon translocated under low irradiance (from 70 to 53%), and also a decrease in the rates of carbon translocation per symbiont cell under both irradiances. The fate of autotrophic and heterotrophic carbon differed according to irradiance. At low irradiance, autotrophic carbon was mostly respired by the host and the symbionts, and heterotrophic feeding led to an increase in host biomass. Under high irradiance, autotrophic carbon was both respired and released as particulate and dissolved organic carbon, and heterotrophic feeding led to an increase in host biomass and symbiont concentration. Overall, the maintenance of high symbiont concentration and high percentage of carbon translocation under low irradiance allow this coral species to optimize its autotrophic carbon acquisition, when irradiance conditions are not favourable to photosynthesis.	[Tremblay, Pascale; Ferrier-Pages, Christine; Rottier, Cecile; Grover, Renaud] Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco; [Tremblay, Pascale; Ferrier-Pages, Christine; Grover, Renaud] LEA CSM CNRS BIOSENSIB, Monaco, Monaco; [Maguer, Jean Francois] Inst Univ Europeen Mer, LEMAR UMR UBO CNRS IRD 6539, Plouzane, France; [Legendre, Louis] Univ Paris 06, UMR 7093, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Legendre, Louis] CNRS, UMR 7093, Lab Oceanog Villefranche, Villefranche Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Tremblay, P (corresponding author), Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco.	pascale_tremblay@globetrotter.net		Jean-Francois, Maguer/0000-0003-3069-2821; Ferrier-Pages, Christine/0000-0002-0357-4486	Centre Scientifique de Monaco; Institut Universitaire Europeen de la Mer; Natural Sciences and Engineering Research Council of Canada [ES D3 - 378797-2009]	Centre Scientifique de Monaco; Institut Universitaire Europeen de la Mer; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this project was provided by the Centre Scientifique de Monaco (http://www.centrescientifique.mc/), the Institut Universitaire Europeen de la Mer (http://www.univ-brest.fr/IUEM/UMR6539/), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp; grant # ES D3 - 378797-2009 to P.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Bachar A, 2007, J EXP MAR BIOL ECOL, V349, P295, DOI 10.1016/j.jembe.2007.05.030; Bianchi C. N., 1994, MEMORIE DESCRITTIVE, V52, P59; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; DAVIES PS, 1984, CORAL REEFS, V2, P181; Davy SK, 1996, MAR BIOL, V126, P773, DOI 10.1007/BF00351344; Davy SK, 2001, MAR BIOL, V139, P999; Davy SK, 2001, COMP BIOCHEM PHYS A, V129, P487, DOI 10.1016/S1095-6433(01)00285-9; Dimond J, 2008, CORAL REEFS, V27, P601, DOI 10.1007/s00338-008-0363-x; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P1, DOI 10.1007/978-94-007-0114-4; DUBINSKY Z, 1984, PROC R SOC SER B-BIO, V222, P203, DOI 10.1098/rspb.1984.0059; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Engebretson HP, 1999, BIOL BULL, V197, P72, DOI 10.2307/1542998; EREZ J, 1978, NATURE, V273, P199, DOI 10.1038/273199a0; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Ferrier-Pages C, 2011, LIMNOL OCEANOGR, V56, P1429, DOI 10.4319/lo.2011.56.4.1429; Ferrier-Pages C, 2012, LIFE MEDITERRANNEAN, P387; Furla P, 2000, J EXP BIOL, V203, P3445; Hoogenboom M, 2010, CORAL REEFS, V29, P21, DOI 10.1007/s00338-009-0558-9; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Ishikura M, 1999, MAR BIOL, V133, P665, DOI 10.1007/s002270050507; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kersting D-K, 2012, MAR ECOL; Kruzic P, 2003, CORAL REEFS, V22, P536, DOI 10.1007/s00338-003-0345-y; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; MCCLOSKEY LR, 1994, MAR BIOL, V119, P13, DOI 10.1007/BF00350101; Morri C, 1994, BIOL MAR MEDIT, V1, P371; Muller-Parker G, 2001, INVERTEBR BIOL, V120, P104, DOI 10.1111/j.1744-7410.2001.tb00115.x; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; MUSCATINE L, 1983, ENDOCYTOBIOLOGY 2, V0002, P00649; Peirano A, 1999, MAR ECOL PROG SER, V185, P195, DOI 10.3354/meps185195; Peirano A, 2005, CORAL REEFS, V24, P404, DOI 10.1007/s00338-005-0020-6; Peirano A, 2007, SCI MAR, V71, P629, DOI 10.3989/scimar.2007.71n4629; Rodolfo-Metalpa R, 2008, CORAL REEFS, V27, P17, DOI 10.1007/s00338-007-0283-1; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith SV, 1978, MONOGR OCEANOGR METH, V5, P469; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tremblay P, 2011, MAR ECOL PROG SER, V422, P165, DOI 10.3354/meps08902; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Verde EA, 1996, J EXP MAR BIOL ECOL, V195, P187, DOI 10.1016/0022-0981(95)00080-1; ZIBROWIUS H, 1980, Memoires de l'Institut Oceanographique (Monaco), P1	57	18	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44672	10.1371/journal.pone.0044672	http://dx.doi.org/10.1371/journal.pone.0044672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970284	Green Submitted, Green Published, gold			2022-12-27	WOS:000308748400028
J	Charlebois, A; Jalbert, LA; Harel, J; Masson, L; Archambault, M				Charlebois, Audrey; Jalbert, Louis-Alexandre; Harel, Josee; Masson, Luke; Archambault, Marie			Characterization of Genes Encoding for Acquired Bacitracin Resistance in Clostridium perfringens	PLOS ONE			English	Article							UNDECAPRENYL PYROPHOSPHATE PHOSPHATASE; GROWTH-PROMOTING ANTIBIOTICS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ABC TRANSPORTER; ENTEROCOCCUS-FAECIUM; ANTIMICROBIAL SUSCEPTIBILITY; HUMAN HEALTH; BACA GENE; LICHENIFORMIS	Phenotypic bacitracin resistance has been reported in Clostridium perfringens. However, the genes responsible for the resistance have not yet been characterized. Ninety-nine C. perfringens isolates recovered from broilers and turkeys were tested for phenotypic bacitracin resistance. Bacitracin MIC90 (>256 mg/ml) was identical for both turkey and chicken isolates; whereas MIC50 was higher in turkey isolates (6 mu g/ml) than in chicken isolates (3 mu g/ml). Twenty-four of the 99 isolates showed high-level bacitracin resistance (MIC breakpoint >256 mu g/ml) and the genes encoding for this resistance were characterized in C. perfringens c1261_A strain using primer walking. Sequence analysis and percentages of amino acid identity revealed putative genes encoding for both an ABC transporter and an overproduced undecaprenol kinase in C. perfringens c1261_A strain. These two mechanisms were shown to be both encoded by the putative bcrABD operon under the control of a regulatory gene, bcrR. Efflux pump inhibitor thioridazine was shown to increase significantly the susceptibility of strain c1261_A to bacitracin. Upstream and downstream from the bcr cluster was an IS1216-like element, which may play a role in the dissemination of this resistance determinant. Pulsed-field gel electrophoresis with prior double digestion with I-CeuI/MluI enzymes followed by hybridization analyses revealed that the bacitracin resistance genes bcrABDR were located on the chromosome. Semi-quantitative RT-PCR demonstrated that this gene cluster is expressed under bacitracin stress. Microarray analysis revealed the presence of these genes in all bacitracin resistant strains. This study reports the discovery of genes encoding for a putative ABC transporter and an overproduced undecaprenol kinase associated with high-level bacitracin resistance in C. perfringens isolates from turkeys and broiler chickens.	[Charlebois, Audrey; Jalbert, Louis-Alexandre; Harel, Josee; Archambault, Marie] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, CRIP, St Hyacinthe, PQ J2S 7C6, Canada; [Masson, Luke] Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	Universite de Montreal; National Research Council Canada	Charlebois, A (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, CRIP, St Hyacinthe, PQ J2S 7C6, Canada.	marie.archambault@umontreal.ca	Harel, Josée/H-1933-2011	Harel, Josée/0000-0002-7822-3795	Natural Sciences and Engineering Research Council of Canada [RGPIN-191461]; Poultry Industry Council of Canada [PIC-212]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Poultry Industry Council of Canada	This work was funded by grants from the Natural Sciences and Engineering Research Council of Canada to M. Archambault (RGPIN-191461) and the Poultry Industry Council (PIC-212) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Bernard R, 2003, FEMS MICROBIOL LETT, V228, P93, DOI 10.1016/S0378-1097(03)00738-9; Bernard R, 2007, J BACTERIOL, V189, P8636, DOI 10.1128/JB.01132-07; Bruant G, 2006, APPL ENVIRON MICROB, V72, P3780, DOI 10.1128/AEM.72.5.3780-3784.2006; Bywater R, 2005, J ANTIMICROB CHEMOTH, V56, P538, DOI 10.1093/jac/dki273; CAIN BD, 1993, J BACTERIOL, V175, P3784, DOI 10.1128/JB.175.12.3784-3789.1993; Cao M, 2002, J BACTERIOL, V184, P6123, DOI 10.1128/JB.184.22.6123-6129.2002; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Chalmers G, 2007, VET MICROBIOL; Champagne J, 2011, APPL ENVIRON MICROB, V77, P2625, DOI 10.1128/AEM.00263-11; Dahan A, 2009, MOL PHARMACEUT, V6, P19, DOI 10.1021/mp800088f; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Engberg RM, 2000, POULTRY SCI, V79, P1311, DOI 10.1093/ps/79.9.1311; FIEDLER W, 1988, J BIOL CHEM, V263, P14684; Frye JG, 2006, INT J ANTIMICROB AG, V27, P138, DOI 10.1016/j.ijantimicag.2005.09.021; Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295; Garneau P, 2010, J ZOONOSES IN PRESS, pSP; Harel YM, 1999, J BACTERIOL, V181, P6176, DOI 10.1128/JB.181.19.6176-6178.1999; Hendricks O, 2005, BASIC CLIN PHARMACOL, V96, P33, DOI 10.1111/j.1742-7843.2005.pto960105.x; Johansson A, 2004, VET MICROBIOL, V99, P251, DOI 10.1016/j.vetmic.2004.01.009; Kaatz Glenn W, 2002, Expert Opin Emerg Drugs, V7, P223, DOI 10.1517/14728214.7.2.223; Kather EJ, 2006, VET MICROBIOL, V113, P97, DOI 10.1016/j.vetmic.2005.10.021; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Kulkarni RS, 1998, WORLD J MICROB BIOT, V14, P255; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Letowski J, 2004, J MICROBIOL METH, V57, P269, DOI 10.1016/j.mimet.2004.02.002; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Lismond A, 2008, ANTIMICROB AGENTS CH, V52, P3040, DOI 10.1128/AAC.00105-08; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Manson JM, 2004, APPL ENVIRON MICROB, V70, P5764, DOI 10.1128/AEM.70.10.5764-5768.2004; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Matos R, 2009, INT J ANTIMICROB AG, V34, P142, DOI 10.1016/j.ijantimicag.2009.02.008; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Neumuller AM, 2001, EUR J BIOCHEM, V268, P3180, DOI 10.1046/j.1432-1327.2001.02203.x; ODONOVAN CA, 1994, DIAGN MICR INFEC DIS, V18, P105, DOI 10.1016/0732-8893(94)90074-4; Pavli V, 2006, BIOL PHARM BULL, V29, P2160, DOI 10.1248/bpb.29.2160; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Phillips I, 1999, J ANTIMICROB CHEMOTH, V44, P725, DOI 10.1093/jac/44.6.725; Phillips I, 2007, INT J ANTIMICROB AG, V30, P101, DOI 10.1016/j.ijantimicag.2007.02.018; PODLESEK Z, 1995, MOL MICROBIOL, V16, P969, DOI 10.1111/j.1365-2958.1995.tb02322.x; POLLOCK TJ, 1994, J BACTERIOL, V176, P6229, DOI 10.1128/jb.176.20.6229-6237.1994; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Slavic D, 2011, CAN J VET RES, V75, P89; SLOAN J, 1994, MOL MICROBIOL, V11, P403, DOI 10.1111/j.1365-2958.1994.tb00320.x; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Spigaglia P, 2005, ANTIMICROB AGENTS CH, V49, P2550, DOI 10.1128/AAC.49.6.2550-2553.2005; STONE KJ, 1972, P NATL ACAD SCI USA, V69, P1287, DOI 10.1073/pnas.69.5.1287; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Thanacoody HKR, 2007, BRIT J CLIN PHARMACO, V64, P566, DOI 10.1111/j.1365-2125.2007.03021.x; Tsuda H, 2002, ANTIMICROB AGENTS CH, V46, P3756, DOI 10.1128/AAC.46.12.3756-3764.2002; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watkins KL, 1997, VET MICROBIOL, V54, P195, DOI 10.1016/S0378-1135(96)01276-X	56	40	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44449	10.1371/journal.pone.0044449	http://dx.doi.org/10.1371/journal.pone.0044449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970221	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400072
J	Ho, WY; Yeap, SK; Ho, CL; Rahim, RA; Alitheen, NB				Ho, Wan Yong; Yeap, Swee Keong; Ho, Chai Ling; Rahim, Raha Abdul; Alitheen, Noorjahan Banu			Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT Assay	PLOS ONE			English	Article							IN-VITRO; MODEL; GENERATION; INHIBITOR; APOPTOSIS; EVALUATE; THERAPY; GROWTH	In comparison to monolayer cells, MCTS has been claimed as more suitable candidate for studying drug penetration due to the high resemblance to solid tumors. However, the cultivation of MCTS is cumbersome, time consuming, and most technique fail to generate spheroids with uniform sizes. Therefore, the application of spheroid cultures in high throughput screening has been rather limiting. Besides, the lack of a well established screening protocol method that is applicable to spheroid could also be attributed to this limitation. Here we report a simple way of cultivating homogenous MCTS cultures with compact and rigid structure from the MCF-7 cells. Besides, we had also made some modifications to the standard MTT assay to realize high throughput screening of these spheroids. Using the modified protocol, tamoxifen showed cytotoxicity effect towards MCTS cultures from MCF-7 with high consistency. The results correlated well with the cultures' response assessed by LDH release assay but the latter assay was not ideal for detecting a wide range of cytotoxicity due to high basal background reading. The MTT assay emerged as a better indicator to apoptosis event in comparison to the LDH release assay. Therefore, the method for spheroid generation and the modified MTT assay we reported here could be potentially applied to high throughput screening for response of spheroid cultures generated from MCF-7 as well as other cancer cell lines towards cytotoxic stimuli.	[Ho, Wan Yong; Ho, Chai Ling; Rahim, Raha Abdul; Alitheen, Noorjahan Banu] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [Yeap, Swee Keong] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Ho, WY (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia.	noorjahan@biotech.upm.edu.my	Ho, Wan Yong/I-1050-2016; Yeap, Swee Keong/H-9285-2013; Alitheen, Noorjahan/AAL-3713-2020	Ho, Wan Yong/0000-0001-5768-0738; Yeap, Swee Keong/0000-0002-4736-0674; 	Research University Grant Scheme under Universiti Putra Malaysia (UPM) [05-01-09-0796RU]; Malaysian Toray Science Foundation (MTSF)	Research University Grant Scheme under Universiti Putra Malaysia (UPM); Malaysian Toray Science Foundation (MTSF)	This research and development project was funded by the Research University Grant Scheme (Project No: 05-01-09-0796RU) under Universiti Putra Malaysia (UPM) and Malaysian Toray Science Foundation (MTSF) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron M, 2012, ECOTOXICOLOGY, P1; Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Fracasso G, 2000, CRIT REV ONCOL HEMAT, V36, P159, DOI 10.1016/S1040-8428(00)00084-6; Herrmann R, 2008, J BIOMOL SCREEN, V13, P1, DOI 10.1177/1087057107310442; Ho WY, 2011, J MED PLANTS RES, V5, P5741; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jin C, 2010, BIOMEDICINE PHARMACO; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lam JT, 2007, CANCER GENE THER, V14, P421, DOI 10.1038/sj.cgt.7701028; Lee J, 2009, BIOMATERIALS, V30, P4687, DOI 10.1016/j.biomaterials.2009.05.024; Madsen SJ, 2006, LASER SURG MED, V38, P555, DOI 10.1002/lsm.20350; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; Nigro P, 2007, LIFE SCI, V81, P873, DOI 10.1016/j.lfs.2007.07.010; Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x; Scherliess R, 2011, INT J PHARMACEUT, V411, P98, DOI 10.1016/j.ijpharm.2011.03.053; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Xiao Yan, 2007, Ai Zheng, V26, P386	25	116	122	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44640	10.1371/journal.pone.0044640	http://dx.doi.org/10.1371/journal.pone.0044640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970274	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400099
J	Hohn, C; Petrie-Hanson, L				Hohn, Claudia; Petrie-Hanson, Lora			Rag1(-/-) Mutant Zebrafish Demonstrate Specific Protection following Bacterial Re-Exposure	PLOS ONE			English	Article							ADAPTIVE IMMUNITY; ENTERIC SEPTICEMIA; INNATE; MODEL; RESPONSES; RECEPTOR; GENES	Background: Recombination activation gene 1 deficient (rag1(-/-)) mutant zebrafish have a reduced lymphocyte-like cell population that lacks functional B and T lymphocytes of the acquired immune system, but includes Natural Killer (NK)-like cells and Non-specific cytotoxic cells (NCC) of the innate immune system. The innate immune system is thought to lack the adaptive characteristics of an acquired immune system that provide enhanced protection to a second exposure of the same pathogen. It has been shown that NK cells have the ability to mediate adaptive immunity to chemical haptens and cytomegalovirus in murine models. In this study we evaluated the ability of rag1(-/-) mutant zebrafish to mount a protective response to the facultative intracellular fish bacterium Edwardsiella ictaluri. Methodology/Principal Findings: Following secondary challenge with a lethal dose of homologous bacteria 4 and 8 weeks after a primary vaccination, rag1(-/-) mutant zebrafish demonstrated protective immunity. Heterologous bacterial exposures did not provide protection. Adoptive leukocyte transfers from previously exposed mutants conferred protective immunity to naive mutants when exposed to homologous bacteria. Conclusions/Significance: Our findings show that a component of the innate immune system mounted a response that provided significantly increased survival when rag1(-/-) mutant zebrafish were re-exposed to the same bacteria. Further, adoptive cell transfers demonstrated that kidney interstitial leukocytes from previously exposed rag1-/-mutant zebrafish transferred this protective immunity. This is the first report of any rag1(-/-) mutant vertebrate mounting a protective secondary immune response to a bacterial pathogen, and demonstrates that a type of zebrafish innate immune cell can mediate adaptive immunity in the absence of T and B cells.	[Hohn, Claudia; Petrie-Hanson, Lora] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Mississippi State University	Hohn, C (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lora@cvm.msstate.edu						Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Cannon JP, 2008, IMMUNITY, V29, P228, DOI 10.1016/j.immuni.2008.05.018; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Hohn C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004314; Jima DD, 2009, MOL IMMUNOL, V46, P1505, DOI 10.1016/j.molimm.2008.12.021; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Kroemer A, 2008, J IMMUNOL, V180, P7818, DOI 10.4049/jimmunol.180.12.7818; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2009, NAT REV IMMUNOL, V9, P302, DOI 10.1038/nri2547; Mackey RB, 2002, SPECIFICITY DEV CHAN; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Petrie-Hanson L, 2007, J AQUAT ANIM HEALTH, V19, P151, DOI 10.1577/H06-026.1; Petrie-Hanson L, 2001, VET IMMUNOL IMMUNOP, V81, P113, DOI 10.1016/S0165-2427(01)00331-2; Petrie-Hanson L, 1999, FISH SHELLFISH IMMUN, V9, P579, DOI 10.1006/fsim.1999.0215; Petrie-Hanson L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-8; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Sha ZX, 2009, DEV COMP IMMUNOL, V33, P991, DOI 10.1016/j.dci.2009.04.004; Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Ugolini S, 2009, NATURE, V457, P544, DOI 10.1038/457544a; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; Vivier E, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00018; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yoder JA, 2008, IMMUNOGENETICS, V60, P257, DOI 10.1007/s00251-008-0285-3; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004	37	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44451	10.1371/journal.pone.0044451	http://dx.doi.org/10.1371/journal.pone.0044451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970222	gold, Green Published, Green Submitted			2022-12-27	WOS:000308458400073
J	Kutsukake, N; Inada, M; Sakamoto, SH; Okanoya, K				Kutsukake, Nobuyuki; Inada, Masayuki; Sakamoto, Shinsuke H.; Okanoya, Kazuo			A Distinct Role of the Queen in Coordinated Workload and Soil Distribution in Eusocial Naked Mole-Rats	PLOS ONE			English	Article							MAGNETIC COMPASS ORIENTATION; ORGANIZING NEST CONSTRUCTION; BURROW ARCHITECTURE; HETEROCEPHALUS-GLABER; SELF-ORGANIZATION; CAPTIVE COLONIES; DECISION-MAKING; BEHAVIOR; COST; HELIOPHOBIUS	We investigated how group members achieve collective decision-making, by considering individual intrinsic behavioural rules and behavioural mechanisms for maintaining social integration. Using a simulated burrow environment, we investigated the behavioural rules of coordinated workload for soil distribution in a eusocial mammal, the naked mole-rat (Heterocephalus glaber). We tested two predictions regarding a distinct role of the queen, a socially dominant individual in the caste system: the presence of a queen would increase the workload of other caste individuals, and the cues by a queen would affect the soil distribution. In experiment 1, we placed four individuals of various castes from the same colony into an experimental burrow. Workers exhibited the highest frequency of workload compared to other castes. The presence of a queen activated the workload by other individuals. Individuals showed a consistent workload in a particular direction so as to bias the soil distribution. These results suggest that individuals have a consensus on soil distribution and that the queen plays a distinct role. In experiment 2, we placed the odour of a queen in one of four cells and observed its effect on other individuals' workload and soil distribution. Relative to other cells, individuals frequently dug in the queen cell so the amount of soil in the queen cell decreased. These results suggest that queen odour is an important cue in coordinated workload and soil distribution in this species.	[Kutsukake, Nobuyuki; Sakamoto, Shinsuke H.] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Kutsukake, Nobuyuki; Inada, Masayuki; Okanoya, Kazuo] RIKEN Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan; [Kutsukake, Nobuyuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Dept Cognit & Behav Sci, Tokyo, Japan	Graduate University for Advanced Studies - Japan; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Kutsukake, N (corresponding author), Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan.	kutsu@soken.ac.jp			Japan Society for the Promotion of Science; Special Postdoctoral Researcher program; Precursory Research for Embryonic Science and Technology (PRESTO); Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18870025, 2077023]; Hayama Center for Advanced Studies; Center for the Promotion of Integrated Sciences at Sokendai	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Postdoctoral Researcher program; Precursory Research for Embryonic Science and Technology (PRESTO); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayama Center for Advanced Studies; Center for the Promotion of Integrated Sciences at Sokendai	This study was financially supported by the Japan Society for the Promotion of Science, Special Postdoctoral Researcher program, Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Ministry of Education, Culture, Sports, Science and Technology (MEXT), grants number 18870025 and 2077023; Hayama Center for Advanced Studies; and The Center for the Promotion of Integrated Sciences at Sokendai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bonabeau E, 1998, PHILOS T R SOC B, V353, P1561, DOI 10.1098/rstb.1998.0310; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bozinovic F, 2005, COMP BIOCHEM PHYS A, V140, P329, DOI 10.1016/j.cbpb.2005.01.015; Brett R.A., 1991, P137; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; Clarke FM, 2001, ANIM BEHAV, V61, P311, DOI 10.1006/anbe.2000.1573; Clarke FM, 1999, P ROY SOC B-BIOL SCI, V266, P1995, DOI 10.1098/rspb.1999.0877; Clarke FM, 1998, P ROY SOC B-BIOL SCI, V265, P1391, DOI 10.1098/rspb.1998.0447; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cox MD, 2000, J THEOR BIOL, V204, P223, DOI 10.1006/jtbi.2000.2010; Detrain C., 1999, INFORM PROCESSING SO; DUTOIT JT, 1985, OECOLOGIA, V66, P81, DOI 10.1007/BF00378556; Ebensperger LA, 2000, J ZOOL, V252, P179; FAULKES CG, 1990, J REPROD FERTIL, V88, P559; FAULKES CG, 1990, J REPROD FERTIL, V89, P317; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; FRANKS NR, 1992, ANIM BEHAV, V44, P357, DOI 10.1016/0003-3472(92)90041-7; Hansell M., 2005, OXF ANIMAL BIOL SER; Herbst M, 2006, J ZOOL, V270, P420, DOI 10.1111/j.1469-7998.2006.00151.x; Heth G, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P85, DOI 10.1007/978-3-540-69276-8_8; Holldobler B., 1990, pi; Jacobs DS, 1996, BEHAV ECOL SOCIOBIOL, V39, P401, DOI 10.1007/s002650050307; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1971, J ZOOL, V163, P451; Judd TM, 1996, ANIM BEHAV, V52, P957, DOI 10.1006/anbe.1996.0244; Katsushima K, 2010, MOL ECOL RESOUR, V10, P222, DOI 10.1111/j.1755-0998.2009.02742.x; Kerth G, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P241, DOI 10.1007/978-3-642-02624-9_9; Kimchi T, 2001, J EXP BIOL, V204, P751; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Lacey E.A., 1991, P275; Lacey Eileen A., 1997, P267; LOVEGROVE BG, 1989, PHYSIOL ZOOL, V62, P449, DOI 10.1086/physzool.62.2.30156179; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; ORiain MJ, 1997, ANIM BEHAV, V53, P487, DOI 10.1006/anbe.1996.0299; Pratt SC, 2004, APIDOLOGIE, V35, P193, DOI 10.1051/apido:2004005; Rasse P, 2001, J INSECT BEHAV, V14, P433, DOI 10.1023/A:1011163804217; Reeve H., 1991, BIOL NAKED MOLE RAT, P337; REEVE HK, 1992, NATURE, V358, P147, DOI 10.1038/358147a0; Robinson EJH, 2008, ANIM BEHAV, V75, P1389, DOI 10.1016/j.anbehav.2007.09.013; Sherman P. W, 1991, BIOL NAKED MOLERAT; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Sumbera R, 2003, NATURWISSENSCHAFTEN, V90, P370, DOI 10.1007/s00114-003-0439-y; Sumbera R, 2008, J ZOOL, V274, P77, DOI 10.1111/j.1469-7998.2007.00359.x; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; THERAULAZ G, 1995, SCIENCE, V269, P686, DOI 10.1126/science.269.5224.686; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Thomas HG, 2009, J ZOOL, V279, P277, DOI 10.1111/j.1469-7998.2009.00616.x; Toffin E, 2010, P ROY SOC B-BIOL SCI, V277, P2617, DOI 10.1098/rspb.2010.0176; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; VLECK D, 1979, PHYSIOL ZOOL, V52, P122, DOI 10.1086/physzool.52.2.30152558	55	5	5	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44584	10.1371/journal.pone.0044584	http://dx.doi.org/10.1371/journal.pone.0044584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957085	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800078
J	Sieh, S; Taubenberger, AV; Rizzi, SC; Sadowski, M; Lehman, ML; Rockstroh, A; An, JY; Clements, JA; Nelson, CC; Hutmacher, DW				Sieh, Shirly; Taubenberger, Anna V.; Rizzi, Simone C.; Sadowski, Martin; Lehman, Melanie L.; Rockstroh, Anja; An, Jiyuan; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.			Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment	PLOS ONE			English	Article							ANDROGEN RECEPTOR-ACTIVITY; DE-NOVO STEROIDOGENESIS; 3-DIMENSIONAL CULTURE; EXTRACELLULAR-MATRIX; SPHEROID FORMATION; COLLAGEN GELS; TUMOR-CELLS; GROWTH; HYPOXIA; BREAST	Biophysical and biochemical properties of the microenvironment regulate cellular responses such as growth, differentiation, morphogenesis and migration in normal and cancer cells. Since two-dimensional (2D) cultures lack the essential characteristics of the native cellular microenvironment, three-dimensional (3D) cultures have been developed to better mimic the natural extracellular matrix. To date, 3D culture systems have relied mostly on collagen and Matrigel (TM) hydrogels, allowing only limited control over matrix stiffness, proteolytic degradability, and ligand density. In contrast, bioengineered hydrogels allow us to independently tune and systematically investigate the influence of these parameters on cell growth and differentiation. In this study, polyethylene glycol (PEG) hydrogels, functionalized with the Arginine-glycine-aspartic acid (RGD) motifs, common cell-binding motifs in extracellular matrix proteins, and matrix metalloproteinase (MMP) cleavage sites, were characterized regarding their stiffness, diffusive properties, and ability to support growth of androgen-dependent LNCaP prostate cancer cells. We found that the mechanical properties modulated the growth kinetics of LNCaP cells in the PEG hydrogel. At culture periods of 28 days, LNCaP cells underwent morphogenic changes, forming tumor-like structures in 3D culture, with hypoxic and apoptotic cores. We further compared protein and gene expression levels between 3D and 2D cultures upon stimulation with the synthetic androgen R1881. Interestingly, the kinetics of R1881 stimulated androgen receptor (AR) nuclear translocation differed between 2D and 3D cultures when observed by immunofluorescent staining. Furthermore, microarray studies revealed that changes in expression levels of androgen responsive genes upon R1881 treatment differed greatly between 2D and 3D cultures. Taken together, culturing LNCaP cells in the tunable PEG hydrogels reveals differences in the cellular responses to androgen stimulation between the 2D and 3D environments. Therefore, we suggest that the presented 3D culture system represents a powerful tool for high throughput prostate cancer drug testing that recapitulates tumor microenvironment.	[Sieh, Shirly; Taubenberger, Anna V.; Rizzi, Simone C.; Sadowski, Martin; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Regenerat Med & Canc Program, Brisbane, Qld 4001, Australia; [Taubenberger, Anna V.; Sadowski, Martin; Lehman, Melanie L.; Rockstroh, Anja; An, Jiyuan; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Woolloongabba, Qld, Australia; [Taubenberger, Anna V.; Sadowski, Martin; Lehman, Melanie L.; Rockstroh, Anja; An, Jiyuan; Clements, Judith A.; Nelson, Colleen C.; Hutmacher, Dietmar W.] Princess Alexandra Hosp, Woolloongabba, Qld 4102, Australia; [Lehman, Melanie L.; Nelson, Colleen C.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of British Columbia	Sieh, S (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Regenerat Med & Canc Program, Brisbane, Qld 4001, Australia.	dietmar.hutmacher@qut.edu.au	An, Jiyuan/ABD-2471-2020	Hutmacher, Dietmar Werner/0000-0001-5678-2134; An, Jiyuan/0000-0002-8183-8248; Taubenberger, Anna/0000-0002-7916-0394; Clements, Judith/0000-0001-6026-1964	Queensland University of Technology; Prostate Cancer Foundation of Australia; Australian Canadian Prostate Cancer Research Alliance; Australian Prostate Cancer Research Centre-Queensland; NHMRC	Queensland University of Technology; Prostate Cancer Foundation of Australia; Australian Canadian Prostate Cancer Research Alliance; Australian Prostate Cancer Research Centre-Queensland; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Queensland University of Technology start up grant for chair Prof. D. W. Hutmacher, Prostate Cancer Foundation of Australia, Australian Canadian Prostate Cancer Research Alliance, Australian Prostate Cancer Research Centre-Queensland and NHMRC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Ballangrud AM, 1999, CLIN CANCER RES, V5, p3171S; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; Butterworth KT, 2008, INT J CANCER, V123, P760, DOI 10.1002/ijc.23418; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chou SC, 2004, BRIT J CANCER, V90, P728, DOI 10.1038/sj.bjc.6601585; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f; Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hensley HH, 2011, INT J CANCER, V128, P962, DOI 10.1002/ijc.25634; Herrala A, 1998, EUR J BIOCHEM, V255, P329, DOI 10.1046/j.1432-1327.1998.2550329.x; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505; Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001; Indra I, 2011, J CELL BIOCHEM, V112, P3151, DOI 10.1002/jcb.23241; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li Song, 2003, FASEB Journal, V17, P97; Li XF, 2008, CANCER LETT, V264, P172, DOI 10.1016/j.canlet.2008.02.037; Li YR, 2011, CLIN CANCER RES, V17, P4414, DOI 10.1158/1078-0432.CCR-11-0431; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Movsas B, 2001, AM J CLIN ONCOL-CANC, V24, P458, DOI 10.1097/00000421-200110000-00009; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Parker C, 2004, INT J RADIAT ONCOL, V58, P750, DOI 10.1016/S0360-3016(03)01621-3; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; PCFA, 2012, PROST CANC STAT; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Quent VMC, 2010, J CELL MOL MED, V14, P1003, DOI 10.1111/j.1582-4934.2010.01013.x; RALEIGH JA, 1987, BRIT J CANCER, V56, P395, DOI 10.1038/bjc.1987.213; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Sieh S, 2010, ORGANOGENESIS, V6, P181, DOI 10.4161/org.6.3.12041; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SYMS AJ, 1985, J BIOL CHEM, V260, P455; Takagi A, 2007, ANTICANCER RES, V27, P45; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tupper J, 2004, CANCER GENE THER, V11, P508, DOI 10.1038/sj.cgt.7700713; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yeap BB, 1999, ENDOCRINOLOGY, V140, P3282, DOI 10.1210/en.140.7.3282; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zhang J, 2007, INT J MOL SCI, V8, P156, DOI 10.3390/i8020156; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544; Zhao DW, 2001, RADIAT RES, V156, P510, DOI 10.1667/0033-7587(2001)156[0510:TODWRT]2.0.CO;2	92	67	68	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e40217	10.1371/journal.pone.0040217	http://dx.doi.org/10.1371/journal.pone.0040217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957009	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800001
J	Terai, G; Okida, H; Asai, K; Mituyama, T				Terai, Goro; Okida, Hiroaki; Asai, Kiyoshi; Mituyama, Toutai			Prediction of Conserved Precursors of miRNAs and Their Mature Forms by Integrating Position-Specific Structural Features	PLOS ONE			English	Article							MICRORNA GENES; IDENTIFICATION; MODEL; BIOGENESIS; SEQUENCE; VERTEBRATE; SYSTEM	MicroRNA (miRNA) precursor hairpins have a unique secondary structure, nucleotide length, and nucleotide content that are in most cases evolutionarily conserved. The aim of this study was to utilize position-specific features of miRNA hairpins to improve their identification. To this end, we defined the evolutionary and structurally conserved features in each position of miRNA hairpins with heuristically derived values, which were successfully integrated using a probabilistic framework. Our method, miRRim2, can not only accurately detect miRNA hairpins, but infer the location of a mature miRNA sequence. To evaluate the accuracy of miRRim2, we designed a cross validation test in which the whole human genome was used for evaluation. miRRim2 could more accurately detect miRNA hairpins than the other computational predictions that had been performed on the human genome, and detect the position of the 5'-end of mature miRNAs with sensitivity and positive predictive value (PPV) above 0.4. To further evaluate miRRim2 on independent data, we applied it to the Ciona intestinalis genome. Our method detected 47 known miRNA hairpins among top 115 candidates, and pinpointed the 5'-end of mature miRNAs with sensitivity and PPV about 0.4. When our results were compared with deep-sequencing reads of small RNA libraries from Ciona intestinalis cells, we found several candidates in which the predicted mature miRNAs were in good accordance with deep-sequencing results.	[Terai, Goro; Okida, Hiroaki] INTEC Inc, Tokyo, Japan; [Terai, Goro; Asai, Kiyoshi; Mituyama, Toutai] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Terai, G (corresponding author), INTEC Inc, Tokyo, Japan.	terai_goro@intec.co.jp	Asai, Kiyoshi/AAT-8344-2020; Mituyama, Toutai/A-5610-2017	Asai, Kiyoshi/0000-0003-0909-4982; Mituyama, Toutai/0000-0002-1110-6375	Functional RNA Project of the New Energy and Industrial Technology Development Organization	Functional RNA Project of the New Energy and Industrial Technology Development Organization	This work was supported partly by a Grant-in-Aid for Scientific Research (A) and the Functional RNA Project of the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; BAUM LE, 1967, B AM MATH SOC, V73, P360, DOI 10.1090/S0002-9904-1967-11751-8; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; DeCaprio D, 2007, GENOME RES, V17, P1389, DOI 10.1101/gr.6558107; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Do CB, 2006, LECT NOTES COMPUT SC, V3909, P160, DOI 10.1007/11732990_15; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Hendrix D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r39; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kiryu H, 2008, BIOINFORMATICS, V24, P367, DOI 10.1093/bioinformatics/btm591; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032797; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Norden-Krichmar TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-445; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saetrom P, 2006, OLIGONUCLEOTIDES, V16, P115, DOI 10.1089/oli.2006.16.115; Sato K, 2005, BIOINFORMATICS, V21, P237, DOI 10.1093/bioinformatics/bti1139; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Terai G, 2007, RNA, V13, P2081, DOI 10.1261/rna.655107; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094	47	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44314	10.1371/journal.pone.0044314	http://dx.doi.org/10.1371/journal.pone.0044314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957063	Green Submitted, Green Published, gold			2022-12-27	WOS:000308463800056
J	Beskow, LM; Check, DK; Namey, EE; Dame, LA; Lin, L; Cooper, A; Weinfurt, KP; Wolf, LE				Beskow, Laura M.; Check, Devon K.; Namey, Emily E.; Dame, Lauren A.; Lin, Li; Cooper, Alexandra; Weinfurt, Kevin P.; Wolf, Leslie E.			Institutional Review Boards' Use and Understanding of Certificates of Confidentiality	PLOS ONE			English	Review								Certificates of Confidentiality, issued by agencies of the U.S. government, are regarded as an important tool for meeting ethical and legal obligations to safeguard research participants' privacy and confidentiality. By shielding against forced disclosure of identifying data, Certificates are intended to facilitate research on sensitive topics critical to the public's health. Although Certificates are potentially applicable to an extensive array of research, their full legal effect is unclear, and little is known about stakeholders' views of the protections they provide. To begin addressing this challenge, we conducted a national survey of institutional review board (IRB) chairs, followed by telephone interviews with selected chairs, to learn more about their familiarity with and opinions about Certificates; their institutions' use of Certificates; policies and practices concerning when Certificates are required or recommended; and the role Certificates play in assessments of research risk. Overall, our results suggest uncertainty about Certificates among IRB chairs. On most objective knowledge questions, most respondents chose the incorrect answer or 'unsure'. Among chairs who reported more familiarity with Certificates, composite opinion scores calculated based on five survey questions were evenly distributed among positive, neutral/middle, and negative views. Further, respondents expressed a variety of ideas about the appropriate use of Certificates, what they are intended to protect, and their effect on research risk. Nevertheless, chairs who participated in our study commonly viewed Certificates as a potentially valuable tool, frequently describing them as an 'extra layer' of protection. These findings lead to several practical observations concerning the need for more stakeholder education about Certificates, consideration of Certificates for a broader range of studies, the importance of remaining vigilant and using all tools available to protect participants' confidentiality, and the need for further empirical investigation of Certificates' effect on researchers and research participants.	[Beskow, Laura M.; Namey, Emily E.; Dame, Lauren A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Check, Devon K.; Lin, Li; Weinfurt, Kevin P.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Cooper, Alexandra] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Wolf, Leslie E.] Georgia State Univ, Coll Law, Ctr Law Hlth & Soc, Atlanta, GA 30303 USA	Duke University; Duke University; Duke University; University System of Georgia; Georgia State University	Beskow, LM (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	laura.beskow@duke.edu	Namey, Emily/K-1975-2019	Namey, Emily/0000-0003-3200-1633; Wolf, Leslie/0000-0002-4660-8383	National Human Genome Research Institute (NHGRI) [R01HG005087]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005087] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The project described was supported by award number R01HG005087 from the National Human Genome Research Institute (NHGRI). The content is solely the responsibility of the authors and does not necessarily represent the official views of NHGRI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beskow LM, 2008, SCIENCE, V322, P1054, DOI 10.1126/science.1164100; Beskow LM, 2009, SCIENCE, V323, P1289; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; Carney PA, 2000, AM J EPIDEMIOL, V152, P371, DOI 10.1093/aje/152.4.371; Catania JA, 2007, J EMPIR RES HUM RES, V2, P53, DOI 10.1525/jer.2007.2.4.53; Catania JA, 2008, J EMPIR RES HUM RES, V3, P71, DOI 10.1525/jer.2008.3.4.71; Coffey MJ, 2004, GENET TEST, V8, P209, DOI 10.1089/gte.2004.8.209; Cooper ZN, 2004, GENET TEST, V8, P214, DOI 10.1089/gte.2004.8.214; Currie Peter M, 2005, IRB, V27, P7, DOI 10.2307/3564529; EARLEY CL, 1995, AM J HUM GENET, V57, P727; Hardy AM, 2012, CERTIFICATES CONFIDE; Hoagwood Kimberly, 1994, Ethics Behav, V4, P123, DOI 10.1207/s15327019eb0402_5; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR), 2011, BEST PRACT BIOSP RES; National Conference of State Legislatures, 2012, ISS RES HLTH SPEC TO; National Institutes of Health, 2011, NIH POINTS CONS IRBS; U.S. Department of Health and Human Services, 2011, RES PORTF ONL REP TO; Wolf L E, 1999, IRB, V21, P4, DOI 10.2307/3563756; Wolf Leslie E, 2004, IRB, V26, P14, DOI 10.2307/3563582; Wolf Leslie E, 2006, IRB, V28, P1	20	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44050	10.1371/journal.pone.0044050	http://dx.doi.org/10.1371/journal.pone.0044050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962599	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600027
J	Crowley, BE; McGoogan, KC; Lehman, SM				Crowley, Brooke E.; McGoogan, Keriann C.; Lehman, Shawn M.			Edge Effects on Foliar Stable Isotope Values in a Madagascan Tropical Dry Forest	PLOS ONE			English	Article							CARBON-ISOTOPE; NATURAL-ABUNDANCE; RAIN-FOREST; NITROGEN; PLANTS; SOIL; FRAGMENTATION; VEGETATION; N-15; PATTERNS	Edge effects represent an inevitable and important consequence of habitat loss and fragmentation. These effects include changes in microclimate, solar radiation, or temperature. Such abiotic effects can, in turn, impact biotic factors. They can have a substantial impact on species, communities, and ecosystems. Here we examine clinal variations in stable carbon and nitrogen isotope values for trees along an edge-interior gradient in the dry deciduous forest at Ankarafantsika National Park. We predicted that soil respiration and differences in solar irradiance would result in stratified delta C-13 values where leaves collected close to the forest floor would have lower delta C-13 values than those growing higher up in the canopy. We also anticipated that plants growing at the savannah-forest boundary would have higher delta C-13 and delta N-15 values than plants growing in the forest interior. As expected, we detected a small but significant canopy effect. Leaves growing below 2 m from the forest floor exhibit delta C-13 values that are, on average, 1.1% lower than those growing above this threshold. We did not, however, find any relationship between foliar delta C-13 and distance from the edge. Unpredictably, we detected a striking positive relationship between foliar delta N-15 values and increasing distance into the forest interior. Variability in physiology among species, anthropogenic influence, organic input, and rooting depth cannot adequately explain this trend. Instead, this unexpected relationship most likely reflects decreasing nutrient or water availability, or a shift in N-sources with increasing distance from the savannah. Unlike most forest communities, the trees at Ampijoroa are growing in nutrient-limited sands. In addition to being nutrient poor, these well-drained soils likely decrease the amount of soil water available to forest vegetation. Continued research on plant responses to edge effects will improve our understanding of the conservation biology of forest ecosystems in Madagascar.	[Crowley, Brooke E.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Crowley, Brooke E.] Univ Cincinnati, Dept Anthropol, Cincinnati, OH 45221 USA; [McGoogan, Keriann C.; Lehman, Shawn M.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Cincinnati; University of Cincinnati; University of Toronto	Crowley, BE (corresponding author), Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA.	brooke.crowley@uc.edu		Crowley, Brooke/0000-0002-8462-6806; Lehman, Shawn/0000-0003-0191-7139	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by an NSERC Discovery Grant awarded to SML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LA, 2002, MADAGASCAR RAP B BIO, V23, P28; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Bloesch U, 1999, APPL VEG SCI, V2, P117, DOI 10.2307/1478888; Bond WJ, 2008, J BIOGEOGR, V35, P1743, DOI 10.1111/j.1365-2699.2008.01923.x; BROADMEADOW MSJ, 1992, OECOLOGIA, V89, P435, DOI 10.1007/BF00317423; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Crowley BE, 2011, J BIOGEOGR, V38, P2106, DOI 10.1111/j.1365-2699.2011.02551.x; Dignan P, 2003, FOREST ECOL MANAG, V179, P95, DOI 10.1016/S0378-1127(02)00491-7; DuPuy DJ, 1996, COLLOQ SEMI, P205; EHLERINGER JR, 1986, OECOLOGIA, V70, P520, DOI 10.1007/BF00379898; Elmqvist T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000402; Evans RD, 2007, ECOL METHOD CONCEPT, P83, DOI 10.1002/9780470691854.ch4; EVANS RD, 1994, OECOLOGIA, V99, P233, DOI 10.1007/BF00627735; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fox-Dobbs K, 2010, ECOLOGY, V91, P1296, DOI 10.1890/09-0653.1; Gade DW, 1996, MT RES DEV, V16, P101, DOI 10.2307/3674005; GARTEN CT, 1992, OECOLOGIA, V90, P1, DOI 10.1007/BF00317801; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gehlhausen SM, 2000, PLANT ECOL, V147, P21, DOI 10.1023/A:1009846507652; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hartley MJ, 1998, CONSERV BIOL, V12, P465, DOI 10.1046/j.1523-1739.1998.96373.x; KAPOS V, 1993, J ECOL, V81, P425, DOI 10.2307/2261521; KOECHLIN J, 1972, P145; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; LAURANCE WF, 1991, BIOL CONSERV, V57, P205, DOI 10.1016/0006-3207(91)90139-Z; Lehman SM, 2006, INT J PRIMATOL, V27, P1569, DOI 10.1007/s10764-006-9099-z; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Lehtinen RM, 2003, BIODIVERS CONSERV, V12, P1357, DOI 10.1023/A:1023673301850; Leopold A., 1933, GAME MANAGEMENT; Li QL, 2007, FOREST ECOL MANAG, V242, P99, DOI 10.1016/j.foreco.2006.11.022; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lourenco WR, 2006, ZOOL ANZ, V244, P181, DOI 10.1016/j.jcz.2005.09.001; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McGoogan K. C., 2011, EDGE EFFECTS BEHAV E; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muzuka ANN, 1999, J AFR EARTH SCI, V28, P757, DOI 10.1016/S0899-5362(99)00044-5; Pardo LH, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P221, DOI 10.1007/978-90-481-3354-3_11; Pons P, 2003, OSTRICH, V74, P146, DOI 10.2989/00306520309485386; Ramanamanjato JB, 2001, ANIM CONSERV, V4, P175, DOI 10.1017/S1367943001001202; Rendigs A, 2003, INT J PRIMATOL, V24, P47, DOI 10.1023/A:1021494428294; Riitters K, 2000, CONSERV ECOL, V4, DOI 10.5751/ES-00209-040203; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; SELLES F, 1986, SOIL SCI SOC AM J, V50, P105, DOI 10.2136/sssaj1986.03615995005000010020x; SHEARER G, 1978, SOIL SCI SOC AM J, V42, P899, DOI 10.2136/sssaj1978.03615995004200060013x; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; Vincelette, 2007, BIODIVERSITY ECOLOGY, P337; Watson JEM, 2004, BIOL CONSERV, V120, P311, DOI 10.1016/j.biocon.2004.03.004; Wiedemeier DB, 2012, J BIOGEOGR, V39, P247, DOI 10.1111/j.1365-2699.2011.02583.x; Wilcove D, 1997, HUMAN IMPACT READER, P237; Williams-Linera G, 2009, BIODIVERS CONSERV, V18, P3269, DOI 10.1007/s10531-009-9641-3; Wooller MJ, 2005, OECOLOGIA, V145, P100, DOI 10.1007/s00442-005-0105-5	63	19	19	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44538	10.1371/journal.pone.0044538	http://dx.doi.org/10.1371/journal.pone.0044538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973460	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600067
J	Roig, M; Skriver, K; Lundbye-Jensen, J; Kiens, B; Nielsen, JB				Roig, Marc; Skriver, Kasper; Lundbye-Jensen, Jesper; Kiens, Bente; Nielsen, Jens Bo			A Single Bout of Exercise Improves Motor Memory	PLOS ONE			English	Article							ACUTE AEROBIC EXERCISE; COGNITIVE FUNCTION; PHYSICAL-EXERCISE; EXECUTIVE CONTROL; WORKING-MEMORY; SHORT-TERM; BRAIN; FITNESS; PERFORMANCE; AROUSAL	Regular physical activity has a positive impact on cognition and brain function. Here we investigated if a single bout of exercise can improve motor memory and motor skill learning. We also explored if the timing of the exercise bout in relation to the timing of practice has any impact on the acquisition and retention of a motor skill. Forty-eight young subjects were randomly allocated into three groups, which practiced a visuomotor accuracy-tracking task either before or after a bout of intense cycling or after rest. Motor skill acquisition was assessed during practice and retention was measured 1 hour, 24 hours and 7 days after practice. Differences among groups in the rate of motor skill acquisition were not significant. In contrast, both exercise groups showed a significantly better retention of the motor skill 24 hours and 7 days after practice. Furthermore, compared to the subjects that exercised before practice, the subjects that exercised after practice showed a better retention of the motor skill 7 days after practice. These findings indicate that one bout of intense exercise performed immediately before or after practicing a motor task is sufficient to improve the long-term retention of a motor skill. The positive effects of acute exercise on motor memory are maximized when exercise is performed immediately after practice, during the early stages of memory consolidation. Thus, the timing of exercise in relation to practice is possibly an important factor regulating the effects of acute exercise on long-term motor memory.	[Roig, Marc; Skriver, Kasper; Lundbye-Jensen, Jesper; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Roig, Marc; Skriver, Kasper; Lundbye-Jensen, Jesper; Kiens, Bente; Nielsen, Jens Bo] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Roig, M (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	markredj@sund.ku.dk	Lundbye-Jensen, Jesper/ABH-4025-2020; Nielsen, Jens Bo/C-7632-2015; Kiens, Bente/B-1375-2015	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Nielsen, Jens Bo/0000-0001-5568-2916; Roig, Marc/0000-0002-1016-467X; Kiens, Bente/0000-0001-5705-5625	Ludvig and Sara Elsass Foundation	Ludvig and Sara Elsass Foundation	The study was supported by the Ludvig and Sara Elsass Foundation (www.elsassfonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Ahlskog JE, 2011, NEUROLOGY, V77, P288, DOI 10.1212/WNL.0b013e318225ab66; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Baldari C, 2009, EUR J APPL PHYSIOL, V107, P105, DOI 10.1007/s00421-009-1107-5; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Brisswalter J, 2002, SPORTS MED, V32, P555, DOI 10.2165/00007256-200232090-00002; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; EYSENCK HJ, 1965, BRIT J PSYCHOL, V56, P163, DOI 10.1111/j.2044-8295.1965.tb00956.x; Globas C, 2011, NEUROREHABILITATION, V26, P85, DOI DOI 10.1177/1545968311418675.[; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Lambourne K, 2012, Q J EXP PSYCHOL, V65, P526, DOI 10.1080/17470218.2011.605959; Lambourne K, 2010, MED SCI SPORT EXER, V42, P1396, DOI 10.1249/MSS.0b013e3181cbee11; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; McGaugh JL, 2006, TRENDS COGN SCI, V10, P345, DOI 10.1016/j.tics.2006.06.001; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Park J, 2005, PSYCHOL REP, V97, P339, DOI 10.2466/PR0.97.6.339-355; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Potter D, 2005, J SPORT EXERCISE PSY, V27, P117, DOI 10.1123/jsep.27.1.117; SASCO AJ, 1992, ARCH NEUROL-CHICAGO, V49, P360, DOI 10.1001/archneur.1992.00530280040020; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; SJOBERG H, 1980, ERGONOMICS, V23, P977, DOI 10.1080/00140138008924807; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; STONES MJ, 1993, J AM GERIATR SOC, V41, P531, DOI 10.1111/j.1532-5415.1993.tb01890.x; Stroth S, 2009, BRAIN RES, V1269, P114, DOI 10.1016/j.brainres.2009.02.073; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; TOMPOROWSKI PD, 1987, ERGONOMICS, V30, P121, DOI 10.1080/00140138708969682; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Tomporowski PD, 2005, INT J SPORT EXERC PS, V3, P131, DOI 10.1080/1612197X.2005.9671763; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; WALKER EL, 1958, PSYCHOL REV, V65, P129, DOI 10.1037/h0049177; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	49	160	163	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44594	10.1371/journal.pone.0044594	http://dx.doi.org/10.1371/journal.pone.0044594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22973462	gold, Green Published, Green Submitted			2022-12-27	WOS:000308577600071
J	Roth, SD; Schuttrumpf, J; Milanov, P; Abriss, D; Ungerer, C; Quade-Lyssy, P; Simpson, JC; Pepperkok, R; Seifried, E; Tonn, T				Roth, Stefanie D.; Schuettrumpf, Joerg; Milanov, Peter; Abriss, Daniela; Ungerer, Christopher; Quade-Lyssy, Patricia; Simpson, Jeremy C.; Pepperkok, Rainer; Seifried, Erhard; Tonn, Torsten			Chemical Chaperones Improve Protein Secretion and Rescue Mutant Factor VIII in Mice with Hemophilia A	PLOS ONE			English	Article							COAGULATION-FACTOR-VIII; GENE-THERAPY; MOUSE MODEL; FACTOR-V; TRAFFICKING; RECOMBINANT; EXPRESSION; MUTATIONS; BETAINE; DISEASE	Inefficient intracellular protein trafficking is a critical issue in the pathogenesis of a variety of diseases and in recombinant protein production. Here we investigated the trafficking of factor VIII (FVIII), which is affected in the coagulation disorder hemophilia A. We hypothesized that chemical chaperones may be useful to enhance folding and processing of FVIII in recombinant protein production, and as a therapeutic approach in patients with impaired FVIII secretion. A tagged B-domain-deleted version of human FVIII was expressed in cultured Chinese Hamster Ovary cells to mimic the industrial production of this important protein. Of several chemical chaperones tested, the addition of betaine resulted in increased secretion of FVIII, by increasing solubility of intracellular FVIII aggregates and improving transport from endoplasmic reticulum to Golgi. Similar results were obtained in experiments monitoring recombinant full-length FVIII. Oral betaine administration also increased FVIII and factor IX (FIX) plasma levels in FVIII or FIX knockout mice following gene transfer. Moreover, in vitro and in vivo applications of betaine were also able to rescue a trafficking-defective FVIII mutant (FVIIIQ305P). We conclude that chemical chaperones such as betaine might represent a useful treatment concept for hemophilia and other diseases caused by deficient intracellular protein trafficking.	[Roth, Stefanie D.; Schuettrumpf, Joerg; Milanov, Peter; Abriss, Daniela; Ungerer, Christopher; Quade-Lyssy, Patricia; Seifried, Erhard; Tonn, Torsten] Clin Johann Wolfgang Goethe Univ, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donor Serv Baden Wuerttemb, Frankfurt, Hesse, Germany; [Schuettrumpf, Joerg] Biomed Res Inst Georg Speyer Haus, Frankfurt, Hesse, Germany; [Simpson, Jeremy C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol & Biophys Dept, Heidelberg, Baden Wuerttemb, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University College Dublin; European Molecular Biology Laboratory (EMBL)	Roth, SD (corresponding author), Clin Johann Wolfgang Goethe Univ, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donor Serv Baden Wuerttemb, Frankfurt, Hesse, Germany.	joerg_schuettrumpf@biotest.de		Simpson, Jeremy/0000-0002-7956-7805; Pepperkok, Rainer/0000-0002-9762-3583; Schuettrumpf, Joerg/0000-0002-8855-4096	Deutsche Forschungsgemeinschaft [GK-1172]; Stiftung Hamotherapie-Forschung e.V.; Excellence Cluster Cardio-Pulmonary System (ECCPS, Deutsche Forschungsgemeinschaft); Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)Center for Cell and Gene Therapy, Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004]; Bayer	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung Hamotherapie-Forschung e.V.; Excellence Cluster Cardio-Pulmonary System (ECCPS, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)Center for Cell and Gene Therapy, Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst; Bayer(Bayer AG)	SR, DA, CU and PQL are students within the graduate study program GK-1172 funded by the Deutsche Forschungsgemeinschaft. The research was supported by the Stiftung Hamotherapie-Forschung e.V. to JS. ES and TT received funding through the Excellence Cluster Cardio-Pulmonary System (ECCPS, Deutsche Forschungsgemeinschaft). ES and JS received support from the Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)Center for Cell and Gene Therapy, Frankfurt, funded by the Hessisches Ministerium fur Wissenschaft und Kunst, funding reference number: III L 4-518/17.004 (2010). JS receives funding from Bayer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Becker S, 2004, THROMB HAEMOSTASIS, V92, P23, DOI 10.1160/th03-06-0360; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; CHUAH MKL, 1995, HUM GENE THER, V6, P1363, DOI 10.1089/hum.1995.6.11-1363; Collins P, 2010, J THROMB HAEMOST, V8, P83, DOI 10.1111/j.1538-7836.2009.03650.x; Connelly S, 1998, BLOOD, V91, P3273, DOI 10.1182/blood.V91.9.3273.3273_3273_3281; Dooriss KL, 2009, HUM GENE THER, V20, P465, DOI 10.1089/hum.2008.150; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Enjolras N, 2004, J THROMB HAEMOST, V2, P1143, DOI 10.1111/j.1538-7836.2004.00756.x; Fakharzadeh SS, 2000, SEMIN THROMB HEMOST, V26, P167, DOI 10.1055/s-2000-9819; Furusho K, 2005, NEUROBIOL DIS, V20, P170, DOI 10.1016/j.nbd.2005.02.011; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Guillet B, 2006, HUM MUTAT, V27, P676, DOI 10.1002/humu.20345; Heinz S, 2009, THROMB HAEMOSTASIS, V102, P925, DOI 10.1160/TH08-12-0807; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; Leandro P, 2008, MINI-REV MED CHEM, V8, P901, DOI 10.2174/138955708785132783; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; O'Mahony B, 2005, SEMIN THROMB HEMOST, V31, P561, DOI 10.1055/s-2005-922228; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; PITTMAN DD, 1993, BLOOD, V81, P2925; Plantier JL, 2005, THROMB HAEMOSTASIS, V93, P824, DOI 10.1160/TH04-09-0579; Rajan RS, 2011, CURR MED CHEM, V18, P1; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Ryu JS, 2000, BIOTECHNOL BIOENG, V70, P167, DOI 10.1002/1097-0290(20001020)70:2<167::AID-BIT6>3.0.CO;2-P; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Schatz SM, 2004, BRIT J HAEMATOL, V125, P629, DOI 10.1111/j.1365-2141.2004.04959.x; Schuettrumpf J, 2005, BLOOD, V105, P2316, DOI 10.1182/blood-2004-08-2990; Schuttrumpf J, 2011, HUM GENE THER, V22, P101, DOI 10.1089/hum.2009.212; Schwab U, 2006, J NUTR, V136, P34, DOI 10.1093/jn/136.1.34; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Soukharev S, 2002, BLOOD CELL MOL DIS, V28, P234, DOI 10.1006/bcmd.2002.0508; Swaroop M, 1997, J BIOL CHEM, V272, P24121, DOI 10.1074/jbc.272.39.24121; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tonn T, 2002, J HEMATOTH STEM CELL, V11, P695, DOI 10.1089/15258160260194848; Wang JW, 2011, J BIOL CHEM, V286, P24180, DOI 10.1074/jbc.M110.215194; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang B, 2006, BLOOD, V107, P1903, DOI 10.1182/blood-2005-09-3620; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	51	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44505	10.1371/journal.pone.0044505	http://dx.doi.org/10.1371/journal.pone.0044505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973456	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600063
J	Javier, AL; Doan, LT; Luong, M; de Mochel, NSR; Sun, AX; Monuki, ES; Cho, KWY				Javier, Anna L.; Doan, Linda T.; Luong, Mui; de Mochel, N. Soledad Reyes; Sun, Aixu; Monuki, Edwin S.; Cho, Ken W. Y.			Bmp Indicator Mice Reveal Dynamic Regulation of Transcriptional Response	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; MOTOR-NEURON INDUCTION; CHICK LIMB DEVELOPMENT; PRIMORDIAL GERM-CELLS; DORSAL SPINAL-CORD; TGF-BETA; MOUSE EMBRYO; WNT/BETA-CATENIN; DISTINCT ROLES; SMAD PROTEINS	Cellular responses to Bmp ligands are regulated at multiple levels, both extracellularly and intracellularly. Therefore, the presence of these growth factors is not an accurate indicator of Bmp signaling activity. While a common approach to detect Bmp signaling activity is to determine the presence of phosphorylated forms of Smad1, 5 and 8 by immunostaining, this approach is time consuming and not quantitative. In order to provide a simpler readout system to examine the presence of Bmp signaling in developing animals, we developed BRE-gal mouse embryonic stem cells and a transgenic mouse line that specifically respond to Bmp ligand stimulation. Our reporter identifies specific transcriptional responses that are mediated by Smad1 and Smad4 with the Schnurri transcription factor complex binding to a conserved Bmp-Responsive Element (BRE), originally identified among Drosophila, Xenopus and human Bmp targets. Our BRE-gal mES cells specifically respond to Bmp ligands at concentrations as low as 5 ng/ml; and BRE-gal reporter mice, derived from the BRE-gal mES cells, show dynamic activity in many cellular sites, including extraembryonic structures and mammary glands, thereby making this a useful scientific tool.	[Javier, Anna L.; Doan, Linda T.; Luong, Mui; de Mochel, N. Soledad Reyes; Sun, Aixu; Monuki, Edwin S.; Cho, Ken W. Y.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Doan, Linda T.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Javier, AL (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	kwcho@uci.edu		Doan, Linda/0000-0003-0274-2529; Monuki, Edwin/0000-0001-5130-781X	National Institutes of Health [RO1HD056219]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056219] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by National Institutes of Health RO1HD056219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Blitz IL, 2009, DEV DYNAM, V238, P1321, DOI 10.1002/dvdy.21984; Bosman EA, 2006, DEVELOPMENT, V133, P3399, DOI 10.1242/dev.02497; Cai XQ, 2011, DEV BIOL, V360, P381, DOI 10.1016/j.ydbio.2011.09.023; Chesnutt C, 2004, DEV BIOL, V274, P334, DOI 10.1016/j.ydbio.2004.07.019; Correia AC, 2007, DEV DYNAM, V236, P2493, DOI 10.1002/dvdy.21256; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Fujiwara T, 2001, P NATL ACAD SCI USA, V98, P13739, DOI 10.1073/pnas.241508898; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200; Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Holzschuh J, 2005, DEVELOPMENT, V132, P3731, DOI 10.1242/dev.01936; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kawakami Y, 1996, DEVELOPMENT, V122, P3557; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lorda-Diez CI, 2009, INT J DEV BIOL, V53, P1495, DOI 10.1387/ijdb.072415cl; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LYONS KM, 1990, DEVELOPMENT, V109, P833; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Macias D, 1997, DEVELOPMENT, V124, P1109; Madabhushi M, 2011, DEV CELL, V21, P907, DOI 10.1016/j.devcel.2011.08.027; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagy A., 2003, MANIPULATING MOUSE E; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakayama T, 1998, GENES CELLS, V3, P387, DOI 10.1046/j.1365-2443.1998.00196.x; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Ohuchi H, 2003, BIOCHEM BIOPH RES CO, V302, P562, DOI 10.1016/S0006-291X(03)00183-9; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; Tomas AR, 2011, DEV BIOL, V355, P324, DOI 10.1016/j.ydbio.2011.04.031; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhao W, 2007, FEBS LETT, V581, P4960, DOI 10.1016/j.febslet.2007.09.033; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	79	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42566	10.1371/journal.pone.0042566	http://dx.doi.org/10.1371/journal.pone.0042566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984405	Green Published, gold			2022-12-27	WOS:000308638700007
J	Palacin, A; Rivas, LA; Gomez-Casado, C; Aguirre, J; Tordesillas, L; Bartra, J; Blanco, C; Carrillo, T; Cuesta-Herranz, J; Bonny, JAC; Flores, E; Garcia-Alvarez-Eire, MG; Garcia-Nunez, I; Fernandez, FJ; Gamboa, P; Munoz, R; Sanchez-Monge, R; Torres, M; Losada, SV; Villalba, M; Vega, F; Parro, V; Blanca, M; Salcedo, G; Diaz-Perales, A				Palacin, Arantxa; Rivas, Luis A.; Gomez-Casado, Cristina; Aguirre, Jacobo; Tordesillas, Leticia; Bartra, Joan; Blanco, Carlos; Carrillo, Teresa; Cuesta-Herranz, Javier; Cumplido Bonny, Jose A.; Flores, Enrique; Garcia-Alvarez-Eire, Mar G.; Garcia-Nunez, Ignacio; Fernandez, Francisco J.; Gamboa, Pedro; Munoz, Rosa; Sanchez-Monge, Rosa; Torres, Maria; Varela Losada, Susana; Villalba, Mayte; Vega, Francisco; Parro, Victor; Blanca, Miguel; Salcedo, Gabriel; Diaz-Perales, Araceli			The Involvement of Thaumatin-Like Proteins in Plant Food Cross-Reactivity: A Multicenter Study Using a Specific Protein Microarray	PLOS ONE			English	Article							LIPID-TRANSFER PROTEINS; COMPLEX NETWORKS; SENSITIZATION PROFILES; CLINICAL-RELEVANCE; MAJOR ALLERGEN; POLLEN; IDENTIFICATION; DIAGNOSIS; EXPRESSION; MOLECULES	Cross-reactivity of plant foods is an important phenomenon in allergy, with geographical variations with respect to the number and prevalence of the allergens involved in this process, whose complexity requires detailed studies. We have addressed the role of thaumatin-like proteins (TLPs) in cross-reactivity between fruit and pollen allergies. A representative panel of 16 purified TLPs was printed onto an allergen microarray. The proteins selected belonged to the sources most frequently associated with peach allergy in representative regions of Spain. Sera from two groups of well characterized patients, one with allergy to Rosaceae fruit (FAG) and another against pollens but tolerant to food-plant allergens (PAG), were obtained from seven geographical areas with different environmental pollen profiles. Cross-reactivity between members of this family was demonstrated by inhibition assays. Only 6 out of 16 purified TLPs showed noticeable allergenic activity in the studied populations. Pru p 2.0201, the peach TLP (41%), chestnut TLP (24%) and plane pollen TLP (22%) proved to be allergens of probable relevance to fruit allergy, being mainly associated with pollen sensitization, and strongly linked to specific geographical areas such as Barcelona, Bilbao, the Canary Islands and Madrid. The patients exhibited >50% positive response to Pru p 2.0201 and to chestnut TLP in these specific areas. Therefore, their recognition patterns were associated with the geographical area, suggesting a role for pollen in the sensitization of these allergens. Finally, the co-sensitizations of patients considering pairs of TLP allergens were analyzed by using the co-sensitization graph associated with an allergen microarray immunoassay. Our data indicate that TLPs are significant allergens in plant food allergy and should be considered when diagnosing and treating pollen-food allergy.	[Palacin, Arantxa; Gomez-Casado, Cristina; Tordesillas, Leticia; Sanchez-Monge, Rosa; Diaz-Perales, Araceli] Ctr Biotecnol & Genom Plantas, Madrid, Spain; [Rivas, Luis A.; Aguirre, Jacobo; Parro, Victor] Ctr Astrobiol INTA CSIC, Dept Evoluc Mol, Madrid, Spain; [Bartra, Joan; Munoz, Rosa] Univ Barcelona, IDIBAPS, Ctr Invest Biomed Red Enfermedad Resp CIBERES, Unitat Allergia,Serv Pneumol & Allergia Resp,Hosp, Barcelona, Spain; [Blanco, Carlos; Vega, Francisco] Hosp Univ Princesa, Serv Alergia, Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Carrillo, Teresa; Cumplido Bonny, Jose A.] Hosp Univ Gran Canaria Dr Negrin, Serv Alergol, Las Palmas Gran Canaria, Spain; [Cuesta-Herranz, Javier] Fdn Jimenez Diaz, Serv Alergia, E-28040 Madrid, Spain; [Flores, Enrique; Fernandez, Francisco J.] Hosp Gen Univ, Unidad Alergia, Alicante, Spain; [Garcia-Alvarez-Eire, Mar G.; Varela Losada, Susana] Complexo Hosp, Unidad Alergol, Orense, Spain; [Garcia-Nunez, Ignacio; Blanca, Miguel] Hosp Civil, Carlos Haya Hosp, Fdn IMABIS, Lab Invest, Malaga, Spain; [Gamboa, Pedro] Hosp Basurto, Serv Alergia, Bilbao, Spain; [Torres, Maria; Villalba, Mayte] Univ Complutense, Dept Bioquim & Biol Mol 1, Fac Quim, E-28040 Madrid, Spain; [Salcedo, Gabriel] Univ Politecn Madrid, Dept Biotecnol, ETSI Agronomos, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; General University Hospital of Alicante; FIMABIS; Hospital Carlos Haya; Basurto Hospital; Complutense University of Madrid; Universidad Politecnica de Madrid	Palacin, A (corresponding author), Ctr Biotecnol & Genom Plantas, Campus Montegancedo, Madrid, Spain.	araceli.diaz@upm.es	Aguirre, Jacobo/K-5855-2014; Torres, María José/T-3518-2017; Villalba, Mayte/K-5365-2014; Villalba, María Teresa/AAW-1067-2020; Díaz-Perales, Araceli/D-8433-2016; Cano, Rosa Munoz/K-9413-2014; Gomez-Casado, Cristina/AAE-4826-2021; Blanco, Carlos/B-3895-2012; Muñoz, Rosa/AAC-7288-2020; Bartra, Joan/L-4550-2014; Parro, Victor/K-3788-2014; Fernandez, Javier/B-6425-2018; Torres, Maria/GVU-3391-2022; FLORES, EMILIO EFP/F-5536-2017; Gomez-Casado, Cristina/K-4031-2016	Aguirre, Jacobo/0000-0003-2196-5103; Torres, María José/0000-0001-5228-471X; Villalba, María Teresa/0000-0002-0042-9953; Díaz-Perales, Araceli/0000-0002-1093-3627; Cano, Rosa Munoz/0000-0001-8566-8285; Blanco, Carlos/0000-0002-2893-6594; Muñoz, Rosa/0000-0001-8566-8285; Bartra, Joan/0000-0001-7767-4730; Fernandez, Javier/0000-0003-1065-7199; FLORES, EMILIO EFP/0000-0001-7524-0808; Gomez-Casado, Cristina/0000-0002-7707-6367; Parro, Victor/0000-0003-3738-0724; Rivas, Luis Alfonso/0000-0001-8392-3000	Ministerio de Ciencia e Innovacion [BIO2009-07050, FIS2011-27569]; Spanish Government (MEC); Comunidad de Madrid, R&D Programme of Activities [MODELICO-CM S2009ESP-1691]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Government (MEC)(Spanish Government); Comunidad de Madrid, R&D Programme of Activities(Comunidad de Madrid)	Ministerio de Ciencia e Innovacion (project BIO2009-07050) and FIS-Thematic Networks and Co-operative Research Centers: RIRAAF (RD07/0064). C. Gomez Casado and L. Tordesillas were supported by training grants from the Spanish Government (FPI and FPU programmes, MEC, respectively). J. Aguirre was supported by the Ministerio de Ciencia e Innovacion (project FIS2011-27569) and Comunidad de Madrid, R&D Programme of Activities, grant MODELICO-CM S2009ESP-1691. The funders had no role in the study design, data collection or analysis, the decision to publish, or the preparation of the manuscript.	Aguirre J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026324; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Asero R, 2008, CLIN EXP ALLERGY, V38, P1033, DOI 10.1111/j.1365-2222.2008.02980.x; Beyer K, 2005, CURR OPIN ALLERGY CL, V5, P261, DOI 10.1097/01.all.0000168792.27948.f9; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Breiteneder H, 2004, ALLERGY, V59, P479, DOI 10.1046/j.1398-9995.2003.00421.x; CANONICA GW, 1989, ALLERGY, V44, P1, DOI 10.1111/j.1398-9995.1989.tb00438.x; Cortegano I, 2004, ALLERGY, V59, P485, DOI 10.1046/j.1398-9995.2003.00363.x; Cuesta-Herranz J, 2010, INT ARCH ALLERGY IMM, V153, P182, DOI 10.1159/000312636; Diaz-Perales A, 2003, J ALLERGY CLIN IMMUN, V112, P1002, DOI 10.1016/j.jaci.2003.07.006; Diaz-Perales A, 2003, J ALLERGY CLIN IMMUN, V111, P628, DOI 10.1067/mai.2003.75; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Rivas MF, 2009, J INVEST ALLERG CLIN, V19, P37; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Fuchs HC, 2006, CLIN EXP ALLERGY, V36, P359, DOI 10.1111/j.1365-2222.2006.02439.x; Gadermaier G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024150; Garcia-Casado C, 2000, PHYSIOL PLANTARUM, V110, P172; Hansen KS, 2010, CURR ALLERGY ASTHM R, V10, P340, DOI 10.1007/s11882-010-0133-z; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lauer I, 2007, CLIN EXP ALLERGY, V37, P261, DOI 10.1111/j.1365-2222.2007.02653.x; Lehto M, 2010, ANN ALLERG ASTHMA IM, V104, P139, DOI 10.1016/j.anai.2009.11.062; Lopez-Torrejon G, 2005, CLIN EXP ALLERGY, V35, P1065, DOI 10.1111/j.1365-2222.2005.02303.x; Menu-Bouaouiche L, 2003, BIOCHIMIE, V85, P123, DOI 10.1016/S0300-9084(03)00058-0; Palacin A, 2008, CLIN EXP ALLERGY, V38, P1220, DOI 10.1111/j.1365-2222.2007.02927.x; Palacin A, 2010, CLIN EXP ALLERGY, V40, P1422, DOI 10.1111/j.1365-2222.2010.03578.x; Palacin A, 2008, ANN ALLERG ASTHMA IM, V101, P200, DOI 10.1016/S1081-1206(10)60210-4; Palacin A, 2011, PEDIAT ALLERG IMM-UK, V22, P186, DOI 10.1111/j.1399-3038.2010.01125.x; Palomares O, 2008, NEW ENGL J MED, V358, P1306, DOI 10.1056/NEJMc0707778; Rivas LA, 2008, ANAL CHEM, V80, P7970, DOI 10.1021/ac8008093; Rivas LA, 2011, ENVIRON MICROBIOL, V13, P1421, DOI 10.1111/j.1462-2920.2011.02442.x; Salcedo G, 2007, BBA-MOL CELL BIOL L, V1771, P781, DOI 10.1016/j.bbalip.2007.01.001; Salcedo G, 2010, CLIN EXP ALLERGY, V40, P836, DOI 10.1111/j.1365-2222.2010.03506.x; Sanz ML, 2011, CURR OPIN ALLERGY CL, V11, P204, DOI 10.1097/ACI.0b013e3283466fe4; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Tordesillas L, 2011, INT ARCH ALLERGY IMM, V156, P291, DOI 10.1159/000323503	41	52	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44088	10.1371/journal.pone.0044088	http://dx.doi.org/10.1371/journal.pone.0044088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970164	Green Published, Green Accepted, gold			2022-12-27	WOS:000308462000012
J	Forman, RA; deSchoolmeester, ML; Hurst, RJM; Wright, SH; Pemberton, AD; Else, KJ				Forman, Ruth A.; deSchoolmeester, Matthew L.; Hurst, Rebecca J. M.; Wright, Steven H.; Pemberton, Alan D.; Else, Kathryn J.			The Goblet Cell Is the Cellular Source of the Anti-Microbial Angiogenin 4 in the Large Intestine Post Trichuris muris Infection	PLOS ONE			English	Article							NEMATODE INFECTION; PANETH CELLS; MEDIATED REGULATION; INNATE IMMUNITY; EXPULSION; MICE; PARASITE; MOUSE; IDENTIFICATION; EXPRESSION	Background: Mouse angiogenin 4 (Ang4) has previously been described as a Paneth cell-derived antimicrobial peptide important in epithelial host defence in the small intestine. However, a source for Ang4 in the large intestine, which is devoid of Paneth cells, has not been defined. Methodology/Principal Findings: Analysis was performed on Ang4 expression in colonic tissue by qPCR and immunohistochemistry following infection with the large intestine dwelling helminth parasite Trichuris muris. This demonstrated an increase in expression of the peptide following infection of resistant BALB/c mice. Further, histological analysis of colonic tissue revealed the cellular source of this Ang4 to be goblet cells. To elucidate the mechanism of Ang4 expression immunohistochemistry and qPCR for Ang4 was performed on colonic tissue from T. muris infected mouse mutants. Experiments comparing C3H/HeN and C3H/HeJ mice, which have a natural inactivating mutation of TLR4, revealed that Ang4 expression is TLR4 independent. Subsequent experiments with IL-13 and IL-4 receptor alpha deficient mice demonstrated that goblet cell expression of Ang4 is controlled either directly or indirectly by IL-13. Conclusions: The cellular source of mouse Ang4 in the colon following T. muris infection is the goblet cell and expression is under the control of IL-13.	[Forman, Ruth A.; deSchoolmeester, Matthew L.; Hurst, Rebecca J. M.; Else, Kathryn J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Wright, Steven H.; Pemberton, Alan D.] Univ Edinburgh, Roslin Inst, Div Vet Clin Sci, Roslin, Midlothian, Scotland	University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Forman, RA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ruth.forman@manchester.ac.uk	Hurst, Rebecca/G-6253-2014	Else, Kathryn/0000-0001-6660-055X; Forman, Ruth/0000-0003-0374-6679	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E012647/1]; Wellcome Trust; BBSRC [BB/E012647/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012647/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/E012647/1. RAF is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2006, INT J PARASITOL, V36, P723, DOI 10.1016/j.ijpara.2006.02.011; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Codoner FM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-310; D'Elia R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-492; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; ELSE K, 1988, PARASITOLOGY, V96, P543, DOI 10.1017/S0031182000080173; ELSE KJ, 1993, PARASITE IMMUNOL, V15, P595; ELSE KJ, 1992, IMMUNOLOGY, V75, P232; ELSE KJ, 1994, J EXP MED, V179, P347, DOI 10.1084/jem.179.1.347; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Grencis RK, 2004, CLIN REV ALLERG IMMU, V26, P51, DOI 10.1385/CRIAI:26:1:51; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hayes KS, 2004, IMMUNOL REV, V201, P75, DOI 10.1111/j.0105-2896.2004.00193.x; Helmby H, 2003, EUR J IMMUNOL, V33, P2974, DOI 10.1002/eji.200324264; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; McDermott JR, 2005, J IMMUNOL, V175, P3207, DOI 10.4049/jimmunol.175.5.3207; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Pemberton AD, 2004, PROTEOMICS, V4, P1101, DOI 10.1002/pmic.200300658; Rumio C, 2011, J CELL PHYSL; RYBAK SM, 1987, BIOCHEM BIOPH RES CO, V146, P1240, DOI 10.1016/0006-291X(87)90781-9; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Wehkamp J, 2006, CURR OPIN GASTROEN, V22, P644, DOI 10.1097/01.mog.0000245541.95408.86	28	42	42	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e42248	10.1371/journal.pone.0042248	http://dx.doi.org/10.1371/journal.pone.0042248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970115	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400003
J	Lee, I; Hendrix, A; Kim, J; Yoshimoto, J; You, YJ				Lee, Inhwan; Hendrix, Amber; Kim, Jeongho; Yoshimoto, Jennifer; You, Young-Jai			Metabolic Rate Regulates L1 Longevity in C-elegans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; CELLULAR-ENERGY; LIFE-SPAN; ARREST; GROWTH; IDENTIFICATION; GERMLINE; SURVIVAL; DIAPAUSE	Animals have to cope with starvation. The molecular mechanisms by which animals survive long-term starvation, however, are not clearly understood. When they hatch without food, C. elegans arrests development at the first larval stage (L1) and survives more than two weeks. Here we show that the survival span of arrested L1s, which we call L1 longevity, is a starvation response regulated by metabolic rate during starvation. A high rate of metabolism shortens the L1 survival span, whereas a low rate of metabolism lengthens it. The longer worms are starved, the slower they grow once they are fed, suggesting that L1 arrest has metabolic costs. Furthermore, mutants of genes that regulate metabolism show altered L1 longevity. Among them, we found that AMP-dependent protein kinase (AMPK), as a key energy sensor, regulates L1 longevity by regulating this metabolic arrest. Our results suggest that L1 longevity is determined by metabolic rate and that AMPK as a master regulator of metabolism controls this arrest so that the animals survive long-term starvation.	[Lee, Inhwan; Hendrix, Amber; You, Young-Jai] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Kim, Jeongho] Inha Univ, Dept Biol Sci, Inchon, South Korea; [Yoshimoto, Jennifer] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Virginia Commonwealth University; Inha University; University of Michigan System; University of Michigan	Lee, I (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	yjyou@vcu.edu		you, young/0000-0002-5716-5418; Yoshimoto, Jennifer/0000-0003-1718-5171	American Heart Association [09SDG2150070]	American Heart Association(American Heart Association)	IL and YY received support from the American Heart Association grant (09SDG2150070). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; AVERY L, 1993, GENETICS, V133, P897; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Castro PV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029984; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Kang C, 2009, AUTOPHAGY, V5, P565, DOI 10.4161/auto.5.4.8171; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Sambrook J., 2002, MOL CLONING LAB MANU; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Watts JL, 2000, DEVELOPMENT, V127, P1467; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108	26	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44720	10.1371/journal.pone.0044720	http://dx.doi.org/10.1371/journal.pone.0044720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970296	Green Submitted, gold, Green Published			2022-12-27	WOS:000308458400111
J	Naesgaard, PA; De La Fuente, RAL; Nilsen, ST; Woie, L; Aarsland, T; Brede, C; Staines, H; Nilsen, DWT				Naesgaard, Patrycja A.; Leon De La Fuente, Ricardo A.; Nilsen, Stein Tore; Woie, Leik; Aarsland, Torbjoern; Brede, Cato; Staines, Harry; Nilsen, Dennis W. T.			Serum 25(OH)D Is a 2-Year Predictor of All-Cause Mortality, Cardiac Death and Sudden Cardiac Death in Chest Pain Patients from Northern Argentina	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RISK; 25-HYDROXYVITAMIN-D; ASSOCIATION; MEN	Background: Several studies have shown an association between vitamin D deficiency and cardiovascular risk. Vitamin D status is assessed by determination of 25-hydroxyvitamin D [25(OH)D] in serum. Methods: We assessed the prognostic utility of 25(OH) D in 982 chest-pain patients with suspected acute coronary syndrome (ACS) from Salta, Northern Argentina. 2-year follow-up data including all-cause mortality, cardiac death and sudden cardiac death were analyzed in quartiles of 25(OH) D, applying univariate and multivariate analysis. Results: There were statistically significant changes in seasonal 25(OH) D levels. At follow-up, 119 patients had died. The mean 25(OH) D levels were significantly lower among patients dying than in long-term survivors, both in the total population and in patients with a troponin T (TnT) release (n = 388). When comparing 25(OH) D in the highest quartile to the lowest quartile in a multivariable Cox regression model for all-cause mortality, the hazard ratio (HR) for cardiac death and sudden cardiac death in the total population was 0.37 (95% CI, 0.19-0.73), p = 0.004, 0.23 (95% CI, 0.08-0.67), p = 0.007, and 0.32 (95% CI, 0.11-0.94), p = 0.038, respectively. In patients with TnT release, the respective HR was 0.24 (95% CI, 0.10-0.54), p = 0.001, 0.18 (95% CI, 0.05-0.60), p = 0.006 and 0.25 (95% CI, 0.07-0.89), p = 0.033. 25(OH) D had no prognostic value in patients with no TnT release. Conclusion: Vitamin D was shown to be a useful biomarker for prediction of mortality when obtained at admission in chest pain patients with suspected ACS.	[Naesgaard, Patrycja A.; Leon De La Fuente, Ricardo A.; Woie, Leik; Nilsen, Dennis W. T.] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Naesgaard, Patrycja A.; Leon De La Fuente, Ricardo A.] Univ Bergen, Inst Med, Bergen, Norway; [Leon De La Fuente, Ricardo A.] Catholic Univ Salta, Cardiol Res Inst, Salta, Argentina; [Nilsen, Stein Tore; Aarsland, Torbjoern] Stavanger Univ Hosp, Dept Res, Stavanger, Norway; [Brede, Cato] Stavanger Univ Hosp, Dept Med Biochem, Stavanger, Norway; [Staines, Harry] Sigma Stat Serv, Balmullo, Scotland	Stavanger University Hospital; University of Bergen; Stavanger University Hospital; Stavanger University Hospital	Naesgaard, PA (corresponding author), Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway.	patrycja_anna_szczepaniak@hotmail.com	Nilsen, Dennis/AAM-4344-2020; Brede, Cato/AGZ-6186-2022	Brede, Cato/0000-0003-2691-6052; Nilsen, Stein Tore/0000-0001-6949-0405	Stavanger University Hospital	Stavanger University Hospital	This work was funded by a research grant from Stavanger University Hospital to PAN. This funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Braunwald E, 2002, NY TIMES        1026, V106, P1883; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Holick MF, 2006, PRIMER METABOLIC BON, P106; Holick MF, 2007, J BONE MINER RES, V22, pV28, DOI 10.1359/JBMR.07S211; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Judd SE, 2009, AM J MED SCI, V338, P40, DOI 10.1097/MAJ.0b013e3181aaee91; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Lee JH, 2011, AM J CARDIOL, V107, P1636, DOI 10.1016/j.amjcard.2011.01.048; de la Fuente RL, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-57; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; MullerBardorff M, 1997, CLIN CHEM, V43, P458; Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784; Pilz S, 2011, CLIN ENDOCRINOL, V75, P575, DOI 10.1111/j.1365-2265.2011.04147.x; Sun Q, 2011, AM J CLIN NUTR, V94, P534, DOI 10.3945/ajcn.110.008763; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	23	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43228	10.1371/journal.pone.0043228	http://dx.doi.org/10.1371/journal.pone.0043228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970121	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400008
J	Yamanari, M; Ishii, K; Fukuda, S; Lim, Y; Duan, L; Makita, S; Miura, M; Oshika, T; Yasuno, Y				Yamanari, Masahiro; Ishii, Kotaro; Fukuda, Shinichi; Lim, Yiheng; Duan, Lian; Makita, Shuichi; Miura, Masahiro; Oshika, Tetsuro; Yasuno, Yoshiaki			Optical Rheology of Porcine Sclera by Birefringence Imaging	PLOS ONE			English	Article							NERVE HEAD; COHERENCE TOMOGRAPHY; PERIPAPILLARY SCLERA; COLLAGEN; ORGANIZATION; DEFORMATION; CORNEA; TISSUE; MYOPIA	Purpose: To investigate a relationship between birefringence and elasticity of porcine sclera ex vivo using polarizationsensitive optical coherence tomography (PS-OCT). Methods: Elastic parameters and birefringence of 19 porcine eyes were measured. Four pieces of scleral strips which were parallel to the limbus, with a width of 4 mm, were dissected from the optic nerve head to the temporal side of each porcine eye. Birefringence of the sclera was measured with a prototype PS-OCT. The strain and force were measured with a uniaxial material tester as the sample was stretched with a speed of 1.8 mm/min after preconditioning. A derivative of the exponentially-fitted stress-strain curve at 0% strain was extracted as the tangent modulus. Power of exponential stress-strain function was also extracted from the fitting. To consider a net stiffness of sclera, structural stiffness was calculated as a product of tangent modulus and thickness. Correlations between birefringence and these elastic parameters were examined. Results: Statistically significant correlations between birefringence and all of the elastic parameters were found at 2 central positions. Structural stiffness and power of exponential stress-strain function were correlated with birefringence at the position near the optic nerve head. No correlation was found at the position near the equator. Conclusions: The evidence of correlations between birefringence and elasticity of sclera tested uniaxially was shown for the first time. This work may become a basis for in vivo measurement of scleral biomechanics using PS-OCT.	[Yamanari, Masahiro; Lim, Yiheng; Duan, Lian; Makita, Shuichi; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan; [Ishii, Kotaro; Fukuda, Shinichi; Oshika, Tetsuro] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Tsukuba, Ibaraki 305, Japan; [Miura, Masahiro] Tokyo Med Univ, Ibaraki Med Ctr, Dept Ophthalmol, Ami, Ibaraki, Japan; [Yamanari, Masahiro; Ishii, Kotaro; Fukuda, Shinichi; Lim, Yiheng; Duan, Lian; Makita, Shuichi; Miura, Masahiro; Oshika, Tetsuro; Yasuno, Yoshiaki] Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Tokyo Medical University	Yamanari, M (corresponding author), Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp	Makita, Shuichi/G-3806-2011; Yamanari, Masahiro/B-3147-2010; Yasuno, Yoshiaki/F-2586-2011	Makita, Shuichi/0000-0002-6614-3640; Yamanari, Masahiro/0000-0001-9873-2151; Yasuno, Yoshiaki/0000-0003-1645-7948	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported in part by the Japan Science and Technology Agency under a program of development of systems and technology for advanced measurement and analysis (http://www.jst.go.jp/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Born M., 2000, PRINCIPLES OPTICS EL; Bouma BE, 2009, CURR OPIN BIOTECH, V20, P111, DOI 10.1016/j.copbio.2009.02.007; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Downs JC, 2003, J BIOMECH ENG-T ASME, V125, P124, DOI 10.1115/1.1536930; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Drexler W, 2001, J RHEUMATOL, V28, P1311; Duan L, OPT EXPRESS UNPUB; Eilaghi A, 2010, J BIOMECH, V43, P1696, DOI 10.1016/j.jbiomech.2010.02.031; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X; Fung Y.C., 1993, BIOMECHANICS MECH PR; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P9684, DOI 10.1167/iovs.11-7894; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113683; Gotzinger E, 2008, OPT EXPRESS, V16, P16410, DOI 10.1364/OE.16.016410; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; INOUE S, 1953, CHROMOSOMA, V5, P487, DOI 10.1007/BF01271498; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Lim Y, 2011, BIOMED OPT EXPRESS, V2, P2392, DOI 10.1364/BOE.2.002892; Litwiller DV, 2010, J MAGN RESON IMAGING, V32, P44, DOI 10.1002/jmri.22217; LU SY, 1994, J OPT SOC AM A, V11, P766, DOI 10.1364/JOSAA.11.000766; Makita S, 2010, OPT EXPRESS, V18, P854, DOI 10.1364/OE.18.000854; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Oldenbourg R, 1998, BIOPHYS J, V74, P645, DOI 10.1016/S0006-3495(98)77824-5; Oldenbourg R, 1996, NATURE, V381, P811, DOI 10.1038/381811a0; Olsen TW, 2002, INVEST OPHTH VIS SCI, V43, P2529; Ophir Jonathan, 2002, J Med Ultrason (2001), V29, P155, DOI 10.1007/BF02480847; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Schultz DS, 2008, INVEST OPHTH VIS SCI, V49, P4232, DOI 10.1167/iovs.08-1970; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047; van Turnhout MC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3241986; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Yamanari M, 2010, OPT EXPRESS, V18, P13964, DOI 10.1364/OE.18.013964; Yan DM, 2011, INVEST OPHTH VIS SCI, V52, P821, DOI 10.1167/iovs.09-4651; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122; ZEIMER RC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1232, DOI 10.1001/archopht.1989.01070020298042	48	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44026	10.1371/journal.pone.0044026	http://dx.doi.org/10.1371/journal.pone.0044026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970158	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400029
J	Zager, MG; Barton, HA				Zager, Michael G.; Barton, Hugh A.			A Multiscale, Mechanism-Driven, Dynamic Model for the Effects of 5 alpha-Reductase Inhibition on Prostate Maintenance	PLOS ONE			English	Article							ANDROGEN RECEPTOR REGULATION; CANCER PREVENTION TRIAL; ADULT MALE RATS; STEROID 5-ALPHA-REDUCTASE; IN-VIVO; MATHEMATICAL-MODEL; MOLECULAR-BIOLOGY; VENTRAL PROSTATE; HORMONAL-CONTROL; MENSTRUAL-CYCLE	A systems-level mathematical model is presented that describes the effects of inhibiting the enzyme 5 alpha-reductase (5aR) on the ventral prostate of the adult male rat under chronic administration of the 5aR inhibitor, finasteride. 5aR is essential for androgen regulation in males, both in normal conditions and disease states. The hormone kinetics and downstream effects on reproductive organs associated with perturbing androgen regulation are complex and not necessarily intuitive. Inhibition of 5aR decreases the metabolism of testosterone (T) to the potent androgen 5 alpha-dihydrotestosterone (DHT). This results in decreased cell proliferation, fluid production and 5aR expression as well as increased apoptosis in the ventral prostate. These regulatory changes collectively result in decreased prostate size and function, which can be beneficial to men suffering from benign prostatic hyperplasia (BPH) and could play a role in prostate cancer. There are two distinct isoforms of 5aR in male humans and rats, and thus developing a 5aR inhibitor is a challenging pursuit. Several inhibitors are on the market for treatment of BPH, including finasteride and dutasteride. In this effort, comparisons of simulated vs. experimental T and DHT levels and prostate size are depicted, demonstrating the model accurately described an approximate 77% decrease in prostate size and nearly complete depletion of prostatic DHT following 21 days of daily finasteride dosing in rats. This implies T alone is not capable of maintaining a normal prostate size. Further model analysis suggests the possibility of alternative dosing strategies resulting in similar or greater effects on prostate size, due to complex kinetics between T, DHT and gene occupancy. With appropriate scaling and parameterization for humans, this model provides a multiscale modeling platform for drug discovery teams to test and generate hypotheses about drugging strategies for indications like BPH and prostate cancer, such as compound binding properties, dosing regimens, and target validation.	[Zager, Michael G.] Pfizer Inc, Worldwide Res & Dev, Dynam & Metab, Pharmacokinet, San Diego, CA USA; [Barton, Hugh A.] Pfizer Inc, Worldwide Res & Dev, Dynam & Metab, Pharmacokinet, Groton, CT 06340 USA	Pfizer; Pfizer	Zager, MG (corresponding author), Pfizer Inc, Worldwide Res & Dev, Dynam & Metab, Pharmacokinet, San Diego, CA USA.	michael.zager@pfizer.com		Barton, Hugh/0000-0002-9948-4724	Environmental Protection Agency/University of North Carolina Toxicology Research Program [T 829472]; Curriculum in Toxicology, University of North Carolina at Chapel Hill	Environmental Protection Agency/University of North Carolina Toxicology Research Program; Curriculum in Toxicology, University of North Carolina at Chapel Hill	MGZ was funded by the Environmental Protection Agency/University of North Carolina Toxicology Research Program, Training Agreement T 829472, with the Curriculum in Toxicology, University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Azzolina B, 1997, J STEROID BIOCHEM, V61, P55, DOI 10.1016/S0960-0760(97)00002-2; Barton HA, 1998, TOXICOL SCI, V45, P174, DOI 10.1093/toxsci/45.2.174; BERMAN DM, 1993, P NATL ACAD SCI USA, V90, P9359, DOI 10.1073/pnas.90.20.9359; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Clark LH, 2003, B MATH BIOL, V65, P157, DOI 10.1006/bulum.2002.0326; Cohen YC, 2007, J NATL CANCER I, V99, P1366, DOI 10.1093/jnci/djm130; Eikenberry SE, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-24; Fell D., 1997, UNDERSTANDING CONTRO; Frye S V, 1998, Pharm Biotechnol, V11, P393; FRYE SV, 1995, J MED CHEM, V38, P2621, DOI 10.1021/jm00014a015; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Gisleskog PO, 1999, BRIT J CLIN PHARMACO, V47, P53, DOI 10.1046/j.1365-2125.1999.00843.x; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; Gubbay J, 1998, ENDOCRINOLOGY, V139, P2935, DOI 10.1210/en.139.6.2935; Habib FK, 1998, J ENDOCRINOL, V156, P509, DOI 10.1677/joe.0.1560509; Heinrich R., 1996, REGULATION CELLULAR; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; ISAACS JT, 1984, PROSTATE, V5, P545, DOI 10.1002/pros.2990050510; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Nnane IP, 1998, CANCER RES, V58, P3826; NORMINGTON K, 1992, J BIOL CHEM, V267, P19548; ORLOWSKI J, 1988, J ENDOCRINOL, V116, P81, DOI 10.1677/joe.0.1160081; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Potter LK, 2006, AM J PHYSIOL-ENDOC M, V291, pE952, DOI 10.1152/ajpendo.00545.2005; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; PRINS GS, 1989, J STEROID BIOCHEM, V33, P319, DOI 10.1016/0022-4731(89)90319-1; RITTMASTER RS, 1995, ENDOCRINOLOGY, V136, P741, DOI 10.1210/en.136.2.741; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SEGAL IH, 1975, ENZYME KINETICS BEHA; Selgrade JF, 2009, J THEOR BIOL, V260, P572, DOI 10.1016/j.jtbi.2009.06.017; Stuart JD, 2001, BIOCHEM PHARMACOL, V62, P933; SUDDUTH SL, 1993, PHARMACOTHERAPY, V13, P309; Suzuki K, 1997, TOHOKU J EXP MED, V183, P159, DOI 10.1620/tjem.183.159; Suzuki R, 2010, DRUG METAB PHARMACOK, V25, P208, DOI 10.2133/dmpk.25.208; TENNISWOOD M, 1982, J STEROID BIOCHEM, V16, P617, DOI 10.1016/0022-4731(82)90096-6; Thomas LN, 2008, J UROLOGY, V179, P147, DOI 10.1016/j.juro.2007.08.155; Thompson IM, 2008, UROLOGY, V71, P854, DOI 10.1016/j.urology.2008.01.025; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tindall DJ, 2008, J UROLOGY, V179, P1235, DOI 10.1016/j.juro.2007.11.033; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Turner TT, 2002, UROLOGY, V60, P186, DOI 10.1016/S0090-4295(02)01673-4; VERMEULEN A, 1991, EUR UROL, V20, P82; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184	54	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44359	10.1371/journal.pone.0044359	http://dx.doi.org/10.1371/journal.pone.0044359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970204	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400061
J	Jeng, SR; Yueh, WS; Pen, YT; Gueguen, MM; Pasquier, J; Dufour, S; Chang, CF; Kah, O				Jeng, Shan-Ru; Yueh, Wen-Shiun; Pen, Yi-Ting; Gueguen, Marie-Madeleine; Pasquier, Jeremy; Dufour, Sylvie; Chang, Ching-Fong; Kah, Olivier			Expression of Aromatase in Radial Glial Cells in the Brain of the Japanese Eel Provides Insight into the Evolution of the cyp191a Gene in Actinopterygians	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CYTOCHROME-P450 AROMATASE; ANGUILLA-JAPONICA; ZEBRAFISH BRAIN; ADULT ZEBRAFISH; PARS-DISTALIS; FOLLICULOSTELLATE CELLS; DIFFERENTIAL EXPRESSION; SUBVENTRICULAR ZONE; GENOME DUPLICATION	The cyp19a1 gene that encodes aromatase, the only enzyme permitting conversion of C19 aromatizable androgens into estrogens, is present as a single copy in the genome of most vertebrate species, except in teleosts in which it has been duplicated. This study aimed at investigating the brain expression of a cyp19a1 gene expressed in both gonad and brain of Japanese eel, a basal teleost. By means of immunohistochemistry and in situ hybridization, we show that cyp19a1 is expressed only in radial glial cells of the brain and in pituitary cells. Treatments with salmon pituitary homogenates (female) or human chorionic gonadotrophin (male), known to turn on steroid production in immature eels, strongly stimulated cyp19a1 messenger and protein expression in radial glial cells and pituitary cells. Using double staining studies, we also showed that aromatase-expressing radial glial cells exhibit proliferative activity in both the brain and the pituitary. Altogether, these data indicate that brain and pituitary expression of Japanese eel cyp19a1 exhibits characteristics similar to those reported for the brain specific cyp19a1b gene in teleosts having duplicated cyp19a1 genes. This supports the hypothesis that, despite the fact that eels also underwent the teleost specific genome duplication, they have a single cyp19a1 expressed in both brain and gonad. Such data also suggest that the intriguing features of brain aromatase expression in teleost fishes were not gained after the whole genome duplication and may reflect properties of the cyp19a1 gene of ancestral Actinopterygians.	[Jeng, Shan-Ru; Yueh, Wen-Shiun; Pen, Yi-Ting] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Jeng, Shan-Ru; Gueguen, Marie-Madeleine; Kah, Olivier] Univ Rennes 1, Team NEED, Inst Rech Sante Environm & Travail, INSERM U1085,IFR140, Rennes, France; [Pasquier, Jeremy; Dufour, Sylvie; Chang, Ching-Fong] Museum Natl Hist Nat, Res Unit BOREA, CNRS IRD UPMC 207 7208, F-75231 Paris, France; [Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Dept Aquaculture, Keelung, Taiwan	National Kaohsiung University of Science & Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); National Taiwan Ocean University	Jeng, SR (corresponding author), Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan.	B0044@mail.ntou.edu.tw; Olivier.kah@univ-rennes1.fr	kah, olivier/K-7624-2012; GUEGUEN, marie madeleine/K-1731-2015		Universite of Rennes 1; CNRS (Centre National de la Recherche Scientifique); bilateral France Agence Nationale Recherche/Taiwan National Science Council project [PUBERTEEL: NSC98-2923-B-019-001-MY3]	Universite of Rennes 1; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); bilateral France Agence Nationale Recherche/Taiwan National Science Council project	This study was supported by the Universite of Rennes 1, the CNRS (Centre National de la Recherche Scientifique) and the bilateral France Agence Nationale Recherche/Taiwan National Science Council project PUBERTEEL: NSC98-2923-B-019-001-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 2010, EUR J HISTOCHEM, V54, P1, DOI 10.4081/ejh.2010.e1; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Anthony TE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-30; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO;2-2; Barha CK, 2010, BBA-GEN SUBJECTS, V1800, P1056, DOI 10.1016/j.bbagen.2010.01.006; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Brock O, 2010, NEUROSCIENCE, V166, P368, DOI 10.1016/j.neuroscience.2009.12.050; BUREK MJ, 1995, DEV BRAIN RES, V85, P220, DOI 10.1016/0165-3806(94)00215-L; CALLARD GV, 1988, GEN COMP ENDOCR, V71, P70, DOI 10.1016/0016-6480(88)90296-1; Cresko WA, 2003, DEV DYNAM, V228, P480, DOI 10.1002/dvdy.10424; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Diotel N, 2012, HORMONE BEH IN PRESS; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Diotel N, 2011, EUR J NEUROSCI, V34, P45, DOI 10.1111/j.1460-9568.2011.07731.x; Diotel N, 2010, J COMP NEUROL, V518, P4855, DOI 10.1002/cne.22492; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; DUFOUR S, 1989, FISH PHYSIOL BIOCHEM, V7, P157, DOI 10.1007/BF00004702; Dufour S, 2003, EEL BIOLOGY, P373; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Force A, 1999, GENETICS, V151, P1531; Forlano PM, 2006, FRONT NEUROENDOCRIN, V27, P247, DOI 10.1016/j.yfrne.2006.05.002; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Gonzalez A, 2002, J EXP ZOOL, V293, P500, DOI 10.1002/jez.90005; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guo BC, 2010, J EXP ZOOL PART B, V314B, P135, DOI 10.1002/jez.b.21318; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harada N, 2005, J STEROID BIOCHEM, V95, P49, DOI 10.1016/j.jsbmb.2005.04.003; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Ijiri S, 2003, GEN COMP ENDOCR, V130, P193, DOI 10.1016/S0016-6480(02)00589-0; Jeng SR, 2007, GEN COMP ENDOCR, V154, P161, DOI 10.1016/j.ygcen.2007.05.026; Jeng SR, 2012, GEN COMP ENDOCR, V175, P163, DOI 10.1016/j.ygcen.2011.11.005; Jeng SR, 2005, J EXP ZOOL PART A, V303A, P802, DOI 10.1002/jez.a.194; Kallivretaki E, 2007, DEV DYNAM, V236, P3155, DOI 10.1002/dvdy.21344; Kazeto Y, 2005, J MOL ENDOCRINOL, V35, P571, DOI 10.1677/jme.1.01805; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Lange IG, 2002, J STEROID BIOCHEM, V83, P219, DOI 10.1016/S0960-0760(02)00225-X; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Lephart ED, 1996, BRAIN RES REV, V22, P1; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Marsh KE, 2006, BRAIN RES, V1126, P91, DOI 10.1016/j.brainres.2006.09.017; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2003, J COMP NEUROL, V462, P180, DOI 10.1002/cne.10726; Mouriec K, 2008, BRAIN RES BULL, V75, P274, DOI 10.1016/j.brainresbull.2007.10.030; Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; Mukuda T., 2003, MEM FAC INTEGR ARTS, V29, P1; Ohno S., 1970, EVOLUTION GENE DUPLI; Okubo K, 2011, J NEUROENDOCRINOL, V23, P412, DOI 10.1111/j.1365-2826.2011.02120.x; OLIVEREAU M, 1986, CELL TISSUE RES, V246, P425, DOI 10.1007/BF00215905; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Piferrer F, 2005, FISH PHYSIOL BIOCHEM, V31, P215, DOI 10.1007/s10695-006-0027-0; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; RAKIC P, 1978, POSTGRAD MED J, V54, P25; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; ROTHENAIGNER I, 2011, DEVELOPMENT; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saldanha CJ, 2010, GEN COMP ENDOCR, V166, P606, DOI 10.1016/j.ygcen.2010.01.007; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Simpson ER, 2004, SEMIN REPROD MED, V22, P11; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Steinke D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-16; Strobl-Mazzulla PH, 2010, BRAIN BEHAV EVOLUT, V76, P20, DOI 10.1159/000316022; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; Tchoudakova A, 1998, ENDOCRINOLOGY, V139, P2179, DOI 10.1210/en.139.4.2179; TIMMERS RJM, 1987, J COMP NEUROL, V258, P368, DOI 10.1002/cne.902580305; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tzchori I, 2004, GEN COMP ENDOCR, V138, P271, DOI 10.1016/j.ygcen.2004.06.007; Veyrac A, 2011, FASEB J, V25, P1048, DOI 10.1096/fj.10-172635; Vosges M, 2010, AQUAT TOXICOL, V99, P479, DOI 10.1016/j.aquatox.2010.06.009; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0; Yamashita M, 2005, PATHOL INT, V55, P244, DOI 10.1111/j.1440-1827.2005.01820.x; Zupanc GKH, 1999, J EXP BIOL, V202, P1435	89	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44750	10.1371/journal.pone.0044750	http://dx.doi.org/10.1371/journal.pone.0044750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957105	Green Published, gold			2022-12-27	WOS:000308463800098
J	Grosjean, M; Rinkenauer, G; Jainta, S				Grosjean, Marc; Rinkenauer, Gerhard; Jainta, Stephanie			Where Do the Eyes Really Go in the Hollow-Face Illusion?	PLOS ONE			English	Article							DISPARITY VERGENCE; GAZE-SHIFTS; PERCEPTION; RESPONSES; ORIENTATION; KNOWLEDGE; SACCADES; DYNAMICS; DEPTH	The hollow-face illusion refers to the finding that people typically perceive a concave (hollow) mask as being convex, despite the presence of binocular disparity cues that indicate the contrary. Unlike other illusions of depth, recent research has suggested that the eyes tend to converge at perceived, rather than actual, depths. However, technical and methodological limitations prevented one from knowing whether disparity cues may still have influenced vergence. In the current study, we presented participants with virtual normal or hollow masks and asked them to fixate the tip of the face's nose until they had indicated whether they perceived it as pointing towards or away from them. The results showed that the direction of vergence was indeed determined by perceived depth, although vergence responses were both somewhat delayed and of smaller amplitude (by a factor of about 0.5) for concave than convex masks. These findings demonstrate how perceived depth can override disparity cues when it comes to vergence, albeit not entirely.	[Grosjean, Marc; Rinkenauer, Gerhard; Jainta, Stephanie] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Grosjean, M (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	grosjean@ifado.de						Alvarez TL, 2002, CAH PSYCHOL COGN, V21, P243; Collewijn H, 1990, Rev Oculomot Res, V4, P213; COLLEWIJN H, 1995, VISION RES, V35, P3335, DOI 10.1016/0042-6989(95)00082-P; Coubard OA, 2008, GRAEF ARCH CLIN EXP, V246, P521, DOI 10.1007/s00417-007-0714-2; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; ENRIGHT JT, 1987, VISION RES, V27, P1513, DOI 10.1016/0042-6989(87)90160-X; Fogt N, 1998, VISION RES, V38, P411, DOI 10.1016/S0042-6989(97)00142-9; Garofeanu C, 2004, EXP BRAIN RES, V159, P55, DOI 10.1007/s00221-004-1932-z; GEORGESON MA, 1979, PERCEPTION, V8, P585, DOI 10.1068/p080585; Gonzalez EG, 2010, VISION RES, V50, P136, DOI 10.1016/j.visres.2009.11.005; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gregory R.L., 1973, ILLUSION NATURE RAT, P49; Grosjean M, 2009, PSYCHOL RES-PSYCH FO, V73, P3, DOI 10.1007/s00426-008-0146-6; Hartung B, 2005, J VISION, V5, P504, DOI 10.1167/5.6.2; HILL H, 1993, PERCEPTION, V22, P887, DOI 10.1068/p220887; Hill H, 2007, PERCEPTION, V36, P199, DOI 10.1068/p5523; Hoffmann J, 2007, PERCEPTION, V36, P461, DOI 10.1068/p5549; Hoormann J, 2008, J EYE MOVEMENT RES, V1, P1; HOWARD IP, 2002, SEEING DEPTH BASIC M, V1; Jainta S, 2010, VISION RES, V50, P1775, DOI 10.1016/j.visres.2010.05.033; Kim EH, 2012, VISION RES, V63, P9, DOI 10.1016/j.visres.2012.04.013; Kloke WB, 2009, J EYE MOVEMENT RES, V3; Kroliczak G, 2006, BRAIN RES, V1080, P9, DOI 10.1016/j.brainres.2005.01.107; Mon-Williams M, 1999, EXP BRAIN RES, V128, P578, DOI 10.1007/s002210050885; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Semmlow JL, 2002, INVEST OPHTH VIS SCI, V43, P2189; Semmlow J, 2007, P ANN INT IEEE EMBS, P4854, DOI 10.1109/IEMBS.2007.4353427; Semmlow JL, 2009, J EYE MOVEMENT RES, V2; Sheliga BM, 2003, J VISION, V3, P654, DOI 10.1167/3.11.2; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Thornton ARD, 2008, J NEUROSCI METH, V168, P248, DOI 10.1016/j.jneumeth.2007.09.031; Wagner M, 2009, NEUROSCI LETT, V449, P142, DOI 10.1016/j.neulet.2008.10.093; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wismeijer DA, 2008, EXP BRAIN RES, V184, P61, DOI 10.1007/s00221-007-1081-2; Wismeijer DA, 2010, J VISION, V10, DOI 10.1167/10.6.25; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495; Zee DS., 1999, NEUROLOGY EYE MOVEME	37	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44706	10.1371/journal.pone.0044706	http://dx.doi.org/10.1371/journal.pone.0044706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962623	gold, Green Published			2022-12-27	WOS:000308577600080
J	Kujala, K; Paavola, J; Lahti, A; Larsson, K; Pekkanen-Mattila, M; Viitasalo, M; Lahtinen, AM; Toivonen, L; Kontula, K; Swan, H; Laine, M; Silvennoinen, O; Aalto-Setala, K				Kujala, Kirsi; Paavola, Jere; Lahti, Anna; Larsson, Kim; Pekkanen-Mattila, Mari; Viitasalo, Matti; Lahtinen, Annukka M.; Toivonen, Lauri; Kontula, Kimmo; Swan, Heikki; Laine, Mika; Silvennoinen, Olli; Aalto-Setala, Katriina			Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations	PLOS ONE			English	Article							TORSADES-DE-POINTES; T-WAVE PEAK; RYANODINE RECEPTORS; CA2+ RELEASE; STEM-CELLS; SUPPRESSION; DYSFUNCTION; MECHANISM	Background: Induced pluripotent stem cells (iPSC) provide means to study the pathophysiology of genetic disorders. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited ion channel disorder predominantly caused by mutations in the cardiac ryanodine receptor (RyR2). In this study the cellular characteristics of CPVT are investigated and whether the electrophysiological features of this mutation can be mimicked using iPSC -derived cardiomyocytes (CM). Methodology/Principal Findings: Spontaneously beating CMs were differentiated from iPSCs derived from a CPVT patient carrying a P2328S mutation in RyR2 and from two healthy controls. Calcium (Ca2+) cycling and electrophysiological properties were studied by Ca2+ imaging and patch-clamp techniques. Monophasic action potential (MAP) recordings and 24h-ECGs of CPVT-P2328S patients were analyzed for the presence of afterdepolarizations. We found defects in Ca2+ cycling and electrophysiology in CPVT CMs, reflecting the cardiac phenotype observed in the patients. Catecholaminergic stress led to abnormal Ca2+ signaling and induced arrhythmias in CPVT CMs. CPVT CMs also displayed reduced sarcoplasmic reticulum (SR) Ca2+ content, indicating leakage of Ca2+ from the SR. Patch-clamp recordings of CPVT CMs revealed both delayed afterdepolarizations (DADs) during spontaneous beating and in response to adrenaline and also early afterdepolarizations (EADs) during spontaneous beating, recapitulating the changes seen in MAP and 24h-ECG recordings of patients carrying the same mutation. Conclusions/Significance: This cell model shows aberrant Ca2+ cycling characteristic of CPVT and in addition to DADs it displays EADs. This cell model for CPVT provides a platform to study basic pathology, to screen drugs, and to optimize drug therapy.	[Kujala, Kirsi; Paavola, Jere; Lahti, Anna; Larsson, Kim; Pekkanen-Mattila, Mari; Silvennoinen, Olli; Aalto-Setala, Katriina] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Kujala, Kirsi; Paavola, Jere; Lahti, Anna; Larsson, Kim; Pekkanen-Mattila, Mari; Silvennoinen, Olli; Aalto-Setala, Katriina] BioMediTech, Tampere, Finland; [Paavola, Jere; Laine, Mika] Minerva Fdn, Helsinki, Finland; [Viitasalo, Matti; Toivonen, Lauri; Laine, Mika] Helsinki Univ Hosp, Dept Cardiol, Helsinki, Finland; [Lahtinen, Annukka M.] Univ Helsinki, Res Programs Unit Mol Med, Helsinki, Finland; [Kontula, Kimmo; Swan, Heikki] Univ Helsinki, Dept Med, Helsinki, Finland; [Silvennoinen, Olli] Tampere Univ Hosp, Tampere, Finland; [Aalto-Setala, Katriina] Ctr Heart, Tampere, Finland	Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Tampere University; Tampere University Hospital	Kujala, K (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	katriina.aalto-setala@uta.fi	Paavola, Jere/GRF-6451-2022; Tuiskula, Annukka/ABF-6377-2020	Tuiskula, Annukka/0000-0002-6538-635X; Pekkanen-Mattila, Mari/0000-0002-8621-4303	Academy of Finland; Finnish Foundation for Cardiovascular Research; Pirkanmaa Hospital District; Ida Montin Foundation; Finnish Medical Foundation/The Finnish Medical Society Duodecim; Aarne Koskelo Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation; Oskar Oflund Foundation; TEKES	Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Pirkanmaa Hospital District; Ida Montin Foundation; Finnish Medical Foundation/The Finnish Medical Society Duodecim; Aarne Koskelo Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Oskar Oflund Foundation; TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by Academy of Finland (http://www.aka.fi/en-GB/A/), TEKES (http://www.tekes.fi/en/), Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi), Pirkanmaa Hospital District (www.pshp.fi), Ida Montin Foundation (http://www.idamontininsaatio.fi), Finnish Medical Foundation/The Finnish Medical Society Duodecim (www.duodecim.fi/), Aarne Koskelo Foundation (www.aarnekoskelonsaatio.fi/), Orion-Farmos Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/), Finnish Cultural Foundation (www.skr.fi/), and Oskar Oflund Foundation (www.oskaroflund.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2006, INT HEART J, V47, P381, DOI 10.1536/ihj.47.381; Antzelevitch C, 2011, HEART RHYTHM, V8, P1281, DOI 10.1016/j.hrthm.2011.03.045; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Choi BR, 2002, J PHYSIOL-LONDON, V543, P615, DOI 10.1113/jphysiol.2002.024570; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Gbadebo TD, 2002, CIRCULATION, V105, P770, DOI 10.1161/hc0602.103724; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JANUARY CT, 1992, ANN NY ACAD SCI, V644, P23, DOI 10.1111/j.1749-6632.1992.tb30999.x; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Morita N, 2011, J AM COLL CARDIOL, V57, P366, DOI 10.1016/j.jacc.2010.07.045; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Paavola J, 2007, EUR HEART J, V28, P1135, DOI 10.1093/eurheartj/ehl543; Parikh A, 2012, HEART RHYTHM, V9, P953, DOI 10.1016/j.hrthm.2012.01.010; PATTERSON E, 1990, J CARDIOVASC PHARM, V15, P323, DOI 10.1097/00005344-199002000-00021; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Spencer CI, 2003, AM J PHYSIOL-HEART C, V285, pH2552, DOI 10.1152/ajpheart.00274.2003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Viitasalo M, 2006, J AM COLL CARDIOL, V47, P112, DOI 10.1016/j.jacc.2005.07.068; Viitasalo M, 2008, HEART RHYTHM, V5, P1382, DOI 10.1016/j.hrthm.2008.06.011; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Volders PGA, 1997, CARDIOVASC RES, V34, P348, DOI 10.1016/S0008-6363(96)00270-2; Vos MA, 2000, MONOPHASIC ACTION POTENTIALS: BRIDGING CELL AND BEDSIDE, P571; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Xu J, 1996, HEART VESSELS, V11, P289, DOI 10.1007/BF01747188	28	93	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44660	10.1371/journal.pone.0044660	http://dx.doi.org/10.1371/journal.pone.0044660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962621	gold, Green Published, Green Submitted			2022-12-27	WOS:000308577600075
J	Maftei, M; Thurm, F; Leirer, VM; von Arnim, CAF; Elbert, T; Przybylski, M; Kolassa, IT; Manea, M				Maftei, Madalina; Thurm, Franka; Leirer, Vera Maria; von Arnim, Christine A. F.; Elbert, Thomas; Przybylski, Michael; Kolassa, Iris-Tatjana; Manea, Marilena			Antigen-Bound and Free beta-Amyloid Autoantibodies in Serum of Healthy Adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; A-BETA; ANTIBODIES; PEPTIDE; IMMUNOGLOBULIN; RECOGNITION; COMPLEXES; DIAGNOSIS; DECLINE	Physiological beta-amyloid autoantibodies (A beta-autoantibodies) are currently investigated as potential diagnostic and therapeutic tools for Alzheimer's disease (AD). In previous studies, their determination in serum and cerebrospinal fluid (CSF) using indirect ELISA has provided controversial results, which may be due to the presence of preformed A beta antigen-antibody immune complexes. Based on the epitope specificity of the A beta-autoantibodies, recently elucidated in our laboratory, we developed (a) a sandwich ELISA for the determination of circulating A beta-IgG immune complexes and (b) an indirect ELISA for the determination of free A beta-autoantibodies. This methodology was applied to the analysis of serum samples from healthy individuals within the age range of 18 to 89 years. Neuropsychological examination of the participants in this study indicated non-pathological, age-related cognitive decline, revealed especially by tests of visual memory and executive function, as well as speed-related tasks. The ELISA serum determinations showed significantly higher levels of A beta-IgG immune complexes compared to free Ab-autoantibodies, while no correlation with age or cognitive performance of the participants was found.	[Maftei, Madalina; Przybylski, Michael; Manea, Marilena] Univ Konstanz, Dept Chem, Lab Analyt Chem & Biopolymer Struct Anal, Constance, Germany; [Maftei, Madalina] Univ Konstanz, Steinbeis Res Ctr Biopolymer Anal, Constance, Germany; [Thurm, Franka; Leirer, Vera Maria; Elbert, Thomas; Kolassa, Iris-Tatjana] Univ Konstanz, Dept Psychol, Constance, Germany; [Thurm, Franka; Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, Ulm, Germany; [von Arnim, Christine A. F.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	University of Konstanz; University of Konstanz; University of Konstanz; Ulm University; Ulm University	Maftei, M (corresponding author), Univ Konstanz, Dept Chem, Lab Analyt Chem & Biopolymer Struct Anal, Constance, Germany.	iris.kolassa@uni-ulm.de; marilena.manea@uni-konstanz.de	Elbert, Thomas/C-8556-2009; Kolassa, Iris Tatjana/Y-3032-2018	Elbert, Thomas/0000-0003-1332-4939; Glockner, Franka/0000-0001-9684-7705	interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany; Zukunftskolleg; Research Center Proteostasis, University of Konstanz	interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany; Zukunftskolleg; Research Center Proteostasis, University of Konstanz	This research was funded as an interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany, awarded to IK, M. Manea and CvA, by the Zukunftskolleg (IK and M. Manea) and Research Center Proteostasis (MP), University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackenheil M., 1999, MINI MINIINTERNATION; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Backman L, 2004, AGING NEUROPSYCHOL C, V11, P212, DOI 10.1080/13825580490511099; Baril L, 2004, NEUROSCI LETT, V355, P226, DOI 10.1016/j.neulet.2003.10.071; Beneduce L, 2007, CANCER DETECT PREV, V31, P402, DOI 10.1016/j.cdp.2007.10.005; Brettschneider S, 2005, BIOL PSYCHIAT, V57, P813, DOI 10.1016/j.biopsych.2004.12.008; Burkle Alexander, 2007, Immun Ageing, V4, P4, DOI 10.1186/1742-4933-4-4; Castaldi F, 2005, INT J BIOL MARKER, V20, P204, DOI 10.1177/172460080502000402; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; Corral M, 2006, DEV NEUROPSYCHOL, V29, P479, DOI 10.1207/s15326942dn2903_6; Dodel R, 2008, European Patent Office, Patent No. [WO/2008/084402, 2008084402]; Dodel R, 2008, Patent International Application, Patent No. [PCT/IB2008/000456, 200800456]; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Gustaw KA, 2008, J NEUROCHEM, V106, P1350, DOI 10.1111/j.1471-4159.2008.05477.x; Gustaw-Rothenberg KA, 2010, EXP GERONTOL, V45, P47, DOI 10.1016/j.exger.2009.10.003; HOLM S, 1979, SCAND J STAT, V6, P65; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Klaver AC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-93; Leirer VM, 2011, BRAIN IMAGING BEHAV, V5, P222, DOI 10.1007/s11682-011-9126-3; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; Manea M, 2008, J MED CHEM, V51, P1150, DOI 10.1021/jm070196e; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Muhamuda K, 2006, J CLIN VIROL, V37, P162, DOI 10.1016/j.jcv.2006.06.010; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pinheiro J., 2011, NLME LINEAR NONLINEA; Przybylski M, 2007, 7 AUSTR PEPT S CAIRN, P32; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Richartz E, 2005, J PSYCHIATR RES, V39, P535, DOI 10.1016/j.jpsychires.2004.12.005; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Song MS, 2007, J INT MED RES, V35, P301, DOI 10.1177/147323000703500303; Steck PH, 2005, ARCH CLIN NEUROPSYCH, V20, P409, DOI 10.1016/j.acn.2004.09.009; Stefanescu R, 2007, EUR J MASS SPECTROM, V13, P69, DOI 10.1255/ejms.849; Tewes U., 1994, HAMBURG WECHSLER INT; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44516	10.1371/journal.pone.0044516	http://dx.doi.org/10.1371/journal.pone.0044516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22973459	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600066
J	Santos, MJ; Carmona-Fernandes, D; Canhao, H; da Silva, JC; Fonseca, JE; Gil, V				Santos, Maria Jose; Carmona-Fernandes, Diana; Canhao, Helena; da Silva, Jose Canas; Fonseca, Joao Eurico; Gil, Victor			Early Vascular Alterations in SLE and RA Patients-A Step towards Understanding the Associated Cardiovascular Risk	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS PATIENTS; CORONARY-HEART-DISEASE; ADHESION MOLECULES ICAM-1; FLOW-MEDIATED DILATION; ENDOTHELIAL FUNCTION; E-SELECTIN; CAROTID ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; ARTERIAL STIFFNESS	Accelerated atherosclerosis represents a major problem in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients, and endothelial damage is a key feature of atherogenesis. We aimed to assess early endothelial changes in SLE and RA female patients (127 SLE and 107 RA) without previous CV events. Biomarkers of endothelial cell activation (intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), thrombomodulin (TM), and tissue factor (TF)) were measured and endothelial function was assessed using peripheral artery tonometry. Reactive hyperemia index (RHI), an indicator of microvascular reactivity, and augmentation index (AIx), a measure of arterial stiffness, were obtained. In addition, traditional CV risk factors, disease activity and medication were determined. Women with SLE displayed higher sICAM-1 and TM and lower TF levels than women with RA (p = 0.001, p < 0.001 and p < 0.001, respectively). These differences remained significant after controlling for CV risk factors and medication. Serum levels of vascular biomarkers were increased in active disease and a moderate correlation was observed between sVCAM-1 levels and lupus disease activity (rho = 0.246) and between TF levels and RA disease activity (rho = 0.301). Although RHI was similar across the groups, AIx was higher in lupus as compared to RA (p = 0.04). Also in active SLE, a trend towards poorer vasodilation was observed (p = 0.06). In conclusion, women with SLE and RA present with distinct patterns of endothelial cell activation biomarkers not explained by differences in traditional CV risk factors. Early vascular alterations are more pronounced in SLE which is in line with the higher CV risk of these patients.	[Santos, Maria Jose; Carmona-Fernandes, Diana; Canhao, Helena; Fonseca, Joao Eurico] Fac Med Lisbon, Rheumatol Res Unit, Inst Med Mol, Lisbon, Portugal; [Santos, Maria Jose; da Silva, Jose Canas] Hosp Garcia de Orta, Dept Rheumatol, Almada, Portugal; [Canhao, Helena; Fonseca, Joao Eurico] Hosp Santa Maria, Rheumatol & Metab Bone Dis Dept, Lisbon, Portugal; [Gil, Victor] Hosp Fernando Fonseca, Dept Cardiol, Amadora, Portugal	Universidade de Lisboa; Hospital Garcia de Orta; Universidade de Lisboa; Hospital Santa Maria; Hospital Professor Doutor Fernando Fonseca, EPE	Santos, MJ (corresponding author), Fac Med Lisbon, Rheumatol Res Unit, Inst Med Mol, Lisbon, Portugal.	mjps@netvisao.pt	Canhao, Helena/C-9611-2018; Santos, Maria Jose/N-6913-2014; Carmona-Fernandes, Diana/D-5916-2011	Canhao, Helena/0000-0003-1894-4870; Santos, Maria Jose/0000-0002-7946-1365; Canhao, Helena/0000-0002-3239-2809; Gil, Victor/0000-0003-4014-5450; Fonseca, Joao/0000-0003-1432-3671; Carmona-Fernandes, Diana/0000-0002-1015-3946	Fundacao para a Ciencia e a Tecnologia, Portugal [PIC/IC/82920/2007]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by a grant from Fundacao para a Ciencia e a Tecnologia, Portugal (PIC/IC/82920/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer J, 2009, LUPUS, V18, P235, DOI 10.1177/0961203308096663; Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; DRAKE TA, 1993, AM J PATHOL, V142, P1458; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Foster W, 2010, J RHEUMATOL, V37, P711, DOI 10.3899/jrheum.090699; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P373; Gonzalez-Gay MA, 2012, ACTA REUMATOL PORT, V37, P155; Gonzalez-Juanatey C, 2004, ARTHRIT RHEUM-ARTHR, V51, P447, DOI 10.1002/art.20407; Gonzalez-Juanatey C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3382; Gustafsson J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2878; Gustafsson JT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3759; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hansel S, 2003, ATHEROSCLEROSIS, V170, P177, DOI 10.1016/S0021-9150(03)00281-8; Hwang SJ, 1997, CIRCULATION, V96, P4219; KIRCHHOFER D, 1994, J CLIN INVEST, V93, P2073, DOI 10.1172/JCI117202; Kozera L, 2011, RHEUMATOLOGY, V50, P1944, DOI 10.1093/rheumatology/ker232; Lane HA, 2006, VASC HEALTH RISK MAN, V2, P19, DOI 10.2147/vhrm.2006.2.1.19; LANGUINO LR, 1995, P NATL ACAD SCI USA, V92, P1505, DOI 10.1073/pnas.92.5.1505; Lopez-Mejias R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3755; Luc G, 2003, ATHEROSCLEROSIS, V170, P169, DOI 10.1016/S0021-9150(03)00280-6; Mak A, 2011, J RHEUMATOL, V38, P1296, DOI 10.3899/jrheum.101182; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Provan SA, 2011, J RHEUMATOL, V38, P606, DOI 10.3899/jrheum.100689; Rho YH, 2008, J RHEUMATOL, V35, P1789; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Sandoo A, 2011, RHEUMATOLOGY, V50, P2125, DOI 10.1093/rheumatology/ker275; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Shang Q, 2008, LUPUS, V17, P1096, DOI 10.1177/0961203308092160; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Thompson T, 2008, ARTHRITIS RHEUM-US, V58, P835, DOI 10.1002/art.23196; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; WOOD KM, 1993, HISTOPATHOLOGY, V22, P437, DOI 10.1111/j.1365-2559.1993.tb00157.x; Yao GH, 2008, LUPUS, V17, P720, DOI 10.1177/0961203308089441; Yee CS, 2011, RHEUMATOLOGY, V50, P982, DOI 10.1093/rheumatology/keq376; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zoller B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033442	51	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44668	10.1371/journal.pone.0044668	http://dx.doi.org/10.1371/journal.pone.0044668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962622	Green Submitted, gold, Green Published			2022-12-27	WOS:000308577600077
J	Tian, XL; Xu, F; Lung, WY; Meyerson, C; Ghaffari, AA; Cheng, GH; Deng, JC				Tian, Xiaoli; Xu, Feng; Lung, Wing Yi; Meyerson, Cherise; Ghaffari, Amir Ali; Cheng, Genhong; Deng, Jane C.			Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTION; TOLL-LIKE RECEPTOR-3; CHRONIC HEPATITIS-C; DOUBLE-STRANDED-RNA; NF-KAPPA-B; INFLUENZA INFECTION; MICROBIAL ETIOLOGY; RIG-I; PANDEMIC INFLUENZA	Secondary bacterial pneumonias are a frequent complication of influenza and other respiratory viral infections, but the mechanisms underlying viral-induced susceptibility to bacterial infections are poorly understood. In particular, it is unclear whether the host's response against the viral infection, independent of the injury caused by the virus, results in impairment of antibacterial host defense. Here, we sought to determine whether the induction of an "antiviral" immune state using various viral recognition receptor ligands was sufficient to result in decreased ability to combat common bacterial pathogens of the lung. Using a mouse model, animals were administered polyinosine-polycytidylic acid (poly I:C) or Toll-like 7 ligand (imiquimod or gardiquimod) intranasally, followed by intratracheal challenge with Streptococcus pneumoniae. We found that animals pre-exposed to poly I:C displayed impaired bacterial clearance and increased mortality. Poly I:C-exposed animals also had decreased ability to clear methicillin-resistant Staphylococcus aureus. Furthermore, we showed that activation of Toll-like receptor (TLR)3 and Retinoic acid inducible gene (RIG-I)/Cardif pathways, which recognize viral nucleic acids in the form of dsRNA, both contribute to poly I:C mediated impairment of bacterial clearance. Finally, we determined that poly I:C administration resulted in significant induction of type I interferons (IFNs), whereas the elimination of type I IFN signaling improved clearance and survival following secondary bacterial pneumonia. Collectively, these results indicate that in the lung, poly I:C administration is sufficient to impair pulmonary host defense against clinically important gram-positive bacterial pathogens, which appears to be mediated by type I IFNs.	[Tian, Xiaoli; Lung, Wing Yi; Deng, Jane C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Xu, Feng] Zhejiang Univ, Sch Med, Dept Resp Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Meyerson, Cherise; Ghaffari, Amir Ali; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Zhejiang University; University of California System; University of California Los Angeles	Tian, XL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA.	JDeng@mednet.ucla.edu			United States National Institutes of Health [5K08HL081229]; Pfizer ASPIRE award; National Natural Science Foundation of China [30871130]; NIH [AI069120, AI056154]; Outstanding Young Investigator of Zhejiang Province [R12H010004]; Qianjiang Talent Project of Science and Technology Department of Zhejiang Province [2010R10080]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI069120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer ASPIRE award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Outstanding Young Investigator of Zhejiang Province; Qianjiang Talent Project of Science and Technology Department of Zhejiang Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health grant 5K08HL081229 and Pfizer ASPIRE award to J.C.D.; National Natural Science Foundation of China (30871130), NIH AI069120 and AI056154 to G.C., and Outstanding Young Investigator of Zhejiang Province (R12H010004), Qianjiang Talent Project of Science and Technology Department of Zhejiang Province (2010R10080) to F.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Marcos MA, 2006, ANTIVIR THER, V11, P351; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hammerbeck DM, 2007, ANTIVIR RES, V73, P1, DOI 10.1016/j.antiviral.2006.07.011; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Korppi M, 2002, APMIS, V110, P515, DOI 10.1034/j.1600-0463.2002.11007801.x; KORPPI M, 1993, ACTA PAEDIATR, V82, P360, DOI 10.1111/j.1651-2227.1993.tb12697.x; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Li Y, 2011, J GENE MED, V13, P60, DOI 10.1002/jgm.1536; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Oliveira EC, 2001, CHEST, V119, P1717, DOI 10.1378/chest.119.6.1717; Pyles RB, 2010, INFECT IMMUN, V78, P1700, DOI 10.1128/IAI.00736-09; Roomer R, 2010, HEPATOLOGY, V52, P1225, DOI 10.1002/hep.23842; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Socan M, 1999, EUR J CLIN MICROBIOL, V18, P777, DOI 10.1007/s100960050400; Soza A, 2002, HEPATOLOGY, V36, P1273, DOI 10.1053/jhep.2002.36502; Stockman LJ, 2010, PEDIATR INFECT DIS J, V29, P1048, DOI 10.1097/INF.0b013e3181eb7315; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Viasus D, 2011, MEDICINE, V90, P328, DOI 10.1097/MD.0b013e31822e67a7; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e41879	10.1371/journal.pone.0041879	http://dx.doi.org/10.1371/journal.pone.0041879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962579	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600006
J	Winder, VL				Winder, Virginia L.			Characterization of Mercury and Its Risk in Nelson's, Saltmarsh, and Seaside Sparrows	PLOS ONE			English	Article							SHARP-TAILED SPARROWS; COMMON LOONS; ENVIRONMENTAL MERCURY; REPRODUCTIVE SUCCESS; MODEL SELECTION; MARKED ANIMALS; EXPOSURE; SURVIVAL; ACCUMULATION; CAUDACUTUS	Background: Nelson's, Saltmarsh, and Seaside Sparrows (Ammodramus nelsoni, A. caudacutus, and A. maritimus, respectively) depend on marsh and wetland habitats - ecosystems in which mercury (Hg) bioavailability is notoriously high. The purpose of the present study was to address the potential impact of Hg on these species using first primary and breast feathers as non-destructive biomonitoring tools. Methods and Principal Findings: Feathers were sampled from wintering sparrows in North Carolina salt marshes (2006-2010). Feather Hg data were used in three risk analysis components (1) Threshold Component - examined feather Hg with regard to published negative effects thresholds; (2) Hg Dynamics Component - examined Hg in sparrows captured multiple times; and (3) Capture Frequency and Survival Component - tested for links between Hg and return frequency and survival. Threshold Component analyses indicated that Hg concentrations in 42-77% of sampled individuals (breast feather n = 879; first primary feather n = 663) were within the range associated with decreased reproduction in other avian species. Hg Dynamics Component analyses demonstrated that Hg increased between first and second captures for Nelson's (n = 9) and Seaside Sparrows (n = 23). Capture Frequency and Survival Component analyses detected a negative relationship between Hg and capture frequency in Nelson's Sparrows (n = 315). However, MARK models detected no effect of Hg on apparent survival in any species. Conclusion and Significance: This study indicates that current Hg exposure places a considerable proportion of each population at risk. In particular, 52% of all sampled Saltmarsh Sparrows exhibited first primary feather Hg concentrations exceeding those associated with a.60% reduction in reproductive success in other species. This study reports evidence for net annual bioaccumulation, indicating an increased risk in older individuals. These data can be used to inform future population assessments and management for these species.	Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Winder, VL (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	vlwinder@k-state.edu			National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship; Ralph Brauer Fellowship; Sigma Xi Grants in Aid of Research; Eastern Bird Banding Association; North Carolina Sea Grant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship; Ralph Brauer Fellowship; Sigma Xi Grants in Aid of Research; Eastern Bird Banding Association; North Carolina Sea Grant; James and Francis Parnell Fellowship; Department of Biology and Marine Biology at the University of North Carolina Wilmington	Funding and support for this project were provided by the National Oceanic and Atmospheric Administration (NOAA) through a National Estuary Research Reserve System Graduate Research Fellowship, Ralph Brauer Fellowship, Sigma Xi Grants in Aid of Research, Eastern Bird Banding Association, North Carolina Sea Grant, the James and Francis Parnell Fellowship, and the Department of Biology and Marine Biology at the University of North Carolina Wilmington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bayard TS, 2011, AUK, V128, P393, DOI 10.1525/auk.2011.10178; Bearhop S, 2000, ENVIRON TOXICOL CHEM, V19, P1638, DOI [10.1002/etc.5620190622, 10.1897/1551-5028(2000)019&lt;1638:DOMIBA&gt;2.3.CO;2]; Brasso RL, 2008, ECOTOXICOLOGY, V17, P133, DOI 10.1007/s10646-007-0163-z; Braune BM, 2005, SCI TOTAL ENVIRON, V351, P4, DOI 10.1016/j.scitotenv.2004.10.034; Burgess NM, 2008, ECOTOXICOLOGY, V17, P83, DOI 10.1007/s10646-007-0167-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cristol DA, 2008, SCIENCE, V320, P335, DOI 10.1126/science.1154082; Cristol DA, 2011, ECOTOXICOLOGY, V20, P1773, DOI 10.1007/s10646-011-0710-5; Dettmers R., 2000, PARTNERS FLIGHT LAND; DiQuinzio DA, 2001, AUK, V118, P888, DOI 10.1642/0004-8038(2001)118[0888:SFPASO]2.0.CO;2; Edmonds ST, 2010, CONDOR, V112, P789, DOI 10.1525/cond.2010.100145; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Evers DC, 2005, ECOTOXICOLOGY, V14, P193, DOI 10.1007/s10646-004-6269-7; Greenlaw JS, 2007, WILSON J ORNITHOL, V119, P361, DOI 10.1676/05-152.1; Greenlaw JS, 1994, BIRDS N AM ONLINE; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Howell S. N, 1997, IDENTIFICATION GUIDE; IUCN, 2019, INT UNION CONSERVATI; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Lane OP, 2011, ECOTOXICOLOGY, V20, P1984, DOI 10.1007/s10646-011-0740-z; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; Meyer MW, 2011, ECOTOXICOLOGY, V20, P1659, DOI 10.1007/s10646-011-0759-1; Michaelis A, 2009, WINTER ECOLOGY SHARP; Mitro MG, 2008, J WILDLIFE MANAGE, V72, P665, DOI 10.2193/2006-551; Pittman HT, 2011, ECOTOXICOLOGY, V20, P1626, DOI 10.1007/s10646-011-0736-8; Post W. W., 2009, BIRDS N AM ONLINE; RICH TD, 2004, PARTNERS FLIGHT N AM; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Seewagen CL, 2010, BIRD CONSERV INT, V20, P112, DOI 10.1017/S095927090999030X; Shriver GW, 2011, BIRDS N AM ONLINE; Shriver W. Gregory, 2006, Environmental Bioindicators, V1, P129, DOI 10.1080/15555270600695734; THOMPSON DR, 1991, J APPL ECOL, V28, P672, DOI 10.2307/2404575; UNEP Chemicals Branch, 2008, GLOB ATM MERC ASS SO; *US FISH WILDL SER, 2002, BIRDS CONS 2002; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS TP, 1994, MAR POLLUT BULL, V28, P277, DOI 10.1016/0025-326X(94)90152-X; Winder V, WINTER SURV IN PRESS; Winder VL, 2011, ECOTOXICOLOGY, V20, P218, DOI 10.1007/s10646-010-0573-1; Winder VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032257; Winder VL, 2012, ECOTOXICOLOGY, V21, P325, DOI 10.1007/s10646-011-0794-y	44	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44446	10.1371/journal.pone.0044446	http://dx.doi.org/10.1371/journal.pone.0044446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962614	gold, Green Published, Green Submitted			2022-12-27	WOS:000308577600055
J	Azzag, N; Haddad, N; Durand, B; Petit, E; Ammouche, A; Chomel, B; Boulouis, HJ				Azzag, Naouelle; Haddad, Nadia; Durand, Benoit; Petit, Elisabeth; Ammouche, Ali; Chomel, Bruno; Boulouis, Henri-Jean			Population Structure of Bartonella henselae in Algerian Urban Stray Cats	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; DOMESTIC CATS; MOLECULAR EPIDEMIOLOGY; SCRATCH DISEASE; PREVALENCE; INFECTION; IDENTIFICATION; VARIANTS; TRANSMISSION; CLARRIDGEIAE	Whole blood samples from 211 stray cats from Algiers, Algeria, were cultured to detect the presence of Bartonella species and to evaluate the genetic diversity of B. henselae strains by multiple locus VNTR analysis (MLVA). Bartonella henselae was the only species isolated from 36 (17%) of 211 cats. B. henselae genotype I was the predominant genotype (64%). MLVA typing of 259 strains from 30 bacteremic cats revealed 52 different profiles as compared to only 3 profiles using MLST. Of these 52 profiles, 48 (92.3%) were identified for the first time. One-third of the cats harbored one MLVA profile only. As there was a correlation between the age of cats and the number of MLVA profiles, we hypothesized that the single profile in these cats was the profile of the initial infecting strain. Two-third of the cats harbored 2 to 6 MLVA profiles simultaneously. The similarity of MLVA profiles obtained from the same cat, neighbor-joining clustering and structure-neighbor clustering indicate that such a diversity likely results from two different mechanisms occurring either independently or simultaneously: independent infections and genetic drift from a primary strain.	[Azzag, Naouelle] Ecole Natl Super Vet Alger, El Harrach, Alger, Algeria; [Haddad, Nadia; Petit, Elisabeth; Boulouis, Henri-Jean] Univ Paris Est, Ecole Natl Vet Alfort, UMR BIPAR ENVA Anses UPEC USC INRA, Maisons Alfort, France; [Durand, Benoit] Anses, Lab St Anim, Unite Epidemiol, Maisons Alfort, France; [Ammouche, Ali] Ecole Natl Super Agron, Dept Technol Alimentaire, El Harrach, Alger, Algeria; [Chomel, Bruno] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Ecole Nationale Superieure Veterinaire; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Polytechnique - Algeria; University of California System; University of California Davis	Azzag, N (corresponding author), Ecole Natl Super Vet Alger, El Harrach, Alger, Algeria.	hjboulouis@vet-alfort.fr	Durand, Benoit/GSE-2511-2022; ENSA - NHSA, Algiers/AAF-1768-2019	Durand, Benoit/0000-0003-0669-1394	Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Algerie; Ministere de l'agriculture, de l'alimentation, de la peche, de la ruralite et de l'amenagement du territories, DGER, France	Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Algerie; Ministere de l'agriculture, de l'alimentation, de la peche, de la ruralite et de l'amenagement du territories, DGER, France	Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Algerie and Ministere de l'agriculture, de l'alimentation, de la peche, de la ruralite et de l'amenagement du territories, DGER, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Angelakis E, 2010, EMERG INFECT DIS, V16, P385, DOI [10.3201/eid1603.091685, 10.3201/eid1603.081685]; Arvand M, 2006, MICROBES INFECT, V8, P1315, DOI 10.1016/j.micinf.2005.12.015; Arvand M, 2001, J CLIN MICROBIOL, V39, P743, DOI 10.1128/JCM.39.2.743-746.2001; Arvand M, 2008, EMERG INFECT DIS, V14, P152, DOI 10.3201/eid1401.070768; Berghoff J, 2007, MICROBIOL-SGM, V153, P2045, DOI 10.1099/mic.0.2007/006379-0; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; Bouchouicha R, 2009, CLIN MICROBIOL INFEC, V15, P104, DOI 10.1111/j.1469-0691.2008.02183.x; Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Buchmann AU, 2010, J CLIN MICROBIOL, V48, P3295, DOI 10.1128/JCM.00750-10; Celebi B, 2009, ZOONOSES PUBLIC HLTH, V56, P169, DOI 10.1111/j.1863-2378.2008.01170.x; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Chung CY, 2004, EMERG INFECT DIS, V10, P1311; Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Fabbi M, 2004, J CLIN MICROBIOL, V42, P264, DOI 10.1128/JCM.42.1.264-268.2004; Frutos R, 2006, J BACTERIOL, V188, P2533, DOI 10.1128/JB.188.7.2533-2542.2006; Gurfield AN, 1997, J CLIN MICROBIOL, V35, P2120, DOI 10.1128/JCM.35.8.2120-2123.1997; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Hall BG, 2010, J CLIN MICROBIOL, V48, P1997, DOI 10.1128/JCM.00149-10; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Inoue K, 2009, EPIDEMIOL INFECT, V137, P1568, DOI 10.1017/S095026880900257X; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; Jensen WA, 2000, J CLIN MICROBIOL, V38, P1717, DOI 10.1128/JCM.38.5.1717-1722.2000; Kabeya H, 2002, VET MICROBIOL, V89, P211, DOI 10.1016/S0378-1135(02)00175-X; KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531; Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06; Maillard R, 2004, VET MICROBIOL, V98, P63, DOI 10.1016/j.vetmic.2003.09.022; Maruyama S, 2000, J VET MED SCI, V62, P273, DOI 10.1292/jvms.62.273; Monteil M, 2007, MICROBIOL-SGM, V153, P1141, DOI 10.1099/mic.0.2006/001164-0; Pritchard JK, 2000, GENETICS, V155, P945; Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997; Team R. D. C, 2011, R LANG ENV STAT COMP; Tsai YL, 2011, VECTOR-BORNE ZOONOT, V11, P1023, DOI 10.1089/vbz.2010.0085; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005; Viezens J, 2008, MICROBIOL-SGM, V154, P2881, DOI 10.1099/mic.0.2008/018630-0; Xu CB, 2009, J MICROBIOL METH, V76, P6, DOI 10.1016/j.mimet.2008.09.001; Yuan CL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001301; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101	44	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43621	10.1371/journal.pone.0043621	http://dx.doi.org/10.1371/journal.pone.0043621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956995	Green Submitted, gold, Green Published			2022-12-27	WOS:000308206500017
J	Everett, DB; Cornick, J; Denis, B; Chewapreecha, C; Croucher, N; Harris, S; Parkhill, J; Gordon, S; Carrol, ED; French, N; Heyderman, RS; Bentley, SD				Everett, Dean B.; Cornick, Jennifer; Denis, Brigitte; Chewapreecha, Claire; Croucher, Nicholas; Harris, Simon; Parkhill, Julian; Gordon, Stephen; Carrol, Enitan D.; French, Neil; Heyderman, Robert S.; Bentley, Stephen D.			Genetic Characterisation of Malawian Pneumococci Prior to the Roll-Out of the PCV13 Vaccine Using a High-Throughput Whole Genome Sequencing Approach	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; BACTERIAL-MENINGITIS; DISEASE; CHILDREN; CLONES; IDENTIFICATION; EVOLUTION; DYNAMICS	Background: Malawi commenced the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the routine infant immunisation schedule in November 2011. Here we have tested the utility of high throughput whole genome sequencing to provide a high-resolution view of pre-vaccine pneumococcal epidemiology and population evolutionary trends to predict potential future change in population structure post introduction. Methods: One hundred and twenty seven (127) archived pneumococcal isolates from randomly selected adults and children presenting to the Queen Elizabeth Central Hospital, Blantyre, Malawi underwent whole genome sequencing. Results: The pneumococcal population was dominated by serotype 1 (20.5% of invasive isolates) prior to vaccine introduction. PCV13 is likely to protect against 62.9% of all circulating invasive pneumococci (78.3% in under-5-year-olds). Several Pneumococcal Molecular Epidemiology Network (PMEN) clones are now in circulation in Malawi which were previously undetected but the pandemic multidrug resistant PMEN1 lineage was not identified. Genome analysis identified a number of novel sequence types and serotype switching. Conclusions: High throughput genome sequencing is now feasible and has the capacity to simultaneously elucidate serotype, sequence type and as well as detailed genetic information. It enables population level characterization, providing a detailed picture of population structure and genome evolution relevant to disease control. Post-vaccine introduction surveillance supported by genome sequencing is essential to providing a comprehensive picture of the impact of PCV13 on pneumococcal population structure and informing future public health interventions.	[Everett, Dean B.; Cornick, Jennifer; Denis, Brigitte; Heyderman, Robert S.] Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [Everett, Dean B.; Cornick, Jennifer; French, Neil; Bentley, Stephen D.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Chewapreecha, Claire; Croucher, Nicholas; Harris, Simon; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge, England; [Gordon, Stephen; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Carrol, Enitan D.] Univ Liverpool, Inst Child Hlth, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Wellcome Trust Sanger Institute; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Everett, DB (corresponding author), Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.	Dean.Everett@liverpool.ac.uk	Parkhill, Julian/G-4703-2011; Chewapreecha, Claire/D-6446-2016; Harris, Simon R/K-1318-2013	Parkhill, Julian/0000-0002-7069-5958; Chewapreecha, Claire/0000-0002-1313-4011; Harris, Simon R/0000-0003-1512-6194; Croucher, Nicholas/0000-0001-6303-8768; Heyderman, Robert/0000-0003-4573-449X; Carrol, Enitan/0000-0001-8357-7726; Gordon, Stephen/0000-0001-6576-1116; Everett, Dean/0000-0002-8458-6779; French, Neil/0000-0003-4814-8293; Cornick, Jen/0000-0001-6841-9842	MLW Clinical Research Programme Core Grant from the Wellcome Trust [084679/Z/08/Z]; Wellcome Trust	MLW Clinical Research Programme Core Grant from the Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the MLW Clinical Research Programme Core Grant (award no: 084679/Z/08/Z) from the Wellcome Trust and funding to the Sanger Institute from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World, 2008, IMPR GLOB HLTH PREV, P1; APPELBAUM PC, 1992, CLIN INFECT DIS, V15, P77, DOI 10.1093/clinids/15.1.77; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2003, EMERG INFECT DIS, V9, P747; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; HEINEMAN HS, 1973, NEW ENGL J MED, V288, P1027; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Klugman Keith P., 2008, P317; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lalitha MK, 1996, B WORLD HEALTH ORGAN, V74, P387; LUND E, 1960, Bull World Health Organ, V23, P5; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; McIntosh EDG, 2011, EXPERT REV VACCINES, V10, P109, DOI 10.1586/ERV.10.145; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2008, MMWR-MORBID MORTAL W, V57, P144; Paton JC, 2008, PROTEIN VACCINES; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	37	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44250	10.1371/journal.pone.0044250	http://dx.doi.org/10.1371/journal.pone.0044250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970189	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000308748400014
J	Nyfeler, B; Hoepfner, D; Palestrant, D; Kirby, CA; Whitehead, L; Yu, R; Deng, G; Caughlan, RE; Woods, AL; Jones, AK; Barnes, SW; Walker, JR; Gaulis, S; Hauy, E; Brachmann, SM; Krastel, P; Studer, C; Riedl, R; Estoppey, D; Aust, T; Movva, NR; Wang, Z; Salcius, M; Michaud, GA; McAllister, G; Murphy, LO; Tallarico, JA; Wilson, CJ; Dean, CR				Nyfeler, Beat; Hoepfner, Dominic; Palestrant, Deborah; Kirby, Christina A.; Whitehead, Lewis; Yu, Robert; Deng, Gejing; Caughlan, Ruth E.; Woods, Angela L.; Jones, Adriana K.; Barnes, S. Whitney; Walker, John R.; Gaulis, Swann; Hauy, Ervan; Brachmann, Saskia M.; Krastel, Philipp; Studer, Christian; Riedl, Ralph; Estoppey, David; Aust, Thomas; Movva, N. Rao; Wang, Zuncai; Salcius, Michael; Michaud, Gregory A.; McAllister, Gregory; Murphy, Leon O.; Tallarico, John A.; Wilson, Christopher J.; Dean, Charles R.			Identification of Elongation Factor G as the Conserved Cellular Target of Argyrin B	PLOS ONE			English	Article							IMMUNOSUPPRESSIVE CYCLIC-PEPTIDES; BACTERIAL PROTEIN-SYNTHESIS; FUSIDIC ACID; EF-G; RIBOSOME; PROTEASOME; MYXOBACTERIA; ELUCIDATION; RESISTANCE; INHIBITORS	Argyrins, produced by myxobacteria and actinomycetes, are cyclic octapeptides with antibacterial and antitumor activity. Here, we identify elongation factor G (EF-G) as the cellular target of argyrin B in bacteria, via resistant mutant selection and whole genome sequencing, biophysical binding studies and crystallography. Argyrin B binds a novel allosteric pocket in EF-G, distinct from the known EF-G inhibitor antibiotic fusidic acid, revealing a new mode of protein synthesis inhibition. In eukaryotic cells, argyrin B was found to target mitochondrial elongation factor G1 (EF-G1), the closest homologue of bacterial EF-G. By blocking mitochondrial translation, argyrin B depletes electron transport components and inhibits the growth of yeast and tumor cells. Further supporting direct inhibition of EF-G1, expression of an argyrin B-binding deficient EF-G1 L693Q variant partially rescued argyrin B-sensitivity in tumor cells. In summary, we show that argyrin B is an antibacterial and cytotoxic agent that inhibits the evolutionarily conserved target EF-G, blocking protein synthesis in bacteria and mitochondrial translation in yeast and mammalian cells.	[Palestrant, Deborah; Kirby, Christina A.] Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA; [Gaulis, Swann; Hauy, Ervan; Brachmann, Saskia M.] Novartis Inst BioMed Res, Dis Area Oncol, Basel, Switzerland; [Yu, Robert; Deng, Gejing; Caughlan, Ruth E.; Woods, Angela L.; Jones, Adriana K.; Dean, Charles R.] Novartis Inst BioMed Res, Emeryville, CA USA; [Barnes, S. Whitney; Walker, John R.] Novartis Inst Biomed Res, Novartis Inst Funct Gen, San Diego, CA USA; [Krastel, Philipp] Novartis Inst BioMed Res, Ctr Prote Chem, Nat Prod Unit, Basel, Switzerland	Novartis; Novartis; Novartis; Novartis; Novartis	Nyfeler, B (corresponding author), Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA.	charlesr.dean@novartis.com		Wilson, Christopher/0000-0002-9146-522X; Whitehead, Lewis/0000-0002-6125-0893	NIBR; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	NIBR; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Funding of this research was provided solely within the Novartis organization as per standard research activities. The funders (NIBR) had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was assessed by the Novartis legal department as well as senior mangement in chemistry and biolgy (Infectious diseases and Global) to ascertain that release of this manuscript did not contravene Novartis policy regarding release of proprietary information, but this was limited only to approval for release of the material and was not related to the results or interpretations/conclusions contained in the manuscript.; We thank Frank Petersen, Jennifer Leeds and Vic E. Myer for their generous support of this project; Travis Stams, Rajiv Chopra and Jason Baird for their assistance with the structural biology effort; JoAnnDzink-Fox and Stacey Tiamfook for assistance with MICs; Silvio Roggo, Carl Balibar, David Six, David Parker, Andreas Katopodis, Sovanda Som and Greg Bebernitz for comments and helpful discussion; Keith Poole and Ian Chopra for bacterial strains. Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; ANGUS BL, 1987, J GEN MICROBIOL, V133, P2905; ANGUS BL, 1982, ANTIMICROB AGENTS CH, V21, P299, DOI 10.1128/AAC.21.2.299; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Brachmann CB, 1998, YEAST, V14, P115; Bulow L, 2010, CHEMMEDCHEM, V5, P832, DOI 10.1002/cmdc.201000080; Caughlan RE, 2012, ANTIMICROB AGENTS CH, V56, P17, DOI 10.1128/AAC.05417-11; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrari P, 1996, J ANTIBIOT, V49, P150, DOI 10.7164/antibiotics.49.150; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Ley SV, 2002, ORG LETT, V4, P711, DOI 10.1021/ol017184m; Li W, 2011, PROTEINS, V79, P1478, DOI 10.1002/prot.22976; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; McConkey DJ, 2008, CANCER CELL, V14, P1, DOI 10.1016/j.ccr.2008.06.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Sasse F, 2002, J ANTIBIOT, V55, P543, DOI 10.7164/antibiotics.55.543; Selva E, 1996, J ANTIBIOT, V49, P145, DOI 10.7164/antibiotics.49.145; Seo HS, 2006, BIOCHEMISTRY-US, V45, P2504, DOI 10.1021/bi0516677; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Stauch B, 2010, ANGEW CHEM INT EDIT, V49, P3934, DOI 10.1002/anie.201000140; TANAKA N, 1968, BIOCHEM BIOPH RES CO, V30, P278, DOI 10.1016/0006-291X(68)90447-6; Vollbrecht L, 2002, J ANTIBIOT, V55, P715, DOI 10.7164/antibiotics.55.715; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773	34	33	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e42657	10.1371/journal.pone.0042657	http://dx.doi.org/10.1371/journal.pone.0042657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970117	Green Submitted, Green Published, gold			2022-12-27	WOS:000308748400003
J	Fujimori, K; Yano, M; Ueno, T				Fujimori, Ko; Yano, Mutsumi; Ueno, Toshiyuki			Synergistic Suppression of Early Phase of Adipogenesis by Microsomal PGE Synthase-1 (PTGES1)-Produced PGE(2) and Aldo-Keto Reductase 1B3-Produced PGF(2 alpha)	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE; POSITIVE FEEDBACK LOOP; ADIPOCYTE DIFFERENTIATION; CYCLOOXYGENASE-2 EXPRESSION; ADIPOSE-TISSUE; RECEPTOR; IDENTIFICATION; FAT; PROSTACYCLIN; OBESITY	We recently reported that aldo-keto reductase 1B3-produced prostaglandin (PG) F-2 alpha suppressed the early phase of adipogenesis. PGE(2) is also known to suppress adipogenesis. In this study, we found that microsomal PGE(2) synthase (PGES)-1 (mPGES-1; PTGES1) acted as the PGES in adipocytes and that PGE(2) and PGF(2 alpha) synergistically suppressed the early phase of adipogenesis. PGE(2) production was detected in preadipocytes and transiently enhanced at 3 h after the initiation of adipogenesis of mouse adipocytic 3T3-L1 cells, followed by a quick decrease; and its production profile was similar to the expression of the cyclooxygenase-2 (PTGS2) gene. When 3T3-L1 cells were transfected with siRNAs for any one of the three major PTGESs, i.e., PTGES1, PTGES2 (mPGES-2), and PTGES3 (cytosolic PGES), only PTGES1 siRNA suppressed PGE(2) production and enhanced the expression of adipogenic genes. AE1-329, a PTGER4 (EP4) receptor agonist, increased the expression of the Ptgs2 gene with a peak at 1 h after the initiation of adipogenesis. PGE(2)-mediated enhancement of the PTGS2 expression was suppressed by the co-treatment with L-161982, a PTGER4 receptor antagonist. Moreover, AE1-329 enhanced the expression of the Ptgs2 gene by binding of the cyclic AMP response element (CRE)-binding protein to the CRE of the Ptgs2 promoter; and its binding was suppressed by co-treatment with L-161982, which was demonstrated by promoter luciferase and chromatin immunoprecipitation assays. Furthermore, when 3T3-L1 cells were caused to differentiate into adipocytes in medium containing both PGE(2) and PGF(2 alpha), the expression of the adipogenic genes and the intracellular triglyceride level were decreased to a greater extent than in medium containing either of them, revealing that PGE(2) and PGF(2 alpha) independently suppressed adipogenesis. These results indicate that PGE(2) was synthesized by PTGES1 in adipocytes and synergistically suppressed the early phase of adipogenesis of 3T3-L1 cells in cooperation with PGF(2 alpha) through receptor-mediated activation of PTGS2 expression.	[Fujimori, Ko; Yano, Mutsumi; Ueno, Toshiyuki] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka, Japan	Osaka University of Pharmaceutical Sciences	Fujimori, K (corresponding author), Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka, Japan.	fujimori@gly.oups.ac.jp	Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769	Ministry of Education, Culture, Sports, Science and Technology of Japan [21570151, 23116516]; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Naito Foundation; Research Foundation for Pharmaceutical Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Research Foundation for Pharmaceutical Sciences	This work was supported in part by Grant-in-Aid for Scientific Research (21570151) and Scientific Research on Innovative Areas (23116516) from The Ministry of Education, Culture, Sports, Science and Technology of Japan, and by grants from Japan Foundation for Applied Enzymology, Takeda Science Foundation, The Naito Foundation, and The Research Foundation for Pharmaceutical Sciences (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Christodoulides C, 2010, MOL CELL ENDOCRINOL, V318, P61, DOI 10.1016/j.mce.2009.09.014; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujimori K, 2012, GENE, V505, P46, DOI 10.1016/j.gene.2012.05.052; Fujimori K, 2010, PROSTAG OTH LIPID M, V93, P52, DOI 10.1016/j.prostaglandins.2010.06.005; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; Fujitani Y, 2010, FEBS J, V277, P1410, DOI 10.1111/j.1742-4658.2010.07565.x; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Inazumi T, 2011, J LIPID RES, V52, P1500, DOI 10.1194/jlr.M013615; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Sales KJ, 2008, MOL CELL ENDOCRINOL, V285, P51, DOI 10.1016/j.mce.2008.01.016; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Ueno T, 2011, FEBS J, V278, P2901, DOI 10.1111/j.1742-4658.2011.08213.x; VASSAUX G, 1992, J BIOL CHEM, V267, P11092; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; Xie Y, 2006, DIABETES OBES METAB, V8, P83, DOI 10.1111/j.1463-1326.2005.00472.x	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44698	10.1371/journal.pone.0044698	http://dx.doi.org/10.1371/journal.pone.0044698			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970288	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000045
J	Sieni, E; Cetica, V; Piccin, A; Gherlinzoni, F; Sasso, FC; Rabusin, M; Attard, L; Bosi, A; Pende, D; Moretta, L; Arico, M				Sieni, Elena; Cetica, Valentina; Piccin, Andrea; Gherlinzoni, Filippo; Sasso, Ferdinando Carlo; Rabusin, Marco; Attard, Luciano; Bosi, Alberto; Pende, Daniela; Moretta, Lorenzo; Arico, Maurizio			Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small Series	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; MUTATIONS; MUNC13-4; CHILDREN; ONSET; EXPRESSION; STXBP2; PRF1; FORM; FHL	Familial Hemophagocytic lymphohistiocytosis (FHL) is a rare immune deficiency with defective cytotoxic function. The age at onset is usually young and the natural course is rapidly fatal if untreated. A later onset of the disease has been sporadically reported even in adolescents and adults. We report the results of our retrospective data collection of all cases diagnosed with FHL at an age of 18 years or older and enrolled in the Italian Registry of HLH. All cases were diagnosed with FHL based on evidence of genetic defect in one FHL-related gene. A total of 11 patients were diagnosed with FHL. They were 9 males and 2 females, from 10 unrelated families; their age ranged between 18 and 43 years (median, 23 years). Family history was unremarkable in eight families at the time of the diagnosis. Their genetic diagnoses are: FHL2 (n = 6), FHL3 (n = 2), FHL5 (n = 1), XLP1 (n = 2). Clinical, molecular and functional data are described. These data confirm that FHL may present beyond the pediatric age and up to the fifth decade. FHL2 due to perforin defect is the most frequently reported subtype. Adult specialists should consider FHL in the differential diagnosis of patients with cytopenia and liver or central nervous system disorders, especially when a lymphoproliferative disease is suspected but eventually not confirmed. FHL may turn to be fatal within a short time course even in adults. This risk, together with the continuous improvement in the transplant technique, especially in the area of transplant from matched unrelated donor, resulting in reduced treatment related mortality, might suggest a wider use of SCT in this population. Current diagnostic approach allows prompt identification of patients by flow-cytometry screening, then confirmed by the genetic study, and treatment with chemo-immunotherapy followed by stem cell transplantation.	[Sieni, Elena; Cetica, Valentina; Arico, Maurizio] Azienda Osped Univ A Meyer Children Hosp, Dept Pediat Hematol Oncol, Florence, Italy; [Piccin, Andrea] San Maurizio Reg Hosp, Dept Hematol, Bolzano, South Tyrol, Italy; [Piccin, Andrea] San Maurizio Reg Hosp, BMT Unit, Bolzano, South Tyrol, Italy; [Gherlinzoni, Filippo] ULSS 9 Osped S Maria di Ca Foncello, Dept Med Specialist, Div Ematol, Treviso, Italy; [Sasso, Ferdinando Carlo] Univ Naples 2, Dept Internal & Expt Med, Naples, Italy; [Rabusin, Marco] IRCCS Burlo Garofolo, UO Pediat Hematooncol, Trieste, Italy; [Attard, Luciano] Azienda Osped Univ S Orsola Malpighi, Bologna, Italy; [Bosi, Alberto] Azienda Osped Univ Careggi, Dept Hematol, Florence, Italy; [Pende, Daniela] IRCCS AOU San Martino IST, Genoa, Italy; [Moretta, Lorenzo] IRCCS Giannina Gaslini, Genoa, Italy	Krankenhaus Bozen; Krankenhaus Bozen; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Universita della Campania Vanvitelli; IRCCS Burlo Garofolo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini	Sieni, E (corresponding author), Azienda Osped Univ A Meyer Children Hosp, Dept Pediat Hematol Oncol, Florence, Italy.	m.arico@meyer.it	Sasso, Ferdinando Carlo/AAA-8423-2020; Cetica, Valentina/J-2885-2018; Arico, Maurizio/S-3039-2019; Piccin, Andrea/L-1632-2018; Sieni, Elena/J-8729-2018; Moretta, Lorenzo/AAA-7239-2020; Pende, Daniela/J-7429-2016; Sasso, Ferdinando Carlo/AAE-5665-2019	Cetica, Valentina/0000-0001-8549-4158; Arico, Maurizio/0000-0002-1908-6671; Piccin, Andrea/0000-0002-2645-8496; Sieni, Elena/0000-0002-6192-9812; Moretta, Lorenzo/0000-0003-4658-1747; Pende, Daniela/0000-0003-1565-451X; Sasso, Ferdinando Carlo/0000-0002-9142-7848; BOSI, ALBERTO/0000-0002-5486-4838	Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche (ARSE); Italian Ministry of Health, Progetti di ricerca finalizzata; Bando Malattie Rare [RF-TOS-2008-1219488]; A.O.U. Meyer	Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche (ARSE); Italian Ministry of Health, Progetti di ricerca finalizzata; Bando Malattie Rare; A.O.U. Meyer	This study was supported by the following: Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche (ARSE); Italian Ministry of Health, Progetti di ricerca finalizzata 2008, Bando Malattie Rare RF-TOS-2008-1219488; A.O.U. Meyer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2001, HAEMATOLOGICA, V86, P499; Arico M, 1996, LEUKEMIA, V10, P197; Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Arico M, 2001, BLOOD, V97, P1131, DOI 10.1182/blood.V97.4.1131; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Cesaro S, 2008, HAEMATOL-HEMATOL J, V93, P1694, DOI 10.3324/haematol.13142; Cetica V, 2010, J MED GENET, V47, P595, DOI 10.1136/jmg.2009.075341; Cetica V, 2010, HAEMATOL-HEMATOL J, V95, P538, DOI 10.3324/haematol.2009.019562; Clementi R, 2002, BLOOD, V100, P2266, DOI 10.1182/blood-2002-04-1030; Cooper N, 2006, BLOOD, V107, P1233, DOI 10.1182/blood-2005-05-1819; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; Imashuku S, 1999, BLOOD, V93, P1869; Kogawa K, 2002, BLOOD, V99, P61, DOI 10.1182/blood.V99.1.61; Mahlaoui N, 2007, PEDIATRICS, V120, pE622, DOI 10.1542/peds.2006-3164; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Santoro A, 2006, J MED GENET, V43, P953, DOI 10.1136/jmg.2006.041863; Sieni E, 2012, CELL MOL LIFE SCI, V69, P29, DOI 10.1007/s00018-011-0835-y; Sieni E, 2011, J MED GENET, V48, P343, DOI 10.1136/jmg.2010.085456; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Trambas C, 2005, BLOOD, V106, P932, DOI 10.1182/blood-2004-09-3713; Trizzino A, 2008, J MED GENET, V45, P15, DOI 10.1136/jmg.2007.052670; Trottestam H, 2011, BLOOD, V118, P4577, DOI 10.1182/blood-2011-06-356261; Ueda I, 2007, AM J HEMATOL, V82, P427, DOI 10.1002/ajh.20878; Zhang KJ, 2011, BLOOD, V118, P5794, DOI 10.1182/blood-2011-07-370148; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	32	52	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44649	10.1371/journal.pone.0044649	http://dx.doi.org/10.1371/journal.pone.0044649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970278	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000041
J	Ditlev, SB; Nielsen, MA; Resende, M; Agerbaek, MO; Pinto, VV; Andersen, PH; Magistrado, P; Lusingu, J; Dahlback, M; Theander, TG; Salanti, A				Ditlev, Sisse B.; Nielsen, Morten A.; Resende, Mafalda; Agerbaek, Mette O.; Pinto, Vera V.; Andersen, Pernille H.; Magistrado, Pamela; Lusingu, John; Dahlback, Madeleine; Theander, Thor G.; Salanti, Ali			Identification and Characterization of B-Cell Epitopes in the DBL4 epsilon Domain of VAR2CSA	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM; ANTIBODIES; PROTEIN; ADHESION; VACCINE; SURFACE	Malaria during pregnancy in Plasmodium falciparum endemic regions is a major cause of mortality and severe morbidity. VAR2CSA is the parasite ligand responsible for sequestration of Plasmodium falciparum infected erythrocytes to the receptor chondroitin sulfate A (CSA) in the placenta and is the leading candidate for a placental malaria vaccine. Antibodies induced in rats against the recombinant DBL4 epsilon domain of VAR2CSA inhibit the binding of a number of laboratory and field parasite isolates to CSA. In this study, we used a DBL4 epsilon peptide-array to identify epitopes targeted by DBL4 epsilon-specific antibodies that inhibit CSA-binding of infected erythrocytes. We identified three regions of overlapping peptides which were highly antigenic. One peptide region distinguished itself particularly by showing a clear difference in the binding profile of highly parasite blocking IgG compared to the IgG with low capacity to inhibit parasite adhesion to CSA. This region was further characterized and together these results suggest that even though antibodies against the synthetic peptides which cover this region did not recognize native protein, the results using the mutant domain suggest that this linear epitope might be involved in the induction of inhibitory antibodies induced by the recombinant DBL4 epsilon domain.	[Ditlev, Sisse B.; Nielsen, Morten A.; Resende, Mafalda; Agerbaek, Mette O.; Pinto, Vera V.; Andersen, Pernille H.; Magistrado, Pamela; Dahlback, Madeleine; Theander, Thor G.; Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Ditlev, Sisse B.; Nielsen, Morten A.; Resende, Mafalda; Agerbaek, Mette O.; Pinto, Vera V.; Andersen, Pernille H.; Magistrado, Pamela; Dahlback, Madeleine; Theander, Thor G.; Salanti, Ali] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Magistrado, Pamela; Lusingu, John] Tanga Med Res Ctr, Natl Inst Med Res, Tanga, Tanzania	University of Copenhagen; Rigshospitalet; University of Copenhagen; National Institute of Medical Research	Ditlev, SB (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	salanti@sund.ku.dk	Theander, Thor/F-6714-2015; Lusingu, John P. A./GSJ-3228-2022	Theander, Thor/0000-0002-3509-7514; Salanti, Ali/0000-0003-2207-5575; Lusingu, John P. A./0000-0002-9407-0602; Nielsen, Morten Agertoug/0000-0003-2668-4992; Ditlev, Sisse Bolm/0000-0003-4417-9711; Agerbaek, Mette Orskov/0000-0001-5865-2034	Danish Research Council for Development Research (RUF); Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	Danish Research Council for Development Research (RUF); Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU	SBD is supported by a PhD studentship from the Danish Research Council for Development Research (RUF). This study received funding from Danish National Advanced Technology Foundation and Proof of Concept Foundation DTU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Clausen TM, 2012, J BIOL CHEM, P18; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Pinto VV, 2012, VACCINE, V30, P572, DOI 10.1016/j.vaccine.2011.11.068; Pinto VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017942; Ricke CH, 2000, PLASMA ANTIBODIES MA; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012	23	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e43663	10.1371/journal.pone.0043663	http://dx.doi.org/10.1371/journal.pone.0043663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970138	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400017
J	Kidd, TJ; Ritchie, SR; Ramsay, KA; Grimwood, K; Bell, SC; Rainey, PB				Kidd, Timothy J.; Ritchie, Stephen R.; Ramsay, Kay A.; Grimwood, Keith; Bell, Scott C.; Rainey, Paul B.			Pseudomonas aeruginosa Exhibits Frequent Recombination, but Only a Limited Association between Genotype and Ecological Setting	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; SEQUENCE; STRAINS; CLONE; VIRULENCE; ENVIRONMENT; INFECTIONS; EVOLUTION; EBURST	Pseudomonas aeruginosa is an opportunistic pathogen and an important cause of infection, particularly amongst cystic fibrosis (CF) patients. While specific strains capable of patient-to-patient transmission are known, many infections appear to be caused by unique and unrelated strains. There is a need to understand the relationship between strains capable of colonising the CF lung and the broader set of P. aeruginosa isolates found in natural environments. Here we report the results of a multilocus sequence typing (MLST)-based study designed to understand the genetic diversity and population structure of an extensive regional sample of P. aeruginosa isolates from South East Queensland, Australia. The analysis is based on 501 P. aeruginosa isolates obtained from environmental, animal and human (CF and non-CF) sources with particular emphasis on isolates from the Lower Brisbane River and isolates from CF patients obtained from the same geographical region. Overall, MLST identified 274 different sequence types, of which 53 were shared between one or more ecological settings. Our analysis revealed a limited association between genotype and environment and evidence of frequent recombination. We also found that genetic diversity of P. aeruginosa in Queensland, Australia was indistinguishable from that of the global P. aeruginosa population. Several CF strains were encountered frequently in multiple ecological settings; however, the most frequently encountered CF strains were confined to CF patients. Overall, our data confirm a non-clonal epidemic structure and indicate that most CF strains are a random sample of the broader P. aeruginosa population. The increased abundance of some CF strains in different geographical regions is a likely product of chance colonisation events followed by adaptation to the CF lung and horizontal transmission among patients.	[Kidd, Timothy J.; Ramsay, Kay A.; Grimwood, Keith; Bell, Scott C.] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ Albany, New Zealand Inst Adv Study, Auckland, New Zealand; [Ritchie, Stephen R.; Rainey, Paul B.] Massey Univ Albany, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand; [Bell, Scott C.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany	Royal Children's Hospital Brisbane; University of Queensland; Massey University; Massey University; Prince Charles Hospital; Max Planck Society	Kidd, TJ (corresponding author), Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia.	Tim_Kidd@health.qld.gov.au	Rainey, Paul/A-3207-2008; Kidd, Timothy/F-2149-2010; Grimwood, Keith/F-9334-2011; Bell, Scott/AAJ-4298-2020; Bell, Scott C/A-7241-2011	Rainey, Paul/0000-0003-0879-5795; Kidd, Timothy/0000-0002-6135-6364; Bell, Scott/0000-0001-8651-7139; Bell, Scott C/0000-0001-8651-7139; Grimwood, Keith/0000-0003-3174-9834; Ritchie, Stephen/0000-0001-5001-8899	Australian Cystic Fibrosis Research Trust; National Health and Medical Research Council [455919]; Children's Health Foundation Queensland; Queensland Health Office of Health and Medical Research; Gerry Lawlor Memorial Scholarship; Prince Charles Hospital Foundation; Rotary Australia; Wellcome Trust	Australian Cystic Fibrosis Research Trust; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Children's Health Foundation Queensland; Queensland Health Office of Health and Medical Research; Gerry Lawlor Memorial Scholarship; Prince Charles Hospital Foundation; Rotary Australia; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Australian Cystic Fibrosis Research Trust, the National Health and Medical Research Council Project Grant 455919, The Children's Health Foundation Queensland, The Queensland Health Office of Health and Medical Research, the Gerry Lawlor Memorial Scholarship, The Prince Charles Hospital Foundation and Rotary Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the participants, research and clinical staff, and clinical microbiology laboratories at The Prince Charles Hospital, Royal Children's Hospital, Mater Adult Hospital, Mater Children's Hospital, and Gold Coast Hospital for the provision of clinical samples and CF isolates. We also thank staff from the Pathology Queensland Central Laboratory, Queensland Health Public Health Microbiology Laboratory, IDEXX Laboratories Pty. Ltd, The University of Queensland Diagnostic Laboratory, Professor Claire Wainwright and Ms Snehal Anuj for the environmental, animal and non-CF human isolates they contributed to the study. PBR is a James Cook Research Fellow and SCB is a Health Research Fellow (Office of Health and Medical Research, Queensland Health). This publication made use of the Pseudomonas aeruginosa PubMLST website (http://pubmlst.org/paeruginosa/) developed by Keith Jolley and sited at the University of Oxford [35]. The development of this site has been funded by the Wellcome Trust.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2012, PSEUDOMONAS AERUGINO; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Blondel-Hill E, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P734; CARSON LA, 1975, APPL MICROBIOL, V30, P935; CHAO A, 1984, SCAND J STAT, V11, P265; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Cramer N, 2010, INT J MED MICROBIOL, V300, P526, DOI 10.1016/j.ijmm.2010.08.004; Curran B, 2005, J CLIN MICROBIOL, V43, P5830, DOI 10.1128/JCM.43.11.5830-5831.2005; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fothergill JL, 2012, EUR RESP J; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Garcia-Castillo M, 2011, J CLIN MICROBIOL, V49, P2905, DOI 10.1128/JCM.00753-11; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Guttman D.S., 2010, BACTERIAL POPULATION, P121; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jones AM, 2005, AM J RESP CRIT CARE, V171, P257, DOI 10.1164/rccm.200404-513OC; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Khan NH, 2007, MICROB ECOL, V53, P173, DOI 10.1007/s00248-006-9059-3; Kidd TJ, 2011, VET MICROBIOL, V149, P508, DOI 10.1016/j.vetmic.2010.11.030; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Kidd TJ, 2009, J CLIN MICROBIOL, V47, P1503, DOI 10.1128/JCM.00014-09; Kidd TJ, 2010, RESPIROLOGY, V15, pA19; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Lederberg Joshua, 2000, PSEUD ENCY MICR, V3, P876; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Lomholt JA, 2001, INFECT IMMUN, V69, P6284, DOI 10.1128/IAI.69.10.6284-6295.2001; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; McVean G, 2002, GENETICS, V160, P1231; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Naughton S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024526; Nemec A, 2010, RES MICROBIOL, V161, P234, DOI 10.1016/j.resmic.2010.02.002; Palleroni Norberto J., 2008, P1; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Regnath T, 2004, INT J HYG ENVIR HEAL, V207, P585, DOI 10.1078/1438-4639-00331; Remold SK, 2011, MICROB ECOL, V62, P505, DOI 10.1007/s00248-011-9844-5; Romling U, 2005, ENVIRON MICROBIOL, V7, P1029, DOI 10.1111/j.1462-2920.2005.00780.x; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Schelstraete P, 2008, EUR RESPIR J, V31, P822, DOI 10.1183/09031936.00088907; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Standards Australia, 2008, 4276132008 AS NZS; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; Tramper-Stranders GA, 2008, CLIN MICROBIOL INFEC, V14, P935, DOI 10.1111/j.1469-0691.2008.02054.x; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Westman EL, 2010, PSEUDOMONAS, P443; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108	75	88	89	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44199	10.1371/journal.pone.0044199	http://dx.doi.org/10.1371/journal.pone.0044199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970178	gold, Green Published			2022-12-27	WOS:000308458400044
J	Ramli, NSK; Guan, CE; Nathan, S; Vadivelu, J				Ramli, Nur Siti K.; Guan, Chua Eng; Nathan, Sheila; Vadivelu, Jamuna			The Effect of Environmental Conditions on Biofilm Formation of Burkholderia pseudomallei Clinical Isolates	PLOS ONE			English	Article							LACTONE SIGNAL MOLECULES; SMALL-COLONY VARIANTS; IDENTIFICATION; SURVIVAL; ASSAY	Burkholderia pseudomallei, a Gram-negative saprophytic bacterium, is the causative agent of the potentially fatal melioidosis disease in humans. In this study, environmental parameters including temperature, nutrient content, pH and the presence of glucose were shown to play a role in in vitro biofilm formation by 28 B. pseudomallei clinical isolates, including four isolates with large colony variants (LCVs) and small colony variants (SCVs) morphotypes. Enhanced biofilm formation was observed when the isolates were tested in LB medium, at 30 degrees C, at pH 7.2, and in the presence of as little as 2 mM glucose respectively. It was also shown that all SVCs displayed significantly greater capacity to form biofilms than the corresponding LCVs when cultured in LB at 37 degrees C. In addition, octanoyl-homoserine lactone (C-8-HSL), a quorum sensing molecule, was identified by mass spectrometry analysis in bacterial isolates referred to as LCV CTH, LCV VIT, SCV TOM, SCV CTH, 1 and 3, and the presence of other AHL's with higher masses; decanoyl-homoserine lactone (C-10-HSL) and dodecanoyl-homoserine lactone (C-12-HSL) were also found in all tested strain in this study. Last but not least, we had successfully acquired two Bacillus sp. soil isolates, termed KW and SA respectively, which possessed strong AHLs degradation activity. Biofilm formation of B. pseudomallei isolates was significantly decreased after treated with culture supernatants of KW and SA strains, demonstrating that AHLs may play a role in B. pseudomallei biofilm formation.	[Ramli, Nur Siti K.; Guan, Chua Eng; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia	Ramli, NSK (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Nathan, Sheila/C-1182-2011; VADIVELU, JAMUNARANI S/B-8696-2010; Chua, Eng Guan/W-3023-2019	Nathan, Sheila/0000-0002-2132-2346; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Chua, Eng Guan/0000-0002-1508-5284	Ministry of Science, Technology and Innovation, Malaysia (IRPA) [06-02-03-1002]; University of Malaya (PPP) [PS202/2010A]; Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project [E000013-20001]	Ministry of Science, Technology and Innovation, Malaysia (IRPA)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); University of Malaya (PPP)(Universiti Malaya); Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project	This work was supported by the Ministry of Science, Technology and Innovation, Malaysia (IRPA grant 06-02-03-1002), University of Malaya (PPP grant (PS202/2010A)) and Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE project (E000013-20001). The authors would like to acknowledge Prof. Shamala Devi Sekaran (University of Malaya) for providing us C. violaceum CV026 strain in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SW, 2007, J CLIN MICROBIOL, V45, P529, DOI 10.1128/JCM.01444-06; Boddey JA, 2006, INFECT IMMUN, V74, P5374, DOI 10.1128/IAI.00569-06; BRENNER S, 1974, GENETICS, V77, P71; Cano DA, 2003, INFECT IMMUN, V71, P3690, DOI 10.1128/IAI.71.7.3690-3698.2003; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Coil DA, 2009, FEMS MICROBIOL LETT, V293, P271, DOI 10.1111/j.1574-6968.2009.01532.x; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Dance D. A. B., 1990, Reviews in Medical Microbiology, V1, P143; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Di Bonaventura G, 2007, FOLIA MICROBIOL, V52, P86, DOI 10.1007/BF02932144; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gan Chan K, 2007, ASIA PAC J MOL BIOL, V15, P153; Harrison JJ, 2005, AM SCI, V93, P508, DOI 10.1511/2005.6.508; Haubler S, 2003, EUR J CLIN MICROBIOL, V22, P249; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; HIRSCH HM, 1961, J BACTERIOL, V81, P448, DOI 10.1128/JB.81.3.448-458.1961; Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Lee SH, 2007, DIAGN MICR INFEC DIS, V58, P263, DOI 10.1016/j.diagmicrobio.2007.01.002; Lopresti AEE, 2005, INFECT IMMUN, V73, P1260; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Puthucheary S D, 2009, Med J Malaysia, V64, P266; Samuelsen O, 2005, J ANTIMICROB CHEMOTH, V56, P1126, DOI 10.1093/jac/dki385; Savoia D, 2007, CURR MICROBIOL, V54, P440, DOI 10.1007/s00284-006-0601-9; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Suppiah J, 2010, FEMS MICROBIOL LETT, V306, P9, DOI 10.1111/j.1574-6968.2010.01923.x; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Vivas J, 2008, VET MICROBIOL, V129, P150, DOI 10.1016/j.vetmic.2007.11.007	38	48	48	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44104	10.1371/journal.pone.0044104	http://dx.doi.org/10.1371/journal.pone.0044104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970167	Green Published, gold, Green Submitted			2022-12-27	WOS:000308458400036
J	Tromas, A; Parizot, B; Diagne, N; Champion, A; Hocher, V; Cissoko, M; Crabos, A; Prodjinoto, H; Lahouze, B; Bogusz, D; Laplaze, L; Svistoonoff, S				Tromas, Alexandre; Parizot, Boris; Diagne, Nathalie; Champion, Antony; Hocher, Valerie; Cissoko, Maimouna; Crabos, Amandine; Prodjinoto, Hermann; Lahouze, Benoit; Bogusz, Didier; Laplaze, Laurent; Svistoonoff, Sergio			Heart of Endosymbioses: Transcriptomics Reveals a Conserved Genetic Program among Arbuscular Mycorrhizal, Actinorhizal and Legume-Rhizobial Symbioses	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; PHOSPHATE TRANSPORTER; CASUARINA-GLAUCA; CORTICAL-CELLS; CHITINASE GENE; EXPRESSION; INFECTION; COMMON; ROOTS; PROTEIN	To improve their nutrition, most plants associate with soil microorganisms, particularly fungi, to form mycorrhizae. A few lineages, including actinorhizal plants and legumes are also able to interact with nitrogen-fixing bacteria hosted intracellularly inside root nodules. Fossil and molecular data suggest that the molecular mechanisms involved in these root nodule symbioses (RNS) have been partially recycled from more ancient and widespread arbuscular mycorrhizal (AM) symbiosis. We used a comparative transcriptomics approach to identify genes involved in establishing these 3 endosymbioses and their functioning. We analysed global changes in gene expression in AM in the actinorhizal tree C. glauca. A comparison with genes induced in AM in Medicago truncatula and Oryza sativa revealed a common set of genes induced in AM. A comparison with genes induced in nitrogen-fixing nodules of C. glauca and M. truncatula also made it possible to define a common set of genes induced in these three endosymbioses. The existence of this core set of genes is in accordance with the proposed recycling of ancient AM genes for new functions related to nodulation in legumes and actinorhizal plants.	[Tromas, Alexandre; Diagne, Nathalie; Champion, Antony; Cissoko, Maimouna; Crabos, Amandine; Prodjinoto, Hermann; Laplaze, Laurent] UCAD, ISRA, IRD, Ctr Rech Bel Air,Lab Commun Microbiol, Dakar, Senegal; [Tromas, Alexandre; Champion, Antony; Hocher, Valerie; Lahouze, Benoit; Bogusz, Didier; Laplaze, Laurent; Svistoonoff, Sergio] IRD, UMR DIADE, Equipe Rhizogenese, Montpellier, France; [Parizot, Boris] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Parizot, Boris] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium	Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Flanders Institute for Biotechnology (VIB); Ghent University	Tromas, A (corresponding author), UCAD, ISRA, IRD, Ctr Rech Bel Air,Lab Commun Microbiol, Dakar, Senegal.	laurent.laplaze@ird.fr	TROMAS, Alexandre/L-5767-2015; Bogusz, Didier/O-6055-2017; SVISTOONOFF, Sergio/X-9659-2019; Champion, Antony/E-4148-2015; Laplaze, Laurent/I-5435-2016	TROMAS, Alexandre/0000-0002-9084-3874; Bogusz, Didier/0000-0002-9094-5870; SVISTOONOFF, Sergio/0000-0001-8554-2922; Champion, Antony/0000-0002-3731-1510; Laplaze, Laurent/0000-0002-6568-6504; PARIZOT, Boris/0000-0003-1445-6925	Institut de Recherche pour le Developpement (IRD); AIRD - Department of Capacity-Building for Southern Scientific Communities (IRD-DPF); Agence Nationale de la Recherche [ANR-08-JCJC-0070-01, ANR-2010 BLAN-1708-01]; Centre National de la Recherche Scientifique (EC2CO-MicrobiEn)	Institut de Recherche pour le Developpement (IRD); AIRD - Department of Capacity-Building for Southern Scientific Communities (IRD-DPF); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (EC2CO-MicrobiEn)	This study was funded by the Institut de Recherche pour le Developpement (IRD; http://www.ird.fr), and grants from the AIRD - Department of Capacity-Building for Southern Scientific Communities (IRD-DPF to ND; http://www.aird.fr), the Agence Nationale de la Recherche (ANR-08-JCJC-0070-01; ANR-2010 BLAN-1708-01; http://www.agence-nationale-recherche.fr/) and the Centre National de la Recherche Scientifique (EC2CO-MicrobiEn; http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bonanomi A, 2001, PLANT BIOLOGY, V3, P194, DOI 10.1055/s-2001-12902; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deguchi Y, 2007, DNA RES, V14, P117, DOI 10.1093/dnares/dsm014; Diagne N, 2011, MYCORRHIZA, V21, P315, DOI 10.1007/s00572-010-0357-8; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; DUC G, 1989, PLANT SCI, V60, P207, DOI 10.1016/0168-9452(89)90168-4; Elfstrand M, 2005, NEW PHYTOL, V167, P557, DOI 10.1111/j.1469-8137.2005.01397.x; Fiorilli V, 2009, NEW PHYTOL, V184, P975, DOI 10.1111/j.1469-8137.2009.03031.x; Geurts R, 2012, CURR OPIN PLANT BIOL, V15, P438, DOI 10.1016/j.pbi.2012.04.004; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Guerra JCP, 2010, PLANT PHYSIOL, V152, P1574, DOI 10.1104/pp.109.151399; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Held M, 2010, TRENDS PLANT SCI, V15, P540, DOI 10.1016/j.tplants.2010.08.001; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Kiss E, 2009, PLANT PHYSIOL, V151, P1239, DOI 10.1104/pp.109.143933; Laplaze L, 2000, MOL PLANT MICROBE IN, V13, P113, DOI 10.1094/MPMI.2000.13.1.113; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Maurel C, 2011, NEW PHYTOL, V190, P815, DOI 10.1111/j.1469-8137.2011.03731.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Pawlowski K, 2012, PROTOPLASMA IN PRESS; Perrine-Walker F, 2011, CURR PROTEIN PEPT SC, V12, P156, DOI 10.2174/138920311795684896; Qian WF, 2010, TRENDS GENET, V26, P425, DOI 10.1016/j.tig.2010.07.002; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Svistoonoff S, 2003, MOL PLANT MICROBE IN, V16, P600, DOI 10.1094/MPMI.2003.16.7.600; Svistoonoff S, 2010, MOL PLANT MICROBE IN, V23, P740, DOI 10.1094/MPMI-23-6-0740; Takeda N, 2009, PLANT J, V58, P766, DOI 10.1111/j.1365-313X.2009.03824.x; Uehlein N, 2007, PHYTOCHEMISTRY, V68, P122, DOI 10.1016/j.phytochem.2006.09.033; Wang LS, 2011, PLANT PHYSIOL, V157, P1283, DOI 10.1104/pp.111.183723; Xiao Kai, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P99; Yokota K, 2011, CELL MOL LIFE SCI, V68, P1341, DOI 10.1007/s00018-011-0651-4; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955	45	50	52	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44742	10.1371/journal.pone.0044742	http://dx.doi.org/10.1371/journal.pone.0044742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970303	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400117
J	Arsenovic, PT; Maldonado, AT; Colleluori, VD; Bloss, TA				Arsenovic, Paul T.; Maldonado, Anthony T.; Colleluori, Vaughn D.; Bloss, Tim A.			Depletion of the C. elegans NAC Engages the Unfolded Protein Response, Resulting in Increased Chaperone Expression and Apoptosis	PLOS ONE			English	Article							POLYPEPTIDE-ASSOCIATED COMPLEX; NEMATODE CAENORHABDITIS-ELEGANS; RIBOSOME-ASSOCIATED CHAPERONES; ENDOPLASMIC-RETICULUM STRESS; HEAT-SHOCK FACTOR; ER STRESS; BETA-NAC; YEAST; PROTEOSTASIS; LIPOFUSCIN	The nascent polypeptide-associated complex (NAC) is a highly conserved heterodimer important for metazoan development, but its molecular function is not well understood. Recent evidence suggests the NAC is a component of the cytosolic chaperone network that interacts with ribosomal complexes and their emerging nascent peptides, such that the loss of the NAC in chaperone-depleted cells results in an increase in misfolded protein stress. We tested whether the NAC functions similarly in Caeonorhabditis (C.) elegans and found that its homologous NAC subunits, i.e. ICD-1 and -2, have chaperone-like characteristics. Loss of the NAC appears to induce misfolded protein stress in the ER triggering the unfolded protein response (UPR). Depletion of the NAC altered the response to heat stress, and led to an up-regulation of hsp-4, a homologue of the human chaperone and ER stress sensor GRP78/BiP. Worms lacking both ICD-1 and the UPR transcription factor XBP-1 generated a higher proportion of defective embryos, showed increased embryonic apoptosis and had a diminished survival rate relative to ICD-1-depleted animals with an intact UPR. Up-regulation of hsp-4 in NAC-depleted animals was specific to certain regions of the embryo; in embryos lacking ICD-1, the posterior region of the embryo showed strong up-regulation of hsp-4, while the anterior region did not. Furthermore, loss of ICD-1 produced prominent lysosomes in the gut region of adults and embryos putatively containing lipofuscins, lipid/protein aggregates associated with cellular aging. These results are the first set of evidence consistent with a role for C. elegans NAC in protein folding and localization during translation. Further, these findings confirm C. elegans as a valuable model for studying organismal and cell-type specific responses to misfolded protein stress.	[Arsenovic, Paul T.; Maldonado, Anthony T.; Colleluori, Vaughn D.; Bloss, Tim A.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	James Madison University	Arsenovic, PT (corresponding author), James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA.	blossta@jmu.edu			NIH Office of the Director; Jeffress Memorial Trust [J-925]; James Madison University	NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jeffress Memorial Trust; James Madison University	We would like to thank Alex Bannigan at James Madison University and Ammasi Periasamy at the W.M. Keck Center for Cellular Imaging at the University of Virginia for their help with microscopy; Ann Rougvie and Aric Daul for the C. elegans strains provided by the Caenorhabditis Genetics Center, funded by the NIH Office of the Director; Kim Slekar and Caylin Murray for comments on the manuscript; members of the Bloss and Slekar labs for discussions, and Robert Rotzin for technical support.; The research presented in this manuscript was funded by a grant from the Jeffress Memorial Trust (grant number J-925), and start-up funding from James Madison University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Chin-Sang ID, 2000, TRENDS GENET, V16, P544, DOI 10.1016/S0168-9525(00)02143-0; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Franke J, 2001, J CELL SCI, V114, P2641; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kapulkin V, 2005, FEBS LETT, V579, P3063, DOI 10.1016/j.febslet.2005.04.062; Kern A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008568; Kim SH, 2002, J INVEST MED, V50, P293, DOI 10.2310/6650.2002.33287; Kimura K, 2007, J BIOL CHEM, V282, P5910, DOI 10.1074/jbc.M609025200; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Ledwich D, 2000, METHOD ENZYMOL, V322, P76; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Markesich DC, 2000, DEVELOPMENT, V127, P559; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Waldmeier PC, 2003, PROG NEURO-PSYCHOPH, V27, P303, DOI 10.1016/S0278-5846(03)00025-3; Walker GA, 2003, FASEB J, V17, P1960, DOI 10.1096/fj.03-0164fje; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	45	26	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44038	10.1371/journal.pone.0044038	http://dx.doi.org/10.1371/journal.pone.0044038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957041	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800033
J	Gettler, LT; McKenna, JJ; McDade, TW; Agustin, SS; Kuzawa, CW				Gettler, Lee T.; McKenna, James J.; McDade, Thomas W.; Agustin, Sonny S.; Kuzawa, Christopher W.			Does Cosleeping Contribute to Lower Testosterone Levels in Fathers? Evidence from the Philippines	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; SALIVARY TESTOSTERONE; SENSATION-SEEKING; SLEEPING ARRANGEMENTS; LIFE-HISTORY; RISK-TAKING; MATO-GROSSO; MEN; BEHAVIOR; HORMONES	Because cross-species evidence suggests that high testosterone (T) may interfere with paternal investment, the relationships between men's transition to parenting and changes in their T are of growing interest. Studies of human males suggest that fathers who provide childcare often have lower T than uninvolved fathers, but no studies to date have evaluated how nighttime sleep proximity between fathers and their offspring may affect T. Using data collected in 2005 and 2009 from a sample of men (n = 362; age 26.0 +/- 6 0.3 years in 2009) residing in metropolitan Cebu, Philippines, we evaluated fathers' T based on whether they slept on the same surface as their children (same surface cosleepers), slept on a different surface but in the same room (roomsharers), or slept separately from their children (solitary sleepers). A large majority (92%) of fathers in this sample reported practicing same surface cosleeping. Compared to fathers who slept solitarily, same surface cosleeping fathers had significantly lower evening (PM) T and also showed a greater diurnal decline in T from waking to evening (both p<0.05). Among men who were not fathers at baseline (2005), fathers who were cosleepers at follow-up (2009) experienced a significantly greater longitudinal decline in PM T over the 4.5-year study period (p<0.01) compared to solitary sleeping fathers. Among these same men, baseline T did not predict fathers' sleeping arrangements at follow-up (p>0.2). These results are consistent with previous findings indicating that daytime father-child interaction contributes to lower T among fathers. Our findings specifically suggest that close sleep proximity between fathers and their offspring results in greater longitudinal decreases in T as men transition to fatherhood and lower PM T overall compared to solitary sleeping fathers.	[Gettler, Lee T.; McKenna, James J.] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA; [Gettler, Lee T.; McDade, Thomas W.; Kuzawa, Christopher W.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Gettler, Lee T.; McDade, Thomas W.; Kuzawa, Christopher W.] Northwestern Univ, Inst Policy Res, Cells Soc Ctr Social Dispar & Hlth C2S, Evanston, IL USA; [Agustin, Sonny S.] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines	University of Notre Dame; Northwestern University; Northwestern University; University of San Carlos	Gettler, LT (corresponding author), Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA.	lgettler@nd.edu		Gettler, Lee/0000-0001-7325-8852	Wenner Gren Foundation [7356, 8186]; National Science Foundation [BCS-0542182, BCS-0962212]; Interdisciplinary Obesity Center [RR20649]; Center for Environmental Health and Susceptibility [ES10126, 7-2004-E]; National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Wenner Gren Foundation; National Science Foundation(National Science Foundation (NSF)); Interdisciplinary Obesity Center; Center for Environmental Health and Susceptibility; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Wenner Gren Foundation (Gr. 7356; Gr. 8186), National Science Foundation (BCS-0542182; BCS-0962212), The Interdisciplinary Obesity Center (RR20649), and The Center for Environmental Health and Susceptibility (ES10126; project 7-2004-E). LTG was supported by a National Science Foundation Graduate Research Fellowship during write-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Alvergne A, 2010, PERS INDIV DIFFER, V49, P840, DOI 10.1016/j.paid.2010.07.006; Alvergne A, 2009, HORM BEHAV, V56, P491, DOI 10.1016/j.yhbeh.2009.07.013; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Baddock SA, 2007, PEDIATRICS, V119, pE200, DOI 10.1542/peds.2006-0744; Ball H, 2006, HUM NATURE-INT BIOS, V17, P301, DOI 10.1007/s12110-006-1011-1; Ball HL, 2003, BIRTH-ISS PERINAT C, V30, P181, DOI 10.1046/j.1523-536X.2003.00243.x; Ball HL, 1999, AM ANTHROPOL, V101, P143, DOI 10.1525/aa.1999.101.1.143; Ball HL, 2000, INFANT CHILD DEV, V9, P67, DOI 10.1002/1522-7219(200006)9:2<67::AID-ICD209>3.3.CO;2-Z; BARRY H, 1971, ETHNOLOGY, V10, P466; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; BOOTH A, 1993, SOC FORCES, V72, P463, DOI 10.2307/2579857; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Burnham TC, 2003, HORM BEHAV, V44, P119, DOI 10.1016/S0018-506X(03)00125-9; CARPENTER RG, 2006, PAEDIAT CHILD HLT SA, V11, pA24; Carroll-Pankhurst C, 2001, PEDIATRICS, V107, P530, DOI 10.1542/peds.107.3.530; Chiocchio SR, 1999, ENDOCRINOLOGY, V140, P1036, DOI 10.1210/en.140.3.1036; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; DABBS JM, 1990, PSYCHOL SCI, V1, P209, DOI 10.1111/j.1467-9280.1990.tb00200.x; DAITZMAN R, 1980, PERS INDIV DIFFER, V1, P103, DOI 10.1016/0191-8869(80)90027-6; Drago DA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e59; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Edelstein RS, 2010, HORM BEHAV, V57, P230, DOI 10.1016/j.yhbeh.2009.11.007; Ellison P.T., 2001, FERTILE GROUND NATUR; Escasa MJ, 2011, ARCH SEX BEHAV, V40, P921, DOI 10.1007/s10508-010-9711-3; Fleming AS, 2002, HORM BEHAV, V42, P399, DOI 10.1006/hbeh.2002.1840; Flinn M, HUMAN NATURE, V23, P68; Flouri E, 2005, FATHERING AND CHILD OUTCOMES, P1, DOI 10.1002/9780470713228; Germo GR, 2007, INFANT CHILD DEV, V16, P433, DOI 10.1002/icd.521; Gerra G, 1999, NEUROPSYCHOBIOLOGY, V39, P207, DOI 10.1159/000026586; Gettler LT, 2011, HORM BEHAV, V60, P599, DOI 10.1016/j.yhbeh.2011.08.009; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gettler LT, 2011, AM J HUM BIOL, V23, P609, DOI 10.1002/ajhb.21187; Gettler LT, 2010, CURR PEDIATR REV, V6, P71, DOI 10.2174/157339610791317250; Gettler LT, 2010, AM J PHYS ANTHROPOL, V142, P590, DOI 10.1002/ajpa.21282; Gettler LT, 2010, AM ANTHROPOL, V112, P7, DOI 10.1111/j.1548-1433.2009.01193.x; Gnessi L, 1997, ENDOCR REV, V18, P541, DOI 10.1210/er.18.4.541; Goudriaan AE, 2010, PSYCHONEUROENDOCRINO, V35, P1416, DOI 10.1016/j.psyneuen.2010.04.005; Gray PB, 2007, HORM BEHAV, V52, P499, DOI 10.1016/j.yhbeh.2007.07.005; Gray PB, 2006, P ROY SOC B-BIOL SCI, V273, P333, DOI 10.1098/rspb.2005.3311; Gray PB, 2004, PSYCHONEUROENDOCRINO, V29, P1153, DOI 10.1016/j.psyneuen.2004.01.008; Gray PB, 2003, AM J PHYS ANTHROPOL, V122, P279, DOI 10.1002/ajpa.10293; Gray Peter B., 2010, FATHERHOOD EVOLUTION; Griffin P. B., 1992, FATHER CHILD RELATIO, P297; Guthrie G., 1966, CHILD REARING PERSON; HART BL, 1974, PSYCHOL BULL, V81, P383, DOI 10.1037/h0036568; Hauck FR, 2008, PEDIATRICS, V122, pS113, DOI 10.1542/peds.2008-1315o; HELLHAMMER DH, 1985, PSYCHONEUROENDOCRINO, V10, P77, DOI 10.1016/0306-4530(85)90041-1; Jenni OG, 2005, PEDIATRICS, V115, P204, DOI 10.1542/peds.2004-0815B; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KLACKENBERG G, 1982, ACTA PAEDIATR SCAND, V71, P501, DOI 10.1111/j.1651-2227.1982.tb09459.x; Kleiman D.G., 1981, P347; Kuzawa CW, 2009, HORM BEHAV, V56, P429, DOI 10.1016/j.yhbeh.2009.07.010; Lamb M. E., 2004, ROLE FATHER CHILD DE, V4th; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leproult R, 2011, JAMA-J AM MED ASSOC, V305, P2173, DOI 10.1001/jama.2011.710; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Luboshitzky R, 2001, J CLIN ENDOCR METAB, V86, P1134, DOI 10.1210/jc.86.3.1134; McGarvey C, 2006, ARCH DIS CHILD, V91, P318, DOI 10.1136/adc.2005.074674; McKenna JJ, 2007, YEARB PHYS ANTHROPOL, V50, P133, DOI 10.1002/ajpa.20736; MCKENNA JJ, 1993, SLEEP, V16, P263, DOI 10.1093/sleep/16.3.263; Messmer RL, 2009, RELATIONSHIP PARENT; Mindell JA, 2010, SLEEP MED, V11, P274, DOI 10.1016/j.sleep.2009.04.012; Mitchell EA, 2009, ACTA PAEDIATR, V98, P1712, DOI 10.1111/j.1651-2227.2009.01503.x; MORELLI GA, 1992, DEV PSYCHOL, V28, P604, DOI 10.1037/0012-1649.28.4.604; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Perini T, 2012, HORM BEHAV, V61, P191, DOI 10.1016/j.yhbeh.2011.12.004; Pollet TV, 2011, HORM BEHAV, V60, P72, DOI 10.1016/j.yhbeh.2011.03.005; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reimao R, 1999, ARQ NEURO-PSIQUIAT, V57, P556, DOI 10.1590/S0004-282X1999000400003; Reimao R, 1998, ARQ NEURO-PSIQUIAT, V56, P703, DOI 10.1590/S0004-282X1998000500001; Rigda RS, 2000, J PAEDIATR CHILD H, V36, P117, DOI 10.1046/j.1440-1754.2000.00468.x; Ronay R, 2010, SOC PSYCHOL PERS SCI, V1, P57, DOI 10.1177/1948550609352807; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Sellers JG, 2007, J RES PERS, V41, P126, DOI 10.1016/j.jrp.2006.02.004; Smart J, 2007, J PAEDIATR CHILD H, V43, P293, DOI 10.1111/j.1440-1754.2007.01060.x; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Storey AE, 2011, HORM BEHAV, V60, P353, DOI 10.1016/j.yhbeh.2011.07.001; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Suay F, 1999, PSYCHONEUROENDOCRINO, V24, P551, DOI 10.1016/S0306-4530(99)00011-6; TOUITOU Y, 1990, EUR J APPL PHYSIOL O, V60, P288, DOI 10.1007/BF00379398; Trivers RL., 1972, SEXUAL SELECTION DES; Trumble BC, 2011, AM J HUM BIOL, V23, P281; Trumble BC, P R SOC B IN PRESS; van Anders SM, HORM BEHAV IN PRESS, V61, P31; Veldhuis JD, 2004, J CLIN ENDOCR METAB, V89, P4474, DOI 10.1210/jc.2004-0203; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P762, DOI 10.1002/ajhb.20927; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; ZOHOORI N, 1993, J BIOSOC SCI, V25, P127, DOI 10.1017/S002193200002037X	95	54	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e41559	10.1371/journal.pone.0041559	http://dx.doi.org/10.1371/journal.pone.0041559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001MC	22957016	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800008
J	Mena, S; Rodriguez, ML; Ponsoda, X; Estrela, JM; Jaattela, M; Ortega, AL				Mena, Salvador; Rodriguez, Maria L.; Ponsoda, Xavier; Estrela, Jose M.; Jaattela, Marja; Ortega, Angel L.			Pterostilbene-Induced Tumor Cytotoxicity: A Lysosomal Membrane Permeabilization-Dependent Mechanism	PLOS ONE			English	Article							INDUCED CELL-DEATH; CANCER-CELLS; B16 MELANOMA; DOWN-REGULATION; CATHEPSIN-D; RESVERATROL; AUTOPHAGY; APOPTOSIS; THERAPY; ARREST	The phenolic phytoalexin resveratrol is well known for its health-promoting and anticancer properties. Its potential benefits are, however, limited due to its low bioavailability. Pterostilbene, a natural dimethoxylated analog of resveratrol, presents higher anticancer activity than resveratrol. The mechanisms by which this polyphenol acts against cancer cells are, however, unclear. Here, we show that pterostilbene effectively inhibits cancer cell growth and stimulates apoptosis and autophagosome accumulation in cancer cells of various origins. However, these mechanisms are not determinant in cell demise. Pterostilbene promotes cancer cell death via a mechanism involving lysosomal membrane permeabilization. Different grades of susceptibility were observed among the different cancer cells depending on their lysosomal heat shock protein 70 (HSP70) content, a known stabilizer of lysosomal membranes. A375 melanoma and A549 lung cancer cells with low levels of HSP70 showed high susceptibility to pterostilbene, whereas HT29 colon and MCF7 breast cancer cells with higher levels of HSP70 were more resistant. Inhibition of HSP70 expression increased susceptibility of HT29 colon and MCF7 breast cancer cells to pterostilbene. Our data indicate that lysosomal membrane permeabilization is the main cell death pathway triggered by pterostilbene.	[Mena, Salvador; Estrela, Jose M.; Ortega, Angel L.] Green Mol, Valencia, Spain; [Rodriguez, Maria L.; Estrela, Jose M.; Ortega, Angel L.] Univ Valencia, Dept Physiol, E-46100 Burjassot, Spain; [Ponsoda, Xavier] Univ Valencia, Dept Cell Biol, E-46100 Burjassot, Spain; [Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, Copenhagen, Denmark; [Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Response, Copenhagen, Denmark	University of Valencia; University of Valencia; Danish Cancer Society; Danish Cancer Society	Mena, S (corresponding author), Green Mol, Valencia, Spain.	angel.ortega@uv.es	Ponsoda, Xavier/L-8272-2014; Mena, Salvador/F-6696-2016; Rodriguez, Maria/A-8510-2016; Jäättelä, Marja/AAT-7932-2021; Estrela, Jose/H-4449-2015; Mena, Salvador/L-8780-2014; Ortega, Angel L./A-4113-2014	Ponsoda, Xavier/0000-0002-4051-4458; Jäättelä, Marja/0000-0001-5950-7111; Estrela, Jose/0000-0002-2540-9190; Mena, Salvador/0000-0002-6423-4741; Ortega, Angel L./0000-0002-9901-3383	MICINN [JC2008-00282, SAF2009-07729, IPT-010000-2010-21]; GV-Conselleria d'Educacio [GVPRE/2008/272]; Danish Cancer Society; Danish Medical Council; Danish National Research Foundation	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); GV-Conselleria d'Educacio; Danish Cancer Society(Danish Cancer Society); Danish Medical Council(Danish Medical Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond)	This research was supported by grants from the MICINN (JC2008-00282 ALO SAF2009-07729 and IPT- 010000-2010-21 to JME), the GV-Conselleria d'Educacio (GVPRE/2008/272 to ALO), the Danish Cancer Society (to MJ), the Danish Medical Council (to MJ) and the Danish National Research Foundation (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Ahmad N, 2001, CLIN CANCER RES, V7, P1466; [Anonymous], 2010, ALTERN MED REV, V15, P159; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Asensi M, 2011, CRIT REV CL LAB SCI, V48, P197, DOI 10.3109/10408363.2011.631268; Bernhard D, 2000, CELL DEATH DIFFER, V7, P834, DOI 10.1038/sj.cdd.4400719; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chen RJ, 2010, MOL NUTR FOOD RES, V54, P1819, DOI 10.1002/mnfr.201000067; Cui J, 2010, PHYTOTHER RES, V24, P1637, DOI 10.1002/ptr.3157; Davalli P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/984219; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Ferrer P, 2005, NEOPLASIA, V7, P37, DOI 10.1593/neo.04337; Ferrer P, 2007, J BIOL CHEM, V282, P2880, DOI 10.1074/jbc.M605934200; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Gassmann P, 2008, CLIN EXP METASTAS, V25, P171, DOI 10.1007/s10585-007-9130-6; Groth-Pedersen L, 2007, CANCER RES, V67, P2217, DOI 10.1158/0008-5472.CAN-06-3520; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Kairisalo M, 2011, NEUROSCI LETT, V488, P263, DOI 10.1016/j.neulet.2010.11.042; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mannal PW, 2010, J GASTROINTEST SURG, V14, P873, DOI 10.1007/s11605-010-1164-4; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Ortega A, 2003, J BIOL CHEM, V278, P39591, DOI 10.1074/jbc.M303753200; Ostenfeld MS, 2008, AUTOPHAGY, V4, P487, DOI 10.4161/auto.5774; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Priego S, 2008, MOL CANCER THER, V7, P3330, DOI 10.1158/1535-7163.MCT-08-0363; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Ruiz MJ, 2009, J AGR FOOD CHEM, V57, P3180, DOI 10.1021/jf803579e; Schneider JG, 2010, J SURG RES, V161, P18, DOI 10.1016/j.jss.2009.06.027; Schneider Y, 2003, INT J CANCER, V107, P189, DOI 10.1002/ijc.11344; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Trincheri NF, 2007, CARCINOGENESIS, V28, P922, DOI 10.1093/carcin/bgl223; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Wang YS, 2012, AM J TRANSL RES, V4, P44; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663	55	76	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44524	10.1371/journal.pone.0044524	http://dx.doi.org/10.1371/journal.pone.0044524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957077	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800070
J	Odeny, TA; Bailey, RC; Bukusi, EA; Simoni, JM; Tapia, KA; Yuhas, K; Holmes, KK; McClelland, RS				Odeny, Thomas A.; Bailey, Robert C.; Bukusi, Elizabeth A.; Simoni, Jane M.; Tapia, Kenneth A.; Yuhas, Krista; Holmes, King K.; McClelland, R. Scott			Text Messaging to Improve Attendance at Post-Operative Clinic Visits after Adult Male Circumcision for HIV Prevention: A Randomized Controlled Trial	PLOS ONE			English	Article							PRIMARY-CARE; REDUCTION; REMINDERS; MEN	Background: Following male circumcision for HIV prevention, a high proportion of men fail to return for their scheduled seven-day post-operative visit. We evaluated the effect of short message service (SMS) text messages on attendance at this important visit. Methodology: We enrolled 1200 participants >18 years old in a two-arm, parallel, randomized controlled trial at 12 sites in Nyanza province, Kenya. Participants received daily SMS text messages for seven days (n = 600) or usual care (n = 600). The primary outcome was attendance at the scheduled seven-day post-operative visit. The primary analysis was by intention-to-treat. Principal Findings: Of participants receiving SMS, 387/592 (65.4%) returned, compared to 356/596 (59.7%) in the control group (relative risk [RR] = 1.09, 95% confidence interval [CI] 1.00-1.20; p = 0.04). Men who paid more than US$1.25 to travel to clinic were at higher risk for failure to return compared to those who spent <= US$1.25 (adjusted relative risk [aRR] 1.35, 95% CI 1.15-1.58; p<0.001). Men with secondary or higher education had a lower risk of failure to return compared to those with primary or less education (aRR 0.87, 95% CI 0.74-1.01; p = 0.07). Conclusions: Text messaging resulted in a modest improvement in attendance at the 7-day post-operative clinic visit following adult male circumcision. Factors associated with failure to return were mainly structural, and included transportation costs and low educational level. Trial Registration: ClinicalTrials.gov NCT01186575	[Odeny, Thomas A.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Odeny, Thomas A.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bailey, Robert C.] Univ Illinois, Chicago Dev Ctr AIDS Res, Chicago, IL USA; [Bukusi, Elizabeth A.; Simoni, Jane M.; Tapia, Kenneth A.; Yuhas, Krista; Holmes, King K.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Bukusi, Elizabeth A.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Simoni, Jane M.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Holmes, King K.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA USA; [Tapia, Kenneth A.; Yuhas, Krista; Holmes, King K.; McClelland, R. Scott] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Odeny, TA (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	mcclell@u.washington.edu	, Holmes/K-6215-2019	Simoni, Jane/0000-0002-8711-1576	University of Washington; Fogarty International Center [NIH 5D43-TW000007]; NIH [P30 AI027757]; NIH Institutes and Center (NIAID); NIH Institutes and Center (NCI); NIH Institutes and Center (NIMH); NIH Institutes and Center (NIDA); NIH Institutes and Center (NICHD); NIH Institutes and Center (NHLBI); NIH Institutes and Center (NIA); FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH093243] Funding Source: NIH RePORTER	University of Washington(University of Washington); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutes and Center (NIAID); NIH Institutes and Center (NCI); NIH Institutes and Center (NIMH); NIH Institutes and Center (NIDA); NIH Institutes and Center (NICHD); NIH Institutes and Center (NHLBI); NIH Institutes and Center (NIA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the University of Washington International AIDS Research and Training Program, which is supported by the Fogarty International Center (NIH 5D43-TW000007). Additional support for the trial was provided by the Department of Epidemiology and Biostatistics at the University of Illinois at Chicago; and the Biostatistics and International Cores of the University of Washington Center for AIDS Research, an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all data in the study, and had final responsibility for the decision to submit for publication.	[Anonymous], 2010, COMM COMM KEN Q SECT; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2009, PREFECT POLICE F PEC; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Downer Sean R, 2006, Aust Health Rev, V30, P389; Foley J, 2009, EUR ARCH PAEDIATR DE, V10, P15, DOI 10.1007/BF03262661; FRANKE RH, 1978, AM SOCIOL REV, V43, P623, DOI 10.2307/2094540; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kharbanda EO, 2011, VACCINE, V29, P2537, DOI 10.1016/j.vaccine.2011.01.065; Leong KC, 2006, FAM PRACT, V23, P699, DOI 10.1093/fampra/cml044; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Liew SM, 2009, BRIT J GEN PRACT, V59, P916, DOI 10.3399/bjgp09X472250; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; National AIDS and STI Control ProgrammeMoH, KEN AIDS IND SURV 20; National Bureau of Statistics Government of Kenya, 2010, 2009 KEN POP HOUS CE; O'Brien G, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e6; Ochieng A, 2011, PREFECT POLICE F PEC; Perron NJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-79; Person AK, 2011, TELEMED E-HEALTH, V17, P189, DOI 10.1089/tmj.2010.0164; Philip R, 1997, RALLOC STATA MODULE; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; WHO/ UNAIDS, 2007, WHO UNAIDS TECHN CON; WHO/UNAIDS/JHPIEGO, 2009, MAN MAL CIRC LOC AN; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	71	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43832	10.1371/journal.pone.0043832	http://dx.doi.org/10.1371/journal.pone.0043832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957034	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800026
J	Tian, SY; Krueger, JG; Li, K; Jabbari, A; Brodmerkel, C; Lowes, MA; Suarez-Farinas, M				Tian, Suyan; Krueger, James G.; Li, Katherine; Jabbari, Ali; Brodmerkel, Carrie; Lowes, Michelle A.; Suarez-Farinas, Mayte			Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the "Core" Pathogenesis of Disease	PLOS ONE			English	Article							GENE-EXPRESSION; SKIN-DISEASE; INFLAMMATORY DISEASES; DENDRITIC CELLS; KAPPA-B; T-CELL; MICROARRAY; ACTIVATION; RECEPTORS; DIFFERENTIATION	The cause of psoriasis, a common chronic inflammatory skin disease, is not fully understood. Microarray experiments have been widely used in recent years to identify genes associated with psoriasis pathology, by comparing expression levels of lesional (LS) with adjacent non-lesional (NL) skin. It is commonly observed that the differentially expressed genes (DEGs) differ greatly across experiments, due to variations introduced in the microarray experiment pipeline. Therefore, a statistically based meta-analytic approach, which combines the results of individual studies, is warranted. In this study, a meta-analysis was conducted on 5 microarray data sets, including 193 LS and NL pairs. We termed this the Meta-Analysis Derived (MAD) transcriptome. In "MAD-5" transcriptome, 677 genes were up-regulated and 443 were down-regulated in LS skin compared to NL skin. This represents a much larger set than the intersection of DEGs of these 5 studies, which consisted of 100 DEGs. We also analyzed 3 of the studies conducted on the Affymetrix hgu133plus2 chips and found a greater number of DEGs (1084 up-and 748 down-regulated). Top canonical pathways over-represented in the MAD transcriptome include Atherosclerosis Signaling and Fatty Acid Metabolism, while several "new" genes identified are involved in Cardiovascular Development and Lipid Metabolism. These findings highlight the relationship between psoriasis and systemic manifestations such as the metabolic syndrome and cardiovascular disease. Then, the Meta Threshold Gradient Descent Regularization (MTGDR) algorithm was used to select potential markers distinguishing LS and NL skin. The resulting set (20 genes) contained many genes that were part of the residual disease genomic profile (RDGP) or "molecular scar" after successful treatment, and also genes subject to differential methylation in LS tissues. To conclude, this MAD transcriptome yielded a reference list of reliable psoriasis DEGs, and represents a robust pool of candidates for further discovery of pathogenesis and treatment evaluation.	[Tian, Suyan; Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Krueger, James G.; Jabbari, Ali; Lowes, Michelle A.; Suarez-Farinas, Mayte] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10021 USA; [Li, Katherine; Brodmerkel, Carrie] Janssen Res & Dev, Immunol & Biomarkers, Radnor, PA USA	Rockefeller University; Rockefeller University	Tian, SY (corresponding author), Rockefeller Univ, Ctr Clin & Translat Sci, 1230 York Ave, New York, NY 10021 USA.	farinam@rockefeller.edu	Suarez-Farinas, Mayte/I-3558-2012; Tian, Suyan/W-3273-2019; Lowes, Michelle A/G-9585-2016	Suarez-Farinas, Mayte/0000-0001-8712-3553; Tian, Suyan/0000-0002-5942-1542; Jabbari, Ali/0000-0002-8559-7314; Lowes, Michelle A/0000-0003-4256-478X	National Center for Research Resources [8 UL1 TR000043]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health; Milstein Program in Medical Research; Doris Duke Foundation;  [R01 AR06022]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060222] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Milstein Program in Medical Research; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by a Clinical and Translational Science Award grant # 8 UL1 TR000043 from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health; MSF is also partially supported by the Milstein Program in Medical Research; and ML by R01 AR06022 and the Doris Duke Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Butt C, 2006, J RHEUMATOL, V33, P1631; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Capon F, 2011, J INVEST DERMATOL; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Clark RA, 2011, J INVEST DERMATOL, V131, P283, DOI 10.1038/jid.2010.374; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; FRIEDMAN JH, 2004, GRADIENT DIRECTED RE; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Hong SW, 2008, BIOCHEM BIOPH RES CO, V365, P426, DOI 10.1016/j.bbrc.2007.10.183; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267; Johansen C, 2004, BRIT J DERMATOL, V151, P600, DOI 10.1111/j.1365-2133.2004.06088.x; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; Lew W, 2004, BRIT J DERMATOL, V150, P668, DOI 10.1111/j.0007-0963.2004.05891.x; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Mitsui H, 2012, J INVEST DERMATOL; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Roberson EDO, 2012, J INVEST DERMATOL, V132, P583, DOI 10.1038/jid.2011.348; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; SATTAR MA, 1991, MED LAB SCI, V48, P36; Sedghizadeh PP, 2006, HEAD NECK-J SCI SPEC, V28, P432, DOI 10.1002/hed.20346; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sharko J, 2008, IEEE T VIS COMPUT GR, V14, P1444, DOI 10.1109/TVCG.2008.173; Stevens JR, 2005, COMP FUNCT GENOM, V6, P116, DOI 10.1002/cfg.460; Suarez-Farinas M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-99; Suarez-Farinas M, 2012, J INVESTIGATIVE DERM; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Suzuki T, 2008, MAMM GENOME, V19, P15, DOI 10.1007/s00335-007-9080-y; Westergaard M, 2003, J INVEST DERMATOL, V121, P1104, DOI 10.1046/j.1523-1747.2003.12536.x; Won HH, 2012, J MOL MED, V90, P201, DOI 10.1007/s00109-011-0818-3; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	56	102	108	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44274	10.1371/journal.pone.0044274	http://dx.doi.org/10.1371/journal.pone.0044274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957057	gold, Green Published, Green Submitted			2022-12-27	WOS:000308463800049
J	Kwong, JC; Ratnasingham, S; Campitelli, MA; Daneman, N; Deeks, SL; Manuel, DG; Allen, VG; Bayoumi, AM; Fazil, A; Fisman, DN; Gershon, AS; Gournis, E; Heathcote, EJ; Jamieson, FB; Jha, P; Khan, KM; Majowicz, SE; Mazzulli, T; McGeer, AJ; Muller, MP; Raut, A; Rea, E; Remis, RS; Shahin, R; Wright, AJ; Zagorski, B; Crowcroft, NS				Kwong, Jeffrey C.; Ratnasingham, Sujitha; Campitelli, Michael A.; Daneman, Nick; Deeks, Shelley L.; Manuel, Douglas G.; Allen, Vanessa G.; Bayoumi, Ahmed M.; Fazil, Aamir; Fisman, David N.; Gershon, Andrea S.; Gournis, Effie; Heathcote, E. Jenny; Jamieson, Frances B.; Jha, Prabhat; Khan, Kamran M.; Majowicz, Shannon E.; Mazzulli, Tony; McGeer, Allison J.; Muller, Matthew P.; Raut, Abhishek; Rea, Elizabeth; Remis, Robert S.; Shahin, Rita; Wright, Alissa J.; Zagorski, Brandon; Crowcroft, Natasha S.			The Impact of Infection on Population Health: Results of the Ontario Burden of Infectious Diseases Study	PLOS ONE			English	Article							VIRUS; CANADA; CANCER; DALYS; HIV	Background: Evidence-based priority setting is increasingly important for rationally distributing scarce health resources and for guiding future health research. We sought to quantify the contribution of a wide range of infectious diseases to the overall infectious disease burden in a high-income setting. Methodology/Principal Findings: We used health-adjusted life years (HALYs), a composite measure comprising premature mortality and reduced functioning due to disease, to estimate the burden of 51 infectious diseases and associated syndromes in Ontario using 2005-2007 data. Deaths were estimated from vital statistics data and disease incidence was estimated from reportable disease, healthcare utilization, and cancer registry data, supplemented by local modeling studies and national and international epidemiologic studies. The 51 infectious agents and associated syndromes accounted for 729 lost HALYs, 44.2 deaths, and 58,987 incident cases per 100,000 population annually. The most burdensome infectious agents were: hepatitis C virus, Streptococcus pneumoniae, Escherichia coli, human papillomavirus, hepatitis B virus, human immunodeficiency virus, Staphylococcus aureus, influenza virus, Clostridium difficile, and rhinovirus. The top five, ten, and 20 pathogens accounted for 46%, 67%, and 75% of the total infectious disease burden, respectively. Marked sex-specific differences in disease burden were observed for some pathogens. The main limitations of this study were the exclusion of certain infectious diseases due to data availability issues, not considering the impact of co-infections and co-morbidity, and the inability to assess the burden of milder infections that do not result in healthcare utilization. Conclusions/Significance: Infectious diseases continue to cause a substantial health burden in high-income settings such as Ontario. Most of this burden is attributable to a relatively small number of infectious agents, for which many effective interventions have been previously identified. Therefore, these findings should be used to guide public health policy, planning, and research.	[Kwong, Jeffrey C.; Ratnasingham, Sujitha; Campitelli, Michael A.; Daneman, Nick; Manuel, Douglas G.; Bayoumi, Ahmed M.; Gershon, Andrea S.; Zagorski, Brandon] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Allen, Vanessa G.; Jamieson, Frances B.; Mazzulli, Tony; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Kwong, Jeffrey C.; Deeks, Shelley L.; Fisman, David N.; Gournis, Effie; Jha, Prabhat; McGeer, Allison J.; Raut, Abhishek; Rea, Elizabeth; Remis, Robert S.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Bayoumi, Ahmed M.; Khan, Kamran M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Allen, Vanessa G.; Jamieson, Frances B.; Mazzulli, Tony; McGeer, Allison J.; Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Bayoumi, Ahmed M.; Heathcote, E. Jenny; Khan, Kamran M.; Mazzulli, Tony; Muller, Matthew P.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Jha, Prabhat] St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.; Khan, Kamran M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Gournis, Effie; Rea, Elizabeth; Shahin, Rita] Toronto Publ Hlth, Toronto, ON, Canada; [Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Majowicz, Shannon E.] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [Majowicz, Shannon E.] Univ Waterloo, Dept Hlth Studies & Gerontol, Waterloo, ON N2L 3G1, Canada; [Fazil, Aamir] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Wright, Alissa J.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Guelph; University of Waterloo; Public Health Agency of Canada; University of British Columbia	Kwong, JC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	jeff.kwong@utoronto.ca	McGeer, Allison/AAB-6885-2020; Allen, Vanessa/AAE-2756-2022; Jamieson, Frances/B-2040-2013; mcgeer, allison/H-7747-2014; Manuel, Doug/D-7100-2014	McGeer, Allison/0000-0001-5647-6137; Allen, Vanessa/0000-0001-9802-9730; mcgeer, allison/0000-0001-5647-6137; Jha, Prabhat/0000-0001-7067-8341; Manuel, Doug/0000-0003-0912-0845; Majowicz, Shannon/0000-0002-0006-8369	Public Health Ontario (PHO); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); MOHLTC; University of Toronto Department of Family and Community Medicine Clinician Scientist Award; Canadian Institutes of Health Research (CIHR); CIHR/Ontario MOHLTC Applied Chair in Health Services and Policy Research; Public Health Agency of Canada; Novartis; Sanofi-Pasteur; GlaxoSmithKline	Public Health Ontario (PHO); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); MOHLTC(Ministry of Health and Long-Term Care, Ontario); University of Toronto Department of Family and Community Medicine Clinician Scientist Award; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/Ontario MOHLTC Applied Chair in Health Services and Policy Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Novartis(Novartis); Sanofi-Pasteur; GlaxoSmithKline(GlaxoSmithKline)	This study was funded by Public Health Ontario (PHO) and was supported by the Institute for Clinical Evaluative Sciences (ICES), both of which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). JCK was supported by a MOHLTC Career Scientist Award and a University of Toronto Department of Family and Community Medicine Clinician Scientist Award. ND was supported by a Canadian Institutes of Health Research (CIHR) Clinician Scientist Award. AMB was supported by a CIHR/Ontario MOHLTC Applied Chair in Health Services and Policy Research. KMK was supported by a CIHR New Investigator Award. DGM was supported by a Chair in Applied Public Health from the CIHR and the Public Health Agency of Canada. The study sponsors were involved in the conception and design of the study, data interpretation, revision of the paper for important intellectual content, and the decision to publish.r The authors have read the journal's policy and the following authors wish to report these potential conflicts. DNF has previously received research funding and/or served as a consultant to Novartis, Sanofi-Pasteur, and GlaxoSmithKline on issues related to vaccination. AJM has received research honoraria from Gilead Biosciences, Hoffman-Laroche, GlaxoSmithKline, Pfizer, Merck, Sanofi-Pasteur, and Wyeth. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors declare that they have no conflict of interest.	Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; [Anonymous], 1996, PATTERNS HLTH CARE O; Barendregt JJ, 1996, B WORLD HEALTH ORGAN, V74, P439; Bonneux L, 2001, J EPIDEMIOL COMMUN H, V55, P123, DOI 10.1136/jech.55.2.123; CBC News, 2009, CBC NEWS; CBC News, 2006, CBC NEWS; Chan B., 1999, SUPPLY PHYS SERVICES; Chan B., 2005, SUPPLY UTILIZATION G; COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567; Evans WK, 2005, HLTH STATE DESCRIPTI; Flanagan W, 2005, POPUL HEALTH METR, V3, P5; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Goodin R. E., 1982, J PUBLIC POLICY, V2, P53; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Improving health care data in Ontario, 2005, IMPR HLTH CAR DAT ON; Juurlink D, 2006, CANADIAN I HLTH INFO; Kliewer EV, 2009, SEX TRANSM DIS, V36, P380, DOI 10.1097/OLQ.0b013e318198de8c; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Mathers C., 1999, BURDEN DIS INJURY AU; McIntosh Cameron N, 2007, Chronic Dis Can, V28, P29; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Naylor CD, 1999, CARDIOVASCULAR HLTH; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Public Health Agency of Canada, 2006, I TRACK ENH SURV RIS; Public Health Agency of Canada, 2006, POP HLTH IMP DIS CAN; Public Health Group Rural and Regional Health and Aged Care Services Division, 2005, VICT BURD DIS STUD M; Remis R, 2008, MODELLING INCIDENCE; Remis RS, 2010, REPORT HIV AIDS ONTA; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Statistics Canada, 2007, ONT 2006 COMM PROF 2; Statistics Canada, 2009, PLAC BIRTH IMM POP P; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Thomas M Kate, 2006, Can J Infect Dis Med Microbiol, V17, P229; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; van Lier E A, 2007, Euro Surveill, V12, pE3; World Health Organization, 2010, SUMM PROB SARS CAS O; World Health Organization, 2011, MEASL OUTBR EUR; Yang HI, 2010, J CLIN ONCOL, V28, P2437, DOI 10.1200/JCO.2009.27.4456; Yang QY, 2010, CAN J PUBLIC HEALTH, V101, P486, DOI 10.1007/BF03403969	41	80	80	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44103	10.1371/journal.pone.0044103	http://dx.doi.org/10.1371/journal.pone.0044103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22962601	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600029
J	Liu, L; Wu, XM; Geng, J; Yuan, Z; Chen, L				Liu, Lei; Wu, Xiaomei; Geng, Jin; Yuan, Zhe; Chen, Lei			IVTA as Adjunctive Treatment to PRP and MPC for PDR and Macular Edema: A Meta-Analysis	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; INTRAVITREAL TRIAMCINOLONE; PANRETINAL PHOTOCOAGULATION; LASER; INJECTION; QUALITY; TRIALS	Background: To quantify the effect of a combination treatment of intravitreal triamcinolone acetonide (IVTA) injection, panretinal photocoagulation (PRP), and macular photocoagulation (MPC) in patients with proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME). Methodology/Principal Findings: We conducted a meta-analysis and searched for reports concerning IVTA injection combined with PRP for the treatment of PDR and DME using Medline, EMbase, Web of Science, the Cochrane Library, and Google according to Cochrane evaluation guidelines. The quality of the reports was evaluated using the Jadad score. Only four studies were ultimately included in this meta-analysis and the fixed-effects model was used. Treatment with IVTA injection combined with PRP and MPC significantly improved BCVA (p<0.001) from one to six months, compared with PRP and MPC alone. There was a statistically significant mean difference in central macular thickness (CMT), at the one-month follow-up (p<0.001). No evidence of publication bias was present. There was a low level of heterogeneity in this group of studies. Conclusions/Significance: This meta-analysis indicates that IVTA injection combined with PRP and MPC results in an improvement of BCVA, and CMT reduction in patients with PDR and DME.	[Liu, Lei; Geng, Jin; Yuan, Zhe; Chen, Lei] China Med Univ, Dept Ophthalmol, Hosp 1, Shenyang, Peoples R China; [Wu, Xiaomei] China Med Univ, Dept Clin Epidemiol & Evidence Med, Hosp 1, Shenyang, Peoples R China; [Liu, Lei; Yuan, Zhe; Chen, Lei] China Med Univ, Key Lab Endocrine Dis Liaoning Prov, Hosp 1, Shenyang, Peoples R China; [Liu, Lei; Yuan, Zhe; Chen, Lei] China Med Univ, Liaoning Diabet Eye Ctr, Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Liu, L (corresponding author), China Med Univ, Dept Ophthalmol, Hosp 1, Shenyang, Peoples R China.	carol1422@163.com	yuan, zhe/GYE-0922-2022		Liaoning Science and Technology Project [2009225005]; Liaoning Department of Health Medical Peak of Construction Project [2010016]; Important Platform of Science and Technology Foundation for Universities, Department of Education, Liaoning Province government, China [2011195]	Liaoning Science and Technology Project; Liaoning Department of Health Medical Peak of Construction Project; Important Platform of Science and Technology Foundation for Universities, Department of Education, Liaoning Province government, China	This work has been supported by three grants: (1) Liaoning Science and Technology Project, (Project Number: 2009225005); (2) Liaoning Department of Health Medical Peak of Construction Project, (Project Number: 2010016); (3) The Important Platform of Science and Technology Foundation for Universities, Department of Education, Liaoning Province government, China, (Project Number: 2011195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, AM J OPHTHALMOL, V81, P383; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Avci R, 2006, GRAEF ARCH CLIN EXP, V244, P28, DOI 10.1007/s00417-005-0069-5; Bandello F, 2006, ARCH OPHTHALMOL-CHIC, V124, P643, DOI 10.1001/archopht.124.5.643; Choi Kyung Seek, 2007, Korean J Ophthalmol, V21, P11, DOI 10.3341/kjo.2007.21.1.11; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Fischer S, 2001, EUR J PHARMACOL, V411, P231, DOI 10.1016/S0014-2999(00)00915-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jonas JB, 2001, AM J OPHTHALMOL, V132, P425, DOI 10.1016/S0002-9394(01)01010-8; Jonas JB, 2005, PROG RETIN EYE RES, V24, P587, DOI 10.1016/j.preteyeres.2005.01.004; Maia OO, 2009, AM J OPHTHALMOL, V147, P291, DOI 10.1016/j.ajo.2008.08.024; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mirshahi A, 2010, RETINA-J RET VIT DIS, V30, P254, DOI 10.1097/IAE.0b013e3181b4f125; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nonaka A, 2002, INVEST OPHTH VIS SCI, V43, P1204; Shimura M, 2003, OPHTHALMOLOGY, V110, P2386, DOI 10.1016/j.ophtha.2003.05.008; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; WILSON CA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1155, DOI 10.1001/archopht.1992.01080200135041; World Health Organization (WHO, 2007, REC PREV BLINDN DIAB, P3; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346	22	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44683	10.1371/journal.pone.0044683	http://dx.doi.org/10.1371/journal.pone.0044683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973465	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600078
J	Porth, I; White, R; Jaquish, B; Alfaro, R; Ritland, C; Ritland, K				Porth, Ilga; White, Richard; Jaquish, Barry; Alfaro, Rene; Ritland, Carol; Ritland, Kermit			Genetical Genomics Identifies the Genetic Architecture for Growth and Weevil Resistance in Spruce	PLOS ONE			English	Article							WHITE-PINE WEEVIL; MEDIATED PLANT DEFENSE; WOOD PROPERTY TRAITS; PISSODES-STROBI; ARABIDOPSIS-THALIANA; INTERIOR SPRUCE; CONIFER DEFENSE; LINKAGE MAPS; TRADE-OFFS; TAEDA L.	In plants, relationships between resistance to herbivorous insect pests and growth are typically controlled by complex interactions between genetically correlated traits. These relationships often result in tradeoffs in phenotypic expression. In this study we used genetical genomics to elucidate genetic relationships between tree growth and resistance to white pine terminal weevil (Pissodes strobi Peck.) in a pedigree population of interior spruce (Picea glauca, P. engelmannii and their hybrids) that was growing at Vernon, B.C. and segregating for weevil resistance. Genetical genomics uses genetic perturbations caused by allelic segregation in pedigrees to co-locate quantitative trait loci (QTLs) for gene expression and quantitative traits. Bark tissue of apical leaders from 188 trees was assayed for gene expression using a 21.8K spruce EST-spotted microarray; the same individuals were genotyped for 384 SNP markers for the genetic map. Many of the expression QTLs (eQTL) co-localized with resistance trait QTLs. For a composite resistance phenotype of six attack and oviposition traits, 149 positional candidate genes were identified. Resistance and growth QTLs also overlapped with eQTL hotspots along the genome suggesting that: 1) genetic pleiotropy of resistance and growth traits in interior spruce was substantial, and 2) master regulatory genes were important for weevil resistance in spruce. These results will enable future work on functional genetic studies of insect resistance in spruce, and provide valuable information about candidate genes for genetic improvement of spruce.	[Porth, Ilga; Ritland, Carol; Ritland, Kermit] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [White, Richard] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Jaquish, Barry] Columbia Minist Forests Lands & Nat Resource Oper, Kalamalka Forestry Ctr, Vernon, BC, Canada; [Alfaro, Rene] Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	University of British Columbia; University of British Columbia; Natural Resources Canada; Canadian Forest Service	Porth, I (corresponding author), Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada.	porth@mail.ubc.ca	Porth, Ilga M/N-4862-2015	Porth, Ilga M/0000-0002-9344-6348	Genome British Columbia; Genome Canada	Genome British Columbia; Genome Canada(Genome Canada)	This work was carried out with financial support from Genome British Columbia and Genome Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2007, ADVANCES IN PLANT ETHYLENE RESEARCH, P81, DOI 10.1007/978-1-4020-6014-4_18; Alfaro RI, 2008, FOREST ECOL MANAG, V255, P1749, DOI 10.1016/j.foreco.2007.11.032; Alfaro RI, 2004, FOREST ECOL MANAG, V202, P369, DOI 10.1016/j.foreco.2004.08.001; ALFARO RI, 1995, CAN J FOREST RES, V25, P1725, DOI 10.1139/x95-186; Alfaro RI, 1997, CAN J BOT, V75, P568, DOI 10.1139/b97-063; Baum G, 1996, PLANT PHYSIOL, V111, P15; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; Chae H, 2005, TRENDS PLANT SCI, V10; Chagne D, 2003, MOL BREEDING, V12, P185, DOI 10.1023/A:1026318327911; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Drost DR, 2010, P NATL ACAD SCI USA, V107, P8492, DOI 10.1073/pnas.0914709107; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Ferreira FJ, 2008, PLANT PHYSIOL, V147, P585, DOI 10.1104/pp.108.118661; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Fu JY, 2006, GENETICS, V172, P1993, DOI 10.1534/genetics.105.047001; Gardner KM, 2007, MOL ECOL, V16, P4195, DOI 10.1111/j.1365-294X.2007.03499.x; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; He FL, 2000, ECOL APPL, V10, P225, DOI 10.1890/1051-0761(2000)010[0225:WPWAOW]2.0.CO;2; HERMS DA, 1992, Q REV BIOL, V67, P478; Holliday JA, 2008, NEW PHYTOL, V178, P103, DOI 10.1111/j.1469-8137.2007.02346.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hu XS, 2004, THEOR APPL GENET, V109, P996, DOI 10.1007/s00122-004-1705-x; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Karrenberg S, 2008, CURR OPIN PLANT BIOL, V11, P156, DOI 10.1016/j.pbi.2008.01.004; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kempel A, 2011, P NATL ACAD SCI USA, V108, P5685, DOI 10.1073/pnas.1016508108; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; KISS GK, 1991, CAN J FOREST RES, V21, P230, DOI 10.1139/x91-028; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Koutaniemi S, 2007, PLANT MOL BIOL, V65, P311, DOI 10.1007/s11103-007-9220-5; Lieutier F, 2003, TREE PHYSIOL, V23, P247, DOI 10.1093/treephys/23.4.247; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; MOLE S, 1994, OIKOS, V71, P3, DOI 10.2307/3546166; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Naranjo MA, 2006, PLANT CELL ENVIRON, V29, P1890, DOI 10.1111/j.1365-3040.2006.01565.x; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Porth I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-608; Pot D, 2005, NEW PHYTOL, V167, P101, DOI 10.1111/j.1469-8137.2005.01417.x; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Ralph S, 2006, PLANT MOL BIOL, V60, P21, DOI 10.1007/s11103-005-2226-y; Ralph SG, 2007, PHYTOCHEMISTRY, V68, P1975, DOI 10.1016/j.phytochem.2007.04.042; Ralph SG, 2006, PLANT CELL ENVIRON, V29, P1545, DOI 10.1111/j.1365-3040.2006.01532.x; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; Schmelz EA, 2007, PLANT PHYSIOL, V144, P793, DOI 10.1104/pp.107.097154; Sewell MM, 1999, GENETICS, V151, P321; Sewell MM, 2002, THEOR APPL GENET, V104, P214, DOI 10.1007/s001220100697; Shanmugam V, 2005, MICROBIOL RES, V160, P83, DOI 10.1016/j.micres.2004.09.014; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Steppuhn Anke, 2008, P61, DOI 10.1007/978-1-4020-8182-8_3; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Street NR, 2006, PLANT J, V48, P321, DOI 10.1111/j.1365-313X.2006.02864.x; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Van Zandt PA, 2007, ECOLOGY, V88, P1984, DOI 10.1890/06-1329.1; vanAkker L, 2004, CAN J FOREST RES, V34, P855, DOI 10.1139/X03-245; VANDERSAR TJD, 1977, CAN J ZOOL, V55, P2042, DOI 10.1139/z77-265; Worley AC, 2003, AM NAT, V161, P153, DOI 10.1086/345461; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Zangerl AR, 1997, OECOLOGIA, V109, P433, DOI 10.1007/s004420050103; Zhao JM, 1996, PLANT CELL, V8, P2235, DOI 10.1105/tpc.8.12.2235	82	17	18	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44397	10.1371/journal.pone.0044397	http://dx.doi.org/10.1371/journal.pone.0044397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973444	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600048
J	Pick, E; Golan, A; Zimbler, JZ; Guo, L; Sharaby, Y; Tsuge, T; Hofmann, K; Wei, N				Pick, Elah; Golan, Amnon; Zimbler, Jacob Z.; Guo, Liquan; Sharaby, Yehonatan; Tsuge, Tomohiko; Hofmann, Kay; Wei, Ning			The Minimal Deneddylase Core of the COP9 Signalosome Excludes the Csn6 MPN- Domain	PLOS ONE			English	Article							UBIQUITIN LIGASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; REGULATORY PARTICLE; 26S PROTEASOME; PCI COMPLEXES; DNA-DAMAGE; YEAST; SUBUNITS; PROTEIN	The COP9 signalosome (CSN) is a eukaryotic protein complex, which regulates a wide range of biological processes mainly through modulating the cullin ubiquitin E3 ligases in the ubiquitin-proteasome pathway. The CSN possesses a highly conserved deneddylase activity that centers at the JAMM motif of the Csn5 subunit but requires other subunits in a complex assembly. The classic CSN is composed of 8 subunits (Csn1-8), yet in several Ascomycota, the complex is smaller and lacks orthologs for a few CSN subunits, but nevertheless contains a conserved Csn5. This feature makes yeast a powerful model to determine the minimal assemblage required for deneddylation activity. Here we report, that Csi1, a diverged S. cerevisiae CSN subunit, displays significant homology with the carboxyl terminal domain of the canonical Csn6, but lacks the amino terminal MPN- domain. Through the comparative and experimental analyses of the budding yeast and the mammalian CSNs, we demonstrate that the MPN- domain of the canonical mouse Csn6 is not part of the CSN deneddylase core. We also show that the carboxyl domain of Csn6 has an indispensable role in maintaining the integrity of the CSN complex. The CSN complex assembled with the carboxyl fragment of Csn6, despite its lack of an MPN- domain, is fully active in deneddylation of cullins. We propose that the budding yeast Csi1 is a functional equivalent of the canonical Csn6, and thus the composition of the CSN across phyla is more conserved than hitherto appreciated.	[Pick, Elah; Golan, Amnon; Zimbler, Jacob Z.; Sharaby, Yehonatan] Univ Haifa, Dept Biol, Tivon, Israel; [Pick, Elah; Zimbler, Jacob Z.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50931 Cologne, Germany; [Guo, Liquan; Tsuge, Tomohiko; Wei, Ning] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of Haifa; University of Haifa; University of Cologne; Yale University	Pick, E (corresponding author), Univ Haifa, Dept Biol, Tivon, Israel.	elahpic@research.haifa.ac.il	Tsuge, Tomohiko/GVY-1467-2022; Pick, Elah/G-6137-2018	Tsuge, Tomohiko/0000-0003-2736-0295; Pick, Elah/0000-0002-6591-2217; Wei, Ning/0000-0001-8827-1320; Sharaby, Yehonatan/0000-0002-1936-431X	Israel Science Foundation grant [EP355/10]; Ministry of Science and Technology, Israel Italy [3-9022]; China Program for New Century Excellent Talent in University [NCET-10-0153]; China Postdoctoral Science Foundation [201104519, 20100481042]; Grants-in-Aid for Scientific Research [22570041] Funding Source: KAKEN	Israel Science Foundation grant(Israel Science Foundation); Ministry of Science and Technology, Israel Italy; China Program for New Century Excellent Talent in University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Israel Science Foundation grant [EP355/10] and by the Ministry of Science and Technology, Israel Italy [3-9022] to EP. LG is supported by China Program for New Century Excellent Talent in University [NCET-10-0153] and China Postdoctoral Science Foundation [201104519; 20100481042]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bellare P, 2006, RNA, V12, P292, DOI 10.1261/rna.2152306; Braus GH, 2010, CURR OPIN MICROBIOL, V13, P672, DOI 10.1016/j.mib.2010.09.011; Chang Eric C, 2004, EMBO Rep, V5, P1041, DOI 10.1038/sj.embor.7400275; Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; Choi HH, 2011, ONCOGENE, V30, P4791, DOI 10.1038/onc.2011.192; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Correia JD, 2007, J BIOL CHEM, V282, P12557, DOI 10.1074/jbc.M609587200; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Golan A, 2010, CELL CYCLE, V9, P2647, DOI 10.4161/cc.9.13.12121; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Hetfeld BKJ, 2008, APOPTOSIS, V13, P187, DOI 10.1007/s10495-007-0164-7; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Jiang HY, 2011, NUCLEIC ACIDS RES, V39, P5119, DOI 10.1093/nar/gkr103; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Maytal-Kivity V, 2002, EMBO REP, V3, P1215, DOI 10.1093/embo-reports/kvf235; Maytal-Kivity V, 2003, INT J BIOCHEM CELL B, V35, P706, DOI 10.1016/S1357-2725(02)00378-3; Menon S, 2005, METHOD ENZYMOL, V398, P468, DOI 10.1016/S0076-6879(05)98038-5; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; Pick E, 2009, EMBO REP IN PRESS; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rossignol T, 2008, NUCLEIC ACIDS RES, V36, pD557, DOI 10.1093/nar/gkm1010; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Su H, 2008, INT J BIOCH CELL BIO; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; von Arnim AG, 2006, MOL CELL, V23, P621, DOI 10.1016/j.molcel.2006.08.012; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yu ZL, 2011, MOL BIOL CELL, V22, P911, DOI 10.1091/mbc.E10-08-0655; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111	56	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2012	7	8							e43980	10.1371/journal.pone.0043980	http://dx.doi.org/10.1371/journal.pone.0043980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	997ZH	22956996	Green Submitted, Green Published, gold			2022-12-27	WOS:000308206500033
J	Dahboul, F; Leroy, P; Gate, KM; Boudier, A; Gaucher, C; Liminana, P; Lartaud, I; Pompella, A; Perrin-Sarrado, C				Dahboul, Fatima; Leroy, Pierre; Gate, Katy Maguin; Boudier, Ariane; Gaucher, Caroline; Liminana, Patrick; Lartaud, Isabelle; Pompella, Alfonso; Perrin-Sarrado, Caroline			Endothelial gamma-Glutamyltransferase Contributes to the Vasorelaxant Effect of S-Nitrosoglutathione in Rat Aorta	PLOS ONE			English	Article							AGONIST-EVOKED CONTRACTION; NITRIC-OXIDE; SMOOTH-MUSCLE; GLUTATHIONE; TRANSPEPTIDASE; SYSTEM; RELAXATION; INCUBATION; SUBSTRATE; DISEASES	S-nitrosoglutathione (GSNO) involved in storage and transport of nitric oxide (N NO) plays an important role in vascular homeostasis. Breakdown of GSNO can be catalyzed by gamma-glutamyltransferase (GGT). We investigated whether vascular GGT influences the vasorelaxant effect of GSNO in isolated rat aorta. Histochemical localization of GGT and measurement of its activity were performed by using chromogenic substrates in sections and in aorta homogenates, respectively. The role of GGT in GSNO metabolism was evaluated by measuring GSNO consumption rate (absorbance decay at 334 nm), (NO)-N-center dot release was visualized and quantified with the fluorescent probe 4,5-diaminofluorescein diacetate. The vasorelaxant effect of GSNO was assayed using isolated rat aortic rings (in the presence or absence of endothelium). The role of GGT was assessed by stimulating enzyme activity with cosubstrate glycylglycine, as well as using two independent inhibitors, competitive serine borate complex and non-competitive acivicin. Specific GGT activity was histochemically localized in the endothelium. Consumption of GSNO and release of free (NO)-N-center dot decreased and increased in presence of serine borate complex and glycylglycine, respectively. In vasorelaxation experiments with endothelium-intact aorta, the half maximal effective concentration of GSNO (EC50 = 3.2 +/- 0.5.10(-7) M) increased in the presence of the two distinct GGT inhibitors, serine borate complex (1.6 +/- 0.2.10(-6) M) and acivicin (8.3 +/- 0.6.10(-7) M), while it decreased with glycylglycine (4.7 +/- 0.9.10(-8) M). In endothelium-denuded aorta, EC50 for GSNO alone increased to 2.3 +/- 0.3.10(-6) M, with no change in the presence of serine borate complex. These data demonstrate the important role of endothelial GGT activity in mediating the vasorelaxant effect of GSNO in rat aorta under physiological conditions. Because therapeutic treatments based on GSNO are presently under development, this endothelium-dependent mechanism involved in the vascular effects of GSNO should be taken into account in a pharmacological perspective.	[Dahboul, Fatima; Leroy, Pierre; Gate, Katy Maguin; Boudier, Ariane; Gaucher, Caroline; Liminana, Patrick; Lartaud, Isabelle; Pompella, Alfonso; Perrin-Sarrado, Caroline] Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France	Universite de Lorraine	Dahboul, F (corresponding author), Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France.	Caroline.Perrin-Sarrado@univ-lorraine.fr	DAHBOUL, Fatima/GWV-1482-2022	perrin-sarrado, caroline/0000-0002-3483-1211; Gaucher, Caroline/0000-0002-0886-5522; Lartaud, Isabelle/0000-0001-9257-6311	National Agency for Research (ANR, NanoSNO project); French Ministry of Education, Research and Technology (Paris, France) [EA3452]; Lorraine Regional Development Committee (Metz, France) [CPER 2007-13 PRST]; Universite de Lorraine (Nancy, France) [UHP_2010_BMS_EA3452_0047]	National Agency for Research (ANR, NanoSNO project)(French National Research Agency (ANR)); French Ministry of Education, Research and Technology (Paris, France); Lorraine Regional Development Committee (Metz, France); Universite de Lorraine (Nancy, France)	The authors are grateful to Melanie THOMAS and Anais DURET for their helpful contribution to experimental studies. The authors acknowledge the National Agency for Research (ANR, NanoSNO project), the French Ministry of Education, Research and Technology (Paris, France, EA3452), the Lorraine Regional Development Committee (Metz, France) (CPER 2007-13 PRST "Ingenierie Moleculaire et Therapeutique - Sante" Pr. P. NETTER, axe "Molecules et Ciblage Therapeutique" Dr. Y. CHAPLEUR), and Universite de Lorraine (Nancy, France) (project UHP_2010_BMS_EA3452_0047).	Alencar JL, 2003, J PHARMACOL EXP THER, V307, P152, DOI 10.1124/jpet.103.052605; Angeli V, 2009, ARCH BIOCHEM BIOPHYS, V481, P191, DOI 10.1016/j.abb.2008.10.027; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bramanti E, 2009, ARCH BIOCHEM BIOPHYS, V487, P146, DOI 10.1016/j.abb.2009.05.012; Corti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034772; COTGREAVE IA, 1994, BBA-MOL CELL RES, V1222, P375, DOI 10.1016/0167-4889(94)90043-4; Dominici S, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-7; Franzini M, 2009, ATHEROSCLEROSIS, V202, P119, DOI 10.1016/j.atherosclerosis.2008.03.023; Gate KM, 2011, BRAIN RES, V1369, P95, DOI 10.1016/j.brainres.2010.10.100; Gaucher C, 2012, CURR PHARM IN PRESS; Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Hanspal IS, 2002, NITRIC OXIDE-BIOL CH, V6, P263, DOI 10.1006/niox.2001.0412; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Heikal L, 2011, BIOMACROMOLECULES, V12, P2103, DOI 10.1021/bm200159h; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; HUSEBY NE, 1974, SCAND J CLIN LAB INV, V34, P357, DOI 10.3109/00365517409049892; KREJCY K, 1995, ARTERIOSCL THROM VAS, V15, P2063, DOI 10.1161/01.ATV.15.11.2063; Lartaud I, 2007, FUND CLIN PHARMACOL, V21, P273, DOI 10.1111/j.1472-8206.2007.00484.x; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; MCANINLY J, 1993, J CHEM SOC CHEM COMM, P1758, DOI 10.1039/c39930001758; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; Pompella A, 2004, CLIN CHEM LAB MED, V42, P1085, DOI 10.1515/CCLM.2004.224; Rassaf T, 2006, EUR HEART J, V27, P1699, DOI 10.1093/eurheartj/ehl096; Resende AC, 2004, LIFE SCI, V76, P9, DOI 10.1016/j.lfs.2004.04.058; Rodriguez J, 2005, FREE RADICAL BIO MED, V38, P356, DOI 10.1016/j.freeradbiomed.2004.10.036; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Sogo N, 2000, BRIT J PHARMACOL, V131, P1236, DOI 10.1038/sj.bjp.0703700; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; Tran NNP, 1998, J PHYSIOL-LONDON, V507, P163, DOI 10.1111/j.1469-7793.1998.163bu.x; Wang CH, 2004, FUND CLIN PHARMACOL, V18, P679, DOI 10.1111/j.1472-8206.2004.00293.x; Xu AM, 2000, HYPERTENSION, V36, P291, DOI 10.1161/01.HYP.36.2.291	33	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43190	10.1371/journal.pone.0043190	http://dx.doi.org/10.1371/journal.pone.0043190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984412	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700014
J	Wang, Q; Lei, Y; Xu, XW; Wang, GJ; Chen, LL				Wang, Qian; Lei, Yang; Xu, Xiwen; Wang, Gejiao; Chen, Ling-Ling			Theoretical Prediction and Experimental Verification of Protein-Coding Genes in Plant Pathogen Genome Agrobacterium tumefaciens Strain C58	PLOS ONE			English	Article							CODON USAGE; RECOGNITION; PROKARYOTES; ANNOTATION; SEQUENCES; BACTERIAL	Agrobacterium tumefaciens strain C58 is a Gram-negative soil bacterium capable of inducing tumors (crown galls) on many dicotyledonous plants. The genome of A. tumefaciens strain C58 was re-annotated based on the Z-curve method. First, all the 'hypothetical genes' were re-identified, and 29 originally annotated 'hypothetical genes' were recognized to be non-coding open reading frames (ORFs). Theoretical evidence obtained from principal component analysis, clusters of orthologous groups of proteins occupation, and average length distribution showed that these non-coding ORFs were highly unlikely to encode proteins. Results from the reverse transcription-polymerase chain reaction (RT-PCR) experiments on three different growth stages of A. tumefaciens C58 confirmed that 23 (79%) of the identified non-coding ORFs have no transcripts in these growth stages. In addition, using theoretical prediction, 19 potential protein-coding genes were predicted to be new protein-coding genes. Fifteen (79%) of these genes were verified with RT-PCR experiments. The RT-PCR experimental results confirmed the reliability of our theoretical prediction, indicating that false-positive prediction and missing genes always exist in the annotation of A. tumefaciens C58 genome. The improved annotation will serve as a valuable resource for the research of the lifestyle, metabolism, and pathogenicity of A. tumefaciens C58. The re-annotation of A. tumefaciens C58 can be obtained from http://211.69.128.148/Atum/.	[Wang, Qian; Lei, Yang; Xu, Xiwen; Wang, Gejiao; Chen, Ling-Ling] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Lei, Yang; Xu, Xiwen; Chen, Ling-Ling] Huazhong Agr Univ, Ctr Bioinformat, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Wang, Q (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn; llchen@mail.hzau.edu.cn	Wang, Qian/AAC-9717-2021; Chen, Ling-Ling/AAY-3547-2021	Wang, Qian/0000-0003-4507-0523; 	National Natural Science Foundation of China [31010103903, 31071659]; National Basic Research Program of China [2010CB126100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the Major International Joint Research Project, National Natural Science Foundation of China (31010103903, 31071659), and the National Basic Research Program of China (2010CB126100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Chen LL, 2003, J BIOMOL STRUCT DYN, V21, P99, DOI 10.1080/07391102.2003.10506908; Chiusano ML, 2000, GENE, V261, P63, DOI 10.1016/S0378-1119(00)00521-7; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Dillon W., 1984, MULTIVARIATE ANAL ME, DOI [10.1002/bimj.4710290617, DOI 10.1002/BIMJ.4710290617]; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rosen R, 2004, PROTEOMICS, V4, P1061, DOI 10.1002/pmic.200300640; Rosen R, 2011, PROTEOMICS, V11, P3134, DOI 10.1002/pmic.201100019; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Sambrook J., 2001, MOL CLONING LAB MANU; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Yu JF, 2011, DNA RES, V18, P435, DOI 10.1093/dnares/dsr030; ZHANG CT, 1991, NUCLEIC ACIDS RES, V19, P6313, DOI 10.1093/nar/19.22.6313; ZHANG CT, 1994, J MOL BIOL, V238, P1, DOI 10.1006/jmbi.1994.1263; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	29	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43176	10.1371/journal.pone.0043176	http://dx.doi.org/10.1371/journal.pone.0043176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984411	Green Submitted, gold, Green Published			2022-12-27	WOS:000308638700013
J	Kovalenko, M; Dragileva, E; St Claire, J; Gillis, T; Guide, JR; New, J; Dong, HL; Kucherlapati, R; Kucherlapati, MH; Ehrlich, ME; Lee, JM; Wheeler, VC				Kovalenko, Marina; Dragileva, Ella; St Claire, Jason; Gillis, Tammy; Guide, Jolene R.; New, Jaclyn; Dong, Hualing; Kucherlapati, Raju; Kucherlapati, Melanie H.; Ehrlich, Michelle E.; Lee, Jong-Min; Wheeler, Vanessa C.			Msh2 Acts in Medium-Spiny Striatal Neurons as an Enhancer of CAG Instability and Mutant Huntingtin Phenotypes in Huntington's Disease Knock-In Mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; REPEAT INSTABILITY; SOMATIC INSTABILITY; LENGTH; EXPANSION; AGE; VULNERABILITY; ONSET; VARIABILITY; CONTRACTION	The CAG trinucleotide repeat mutation in the Huntington's disease gene (HTT) exhibits age-dependent tissue-specific expansion that correlates with disease onset in patients, implicating somatic expansion as a disease modifier and potential therapeutic target. Somatic HTT CAG expansion is critically dependent on proteins in the mismatch repair (MMR) pathway. To gain further insight into mechanisms of somatic expansion and the relationship of somatic expansion to the disease process in selectively vulnerable MSNs we have crossed HTT CAG knock-in mice (HdhQ111) with mice carrying a conditional (floxed) Msh2 allele and D9-Cre transgenic mice, in which Cre recombinase is expressed specifically in MSNs within the striatum. Deletion of Msh2 in MSNs eliminated Msh2 protein in those neurons. We demonstrate that MSN-specific deletion of Msh2 was sufficient to eliminate the vast majority of striatal HTT CAG expansions in HdhQ111 mice. Furthermore, MSN-specific deletion of Msh2 modified two mutant huntingtin phenotypes: the early nuclear localization of diffusely immunostaining mutant huntingtin was slowed; and the later development of intranuclear huntingtin inclusions was dramatically inhibited. Therefore, Msh2 acts within MSNs as a genetic enhancer both of somatic HTT CAG expansions and of HTT CAG-dependent phenotypes in mice. These data suggest that the selective vulnerability of MSNs may be at least in part contributed by the propensity for somatic expansion in these neurons, and imply that intervening in the expansion process is likely to have therapeutic benefit.	[Kovalenko, Marina; Dragileva, Ella; St Claire, Jason; Gillis, Tammy; Guide, Jolene R.; New, Jaclyn; Dong, Hualing; Lee, Jong-Min; Wheeler, Vanessa C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kucherlapati, Raju; Kucherlapati, Melanie H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ehrlich, Michelle E.] Thomas Jefferson Univ, Coll Med, Farber Inst Neurosci, Philadelphia, PA 19107 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Jefferson University	Kovalenko, M (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	Wheeler@chgr.mgh.harvard.edu	Kucherlapati, Raju/ABC-8807-2021; Kucherlapati, Melanie/GXN-1132-2022		National Institutes of Health [NS049206]; CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NS049206] and the CHDI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogush AI, 2005, GENESIS, V42, P37, DOI 10.1002/gene.20118; Chung DW, 2011, HUM MOL GENET, V20, P3467, DOI 10.1093/hmg/ddr263; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Harper PS, 1999, PHILOS T ROY SOC B, V354, P957, DOI 10.1098/rstb.1999.0446; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Jung J, 2011, GENETICS, V187, P61, DOI 10.1534/genetics.110.121418; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023647; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; McFarland Karen N, 2011, Handb Clin Neurol, V100, P25, DOI 10.1016/B978-0-444-52014-2.00003-3; Nakamori M, 2011, MOL THER, V19, P2222, DOI 10.1038/mt.2011.191; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Silva-Fernandes A, 2010, NEUROBIOL DIS, V40, P163, DOI 10.1016/j.nbd.2010.05.021; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Veitch NJ, 2007, DNA REPAIR, V6, P789, DOI 10.1016/j.dnarep.2007.01.002; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Watase K, 2003, HUM MOL GENET, V12, P2789, DOI 10.1093/hmg/ddg300; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Wheeler VC, 2007, J MED GENET, V44, P695, DOI 10.1136/jmg.2007.050930; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063	44	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44273	10.1371/journal.pone.0044273	http://dx.doi.org/10.1371/journal.pone.0044273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970194	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000017
J	Lin, LL; Huang, HC; Juan, HF				Lin, Li-Ling; Huang, Hsuan-Cheng; Juan, Hsueh-Fen			Revealing the Molecular Mechanism of Gastric Cancer Marker Annexin A4 in Cancer Cell Proliferation Using Exon Arrays	PLOS ONE			English	Article							HELICOBACTER-PYLORI; EXPRESSION; IV; CALCIUM; OVEREXPRESSION; KINASE; AKT; ACTIVATION; PACLITAXEL; CARCINOMA	Gastric cancer is a malignant disease that arises from the gastric epithelium. A potential biomarker for gastric cancer is the protein annexin A4 (ANXA4), an intracellular Ca2+ sensor. ANXA4 is primarily found in epithelial cells, and is known to be involved in various biological processes, including apoptosis, cell cycling and anticoagulation. In respect to cancer, ANXA4-overexpression has been observed in cancers of various origins, including gastric tumors associated with Helicobacter pylori infection. H. pylori induces ANXA4 expression and intracellular [Ca2+](i) elevation, and is an important risk factor for carcinogenesis that results in gastric cancer. Despite this correlation, the role of ANXA4 in the progression of gastric tumors remains unclear. In this study, we have investigated whether ANXA4 can mediate the rate of cell growth and whether ANXA4 downstream signals are involved in tumorigenesis. After observing the rate of cell growth in real-time, we determined that ANXA4 promotes cell proliferation. The transcription gene profile of ANXA4-overexpressing cells was measured and analyzed by human exon arrays. From this transcriptional gene data, we show that overexpression of ANXA4 regulates genes that are known to be related to cancer, for example the activation of hyaluronan mediated motility receptor (RHAMM), AKT, and cyclin-dependent kinase 1 (CDK1) as well as the suppression of p21. The regulation of these genes further induces cancer cell proliferation. We also found Ca2+ could regulate the transmission of downstream signals by ANXA4. We suggest that ANXA4 triggers a signaling cascade, leading to increased epithelial cell proliferation, ultimately promoting carcinogenesis. These results might therefore provide a new insight for gastric cancer therapy, specifically through the modification of ANXA4 activity.	[Lin, Li-Ling; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University	Lin, LL (corresponding author), Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hsuancheng@ym.edu.tw; yukijuan@ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Lin, Li-Ling/0000-0001-9891-5900; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council of Taiwan [NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001-MY3]; National Taiwan University Cutting-Edge Steering Research Project [10R70602C3]; National Health Research Institute, Taiwan [NHRIEX100-9819PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001-MY3), the National Taiwan University Cutting-Edge Steering Research Project (10R70602C3) and the National Health Research Institute, Taiwan (NHRIEX100-9819PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Banerjee SK, 2000, AM J PATHOL, V156, P217, DOI 10.1016/S0002-9440(10)64722-0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Cinti C, 2008, VIRCHOWS ARCH, V453, P449, DOI 10.1007/s00428-008-0676-8; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Emoto K, 2001, ANTICANCER RES, V21, P1339; Fan XG, 1996, GUT, V38, P19, DOI 10.1136/gut.38.1.19; Fatimathas L, 2010, HISTOL HISTOPATHOL, V25, P527, DOI 10.14670/HH-25.527; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Han EKH, 2000, BRIT J CANCER, V83, P83; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Kim A, 2009, INT J CANCER, V125, P2316, DOI 10.1002/ijc.24587; Kim SS, 2011, CANCER LETT, V305, P228, DOI 10.1016/j.canlet.2010.07.014; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Li H, 2000, INT J ONCOL, V17, P927; Li WW, 1999, MOL PHARMACOL, V55, P1088, DOI 10.1124/mol.55.6.1088; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin LL, 2008, PROTEOM CLIN APPL, V2, P619, DOI 10.1002/prca.200780088; Lin LL, 2012, J PROTEOMICS, V75, P3081, DOI 10.1016/j.jprot.2012.03.046; LIU CM, 1978, J BIOL CHEM, V253, P5892; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; Masuda J, 2004, THROMB HAEMOSTASIS, V91, P1129, DOI 10.1160/TH03-12-0778; Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Ohkawa H, 2002, BBA-MOL BASIS DIS, V1588, P217, DOI 10.1016/S0925-4439(02)00168-0; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Richardson PG, 2011, J CLIN ONCOL, V29, P4243, DOI 10.1200/JCO.2010.33.9788; Sampson HA, 2011, J ALLERGY CLIN IMMUN, V127, P1309, DOI 10.1016/j.jaci.2011.01.051; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Shinwari Z, 2008, J NEURO-ONCOL, V87, P123, DOI 10.1007/s11060-007-9502-4; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; VERITY MA, 1992, NEUROTOXICOLOGY, V13, P139; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yamashita T, 2012, BIOCHEM BIOPH RES CO, V421, P140, DOI 10.1016/j.bbrc.2012.03.144; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhai SP, 2002, ANN PHARMACOTHER, V36, P905; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002	63	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44615	10.1371/journal.pone.0044615	http://dx.doi.org/10.1371/journal.pone.0044615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970268	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000038
J	Van Engen, KJ; Chandrasekaran, B; Smiljanic, R				Van Engen, Kristin J.; Chandrasekaran, Bharath; Smiljanic, Rajka			Effects of Speech Clarity on Recognition Memory for Spoken Sentences	PLOS ONE			English	Article							CLEAR SPEECH; VOWEL INTELLIGIBILITY; CONVERSATIONAL SPEECH; HEARING-LOSS; ACOUSTIC CHARACTERISTICS; TALKER DIFFERENCES; VOICE RECOGNITION; OLDER-ADULTS; SPEAKING; WORD	Extensive research shows that inter-talker variability (i.e., changing the talker) affects recognition memory for speech signals. However, relatively little is known about the consequences of intra-talker variability (i.e. changes in speaking style within a talker) on the encoding of speech signals in memory. It is well established that speakers can modulate the characteristics of their own speech and produce a listener-oriented, intelligibility-enhancing speaking style in response to communication demands (e. g., when speaking to listeners with hearing impairment or non-native speakers of the language). Here we conducted two experiments to examine the role of speaking style variation in spoken language processing. First, we examined the extent to which clear speech provided benefits in challenging listening environments (i.e. speech-in-noise). Second, we compared recognition memory for sentences produced in conversational and clear speaking styles. In both experiments, semantically normal and anomalous sentences were included to investigate the role of higher-level linguistic information in the processing of speaking style variability. The results show that acoustic-phonetic modifications implemented in listener-oriented speech lead to improved speech recognition in challenging listening conditions and, crucially, to a substantial enhancement in recognition memory for sentences.	[Van Engen, Kristin J.; Smiljanic, Rajka] Univ Texas Austin, Dept Linguist, Austin, TX 78712 USA; [Van Engen, Kristin J.; Chandrasekaran, Bharath] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Dept Psychol, Inst Neurosci, Ctr Perceptual Syst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Van Engen, KJ (corresponding author), Univ Texas Austin, Dept Linguist, Austin, TX 78712 USA.	kvanengen@wustl.edu		Van Engen, Kristin/0000-0001-9069-5464; Chandrasekaran, Bharath/0000-0002-3673-9435				Abercrombie D., 1967, ELEMENTS GEN PHONETI; [Anonymous], 1979, SOCIAL MARKERS SPEEC; Boersma P, 2021, PRAAT DOING PHONETIC; BOOTHROYD A, 1988, J ACOUST SOC AM, V84, P101, DOI 10.1121/1.396976; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P206, DOI 10.3758/BF03206883; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); Bradlow AR, 2002, J ACOUST SOC AM, V112, P272, DOI 10.1121/1.1487837; Calandruccio L, 2012, J SPEECH LANG HEAR R; Chandrasekaran B, 2011, J COGNITIVE NEUROSCI, V23, P2690, DOI 10.1162/jocn.2011.21631; Clopper CG, 2005, BLACKW HBK LINGUIST, P313; DAVIES GM, 1979, AM J PSYCHOL, V92, P507, DOI 10.2307/1421569; Ferguson SH, 2012, J SPEECH LANG HEAR R, V55, P779, DOI 10.1044/1092-4388(2011/10-0342); Ferguson SH, 2004, J ACOUST SOC AM, V116, P2365, DOI 10.1121/1.1788730; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; GLANZER M, 1974, J VERB LEARN VERB BE, V13, P114, DOI 10.1016/S0022-5371(74)80036-8; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; GOLDINGER SD, 1991, J EXP PSYCHOL LEARN, V17, P152, DOI 10.1037/0278-7393.17.1.152; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Hazan V, 2004, J ACOUST SOC AM, V116, P3108, DOI 10.1121/1.1806826; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kang KH, 2008, J ACOUST SOC AM, V124, P3909, DOI 10.1121/1.2988292; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Krause JC, 2002, J ACOUST SOC AM, V112, P2165, DOI 10.1121/1.1509432; KREIMAN J, 1988, BRAIN LANG, V34, P246, DOI 10.1016/0093-934X(88)90136-8; Kreiman J., 1997, TALKER VARIABILITY S, P85; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209; LANDIS T, 1982, NEUROPSYCHOLOGIA, V20, P501, DOI 10.1016/0028-3932(82)90049-5; Laver J, 1989, LOGIC LINGUISTICS, P37; LAVER JDM, 1968, BRIT J DISORD COMMUN, V3, P43; Liu S, 2004, J ACOUST SOC AM, V116, P2374, DOI 10.1121/1.1787528; Liu S, 2006, J ACOUST SOC AM, V120, P424, DOI 10.1121/1.2208427; Maniwa K, 2009, J ACOUST SOC AM, V125, P3962, DOI 10.1121/1.2990715; Matthies M, 2001, J SPEECH LANG HEAR R, V44, P340, DOI 10.1044/1092-4388(2001/028); McCoy SL, 2005, Q J EXP PSYCHOL-A, V58, P22, DOI 10.1080/02724980443000151; MILLER GA, 1963, J VERB LEARN VERB BE, V2, P217, DOI 10.1016/S0022-5371(63)80087-0; MULLENNIX JW, 1990, PERCEPT PSYCHOPHYS, V47, P379, DOI 10.3758/BF03210878; Murphy DR, 2000, PSYCHOL AGING, V15, P49; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nye PW, 1974, SR3738 HASK LAB; NYGAARD LC, 1994, PSYCHOL SCI, V5, P42, DOI 10.1111/j.1467-9280.1994.tb00612.x; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; PAYTON KL, 1994, J ACOUST SOC AM, V95, P1581, DOI 10.1121/1.408545; Perkell JS, 2002, J ACOUST SOC AM, V112, P1627, DOI 10.1121/1.1506369; PICHENY MA, 1989, J SPEECH HEAR RES, V32, P600, DOI 10.1044/jshr.3203.600; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; PODD J, 1990, APPL COGNITIVE PSYCH, V4, P47, DOI 10.1002/acp.2350040105; R Development Core Team, 2005, R LANG ENV STAT COMP; RABBITT P, 1991, ACTA OTO-LARYNGOL, P167; RABBITT PMA, 1968, Q J EXP PSYCHOL, V20, P241, DOI 10.1080/14640746808400158; Remez RE, 1997, J EXP PSYCHOL HUMAN, V23, P651, DOI 10.1037/0096-1523.23.3.651; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Schneider W., 2002, E PRIME USERS GUIDE; Schum D J, 1996, J Am Acad Audiol, V7, P212; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Smiljanic R, 2005, J ACOUST SOC AM, V118, P1677, DOI 10.1121/1.2000788; Smiljanic R, 2008, J ACOUST SOC AM, V124, P3171, DOI 10.1121/1.2990712; Smiljanic R, 2009, LANG LINGUIST COMPAS, V3, P236, DOI 10.1111/j.1749-818x.2008.00112.x; Smlljanlc R, 2008, J PHONETICS, V36, P91, DOI 10.1016/j.wocn.2007.02.002; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stevens AA, 2004, COGNITIVE BRAIN RES, V18, P162, DOI 10.1016/j.cogbrainres.2003.10.008; Surprenant AM, 2007, AGING NEUROPSYCHOL C, V14, P126, DOI 10.1080/13825580701217710; Surprenant AM, 1999, INT J PSYCHOL, V34, P328, DOI 10.1080/002075999399648; TULVING E, 1962, CAN J PSYCHOLOGY, V16, P83, DOI 10.1037/h0083231; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Uchanski RM, 2005, BLACKW HBK LINGUIST, P207, DOI 10.1002/9780470757024.ch9; van Boxtel MPJ, 2000, J CLIN EXP NEUROPSYC, V22, P147, DOI 10.1076/1380-3395(200002)22:1;1-8;FT147; VANLANCKER D, 1985, J PHONETICS, V13, P19, DOI 10.1016/S0095-4470(19)30723-5; Wingfield A, 2005, CURR DIR PSYCHOL SCI, V14, P144, DOI 10.1111/j.0963-7214.2005.00356.x	72	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e43753	10.1371/journal.pone.0043753	http://dx.doi.org/10.1371/journal.pone.0043753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970141	Green Published, gold, Green Submitted			2022-12-27	WOS:000308462000006
J	Wang, XY; Xiong, WL; Ma, XC; Wei, ML; Chen, YX; Lu, L; Debnath, AK; Jiang, SB; Pan, CG				Wang, Xiaoyi; Xiong, Weiliang; Ma, Xiaochu; Wei, Meili; Chen, Yanxia; Lu, Lu; Debnath, Asim K.; Jiang, Shibo; Pan, Chungen			The Conserved Residue Arg46 in the N-Terminal Heptad Repeat Domain of HIV-1 gp41 Is Critical for Viral Fusion and Entry	PLOS ONE			English	Article							ALANINE-SCANNING MUTAGENESIS; TRANSMEMBRANE PROTEIN GP41; COILED-COIL DOMAIN; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; INTERHELICAL INTERACTIONS; HELICAL INTERACTIONS; FUNCTIONAL-ANALYSIS; INHIBITORY-ACTIVITY; ATOMIC-STRUCTURE	During the process of HIV-1 fusion with the target cell, the N-terminal heptad repeat (NHR) of gp41 interacts with the C-terminal heptad repeat (CHR) to form fusogenic six-helix bundle (6-HB) core. We previously identified a crucial residue for 6-HB formation and virus entry - Lys63 (K63) in the C-terminal region of NHR (aa 54-70), which forms a hydrophobic cavity. It can form an important salt bridge with Asp121 (D121) in gp41 CHR. Here, we found another important conserved residue for virus fusion and entry, Arg46 (R46), in the N-terminal region of NHR (aa 35-53), which forms a hydrogen bond with a polar residue, Asn43 (N43), in NHR, as a part of the hydrogen-bond network. R46 can also form a salt bridge with a negatively charged residue, Glu137 (E137), in gp41 CHR. Substitution of R46 with the hydrophobic residue Ala (R46A) or the negatively charged residue Glu (R46E) resulted in disruption of the hydrogen bond network, breakage of the salt bridge and reduction of 6-HB's stability, leading to impairment of viral fusion and decreased inhibition of N36, an NHR peptide. Similarly, CHR peptide C34 with substitution of E137 for Ala (E137A) or Arg (E137R) also exhibited reduced inhibitory activity against HIV-1 infection and HIV-1-mediated cell-to-cell fusion. These results suggest that the positively charged residue R46 and its hydrogen bond network, together with the salt bridge between R46 and E137, are important for viral fusion and entry and may therefore serve as a target for designing novel HIV fusion/entry inhibitors.	[Wang, Xiaoyi; Xiong, Weiliang; Ma, Xiaochu; Wei, Meili; Chen, Yanxia; Pan, Chungen] Sun Yat Sen Univ, Dept Biochem, Key Lab Trop Dis Control MOE, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xiaoyi; Xiong, Weiliang; Ma, Xiaochu; Wei, Meili; Chen, Yanxia; Pan, Chungen] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Lu, Lu; Debnath, Asim K.; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Sun Yat Sen University; Sun Yat Sen University; Fudan University; Fudan University; New York Blood Center	Wang, XY (corresponding author), Sun Yat Sen Univ, Dept Biochem, Key Lab Trop Dis Control MOE, Guangzhou 510275, Guangdong, Peoples R China.	Shibojiang@fudan.edu.cn; Panchung@mail.sysu.edu.cn	Wang, Xiaoyi/AAD-9977-2019; lu, lu/HII-7530-2022; Lu, Lu/K-7070-2014; Jiang, Shibo/L-4500-2014; lu, lu/HGA-0894-2022	Wang, Xiaoyi/0000-0001-9373-8730; Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135; 	Guangdong Recruitment Program of Creative Research Groups [50000-3210004]; National 973 Program [2012CB519001, 2012CB519002]; National Natural Science Foundation of China [81173098]	Guangdong Recruitment Program of Creative Research Groups; National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Guangdong Recruitment Program of Creative Research Groups (50000-3210004) to CP, the National 973 Program (#2012CB519001 and 2012CB519002) to SJ and CP, respectively, and the National Natural Science Foundation of China (#81173098) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang DK, 2000, BBA-PROTEIN STRUCT M, V1478, P39, DOI 10.1016/S0167-4838(99)00286-1; Dai SJ, 2005, ACTA PHARMACOL SIN, V26, P1274, DOI 10.1111/j.1745-7254.2005.00163.x; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Follis KE, 2002, J VIROL, V76, P7356, DOI 10.1128/JVI.76.14.7356-7362.2002; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Gochin M, 2009, J MED CHEM, V52, P4338, DOI 10.1021/jm900190q; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; He YX, 2003, VACCINE, V21, P4421, DOI 10.1016/S0264-410X(03)00451-1; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu J, 2001, BIOCHEMISTRY-US, V40, P2797, DOI 10.1021/bi0024759; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang SL, 2002, BIOCHEMISTRY-US, V41, P7283, DOI 10.1021/bi025648y; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1997, P NATL ACAD SCI USA, V94, P6065, DOI 10.1073/pnas.94.12.6065; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	36	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44874	10.1371/journal.pone.0044874	http://dx.doi.org/10.1371/journal.pone.0044874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970321	gold, Green Published, Green Submitted			2022-12-27	WOS:000308462000053
J	Hayes, RD; Chang, CK; Fernandes, AC; Begum, A; To, D; Broadbent, M; Hotopf, M; Stewart, R				Hayes, Richard D.; Chang, Chin-Kuo; Fernandes, Andrea C.; Begum, Aysha; To, David; Broadbent, Matthew; Hotopf, Matthew; Stewart, Robert			Functional Status and All-Cause Mortality in Serious Mental Illness	PLOS ONE			English	Article							NATION OUTCOME SCALES; PSYCHIATRIC-PATIENTS; MEDICAL ILLNESSES; PEOPLE; HEALTH; SCHIZOPHRENIA; ASSOCIATIONS; EMPLOYMENT; SYMPTOMS; DISORDER	Background: Serious mental illness can affect many aspects of an individual's ability to function in daily life. The aim of this investigation was to determine if the environmental and functional status of people with serious mental illness contribute to the high mortality risk observed in this patient group. Methods: We identified cases of schizophrenia, schizoaffective and bipolar disorder aged >= 15 years in a large secondary mental healthcare case register linked to national mortality tracing. We modelled the effect of activities of daily living (ADLs), living conditions, occupational and recreational activities and relationship factors (Health of the Nation Outcome Scale [HoNOS] subscales) on all-cause mortality over a 4-year observation period (2007-10) using Cox regression. Results: We identified 6,880 SMI cases (242 deaths) in the observation period. ADL impairment was associated with an increased risk of all-cause mortality (adjusted HR 1.9; 95% CI 1.3-2.8; p = 0.001, p for trend across ADL categories = 0.001) after controlling for a broad range of covariates (including demographic factors, physical health, mental health symptoms and behaviours, socio-economic status and mental health service contact). No associations were found for the other three exposures. Stratification by age indicated that ADLs were most strongly associated with mortality in the youngest (15 to <35 years) and oldest (>= 55 years) groups. Conclusions: Functional impairment in people with serious mental illness diagnoses is a marker of increased mortality risk, possibly in younger age groups as a marker of negative symptomatology.	[Hayes, Richard D.; Chang, Chin-Kuo; Fernandes, Andrea C.; Begum, Aysha; Stewart, Robert] Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London WC2R 2LS, England; [To, David] Kings Coll London, Dept Biostat, London WC2R 2LS, England; [Broadbent, Matthew] S London & Maudsley NHS Fdn Trust, London, England; [Hotopf, Matthew] Kings Coll London, Inst Psychiat, Acad Dept Psychol Med, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Hayes, RD (corresponding author), Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London WC2R 2LS, England.	richard.hayes@kcl.ac.uk	Hotopf, Matthew/E-4971-2010; Hayes, Richard/D-2382-2010; Stewart, Robert/B-1667-2010; Chang, Chin-Kuo/E-4991-2010	Stewart, Robert/0000-0002-4435-6397; Chang, Chin-Kuo/0000-0002-8338-7196; Hayes, Richard/0000-0003-4453-244X; Hotopf, Matthew/0000-0002-3980-4466	Clinical Records Interactive Search (CRIS) system; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charity; Maudsley Charity	Clinical Records Interactive Search (CRIS) system; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; Guy's and St Thomas' Charity; Maudsley Charity	This study was supported by the Clinical Records Interactive Search (CRIS) system funded and developed by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. RH, CKC, AF, AB, DT, MB, MH and RS are funded by the NIHR Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The sponsors had no further role in the study design; in the collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Auquier P, 2006, PHARMACOEPIDEM DR S, V15, P873, DOI 10.1002/pds.1325; Borba CP, 2011, WOMENS HLTH ISSUES; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Capasso RM, 2008, SCHIZOPHR RES, V98, P287, DOI 10.1016/j.schres.2007.10.005; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Daumit GL, 2005, J NERV MENT DIS, V193, P641, DOI 10.1097/01.nmd.0000180737.85895.60; Dervic K, 2011, J CLIN PSYCHIAT; Fagiolini A, 2009, J CLIN PSYCHIAT, V70, P22, DOI 10.4088/JCP.7075su1c.04; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hayes RD, 2012, J PSYCHOSOM RES, V72, P114, DOI 10.1016/j.jpsychores.2011.09.012; Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hunter R, 2009, PSYCHIAT SERV, V60, P240, DOI 10.1176/appi.ps.60.2.240; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; Kilbourne AM, 2007, BIPOLAR DISORD, V9, P443, DOI 10.1111/j.1399-5618.2007.00386.x; Levinson D, 2010, BRIT J PSYCHIAT, V197, P114, DOI 10.1192/bjp.bp.109.073635; Loas G, 2011, PSYCHIAT RES, V185, P49, DOI 10.1016/j.psychres.2010.04.047; Majer I. M., 2011, American Journal of Public Health, V101, pe9, DOI 10.2105/AJPH.2011.300361; Marwaha S, 2007, BRIT J PSYCHIAT, V191, P30, DOI 10.1192/bjp.bp.105.020982; Morrell S, 1999, SOC SCI MED, V49, P383, DOI 10.1016/S0277-9536(99)00102-1; NEWMAN SJ, 1994, HOSP COMMUNITY PSYCH, V45, P338; Noble M, 2008, ENGLISH INDICES DEPR; Orrell M, 1999, BRIT J PSYCHIAT, V174, P409, DOI 10.1192/bjp.174.5.409; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Pirkis Jane E, 2005, Health Qual Life Outcomes, V3, P76, DOI 10.1186/1477-7525-3-76; Politi P, 2002, PSYCHOL MED, V32, P227, DOI 10.1017/S0033291701005116; Ramos LR, 2001, J AM GERIATR SOC, V49, P1168, DOI 10.1046/j.1532-5415.2001.49233.x; Robson D, 2007, INT J NURS STUD, V44, P457, DOI 10.1016/j.ijnurstu.2006.07.013; Roshanaei-Moghaddam B, 2009, PSYCHIAT SERV, V60, P147, DOI 10.1176/appi.ps.60.2.147; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Siris SG, 2001, J PSYCHOPHARMACOL, V15, P127, DOI 10.1177/026988110101500209; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Tilvis Reijo S, 2011, J Aging Res, V2011, P534781, DOI 10.4061/2011/534781; Wing J, 1999, BRIT J PSYCHIAT, V174, P432, DOI 10.1192/bjp.174.5.432; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11; World Health Organization, 2000, MAN INT STAT CLASS D; Wright ER, 2000, J HEALTH SOC BEHAV, V41, P68, DOI 10.2307/2676361; Wu C-Y, 2012, PSYCHOL MED IN PRESS; ZHAO L, 1993, J EPIDEMIOL COMMUN H, V47, P298, DOI 10.1136/jech.47.4.298	41	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44613	10.1371/journal.pone.0044613	http://dx.doi.org/10.1371/journal.pone.0044613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970266	Green Published, Green Submitted, gold			2022-12-27	WOS:000308458400094
J	He, YG; Wang, WR; Li, R; Wang, SJ; Jin, L				He, Yungang; Wang, Wei R.; Li, Ran; Wang, Sijia; Jin, Li			Genetic Divergence Disclosing a Rapid Prehistorical Dispersion of Native Americans in Central and South America	PLOS ONE			English	Article							MODERN HUMANS; ALLELE FREQUENCIES; FLOW; HISTORY; ORIGIN; SINGLE; MODEL; MICROSATELLITES; EVOLUTION; ASIA	An accurate estimate of the divergence time between Native Americans is important for understanding the initial entry and early dispersion of human beings in the New World. Current methods for estimating the genetic divergence time of populations could seriously depart from a linear relationship with the true divergence for multiple populations of a different population size and significant population expansion. Here, to address this problem, we propose a novel measure to estimate the genetic divergence time of populations. Computer simulation revealed that the new measure maintained an excellent linear correlation with the population divergence time in complicated multi-population scenarios with population expansion. Utilizing the new measure and microsatellite data of 21 Native American populations, we investigated the genetic divergences of the Native American populations. The results indicated that genetic divergences between North American populations are greater than that between Central and South American populations. None of the divergences, however, were large enough to constitute convincing evidence supporting the two-wave or multi-wave migration model for the initial entry of human beings into America. The genetic affinity of the Native American populations was further explored using Neighbor-Net and the genetic divergences suggested that these populations could be categorized into four genetic groups living in four different ecologic zones. The divergence of the population groups suggests that the early dispersion of human beings in America was a multi-step procedure. Further, the divergences suggest the rapid dispersion of Native Americans in Central and South Americas after a long standstill period in North America.	[He, Yungang; Wang, Wei R.; Li, Ran; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG, Partner Inst Computat Biol, Shanghai, Peoples R China; [He, Yungang; Wang, Wei R.; Li, Ran; Jin, Li] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Wang, Sijia] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Jin, Li] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Harvard University; Fudan University; Fudan University	He, YG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG, Partner Inst Computat Biol, Shanghai, Peoples R China.	yunganghe@picb.ac.cn; lijin.fudan@gmail.com	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; He, Yungang/0000-0002-2931-2871	Shanghai Institutes of Biological Sciences [2010KIP206]; National Natural Science Foundation of China [30890034, 30625016, 81100997, 31171279]; Shanghai Leading Academic Discipline Project [B111]; Center for Evolutionary Biology at Fudan University; SA-SIBS scholarship program; Youth Innovation Promotion Association, CAS	Shanghai Institutes of Biological Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Center for Evolutionary Biology at Fudan University; SA-SIBS scholarship program; Youth Innovation Promotion Association, CAS	This work was supported by grants from Shanghai Institutes of Biological Sciences (2010KIP206 to YH) and National Natural Science Foundation of China (30890034 and 30625016 to LJ, 81100997 and 31171279 to YH). LJ was also supported by Shanghai Leading Academic Discipline Project (B111) and the Center for Evolutionary Biology at Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the individuals who contributed genetic subjects and members of investigation teams who published the data set. We also thank anonymous reviewers for their comments, which improved the study and the manuscript. Y.H. gratefully acknowledges the support of SA-SIBS scholarship program and Youth Innovation Promotion Association, CAS.	Barton NH, 2008, GENET RES, V90, P139, DOI 10.1017/S0016672307009081; Beaumont MA, 1999, GENETICS, V153, P2013; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Diamond J, 2011, NATURE, V476, P291, DOI 10.1038/476291a; DILLEHAY TD, 1992, J WORLD PREHIST, V6, P145, DOI 10.1007/BF00975549; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Forster P, 1996, AM J HUM GENET, V59, P935; Galantai A, 2000, J COMPUT APPL MATH, V124, P25, DOI 10.1016/S0377-0427(00)00435-0; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Haynes G., 2002, EARLY SETTLEMENT N A; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hunley K, 2011, AM J PHYS ANTHROPOL, V146, P530, DOI 10.1002/ajpa.21506; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Neves W, 1993, AM J PHYS ANTHR S, V16, P150; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; STOTHERT KE, 1985, AM ANTIQUITY, V50, P613, DOI 10.2307/280325; Sun JX, 2009, MOL BIOL EVOL, V26, P1017, DOI 10.1093/molbev/msp025; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; VALDES AM, 1993, GENETICS, V133, P737; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILLIAMS RC, 1992, AM J HUM GENET, V51, P101; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	43	2	2	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44788	10.1371/journal.pone.0044788	http://dx.doi.org/10.1371/journal.pone.0044788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	001KC	22970308	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400121
J	Sohn, JJ; Schetter, AJ; Yfantis, HG; Ridnour, LA; Horikawa, I; Khan, MA; Robles, AI; Hussain, SP; Goto, A; Bowman, ED; Hofseth, LJ; Bartkova, J; Bartek, J; Wogan, GN; Wink, DA; Harris, CC				Sohn, Jane J.; Schetter, Aaron J.; Yfantis, Harris G.; Ridnour, Lisa A.; Horikawa, Izumi; Khan, Mohammed A.; Robles, Ana I.; Hussain, S. Perwez; Goto, Akiteru; Bowman, Elise D.; Hofseth, Lorne J.; Bartkova, Jirina; Bartek, Jiri; Wogan, Gerald N.; Wink, David A.; Harris, Curtis C.			Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; ULCERATIVE-COLITIS; CELLULAR SENESCENCE; COLORECTAL-CANCER; CROHNS-DISEASE; SYNTHASE EXPRESSION; SUSCEPTIBILITY LOCI; BREAST-CANCER; TUMOR-GROWTH; IN-VIVO	Background: Cellular senescence can be a functional barrier to carcinogenesis. We hypothesized that inflammation modulates carcinogenesis through senescence and DNA damage response (DDR). We examined the association between senescence and DDR with macrophage levels in inflammatory bowel disease (IBD). In vitro experiments tested the ability of macrophages to induce senescence in primary cells. Inflammation modulating microRNAs were identified in senescence colon tissue for further investigation. Methodology/Principal Findings: Quantitative immunohistochemistry identified protein expression by colon cell type. Increased cellular senescence (HP1 gamma; P = 0.01) or DDR (gamma H2A.X; P = 0.031, phospho-Chk2, P = 0.014) was associated with high macrophage infiltration in UC. Co-culture with macrophages (ANA-1) induced senescence in .80% of primary cells (fibroblasts MRC5, WI38), illustrating that macrophages induce senescence. Interestingly, macrophage-induced senescence was partly dependent on nitric oxide synthase, and clinically relevant NO center dot levels alone induced senescence. NO center dot induced DDR in vitro, as detected by immunofluorescence. In contrast to UC, we noted in Crohn's disease (CD) that senescence (HP1 gamma; P < 0.001) and DDR (gamma H2A.X; P < 0.05, phospho-Chk2; P < 0.001) were higher, and macrophages were not associated with senescence. We hypothesize that nitric oxide may modulate senescence in CD; epithelial cells of CD had higher levels of NOS2 expression than in UC (P = 0.001). Microarrays and quantitative-PCR identified miR-21 expression associated with macrophage infiltration and NOS2 expression. Conclusions: Senescence was observed in IBD with senescence-associated beta-galactosidase and HP1 gamma. Macrophages were associated with senescence and DDR in UC, and in vitro experiments with primary human cells showed that macrophages induce senescence, partly through NO center dot, and that NO center dot can induce DDR associated with senescence. Future experiments will investigate the role of NO center dot and miR-21 in senescence. This is the first study to implicate macrophages and nitrosative stress in a direct effect on senescence and DDR, which is relevant to many diseases of inflammation, cancer, and aging.	[Sohn, Jane J.; Schetter, Aaron J.; Horikawa, Izumi; Khan, Mohammed A.; Robles, Ana I.; Hussain, S. Perwez; Goto, Akiteru; Bowman, Elise D.; Harris, Curtis C.] Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD USA; [Yfantis, Harris G.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Yfantis, Harris G.] Univ Maryland, Sch Med, Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Ridnour, Lisa A.; Wink, David A.] Natl Canc Inst, Radiat Biol Branch, Bethesda, MD USA; [Hofseth, Lorne J.] Univ S Carolina, S Carolina Coll Pharm, Dept Pharmaceut & Biomed Sci, Columbia, SC USA; [Bartkova, Jirina; Bartek, Jiri] Canc Soc Res Ctr, Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Wogan, Gerald N.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Danish Cancer Society; Palacky University Olomouc; Massachusetts Institute of Technology (MIT)	Sohn, JJ (corresponding author), Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Bethesda, MD USA.	Curtis_Harris@nih.gov	Bartek, Jiri/G-5870-2014; Goto, Akiteru/P-5775-2014	Goto, Akiteru/0000-0001-8776-9004; Hussain, S. Perwez/0000-0002-2294-522X; Wink, David/0000-0002-5652-7480; Ridnour, Lisa A./0000-0001-9446-8349; Robles, Ana/0000-0001-5019-4374; Azad, Mahan/0000-0002-8633-3513	National Cancer Institute; Danish Cancer Society; Danish National Research Foundation; European Commission	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the Intramural Research Program of the National Cancer Institute. Dr. Sohn was supported by the Cancer Research Training Award Fellowship from the National Cancer Institute. Dr. Bartkova and Dr. Bartek were supported by the Danish Cancer Society, the Danish National Research Foundation, and the European Commission (projects: Infla-Care, Biomedreg and DDResponse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957; Ambs S, 1999, J NATL CANCER I, V91, P86, DOI 10.1093/jnci/91.1.86; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Clemons NJ, 2007, GASTROENTEROLOGY, V133, P1198, DOI 10.1053/j.gastro.2007.06.061; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341; Favetta LA, 2004, EXP CELL RES, V299, P36, DOI 10.1016/j.yexcr.2004.05.009; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Hussain SP, 2000, CANCER RES, V60, P3333; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Nair J, 2006, ANTIOXID REDOX SIGN, V8, P1003, DOI 10.1089/ars.2006.8.1003; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Oliveira CJR, 2003, FREE RADICAL BIO MED, V35, P381, DOI 10.1016/S0891-5849(03)00311-3; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Risques RA, 2011, CANCER RES, V71, P1669, DOI 10.1158/0008-5472.CAN-10-1966; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Salk JJ, 2009, P NATL ACAD SCI US; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Stewart B, 2003, WORLD CANC REPORT, P56; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	68	48	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44156	10.1371/journal.pone.0044156	http://dx.doi.org/10.1371/journal.pone.0044156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970173	gold, Green Submitted, Green Published			2022-12-27	WOS:000308458400040
J	Feng, J; Pan, XL; Yu, JB; Chen, Z; Xu, H; El-Rifai, W; Zhang, GX; Xu, ZK				Feng, Jin; Pan, Xiaolin; Yu, Junbo; Chen, Zheng; Xu, Hao; El-Rifai, Wael; Zhang, Guoxin; Xu, Zekuan			Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; CYTOCHROME-P450 2E1; N-NITROSODIALKYLAMINES; METABOLIZING-ENZYMES; LUNG-CANCER; P450 2E1; RISK; SUSCEPTIBILITY; TOBACCO; EXPRESSION	Background: Cytochrome P450 2E1 (CYP2E1), an ethanol-inducible enzyme, has been shown to metabolically activate various carcinogens, which is critical for the development and progression of cancers. It has demonstrated that CYP2E1 polymorphisms alter the transcriptional activity of the gene. However, studies on the association between CYP2E1 polymorphisms (PstI/RsaI or DraI) and gastric cancer have reported conflicting results. Thus, the aim of the present study was to investigate whether CYP2E1 polymorphisms is associated with the development and progression of gastric cancer and its prognosis in Chinese patients. Methods: A case-control study was conducted in which CYP2E1 PstI/RsaI and DraI polymorphisms were analyzed in 510 Chinese patients with gastric cancer and 510 age- and sex-matched healthy controls by PCR-RFLP. Odds ratios were estimated by multivariate logistic regression, and the lifetime was calculated by Kaplan-Meier survival curves. In addition, a meta-analysis was also conducted to verify the findings. Results: For CYP2E1 PstI/RsaI polymorphism, C2C2 homozygotes (OR = 2.15; CI: 1.18-3.94) and C2 carriers (OR = 1.48; CI: 1.13-1.96) were associated with an increased risk of gastric cancer when compared with C1C1 homozygotes. Both C1C2 and C2C2 genotypes were associated with advanced stage, but not the grade of gastric cancer. Moreover, C2C2 genotype was identified as an independent marker of poor overall survival for gastric cancer. However, there was not any significant association between CYP2E1 DraI polymorphism and the risk of gastric cancer. In the meta-analysis, pooled data from 13 studies confirmed that the CYP2E1 PstI/RsaI polymorphism was associated with a significantly increased risk of gastric cancer. Conclusion: CYP2E1 PstI/RsaI polymorphism is associated with increased risk of development, progression and poor prognosis of gastric cancer in Chinese patients. Pooled data from 13 studies, mainly in Asian countries, are in agreement with our findings.	[Feng, Jin; Yu, Junbo; Chen, Zheng; Xu, Hao; Xu, Zekuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China; [Pan, Xiaolin; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Peoples R China; [El-Rifai, Wael] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [El-Rifai, Wael] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Nanjing Medical University; Nanjing Medical University; Vanderbilt University; Vanderbilt University	Feng, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China.	guoxinz@njmu.edu.cn; xuzekuan@njmu.edu.cn			National Natural Science Foundation of China [81072031(BA10)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [NO. 81072031(BA10)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Augenlicht LH, 2002, EUR J CANCER PREV, V11, pS12; Balaji L, 2011, ASIAN PAC J CANCER P, V12, P1523; Bellec G, 1996, CARCINOGENESIS, V17, P2029, DOI 10.1093/carcin/17.9.2029; Boccia S, 2007, CARCINOGENESIS, V28, P101, DOI 10.1093/carcin/bgl124; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Cai L, 2001, WORLD J GASTROENTERO, V7, P792, DOI 10.3748/wjg.v7.i6.792; Cai L, 2001, WORLD J GASTROENTERO, V7, P506; Cai L, 2005, WORLD J GASTROENTERO, V11, P1867, DOI 10.3748/wjg.v11.i12.1867; CAMUS AM, 1993, MOL CARCINOGEN, V7, P268, DOI 10.1002/mc.2940070410; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; Gao CM, 2002, CANCER EPIDEM BIOMAR, V11, P29; Glatt HR, 2000, BIOCHEM SOC T, V28, P1; Haque AK, 2004, APPL IMMUNOHISTO M M, V12, P315, DOI 10.1097/00129039-200412000-00005; HAYASHI S, 1991, J BIOCHEM-TOKYO, V110, P559, DOI 10.1093/oxfordjournals.jbchem.a123619; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; HOFFMANN D, 1985, CANCER RES, V45, P935; Hu Y, 1999, BIOCHEM BIOPH RES CO, V263, P286, DOI 10.1006/bbrc.1999.1362; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Indulski JA, 2000, INT ARCH OCC ENV HEA, V73, P71, DOI 10.1007/PL00007942; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato S, 2011, J NIPPON MED SCH, V78, P224, DOI 10.1272/jnms.78.224; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kiyohara C, 2000, J Epidemiol, V10, P349; Kuno S, 1996, CANCER CAUSE CONTROL, V7, P41; Lee Han Chu, 1997, Korean Journal of Internal Medicine (English Edition), V12, P128; Malats N, 2001, PANCREATOLOGY, V1, P472, DOI 10.1159/000055850; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; Munaka M, 2003, J CANCER RES CLIN, V129, P355, DOI 10.1007/s00432-003-0439-5; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3175, DOI 10.3748/wjg.v11.i21.3175; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3834; Neuhaus T, 2004, TOXICOL LETT, V151, P273, DOI 10.1016/j.toxlet.2003.09.017; Nishimoto IN, 2000, CANCER EPIDEM BIOMAR, V9, P675; Oyama T, 2007, FRONT BIOSCI, V12, P4497, DOI 10.2741/2404; Park GT, 2003, J GASTROEN HEPATOL, V18, P1257, DOI 10.1046/j.1440-1746.2003.03167.x; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Olivieri EHR, 2009, ORAL ONCOL, V45, pE73, DOI 10.1016/j.oraloncology.2009.03.004; Shparyk Ia V, 1998, Klin Khir, P36; SOBIN LH, 1981, B WORLD HEALTH ORGAN, V59, P813; Suzuki S, 2004, J GASTROENTEROL, V39, P220, DOI 10.1007/s00535-003-1281-x; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Tsukino H, 2002, INT J CANCER, V100, P425, DOI 10.1002/ijc.10492; Tsunedomi R, 2005, INT J ONCOL, V27, P661; UMENO M, 1988, BIOCHEMISTRY-US, V27, P9006, DOI 10.1021/bi00425a019; Vaclavikova R, 2007, ANTICANCER RES, V27, P4443; WATANABE J, 1994, J BIOCHEM-TOKYO, V116, P321, DOI 10.1093/oxfordjournals.jbchem.a124526; Wu MS, 2002, INT J COLORECTAL DIS, V17, P338, DOI 10.1007/s00384-001-0383-2; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zagorac D, 2008, J CEREBR BLOOD F MET, V28, P1431, DOI 10.1038/jcbfm.2008.31; Zhan P, 2010, LUNG CANCER, V69, P19, DOI 10.1016/j.lungcan.2009.09.001	52	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44478	10.1371/journal.pone.0044478	http://dx.doi.org/10.1371/journal.pone.0044478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957075	Green Submitted, gold, Green Published			2022-12-27	WOS:000308463800068
J	Foulquier, S; Dupuis, F; Perrin-Sarrado, C; Gate, KM; Leroy, P; Liminana, P; Atkinson, J; Capdeville-Atkinson, C; Lartaud, I				Foulquier, Sebastien; Dupuis, Francois; Perrin-Sarrado, Caroline; Gate, Katy Maguin; Leroy, Pierre; Liminana, Patrick; Atkinson, Jeffrey; Capdeville-Atkinson, Christine; Lartaud, Isabelle			Differential Effects of Short-Term Treatment with Two AT(1) Receptor Blockers on Diameter of Pial Arterioles in SHR	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; CONVERTING ENZYME-INHIBITOR; NITRIC-OXIDE SYNTHASE; HIGH-SALT INTAKE; ANGIOTENSIN-II; PPAR-GAMMA; CEREBRAL ARTERIOLES; BLOOD-PRESSURE; INCREASED EXPRESSION; BRAIN MICROVESSELS	Chronic treatment with angiotensin receptor blockers is largely accepted for protecting cerebral circulation during hypertension, but beneficial effects of short-term treatments are questionable, as highlighted by the recent SCAST trial. We compared the impact of 10 days treatment with candesartan (as SCAST) versus telmisartan (previously described to reverse arteriolar remodeling, chronic treatment) on pial arterioles of spontaneously hypertensive rats (SHR). We explored whether PPAR-gamma agonist activity or AT(1) receptor blockade are involved in their differential effects. In the first study, 4-monthold male SHR were treated with telmisartan (TELMI, 2 mg/kg per day) or candesartan cilexetil (CANDE, 10 mg/kg per day) and compared to vehicle treated SHR and normotensive WKY. In a second study, SHR were treated with CANDE, pioglitazone (a PPAR-gamma agonist, PIO 2.5 mg/kg per day) or CANDE+PIO, compared to TELMI. Internal diameter of pial arterioles (ID, cranial window) was measured at baseline, during hemorrhage-induced hypotension, or following suffusion of Ang II (10(-6) mol/L) or EDTA inactivation of smooth muscle cells (passive ID). PPAR-gamma and eNOS (target gene of PPARgamma) mRNA were evaluated in brain microvessels. For similar antihypertensive effects, TELMI (+44% versus SHR), but not CANDE, increased baseline ID. During hemorrhage, ID in TELMI group was similar to WKY, while ID in SHR and CANDE remained lower. In the second study, TELMI (+36%, versus SHR) and CANDE+PIO (+43%) increased baseline ID, but not CANDE or PIO alone. TELMI (-66%) and CANDE+PIO (-69%), but neither CANDE nor PIO alone, decreased Ang II-induced vasoconstriction. CANDE+PIO, but not CANDE, increased passive ID. In both studies, PPAR-gamma and eNOS expressions were higher in TELMI than CANDE. Short-term treatment with TELMI, but not with CANDE, reverses narrowing of pial arteriolar ID in SHR. This may involve PPAR-gamma related mechanisms, since CANDE+PIO treatment induced similar effects, and a better blockade of AT(1) receptors.	[Foulquier, Sebastien; Dupuis, Francois; Perrin-Sarrado, Caroline; Gate, Katy Maguin; Leroy, Pierre; Liminana, Patrick; Atkinson, Jeffrey; Capdeville-Atkinson, Christine; Lartaud, Isabelle] Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France	Universite de Lorraine	Foulquier, S (corresponding author), Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France.	isabelle.lartaud@univ-lorraine.fr	Foulquier, Sébastien/AAE-6998-2019	Foulquier, Sébastien/0000-0002-2523-0748; DUPUIS, Francois/0000-0003-1947-3839; perrin-sarrado, caroline/0000-0002-3483-1211; Lartaud, Isabelle/0000-0001-9257-6311	French Ministry of Education, Research and Technology (Paris, France) [EA3452]; Lorraine Regional Development Committee (Metz, France); Regional Coordination and Research Council (Nancy, Metz, France); "Universite de Lorraine" (Nancy, France); Pharmacolor Association (Nancy, France)	French Ministry of Education, Research and Technology (Paris, France); Lorraine Regional Development Committee (Metz, France); Regional Coordination and Research Council (Nancy, Metz, France); "Universite de Lorraine" (Nancy, France); Pharmacolor Association (Nancy, France)	The work was funded by the French Ministry of Education, Research and Technology (Paris, France, EA3452), the Lorraine Regional Development Committee (Metz, France), the Regional Coordination and Research Council (Nancy, Metz, France), the "Universite de Lorraine" (Nancy, France) and the Pharmacolor Association (Nancy, France). Sebastien Foulquier had a PhD grant from the Lorraine Regional Development Committee (Metz, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, NEUROCHEM RES, V24, P1507, DOI 10.1023/A:1021191729865; Ando H, 2004, STROKE, V35, P1726, DOI 10.1161/01.STR.0000129788.26346.18; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; Bian C, 2009, BIOL PHARM BULL, V32, P416, DOI 10.1248/bpb.32.416; Chan SL, 2008, J CARDIOVASC PHARM, V51, P304, DOI 10.1097/FJC.0b013e318163a946; Chillon JM, 1999, HYPERTENSION, V33, P856, DOI 10.1161/01.HYP.33.3.856; Diener HC, 2009, J HYPERTENS, V27, pS31, DOI 10.1097/01.hjh.0000357906.60778.7f; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Dupuis F, 2005, J HYPERTENS, V23, P1061, DOI 10.1097/01.hjh.0000166848.95592.a5; Dupuis F, 2010, J HYPERTENS, V28, P1566, DOI 10.1097/HJH.0b013e328339f1f3; Fog M, 1937, ARCH NEURO PSYCHIATR, V37, P351, DOI 10.1001/archneurpsyc.1937.02260140137007; Foulquier S, 2011, J HYPERTENS, V29, P1392, DOI 10.1097/HJH.0b013e328347050e; Gaillard V, 2005, HYPERTENSION, V46, P372, DOI 10.1161/01.HYP.0000171472.24422.33; Gate KM, 2011, BRAIN RES, V1369, P95, DOI 10.1016/j.brainres.2010.10.100; Gohlke P, 2002, J HYPERTENS, V20, P909, DOI 10.1097/00004872-200205000-00026; Iwanami J, 2010, J HYPERTENS, V28, P1730, DOI 10.1097/HJH.0b013e32833a551a; Kagota S, 2001, BRIT J PHARMACOL, V134, P737, DOI 10.1038/sj.bjp.0704300; Kobayashi N, 2008, AM J HYPERTENS, V21, P576, DOI 10.1038/ajh.2008.27; Kuipers I, 2008, HYPERTENSION, V51, P1442, DOI 10.1161/HYPERTENSIONAHA.107.108530; Kumai Y, 2008, EXP NEUROL, V210, P441, DOI 10.1016/j.expneurol.2007.11.028; Li YQ, 2007, EUR J PHARMACOL, V577, P100, DOI 10.1016/j.ejphar.2007.08.008; Nakamura T, 2007, STROKE, V38, P3016, DOI 10.1161/STROKEAHA.107.486522; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; Pelisch N, 2010, HYPERTENS RES, V33, P161, DOI 10.1038/hr.2009.200; Roberts TJM, 2009, AM J PHYSIOL-HEART C, V297, pH1347, DOI 10.1152/ajpheart.00630.2009; Ryan MJ, 2004, HYPERTENSION, V43, P661, DOI 10.1161/01.HYP.0000116303.71408.c2; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Seltzer A, 2004, BRAIN RES, V1028, P9, DOI 10.1016/j.brainres.2004.06.079; Sigmund CD, 2010, HYPERTENSION, V55, P437, DOI 10.1161/HYPERTENSIONAHA.109.144170; SUGIYAMA Y, 1990, ARZNEIMITTEL-FORSCH, V40-1, P263; Touyz RM, 2006, VASC PHARMACOL, V45, P19, DOI 10.1016/j.vph.2005.11.014; Trenkwalder P, 2006, J HYPERTENS, V24, pS107, DOI 10.1097/01.hjh.0000220415.99610.22; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vincent JM, 2005, STROKE, V36, P2691, DOI 10.1161/01.STR.0000190002.79052.bf; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Xiao J, 2009, CLIN IMMUNOL, V132, P266, DOI 10.1016/j.clim.2009.04.004; Yamakawa H, 2003, J CEREBR BLOOD F MET, V23, P371, DOI 10.1097/01.WCB.0000047369.05600.03; Yuen CY, 2011, CARDIOVASC RES, V90, P122, DOI 10.1093/cvr/cvq392; Zhou J, 2005, J CEREBR BLOOD F MET, V25, P878, DOI 10.1038/sj.jcbfm.9600082; Zorad S, 2006, EUR J PHARMACOL, V552, P112, DOI 10.1016/j.ejphar.2006.08.062	43	6	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e42469	10.1371/journal.pone.0042469	http://dx.doi.org/10.1371/journal.pone.0042469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957022	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800014
J	Hu, CP; Zou, YQ; Feng, JT; Li, XZ				Hu, Cheng-Ping; Zou, Ye-Qiang; Feng, Jun-Tao; Li, Xiao-Zhao			The Effect of Unilateral Adrenalectomy on Transformation of Adrenal Medullary Chromaffin Cells In Vivo: A Potential Mechanism of Asthma Pathogenesis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; CIRCULATING CATECHOLAMINES; NGF; TRANSCRIPTION; DYSFUNCTION; EXPRESSION	Background: Decreased epinephrine (EPI) is an important underlying factor of bronchoconstriction in asthma. Exogenous beta(2)-adrenergic receptor agonist is one of the preferred options to treat asthma. We previously showed that this phenomenon involved adrenal medullary chromaffin cell (AMCC) transformation to a neuron phenotype. However, the underlying molecular mechanism is not fully understood. To further explore this, an asthmatic model with unilateral adrenalectomy was established in this study. Methodology/Principal Findings: Thirty-two rats were randomly into four groups (n = 8 each) control rats (controls), unilateral adrenalectomy rats (surgery-control, s-control), asthmatic rats (asthma), unilateral adrenalectomy asthmatic rats (surgery-induced asthma, s-asthma). Asthmatic rats and s-asthmatic rats were sensitized and challenged with ovalbumin (OVA). The pathological changes in adrenal medulla tissues were observed under microscopy. EPI and its rate-limiting enzyme, phenylethanolamine N-methyl transferase (PNMT), were measured. Peripherin, a type III intermediate filament protein, was also detected in each group. The asthmatic rats presented with decreased chromaffin granules and swollen mitochondria in AMCCs, and the s-asthmatic rats presented more serious pathological changes than those in asthmatic rats and s-control rats. The expressions of EPI and PNMT in asthmatic rats were significantly decreased, as compared with levels in controls (P<0.05), and a further decline was observed in s-asthmatic rats (P<0.05). The expression of peripherin was higher in the asthmatic rats than in the controls, and the highest level was found in the s-asthmatic rats (P<0.05). Conclusion/Significance: Compared with asthmatic rats and s-control rats, the transformation tendency of AMCCs to neurons is more obvious in the s-asthmatic rats. Moreover, this phenotype alteration in the asthmatic rats is accompanied by reduced EPI and PNMT, and increased peripherin expression. This result provides further evidence to support the notion that phenotype alteration of AMCCs contributes to asthma pathogenesis.	[Hu, Cheng-Ping; Zou, Ye-Qiang; Feng, Jun-Tao; Li, Xiao-Zhao] Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Peoples R China; [Zou, Ye-Qiang] First Peoples Hosp Changde, Dept Resp Med, Changde, Peoples R China	Central South University	Hu, CP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Resp Med, Changsha, Peoples R China.	jtfeng1976@hotmail.com; xiaozhaosun@hotmail.com			National Natural Science Foundation of China [30801505, 30800502, 81070026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30801505, No. 30800502 and No. 81070026) [http://www.nsfc.gov.cn/Portal0/default124.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; BARNES PJ, 1981, THORAX, V36, P435, DOI 10.1136/thx.36.6.435; BLASCHKO H, 1967, BIOCHEM J, V104, P545, DOI 10.1042/bj1040545; Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; DERER M, 1989, NEUROSCIENCE, V31, P471, DOI 10.1016/0306-4522(89)90389-8; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; EVINGER MJ, 1992, CELL MOL NEUROBIOL, V12, P193, DOI 10.1007/BF00712926; Feng JT, 2005, MED HYPOTHESES, V65, P1043, DOI 10.1016/j.mehy.2005.06.029; Feng JT, 2010, CHINESE MED J-PEKING, V123, P1333, DOI 10.3760/cma.j.issn.0366-6999.2010.10.020; Fukuda T, 2007, J ANESTH, V21, P348, DOI 10.1007/s00540-007-0521-2; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Hodel A, 2001, J NEUROENDOCRINOL, V13, P217; Huber K, 2002, DEVELOPMENT, V129, P4729; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; IND PW, 1985, BRIT MED J, V290, P267, DOI 10.1136/bmj.290.6464.267; JENKINS CJ, 1987, THORAX, V42, P664, DOI 10.1136/thx.42.9.664; Kvetnansky R, 2006, CELL MOL NEUROBIOL, V26, P735, DOI 10.1007/s10571-006-9063-7; LILLIEN LE, 1985, NATURE, V317, P632, DOI 10.1038/317632a0; LILLIEN LE, 1985, EXP CELL RES, V161, P255, DOI 10.1016/0014-4827(85)90083-7; Liu Yi, 2000, Shengli Xuebao, V52, P5; MORIMOTO M, 1994, NEUROREPORT, V5, P954, DOI 10.1097/00001756-199404000-00025; Nie HP, 2010, THESIS CENTRAL S U C; Qin LY, 2009, J SNAKE, V21, P257; Unsicker K, 2005, NEUROCHEM RES, V30, P921, DOI 10.1007/s11064-005-6966-5; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Wang Jun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P812; Wu XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020337; Yamaguchi-Shima N, 2007, EUR J PHARMACOL, V564, P94, DOI 10.1016/j.ejphar.2007.02.021	29	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44586	10.1371/journal.pone.0044586	http://dx.doi.org/10.1371/journal.pone.0044586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957086	Green Published, gold, Green Submitted			2022-12-27	WOS:000308463800079
J	Jiang, ZW; Wang, L; Li, CJ; Xia, JL; Jia, HX				Jiang, Zhiwei; Wang, Ling; Li, Chanjuan; Xia, Jielai; Jia, Hongxia			A Practical Simulation Method to Calculate Sample Size of Group Sequential Trials for Time-to-Event Data under Exponential and Weibull Distribution	PLOS ONE			English	Article							CLINICAL-TRIALS; SURVIVAL TRIALS; ADAPTIVE DESIGN; REESTIMATION; POWER	Group sequential design has been widely applied in clinical trials in the past few decades. The sample size estimation is a vital concern of sponsors and investigators. Especially in the survival group sequential trials, it is a thorny question because of its ambiguous distributional form, censored data and different definition of information time. A practical and easy-to-use simulation-based method is proposed for multi-stage two-arm survival group sequential design in the article and its SAS program is available. Besides the exponential distribution, which is usually assumed for survival data, the Weibull distribution is considered here. The incorporation of the probability of discontinuation in the simulation leads to the more accurate estimate. The assessment indexes calculated in the simulation are helpful to the determination of number and timing of the interim analysis. The use of the method in the survival group sequential trials is illustrated and the effects of the varied shape parameter on the sample size under the Weibull distribution are explored by employing an example. According to the simulation results, a method to estimate the shape parameter of the Weibull distribution is proposed based on the median survival time of the test drug and the hazard ratio, which are prespecified by the investigators and other participants. 10+ simulations are recommended to achieve the robust estimate of the sample size. Furthermore, the method is still applicable in adaptive design if the strategy of sample size scheme determination is adopted when designing or the minor modifications on the program are made.	[Jiang, Zhiwei; Wang, Ling; Li, Chanjuan; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Sch Preventat Med, Xian 710032, Shaanxi, Peoples R China; [Jiang, Zhiwei; Wang, Ling; Li, Chanjuan; Xia, Jielai] Fourth Mil Med Univ, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Shaanxi, Peoples R China; [Jia, Hongxia] Jinan Gen Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jiang, ZW (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Sch Preventat Med, Xian 710032, Shaanxi, Peoples R China.	chanjuan_li@sohu.com; jielaixia@yahoo.com			National Science Foundation of China [81072390, 81001290]; program for Changjiang Scholars and Innovative Research Team in University (PCISIRT)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team in University (PCISIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The study was partially supported by the research grants (81072390, 81001290) from National Science Foundation of China and program for Changjiang Scholars and Innovative Research Team in University (PCISIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chow S. C., 2003, SAMPLE SIZE CALCULAT; Cui L, 1999, BIOMETRICS, V55, P853, DOI 10.1111/j.0006-341X.1999.00853.x; DAVIS DJ, 1952, J AM STAT ASSOC, V47, P113, DOI 10.2307/2280740; Desseaux K, 2007, STAT MED, V26, P5002, DOI 10.1002/sim.2966; EPSTEIN B, 1953, J AM STAT ASSOC, V48, P486, DOI 10.2307/2281004; Epstein B., 1958, IND QUALITY CONTROL, V15, P2; Heo M, 1998, MECH AGEING DEV, V102, P45, DOI 10.1016/S0047-6374(98)00010-4; Jennison C, 2000, GROUP SEQUENTIAL MET; Jiang ZW, 2010, CONTEMP CLIN TRIALS, V31, P242, DOI 10.1016/j.cct.2010.02.001; Lakatos E, 2002, STAT MED, V21, P1969, DOI 10.1002/sim.1193; LAN KKG, 1989, STAT MED, V8, P1191, DOI 10.1002/sim.4780081003; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; Li G, 2005, J BIOPHARM STAT, V15, P707, DOI 10.1081/BIP-200062293; Li ZG, 2011, BIOMETRIKA, V98, P503, DOI 10.1093/biomet/asr019; Lu QS, 2010, J BIOPHARM STAT, V20, P705, DOI 10.1080/10543401003618066; Lu QS, 2009, J BIOPHARM STAT, V19, P311, DOI 10.1080/10543400802622527; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; NCSS, GROUP SEQ LOG RANK T; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Schafer H, 2001, STAT MED, V20, P3741, DOI 10.1002/sim.1136; Shen Y, 2003, J AM STAT ASSOC, V98, P418, DOI 10.1198/016214503000206; Togo K, 2011, PHARM STAT, V10, P325, DOI 10.1002/pst.469; Wassmer G, 2006, BIOMETRICAL J, V48, P714, DOI 10.1002/bimj.200510190; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Weibull W, 1939, ING VETENSKAPSAKAD H, V151, P293; Wllenberg SS, 2003, DATA MONITORING COMM	28	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e44013	10.1371/journal.pone.0044013	http://dx.doi.org/10.1371/journal.pone.0044013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957040	Green Published, Green Submitted, gold			2022-12-27	WOS:000308463800032
J	Toure, O; Konate, S; Sissoko, S; Niangaly, A; Barry, A; Sall, AH; Diarra, E; Poudiougou, B; Sepulveda, N; Campino, S; Rockett, KA; Clark, TG; Thera, MA; Doumbo, O				Toure, Ousmane; Konate, Salimata; Sissoko, Sibiri; Niangaly, Amadou; Barry, Abdoulaye; Sall, Abdourahmane H.; Diarra, Elisabeth; Poudiougou, Belco; Sepulveda, Nuno; Campino, Susana; Rockett, Kirk A.; Clark, Taane G.; Thera, Mahamadou A.; Doumbo, Ogobara		MalariaGEN Consortium	Candidate Polymorphisms and Severe Malaria in a Malian Population	PLOS ONE			English	Article							SUSCEPTIBILITY; ASSOCIATION; PROTECTION	Malaria is a major health burden in sub-Saharan African countries, including Mali. The disease is complex, with multiple genetic determinants influencing the observed variation in response to infection, progression, and severity. We assess the influence of sixty-four candidate loci, including the sickle cell polymorphism (HbS), on severe malaria in a case-control study consisting of over 900 individuals from Bamako, Mali. We confirm the known protective effects of the blood group O and the HbS AS genotype on life-threatening malaria. In addition, our analysis revealed a marginal susceptibility effect for the CD40 ligand (CD40L)+220C allele. The lack of statistical evidence for other candidates may demonstrate the need for large-scale genome-wide association studies in malaria to discover new polymorphisms. It also demonstrates the need for establishing the region-specific repertoire of functional variation in important genes, including the glucose-6-phosphatase deficiency gene, before embarking on focused genotyping.	[Toure, Ousmane; Konate, Salimata; Sissoko, Sibiri; Niangaly, Amadou; Barry, Abdoulaye; Sall, Abdourahmane H.; Diarra, Elisabeth; Poudiougou, Belco; Thera, Mahamadou A.; Doumbo, Ogobara] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Dent, Bamako, Mali; [Barry, Abdoulaye; Sall, Abdourahmane H.; Diarra, Elisabeth] Gabriel Toure Hosp, Ctr Hosp Univ, Bamako, Mali; [Sepulveda, Nuno; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Campino, Susana] Wellcome Trust Sanger Inst, Cambridge, England; [Rockett, Kirk A.; MalariaGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of Bamako; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Toure, O (corresponding author), Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Dent, Bamako, Mali.	taane.clark@lshtm.ac.uk; mthera@icermali.org; okd@icermali.org	Sepulveda, Nuno/AAA-5544-2021; Sepulveda, Nuno/S-9936-2019; Clark, Taane G./AAM-2570-2020; Campino, Susana/AAM-2577-2020	Clark, Taane G./0000-0001-8985-9265; Campino, Susana/0000-0003-1403-6138; Sepulveda, Nuno/0000-0002-8542-1706; Thera, Mahamadou A/0000-0002-2679-035X	Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z]; Foundation for the National Institutes of Health as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]; Medical Research Council [G0600718, G0600230]; Wellcome Trust Sanger Institute [G0600230, 077012/Z/05/Z, 087285, 096527]; MRC [G0600230, G0600718] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Foundation for the National Institutes of Health as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Sanger Institute(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and by the Foundation for the National Institutes of Health (566) as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (G0600718; G0600230). The Wellcome Trust also provided core awards to the Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (077012/Z/05/Z). G0600230), the Wellcome Trust Biomedical ethics Enhancement Award (087285) and Strategic Award (096527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Modiano D., 1995, Parassitologia (Rome), V37, P255; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	23	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2012	7	9							e43987	10.1371/journal.pone.0043987	http://dx.doi.org/10.1371/journal.pone.0043987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001MC	22957039	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000308463800031
J	Li, XX; Xu, X; Wang, JN; Yu, H; Wang, X; Yang, HJ; Xu, HY; Tang, SH; Li, Y; Yang, L; Huang, LQ; Wang, YH; Yang, SL				Li, Xiuxiu; Xu, Xue; Wang, Jinan; Yu, Hua; Wang, Xia; Yang, Hongjun; Xu, Haiyu; Tang, Shihuan; Li, Yan; Yang, Ling; Huang, Luqi; Wang, Yonghua; Yang, Shengli			A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment	PLOS ONE			English	Article							SALVIANOLIC-ACID-B; SMOOTH-MUSCLE-CELLS; P-GLYCOPROTEIN; DRUG DISCOVERY; MOLECULAR-MECHANICS; PANAX-NOTOGINSENG; GINSENOSIDE RB-1; IN-VITRO; MILTIORRHIZA; INHIBITORS	Compound Danshen Formula (CDF) is a widely used Traditional Chinese Medicine (TCM) which has been extensively applied in clinical treatment of cardiovascular diseases (CVDs). However, the underlying mechanism of clinical administrating CDF on CVDs is not clear. In this study, the pharmacological effect of CDF on CVDs was analyzed at a systemic point of view. A systems-pharmacological model based on chemical, chemogenomics and pharmacological data is developed via network reconstruction approach. By using this model, we performed a high-throughput in silico screen and obtained a group of compounds from CDF which possess desirable pharmacodynamical and pharmacological characteristics. These compounds and the corresponding protein targets are further used to search against biological databases, such as the compound-target associations, compound-pathway connections and disease-target interactions for reconstructing the biologically meaningful networks for a TCM formula. This study not only made a contribution to a better understanding of the mechanisms of CDF, but also proposed a strategy to develop novel TCM candidates at a network pharmacology level.	[Li, Xiuxiu; Xu, Xue; Wang, Jinan; Yu, Hua; Wang, Xia; Wang, Yonghua] NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yang, Hongjun; Xu, Haiyu; Tang, Shihuan; Huang, Luqi] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Li, Yan] Dalian Univ Technol, Sch Chem Engn, Dalian, Liaoning, Peoples R China; [Yang, Ling; Yang, Shengli] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Liaoning, Peoples R China	Northwest A&F University - China; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Li, XX (corresponding author), NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	huangluqi@263.net; yh_wang@nwsuaf.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; WANG, XIA/S-3431-2018; li, yong/HDN-3885-2022; , Paulin/U-9063-2019	WANG, XIA/0000-0003-1960-4157; , Paulin/0000-0001-6045-3712; Tang, Shihuan/0000-0003-0589-4499; ling, yang/0000-0001-7093-5926	National Natural Science Fund of China [31170796]; Special Research Foundation for Traditional Chinese Medicine [200907001-5]; Innovation Fund of Northwest AF University	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Special Research Foundation for Traditional Chinese Medicine; Innovation Fund of Northwest AF University	This work was supported by the National Natural Science Fund of China (Grant No. 31170796), the Special Research Foundation for Traditional Chinese Medicine (Grant No. 200907001-5), as well as the Innovation Fund of Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 1998, J PHARM PHARMACOL, V50, P1155, DOI 10.1111/j.2042-7158.1998.tb03327.x; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Azuaje FJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00052; Bae EA, 2004, ARCH PHARM RES, V27, P61, DOI 10.1007/BF02980048; Bao Hua-ying, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P28; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case D., 2008, AMBER 10, P32; Cases M, 2009, DRUG DISCOV TODAY, V14, P479, DOI 10.1016/j.drudis.2009.02.010; Chang Y, 2009, SEEK MED ASK MED, V1, P32; Chen F, 2006, FASEB J, V20, P1269, DOI 10.1096/fj.05-5530fje; Chen XH, 2010, J PHARM PHARMACOL, V62, P915, DOI 10.1211/jpp.62.07.0013; Chen Yan-ming, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P632; Chen YL, 2006, J CELL BIOCHEM, V98, P618, DOI 10.1002/jcb.20793; Citterio L, 2011, PHARMACOGENOMICS, V12, P1587, DOI [10.2217/PGS.11.110, 10.2217/pgs.11.110]; Du D, 2008, CHIN J INF TCM, V9, P44; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DZAU V, 1991, AM HEART J, V121, P1244, DOI 10.1016/0002-8703(91)90694-D; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gu Y, 2009, FOOD CHEM TOXICOL, V47, P2257, DOI 10.1016/j.fct.2009.06.013; Han M, 2006, ACTA PHARMACOL SIN, V27, P499, DOI 10.1111/j.1745-7254.2006.00303.x; Hasegawa H, 1997, PLANTA MED, V63, P436, DOI 10.1055/s-2006-957729; He F, 2007, J CARDIOVASC PHARM, V50, P314, DOI 10.1097/FJC.0b013e3180cab12e; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Janga SC, 2009, MOL BIOSYST, V5, P1536, DOI [10.1039/b908147j, 10.1039/B908147j]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; KARIKURA M, 1990, CHEM PHARM BULL, V38, P2859, DOI 10.1248/cpb.38.2859; Karmin O, 2001, LIFE SCI, V68, P903, DOI 10.1016/S0024-3205(00)00989-9; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kong DX, 2009, DRUG DISCOV TODAY, V14, P115, DOI 10.1016/j.drudis.2008.07.002; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee S, 2009, EXPERT OPIN DRUG DIS, V4, P1177, DOI 10.1517/17460440903322234; Leung K.W., 2010, CHINESE MED, V5, P20; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li J, 2011, ILLUSTRATION TRADITI; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Li XM, 2009, J ALLERGY CLIN IMMUN, V123, P297, DOI 10.1016/j.jaci.2008.12.026; Li Y, 2005, J MOL STRUCT, V733, P111, DOI 10.1016/j.molstruc.2004.08.012; Liu H, 2008, MODERN J INTEGRATED, V17, P5397; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; McQuarrie DA, 2000, STAT MECH; Medina-Franco JL, 2011, MOL DIVERS, V15, P293, DOI 10.1007/s11030-010-9262-5; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; ODANI T, 1983, CHEM PHARM BULL, V31, P292; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Pei WJ, 2004, J CHROMATOGR B, V809, P237, DOI 10.1016/j.jchromb.2004.06.028; Peitz GJ, 2009, SOUTH MED J, V102, P411, DOI 10.1097/SMJ.0b013e31818fc03a; Popovich DG, 2002, ARCH BIOCHEM BIOPHYS, V406, P1, DOI 10.1016/S0003-9861(02)00398-3; Qiao XB, 2002, J CHEM INF COMP SCI, V42, P481, DOI 10.1021/ci010113h; Reddy AS, 2007, CURR PROTEIN PEPT SC, V8, P329; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sangkuhl K, 2011, PHARMACOGENET GENOM, V21, P516, DOI 10.1097/FPC.0b013e3283406323; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shen YJ, 2009, PHARM TRADITIONAL CH; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Sucher NJ, 2006, EPILEPSY BEHAV, V8, P350, DOI 10.1016/j.yebeh.2005.11.015; Takahashi K, 2002, BIOCHEM PHARMACOL, V64, P745, DOI 10.1016/S0006-2952(02)01250-9; The State Pharmacopoeia Commission of the PRC, 2005, PHARM PEOPL REP CHIN; Thorn CF, 2005, METH MOL B, V311, P179; Tian P, 2011, NATURE, V480, pS84, DOI 10.1038/480S84a; Tian Xiao-hui, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P404; van der Greef J, 2011, NATURE, V480, pS87, DOI 10.1038/480S87a; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang BQ, 2010, J MED PLANTS RES, V4, P2813; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang Y S, 1998, PHARM APPL CHINESE M; Wang YH, 2005, J COMPUT AID MOL DES, V19, P137, DOI 10.1007/s10822-005-3321-5; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; [吴寿荣 Wu Shourong], 2003, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V20, P245; Wu YJ, 1998, ARTERIOSCL THROM VAS, V18, P481, DOI 10.1161/01.ATV.18.3.481; Wu YT, 2006, INT J PHARM, V326, P25, DOI 10.1016/j.ijpharm.2006.07.003; WYATT AW, 2004, BIOCH SOC S, V71, P143; Xie GX, 2007, J PHARMACEUT BIOMED, V43, P920, DOI 10.1016/j.jpba.2006.09.009; Xie HT, 2005, BIOL PHARM BULL, V28, P383, DOI 10.1248/bpb.28.383; Xu De-Ran, 2005, Chinese Journal of Natural Medicines, V3, P148; Xu J., 2009, J GERIATR CARDIOL, V6, P56; Xu QF, 2003, J ETHNOPHARMACOL, V84, P187, DOI 10.1016/S0378-8741(02)00317-3; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Xu X, 2012, SOFT MATTER, V8, P2915, DOI 10.1039/c2sm06811g; Yang L. L., 2007, WORLD SCI TECH MODER, V9, P98; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu XY, 2007, NEUROSCI LETT, V417, P261, DOI 10.1016/j.neulet.2007.02.079; Zhang HX, 2011, CURR MED CHEM, V18, P4019, DOI 10.2174/092986711796957220; Zhang HS, 2006, J MOL CELL CARDIOL, V41, P138, DOI 10.1016/j.yjmcc.2006.03.007; Zhang JL, 2005, BIOMED CHROMATOGR, V19, P51, DOI 10.1002/bmc.415; Zhang Mei, 2003, Zhong Yao Cai, V26, P738; Zhao BL, 1996, BIOCHEM MOL BIOL INT, V38, P1171; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zheng X, 2007, J XIAN JIAOTONG U ME, V28, P171; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou M, 2009, CHIN J THROMB HEM, V15, P8; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020; 鲍建才, 2006, [中成药, Chinese Traditional Patent Medicine], V28, P246; 赵保胜, 2002, [中国药理学通报, Chinese Pharmacological Bulletin], V18, P590; 丁宁, 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P1147; 陈建南, 2005, [中药材, Journal of Chinese Medicinal Materials], V28, P781	120	134	148	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43918	10.1371/journal.pone.0043918	http://dx.doi.org/10.1371/journal.pone.0043918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962593	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600021
J	Li, YX; Wang, W; Wu, QL; Li, YP; Tang, M; Ye, BP; Wang, DY				Li, Yinxia; Wang, Wei; Wu, Qiuli; Li, Yiping; Tang, Meng; Ye, Boping; Wang, Dayong			Molecular Control of TiO2-NPs Toxicity Formation at Predicted Environmental Relevant Concentrations by Mn-SODs Proteins	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; TITANIUM-DIOXIDE NANOPARTICLES; LOCOMOTION BEHAVIORS; OXIDATIVE DAMAGE; SOIL NEMATODE; C-ELEGANS; LIFE-SPAN; BULK ZNO; EXPOSURE; EXPRESSION	With growing concerns of the safety of nanotechnology, the in vivo toxicity of nanoparticles (NPs) at environmental relevant concentrations has drawn increasing attentions. We investigated the possible molecular mechanisms of titanium nanoparticles (Ti-NPs) in the induction of toxicity at predicted environmental relevant concentrations. In nematodes, small sizes (4 nm and 10 nm) of TiO2-NPs induced more severe toxicities than large sizes (60 nm and 90 nm) of TiO2-NPs on animals using lethality, growth, reproduction, locomotion behavior, intestinal autofluorescence, and reactive oxygen species (ROS) production as endpoints. Locomotion behaviors could be significantly decreased by exposure to 4-nm and 10-nm TiO2-NPs at concentration of 1 ng/L in nematodes. Among genes required for the control of oxidative stress, only the expression patterns of sod-2 and sod-3 genes encoding Mn-SODs in animals exposed to small sizes of TiO2-NPs were significantly different from those in animals exposed to large sizes of TiO2-NPs. sod-2 and sod-3 gene expressions were closely correlated with lethality, growth, reproduction, locomotion behavior, intestinal autofluorescence, and ROS production in TiO2-NPs-exposed animals. Ectopically expression of human and nematode Mn-SODs genes effectively prevented the induction of ROS production and the development of toxicity of TiO2-NPs. Therefore, the altered expression patterns of Mn-SODs may explain the toxicity formation for different sizes of TiO2-NPs at predicted environmental relevant concentrations. In addition, we demonstrated here a strategy to investigate the toxicological effects of exposure to NPs upon humans by generating transgenic strains in nematodes for specific human genes.	[Li, Yinxia; Wang, Wei; Wu, Qiuli; Li, Yiping; Wang, Dayong] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Dept Biochem & Mol Biol,Med Sch, Nanjing, Jiangsu, Peoples R China; [Wang, Wei; Ye, Boping] China Pharmaceut Univ, Coll Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Tang, Meng] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; China Pharmaceutical University; Southeast University - China	Li, YX (corresponding author), Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Dept Biochem & Mol Biol,Med Sch, Nanjing, Jiangsu, Peoples R China.	dayongw@seu.edu.cn			NIH National Center for Research Resource, USA; National Basic Research Program of China [2011CB933404]; National Natural Science Foundation of China [81172698]; Postdoctoral Foundation of China [2011M500835]; Postdoctoral Foundation in Jiangsu Province of China; Special Postdoctoral Supporting Plan in Southeast University; Supporting Program in the Key Laboratory of Developmental Genes and Human Disease in Ministry of Education [201104]	NIH National Center for Research Resource, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Foundation in Jiangsu Province of China; Special Postdoctoral Supporting Plan in Southeast University; Supporting Program in the Key Laboratory of Developmental Genes and Human Disease in Ministry of Education	The wild-type nematode strain used in this study was provided by the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resource, USA). We thank Dan Chase for the pCL40 (Pdop1::rfp) vector.; This work was supported by grants from the National Basic Research Program of China (No. 2011CB933404), the National Natural Science Foundation of China (No. 81172698), the Postdoctoral Foundation of China (No. 2011M500835), the Postdoctoral Foundation in Jiangsu Province of China, the Special Postdoctoral Supporting Plan in Southeast University, and the Supporting Program in the Key Laboratory of Developmental Genes and Human Disease in Ministry of Education (201104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; BRENNER S, 1974, GENETICS, V77, P71; Chen JY, 2011, AQUAT TOXICOL, V101, P493, DOI 10.1016/j.aquatox.2010.12.004; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; DONKIN SG, 1993, ARCH ENVIRON CON TOX, V25, P145, DOI 10.1007/BF00212125; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Guo YL, 2009, REPROD TOXICOL, V28, P90, DOI 10.1016/j.reprotox.2009.03.007; Hassellov M, 2008, ECOTOXICOLOGY, V17, P344, DOI 10.1007/s10646-008-0225-x; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; HSU DR, 1994, GENETICS, V137, P999; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Huang S, 2009, TOXICOL APPL PHARM, V241, P182, DOI 10.1016/j.taap.2009.08.013; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Khare P, 2011, J BIOMED NANOTECHNOL, V7, P116, DOI 10.1166/jbn.2011.1229; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Lomer MCE, 2004, BRIT J NUTR, V92, P947, DOI 10.1079/BJN20041276; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Ma H, 2011, ENVIRON POLLUT, V159, P1473, DOI 10.1016/j.envpol.2011.03.013; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1324, DOI 10.1897/08-262.1; Ma LL, 2009, NANOSCALE RES LETT, V4, P1275, DOI 10.1007/s11671-009-9393-8; Ma-Hock L, 2009, INHAL TOXICOL, V21, P102, DOI 10.1080/08958370802361057 ; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Peng L, 2010, NANO LETT, V10, P143, DOI 10.1021/nl903043z; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Roh JY, 2010, ENVIRON TOXICOL PHAR, V29, P167, DOI 10.1016/j.etap.2009.12.003; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Shen LL, 2010, MECH AGEING DEV, V131, P732, DOI 10.1016/j.mad.2010.10.005; Shen LL, 2009, ENVIRON TOXICOL PHAR, V28, P125, DOI 10.1016/j.etap.2009.03.009; Shimizu M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-20; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Stone V, 2006, NAT NANOTECHNOL, V1, P23, DOI 10.1038/nnano.2006.69; Tang M, 2010, J NANOSCI NANOTECHNO, V10, P8575, DOI 10.1166/jnn.2010.2482; Tiede K, 2009, J CHROMATOGR A, V1216, P503, DOI 10.1016/j.chroma.2008.09.008; Vigneshkumar B, 2013, ENVIRON TOXICOL, V28, P313, DOI 10.1002/tox.20722; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P423, DOI 10.1016/j.ecoenv.2009.12.014; Wang HH, 2009, ENVIRON POLLUT, V157, P1171, DOI 10.1016/j.envpol.2008.11.004; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Wu S, 2011, ENVIRON TOXICOL PHAR, V31, P179, DOI 10.1016/j.etap.2010.10.005; Xing XJ, 2009, ECOTOX ENVIRON SAFE, V72, P1819, DOI 10.1016/j.ecoenv.2009.06.006; Xiong DW, 2011, SCI TOTAL ENVIRON, V409, P1444, DOI 10.1016/j.scitotenv.2011.01.015; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Zhang HF, 2011, ENVIRON SCI TECHNOL, V45, P3725, DOI 10.1021/es103309n; Zhang WD, 2011, NANOSCALE, V3, P2636, DOI 10.1039/c1nr10239g	62	40	45	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44688	10.1371/journal.pone.0044688	http://dx.doi.org/10.1371/journal.pone.0044688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973466	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600079
J	Liu, WL; Yang, HC; Su, WC; Wang, CC; Chen, HL; Wang, HY; Huang, WH; Chen, DS; Lai, MY				Liu, Wei-Liang; Yang, Hung-Chih; Su, Wen-Cheng; Wang, Chih-Chiang; Chen, Hui-Ling; Wang, Hurng-Yi; Huang, Wen-Hung; Chen, Ding-Shinn; Lai, Ming-Yang			Ribavirin Enhances the Action of Interferon-alpha against Hepatitis C Virus by Promoting the p53 Activity through the ERK1/2 Pathway	PLOS ONE			English	Article							SUBGENOMIC REPLICON; PHOSPHORYLATION; DIFFERENTIATION; REPLICATION; SUPPRESSION; EXPRESSION; INHIBITORS; RESPONSES; NS5B	Background/Aims: Ribavirin significantly enhances the antiviral response of interferon-alpha (IFN-alpha) against Hepatitis C virus (HCV), but the underlying mechanisms remain poorly understood. Recently, p53 has been identified as an important factor involving the suppression of HCV replication in hepatocytes. We, therefore, decided to investigate whether and how ribavirin inhibits the replication of HCV by promoting the activity of p53. Methods: HepG2 and HCV replicons (JFH1/HepG2) were utilized to study the relationship between ribavirin and p53. The effect of ribavirin on cell cycles was analyzed by flow cytometry. The activation of p53 and the signaling pathways were determined using immunoblotting. By knocking down ERK1/ERK2 and p53 utilizing RNA interference strategy, we further assessed the role of ERK1/2 and p53 in the suppression of HCV replication by ribavirin in a HCV replicon system. Results: Using HepG2 and HCV replicons, we demonstrated that ribavirin caused the cell cycle arrest at G1 phase and stabilized and activated p53, which was associated with the antiviral activity of ribavirin. Compared to either ribavirin or IFN-alpha alone, ribavirin plus IFN-alpha resulted in greater p53 activation and HCV suppression. We further identified ERK1/2 that linked ribavirin signals to p53 activation. More importantly, knockdown of ERK1/2 and p53 partially mitigated the inhibitory effects of ribavirin on the HCV replication, indicating that ERK1/2-p53 pathway was involved in the anti-HCV effects of ribavirin. Conclusion: Ribavirin stimulates ERK1/2 and subsequently promotes p53 activity which at least partly contributes to the enhanced antiviral response of IFN-alpha plus ribavirin against HCV.	[Liu, Wei-Liang; Su, Wen-Cheng; Wang, Chih-Chiang; Wang, Hurng-Yi; Huang, Wen-Hung; Chen, Ding-Shinn; Lai, Ming-Yang] Natl Taiwan Univ, Coll Med & Hosp, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Wei-Liang; Su, Wen-Cheng; Wang, Chih-Chiang; Wang, Hurng-Yi; Huang, Wen-Hung; Chen, Ding-Shinn; Lai, Ming-Yang] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Taipei 10764, Taiwan; [Yang, Hung-Chih] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Chen, Hui-Ling; Chen, Ding-Shinn; Lai, Ming-Yang] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Liu, WL (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Grad Inst Clin Med, Taipei 10764, Taiwan.	hcyang88@ntu.edu.tw; mylai@ntu.edu.tw	CHEN, DING-SHINN/T-4395-2019	Chen, Hui-Ling/0000-0002-2572-0595; LIU, WEI-LIANG/0000-0002-1159-1286; CHEN, DING-SHINN/0000-0001-7791-6154; WANG, HURNG-YI/0000-0003-1708-8734; YANG, HUNG-CHIH/0000-0003-3864-9895	National Science Council [NSC-97-2314-B-002-147-MY3]; Department of Health of the Executive Yuan in Taiwan [DOH95-DC-1002]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health of the Executive Yuan in Taiwan	This research was supported by grants from the National Science Council (NSC-97-2314-B-002-147-MY3) and Department of Health of the Executive Yuan in Taiwan (DOH95-DC-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Corouge M, 2011, MED MALADIES INFECT, V41, P579, DOI 10.1016/j.medmal.2011.04.003; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Lutchman G, 2007, GASTROENTEROLOGY, V132, P1757, DOI 10.1053/j.gastro.2007.03.035; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MALINOSKI F, 1981, VIROLOGY, V110, P281, DOI 10.1016/0042-6822(81)90060-X; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Ning Q, 1998, J IMMUNOL, V160, P3487; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Reyes G R, 2001, Curr Opin Drug Discov Devel, V4, P651; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Su WC, 2009, FEBS LETT, V583, P2793, DOI 10.1016/j.febslet.2009.07.027; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Vo NV, 2003, BIOCHEMISTRY-US, V42, P10462, DOI 10.1021/bi0344681; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Yalowitz JA, 2000, ANTICANCER RES, V20, P2329; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	44	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e43824	10.1371/journal.pone.0043824	http://dx.doi.org/10.1371/journal.pone.0043824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962590	Green Published, gold, Green Submitted			2022-12-27	WOS:000308577600018
J	Quirie, A; Hervieu, M; Garnier, P; Demougeot, C; Mossiat, C; Bertrand, N; Martin, A; Marie, C; Prigent-Tessier, A				Quirie, Aurore; Hervieu, Marie; Garnier, Philippe; Demougeot, Celine; Mossiat, Claude; Bertrand, Nathalie; Martin, Alain; Marie, Christine; Prigent-Tessier, Anne			Comparative Effect of Treadmill Exercise on Mature BDNF Production in Control versus Stroke Rats	PLOS ONE			English	Article							FOCAL BRAIN ISCHEMIA; NEUROTROPHIC FACTOR; BEHAVIORAL RECOVERY; HIPPOCAMPAL PLASTICITY; AXONAL-TRANSPORT; CONTROLLED-TRIAL; MOTOR RECOVERY; EXPRESSION; CORTEX; TRKB	Physical exercise constitutes an innovative strategy to treat deficits associated with stroke through the promotion of BDNF-dependent neuroplasticity. However, there is no consensus on the optimal intensity/duration of exercise. In addition, whether previous stroke changes the effect of exercise on the brain is not known. Therefore, the present study compared the effects of a clinically-relevant form of exercise on cerebral BDNF levels and localization in control versus stroke rats. For this purpose, treadmill exercise (0.3 m/s, 30 min/day, for 7 consecutive days) was started in rats with a cortical ischemic stroke after complete maturation of the lesion or in control rats. Sedentary rats were run in parallel. Mature and proBDNF levels were measured on the day following the last boot of exercise using Western blotting analysis. Total BDNF levels were simultaneously measured using ELISA tests. As compared to the striatum and the hippocampus, the cortex was the most responsive region to exercise. In this region, exercise resulted in a comparable increase in the production of mature BDNF in intact and stroke rats but increased proBDNF levels only in intact rats. Importantly, levels of mature BDNF and synaptophysin were strongly correlated. These changes in BDNF metabolism coincided with the appearance of intense BDNF labeling in the endothelium of cortical vessels. Notably, ELISA tests failed to detect changes in BDNF forms. Our results suggest that control beings can be used to find conditions of exercise that will result in increased mBDNF levels in stroke beings. They also suggest cerebral endothelium as a potential source of BDNF after exercise and highlight the importance to specifically measure the mature form of BDNF to assess BDNF-dependent plasticity in relation with exercise.	[Quirie, Aurore; Hervieu, Marie; Garnier, Philippe; Mossiat, Claude; Martin, Alain; Marie, Christine; Prigent-Tessier, Anne] INSERM, U1093, Unite Cognit Act & Plasticite Sensorimotrice, Dijon, France; [Quirie, Aurore; Garnier, Philippe; Mossiat, Claude; Bertrand, Nathalie; Martin, Alain; Marie, Christine; Prigent-Tessier, Anne] Univ Bourgogne, Dijon, France; [Hervieu, Marie] Univ Hosp, Dept Neurol, Dijon, France; [Demougeot, Celine] Fac Med Pharm, EA Fonct & Dysfonct Epitheliales 4267, Besancon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne	Quirie, A (corresponding author), INSERM, U1093, Unite Cognit Act & Plasticite Sensorimotrice, Dijon, France.	anne.tessier@u-bourgogne.fr	QUIRIE, Aurore/AAZ-4875-2021	QUIRIE, Aurore/0000-0002-8926-1834; Demougeot, Celine/0000-0003-0639-9756; Garnier, Philippe/0000-0002-7877-3113; marie, christine/0000-0003-3724-0713; tessier, anne/0000-0001-6655-5074	Conseil Regional de Bourgogne, France; INSERM	Conseil Regional de Bourgogne, France(Region Bourgogne-Franche-Comte); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the Conseil Regional de Bourgogne, France and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Chang HC, 2009, BEHAV BRAIN RES, V205, P450, DOI 10.1016/j.bbr.2009.07.033; CLARKE KA, 1986, PHYSIOL BEHAV, V38, P345, DOI 10.1016/0031-9384(86)90105-8; COMELLI MC, 1993, NEUROSCIENCE, V55, P473, DOI 10.1016/0306-4522(93)90517-J; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Luft AR, 2008, STROKE, V39, P3341, DOI 10.1161/STROKEAHA.108.527531; Macias M, 2007, EUR J NEUROSCI, V25, P2425, DOI 10.1111/j.1460-9568.2007.05498.x; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Matsuda F, 2011, ACTA PHYSIOL, V201, P275, DOI [10.1111/j.1748-1716.2010.02174.x, 10.1111/j.1748-1708.2010.02174.x]; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; Sartori CR, 2011, NEUROSCIENCE, V180, P9, DOI 10.1016/j.neuroscience.2011.02.055; Sartori CR, 2009, BEHAV BRAIN RES, V203, P165, DOI 10.1016/j.bbr.2009.04.022; Shanina EV, 2006, NEUROSCIENCE, V139, P1495, DOI 10.1016/j.neuroscience.2006.01.016; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Sulejczak D, 2007, J NEUROTRAUM, V24, P1362, DOI 10.1089/neu.2006.0261; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Yang YR, 2003, NEUROSCI LETT, V339, P91, DOI 10.1016/S0304-3940(03)00010-7; Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533	43	62	64	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44218	10.1371/journal.pone.0044218	http://dx.doi.org/10.1371/journal.pone.0044218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22962604	gold, Green Submitted, Green Published			2022-12-27	WOS:000308577600032
J	Rau, TF; Lu, Q; Sharma, S; Sun, XT; Leary, G; Beckman, ML; Hou, YL; Wainwright, MS; Kavanaugh, M; Poulsen, DJ; Black, SM				Rau, Thomas F.; Lu, Qing; Sharma, Shruti; Sun, Xutong; Leary, Gregory; Beckman, Matthew L.; Hou, Yali; Wainwright, Mark S.; Kavanaugh, Michael; Poulsen, David J.; Black, Stephen M.			Oxygen Glucose Deprivation in Rat Hippocampal Slice Cultures Results in Alterations in Carnitine Homeostasis and Mitochondrial Dysfunction	PLOS ONE			English	Article							ACETYL-L-CARNITINE; OLD RATS; PULMONARY-HYPERTENSION; OXIDATIVE STRESS; ENERGY DEPLETION; NEURONAL DEATH; BRAIN-INJURY; LIPOIC ACID; ISCHEMIA; DECAY	Mitochondrial dysfunction characterized by depolarization of mitochondrial membranes and the initiation of mitochondrial-mediated apoptosis are pathological responses to hypoxia-ischemia (HI) in the neonatal brain. Carnitine metabolism directly supports mitochondrial metabolism by shuttling long chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Our previous studies have shown that HI disrupts carnitine homeostasis in neonatal rats and that L-carnitine can be neuroprotective. Thus, this study was undertaken to elucidate the molecular mechanisms by which HI alters carnitine metabolism and to begin to elucidate the mechanism underlying the neuroprotective effect of L-carnitine (LCAR) supplementation. Utilizing neonatal rat hippocampal slice cultures we found that oxygen glucose deprivation (OGD) decreased the levels of free carnitines (FC) and increased the acylcarnitine (AC): FC ratio. These changes in carnitine homeostasis correlated with decreases in the protein levels of carnitine palmitoyl transferase (CPT) 1 and 2. LCAR supplementation prevented the decrease in CPT1 and CPT2, enhanced both FC and the AC: FC ratio and increased slice culture metabolic viability, the mitochondrial membrane potential prior to OGD and prevented the subsequent loss of neurons during later stages of reperfusion through a reduction in apoptotic cell death. Finally, we found that LCAR supplementation preserved the structural integrity and synaptic transmission within the hippocampus after OGD. Thus, we conclude that LCAR supplementation preserves the key enzymes responsible for maintaining carnitine homeostasis and preserves both cell viability and synaptic transmission after OGD.	[Rau, Thomas F.; Leary, Gregory; Beckman, Matthew L.; Kavanaugh, Michael; Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Lu, Qing; Sharma, Shruti; Sun, Xutong; Hou, Yali; Black, Stephen M.] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Wainwright, Mark S.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	University of Montana System; University of Montana; University System of Georgia; Augusta University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Rau, TF (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	david.poulsen@umontana.edu; sblack@georgiahealth.edu		Sharma, Shruti/0000-0001-8200-108X; Verma, Vipin/0000-0002-3296-5494	United States National Institutes of Health [HD039110, HL60190, HL67841, HL084739, HD057406]; Fondation LeDucq; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039110, R21HD057406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067841, R01HL084739, R01HL060190] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation LeDucq(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HD039110 (SMB), HL60190 (SMB), HL67841 (SMB), HL084739 (SMB), and HD057406 (SMB) all from the United States National Institutes of Health and by a grant from the Fondation LeDucq (SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2006, CLIN EXP PHARMACOL P, V33, P725, DOI 10.1111/j.1440-1681.2006.04425.x; Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; Ames BN, 1998, TOXICOL LETT, V103, P5, DOI 10.1016/S0378-4274(98)00282-3; Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; Ames BN, 2004, ARCH BIOCHEM BIOPHYS, V423, P227, DOI 10.1016/j.abb.2003.11.002; Ames BN, 2003, J NUTR, V133, p1544S, DOI 10.1093/jn/133.5.1544S; Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; Budd SL, 1998, PHARMACOL THERAPEUT, V80, P203, DOI 10.1016/S0163-7258(98)00029-1; Burda J, 2009, CELL MOL NEUROBIOL, V29, P821, DOI 10.1007/s10571-009-9363-9; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; Domorakova I, 2009, CELL MOL NEUROBIOL, V29, P837, DOI 10.1007/s10571-009-9365-7; Dutta A, 2009, INT J BIOMETEOROL, V53, P397, DOI 10.1007/s00484-009-0224-5; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; HOSHIDA S, 1993, AM J PHYSIOL, V264, pH33, DOI 10.1152/ajpheart.1993.264.1.H33; Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1; HOSHIDA S, 1993, HEART VESSELS, V8, P115, DOI 10.1007/BF01744795; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Hwang YC, 2002, CORONARY ARTERY DIS, V13, P313, DOI 10.1097/00019501-200209000-00002; Kim JH, 2007, NEUROSCI LETT, V411, P56, DOI 10.1016/j.neulet.2006.10.004; Kim JH, 2006, NEUROSCI LETT, V400, P1, DOI 10.1016/j.neulet.2006.01.035; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Long JG, 2009, NEUROCHEM RES, V34, P755, DOI 10.1007/s11064-008-9850-2; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Nabetani M, 1997, BRAIN RES, V769, P158, DOI 10.1016/S0006-8993(97)00819-6; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Pogatsa G, 2001, CORONARY ARTERY DIS, V12, pS29; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Singh N, 2012, CELL MOL NEUROBIOL; SOMJEN GG, 1993, RES P ARNMD, V71, P51; Stubbs M, 2010, ADV ENZYME REGUL, V50, P44, DOI 10.1016/j.advenzreg.2009.10.027; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; VALLEE L, 1994, EUR J PEDIATR, V153, P598, DOI 10.1007/BF02190669; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	45	70	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e40881	10.1371/journal.pone.0040881	http://dx.doi.org/10.1371/journal.pone.0040881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	23112863	gold, Green Published, Green Submitted			2022-12-27	WOS:000308638700001
J	Li, WD; Zhou, Y; Tian, XL; Kim, TY; Ito, N; Watanabe, K; Tsuji, A; Niimi, K; Aoyama, Y; Arai, T; Takahashi, E				Li, Weidong; Zhou, Ying; Tian, Xiaoli; Kim, Tae Yeon; Ito, Namiko; Watanabe, Kaori; Tsuji, Akiko; Niimi, Kimie; Aoyama, Yo; Arai, Takashi; Takahashi, Eiki			New Ataxic Tottering-6j Mouse Allele Containing a Cacna1a Gene Mutation	PLOS ONE			English	Article							DEPENDENT CALCIUM-CHANNEL; CORTICAL SPREADING DEPRESSION; GATED CA2+ CHANNELS; NEUROTRANSMITTER RELEASE; MISSENSE MUTATION; ROLLING-NAGOYA; PURKINJE-CELLS; MUTANT MOUSE; MICE; DYSFUNCTION	Voltage-gated Ca2+ (Ca-v) channels control neuronal functions including neurotransmitter release and gene expression. The Cacna1a gene encodes the alpha 1 subunit of the pore-forming Ca(v)2.1 channel. Mice with mutations in this gene form useful tools for defining channel functions. The recessive ataxic tottering-6j strain that was generated in the Neuroscience Mutagenesis Facility at The Jackson Laboratory has a mutation in the Cacna1a gene. However, the effect of this mutation has not been investigated in detail. In this study, mutation analysis shows a base substitution (C-to-A) in the consensus splice acceptor sequence linked to exon 5, which results in the skipping of exon 5 and the splicing of exon 4 directly to exon 6. The effect of this mutation is expected to be severe as the expressed alpha 1 subunit protein lacks a significant part of the S4-S5 linker, S5, and part of S5-S6 linker in domain I. Tottering-6j mice display motor dysfunctions in the footprint, rotating rod, and hind-limb extension tests. Although cytoarchitecture of the mutant brains appears normal, tyrosine hydroxylase was persistently expressed in cerebellar Purkinje cells in the adult mutant mice. These results indicate that tottering-6j is a useful model for functional studies of the Ca(v)2.1 channel.	[Li, Weidong; Zhou, Ying; Takahashi, Eiki] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Tian, Xiaoli] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Kim, Tae Yeon; Ito, Namiko; Watanabe, Kaori; Tsuji, Akiko; Niimi, Kimie; Aoyama, Yo; Arai, Takashi; Takahashi, Eiki] RIKEN Brain Sci Inst, Res Resources Ctr, Saitama, Japan	Shanghai Jiao Tong University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN	Li, WD (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	liwd@sjtu.edu.cn; etakahashi@brain.riken.jp	Niimi, Kimie/S-8264-2019; Takahashi, Eiki/N-6998-2015	Niimi, Kimie/0000-0001-5240-5745; Dubnau, Josh/0000-0002-9285-7444; Hammell, Molly/0000-0003-0405-8392; Li, Weidong/0000-0001-5384-4838	KAKENHI [22500396]; China 973 Program [2010CB529604]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); China 973 Program(National Basic Research Program of China)	This work was supported by Grants-in-Aid for Scientific Research KAKENHI (22500396) to ET and China 973 Program (2010CB529604) to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN MC, 1992, MOL BRAIN RES, V15, P227, DOI 10.1016/0169-328X(92)90113-P; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Day NC, 1997, J NEUROSCI, V17, P6226; Fletcher CF, 2001, FASEB J, V15, P1288, DOI 10.1096/fj.00-0562fje; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FU XD, 1995, RNA, V1, P663; Jaworski DM, 2006, J NEUROBIOL, V66, P82, DOI 10.1002/neu.20205; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; Liu L, 2003, J BIOENERG BIOMEMBR, V35, P671, DOI 10.1023/B:JOBB.0000008031.12485.ee; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Miki T, 2008, NEUROSCIENCE, V155, P31, DOI 10.1016/j.neuroscience.2008.05.028; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Mori Y, 2000, J NEUROSCI, V20, P5654, DOI 10.1523/JNEUROSCI.20-15-05654.2000; MURAMOTO O, 1981, BRAIN RES, V215, P295, DOI 10.1016/0006-8993(81)90508-4; Niimi K, 2009, PHYSIOL BEHAV, V96, P464, DOI 10.1016/j.physbeh.2008.11.012; Oda S, 1973, Jikken Dobutsu, V22, P281; Ogura H, 2001, BEHAV BRAIN RES, V122, P215, DOI 10.1016/S0166-4328(01)00187-5; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Rhyu IJ, 1999, NEUROSCIENCE, V90, P717, DOI 10.1016/S0306-4522(98)00518-1; Rhyu IJ, 1999, NEUROSCI LETT, V266, P49, DOI 10.1016/S0304-3940(99)00254-2; Takahashi E., 2012, CALCIUM SIGNALING, P149; Takahashi E, 2009, BRAIN RES, V1279, P50, DOI 10.1016/j.brainres.2009.05.016; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tokuda S, 2007, BRAIN RES, V1133, P168, DOI 10.1016/j.brainres.2006.10.086; Van Damme P, 2003, NEUROSCI LETT, V343, P81, DOI 10.1016/S0304-3940(03)00314-8; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Xie G, 2007, GENES BRAIN BEHAV, V6, P717, DOI 10.1111/j.1601-183X.2007.00302.x; Zwingman TA, 2001, J NEUROSCI, V21, P1169	38	85	87	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e44230	10.1371/journal.pone.0044230	http://dx.doi.org/10.1371/journal.pone.0044230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	22952933	Green Published, Green Submitted, gold			2022-12-27	WOS:000308221300065
J	Wu, B; Miao, YF; Bai, YR; Ye, M; Xu, YJ; Chen, HF; Shen, JF; Qiu, YM				Wu, Bin; Miao, Yifeng; Bai, Yongrui; Ye, Min; Xu, Yuejuan; Chen, Huafeng; Shen, Jinfang; Qiu, Yongming			Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; COST-EFFECTIVENESS; MALIGNANT GLIOMAS; RADIOTHERAPY; THERAPY; CHEMOTHERAPY; MULTIFORME; BEVACIZUMAB	Background: The aim of this research was to evaluate the economic outcomes of radiotherapy (RT), temozolomide (TMZ) and nitrosourea (NT) strategies for glioblastoma patients with different prognostic factors. Methodology/Principal Findings: A Markov model was developed to track monthly patient transitions. Transition probabilities and utilities were derived primarily from published reports. Costs were estimated from the perspective of the Chinese healthcare system. The survival data with different prognostic factors were simulated using Weibull survival models. Costs over a 5-year period and quality-adjusted life years (QALYs) were estimated. Probabilistic sensitivity and one-way analyses were performed. The baseline analysis in the overall cohort showed that the TMZ strategy increased the cost and QALY relative to the RT strategy by $ 25,328.4 and 0.29, respectively; and the TMZ strategy increased the cost and QALY relative to the NT strategy by $ 23,906.5 and 0.25, respectively. Therefore, the incremental cost effectiveness ratio (ICER) per additional QALY of the TMZ strategy, relative to the RT strategy and the NT strategy, amounts to $ 87,940.6 and $ 94,968.3, respectively. Subgroups with more favorable prognostic factors achieved more health benefits with improved ICERs. Probabilistic sensitivity analyses confirmed that the TMZ strategy was not cost-effective. In general, the results were most sensitive to the cost of TMZ, which indicates that better outcomes could be achieved by decreasing the cost of TMZ. Conclusions/Significance: In health resource-limited settings, TMZ is not a cost-effective option for glioblastoma patients. Selecting patients with more favorable prognostic factors increases the likelihood of cost-effectiveness.	[Wu, Bin; Chen, Huafeng; Shen, Jinfang] Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Clin Outcomes & Econ Grp,Renji Hosp, Shanghai 200030, Peoples R China; [Miao, Yifeng] Nanjing Med Univ, Wuxi Peoples Hosp 2, Ctr Neurosci, Shanghai, Peoples R China; [Bai, Yongrui] Shanghai Jiao Tong Univ, Sch Med, Dept Radiotherapy, Renji Hosp, Shanghai 200030, Peoples R China; [Ye, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Renji Hosp, Shanghai 200030, Peoples R China; [Xu, Yuejuan] South East Univ, Sch Med, Dept Oncol, Hosp Nanjing 2, Nanjing, Jiangsu, Peoples R China; [Qiu, Yongming] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Southeast University - China; Shanghai Jiao Tong University	Wu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Clin Outcomes & Econ Grp,Renji Hosp, Shanghai 200030, Peoples R China.	qiuzhoub@sina.com	Ma, Yimian/AAD-8777-2019	Ma, Yimian/0000-0003-2466-7697; Yuan, lichai/0000-0002-6413-8848	project of building hospital clinical key disciplines [RJ.4101307]; Shanghai government [0952nm03900]	project of building hospital clinical key disciplines; Shanghai government	This work was supported by a project of building hospital clinical key disciplines (NO. RJ.4101307) and a grant from Shanghai government (NO. 0952nm03900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Aoki T, 2006, J NEUROSURG, V105, P385, DOI 10.3171/jns.2006.105.3.385; Chamberlain M, 2011, EXPERT REV NEUROTHER, V11, P519, DOI [10.1586/ERN.11.30, 10.1586/ern.11.30]; Chamberlain MC, 2010, J NEURO-ONCOL, V96, P259, DOI 10.1007/s11060-009-9957-6; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Garside R, 2007, Health Technol Assess, V11, piii; Garside R, 2007, HEALTH TECHNOL ASSES, V11, P221; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hu Y M, 1999, Sheng Li Xue Bao, V51, P45; Lamers LM, 2008, CANCER-AM CANCER SOC, V112, P1337, DOI 10.1002/cncr.23297; Mangiola A, 2010, EXPERT REV NEUROTHER, V10, P507, DOI [10.1586/ern.09.158, 10.1586/ERN.09.158]; Mason WP, 2005, NAT CLIN PRACT NEURO, V1, P88, DOI 10.1038/ncpneuro0045; Moen MD, 2010, DRUGS, V70, P181, DOI 10.2165/11203890-000000000-00000; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Nishikawa R, 2010, NEUROL MED-CHIR, V50, P713, DOI 10.2176/nmc.50.713; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Schmidt F, 2006, NEUROLOGY, V66, P587, DOI 10.1212/01.wnl.0000197792.73656.c2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uyl-de Groot Carin A, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P235, DOI 10.1586/erp.09.15; Vordermark D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-247; Wasserfallen JB, 2005, NEURO-ONCOLOGY, V7, P189, DOI 10.1215/S1152851704000687; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5	24	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34588	10.1371/journal.pone.0034588	http://dx.doi.org/10.1371/journal.pone.0034588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511951	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600037
J	Jun, HJ; Kim, J; Hoang, MH; Lee, SJ				Jun, Hee-Jin; Kim, Jinyoung; Hoang, Minh-Hien; Lee, Sung-Joon			Hepatic Lipid Accumulation Alters Global Histone H3 Lysine 9 and 4 Trimethylation in the Peroxisome Proliferator-Activated Receptor Alpha Network	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GENE-EXPRESSION; ACID OXIDATION; CARDIOVASCULAR-DISEASE; HUMAN HEPATOCYTE; CELL-LINES; METABOLISM; METHYLATION; CANCER; MICE	Recent data suggest that the etiology of several metabolic diseases is closely associated with transcriptome alteration by aberrant histone methylation. We performed DNA microarray and ChIP-on-chip analyses to examine transcriptome profiling and trimethylation alterations to identify the genomic signature of nonalcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. Transcriptome analysis showed that steatotic livers in high-fat diet-fed apolipoprotein E2 mice significantly altered the expression of approximately 70% of total genes compared with normal diet-fed control livers, suggesting that hepatic lipid accumulation induces dramatic alterations in gene expression in vivo. Also, pathway analysis suggested that genes encoding chromatin-remodeling enzymes, such as jumonji C-domain-containing histone demethylases that regulate histone H3K9 and H3K4 trimethylation (H3K9me3, H3K4me3), were significantly altered in steatotic livers. Thus, we further investigated the global H3K9me3 and H3K4me3 status in lipid-accumulated mouse primary hepatocytes by ChIP-on-chip analysis. Results showed that hepatic lipid accumulation induced aberrant H3K9me3 and H3K4me3 status in peroxisome proliferator-activated receptor alpha and hepatic lipid catabolism network genes, reducing their mRNA expression compared with non-treated control hepatocytes. This study provides the first evidence that epigenetic regulation by H3K9me3 and H3K4me3 in hepatocytes may be involved in hepatic steatosis and the pathogenesis of NAFLD. Thus, control of H3K9me3 and H3K4me3 represents a potential novel NAFLD prevention and treatment strategy.	[Jun, Hee-Jin; Kim, Jinyoung; Hoang, Minh-Hien; Lee, Sung-Joon] Korea Univ, Dept Biotechnol, Grad Sch Life Sci & Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Korea University	Jun, HJ (corresponding author), Korea Univ, Dept Biotechnol, Grad Sch Life Sci & Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea.	junelee@korea.ac.kr	Lee, Sung-Joon/F-2435-2013		Technology Development Program for Fisheries of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (iPET) [F20926409H220000110]; Basic Science Research Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20100028180]	Technology Development Program for Fisheries of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (iPET)(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Basic Science Research Program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Technology Development Program for Fisheries of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (iPET, F20926409H220000110), and the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (20100028180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Al-Adsani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013650; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Assy N, 2000, DIGEST DIS SCI, V45, P1929, DOI 10.1023/A:1005661516165; Boess F, 2003, TOXICOL SCI, V73, P386, DOI 10.1093/toxsci/kfg064; Casciano DA, 2000, DRUG METAB REV, V32, P1, DOI 10.1081/DMR-100100561; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Larter CZ, 2011, J GASTROENTEROL HEPA; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Marz W, 1993, TRANSPLANTATION, V55, P2848; MASLANSKY CJ, 1982, IN VITRO CELL DEV B, V18, P683; Nakamuta M, 2008, INT J MOL MED, V22, P663, DOI 10.3892/ijmm_00000070; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Preiss D, 2008, CLIN SCI, V115, P141, DOI 10.1042/CS20070402; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	40	33	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44345	10.1371/journal.pone.0044345	http://dx.doi.org/10.1371/journal.pone.0044345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973438	Green Submitted, Green Published, gold			2022-12-27	WOS:000308577600040
J	Tian, DL; Peiffer, M; Shoemaker, E; Tooker, J; Haubruge, E; Francis, F; Luthe, DS; Felton, GW				Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Haubruge, Eric; Francis, Frederic; Luthe, Dawn S.; Felton, Gary W.			Salivary Glucose Oxidase from Caterpillars Mediates the Induction of Rapid and Delayed-Induced Defenses in the Tomato Plant	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TRANSCRIPTIONAL RESPONSES; HELICOVERPA-ARMIGERA; GLANDULAR TRICHOMES; GENE-EXPRESSION; HOST-PLANT; CROSS-TALK; ARMS-RACE; JASMONATE; HERBIVORY	Caterpillars produce oral secretions that may serve as cues to elicit plant defenses, but in other cases these secretions have been shown to suppress plant defenses. Ongoing work in our laboratory has focused on the salivary secretions of the tomato fruitworm, Helicoverpa zea. In previous studies we have shown that saliva and its principal component glucose oxidase acts as an effector by suppressing defenses in tobacco. In this current study, we report that saliva elicits a burst of jasmonic acid (JA) and the induction of late responding defense genes such as proteinase inhibitor 2 (Pin2). Transcripts encoding early response genes associated with the JA pathway were not affected by saliva. We also observed a delayed response to saliva with increased densities of Type VI glandular trichomes in newly emerged leaves. Proteomic analysis of saliva revealed glucose oxidase (GOX) was the most abundant protein identified and we confirmed that it plays a primary role in the induction of defenses in tomato. These results suggest that the recognition of GOX in tomato may represent a case for effector-triggered immunity. Examination of saliva from other caterpillar species indicates that saliva from the noctuids Spodoptera exigua and Heliothis virescens also induced Pin2 transcripts.	[Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Luthe, Dawn S.; Felton, Gary W.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Haubruge, Eric; Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Liege, Belgium; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, Ctr Chem Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tian, DL (corresponding author), Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA.	gwf10@psu.edu	Felton, Gary W./E-8575-2013; Tooker, John/P-6421-2014; Han, Xingguo/K-7552-2016	Tooker, John/0000-0002-9303-6699; Haubruge, Eric/0000-0002-8138-0476; Han, Xingguo/0000-0002-1836-975X	United States Department of Agriculture and Food Research Initiative program [2010-65105-20639, 2011-67013-30352]	United States Department of Agriculture and Food Research Initiative program	Support by the United States Department of Agriculture and Food Research Initiative program (2010-65105-20639 and 2011-67013-30352) awarded to GWF and DSL made this research possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bassel GW, 2004, PLANT PHYSIOL, V136, P2782, DOI 10.1104/pp.103.034876; Bede JC, 2006, PLANT MOL BIOL, V60, P519, DOI 10.1007/s11103-005-4923-y; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Campos ML, 2009, J EXP BOT, V60, P4346, DOI 10.1093/jxb/erp270; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung SH, 2011, J CHEM ECOL, V37, P378, DOI 10.1007/s10886-011-9937-0; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Dalin P, 2003, OECOLOGIA, V134, P112, DOI 10.1007/s00442-002-1093-3; Delphia CM, 2006, PLANT SIGNAL BEHAV, V1, P243, DOI 10.4161/psb.1.5.3279; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Diez-Diaz M, 2004, PHYTOCHEMISTRY, V65, P1919, DOI 10.1016/j.phytochem.2004.06.007; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2002, J INSECT PHYSIOL, V48, P311, DOI 10.1016/S0022-1910(01)00178-0; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Felton Gary W., 2008, P369, DOI 10.1007/978-1-4020-8182-8_18; Felton GW, 2005, P NATL ACAD SCI USA, V102, P18771, DOI 10.1073/pnas.0509895102; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; FELTON GW, 1993, J CHEM ECOL, V19, P1553, DOI 10.1007/BF00984896; FELTON GW, 1992, J CHEM ECOL, V18, P571, DOI 10.1007/BF00987820; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gurr GM, 2002, ENTOMOL EXP APPL, V103, P35, DOI 10.1023/A:1019819722203; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Howe G-A, 1996, PLANT CELL; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Jia YL, 1999, PLANT MOL BIOL, V40, P455, DOI 10.1023/A:1006213324555; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Lawrence SD, 2007, J CHEM ECOL, V33, P1041, DOI 10.1007/s10886-007-9285-2; Leitner M, 2005, NEW PHYTOL, V167, P597, DOI 10.1111/j.1469-8137.2005.01426.x; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; LIGHTNER J, 1993, MOL GEN GENET, V241, P595, DOI 10.1007/BF00279902; Lin L, 2008, J CHEM ECOL, V34, P353, DOI 10.1007/s10886-008-9439-x; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mori N, 2001, J INSECT PHYSIOL, V47, P749, DOI 10.1016/S0022-1910(00)00171-2; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Narvaez-Vasquez J, 2004, PLANTA, V218, P360, DOI 10.1007/s00425-003-1115-3; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Orozco-Cardenas ML, 2002, PLANT PHYSIOL, V130, P487, DOI 10.1104/pp.008375; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; Peiffer M, 2005, ARCH INSECT BIOCHEM, V58, P106, DOI 10.1002/arch.20034; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Qu N, 2004, PLANT PHYSIOL, V135, P539, DOI 10.1104/pp.103.037036; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sagi M, 2004, PLANT CELL, V16, P616, DOI 10.1105/tpc.019398; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Schmidt DD, 2005, PLANT PHYSIOL, V138, P1763, DOI 10.1104/pp.105.061192; Simmons AT, 2004, AUST J ENTOMOL, V43, P196, DOI 10.1111/j.1440-6055.2004.00414.x; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thaler J-S, 2001, ECOLOGICAL ENTOMOLOG; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Tooker JF, 2005, J CHEM ECOL, V31, P2753, DOI 10.1007/s10886-005-8553-2; Traw MB, 2002, OECOLOGIA, V131, P526, DOI 10.1007/s00442-002-0924-6; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Victoriano E, 2002, ARTHROPOD STRUCT DEV, V31, P15, DOI 10.1016/S1467-8039(02)00013-0; VINCENT R, 1983, ANAL BIOCHEM, V135, P355, DOI 10.1016/0003-2697(83)90696-6; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Yoshinaga N, 2007, J CHEM ECOL, V33, P1376, DOI 10.1007/s10886-007-9321-2	93	96	107	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36168	10.1371/journal.pone.0036168	http://dx.doi.org/10.1371/journal.pone.0036168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558369	gold, Green Published			2022-12-27	WOS:000305340200046
J	Wu, JY; Wang, YH; Wang, GJ; Ho, ML; Wang, CZ; Yeh, ML; Chen, CH				Wu, Jyun-Yi; Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen; Yeh, Ming-Long; Chen, Chia-Hsin			Low-Power GaAlAs Laser Irradiation Promotes the Proliferation and Osteogenic Differentiation of Stem Cells via IGF1 and BMP2	PLOS ONE			English	Article							RAT CALVARIAL CELLS; BONE-MARROW; IN-VITRO; GENE-EXPRESSION; THERAPY; OSTEOBLASTS; OSTEOPOROSIS; TGF-BETA-1; CULTURE; ARREST	Low-power laser irradiation (LPLI) has been found to induce various biological effects and cellular processes. Also, LPLI has been shown to promote fracture repair. Until now, it has been unclear how LPLI promotes bone formation and fracture healing. The aim of this study was to investigate the potential mechanism of LPLI-mediated enhancement of bone formation using mouse bone marrow mesenchymal stem cells (D1 cells). D1 cells were irradiated daily with a gallium-aluminum-arsenide (GaAlAs) laser at dose of 0, 1, 2, or 4 J/cm(2). The lactate dehydrogenase (LDH) assay showed no cytotoxic effects of LPLI on D1 cells, and instead, LPLI at 4 J/cm(2) significantly promoted D1 cell proliferation. LPLI also enhanced osteogenic differentiation in a dose-dependent manner and moderately increased expression of osteogenic markers. The neutralization experiments indicated that LPLI regulated insulin-like growth factor 1 (IGF1) and bone morphogenetic protein 2 (BMP2) signaling to promote cell proliferation and/or osteogenic differentiation. In conclusion, our study suggests that LPLI may induce IGF1 expression to promote both the proliferation and osteogenic differentiation of D1 cells, whereas it may induce BMP2 expression primarily to enhance osteogenic differentiation.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Dept Orthopaed, Coll Med, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Dept Phys Med & Rehabil, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Virginia; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Wu, JY (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020; Wang, Yan-Hsiung/C-8792-2009; Zhu, Zhi/D-3721-2011	Wang, Yan-Hsiung/0000-0001-8161-7472; Zhu, Zhi/0000-0002-3287-4920; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Science Council [NSC 96-2221-E-006-259, NSC 96-2314-B-037-059]; National Health Research Institutes, Taiwan [NHRI-EX97-9615EP]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by two grants from the National Science Council (NSC 96-2221-E-006-259, NSC 96-2314-B-037-059) and a grant from the National Health Research Institutes (NHRI-EX97-9615EP) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9; Bouvet-Gerbettaz S, 2009, LASER SURG MED, V41, P291, DOI 10.1002/lsm.20759; Cen Shiqiang, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P84; Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0; Coombe A R, 2001, Clin Orthod Res, V4, P3, DOI 10.1034/j.1600-0544.2001.040102.x; Dahir GA, 2000, CLIN ORTHOP RELAT R, pS134; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Eduardo FD, 2008, LASER SURG MED, V40, P433, DOI 10.1002/lsm.20646; Fukuhara E, 2006, CALCIFIED TISSUE INT, V79, P443, DOI 10.1007/s00223-006-0072-9; Gal P, 2009, LASER MED SCI, V24, P539, DOI 10.1007/s10103-008-0604-9; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Horvat-Karajz K, 2009, LASER SURG MED, V41, P463, DOI 10.1002/lsm.20791; Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; IIJIMA K, 1989, CLIN J PAIN, V5, P271; Jin Dong-mei, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P55; Khadra M, 2005, BIOMATERIALS, V26, P3503, DOI 10.1016/j.biomaterials.2004.09.033; Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x; Mehler PS, 2009, INT J EAT DISORDER, V42, P195, DOI 10.1002/eat.20593; Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019; Mvula B, 2008, LASER MED SCI, V23, P277, DOI 10.1007/s10103-007-0479-1; Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011; Oliveira DAAP, 2008, PHOTOMED LASER SURG, V26, P401, DOI 10.1089/pho.2007.2101; Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; Schindl A, 2003, BRIT J DERMATOL, V148, P334, DOI 10.1046/j.1365-2133.2003.05070.x; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Stein E, 2008, WIEN KLIN WOCHENSCHR, V120, P112, DOI 10.1007/s00508-008-0932-6; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Taniguchi D, 2009, LASER SURG MED, V41, P232, DOI 10.1002/lsm.20750; Totosy de Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI 10.1682/JRRD.2008.09.0136; Tuby H, 2007, LASER SURG MED, V39, P373, DOI 10.1002/lsm.20492; Wang YH, 2009, MOL THER, V17, P302, DOI 10.1038/mt.2008.267; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Xu M, 2009, PHOTOMED LASER SURG, V27, P309, DOI 10.1089/pho.2008.2283	41	76	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44027	10.1371/journal.pone.0044027	http://dx.doi.org/10.1371/journal.pone.0044027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	23029506	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600024
J	Lee, HP; Pancholi, N; Esposito, L; Previll, LA; Wang, XL; Zhu, XW; Smith, MA; Lee, HG				Lee, Hyun-Pil; Pancholi, Neel; Esposito, Luke; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon			Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity	PLOS ONE			English	Article							LIPID-PEROXIDATION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PLAQUE-FORMATION; DNA-DAMAGE; IN-VIVO; REDUCTION; PATHOLOGY; PROTEINS; DYSFUNCTION	While oxidative stress has been linked to Alzheimer's disease, the underlying pathophysiological relationship is unclear. To examine this relationship, we induced oxidative stress through the genetic ablation of one copy of mitochondrial antioxidant superoxide dismutase 2 (Sod2) allele in mutant human amyloid precursor protein (hAPP) transgenic mice. The brains of young (5-7 months of age) and old (25-30 months of age) mice with the four genotypes, wild-type (Sod2(+/+)), hemizygous Sod2 (Sod2(+/-)), hAPP/wild-type (Sod2(+/+)), and hAPP/hemizygous (Sod2(+/-)) were examined to assess levels of oxidative stress markers 4-hydroxy-2-nonenal and heme oxygenase-1. Sod2 reduction in young hAPP mice resulted in significantly increased oxidative stress in the pyramidal neurons of the hippocampus. Interestingly, while differences resulting from hAPP expression or Sod2 reduction were not apparent in the neurons in old mice, oxidative stress was increased in astrocytes in old, but not young hAPP mice with either Sod2(+/+) or Sod2(+/-). Our study shows the specific changes in oxidative stress and the causal relationship with the pathological progression of these mice. These results suggest that the early neuronal susceptibility to oxidative stress in the hAPP/Sod2(+/-) mice may contribute to the pathological and behavioral changes seen in this animal model.	[Lee, Hyun-Pil; Pancholi, Neel; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Esposito, Luke] Univ Calif San Francisco, Dept Neurol & Neurosci, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA	Case Western Reserve University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lee, HP (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	hyoung-gon.lee@case.edu	Lee, Hyoung-gon/A-9637-2009; Meyer, Axel/C-9826-2009	Wang, Xinglong/0000-0001-8657-0159; Meyer, Axel/0000-0002-0888-8193; WU, LI-TZY/0000-0002-5909-2259; Oh, Yu-Kyoung/0000-0002-0969-3339; Previll, Laura/0000-0001-5541-8111	National Institutes of Health [AG028679]; Alzheimer's Association [NIRG-09-132727]; Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING [R01AG028679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the National Institutes of Health (AG028679 to Dr. Hyoung-gon Lee), the Alzheimer's Association (NIRG-09-132727 to Dr. Hyoung-gon Lee), and the Dr. Robert M. Kohrman Memorial Fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Omar Rawhi A., 1999, J Alzheimers Dis, V1, P139; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; SMITH MA, 1994, AM J PATHOL, V145, P42; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; STEELE ML, 2010, NEUROBIOL A IN PRESS; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	36	113	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28033	10.1371/journal.pone.0028033	http://dx.doi.org/10.1371/journal.pone.0028033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22970282	Green Submitted, Green Published, gold			2022-12-27	WOS:000301457200001
